<SEC-DOCUMENT>0001140361-21-006642.txt : 20210301
<SEC-HEADER>0001140361-21-006642.hdr.sgml : 20210301
<ACCEPTANCE-DATETIME>20210301161844
ACCESSION NUMBER:		0001140361-21-006642
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		90
CONFORMED PERIOD OF REPORT:	20201231
FILED AS OF DATE:		20210301
DATE AS OF CHANGE:		20210301

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			U S PHYSICAL THERAPY INC /NV
		CENTRAL INDEX KEY:			0000885978
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-HEALTH SERVICES [8000]
		IRS NUMBER:				760364866
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11151
		FILM NUMBER:		21698005

	BUSINESS ADDRESS:	
		STREET 1:		1300 WEST SAM HOUSTON PARKWAY
		STREET 2:		SUITE 300
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77043
		BUSINESS PHONE:		7132977000

	MAIL ADDRESS:	
		STREET 1:		1300 WEST SAM HOUSTON PARKWAY
		STREET 2:		SUITE 300
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77043
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>brhc10020853_10k.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:usph="http://usph.com/20201231" xmlns="http://www.w3.org/1999/xhtml">
<head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using EDGARfilings PROfile 7.3.2.0
         Copyright 1995 - 2021 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html" />
</head>
<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; background-color: #FFFFFF;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_f2da9d2421674ebe8d6c38534d4d877f" contextRef="c20200101to20201231">U S PHYSICAL THERAPY INC /NV</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_e45ab1e1281a419992201107edbe2d66" contextRef="c20200101to20201231">0000885978</ix:nonNumeric><ix:nonNumeric name="dei:CurrentFiscalYearEndDate" id="Fact_9738d431d7564b778d3953c83e90c37d" contextRef="c20200101to20201231" format="ixt:datemonthday">12-31</ix:nonNumeric><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_ef07dff40cb44c63bf4ee4594cac7983" contextRef="c20200101to20201231" format="ixt:booleanfalse">false</ix:nonNumeric><ix:nonNumeric name="dei:DocumentFiscalYearFocus" id="Fact_97b65cfe11054ae3a64529f51da52532" contextRef="c20200101to20201231">2020</ix:nonNumeric><ix:nonNumeric name="dei:DocumentFiscalPeriodFocus" id="Fact_7ca76cb7cf70452fa0f11d9f553f73c6" contextRef="c20200101to20201231">FY</ix:nonNumeric><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_555251a9a4f249158279069f9fa10a71" contextRef="c20200101to20201231">NV</ix:nonNumeric><ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_e48ef9b1762e421fa2a66cdc7e8e4662" contextRef="c20200101to20201231">TX</ix:nonNumeric><ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="Fact_82099ea63dd944a793bca0b3ef182707" contextRef="c20200101to20201231_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember_RangeAxis_MinimumMember">P3Y</ix:nonNumeric><ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="Fact_d794a755570f470987cd83402baa1e26" contextRef="c20200101to20201231_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember_RangeAxis_MinimumMember">P3Y</ix:nonNumeric><ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="Fact_c914f2e353b54597a7cd8a612b794874" contextRef="c20200101to20201231_PropertyPlantAndEquipmentByTypeAxis_ComputerSoftwareIntangibleAssetMember_RangeAxis_MinimumMember">P3Y</ix:nonNumeric><ix:nonNumeric name="usph:RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" id="Fact_74434238a9e847afae6e8bd50f9c3ecb" contextRef="c20200101to20201231_RangeAxis_MinimumMember">P3Y</ix:nonNumeric><ix:nonNumeric name="us-gaap:DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" id="Fact_d66bd8ac9de54f2492bfbf867e9180fc" contextRef="c20200101to20201231_TitleOfIndividualAxis_DirectorMember">P1Y</ix:nonNumeric><ix:nonNumeric name="us-gaap:DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" id="Fact_e171b1cb7c524fee994efb673b5c1ee0" contextRef="c20200101to20201231_TitleOfIndividualAxis_EmployeeMember">P4Y</ix:nonNumeric><ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_29c0aadade644e9a962b7bfbcb82c179" contextRef="c20200101to20201231_BusinessAcquisitionAxis_SeptemberTwoThousandTwentyAcquisitionMember" unitRef="U007" xsi:nil="true"></ix:nonFraction><ix:nonNumeric name="usph:TermOfEmploymentAgreement" id="Fact_52fb956c20c94f01b9b7ffcd0435f795" contextRef="c20200101to20201231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember_RangeAxis_MinimumMember">P3Y</ix:nonNumeric><ix:nonNumeric name="usph:NonCompeteAgreementBasicTerm" id="Fact_c128a6eff4b84ab0bfde32533264356c" contextRef="c20200101to20201231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember_RangeAxis_MinimumMember">P5Y</ix:nonNumeric><ix:nonNumeric name="us-gaap:IncomeTaxExaminationYearUnderExamination" id="Fact_c614eba92f724091923d077cce15bd38" contextRef="c20200101to20201231_IncomeTaxAuthorityAxis_ForeignCountryMember">2017 2018 2019</ix:nonNumeric><ix:nonNumeric name="us-gaap:IncomeTaxExaminationYearUnderExamination" id="Fact_a3d421d0c572494d8b850b77d069a61f" contextRef="c20200101to20201231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember">2016 2017 2018 2019</ix:nonNumeric><ix:nonNumeric name="usph:RestrictedPeriodToEmployeesOnTheStockGranted" id="Fact_5193d5e0f71242e78d0ec8f60c9b56d8" contextRef="c20200101to20201231_TitleOfIndividualAxis_EmployeesMember">P4Y</ix:nonNumeric><ix:nonNumeric name="usph:EmploymentAgreementsRetirementDate" id="Fact_07fa882becbb4980afaa1f4e941716d5" contextRef="c20200101to20201231">2021-08-31</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="usph-20201231.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c20200101to20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20190101to20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190101to20191231_ProductOrServiceAxis_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20180101to20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190101to20191231_ProductOrServiceAxis_NetPatientRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:NetPatientRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_ProductOrServiceAxis_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20180101to20181231_ProductOrServiceAxis_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20180101to20181231_ProductOrServiceAxis_NetPatientRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:NetPatientRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_ProductOrServiceAxis_NetPatientRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:NetPatientRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20171231_StatementEquityComponentsAxis_ParentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20171231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20171231_StatementEquityComponentsAxis_TreasuryStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20171231_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20171231_StatementEquityComponentsAxis_NoncontrollingInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20171231_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20180101to20181231_StatementEquityComponentsAxis_ParentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20180101to20181231_StatementEquityComponentsAxis_NoncontrollingInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190101to20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20180101to20181231_StatementEquityComponentsAxis_TreasuryStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190101to20191231_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20180101to20181231_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_StatementEquityComponentsAxis_ParentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190101to20191231_StatementEquityComponentsAxis_ParentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20180101to20181231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20180101to20181231_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190101to20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20191231_StatementEquityComponentsAxis_TreasuryStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20191231_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20181231_StatementEquityComponentsAxis_TreasuryStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20191231_StatementEquityComponentsAxis_ParentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20191231_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20181231_StatementEquityComponentsAxis_NoncontrollingInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20181231_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementEquityComponentsAxis_TreasuryStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20181231_StatementEquityComponentsAxis_ParentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20181231_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementEquityComponentsAxis_ParentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20181231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_RangeAxis_MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20201231_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20180831to20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:LeadingProviderOfIndustrialInjuryPreventionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20170331_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:LeadingProviderOfIndustrialInjuryPreventionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20180430_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:LeadingProviderOfIndustrialInjuryPreventionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20180430to20180430_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:LeadingProviderOfIndustrialInjuryPreventionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-30</xbrli:startDate><xbrli:endDate>2018-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190411to20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:LeadingProviderOfIndustrialInjuryPreventionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-11</xbrli:startDate><xbrli:endDate>2019-04-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200401to20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200701to20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20201001to20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20200502"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-05-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_UnusualOrInfrequentItemAxis_MedicareAcceleratedAndAdvancePaymentsProgramMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">usph:MedicareAcceleratedAndAdvancePaymentsProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_UnusualOrInfrequentItemAxis_PublicHealthAndSocialServicesEmergencyFundMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">usph:PublicHealthAndSocialServicesEmergencyFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_UnusualOrInfrequentItemAxis_PublicHealthAndSocialServicesEmergencyFundMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">usph:PublicHealthAndSocialServicesEmergencyFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_BusinessAcquisitionAxis_FebruaryTwoThousandTwentyAcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:FebruaryTwoThousandTwentyAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_BusinessAcquisitionAxis_SeptemberTwoThousandNineteenAcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:SeptemberTwoThousandNineteenAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_BusinessAcquisitionAxis_NovemberTwoThousandTwentyAcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:NovemberTwoThousandTwentyAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_BusinessAcquisitionAxis_SeptemberTwoThousandTwentyAcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:SeptemberTwoThousandTwentyAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_BusinessAcquisitionAxis_August2018AcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:August2018AcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200930_BusinessAcquisitionAxis_SeptemberTwoThousandTwentyAcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:SeptemberTwoThousandTwentyAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201130_BusinessAcquisitionAxis_NovemberTwoThousandTwentyAcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:NovemberTwoThousandTwentyAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20190930_BusinessAcquisitionAxis_SeptemberTwoThousandNineteenAcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:SeptemberTwoThousandNineteenAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20200227_BusinessAcquisitionAxis_FebruaryTwoThousandTwentyAcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:FebruaryTwoThousandTwentyAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20180831_BusinessAcquisitionAxis_August2018AcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:August2018AcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20200930to20200930_BusinessAcquisitionAxis_SeptemberTwoThousandTwentyAcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:SeptemberTwoThousandTwentyAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-30</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20180831to20180831_BusinessAcquisitionAxis_August2018AcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:August2018AcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190930to20190930_BusinessAcquisitionAxis_SeptemberTwoThousandNineteenAcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:SeptemberTwoThousandNineteenAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-30</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20201130to20201130_BusinessAcquisitionAxis_NovemberTwoThousandTwentyAcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:NovemberTwoThousandTwentyAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-30</xbrli:startDate><xbrli:endDate>2020-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200227to20200227_BusinessAcquisitionAxis_ClinicPracticeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-27</xbrli:startDate><xbrli:endDate>2020-02-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200227to20200227_BusinessAcquisitionAxis_FebruaryTwoThousandTwentyAcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:FebruaryTwoThousandTwentyAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-27</xbrli:startDate><xbrli:endDate>2020-02-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200930to20200930_BusinessAcquisitionAxis_ManagementContractsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ManagementContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-30</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_ProductOrServiceAxis_OtherRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:OtherRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190101to20191231_ProductOrServiceAxis_OtherRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:OtherRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190101to20191231_ProductOrServiceAxis_ManagementContractRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:ManagementContractRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20180101to20181231_ProductOrServiceAxis_OtherRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:OtherRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20180101to20181231_ProductOrServiceAxis_IndustrialInjuryPreventionServicesRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:IndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_ProductOrServiceAxis_IndustrialInjuryPreventionServicesRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:IndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190101to20191231_ProductOrServiceAxis_IndustrialInjuryPreventionServicesRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:IndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20180101to20181231_ProductOrServiceAxis_ManagementContractRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:ManagementContractRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_ProductOrServiceAxis_PhysicalTherapyOperationsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190101to20191231_ProductOrServiceAxis_PhysicalTherapyOperationsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20180101to20181231_ProductOrServiceAxis_PhysicalTherapyOperationsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_ProductOrServiceAxis_ManagementContractRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:ManagementContractRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember_RangeAxis_MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember_RangeAxis_MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_PropertyPlantAndEquipmentByTypeAxis_ComputerSoftwareIntangibleAssetMember_RangeAxis_MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_PropertyPlantAndEquipmentByTypeAxis_ComputerSoftwareIntangibleAssetMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_UnusualOrInfrequentItemAxis_Year2019Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">usph:Year2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_UnusualOrInfrequentItemAxis_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">usph:FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_UnusualOrInfrequentItemAxis_Year2018Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">usph:Year2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20201227to20201227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2020-12-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_UnusualOrInfrequentItemAxis_FromTwoThousandNineteenThroughTwoThousandTwentyFourMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">usph:FromTwoThousandNineteenThroughTwoThousandTwentyFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20180209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-02-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20151102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2015-11-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20130401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2013-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210331_StatementScenarioAxis_ScenarioForecastMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_RangeAxis_MaximumMember_UnusualOrInfrequentItemAxis_Year2017Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">usph:Year2017Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20201231_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201602Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210129_DebtInstrumentAxis_CreditAgreementMember_SubsequentEventTypeAxis_SubsequentEventMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usph:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_DebtInstrumentAxis_CreditAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usph:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210129to20210129_DebtInstrumentAxis_CreditAgreementMember_SubsequentEventTypeAxis_SubsequentEventMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usph:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-29</xbrli:startDate><xbrli:endDate>2021-01-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_TitleOfIndividualAxis_DirectorMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_TitleOfIndividualAxis_OfficerMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:OfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_TitleOfIndividualAxis_EmployeeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">usph:EmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20201130_BusinessAcquisitionAxis_ClinicPracticeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_BusinessAcquisitionAxis_SeptemberTwoThousandTwentyAcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:SeptemberTwoThousandTwentyAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_BusinessAcquisitionAxis_FebruaryTwoThousandTwentyAcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:FebruaryTwoThousandTwentyAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20200930_BusinessAcquisitionAxis_ManagementContractsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ManagementContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_BusinessAcquisitionAxis_SeptemberTwoThousandNineteenAcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:SeptemberTwoThousandNineteenAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20190411_BusinessAcquisitionAxis_AprilTwoThousandNineteenAcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:AprilTwoThousandNineteenAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_BusinessAcquisitionAxis_August2018AcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:August2018AcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_BusinessAcquisitionAxis_NovemberTwoThousandTwentyAcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:NovemberTwoThousandTwentyAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201130to20201130_BusinessAcquisitionAxis_ClinicPracticeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-30</xbrli:startDate><xbrli:endDate>2020-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20180101to20181231_BusinessAcquisitionAxis_AcquisitionOfFiveClinicPracticesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:AcquisitionOfFiveClinicPracticesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200930to20200930_BusinessAcquisitionAxis_ManagementAndServicesContractsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ManagementAndServicesContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-30</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_BusinessAcquisitionAxis_ManagementContractsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ManagementContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_BusinessAcquisitionAxis_ManagementAndServicesContractsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ManagementAndServicesContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190411to20190411_BusinessAcquisitionAxis_AprilTwoThousandNineteenAcquisitionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:AprilTwoThousandNineteenAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-11</xbrli:startDate><xbrli:endDate>2019-04-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190930to20190930_BusinessAcquisitionAxis_SeptemberTwoThousandNineteenAcquisitionMember_StatementScenarioAxis_SeptemberTwoThousandTwentyMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:SeptemberTwoThousandNineteenAcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">usph:SeptemberTwoThousandTwentyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-30</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190930to20190930_BusinessAcquisitionAxis_SeptemberTwoThousandNineteenAcquisitionMember_StatementScenarioAxis_SeptemberTwoThousandTwentyOneMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">usph:SeptemberTwoThousandTwentyOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:SeptemberTwoThousandNineteenAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-30</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20180831_BusinessAcquisitionAxis_August2018AcquisitionMember_StatementScenarioAxis_AugustTwoThousandTwentyMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:August2018AcquisitionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">usph:AugustTwoThousandTwentyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20180831_BusinessAcquisitionAxis_August2018AcquisitionMember_StatementScenarioAxis_AugustTwoThousandNineteenMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">usph:AugustTwoThousandNineteenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:August2018AcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20181231_BusinessAcquisitionAxis_AcquisitionOfFiveClinicPracticesMember_StatementScenarioAxis_AugustTwoThousandNineteenMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:AcquisitionOfFiveClinicPracticesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">usph:AugustTwoThousandNineteenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20200930_BusinessAcquisitionAxis_ManagementContractsMember_ShortTermDebtTypeAxis_NotesPayableOneMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">usph:NotesPayableOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ManagementContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190101to20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190930to20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-30</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20180430to20180430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-30</xbrli:startDate><xbrli:endDate>2018-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20200930_BusinessAcquisitionAxis_ManagementContractsMember_ShortTermDebtTypeAxis_NotesPayableTwoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ManagementContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">usph:NotesPayableTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20181231_BusinessAcquisitionAxis_AcquisitionOfFiveClinicPracticesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:AcquisitionOfFiveClinicPracticesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20180430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20180101to20181231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">usph:ReferralRelationshipMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20180101to20181231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">usph:ReferralRelationshipMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190101to20191231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190101to20191231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">usph:ReferralRelationshipMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20191231_RangeAxis_MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_RangeAxis_MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20191231_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TherapyPracticeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_BusinessAcquisitionAxis_TherapyPracticeMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TherapyPracticeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_BusinessAcquisitionAxis_TherapyPracticeMember_RangeAxis_MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TherapyPracticeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TherapyPracticeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TherapyPracticeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember_RangeAxis_MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TherapyPracticeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20171231_OwnershipAxis_RedeemableNonControllingInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">usph:RedeemableNonControllingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20191231_OwnershipAxis_RedeemableNonControllingInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">usph:RedeemableNonControllingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20181231_OwnershipAxis_RedeemableNonControllingInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">usph:RedeemableNonControllingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20190101to20191231_OwnershipAxis_RedeemableNonControllingInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">usph:RedeemableNonControllingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_OwnershipAxis_RedeemableNonControllingInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">usph:RedeemableNonControllingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20180101to20181231_OwnershipAxis_RedeemableNonControllingInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">usph:RedeemableNonControllingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20201231_OwnershipAxis_RedeemableNonControllingInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">usph:RedeemableNonControllingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20191231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20191231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">usph:ReferralRelationshipMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20191231_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">usph:ReferralRelationshipMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember_RangeAxis_MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">usph:ReferralRelationshipMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember_RangeAxis_MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">usph:ReferralRelationshipMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20191231_CreditFacilityAxis_RevolvingCreditFacilityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_CreditFacilityAxis_RevolvingCreditFacilityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20191231_DebtInstrumentAxis_PromissoryNotesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usph:PromissoryNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_DebtInstrumentAxis_PromissoryNotesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usph:PromissoryNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20190101to20191231_CreditFacilityAxis_RevolvingCreditFacilityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_CreditFacilityAxis_RevolvingCreditFacilityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20201231_DebtInstrumentAxis_PromissoryNotesMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usph:PromissoryNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_DebtInstrumentAxis_PromissoryNotesMember_RangeAxis_MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usph:PromissoryNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20131205_CreditFacilityAxis_RevolvingCreditFacilityMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2013-12-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20160101to20160131_DebtInstrumentAxis_CreditAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usph:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-01-01</xbrli:startDate><xbrli:endDate>2016-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20160101to20160131_DebtInstrumentAxis_CreditAgreementMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usph:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-01-01</xbrli:startDate><xbrli:endDate>2016-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20201231_ShortTermDebtTypeAxis_NotesPayableMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">usph:NotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_RangeAxis_MaximumMember_ShortTermDebtTypeAxis_NotesPayableMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">usph:NotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_RangeAxis_MinimumMember_ShortTermDebtTypeAxis_NotesPayableMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">usph:NotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20191231_ShortTermDebtTypeAxis_NotesPayableMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">usph:NotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_IncomeTaxAuthorityAxis_ForeignCountryMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_IncomeTaxAuthorityAxis_ForeignCountryMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20180101to20181231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20180101to20181231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:IndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190101to20191231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:IndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:IndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190101to20191231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20180101to20181231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsExcludingClosureCostsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsExcludingClosureCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_ConsolidationItemsAxis_OperatingSegmentsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsExcludingClosureCostsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsExcludingClosureCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190101to20191231_ConsolidationItemsAxis_OperatingSegmentsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190101to20191231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsExcludingClosureCostsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsExcludingClosureCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20180101to20181231_ConsolidationItemsAxis_OperatingSegmentsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20201231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20181231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:IndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20191231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:IndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20191231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:IndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20181231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20160317_PlanNameAxis_AmendedTwoThousandThreePlanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">usph:AmendedTwoThousandThreePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-03-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_AwardTypeAxis_NonQualifiedStockOptionsMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">usph:NonQualifiedStockOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20160316_PlanNameAxis_AmendedTwoThousandThreePlanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">usph:AmendedTwoThousandThreePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-03-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_PlanNameAxis_AmendedTwoThousandThreePlanMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">usph:AmendedTwoThousandThreePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_PlanNameAxis_AmendedTwoThousandThreePlanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">usph:AmendedTwoThousandThreePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_PlanNameAxis_AmendedNineteenNinetyNinePlanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">usph:AmendedNineteenNinetyNinePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20180101to20181231_AwardTypeAxis_RestrictedStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190101to20191231_AwardTypeAxis_RestrictedStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_AwardTypeAxis_RestrictedStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_TitleOfIndividualAxis_ExecutiveOfficerMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_TitleOfIndividualAxis_EmployeesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">usph:EmployeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20201231_AwardTypeAxis_RestrictedStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20090331_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2009-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20081231_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2008-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20090301to20090331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2009-03-01</xbrli:startDate><xbrli:endDate>2009-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20171231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20191231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20181231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20180101to20181231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190101to20191231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20201231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="U001"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="U002"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="U003"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="U004"><xbrli:measure>usph:Segment</xbrli:measure></xbrli:unit><xbrli:unit id="U005"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="U006"><xbrli:measure>usph:Location</xbrli:measure></xbrli:unit><xbrli:unit id="U007"><xbrli:measure>usph:Clinic</xbrli:measure></xbrli:unit><xbrli:unit id="U008"><xbrli:measure>usph:State</xbrli:measure></xbrli:unit><xbrli:unit id="U009"><xbrli:measure>usph:Facility</xbrli:measure></xbrli:unit><xbrli:unit id="U010"><xbrli:measure>usph:Installment</xbrli:measure></xbrli:unit><xbrli:unit id="U011"><xbrli:measure>usph:Business</xbrli:measure></xbrli:unit><xbrli:unit id="U012"><xbrli:measure>usph:Volume</xbrli:measure></xbrli:unit><xbrli:unit id="U013"><xbrli:measure>usph:Employee</xbrli:measure></xbrli:unit><xbrli:unit id="U014"><xbrli:measure>usph:Contract</xbrli:measure></xbrli:unit><xbrli:unit id="U015"><xbrli:measure>usph:Partnership</xbrli:measure></xbrli:unit><xbrli:unit id="U016"><xbrli:measure>usph:Region</xbrli:measure></xbrli:unit><xbrli:unit id="U017"><xbrli:measure>usph:Operation</xbrli:measure></xbrli:unit><xbrli:unit id="U018"><xbrli:measure>usph:Officer</xbrli:measure></xbrli:unit><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_3b1220179ecd4076b3fbc66ee0581ec9" toRefs="Foot_09a4cffadb2444b88d15b3ec81bd76d1" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_eee67263780a49acaa0581ec533a3e2a" toRefs="Foot_09a4cffadb2444b88d15b3ec81bd76d1" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_69726b880894406db2f8a42ee390913d" toRefs="Foot_09a4cffadb2444b88d15b3ec81bd76d1" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_8cff895473e241e59d08ae7680b476bc" toRefs="Foot_09a4cffadb2444b88d15b3ec81bd76d1" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_a9bd169930b446c6aabd97b8503b9e92" toRefs="Foot_09a4cffadb2444b88d15b3ec81bd76d1" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_6d1cfd3236f143b99ad407ad2c842c35" toRefs="Foot_09a4cffadb2444b88d15b3ec81bd76d1" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_1c91e22e04a04be59bf9c144d53a2b33" toRefs="Foot_09a4cffadb2444b88d15b3ec81bd76d1" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_4aa84586d91a445394a1e77ae4ad8e6a" toRefs="Foot_09a4cffadb2444b88d15b3ec81bd76d1" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_71db7b39649a460f8cbeab4608e180da" toRefs="Foot_09a4cffadb2444b88d15b3ec81bd76d1" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_cf8bc979288c40a7972a4f53552b1ec9" toRefs="Foot_09a4cffadb2444b88d15b3ec81bd76d1" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_69f109e55bc142d7adbb5f8d48c32af4" toRefs="Foot_09a4cffadb2444b88d15b3ec81bd76d1" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_0146285d8d254416a7685fa0372d43c7" toRefs="Foot_09a4cffadb2444b88d15b3ec81bd76d1" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_f4ccac10433342e882be0539ab3cc980" toRefs="Foot_09a4cffadb2444b88d15b3ec81bd76d1" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_97c36c006efd4508940b439ef40e5fd4" toRefs="Foot_09a4cffadb2444b88d15b3ec81bd76d1" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_be63fda669ef48c48951108c9fa8d90d" toRefs="Foot_089e16638e954876a030f33789a71503" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_0320094539f74ee99f3fbef241f00d39" toRefs="Foot_c17d1a5ce0344dbb9898dd830df565d6" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_bfd896794afb43ceb5f52155240c54ac" toRefs="Foot_aeaed244265844d580a05be145ffd595" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_87de7115dd224e8ab5349b8ca49d2604" toRefs="Foot_aeaed244265844d580a05be145ffd595" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_74729e999361491e8eb1757c704e74be" toRefs="Foot_b182115cb6ef4d009deff873b8909b51" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_29c0aadade644e9a962b7bfbcb82c179" toRefs="Foot_b182115cb6ef4d009deff873b8909b51" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_500b5cc37a5c47c6ab25797c123a9f6e" toRefs="Foot_2ef12113298047418d3d8f899b71e83a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_8f96c3837ba5401590c591d7e2b74710" toRefs="Foot_2ef12113298047418d3d8f899b71e83a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_bb699c43da284af58e2748b717ff4b1b" toRefs="Foot_c1daa8198f5247f8b265a5b321d9c423" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_e131ad63ad1041799466edcdc9c10b29" toRefs="Foot_c1daa8198f5247f8b265a5b321d9c423" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_c9284f57288c4ed9a5b4a222fc4e71e4" toRefs="Foot_c1daa8198f5247f8b265a5b321d9c423" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_b19a53519bab4348911ce11f977f1667" toRefs="Foot_c1daa8198f5247f8b265a5b321d9c423" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_5fde58692cd0441b89744b3b76fd84f8" toRefs="Foot_c1daa8198f5247f8b265a5b321d9c423" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_5fde58692cd0441b89744b3b76fd84f8" toRefs="Foot_48f584180c61464eac6330240454329a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_ae81df1cdd664746aa4f7c582ca0406a" toRefs="Foot_48f584180c61464eac6330240454329a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship><ix:relationship order="1.0" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="Fact_1f7983ae02f14d5eaa69d3a489cef97f" toRefs="Foot_48f584180c61464eac6330240454329a" linkRole="http://www.xbrl.org/2003/role/link"></ix:relationship></ix:resources></ix:header></div>
<div></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" /></div>
<div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;"><span style="font-size: 14pt; font-family: 'Times New Roman';">UNITED STATES</span><span style="font-size: 12pt; font-family: 'Times New Roman';"><br /></span><span style="font-size: 14pt; font-family: 'Times New Roman';">SECURITIES AND EXCHANGE COMMISSION</span><span style="font-size: 12pt; font-family: 'Times New Roman';"><br /></span>Washington, D.C. 20549</div>
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><hr style="height: 2px; width: 20%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>
<div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 18pt; font-weight: bold;">Form <ix:nonNumeric name="dei:DocumentType" id="Fact_5f2506a0b8034f10b4ae5a6c0ad93ab1" contextRef="c20200101to20201231">10-K</ix:nonNumeric></div>
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><hr style="height: 2px; width: 20%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Mark One)</div>
<div><br /></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z7c168d24024d47a18455e18cf6ba0b3e">
  <tr>
    <td style="width: 27pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:DocumentAnnualReport" id="Fact_622920f4c0b94da3b709f753b4c52de4" contextRef="c20200101to20201231" format="ixt-sec:boolballotbox">&#x2611;</ix:nonNumeric></td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</div></td>
  </tr>
</table>
<div><br /></div>
<div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">FOR THE FISCAL YEAR ENDED <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_b415b2d8269f4592b0818122a6c85fc5" contextRef="c20200101to20201231" format="ixt:datemonthdayyearen">DECEMBER 31, 2020</ix:nonNumeric></div>
<div><br /></div>
<div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">OR</div>
<div><br /></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z41c54705dc534762b95652e4920e0dfa">
  <tr>
    <td style="width: 27pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:DocumentTransitionReport" id="Fact_5faa561af39a4008b749bd32c2e002fd" contextRef="c20200101to20201231" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</div></td>
  </tr>
</table>
<div><br /></div>
<div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">FOR THE TRANSITION PERIOD FROM <span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="text-decoration: underline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></span>TO<span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="text-decoration: underline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></span></div>
<div><br /></div>
<div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">COMMISSION FILE NUMBER <ix:nonNumeric name="dei:EntityFileNumber" id="Fact_fcb5ba67bf1d4778b2c57f69cd6bef4a" contextRef="c20200101to20201231">1-11151</ix:nonNumeric></div>
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><hr style="height: 2px; width: 20%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>
<div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="font-size: 24pt; font-family: 'Times New Roman';"><span style="-sec-ix-hidden:Fact_f2da9d2421674ebe8d6c38534d4d877f">U.S. PHYSICAL THERAPY, INC.</span></span><span style="font-size: 10pt; font-family: 'Times New Roman';"><br /></span><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)</span></div>
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><hr style="height: 2px; width: 20%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>
<div><br /></div>
<table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zf2381c1cc81248488a3845bcbc4d0bb4">
  <tr>
    <td style="width: 49%; vertical-align: top;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="-sec-ix-hidden:Fact_555251a9a4f249158279069f9fa10a71">NEVADA</span></div></td>
    <td style="width: 2%; vertical-align: top;">&#160;</td>
    <td style="width: 49%; vertical-align: bottom;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_cd283d3f79ed4c21ad91859b63101f0b" contextRef="c20200101to20201231">76-0364866</ix:nonNumeric></div></td>
  </tr>
  <tr>
    <td style="width: 49%; vertical-align: top;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">(STATE OR OTHER JURISDICTION OF INCORPORATION<span style="font-size: 10pt; font-family: 'Times New Roman';"><br /></span>OR ORGANIZATION)</div></td>
    <td style="width: 2%; vertical-align: top;">&#160;</td>
    <td style="width: 49%; vertical-align: top;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">(I.R.S. EMPLOYER IDENTIFICATION NO.)</div></td>
  </tr>
</table>
<div><br /></div>
<table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z89542fb7b8b54ef0a9100048e4de8f63">
  <tr>
    <td style="width: 49%; vertical-align: top;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_e46170a6442241bbb38ea0fbcadc7742" contextRef="c20200101to20201231">1300 WEST SAM HOUSTON PARKWAY SOUTH</ix:nonNumeric>,<span style="font-size: 10pt; font-family: 'Times New Roman';"><br /></span><ix:nonNumeric name="dei:EntityAddressAddressLine2" id="Fact_34ec21b8954a4b32b064d93d9514f745" contextRef="c20200101to20201231">SUITE 300</ix:nonNumeric>,<span style="font-size: 10pt; font-family: 'Times New Roman';"><br /></span><ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_71a088f56e9f4bb5a4302f52ad550eab" contextRef="c20200101to20201231">HOUSTON</ix:nonNumeric>, <span style="-sec-ix-hidden:Fact_e48ef9b1762e421fa2a66cdc7e8e4662">TEXAS</span></div></td>
    <td style="width: 2%; vertical-align: top;">&#160;</td>
    <td style="width: 49%; vertical-align: bottom;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_1e6f912f18c94ddd809626ccf11d1777" contextRef="c20200101to20201231">77042</ix:nonNumeric></div></td>
  </tr>
  <tr>
    <td style="width: 49%; vertical-align: top;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)</div></td>
    <td style="width: 2%; vertical-align: top;">&#160;</td>
    <td style="width: 49%; vertical-align: bottom;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">(ZIP CODE)</div></td>
  </tr>
</table>
<div><br /></div>
<div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">REGISTRANT&#8217;S TELEPHONE NUMBER, INCLUDING AREA CODE: (<ix:nonNumeric name="dei:CityAreaCode" id="Fact_49a6a1097c3d4234a2d39f6ff5281844" contextRef="c20200101to20201231">713</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_33984dda15a4462ea4944784e7494132" contextRef="c20200101to20201231">297-7000</ix:nonNumeric><span style="font-size: 10pt; font-family: 'Times New Roman';"><br /></span>SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE EXCHANGE ACT:</div>
<div><br /></div>
<table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zbfeedf5290cb4d4a8034f4f1780690e3">
  <tr>
    <td style="width: 40%; vertical-align: top;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="text-decoration: underline;">Title of Each Class</span></div></td>
    <td style="width: 18%; vertical-align: bottom;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="text-decoration: underline;">Trading Symbol</span></div></td>
    <td style="width: 42%; vertical-align: bottom;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="text-decoration: underline;">Name of Each Exchange on Which Registered</span></div></td>
  </tr>
  <tr>
    <td style="width: 40%; vertical-align: top;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_aeef2e992004459980f9c95231e65b9a" contextRef="c20200101to20201231">Common Stock, $.01 par value</ix:nonNumeric></div></td>
    <td style="width: 18%; vertical-align: bottom;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_9467b6550fe944788d34f504711ecd34" contextRef="c20200101to20201231">USPH</ix:nonNumeric></div></td>
    <td style="width: 42%; vertical-align: bottom;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_93e7680d211142e5ab04ab235fefd5e5" contextRef="c20200101to20201231" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric></div></td>
  </tr>
</table>
<div><br /></div>
<div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SECURITIES REGISTERED PURSUANT TO SECTION 12(g) OF THE EXCHANGE ACT: NONE</div>
<div><br /></div>
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><hr style="height: 2px; width: 20%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>
<div><br /></div>
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes <span style="font-size: 10pt; font-family: 'Times New Roman';">&#x2610;</span>&#160;<ix:nonNumeric name="dei:EntityWellKnownSeasonedIssuer" id="Fact_0c03ea6ce46849278312505e990c1e4e" contextRef="c20200101to20201231">No</ix:nonNumeric>&#160;<span style="font-size: 10pt; font-family: 'Times New Roman';">&#x2611;</span></div>
<div><br /></div>
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes <span style="font-size: 10pt; font-family: 'Times New Roman';">&#x2610;</span>&#160;<ix:nonNumeric name="dei:EntityVoluntaryFilers" id="Fact_127aefd2421c41179b770c1773e41392" contextRef="c20200101to20201231">No</ix:nonNumeric><span style="font-size: 10pt; font-family: 'Times New Roman';">&#x2611;</span></div>
<div><br /></div>
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric name="dei:EntityCurrentReportingStatus" id="Fact_f68c618b669d4a70b4d5813aeffbfca5" contextRef="c20200101to20201231">Yes</ix:nonNumeric>&#160;<span style="font-size: 10pt; font-family: 'Times New Roman';">&#x2611;</span> No <span style="font-size: 10pt; font-family: 'Times New Roman';">&#x2610;</span></div>
<div><br /></div>
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric name="dei:EntityInteractiveDataCurrent" id="Fact_fc660aa9cdaa447ea0411ee8a0f8a7e2" contextRef="c20200101to20201231">Yes</ix:nonNumeric>&#160;<span style="font-size: 10pt; font-family: 'Times New Roman';">&#x2611;</span> No <span style="font-size: 10pt; font-family: 'Times New Roman';">&#x2610;</span></div>
<div><br /></div>
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221;, &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</div>
<div><br /></div>
<table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zfee11a3c18a043919f3451996a60dd20">
  <tr>
    <td style="width: 27.49%; vertical-align: top; white-space: nowrap;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:EntityFilerCategory" id="Fact_65c71415128e4218a76d852519a4ba8c" contextRef="c20200101to20201231" format="ixt-sec:entityfilercategoryen">Large accelerated filer</ix:nonNumeric></div></td>
    <td style="width: 34.49%; vertical-align: bottom; white-space: nowrap;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#x2611;</div></td>
    <td style="width: 22.99%; vertical-align: bottom; white-space: nowrap;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Accelerated filer</div></td>
    <td style="width: 15.04%; vertical-align: bottom; white-space: nowrap;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#x2610;</div></td>
  </tr>
  <tr>
    <td style="width: 27.49%; vertical-align: top;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Non-accelerated filer</div></td>
    <td style="width: 34.49%; vertical-align: bottom;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">&#x2610; </span>(Do not check if a smaller reporting company)</div></td>
    <td style="width: 22.99%; vertical-align: bottom;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Smaller reporting company</div></td>
    <td style="width: 15.04%; vertical-align: bottom;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:EntitySmallBusiness" id="Fact_4cabba4230d94b3c9fdb7a5ec9b01d48" contextRef="c20200101to20201231" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></div></td>
  </tr>
  <tr>
    <td style="width: 27.49%; vertical-align: top;">&#160;</td>
    <td style="width: 34.49%; vertical-align: bottom;">&#160;</td>
    <td style="width: 22.99%; vertical-align: bottom;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Emerging growth company</div></td>
    <td style="width: 15.04%; vertical-align: bottom;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_027d1fe547434fbba7cdd63572ca7ac1" contextRef="c20200101to20201231" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></div></td>
  </tr>
</table>
<div><br /></div>
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#8201;<span style="font-size: 10pt; font-family: 'Times New Roman';">&#x2610;</span></div>
<div><br /></div>
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.&#160;&#160; </span><span style="font-size: 10pt; font-family: 'Times New Roman';">&#x2611;</span></div>
<div><br /></div>
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes &#8201;<span style="font-size: 10pt; font-family: 'Times New Roman';"><ix:nonNumeric name="dei:EntityShellCompany" id="Fact_dd853894d9c84ab1be2ee8ecf448a09c" contextRef="c20200101to20201231" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></span> No <span style="font-size: 10pt; font-family: 'Times New Roman';">&#x2611;</span></div>
<div><br /></div>
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The aggregate market value of the shares of the registrant&#8217;s common stock held by non-affiliates of the registrant at June 30, 2020 was $<ix:nonFraction name="dei:EntityPublicFloat" id="Fact_1831e346d0e347899a382a4775eddb1b" contextRef="c20200630" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">565.3</ix:nonFraction> million based on the closing sale price reported on the NYSE for the registrant&#8217;s common stock on June 30, 2020, the last business day of the registrant&#8217;s most recently completed second fiscal quarter. For purposes of this computation, all executive officers, directors and 5% or greater beneficial owners of the registrant were deemed to be affiliates. Such determination should not be deemed an admission that such executive officers, directors and beneficial owners are, in fact, affiliates of the registrant.</div>
<div><br /></div>
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">As of March 1, 2021, the number of shares outstanding of the registrant&#8217;s common stock, par value $.01 per share, was: <ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" id="Fact_a15106f84d2b46c7b0733af2b0f00bca" contextRef="c20210301" unitRef="U002" decimals="INF" scale="0" format="ixt:numdotdecimal">12,897,096</ix:nonFraction>.</div>
<div><br /></div>
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" /></div>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div><br /></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">DOCUMENTS INCORPORATED BY REFERENCE</div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><!--PROfilePageNumberReset%Num%2%%%--></div>
<table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zd9d17760522b471fb6964ecf094ff0a0">
  <tr>
    <td style="width: 73.16%; vertical-align: bottom;"><div style="text-align: left; margin-left: 189pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">DOCUMENT</div></td>
    <td style="width: 26.84%; vertical-align: bottom;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">PART OF FORM 10-K</div></td>
  </tr>
  <tr>
    <td style="width: 73.16%; vertical-align: bottom;"><div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Portions of Definitive Proxy Statement for the 2021 Annual Meeting of Shareholders</div></td>
    <td style="width: 26.84%; vertical-align: bottom;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Part III</div></td>
  </tr>
</table>
<div><br /></div>
<div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><a id="TableofContents"><!--Anchor--></a>Table of Contents</div>
<div><br /></div>
<table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zcf4c4cec04334a9d8e5b051233b46a65">
  <tr>
    <td style="width: 10.16%; vertical-align: bottom;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 81.99%; vertical-align: bottom;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 7.85%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: center; margin-right: 2.05pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Page</div></td>
  </tr>
  <tr>
    <td style="width: 10.16%; vertical-align: bottom;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">PART I</div></td>
    <td style="width: 81.99%; vertical-align: bottom;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 7.85%; vertical-align: bottom;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 10.16%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Item 1.</div></td>
    <td style="width: 81.99%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="#ITEM1" style="font-family: 'Times New Roman'; font-size: 10pt;">Business</a></div></td>
    <td style="width: 7.85%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">4</div></td>
  </tr>
  <tr>
    <td style="width: 10.16%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Item 1A.</div></td>
    <td style="width: 81.99%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="#ITEM1A" style="font-family: 'Times New Roman'; font-size: 10pt;">Risk Factors</a></div></td>
    <td style="width: 7.85%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">15</div></td>
  </tr>
  <tr>
    <td style="width: 10.16%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Item 1B.</div></td>
    <td style="width: 81.99%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="#ITEM1B" style="font-family: 'Times New Roman'; font-size: 10pt;">Unresolved Staff Comments</a></div></td>
    <td style="width: 7.85%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">22</div></td>
  </tr>
  <tr>
    <td style="width: 10.16%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Item 2.</div></td>
    <td style="width: 81.99%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="#ITEM2" style="font-family: 'Times New Roman'; font-size: 10pt;">Properties</a></div></td>
    <td style="width: 7.85%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">22</div></td>
  </tr>
  <tr>
    <td style="width: 10.16%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Item 3.</div></td>
    <td style="width: 81.99%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="#ITEM3" style="font-family: 'Times New Roman'; font-size: 10pt;">Legal Proceedings</a></div></td>
    <td style="width: 7.85%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">22</div></td>
  </tr>
  <tr>
    <td style="width: 10.16%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Item 4.</div></td>
    <td style="width: 81.99%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="#ITEM4" style="font-family: 'Times New Roman'; font-size: 10pt;">Mine Safety Disclosures</a></div></td>
    <td style="width: 7.85%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">23</div></td>
  </tr>
  <tr>
    <td style="width: 10.16%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td colspan="2" style="width: 89.84%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 10.16%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">PART II</div></td>
    <td style="width: 81.99%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 7.85%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 10.16%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Item 5.</div></td>
    <td style="width: 81.99%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="#ITEM5" style="font-family: 'Times New Roman'; font-size: 10pt;">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></div></td>
    <td style="width: 7.85%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">23</div></td>
  </tr>
  <tr>
    <td style="width: 10.16%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Item 6.</div></td>
    <td style="width: 81.99%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="#ITEM6" style="font-family: 'Times New Roman'; font-size: 10pt;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></div></td>
    <td style="width: 7.85%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">25</div></td>
  </tr>
  <tr>
    <td style="width: 10.16%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Item 7.</div></td>
    <td style="width: 81.99%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="#ITEM7AQuantitativeQualitative" style="font-family: 'Times New Roman'; font-size: 10pt;">Quantitative and Qualitative Disclosures About Market Risk</a></div></td>
    <td style="width: 7.85%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">40</div></td>
  </tr>
  <tr>
    <td style="width: 10.16%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Item 8.</div></td>
    <td style="width: 81.99%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="#ITEM8" style="font-family: 'Times New Roman'; font-size: 10pt;">Financial Statements and Supplementary Data</a></div></td>
    <td style="width: 7.85%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">41</div></td>
  </tr>
  <tr>
    <td style="width: 10.16%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 81.99%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="#PHYSICAL" style="font-family: 'Times New Roman'; font-size: 10pt;">Notes to Consolidated Financial Statements</a></div></td>
    <td style="width: 7.85%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">49</div></td>
  </tr>
  <tr>
    <td style="width: 10.16%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Item 9.</div></td>
    <td style="width: 81.99%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="#ITEM9" style="font-family: 'Times New Roman'; font-size: 10pt;">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></div></td>
    <td style="width: 7.85%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">74</div></td>
  </tr>
  <tr>
    <td style="width: 10.16%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Item 9A.</div></td>
    <td style="width: 81.99%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="#ITEM9A" style="font-family: 'Times New Roman'; font-size: 10pt;">Controls and Procedures</a></div></td>
    <td style="width: 7.85%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">74</div></td>
  </tr>
  <tr>
    <td style="width: 10.16%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Item 9B.</div></td>
    <td style="width: 81.99%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="#ITEM9B" style="font-family: 'Times New Roman'; font-size: 10pt;">Other Information</a></div></td>
    <td style="width: 7.85%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">75</div></td>
  </tr>
  <tr>
    <td style="width: 10.16%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 81.99%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 7.85%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 10.16%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">PART III</div></td>
    <td style="width: 81.99%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 7.85%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 10.16%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Item 10.</div></td>
    <td style="width: 81.99%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="#ITEM10" style="font-family: 'Times New Roman'; font-size: 10pt;">Directors, Executive Officers and Corporate Governance</a></div></td>
    <td style="width: 7.85%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">75</div></td>
  </tr>
  <tr>
    <td style="width: 10.16%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Item 11.</div></td>
    <td style="width: 81.99%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="#ITEM11" style="font-family: 'Times New Roman'; font-size: 10pt;">Executive Compensation</a></div></td>
    <td style="width: 7.85%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">75</div></td>
  </tr>
  <tr>
    <td style="width: 10.16%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Item 12.</div></td>
    <td style="width: 81.99%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="#ITEM12" style="font-family: 'Times New Roman'; font-size: 10pt;">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></div></td>
    <td style="width: 7.85%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">75</div></td>
  </tr>
  <tr>
    <td style="width: 10.16%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Item 13.</div></td>
    <td style="width: 81.99%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="#ITEM13" style="font-family: 'Times New Roman'; font-size: 10pt;">Certain Relationships and Related Transactions, and Director Independence</a></div></td>
    <td style="width: 7.85%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">75</div></td>
  </tr>
  <tr>
    <td style="width: 10.16%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Item 14.</div></td>
    <td style="width: 81.99%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="#ITEM14" style="font-family: 'Times New Roman'; font-size: 10pt;">Principal Accountant Fees and Services</a></div></td>
    <td style="width: 7.85%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">75</div></td>
  </tr>
  <tr>
    <td style="width: 10.16%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 81.99%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 7.85%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 10.16%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">PART IV</div></td>
    <td style="width: 81.99%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 7.85%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 10.16%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Item 15.</div></td>
    <td style="width: 81.99%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="#ITEM15" style="font-family: 'Times New Roman'; font-size: 10pt;">Exhibits and Financial Statement Schedules</a></div></td>
    <td style="width: 7.85%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">75</div></td>
  </tr>
  <tr>
    <td style="width: 10.16%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Item 16.</div></td>
    <td style="width: 81.99%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="#ITEM16" style="font-family: 'Times New Roman'; font-size: 10pt;">Form 10-K Summary</a></div></td>
    <td style="width: 7.85%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">75</div></td>
  </tr>
  <tr>
    <td style="width: 10.16%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="#SIGNATURES" style="font-family: 'Times New Roman'; font-size: 10pt;">Signatures</a></div></td>
    <td style="width: 81.99%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 7.85%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">82</div></td>
  </tr>
</table>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>2</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">FORWARD-LOOKING STATEMENTS</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">We make statements in this report that are considered to be forward-looking statements within the meaning given such term under Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). These statements contain forward-looking information relating to the financial condition, results of operations, plans, objectives, future performance and business of our Company. These statements (often using words such as &#8220;believes&#8221;, &#8220;expects&#8221;, &#8220;intends&#8221;, &#8220;plans&#8221;, &#8220;appear&#8221;, &#8220;should&#8221; and similar words) involve risks and uncertainties that could cause actual results to differ materially from those we project. Included among such statements are those relating to opening clinics, availability of personnel and the reimbursement environment. The forward-looking statements are based on our current views and assumptions and actual results could differ materially from those anticipated in such forward-looking statements as a result of certain risks, uncertainties, and factors, which include, but are not limited to:</div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">business can be affected by certain risks, uncertainties and factors which include, but are not limited to:</div>
<div><br /></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="ze31b1514d7c34215a15323e68bd0faf2">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">the multiple effects of the impact of public health crises and epidemics/pandemics, such as the novel strain of COVID-19 (coronavirus) for which the financial magnitude cannot be currently estimated;</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z9e7bf4a8f4a44cac82c7bfd67fafbe71">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">changes as the result of government enacted national healthcare reform&#894;</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z2808a0b720214b01a57a4bb2311f0532">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">changes in Medicare rules and guidelines and reimbursement or failure of our clinics to maintain their Medicare certification and/or enrollment status, including Medicare reimbursement reductions.</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="zfde2f0d2b8404a08bb0ca329f250d1b0">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">revenue we receive from Medicare and Medicaid being subject to potential retroactive reduction&#894;</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z7fd641276db448b0a7c0cd6061f11e6c">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">business and regulatory conditions including federal and state regulations&#894;</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z844138e815ef4bca8b6e1d47a25474d0">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">governmental and other third-party payor inspections, reviews, investigations and audits, which may result in sanctions or reputational harm and increased costs&#894;</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z7d0283ee35b84a97b84cd7abfecf9253">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">compliance with federal and state laws and regulations relating to the privacy of individually identifiable patient information, and associated fines and penalties for failure to comply&#894;</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="zbb46f0419ff246f1a25ea929255b53c0">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">changes in reimbursement rates or payment methods from third party payors including government agencies, and changes in the deductibles and co-pays owed by patients&#894;</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="zc558c02dd4a6419f93e209295074aa02">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">revenue and earnings expectations&#894;</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z85f556755545422a95fc98c1b900c445">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">legal actions, which could subject us to increased operating costs and uninsured liabilities&#894;</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z159841406eb64cacbc0fd0cede9fe336">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">general economic conditions&#894;</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="zc12f8dc979e34d4faeff506ce804a839">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">availability and cost of qualified physical therapists&#894;</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="ze1d1f2ae41334a62aacb07fb39b279e1">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">personnel productivity and retaining key personnel&#894;</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z5798fe49d1144ca699432d0385d778e2">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">competitive, economic or reimbursement conditions in our markets which may require us to reorganize or close certain clinics and thereby incur losses and/or closure costs including the possible write-down or write-off of goodwill and other intangible assets&#894;</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z0e37c714ba8c4648bce467e5864b27c4">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">competitive environment in the industrial injury prevention business, which could result in the termination or non-renewal of contractual service arrangements and other adverse financial consequences for that service line;</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="zaee800506cc64fff8250be343cf47234">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">acquisitions, purchase of non-controlling interests (minority interests) and the successful integration of the operations of the acquired businesses&#894;</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z1b8e0d0fac56488fa650698aefe03e73">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">maintaining our information technology systems with adequate safeguards to protect against cyber-attacks&#894;</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z1b59e3405bbc4bfe875a1ebb75d30e6c">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">a security breach of our or our third party vendors&#8217; information technology systems may subject us to potential legal action and reputational harm and may result in a violation of the Health Insurance Portability and Accountability Act of 1996 of the Health Information Technology for Economic and Clinical Health Act;</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="zaf31deb4cd594423b1efa10f17768213">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">maintaining adequate internal controls&#894;</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z621bb7e83b534e95826cb30e69e2111b">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">maintaining necessary insurance coverage&#894;</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z3035e271e09142bf88953f485e066663">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">availability, terms, and use of capital&#894; and</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z5a23fd2edf7d4674ad9b315493586e8a">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">weather and other seasonal factors.</div></td>
  </tr>
</table>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; font-family: 'Times New Roman'; font-size: 10pt;">Many factors are beyond our control. Given these uncertainties, you should not place undue reliance on our forward-looking statements. Please see the other sections of this report and our other periodic reports filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) for more information on these factors. Our forward-looking statements represent our estimates and assumptions only as of the date of this report. Except as required by law, we are under no obligation to update any forward-looking statement, regardless of the reason the statement may no longer be accurate.</div>
<div><br /></div>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>3</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">PART I</div>
<div><br /></div>
<div><a id="ITEM1"><!--Anchor--></a></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="za4067749e37842f38d8f6a11d165de58">
  <tr>
    <td style="width: 72pt; vertical-align: top; align: right;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">ITEM 1.</span></td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">BUSINESS.</div></td>
  </tr>
</table>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">GENERAL</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">Our Company, U.S. Physical Therapy, Inc. and subsidiaries (&#8220;we&#8221;, &#8220;us&#8221;, &#8220;our&#8221; or the &#8220;Company&#8221;), operates its business through two reportable business segments. Our reportable segments include the physical therapy operations segment and the industrial injury prevention services segment. Our Company, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, treatment for neurological-related injuries and rehabilitation of injured workers. We primarily operate through subsidiary clinic partnerships in which we generally own a 1% general partnership interest and a 10% to 99% limited partnership interest and the managing therapist(s) of the clinics owns the remaining limited partnership interest in the majority of the clinics (hereinafter referred to as &#8220;Clinic Partnerships&#8221;). To a lesser extent, we operate some clinics through wholly-owned subsidiaries under profit sharing arrangements with therapists (hereinafter referred to as &#8220;Wholly-Owned Facilities&#8221;). We also have a majority interest in a company which is a leading provider of industrial injury prevention services. Services provided in this business include onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations and ergonomic assessments. The majority of these services are contracted with and paid for directly by employers, including a number of Fortune 500 companies. Other clients include large insurers and their contractors. These services are performed through Industrial Sports Medicine Professionals, consisting of both physical therapists and specialized certified athletic trainers (ATCs).</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; margin-right: 8pt; font-family: 'Times New Roman'; font-size: 10pt;">Our strategy is to acquire multi-clinic outpatient physical therapy practices, to develop outpatient physical therapy clinics as satellites in existing partnerships, and to continue to acquire companies that provide industrial injury prevention services. At December 31, 2020, we operated 554 clinics in 39 states. The average age of the 554 clinics in operation at December 31, 2020 was 11.03 years. Our highest concentration of clinics are in the following states: Texas, Tennessee, Michigan, Virginia, Florida, Oregon, Maryland, Georgia, Pennsylvania, Arizona, Idaho and Missouri. In addition to our 554 clinics, at December 31, 2020, we also managed 38 physical therapy practices for unrelated physician groups and hospitals, and operated the industrial injury prevention business, as described below.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">During the last three years, we completed the following acquisitions:</div>
<div><br /></div>
<div style="margin-left: 18pt;">
<table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 90%; border-collapse: collapse; text-align: left; color: #000000;" id="zd007479235c84ff18bc2a2eefbf3696a">
  <tr>
    <td style="width: 29.89%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Acquisition</div></td>
    <td style="width: 1.11%; vertical-align: bottom;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 25.47%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: center; margin-left: 3.1pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Date</div></td>
    <td style="width: 1.11%; vertical-align: bottom;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 23.58%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: center; margin-right: 2.1pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">% Interest</div><div style="text-align: center; margin-right: 2.1pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Acquired</div></td>
    <td style="width: 1.11%; vertical-align: bottom;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 17.73%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: center; margin-left: 25.1pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Number of</div><div style="text-align: center; margin-left: 24.1pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Clinics</div></td>
  </tr>
  <tr>
    <td style="width: 29.89%; vertical-align: bottom; border-top: #000000 2px solid; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">November 2020 Acquisition</div></td>
    <td style="width: 1.11%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 25.47%; vertical-align: bottom; border-top: #000000 2px solid; background-color: #CCEEFF;"><div style="text-align: center; margin-left: 5.1pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">November 30, 2020</div></td>
    <td style="width: 1.11%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 23.58%; vertical-align: bottom; border-top: #000000 2px solid; background-color: #CCEEFF;"><div style="text-align: center; margin-right: 2.1pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">75%</div></td>
    <td style="width: 1.11%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 17.73%; vertical-align: bottom; border-top: #000000 2px solid; background-color: #CCEEFF;"><div style="text-align: center; margin-left: 25.1pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">3</div></td>
  </tr>
  <tr>
    <td style="width: 29.89%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">September 2020 Acquisition</div></td>
    <td style="width: 1.11%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 25.47%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: center; margin-left: 4.1pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">September 30, 2020</div></td>
    <td style="width: 1.11%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 23.58%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: center; margin-right: 2.1pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">70%</div></td>
    <td style="width: 1.11%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 17.73%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: center; margin-left: 24.1pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">*</div></td>
  </tr>
  <tr>
    <td style="width: 29.89%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">February 2020 Acquisition</div></td>
    <td style="width: 1.11%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 25.47%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: center; margin-left: 4.1pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">February 27, 2020</div></td>
    <td style="width: 1.11%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 23.58%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: center; margin-right: 1.1pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">65% **</div></td>
    <td style="width: 1.11%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 17.73%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: center; margin-left: 25.1pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">4</div></td>
  </tr>
  <tr>
    <td style="width: 29.89%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">September 2019 Acquisition</div></td>
    <td style="width: 1.11%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 25.47%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: center; margin-left: 4.1pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">September 30, 2019</div></td>
    <td style="width: 1.11%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 23.58%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: center; margin-right: 2.1pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">67%</div></td>
    <td style="width: 1.11%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 17.73%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: center; margin-left: 25.1pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">11</div></td>
  </tr>
  <tr>
    <td style="width: 29.89%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">August 2018 Acquisition</div></td>
    <td style="width: 1.11%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 25.47%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: center; margin-left: 5.1pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">August 31, 2018</div></td>
    <td style="width: 1.11%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 23.58%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: center; margin-right: 2.1pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">70%</div></td>
    <td style="width: 1.11%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 17.73%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: center; margin-left: 25.1pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">4</div></td>
  </tr>
</table>
</div>
<div><br /></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z0608bae33a554145b9d6456242a65966">
  <tr>
    <td style="width: 36pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">*</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">The business includes six management and services contracts which had a remaining term of approximately five years as of the date acquired.</div></td>
  </tr>
</table>
<div><br /></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z32d9a30d037a497c82fe4c549f38eb1b">
  <tr>
    <td style="width: 36pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">**</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">The four clinics are in four separate partnerships. The Company's interest in the four partnerships&#160;&#160; range from 10.0% to 83.8%, with an overall 65.0% based on the initial purchase transaction.</div></td>
  </tr>
</table>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; margin-right: 3pt; font-family: 'Times New Roman'; font-size: 10pt;">In addition to the above acquisitions, in March 2017, we acquired a 55% interest in the initial industrial injury prevention business. On April 30, 2018, we acquired a 65% interest in another business in the industrial injury prevention sector and in connection with the closing we combined the two businesses. After the combination, we owned a 59.45% interest in the combined business, Briotix Health, Limited Partnership (&#8220;Briotix Health&#8221;). On April 11, 2019, we acquired a third company that is a provider of industrial injury prevention services. This acquired company specializes in delivering injury prevention and care, post offer employment testing, functional capacity evaluations and return-to-work services. It performs these services across a network in 45 states including onsite at eleven client locations. After the acquisition, the business was then combined with Briotix Health increasing our ownership position in Briotix to approximately 76.0%.</div>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>4</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div style="text-align: left; text-indent: 18pt; margin-right: 3pt; font-family: 'Times New Roman'; font-size: 10pt;">During the year ended December 31, 2020, we sold 14 previously closed clinics. The aggregate sales price was $1.1 million, of which $0.7 million was paid in cash and $0.4 million in a note receivable, payable in two equal installments of principal and any accrued interest on June 15, 2021 and 2022.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">Also during 2019, we purchased the assets and business of one physical therapy clinic in a separate transaction. The clinic operates as a satellite clinic of one of our existing partnerships. Besides the August 2018 multi-clinic acquisition referenced in the table above, we acquired five separate clinic practices that year through several of our majority owned Clinic Partnerships. These practices operate as satellites of the respective existing Clinic Partnerships.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 20.15pt; margin-right: 9pt; font-family: 'Times New Roman'; font-size: 10pt;">We continue to seek to attract for employment physical therapists who have established relationships with physicians and other referral sources by offering these therapists a competitive salary and incentives based on the profitability of the clinic that they manage. For multi-site clinic practices in which a controlling interest is acquired by us, the prior owners typically continue on as employees to manage the clinic operations, retaining a non-controlling ownership interest in the clinics and receiving a competitive salary for managing the clinic operations. In addition, we have developed satellite clinic facilities as part of existing Clinic Partnerships and Wholly-Owned Facilities, with the result that a substantial number of Clinic Partnerships and Wholly-Owned Facilities operate more than one clinic location. During 2021, we intend to continue to acquire multi-clinic practices and to continue to develop outpatient physical therapy clinics as satellites in existing partnerships, along with increasing our patient volume through marketing and new programs.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 20.15pt; margin-right: 5pt; font-family: 'Times New Roman'; font-size: 10pt;">Therapists at our clinics initially perform a comprehensive evaluation of each patient, which is then followed by a treatment plan specific to the injury as prescribed by the patient&#8217;s physician. The treatment plan may include a number of procedures, including therapeutic exercise, manual therapy techniques, ultrasound, electrical stimulation, hot packs, iontophoresis, education on management of daily life skills and home exercise programs. A clinic&#8217;s business primarily comes from referrals by local physicians. The principal sources of payment for the clinics&#8217; services are managed care programs, commercial health insurance, Medicare/Medicaid and workers&#8217; compensation insurance.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 20.15pt; font-family: 'Times New Roman'; font-size: 10pt;">We were re-incorporated in April 1992 under the laws of the State of Nevada and have operating subsidiaries organized in various states in the form of limited partnerships, limited liability companies and wholly-owned corporations. This description of our business should be read in conjunction with our financial statements and the related notes contained in Item 8 in this Annual Report on Form 10-K. Our principal executive offices are located at 1300 West Sam Houston Parkway South, Suite 300, Houston, Texas 77042. Our telephone number is (713) 297-7000. Our website is&#160; <span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"><span style="text-decoration: underline;">www.usph.com.</span></span></div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">OUR CLINICS</div>
<div><br /></div>
<div style="text-align: left; text-indent: 20.15pt; margin-right: 8pt; font-family: 'Times New Roman'; font-size: 10pt;">Most of our clinics are operated as Clinic Partnerships in which we own the general partnership interest and a majority of the limited partnership interests. The managing healthcare practitioner of the clinics usually owns a portion of the limited partnership interests. Generally, the therapist partners have no interest in the net losses of Clinic Partnerships, except to the extent of their capital accounts. Since we also develop satellite clinic facilities of existing clinics, most Clinic Partnerships consist of more than one clinic location. As of December 31, 2020, through wholly-owned subsidiaries, we owned a 1% general partnership interest in all the Clinic Partnerships. Our limited partnership interests range from 10% to 99% in the Clinic Partnerships. For the vast majority of the Clinic Partnerships, the managing healthcare practitioner is a physical therapist who owns the remaining limited partnership interest in the Clinic Partnership.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 20.15pt; font-family: 'Times New Roman'; font-size: 10pt;">For our Clinic Partnership agreements related to those in which we acquired a majority interest, generally, the prior management continues to own a 10% to 50% interest.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 20.15pt; margin-right: 1pt; font-family: 'Times New Roman'; font-size: 10pt;">Typically, each therapist partner or director, including those employed by Clinic Partnerships in which we acquired a majority interest, enters into an employment agreement for a term of up to five years with their Clinic Partnership. Each agreement typically provides for a covenant not to compete during the period of his or her employment and for up to two years thereafter. Under each employment agreement, the therapist partner receives a base salary and may receive a bonus based on the net revenues or profits generated by their Clinic Partnership or specific clinic. In the case of Clinic Partnerships, the therapist partner receives earnings distributions based upon their ownership interest. Upon termination of employment, we typically have the right, but not the obligation, to purchase the therapist&#8217;s partnership interest in de novo Clinic Partnerships. In connection with most of our acquired clinics, in the event that a limited minority partner&#8217;s employment ceases and certain requirements are met as detailed in the respective limited partnership agreements, we have a call right (the &#8220;Call Right&#8221;) and the selling entity or individual has a put right (the &#8220;Put Right&#8221;) with respect to the partner&#8217;s limited partnership interests. The Put Right and the Call Right do not expire, even upon an individual partner&#8217;s death, and contain no mandatory redemption feature. The purchase price of the partner&#8217;s limited partnership interest upon exercise of the Put Right or the Call Right is calculated at a predetermined multiple of earnings performance as detailed in the respective agreements.</div>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>5</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div style="text-align: left; text-indent: 20.15pt; font-family: 'Times New Roman'; font-size: 10pt;">Each Clinic Partnership maintains an independent local identity, while at the same time enjoying the benefits of national purchasing, negotiated third-party payor contracts, centralized support services and management practices. Under a management agreement, one of our subsidiaries provides a variety of support services to each clinic, including supervision of site selection, construction, clinic design and equipment selection, establishment of accounting systems and billing procedures and training of office support personnel, processing of accounts payable, operational direction, auditing of regulatory compliance, payroll, benefits administration, accounting services, legal services, quality assurance and marketing support.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; font-family: 'Times New Roman'; font-size: 10pt;">Our typical clinic occupies 1,000 to 7,000 square feet of leased space in an office building or shopping center. There are 14 clinics occupying space in the range of over 7,000 square feet to 13,500.square feet. We attempt to lease ground level space for patient ease of access to our clinics.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; margin-right: 8pt; font-family: 'Times New Roman'; font-size: 10pt;">Typical minimum staff at a clinic consists of a licensed physical therapist and an office manager. As patient visits grow, staffing may also include additional physical therapists, occupational therapists, therapy assistants, aides, exercise physiologists, athletic trainers and office personnel. Therapy services are performed under the supervision of a licensed therapist.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; margin-right: 8pt; font-family: 'Times New Roman'; font-size: 10pt;">We provide services at our clinics on an outpatient basis. Patients are usually treated for approximately one hour per day, two to three times a week, typically for two to six weeks. We generally charge for treatment on a per procedure basis. Medicare patients are charged based on prescribed time increments and Medicare billing standards. In addition, our clinics will develop, when appropriate, individual maintenance and self-management exercise programs to be continued after treatment. We continually assess the potential for developing new services and expanding the methods of providing our existing services in the most efficient manner while providing high quality patient care.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; margin-right: 2pt; font-family: 'Times New Roman'; font-size: 10pt;">Services provided in the industrial injury prevention services segment include onsite injury prevention and rehabilitation, performance optimization, post offer employment testing, functional capacity evaluations, and ergonomic assessments. The majority of these services are contracted with and paid for directly by employers, including a number of Fortune 500 companies. Other clients include large insurers and their contractors. We perform these services through Industrial Sports Medicine Professionals, consisting of both physical therapists and specialized certified athletic trainers (ATCs).</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">FACTORS INFLUENCING DEMAND FOR PHYSICAL THERAPY SERVICES</div>
<div><br /></div>
<div style="text-align: left; margin-left: 20pt; font-family: 'Times New Roman'; font-size: 10pt;">We believe that the following factors, among others, influence the growth of outpatient physical therapy services:</div>
<div><br /></div>
<div style="text-align: left; text-indent: 20.15pt; margin-right: 12pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Economic Benefits of Therapy Services. </span>Purchasers and providers of healthcare services, such as insurance companies, health<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">&#160;</span>maintenance organizations, businesses and industries, continuously seek cost savings for traditional healthcare services. We believe that our therapy services provide a cost-effective way to prevent short-term disabilities from becoming chronic conditions, to help avoid invasive procedures, to speed recovery from surgery and musculoskeletal injuries and eliminate or minimize the need for opioids.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 20.15pt; margin-right: 8pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Earlier Hospital Discharge. </span>Changes in health insurance reimbursement, both public and private, have encouraged the earlier<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">&#160;</span>discharge of patients to reduce costs. We believe that early hospital discharge practices foster greater demand for outpatient physical therapy services.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 20.15pt; margin-right: 7pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Aging Population. </span>In general, the elderly population has a greater incidence of disability compared to the population as a whole.<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">&#160;</span>As this segment of the population continues to grow, we believe that demand for rehabilitation services will expand.</div>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>6</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div style="text-align: left; text-indent: 22.5pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Increase in Obesity</span>. Two of every three American men are considered to be overweight or obese and the rate continues to grow.<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">&#160;</span>The strain on a person&#8217;s body can be significant. Physical therapy services help the obese become more active and fit by teaching them how to move in ways that are pain free.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">MARKETING</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; font-family: 'Times New Roman'; font-size: 10pt;">We focus our marketing efforts primarily on physicians, including orthopedic surgeons, neurosurgeons, physiatrists, internal medicine physicians, podiatrists, occupational medicine physicians and general practitioners. In marketing to the physician community, we emphasize our commitment to quality patient care and regular communication with physicians regarding patient progress. We employ personnel to assist clinic directors in developing and implementing marketing plans for the physician community and to assist in establishing relationships with health maintenance organizations, preferred provider organizations, case managers and insurance companies.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SOURCES OF REVENUE FOR PHYSICAL THERAPY OPERATIONS</div>
<div><br /></div>
<div style="text-align: left; text-indent: 20pt; font-family: 'Times New Roman'; font-size: 10pt;">Payor sources for physical therapy operations are primarily managed care programs, commercial health insurance, Medicare/Medicaid and workers&#8217; compensation insurance. Commercial health insurance, Medicare and managed care programs generally provide coverage to patients utilizing our clinics after payment by the patients of normal deductibles and co-insurance payments. Workers&#8217; compensation laws generally require employers to provide, directly or indirectly through insurance, costs of medical rehabilitation for their employees from work-related injuries and disabilities and, in some jurisdictions, mandatory vocational rehabilitation, usually without any deductibles, co-payments or cost sharing. Treatments for patients who are parties to personal injury cases are generally paid from the proceeds of settlements with insurance companies or from favorable judgments. If an unfavorable judgment is received, collection efforts are generally not pursued against the patient and the patient&#8217;s account is written-off against established reserves. Bad debt reserves relating to all receivable types are regularly reviewed and adjusted as appropriate.</div>
<div><br /></div>
<div style="text-align: left; margin-left: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">The following table shows our payor mix for the years ended ($ in thousands):</div>
<div><br /></div>
<div style="margin-left: 18pt;">
<table cellpadding="0" cellspacing="0" id="z6d5092a1ac2d4339aeaa2b55cd9aafe4" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 90%;">
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"></div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="6" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">December 31, 2020</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="6" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">December 31, 2019</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="6" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">December 31, 2018</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Payor</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Net Patient</div><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Revenue</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Percentage</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Net Patient</div><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Revenue</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Percentage</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Net Patient</div><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Revenue</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Percentage</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Managed Care Programs</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">104,513</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">28.0</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">%</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">124,516</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">28.7</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">%</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">134,748</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">32.3</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">%</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 28%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Commercial Health</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Insurance</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">73,364</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">19.7</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">%</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">79,535</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">18.4</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">%</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">72,786</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">17.4</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">%</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 28%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Medicare/Medicaid</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">118,030</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">31.6</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">%</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">132,611</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">30.6</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">%</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">117,554</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">28.1</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">%</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Workers' Compensation</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 28%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Insurance</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">48,628</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">13.0</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">%</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">63,542</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">14.7</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">%</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">59,942</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">14.4</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">%</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 28%; padding-bottom: 2px; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Other</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">28,805</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">7.7</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">%</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">33,141</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">7.6</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">%</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">32,673</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">7.8</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">%</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 28%; padding-bottom: 4px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Total</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">373,340</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">100.0</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">%</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">433,345</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">100.0</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">%</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">417,703</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">100.0</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">%</div></td>
  </tr>
</table>
</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">Our physical therapy business depends to a significant extent on our relationships with commercial health insurers, health maintenance organizations, preferred provider organizations and workers&#8217; compensation insurers. In some geographical areas, our clinics must be approved as providers by key health maintenance organizations and preferred provider plans to obtain payments. Failure to obtain or maintain these approvals would adversely affect financial results.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; margin-right: 3pt; font-family: 'Times New Roman'; font-size: 10pt;">During the year ended December 31, 2020, approximately 35.3% of our visits and 31.6% of our net patient revenues were from patients with Medicare or Medicaid program coverage. To receive Medicare reimbursement, a facility (Medicare Certified Rehabilitation Agency) or the individual therapist (Physical/Occupational Therapist in Private Practice) must meet applicable participation conditions set by the Department of Health and Human Services (&#8220;HHS&#8221;) relating to the type of facility, equipment, recordkeeping, personnel and standards of medical care, and also must comply with all state and local laws. HHS, through Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;) and designated agencies, periodically inspects or surveys clinics/providers for approval and/or compliance. We anticipate that our newly developed and acquired clinics will become certified as Medicare providers or will be enrolled as a group of physical/occupation therapists in a private practice. Failure to obtain or maintain this certification would adversely affect financial results.</div>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>7</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div style="text-align: left; text-indent: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">The Medicare program reimburses outpatient rehabilitation providers based on the Medicare Physician Fee Schedule (&#8216;&#8216;MPFS&#8217;&#8217;). For services provided in 2018, a 0.5% increase was applied to the fee schedule payment rates; for services provided in 2019, a 0.25% increase was applied to the fee schedule payment rates before applying the mandatory budget neutrality adjustment. For services provided in 2020 through 2025, a 0.0% percent update is expected to be applied each year to the fee schedule payment rates, before applying the mandatory budget neutrality adjustment. However, in the 2020 MPFS Final Rule, CMS proposed an increase to the code values for office/outpatient evaluation and management (E/M) codes and cuts to other codes to maintain budget neutrality of the MPFS. This change in code valuations was to become effective January 1, 2021 under the 2021 MPFS Final Rule, reimbursement for the codes applicable to physical/occupational therapy services were to be reduced by approximately 9% in the aggregate. The 9% reduction in payment was addressed by the Consolidated Appropriations Act, 2021 (&#8220;Act&#8221;) signed into law on December 27, 2020. Based on various provisions in the Act, we now estimate that the Medicare rate reduction for the full year of 2021 will be approximately 3.5% in aggregate.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; margin-right: 2pt; font-family: 'Times New Roman'; font-size: 10pt;">Beginning in 2021, payments to individual therapists (Physical/Occupational Therapist in Private Practice) paid under the fee schedule may be subject to adjustment based on performance in the Merit Based Incentive Payment System (&#8220;MIPS&#8221;), which measures performance based on certain quality metrics, resource use, and meaningful use of electronic health records. Under the MIPS requirements, a provider's performance is assessed according to established performance standards each year and then is used to determine an adjustment factor that is applied to the professional's payment for the corresponding payment year. The provider&#8217;s MIPS performance in 2019 will determine the payment adjustment in 2021. Each year from 2019 through 2024, professionals who receive a significant share of their revenues through an alternate payment model (&#8220;APM&#8221;), (such as accountable care organizations or bundled payment arrangements) that involves risk of financial losses and a quality measurement component will receive a 5% bonus in the corresponding payment year. The bonus payment for APM participation is intended to encourage participation and testing of new APMs and to promote the alignment of incentives across payors. The specifics of the MIPS and APM adjustments will be subject to future notice and comment rule-making.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">The Budget Control Act of 2011 increased the federal debt ceiling in connection with deficit reductions over the next ten years, and requires automatic reductions in federal spending by approximately $1.2 trillion. Payments to Medicare providers are subject to these automatic spending reductions, subject to a 2% cap. On April 1, 2013, a 2% reduction to Medicare payments was implemented. The Bipartisan Budget Act of 2015, enacted on November 2, 2015, extended the 2% reductions to Medicare payments through fiscal year 2025. The Bipartisan Budget Act of 2018, enacted on February 9, 2018, extends the 2% reductions to Medicare payments through fiscal year 2027. The Coronavirus Aid, Relief, and Economic Security (CARES) Act suspended the 2% payment reduction Medicare payments for dates of service from May 1, 2020, through December 31, 2020. The Consolidated Appropriations Act, 2021 further suspended the 2% payment reduction until March 31, 2021.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; margin-right: 1pt; font-family: 'Times New Roman'; font-size: 10pt;">Under the Middle Class Tax Relief and Job Creation Act of 2012 (&#8216;&#8216;MCTRA&#8217;&#8217;), since October 1, 2012, patients who met or exceeded $3,700 in therapy expenditures during a calendar year have been subject to a manual medical review to determine whether applicable payment criteria are satisfied. The $3,700 threshold is applied to Physical Therapy and Speech Language Pathology Services; a separate $3,700 threshold is applied to the Occupational Therapy. The Medicare Access and CHIP Reauthorization Act of 2015 (&#8220;MACRA&#8221;) directed CMS to modify the manual medical review process such that those reviews will no longer apply to all claims exceeding the $3,700 threshold and instead will be determined on a targeted basis based on a variety of factors that CMS considers appropriate The Bipartisan Budget Act of 2018 extends the targeted medical review indefinitely, but reduces the threshold to $3,000 through December 31, 2027. For 2028, the threshold amount will be increased by the percentage increase in the Medicare Economic Index (&#8220;MEI&#8221;) for 2028 and in subsequent years the threshold amount will increase based on the corresponding percentage increase in the MEI for such subsequent year.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; margin-right: 1pt; font-family: 'Times New Roman'; font-size: 10pt;">CMS adopted a multiple procedure payment reduction (&#8216;&#8216;MPPR&#8217;&#8217;) for therapy services in the final update to the MPFS for calendar year 2011. The MPPR applied to all outpatient therapy services paid under Medicare Part B &#8212; occupational therapy, physical therapy and speech-language pathology. Under the policy, the Medicare program pays 100% of the practice expense component of the Relative Value Unit (&#8216;&#8216;RVU&#8217;&#8217;) for the therapy procedure with the highest practice expense RVU, then reduces the payment for the practice expense component for the second and subsequent therapy procedures or units of service furnished during the same day for the same patient, regardless of whether those therapy services are furnished in separate sessions. Since 2013, the practice expense component for the second and subsequent therapy service furnished during the same day for the same patient was reduced by 50%. In addition, the MCTRA directed CMS to implement a claims-based data collection program to gather additional data on patient function during the course of therapy in order to better understand patient conditions and outcomes. All practice settings that provide outpatient therapy services are required to include this data on the claim form. Since 2013, therapists have been required to report new codes and modifiers on the claim form that reflect a patient&#8217;s functional limitations and goals at initial evaluation, periodically throughout care, and at discharge. Reporting of these functional limitation codes and modifiers are required on the claim for payment.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; margin-right: 5pt; font-family: 'Times New Roman'; font-size: 10pt;">Medicare claims for outpatient therapy services furnished by therapy assistants on or after January 1, 2020 must include a modifier indicating the service was furnished by a therapy assistant. Outpatient therapy services furnished on or after January 1, 2022 in whole or part by a therapy assistant will be paid at an amount equal to 85% of the payment amount otherwise applicable for the service.</div>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>8</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div style="text-align: left; text-indent: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">Statutes, regulations, and payment rules governing the delivery of therapy services to Medicare beneficiaries are complex and subject to interpretation. We believe that we are in compliance, in all material respects, with all applicable laws and regulations and are not aware of any pending or threatened investigations involving allegations of potential wrongdoing that would have a material effect on the our financial statements as of December 31, 2020. Compliance with such laws and regulations can be subject to future government review and interpretation, as well as significant regulatory action including fines, penalties, and exclusion from the Medicare program. For year ended December 31, 2020, net patient revenues from Medicare were approximately $101.6 million.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">REGULATION AND HEALTHCARE REFORM</div>
<div><br /></div>
<div style="text-align: left; text-indent: 20.15pt; margin-right: 1pt; font-family: 'Times New Roman'; font-size: 10pt;">Numerous federal, state and local regulations regulate healthcare services and those who provide them. Some states into which we may expand have laws requiring facilities employing health professionals and providing health-related services to be licensed and, in some cases, to obtain a certificate of need (that is, demonstrating to a state regulatory authority the need for, and financial feasibility of, new facilities or the commencement of new healthcare services). Only one of the states in which we currently operate requires a certificate of need for the operation of our physical therapy business functions. Our therapists and/or clinics, however, are required to be licensed, as determined by the state in which they provide services. Failure to obtain or maintain any required certificates, approvals or licenses could have a material adverse effect on our business, financial condition and results of operations.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 20.15pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Regulations Controlling Fraud and Abuse. </span>Various federal and state laws regulate financial relationships involving providers of<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">&#160;</span>healthcare services. These laws include Section 1128B(b) of the Social Security Act (42 U.S. C. &#167; 1320a-7b[b]) (the &#8220;Fraud and Abuse Law&#8221;), under which civil and criminal penalties can be imposed upon persons who, among other things, offer, solicit, pay or receive remuneration in return for (i) the referral of patients for the rendering of any item or service for which payment may be made, in whole or in part, by a Federal health care program (including Medicare and Medicaid); or (ii) purchasing, leasing, ordering, or arranging for or recommending purchasing, leasing, ordering any good, facility, service, or item for which payment may be made, in whole or in part, by a Federal health care program (including Medicare and Medicaid). We believe that our business procedures and business arrangements are in compliance with these provisions. However, the provisions are broadly written and the full extent of their specific application to specific facts and arrangements to which we are a party is uncertain and difficult to predict. In addition, several states have enacted state laws similar to the Fraud and Abuse Law, which may be more restrictive than the federal Fraud and Abuse Law.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 20.15pt; margin-right: 4pt; font-family: 'Times New Roman'; font-size: 10pt;">The Office of the Inspector General (&#8220;OIG&#8221;) of HHS has issued regulations describing compensation financial arrangements that fall within a &#8220;Safe Harbor&#8221; and, therefore, are not viewed as illegal remuneration under the Fraud and Abuse Law. Failure to fall within a Safe Harbor does not mean that the Fraud and Abuse Law has been violated; however, the OIG has indicated that failure to fall within a Safe Harbor may subject an arrangement to increased scrutiny under a &#8220;facts and circumstances&#8221; test.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 20.15pt; font-family: 'Times New Roman'; font-size: 10pt;">The OIG also has issued special fraud alerts and special advisory bulletins to remind the provider community of the importance and application of certain aspects of the Fraud and Abuse Law. One of the OIG special fraud alerts related to the rental of space in physician offices by persons or entities to which the physicians refer patients. The OIG&#8217;s stated concern in these arrangements is that rental payments may be disguised kickbacks to the physician-landlords to induce referrals. We rent clinic space for some of our clinics from referring physicians and have taken the steps that we believe are necessary to ensure that all leases comply to the extent possible and applicable, with the space rental Safe Harbor to the Fraud and Abuse Law.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 20.15pt; font-family: 'Times New Roman'; font-size: 10pt;">One of the OIG&#8217;s special advisory bulletins addressed certain complex contractual arrangements for the provision of items and services. This special advisory bulletin identified several characteristics commonly exhibited by suspect arrangements, the existence of one or more of which could indicate a prohibited arrangement to the OIG. Generally, the indicia of a suspect contractual joint venture as identified by the special advisory bulletin and an associated OIG advisory opinion include the following:</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><span style="text-decoration: underline;">New Line of Business</span></span><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">.</span><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><span style="text-decoration: underline;">&#160;</span></span>A<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><span style="text-decoration: underline;">&#160;</span></span>provider in one line of business (&#8220;Owner&#8221;) expands into a new line of business that can be provided to the<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><span style="text-decoration: underline;">&#160;</span></span>Owner&#8217;s existing patients, with another party who currently provides the same or similar item or service as the new business (&#8220;Manager/Supplier&#8221;).</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><span style="text-decoration: underline;">Captive Referral Base. </span></span>The arrangement predominantly or exclusively serves the Owner&#8217;s existing patient base (or patients under the<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><span style="text-decoration: underline;">&#160;</span></span>control or influence of the Owner).</div>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>9</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><span style="text-decoration: underline;">Little or No Bona Fide Business Risk</span></span>. The Owner&#8217;s primary contribution to the venture is referrals; it makes little or no financial or<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><span style="text-decoration: underline;">&#160;</span></span>other investment in the business, delegating the entire operation to the Manager/Supplier, while retaining profits generated from its captive referral base.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><span style="text-decoration: underline;">Status of the Manager/Supplier</span></span>. The Manager/Supplier is a would-be competitor of the Owner&#8217;s new line of business and would<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><span style="text-decoration: underline;">&#160;</span></span>normally compete for the captive referrals. It has the capacity to provide virtually identical services in its own right and bill insurers and patients for them in its own name.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><span style="text-decoration: underline;">Scope of Services Provided by the Manager/Supplier</span></span>. The Manager/Supplier provides all, or many, of the new business&#8217; key services.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><span style="text-decoration: underline;">Remuneration</span></span>. The practical effect of the arrangement, viewed in its entirety, is to provide the Owner the opportunity to bill insurers<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><span style="text-decoration: underline;">&#160;</span></span>and patients for business otherwise provided by the Manager/Supplier. The remuneration from the venture to the Owner (i.e., the profits of the venture) takes into account the value and volume of business the Owner generates.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><span style="text-decoration: underline;">Exclusivity</span></span>. The arrangement bars the Owner from providing items or services to any patients other than those coming from Owner<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><span style="text-decoration: underline;">&#160;</span></span>and/or bars the Manager/Supplier from providing services in its own right to the Owner&#8217;s patients.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; margin-right: 4pt; font-family: 'Times New Roman'; font-size: 10pt;">Due to the nature of our business operations, many of our management service arrangements exhibit one or more of these characteristics. However, we believe we have taken steps regarding the structure of such arrangements as necessary to sufficiently distinguish them from these suspect ventures, and to comply with the requirements of the Fraud and Abuse Law. However, if the OIG believes we have entered into a prohibited contractual joint venture, it could have an adverse effect on our business, financial condition and results of operations.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 20.15pt; margin-right: 2pt; font-family: 'Times New Roman'; font-size: 10pt;">Although the business of managing physician-owned and hospital-owned physical therapy facilities is regulated by the Fraud and Abuse Law, the manner in which we contract with such facilities often falls outside the complete scope of available Safe Harbors. We believe our arrangements comply with the Fraud and Abuse Law, even though federal courts provide limited guidance as to the application of the Fraud and Abuse Law to these arrangements. If our management contracts are held to violate the Fraud and Abuse Law, it could have an adverse effect on our business, financial condition and results of operations.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 20.15pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Stark Law. </span>Provisions of the Omnibus Budget Reconciliation Act of 1993 (42 U.S.C. &#167; 1395nn) (the &#8220;Stark Law&#8221;) prohibit<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">&#160;</span>referrals by a physician of &#8220;designated health services&#8221; which are payable, in whole or in part, by Medicare or Medicaid, to an entity in which the physician or the physician&#8217;s immediate family member has an investment interest or other financial relationship, subject to several exceptions. Unlike the Fraud and Abuse Law, the Stark Law is a strict liability statute. Proof of intent to violate the Stark Law is not required. Physical therapy and occupational therapy services are among the &#8220;designated health services&#8221;. Further, the Stark Law has application to our management contracts with individual physicians and physician groups, as well as, any other financial relationship between us and referring physicians, including medical advisor arrangements and any financial transaction resulting from a clinic acquisition. The Stark Law also prohibits billing for services rendered pursuant to a prohibited referral. Several states have enacted laws similar to the Stark Law. These state laws may cover all (not just Medicare and Medicaid) patients. As with the Fraud and Abuse Law, we consider the Stark Law in planning our clinics, establishing contractual and other arrangements with physicians, marketing and other activities, and believe that our operations are in compliance with the Stark Law. If we violate the Stark Law or any similar state laws, our financial results and operations could be adversely affected. Penalties for violations include denial of payment for the services, significant civil monetary penalties, and exclusion from the Medicare and Medicaid programs.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 20.15pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">HIPAA. </span>In an effort to further combat healthcare fraud and protect patient confidentially, Congress included several anti-fraud<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">&#160;</span>measures in the Health Insurance Portability and Accountability Act of 1996 (&#8220;HIPAA&#8221;). HIPAA created a source of funding for fraud control to coordinate federal, state and local healthcare law enforcement programs, conduct investigations, provide guidance to the healthcare industry concerning fraudulent healthcare practices, and establish a national data bank to receive and report final adverse actions. HIPAA also criminalized certain forms of health fraud against all public and private payors. Additionally, HIPAA mandates the adoption of standards regarding the exchange of healthcare information in an effort to ensure the privacy and electronic security of patient information and standards relating to the privacy of health information. Sanctions for failing to comply with HIPAA include criminal penalties and civil sanctions. In February of 2009, the American Recovery and Reinvestment Act of 2009 (&#8220;ARRA&#8221;) was signed into law. Title XIII of ARRA, the Health Information Technology for Economic and Clinical Health Act (&#8220;HITECH&#8221;), provided for substantial Medicare and Medicaid incentives for providers to adopt electronic health records (&#8220;EHRs&#8221;) and grants for the development of health information exchange (&#8220;HIE&#8221;). Recognizing that HIE and EHR systems will not be implemented unless the public can be assured that the privacy and security of patient information in such systems is protected, HITECH also significantly expanded the scope of the privacy and security requirements under HIPAA. Most notable are the mandatory breach notification requirements and a heightened enforcement scheme that includes increased penalties, and which now apply to business associates as well as to covered entities. In addition to HIPAA, a number of states have adopted laws and/or regulations applicable in the use and disclosure of individually identifiable health information that can be more stringent than comparable provisions under HIPAA.</div>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>10</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div style="text-align: left; text-indent: 20.15pt; font-family: 'Times New Roman'; font-size: 10pt;">We believe that our operations comply with applicable standards for privacy and security of protected healthcare information. We cannot predict what negative effect, if any, HIPAA/HITECH or any applicable state law or regulation will have on our business.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 20.15pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Other Regulatory Factors. </span>Political, economic and regulatory influences are fundamentally changing the healthcare industry in<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">&#160;</span>the United States. Congress, state legislatures and the private sector continue to review and assess alternative healthcare delivery and payment systems. Potential alternative approaches could include mandated basic healthcare benefits, controls on healthcare spending through limitations on the growth of private health insurance premiums and Medicare and Medicaid spending, the creation of large insurance purchasing groups, and price controls. Legislative debate is expected to continue in the future and market forces are expected to demand only modest increases or reduced costs. For instance, managed care entities are demanding lower reimbursement rates from healthcare providers and, in some cases, are requiring or encouraging providers to accept capitated payments that may not allow providers to cover their full costs or realize traditional levels of profitability. We cannot reasonably predict what impact the adoption of federal or state healthcare reform measures or future private sector reform may have on our business.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">COMPETITION</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; font-family: 'Times New Roman'; font-size: 10pt;">The healthcare industry, including the physical therapy business, and the industrial injury prevention services business are highly competitive. The physical therapy business as well as the industrial injury prevention services business are both highly fragmented with no company having a significant market share nationally. We believe that we are one of the largest national outpatient physical therapy services providers.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 20.15pt; margin-right: 1pt; font-family: 'Times New Roman'; font-size: 10pt;">Competitive factors affecting our business include quality of care, cost, treatment outcomes, convenience of location, and relationships with, and ability to meet the needs of, referral and payor sources. Our clinics compete, directly or indirectly, with many types of healthcare providers including the physical therapy departments of hospitals, private therapy clinics, physician-owned therapy clinics, and chiropractors. We may face more intense competition if consolidation of the therapy industry continues.</div>
<div><br /></div>
<div style="text-align: justify; text-indent: 20.15pt; margin-right: 3pt; font-family: 'Times New Roman'; font-size: 10pt;">We believe that our strategy of providing key therapists in a community with an opportunity to participate in ownership or clinic profitability provides us with a competitive advantage by helping to ensure the commitment of local management to the success of the clinic.</div>
<div><br /></div>
<div style="text-align: justify; text-indent: 19.9pt; margin-right: 12pt; font-family: 'Times New Roman'; font-size: 10pt;">We also believe that our competitive position is enhanced by our strategy of locating our clinics, when possible, on the ground floor of buildings and shopping centers with nearby parking, thereby making the clinics more easily accessible to patients. We offer convenient hours. We also attempt to make the decor in our clinics less institutional and more aesthetically pleasing than traditional hospital clinics.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ENFORCEMENT ENVIRONMENT</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; font-family: 'Times New Roman'; font-size: 10pt;">In recent years, federal and state governments have launched several initiatives aimed at uncovering behavior that violates the federal civil and criminal laws regarding false claims and fraudulent billing and coding practices. Such laws require providers to adhere to complex reimbursement requirements regarding proper billing and coding in order to be compensated for their services by government payors. Our compliance program requires adherence to applicable law and promotes reimbursement education and training&#894; however, a determination that our clinics&#8217; billing and coding practices are false or fraudulent could have a material adverse effect on us.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; font-family: 'Times New Roman'; font-size: 10pt;">As a result of our participation in the Medicare and Medicaid programs, we are subject to various governmental inspections, reviews, audits and investigations to verify our compliance with these programs and applicable laws and regulations. In addition, our Corporate Integrity Agreement, which expired in February 2021, required annual audits to be performed by an independent review organization on a small sample of our clinics, the results of which were reported to the federal government. See &#8220;-Compliance Program &#8211; Corporate Integrity Agreement&#8221; for more on the Corporate Integrity Agreement (&#8220;CIA&#8221;). Managed care payors may also reserve the right to conduct audits. An adverse inspection, review, audit or investigation could result in: refunding amounts we have been paid; fines penalties and/or revocation of billing privileges for the affected clinics; the imposition of a new Corporate Integrity Agreement; exclusion from participation in the Medicare or Medicaid programs or one or more managed care payor network; or damage to our reputation.</div>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>11</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div style="text-align: left; text-indent: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">We and our clinics are subject to federal and state laws prohibiting entities and individuals from knowingly and willfully making claims to Medicare, Medicaid and other governmental programs and third party payors that contain false or fraudulent information. The federal False Claims Act encourages private individuals to file suits on behalf of the government against healthcare providers such as us. As such suits are generally filed under seal with a court to allow the government adequate time to investigate and determine whether it will intervene in the action, the implicated healthcare providers often are unaware of the suit until the government has made its determination and the seal is lifted. Violations or alleged violations of such laws, and any related lawsuits, could result in (i) exclusion from participation in Medicare, Medicaid and other federal healthcare programs, or (ii) significant financial or criminal sanctions, resulting in the possibility of substantial financial penalties for small billing errors that are replicated in a large number of claims, as each individual claim could be deemed a separate violation. In addition, many states also have enacted similar statutes, which may include criminal penalties, substantial fines, and treble damages.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">COMPLIANCE PROGRAM</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; margin-right: 6pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Our Compliance Program. </span>Our ongoing success depends upon our reputation for quality service and ethical business practices.<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">&#160;</span>We operate in a highly regulated environment with many federal, state and local laws and regulations. We take a proactive interest in understanding and complying with the laws and regulations that apply to our business.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 20.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Our Board of Directors (the &#8220;Board&#8221;) has adopted a Code of Business Conduct and Ethics and a set of Corporate Governance Guidelines to clarify the ethical standards under which the Board and management carry out their duties. In addition, the Board has created a Compliance Committee of the Board (&#8220;Compliance Committee&#8221;) whose purpose is to assist the Board in discharging their oversight responsibilities with respect to compliance with federal and state laws and regulations relating to healthcare.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; font-family: 'Times New Roman'; font-size: 10pt;">We have issued a Compliance Manual and created compliance training materials, hand-outs and an on-line testing program. These tools were prepared to ensure that every employee of our Company and subsidiaries has a clear understanding of our mutual commitment to high standards of professionalism, honesty, fairness and compliance with the law in conducting business. These standards are administered by our Chief Compliance Officer (&#8220;CCO&#8221;), who has the responsibility for the day-to-day oversight, administration and development of our compliance program. The CCO, internal and external counsel, management and the Compliance Committee review our policies and procedures for our compliance program from time to time in an effort to improve operations and to ensure compliance with requirements of standards, laws and regulations and to reflect the on-going compliance focus areas which have been identified by management, counsel or the Compliance Committee. We also have established systems for reporting potential violations, educating our employees, monitoring and auditing compliance and handling enforcement and discipline.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 20pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Committees. </span>Our Compliance Committee, appointed by the Board, consists of four independent directors. The Compliance Committee has general oversight of our Company&#8217;s compliance with the legal and regulatory requirements regarding healthcare operations. The Compliance Committee relies on the expertise and knowledge of management, the CCO and other compliance and legal personnel. The CCO regularly communicates with the Chairman of the Compliance Committee. The Compliance Committee meets at least four times a year or more frequently as necessary to carry out its responsibilities and reports regularly to the Board regarding its actions and recommendations.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; margin-right: 7pt; font-family: 'Times New Roman'; font-size: 10pt;">We also have an Internal Compliance Committee, which is comprised of Company leaders in the areas of operations, clinical services, finance, human resources, legal, information technology and credentialing. The Internal Compliance Committee has the responsibility for evaluating and assessing Company areas of risk relating to compliance with federal and state healthcare laws, and generally to assist the CCO. The Internal Compliance Committee meets at least four times a year or more frequently as necessary to carry out its responsibilities. In addition, management has appointed a team to address our Company&#8217;s compliance with HIPAA. The HIPAA team consists of a security officer and employees from our legal, information systems, finance, operations, compliance, business services and human resources departments. The team prepares assessments and makes recommendations regarding operational changes and/or new systems, if needed, to comply with HIPAA.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; margin-right: 2pt; font-family: 'Times New Roman'; font-size: 10pt;">Each clinic certified as a Medicare Rehabilitation Agency has a formally appointed governing body composed of a member of our management and the director/administrator of the clinic. The governing body retains legal responsibility for the overall conduct of the clinic. The members confer regularly and discuss, among other issues, clinic compliance with applicable laws and regulations. In addition, there are Professional Advisory Committees which serve as Infection Control Committees. These committees meet in the facilities and function as advisors.</div>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>12</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div style="text-align: left; text-indent: 19.9pt; font-family: 'Times New Roman'; font-size: 10pt;">We have in place a Risk Management Committee consisting of, among others, the CCO, the Vice President of Human Resources, and other legal, compliance and operations personnel. This committee reviews and monitors all employee and patient incident reports and provides clinic personnel with actions to be taken in response to the reports.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; margin-right: 4pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Reporting Violations. </span>In order to facilitate our employees&#8217; ability to report in<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">&#160;</span>confidence, anonymously and without retaliation<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">&#160;</span>any perceived improper work-related activities, accounting irregularities and other violations of our compliance program, we have set up an independent national compliance hotline. The compliance hotline is available to receive confidential reports of wrongdoing Monday through Friday (excluding holidays), 24 hours a day. The compliance hotline is staffed by experienced third party professionals trained to utilize utmost care and discretion in handling sensitive issues and confidential information. The information received is documented and forwarded timely to the CCO, who, together with the Compliance Committee, has the power and resources to investigate and resolve matters of improper conduct.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Educating Our Employees. </span>We utilize numerous methods to train our employees in compliance related issues, including an online<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">&#160;</span>learning management system. All employees complete a comprehensive training program comprised of numerous modules relating to our business and proper practices when newly hired and annually thereafter. The directors/administrators also provide periodic &#8220;refresher&#8221; training for existing employees and one-on-one comprehensive training with new hires. The corporate compliance group responds to questions from clinic personnel and conducts frequent teleconference meetings, webinars and training sessions on a variety of compliance related topics.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; font-family: 'Times New Roman'; font-size: 10pt;">When a clinic opens, we provide a package of compliance materials containing manuals and detailed instructions for meeting Medicare Conditions of Participation Standards and other compliance requirements. During follow up training with the director/administrator of the clinic, compliance department staff explain various details regarding requirements and compliance standards. Compliance staff will remain in contact with the director/administrator while the clinic is implementing compliance standards and will provide any assistance required. All new office managers receive training (including Medicare, regulatory and corporate compliance, insurance billing, charge entry and transaction posting and coding, daily, weekly and monthly accounting reports) from the training staff at the corporate office. The corporate compliance group will assist in continued compliance, including guidance to the clinic staff with regard to Medicare certifications, state survey requirements and responses to any inquiries from regulatory agencies.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; margin-right: 3pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Monitoring and Auditing Clinic Operational Compliance. </span>We have in place audit programs and other procedures to monitor and<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">&#160;</span>audit clinic operational compliance with applicable policies and procedures. We employ internal auditors who, as part of their job responsibilities, conduct periodic audits of each clinic. Most clinics are audited at least once every 24 months and additional focused audits are performed as deemed necessary. During these audits, particular attention is given to compliance with Medicare and internal policies, Federal and state laws and regulations, third party payor requirements, and patient chart documentation, billing, reporting, record keeping, collections and contract procedures. The audits are conducted on site or remotely and include interviews with the employees involved in management, operations, billing and accounts receivable.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">Formal audit reports are prepared and reviewed with corporate management and the Compliance Committee. Each clinic director/administrator receives a letter instructing them of any corrective measures required. Each clinic director/administrator then works with the compliance team and operations to ensure such corrective measures are achieved.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Handling Enforcement and Discipline. </span>It is our policy that any employee who fails to comply with compliance program<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">&#160;</span>requirements or who negligently or deliberately fails to comply with known laws or regulations specifically addressed in our compliance program should be subject to disciplinary action up to and including discharge from employment. The Compliance Committee, compliance staff, human resources staff and management investigate violations of our compliance program and impose disciplinary action as considered appropriate.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; margin-right: 2pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Corporate Integrity Agreement. </span>We also performed certain additional compliance related functions pursuant to CIA that we<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">&#160;</span>entered into with the OIG. The CIA, which became effective as of December 21, 2015, and expired in February 2021, outlined certain specific requirements relating to compliance oversight and program implementation, as well as periodic reporting. In addition, pursuant to the CIA, an independent review organization annually performed a Medicare billing and coding audit on a small group of randomly selected Company clinics. Our Compliance Program was modified so as to comply with the requirements of the CIA. The term of the CIA was five years and expired in February 2021.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; margin-right: 7pt; font-family: 'Times New Roman'; font-size: 10pt;">The CIA was entered into as part of the settlement by one of our Subsidiaries with the U. S. Department of Justice related to certain Medicare billings that occurred between 2007 and 2009 at a single outpatient physical therapy clinic. The settlement resolved claims relating to whether certain physical therapy services provided to a limited number of Medicare patients at the clinic satisfied all of the criteria for payment by the Medicare program, including proper supervision of physical therapist assistants. The Subsidiary paid $718,000 in 2015 to resolve the matter, and we and the Subsidiary entered into the CIA. The Subsidiary no longer conducts any business.</div>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>13</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">EMPLOYEES</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">Our strategy to acquire physical therapy practices, develop outpatient physical therapy clinics as satellites within existing partnerships, acquire industrial injury prevention businesses, and to continue to support the growth of our existing businesses requires a talented workforce that can grow with us. As of December 31, 2020, we employed approximately 4,630 people nationwide, of which approximately 2,550 were full-time employees.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">It is crucial that we continue to attract and retain top talent. To attract and retain talented employees, we strive to make our corporate office and all of our practices and businesses a diverse and healthy workplace, with opportunities for our employees to receive continuing education, skill development, encouragement to grow and develop their career, all supported by competitive compensation, incentives, and benefits. Our clinical professionals are all licensed and a vast majority have advanced degrees. Our operational leadership teams have long-standing relationships with local and regional universities, professional affiliations, and other applicable sources that provide our practices with a talent pipeline.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">We provide competitive compensation and benefits programs to help meet our employees' needs in the practices and communities in which they serve. These programs (which can vary by practice and employment classification) include incentive compensation plans, a 401(k) plan, healthcare and insurance benefits, health savings and flexible spending accounts, paid time off, family leave, education assistance, mental health, and other employee assistance benefits.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; margin-right: 9pt; font-family: 'Times New Roman'; font-size: 10pt;">We invest resources to develop the talent needed to support our business strategy. Resources include a multitude of training and development programs delivered internally and externally, online and instructor-led, and on-the-job learning formats.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">We expect to continue adding personnel in the future as we focus on potential acquisition targets and organic growth opportunities.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; margin-right: 6pt; font-family: 'Times New Roman'; font-size: 10pt;">Beginning in March 2020, we have supported our employees and government efforts to curb the COVID-19 pandemic through a multifaceted communication, infrastructure, and behavior modification and enforcement effort:</div>
<div><br /></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z6fd06c0b30294700b520b5aba0b9f941">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">Establishing clear COVID-19 policies, health and safety protocols, and routine updates to our employees and patients;</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z1f147a69a6ec471a826ad06e94b6d026">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">Increasing cleaning protocols and hand hygiene across all locations;</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="zae99e273aa8b49df8ebd8ce6c08ad758">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">Providing additional personal protective equipment and cleaning supplies;</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z95820a1511eb4bd1a2d33135fc65ec21">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">Implementing protocols to address actual and suspected COVID-19 cases and potential exposures;</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="zdfe92025609747c59f750457458aeb5b">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">Limiting non-essential travel for all employees;</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z0a72847a01544f43844b87a82e1b4a14">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">Adjusting schedules and workload to permit remote working where possible;</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z0f42c2e320d7488fb5ff8d187618dcf8">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">Decreasing density, increasing social distancing and restricting visitors in our clinics and offices for employees working onsite; and</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="zbc2b814230294ce183f55f2c8568f973">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">Requiring masks to be worn by all individuals in all locations.</div></td>
  </tr>
</table>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; margin-right: 1pt; font-family: 'Times New Roman'; font-size: 10pt;">Additionally, due to the impact of COVID-19 on our operations, we have generated efficiencies in staffing, including limiting hiring to critical business roles, reducing scheduled hours, furloughs, and reductions-in-force. Through our employees' commitment to following operational protocols and their continued efforts to provide quality services to our patients, we have seen much of the workforce and our operations return to pre-pandemic levels. Throughout 2020, we conducted approximately 2,300 furloughs and reductions-in-force and have seen approximately 1,200 of these employees or 52%, return back to work.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">AVAILABLE INFORMATION</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; margin-right: 1pt; font-family: 'Times New Roman'; font-size: 10pt;">Our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act are made available free of charge on our internet website at <span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="text-decoration: underline;">www.usph.com </span></span>as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC.</div>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>14</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div><a id="ITEM1A"><!--Anchor--></a></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z078a79483974495995eda0624d34870b">
  <tr>
    <td style="width: 72pt; vertical-align: top; align: right;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">ITEM 1A.</span></td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">RISK FACTORS.</div></td>
  </tr>
</table>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; margin-right: 2pt; font-family: 'Times New Roman'; font-size: 10pt;">Our business, operations and financial condition are subject to various risks. Some of these risks are described below, and readers of this Annual Report on Form 10-K should take such risks into account in evaluating our Company or making any decision to invest in us. This section does not describe all risks applicable to our Company, our industry or our business, and it is intended only as a summary of material factors affecting our business.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Risks related to our business and operations</div>
<div><br /></div>
<div style="text-align: left; color: #252525; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">We are subject to risks associated with public health crises and epidemics/pandemics, such as the novel strain of coronavirus</div>
<div style="text-align: left; color: #252525; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">(&#8220;COVID-19&#8221;).</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; color: #252525; font-family: 'Times New Roman'; font-size: 10pt;">Our operations expose us to risks associated with public health crises and epidemics/pandemics, such as COVID-19 that has spread globally. Since February 2020, the continued spread has led to disruption and volatility in the global capital markets, which increases the cost of, and adversely impacts access to, capital and increases economic uncertainty. The pandemic has caused an economic slowdown of potentially extended duration, and it is possible that it could cause a global recession.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; margin-right: 2pt; color: #252525; font-family: 'Times New Roman'; font-size: 10pt;">COVID-19 is having, and will continue to have, an adverse impact on our operations and supply chains, including a temporary loss of physical therapists and other employees who are infected or quarantined for a period of time, an increase in cancellations of physical therapy patient appointments and a decline in the scheduling of new or additional patient appointments. Due to these impacts and measures, we have experienced, and will continue to experience, significant and unpredictable impact on employees and reductions and cancellations of our patient visits.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Impact on the business and cash reserves resulting from retirement or resignation of key partners and resulting purchase of their non-controlling interests (minority interests)</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; margin-right: 2pt; font-family: 'Times New Roman'; font-size: 10pt;">As described in Note 5, the redeemable non-controlling interests in our partnerships are held by our partners. Upon the occurrence of certain events, such as retirement or other termination of employment, partners from acquired partnerships may have the right to exercise a &#8220;put&#8221; to cause us to purchase their redeemable non-controlling interests. Depending on the amount and timing of the exercise of any &#8220;put&#8221; rights, the funds required could have an adverse impact on our capital structure.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Healthcare reform legislation may affect our business.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; margin-right: 1pt; font-family: 'Times New Roman'; font-size: 10pt;">In recent years, many legislative proposals have been introduced or proposed in Congress and in some state legislatures that would affect major changes in the healthcare system, either nationally or at the state level. At the federal level, Congress has continued to propose or consider healthcare budgets that substantially reduce payments under the Medicare programs. See &#8220;Business- Sources of Revenue&#8221; in Item 1 for more information. The ultimate content, timing or effect of any healthcare reform legislation and the impact of potential legislation on us is uncertain and difficult, if not impossible, to predict. That impact may be material to our business, financial condition or results of operations.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Our operations are subject to extensive regulation.</div>
<div><br /></div>
<div style="text-align: left; margin-left: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">The healthcare industry is subject to extensive federal, state and local laws and regulations relating to:</div>
<div><br /></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z0faf18aba1c84d46bc29448893844266">
  <tr>
    <td style="width: 27.15pt;"></td>
    <td style="width: 17.85pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">facility and professional licensure/permits, including certificates of need;</div></td>
  </tr>
</table>
<div><br /></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="zd2e8917bd732439fbc7d3871cea8271e">
  <tr>
    <td style="width: 27.15pt;"></td>
    <td style="width: 17.85pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">conduct of operations, including financial relationships among healthcare providers, Medicare fraud and abuse, and physician self-referral;</div></td>
  </tr>
</table>
<div><br /></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="zd9ab4af35e2449dabc1168110986d5b7">
  <tr>
    <td style="width: 27.15pt;"></td>
    <td style="width: 17.85pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">addition of facilities and services; and</div></td>
  </tr>
</table>
<div><br /></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="zad9f5957116142438fffddc525b127ad">
  <tr>
    <td style="width: 27.15pt;"></td>
    <td style="width: 17.85pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">billing and payment for services.</div></td>
  </tr>
</table>
<div><br /></div>
<div style="text-align: left; text-indent: 20.15pt; margin-right: 1pt; font-family: 'Times New Roman'; font-size: 10pt;">In recent years, there have been heightened coordinated civil and criminal enforcement efforts by both federal and state government agencies relating to the healthcare industry. We believe we are in substantial compliance with all laws, but differing interpretations or enforcement of these laws and regulations could subject our current practices to allegations of impropriety or illegality or could require us to make changes in our methods of operations, facilities, equipment, personnel, services and capital expenditure programs and increase our operating expenses. If we fail to comply with these extensive laws and government regulations, we could become ineligible to receive government program reimbursement, suffer civil or criminal penalties or be required to make significant changes to our operations. In addition, we could be forced to expend considerable resources responding to an investigation or other enforcement action under these laws or regulations. For a more complete description of certain of these laws and regulations, see &#8220;Business&#8212;Regulation and Healthcare Reform&#8221; and &#8220;Business &#8211; Compliance Program&#8221; in Item 1.</div>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>15</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div style="text-align: left; text-indent: 18pt; margin-right: 1pt; font-family: 'Times New Roman'; font-size: 10pt;">The healthcare industry is subject to extensive federal, state and local laws and regulations relating to (1) facility and professional licensure, including certificates of need, (2) conduct of operations, including financial relationships among healthcare providers, Medicare fraud and abuse and physician self-referral, (3) addition of facilities and services and enrollment of newly developed facilities in the Medicare program, (4) payment for services and (5) safeguarding protected health information.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 20.15pt; font-family: 'Times New Roman'; font-size: 10pt;">Both federal and state regulatory agencies inspect, survey and audit our facilities to review our compliance with these laws and regulations. While our facilities intend to comply with the existing licensing, Medicare certification requirements and accreditation standards, there can be no assurance that these regulatory authorities will determine that all applicable requirements are fully met at any given time. A determination by any of these regulatory authorities that a facility is not in compliance with these requirements could lead to the imposition of requirements that the facility takes corrective action, assessment of fines and penalties, or loss of licensure or Medicare certification of accreditation. These consequences could have an adverse effect on us.</div>
<div><br /></div>
<div style="text-align: left; margin-right: 14pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Decreases in Medicare reimbursement rates and payment reductions applied to the second and subsequent therapy services may adversely affect our financial results.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">The Medicare program reimburses outpatient rehabilitation providers based on the Medicare Physician Fee Schedule (&#8216;&#8216;MPFS&#8217;&#8217;). For services provided in 2018, a 0.5% increase was applied to the fee schedule payment rates; for services provided in 2019, a 0.25% increase was applied to the fee schedule payment rates before applying the mandatory budget neutrality adjustment. For services provided in 2020 through 2025, a 0.0% percent update is expected to be applied each year to the fee schedule payment rates, before applying the mandatory budget neutrality adjustment. However, in the 2020 MPFS Final Rule, CMS proposed an increase to the code values for office/outpatient evaluation and management (E/M) codes and cuts to other codes to maintain budget neutrality of the MPFS. Under the 2021 MPFS Final Rule, reimbursement for the codes applicable to physical/occupational therapy services were to be reduced by approximately 9% in the aggregate. The 9% reduction in payment was addressed by the Consolidated Appropriations Act, 2021 (&#8220;Act&#8221;) signed into law on December 27, 2020. Based on various provisions in the Act, we now estimate that the Medicare rate reduction for the full year of 2021 will be approximately 3.5% in aggregate.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; margin-right: 2pt; font-family: 'Times New Roman'; font-size: 10pt;">Beginning in 2021, payments to individual therapists (Physical/Occupational Therapist in Private Practice) paid under the fee schedule may be subject to adjustment based on performance in the Merit Based Incentive Payment System (&#8220;MIPS&#8221;), which measures performance based on certain quality metrics, resource use, and meaningful use of electronic health records. Under the MIPS requirements, a provider's performance is assessed according to established performance standards each year and then is used to determine an adjustment factor that is applied to the professional's payment for the corresponding payment year. The provider&#8217;s MIPS performance in 2019 will determine the payment adjustment in 2021. Each year from 2019 through 2024, professionals who receive a significant share of their revenues through an alternate payment model (&#8220;APM&#8221;), (such as accountable care organizations or bundled payment arrangements) that involves risk of financial losses and a quality measurement component will receive a 5% bonus in the corresponding payment year. The bonus payment for APM participation is intended to encourage participation and testing of new APMs and to promote the alignment of incentives across payors. The specifics of the MIPS and APM adjustments will be subject to future notice and comment rule-making.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">The Budget Control Act of 2011 increased the federal debt ceiling in connection with deficit reductions over the next ten years, and requires automatic reductions in federal spending by approximately $1.2 trillion. Payments to Medicare providers are subject to these automatic spending reductions, subject to a 2% cap. On April 1, 2013, a 2% reduction to Medicare payments was implemented. The Bipartisan Budget Act of 2015, enacted on November 2, 2015, extended the 2% reductions to Medicare payments through fiscal year 2025. The Bipartisan Budget Act of 2018, enacted on February 9, 2018, extends the 2% reductions to Medicare payments through fiscal year 2027. The Coronavirus Aid, Relief, and Economic Security (CARES) Act suspended the 2% payment reduction Medicare payments for dates of service from May 1, 2020, through December 31, 2020. The Consolidated Appropriations Act, 2021 further suspended the 2% payment reduction until March 31, 2021.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">Under the Middle Class Tax Relief and Job Creation Act of 2012 (&#8216;&#8216;MCTRA&#8217;&#8217;), since October 1, 2012, patients who met or exceeded $3,700 in therapy expenditures during a calendar year have been subject to a manual medical review to determine whether applicable payment criteria are satisfied. The $3,700 threshold is applied to Physical Therapy and Speech Language Pathology Services; a separate $3,700 threshold is applied to the Occupational Therapy. The MACRA directed CMS to modify the manual medical review process such that those reviews will no longer apply to all claims exceeding the $3,700 threshold and instead will be determined on a targeted basis based on a variety of factors that CMS considers appropriate The Bipartisan Budget Act of 2018 extends the targeted medical review indefinitely, but reduces the threshold to $3,000 through December 31, 2027. For 2028, the threshold amount will be increased by the percentage increase in the Medicare Economic Index (&#8220;MEI&#8221;) for 2028 and in subsequent years the threshold amount will increase based on the corresponding percentage increase in the MEI for such subsequent year.</div>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>16</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div style="text-align: left; text-indent: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">CMS adopted a multiple procedure payment reduction (&#8216;&#8216;MPPR&#8217;&#8217;) for therapy services in the final update to the MPFS for calendar year 2011. The MPPR applied to all outpatient therapy services paid under Medicare Part B &#8212; occupational therapy, physical therapy and speech-language pathology. Under the policy, the Medicare program pays 100% of the practice expense component of the Relative Value Unit (&#8216;&#8216;RVU&#8217;&#8217;) for the therapy procedure with the highest practice expense RVU, then reduces the payment for the practice expense component for the second and subsequent therapy procedures or units of service furnished during the same day for the same patient, regardless of whether those therapy services are furnished in separate sessions. Since 2013, the practice expense component for the second and subsequent therapy service furnished during the same day for the same patient was reduced by 50%. In addition, the MCTRA directed CMS to implement a claims-based data collection program to gather additional data on patient function during the course of therapy in order to better understand patient conditions and outcomes. All practice settings that provide outpatient therapy services are required to include this data on the claim form. Since 2013, therapists have been required to report new codes and modifiers on the claim form that reflect a patient&#8217;s functional limitations and goals at initial evaluation, periodically throughout care, and at discharge. Reporting of these functional limitation codes and modifiers are required on the claim for payment.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">Medicare claims for outpatient therapy services furnished by therapy assistants on or after January 1, 2020 must include a modifier indicating the service was furnished by a therapy assistant. Outpatient therapy services furnished on or after January 1, 2022 in whole or part by a therapy assistant will be paid at an amount equal to 85% of the payment amount otherwise applicable for the service.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">Statutes, regulations, and payment rules governing the delivery of therapy services to Medicare beneficiaries are complex and subject to interpretation. We believe that we are in compliance, in all material respects, with all applicable laws and regulations and are not aware of any pending or threatened investigations involving allegations of potential wrongdoing that would have a material effect on the our financial statements as of December 31, 2020. Compliance with such laws and regulations can be subject to future government review and interpretation, as well as significant regulatory action including fines, penalties, and exclusion from the Medicare program. For year ended December 31, 2020, net patient revenues from Medicare were approximately $101.6 million.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 20.15pt; margin-right: 3pt; font-family: 'Times New Roman'; font-size: 10pt;">Given the history of frequent revisions to the Medicare program and its reimbursement rates and rules, we may not continue to receive reimbursement rates from Medicare that sufficiently compensate us for our services or, in some instances, cover our operating costs. Limits on reimbursement rates or the scope of services being reimbursed could have a material adverse effect on our revenue, financial condition and results of operations. Additionally, any delay or default by the federal or state governments in making Medicare and/or Medicaid reimbursement payments could materially and, adversely, affect our business, financial condition and results of operations.</div>
<div><br /></div>
<div style="text-align: left; margin-right: 18pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">We expect the federal and state governments to continue their efforts to contain growth in Medicaid expenditures, which could adversely affect our revenue and profitability.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; margin-right: 1pt; font-family: 'Times New Roman'; font-size: 10pt;">Medicaid spending has increased rapidly in recent years, becoming a significant component of state budgets. This, combined with slower state revenue growth, has led both the federal government and many states to institute measures aimed at controlling the growth of Medicaid spending, and in some instances reducing aggregate Medicaid spending. We expect these state and federal efforts to continue for the foreseeable future. Furthermore, not all of the states in which we operate, most notably Texas, have elected to expand Medicaid as part of federal healthcare reform legislation. There can be no assurance that the program, on the current terms or otherwise, will continue for any particular period of time beyond the foreseeable future. If Medicaid reimbursement rates are reduced or fail to increase as quickly as our costs, or if there are changes in the rules governing the Medicaid program that are disadvantageous to our businesses, our business and results of operations could be materially and adversely affected.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Revenue we receive from Medicare and Medicaid is subject to potential retroactive reduction.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; font-family: 'Times New Roman'; font-size: 10pt;">Payments we receive from Medicare and Medicaid can be retroactively adjusted after examination during the claims settlement process or as a result of post-payment audits. Payors may disallow our requests for reimbursement, or recoup amounts previously reimbursed, based on determinations by the payors or their third-party audit contractors that certain costs are not reimbursable because either adequate or additional documentation was not provided or because certain services were not covered or deemed to not be medically necessary. Significant adjustments, recoupments or repayments of our Medicare or Medicaid revenue, and the costs associated with complying with investigative audits by regulatory and governmental authorities, could adversely affect our financial condition and results of operations.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; margin-right: 4pt; font-family: 'Times New Roman'; font-size: 10pt;">Additionally, from time to time we become aware, either based on information provided by third parties and/or the results of internal audits, of payments from payor sources that were either wholly or partially in excess of the amount that we should have been paid for the service provided. Overpayments may result from a variety of factors, including insufficient documentation supporting the services rendered or medical necessity of the services or other failures to document the satisfaction of the necessary conditions of payment. We are required by law in most instances to refund the full amount of the overpayment after becoming aware of it, and failure to do so within requisite time limits imposed by the law could lead to significant fines and penalties being imposed on us. Furthermore, our initial billing of and payments for services that are unsupported by the requisite documentation and satisfaction of any other conditions of payment, regardless of our awareness of the failure at the time of the billing or payment, could expose us to significant fines and penalties. We, and/or certain of our operating companies, could also be subject to exclusion from participation in the Medicare or Medicaid programs in some circumstances as well, in addition to any monetary or other fines, penalties or sanctions that we may incur under applicable federal and/or state law. Our repayment of any such amounts, as well as any fines, penalties or other sanctions that we may incur, could be significant and could have a material and adverse effect on our results of operations and financial condition.</div>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>17</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div style="text-align: left; text-indent: 19.9pt; font-family: 'Times New Roman'; font-size: 10pt;">From time to time we are also involved in various external governmental investigations, audits and reviews. Reviews, audits and investigations of this sort can lead to government actions, which can result in the assessment of damages, civil or criminal fines or penalties, or other sanctions, including restrictions or changes in the way we conduct business, loss of licensure or exclusion from participation in government programs. Failure to comply with applicable laws, regulations and rules could have a material and adverse effect on our results of operations and financial condition. Furthermore, becoming subject to these governmental investigations, audits and reviews can also require us to incur significant legal and document production expenses as we cooperate with the government authorities, regardless of whether the particular investigation, audit or review leads to the identification of underlying issues.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">As a result of increased post-payment reviews of claims we submit to Medicare for our services, we may incur additional costs and may be required to repay amounts already paid to us.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; font-family: 'Times New Roman'; font-size: 10pt;">We are subject to regular post-payment inquiries, investigations and audits of the claims we submit to Medicare for payment for our services. These post-payment reviews have increased as a result of government cost-containment initiatives. These additional post-payment reviews may require us to incur additional costs to respond to requests for records and to pursue the reversal of payment denials, and ultimately may require us to refund amounts paid to us by Medicare that are determined to have been overpaid.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; font-family: 'Times New Roman'; font-size: 10pt;">For a further description of this and other laws and regulations involving governmental reimbursements, see &#8220;Business&#8212;Sources of Revenue&#8221; and &#8220;&#8212;Regulation and Healthcare Reform&#8221; in Item 1.</div>
<div><br /></div>
<div style="text-align: left; margin-right: 1pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">An economic downturn, state budget pressures, sustained unemployment and continued deficit spending by the federal government may result in a reduction in reimbursement and covered services.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 20.15pt; font-family: 'Times New Roman'; font-size: 10pt;">An economic downturn, including the consequences of a pandemic, such as COVID-19, could have a detrimental effect on our revenues. Historically, state budget pressures have translated into reductions in state spending. Given that Medicaid outlays are a significant component of state budgets, we can expect continuing cost containment pressures on Medicaid outlays for our services in the states in which we operate. In addition, an economic downturn, coupled with sustained unemployment, may also impact the number of enrollees in managed care programs as well as the profitability of managed care companies, which could result in reduced reimbursement rates.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 20.15pt; font-family: 'Times New Roman'; font-size: 10pt;">The existing federal deficit, as well as deficit spending by federal and state governments as the result of adverse developments in the economy or other reasons, can lead to continuing pressure to reduce governmental expenditures for other purposes, including government-funded programs in which we participate, such as Medicare and Medicaid. Such actions in turn may adversely affect our results of operations.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">We depend upon reimbursement by third-party payors.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; font-family: 'Times New Roman'; font-size: 10pt;">Substantially all of our revenues are derived from private and governmental third-party payors. In 2020, approximately 68.4% of our revenues were derived collectively from managed care plans, commercial health insurers, workers&#8217; compensation payors, and other private pay revenue sources while approximately 31.6% of our revenues were derived from Medicare and Medicaid. Initiatives undertaken by industry and government to contain healthcare costs affect the profitability of our clinics. These payors attempt to control healthcare costs by contracting with healthcare providers to obtain services on a discounted basis. We believe that this trend will continue and may limit reimbursement for healthcare services. If insurers or managed care companies from whom we receive substantial payments were to reduce the amounts they pay for services, our profit margins may decline, or we may lose patients if we choose not to renew our contracts with these insurers at lower rates. In addition, in certain geographical areas, our clinics must be approved as providers by key health maintenance organizations and preferred provider plans. Failure to obtain or maintain these approvals would adversely affect our financial results.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; font-family: 'Times New Roman'; font-size: 10pt;">In recent years, through legislative and regulatory actions, the federal government has made substantial changes to various payment systems under the Medicare program. See &#8220;Business&#8212;Sources of Revenue&#8221; in Item 1 for more information including changes to Medicare reimbursement. Additional reforms or other changes to these payment systems may be proposed or adopted, either by the U.S. Congress or by CMS, including bundled payments, outcomes-based payment methodologies and a shift away from traditional fee-for-service reimbursement. If revised regulations are adopted, the availability, methods and rates of Medicare reimbursements for services of the type furnished at our facilities could change. Some of these changes and proposed changes could adversely affect our business strategy, operations and financial results.</div>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>18</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div style="text-align: left; margin-right: 9pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">We face inspections, reviews, audits and investigations under federal and state government programs and contracts. These audits could have adverse findings that may negatively affect our business.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; font-family: 'Times New Roman'; font-size: 10pt;">As a result of our participation in the Medicare and Medicaid programs, we are subject to various governmental inspections, reviews, audits and investigations to verify our compliance with these programs and applicable laws and regulations. Managed care payors may also reserve the right to conduct audits. An adverse inspection, review, audit or investigation could result in:</div>
<div><br /></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z8dbf2bda625f4eb99e8d73126245d380">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">refunding amounts we have been paid pursuant to the Medicare or Medicaid programs or from managed care payors;</div></td>
  </tr>
</table>
<div><br /></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z416a8aff90f6499e8db99ea944b2d26f">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">state or federal agencies imposing fines, penalties and other sanctions on us;</div></td>
  </tr>
</table>
<div><br /></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z557b73880c8c45ee978fb291e70581b3">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">temporary suspension of payment for new patients to the facility or agency;</div></td>
  </tr>
</table>
<div><br /></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z1c56a5ca4c0f4a9fbae770e0450e42c1">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">decertification or exclusion from participation in the Medicare or Medicaid programs or one or more managed care payor networks;</div></td>
  </tr>
</table>
<div><br /></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z5126283db8f54ec6993e3d06b90b0c8a">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">expansion of the scope of our Corporate Integrity Agreement or the imposition of a new Corporate Integrity Agreement;</div></td>
  </tr>
</table>
<div><br /></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="ze162aa3ee440409da94cb0d4936e33e2">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">damage to our reputation;</div></td>
  </tr>
</table>
<div><br /></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z41e95db9fd1b4182ba7485c7552df609">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">the revocation of a facility&#8217;s or agency&#8217;s license&#894; and</div></td>
  </tr>
</table>
<div><br /></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z859fd9862fb949d8aa585c8b8df69d64">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">loss of certain rights under, or termination of, our contracts with managed care payors.</div></td>
  </tr>
</table>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; font-family: 'Times New Roman'; font-size: 10pt;">If adverse inspections, reviews, audits or investigations occur and any of the results noted above occur, it could have a material adverse effect on our business and operating results.</div>
<div><br /></div>
<div style="text-align: left; margin-right: 25pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Our facilities are subject to extensive federal and state laws and regulations relating to the privacy of individually identifiable information.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 20.15pt; margin-right: 1pt; font-family: 'Times New Roman'; font-size: 10pt;">HIPAA required the HHS to adopt standards to protect the privacy and security of individually identifiable health-related information. The department released final regulations containing privacy standards in 2000 and published revisions to the final regulations in 2002. The privacy regulations extensively regulate the use and disclosure of individually identifiable health-related information. The regulations also provide patients with significant rights related to understanding and controlling how their health information is used or disclosed. The security regulations require healthcare providers to implement administrative, physical and technical practices to protect the security of individually identifiable health information that is maintained or transmitted electronically. HITECH, which was signed into law in 2009, enhanced the privacy, security and enforcement provisions of HIPAA by, among other things establishing security breach notification requirements, allowing enforcement of HIPAA by state attorneys general, and increasing penalties for HIPAA violations. Violations of HIPAA or HITECH could result in civil or criminal penalties.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 20.15pt; font-family: 'Times New Roman'; font-size: 10pt;">In addition to HIPAA, there are numerous federal and state laws and regulations addressing patient and consumer privacy concerns, including unauthorized access or theft of personal information. State statutes and regulations vary from state to state. Lawsuits, including class actions and action by state attorneys general, directed at companies that have experienced a privacy or security breach also can occur.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 20.15pt; margin-right: 2pt; font-family: 'Times New Roman'; font-size: 10pt;">We have established policies and procedures in an effort to ensure compliance with these privacy related requirements. However, if there is a breach, we may be subject to various penalties and damages and may be required to incur costs to mitigate the impact of the breach on affected individuals.</div>
<div><br /></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">In conducting our business, we are required to comply with applicable laws regarding fee-splitting and the corporate practice of medicine.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;">Some states prohibit the &#8220;corporate practice of therapy&#8221; that restricts business corporations from providing physical therapy services through the direct employment of therapist physicians or from exercising control over medical decisions by therapists. The laws relating to corporate practice vary from state to state and are not fully developed in each state in which we have facilities. Typically, however, professional corporations owned and controlled by licensed professionals are exempt from corporate practice restrictions and may employ therapists to furnish professional services. Those professional corporations may be managed by business corporations, such as the Company.</div>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>19</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div style="text-align: left; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;">Some states also prohibit entities from engaging in certain financial arrangements, such as fee-splitting, with physicians or therapists. The laws relating to fee-splitting also vary from state to state and are not fully developed. Generally, these laws restrict business arrangements that involve a physician or therapist sharing medical fees with a referral source, but in some states, these laws have been interpreted to extend to management agreements between physicians or therapists and business entities under some circumstances.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 23.75pt; font-family: 'Times New Roman'; font-size: 10pt;">We believe that our current and planned activities do not constitute fee-splitting or the unlawful corporate practice of medicine as contemplated by these state laws. However, there can be no assurance that future interpretations of such laws will not require structural and organizational modification of our existing relationships with the practices. If a court or regulatory body determines that we have violated these laws or if new laws are introduced that would render our arrangements illegal, we could be subject to civil or criminal penalties, our contracts could be found legally invalid and unenforceable (in whole or in part), or we could be required to restructure our contractual arrangements with our affiliated physicians and other licensed providers.</div>
<div><br /></div>
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Failure to maintain effective internal control over our financial reporting could have an adverse effect on our ability to report our financial results on a timely and accurate basis.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; font-family: 'Times New Roman'; font-size: 10pt;">We are required to produce our consolidated financial statements in accordance with the requirements of accounting principles generally accepted in the United States of America. Effective internal control over financial reporting is necessary for us to provide reliable financial reports, to help mitigate the risk of fraud and to operate successfully. We are required by federal securities laws to document and test our internal control procedures in order to satisfy the requirements of the Sarbanes-Oxley Act of 2002, which requires annual management assessments of the effectiveness of our internal control over financial reporting.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; margin-right: 2pt; font-family: 'Times New Roman'; font-size: 10pt;">Testing and maintaining our internal control over financial reporting can be expensive and divert our management&#8217;s attention from other matters that are important to our business. We may not be able to conclude on an ongoing basis that we have effective internal control over financial reporting in accordance with applicable law, or our independent registered public accounting firm may not be able to issue an unqualified attestation report if we conclude that our internal control over financial reporting is not effective. If we fail to maintain effective internal control over financial reporting, or our independent registered public accounting firm is unable to provide us with an unqualified attestation report on our internal control, we could be required to take costly and time-consuming corrective measures, be required to restate the affected historical financial statements, be subjected to investigations and/or sanctions by federal and state securities regulators, and be subjected to civil lawsuits by security holders. Any of the foregoing could also cause investors to lose confidence in our reported financial information and in us and would likely result in a decline in the market price of our stock and in our ability to raise additional financing if needed in the future.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">We may be adversely affected by a security breach, such as a cyber-attack, which may cause a violation of HIPAA or HITECH and subject us to potential legal and reputational harm.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 24pt; margin-right: 1pt; font-family: 'Times New Roman'; font-size: 10pt;">In the normal course of business, our information technology systems hold sensitive patient information including patient demographic data and other protected health information, which is subject to HIPAA and HITECH. We also contract with third-party vendors to maintain and store our patient&#8217;s individually identifiable health information. Numerous state and federal laws and regulations address privacy and information security concerns resulting from our access to our patient&#8217;s and employee&#8217;s personal information.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 24pt; font-family: 'Times New Roman'; font-size: 10pt;">Our information technology systems and those of our vendors that process, maintain, and transmit such data are subject to computer viruses, cyber-attacks, or breaches. We adhere to policies and procedures designed to ensure compliance with HIPAA and other privacy and information security laws and require our third-party vendors to do so as well. If, however, we or our third-party vendors experience a breach, loss, or other compromise of unsecured protected health information or other personal information, such an event could result in significant civil and criminal penalties, lawsuits, reputational harm, and increased costs to us, any of which could have a material adverse effect on our financial condition and results of operations.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 22.55pt; margin-right: 1pt; font-family: 'Times New Roman'; font-size: 10pt;">Furthermore, while our information technology systems, and those of our third-party vendors, are maintained with safeguards protecting against cyber-attacks. A cyber-attack that bypasses our information technology security systems, or those of our third-party vendors, could result in a material adverse effect on our business, financial condition, results of operations, or cash flows. In addition, our future results could be adversely affected due to the theft, destruction, loss, misappropriation, or release of protected health information, other confidential data or proprietary business information, operational or business delays resulting from the disruption of information technology systems and subsequent mitigation activities, or regulatory action taken as a result of such incident. We provide our employees training and regular reminders on important measures they can take to prevent breaches. We routinely identify attempts to gain unauthorized access to our systems. However, given the rapidly evolving nature and proliferation of cyber threats, there can be no assurance our training and network security measures or other controls will detect, prevent, or remediate security or data breaches in a timely manner or otherwise prevent unauthorized access to, damage to, or interruption of our systems and operations. Accordingly, we may be vulnerable to losses associated with the improper functioning, security breach, or unavailability of our information systems as well as any systems used in acquired operations.</div>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>20</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">We depend upon the cultivation and maintenance of relationships with the physicians in our markets.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 22.55pt; margin-right: 1pt; font-family: 'Times New Roman'; font-size: 10pt;">Our success is dependent upon referrals from physicians in the communities our clinics serve and our ability to maintain good relations with these physicians and other referral sources. Physicians referring patients to our clinics are free to refer their patients to other therapy providers or to their own physician owned therapy practice. If we are unable to successfully cultivate and maintain strong relationships with physicians and other referral sources, our business may decrease and our net operating revenues may decline.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">We depend upon our ability to recruit and retain experienced physical therapists.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 20.15pt; font-family: 'Times New Roman'; font-size: 10pt;">Our revenue generation is dependent upon referrals from physicians in the communities our clinics serve, and our ability to maintain good relations with these physicians. Our therapists are the front line for generating these referrals and we are dependent on their talents and skills to successfully cultivate and maintain strong relationships with these physicians. If we cannot recruit and retain our base of experienced and clinically skilled therapists, our business may decrease and our net operating revenues may decline. Periodically, we have clinics in isolated communities that are temporarily unable to operate due to the unavailability of a therapist who satisfies our standards.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">We may also experience increases in our labor costs, primarily due to higher wages and greater benefits required to attract and retain qualified healthcare personnel, and such increases may adversely affect our profitability. Furthermore, while we attempt to manage overall labor costs in the most efficient way, our efforts to manage them may have limited effectiveness and may lead to increased turnover and other challenges.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Our revenues may fluctuate due to weather.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; font-family: 'Times New Roman'; font-size: 10pt;">We have a significant number of clinics in states that normally experience snow and ice during the winter months. Also, a significant number of our clinics are located in states along the Gulf Coast and Atlantic Coast which are subject to periodic winter storms, hurricanes and other severe storm systems. Periods of severe weather may cause physical damage to our facilities or prevent our staff or patients from traveling to our clinics, which may cause a decrease in our net operating revenues.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">We operate in a highly competitive industry.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; font-family: 'Times New Roman'; font-size: 10pt;">We encounter competition from local, regional or national entities, some of which have superior resources or other competitive advantages. Intense competition may adversely affect our business, financial condition or results of operations. For a more complete description of this competitive environment, see &#8220;Business&#8212;Competition&#8221; in Item 1. An adverse effect on our business, financial condition or results of operations may require us to write down goodwill.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">We may incur closure costs and losses.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 20.15pt; font-family: 'Times New Roman'; font-size: 10pt;">The competitive, economic or reimbursement conditions in our markets in which we operate may require us to reorganize or to close certain clinics. In the event a clinic is reorganized or closed, we may incur losses and closure costs. The closure costs and losses may include, but are not limited to, lease obligations, severance, and write-down or write-off of goodwill and other intangible assets.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Future acquisitions may use significant resources, may be unsuccessful and could expose us to unforeseen liabilities.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; margin-right: 2pt; font-family: 'Times New Roman'; font-size: 10pt;">As part of our growth strategy, we intend to continue pursuing acquisitions of outpatient physical therapy clinics and industrial injury prevention businesses. Acquisitions may involve significant cash expenditures, potential debt incurrence and operational losses, dilutive issuances of equity securities and expenses that could have an adverse effect on our financial condition and results of operations. Acquisitions involve numerous risks, including:</div>
<div><br /></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z5df03ff8339a4a8096c9e96116e5989c">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">the difficulty and expense of integrating acquired personnel into our business;</div></td>
  </tr>
</table>
<div><br /></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="zabc8be0a559c4a26b5761ffdca88493b">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">the diversion of management&#8217;s time from existing operations&#894;</div></td>
  </tr>
</table>
<div><br /></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z1f14a296f8d24a0b991c9b6d1c4e316d">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">the potential loss of key employees of acquired companies;</div></td>
  </tr>
</table>
<div><br /></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z0c271e0942134015a32f7230052ca0bb">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">the difficulty of assignment and/or procurement of managed care contractual arrangements; and</div></td>
  </tr>
</table>
<div><br /></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="zbf6c4fd370384bbcb04d5d04675eda2e">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">the assumption of the liabilities and exposure to unforeseen liabilities of acquired companies, including liabilities for failure to comply with healthcare regulations.</div></td>
  </tr>
</table>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>21</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Risks related to our common stock</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Issuance of shares in connection with financing transactions or under stock incentive plans will dilute current stockholders.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to our stock incentive plans, our Compensation Committee of the Board, consisting solely of independent directors, is authorized to grant stock awards to our employees, directors and consultants. Shareholders will incur dilution upon the exercise of any outstanding stock awards or the grant of any restricted stock. In addition, if we raise additional funds by issuing additional common stock, or securities convertible into or exchangeable or exercisable for common stock, further dilution to our existing stockholders will result, and new investors could have rights superior to existing stockholders.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">The number of shares of our common stock eligible for future sale could adversely affect the market price of our stock.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 20.15pt; margin-right: 1pt; font-family: 'Times New Roman'; font-size: 10pt;">At December 31, 2020, we had reserved approximately 233,000 shares for future equity grants. We may issue additional restricted securities or register additional shares of common stock under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), in the future. The issuance of a significant number of shares of common stock upon the exercise of stock options or the availability for sale, or sale, of a substantial number of the shares of common stock eligible for future sale under effective registration statements, under Rule 144 or otherwise, could adversely affect the market price of the common stock.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Provisions in our articles of incorporation and bylaws could delay or prevent a change in control of our company, even if that change would be beneficial to our stockholders.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; font-family: 'Times New Roman'; font-size: 10pt;">Certain provisions of our articles of incorporation and bylaws may delay, discourage, prevent or render more difficult an attempt to obtain control of our company, whether through a tender offer, business combination, proxy contest or otherwise. These provisions include the charter authorization of &#8220;blank check&#8221; preferred stock and a restriction on the ability of stockholders to call a special meeting.</div>
<div><br /></div>
<div><a id="ITEM1B"><!--Anchor--></a></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="zf22d912a6e3b41f19efcbbeab67ec276">
  <tr>
    <td style="width: 72pt; vertical-align: top; align: right;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">ITEM 1B.</span></td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">UNRESOLVED STAFF COMMENTS.</div></td>
  </tr>
</table>
<div><br /></div>
<div style="text-align: left; margin-left: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">None</div>
<div><br /></div>
<div><a id="ITEM2"><!--Anchor--></a></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z4fcecb0370c64acf87b60b26b6ee13cd">
  <tr>
    <td style="width: 72pt; vertical-align: top; align: right;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">ITEM 2.</span></td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">PROPERTIES.</div></td>
  </tr>
</table>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; font-family: 'Times New Roman'; font-size: 10pt;">We lease the properties used for our clinics under non-cancelable operating leases with terms ranging from one to five years, with the exception of the property for one clinic which we own. We intend to lease the premises for any new clinic locations except in rare instances where leasing is not a cost-effective alternative. Our typical clinic occupies 1,000 to 7,000 square feet. There are 14 clinics occupying space in the range of over 7,000 square feet to 13,500 square feet.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 20.15pt; font-family: 'Times New Roman'; font-size: 10pt;">We also lease our executive offices located in Houston, Texas, under a non-cancelable operating lease expiring in February 2028. We currently lease approximately 44,000 square feet of space (including allocations for common areas) at our executive offices.</div>
<div><br /></div>
<div><a id="ITEM3"><!--Anchor--></a></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="zb5ce55928e7e4bdbb29877f24182bc7d">
  <tr>
    <td style="width: 72pt; vertical-align: top; align: right;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">ITEM 3.</span></td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">LEGAL PROCEEDINGS.</div></td>
  </tr>
</table>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">We are a party to various legal actions, proceedings, and claims (some of which are not insured), and regulatory and other governmental audits and investigations in the ordinary course of our business. We cannot predict the ultimate outcome of pending litigation, proceedings, and regulatory and other governmental audits and investigations. These matters could potentially subject us to sanctions, damages, recoupments, fines, and other penalties. The Department of Justice, CMS, or other federal and state enforcement and regulatory agencies may conduct additional investigations related to our businesses in the future that may, either individually or in the aggregate, have a material adverse effect on our business, financial position, results of operations, and liquidity.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">Healthcare providers are subject to lawsuits under the qui tam provisions of the federal False Claims Act. Qui tam lawsuits typically remain under seal for some time while the government decides whether or not to intervene on behalf of a private qui tam plaintiff (known as a relator) and take the lead in the litigation. These lawsuits can involve significant monetary damages and penalties and award bounties to private plaintiffs who successfully bring the suits. We are and have been a defendant in these cases in the past, and may be named as a defendant in similar cases from time to time in the future.</div>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>22</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Florida Litigation</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">On August 19, 2019, we received notice of a qui tam lawsuit filed by a relator on behalf of the United States, titled U.S. ex rel. Bonnie Elsdon, v. U.S. Physical Therapy, Inc., U.S. Physical Therapy, Ltd., Rehab Partners #2, Inc., The Hale Hand Center, Limited Partnership (the &#8220;Hale Partnership&#8221;), and Suzanne Hale. This whistleblower lawsuit was filed in the U.S. District Court for the Southern District of Texas, seeking damages and civil penalties under the federal False Claim Act. This lawsuit was originally filed under seal by a former employee of The Hale Hand Center, Limited Partnership (&#8220;Hale Partnership&#8221;), a majority-owned subsidiary of the Company, on May 25, 2018. The U.S Government declined to intervene in the case and unsealed the Complaint on July 17, 2019. The plaintiff - relator served the Complaint on us and the other named defendants on August 19, 2019.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">The Complaint alleges that the Hale Partnership engaged in conduct to purposely &#8220;upcode&#8221; its billings for services provided to Medicare patients. The plaintiff - relator points to three dates of service and provides examples of what it alleges are inflated billings by the Hale Partnership; the relator then claims that similar false claims must have occurred on other days and at other Company-owned partnerships.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; margin-right: 5pt; font-family: 'Times New Roman'; font-size: 10pt;">On October 3, 2019, we filed Motions to Dismiss based on numerous grounds on behalf of each of the named defendants. On October 29, 2019, the plaintiff-relator dismissed three of the named defendants, Rehab Partners #2, Inc., U.S. Physical Therapy, Ltd., and Suzanne Hale. The Motions to Dismiss as to the remaining two defendants has been fully briefed and is pending before the Court for a ruling.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">We have engaged counsel and fully investigated the matter, and believe that the allegations in the Complaint have no merit. We intend to vigorously defend this action, but at this time we are unable to predict the timing and outcome of the matter.</div>
<div><br /></div>
<div><a id="ITEM4"><!--Anchor--></a></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z68d0ff82de0847f18d0a405da2c43a04">
  <tr>
    <td style="width: 72pt; vertical-align: top; align: right;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">ITEM 4.</span></td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">MINE SAFETY DISCLOSURES.</div></td>
  </tr>
</table>
<div><br /></div>
<div style="text-align: left; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Not Applicable.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">PART II</div>
<div><br /></div>
<div><a id="ITEM5"><!--Anchor--></a></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z373446fb7bc944498557515f73fbfdb2">
  <tr>
    <td style="width: 72pt; vertical-align: top; align: right;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">ITEM 5.</span></td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">MARKET FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.</div></td>
  </tr>
</table>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">Our common stock has traded on the New York Stock Exchange (&#8220;NYSE&#8221;) since August 14, 2012 under the symbol &#8220;USPH.&#8221; Prior to that, our common stock was traded on the Nasdaq Global Select Market under the symbol &#8220;USPH&#8221;. As of March 1, 2021, there were 79 holders of record of our outstanding common stock.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">DIVIDENDS</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">On February 23, 2021, our Board of Directors declared a dividend of $0.35 per share which will be paid on April 9, 2021 to shareholders of record as of March 12, 2021. During 2020, we paid a cash dividend for the first quarter of 2020 of $0.32 per share on all shares of common stock issued and outstanding as of April 17, 2020 which amounted to $4.1 million. In March 2020, our Board of Directors announced the suspension of any further dividends in 2020. During 2019, we paid a quarterly dividend of $0.27 for the first and second quarters and $0.30 per share for the third and fourth quarters, totaling $1.14 per share for the year, which amounted to total aggregate cash payments of dividends to holders of our common stock in 2019 of approximately $14.5 million. During 2018, we paid a regular quarterly dividend of $0.23 per share, totaling $0.92 per share, which amounted to total aggregate cash payments of dividends to holders of our common stock in 2018 of approximately $11.7 million. We are currently restricted from paying dividends in excess of $50,000,000 in any fiscal year on our common stock under the Credit Agreement (as defined in &#8216;&#8216;Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations &#8212; Liquidity and Capital Resources&#8217;&#8217;).</div>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>23</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">FIVE YEAR PERFORMANCE GRAPH</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; font-family: 'Times New Roman'; font-size: 10pt;">The performance graph and related description shall not be deemed incorporated by reference into any filing under the Securities Act or under the Exchange Act, except to the extent that we specifically incorporate this information by reference. In addition, the performance graph and the related description shall not be deemed &#8220;soliciting material&#8221; or &#8220;filed&#8221; with the SEC or subject to</div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Regulation 14A or 14C.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; margin-right: 8pt; font-family: 'Times New Roman'; font-size: 10pt;">On August 14, 2012, our common stock began trading on NYSE. The following performance graph compares the cumulative total stockholder return of our common stock to The NYSE Composite Index and the NYSE Health Care Index for the period from December 31, 2015 through December 31, 2020. The graph assumes that $100 was invested in our common stock and the common stock of each of the companies listed on The NYSE Composite Index and The NYSE Health Care Index on December 31, 2015 and that any dividends were reinvested.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Comparison of Five Years Cumulative Total Return for the Year Ended December 31, 2020</div>
<div><br /></div>
<div style="text-align: center;"><img src="image0.jpg" width="721" height="522" alt="graphic" /></div>
<div><br /></div>
<table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zda687ea04fb64678994633edc31741d6">
  <tr>
    <td style="width: 36%; vertical-align: bottom; border-left: #000000 2px solid; border-top: #000000 2px solid;"><div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"></div></td>
    <td style="width: 12%; vertical-align: bottom; border-left: #000000 2px solid; border-top: #000000 2px solid;"><div style="text-align: center; margin-right: 5.55pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">12/15</div></td>
    <td style="width: 12%; vertical-align: bottom; border-left: #000000 2px solid; border-top: #000000 2px solid;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">12/16</div></td>
    <td style="width: 10%; vertical-align: bottom; border-left: #000000 2px solid; border-top: #000000 2px solid;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">12/17</div></td>
    <td style="width: 10%; vertical-align: bottom; border-left: #000000 2px solid; border-top: #000000 2px solid;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">12/18</div></td>
    <td style="width: 10%; vertical-align: bottom; border-left: #000000 2px solid; border-top: #000000 2px solid;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">12/19</div></td>
    <td style="width: 10%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">12/20</div></td>
  </tr>
  <tr>
    <td style="width: 36%; vertical-align: bottom; border-left: #000000 2px solid; border-top: #000000 2px solid; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U. S. Physical Therapy, Inc.</div></td>
    <td style="width: 12%; vertical-align: bottom; border-left: #000000 2px solid; border-top: #000000 2px solid; background-color: #CCEEFF;"><div style="text-align: right; margin-right: 5.9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">100</div></td>
    <td style="width: 12%; vertical-align: bottom; border-left: #000000 2px solid; border-top: #000000 2px solid; background-color: #CCEEFF;"><div style="text-align: right; margin-right: 3.9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">131</div></td>
    <td style="width: 10%; vertical-align: bottom; border-left: #000000 2px solid; border-top: #000000 2px solid; background-color: #CCEEFF;"><div style="text-align: right; margin-right: 5.9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">135</div></td>
    <td style="width: 10%; vertical-align: bottom; border-left: #000000 2px solid; border-top: #000000 2px solid; background-color: #CCEEFF;"><div style="text-align: right; margin-right: 2.9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">191</div></td>
    <td style="width: 10%; vertical-align: bottom; border-left: #000000 2px solid; border-top: #000000 2px solid; background-color: #CCEEFF;"><div style="text-align: right; margin-right: 2.9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">213</div></td>
    <td style="width: 10%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">224</div></td>
  </tr>
  <tr>
    <td style="width: 36%; vertical-align: bottom; border-left: #000000 2px solid; border-top: #000000 2px solid; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">NYSE Composite</div></td>
    <td style="width: 12%; vertical-align: bottom; border-left: #000000 2px solid; border-top: #000000 2px solid; background-color: #FFFFFF;"><div style="text-align: right; margin-right: 5.9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">100</div></td>
    <td style="width: 12%; vertical-align: bottom; border-left: #000000 2px solid; border-top: #000000 2px solid; background-color: #FFFFFF;"><div style="text-align: right; margin-right: 3.9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">109</div></td>
    <td style="width: 10%; vertical-align: bottom; border-left: #000000 2px solid; border-top: #000000 2px solid; background-color: #FFFFFF;"><div style="text-align: right; margin-right: 5.9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">126</div></td>
    <td style="width: 10%; vertical-align: bottom; border-left: #000000 2px solid; border-top: #000000 2px solid; background-color: #FFFFFF;"><div style="text-align: right; margin-right: 2.9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">112</div></td>
    <td style="width: 10%; vertical-align: bottom; border-left: #000000 2px solid; border-top: #000000 2px solid; background-color: #FFFFFF;"><div style="text-align: right; margin-right: 2.9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">137</div></td>
    <td style="width: 10%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">143</div></td>
  </tr>
  <tr>
    <td style="width: 36%; vertical-align: bottom; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">NYSE Healthcare Index</div></td>
    <td style="width: 12%; vertical-align: bottom; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid; background-color: #CCEEFF;"><div style="text-align: right; margin-right: 5.9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">100</div></td>
    <td style="width: 12%; vertical-align: bottom; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid; background-color: #CCEEFF;"><div style="text-align: right; margin-right: 3.9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">97</div></td>
    <td style="width: 10%; vertical-align: bottom; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid; background-color: #CCEEFF;"><div style="text-align: right; margin-right: 5.9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">115</div></td>
    <td style="width: 10%; vertical-align: bottom; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid; background-color: #CCEEFF;"><div style="text-align: right; margin-right: 2.9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">122</div></td>
    <td style="width: 10%; vertical-align: bottom; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid; background-color: #CCEEFF;"><div style="text-align: right; margin-right: 2.9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">146</div></td>
    <td style="width: 10%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">162</div></td>
  </tr>
</table>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>24</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div><a id="ITEM6"><!--Anchor--></a></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="zcd759ca4464443a4b84feb05a74a00fd">
  <tr>
    <td style="width: 72pt; vertical-align: top; align: right;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">ITEM 6.</span></td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.</div></td>
  </tr>
</table>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">EXECUTIVE SUMMARY</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; margin-right: 4pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Our Business. </span>We operate outpatient physical therapy clinics that provide pre- and post-operative care and treatment for a variety<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">&#160;</span>of orthopedic-related disorders and sports-related injuries, neurologically-related injuries and rehabilitation of injured workers. At December 31, 2020, we operated 554 clinics in 39 states. The average age of our clinics at December 31, 2020 was 11.03 years. In addition to our ownership and operation of outpatient physical therapy clinics, we also manage physical therapy facilities for third parties, such as physicians and hospitals, with 38 such third-party facilities under management as of December 31, 2020.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; margin-right: 1pt; font-family: 'Times New Roman'; font-size: 10pt;">In March 2017, we acquired a 55% interest in the initial industrial injury prevention business. On April 30, 2018, we made a second acquisition and subsequently combined the two businesses. After the combination, the Company owned a 59.45% interest in the combined business, Briotix Health, Limited Partnership (&#8220;Briotix Health&#8221;). Services provided include onsite injury and ergonomic assessments. The majority of these services are contracted with and paid for directly by employers, including a number of Fortune 500 companies. Other clients include large insurers and their contractors. We perform these services through Industrial Sports Medicine Professionals, consisting of both physical therapists and specialized certified athletic trainers (ATCs). On April 11, 2019, we acquired a third company that is a provider of industrial injury prevention services. This acquired company specializes in delivering injury prevention and care, post offer employment testing, functional capacity evaluations and return-to-work services. It performs these services across a network in 45 states including onsite at eleven client locations. After the acquisition, the business was then combined with Briotix Health increasing our ownership position in the partnership to approximately 76.0%.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; margin-right: 37pt; font-family: 'Times New Roman'; font-size: 10pt;">In addition to the above acquired interests in the industrial injury prevention businesses, during 2020, 2019 and 2018, we completed the following acquisitions in our physical therapy operations:</div>
<div><br /></div>
<div style="margin-left: 18pt;">
<table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; border-collapse: collapse; text-align: left; color: #000000; width: 90%;" id="z9f428b5670a84c319fd57ff7286e140e">
  <tr>
    <td style="width: 25.44%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Acquisition</div></td>
    <td style="width: 2.62%; vertical-align: bottom;">&#160;</td>
    <td style="width: 33.06%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: center; margin-left: 3.1pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Date</div></td>
    <td style="width: 1.94%; vertical-align: bottom;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 19.58%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: center; margin-right: 3.1pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">% Interest</div><div style="text-align: center; margin-right: 2.1pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Acquired</div></td>
    <td style="width: 0.69%; vertical-align: bottom;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 16.67%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: center; margin-left: 24.1pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Number of</div><div style="text-align: center; margin-left: 24.1pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Clinics</div></td>
  </tr>
  <tr>
    <td style="width: 25.44%; vertical-align: bottom; border-top: #000000 2px solid;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">November 2020 Acquisition</div></td>
    <td style="width: 2.62%; vertical-align: bottom;">&#160;</td>
    <td style="width: 33.06%; vertical-align: bottom; border-top: #000000 2px solid;"><div style="text-align: center; margin-left: 4.1pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">November 30, 2020</div></td>
    <td style="width: 1.94%; vertical-align: bottom;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 19.58%; vertical-align: bottom; border-top: #000000 2px solid;"><div style="text-align: center; margin-right: 2.1pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">75%</div></td>
    <td style="width: 0.69%; vertical-align: bottom;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 16.67%; vertical-align: bottom; border-top: #000000 2px solid;"><div style="text-align: center; margin-left: 25.1pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">3</div></td>
  </tr>
  <tr>
    <td style="width: 25.44%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">September 2020 Acquisition</div></td>
    <td style="width: 2.62%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 33.06%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: center; margin-left: 3.1pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">September 30, 2020</div></td>
    <td style="width: 1.94%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 19.58%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: center; margin-right: 2.1pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">70%</div></td>
    <td style="width: 0.69%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 16.67%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: center; margin-left: 23.1pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">*</div></td>
  </tr>
  <tr>
    <td style="width: 25.44%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">February 2020 Acquisition</div></td>
    <td style="width: 2.62%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 33.06%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: center; margin-left: 3.1pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">February 27, 2020</div></td>
    <td style="width: 1.94%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 19.58%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: center; margin-right: 2.1pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">65% **</div></td>
    <td style="width: 0.69%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 16.67%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: center; margin-left: 25.1pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">4</div></td>
  </tr>
  <tr>
    <td style="width: 25.44%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">September 2019 Acquisition</div></td>
    <td style="width: 2.62%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 33.06%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: center; margin-left: 3.1pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">September 30, 2019</div></td>
    <td style="width: 1.94%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 19.58%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: center; margin-right: 2.1pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">67%</div></td>
    <td style="width: 0.69%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 16.67%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: center; margin-left: 25.1pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">11</div></td>
  </tr>
  <tr>
    <td style="width: 25.44%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">August 2018 Acquisition</div></td>
    <td style="width: 2.62%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 33.06%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: center; margin-left: 4.1pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">August 31, 2018</div></td>
    <td style="width: 1.94%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 19.58%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: center; margin-right: 2.1pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">70%</div></td>
    <td style="width: 0.69%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 16.67%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: center; margin-left: 25.1pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">4</div></td>
  </tr>
</table>
</div>
<div><br /></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z259b410dac6b475b9a53ae2668bad755">
  <tr>
    <td style="width: 20pt;"></td>
    <td style="width: 16pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">*</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">The business includes six management and services contracts which had a remaining term of approximately five years as of the date acquired.</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="zf0a5dbdd797f4e8b8d61af99088bd810">
  <tr>
    <td style="width: 20pt;"></td>
    <td style="width: 16pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">**</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">The four clinics are in four separate partnerships. The Company's interest in the four partnerships&#160;&#160; range from 10.0% to 83.8%, with an overall 65.0% based on the initial purchase transaction.</div></td>
  </tr>
</table>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">Also during 2019, we purchased the assets and business of one physical therapy clinic in a separate transaction. The clinic operates as a satellite clinic of one of our existing partnerships. Besides the multi-clinic acquisition in 2018 referenced in the table above, we acquired five separate clinic practices through several of our majority owned Clinic Partnerships. These practices operate as satellites of the respective existing Clinic Partnerships.</div>
<div><br /></div>
<div style="text-align: left; margin-left: 20pt; font-family: 'Times New Roman'; font-size: 10pt;">We intend to continue to pursue additional acquisition opportunities, develop new clinics and open satellite clinics.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Impact of COVID-19</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">As previously disclosed in a series of filings with the SEC and further described in detail in our Quarterly Reports on Form 10-Q for the quarters ended March 31, 2020, June 30, 2020 and September 30, 2020 filed with the SEC on May 21, 2020, August 7, 2020, and November 6, 2020, respectively, our results have been negatively impacted by the effects of the COVID-19 pandemic. Management has taken a number of steps to reduce costs, make up for operating losses incurred in March and April, and increase profits. We continue to experience somewhat lower physical therapy patient volumes; however revenues improved significantly in the 2020 fourth quarter, compared to the 2020 second and third quarters. Our average physical therapy patient volumes per day per clinic were 26.2, 18.9, 25.8 and 27.7 respectively, in the first to fourth quarters of 2020. Our industrial injury prevention business has been less affected by the pandemic.</div>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>25</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div style="text-align: justify; text-indent: 18pt; margin-right: 1pt; font-family: 'Times New Roman'; font-size: 10pt;">In March, with the onset of the COVID-19 pandemic, we began to furlough or terminate approximately 40% of our 5,500 full and part-time workforce. As of December 31, 2020 approximately 1,200 of the furloughed employees have returned to work at some point during the year.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 13.45pt; margin-right: 3pt; font-family: 'Times New Roman'; font-size: 10pt;">As of the filing of this annual report, we continue to experience lower physical therapy revenues. As stay at home orders and other restrictions have been lifted, we have seen our physical therapy volumes trending upwards. Should stay at home orders or other restrictions be reenacted, we could see our patient volume and revenues decline again.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">We have put preparedness plans in place at our facilities to maintain continuity of operations, while also taking steps to keep employees and patients safe. In line with recommendations to reduce large gatherings and increase social distancing, we have, where practical, transitioned a large number of office-based employees to a remote work environment.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">In March 2020, in response to the COVID-19 pandemic, the Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES Act&#8221;) was signed into law. The CARES Act provides numerous tax provisions and other stimulus measures, including temporary changes regarding the prior and future utilization of net operating losses, temporary changes to the prior and future limitations on interest deductions, temporary suspension of certain payment requirements for the employer portion of Social Security taxes, technical corrections from prior tax legislation for tax depreciation of certain qualified improvement property, and the creation of certain payroll tax credits associated with the retention of employees.</div>
<div><br /></div>
<div style="text-align: left; margin-left: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">We have received a number of benefits under the CARES Act including, but not limited to:</div>
<div><br /></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z149eb2f53e85438c82962010edce4370">
  <tr>
    <td style="width: 27.15pt;"></td>
    <td style="width: 17.85pt; vertical-align: top; align: right; color: #212529; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #212529;">The CARES Act allowed for qualified healthcare providers to receive advanced payments under the existing Medicare Accelerated and Advance Payments Program (&#8220;MAAPP funds&#8221;) during the COVID-19 pandemic. Under this program, healthcare providers could choose to receive advanced payments for future Medicare services provided. We applied for and received approval to receive MAAP funds from Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;) in April 2020. We </span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #211D1E;">will record these payments as a liability until all performance obligations have been met as the payments</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #212529;">&#160;</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #211D1E;">were made on behalf of patients before services were provided. Currently, MAAPP funds received are required to be applied to future Medicare billings commencing in August 2021, with all such remaining amounts required to be repaid by January 2024. Beginning January 2024, any unpaid balance will begin accruing interest. </span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #212529;">We currently intend</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #211D1E;">&#160;</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #212529;">to repay funds prior to August 2021. Included in cash and cash equivalents and accrued liabilities at December 31, 2020 is $14.1 million of MAAPP funds.</span></div></td>
  </tr>
</table>
<div><br /></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z449307b556074763bbc0d328e654adb2">
  <tr>
    <td style="width: 27.15pt;"></td>
    <td style="width: 17.85pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">We elected to defer depositing the employer&#8217;s share of Social Security taxes for payments due from March 27, 2020 through December 31, 2020, interest-free and penalty-free. As of December 31, 2020, $4.2 million related to these deferred payments is included in accrued liabilities and $4.1 million is included in long term liabilities.</div></td>
  </tr>
</table>
<div><br /></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z829405c1784943edb9a1f8370a14adad">
  <tr>
    <td style="width: 27.15pt;"></td>
    <td style="width: 17.85pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">The CARES Act provided additional waivers, reimbursement, grants and other funds to assist health care providers during the COVID-19 pandemic, including $100.0 billion in appropriations for the Public Health and Social Services Emergency Fund, also referred to as the Provider Relief Fund, to be used for preventing, preparing, and responding to the coronavirus, and for reimbursing eligible health care providers for lost revenues and health care related expenses that are attributable to COVID-19. Through December 31, 2020, our consolidated subsidiaries received approximately $13.5 million of payments under the CARES Act (&#8220;Relief Funds&#8221;). In accordance with GAAP, these payments have been recorded as Other income &#8211; Relief Funds. For the year ended December 31, 2020, we have recognized approximately $13.5 million, as Other income &#8211; Relief Funds on the accompanying consolidated statements of income. These funds are not required to be repaid upon attestation and provided that we comply with certain terms and conditions regarding the use of such funds, which could change materially based on evolving grant compliance provisions and guidance provided by the U.S. Department of Health and Human Services. Currently, we can attest to and comply with the terms and conditions. We will continue to monitor the evolving guidelines and may record adjustments as additional information is released.</div></td>
  </tr>
</table>
<div><br /></div>
<div style="text-align: left; margin-left: 20pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CRITICAL ACCOUNTING POLICIES</div>
<div><br /></div>
<div style="text-align: left; text-indent: 20.15pt; font-family: 'Times New Roman'; font-size: 10pt;">Critical accounting policies are those that have a significant impact on our results of operations and financial position involving significant estimates requiring our judgment. Our critical accounting policies are:</div>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>26</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div style="text-align: left; margin-left: 20pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Revenue Recognition.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 20.15pt; font-family: 'Times New Roman'; font-size: 10pt;">Revenues are recognized in the period in which services are rendered. Net patient revenues consists of revenues for physical therapy and occupational therapy clinics that provide pre-and post-operative care and treatment for orthopedic related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries. Net patient revenues (patient revenues less estimated contractual adjustments) are recognized at the estimated net realizable amounts from third-party payors, patients and others in exchange for services rendered when obligations under the terms of the contract are satisfied. There is an implied contract between us and the patient upon each patient visit. Generally, this occurs as we provide physical and occupational therapy services, as each service provided is distinct and future services rendered are not dependent on previously rendered services. We have agreements with third-party payors that provide for payments to us at amounts different from our established rates. The allowance for estimated contractual adjustments is based on terms of payor contracts and historical collection and write-off experience.</div>
<div><br /></div>
<div style="text-align: justify; text-indent: 19.9pt; margin-right: 13pt; font-family: 'Times New Roman'; font-size: 10pt;">Management contract revenues, which are included in other revenues in the consolidated statements of net income, are derived from contractual arrangements whereby we manage a clinic owned by a third party. We do not have any ownership interest in these clinics. Typically, revenues are determined based on the number of visits conducted at the clinic and recognized at the point in time when services are performed. Costs, typically salaries for our employees, are recorded when incurred.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; margin-right: 2pt; font-family: 'Times New Roman'; font-size: 10pt;">Revenues from the industrial injury prevention business, which are also included in other revenues in the consolidated statements of net income, are derived from onsite services we provide to clients&#8217; employees including injury prevention, rehabilitation, ergonomic assessments and performance optimization. Revenue from the industrial injury prevention business is recognized when obligations under the terms of the contract are satisfied. Revenues are recognized at an amount equal to the consideration we expect to receive in exchange for providing injury prevention services to its clients. The revenue is determined and recognized based on the number of hours and respective rate for services provided in a given period.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; margin-right: 2pt; font-family: 'Times New Roman'; font-size: 10pt;">Additionally, other revenues include services we provide on-site at locations such as schools and industrial worksites for physical or occupational therapy services, athletic trainers and gym membership fees. Contract terms and rates are agreed to in advance between us and the third parties. Services are typically performed over the contract period and revenue is recorded at the point of service. If the services are paid in advance, revenue is recorded as a contract liability over the period of the agreement and recognized at the point in time when the services are performed.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 20pt; font-family: 'Times New Roman'; font-size: 10pt;">In May 2014, March 2016, April 2016, and December 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2014-09, Revenue from Contracts with Customers, ASU 2016-08, Revenue from Contracts with Customers, Principal versus Agent Considerations, ASU 2016-10, Revenue from Contracts with Customers, Identifying Performance Obligations and Licensing, ASU 2016-12, Revenue from Contracts with Customers, Narrow Scope Improvements and Practical Expedients, and ASU 2016-20, Technical Corrections and Improvements to Topic 606, Revenue from Contracts with Customer (collectively the &#8220;standards&#8221;), respectively, which supersede most of the current revenue recognition requirements (&#8220;ASC 606&#8221;). The core principle of the new guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; margin-right: 3pt; font-family: 'Times New Roman'; font-size: 10pt;">We implemented the new standards beginning January 1, 2018 using a modified retrospective transition method. The principal change relates to how the new standard requires healthcare providers to estimate the amount of variable consideration to be included in the transaction price up to an amount which is probable that a significant reversal will not occur. The most common forms of variable consideration we experience are amounts for services provided that are ultimately not realizable from a customer. There were no changes to revenues or other revenues upon implementation. Under the new standards, our estimate for unrealizable amounts will continue to be recognized as a reduction to revenue. The bad debt expense historically reported will not materially change.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; margin-right: 2pt; font-family: 'Times New Roman'; font-size: 10pt;">For ASC 606, there is an implied contract between us and the patient upon each patient visit. Separate contractual arrangements exist between us and third party payors (e.g. insurers, managed care programs, government programs, and workers' compensation programs which establish the amounts the third parties pay on behalf of the patients for covered services rendered. While these agreements are not considered contracts with the customer, they are used for determining the transaction price for services provided to the patients covered by the third party payors. The payor contracts do not indicate performance obligations for us, but indicate reimbursement rates for patients who are covered by those payors when the services are provided. At that time, we are obligated to provide services for the reimbursement rates stipulated in the payor contracts. The execution of the contract alone does not indicate a performance obligation. For self-paying customers, the performance obligation exists when we provide the services at established rates. The difference between our established rate and the anticipated reimbursement rate is accounted for as an offset to revenue &#8211; contractual allowance.</div>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>27</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div style="text-align: left; text-indent: 20.15pt; margin-right: 5pt; font-family: 'Times New Roman'; font-size: 10pt;">We determine allowances for credit losses based on the specific agings and payor classifications at each clinic. The provision for credit losses is included in clinic operating costs in the statements of net income. Patient accounts receivable, which are stated at the historical carrying amount net of contractual allowances, write-offs and allowance for credit losses, includes only those amounts we estimate to be collectible.</div>
<div><br /></div>
<div style="text-align: left; margin-left: 20pt; font-family: 'Times New Roman'; font-size: 10pt;">The following table details the revenue related to the various categories (in thousands).</div>
<div><br /></div>
<div style="margin-left: 24pt;">
<table cellpadding="0" cellspacing="0" id="z84c0b2a24eb842c6a75a517512e3bfa2" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 90%; margin-left: 0px; margin-right: auto;">
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"></div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="10" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2018</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Net patient revenues</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">373,340</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">433,345</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">417,703</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Management contract revenues</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">8,410</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">8,676</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">8,339</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Other revenues</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">2,020</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">2,486</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">2,403</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Physical therapy operations</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">383,770</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">444,507</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">428,445</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Industrial injury prevention services revenues</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">39,199</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">37,462</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">25,466</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">422,969</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">481,969</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">453,911</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
  </tr>
</table>
</div>
<div style="text-align: left;"><img src="image00002.jpg" width="4" height="4" alt="graphic" /></div>
<div style="text-align: left;"><img src="image00002.jpg" width="4" height="4" alt="graphic" /></div>
<div><br /></div>
<div style="text-align: left; text-indent: 20.15pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Contractual Allowances. </span>Contractual allowances result from the differences between the rates charged for services performed and<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">&#160;</span>expected reimbursements by both insurance companies and government sponsored healthcare programs for such services. Medicare regulations and the various third party payors and managed care contracts are often complex and may include multiple reimbursement mechanisms payable for the services provided in our clinics. We estimate contractual allowances based on our interpretation of the applicable regulations, payor contracts and historical calculations. Each month we estimate our contractual allowance for each clinic based on payor contracts and the historical collection experience of the clinic and apply an appropriate contractual allowance reserve percentage to the gross accounts receivable balances for each payor of the clinic. Based on our historical experience, calculating the contractual allowance reserve percentage at the payor level is sufficient to allow us to provide the necessary detail and accuracy with our collectability estimates. However, the services authorized and provided and related reimbursement are subject to interpretation that could result in payments that differ from our estimates. Payor terms are periodically revised necessitating continual review and assessment of the estimates made by management. Our billing systems may not capture the exact change in our contractual allowance reserve estimate from period to period. Therefore, in order to assess the accuracy of our revenues and hence our contractual allowance reserves, our management regularly compares our cash collections to corresponding net revenues measured both in the aggregate and on a clinic-by-clinic basis. In the aggregate, the historical difference between net revenues and corresponding cash collections in any given fiscal year has generally reflected a difference within approximately 1.0% to 1.5% of net revenues. Additionally, analysis of subsequent period&#8217;s contractual write-offs on a payor basis reflects a difference within approximately 1.0% to 1.5% between the actual aggregate contractual reserve percentage as compared to the estimated contractual allowance reserve percentage associated with the same period end balance. As a result, we believe that a reasonable likely change in the contractual allowance reserve estimate would not be more than 1% to 1.5% of gross billings in accounts receivable at December 31, 2020. For purposes of demonstrating the sensitivity of this estimate on our Company&#8217;s financial condition, a 1% to 1.5% increase or decrease in our aggregate contractual allowance reserve percentage would decrease or increase, respectively, net patient revenue by approximately $1.2 million to $1.8 million for the year ended December 31, 2020. Management believes the changes in the estimate of the contractual allowance reserve for the periods ended December 31, 2020, 2019 and 2018 have not been material to the statement of income.</div>
<div><br /></div>
<div style="text-align: left; margin-left: 20.2pt; font-family: 'Times New Roman'; font-size: 10pt;">The following table sets forth information regarding our patient accounts receivable as of the dates indicated (in thousands):</div>
<div><br /></div>
<div style="margin-left: 22pt;">
<table cellpadding="0" cellspacing="0" id="z33af178439c043ba871533fddbf9e1ef" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 80%;">
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"></div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="6" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">December 31,</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> 2020</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> 2019</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Gross patient accounts receivable</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">119,180</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">124,035</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Less contractual allowances</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">75,266</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">75,109</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Subtotal - accounts receivable</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">43,914</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">48,926</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Less allowance for credit losses</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">2,008</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">2,698</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Net patient accounts receivable</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">41,906</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">46,228</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
</table>
</div>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>28</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div style="text-align: left; margin-left: 23.05pt; font-family: 'Times New Roman'; font-size: 10pt;">The following table presents our patient accounts receivable aging by payor class as of the dates indicated (in thousands):</div>
<div><br /></div>
<table cellpadding="0" cellspacing="0" id="zcb98668ad2ed4453905ccdf677ca1bc2" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"></div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="10" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">December 31, 2020</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="10" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">December 31, 2019</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Payor</span></div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Current to</div><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">120 Days</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">120+ Days</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Total</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Current to</div><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">120 Days</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">120+ Days</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Total</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Managed Care/ Commercial Plans</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">13,053</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">1,774</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">14,827</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">14,159</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">1,783</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">15,942</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 28%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Medicare/Medicaid</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">10,707</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">1,196</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">11,903</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">11,408</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">1,491</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">12,899</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Workers Compensation*</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">6,576</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">926</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">7,502</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">6,593</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">1,121</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">7,714</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 28%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Self-pay</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">4,086</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">3,146</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">7,232</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">4,365</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">3,040</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">7,405</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 28%; padding-bottom: 2px; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Other**</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">1,108</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">1,342</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">2,450</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">808</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">1,460</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">2,268</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 28%; padding-bottom: 4px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Totals</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">35,530</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">8,384</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">43,914</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">37,333</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">8,895</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">46,228</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
  </tr>
</table>
<div><br /></div>
<div style="text-align: justify; text-indent: -7.65pt; margin-left: 12pt; font-family: 'Times New Roman'; font-size: 10pt;">*&#160; &#160; Workers compensation is paid by state administrators or their designated agents.</div>
<div><br /></div>
<div style="text-align: justify; text-indent: -12.4pt; margin-left: 17pt; font-family: 'Times New Roman'; font-size: 10pt;">**&#160; Other includes primarily litigation claims and, to a lesser extent, vehicular insurance claims.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; margin-right: 10pt; font-family: 'Times New Roman'; font-size: 10pt;">Reimbursement for Medicare beneficiaries is based upon a fee schedule published by HHS. For a more complete description of our third party revenue sources, see &#8220;Business&#8212;Sources of Revenue&#8221; in Item 1.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; margin-right: 8pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Goodwill. </span>The fair value of goodwill and other identifiable intangible assets with indefinite lives are evaluated for impairment at<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">&#160;</span>least annually and upon the occurrence of certain events or conditions, and are written down to fair value if considered impaired. These events or conditions include, but are not limited to: a significant adverse change in the business environment, regulatory environment, or legal factors; a current period operating or cash flow loss combined with a history of such losses or a projection of continuing losses; or a sale or disposition of a significant portion of a reporting unit. The occurrence of one of these events or conditions could significantly impact an impairment assessment, necessitating an impairment charge. We evaluate indefinite-lived tradenames using the relief from royalty method in conjunction with its annual goodwill impairment test.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; margin-right: 3pt; font-family: 'Times New Roman'; font-size: 10pt;">We operate a two segment business which is made up of various clinics within partnerships, and the other is industrial injury prevention services business. The partnerships are components of regions and are aggregated to the operating segment level for the purpose of determining our reporting units when performing our annual goodwill impairment test. In 2020, 2019 and 2018, there were six regions. In addition to the six regions, in 2020 and 2019, the impairment analysis included a separate analysis for the industrial injury prevention business, as a separate reporting unit.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">As part of the impairment analysis, we are first required to assess qualitatively if we can conclude whether goodwill is more likely than not impaired. If goodwill is more likely than not impaired, we are then required to complete a quantitative analysis of whether a reporting unit&#8217;s fair value is less than its carrying amount. In evaluating whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, the Company considers relevant events or circumstances that affect the fair value or carrying amount of a reporting unit. The Company considers both the income and market approach in determining the fair value of its reporting units when performing a quantitative analysis.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; margin-right: 8pt; font-family: 'Times New Roman'; font-size: 10pt;">An impairment loss generally would be recognized when the carrying amount of the net assets of a reporting unit, inclusive of goodwill and other identifiable intangible assets, exceeds the estimated fair value of the reporting unit. The evaluation of goodwill in 2020, 2019 and 2018 did not result in any goodwill amounts that were deemed impaired.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; margin-right: 6pt; font-family: 'Times New Roman'; font-size: 10pt;">Based on the economic conditions in 2020, and the decline in patient visits due to the pandemic, we evaluated whether events or circumstances indicated that it was more likely than not that the fair value of the reporting units were reduced below their carrying value as of December 31, 2020. As a result of the assessment, we determined that it was not more likely than not that goodwill and tradenames of the reporting units was impaired as of December 31, 2020. Due to the uncertainty of the current economic conditions resulting from the COVID-19 pandemic, we will continue to review the carrying amounts of goodwill and other intangibles.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; margin-right: 19pt; font-family: 'Times New Roman'; font-size: 10pt;">For the year ended December 31, 2020, we derecognized (wrote-off) goodwill in the amount of $1.9 million related to certain closed clinics due to COVID-19.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; margin-right: 1pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Redeemable Non-Controlling Interests </span><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">&#8211;</span><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">&#160;</span>The non-controlling interests that are reflected as redeemable non-controlling interests in<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">&#160;</span>our consolidated financial statements consist of those owners, including us, that have certain redemption rights, whether currently exercisable or not, and which currently, or in the future, require that we purchase or the owner sell the non-controlling interest held by the owner, if certain conditions are met and the owners request the purchase (&#8220;Put Right&#8221;). We also have a call right (&#8220;Call Right&#8221;). The Put Right or Call Right may be triggered by the owner or us, respectively, at such time as both of the following events have occurred: 1) termination of the owner&#8217;s employment, regardless of the reason for such termination, and 2) the passage of specified number of years after the closing of the transaction, typically three to five years, as defined in the limited partnership agreement. The Put Rights and Call Rights are not automatic (even upon death) and require either the owner or us to exercise our rights when the conditions triggering the Put or Call Rights have been satisfied. The purchase price is derived at a predetermined formula based on a multiple of trailing twelve months earnings performance as defined in the respective limited partnership agreements.</div>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>29</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div style="text-align: left; text-indent: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">On the date we acquire a controlling interest in a partnership and the limited partnership agreement for such partnerships contains redemption rights not under our control, the fair value of the non-controlling interest is recorded in the consolidated balance sheet under the caption &#8211; <span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Redeemable non-controlling interests</span>. Then, in each reporting period thereafter until it is purchased by us, the redeemable non-controlling interest is adjusted to the greater of its then current redemption value or initial value, based on the predetermined formula defined in the respective limited partnership agreement. As a result, the value of the non-controlling interest is not adjusted below its initial value. We record any adjustment in the redemption value, net of tax, directly to retained earnings and not in the consolidated statements of income. Although the adjustments are not reflected in the consolidated statements of income, current accounting rules require that we reflect the adjustments, net of tax, in the earnings per share calculation. The amount of net income attributable to redeemable non-controlling interest owners is included in consolidated net income on the face of the consolidated income statement. We believe the redemption value (i.e. the carrying amount) and fair value are the same.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; margin-right: 19pt; font-family: 'Times New Roman'; font-size: 10pt;">Effective December 31, 2017, we entered into amendments to our limited partnership agreements for our acquired partnerships replacing the mandatory redemption feature. No monetary consideration was paid to the partners to amend the agreements. The amended limited partnership agreements provide that, upon the triggering events, we have a Call Right and the selling entity or individual has a Put Right for the purchase and sale of the limited partnership interest held by the partner. Once triggered, the Put Right and the Call Right do not expire, even upon an individual partner&#8217;s death, and contain no mandatory redemption feature. The purchase price of the partner&#8217;s limited partnership interest upon the exercise of either the Put Right or the Call Right is calculated per the terms of the respective agreements. We accounted for the amendment of the limited partnership agreements as an extinguishment of the outstanding mandatorily redeemable non-controlling interests, which were classified as liabilities, through the issuance of new redeemable non-controlling interests classified in temporary equity. Pursuant to Accounting Standards Codification (&#8220;ASC&#8221;) 470-50-40-2, we removed the outstanding liabilities at their carrying amounts, recognized the new temporary equities at their fair value, and recorded no gain or loss on extinguishment as management believes the redemption value (i.e. the carrying amount) and fair value are the same. In summary, the redemption values of the mandatorily redeemable non-controlling interest (previously classified as liabilities) were reclassified as redeemable non-controlling interest (temporary equity) at fair value on the December 31, 2017 consolidated balance sheet.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; margin-right: 3pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Non-Controlling Interests &#8211; </span>We recognize non-controlling interests, in which we have no obligation but the right to purchase the<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">&#160;</span>non-controlling interests, as equity in the consolidated financial statements separate from the parent entity&#8217;s equity. The amount of net income attributable to non-controlling interests is included in consolidated net income on the face of the consolidated statements of income. Operating losses are allocated to non-controlling interests even when such allocation creates a deficit balance for the non-controlling interest partner. When we purchase a non-controlling interest and the purchase differs from the book value at the time of purchase, any excess or shortfall is recognized as an adjustment to additional paid-in capital.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SELECTED OPERATING AND FINANCIAL DATA</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; margin-right: 40pt; font-family: 'Times New Roman'; font-size: 10pt;">The following table and discussion relates to continuing operations unless otherwise noted. The defined terms with their respective description used in the following discussion are listed below:</div>
<div><br /></div>
<table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z56058ad08ad64a96affde4a7bf28446b">
  <tr>
    <td style="width: 29.17%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: justify; margin-right: 90pt; font-family: 'Times New Roman'; font-size: 10pt;">2020</div></td>
    <td style="width: 70.83%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: justify; margin-right: 90pt; font-family: 'Times New Roman'; font-size: 10pt;">&#160;Year ended December 31, 2020</div></td>
  </tr>
  <tr>
    <td style="width: 29.17%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: justify; margin-right: 90pt; font-family: 'Times New Roman'; font-size: 10pt;">2019</div></td>
    <td style="width: 70.83%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: justify; margin-right: 90pt; font-family: 'Times New Roman'; font-size: 10pt;">&#160;Year ended December 31, 2019</div></td>
  </tr>
  <tr>
    <td style="width: 29.17%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: justify; margin-right: 90pt; font-family: 'Times New Roman'; font-size: 10pt;">New Clinics</div></td>
    <td style="width: 70.83%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: justify; margin-right: 90pt; font-family: 'Times New Roman'; font-size: 10pt;">Clinics opened or acquired during the year ended December 31, 2020</div></td>
  </tr>
  <tr>
    <td style="width: 29.17%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: justify; margin-right: 90pt; font-family: 'Times New Roman'; font-size: 10pt;">Mature Clinics</div></td>
    <td style="width: 70.83%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: justify; margin-right: 90pt; font-family: 'Times New Roman'; font-size: 10pt;">Clinics opened or acquired prior to January 1, 2020 and are still operating</div></td>
  </tr>
</table>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>30</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div style="text-align: left; text-indent: 18pt; margin-right: 33pt; font-family: 'Times New Roman'; font-size: 10pt;">The following table presents selected operating and financial data, used by management as key indicators of our operating performance:</div>
<div><br /></div>
<div style="margin-left: 18pt;">
<table cellpadding="0" cellspacing="0" id="z5a9e65af8d2d4080b88245475e9ce6fe" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 80%;">
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"><div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"></div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="6" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">For the Years Ended December 31,</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> 2020</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">2019</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Number of clinics, at the end of period</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">554</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">583</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #FFFFFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Working Days</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">256</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">255</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Average visits per day per clinic</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">24.6</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">27.6</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #FFFFFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Total patient visits</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">3,533,371</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #FFFFFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">4,091,967</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Net patient revenue per visit</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">105.66</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">105.90</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
</table>
</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">RESULTS OF OPERATIONS</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">FISCAL YEAR 2020 COMPARED TO FISCAL 2019</div>
<div><br /></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z7045ba4e689b4c629069067b76fc5fb9">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">Reported net revenues for 2020 was $423.0 million as compared to $482.0 million for 2019. See table below for a detail of reported net revenues (in thousands):</div></td>
  </tr>
</table>
<div><br /></div>
<div style="margin-left: 38pt;">
<table cellpadding="0" cellspacing="0" id="z02eab41685184c20a3dc60f1cf87ddba" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 80%; margin-left: 0px; margin-right: auto;">
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;"><div style="text-align: left; margin-left: 7.9pt; font-family: 'Times New Roman'; font-size: 10pt;"></div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="6" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">For the Year Ended</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Revenues:</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Net patient revenues</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">373,340</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">433,345</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Management contract revenue</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">8,410</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">8,676</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Other patient revenues</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">2,020</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">2,486</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Physical therapy operations</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">383,770</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">444,507</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Industrial injury prevention services</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">39,199</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">37,462</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">422,969</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">481,969</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
  </tr>
</table>
</div>
<div><br /></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z2cc4ff3ce0314b039d2bed636522f95d">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">For 2020, our net income attributable to shareholders, in accordance with GAAP, was $35.2 million as compared to $40.0 million for the comparable period of 2019. Inclusive of the charge for revaluation of non-controlling interest, net of tax, used to compute diluted earnings per share in accordance with GAAP, earnings per share was $2.48 per share for 2020 and $2.45 per share for 2019. For both 2020 and 2019, in accordance with current accounting guidance, the revaluation of redeemable non-controlling interest, net of tax, is not included in net income but rather charged directly to retained earnings; however, the charge for this change is included in the earnings per basic and diluted share calculation. See table below (in thousands, except per share data).</div></td>
  </tr>
</table>
<div><br /></div>
<div style="margin-left: 36pt;">
<table cellpadding="0" cellspacing="0" id="zb01127d0e42a4c15a6980e2ef0ec31e7" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 90%;">
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"></div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="6" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended December 31,</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> 2020</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2019</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Computation of earnings per share - USPH shareholders:</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -11.4pt; margin-left: 21pt; font-family: 'Times New Roman'; font-size: 10pt;">Net income attributable to USPH shareholders</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">35,194</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">40,039</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 16.9pt; font-family: 'Times New Roman'; font-size: 10pt;">Credit (charges) to retained earnings:</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 34.9pt; font-family: 'Times New Roman'; font-size: 10pt;">Revaluation of redeemable non-controlling interest</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">(4,632</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">(11,893</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 34.9pt; font-family: 'Times New Roman'; font-size: 10pt;">Tax effect at statutory rate (federal and state) of 26.25%</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">1,216</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">3,121</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">31,778</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">31,267</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Earnings per share (basic and diluted)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">2.48</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">2.45</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
  </tr>
</table>
</div>
<div><br /></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="zf776b1325d7840a59074ef3e3b9bf7d1">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">For 2020, our Operating Results (as defined below), including Relief Funds (defined below), was $38.4 million, or $2.99 per diluted share, as compared to $36.0 million, or $2.82 per diluted share in 2019. For 2020, our Operating Results, excluding Relief Funds, was $30.6 million, or $2.39 per diluted share, as compared to $36.0 million, or $2.82 per diluted share in 2019. Operating Results, a non-Generally Accepted Accounting Principle (&#8220;GAAP&#8221;) measure, equals net income attributable to our shareholders per the consolidated statements of net income plus charges incurred for closure&#160; costs, less gain on the sale of partnership interests and clinics, less allocated non-controlling interests, excludes expenses incurred for the transition to our new Chief Financial Officer, all net of tax. The earnings per share from Operating Results also excludes the impact of the revaluation of redeemable non-controlling interest. See table below for a detailed computation (in thousands, except per share data):</div></td>
  </tr>
</table>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>31</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div><br /></div>
<table cellpadding="0" cellspacing="0" id="zfb385d0ad96a467398fc9d385464a3e2" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"><div style="text-align: left; text-indent: -18pt; margin-right: 20pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"></div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="6" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended December 31,</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> 2020</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> 2019</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Computation of earnings per share - USPH shareholders:</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Net income attributable to USPH shareholders</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">35,194</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">40,039</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Credit (charges) to retained earnings:</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Revaluation of redeemable non-controlling interest</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">(4,632</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">(11,893</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Tax effect at statutory rate (federal and state) of 26.25%</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">1,216</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">3,121</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">31,778</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">31,267</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Earnings per share (basic and diluted)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">2.48</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">2.45</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Adjustments:</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Expenses related to CFO transition</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">1,331</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Closure costs</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">3,931</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Gain on sale of partnership interest and clinics</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">(1,091</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">(5,514</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Relief Funds</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">(13,500</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Allocation to non-controlling interest</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">3,116</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Revaluation of redeemable non-controlling interest</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">4,632</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">11,893</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Tax effect at statutory rate (federal and state) of 26.25%</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">415</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">(1,674</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Operating Results (without Relief Funds)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">30,612</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">35,972</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Relief Funds</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">13,500</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Allocation to non-controlling interest</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">(2,893</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Tax effect at statutory rate (federal and state) of 26.25%</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">(2,784</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Operating Results (including Relief Funds)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">38,435</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">35,972</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Basic and diluted Operating Results (without Relief Funds) per share</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">2.39</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">2.82</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Basic and diluted Operating Results (including Relief Funds) per share</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">2.99</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">2.82</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Shares used in computation - basic and diluted</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">12,835</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">12,756</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
  </tr>
</table>
<div><br /></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z4c4852c99e62413882096f421b7a44b9">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">For 2020, the Company's Adjusted EBITDA was $70.0 million compared to $72.8 million in 2019. For 2020, the Company's Adjusted EBITDA, excluding Relief Funds, was $56.5 million. Adjusted EBITDA is defined as earnings before interest income, interest expense &#8211; debt and other, taxes, depreciation, amortization, derecognition of goodwill and equity-based awards compensation expense. See reconciliation of Adjusted EBITDA to net income attributable to our shareholders in the following table (in thousands):</div></td>
  </tr>
</table>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>32</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div><br /></div>
<div style="margin-left: 18pt;">
<table cellpadding="0" cellspacing="0" id="z28cee80a66a5433c9794c95b4cdff6f0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 90%;">
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"></div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="6" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended December 31,</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> 2020</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> 2019</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Net income attributable to USPH shareholders</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">35,194</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">40,039</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Adjustments:</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Depreciation and amortization</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">10,533</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">10,095</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Closure costs - derecognition of goodwill</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">1,859</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Relief Funds</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">(13,500</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Interest income</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">(142</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">(46</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Interest expense - debt and other</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">1,634</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">2,079</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Provision for income taxes</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">13,022</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">13,647</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Equity-based awards compensation expense</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">7,917</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">6,985</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Adjusted EBITDA (without Relief Funds)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">56,517</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">72,799</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Relief Funds</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">13,500</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Adjusted EBITDA</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">70,017</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">72,799</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
  </tr>
</table>
</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">The above tables reconcile net income attributable to our shareholders calculated in accordance with GAAP to Adjusted EBITDA and Operating Results, non-GAAP measures defined above. We believe that Operating Results, which eliminates certain items described above that can be subject to volatility and unusual costs, is one of the principal measures to evaluate and monitor financial performance period over period. We also believe that Operating Results is useful information for investors to use in comparing the Company's period-to-period results as well as for comparing with other similar businesses. We believe Adjusted EBITDA is useful information for investors in comparing the Company&#8217;s period-to-period results as well as comparing with similar businesses which report adjusted EBITDA as defined by their company.</div>
<div><br /></div>
<div style="text-align: justify; text-indent: 18pt; margin-right: 32pt; font-family: 'Times New Roman'; font-size: 10pt;">Operating Results and Adjusted EBITDA are not measures of financial performance under GAAP. Operating Results and Adjusted EBITDA should not be considered in isolation or as an alternative to, or substitute for, net income attributable to our shareholders presented in the consolidated financial statements.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Net Patient Revenues</div>
<div><br /></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="zf83045ab5eca48279cf657a026035497">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">Net patient revenues from physical therapy operations decreased approximately 13.8% or $60.0 million to $373.3 million in 2020 from $433.3 million in 2019. Included in net patient revenues above are revenues related to clinics sold or closed in 2020 and 2019 of $4.4 million in 2020 and $28.6 million in 2019. During 2020, the Company sold its interest in 14 clinics and closed 34 clinics. During 2019, the Company sold its interest in a partnership which include 30 clinics and closed 11 clinics. For comparison purposes, adjusted for revenue from the clinics sold or closed, net patient revenues from physical therapy operations was approximately $369.0 million in 2020, inclusive of $9.7 million related to New Clinics and $404.8 million in 2019. Net patient revenues related to Mature Clinics decreased by $45.5 million in 2020 compared to 2019. The reduction is largely attributable to the adverse effects of the COVID-19 pandemic. See table below for a detail of net patient revenues from physical therapy operations (in thousands):</div></td>
  </tr>
</table>
<div><br /></div>
<div style="margin-left: 38pt;">
<table cellpadding="0" cellspacing="0" id="z3164bd9c585c481d8b69d64496d5cce7" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 90%; margin-left: 0px; margin-right: auto;">
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;"><div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"></div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="6" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">For the Year Ended</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;"><div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Related to Mature Clinics</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">359,294</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">404,784</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;"><div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Related to New Clinics</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">9,664</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;"><div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">From 2020 sold and closed clinics</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">4,382</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">15,542</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; white-space: nowrap;"><div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">From 2019 sold and closed clinics</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">13,019</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">373,340</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">433,345</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
</table>
</div>
<div><br /></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="zb16835c7f4b947578ef6a21d7dffb748">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">Including all clinics operational during 2020 and 2019, the average net patient revenue per visit was $105.66 and $105.90 respectively. Total patient visits were 3,533,371 in 2020 and 4,091,967 in 2019. The reduction is largely attributable to the adverse effects of the COVID-19 pandemic.</div></td>
  </tr>
</table>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>33</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="za4de891b69c54947a74d333107af94ac">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">Net patient revenues are based on established billing rates less allowances and discounts for patients covered by contractual programs and workers&#8217; compensation. Net patient revenues reflect contractual and other adjustments, which we evaluate monthly, relating to patient discounts from certain payors. Payments received under these contractual programs and workers&#8217; compensation are based on predetermined rates and are generally less than the established billing rates of the clinics.</div></td>
  </tr>
</table>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Other Revenues</div>
<div><br /></div>
<div style="text-align: left; text-indent: 20.15pt; font-family: 'Times New Roman'; font-size: 10pt;">Other revenues, consisting primarily of revenues from our industrial injury prevention business and management fees revenue, increased by $1.0 million, from $48.6 million in 2019 to $49.6 million in 2020. Revenues from management contracts were $8.4 million for 2020 as compared to $8.7 million for 2019. Revenue from our industrial injury prevention business increased 4.6% to $39.2 million in 2020 compared to $37.5 million in 2019. Other revenues were $2.0 million in 2020 and $2.4 million in 2019. See table below for a detail of reported net revenues (in thousands):</div>
<div><br /></div>
<div style="margin-left: 54pt;">
<table cellpadding="0" cellspacing="0" id="z129f88e8eb7047c8b6b0273d9eca4a8e" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 90%;">
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"></div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="6" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">For the Year Ended</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Revenues:</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Net patient revenues</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">373,340</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">433,345</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Management contract revenue</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">8,410</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">8,676</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Other patient revenues</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">2,020</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">2,486</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Physical therapy operations</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">383,770</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">444,507</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Industrial injury prevention services</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">39,199</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">37,462</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">422,969</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">481,969</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
  </tr>
</table>
</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Operating Costs</div>
<div><br /></div>
<div style="text-align: justify; text-indent: 18pt; margin-right: 4pt; font-family: 'Times New Roman'; font-size: 10pt;">Total operating costs, excluding closure costs, were $324.6 million in 2020, as compared to $369.5 million in 2019. Operating costs were 76.7% as a percentage of net revenues in both 2020 and 2019. Included in operating costs for 2020 was $8.4 million related to New Clinics. Operating costs for Mature Clinics decreased by $31.3 million in 2020 compared to 2019. Operating costs related to management contracts decreased by $0.7 million. Operating costs related to the industrial injury prevention business were $29.1 million in both 2020 and 2019. See table below for a detail of operating costs, excluding closure costs (in thousands):</div>
<div><br /></div>
<div style="margin-left: 18pt;">
<table cellpadding="0" cellspacing="0" id="z870c4db8247b4c778159c940477e89c0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 90%;">
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"></div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="6" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">For the Year Ended</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Physical Therapy Operations</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Related to Mature Clinics</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">274,781</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">306,128</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Related to New Clinics</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">8,416</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Related to 2020 closed and sold clinics</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">5,583</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">14,588</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Related to 2019 closed and sold clinics</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">40</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">12,283</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Physical therapy management contracts</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">6,654</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">7,389</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Total Physical Therapy Operations</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">295,474</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">340,388</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Industrial injury prevention services</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">29,114</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">29,082</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Total operating costs, excluding closure costs</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">324,588</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">369,470</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
  </tr>
</table>
</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; margin-right: 5pt; font-family: 'Times New Roman'; font-size: 10pt;">Closure costs in the current period of $3.9 million include estimates of remaining lease obligations, derecognition of goodwill and other costs related to closed and sold clinics. Each component of clinic operating costs is discussed below:</div>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>34</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div style="text-align: left; margin-left: 18pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Operating Costs&#8212;Salaries and Related Costs</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; font-family: 'Times New Roman'; font-size: 10pt;">Salaries and related costs decreased to $235.6 million for 2020 from $274.2 million in 2019, a decrease of $38.6 million, or 14.1%. Included in salaries and related costs for 2020 was $5.5 million related to New Clinics. Salaries and related costs for clinics sold or closed in 2020 and 2019 were $3.0 million and $16.7 million in 2020 and 2019, respectively. Salaries and related costs for Mature Clinics decreased $31.2 million in 2020 compared to 2019. Salaries and related costs for management contracts decreased $0.4 million. Salaries and related costs for the industrial injury prevention business increased $1.1 million. Salaries and related costs as a percentage of net revenues was 55.7% for 2020 and 56.9% for 2019. See table below for a detail of salaries and related costs (in thousands):</div>
<div><br /></div>
<div style="margin-left: 18pt;">
<table cellpadding="0" cellspacing="0" id="z8a6293b1ec0245ad9cefce6b9bdf2dcf" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 90%;">
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"></div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="6" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">For the Year Ended</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Physical Therapy Operations</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Related to Mature Clinics</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">196,686</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">227,859</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Related to New Clinics</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">5,495</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Related to 2020 closed and sold clinics</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">3,089</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">9,494</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Related to 2019 closed and sold clinics</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">7,248</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Related to Physical therapy management contracts</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">5,921</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">6,337</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Total Physical Therapy Operations</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">211,191</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">250,938</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Related to Industrial injury prevention services</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">24,437</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">23,295</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Total Salaries and related costs</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">235,628</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">274,233</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
  </tr>
</table>
</div>
<div><br /></div>
<div style="text-align: left; margin-left: 18pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Operating Costs&#8212;Rent, Supplies, Contract Labor and Other</div>
<div><br /></div>
<div style="text-align: left; text-indent: 20.15pt; font-family: 'Times New Roman'; font-size: 10pt;">Rent, supplies, contract labor and other costs decreased to $84.3 million for 2020 from $90.4 million for 2019, a decrease of $6.0 million, or 6.7%. Included in rent, supplies, contract labor and other costs for 2020 was $2.8 million related to New Clinics. Rent, supplies, contract labor and other costs for clinics related to partnership interests closed or sold in 2020 and 2019 were $2.4 million and $9.8 million in 2020 and 2019, respectively, rent, supplies, contract labor and other costs related to Mature Clinics were the same for both periods 2020 and 2019. Rent, supplies, contract labor and other costs as a percent of net revenues was 18.8% for 2019 and 19.9% for 2020. See table below for a detail of rent, supplies, contract labor and other costs (in thousands):</div>
<div><br /></div>
<div style="margin-left: 18pt;">
<table cellpadding="0" cellspacing="0" id="z7c6adf8116ab4a1ea39da7dc1d838ea4" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 90%;">
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"></div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="6" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">For the Year Ended</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Physical Therapy Operations</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Related to Mature Clinics</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">73,726</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">73,766</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Related to New Clinics</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">2,846</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Related to 2020 closed and sold clinics</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">2,437</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">4,896</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Related to 2019 closed and sold clinics</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">41</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">4,908</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Related to Physical therapy management contracts</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">734</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">1,052</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Total Physical Therapy Operations</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">79,784</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">84,622</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Related to Industrial injury prevention services</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">4,552</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">5,757</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Total Rent and other costs</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">84,336</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">90,379</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
  </tr>
</table>
</div>
<div><br /></div>
<div style="text-align: left; margin-left: 18pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Operating Costs&#8212;Provision for Credit Losses</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">The provision for credit losses for net patient receivables was $4.6 million for 2020 and $4.9 million for 2019. As a percentage of net patient revenues, the provision for credit losses was 1.1% for 2020 and 1.0% for 2019.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; font-family: 'Times New Roman'; font-size: 10pt;">Our provision for credit losses as a percentage of total patient accounts receivable was 4.5% at December 31, 2020 and 5.5% at December 31, 2019. The provision for credit losses at the end of each period is based on a detailed, clinic-by-clinic review of overdue accounts and is regularly reviewed in the aggregate in light of historical experience.</div>
<div><br /></div>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>35</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div style="text-align: left; text-indent: 19.9pt; margin-right: 10pt; font-family: 'Times New Roman'; font-size: 10pt;">The average accounts receivable days outstanding were 32 days at December 31, 2020 and 33 days at December 31, 2019. Net patient receivables in the amount of $4.5 million and $4.8 million were written-off in 2020 and 2019, respectively.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Gross Profit</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; margin-right: 2pt; font-family: 'Times New Roman'; font-size: 10pt;">Gross profit, excluding closure costs, for 2020 was $98.4 million, as compared to $112.5 million in 2019. Gross profit excluding closure costs as a percentage of net revenue for the Company&#8217;s physical therapy clinics was 23.1% in 2020 compared to 23.6% in 2019. The gross profit percentage on management contracts increased to 20.9% in 2020 as compared to 14.8% in the 2019. The gross profit for the industrial injury prevention business was $10.1 million, or 25.7% as a percentage of industrial injury prevention revenues, in 2020 as compared to $8.4 million, or 22.4% as a percentage of industrial injury prevention revenues, in the comparable 2019 period. The table below details the gross profit, excluding closure costs (in thousands):</div>
<div><br /></div>
<div style="margin-left: 18pt;">
<table cellpadding="0" cellspacing="0" id="z40c0f8ac403b436eb4f7474ec65736c1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 80%;">
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"></div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="6" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">For the Year Ended</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Gross profit, excluding closure costs:</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Physical therapy clinics</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">86,540</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">102,833</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Management contracts</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">1,755</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">1,287</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Industrial injury prevention services</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">10,086</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">8,379</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Gross profit, excluding closure costs</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">98,381</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">112,499</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
  </tr>
</table>
</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Corporate Office Costs</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; font-family: 'Times New Roman'; font-size: 10pt;">Corporate office costs, consisting primarily of salaries, benefits and equity based compensation of corporate office personnel and directors, rent, insurance costs, depreciation and amortization, travel, legal, compliance, professional, marketing and recruiting fees, were $42.0 million for 2020 and $45.0 million for 2019. Corporate office costs as a percentage of net revenues were 9.9% for 2020 and 9.3% in 2019.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Operating Income</div>
<div><br /></div>
<div style="text-align: left; text-indent: 20.2pt; margin-right: 11pt; font-family: 'Times New Roman'; font-size: 10pt;">Operating income for 2020 was $52.4 million as compared to $67.4 million for 2019. Operating income as a percentage of net revenue decreased from 14.0% in 2019 to 12.4% in 2020.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Other Income - Gain on Sale of Partnership Interest</div>
<div><br /></div>
<div style="text-align: left; text-indent: 20.2pt; margin-right: 7pt; font-family: 'Times New Roman'; font-size: 10pt;">Included in other income was the gain of $1.1 million in 2020 resulting from the sale of 14 previously closed clinics and, in 2019, a gain of $5.5 million resulting from the sale of a partnership interest with 30 clinics.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Other Income - Relief Funds</div>
<div><br /></div>
<div style="text-align: left; text-indent: 20.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Included in other income in 2020 was $13.5 million of Relief Funds.&#160; See discussion of Relief Funds on page <span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">26.</span></div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Interest Expense &#8211; Debt and Other</div>
<div><br /></div>
<div style="text-align: left; text-indent: 20.2pt; margin-right: 3pt; font-family: 'Times New Roman'; font-size: 10pt;">Interest expense &#8211; debt and other was $1.6 million for 2020 and $2.1 million for 2019. At December 31, 2020, $16.0 million was outstanding under our Amended Credit Agreement (as defined below under &#8220;&#8212;Liquidity and Capital Resources&#8221;). See &#8220;&#8212; Liquidity and Capital Resources&#8221; below for a discussion of the terms of our Amended Credit Agreement.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Provision for Income Taxes</div>
<div><br /></div>
<div style="text-align: left; text-indent: 20.2pt; margin-right: 4pt; font-family: 'Times New Roman'; font-size: 10pt;">The provision for income tax was $13.0 million for 2020 and $13.6 million for 2019. The provision for income tax as a percentage of income before taxes less net income attributable to non-controlling interest (effective tax rate) was 27.0% for 2020 and 25.4% for 2019. See table below ($ in thousands):</div>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>36</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div><br /></div>
<table cellpadding="0" cellspacing="0" id="z10bacfeab9944209971063c42f428af5" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"></div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="6" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Income before taxes</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">65,513</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">70,906</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Less: net income attributable to non-controlling interests:</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Non-controlling interests - permanent equity</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">(6,122</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">(6,561</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; font-family: 'Times New Roman'; font-size: 10pt;">Redeemable non-controlling interests - temporary equity</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">(11,175</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">(10,659</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">(17,297</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">(17,220</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Income before taxes less net income attributable to non-controlling interests</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">48,216</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">53,686</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Provision for income taxes</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">13,022</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">13,647</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Effective tax rate</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">27.0</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">%</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">25.4</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">%</div></td>
  </tr>
</table>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Net Income Attributable to Non-controlling Interests</div>
<div><br /></div>
<div style="text-align: justify; text-indent: 20.2pt; margin-right: 13pt; font-family: 'Times New Roman'; font-size: 10pt;">Net income attributable to non-controlling interests (permanent equity) was $6.1 million in 2020 and $6.6 million in 2019. Net income attributable to redeemable non-controlling interests (temporary equity) was $11.2 million in 2020 and $10.6 million in 2019.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">LIQUIDITY AND CAPITAL RESOURCES</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; margin-right: 1pt; font-family: 'Times New Roman'; font-size: 10pt;">We believe that our business is generating sufficient cash flow from operating activities to allow us to meet our short-term and long-term cash requirements, other than those with respect to future significant acquisitions. At December 31, 2020, we had $32.9 million in cash and cash equivalents compared to $23.5 million at December 31, 2019. Although the start-up costs associated with opening new clinics and our planned capital expenditures are significant, we believe that our cash and cash equivalents and availability under our Amended Credit Agreement are sufficient to fund the working capital needs of our operating subsidiaries, future clinic development and acquisitions and investments through at least December 2021. Significant acquisitions would likely require financing under our Amended Credit Agreement.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 20.15pt; font-family: 'Times New Roman'; font-size: 10pt;">Effective December 5, 2013, we entered into an Amended and Restated Credit Agreement with a commitment for a $125.0 million revolving credit facility. This agreement was amended in August 2015, January 2016, March 2017 and November 2017 (hereafter referred to as &#8220;Amended Credit Agreement&#8221;). The Amended Credit Agreement is unsecured and has loan covenants, including requirements that we comply with a consolidated fixed charge coverage ratio and consolidated leverage ratio. Proceeds from the Amended Credit Agreement may be used for working capital, acquisitions, purchases of our common stock, dividend payments to our common stockholders, capital expenditures and other corporate purposes. The pricing grid is based on our consolidated leverage ratio with the applicable spread over LIBOR ranging from 1.25% to 2.0% or the applicable spread over the Base Rate ranging from 0.1% to 1%. Fees under the Amended Credit Agreement include an unused commitment fee ranging from 0.25% to 0.3% depending on our consolidated leverage ratio and the amount of funds outstanding under the Amended Credit Agreement.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">The January 2016 amendment to the Amended Credit Agreement increased the cash and noncash consideration that we could pay with respect to acquisitions permitted under the Amended Credit Agreement to $50,000,000 for any fiscal year, and increased the amount we may pay in cash dividends to our shareholders in an aggregate amount not to exceed $10,000,000 in any fiscal year. The March 2017 amendment, among other items, increased the amount we may pay in cash dividends to our shareholders in an aggregate amount not to exceed $15,000,000 in any fiscal year. The November 2017 amendment, among other items, adjusted the pricing grid as described above, increased the aggregate amount we may pay in cash dividends to $20,000,000 to our shareholders and extended the maturity date to November 30, 2021.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; margin-right: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">On December 31, 2020, $16.0 million was outstanding on the Amended Credit Agreement resulting in $109.0 million of availability. As of the date of this report, we were in compliance with all of the covenants thereunder.</div>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>37</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div style="text-align: left; text-indent: 18pt; margin-right: 5pt; font-family: 'Times New Roman'; font-size: 10pt;">Cash provided by operations was $99.9 million and net proceeds from our Amended Credit Agreement amounted to $30.0 million. The major uses of cash for investing and financing activities included: purchase of interests in businesses ($23.9 million), purchases of redeemable non-controlling interest, temporary equity ($20.4 million), purchases of fixed assets ($7.6 million), proceeds on sale of partnership interest ($0.8 million), distributions to non-controlling interests ($18.3 million), payments of cash dividends to our shareholders ($4.1 million), and payments on notes payable ($1.0 million)</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; margin-right: 10pt; font-family: 'Times New Roman'; font-size: 10pt;">On November 30, 2020, we acquired a 75% interest in a three-clinic physical therapy practice. The purchase price for the 75% interest was $8.9 million (net of cash acquired), of which $8.6 million was paid in cash and $0.3 million in the form of a seller note that is payable in two principal installments totaling $162,500 each. The first principal payment plus accrued interest will be paid on November 2021 with the second installment to be paid in November 2022. The note accrues interest at 3.25% per annum.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">On September 30, 2020, we acquired a 70% interest in an entity which holds six management contracts that have been in place for a number of years and had five years remaining on their term as of the acquisition date. The purchase price for the 70% interest was approximately $4.2 million, with $3.7 million payable in cash and $0.5 million in notes payable. One of the notes payable of $0.2 million is payable, with any accrued interest at 5% per annum, on September 30, 2021. The remaining note of $0.3 million was paid in November 2020.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; margin-right: 2pt; font-family: 'Times New Roman'; font-size: 10pt;">On February 27, 2020, we acquired interests in a four-clinic physical therapy practice. The four clinics are operated in four separate partnerships. The Company&#8217;s interests in the four partnerships range from 10.0% to 83.8%, with an overall 65.0% based on the initial purchase transaction. The aggregate purchase price was $11.9 million, of which $11.6 million was paid in cash and $0.3 million in the form of a seller note. The note accrues interest at 4.75% per annum and the principal and interest is payable in February 2022.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; margin-right: 4pt; font-family: 'Times New Roman'; font-size: 10pt;">On September 30, 2019, we acquired a 67% interest in an eleven-clinic physical therapy practice. The purchase price for the 67% interest was $12.4 million, of which $12.1 million was paid in cash and $0.3 million in the form of a seller note that is payable in two principal installments totaling $150,000 each. The first principal payment plus accrued interest was paid in September 2020 with the second installment to be paid in September 2021. The note accrues interest at 5.0% per annum.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; margin-right: 1pt; font-family: 'Times New Roman'; font-size: 10pt;">On April 11, 2019, we acquired a company that is a provider of industrial injury prevention services. The acquired company specializes in delivering injury prevention and care, post offer employment testing, functional capacity evaluations and return-to-work services. It performs these services across a network of 45 states including onsite at eleven client locations. The business was then combined with Briotix Health, the Company&#8217;s industrial injury prevention operation, increasing the Company&#8217;s ownership position in the Briotix Health partnership to approximately 76.0%. The purchase price for the acquired company was $22.9 million ($23.6 million less cash acquired of $0.7 million), which consisted of $18.9 million in cash, (of which $0.5 million will be paid to certain shareholders), and a $4.0 million seller note. The note accrues interest at 5.5% and the principal and accrued interest is payable on April 9, 2021.</div>
<div><br /></div>
<div style="text-align: justify; text-indent: 19.9pt; margin-right: 10pt; font-family: 'Times New Roman'; font-size: 10pt;">On March 4, 2019, in conjunction with the purchase of a redeemable non-controlling interest, we entered into a note payable in the amount of $228,120 that was payable in two equal installments of $114,080 each, plus accrued interest. The first installment was paid in March 2020 and the second installment remains payable in March 2021.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; margin-right: 2pt; font-family: 'Times New Roman'; font-size: 10pt;">On August 31, 2018 we acquired a 70% interest in a four-clinic physical therapy practice. The purchase price for the 70% interest was $7.3 million in cash and $400,000 in a seller note that is payable in two principal installments totaling $200,000 each, plus accrued interest. The first installment was paid in August 2019 and the second installment was paid in August 2020.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; margin-right: 8pt; font-family: 'Times New Roman'; font-size: 10pt;">On February 28, 2018, through one of our majority owned partnerships, we acquired the assets and business of two physical therapy clinics, for an aggregate purchase price of $760,000 in cash and $150,000 in a seller note which was paid along with accrued interest on August 31, 2019.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; margin-right: 34pt; font-family: 'Times New Roman'; font-size: 10pt;">In addition to the multi-clinic acquisitions above in 2020, we acquired five separate clinic practices through several of our majority-owned Clinic Partnerships. These practices will operate as satellites of the respective existing clinic partnership.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; margin-right: 2pt; font-family: 'Times New Roman'; font-size: 10pt;">Historically, we have generated sufficient cash from operations to fund our development activities and to cover operational needs. We plan to continue developing new clinics and making additional acquisitions. We have from time to time purchased the non-controlling interests of limited partners in our Clinic Partnerships. We may purchase additional non-controlling interests in the future. Generally, any acquisition or purchase of non-controlling interests is expected to be accomplished using a combination of cash and financing. Any large acquisition would likely require financing.</div>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>38</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div style="text-align: left; text-indent: 19.9pt; font-family: 'Times New Roman'; font-size: 10pt;">We make reasonable and appropriate efforts to collect accounts receivable, including applicable deductible and co-payment amounts. Claims are submitted to payors daily, weekly or monthly in accordance with our policy or payor&#8217;s requirements. When possible, we submit our claims electronically. The collection process is time consuming and typically involves the submission of claims to multiple payors whose payment of claims may be dependent upon the payment of another payor. Claims under litigation and vehicular incidents can take a year or longer to collect. Medicare and other payor claims relating to new clinics awaiting CMS approval initially may not be submitted for six months or more. When all reasonable internal collection efforts have been exhausted, accounts are written off prior to sending them to outside collection firms. With managed care, commercial health plans and self-pay payor type receivables, the write-off generally occurs after the account receivable has been outstanding for 120 days or longer.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; margin-right: 16pt; font-family: 'Times New Roman'; font-size: 10pt;">We have future obligations for debt repayments, employment agreements and future minimum rentals under operating leases. The obligations as of December 31, 2020 are summarized as follows (in thousands):</div>
<div><br /></div>
<table cellpadding="0" cellspacing="0" id="zb3b74da86ba4450eae759fe293693c7b" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"></div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Total</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> 2021</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> 2022</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> 2023</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> 2024</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> 2025</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Thereafter</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 16%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Credit Agreement</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">16,000</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">16,000</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 16%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Notes Payable</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">5,495</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">4,899</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">596</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 16%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Interest Payable</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">114</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">107</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">7</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 16%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Employee Agreements</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">47,884</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">39,402</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">7,145</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">1,332</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">5</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 16%; padding-bottom: 2px; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">Operating Leases</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">119,834</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">37,427</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">29,655</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">22,233</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">14,379</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">7,909</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">8,231</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 16%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">189,327</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">97,835</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">37,403</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">23,565</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">14,384</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">7,909</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">8,231</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
  </tr>
</table>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; margin-right: 1pt; font-family: 'Times New Roman'; font-size: 10pt;">We generally enter into various notes payable as a means of financing our acquisitions. Our present outstanding notes payable primarily relate to the acquisitions of a business or acquisitions of majority interests in businesses. At December 31, 2020, our remaining outstanding balance on these notes aggregated $5.5 million. The notes payable for the acquisition of businesses of $5.5 million are payable in 2021 and 2022. Notes are generally payable in equal annual installments of principal over two years plus any accrued and unpaid interest. See above table for a detail of future principal payments. Interest accrues at various interest rates ranging from 3.25% to 5.50% per annum, subject to adjustment.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; margin-right: 4pt; font-family: 'Times New Roman'; font-size: 10pt;">In conjunction with acquisitions, we entered into amendments to our limited partnership agreements for our acquired partnerships. The limited partnership agreements, as amended, provide that, upon the triggering events, we have a Call Right and the selling entity or individual has a Put Right for the purchase and sale of the limited partnership interest held by the partner. Once triggered, the Put Right and the Call Right do not expire, even upon an individual partner&#8217;s death, and contain no mandatory redemption feature. The purchase price of the partner&#8217;s limited partnership interest upon the exercise of either the Put Right or the Call Right is calculated per the terms of the respective agreements and classified as redeemable non-controlling interest (temporary equity) in our consolidated balance sheets. The fair value of the redeemable non-controlling interest at December 31, 2020 was $132.3 million.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; margin-right: 5pt; font-family: 'Times New Roman'; font-size: 10pt;">As of December 31, 2020, we have accrued $5.7 million related to credit balances and overpayments due to patients and payors. This amount is expected to be paid in 2021.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 22.55pt; margin-right: 5pt; font-family: 'Times New Roman'; font-size: 10pt;">From September 2001 through December 31, 2008, our Board of Directors (&#8220;Board&#8221;) authorized us to purchase, in the open market or in privately negotiated transactions, up to 2,250,000 shares of our common stock. In March 2009, the Board authorized the repurchase of up to 10% or approximately 1,200,000 shares of our common stock (&#8220;March 2009 Authorization&#8221;). Our Amended Credit Agreement permits share repurchases of up to $15,000,000 in the aggregate, subject to compliance with covenants. We are required to retire shares purchased under the March 2009 Authorization.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 22.55pt; margin-right: 7pt; font-family: 'Times New Roman'; font-size: 10pt;">There is no expiration date for the share repurchase program. As of December 31, 2020, there are currently an additional estimated 124,740 shares (based on the closing price of $120.25 on December 31, 2020) that may be purchased from time to time in the open market or private transactions depending on price, availability and our cash position. We did not purchase any shares of our common stock during the year ended December 31, 2020 and 2019.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Off Balance Sheet Arrangements</div>
<div><br /></div>
<div style="text-align: left; margin-left: 20pt; font-family: 'Times New Roman'; font-size: 10pt;">We have no off-balance sheet debt or other off-balance sheet financing arrangements.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">FACTORS AFFECTING FUTURE RESULTS</div>
<div><br /></div>
<div style="text-align: left; margin-left: 20pt; font-family: 'Times New Roman'; font-size: 10pt;">The risks related to our business and operations include:</div>
<div><br /></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="zf325d08f4d2f4d51bec826b5f15d36a6">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">the multiple effects of the impact of public health crises and epidemics/pandemics, such as the novel strain of COVID-19 (coronavirus) which the financial magnitude cannot be currently estimated;</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="zae140c22069f46f18b1d99ea4e10518d">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">changes as the result of government enacted national healthcare reform&#894;</div></td>
  </tr>
</table>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>39</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z9a757565cf2d48e3aef94148dc4c8c3f">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">changes in Medicare rules and guidelines and reimbursement or failure of our clinics to maintain their Medicare certification and/or enrollment status, including the Medicare reimbursement reductions</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="zbedf1bd7492343868684f47a505c391a">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">revenue we receive from Medicare and Medicaid being subject to potential retroactive reduction&#894;</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z43d72c65e0d54c5da925810f9dc85761">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">business and regulatory conditions including federal and state regulations&#894;</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z2c26f029949e447f8584524e4400882a">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">governmental and other third-party payor inspections, reviews, investigations and audits, which may result in sanctions or reputational harm and increased costs&#894;</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="zb32fec114faf4f5fa40c29bdb988025f">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">compliance with federal and state laws and regulations relating to the privacy of individually identifiable patient information, and associated fines and penalties for failure to comply&#894;</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z3c4427f4656943cebe4552a34d4b614c">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">changes in reimbursement rates or payment methods from third party payors including government agencies, and changes in the deductibles and co-pays owed by patients&#894;</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z359ed3f37da648a698086649c6e778d2">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">revenue and earnings expectations&#894;</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="zfa6b9dac807049c49a75f9713c41fb01">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">legal actions, which could subject us to increased operating costs and uninsured liabilities&#894;</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z52e6199049c64ab18bbea34550bd9809">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">general economic conditions&#894;</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="za5814bbb623049ca8fc2c9389d679951">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">availability and cost of qualified physical therapists&#894;</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z6fabd7cec9eb47c0886234f8ad2c1e9d">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">personnel productivity and retaining key personnel&#894;</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="zef80e37bd8aa40b5a749aecff3ec128f">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">competitive, economic or reimbursement conditions in our markets which may require us to reorganize or close certain clinics and thereby incur losses and/or closure costs including the possible write-down or write-off of goodwill and other intangible assets&#894;</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="zb16b1b2e759d498382ea935d6246507b">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">competitive environment in the industrial injury prevention business, which could result in the termination or non-renewal of contractual service arrangements and other adverse financial consequences for that service line;</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="zb2ea0e7ce6d74e7b9a0e930b35b0c7fb">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">acquisitions, purchase of non-controlling interests (minority interests) and the successful integration of the operations of the acquired businesses&#894;</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="zed3f1f9f27d04811ab105a4651f5d5ef">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">maintaining our information technology systems with adequate safeguards to protect against cyber-attacks&#894;</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z9b401031ff1c432cbaaab27b8acfc226">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">a security breach of our or our third party vendors&#8217; information technology systems may subject us to potential legal action and reputational harm and may result in a violation of the Health Insurance Portability and Accountability Act of 1996 of the Health Information Technology for Economic and Clinical Health Act;</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z6fa4fd93e93d4b4a934a9bcdaaa8aaa2">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">maintaining adequate internal controls&#894;</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z876fef7861ec452fa96631e6b9a198a9">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">maintaining necessary insurance coverage&#894;</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z4367e5289a8646f5b5c2674b338a1a84">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">availability, terms, and use of capital&#894; and</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z689dcdb22b43419796dfe5199b3a4e6b">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">weather and other seasonal factors.</div></td>
  </tr>
</table>
<div><br /></div>
<div style="text-align: left; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">See also Risk Factors in Item 1A of this Annual Report on Form 10-K.</div>
<div><br /></div>
<div><a id="ITEM7AQuantitativeQualitative"><!--Anchor--></a></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="zec32bf16a0274ac6ac6a3dc15dec14ed">
  <tr>
    <td style="width: 72pt; vertical-align: top; align: right;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">ITEM 7A.</span></td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.</div></td>
  </tr>
</table>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; font-family: 'Times New Roman'; font-size: 10pt;">We do not maintain any derivative instruments such as interest rate swap arrangements, hedging contracts, futures contracts or the like. Our only indebtedness as of December 31, 2020 was the outstanding balance of seller notes from our acquisitions of $5.5 million and an outstanding balance on our Amended Credit Agreement of $16.0 million. The outstanding balance under our Amended Credit Agreement is subject to fluctuating interest rates. A 1% change in the interest rate would yield an additional $160,000 of interest expense. See Note 9 to our consolidated financial statements included in Item 8.</div>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>40</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div style="text-align: left;"><a id="ITEM8"><!--Anchor--></a><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">ITEM 8.</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.</span></div>
<div><br /></div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">U.S. PHYSICAL THERAPY, INC. AND SUBSIDIARIES</div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS AND RELATED INFORMATION</div>
<div><br /></div>
<table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="za2aa9996cfe849739ed928e4f0afe6ee">
  <tr>
    <td style="width: 92.9%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Reports of Independent Registered Public Accounting Firm&#8212;Grant Thornton LLP</div></td>
    <td style="width: 7.1%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">42</div></td>
  </tr>
  <tr>
    <td style="width: 92.9%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 7.1%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 92.9%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Audited Financial Statements:</div></td>
    <td style="width: 7.1%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 92.9%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Consolidated Balance Sheets as of December 31, 2020 and 2019</div></td>
    <td style="width: 7.1%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">45</div></td>
  </tr>
  <tr>
    <td style="width: 92.9%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Consolidated Statements of Income for the years ended December 31, 2020, 2019 and 2018</div></td>
    <td style="width: 7.1%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">46</div></td>
  </tr>
  <tr>
    <td style="width: 92.9%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Consolidated Statements of Changes in Equity for the years ended December 31, 2020, 2019 and 2018</div></td>
    <td style="width: 7.1%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">47</div></td>
  </tr>
  <tr>
    <td style="width: 92.9%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Consolidated Statements of Cash Flows for the years ended December 31, 2020, 2019 and 2018</div></td>
    <td style="width: 7.1%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">48</div></td>
  </tr>
  <tr>
    <td style="width: 92.9%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Notes to Consolidated Financial Statements</div></td>
    <td style="width: 7.1%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">49</div></td>
  </tr>
</table>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>41</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Board of Directors and Shareholders</div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">U.S. Physical Therapy, Inc.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Opinion on the financial statements</div>
<div><br /></div>
<div style="text-align: left; margin-right: 5pt; font-family: 'Times New Roman'; font-size: 10pt;">We have audited the accompanying consolidated balance sheets of U.S. Physical Therapy, Inc. (a Nevada corporation) and subsidiaries (the &#8220;Company&#8221;) as of December 31, 2020 and 2019, the related consolidated statements of income, changes in equity, and cash flows for each of the three years in the period ended December 31, 2020, and the related notes and financial statement schedule included under Item 15(a) (collectively referred to as the &#8220;financial statements&#8221;). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2020 and 2019, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2020, in conformity with accounting principles generally accepted in the United States of America.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;), the Company&#8217;s internal control over financial reporting as of December 31, 2020, based on criteria established in the 2013 <span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Internal Control&#8212;Integrated Framework</span> issued by the Committee of Sponsoring Organizations of the Treadway Commission (&#8220;COSO&#8221;), and our report dated March 1, 2021 expressed an unqualified opinion.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Basis for opinion</div>
<div><br /></div>
<div style="text-align: left; margin-right: 5pt; font-family: 'Times New Roman'; font-size: 10pt;">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</div>
<div><br /></div>
<div style="text-align: left; margin-right: 2pt; font-family: 'Times New Roman'; font-size: 10pt;">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Critical audit matter</div>
<div><br /></div>
<div style="text-align: left; margin-right: 3pt; font-family: 'Times New Roman'; font-size: 10pt;">The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of&#160; critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Measurement of Patient Revenue Net of Contractual Adjustments</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">As discussed in Note 2 to the consolidated financial statements, revenues are recognized in the period in which services are rendered. Net patient revenues (patient revenues less estimated contractual adjustments) are recognized at the estimated net realizable amounts from third-party payors, patients and others in exchange for services rendered when obligations under the terms of the contract are satisfied. The Company has agreements with third-party payors that provides for payments at amounts different from its established rates. Each month the Company estimates its contractual adjustment for each clinic based on the terms of third-party payor contracts and the historical collection and write-off experience of the clinic and applies a contractual adjustment reserve percentage to the gross accounts receivable balances. The Company then performs a comparison of cash collections to corresponding net revenues for the prior twelve months. We identified the measurement of contractual adjustments as a critical audit matter.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The principal consideration for our determination that the measurement of contractual adjustments is a critical audit matter is that the estimate requires a high degree of auditor subjectivity in evaluating management&#8217;s assumptions related to developing future collection patterns across the various clinic locations.</div>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>42</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Our audit procedures related to the Company&#8217;s measurement of contractual adjustments included the following, among others.</div>
<div><br /></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z23e541301bed470a8753286181fc7fac">
  <tr>
    <td style="width: 21.15pt;"></td>
    <td style="width: 17.85pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">We tested the design and operating effectiveness of controls relating to billing and cash collection, net rate trend analysis by clinic and cash collection versus net revenue trend analysis.</div></td>
  </tr>
</table>
<div><br /></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="za31c9c29052b43398c0b8e66c638804a">
  <tr>
    <td style="width: 21.15pt;"></td>
    <td style="width: 17.85pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">For a sample of patient visits, we inspected and compared underlying documents for each transaction, which included gross billing rates and cash collected (net revenue).</div></td>
  </tr>
</table>
<div><br /></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="za8e0ad811497428ca0f99554898bc4c9">
  <tr>
    <td style="width: 21.15pt;"></td>
    <td style="width: 17.85pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">For a sample of patient visits, we traced gross billings and net revenue to net revenue recorded in the general ledger and to each report used in determining and assessing the contractual adjustment calculation.</div></td>
  </tr>
</table>
<div><br /></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z120c710dfe694ec48c74d29b52b68063">
  <tr>
    <td style="width: 21.15pt;"></td>
    <td style="width: 17.85pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">We compared cash collections to recorded net revenue over a twelve month period ending December 31, 2020 and again for the twelve month period ending in the first month subsequent to period end, to identify whether there were unusual trends that would indicate that the usage of historical collection patterns would no longer be reasonable to predict future collection patterns.</div></td>
  </tr>
</table>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">/s/ GRANT THORNTON LLP</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">We have served as the Company&#8217;s auditor since 2004.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Houston, Texas</div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">March 1, 2021</div>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>43</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Board of Directors and Shareholders</div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">U.S. Physical Therapy, Inc.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Opinion on internal control over financial reporting</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">We have audited the internal control over financial reporting of U.S. Physical Therapy, Inc. (a Nevada corporation) and subsidiaries (the &#8220;Company&#8221;) as of December 31, 2020, based on criteria established in the 2013 <span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Internal Control&#8212;Integrated Framework</span> issued by the Committee of Sponsoring Organizations of the Treadway Commission (&#8220;COSO&#8221;). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2020, based on criteria established in the 2013 <span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Internal Control&#8212;Integrated Framework</span> issued by COSO.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;), the consolidated financial statements of the Company as of and for the year ended December 31, 2020, and our report dated March 1, 2021 expressed an unqualified opinion on those financial statements.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Basis for opinion</div>
<div><br /></div>
<div style="text-align: left; margin-right: 1pt; font-family: 'Times New Roman'; font-size: 10pt;">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management&#8217;s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Definition and limitations of internal control over financial reporting</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</div>
<div><br /></div>
<div style="text-align: left; margin-right: 3pt; font-family: 'Times New Roman'; font-size: 10pt;">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">/s/ GRANT THORNTON LLP</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Houston, Texas</div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">March 1, 2021</div>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>44</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div><br /></div>
<div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">U.S. PHYSICAL THERAPY, INC. AND SUBSIDIARIES<span style="font-size: 10pt; font-family: 'Times New Roman';"><br /></span>CONSOLIDATED BALANCE SHEETS<span style="font-size: 10pt; font-family: 'Times New Roman';"><br /></span>(In thousands, except share data)</div>
<div><br /></div>
<table cellpadding="0" cellspacing="0" id="zed4fcfeca8d14c9b845b23a8712dd000" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"></div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom;"><div style="text-align: center; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">ASSETS</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Current assets:</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Cash and cash equivalents</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" id="Fact_2ce2d5105c7b4dc28dc233e436489a8f" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">32,918</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" id="Fact_05bade75101f4225bd86ecb6d0e494d6" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">23,548</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Patient accounts receivable, less allowance for credit losses of $<ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" id="Fact_6b920a7b30204a83a34a0b072d0c975e" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,008</ix:nonFraction> and $<ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" id="Fact_d365d56031ec4deab5ddb4e95063a4f1" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,698</ix:nonFraction>, respectively</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" id="Fact_7fe3ae65f699406595ff153fdedc0e83" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">41,906</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" id="Fact_dea4543ee9e847f596c2355be0405581" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">46,228</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Accounts receivable - other</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AccountsAndOtherReceivablesNetCurrent" id="Fact_d4af189555f446769a4ab47c9114f959" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">9,039</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AccountsAndOtherReceivablesNetCurrent" id="Fact_0969a7f302e64132bafa6b306a4469db" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">9,823</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Other current assets</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OtherAssetsCurrent" id="Fact_bf4b5518a96a442aa6e5155f352e4931" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">3,773</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OtherAssetsCurrent" id="Fact_f9d3bae1d6b044f9bdca267945d446cf" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,787</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total current assets</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AssetsCurrent" id="Fact_9c42641ce4ca4bf992926b523e516cb7" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">87,636</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AssetsCurrent" id="Fact_fc0f93d3d0fc4ce08c3fca87fed34ba2" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">85,386</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Fixed assets:</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Furniture and equipment</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FurnitureAndFixturesGross" id="Fact_f1d90ca3b0d64579b9569dad07437d1e" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">55,426</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FurnitureAndFixturesGross" id="Fact_9ef119e111d442a38a490351866dac13" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">54,942</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Leasehold improvements</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LeaseholdImprovementsGross" id="Fact_442c99afe67a44349e10142b8afe9b16" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">35,320</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LeaseholdImprovementsGross" id="Fact_77ee5b7915634df2963ec38be67dd419" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">33,247</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Fixed assets, gross</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" id="Fact_daa7f1d8eb1b4fb6a33557b392b32e75" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">90,746</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" id="Fact_2f7e6f7be46046d0870f2e3ee61463bb" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">88,189</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Less accumulated depreciation and amortization</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" id="Fact_f52e0122f4cf4daa9aed6baa2a9d0fc5" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">69,081</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" id="Fact_35f64a30bfe54397a1bafd73b9c406f5" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">66,099</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Fixed assets, net</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" id="Fact_d67b9a45298040939fe0f8ae2bb3a76f" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">21,665</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" id="Fact_f16d84cf150f40f9ad4136baab4d6d0c" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">22,090</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Operating lease right-of-use assets</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" id="Fact_789cf4b05c3a41979723e3f06166d40b" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">81,595</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" id="Fact_af30bcff1ef440bb930a11abe8db7d1c" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">81,586</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Goodwill</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Goodwill" id="Fact_33d4620d152b4f588ff917afe3eb01aa" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">345,646</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Goodwill" id="Fact_3fbed941dc8b432884104ba029c5c926" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">317,676</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Other identifiable intangible assets, net</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" id="Fact_bfd7c6f1e4dd448ea716065aa8d9c18e" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">56,280</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" id="Fact_a79f2d798b4a49528e12a1a917c67a1f" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">52,588</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Other assets</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" id="Fact_2d9dff42930e40a4ae33352c57ea3fb0" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,539</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" id="Fact_513b098804b341729fcc92b16a304b6e" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,519</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 33.85pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total assets</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Assets" id="Fact_2e900d70673745e68e79e37c1b39b23b" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">594,361</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Assets" id="Fact_e60e3ebb34dc4f398fcced329287a18e" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">560,845</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: center; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LIABILITIES, REDEEMABLE NON-CONTROLLING INTERESTS, USPH</div><div style="text-align: center; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">SHAREHOLDERS&#8217; EQUITY AND NON-CONTROLLING INTERESTS</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Current liabilities:</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Accounts payable - trade</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AccountsPayableTradeCurrent" id="Fact_16d722628c304cd6b771c39940c3ab32" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,335</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AccountsPayableTradeCurrent" id="Fact_fc8b850a65cf4c94808447bff5cee5ad" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,494</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Accrued expenses</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" id="Fact_59c6efc0e5254574ac8b52145204d515" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">59,746</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" id="Fact_7f721b421c4e49e3ac23616b60cd6d2d" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">30,855</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Current portion of operating lease liabilities</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" id="Fact_7528e83538fa44a686c97c6d7f45046b" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">27,512</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" id="Fact_559302aefaac443e84392ed642cab1bb" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">26,486</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Current portion of notes payable</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermDebtCurrent" id="Fact_4c30ec4007054809919a6939047345f6" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,899</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermDebtCurrent" id="Fact_c3ba565395b147a497f11f3c2bbc7687" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">728</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total current liabilities</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" id="Fact_c0bb6ede3f4841f99e2d812c7cb73fca" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">93,492</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" id="Fact_572f2ccbb3d24855849448caec530103" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">60,563</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Notes payable, net of current portion</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermNotesPayable" id="Fact_a1b6c782a1544ec29dae0d15d66ba078" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">596</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermNotesPayable" id="Fact_6d5d2017a2a14cbd8d94fdc5169747a0" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,361</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Revolving line of credit</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermLineOfCredit" id="Fact_e727a06037a1462c9a9a27dcab9008cf" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">16,000</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermLineOfCredit" id="Fact_fd624ba6d8674b0491f8e7569ff13a60" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">46,000</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Deferred taxes</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredIncomeTaxLiabilitiesNet" id="Fact_d05c866eccd5474caa69f057e9e2ad9e" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">7,779</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredIncomeTaxLiabilitiesNet" id="Fact_445f572077104ea9bb6aff4222768cee" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">10,071</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Operating lease liabilities, net of current portion</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" id="Fact_aa0942dfda90437b927a5e77709391c4" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">61,985</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" id="Fact_c4377a58ffc64541a0fc681366b50add" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">60,258</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Other long-term liabilities</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" id="Fact_e502a01909f74f448dedd223e84cb516" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,539</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" id="Fact_6d442207476d4d74af37aa78d2757010" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">141</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 33.85pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total liabilities</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Liabilities" id="Fact_e323b6f938af4b73bf9e6b318459627e" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">184,391</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Liabilities" id="Fact_1804dd88c3be496d94b195b791f3c6c8" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">181,394</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Redeemable non-controlling interests - temporary equity</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" id="Fact_dc76525c9c3540e9a00130be00622ca5" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">132,340</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" id="Fact_fa94725061404027a4a9d8cec3dc80f9" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">137,750</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Commitments and Contingencies (Note 17)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CommitmentsAndContingencies" id="Fact_f51bdff43632426686f66c4c43387d1d" contextRef="c20201231" unitRef="U001" xsi:nil="true" format="ixt:nocontent"></ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CommitmentsAndContingencies" id="Fact_6f923232041d44f586caab32061eacfa" contextRef="c20191231" unitRef="U001" xsi:nil="true" format="ixt:nocontent"></ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U.S. Physical Therapy, Inc. (&#8220;USPH&#8221;) shareholders&#8217; equity:</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Preferred stock, $<ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" id="Fact_533717d3ecf644b689249608603441a0" contextRef="c20191231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" id="Fact_2f8dcac6aa0b4a7a91b8290b1b4f078a" contextRef="c20201231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">0.01</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" id="Fact_55f9a2b40e244bac9734f259a2f092fa" contextRef="c20201231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" id="Fact_e4969dea983746029ed7c008889aad23" contextRef="c20191231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">500,000</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" id="Fact_445d545663f340c3b29cb24fff1339a8" contextRef="c20201231" unitRef="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" id="Fact_9e907d0793014e1a8f5e41ff7dfe33c9" contextRef="c20191231" unitRef="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" id="Fact_7a2e0a6634e14018aa4627ac4ac73ebd" contextRef="c20201231" unitRef="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" id="Fact_6969c36e3f3f40ce95dd91607ef09a0b" contextRef="c20191231" unitRef="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:PreferredStockValue" id="Fact_22ee4fb801cc489cb72c297acf3c0ee8" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:PreferredStockValue" id="Fact_5cc2b9910a794bd685adac6113855292" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Common stock, $<ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" id="Fact_23df58c641ef47d3b8ab61c72122c7b3" contextRef="c20201231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" id="Fact_7729113373134ace9784335566bd5dea" contextRef="c20191231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">0.01</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" id="Fact_bf3d1d5431f84e74a721b9cf003ab13b" contextRef="c20191231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" id="Fact_b5f9c671d2234ee8b496fae75090a7f6" contextRef="c20201231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">20,000,000</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction name="us-gaap:CommonStockSharesIssued" id="Fact_c6172ad2dab0462284b448937cfa778f" contextRef="c20201231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">15,066,282</ix:nonFraction> and <ix:nonFraction name="us-gaap:CommonStockSharesIssued" id="Fact_5306c9d2f0be43e2874b69c7b0d19fb2" contextRef="c20191231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">14,989,337</ix:nonFraction> shares issued, respectively</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CommonStockValue" id="Fact_14d1307248364171959a49cf82445478" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">151</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CommonStockValue" id="Fact_637938b9d07340fe9525e8d03e2f3d66" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">150</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Additional paid-in capital</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" id="Fact_c43e3fae9f8141c1ae9272c4e591adf5" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">95,622</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" id="Fact_5e97ad0fa1a640d39c62198739354026" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">87,383</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Retained earnings</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" id="Fact_36769be17bbc446a9560ebef73fddc1d" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">212,015</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" id="Fact_b9798d73605243dc9ed81d125b7c9b47" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">184,352</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Treasury stock at cost, <ix:nonFraction name="us-gaap:TreasuryStockShares" id="Fact_7a6c599fd0f544529201120d61801a08" contextRef="c20201231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:TreasuryStockShares" id="Fact_75ac6df5c07e40c1b74dac393f776266" contextRef="c20191231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">2,214,737</ix:nonFraction></ix:nonFraction> shares</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:TreasuryStockValue" id="Fact_ade910b159cb44d2862fa6e1691bc879" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">31,628</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:TreasuryStockValue" id="Fact_350010c45bd04c989aefd046a151ee84" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">31,628</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total USPH shareholders&#8217; equity</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_4b0f79582bed43e6861baf5074a2ad68" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">276,160</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_51e985b0b53d4356a4f86b0c23542f8a" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">240,257</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Non-controlling interests - permanent equity</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterest" id="Fact_644db5a6fe8d4c2dbd3a870f7764a784" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,470</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterest" id="Fact_e059b9d1754349bcafab4a127948934f" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,444</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total USPH shareholders' equity and non-controlling interests</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_3ca81ed110b945db8e535902354c9df1" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">277,630</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_150345a2b01a4be19f74969975f156bc" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">241,701</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 33.85pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total liabilities, redeemable non-controlling interests, USPH shareholders' equity and non-controlling interests</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" id="Fact_d9c7daef913840919caa962c18b140a8" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">594,361</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" id="Fact_566c9d007e0b42cab75eeef97e82b2c5" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">560,845</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
  </tr>
</table>
<div><br /></div>
<div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">See notes to consolidated financial statements.</div>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>45</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">U.S. PHYSICAL THERAPY, INC. AND SUBSIDIARIES<span style="font-size: 10pt; font-family: 'Times New Roman';"><br /></span>CONSOLIDATED STATEMENTS OF INCOME<span style="font-size: 10pt; font-family: 'Times New Roman';"><br /></span>(In thousands, except per share data)</div>
<div><br /></div>
<table cellpadding="0" cellspacing="0" id="zc12ab9ffb9e64a8d8d1a70e2443244df" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"></div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="10" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2018</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Net patient revenues</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_e35c9967bb9f4dd0b0204873f5680460" contextRef="c20200101to20201231_ProductOrServiceAxis_NetPatientRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">373,340</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_7ad59bf422cc49eb8655247753eb9c6f" contextRef="c20190101to20191231_ProductOrServiceAxis_NetPatientRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">433,345</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_770be3cf31534bc69d1a71a5aa7407c7" contextRef="c20180101to20181231_ProductOrServiceAxis_NetPatientRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">417,703</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Other revenues</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_00042d1941d245cc89cdeb1d8eceb009" contextRef="c20200101to20201231_ProductOrServiceAxis_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">49,629</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_e8811db838ab4cc0bf0d9729e13f6fb5" contextRef="c20190101to20191231_ProductOrServiceAxis_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">48,624</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_65682071f9e241dda91e9425e8d0e987" contextRef="c20180101to20181231_ProductOrServiceAxis_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">36,208</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Net revenues</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_6ce856a4fb56458592e0ba2e79cf86b5" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">422,969</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_c5dda4651d6d42dabbb350296d0b02af" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">481,969</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_97ca2440635c46a6b04ca7f62cc528d3" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">453,911</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Operating costs:</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Salaries and related costs</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LaborAndRelatedExpense" id="Fact_61def78b225b4c30a5cb11c226fe1036" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">235,629</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LaborAndRelatedExpense" id="Fact_9e6121bed2844723aa8fc8d6fd1c09a1" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">274,233</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LaborAndRelatedExpense" id="Fact_a14809dd412949f89d2b60ccb841ca6b" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">259,228</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rent, supplies, contract labor and other</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RentSuppliesContractLaborAndOther" id="Fact_65191cada3724f26af3313be7972cc22" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">84,336</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RentSuppliesContractLaborAndOther" id="Fact_a2d5ea7b395e42fbab658c2dc675a38b" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">90,379</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RentSuppliesContractLaborAndOther" id="Fact_ab34ea46a55d490da607b55e8dd20267" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">88,426</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Provision for credit losses</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProvisionForDoubtfulAccounts" id="Fact_ba0b2faa79014c53a03219397ae2999a" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,623</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProvisionForDoubtfulAccounts" id="Fact_3a2c59168e04419397ea50e3c1acfe5b" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,858</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProvisionForDoubtfulAccounts" id="Fact_a6c41c88b78540a78f27357bd130f0c5" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,603</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Closure costs - lease and other</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RestructuringCharges" id="Fact_f50737667fe349dc8e394ee71d4582d4" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,072</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RestructuringCharges" id="Fact_feb32cd04e904fa68d1d28abbadbbce3" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">25</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:RestructuringCharges" id="Fact_fadd9a615cbf448889894ab46a2163be" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">9</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Closure costs - derecognition of goodwill</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" id="Fact_718aab7d5e95400f9f9a3fd2279ee369" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,859</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" id="Fact_817d4b0b29484fe5ad372109012ea095" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" id="Fact_1ac475118fc84568a9b88bb9e74750a8" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total operating costs</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CostsAndExpenses" id="Fact_356252ae6bd84f93883aee6dd172838e" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">328,519</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CostsAndExpenses" id="Fact_badc1a42bbd043cda9b49a3fbb78c88d" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">369,495</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CostsAndExpenses" id="Fact_5fa9cf00b4724588af5f6416f755625b" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">352,248</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Gross profit</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GrossProfit" id="Fact_8aa965161a974bd7977f8e27c43a46db" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">94,450</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GrossProfit" id="Fact_519be4070e5c4ab1a3ddb9049660d266" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">112,474</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GrossProfit" id="Fact_6669eddc33e24d509545e52a263ee948" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">101,663</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Corporate office costs</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" id="Fact_dc4d6615516547ccbaf131801ad2b43c" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">42,037</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" id="Fact_339e858f87bc4a5d8088f523f3ce04a7" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">45,049</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" id="Fact_a40c8d642e464b7087190a436a6e6001" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">41,349</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Operating income</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" id="Fact_232585ea62b3409ea2fa980846a4e095" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">52,413</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" id="Fact_cb5eee5f9927401eb5e41adf051f3f4d" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">67,425</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" id="Fact_6d793eb1111c421294c3b7c204ed8726" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">60,314</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Other income and expense:</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Relief Funds</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:ReliefFunds" id="Fact_0dd041d1d5434432b48526438ab4920b" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">13,501</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:ReliefFunds" id="Fact_2d0e9091e77b4d89a326543a7e603d0b" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:ReliefFunds" id="Fact_eeae2d8bded34765b962710c07cc0399" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Gain on sale of partnership interest and clinics</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GainLossOnSaleOfInterestInProjects" id="Fact_11b6a467e6f44604b8b221056cfc8ecb" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,091</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GainLossOnSaleOfInterestInProjects" id="Fact_a9640dd66b1645599f70a042c075754f" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,514</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GainLossOnSaleOfInterestInProjects" id="Fact_36494e685a0e4653a371a30c3bc29263" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Gain on derecognition of debt</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" id="Fact_126b099faf3c4303b54211f64fc37e4d" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" id="Fact_07ca9e6121504d3dad8a10d713599707" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" id="Fact_7e64e762420747d28b35ef7096a8fdff" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,846</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Interest and other income, net</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:InterestAndOtherIncome" id="Fact_47a6948804e6421aa7c5569ddfb6f432" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">142</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:InterestAndOtherIncome" id="Fact_6673f1ddb6de4e3e88cef8bffb09c538" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">46</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:InterestAndOtherIncome" id="Fact_0fb4e652a83d40ca9380dd08c22e143c" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">93</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Interest expense - debt and other</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:InterestExpenseDebtAndOther" id="Fact_5edcd5c5fc24482ea39a16479f7f01cc" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,634</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:InterestExpenseDebtAndOther" id="Fact_6c0bf53b06c24910b90862697a113664" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,079</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:InterestExpenseDebtAndOther" id="Fact_114139eb1d40479b920e5abfd30dfde3" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,042</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total other income and expense</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" id="Fact_1ecc0a48dcab42f28074ebd74a033757" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">13,100</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" id="Fact_0fac39fce89a4f02b908280d94c0dbea" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">3,481</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" id="Fact_a5241686e8e3460b967a8f55b9422da3" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">103</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Income before taxes</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" id="Fact_c265a78c41644118bf05f565239b1b7a" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">65,513</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" id="Fact_d33c361e91fa42ec9279c95e7045f44b" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">70,906</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" id="Fact_3f1829e853174cad87037a0923a0853b" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">60,211</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Provision for income taxes</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" id="Fact_ed64e716c78c408395d255cf5ff6f76c" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">13,022</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" id="Fact_275eae87f6164f3cbf8a9de99e43c183" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">13,647</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" id="Fact_28ae1dac79474472b8b70839a93cd2b9" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">11,369</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Net income</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProfitLoss" id="Fact_29155edc6b2641ed8c87262ae24397ca" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">52,491</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProfitLoss" id="Fact_6f9b95ec0bc34e92aa05c9fcaec0fa9f" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">57,259</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProfitLoss" id="Fact_d69789a070424537a32da77e2c0a7173" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">48,842</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Less: net income attributable to non-controlling interests:</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Non-controlling interests - permanent equity</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_088facc727da4e8dae55d74920778473" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,122</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_8175e81b6b48483ab14eab2cae8ef10b" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,561</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_dcea8686fab849c88225d1bf710e3485" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,536</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Redeemable non-controlling interests - temporary equity</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" id="Fact_438b4fecd99746a995c3c21718f20cb3" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">11,175</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" id="Fact_70cea6ef71224e2eadc5867ad8e2e3b3" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">10,659</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" id="Fact_51c2b86a0f3c441daa44495c7520799b" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">8,433</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" id="Fact_7f61bf9462694815bd16de14e473ed79" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">17,297</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" id="Fact_834f06bee5924c12b3ca4785b8102173" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">17,220</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" id="Fact_e03a86e004484de3aa213f2bb2d7b4de" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">13,969</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Net income attributable to USPH shareholders</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_31bdbfb4915f47acb8218bf15a52ad49" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">35,194</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_dd6f30fb2a9346cd878ccf29d188cf37" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">40,039</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_13ad099f58fb4769a198359989747e09" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">34,873</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Basic and diluted earnings per share attributable to USPH shareholders</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" id="Fact_c585bb89c2ac4e25a129f456266e225e" contextRef="c20200101to20201231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">2.48</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" id="Fact_ab4ab6f15414421da7be1eb830722efd" contextRef="c20190101to20191231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">2.45</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" id="Fact_0172f895a68642baba3a75c813fc1554" contextRef="c20180101to20181231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">1.31</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Shares used in computation - basic and diluted</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" id="Fact_52a84381861042c5b5aa644dda136413" contextRef="c20200101to20201231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">12,835</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" id="Fact_6beed9c77fc048a1a38adcc0b7461c9a" contextRef="c20190101to20191231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">12,756</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" id="Fact_c0469b8922514ae794bc545d836ff24a" contextRef="c20180101to20181231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">12,666</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Dividends declared per common share</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CommonStockDividendsPerShareDeclared" id="Fact_012f9768e29b4bf2be07d6b5d4720ae9" contextRef="c20200101to20201231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">0.32</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CommonStockDividendsPerShareDeclared" id="Fact_482dee4cca2448898c010e7bd16cc319" contextRef="c20190101to20191231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">1.14</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CommonStockDividendsPerShareDeclared" id="Fact_6896edea7afa4e1593c24d01ff57d231" contextRef="c20180101to20181231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">0.92</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
  </tr>
</table>
<div><br /></div>
<div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">See notes to consolidated financial statements.</div>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>46</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">U.S. PHYSICAL THERAPY, INC. AND SUBSIDIARIES</div>
<div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY</div>
<div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(In thousands)</div>
<div><br /></div>
<table cellpadding="0" cellspacing="0" id="zfb6f613397ee4e71be067ac21dd8f737" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"></div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="26" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">U.S. Physical Therapy, Inc.</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="6" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Common Stock</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" rowspan="2" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" rowspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Additional</div><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Paid-In Capital</div></td>
    <td colspan="1" rowspan="2" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" rowspan="2" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" rowspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Retained</div><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Earnings</div></td>
    <td colspan="1" rowspan="2" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="6" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Treasury Stock</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" rowspan="2" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" rowspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Total Shareholders&#8217;</div><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Equity</div></td>
    <td colspan="1" rowspan="2" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" rowspan="2" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" rowspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Non-Controlling</div><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Interests</div></td>
    <td colspan="1" rowspan="2" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" rowspan="2" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" rowspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Total</div></td>
    <td colspan="1" rowspan="2" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Shares</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Amount</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Shares</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Amount</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 10%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Balance January 1, 2018</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_f83d1c0691e5479f9b523544afe15332" contextRef="c20171231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">14,809</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_785fd350be414c27a44c27ca72cf45a1" contextRef="c20171231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">148</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_7e352e549c6e441fbef6007e2a1fefca" contextRef="c20171231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">73,940</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_4312cc04e3974531b02d3117342264c5" contextRef="c20171231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">162,406</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_27c7420849724d44be51d6630cbf3dc2" contextRef="c20171231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">2,215</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_c1c6aaec27504359aed8a8c9b8eb694c" contextRef="c20171231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">31,628</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_72d470802917488cb4ddaa481edbb992" contextRef="c20171231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">204,866</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_d2c23374fa364405993f70ce658c1b93" contextRef="c20171231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,204</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_1befc4da3b9941dbaace34d4cd9a7c3f" contextRef="c20171231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">206,070</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 10%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 10%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Issuance of restricted stock, net of cancellations</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" id="Fact_c41034e530d94d4c89eb8205193aae40" contextRef="c20180101to20181231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">90</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_5a83464f42c54a82a1776bdff0720ede" contextRef="c20180101to20181231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_99c8243ce9fa42c3a69995618ddded14" contextRef="c20180101to20181231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_582ca17769554fab94e8ad4bb8c3dcc2" contextRef="c20180101to20181231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" id="Fact_e2a97c06e0b84ac3badf01d7f77cead8" contextRef="c20180101to20181231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_f5b8f2a6252e40f6a6d8f2a794348aa4" contextRef="c20180101to20181231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_9fe6844a20a24aad91d532abd5ef92e4" contextRef="c20180101to20181231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_0566adc9664d42d0b9b3af67d87db3a6" contextRef="c20180101to20181231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_7ae29ff14cf94b74b14e52d12ceacb4f" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 10%;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Revaluation of redeemable non-controlling interest, net of tax</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" id="Fact_45d68bdf28734cec8337203f23dcd3f0" contextRef="c20180101to20181231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="0" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_78b2d56c333f42ab96a92f971fa3765d" contextRef="c20180101to20181231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_f6e604376a964b4a97a0d47272d71f5e" contextRef="c20180101to20181231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_22d5e8143ef74d338632b150c670e69b" contextRef="c20180101to20181231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">18,268</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" id="Fact_222ccc34cd5f4258b204c2f36bc7f6c1" contextRef="c20180101to20181231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3" scale="0" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_188b85854ebe4752bf2644c6efaba986" contextRef="c20180101to20181231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_4f244c49e0b443169c4ef16fc8ce7936" contextRef="c20180101to20181231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">18,268</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_41e1cc8b1e714ed7ac8c034c1cac923f" contextRef="c20180101to20181231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_2d2c8b14be784a43b2ebdda1a91f8978" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">18,268</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 10%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Compensation expense - equity-based awards</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_d4dd4eac340d49ef97a0b8d520073d28" contextRef="c20180101to20181231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_4d52a212f6324f289699435b35292b64" contextRef="c20180101to20181231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,939</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_eef8f4fbf54547ce9cd24ccef0016531" contextRef="c20180101to20181231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_fcb1c70e24004eee9ba68398ba0f9206" contextRef="c20180101to20181231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_9886660aab334f018cd30c5260157631" contextRef="c20180101to20181231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,939</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_84a5d527a51d4d3d9affdc9c198f8924" contextRef="c20180101to20181231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_58891e2c2fa147029756bd062babf481" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,939</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 10%;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Transfer of compensation liability for certain stock issued pursuant to long-term incentive plans</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" id="Fact_814ff93eb0af482b95ce3c98660ae883" contextRef="c20180101to20181231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" id="Fact_7efef34746e249babfdb69a5fb30485c" contextRef="c20180101to20181231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">373</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" id="Fact_a07cb379ee34480ca3a2e5640b46fec2" contextRef="c20180101to20181231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" id="Fact_a41b9228c43c4c34b56eaf28788a9961" contextRef="c20180101to20181231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" id="Fact_c86bdbff5e954fe4b22ecbbd7b2f049f" contextRef="c20180101to20181231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">373</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" id="Fact_e541bd54d3e248a5b257a44b7ec93be9" contextRef="c20180101to20181231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" id="Fact_dfd9729acbce4790abc1171175801f29" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">373</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 10%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Sale of non-controlling interest, net of purchases and tax</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:SaleOfNonControllingInterestNetOfTaxAndPurchases" id="Fact_e14d559ac74e49d4adf17d7c7a852c32" contextRef="c20180101to20181231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:SaleOfNonControllingInterestNetOfTaxAndPurchases" id="Fact_88daaa2d7ccc4a16b5d3efa00ec12703" contextRef="c20180101to20181231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">224</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:SaleOfNonControllingInterestNetOfTaxAndPurchases" id="Fact_7caaadbb0be144549ec3fa448c6ca4f3" contextRef="c20180101to20181231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:SaleOfNonControllingInterestNetOfTaxAndPurchases" id="Fact_8ca26989ad6f42babeb271299d7c0463" contextRef="c20180101to20181231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:SaleOfNonControllingInterestNetOfTaxAndPurchases" id="Fact_ecebe879e5714097a9a58c5eb3321d29" contextRef="c20180101to20181231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">224</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:SaleOfNonControllingInterestNetOfTaxAndPurchases" id="Fact_80bf2673caa04e2f854d569302b934dd" contextRef="c20180101to20181231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">48</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:SaleOfNonControllingInterestNetOfTaxAndPurchases" id="Fact_9c558c9878f04cbdb3b4bee473371003" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">272</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 10%; white-space: nowrap;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Dividends paid to USPT shareholders</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_c4cb5df92e5449ada53bb6a32b50afe1" contextRef="c20180101to20181231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_0a1c0df69a7a4fc6a407d3c7ab5df1d4" contextRef="c20180101to20181231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_c8496b9f57c54211a9b7db34cc824158" contextRef="c20180101to20181231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">11,664</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_e2c4da697e984235a2ae0cb7ee540485" contextRef="c20180101to20181231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_8bb85119d7d3450c88cbe63dc35ff156" contextRef="c20180101to20181231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">11,664</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_aaeab31d4d5b4713b7a82c3e65688df4" contextRef="c20180101to20181231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_5fe7630b42cb400485e8db70eff2f864" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">11,664</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 10%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Distributions to non-controlling interest partners - permanent equity</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_0e0f991709624c65b419e58136b56939" contextRef="c20180101to20181231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_d35495ae9a7b411d8c5194173803cc80" contextRef="c20180101to20181231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_dc07b82449924af8811482ff6a5e5e89" contextRef="c20180101to20181231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_d267f6142a0f418dba781946684168fc" contextRef="c20180101to20181231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_68bdb48497da4234a2de4bcfaba7e085" contextRef="c20180101to20181231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_e1c8464bad4f4efd80623bc858874933" contextRef="c20180101to20181231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,812</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_486710db13f241518b5502f14d9d3288" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,812</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 10%;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Other</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_ef52e274790444f2b8a80098b13232da" contextRef="c20180101to20181231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_05c27d301c21402db5c08c897d291e58" contextRef="c20180101to20181231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_188ffdc526824e81a6634e50d8c07601" contextRef="c20180101to20181231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">49</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_31955495fe2a4e3eb5b193f3c4dad57a" contextRef="c20180101to20181231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_3a79bdb7185e4057b2a84cbf1e665246" contextRef="c20180101to20181231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">49</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_080ea18b407f458489dccaae58993f19" contextRef="c20180101to20181231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">50</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_9a2041ef82984acdab3c3a5ce78c7865" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">99</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 10%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Net income attributable to non-controlling interest - permanent equity</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_e87f49f678ff44a99b53d903f49c34fe" contextRef="c20180101to20181231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_053dfe1e6ca946069d17ecd1e6674698" contextRef="c20180101to20181231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_d3cd1f182f3b49feb893afcad0b6e130" contextRef="c20180101to20181231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_b4a76cb5f5464f1681667832a46094ee" contextRef="c20180101to20181231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_d077ca2f47184d78bfc90db118b77943" contextRef="c20180101to20181231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_843e806a1e03474694c78867584a9727" contextRef="c20180101to20181231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,536</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_fffd2ede8c194e97b75982fe818c1009" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,536</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 10%; padding-bottom: 2px;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Net income attributable to USPH shareholders</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_af4ee5e789074be3969bd62e6288224d" contextRef="c20180101to20181231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_8dab10a1a0c8491c931054dcd987c02f" contextRef="c20180101to20181231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_f8ddb88bb7284bf4bb277f3cc6fc20c1" contextRef="c20180101to20181231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">34,873</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_de9b290c82754f5cbda8e291ec8b91e9" contextRef="c20180101to20181231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_43e1fd5fa46b40b2be7931b5ef310914" contextRef="c20180101to20181231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">34,873</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_15bce0f434a84f978718b6ff6bbe5e25" contextRef="c20180101to20181231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_035f5af1410243c1857de6b4cfe0524b" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">34,873</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 10%; padding-bottom: 4px; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Balance December 31, 2018</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_d328c16690f14d1c9179925509c779d9" contextRef="c20181231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">14,899</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_9ca7273bd1f349ecba616edcac8f263c" contextRef="c20181231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">149</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_19ec2f70a2d14d4187cf0264549666d4" contextRef="c20181231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">80,028</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_f5bf7b724d4f407fbc3b90b795e52b09" contextRef="c20181231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">167,396</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_c5f6934f13144d18b2bc12960d84e0de" contextRef="c20181231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">2,215</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_164ebc8c07ce44859fefd2d54eac8c43" contextRef="c20181231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">31,628</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_4597971c648e4d088b915c455a5c01b8" contextRef="c20181231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">215,945</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_b0b0817c72c741a49bd69f231ba0cf18" contextRef="c20181231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">930</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_13b0682169d144fcb6eebc6cdf90bb81" contextRef="c20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">216,875</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
</table>
<div><br /></div>
<table cellpadding="0" cellspacing="0" id="z5b75842ef0a5479482b8aaa9bc5be444" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"></div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="26" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">U.S. Physical Therapy, Inc.</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="6" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Common Stock</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" rowspan="2" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" rowspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Additional</div><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Paid-In Capital</div></td>
    <td colspan="1" rowspan="2" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" rowspan="2" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" rowspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Retained</div><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Earnings</div></td>
    <td colspan="1" rowspan="2" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="6" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Treasury Stock</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" rowspan="2" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" rowspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Total Shareholders&#8217;</div><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Equity</div></td>
    <td colspan="1" rowspan="2" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" rowspan="2" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" rowspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Non-Controlling</div><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Interests</div></td>
    <td colspan="1" rowspan="2" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" rowspan="2" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" rowspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Total</div></td>
    <td colspan="1" rowspan="2" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Shares</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Amount</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Shares</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Amount</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 10%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Issuance of restricted stock, net of cancellations</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" id="Fact_9d19eeb28dd44a2083aa4a0449473ca5" contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">90</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_aed065bf5dcd4cc7b062346cafbe3e7f" contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_627fbc1991ad4cc38b113547795cb610" contextRef="c20190101to20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_31b293cd305d43a8a008271f36ed6d7e" contextRef="c20190101to20191231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" id="Fact_b66262c821654082bebb4b22255686a5" contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_65d76d958e0f487c8cb57a8808b6b40b" contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_aa6fb3875abd4ff0832fd267df2ab1dc" contextRef="c20190101to20191231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_01a7e47d25e84fd0b0950334d9e79a23" contextRef="c20190101to20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_393a1a99d3104397b4c72b1ee6592c48" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 10%;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Revaluation of redeemable non-controlling interest, net of tax</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" id="Fact_6ced11221b9248cbbf5426d610fcdfbc" contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="0" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_8d1b16311de34bc5b6f8d6f86ed376ea" contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_5769d2fb4ecb4815838a5c41043627cf" contextRef="c20190101to20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_d512cf7b90204bcdaf0e8408c1535ab8" contextRef="c20190101to20191231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">8,771</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" id="Fact_516f1f1584324518b11515ed80640945" contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3" scale="0" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_60f01d53931046bd8cc89ffa9d636763" contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_3bfbc83f7dcd45baba40d58b5eb6dd1e" contextRef="c20190101to20191231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">8,771</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_c77b493a63d64b1fbfa44915456e4e61" contextRef="c20190101to20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_7fde35ed85274d4ab82449be7cef6e19" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">8,771</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 10%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Compensation expense - equity-based awards</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_1277c008ae2841d0ae7fe8255a4555f9" contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_eb3f85f224f24c2993aa0c2ed4f5efc7" contextRef="c20190101to20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,985</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_6e16dab575e14c1993afa95e95032840" contextRef="c20190101to20191231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_107bd6ea897f41eeb9bb3c440a0060a0" contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_af7662f9cfc049aba219a15b353af83a" contextRef="c20190101to20191231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,985</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_c62f9ada6a924df1a9e4e7c3dd7e1c60" contextRef="c20190101to20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_90041b9c73534d0086debe52d9084cc8" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,985</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 10%;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Transfer of compensation liability for certain stock issued pursuant to long-term incentive plans</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" id="Fact_c47e8dede2124c08a3ed8fd7f8eacdbf" contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" id="Fact_a23bce2be4804b4da28e72a8f5f06c9b" contextRef="c20190101to20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">636</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" id="Fact_684cfb4c1aa3432284d5185838e87ff1" contextRef="c20190101to20191231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" id="Fact_0795acc34576457fbfac13c448d606aa" contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" id="Fact_46b8c0101a6545b1a037cd32602d2386" contextRef="c20190101to20191231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">636</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" id="Fact_3560d2756fe948eea8c18fd1e4e1425b" contextRef="c20190101to20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" id="Fact_d2ac7756549c42fb8bd94b66481270ed" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">636</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 10%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Purchase of partnership interests - redeemable non-controlling interests</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PurchaseOfPartnershipInterestsRedeemableNonControllingInterests" id="Fact_9aea48b0516249a4b3d50a6f6d75caa5" contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:PurchaseOfPartnershipInterestsRedeemableNonControllingInterests" id="Fact_4f0d23f93caa4bd5aac363d52cc5cc14" contextRef="c20190101to20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">266</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PurchaseOfPartnershipInterestsRedeemableNonControllingInterests" id="Fact_cdfb7092e94b453c91763aabf28dcff3" contextRef="c20190101to20191231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PurchaseOfPartnershipInterestsRedeemableNonControllingInterests" id="Fact_9bf4c46c090a4ff192875f1d7b82f5f2" contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:PurchaseOfPartnershipInterestsRedeemableNonControllingInterests" id="Fact_c2241718c2a94bce83f3fb14c7ea4047" contextRef="c20190101to20191231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">266</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:PurchaseOfPartnershipInterestsRedeemableNonControllingInterests" id="Fact_87995c773bf64a7e9d9f84181ecc4591" contextRef="c20190101to20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">26</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:PurchaseOfPartnershipInterestsRedeemableNonControllingInterests" id="Fact_e8901c4d30e349b6bbccf2160cc69e46" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">292</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 10%;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Sale of non-controlling interest, net of purchases and tax</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:SaleOfNonControllingInterestNetOfTaxAndPurchases" id="Fact_5f3c5917723d434bbe0bdffa5837779c" contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:SaleOfNonControllingInterestNetOfTaxAndPurchases" id="Fact_d9ea9d5ed30146879fb1af4f93b39666" contextRef="c20190101to20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:SaleOfNonControllingInterestNetOfTaxAndPurchases" id="Fact_2e353296e9754d7fb5f5852448b7e3b7" contextRef="c20190101to20191231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">196</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:SaleOfNonControllingInterestNetOfTaxAndPurchases" id="Fact_0a9977d7ea654862bf088ae1be4435ac" contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:SaleOfNonControllingInterestNetOfTaxAndPurchases" id="Fact_7a525a26c43e48769fd3aaa9be8ecb10" contextRef="c20190101to20191231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">196</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:SaleOfNonControllingInterestNetOfTaxAndPurchases" id="Fact_6e28b9f10804496aa31f7bcb9975f8bd" contextRef="c20190101to20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:SaleOfNonControllingInterestNetOfTaxAndPurchases" id="Fact_4918ba63b46843b6a78a9499c34a08c6" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">196</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 10%; background-color: #CCEEFF; white-space: nowrap;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Dividends paid to USPT shareholders</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_d6442e09148c46019c080ff9826226be" contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_f065a82ff86748469be2a7c1f450f4da" contextRef="c20190101to20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_6d22dde1877e4b40a2d887a3e3f68258" contextRef="c20190101to20191231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">14,555</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_52d830115c33444e827188977e76c174" contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_7f67e2ea1d01449bb2651603699d60c5" contextRef="c20190101to20191231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">14,555</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_f09b1cad120d4932b468bd7a27b6b1cd" contextRef="c20190101to20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_75bfb5d85126419fba9fc98c26de27bb" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">14,555</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 10%;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Distributions to non-controlling interest partners - permanent equity</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_a4e0d42e85f14da7b2fb7fa1c781440e" contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_dda90d7fe7b4491d9e39acaa532ead6f" contextRef="c20190101to20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_32b0f66524b547f19aa9d1081c78b0c5" contextRef="c20190101to20191231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_cb11cb4ca5614e1da6a088a92b5b5c42" contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_9af08121669748fbb157a8b9b1e37959" contextRef="c20190101to20191231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_0b7697055b6148c9b70309464938dc4b" contextRef="c20190101to20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,014</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_bc859fe506e64c42857be43e2f163395" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,014</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 10%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Other</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_602e25321e9f47558197c645c62ded24" contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_18ee574153154452ba35ce1f0bf25a6f" contextRef="c20190101to20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_69d8ec44d7624447af2f0a0f3a519519" contextRef="c20190101to20191231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">47</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_d29252d168b24ed0a6045989e5d8a921" contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_876e99729a7945e9ba04dbda9ca490d4" contextRef="c20190101to20191231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">47</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_c8c35df23d6f495290845dde87d42f72" contextRef="c20190101to20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">7</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_586613367d9a4359995036473d46a9be" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">40</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 10%;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Net income attributable to non-controlling interest - permanent equity</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_97cc82717e94464d83cc8d1be4fecc56" contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_bdd3679a44784736938427b876bd47f9" contextRef="c20190101to20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_b5d2bbb4dccd4c8b891de03abbd3ab5f" contextRef="c20190101to20191231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_3c5b91ab11454f1f887df73814798122" contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_9fb83d0c89af473da9d1b0ca3deacd98" contextRef="c20190101to20191231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_185a429f3489476c9dc1a7d79cbb756e" contextRef="c20190101to20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,561</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_1029402fafdb44f8aba784f2b387a1cd" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,561</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 10%; padding-bottom: 2px; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Net income attributable to USPH shareholders</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_d76100fb65384b5d9a630e86f2cad8e9" contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_66eb3505956545edb9be468aeac02ecd" contextRef="c20190101to20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_670a8706b48540a8a206fce257c58bbf" contextRef="c20190101to20191231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">40,039</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_4f579fa22a4e4b6b90523bcec4a05bd8" contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_db7194d6ceb34189adb94cf43fb4b62f" contextRef="c20190101to20191231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">40,039</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_41f429a79d49438f9e927c0d9def0a56" contextRef="c20190101to20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_31671a1bcee0461e89aa645ac5ab9bd4" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">40,039</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 10%; padding-bottom: 4px;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Balance December 31, 2019</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_c62df02de46b43cf96ee3dc2a881e91f" contextRef="c20191231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">14,989</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_4f5534e7c46e4024b5b82adf4a8c4b81" contextRef="c20191231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">150</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_5253cdd4963f4b1eb45700924bf837ed" contextRef="c20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">87,383</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_253b2ed6a4af4ea985449d5be4056bf4" contextRef="c20191231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">184,352</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_071baf6ebe6c4b0aa6e4bf340828dc05" contextRef="c20191231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">2,215</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_247466b354454eb7b07926c334751cbb" contextRef="c20191231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">31,628</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_62e87ff0164f4fb7aee303b113ff0b9e" contextRef="c20191231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">240,257</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_af40a826b6e0414688597bd21bd7dc9a" contextRef="c20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,444</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_a00c2f95a2cf4cf8b062b42e5ca1253c" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">241,701</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
  </tr>
</table>
<div><br /></div>
<table cellpadding="0" cellspacing="0" id="z7ee69a37be084d8ba7b31741f7d1216a" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"></div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="26" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">U.S. Physical Therapy, Inc.</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="6" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Common Stock</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" rowspan="2" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" rowspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Additional</div><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Paid-In Capital</div></td>
    <td colspan="1" rowspan="2" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" rowspan="2" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" rowspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Retained</div><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Earnings</div></td>
    <td colspan="1" rowspan="2" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="6" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Treasury Stock</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" rowspan="2" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" rowspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Total Shareholders&#8217;</div><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Equity</div></td>
    <td colspan="1" rowspan="2" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" rowspan="2" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" rowspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Non-Controlling</div><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Interests</div></td>
    <td colspan="1" rowspan="2" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" rowspan="2" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" rowspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Total</div></td>
    <td colspan="1" rowspan="2" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Shares</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Amount</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Shares</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Amount</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 10%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Issuance of restricted stock, net of cancellations</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" id="Fact_cf42913a55e644359dcddeed67a8ffa0" contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">76</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_67f9fa07af8d478f829053eae3bb43f7" contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_e4a1dfde09cc42a98226738b47cef8fb" contextRef="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_e64fd0edcc2b4518be1e96ea7cf082e6" contextRef="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" id="Fact_582dbbc940ff435caa2317186cf5b151" contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_1840a95365e34d7e899c7be37a34b4b2" contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_93550e8c87ad481ebe78c822ed2d3e4c" contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_e007e9971a6d40589c59ae8177060dfc" contextRef="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" id="Fact_dd744078131b4659b99594c6c4d1f174" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 10%;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Revaluation of redeemable non-controlling interest, net of tax</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" id="Fact_ff05884ca7094c4699aec85d40af0883" contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="0" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_5892ee2c49ba48ed99824d677400b273" contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_fc7dcd3164164c31afd8dfc3eafb956e" contextRef="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_0918aad158e246539b023dd9578f1235" contextRef="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">3,415</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" id="Fact_26325bd617884128812992661f625abe" contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3" scale="0" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_31fae65b0b6f4947922ae25b4a4e8435" contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_8f4cefb69896453e88e5c2d1387ea5ca" contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">3,415</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_c5355d138d734584ad25dc988b928882" contextRef="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:RevaluationOfRedeemableNonControllingInterestNetOfTax" id="Fact_84459a894a664d5fb02f174297ef8b1c" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">3,415</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 10%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Compensation expense - equity-based awards</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_d7093df019cd454aa16f6b48d9d9fd7f" contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_aad311e2898e44a59fdeefdf327bddbf" contextRef="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">7,917</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_2df06227d43d43aa9adccf6536ab9383" contextRef="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_7d14099e155a49fda06db6739eaa7285" contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_6295cf23268044b9948d41b02daf63f5" contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">7,917</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_b876d48d80e34daca7c704cb32695b3f" contextRef="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" id="Fact_9874b51c369f4b88804dbe5702c59e0b" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">7,917</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 10%;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Transfer of compensation liability for certain stock issued pursuant to long-term incentive plans</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" id="Fact_eb638845c7634740a27faf93270c0473" contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" id="Fact_1d43842204264e65987bdefbaa935ca4" contextRef="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">486</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" id="Fact_1b68911bf92b45a2a2c88a0a52ce1bc9" contextRef="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" id="Fact_ccd8a1d32107492e8d6a87aac6542775" contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" id="Fact_1384706a20f743c48553ea235ef3179a" contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">486</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" id="Fact_d745f30492994cc4b88aa8e0485b2c50" contextRef="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" id="Fact_10231e3d07c949afa6785156d7797be3" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">486</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 10%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Purchase of partnership interests - redeemable non-controlling interests</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PurchaseOfPartnershipInterestsRedeemableNonControllingInterests" id="Fact_6e75d5e95d70484d871ffb7dbb298518" contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PurchaseOfPartnershipInterestsRedeemableNonControllingInterests" id="Fact_b32194e2227d496c9e239e09f826e7b7" contextRef="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PurchaseOfPartnershipInterestsRedeemableNonControllingInterests" id="Fact_0b8e27211ea54645a17777b1fa19d292" contextRef="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PurchaseOfPartnershipInterestsRedeemableNonControllingInterests" id="Fact_3d978d1a74f34f5ebfa3ecd4aeb67b7d" contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PurchaseOfPartnershipInterestsRedeemableNonControllingInterests" id="Fact_f00bf1fba39d4d3999f1adf92e4be5ef" contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:PurchaseOfPartnershipInterestsRedeemableNonControllingInterests" id="Fact_4d53478be8df46469af58fc2dc0c1a9e" contextRef="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">168</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:PurchaseOfPartnershipInterestsRedeemableNonControllingInterests" id="Fact_f765f04716f843f2b626339ebdaa0428" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">168</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 10%;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Sale of non-controlling interest, net of purchases and tax</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:SaleOfNonControllingInterestNetOfTaxAndPurchases" id="Fact_89551c498ee8406aac635ce703654284" contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:SaleOfNonControllingInterestNetOfTaxAndPurchases" id="Fact_35a0998a7af4481981770be1ff6b24f6" contextRef="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">164</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:SaleOfNonControllingInterestNetOfTaxAndPurchases" id="Fact_777d872e493f45a5bebd5e11ff97d69a" contextRef="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:SaleOfNonControllingInterestNetOfTaxAndPurchases" id="Fact_75fc178a488d44209855cb20d9735566" contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:SaleOfNonControllingInterestNetOfTaxAndPurchases" id="Fact_bb18618307444c84856d8bbce8dbb5ed" contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">164</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:SaleOfNonControllingInterestNetOfTaxAndPurchases" id="Fact_93ac07d13721455d8646413f98787da2" contextRef="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:SaleOfNonControllingInterestNetOfTaxAndPurchases" id="Fact_dae39a2b30b8404fa9705fc2cfc0ed71" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">164</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 10%; background-color: #CCEEFF; white-space: nowrap;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Dividends paid to USPT shareholders</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_182e92d62d91443ab601e8e0cfb4f0ba" contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_be79880261fc4b4eaeec33c823ce2f5f" contextRef="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_0d2b59d354ba4fcb86b3014ca0b2b562" contextRef="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,110</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_e7a36e13f94f4178bc3bd8037f92c428" contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_150d7264ab794f6f9b0873ef83bdcc51" contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,110</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_6b6344a7eae045aa888c4d7ffdb74eb3" contextRef="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DividendsCommonStockCash" id="Fact_92a123a181cd46c095b75cb3c12fa114" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,110</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 10%;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Distributions to non-controlling interest partners - permanent equity</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_fc481bda61ee4018aa01c5e9afbb96c0" contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_944d05de06b24937b838152975921e6b" contextRef="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_a3170e893b134c799f923abbc6e41bb4" contextRef="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_518aa71bfc7440d981372a63429a8dcb" contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_c962f31058784e05b76fda26ae522e33" contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_113a3b878d674d2c8444d3520c6352c7" contextRef="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,928</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" id="Fact_8b5bf3cf105d4916badc8dd2b94c840a" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,928</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 10%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Other</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_c079de163135413ba02e5b375d8cacfc" contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_af6d38fe6e334977be5a6a54cca2da5b" contextRef="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_0ebaed835131442484433b04edcb3c34" contextRef="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">6</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_31eddebb3946476a904d6ae58cc12273" contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_963d4e277372411fba094dfaaa94d983" contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">6</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_6fccdedb59ef40f986601b7baf124ffc" contextRef="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:StockholdersEquityOther" id="Fact_79334fa36db140c5bc35755214242f96" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">6</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 10%;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Net income attributable to non-controlling interest - permanent equity</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_1816d44652cb4004b6b146b381bdc92c" contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_7008171cc8a546a4830214db364922ca" contextRef="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_6a10a7df05864a22bde89c3ba3c587ab" contextRef="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_c7745a0af1aa45749fa2f7c32a1856a2" contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_2b0dd70d26c84e8e92034be7cda11096" contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_f1e4f738368c4a1694baa8ffe4f1f928" contextRef="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,122</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="Fact_2257dafe8fc447d68c1a80ff8b1295e2" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,122</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 10%; padding-bottom: 2px; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Net income attributable to USPH shareholders</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_f7fea1e16b664519918f0b20fa6c0d9b" contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_d7903201039048dabeef595b18583fdb" contextRef="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_45908be2d7d84705915e7b8687c1900c" contextRef="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">35,194</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_7e5eec8b906e45edbf13590cbdb93e6a" contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_84e8dc4c82474e5eb7968656326d7ee9" contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">35,194</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_c2dba2d021664012885f15c3d3cf7e82" contextRef="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_aad493baac264f568bebb0b28544e99c" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">35,194</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 10%; padding-bottom: 4px;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Balance December 31, 2020</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_a4c0f34763d6493eb99228b836735c74" contextRef="c20201231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">15,065</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_469c6a1adf164acbb793c7104ce62ae7" contextRef="c20201231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">151</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_7a243a23836f40b39feb8dfafcef9eb4" contextRef="c20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">95,622</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_f364babd46e24017aa41080fcdea0df2" contextRef="c20201231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">212,015</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_efc50bb202fd410c985e96282918f90d" contextRef="c20201231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">2,215</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_12f3cc337ad84867be6922cf0b92fa4a" contextRef="c20201231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">31,628</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_58dbce2609844ea6a88213097aafc19d" contextRef="c20201231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">276,160</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_0d3d3f870fd245e3a182ab16587a6740" contextRef="c20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,470</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 7%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_05694e8141664bfea5ec2c409dbf48ea" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">277,630</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
  </tr>
</table>
<div><br /></div>
<div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">See notes to consolidated financial statements.</div>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>47</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">U.S. PHYSICAL THERAPY, INC. AND SUBSIDIARIES<span style="font-size: 10pt; font-family: 'Times New Roman';"><br /></span>CONSOLIDATED STATEMENTS OF CASH FLOWS<span style="font-size: 10pt; font-family: 'Times New Roman';"><br /></span>(In thousands)</div>
<div><br /></div>
<table cellpadding="0" cellspacing="0" id="z59b4786584a64e0c80db2cfa880509fa" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"></div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="10" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2018</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">OPERATING ACTIVITIES</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Net income including non-controlling interests</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProfitLoss" id="Fact_3d4a40ab76a5449a86d374f557d3ff08" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">52,491</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProfitLoss" id="Fact_110c1ad1248f4ff8810d630583bb6b3b" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">57,259</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProfitLoss" id="Fact_014b2e9f759d4c5882a9da49cba14788" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">48,842</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Adjustments to reconcile net income including non-controlling interests to net cash provided by operating activities:</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 33.85pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Depreciation and amortization</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" id="Fact_4672ed17ad464edc99bfbee3501fbb7a" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">10,533</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" id="Fact_92714c1cf35f4d8cbf6337e51ff84532" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">10,095</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" id="Fact_e50a1241c15644018f3d24f4c051d626" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">9,755</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 33.85pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Provision for credit losses</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProvisionForDoubtfulAccounts" id="Fact_13b24af077fe4156ad4bc13afea48f97" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,623</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProvisionForDoubtfulAccounts" id="Fact_c15655b1110742aabc6a68877f9eb2c2" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,858</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProvisionForDoubtfulAccounts" id="Fact_a3f4e6e667a94155b94f7f82c0e6da78" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,603</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 33.85pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Equity-based awards compensation expense</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensation" id="Fact_06ec87c57d7842088b7d3f32bbdb65dc" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">7,917</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensation" id="Fact_8b006ccbdc1248069ef9b990ea4a9a70" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,985</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensation" id="Fact_deb0d11f02524c07b5f451cdced3af1c" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,939</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 33.85pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Deferred income taxes</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" id="Fact_4d91369e230344a0ab6c3004c49cff6a" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">258</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" id="Fact_205e29714f9f447393313e699733b8ee" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,651</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" id="Fact_6a0494c2f6c14b39a8f3b4c38fd3dead" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,813</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 33.85pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Gain on sale of partnership interest</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:GainOnSaleOfPartnershipInterestNetOfTax" id="Fact_38b62a4c171d4c91ae5403dd60968a9b" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,091</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:GainOnSaleOfPartnershipInterestNetOfTax" id="Fact_bbb564ee12ff4879ae96bb53a6aeb5b7" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,514</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:GainOnSaleOfPartnershipInterestNetOfTax" id="Fact_02530686b78d445ea31761f5aef7c518" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,846</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 33.85pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Write-off of goodwill - closed clinics</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" id="Fact_db0c6a524a334fd993e5ef36fe325567" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,859</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" id="Fact_1ad790cbe34a4fe790df481e3610568e" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" id="Fact_7e4616547c774f0c94845fee3c26c590" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 33.85pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Other</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OtherOperatingActivitiesCashFlowStatement" id="Fact_ccc42a650f4c4929b831af1779d6ae8d" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">281</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OtherOperatingActivitiesCashFlowStatement" id="Fact_0183991bb8494e0a8366bc67e3d108ac" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">96</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OtherOperatingActivitiesCashFlowStatement" id="Fact_8d0f41a22de4425b942c6615d6549d22" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">167</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Changes in operating assets and liabilities:</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 33.85pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Decrease (increase) in patient accounts receivable</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" id="Fact_2df6ba5dc0c3477fb7b04f7d7705296b" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">899</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" id="Fact_9a0028af42554e1c87e772ebcc8e03f6" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,376</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" id="Fact_76ef5d3d8b2147388a9be7da273b7694" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">3,434</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 33.85pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Decrease(increase) in accounts receivable - other</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" id="Fact_eb28d8e06cd544399c4a30da4e0f777f" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">1,661</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" id="Fact_ed8d42707579460e80c38b96e79c94ed" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,499</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" id="Fact_e551a6b1aa8e4b0f948432666e4b6090" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,087</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 33.85pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Decrease (increase) in other assets</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" id="Fact_32210e2e686b4ee9a1f3f3fe85a96fba" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">4,161</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" id="Fact_673b4340a5d84908afb8713a1d17689c" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,878</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" id="Fact_19940dde9e284c78a55289eeac947aa3" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">345</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 33.85pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Increase (decrease) in accounts payable and accrued expenses</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" id="Fact_d4b63a138c8e4df980b940233c616546" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">12,427</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" id="Fact_83b6ed74eaad43b7be580bad0cd724b6" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">4,209</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" id="Fact_fb2a9304db70499299c806767ad3cff0" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,876</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 33.85pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Increase (decrease) in other long-term liabilities</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" id="Fact_1174c618ff0b4b4c94c821196acf95a1" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,492</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" id="Fact_92ed1fb97a00448facf969aacbb46f4c" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">1,020</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" id="Fact_abce45fb6f6e494da594563e19bcd0ba" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">32</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Net cash provided by operating activities</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" id="Fact_1f573f4974b446df9f0c199882efc21a" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">99,995</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" id="Fact_e203ae84474b499ca8419a3ccc6a435e" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">62,448</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" id="Fact_306c0d9b1c0a4ef7b29e0d058bcadea4" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">73,005</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td colspan="12" valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">INVESTING ACTIVITIES</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Purchase of fixed assets</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" id="Fact_df07545d6eff49cf9daccdcf04cb774f" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">7,639</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" id="Fact_d7e73fba2b024792b408fe9b33be63aa" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">10,189</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" id="Fact_eae80edeefd24c6e82ff91a345b7da25" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">7,193</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Purchase of majority interest in businesses, net of cash acquired</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" id="Fact_e93d024bbc694bf9a5e871e4726d16b2" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">23,907</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" id="Fact_b21a92c21735462e8a28eb97e03e2191" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">30,597</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" id="Fact_c3f7980a75e34c3c8ffa4b0111118bed" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">16,367</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Purchase of redeemable non-controlling interest, temporary equity</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:PaymentsToAcquireRedeemableNonControllingInterest" id="Fact_eb7e2c00dd7d40e7b64712a335793f09" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">20,385</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:PaymentsToAcquireRedeemableNonControllingInterest" id="Fact_7070a3005c70497595ff76b71faa19e7" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">8,651</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PaymentsToAcquireRedeemableNonControllingInterest" id="Fact_e9a27e610baa48ab95a9d44d01610111" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Purchase of non-controlling interest, permanent equity</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates" id="Fact_89814b35c0ca46f2aeb84dcac31b5fb7" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">238</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates" id="Fact_4e2cdc01bbdd485d81ca6d43620870f9" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">428</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates" id="Fact_f4b5372a112e46ecbd66bd1d2f8f8c6c" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">350</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Proceeds on sale of redeemable non-controlling interest, temporary equity</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" id="Fact_6a56dc796b5a4c64ac80b3a24b9678c0" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">127</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" id="Fact_4a4673b00e6044848ed4c8b76618f4cb" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">207</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" id="Fact_623e1f7906e9428d8c74c7eb6d6fcbf9" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Proceeds on sales of partnership interest, clinics and fixed assets</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProceedsFromDivestitureOfBusinesses" id="Fact_a82ac8b47d7447028bf08d914bbe402e" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">839</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProceedsFromDivestitureOfBusinesses" id="Fact_80ac043b20684994a820796b8ed45cee" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">11,665</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProceedsFromDivestitureOfBusinesses" id="Fact_a8b16a7b3beb4e10ae1859a2ee9d65e8" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Net cash used in investing activities</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" id="Fact_c141bb06aeb04ce79c0da6f890b0956a" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">51,203</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" id="Fact_5a65d112dfa34888a73979be2ee57e37" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">37,993</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" id="Fact_781a26f700e94f39aa52dc9b21ca1f3a" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">23,909</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td colspan="12" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">FINANCING ACTIVITIES</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Distributions to non-controlling interests, permanent and temporary equity</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsMinorityInterest" id="Fact_ccae4839fe90447b8629301b080a132b" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">18,331</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsMinorityInterest" id="Fact_8b7f159a4b70462f9c6fcbd115aee702" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">16,235</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsMinorityInterest" id="Fact_11483e389dbc41b8b7fc2cb70b33f83e" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">15,646</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Cash dividends paid to shareholders</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsCommonStock" id="Fact_c4e54b8ba125470da87843ab4ad05b6c" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,110</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsCommonStock" id="Fact_509e395458894ed29b04268c4dc346da" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">14,555</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsCommonStock" id="Fact_ebfd6ec3b53249dabf9a88937b796ad3" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">11,664</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Proceeds from revolving line of credit</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProceedsFromLinesOfCredit" id="Fact_46f036fb8b8040819014852d8f40083a" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">214,000</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProceedsFromLinesOfCredit" id="Fact_1063e64d3b034383958133fbf6250a64" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">145,000</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProceedsFromLinesOfCredit" id="Fact_2e9000ac72e143c5b1b7b96b5248003d" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">103,000</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Payments on revolving line of credit</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:RepaymentsOfLinesOfCredit" id="Fact_d20c4172db0545448aa0dac7df0da45a" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">244,000</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:RepaymentsOfLinesOfCredit" id="Fact_32c533b4bc034f3298f5bf72db390201" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">137,000</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:RepaymentsOfLinesOfCredit" id="Fact_782d6fd000d04598bcf62194917f1570" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">119,000</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Payments to settle mandatorily redeemable non-controlling interests</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" id="Fact_67c4548cd2084db19e676d3050a99e1b" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" id="Fact_943ff3b5778d4125a7e0b6d70bc71b90" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" id="Fact_d13898c21b9b449dbcbe43f216177231" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">265</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Principal payments on notes payable</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:RepaymentsOfNotesPayable" id="Fact_d562c8f30fb940ffb63872f5700fea66" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,037</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:RepaymentsOfNotesPayable" id="Fact_b7a62c277b8846e58648e15f46f9135f" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,433</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:RepaymentsOfNotesPayable" id="Fact_604a89f4931f4f4ab181d253d5f5e48d" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,044</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Medicare Accelerated and Advance Payment Funds</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:MedicareAcceleratedAndAdvancePaymentFunds" id="Fact_c251aeb49d5b4c6a9126f2d8f1c9303f" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">14,054</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:MedicareAcceleratedAndAdvancePaymentFunds" id="Fact_0e0b284ad9b14d99886adfb439f8abc5" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:MedicareAcceleratedAndAdvancePaymentFunds" id="Fact_5a5b4b116e6e4e379c5a72f1a07f3e68" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Other</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" id="Fact_1bd3d9a074944d0492ec27021b5ae304" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" id="Fact_de03d0b606cd415ea4ff6a460900168a" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">52</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" id="Fact_7c729fd7e707460db8d50ab3a560cb0c" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">42</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Net cash used in financing activities</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" id="Fact_955b20996ae94f349727f3b9ed3ac9bf" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">39,422</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" id="Fact_bc82fd15bec84132ac47fbd449afb665" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">24,275</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" id="Fact_e7c3fdfd0bc14f51a7b38823ddf044d4" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">47,661</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Net increase in cash and cash equivalents</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" id="Fact_42e39c09a0f74e0796a97902e96517a8" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">9,370</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" id="Fact_24e07632d20d48098616db6f4db73ea5" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">180</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" id="Fact_d997254f4e684801b9e7f851e8c16348" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,435</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Cash and cash equivalents - beginning of period</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" id="Fact_777f00e897fb4b248155bf5045914fe1" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">23,548</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" id="Fact_f67a26f46be2436f9912b296f8908faa" contextRef="c20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">23,368</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" id="Fact_10c889bea641463c94b9e4dc89634c50" contextRef="c20171231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">21,933</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Cash and cash equivalents - end of period</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" id="Fact_f504fdbea1fc49dabdc52956c195c950" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">32,918</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" id="Fact_25bb31a1a11449b4a7017b729498d3dd" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">23,548</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" id="Fact_5697f6d3605441a195686b92a609d85f" contextRef="c20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">23,368</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Cash paid during the period for:</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Income taxes</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" id="Fact_b167ddfd15494b91a79965fb35f05fb8" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">7,677</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" id="Fact_80127d333db4455aa0423641961abdd1" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">9,856</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" id="Fact_1a889cf355d94e5490baed6b0342b745" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">9,183</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Interest</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:InterestPaidNet" id="Fact_3d6f57ffeba14e5e92570007a015215a" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,202</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:InterestPaidNet" id="Fact_8551ccd229604176936a6d07e6c0cc76" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,890</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:InterestPaidNet" id="Fact_3f97c0f442d249c8bfaddb23b8828ded" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,357</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Non-cash investing and financing transactions during the period:</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Purchase of businesses - seller financing portion</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PurchaseOfBusinessSellerFinancingPortion" id="Fact_b665651e2b8c43c88762ae6c61f0a693" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,121</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PurchaseOfBusinessSellerFinancingPortion" id="Fact_adefb4a410934e9db42b839f5e2c6a85" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,300</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PurchaseOfBusinessSellerFinancingPortion" id="Fact_407dd64e763945b3b7662da0ff0bd736" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">950</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Purchase of business - payable to common shareholders of acquired business</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NoncashOrPartNoncashAcquisitionPayablesAssumed1" id="Fact_ac0f3fdfc24a418c9498f237ec1b2c6e" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NoncashOrPartNoncashAcquisitionPayablesAssumed1" id="Fact_0c8824a0eb5a4bf6ab02e09ada5ddf8b" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">502</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NoncashOrPartNoncashAcquisitionPayablesAssumed1" id="Fact_dbd16575d6a44f7ba76a1a836546d989" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Notes payable related to purchase of redeemable non-controlling interest, temporary equity</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity" id="Fact_8d7731e274ec4054b8493bc7ab3e110b" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">136</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity" id="Fact_3ec938d5f2eb40b890475746c4bc0d95" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">283</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity" id="Fact_ce1c8e6995ab4291805b77630e9ebedf" contextRef="c20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Notes payable related to purchase of non-controlling interest, permanent equity</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity" id="Fact_ec3c095f5a32498fa251a708195e9a3b" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">699</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity" id="Fact_570d4dde67c349b3b373c4ed2b9586fe" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">103</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity" id="Fact_f1a7b66bc9da4be6ab500609d92deb4e" contextRef="c20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Notes receivable related to sale of partnership interest - redeemable non-controlling interest</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProceedsFromMinorityShareholders" id="Fact_aa6dbc596724477b8a729d3f0cc2ce44" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProceedsFromMinorityShareholders" id="Fact_1dadb3586c04495eac0d194c3e7fd04d" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,870</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProceedsFromMinorityShareholders" id="Fact_11df266f82824b78a84d6e43f96bdc97" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Notes receivables related to sale of partnership interest</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" id="Fact_64dfddccb9534d81ac6a365b681c63da" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">994</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" id="Fact_1fd864a38bb64910a63b1fec8c34fdd8" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" id="Fact_cceb83364f2a45048bde038801c89602" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
</table>
<div><br /></div>
<div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">See notes to consolidated financial statements.</div>
<div><br /></div>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>48</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><a id="US"><!--Anchor--></a>U.S. <a id="PHYSICAL"><!--Anchor--></a>PHYSICAL THERAPY, INC. AND SUBSIDIARIES<span style="font-size: 10pt; font-family: 'Times New Roman';"><br /></span><a id="NOTESTOCONSOLIDATEDFINANC"><!--Anchor--></a>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS<span style="font-size: 10pt; font-family: 'Times New Roman';"><br /></span>YEARS ENDED DECEMBER 31, 2020, 2019 and 2018</div>
<div><br /></div>
<div><ix:nonNumeric name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="Text_740229741e4a4bce838119035adbdd2a" contextRef="c20200101to20201231" escape="true" continuedAt="Text_86926e634fbc433f9e40485e91eca3f11">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">1. Organization, Nature of Operations and Basis of Presentation</div>
</ix:nonNumeric><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f11" continuedAt="Text_86926e634fbc433f9e40485e91eca3f12">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f12" continuedAt="Text_86926e634fbc433f9e40485e91eca3f13">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The consolidated financial statements include the accounts of U.S. Physical Therapy, Inc. and its subsidiaries (the &#8220;Company&#8221;). All significant intercompany transactions and balances have been eliminated.</div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f13" continuedAt="Text_86926e634fbc433f9e40485e91eca3f14">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f14" continuedAt="Text_86926e634fbc433f9e40485e91eca3f15">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company operates its business through <ix:nonFraction name="us-gaap:NumberOfReportableSegments" id="Fact_16d5f19e7d704b479cc15f58ac30301e" contextRef="c20200101to20201231" unitRef="U004" decimals="INF" scale="0" format="ixt-sec:numwordsen">two</ix:nonFraction> reportable business segments. The Company&#8217;s reportable segments include the physical therapy operations segment and the industrial injury prevention services segment. The Company&#8217;s physical therapy operations consist of physical therapy and occupational therapy clinics that provide pre-and post-operative care and treatment for orthopedic related disorders, sports-related injuries, preventive care, rehabilitation of injured workers and neurological injuries. The industrial injury prevention services segment includes onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments. Prior to the second quarter of 2020, the Company operated as a single segment.&#160; All prior year segment information has been reclassified to conform to the 2020 segment presentation. See Note 12. Segment Information.</div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f15" continuedAt="Text_86926e634fbc433f9e40485e91eca3f16">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f16" continuedAt="Text_86926e634fbc433f9e40485e91eca3f17">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Physical Therapy Operations</div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f17" continuedAt="Text_86926e634fbc433f9e40485e91eca3f18">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f18" continuedAt="Text_86926e634fbc433f9e40485e91eca3f19">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The physical therapy operations segment primarily operates through subsidiary clinic partnerships, in which the Company generally owns a <ix:nonFraction name="usph:PercentageOfGeneralPartnershipInterestOwned" id="Fact_d8561842ba9944388f9c45bce79b67d4" contextRef="c20200101to20201231" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">1</ix:nonFraction>% general partnership interest in all the Clinic Partnerships. Our limited partnership interests typically range from <ix:nonFraction name="usph:PercentageOfLimitedPartnershipInterestOwned" id="Fact_caf7b1fe8e354b0283e159539052ea66" contextRef="c20200101to20201231_RangeAxis_MinimumMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">10</ix:nonFraction>% to <ix:nonFraction name="usph:PercentageOfLimitedPartnershipInterestOwned" id="Fact_e7aeb478d9034cc9b159dff2cb9ed204" contextRef="c20200101to20201231_RangeAxis_MaximumMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">99</ix:nonFraction>% in the Clinic Partnerships. The managing therapist of each clinic owns, directly or indirectly, the remaining limited partnership interest in most of the clinics (hereinafter referred to as &#8220;Clinic Partnerships&#8221;). To a lesser extent, the Company operates some clinics, through wholly-owned subsidiaries, under profit sharing arrangements with therapists (hereinafter referred to as &#8220;Wholly-Owned Facilities&#8221;).</div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f19" continuedAt="Text_86926e634fbc433f9e40485e91eca3f110">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f110" continuedAt="Text_86926e634fbc433f9e40485e91eca3f111">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company continues to seek to attract for employment physical therapists who have established relationships with physicians and other referral sources, by offering these therapists a competitive salary and incentives based on the profitability of the clinic that they manage. For multi-site clinic practices in which a controlling interest is acquired by the Company, the prior owners typically continue on as employees to manage the clinic operations, retaining a non-controlling ownership interest in the clinics and receiving a competitive salary for managing the clinic operations. In addition, the Company has developed satellite clinic facilities as part of existing Clinic Partnerships and Wholly-Owned Facilities, with the result that a substantial number of Clinic Partnerships and Wholly-Owned Facilities operate more than <ix:nonFraction name="usph:NumberOfOperatingClinicLocations" id="Fact_df3f5aab4e544df7803635c0683c9dcb" contextRef="c20201231_RangeAxis_MaximumMember" unitRef="U006" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction> clinic location.</div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f111" continuedAt="Text_86926e634fbc433f9e40485e91eca3f112">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f112" continuedAt="Text_86926e634fbc433f9e40485e91eca3f113">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">As of December 31, 2020, the Company owned and/or operated <ix:nonFraction name="usph:NumberOfClinicsOperated" id="Fact_41532647d1444e54a6be2338db501131" contextRef="c20201231" unitRef="U007" decimals="0" scale="0" format="ixt:numdotdecimal">554</ix:nonFraction> clinics in <ix:nonFraction name="us-gaap:NumberOfStatesInWhichEntityOperates" id="Fact_49da464d43b44b91a61043567807c87b" contextRef="c20201231" unitRef="U008" decimals="0" scale="0" format="ixt:numdotdecimal">39</ix:nonFraction> states. The clinics&#8217; business primarily originates from physician referrals. The principal sources of payment for the clinics&#8217; services are managed care programs, commercial health insurance, Medicare/Medicaid, workers&#8217; compensation insurance and proceeds from personal injury cases. In addition to the Company&#8217;s ownership and operation of outpatient physical therapy clinics, it also manages physical therapy facilities for third parties, such as physicians and hospitals, with <ix:nonFraction name="usph:NumberOfThirdPartyFacilities" id="Fact_38449ebfd6b8475186988c2ff1be7d75" contextRef="c20200101to20201231" unitRef="U009" decimals="0" scale="0" format="ixt:numdotdecimal">38</ix:nonFraction> such third-party facilities under management as of December 31, 2020.</div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f113" continuedAt="Text_86926e634fbc433f9e40485e91eca3f114">
<div><br /></div>
</ix:continuation><ix:nonNumeric name="usph:ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock" id="Text_2899ee22700e400f9a51e1b4daeab2d6" contextRef="c20200101to20201231" escape="true" continuedAt="Text_d0cb3fcb1d7844ec94d3aaa231c6e6301"><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f114" continuedAt="Text_86926e634fbc433f9e40485e91eca3f115">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 27.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">During the last three years, the Company completed the following acquisitions within its physical therapy operations segment:</div>
</ix:continuation></ix:nonNumeric><ix:continuation id="Text_d0cb3fcb1d7844ec94d3aaa231c6e6301" continuedAt="Text_d0cb3fcb1d7844ec94d3aaa231c6e6302"><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f115" continuedAt="Text_86926e634fbc433f9e40485e91eca3f116">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_d0cb3fcb1d7844ec94d3aaa231c6e6302" continuedAt="Text_d0cb3fcb1d7844ec94d3aaa231c6e6303"><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f116" continuedAt="Text_86926e634fbc433f9e40485e91eca3f117">
<table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z329b3aa4a904444f99fe9105ae0bad7b">
  <tr>
    <td style="width: 34.03%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Acquisition</div></td>
    <td style="width: 2.78%; vertical-align: bottom;">&#160;</td>
    <td style="width: 25.28%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Date</div></td>
    <td style="width: 2.5%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td style="width: 16.67%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">% Interest<span style="font-size: 10pt; font-family: 'Times New Roman';"><br /></span>Acquired</div></td>
    <td style="width: 2.5%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td style="width: 16.25%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Number of<span style="font-size: 10pt; font-family: 'Times New Roman';"><br /></span>Clinics</div></td>
  </tr>
  <tr>
    <td style="width: 34.03%; vertical-align: bottom;">&#160;</td>
    <td style="width: 2.78%; vertical-align: bottom;">&#160;</td>
    <td style="width: 25.28%; vertical-align: bottom; border-top: #000000 2px solid;">&#160;</td>
    <td style="width: 2.5%; vertical-align: bottom;">&#160;</td>
    <td style="width: 16.67%; vertical-align: bottom;">&#160;</td>
    <td style="width: 2.5%; vertical-align: bottom;">&#160;</td>
    <td style="width: 16.25%; vertical-align: bottom;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 34.03%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">November 2020 Acquisition</div></td>
    <td style="width: 2.78%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 25.28%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1" id="Fact_fb0bd85c77954fe5ad38e626357a93c3" contextRef="c20200101to20201231_BusinessAcquisitionAxis_NovemberTwoThousandTwentyAcquisitionMember" format="ixt:datemonthdayyearen">November 30, 2020</ix:nonNumeric></div></td>
    <td style="width: 2.5%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 16.67%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_796590de33b64f9b88175afeae13776d" contextRef="c20201130_BusinessAcquisitionAxis_NovemberTwoThousandTwentyAcquisitionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">75</ix:nonFraction>%</div></td>
    <td style="width: 2.5%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 16.25%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_d00ee5ee40154adbb16c4f32d3f125fa" contextRef="c20201130to20201130_BusinessAcquisitionAxis_NovemberTwoThousandTwentyAcquisitionMember" unitRef="U007" decimals="0" scale="0" format="ixt:numdotdecimal">3</ix:nonFraction></div></td>
  </tr>
  <tr>
    <td style="width: 34.03%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">September 2020 Acquisition</div></td>
    <td style="width: 2.78%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 25.28%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1" id="Fact_89660600b9624992880d61e795a03e25" contextRef="c20200101to20201231_BusinessAcquisitionAxis_SeptemberTwoThousandTwentyAcquisitionMember" format="ixt:datemonthdayyearen">September 30, 2020</ix:nonNumeric></div></td>
    <td style="width: 2.5%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 16.67%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_ea6ef6bf1dbb4ecc89b878a2f31f7b20" contextRef="c20200930_BusinessAcquisitionAxis_SeptemberTwoThousandTwentyAcquisitionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">70</ix:nonFraction>%</div></td>
    <td style="width: 2.5%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 16.25%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">*<ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_74729e999361491e8eb1757c704e74be" contextRef="c20200930to20200930_BusinessAcquisitionAxis_SeptemberTwoThousandTwentyAcquisitionMember" unitRef="U007" xsi:nil="true" format="ixt:nocontent"></ix:nonFraction></div></td>
  </tr>
  <tr>
    <td style="width: 34.03%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">February 2020 Acquisition</div></td>
    <td style="width: 2.78%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 25.28%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1" id="Fact_2ca6f4248b784b7eb286542bcfc7519e" contextRef="c20200101to20201231_BusinessAcquisitionAxis_FebruaryTwoThousandTwentyAcquisitionMember" format="ixt:datemonthdayyearen">February 27, 2020</ix:nonNumeric></div></td>
    <td style="width: 2.5%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 16.67%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_be63fda669ef48c48951108c9fa8d90d" contextRef="c20200227_BusinessAcquisitionAxis_FebruaryTwoThousandTwentyAcquisitionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">65</ix:nonFraction>%</div></td>
    <td style="width: 2.5%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">**</div></td>
    <td style="width: 16.25%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_b984ea6b9b9f4c38a04b5eb4a1c4fa24" contextRef="c20200227to20200227_BusinessAcquisitionAxis_FebruaryTwoThousandTwentyAcquisitionMember" unitRef="U007" decimals="0" scale="0" format="ixt:numdotdecimal">4</ix:nonFraction></div></td>
  </tr>
  <tr>
    <td style="width: 34.03%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">September 2019 Acquisition</div></td>
    <td style="width: 2.78%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 25.28%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1" id="Fact_c49c1388fbfe44a0903c42e91de35023" contextRef="c20200101to20201231_BusinessAcquisitionAxis_SeptemberTwoThousandNineteenAcquisitionMember" format="ixt:datemonthdayyearen">September 30, 2019</ix:nonNumeric></div></td>
    <td style="width: 2.5%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 16.67%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_cc4f495c2b5d4d3aab9559bb5cb0c321" contextRef="c20190930_BusinessAcquisitionAxis_SeptemberTwoThousandNineteenAcquisitionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">67</ix:nonFraction>%</div></td>
    <td style="width: 2.5%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 16.25%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_4b25800a56fc43858041d726d134d1e8" contextRef="c20190930to20190930_BusinessAcquisitionAxis_SeptemberTwoThousandNineteenAcquisitionMember" unitRef="U007" decimals="0" scale="0" format="ixt:numdotdecimal">11</ix:nonFraction></div></td>
  </tr>
  <tr>
    <td style="width: 34.03%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">August 2018 Acquisition</div></td>
    <td style="width: 2.78%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 25.28%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1" id="Fact_c7e1cb913c204ea382b7756a9dc60372" contextRef="c20200101to20201231_BusinessAcquisitionAxis_August2018AcquisitionMember" format="ixt:datemonthdayyearen">August 31, 2018</ix:nonNumeric></div></td>
    <td style="width: 2.5%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 16.67%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_b45a638e89da4f9c8a47b2c4d386bafa" contextRef="c20180831_BusinessAcquisitionAxis_August2018AcquisitionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">70</ix:nonFraction>%</div></td>
    <td style="width: 2.5%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 16.25%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_759ad8ba50df45b5ac9e49977955c2f5" contextRef="c20180831to20180831_BusinessAcquisitionAxis_August2018AcquisitionMember" unitRef="U007" decimals="0" scale="0" format="ixt:numdotdecimal">4</ix:nonFraction></div></td>
  </tr>
</table>
</ix:continuation></ix:continuation><ix:continuation id="Text_d0cb3fcb1d7844ec94d3aaa231c6e6303" continuedAt="Text_d0cb3fcb1d7844ec94d3aaa231c6e6304"><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f117" continuedAt="Text_86926e634fbc433f9e40485e91eca3f118">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_d0cb3fcb1d7844ec94d3aaa231c6e6304" continuedAt="Text_d0cb3fcb1d7844ec94d3aaa231c6e6305"><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f118" continuedAt="Text_86926e634fbc433f9e40485e91eca3f119">
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z70c8f2b5b53b4524bb7ccfe492028040">
  <tr>
    <td style="width: 27pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">*</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:footnote id="Foot_b182115cb6ef4d009deff873b8909b51" footnoteRole="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US" continuedAt="Foot_63dde6dec46c49b58ecd2068ef642f4a1">The business includes <ix:nonFraction name="usph:NumberOfManagementContracts" id="Fact_eaf3f38d456349518b47f7ccea240f58" contextRef="c20200930to20200930_BusinessAcquisitionAxis_ManagementContractsMember" unitRef="U014" decimals="INF" scale="0" format="ixt-sec:numwordsen">six</ix:nonFraction></ix:footnote><ix:continuation id="Foot_63dde6dec46c49b58ecd2068ef642f4a1" continuedAt="Foot_63dde6dec46c49b58ecd2068ef642f4a2"> management and services contracts which had a remaining term of approximately <ix:nonNumeric name="usph:RemainingContractTerm" id="Fact_0548ae892f53427394e458c284fc7aa6" contextRef="c20200930to20200930_BusinessAcquisitionAxis_ManagementContractsMember" format="ixt-sec:durwordsen">five years</ix:nonNumeric></ix:continuation><ix:continuation id="Foot_63dde6dec46c49b58ecd2068ef642f4a2"> as of the date acquired.</ix:continuation></div></td>
  </tr>
</table>
</ix:continuation></ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f119" continuedAt="Text_86926e634fbc433f9e40485e91eca3f120"><ix:continuation id="Text_d0cb3fcb1d7844ec94d3aaa231c6e6305">
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z46f47f69a0da4fb98e548c6918a6352a">
  <tr>
    <td style="width: 27pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">**</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:footnote id="Foot_089e16638e954876a030f33789a71503" footnoteRole="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US" continuedAt="Foot_6f6703b1e51d423db835417c32a3b8da1">The <ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_3635a43d868a48c5aa247136b7e14a27" contextRef="c20200227to20200227_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U007" decimals="INF" scale="0" format="ixt-sec:numwordsen">four</ix:nonFraction></ix:footnote><ix:continuation id="Foot_6f6703b1e51d423db835417c32a3b8da1" continuedAt="Foot_6f6703b1e51d423db835417c32a3b8da2"> clinics are in <ix:nonFraction name="usph:NumberOfPartnershipInWhichInterestAcquired" id="Fact_208002b0c43040c39ba07a0bf93db577" contextRef="c20200227to20200227_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U015" decimals="INF" scale="0" format="ixt-sec:numwordsen">four</ix:nonFraction></ix:continuation><ix:continuation id="Foot_6f6703b1e51d423db835417c32a3b8da2" continuedAt="Foot_6f6703b1e51d423db835417c32a3b8da3"> separate partnerships. The Company's interest in the <ix:nonFraction name="usph:NumberOfPartnershipInWhichInterestAcquired" id="Fact_841f049d97e1418fb2a3a7c85659f6b8" contextRef="c20200227to20200227_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U015" decimals="INF" scale="0" format="ixt-sec:numwordsen">four</ix:nonFraction></ix:continuation><ix:continuation id="Foot_6f6703b1e51d423db835417c32a3b8da3" continuedAt="Foot_6f6703b1e51d423db835417c32a3b8da4"> partnerships range from <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_ffe23fc52fd24e85960b6feb72b3981b" contextRef="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MinimumMember" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">10.0</ix:nonFraction></ix:continuation><ix:continuation id="Foot_6f6703b1e51d423db835417c32a3b8da4" continuedAt="Foot_6f6703b1e51d423db835417c32a3b8da5">% to <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_e6648510a8224088825d4123d59b0419" contextRef="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MaximumMember" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">83.8</ix:nonFraction></ix:continuation><ix:continuation id="Foot_6f6703b1e51d423db835417c32a3b8da5" continuedAt="Foot_6f6703b1e51d423db835417c32a3b8da6">%, with an overall <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_0f36062692be44299e3de4292ebe8313" contextRef="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">65.0</ix:nonFraction></ix:continuation><ix:continuation id="Foot_6f6703b1e51d423db835417c32a3b8da6">% based on the initial purchase transaction.</ix:continuation></div></td>
  </tr>
</table>
</ix:continuation></ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f120" continuedAt="Text_86926e634fbc433f9e40485e91eca3f121">
<div><br /></div>
</ix:continuation></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>49</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f121" continuedAt="Text_86926e634fbc433f9e40485e91eca3f122">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Also during 2019, we purchased the assets and business of <ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_40193de58a8246759d8fc232bf9167c5" contextRef="c20190101to20191231" unitRef="U007" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction> physical therapy clinic in a separate transaction. The clinic operates as a satellite clinic of <ix:nonFraction name="usph:NumberOfClinicsOperatesAsASatelliteClinicWithExistingPartnerships" id="Fact_d7f7b6d4db644d69918beceaf42e3bf5" contextRef="c20190101to20191231" unitRef="U007" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction> of the existing partnerships. Besides the August 2018 multi-clinic acquisition, we acquired <ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_f32329daf3ca4cb69e7007d2e6111dd9" contextRef="c20180831to20180831" unitRef="U007" decimals="INF" scale="0" format="ixt-sec:numwordsen">five</ix:nonFraction> separate clinic practices that year through several of our majority owned Clinic Partnerships. These practices operate as satellites of the respective existing Clinic Partnerships.</div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f122" continuedAt="Text_86926e634fbc433f9e40485e91eca3f123">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f123" continuedAt="Text_86926e634fbc433f9e40485e91eca3f124">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">During the year ended December 31, 2020, the Company sold <ix:nonFraction name="usph:NumberOfClosedClinicsSold" id="Fact_a97655b2f17c43c7b1599105ec47c51d" contextRef="c20201231" unitRef="U007" decimals="0" scale="0" format="ixt:numdotdecimal">14</ix:nonFraction> previously closed clinics. The aggregate sales price was $<ix:nonFraction name="usph:AggregateSalePriceOfCinics" id="Fact_b55d0220d44d4d6c95bbb07771156303" contextRef="c20200101to20201231" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">1.1</ix:nonFraction> million, of which $<ix:nonFraction name="usph:CashReceivedRelatedToSaleOfClinics" id="Fact_d63eabcc819744eeb79b1947dbe595fb" contextRef="c20201231" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.7</ix:nonFraction> million was paid in cash and $<ix:nonFraction name="usph:NoteReceivableRelatedToSaleOfClinics" id="Fact_763b8020dce84abe8d6227d83a587a0d" contextRef="c20201231" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.4</ix:nonFraction> million in a note receivable, payable in <ix:nonFraction name="usph:NumberOfInstallmentsForNoteReceivableInSaleConsideration" id="Fact_b49b36e8e161440080018d9682ac31ab" contextRef="c20200101to20201231" unitRef="U010" decimals="INF" scale="0" format="ixt-sec:numwordsen">two</ix:nonFraction> equal installments of principal and any accrued interest on June 15, 2021 and 2022.</div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f124" continuedAt="Text_86926e634fbc433f9e40485e91eca3f125">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f125" continuedAt="Text_86926e634fbc433f9e40485e91eca3f126">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company intends to continue to pursue additional acquisition opportunities, develop new clinics and open satellite clinics.</div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f126" continuedAt="Text_86926e634fbc433f9e40485e91eca3f127">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f127" continuedAt="Text_86926e634fbc433f9e40485e91eca3f128">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Clinic Partnerships</div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f128" continuedAt="Text_86926e634fbc433f9e40485e91eca3f129">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f129" continuedAt="Text_86926e634fbc433f9e40485e91eca3f130">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">For non-acquired Clinic Partnerships, the earnings and liabilities attributable to the non-controlling interests, typically owned by the managing therapist, directly or indirectly, are recorded within the balance sheets and income statements as non-controlling interests &#8211; permanent equity. For acquired Clinic Partnerships with redeemable non-controlling interests, the earnings attributable to the redeemable non-controlling interests are recorded within the consolidated statements of income line item &#8211; <span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">net income attributable to redeemable non-controlling interests &#8211; temporary equity</span> and the equity interests are recorded on the consolidated balance sheet as <span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">redeemable non-controlling interests &#8211; temporary equity</span>.</div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f130" continuedAt="Text_86926e634fbc433f9e40485e91eca3f131">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f131" continuedAt="Text_86926e634fbc433f9e40485e91eca3f132">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Effective December 31, 2017, the Company entered into amendments to its acquired limited partnership agreements replacing the mandatory redemption features. No monetary consideration was paid to the partners to amend the agreements. The amended limited partnership agreements provide that, upon certain events, the Company has a call right (the &#8220;Call Right&#8221;) and the selling entity has a put right (the &#8220;Put Right&#8221;) for the purchase and sale of the limited partnership interest held by the partner. Once triggered, the Put Right and the Call Right do not expire, even upon an individual partner&#8217;s death, and contain no mandatory redemption feature. The purchase price of the partner&#8217;s limited partnership interest upon the exercise of either the Put Right or the Call Right is calculated per the terms of the respective agreements. The Company accounted for the amendment of its limited partnership agreements as an extinguishment of the outstanding Seller Entity Interests, as defined in Note 5, classified as liabilities through the issuance of new Seller Entity Interests classified in temporary equity. Pursuant to ASC 470-50-40-2, the Company removed the outstanding liability-classified Seller Entity Interests at their carrying amounts, recognized the new temporary-equity-classified Seller Entity Interests at their fair value, and recorded no gain or loss on extinguishment as management believes the redemption value (i.e. the carrying amount) and fair value are the same. In summary, the redemption values of the mandatorily redeemable non-controlling interest (previously classified as liabilities) were reclassified as redeemable non-controlling interest (temporary equity) at fair value on the December 31, 2017 consolidated balance sheet. See Note 5 - Redeemable Non-Controlling Interests &#8211; for further discussion.</div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f132" continuedAt="Text_86926e634fbc433f9e40485e91eca3f133">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f133" continuedAt="Text_86926e634fbc433f9e40485e91eca3f134">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Wholly-Owned Facilities</div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f134" continuedAt="Text_86926e634fbc433f9e40485e91eca3f135">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f135" continuedAt="Text_86926e634fbc433f9e40485e91eca3f136">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">For Wholly-Owned Facilities with profit sharing arrangements, an appropriate accrual is recorded for the amount of profit sharing due the clinic partners/directors. The amount is expensed as compensation and included in clinic operating costs&#8212;salaries and related costs. The respective liability is included in current liabilities&#8212;<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">accrued expenses</span> on the consolidated balance sheets.</div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f136" continuedAt="Text_86926e634fbc433f9e40485e91eca3f137">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f137" continuedAt="Text_86926e634fbc433f9e40485e91eca3f138">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Industrial Injury Prevention Services</div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f138" continuedAt="Text_86926e634fbc433f9e40485e91eca3f139">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f139" continuedAt="Text_86926e634fbc433f9e40485e91eca3f140">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In March 2017, the Company acquired a <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_23ebf9b6926f4a34847f938978965ff7" contextRef="c20170331_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">55</ix:nonFraction>% interest in the initial industrial injury prevention business. On April 30, 2018, the Company acquired a <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_21150a54f49147d781c5787c67efe985" contextRef="c20180430_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">65</ix:nonFraction>% interest in another business in the industrial injury prevention sector. On April 30, 2018, the Company combined the <ix:nonFraction name="usph:NumberOfBusinessesMerged" id="Fact_a5fb3821a94f45e3906d3eeb26caa790" contextRef="c20180430to20180430_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U011" decimals="INF" scale="0" format="ixt-sec:numwordsen">two</ix:nonFraction> businesses.&#160; After the combination, the Company owned a <ix:nonFraction name="usph:PercentageOfCombinedBusinessInterestOwned" id="Fact_30c467607d914e83adbbbceab24953e4" contextRef="c20180430to20180430_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U005" decimals="4" scale="-2" format="ixt:numdotdecimal">59.45</ix:nonFraction>% interest in the combined business, Briotix Health, Limited Partnership (&#8220;Briotix Health&#8221;), which is the Company&#8217;s industrial injury prevention operation.</div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f140" continuedAt="Text_86926e634fbc433f9e40485e91eca3f141">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f141" continuedAt="Text_86926e634fbc433f9e40485e91eca3f142">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">On April 11, 2019, the Company acquired <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_e8239b7779744b42bddecc311959b2ea" contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">100</ix:nonFraction>% of a third provider of industrial injury prevention services. The acquired company specializes in delivering injury prevention and care, post offer employment testing, functional capacity evaluations and return-to-work services. It performs these services across a network in <ix:nonFraction name="usph:NumberOfStatesOfNetworkServices" id="Fact_e344a66cc474439b8c548811351c98fa" contextRef="c20190411to20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U008" decimals="0" scale="0" format="ixt:numdotdecimal">45</ix:nonFraction> states including onsite at <ix:nonFraction name="usph:NumberOfOnsiteClientLocations" id="Fact_d00deb3d891642f4aa4fa2fee6086eee" contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U006" decimals="INF" scale="0" format="ixt-sec:numwordsen">eleven</ix:nonFraction> client locations. After the acquisition, the business was then combined with Briotix Health increasing the Company&#8217;s ownership position in the partnership to approximately <ix:nonFraction name="usph:PercentageOfCombinedBusinessInterestOwned" id="Fact_06039fa2c858468db6bdfcc3323e42aa" contextRef="c20190411to20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">76.0</ix:nonFraction>%.</div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f142" continuedAt="Text_86926e634fbc433f9e40485e91eca3f143">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f143" continuedAt="Text_86926e634fbc433f9e40485e91eca3f144">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Services provided in the industrial injury prevention services segment include onsite injury prevention and rehabilitation, performance optimization, post offer employment testing, functional capacity evaluations, and ergonomic assessments. The majority of these services are contracted with and paid for directly by employers, including a number of Fortune 500 companies. Other clients include large insurers and their contractors. The Company performs these services through Industrial Sports Medicine Professionals, consisting of both physical therapists and specialized certified athletic trainers (ATCs).</div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f144" continuedAt="Text_86926e634fbc433f9e40485e91eca3f145">
<div><br /></div>
</ix:continuation></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>50</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f145" continuedAt="Text_86926e634fbc433f9e40485e91eca3f146">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Impact of COVID-19</div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f146" continuedAt="Text_86926e634fbc433f9e40485e91eca3f147">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f147" continuedAt="Text_86926e634fbc433f9e40485e91eca3f148">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">As previously disclosed in a series of filings with the SEC and further described in detail in our Quarterly Reports on Form 10-Q for the first three quarters of 2020, the Company&#8217;s results have been negatively impacted by the effects of the COVID-19 pandemic. Management has taken a number of steps to reduce costs, make up for operating losses incurred in March and April, and increase profits subsequently. The Company continues to experience somewhat lower physical therapy patient volumes; however revenues improved significantly in the 2020 fourth quarter compared to the 2020 second and third quarters. The Company&#8217;s average physical therapy patient volumes per day per clinic were <ix:nonFraction name="usph:AveragePhysicalTherapyPatientsVolumesPerDayPerClinic" id="Fact_6e61fdd14e554039a8746e0c97e9f8d9" contextRef="c20200101to20200331" unitRef="U012" decimals="1" scale="0" format="ixt:numdotdecimal">26.2</ix:nonFraction>, <ix:nonFraction name="usph:AveragePhysicalTherapyPatientsVolumesPerDayPerClinic" id="Fact_a5d61f502b7b473a89447502ea03e5b9" contextRef="c20200401to20200630" unitRef="U012" decimals="1" scale="0" format="ixt:numdotdecimal">18.9</ix:nonFraction>, <ix:nonFraction name="usph:AveragePhysicalTherapyPatientsVolumesPerDayPerClinic" id="Fact_0ddf92dce4304181bff2b85a958deeee" contextRef="c20200701to20200930" unitRef="U012" decimals="1" scale="0" format="ixt:numdotdecimal">25.8</ix:nonFraction>, and <ix:nonFraction name="usph:AveragePhysicalTherapyPatientsVolumesPerDayPerClinic" id="Fact_ba4f8dcbca61401d9b673bdb5c7fdbe0" contextRef="c20201001to20201231" unitRef="U012" decimals="1" scale="0" format="ixt:numdotdecimal">27.7</ix:nonFraction>, respectively, in the first four quarters of 2020. The Company&#8217;s industrial injury prevention business was less affected by the pandemic in 2020.</div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f148" continuedAt="Text_86926e634fbc433f9e40485e91eca3f149">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f149" continuedAt="Text_86926e634fbc433f9e40485e91eca3f150">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In March, with the onset of the COVID-19 pandemic, the Company began to furlough or terminate approximately <ix:nonFraction name="usph:PercentageOfEmployeesFurloughedOrTerminated" id="Fact_1b8f84e167d648b58e5e215d9bb0fb14" contextRef="c20200101to20200331" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">40</ix:nonFraction>% of its <ix:nonFraction name="dei:EntityNumberOfEmployees" id="Fact_ecd27b620ea247a99e821c0bc52d4d3e" contextRef="c20200331" unitRef="U013" decimals="0" scale="0" format="ixt:numdotdecimal">5,500</ix:nonFraction> full and part-time workforce. Since early May, approximately <ix:nonFraction name="usph:NumberOfFurloughedEmployeesReturned" id="Fact_fd21e9f43a4943e4a8bd9436337a348e" contextRef="c20200502" unitRef="U013" decimals="0" scale="0" format="ixt:numdotdecimal">1,200</ix:nonFraction> of the furloughed employees have returned to work on a full or part-time basis.</div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f150" continuedAt="Text_86926e634fbc433f9e40485e91eca3f151">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f151" continuedAt="Text_86926e634fbc433f9e40485e91eca3f152">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">As of the filing of this annual report, the Company continues to experience lower physical therapy revenues. As stay at home orders and other restrictions have been lifted, we have seen our physical therapy volumes trending upwards. Should stay at home orders or other restrictions be reenacted, the Company could see its Company&#8217;s patient volume and revenues decline again.</div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f152" continuedAt="Text_86926e634fbc433f9e40485e91eca3f153">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f153" continuedAt="Text_86926e634fbc433f9e40485e91eca3f154">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company has put preparedness plans in place at its facilities to maintain continuity of operations, while also taking steps to keep employees and patients safe. In line with recommendations to reduce large gatherings and increase social distancing, the Company has, where practical, transitioned a large number of office-based employees to a remote work environment.</div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f154" continuedAt="Text_86926e634fbc433f9e40485e91eca3f155">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f155" continuedAt="Text_86926e634fbc433f9e40485e91eca3f156">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Medicare Accelerated and Advance Payment Program (&#8220;MAAPP Funds&#8221;)</div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f156" continuedAt="Text_86926e634fbc433f9e40485e91eca3f157">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f157" continuedAt="Text_86926e634fbc433f9e40485e91eca3f158">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 27pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #212529;">In response to the COVID-19 pandemic, the federal government approved the Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES Act&#8221;). The CARES Act allowed for qualified healthcare providers to receive advanced payments under the existing MAAPP Funds during the COVID-19 pandemic. Under this program, healthcare providers could choose to receive advanced payments for future Medicare services provided. The Company applied for and received approval from</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #222222;">&#160;</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #212529;">Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;) in April 2020. T</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #211D1E;">he Company recorded these payments as a liability until all performance obligations have been met as the payments were made on behalf of patients before services were provided. Currently, MAAPP funds received are required to be applied to future Medicare billings commencing in August 2021, with all such remaining amounts required to be repaid by January 2024. Beginning January 2024, any unpaid balance will begin accruing interest.</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #212529;"> The Company currently intends to repay funds prior to August 2021. Included in cash and cash equivalents and accrued liabilities at December 31, 2020 is $</span><ix:nonFraction name="usph:CashAndCashEquivalentsAndAccruedLiabilities" id="Fact_51efc329adf94088ae2328b26dd67e91" contextRef="c20201231_UnusualOrInfrequentItemAxis_MedicareAcceleratedAndAdvancePaymentsProgramMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">14.1</ix:nonFraction><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #212529;"> million of MAAPP Funds.</span></div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f158" continuedAt="Text_86926e634fbc433f9e40485e91eca3f159">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f159" continuedAt="Text_86926e634fbc433f9e40485e91eca3f160">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Relief Funds</div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f160" continuedAt="Text_86926e634fbc433f9e40485e91eca3f161">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f161" continuedAt="Text_86926e634fbc433f9e40485e91eca3f162">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The CARES Act also provided additional waivers, reimbursement, grants and other funds to assist health care providers during the COVID-19 pandemic, including $<ix:nonFraction name="usph:GrantsAndOtherFunds" id="Fact_7d120d9c1d9849eaa24bf6662cc085e7" contextRef="c20201231_UnusualOrInfrequentItemAxis_PublicHealthAndSocialServicesEmergencyFundMember" unitRef="U001" decimals="-8" scale="9" format="ixt:numdotdecimal">100.0</ix:nonFraction> billion in appropriations for the Public Health and Social Services Emergency Fund, also referred to as the Provider Relief Fund, to be used for preventing, preparing, and responding to the coronavirus, and for reimbursing eligible health care providers for lost revenues and health care related expenses that are attributable to COVID-19.</div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f162" continuedAt="Text_86926e634fbc433f9e40485e91eca3f163">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
</ix:continuation><ix:continuation id="Text_86926e634fbc433f9e40485e91eca3f163">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Through December 31, 2020, the Company&#8217;s consolidated subsidiaries received approximately $<ix:nonFraction name="us-gaap:GrantsReceivable" id="Fact_3041df8fef544458842ee063d7a71bb7" contextRef="c20201231_UnusualOrInfrequentItemAxis_PublicHealthAndSocialServicesEmergencyFundMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">13.5</ix:nonFraction> million of payments under the CARES Act (&#8220;Relief Funds&#8221;). For the year ended December 31, 2020, the Company has recognized approximately $<ix:nonFraction name="usph:ReliefFunds" id="Fact_04c69dd76927408eb54d39c55e68df0f" contextRef="c20200101to20201231_UnusualOrInfrequentItemAxis_PublicHealthAndSocialServicesEmergencyFundMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">13.5</ix:nonFraction> million, as Other income &#8211; Relief Funds on the accompany consolidated statement of operations. These funds are not required to be repaid upon attestation and compliance with certain terms and conditions, which could change materially based on evolving grant compliance provisions and guidance provided by the U.S. Department of Health and Human Services. Currently, the Company can attest and comply with the terms and conditions of the grant guidance.&#160; The Company will continue to monitor the evolving guidelines and may record adjustments as additional information is released.</div>
</ix:continuation></div>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>51</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div><br /></div>
<div><ix:nonNumeric name="us-gaap:SignificantAccountingPoliciesTextBlock" id="Text_dd60cb8835484300b0c375d0823aefe8" contextRef="c20200101to20201231" escape="true" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c1">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2. Significant Accounting Policies</div>
</ix:nonNumeric><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c1" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c2">
<div><br /></div>
</ix:continuation><ix:nonNumeric name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="Text_f654e6e9d34c410f8184c36d01fea70c" contextRef="c20200101to20201231" escape="true" continuedAt="Text_6d5455c4799a4d7e87f81810e94c98fc1"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c2" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c3">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Cash Equivalents</div>
</ix:continuation></ix:nonNumeric><ix:continuation id="Text_6d5455c4799a4d7e87f81810e94c98fc1" continuedAt="Text_6d5455c4799a4d7e87f81810e94c98fc2"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c3" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c4">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c4" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c5"><ix:continuation id="Text_6d5455c4799a4d7e87f81810e94c98fc2">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company maintains its cash and cash equivalents at financial institutions. The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. The combined account balances at several institutions typically exceed Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) insurance coverage and, as a result, there is a concentration of credit risk related to amounts on deposit in excess of FDIC insurance coverage. Management believes that this risk is not significant.</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c5" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c6">
<div><br /></div>
</ix:continuation><ix:nonNumeric name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" id="Text_82478d6cd0114cd88193d5a5cad28fdb" contextRef="c20200101to20201231" escape="true" continuedAt="Text_f67a1d1b871245d6b9dcbb87cc0b21de1"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c6" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c7">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Long-Lived Assets</div>
</ix:continuation></ix:nonNumeric><ix:continuation id="Text_f67a1d1b871245d6b9dcbb87cc0b21de1" continuedAt="Text_f67a1d1b871245d6b9dcbb87cc0b21de2"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c7" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c8">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c8" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c9"><ix:continuation id="Text_f67a1d1b871245d6b9dcbb87cc0b21de2">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Fixed assets are stated at cost. Depreciation is computed on the straight-line method over the estimated useful lives of the related assets. Estimated useful lives for furniture and equipment range from <span style="-sec-ix-hidden:Fact_82099ea63dd944a793bca0b3ef182707">three</span> to <ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="Fact_19d1a963bce6491ba0e785cd1568213f" contextRef="c20200101to20201231_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember_RangeAxis_MaximumMember" format="ixt-sec:durwordsen">eight years</ix:nonNumeric> and for software purchased from <span style="-sec-ix-hidden:Fact_c914f2e353b54597a7cd8a612b794874">three</span> to <ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="Fact_a1883202b29d49a9889f9e0df8891930" contextRef="c20200101to20201231_PropertyPlantAndEquipmentByTypeAxis_ComputerSoftwareIntangibleAssetMember_RangeAxis_MaximumMember" format="ixt-sec:durwordsen">seven years</ix:nonNumeric>. Leasehold improvements are amortized over the shorter of the related lease term or estimated useful lives of the assets, which is generally <span style="-sec-ix-hidden:Fact_d794a755570f470987cd83402baa1e26">three</span> to <ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="Fact_6141ef64f1024cc9b8d39878b3642033" contextRef="c20200101to20201231_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember_RangeAxis_MaximumMember" format="ixt-sec:durwordsen">five years</ix:nonNumeric>.</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c9" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c10">
<div><br /></div>
</ix:continuation><ix:nonNumeric name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" id="Text_0e89c96f275d420791e129ad72bb61c7" contextRef="c20200101to20201231" escape="true" continuedAt="Text_65f8ebe18b62460ab7e8f79278aafef11"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c10" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c11">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Impairment of Long-Lived Assets and Long-Lived Assets to Be Disposed Of</div>
</ix:continuation></ix:nonNumeric><ix:continuation id="Text_65f8ebe18b62460ab7e8f79278aafef11" continuedAt="Text_65f8ebe18b62460ab7e8f79278aafef12"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c11" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c12">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c12" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c13"><ix:continuation id="Text_65f8ebe18b62460ab7e8f79278aafef12">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company reviews property and equipment and intangible assets with finite lives for impairment upon the occurrence of certain events or circumstances that indicate the related amounts may be impaired. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c13" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c14">
<div><br /></div>
</ix:continuation><ix:nonNumeric name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock" id="Text_6e277d5e92864848a5a510a2dc14f342" contextRef="c20200101to20201231" escape="true" continuedAt="Text_cb952715da974e3a90b5f0c80d9944491"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c14" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c15">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Goodwill</div>
</ix:continuation></ix:nonNumeric><ix:continuation id="Text_cb952715da974e3a90b5f0c80d9944491" continuedAt="Text_cb952715da974e3a90b5f0c80d9944492"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c15" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c16">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_cb952715da974e3a90b5f0c80d9944492" continuedAt="Text_cb952715da974e3a90b5f0c80d9944493"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c16" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c17">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">Goodwill represents the excess of the amount paid and fair value of the non-controlling interests over the fair value of the acquired business assets, which include certain identifiable intangible assets. Historically, goodwill has been derived from acquisitions and, prior to 2009</span>,<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> from the purchase of some or all of a particular local management&#8217;s equity interest in an existing clinic. Effective January 1, 2009</span>,<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> if the purchase price of a non-controlling interest by the Company exceeds or is less than the book value at the time of purchase, any excess or shortfall is recognized as an adjustment to additional paid-in capital.</span></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_cb952715da974e3a90b5f0c80d9944493" continuedAt="Text_cb952715da974e3a90b5f0c80d9944494"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c17" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c18">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_cb952715da974e3a90b5f0c80d9944494" continuedAt="Text_cb952715da974e3a90b5f0c80d9944495"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c18" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c19">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Goodwill and other indefinite-lived intangible assets are not amortized, but are instead subject to periodic impairment evaluations. The fair value of goodwill and other identifiable intangible assets with indefinite lives are evaluated for impairment at least annually and upon the occurrence of certain events or conditions, and are written down to fair value if considered impaired. These events or conditions include, but are not limited to: a significant adverse change in the business environment, regulatory environment, or legal factors; a current period operating or cash flow loss combined with a history of such losses or a projection of continuing losses; or a sale or disposition of a significant portion of a reporting unit. The occurrence of one of these events or conditions could significantly impact an impairment assessment, necessitating an impairment charge. The Company evaluates indefinite lived tradenames using the relief from royalty method in conjunction with its annual goodwill impairment test.</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_cb952715da974e3a90b5f0c80d9944495" continuedAt="Text_cb952715da974e3a90b5f0c80d9944496"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c19" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c20">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_cb952715da974e3a90b5f0c80d9944496" continuedAt="Text_cb952715da974e3a90b5f0c80d9944497"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c20" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c21">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">The Company operates a </span><ix:nonFraction name="us-gaap:NumberOfOperatingSegments" id="Fact_3512773c39804d5bb7e82aff520b97ef" contextRef="c20200101to20201231" unitRef="U004" decimals="INF" scale="0" format="ixt-sec:numwordsen">two</ix:nonFraction><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> segment business which is made up of various clinics within partnerships, and the other is industrial injury prevention services business. The partnerships are components of regions and are aggregated to the operating segment level for the purpose of determining the Company&#8217;s reporting units when performing its annual goodwill impairment test. In 2020, 2019 and 2018</span>,<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> there were </span><ix:nonFraction name="usph:NumberOfRegions" id="Fact_6b67e9fb5f084286bc76babfd92350dc" contextRef="c20180101to20181231" unitRef="U016" decimals="INF" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="usph:NumberOfRegions" id="Fact_24374ec3d07b423d929dd87f5452d1ad" contextRef="c20190101to20191231" unitRef="U016" decimals="INF" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="usph:NumberOfRegions" id="Fact_0847d4d192ef478d850e942cc9b26058" contextRef="c20200101to20201231" unitRef="U016" decimals="INF" scale="0" format="ixt-sec:numwordsen">six</ix:nonFraction></ix:nonFraction></ix:nonFraction><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> regions. In addition to the six regions, in 2020 and 2019</span>,<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> the impairment analysis included a separate analysis for the industrial injury prevention business, as a separate reporting unit.</span></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_cb952715da974e3a90b5f0c80d9944497" continuedAt="Text_cb952715da974e3a90b5f0c80d9944498"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c21" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c22">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_cb952715da974e3a90b5f0c80d9944498" continuedAt="Text_cb952715da974e3a90b5f0c80d9944499"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c22" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c23">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">As part of the impairment analysis, the Company is first required to assess qualitatively if it can conclude whether goodwill is more likely than not impaired. If goodwill is more likely than not impaired, the Company is then required to complete a quantitative analysis of whether a reporting unit&#8217;s fair value is less than its carrying amount. In evaluating whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, the Company considers relevant events or circumstances that affect the fair value or carrying amount of a reporting unit. The Company considers both the income and market approach in determining the fair value of its reporting units when performing a quantitative analysis.</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_cb952715da974e3a90b5f0c80d9944499" continuedAt="Text_cb952715da974e3a90b5f0c80d99444910"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c23" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c24">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_cb952715da974e3a90b5f0c80d99444910" continuedAt="Text_cb952715da974e3a90b5f0c80d99444911"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c24" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c25">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">An impairment loss generally would be recognized when the carrying amount of the net assets of a reporting unit, inclusive of goodwill and other identifiable intangible assets, exceeds the estimated fair value of the reporting unit. The evaluation of goodwill in 2020, 2019 and 2018 did not result in any goodwill amounts that were deemed impaired.</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_cb952715da974e3a90b5f0c80d99444911" continuedAt="Text_cb952715da974e3a90b5f0c80d99444912"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c25" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c26">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_cb952715da974e3a90b5f0c80d99444912" continuedAt="Text_cb952715da974e3a90b5f0c80d99444913"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c26" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c27">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">Based on the economic conditions experienced in 2020 and the decline in patient visits due to the pandemic, the Company evaluated whether events or circumstances indicated that it was more likely than not that the fair value of the reporting units were reduced below their carrying value as of December 31, 2020</span>.<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> As a result of the assessment, the Company determined that it was not more likely than not that goodwill and tradenames of the reporting units were impaired as of December 31, 2020</span>.</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_cb952715da974e3a90b5f0c80d99444913" continuedAt="Text_cb952715da974e3a90b5f0c80d99444914"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c27" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c28">
<div><br /></div>
</ix:continuation></ix:continuation></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>52</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div><ix:continuation id="Text_cb952715da974e3a90b5f0c80d99444914" continuedAt="Text_cb952715da974e3a90b5f0c80d99444915"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c28" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c29">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company will continue to monitor for any triggering events or other indicators of impairment.&#160; Due to the uncertainty of the current economic conditions resulting from the COVID-19 pandemic, the Company will continue to review its carrying amounts of goodwill and other intangibles quarterly.</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_cb952715da974e3a90b5f0c80d99444915" continuedAt="Text_cb952715da974e3a90b5f0c80d99444916"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c29" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c30">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c30" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c31"><ix:continuation id="Text_cb952715da974e3a90b5f0c80d99444916">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">For the year ended December 31, 2020</span>,<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> the Company derecognized (wrote-off) goodwill in the amount of </span>$<ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" id="Fact_f5b604ece7fb42bdbbab7830c4664ca5" contextRef="c20200101to20201231" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">1.9</ix:nonFraction> million<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> related to closed clinics due to COVID-19</span>.</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c31" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c32">
<div><br /></div>
</ix:continuation><ix:nonNumeric name="usph:RedeemableNonControllingInterestsPolicyTextBlock" id="Text_b6c58a5603fd4c7e8fa3b0bc88dda8b1" contextRef="c20200101to20201231" escape="true" continuedAt="Text_6384483d2d5347cf9ff0c9eaf64084371"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c32" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c33">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Redeemable Non-Controlling Interests</div>
</ix:continuation></ix:nonNumeric><ix:continuation id="Text_6384483d2d5347cf9ff0c9eaf64084371" continuedAt="Text_6384483d2d5347cf9ff0c9eaf64084372"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c33" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c34">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_6384483d2d5347cf9ff0c9eaf64084372" continuedAt="Text_6384483d2d5347cf9ff0c9eaf64084373"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c34" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c35">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The non-controlling interests that are reflected as redeemable non-controlling interests in the consolidated financial statements consist of those in which the owners and the Company have certain redemption rights, whether currently exercisable or not, and which currently, or in the future, require that the Company purchase or the owner sell the non-controlling interest held by the owner, if certain conditions are met. The purchase price is derived at a predetermined formula based on a multiple of trailing twelve months earnings performance as defined in the respective limited partnership agreements. The redemption rights can be triggered by the owner or the Company at such time as both of the following events have occurred: 1) termination of the owner&#8217;s employment, regardless of the reason for such termination, and 2) the passage of specified number of years after the closing of the transaction, typically <span style="-sec-ix-hidden:Fact_74434238a9e847afae6e8bd50f9c3ecb">three</span> to <ix:nonNumeric name="usph:RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" id="Fact_0ee28dc40f114fa6a737957c7f31d0bc" contextRef="c20200101to20201231_RangeAxis_MaximumMember" format="ixt-sec:durwordsen">five years</ix:nonNumeric>, as defined in the limited partnership agreement. The redemption rights are not automatic or mandatory (even upon death) and require either the owner or the Company to exercise its rights when the conditions triggering the redemption rights have been satisfied.</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_6384483d2d5347cf9ff0c9eaf64084373" continuedAt="Text_6384483d2d5347cf9ff0c9eaf64084374"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c35" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c36">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c36" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c37"><ix:continuation id="Text_6384483d2d5347cf9ff0c9eaf64084374">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">On the date the Company acquires a controlling interest in a partnership, and the limited partnership agreement for such partnership contains redemption rights not under the control of the Company, the fair value of the non-controlling interest is recorded in the consolidated balance sheet under the caption &#8211; Redeemable non-controlling interests. Then, in each reporting period thereafter until it is purchased by the Company, the redeemable non-controlling interest is adjusted to the greater of its then current redemption value or initial carrying value, based on the predetermined formula defined in the respective limited partnership agreement. As a result, the value of the non-controlling interest is not adjusted below its initial carrying value. The Company records any adjustment in the redemption value, net of tax, directly to retained earnings and are not reflected in the consolidated statements of income. Although the adjustments are not reflected in the consolidated statements of income, current accounting rules require that the Company reflects the adjustments, net of tax, in the earnings per share calculation. The amount of net income attributable to redeemable non-controlling interest owners is included in consolidated net income on the face of the consolidated statements of net income. Management believes the redemption value (i.e. the carrying amount) and fair value are the same.</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c37" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c38">
<div><br /></div>
</ix:continuation><ix:nonNumeric name="usph:NonControllingInterestsPolicyPolicyTextBlock" id="Text_c31070a799ae47149a2ffcab8e9d302c" contextRef="c20200101to20201231" escape="true" continuedAt="Text_ddf484b3d0b64c089083ddb6ee478dae1"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c38" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c39">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Non-Controlling Interests</div>
</ix:continuation></ix:nonNumeric><ix:continuation id="Text_ddf484b3d0b64c089083ddb6ee478dae1" continuedAt="Text_ddf484b3d0b64c089083ddb6ee478dae2"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c39" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c40">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_ddf484b3d0b64c089083ddb6ee478dae2" continuedAt="Text_ddf484b3d0b64c089083ddb6ee478dae3"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c40" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c41">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company recognizes non-controlling interests, in which the Company has no obligation but the right to purchase the non-controlling interests, as permanent equity in the consolidated financial statements separate from the parent entity&#8217;s equity. The amount of net income attributable to non-controlling interests is included in consolidated net income on the face of the statements of net income. Changes in a parent entity&#8217;s ownership interest in a subsidiary that do not result in deconsolidation are treated as equity transactions if the parent entity retains its controlling financial interest. The Company recognizes a gain or loss in net income when a subsidiary is deconsolidated. Such gain or loss is measured using the fair value of the non-controlling equity investment on the deconsolidation date.</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_ddf484b3d0b64c089083ddb6ee478dae3" continuedAt="Text_ddf484b3d0b64c089083ddb6ee478dae4"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c41" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c42">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c42" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c43"><ix:continuation id="Text_ddf484b3d0b64c089083ddb6ee478dae4">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">When the purchase price of a non-controlling interest by the Company exceeds the book value at the time of purchase, any excess or shortfall is recognized as an adjustment to additional paid-in capital. Additionally, operating losses are allocated to non-controlling interests even when such allocation creates a deficit balance for the non-controlling interest partner.</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c43" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c44">
<div><br /></div>
</ix:continuation></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>53</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div><ix:nonNumeric name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="Text_4d84eb0d57fb44068add3e471f7e1fb2" contextRef="c20200101to20201231" escape="true" continuedAt="Text_fc5da5bf096e4a418dbee70ef479a0151"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c44" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c45">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Revenue Recognition</div>
</ix:continuation></ix:nonNumeric><ix:continuation id="Text_fc5da5bf096e4a418dbee70ef479a0151" continuedAt="Text_fc5da5bf096e4a418dbee70ef479a0152"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c45" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c46">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fc5da5bf096e4a418dbee70ef479a0152" continuedAt="Text_fc5da5bf096e4a418dbee70ef479a0153"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c46" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c47">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In May 2014, March 2016, April 2016, and December 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2014-09, Revenue from Contracts with Customers, ASU 2016-08, Revenue from Contracts with Customers, Principal versus Agent Considerations, ASU 2016-10, Revenue from Contracts with Customers, Identifying Performance Obligations and Licensing, ASU 2016-12, Revenue from Contracts with Customers, Narrow Scope Improvements and Practical Expedients, and ASU 2016-20, Technical Corrections and Improvements to Topic 606, Revenue from Contracts with Customer (collectively the &#8220;standards&#8221;), respectively, which supersede most of the current revenue recognition requirements (&#8220;ASC 606&#8221;). The core principle of the new guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fc5da5bf096e4a418dbee70ef479a0153" continuedAt="Text_fc5da5bf096e4a418dbee70ef479a0154"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c47" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c48">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fc5da5bf096e4a418dbee70ef479a0154" continuedAt="Text_fc5da5bf096e4a418dbee70ef479a0155"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c48" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c49">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company implemented the new standards beginning January 1, 2018 using a modified retrospective transition method. The principal change relates to how the new standard requires healthcare providers to estimate the amount of variable consideration to be included in the transaction price up to an amount which is probable that a significant reversal will not occur. The most common forms of variable consideration the Company experiences are amounts for services provided that are ultimately not realizable from a customer. There were no changes to revenues or other revenues upon implementation. Under the new standards, the Company&#8217;s estimate for unrealizable amounts will continue to be recognized as a reduction to revenue. The bad debt expense historically reported will not materially change.</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fc5da5bf096e4a418dbee70ef479a0155" continuedAt="Text_fc5da5bf096e4a418dbee70ef479a0156"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c49" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c50">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fc5da5bf096e4a418dbee70ef479a0156" continuedAt="Text_fc5da5bf096e4a418dbee70ef479a0157"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c50" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c51">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">For ASC 606, there is an implied contract between us and the patient upon each patient visit. Separate contractual arrangements exist between us and third-party payors (e.g. insurers, managed care programs, government programs, workers' compensation) which establish the amounts the third parties pay on behalf of the patients for covered services rendered. While these agreements are not considered contracts with the customer, they are used for determining the transaction price for services provided to the patients covered by the third party payors. The payor contracts do not indicate performance obligations for us, but indicate reimbursement rates for patients who are covered by those payors when the services are provided. At that time, the Company is obligated to provide services for the reimbursement rates stipulated in the payor contracts. The execution of the contract alone does not indicate a performance obligation. For self-paying customers, the performance obligation exists when we provide the services at established rates. The difference between the Company&#8217;s established rate and the anticipated reimbursement rate is accounted for as an offset to revenue &#8211; contractual allowance.</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fc5da5bf096e4a418dbee70ef479a0157" continuedAt="Text_fc5da5bf096e4a418dbee70ef479a0158"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c51" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c52">
<div><br /></div>
</ix:continuation></ix:continuation><ix:nonNumeric name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="Text_60a8c81cb7334ff3be592479d26af01b" contextRef="c20200101to20201231" escape="true" continuedAt="Text_486328eed8524bb59520e6fe38e6bdf51"><ix:continuation id="Text_fc5da5bf096e4a418dbee70ef479a0158" continuedAt="Text_fc5da5bf096e4a418dbee70ef479a0159"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c52" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c53">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The following table details the revenue related to the various categories (in thousands).</div>
</ix:continuation></ix:continuation></ix:nonNumeric><ix:continuation id="Text_486328eed8524bb59520e6fe38e6bdf51" continuedAt="Text_486328eed8524bb59520e6fe38e6bdf52"><ix:continuation id="Text_fc5da5bf096e4a418dbee70ef479a0159" continuedAt="Text_fc5da5bf096e4a418dbee70ef479a01510"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c53" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c54">
<div><br /></div>
</ix:continuation></ix:continuation></ix:continuation><ix:continuation id="Text_486328eed8524bb59520e6fe38e6bdf52"><ix:continuation id="Text_fc5da5bf096e4a418dbee70ef479a01510" continuedAt="Text_fc5da5bf096e4a418dbee70ef479a01511"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c54" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c55">
<table cellpadding="0" cellspacing="0" id="z8c0b8e1e67b64cb6b6522cc37bfa309c" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"></div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="10" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2018</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Net patient revenues</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_7d15d9f7b77b4199add83e4e16fdb322" contextRef="c20200101to20201231_ProductOrServiceAxis_NetPatientRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">373,340</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_470b1becb47c45a3994093def0561fdf" contextRef="c20190101to20191231_ProductOrServiceAxis_NetPatientRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">433,345</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_b00d080f62d24b45aba3a04bc1d30534" contextRef="c20180101to20181231_ProductOrServiceAxis_NetPatientRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">417,703</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Management contract revenues</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_8fb2c4e8bfbb44deaf6c8a8b5290fbd2" contextRef="c20200101to20201231_ProductOrServiceAxis_ManagementContractRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">8,410</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_dba7330725544719ad5b3d5b208e8384" contextRef="c20190101to20191231_ProductOrServiceAxis_ManagementContractRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">8,676</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_e63fec09320a4e3b9c36d4ac0655f27d" contextRef="c20180101to20181231_ProductOrServiceAxis_ManagementContractRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">8,339</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Other revenues</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_e986d39788034d52a705fa40894dc971" contextRef="c20200101to20201231_ProductOrServiceAxis_OtherRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,020</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_6f6de22f96704808aa3490beffbb7e4a" contextRef="c20190101to20191231_ProductOrServiceAxis_OtherRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,486</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_0c61ed87a7264de79a4cb06d6d391dcf" contextRef="c20180101to20181231_ProductOrServiceAxis_OtherRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,403</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;"><div style="text-align: left; text-indent: -9pt; margin-left: 17.65pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Physical therapy operations</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_13919e12e38c4ab1b03012221e4c8ba9" contextRef="c20200101to20201231_ProductOrServiceAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">383,770</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_dae883461d7346ab89e2edfbc38ca1c7" contextRef="c20190101to20191231_ProductOrServiceAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">444,507</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_09cfbabaf4054929aced42d683ade9b6" contextRef="c20180101to20181231_ProductOrServiceAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">428,445</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Industrial injury prevention services revenues</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_ba78a2856c8e41898d43daa36e229854" contextRef="c20200101to20201231_ProductOrServiceAxis_IndustrialInjuryPreventionServicesRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">39,199</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_53436a8b2963429284c4f18074428a33" contextRef="c20190101to20191231_ProductOrServiceAxis_IndustrialInjuryPreventionServicesRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">37,462</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_08e2bff9eb484919b7f29ad319f0413a" contextRef="c20180101to20181231_ProductOrServiceAxis_IndustrialInjuryPreventionServicesRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">25,466</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_f44d9fbbb77349578c17f58254b5694a" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">422,969</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_48fba03a28d344e1ba39c354a972e545" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">481,969</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" id="Fact_1bfae90c78024cbda4133f6858f83473" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">453,911</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
  </tr>
</table>
</ix:continuation></ix:continuation></ix:continuation><ix:continuation id="Text_fc5da5bf096e4a418dbee70ef479a01511" continuedAt="Text_fc5da5bf096e4a418dbee70ef479a01512"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c55" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c56">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fc5da5bf096e4a418dbee70ef479a01512" continuedAt="Text_fc5da5bf096e4a418dbee70ef479a01513"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c56" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c57">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Patient revenues</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fc5da5bf096e4a418dbee70ef479a01513" continuedAt="Text_fc5da5bf096e4a418dbee70ef479a01514"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c57" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c58">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fc5da5bf096e4a418dbee70ef479a01514" continuedAt="Text_fc5da5bf096e4a418dbee70ef479a01515"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c58" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c59">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Revenues are recognized in the period in which services are rendered. Net patient revenues consists of revenues for physical therapy and occupational therapy clinics that provide pre-and post-operative care and treatment for orthopedic related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries. Net patient revenues (patient revenues less estimated contractual adjustments) are recognized at the estimated net realizable amounts from third-party payors, patients and others in exchange for services rendered when obligations under the terms of the contract are satisfied. There is an implied contract between us and the patient upon each patient visit. Generally, this occurs as the Company provides physical and occupational therapy services, as each service provided is distinct and future services rendered are not dependent on previously rendered services. The Company has agreements with third-party payors that provide for payments to the Company at amounts different from its established rates.</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fc5da5bf096e4a418dbee70ef479a01515" continuedAt="Text_fc5da5bf096e4a418dbee70ef479a01516"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c59" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c60">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fc5da5bf096e4a418dbee70ef479a01516" continuedAt="Text_fc5da5bf096e4a418dbee70ef479a01517"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c60" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c61">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Medicare Reimbursement</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fc5da5bf096e4a418dbee70ef479a01517" continuedAt="Text_fc5da5bf096e4a418dbee70ef479a01518"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c61" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c62">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fc5da5bf096e4a418dbee70ef479a01518" continuedAt="Text_fc5da5bf096e4a418dbee70ef479a01519"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c62" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c63">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Medicare program reimburses outpatient rehabilitation providers based on the Medicare Physician Fee Schedule (&#8216;&#8216;MPFS&#8217;&#8217;). For services provided in 2018, a <ix:nonFraction name="usph:PercentageOfMedicarePaymentIncrease" id="Fact_55d8101f79b54e519637ca6f493943a7" contextRef="c20200101to20201231_UnusualOrInfrequentItemAxis_Year2018Member" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">0.5</ix:nonFraction>% increase was applied to the fee schedule payment rates; for services provided in 2019, a <ix:nonFraction name="usph:PercentageOfMedicarePaymentIncrease" id="Fact_8dd8a88490184f15871b658d9ab6268a" contextRef="c20200101to20201231_UnusualOrInfrequentItemAxis_Year2019Member" unitRef="U005" decimals="4" scale="-2" format="ixt:numdotdecimal">0.25</ix:nonFraction>% increase was applied to the fee schedule payment rates before applying the mandatory budget neutrality adjustment. For services provided in 2020 through 2025, a <ix:nonFraction name="usph:PercentageOfMedicarePaymentIncrease" id="Fact_3c8d539ce8704abca3c617612aeefe90" contextRef="c20200101to20201231_UnusualOrInfrequentItemAxis_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">0.0</ix:nonFraction>% percent update will be applied each year to the fee schedule payment rates, before applying the mandatory budget neutrality adjustment. However, in the 2020 MPFS Final Rule, CMS proposed an increase to the code values for office/outpatient evaluation and management (E/M) codes and cuts to other codes to maintain budget neutrality of the MPFS. This change in code valuations was to become effective January 1, 2021.&#160; Under the 2021 MPFS Final Rule, reimbursement for the codes applicable to physical/occupational therapy services were to be reduced by approximately <ix:nonFraction name="usph:EstimatedPercentageOfDecreaseInPayment" id="Fact_d305fe06fc7647f991bf0269995882b2" contextRef="c20201227to20201227" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">9</ix:nonFraction>% in the aggregate. <span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">The </span><ix:nonFraction name="usph:EstimatedPercentageOfDecreaseInPayment" id="Fact_97eab72864054614b9a0a38b8dc21685" contextRef="c20201227to20201227" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">9</ix:nonFraction>%<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> reduction in payment was addressed by the Consolidated Appropriations Act, </span><span style="font-size: 10pt; font-family: 'Times New Roman';">2021</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> (&#8220;Act&#8221;) signed into law on December </span><span style="font-size: 10pt; font-family: 'Times New Roman';">27,</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">&#160;</span><span style="font-size: 10pt; font-family: 'Times New Roman';">2020.</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">&#160; Based on various provisions in the Act, the Company now estimates that the Medicare rate reduction for the full year of </span><span style="font-size: 10pt; font-family: 'Times New Roman';">2021</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> will be approximately </span><ix:nonFraction name="usph:EstimatedPercentageOfDecreaseInPayment" id="Fact_653042824c33400abe3873c1cd2eb78f" contextRef="c20200101to20201231" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">3.5</ix:nonFraction>%<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> in aggregate.</span></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fc5da5bf096e4a418dbee70ef479a01519" continuedAt="Text_fc5da5bf096e4a418dbee70ef479a01520"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c63" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c64">
<div><br /></div>
</ix:continuation></ix:continuation></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>54</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div><ix:continuation id="Text_fc5da5bf096e4a418dbee70ef479a01520" continuedAt="Text_fc5da5bf096e4a418dbee70ef479a01521"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c64" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c65">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Beginning in 2021, payments to individual therapists (Physical/Occupational Therapist in Private Practice) paid under the fee schedule may be subject to adjustment based on performance in the Merit Based Incentive Payment System (&#8220;MIPS&#8221;), which measures performance based on certain quality metrics, resource use, and meaningful use of electronic health records. Under the MIPS requirements, a provider's performance is assessed according to established performance standards each year and then is used to determine an adjustment factor that is applied to the professional's payment for the corresponding payment year. The provider&#8217;s MIPS performance in 2019 will determine the payment adjustment in 2021. Each year from 2019 through 2024, professionals who receive a significant share of their revenues through an alternate payment model (&#8220;APM&#8221;), (such as accountable care organizations or bundled payment arrangements) that involves risk of financial losses and a quality measurement component will receive a <ix:nonFraction name="usph:PercentageOfBonusPayment" id="Fact_1eb1093db0b94d5f92319badaa306101" contextRef="c20200101to20201231_UnusualOrInfrequentItemAxis_FromTwoThousandNineteenThroughTwoThousandTwentyFourMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">5</ix:nonFraction>% bonus in the corresponding payment year. The bonus payment for APM participation is intended to encourage participation and testing of new APMs and to promote the alignment of incentives across payors. The specifics of the MIPS and APM adjustments will be subject to future notice and comment rule-making.</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fc5da5bf096e4a418dbee70ef479a01521" continuedAt="Text_fc5da5bf096e4a418dbee70ef479a01522"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c65" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c66">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fc5da5bf096e4a418dbee70ef479a01522" continuedAt="Text_fc5da5bf096e4a418dbee70ef479a01523"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c66" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c67">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Budget Control Act of 2011 increased the federal debt ceiling in connection with deficit reductions over the next <ix:nonNumeric name="usph:PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" id="Fact_bc91d93becfd4b939d7adf7eef9c1564" contextRef="c20200101to20201231" format="ixt-sec:durwordsen">ten years</ix:nonNumeric>, and requires automatic reductions in federal spending by approximately $<ix:nonFraction name="usph:AmountOfReductionsInFederalSpending" id="Fact_a8437730cce14fcdb9ff08527ff24bae" contextRef="c20200101to20201231" unitRef="U001" decimals="-11" scale="12" format="ixt:numdotdecimal">1.2</ix:nonFraction> trillion. Payments to Medicare providers are subject to these automatic spending reductions, subject to a <ix:nonFraction name="usph:ReductionInMedicareSpendingPercentage" id="Fact_7766973703ec41d78f6dd4cf98b60bd1" contextRef="c20200101to20201231" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">2</ix:nonFraction>% cap. On April 1, 2013, a <ix:nonFraction name="usph:ExpectedReductionInMedicareSpendingPercentage" id="Fact_99efd21eb1454bb58038291f19499e9b" contextRef="c20130401" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">2</ix:nonFraction>% reduction to Medicare payments was implemented. The Bipartisan Budget Act of 2015, enacted on November 2, 2015, extended the <ix:nonFraction name="usph:ExpectedReductionInMedicareSpendingPercentage" id="Fact_c7600ea77d5a4a1ea57c3c9bfec86257" contextRef="c20151102" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">2</ix:nonFraction>% reductions to Medicare payments through fiscal year 2025. The Bipartisan Budget Act of 2018, enacted on February 9, 2018, extends the <ix:nonFraction name="usph:ExpectedReductionInMedicareSpendingPercentage" id="Fact_3ea905d1f5184b7e8f5e29f3db8f9f0b" contextRef="c20180209" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">2</ix:nonFraction>% reductions to Medicare payments through fiscal year 2027. <span style="font-size: 10pt; font-family: 'Times New Roman';">The Coronavirus Aid, Relief, and Economic Security (CARES) Act suspended the </span><ix:nonFraction name="usph:ExpectedReductionInMedicareSpendingPercentage" id="Fact_69d5c80cb2be4b39949c529928910a1f" contextRef="c20201231" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">2</ix:nonFraction>%<span style="font-size: 10pt; font-family: 'Times New Roman';"> payment reduction Medicare payments for dates of service from May 1, 2020, through December 31, 2020. The Consolidated Appropriations Act, 2021 further suspended the </span><ix:nonFraction name="usph:ExpectedReductionInMedicareSpendingPercentage" id="Fact_8560d06d39e346d3a71905c3e98e2bae" contextRef="c20210331_StatementScenarioAxis_ScenarioForecastMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">2</ix:nonFraction>%<span style="font-size: 10pt; font-family: 'Times New Roman';"> payment reduction until March 31, 2021.</span></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fc5da5bf096e4a418dbee70ef479a01523" continuedAt="Text_fc5da5bf096e4a418dbee70ef479a01524"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c67" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c68">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fc5da5bf096e4a418dbee70ef479a01524" continuedAt="Text_fc5da5bf096e4a418dbee70ef479a01525"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c68" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c69">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Historically, the total amount paid by Medicare in any one year for outpatient physical therapy, occupational therapy, and/or speech-language pathology services provided to any Medicare beneficiary was subject to an annual dollar limit (i.e., the &#8220;Therapy Cap&#8221; or &#8220;Limit&#8221;). For 2017, the annual Limit on outpatient therapy services was $<ix:nonFraction name="usph:AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices" id="Fact_b6e707cdbfff41cb8fee3c35c6d9a199" contextRef="c20200101to20201231_RangeAxis_MaximumMember_UnusualOrInfrequentItemAxis_Year2017Member" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">1,980</ix:nonFraction> for combined Physical Therapy and Speech Language Pathology services and $<ix:nonFraction name="usph:AnnualLimitOccupationalTherapyServices" id="Fact_201edd422af141bd9baebe16318b73c6" contextRef="c20200101to20201231_RangeAxis_MaximumMember_UnusualOrInfrequentItemAxis_Year2017Member" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">1,980</ix:nonFraction> for Occupational Therapy services. As a result of Bipartisan Budget Act of 2018, the Therapy Caps have been eliminated, effective as of January 1, 2018.</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fc5da5bf096e4a418dbee70ef479a01525" continuedAt="Text_fc5da5bf096e4a418dbee70ef479a01526"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c69" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c70">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fc5da5bf096e4a418dbee70ef479a01526" continuedAt="Text_fc5da5bf096e4a418dbee70ef479a01527"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c70" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c71">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Under the Middle Class Tax Relief and Job Creation Act of 2012 (&#8220;MCTRA&#8221;), since October 1, 2012, patients who met or exceeded $<ix:nonFraction name="usph:CombinedPhysicalTherapySpeechLanguagePathologyExpenses" id="Fact_e4e6f5b412cf49a3b7bfe95f680edc83" contextRef="c20200101to20201231" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">3,700</ix:nonFraction> in therapy expenditures during a calendar year have been subject to a manual medical review to determine whether applicable payment criteria are satisfied. The $<ix:nonFraction name="usph:CombinedPhysicalTherapySpeechLanguagePathologyExpenses" id="Fact_baefb9408d9748279ad759a3661488bd" contextRef="c20200101to20201231" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">3,700</ix:nonFraction> threshold is applied to Physical Therapy and Speech Language Pathology Services; a separate $<ix:nonFraction name="usph:CombinedPhysicalTherapySpeechLanguagePathologyExpenses" id="Fact_b6c4a0ce89c742978eac930f06e87577" contextRef="c20200101to20201231" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">3,700</ix:nonFraction> threshold is applied to the Occupational Therapy. The MACRA directed CMS to modify the manual medical review process such that those reviews will no longer apply to all claims exceeding the $<ix:nonFraction name="usph:CombinedPhysicalTherapySpeechLanguagePathologyExpenses" id="Fact_724021545e294470a1fdee7749ee6350" contextRef="c20200101to20201231" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">3,700</ix:nonFraction> threshold and instead will be determined on a targeted basis based on a variety of factors that CMS considers appropriate. The Bipartisan Budget Act of 2018 extends the targeted medical review indefinitely, but reduces the threshold to $<ix:nonFraction name="usph:ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" id="Fact_10987fdc52dd4264b56b4f3c57785ad8" contextRef="c20200101to20201231" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">3,000</ix:nonFraction> through December 31, 2027. For 2028, the threshold amount will be increased by the percentage increase in the Medicare Economic Index (&#8220;MEI&#8221;) for 2028 and in subsequent years the threshold amount will increase based on the corresponding percentage increase in the MEI for such subsequent year.</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fc5da5bf096e4a418dbee70ef479a01527" continuedAt="Text_fc5da5bf096e4a418dbee70ef479a01528"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c71" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c72">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fc5da5bf096e4a418dbee70ef479a01528" continuedAt="Text_fc5da5bf096e4a418dbee70ef479a01529"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c72" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c73">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">CMS adopted a multiple procedure payment reduction (&#8220;MPPR&#8221;) for therapy services in the final update to the MPFS for calendar year 2011. The MPPR applied to all outpatient therapy services paid under Medicare Part B &#8212; occupational therapy, physical therapy and speech-language pathology. Under the policy, the Medicare program pays </span><ix:nonFraction name="usph:PercentageOfPracticeExpenseComponentOfRelativeValueUnit" id="Fact_af6895816b7b45a7b32f347361ac9fe8" contextRef="c20200101to20201231" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">100</ix:nonFraction>%<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> of the practice expense component of the Relative Value Unit (&#8220;RVU&#8221;) for the therapy procedure with the highest practice expense RVU, then reduces the payment for the practice expense component for the second and subsequent therapy procedures or units of service furnished during the same day for the same patient, regardless of whether those therapy services are furnished in separate sessions. Since 2013, the practice expense component for the second and subsequent therapy service furnished during the same day for the same patient was reduced by </span><ix:nonFraction name="usph:PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" id="Fact_cb29fd23afc44bc192568609fd3ba508" contextRef="c20200101to20201231" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">50</ix:nonFraction>%<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">. </span>In addition, the MCTRA directed CMS to implement a claims-based data collection program to gather additional data on patient function during the course of therapy in order to better understand patient conditions and outcomes. All practice settings that provide outpatient therapy services are required to include this data on the claim form. Since 2013, therapists have been required to report new codes and modifiers on the claim form that reflect a patient&#8217;s functional limitations and goals at initial evaluation, periodically throughout care, and at discharge. Reporting of these functional limitation codes and modifiers are required on the claim for payment.</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fc5da5bf096e4a418dbee70ef479a01529" continuedAt="Text_fc5da5bf096e4a418dbee70ef479a01530"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c73" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c74">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fc5da5bf096e4a418dbee70ef479a01530" continuedAt="Text_fc5da5bf096e4a418dbee70ef479a01531"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c74" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c75">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Medicare claims for outpatient therapy services furnished by therapy assistants on or after January 1, 2020 must include a modifier indicating the service was furnished by a therapy assistant. Outpatient therapy services furnished on or after January 1, 2022 in whole or part by a therapy assistant will be paid at an amount equal to <ix:nonFraction name="usph:PercentageOfPaymentForOutpatientTherapyServices" id="Fact_e847ee5f09ba478f8e42a36a52371ae3" contextRef="c20200101to20201231" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">85</ix:nonFraction>% of the payment amount otherwise applicable for the service.</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fc5da5bf096e4a418dbee70ef479a01531" continuedAt="Text_fc5da5bf096e4a418dbee70ef479a01532"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c75" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c76">
<div><br /></div>
</ix:continuation></ix:continuation></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>55</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div><ix:continuation id="Text_fc5da5bf096e4a418dbee70ef479a01532" continuedAt="Text_fc5da5bf096e4a418dbee70ef479a01533"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c76" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c77">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Statutes, regulations, and payment rules governing the delivery of therapy services to Medicare beneficiaries are complex and subject to interpretation. We believe that we are in compliance, in all material respects, with all applicable laws and regulations and are not aware of any pending or threatened investigations involving allegations of potential wrongdoing that would have a material effect on the our financial statements as of December 31, 2020. Compliance with such laws and regulations can be subject to future government review and interpretation, as well as significant regulatory action including fines, penalties, and exclusion from the Medicare program. For year ended December 31, 2020, net patient revenues from Medicare were approximately $<ix:nonFraction name="usph:NetRevenueFromMedicare" id="Fact_f4ebeb7701bd4a838252c0a679d069d5" contextRef="c20200101to20201231" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">101.6</ix:nonFraction> million.</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fc5da5bf096e4a418dbee70ef479a01533" continuedAt="Text_fc5da5bf096e4a418dbee70ef479a01534"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c77" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c78">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fc5da5bf096e4a418dbee70ef479a01534" continuedAt="Text_fc5da5bf096e4a418dbee70ef479a01535"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c78" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c79">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Given the history of frequent revisions to the Medicare program and its reimbursement rates and rules, we may not continue to receive reimbursement rates from Medicare that sufficiently compensate us for our services or, in some instances, cover our operating costs. Limits on reimbursement rates or the scope of services being reimbursed could have a material adverse effect on our revenue, financial condition and results of operations. Additionally, any delay or default by the federal or state governments in making Medicare and/or Medicaid reimbursement payments could materially and, adversely, affect our business, financial condition and results of operations.</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fc5da5bf096e4a418dbee70ef479a01535" continuedAt="Text_fc5da5bf096e4a418dbee70ef479a01536"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c79" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c80">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fc5da5bf096e4a418dbee70ef479a01536" continuedAt="Text_fc5da5bf096e4a418dbee70ef479a01537"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c80" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c81">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Management Contract Revenues</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fc5da5bf096e4a418dbee70ef479a01537" continuedAt="Text_fc5da5bf096e4a418dbee70ef479a01538"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c81" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c82">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fc5da5bf096e4a418dbee70ef479a01538" continuedAt="Text_fc5da5bf096e4a418dbee70ef479a01539"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c82" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c83">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Management contract revenues, which are included in other revenues, are derived from contractual arrangements whereby the Company manages a clinic for third party owners. The Company does not have any ownership interest in these clinics. Typically, revenues are determined based on the number of visits conducted at the clinic and recognized at a point in time when services are performed. Costs, typically salaries for the Company&#8217;s employees, are recorded when incurred.</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fc5da5bf096e4a418dbee70ef479a01539" continuedAt="Text_fc5da5bf096e4a418dbee70ef479a01540"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c83" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c84">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fc5da5bf096e4a418dbee70ef479a01540" continuedAt="Text_fc5da5bf096e4a418dbee70ef479a01541"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c84" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c85">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Industrial Injury Prevention Services Revenues</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fc5da5bf096e4a418dbee70ef479a01541" continuedAt="Text_fc5da5bf096e4a418dbee70ef479a01542"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c85" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c86">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fc5da5bf096e4a418dbee70ef479a01542" continuedAt="Text_fc5da5bf096e4a418dbee70ef479a01543"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c86" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c87">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Revenue from the industrial injury prevention business, which are also included in other revenues in the consolidated statements of net income, are derived from onsite services we provide to clients&#8217; employees including injury prevention, rehabilitation, ergonomic assessments and performance optimization. Revenue from the Company&#8217;s industrial injury prevention business is recognized when obligations under the terms of the contract are satisfied. Revenues are recognized at an amount equal to the consideration the company expects to receive in exchange for providing injury prevention services to its clients. The revenue is determined and recognized based on the number of hours and respective rate for services provided in a given period.</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fc5da5bf096e4a418dbee70ef479a01543" continuedAt="Text_fc5da5bf096e4a418dbee70ef479a01544"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c87" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c88">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fc5da5bf096e4a418dbee70ef479a01544" continuedAt="Text_fc5da5bf096e4a418dbee70ef479a01545"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c88" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c89">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Other Revenues</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fc5da5bf096e4a418dbee70ef479a01545" continuedAt="Text_fc5da5bf096e4a418dbee70ef479a01546"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c89" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c90">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c90" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c91"><ix:continuation id="Text_fc5da5bf096e4a418dbee70ef479a01546">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Additionally, other revenues include services the Company provides on-site at locations such as schools and industrial worksites for physical or occupational therapy services, athletic trainers and gym membership fees. Contract terms and rates are agreed to in advance between the Company and the third parties. Services are typically performed over the contract period and revenue is recorded at the point of service. If the services are paid in advance, revenue is recorded as a contract liability over the period of the agreement and recognized at the point in time, when the services are performed.</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c91" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c92">
<div><br /></div>
</ix:continuation><ix:nonNumeric name="us-gaap:ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock" id="Text_82a6d009eac84f93b353ec5577075163" contextRef="c20200101to20201231" escape="true" continuedAt="Text_04a8268af9e54bb0964e9ab1044d2bcd1"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c92" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c93">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Contractual Allowances</div>
</ix:continuation></ix:nonNumeric><ix:continuation id="Text_04a8268af9e54bb0964e9ab1044d2bcd1" continuedAt="Text_04a8268af9e54bb0964e9ab1044d2bcd2"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c93" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c94">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c94" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c95"><ix:continuation id="Text_04a8268af9e54bb0964e9ab1044d2bcd2">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The allowance for estimated contractual adjustments is based on terms of payor contracts and historical collection and write-off experience. Contractual allowances result from the differences between the rates charged for services performed and expected reimbursements by both insurance companies and government sponsored healthcare programs for such services. Medicare regulations and the various third party payors and managed care contracts are often complex and may include multiple reimbursement mechanisms payable for the services provided in Company clinics. The Company estimates contractual allowances based on its interpretation of the applicable regulations, payor contracts and historical calculations. Each month the Company estimates its contractual allowance for each clinic based on payor contracts and the historical collection experience of the clinic and applies an appropriate contractual allowance reserve percentage to the gross accounts receivable balances for each payor of the clinic. Based on the Company&#8217;s historical experience, calculating the contractual allowance reserve percentage at the payor level is sufficient to allow the Company to provide the necessary detail and accuracy with its collectability estimates. However, the services authorized and provided and related reimbursement are subject to interpretation that could result in payments that differ from the Company&#8217;s estimates. Payor terms are periodically revised necessitating continual review and assessment of the estimates made by management. The Company&#8217;s billing system does not capture the exact change in its contractual allowance reserve estimate from period to period in order to assess the accuracy of its revenues and hence its contractual allowance reserves. Management regularly compares its cash collections to corresponding net revenues measured both in the aggregate and on a clinic-by-clinic basis. In the aggregate, historically the difference between net revenues and corresponding cash collections for any fiscal year has generally reflected a difference within approximately <ix:nonFraction name="usph:DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" id="Fact_735d2b583918424a8c7cf9c6e59abdf8" contextRef="c20200101to20201231_RangeAxis_MinimumMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">1</ix:nonFraction>% to <ix:nonFraction name="usph:DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" id="Fact_710ed313f3b742449e6986013017f86e" contextRef="c20200101to20201231_RangeAxis_MaximumMember" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">1.5</ix:nonFraction>% of net revenues. Additionally, analysis of subsequent periods&#8217; contractual write-offs on a payor basis reflects a difference within approximately <ix:nonFraction name="usph:DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" id="Fact_abb0edecd76e42958911800b5e23f240" contextRef="c20200101to20201231_RangeAxis_MinimumMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">1</ix:nonFraction>% to <ix:nonFraction name="usph:DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" id="Fact_2d77fc8668c743d8a3e0b731707afe23" contextRef="c20200101to20201231_RangeAxis_MaximumMember" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">1.5</ix:nonFraction>% between the actual aggregate contractual reserve percentage as compared to the estimated contractual allowance reserve percentage associated with the same period end balance. As a result, the Company believes that a change in the contractual allowance reserve estimate would not likely be more than <ix:nonFraction name="usph:MaximumContractualAllowanceReserveEstimate" id="Fact_feaa9786f1b348aa92993a3ad1d3dde5" contextRef="c20200101to20201231_RangeAxis_MinimumMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">1</ix:nonFraction>% to <ix:nonFraction name="usph:MaximumContractualAllowanceReserveEstimate" id="Fact_34050b62d3ac4198b86ddace8d745012" contextRef="c20200101to20201231_RangeAxis_MaximumMember" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">1.5</ix:nonFraction>% of gross billings included in accounts receivable at December 31, 2020.</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c95" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c96">
<div><br /></div>
</ix:continuation></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>56</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div><ix:nonNumeric name="us-gaap:FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts" id="Text_36fd587d12c04cefbe52ae0b96d83dc1" contextRef="c20200101to20201231" escape="true" continuedAt="Text_226b40810cb948e6a4b1fb3450262ab31"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c96" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c97">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Allowance for Credit Losses</div>
</ix:continuation></ix:nonNumeric><ix:continuation id="Text_226b40810cb948e6a4b1fb3450262ab31" continuedAt="Text_226b40810cb948e6a4b1fb3450262ab32"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c97" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c98">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c98" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c99"><ix:continuation id="Text_226b40810cb948e6a4b1fb3450262ab32">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company determines allowances for credit losses based on the specific agings and payor classifications at each clinic. The provision for credit losses is included in operating costs in the statements of net income. Patient accounts receivable, which are stated at the historical carrying amount net of contractual allowances, write-offs and allowance for credit losses, includes only those amounts the Company estimates to be collectible.</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c99" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c100">
<div><br /></div>
</ix:continuation><ix:nonNumeric name="us-gaap:IncomeTaxPolicyTextBlock" id="Text_499b9437e84f4f86943adb15b90ed92d" contextRef="c20200101to20201231" escape="true" continuedAt="Text_122040a1a29c4c229e79ebb8bcbbf93a1"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c100" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c101">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Income Taxes</div>
</ix:continuation></ix:nonNumeric><ix:continuation id="Text_122040a1a29c4c229e79ebb8bcbbf93a1" continuedAt="Text_122040a1a29c4c229e79ebb8bcbbf93a2"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c101" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c102">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_122040a1a29c4c229e79ebb8bcbbf93a2" continuedAt="Text_122040a1a29c4c229e79ebb8bcbbf93a3"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c102" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c103">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_122040a1a29c4c229e79ebb8bcbbf93a3" continuedAt="Text_122040a1a29c4c229e79ebb8bcbbf93a4"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c103" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c104">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_122040a1a29c4c229e79ebb8bcbbf93a4" continuedAt="Text_122040a1a29c4c229e79ebb8bcbbf93a5"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c104" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c105">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount to be recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority.</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_122040a1a29c4c229e79ebb8bcbbf93a5" continuedAt="Text_122040a1a29c4c229e79ebb8bcbbf93a6"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c105" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c106">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c106" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c107"><ix:continuation id="Text_122040a1a29c4c229e79ebb8bcbbf93a6">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company did <ix:nonFraction name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" id="Fact_e42c06d7349b4065a0a5af72b08f344f" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" id="Fact_baaf3ff90cf44b20a88a92d3be31e64e" contextRef="c20181231" unitRef="U001" decimals="-3" scale="3" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" id="Fact_b6afa75754ea4f08af3eac2e360dc356" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction>t have any accrued interest or penalties associated with any unrecognized tax benefits <ix:nonFraction name="us-gaap:InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" id="Fact_a4734842251b46f3ac49474f6792f2d3" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" id="Fact_7a6a308e051c41c99a92c335d8a7dd39" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" id="Fact_200af74610e7409dadacedb241ef6b07" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction>r was any interest expense recognized during the twelve months ended December 31, 2020, 2019 and 2018. The Company will book any interest or penalties, if required, in interest and other expense, as appropriate.</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c107" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c108">
<div><br /></div>
</ix:continuation><ix:nonNumeric name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="Text_fab030a786d84d99b984fa4de13e2ae9" contextRef="c20200101to20201231" escape="true" continuedAt="Text_2cd1bf1929cc42fd8bde32c87f5836a61"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c108" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c109">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Fair Values of Financial Instruments</div>
</ix:continuation></ix:nonNumeric><ix:continuation id="Text_2cd1bf1929cc42fd8bde32c87f5836a61" continuedAt="Text_2cd1bf1929cc42fd8bde32c87f5836a62"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c109" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c110">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c110" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c111"><ix:continuation id="Text_2cd1bf1929cc42fd8bde32c87f5836a62">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The carrying amounts reported in the balance sheets for cash and cash equivalents, accounts receivable, accounts payable and notes payable approximate their fair values due to the short-term maturity of these financial instruments. The carrying amount under the Amended Credit Agreement and the redemption value of Redeemable non-controlling interests approximate the respective fair values. The fair value of the Company&#8217;s redeemable non-controlling interests is determined based on &#8220;Level 3&#8221; inputs. The interest rate on the Amended Credit Agreement, which is tied to LIBOR, is set at various short-term intervals, as detailed in the Amended Credit Agreement.</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c111" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c112">
<div><br /></div>
</ix:continuation><ix:nonNumeric name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="Text_f41d6361623e42e1ae6a35d3551953a7" contextRef="c20200101to20201231" escape="true" continuedAt="Text_2e1d8e9a3e5c4617bf4c5ba59dcc55071"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c112" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c113">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Segment Reporting</div>
</ix:continuation></ix:nonNumeric><ix:continuation id="Text_2e1d8e9a3e5c4617bf4c5ba59dcc55071" continuedAt="Text_2e1d8e9a3e5c4617bf4c5ba59dcc55072"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c113" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c114">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c114" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c115"><ix:continuation id="Text_2e1d8e9a3e5c4617bf4c5ba59dcc55072">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">Operating segments are components of an enterprise for which separate financial information is available that is evaluated regularly by chief operating decision makers in determining the allocation of resources and in assessing performance. </span>The Company currently operates through two segments: physical therapy operations and industrial injury prevention services.</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c115" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c116">
<div><br /></div>
</ix:continuation><ix:nonNumeric name="us-gaap:UseOfEstimates" id="Text_9419282af8d04821b335d3e40b9355b7" contextRef="c20200101to20201231" escape="true" continuedAt="Text_08bf8fd779b441d3b22179136419b5cb1"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c116" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c117">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Use of Estimates</div>
</ix:continuation></ix:nonNumeric><ix:continuation id="Text_08bf8fd779b441d3b22179136419b5cb1" continuedAt="Text_08bf8fd779b441d3b22179136419b5cb2"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c117" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c118">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c118" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c119"><ix:continuation id="Text_08bf8fd779b441d3b22179136419b5cb2">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In preparing the Company&#8217;s consolidated financial statements, management makes certain estimates and assumptions, especially in relation to, but not limited to, goodwill impairment, tradenames, allocations of purchase price, allowance for receivables, tax provision and contractual allowances, that affect the amounts reported in the consolidated financial statements and related disclosures. Actual results may differ from these estimates.</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c119" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c120">
<div><br /></div>
</ix:continuation><ix:nonNumeric name="usph:SelfInsuranceProgramPolicyPolicyTextBlock" id="Text_7d4be4693df34678bbf20b78780bbe72" contextRef="c20200101to20201231" escape="true" continuedAt="Text_af20e5cb6fd24eba9c8138b42c28acc21"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c120" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c121">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Self-Insurance Program</div>
</ix:continuation></ix:nonNumeric><ix:continuation id="Text_af20e5cb6fd24eba9c8138b42c28acc21" continuedAt="Text_af20e5cb6fd24eba9c8138b42c28acc22"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c121" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c122">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c122" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c123"><ix:continuation id="Text_af20e5cb6fd24eba9c8138b42c28acc22">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company utilizes a self-insurance plan for its employee group health and dental insurance coverage administered by a third party. Predetermined loss limits have been arranged with the insurance company to minimize the Company&#8217;s maximum liability and cash outlay. Accrued expenses include the estimated incurred but unreported costs to settle unpaid claims and estimated future claims. Management believes that the current accrued amounts are sufficient to pay claims arising from self-insurance claims incurred through December 31, 2020.</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c123" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c124">
<div><br /></div>
</ix:continuation></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>57</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div><ix:nonNumeric name="usph:RestrictedStockPolicyPolicyTextBlock" id="Text_ca0fc14eecc64d74b297a6d12a3ff19a" contextRef="c20200101to20201231" escape="true" continuedAt="Text_315cd8c6dcb54e06a40df16a3ecce48b1"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c124" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c125">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Restricted Stock</div>
</ix:continuation></ix:nonNumeric><ix:continuation id="Text_315cd8c6dcb54e06a40df16a3ecce48b1" continuedAt="Text_315cd8c6dcb54e06a40df16a3ecce48b2"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c125" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c126">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c126" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c127"><ix:continuation id="Text_315cd8c6dcb54e06a40df16a3ecce48b2">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Restricted stock issued to employees and directors is subject to continued employment or continued service on the board, respectively. Generally, restrictions on the stock granted to employees lapse in equal annual installments on the following <span style="-sec-ix-hidden:Fact_e171b1cb7c524fee994efb673b5c1ee0">four</span> anniversaries of the date of grant. For those shares granted to directors, the restrictions will lapse in equal quarterly installments during the <span style="-sec-ix-hidden:Fact_d66bd8ac9de54f2492bfbf867e9180fc">first</span> year after the date of grant. For those granted to officers, the restriction will lapse in equal quarterly installments during the <ix:nonNumeric name="us-gaap:DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" id="Fact_decb0cbb01da4c6cbe4a3c50d6feff8c" contextRef="c20200101to20201231_TitleOfIndividualAxis_OfficerMember" format="ixt-sec:durwordsen">four years</ix:nonNumeric> following the date of grant. Compensation expense for grants of restricted stock is recognized based on the fair value per share on the date of grant amortized over the vesting period. The Company recognizes any forfeitures as they occur. The restricted stock issued is included in basic and diluted shares for the earnings per share computation.</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c127" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c128">
<div><br /></div>
</ix:continuation><ix:nonNumeric name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="Text_3b238b06a0a24633b2bc213616210fea" contextRef="c20200101to20201231" escape="true" continuedAt="Text_fb7831f43c554fb1b53ff9d34b8a1cc31"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c128" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c129">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Recently Adopted Accounting Guidance</div>
</ix:continuation></ix:nonNumeric><ix:continuation id="Text_fb7831f43c554fb1b53ff9d34b8a1cc31" continuedAt="Text_fb7831f43c554fb1b53ff9d34b8a1cc32"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c129" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c130">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fb7831f43c554fb1b53ff9d34b8a1cc32" continuedAt="Text_fb7831f43c554fb1b53ff9d34b8a1cc33"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c130" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c131">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In February 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2016-02, Leases (Topic 842) (&#8220;ASC 842&#8221;), which amended prior accounting standards for leases.</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fb7831f43c554fb1b53ff9d34b8a1cc33" continuedAt="Text_fb7831f43c554fb1b53ff9d34b8a1cc34"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c131" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c132">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fb7831f43c554fb1b53ff9d34b8a1cc34" continuedAt="Text_fb7831f43c554fb1b53ff9d34b8a1cc35"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c132" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c133">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company implemented the new lease standard, ASC Topic 842 &#8211; Leases as of January 1, 2019 using the transition method in ASU 2018-11 issued in July 2018 which allows the Company to initially apply the new leases standard at adoption date and recognize a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. There was no adjustment required to retained earnings upon adoption. Accordingly, no retrospective adjustments were made to the comparative periods presented. The Company elected certain of the practical expedients permitted, including the expedient that allows the Company to retain its existing lease assessment and classification.</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fb7831f43c554fb1b53ff9d34b8a1cc35" continuedAt="Text_fb7831f43c554fb1b53ff9d34b8a1cc36"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c133" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c134">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fb7831f43c554fb1b53ff9d34b8a1cc36" continuedAt="Text_fb7831f43c554fb1b53ff9d34b8a1cc37"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c134" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c135">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Adoption of ASC 842 resulted in an increase to total assets and liabilities due to the recording of operating lease right-of-use assets (&#8220;ROU&#8221;) and operating lease liabilities of approximately $<ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" id="Fact_6a3b94af9bd443bf80feeca9badde6dd" contextRef="c20201231_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201602Member" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">78.0</ix:nonFraction> million and $<ix:nonFraction name="us-gaap:OperatingLeaseLiability" id="Fact_7e43e5cacb054a9484c433d9ed8ad8b7" contextRef="c20201231_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201602Member" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">82.6</ix:nonFraction> million respectively, as of January 1, 2019 for operating leases as a lessee. The adoption did not materially impact the Company&#8217;s consolidated statement of income or cash flows. See Footnote 10 - Leases for further discussion of leases.</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fb7831f43c554fb1b53ff9d34b8a1cc37" continuedAt="Text_fb7831f43c554fb1b53ff9d34b8a1cc38"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c135" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c136">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fb7831f43c554fb1b53ff9d34b8a1cc38" continuedAt="Text_fb7831f43c554fb1b53ff9d34b8a1cc39"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c136" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c137">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In August 2018, the Securities Exchange Commission (&#8220;SEC&#8221;) issued Final Rule 33-10532, Disclosure Update and Simplification, which amends certain disclosure requirements that were redundant, duplicative, overlapping or superseded by other SEC disclosure requirements. The amendments generally eliminated or otherwise reduced certain disclosure requirements of various SEC rules and regulations. However, in some cases, the amendments require additional information to be disclosed, including changes in stockholders&#8217; equity in interim periods. The rule is effective 30 days after its publication in the Federal Register. The rule was posted on October 4, 2018. On September 25, 2018, the SEC released guidance advising it will not object to a registrant adopting the requirement to include changes in stockholders&#8217; equity in the Form 10-Q for the first quarter beginning after the effective date of the rule. The Company adopted this guidance in its Form 10-Q for the period ended March 31, 2019.</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fb7831f43c554fb1b53ff9d34b8a1cc39" continuedAt="Text_fb7831f43c554fb1b53ff9d34b8a1cc310"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c137" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c138">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fb7831f43c554fb1b53ff9d34b8a1cc310" continuedAt="Text_fb7831f43c554fb1b53ff9d34b8a1cc311"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c138" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c139">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In June 2016, the FASB issued ASU 2016-13, Financial Instruments &#8211; Credit Losses, which added a new impairment model (known as the current expected credit loss (CECL) model) that is based on expected losses rather than incurred losses. Under the new guidance, an entity recognizes as an allowance its estimate of expected credit losses. The CECL model applies to most debt instruments, including trade receivables. The CECL model does not have a minimum threshold for recognition of impairment losses and entities will need to measure expected credit losses on assets that have a low risk of loss. The standard is required to be applied using the modified retrospective approach with a cumulative-effect adjustment to retained earnings, if any, upon adoption.</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fb7831f43c554fb1b53ff9d34b8a1cc311" continuedAt="Text_fb7831f43c554fb1b53ff9d34b8a1cc312"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c139" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c140">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fb7831f43c554fb1b53ff9d34b8a1cc312" continuedAt="Text_fb7831f43c554fb1b53ff9d34b8a1cc313"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c140" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c141">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Company completed the adoption of ASU 2016-13, <span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Financial Instruments &#8211; Credit Losses</span>&#160; on January 1, 2020. The financial instruments subject to ASU 2016-13 are the Company&#8217;s accounts receivable derived from contracts with customers. A significant portion of the Company&#8217;s accounts receivable are from highly-solvent, creditworthy payors including governmental programs such as Medicare and Medicaid, and highly regulated commercial insurers. The Company&#8217;s estimate of expected credit losses as of January 1, 2020, using its expected credit loss evaluation process, resulted in no adjustments to the allowance for credit losses and no cumulative-effect adjustment to retained earnings on the adoption date of the standard.</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fb7831f43c554fb1b53ff9d34b8a1cc313" continuedAt="Text_fb7831f43c554fb1b53ff9d34b8a1cc314"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c141" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c142">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fb7831f43c554fb1b53ff9d34b8a1cc314" continuedAt="Text_fb7831f43c554fb1b53ff9d34b8a1cc315"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c142" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c143">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In January 2017, the FASB issued ASU 2017-04, <span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Simplifying the Test for Goodwill Impairment (Topic 350),</span> which eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment charge. ASU 2017-04 is effective prospectively for fiscal years, and the interim periods within those years, beginning after December 15, 2019. The Company completed the adoption of the standard effective January 1, 2020 and there was no impact to goodwill from the Company&#8217;s adoption of this change.</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fb7831f43c554fb1b53ff9d34b8a1cc315" continuedAt="Text_fb7831f43c554fb1b53ff9d34b8a1cc316"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c143" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c144">
<div><br /></div>
</ix:continuation></ix:continuation></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>58</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div><ix:continuation id="Text_fb7831f43c554fb1b53ff9d34b8a1cc316" continuedAt="Text_fb7831f43c554fb1b53ff9d34b8a1cc317"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c144" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c145">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Recently Issued Accounting Guidance</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fb7831f43c554fb1b53ff9d34b8a1cc317" continuedAt="Text_fb7831f43c554fb1b53ff9d34b8a1cc318"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c145" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c146">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fb7831f43c554fb1b53ff9d34b8a1cc318" continuedAt="Text_fb7831f43c554fb1b53ff9d34b8a1cc319"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c146" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c147">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. This ASU provides temporary optional expedients and exceptions to the guidance on contract modifications and hedge accounting to ease the financial reporting burdens of the expected market transition from the London Interbank Offered Rate (&#8220;LIBOR&#8221;) and other interbank offered rates to alternative reference rates. The new guidance was effective upon issuance, and the Company is allowed to elect to apply the amendments prospectively through December 31, 2022. Borrowings under the Amended Credit Agreement bear interest based on LIBOR or an alternate base rate. Provisions within the agreement currently provide the Company with the ability to replace LIBOR with a different reference rate in the event LIBOR ceases to exist.</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fb7831f43c554fb1b53ff9d34b8a1cc319" continuedAt="Text_fb7831f43c554fb1b53ff9d34b8a1cc320"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c147" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c148">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fb7831f43c554fb1b53ff9d34b8a1cc320" continuedAt="Text_fb7831f43c554fb1b53ff9d34b8a1cc321"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c148" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c149">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In August 2020, the FASB issued ASU 2020-06&#160;<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity </span>which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity&#8217;s own equity. As part of this update, convertible instruments are to be included in diluted earnings per share using the if-converted method, rather than the treasury stock method. Further, contracts which can be settled in cash or shares, excluding liability-classified share-based payment awards, are to be included in diluted earnings per share on an if-converted basis if the effect is dilutive, regardless of whether the entity or the counterparty can choose between cash and share settlement. The share-settlement presumption may not be rebutted based on past experience or a stated policy.</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fb7831f43c554fb1b53ff9d34b8a1cc321" continuedAt="Text_fb7831f43c554fb1b53ff9d34b8a1cc322"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c149" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c150">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fb7831f43c554fb1b53ff9d34b8a1cc322" continuedAt="Text_fb7831f43c554fb1b53ff9d34b8a1cc323"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c150" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c151">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">This pronouncement is effective for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2021. The Company plans to adopt this pronouncement as of January 1, 2022. The use of either the modified retrospective or fully retrospective method of transition is permitted. The Company is currently evaluating the impact of the adoption of ASU 2020-06 on the Company's consolidated financial statements.</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fb7831f43c554fb1b53ff9d34b8a1cc323" continuedAt="Text_fb7831f43c554fb1b53ff9d34b8a1cc324"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c151" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c152">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c152" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c153"><ix:continuation id="Text_fb7831f43c554fb1b53ff9d34b8a1cc324">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In December 2019, the FASB issued ASU 2019-12,&#160;Income Taxes (Topic 740) &#8211; Simplifying the Accounting for Income Taxes (&#8220;ASU 2019-12&#8221;). The objective of ASU 2019-12 is to simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740 and to provide more consistent application to improve the comparability of financial statements. The amendments in this ASU are effective for fiscal years beginning after December 15, 2020, and early adoption is permitted. We are currently evaluating the impact this guidance may have on our consolidated financial statements and related footnote disclosures.</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c153" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c154">
<div><br /></div>
</ix:continuation><ix:nonNumeric name="us-gaap:SubsequentEventsPolicyPolicyTextBlock" id="Text_ab44d1b7266b41689f34baf05a01821e" contextRef="c20200101to20201231" escape="true" continuedAt="Text_d03018ee2c8e4f209097a010b25f2a941"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c154" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c155">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Subsequent Event</div>
</ix:continuation></ix:nonNumeric><ix:continuation id="Text_d03018ee2c8e4f209097a010b25f2a941" continuedAt="Text_d03018ee2c8e4f209097a010b25f2a942"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c155" continuedAt="Text_badb8b33d7d44e55bf8497abd966129c156">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_d03018ee2c8e4f209097a010b25f2a942"><ix:continuation id="Text_badb8b33d7d44e55bf8497abd966129c156">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">On January 29, 2021, the Company, entered into the First Amendment to Second Amended and Restated Credit Agreement (hereafter referred to as &#8220;Amended Credit Agreement&#8221;) extending the maturity date from <ix:nonNumeric name="us-gaap:DebtInstrumentMaturityDate" id="Fact_3c066b5e24634ed1b00358519b10f9d1" contextRef="c20210129to20210129_DebtInstrumentAxis_CreditAgreementMember_SubsequentEventTypeAxis_SubsequentEventMember" format="ixt:datemonthdayyearen">November 30, 2021</ix:nonNumeric> to <ix:nonNumeric name="us-gaap:DebtInstrumentMaturityDate" id="Fact_88af0ea6de7b4cf4a02c5962e39597b8" contextRef="c20200101to20201231_DebtInstrumentAxis_CreditAgreementMember" format="ixt:datemonthdayyearen">November 30, 2025</ix:nonNumeric>. The commitment under the Amended Credit Agreement remains at $<ix:nonFraction name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" id="Fact_bd8e4eafc51b48218eedd2c2e071add4" contextRef="c20210129_DebtInstrumentAxis_CreditAgreementMember_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="U001" decimals="-6" scale="6" format="ixt:numdotdecimal">125</ix:nonFraction> million, however the accordion feature in the agreement was expanded to provide for capacity up to $<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" id="Fact_85842de4d97f47688caed73f8663c0a0" contextRef="c20210129_DebtInstrumentAxis_CreditAgreementMember_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="U001" decimals="-6" scale="6" format="ixt:numdotdecimal">150</ix:nonFraction> million. See Note 9 for more information on the Amended Credit Agreement.</div>
</ix:continuation></ix:continuation></div>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>59</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div><br /></div>
<div><ix:nonNumeric name="us-gaap:BusinessCombinationDisclosureTextBlock" id="Text_27186a00161449d7ada7cce8030f6001" contextRef="c20200101to20201231" escape="true" continuedAt="Text_48a61b40805447b88eb0e001fea2a5591">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">3. Acquisitions of Businesses</div>
</ix:nonNumeric><ix:continuation id="Text_48a61b40805447b88eb0e001fea2a5591" continuedAt="Text_48a61b40805447b88eb0e001fea2a5592">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_48a61b40805447b88eb0e001fea2a5592" continuedAt="Text_48a61b40805447b88eb0e001fea2a5593"><ix:nonNumeric name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="Text_26c49011939c4398a618e5abaeeecb97" contextRef="c20200101to20201231" escape="true" continuedAt="Text_6ed12680eeeb493b9bf0233a0d1d17ee1">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">During 2020, 2019 and 2018, the Company acquired a majority interest in the following physical therapy practices:</div>
</ix:nonNumeric></ix:continuation><ix:continuation id="Text_48a61b40805447b88eb0e001fea2a5593" continuedAt="Text_48a61b40805447b88eb0e001fea2a5594"><ix:continuation id="Text_6ed12680eeeb493b9bf0233a0d1d17ee1" continuedAt="Text_6ed12680eeeb493b9bf0233a0d1d17ee2">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_48a61b40805447b88eb0e001fea2a5594" continuedAt="Text_48a61b40805447b88eb0e001fea2a5595"><ix:continuation id="Text_6ed12680eeeb493b9bf0233a0d1d17ee2" continuedAt="Text_6ed12680eeeb493b9bf0233a0d1d17ee3">
<table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zf55e47efd599479e982bad9962730ad0">
  <tr>
    <td style="width: 39.03%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Acquisition</div></td>
    <td style="width: 3.06%; vertical-align: bottom;">&#160;</td>
    <td style="width: 22.92%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Date</div></td>
    <td style="width: 2.78%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td style="width: 14.72%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">% Interest<span style="font-size: 10pt; font-family: 'Times New Roman';"><br /></span>Acquired</div></td>
    <td style="width: 2.92%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td style="width: 14.58%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Number of<span style="font-size: 10pt; font-family: 'Times New Roman';"><br /></span>Clinics</div></td>
  </tr>
  <tr>
    <td style="width: 39.03%; vertical-align: bottom;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">November 2020 Acquisition</div></td>
    <td style="width: 3.06%; vertical-align: bottom;">&#160;</td>
    <td style="width: 22.92%; vertical-align: bottom; border-top: #000000 2px solid;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1" id="Fact_8cc617e77b2341aba28c923aeb808266" contextRef="c20200101to20201231_BusinessAcquisitionAxis_NovemberTwoThousandTwentyAcquisitionMember" format="ixt:datemonthdayyearen">November 30, 2020</ix:nonNumeric></div></td>
    <td style="width: 2.78%; vertical-align: bottom;">&#160;</td>
    <td style="width: 14.72%; vertical-align: bottom;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_ff759822b2cf4e63a369407031450679" contextRef="c20201231_BusinessAcquisitionAxis_NovemberTwoThousandTwentyAcquisitionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">75</ix:nonFraction>%</div></td>
    <td style="width: 2.92%; vertical-align: bottom;">&#160;</td>
    <td style="width: 14.58%; vertical-align: bottom;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_7effcacf8a9b4fcb88e2d01c3383440e" contextRef="c20200101to20201231_BusinessAcquisitionAxis_NovemberTwoThousandTwentyAcquisitionMember" unitRef="U007" decimals="0" scale="0" format="ixt:numdotdecimal">3</ix:nonFraction></div></td>
  </tr>
  <tr>
    <td style="width: 39.03%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">September 2020 Acquisition</div></td>
    <td style="width: 3.06%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 22.92%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1" id="Fact_e245152f416a4ee7ab45cd34b0016d12" contextRef="c20200101to20201231_BusinessAcquisitionAxis_SeptemberTwoThousandTwentyAcquisitionMember" format="ixt:datemonthdayyearen">September 30, 2020</ix:nonNumeric></div></td>
    <td style="width: 2.78%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 14.72%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_f12369ff56344b0dbf644b88d74dbd01" contextRef="c20201231_BusinessAcquisitionAxis_SeptemberTwoThousandTwentyAcquisitionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">70</ix:nonFraction>%</div></td>
    <td style="width: 2.92%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 14.58%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><span style="-sec-ix-hidden:Fact_29c0aadade644e9a962b7bfbcb82c179">*</span></div></td>
  </tr>
  <tr>
    <td style="width: 39.03%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">February 2020 Acquisition</div></td>
    <td style="width: 3.06%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 22.92%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1" id="Fact_820f42ef16464009a185c09fb7295238" contextRef="c20200101to20201231_BusinessAcquisitionAxis_FebruaryTwoThousandTwentyAcquisitionMember" format="ixt:datemonthdayyearen">February 27, 2020</ix:nonNumeric></div></td>
    <td style="width: 2.78%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 14.72%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_0320094539f74ee99f3fbef241f00d39" contextRef="c20201231_BusinessAcquisitionAxis_FebruaryTwoThousandTwentyAcquisitionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">65</ix:nonFraction>%</div></td>
    <td style="width: 2.92%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">**</div></td>
    <td style="width: 14.58%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_33b9ee538a0648e98415f462fe900865" contextRef="c20200101to20201231_BusinessAcquisitionAxis_FebruaryTwoThousandTwentyAcquisitionMember" unitRef="U007" decimals="0" scale="0" format="ixt:numdotdecimal">4</ix:nonFraction></div></td>
  </tr>
  <tr>
    <td style="width: 39.03%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">September 2019 Acquisition</div></td>
    <td style="width: 3.06%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 22.92%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1" id="Fact_2fdcb59510004222884c22d3c0f43911" contextRef="c20200101to20201231_BusinessAcquisitionAxis_SeptemberTwoThousandNineteenAcquisitionMember" format="ixt:datemonthdayyearen">September 30, 2019</ix:nonNumeric></div></td>
    <td style="width: 2.78%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 14.72%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_7b588b69747c47199e33ce2a68c5d23b" contextRef="c20201231_BusinessAcquisitionAxis_SeptemberTwoThousandNineteenAcquisitionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">67</ix:nonFraction>%</div></td>
    <td style="width: 2.92%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 14.58%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_366c31ed1d7d453aab63052acfeebdfd" contextRef="c20200101to20201231_BusinessAcquisitionAxis_SeptemberTwoThousandNineteenAcquisitionMember" unitRef="U007" decimals="0" scale="0" format="ixt:numdotdecimal">11</ix:nonFraction></div></td>
  </tr>
  <tr>
    <td style="width: 39.03%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">August 2018 Acquisition</div></td>
    <td style="width: 3.06%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 22.92%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1" id="Fact_cf0376377e99455ba2125a8b4d9c3e7d" contextRef="c20200101to20201231_BusinessAcquisitionAxis_August2018AcquisitionMember" format="ixt:datemonthdayyearen">August 31, 2018</ix:nonNumeric></div></td>
    <td style="width: 2.78%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 14.72%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_a50a8121e7f14faab5cf59fdf0bb9c6f" contextRef="c20201231_BusinessAcquisitionAxis_August2018AcquisitionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">70</ix:nonFraction>%</div></td>
    <td style="width: 2.92%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 14.58%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_479ffaa695ba4e708eb3a716514358b6" contextRef="c20200101to20201231_BusinessAcquisitionAxis_August2018AcquisitionMember" unitRef="U007" decimals="0" scale="0" format="ixt:numdotdecimal">4</ix:nonFraction></div></td>
  </tr>
</table>
</ix:continuation></ix:continuation><ix:continuation id="Text_48a61b40805447b88eb0e001fea2a5595" continuedAt="Text_48a61b40805447b88eb0e001fea2a5596"><ix:continuation id="Text_6ed12680eeeb493b9bf0233a0d1d17ee3" continuedAt="Text_6ed12680eeeb493b9bf0233a0d1d17ee4">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_48a61b40805447b88eb0e001fea2a5596" continuedAt="Text_48a61b40805447b88eb0e001fea2a5597"><ix:continuation id="Text_6ed12680eeeb493b9bf0233a0d1d17ee4" continuedAt="Text_6ed12680eeeb493b9bf0233a0d1d17ee5">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">*&#160; &#160; </span><ix:footnote id="Foot_daa3f0e35dde4f99997e6a382a591d10" footnoteRole="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US" continuedAt="Foot_e6937986a4eb4d7cbeaaff159a61357b1">The business includes <ix:nonFraction name="usph:NumberOfManagementContracts" id="Fact_a937be94f3554d02a7c3445463d89281" contextRef="c20200930to20200930_BusinessAcquisitionAxis_ManagementAndServicesContractsMember" unitRef="U014" decimals="INF" scale="0" format="ixt-sec:numwordsen">six</ix:nonFraction></ix:footnote><ix:continuation id="Foot_e6937986a4eb4d7cbeaaff159a61357b1" continuedAt="Foot_e6937986a4eb4d7cbeaaff159a61357b2"> management and services contracts which had a remaining term of approximately <ix:nonNumeric name="usph:RemainingContractTerm" id="Fact_9adb28d8758e4f12b149cfdb5a66f7d9" contextRef="c20200101to20201231_BusinessAcquisitionAxis_ManagementAndServicesContractsMember" format="ixt-sec:durwordsen">five years</ix:nonNumeric></ix:continuation><ix:continuation id="Foot_e6937986a4eb4d7cbeaaff159a61357b2"> as of the date acquired.</ix:continuation></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_48a61b40805447b88eb0e001fea2a5597" continuedAt="Text_48a61b40805447b88eb0e001fea2a5598"><ix:continuation id="Text_6ed12680eeeb493b9bf0233a0d1d17ee5">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">**&#160;&#160; </span><ix:footnote id="Foot_c17d1a5ce0344dbb9898dd830df565d6" footnoteRole="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US" continuedAt="Foot_aa90c7ff268742c9bd6ffe0fb25308871">The <ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_ce6bef34a7ee440f8359ff11eb5321bb" contextRef="c20200227to20200227_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U007" decimals="INF" scale="0" format="ixt-sec:numwordsen">four</ix:nonFraction></ix:footnote><ix:continuation id="Foot_aa90c7ff268742c9bd6ffe0fb25308871" continuedAt="Foot_aa90c7ff268742c9bd6ffe0fb25308872"> clinics are in <ix:nonFraction name="usph:NumberOfPartnershipInWhichInterestAcquired" id="Fact_19e56ea82f62430f9e9094120e17254b" contextRef="c20200227to20200227_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U015" decimals="INF" scale="0" format="ixt-sec:numwordsen">four</ix:nonFraction></ix:continuation><ix:continuation id="Foot_aa90c7ff268742c9bd6ffe0fb25308872" continuedAt="Foot_aa90c7ff268742c9bd6ffe0fb25308873"> separate partnerships.&#160; The Company's interest in the <ix:nonFraction name="usph:NumberOfPartnershipInWhichInterestAcquired" id="Fact_a30b5bc6f6d74c0fba36f0154dc78f22" contextRef="c20200227to20200227_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U015" decimals="INF" scale="0" format="ixt-sec:numwordsen">four</ix:nonFraction></ix:continuation><ix:continuation id="Foot_aa90c7ff268742c9bd6ffe0fb25308873" continuedAt="Foot_aa90c7ff268742c9bd6ffe0fb25308874"> partnerships range from <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_ecb4b7689056458682d5e2ba644d8d3c" contextRef="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MinimumMember" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">10.0</ix:nonFraction></ix:continuation><ix:continuation id="Foot_aa90c7ff268742c9bd6ffe0fb25308874" continuedAt="Foot_aa90c7ff268742c9bd6ffe0fb25308875">% to <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_62be7f93bd514451aabe2787ecf045eb" contextRef="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MaximumMember" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">83.8</ix:nonFraction></ix:continuation><ix:continuation id="Foot_aa90c7ff268742c9bd6ffe0fb25308875" continuedAt="Foot_aa90c7ff268742c9bd6ffe0fb25308876">%, with an overall <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_1073cde8e9024d1590350271777ef5e7" contextRef="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">65.0</ix:nonFraction></ix:continuation><ix:continuation id="Foot_aa90c7ff268742c9bd6ffe0fb25308876">% based on the initial purchase transaction.</ix:continuation></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_48a61b40805447b88eb0e001fea2a5598" continuedAt="Text_48a61b40805447b88eb0e001fea2a5599">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_48a61b40805447b88eb0e001fea2a5599" continuedAt="Text_48a61b40805447b88eb0e001fea2a55910">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">On November 30, 2020, the Company acquired a <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_fba4a08401d44bdf885492deafa4e2fc" contextRef="c20201130_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">75</ix:nonFraction>% interest in a <ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_8a08c6f41a9c4d5db89abe7642d2054a" contextRef="c20201130to20201130_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U007" decimals="INF" scale="0" format="ixt-sec:numwordsen">three</ix:nonFraction>-clinic physical therapy practice. The purchase price for the <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_ceb2c7240053487086cdf85b6ca6a0a6" contextRef="c20201130_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">75</ix:nonFraction>% interest was $<ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" id="Fact_3b11b9a7fd954bb5b57cfc93199d7923" contextRef="c20201130to20201130_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">9.1</ix:nonFraction> million, of which $<ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesGross" id="Fact_dd9e4850aa114d76aca61dfd85573448" contextRef="c20201130to20201130_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">8.8</ix:nonFraction> million was paid in cash and $<ix:nonFraction name="usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued" id="Fact_69f91d3fc6064a4db3d5f2b908af14a1" contextRef="c20201130_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction> million in the form of a seller note that is payable in <ix:nonFraction name="usph:BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" id="Fact_6065646e07e14dc19e21b487270b7ea1" contextRef="c20201130to20201130_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U010" decimals="INF" scale="0" format="ixt-sec:numwordsen">two</ix:nonFraction> principal installments totaling $<ix:nonFraction name="us-gaap:DebtInstrumentAnnualPrincipalPayment" id="Fact_a3bef9f39abb47eba3184ad8200754cb" contextRef="c20201130_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">162,500</ix:nonFraction> each. The first principal payment plus accrued interest will be paid on November 2021 with the second installment to be paid in November 2022. The note accrues interest at <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" id="Fact_c19d8976ed8646eca5ee57c5ea5a0372" contextRef="c20201130_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U005" decimals="4" scale="-2" format="ixt:numdotdecimal">3.25</ix:nonFraction>% per annum.</div>
</ix:continuation><ix:continuation id="Text_48a61b40805447b88eb0e001fea2a55910" continuedAt="Text_48a61b40805447b88eb0e001fea2a55911">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_48a61b40805447b88eb0e001fea2a55911" continuedAt="Text_48a61b40805447b88eb0e001fea2a55912">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">On September 30, 2020, the Company acquired a <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_566e201b0848416dbab04346a6a773dc" contextRef="c20200930_BusinessAcquisitionAxis_ManagementContractsMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">70</ix:nonFraction>% interest in an entity which holds <ix:nonFraction name="usph:NumberOfManagementContracts" id="Fact_9be31bb77df84eb79f46543135f43946" contextRef="c20200930to20200930_BusinessAcquisitionAxis_ManagementContractsMember" unitRef="U014" decimals="INF" scale="0" format="ixt-sec:numwordsen">six</ix:nonFraction>-management contracts that have been in place for a number of years. Currently, these contracts have a <ix:nonNumeric name="usph:RemainingContractTerm" id="Fact_686208299a8f46edb3f17203cbe99d71" contextRef="c20200101to20201231_BusinessAcquisitionAxis_ManagementContractsMember" format="ixt-sec:durwordsen">five year</ix:nonNumeric> term. The purchase price for the <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_65dfc2538f304229ba2bd09b497418e1" contextRef="c20200930_BusinessAcquisitionAxis_ManagementContractsMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">70</ix:nonFraction>% interest was approximately $<ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" id="Fact_72dd7e912e664a2eab2a5a192f0a2845" contextRef="c20200930to20200930_BusinessAcquisitionAxis_ManagementContractsMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">4.2</ix:nonFraction> million, with $<ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesGross" id="Fact_2207a399bcc543798b9719a7b2ae7d52" contextRef="c20200930to20200930_BusinessAcquisitionAxis_ManagementContractsMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">3.7</ix:nonFraction> million payable in cash and $<ix:nonFraction name="usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued" id="Fact_7453b569457545f5b831a8547015d119" contextRef="c20200930_BusinessAcquisitionAxis_ManagementContractsMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.5</ix:nonFraction> million in notes payable. One of the notes payable of $<ix:nonFraction name="usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued" id="Fact_6050a2913a4e46329f71b31b71e58215" contextRef="c20200930_BusinessAcquisitionAxis_ManagementContractsMember_ShortTermDebtTypeAxis_NotesPayableOneMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.2</ix:nonFraction> million is payable, with any accrued interest at <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" id="Fact_0dd2ef7911084e28a03a0f69464bf2cd" contextRef="c20200930_BusinessAcquisitionAxis_ManagementContractsMember_ShortTermDebtTypeAxis_NotesPayableOneMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">5</ix:nonFraction>% per annum, on September 30, 2021.&#160; The remaining note of $<ix:nonFraction name="usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued" id="Fact_0d6d705473a2414a9354438da247069d" contextRef="c20200930_BusinessAcquisitionAxis_ManagementContractsMember_ShortTermDebtTypeAxis_NotesPayableTwoMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction> million was paid in November 2020.</div>
</ix:continuation><ix:continuation id="Text_48a61b40805447b88eb0e001fea2a55912" continuedAt="Text_48a61b40805447b88eb0e001fea2a55913">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_48a61b40805447b88eb0e001fea2a55913" continuedAt="Text_48a61b40805447b88eb0e001fea2a55914">
<div style="display:none;"><br /></div>
<div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">On February 27, 2020, the Company acquired interests in a <ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_4284c5d2ef6f4ae1bc3917b13fbe5bc3" contextRef="c20200227to20200227_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U007" decimals="INF" scale="0" format="ixt-sec:numwordsen">four</ix:nonFraction>-clinic physical therapy practice. The <ix:nonFraction name="usph:NumberOfPartnershipInWhichInterestAcquired" id="Fact_f6e868a352ee470ab4dd704b10f8f69b" contextRef="c20200227to20200227_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U015" decimals="INF" scale="0" format="ixt-sec:numwordsen">four</ix:nonFraction> clinics are operated in <ix:nonFraction name="usph:NumberOfPartnershipInWhichInterestAcquired" id="Fact_637db30992a8494bbff1da37f33b69ec" contextRef="c20200227to20200227_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U015" decimals="INF" scale="0" format="ixt-sec:numwordsen">four</ix:nonFraction> separate partnerships.&#160; The Company&#8217;s interests in the <ix:nonFraction name="usph:NumberOfPartnershipInWhichInterestAcquired" id="Fact_1d265c000845400b95c3ba94f093ea54" contextRef="c20200227to20200227_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U015" decimals="INF" scale="0" format="ixt-sec:numwordsen">four</ix:nonFraction> partnerships range from <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_a1462a7f8dea45039c8e8deba602e150" contextRef="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MinimumMember" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">10.0</ix:nonFraction>% to <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_4bdb9a298d814169b8e8a59d19aaef7d" contextRef="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MaximumMember" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">83.8</ix:nonFraction>%, with an overall <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_9d1802cc99c547c79b57b176265d8de7" contextRef="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">65.0</ix:nonFraction>% based on the initial purchase transaction. The aggregate purchase price was $<ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" id="Fact_c78cab37b9434ad59fbea83717026db1" contextRef="c20200227to20200227_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">12.3</ix:nonFraction> million, of which $<ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesGross" id="Fact_d89abe25309a43a8871f8f619bc3b387" contextRef="c20200227to20200227_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">11.9</ix:nonFraction> million was paid in cash and $<ix:nonFraction name="usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued" id="Fact_e6bc523e6e834ed1ac9ddfc7fdc6669c" contextRef="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction> million in the form of a seller note.&#160; The note accrues interest at <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" id="Fact_3fab593f97614d5bacc404f565a80c44" contextRef="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember" unitRef="U005" decimals="4" scale="-2" format="ixt:numdotdecimal">4.75</ix:nonFraction>% per annum and the principal and interest is payable on February 2022.</div>
</ix:continuation><ix:continuation id="Text_48a61b40805447b88eb0e001fea2a55914" continuedAt="Text_48a61b40805447b88eb0e001fea2a55915">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_48a61b40805447b88eb0e001fea2a55915" continuedAt="Text_48a61b40805447b88eb0e001fea2a55916"><ix:nonNumeric name="us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" id="Text_49f8a361ae8444528e465d9c221ad2d2" contextRef="c20200101to20201231" escape="true" continuedAt="Text_24e8c691da7348a7b9db214a6ae07d411">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The purchase price for the 2020 physical therapy operations acquisitions has been preliminarily allocated as follows (in thousands):</div>
</ix:nonNumeric></ix:continuation><ix:continuation id="Text_48a61b40805447b88eb0e001fea2a55916" continuedAt="Text_48a61b40805447b88eb0e001fea2a55917"><ix:continuation id="Text_24e8c691da7348a7b9db214a6ae07d411" continuedAt="Text_24e8c691da7348a7b9db214a6ae07d412">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_48a61b40805447b88eb0e001fea2a55917" continuedAt="Text_48a61b40805447b88eb0e001fea2a55918"><ix:continuation id="Text_24e8c691da7348a7b9db214a6ae07d412" continuedAt="Text_24e8c691da7348a7b9db214a6ae07d413">
<table cellpadding="0" cellspacing="0" id="za1a0966005394e48a9d620aafba9caf2" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Cash paid, net of cash acquired ($<ix:nonFraction name="us-gaap:CashAcquiredFromAcquisition" id="Fact_8704f0e048314626b8e414348851e84b" contextRef="c20200101to20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">500</ix:nonFraction>)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" id="Fact_3488c1bfe9a049d4b4b784d52cdad4e8" contextRef="c20200101to20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">23,907</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 2px;"><div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Seller note</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued" id="Fact_7ee80fd8a32a47388762fc64bfa8db3c" contextRef="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,121</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total consideration</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PaymentsToAcquireBusinessesConsideration" id="Fact_a9c481a8edc547eb8653efaee3994407" contextRef="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">25,028</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 88%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Estimated fair value of net tangible assets acquired:</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 88%;"><div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total current assets</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" id="Fact_161ea83d639545b69fbbb15074e18d02" contextRef="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,271</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total non-current assets</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" id="Fact_308119415bef4bd28b0945a23579d370" contextRef="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">134</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 2px;"><div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total liabilities</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" id="Fact_69c0e622550f46acade32f0be0312131" contextRef="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">555</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -15.85pt; margin-left: 33.85pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Net tangible assets acquired</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" id="Fact_180cc378e7b742659e1c8be65f2d97ea" contextRef="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">850</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 88%;"><div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Referral relationships</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" id="Fact_4bfdfed0a8834966a7a96a1bac1d0fb8" contextRef="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">3,597</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Non-compete</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" id="Fact_c30390cef0ef4525a8b620fb28628f26" contextRef="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,012</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 88%;"><div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Tradename</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" id="Fact_4e07f7e8fa6b41a2badeb9fe98f3fd16" contextRef="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,326</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Goodwill</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" id="Fact_5b60ac81d10843fc9b70cdc503b0dfb1" contextRef="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">28,540</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 2px;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Fair value of non-controlling interest (classified as redeemable non-controlling interests)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" id="Fact_097e01a6b9474f4fa46e5ec70f58af1b" contextRef="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">11,297</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PaymentsToAcquireBusinessesConsideration" id="Fact_02bf68e439bc431db5076d92008d3123" contextRef="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">25,028</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
</table>
</ix:continuation></ix:continuation><ix:continuation id="Text_48a61b40805447b88eb0e001fea2a55918" continuedAt="Text_48a61b40805447b88eb0e001fea2a55919"><ix:continuation id="Text_24e8c691da7348a7b9db214a6ae07d413" continuedAt="Text_24e8c691da7348a7b9db214a6ae07d414">
<div><br /></div>
</ix:continuation></ix:continuation></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>60</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div><ix:continuation id="Text_48a61b40805447b88eb0e001fea2a55919" continuedAt="Text_48a61b40805447b88eb0e001fea2a55920"><ix:continuation id="Text_24e8c691da7348a7b9db214a6ae07d414" continuedAt="Text_24e8c691da7348a7b9db214a6ae07d415">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_48a61b40805447b88eb0e001fea2a55920" continuedAt="Text_48a61b40805447b88eb0e001fea2a55921">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">On September 30, 2019, the Company acquired a <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_ce9d9458ef4b40ee94e827b692cf6b2a" contextRef="c20190930_BusinessAcquisitionAxis_SeptemberTwoThousandNineteenAcquisitionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">67</ix:nonFraction>% interest in an <ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_65c9850dba784e418d944b3efd2d59a8" contextRef="c20190930to20190930_BusinessAcquisitionAxis_SeptemberTwoThousandNineteenAcquisitionMember" unitRef="U007" decimals="INF" scale="0" format="ixt-sec:numwordsen">eleven</ix:nonFraction>-clinic physical therapy practice. The purchase price for the <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_4c59dc06cb39436191d2f1cce4f785f2" contextRef="c20201231_BusinessAcquisitionAxis_SeptemberTwoThousandNineteenAcquisitionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">67</ix:nonFraction>% interest was $<ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" id="Fact_598b6cbd115b40cd8d7ad2670c8c19c8" contextRef="c20190930to20190930_BusinessAcquisitionAxis_SeptemberTwoThousandNineteenAcquisitionMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">12.4</ix:nonFraction> million ($<ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" id="Fact_38ab62f464d14d66922b1cf9bf1bbf1d" contextRef="c20190930to20190930_BusinessAcquisitionAxis_SeptemberTwoThousandNineteenAcquisitionMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">12.6</ix:nonFraction> million less cash acquired of $<ix:nonFraction name="us-gaap:CashAcquiredFromAcquisition" id="Fact_a98b83e1b4094fb7a53a69d7214df153" contextRef="c20190930to20190930_BusinessAcquisitionAxis_SeptemberTwoThousandNineteenAcquisitionMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.2</ix:nonFraction> million), of which $<ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesGross" id="Fact_13b13bc51d2b4ecf8f6a4980d09a4ed3" contextRef="c20190930to20190930_BusinessAcquisitionAxis_SeptemberTwoThousandNineteenAcquisitionMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">12.3</ix:nonFraction> million was paid in cash and $<ix:nonFraction name="usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued" id="Fact_d78a3d303b4c4294b24977f0dd681bbd" contextRef="c20190930_BusinessAcquisitionAxis_SeptemberTwoThousandNineteenAcquisitionMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction> million in a seller note payable in <ix:nonFraction name="usph:BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" id="Fact_5a0506ba2e0f4ff5b3689213c119ab0b" contextRef="c20190930to20190930_BusinessAcquisitionAxis_SeptemberTwoThousandNineteenAcquisitionMember" unitRef="U010" decimals="INF" scale="0" format="ixt-sec:numwordsen">two</ix:nonFraction> principal installments totaling $<ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesGross" id="Fact_7dd16eb3f00a4588af2a31d7f1aed6c3" contextRef="c20190930to20190930_BusinessAcquisitionAxis_SeptemberTwoThousandNineteenAcquisitionMember_StatementScenarioAxis_SeptemberTwoThousandTwentyMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">150,000</ix:nonFraction> each, plus accrued interest. A payment of $<ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesGross" id="Fact_47bf72b50618414a97c4713b2c265aec" contextRef="c20190930to20190930_BusinessAcquisitionAxis_SeptemberTwoThousandNineteenAcquisitionMember_StatementScenarioAxis_SeptemberTwoThousandTwentyOneMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">150,000</ix:nonFraction> plus accrued interest was paid in September 2020 and a second payment is due in September 2021. The note accrues interest at <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" id="Fact_6382adcd3c02474bae0c9126bb640bbb" contextRef="c20190930_BusinessAcquisitionAxis_SeptemberTwoThousandNineteenAcquisitionMember" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">5.0</ix:nonFraction>% per annum.</div>
</ix:continuation><ix:continuation id="Text_48a61b40805447b88eb0e001fea2a55921" continuedAt="Text_48a61b40805447b88eb0e001fea2a55922">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_48a61b40805447b88eb0e001fea2a55922" continuedAt="Text_48a61b40805447b88eb0e001fea2a55923">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">On April 11, 2019, the Company acquired a company that is a provider of industrial injury prevention services. The acquired company specializes in delivering injury prevention and care, post offer employment testing, functional capacity evaluations and return-to-work services. It performs these services across a network of <ix:nonFraction name="usph:NumberOfStatesOfNetworkServices" id="Fact_b7c0864afe2341d7ab3647cf3d2f0044" contextRef="c20190411to20190411_BusinessAcquisitionAxis_AprilTwoThousandNineteenAcquisitionMember" unitRef="U008" decimals="INF" scale="0" format="ixt:numdotdecimal">45</ix:nonFraction> states including onsite at <ix:nonFraction name="usph:NumberOfOnsiteClientLocations" id="Fact_4f770873933743e8821cdb9b330f5f81" contextRef="c20190411_BusinessAcquisitionAxis_AprilTwoThousandNineteenAcquisitionMember" unitRef="U006" decimals="INF" scale="0" format="ixt-sec:numwordsen">eleven</ix:nonFraction> client locations. The acquired business was then combined with Briotix Health, the Company&#8217;s industrial injury prevention operation, increasing the Company&#8217;s ownership position in the Briotix Health partnership to approximately <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_b29d5a235d3d4ee3abd9015ce1500fc9" contextRef="c20190411_BusinessAcquisitionAxis_AprilTwoThousandNineteenAcquisitionMember" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">76.0</ix:nonFraction>%. The purchase price for the acquired company was $<ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" id="Fact_da40d395126d49b29575bee2ec47ff4f" contextRef="c20190411to20190411_BusinessAcquisitionAxis_AprilTwoThousandNineteenAcquisitionMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">22.9</ix:nonFraction> million ($<ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" id="Fact_5c2071460fd34bf9897aae6b8246aeff" contextRef="c20190411to20190411_BusinessAcquisitionAxis_AprilTwoThousandNineteenAcquisitionMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">23.6</ix:nonFraction> million less cash acquired of $<ix:nonFraction name="us-gaap:CashAcquiredFromAcquisition" id="Fact_ec214afe139b4f9ab54ee742a30c76a3" contextRef="c20190411to20190411_BusinessAcquisitionAxis_AprilTwoThousandNineteenAcquisitionMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.7</ix:nonFraction> million), which consisted of $<ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesGross" id="Fact_c4761e8a09334f9fb6422683089ed4ae" contextRef="c20190411to20190411_BusinessAcquisitionAxis_AprilTwoThousandNineteenAcquisitionMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">18.9</ix:nonFraction> million in cash, (of which $<ix:nonFraction name="usph:BusinessAcquisitionPayableToShareholdersOfSeller" id="Fact_b88c3caad01d4c9f8339212d6929314d" contextRef="c20190411_BusinessAcquisitionAxis_AprilTwoThousandNineteenAcquisitionMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.5</ix:nonFraction> million will be paid to certain shareholders), and a $<ix:nonFraction name="usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued" id="Fact_8645919ffc0f4251a069bf7682728b2f" contextRef="c20190411_BusinessAcquisitionAxis_AprilTwoThousandNineteenAcquisitionMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">4.0</ix:nonFraction> million seller note. The note accrues interest at <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" id="Fact_f7495f017ef34730a32152fa21cee643" contextRef="c20190411_BusinessAcquisitionAxis_AprilTwoThousandNineteenAcquisitionMember" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">5.5</ix:nonFraction>% and the principal and accrued interest is payable, on April 9, 2021.</div>
</ix:continuation><ix:continuation id="Text_48a61b40805447b88eb0e001fea2a55923" continuedAt="Text_48a61b40805447b88eb0e001fea2a55924">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_48a61b40805447b88eb0e001fea2a55924" continuedAt="Text_48a61b40805447b88eb0e001fea2a55925">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The results of operations of the acquired clinics have been included in the Company&#8217;s consolidated financial statements since the date of their respective acquisition. The Company intends to continue to pursue additional acquisition opportunities, develop new clinics and open satellite clinics.</div>
</ix:continuation><ix:continuation id="Text_48a61b40805447b88eb0e001fea2a55925" continuedAt="Text_48a61b40805447b88eb0e001fea2a55926">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_48a61b40805447b88eb0e001fea2a55926" continuedAt="Text_48a61b40805447b88eb0e001fea2a55927"><ix:continuation id="Text_24e8c691da7348a7b9db214a6ae07d415" continuedAt="Text_24e8c691da7348a7b9db214a6ae07d416">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The purchase price for the 2019 acquisitions were allocated as follows (in thousands):</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_48a61b40805447b88eb0e001fea2a55927" continuedAt="Text_48a61b40805447b88eb0e001fea2a55928"><ix:continuation id="Text_24e8c691da7348a7b9db214a6ae07d416" continuedAt="Text_24e8c691da7348a7b9db214a6ae07d417">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_48a61b40805447b88eb0e001fea2a55928" continuedAt="Text_48a61b40805447b88eb0e001fea2a55929"><ix:continuation id="Text_24e8c691da7348a7b9db214a6ae07d417" continuedAt="Text_24e8c691da7348a7b9db214a6ae07d418">
<table cellpadding="0" cellspacing="0" id="z0200ec8ec07146f3bd1815fa975597c6" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"></div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">IIPS*</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> Physical Therapy Operations</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Total</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Cash paid, net of cash acquired ($<ix:nonFraction name="us-gaap:CashAcquiredFromAcquisition" id="Fact_7ebc4389c00540a9997a48ce11a451fd" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">890</ix:nonFraction>)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" id="Fact_a9bd169930b446c6aabd97b8503b9e92" contextRef="c20190411to20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">18,428</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" id="Fact_5caa5c1496224092953567fc37f46c5c" contextRef="c20190930to20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">12,170</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" id="Fact_3820623257be4d75958716daf5e6a83f" contextRef="c20190101to20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">30,598</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;"><div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Payable to shareholders of seller</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessAcquisitionPayableToShareholdersOfSeller" id="Fact_97c36c006efd4508940b439ef40e5fd4" contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">485</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessAcquisitionPayableToShareholdersOfSeller" id="Fact_887f58f0b6b14343a0c101e38ad063f5" contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessAcquisitionPayableToShareholdersOfSeller" id="Fact_5750ed2f7dd0447699bbdacd43dfe0a1" contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">485</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Seller note</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued" id="Fact_71db7b39649a460f8cbeab4608e180da" contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,000</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued" id="Fact_975faa083fb54489ab87d7031f5819bc" contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">300</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued" id="Fact_d7790b95065e483984fd48c5746c9485" contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,300</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px;"><div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total consideration</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PaymentsToAcquireBusinessesConsideration" id="Fact_69f109e55bc142d7adbb5f8d48c32af4" contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">22,913</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PaymentsToAcquireBusinessesConsideration" id="Fact_c82e0cdb0a47486d9eebc40bc01e7f53" contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">12,470</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PaymentsToAcquireBusinessesConsideration" id="Fact_caef6a914d5a427bade4c185cb3c7e10" contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">35,383</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;"><div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Estimated fair value of net tangible assets acquired:</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total current assets</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" id="Fact_eee67263780a49acaa0581ec533a3e2a" contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,641</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" id="Fact_621a82666ed642d9ba9757af756b55a8" contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">650</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" id="Fact_34d6552bbfed48e68b6ea25e4780c4fe" contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,291</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;"><div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total non-current assets</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" id="Fact_3b1220179ecd4076b3fbc66ee0581ec9" contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">848</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" id="Fact_e9734a1bf0d64ea589d20dbcac27b227" contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">394</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" id="Fact_d82c91f477494f59ae77862359e74789" contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,242</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total liabilities</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" id="Fact_8cff895473e241e59d08ae7680b476bc" contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">2,978</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" id="Fact_79d2a1744e4f432fae7bb19628341aca" contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">191</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" id="Fact_aafb5ad8a15a4be58dd750bce359549c" contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">3,169</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;"><div style="text-align: left; text-indent: -15.85pt; margin-left: 33.85pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Net tangible assets acquired</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" id="Fact_1c91e22e04a04be59bf9c144d53a2b33" contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">489</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" id="Fact_2cf7bb08fb2941d9a675563050f8d65b" contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">853</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" id="Fact_1935f97c2fb7488380293114c64da9bc" contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">364</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Referral relationships</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" id="Fact_f4ccac10433342e882be0539ab3cc980" contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">3,400</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" id="Fact_619f046a6fd44300bef3988cba09df5d" contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,600</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" id="Fact_a594f8c9d56c4369870c95ee343976bc" contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,000</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;"><div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Non-compete</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" id="Fact_cf8bc979288c40a7972a4f53552b1ec9" contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">250</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" id="Fact_2fbcfb6519264127bc3d9ecbf691956a" contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">270</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" id="Fact_644347ef1709479390f677ee9ad52093" contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">520</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Tradename</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" id="Fact_6d1cfd3236f143b99ad407ad2c842c35" contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,300</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" id="Fact_3a3cca8d04ea4135b82dd10e71ec5a2c" contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">740</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" id="Fact_9b6b4f5601fc4b88a2660d9bb08f2b7f" contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,040</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;"><div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Goodwill</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" id="Fact_69726b880894406db2f8a42ee390913d" contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">18,452</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" id="Fact_76b8e6ad46874e0fa7bdc985ad270524" contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">14,237</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" id="Fact_b54cb154402849b3ac75f20b20009ab3" contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">32,689</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Fair value of non-controlling interest (classified as redeemable non-controlling interests)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" id="Fact_4aa84586d91a445394a1e77ae4ad8e6a" contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" id="Fact_5528639f17314b21b3424b6aae8df023" contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,230</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" id="Fact_94a9d235bbfe4d16802371f21e5cfc4a" contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,230</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PaymentsToAcquireBusinessesConsideration" id="Fact_0146285d8d254416a7685fa0372d43c7" contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">22,913</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PaymentsToAcquireBusinessesConsideration" id="Fact_9d8ec51540754a98a640e58301dc6d10" contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">12,470</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PaymentsToAcquireBusinessesConsideration" id="Fact_014c586bbc124c9f8465e1b9177bcf03" contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">35,383</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
  </tr>
</table>
</ix:continuation></ix:continuation><ix:continuation id="Text_48a61b40805447b88eb0e001fea2a55929" continuedAt="Text_48a61b40805447b88eb0e001fea2a55930"><ix:continuation id="Text_24e8c691da7348a7b9db214a6ae07d418" continuedAt="Text_24e8c691da7348a7b9db214a6ae07d419">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_48a61b40805447b88eb0e001fea2a55930" continuedAt="Text_48a61b40805447b88eb0e001fea2a55931"><ix:continuation id="Text_24e8c691da7348a7b9db214a6ae07d419" continuedAt="Text_24e8c691da7348a7b9db214a6ae07d4110">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">* <ix:footnote id="Foot_09a4cffadb2444b88d15b3ec81bd76d1" footnoteRole="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US">Industrial injury prevention services</ix:footnote></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_48a61b40805447b88eb0e001fea2a55931" continuedAt="Text_48a61b40805447b88eb0e001fea2a55932"><ix:continuation id="Text_24e8c691da7348a7b9db214a6ae07d4110" continuedAt="Text_24e8c691da7348a7b9db214a6ae07d4111">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_48a61b40805447b88eb0e001fea2a55932" continuedAt="Text_48a61b40805447b88eb0e001fea2a55933">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">On August 31, 2018, the Company acquired a <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_937e3830bd704aa696d2f8d440f8f775" contextRef="c20180831_BusinessAcquisitionAxis_August2018AcquisitionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">70</ix:nonFraction>% interest in a <ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_586b04b8d4d3474489f54d609c7c4539" contextRef="c20180831to20180831_BusinessAcquisitionAxis_August2018AcquisitionMember" unitRef="U007" decimals="INF" scale="0" format="ixt-sec:numwordsen">four</ix:nonFraction>-clinic physical therapy practice. The purchase price for the <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_9e30a4eeb49a4d5ab0942a1a69bb2c7f" contextRef="c20180831_BusinessAcquisitionAxis_August2018AcquisitionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">70</ix:nonFraction>% interest was $<ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesGross" id="Fact_d700af96fcb745bebb4ebae8da88b659" contextRef="c20180831to20180831_BusinessAcquisitionAxis_August2018AcquisitionMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">7.3</ix:nonFraction> million in cash and $<ix:nonFraction name="usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued" id="Fact_7aaa1a13bb3c4b84a3a9b7a77ea297b5" contextRef="c20180831_BusinessAcquisitionAxis_August2018AcquisitionMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.4</ix:nonFraction> million in a seller note that was payable in <ix:nonFraction name="usph:BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" id="Fact_ad4a9d9d6d3844189d496246cde3ad91" contextRef="c20180831to20180831_BusinessAcquisitionAxis_August2018AcquisitionMember" unitRef="U010" decimals="INF" scale="0" format="ixt-sec:numwordsen">two</ix:nonFraction> principal installments totaling $<ix:nonFraction name="us-gaap:DebtInstrumentAnnualPrincipalPayment" id="Fact_3f5f1f5a01cd4559aab746b2ca08444e" contextRef="c20180831_BusinessAcquisitionAxis_August2018AcquisitionMember_StatementScenarioAxis_AugustTwoThousandNineteenMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:DebtInstrumentAnnualPrincipalPayment" id="Fact_3a43b50e52f84c6a9fd361e3761dc9f4" contextRef="c20180831_BusinessAcquisitionAxis_August2018AcquisitionMember_StatementScenarioAxis_AugustTwoThousandTwentyMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">200,000</ix:nonFraction></ix:nonFraction> each, plus accrued interest. The first installment was paid in cash in August 2019 and the second installment was paid in August 2020.</div>
</ix:continuation><ix:continuation id="Text_48a61b40805447b88eb0e001fea2a55933" continuedAt="Text_48a61b40805447b88eb0e001fea2a55934">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_48a61b40805447b88eb0e001fea2a55934" continuedAt="Text_48a61b40805447b88eb0e001fea2a55935">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">On April 30, 2018, the Company acquired a <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_747f09436dca419e94907ea697c31aa7" contextRef="c20180430_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">65</ix:nonFraction>% interest in another business in the industrial injury prevention sector. The aggregate purchase price for the <ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_f44994f73b1a4be1bde963730300b54a" contextRef="c20180430_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">65</ix:nonFraction>% interest was $<ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesGross" id="Fact_c89822b9024e4e4d8432377978e816f5" contextRef="c20180430to20180430_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">8.6</ix:nonFraction> million in cash and $<ix:nonFraction name="usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued" id="Fact_71fb14386fb440f8b03aabcceecd00cf" contextRef="c20180430_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">400,000</ix:nonFraction> in a seller note that was paid on April 30, 2019. On April 30, 2018, the Company combined its <ix:nonFraction name="usph:NumberOfBusinessesMerged" id="Fact_05dfc44e2d7c4b45a906498e5bc48b14" contextRef="c20180430to20180430_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U011" decimals="INF" scale="0" format="ixt-sec:numwordsen">two</ix:nonFraction> businesses. After the combination, the Company owned a <ix:nonFraction name="usph:PercentageOfCombinedBusinessInterestOwned" id="Fact_c7a8cf2d85f544c694aa688fc95cb935" contextRef="c20180430to20180430_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember" unitRef="U005" decimals="4" scale="-2" format="ixt:numdotdecimal">59.45</ix:nonFraction>% interest in the combined business, Briotix Health. See discussion above regarding an additional acquisition on April 11, 2019 in the industrial injury prevention business.</div>
</ix:continuation><ix:continuation id="Text_48a61b40805447b88eb0e001fea2a55935" continuedAt="Text_48a61b40805447b88eb0e001fea2a55936">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_48a61b40805447b88eb0e001fea2a55936" continuedAt="Text_48a61b40805447b88eb0e001fea2a55937">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In addition, during 2018, the Company, through several of its majority owned Clinic Partnerships, acquired <ix:nonFraction name="us-gaap:NumberOfBusinessesAcquired" id="Fact_3f32217e494847779b3c1d8453c3a06d" contextRef="c20180101to20181231_BusinessAcquisitionAxis_AcquisitionOfFiveClinicPracticesMember" unitRef="U007" decimals="INF" scale="0" format="ixt-sec:numwordsen">five</ix:nonFraction> separate clinic practices. These practices operate as satellites of the existing Clinic Partnership. The aggregate purchase price was $<ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesGross" id="Fact_b682b95ebdac4d5abfb31ed27f89ab0c" contextRef="c20180101to20181231_BusinessAcquisitionAxis_AcquisitionOfFiveClinicPracticesMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">1.0</ix:nonFraction> million inclusive of cash of $<ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" id="Fact_c0aeb2c5683b42adaa3b0bdc6a67aef5" contextRef="c20180101to20181231_BusinessAcquisitionAxis_AcquisitionOfFiveClinicPracticesMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">850,000</ix:nonFraction> and a note payable of $<ix:nonFraction name="usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued" id="Fact_108a3c6c32f24864a6031b3e0e18aefc" contextRef="c20181231_BusinessAcquisitionAxis_AcquisitionOfFiveClinicPracticesMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">150,000</ix:nonFraction>. The note accrued interest at <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" id="Fact_a48ecd5a8c024fdda960774e2b9928b4" contextRef="c20181231_BusinessAcquisitionAxis_AcquisitionOfFiveClinicPracticesMember_StatementScenarioAxis_AugustTwoThousandNineteenMember" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">4.5</ix:nonFraction>% and the principal and accrued interest, was paid in cash on August 31, 2019.</div>
</ix:continuation><ix:continuation id="Text_48a61b40805447b88eb0e001fea2a55937" continuedAt="Text_48a61b40805447b88eb0e001fea2a55938">
<div><br /></div>
</ix:continuation></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>61</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div><ix:continuation id="Text_48a61b40805447b88eb0e001fea2a55938" continuedAt="Text_48a61b40805447b88eb0e001fea2a55939"><ix:continuation id="Text_24e8c691da7348a7b9db214a6ae07d4111" continuedAt="Text_24e8c691da7348a7b9db214a6ae07d4112">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The purchase price for the 2018 acquisitions were allocated as follows (in thousands):</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_48a61b40805447b88eb0e001fea2a55939" continuedAt="Text_48a61b40805447b88eb0e001fea2a55940"><ix:continuation id="Text_24e8c691da7348a7b9db214a6ae07d4112" continuedAt="Text_24e8c691da7348a7b9db214a6ae07d4113">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_48a61b40805447b88eb0e001fea2a55940" continuedAt="Text_48a61b40805447b88eb0e001fea2a55941"><ix:continuation id="Text_24e8c691da7348a7b9db214a6ae07d4113">
<table cellpadding="0" cellspacing="0" id="z4cea7993c4404e908d071694d5887404" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Cash paid, net of cash acquired ($<ix:nonFraction name="us-gaap:CashAcquiredFromAcquisition" id="Fact_a3e51969ca0f4e00ae14106e81e6d1c4" contextRef="c20180430to20180430" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">372</ix:nonFraction>)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" id="Fact_a7eae685111448d385f635bff4c72a92" contextRef="c20180430to20180430" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">16,367</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 2px;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Seller note</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued" id="Fact_f1f3884cc4ab4d5b851733be8f204f28" contextRef="c20180430" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">950</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total consideration</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PaymentsToAcquireBusinessesConsideration" id="Fact_5e456a02d1664d2d881c3d17b5461f15" contextRef="c20180430" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">17,317</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 88%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Estimated fair value of net tangible assets acquired:</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 88%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total current assets</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" id="Fact_94d47e04479f4382bee778eefa658517" contextRef="c20180430" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,633</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total non-current assets</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" id="Fact_52f0fd903b3747e2a8beaeb40614dbf8" contextRef="c20180430" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">305</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 2px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total liabilities</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" id="Fact_2a3cf53d95e942fb88945c19980eebef" contextRef="c20180430" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">525</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Net tangible assets acquired</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" id="Fact_2575a5505ca745ce8e8ccaaede4f84bb" contextRef="c20180430" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,413</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 88%;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Referral relationships</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" id="Fact_5ccfac19cb4a452bb0830ec063da4a2d" contextRef="c20180430" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,926</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Non-compete</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" id="Fact_f276473a887d4495bac2a5c4f4f7b483" contextRef="c20180430" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">298</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 88%;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Tradename</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" id="Fact_9a3c7be172ed488b97aea96ebdf90652" contextRef="c20180430" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">990</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Goodwill</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" id="Fact_f823fd9ea9e34c9aa5488b9d66f69fd5" contextRef="c20180430" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">19,835</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 2px;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Fair value of non-controlling interest (classified as redeemable non-controlling interests)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" id="Fact_642bed6482a648aca23c9beae41e9433" contextRef="c20180430" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">8,145</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PaymentsToAcquireBusinessesConsideration" id="Fact_9f9a36d8d34c4eedaf9299b5173eef27" contextRef="c20180430" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">17,317</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
</table>
</ix:continuation></ix:continuation><ix:continuation id="Text_48a61b40805447b88eb0e001fea2a55941" continuedAt="Text_48a61b40805447b88eb0e001fea2a55942">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><br /></div>
</ix:continuation><ix:continuation id="Text_48a61b40805447b88eb0e001fea2a55942" continuedAt="Text_48a61b40805447b88eb0e001fea2a55943">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The finalized purchase prices plus the fair value of the non-controlling interests for the acquisitions in 2019 and 2018 were allocated to the fair value of the assets acquired, inclusive of identifiable intangible assets, i.e. trade names, referral relationships and non-compete agreements, and liabilities assumed based on the fair values at the acquisition date, with the amount exceeding the fair values being recorded as goodwill. For the acquisitions in 2020, the Company is in the process of completing its formal valuation analysis to identify and determine the fair value of tangible and identifiable intangible assets acquired and the liabilities assumed. Thus, the final allocation of the purchase price may differ from the preliminary estimates used at December 31, 2020 based on additional information obtained and completion of the valuation of the identifiable intangible assets. Changes in the estimated valuation of the tangible assets acquired, the completion of the valuation of identifiable intangible assets and the completion by the Company of the identification of any unrecorded pre-acquisition contingencies, where the liability is probable and the amount can be reasonably estimated, will likely result in adjustments to goodwill. The Company does not expect the adjustments to be material.</div>
</ix:continuation><ix:continuation id="Text_48a61b40805447b88eb0e001fea2a55943" continuedAt="Text_48a61b40805447b88eb0e001fea2a55944">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_48a61b40805447b88eb0e001fea2a55944" continuedAt="Text_48a61b40805447b88eb0e001fea2a55945">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">For the acquisitions in 2020, the values assigned to the referral relationships and non-compete agreements are being amortized to expense equally over the respective estimated lives. For referral relationships, the amortization period is <ix:nonNumeric name="usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" id="Fact_77705a39aaf74c1cab4032e9a344912d" contextRef="c20200101to20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember" format="ixt-sec:duryear">11.0</ix:nonNumeric> years. For non-compete agreements, the amortization period is <ix:nonNumeric name="usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" id="Fact_3e5827b618f44c66985365b15a91851a" contextRef="c20200101to20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" format="ixt-sec:duryear">6.0</ix:nonNumeric> years. The values assigned to tradenames are tested annually for impairment.</div>
</ix:continuation><ix:continuation id="Text_48a61b40805447b88eb0e001fea2a55945" continuedAt="Text_48a61b40805447b88eb0e001fea2a55946">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_48a61b40805447b88eb0e001fea2a55946" continuedAt="Text_48a61b40805447b88eb0e001fea2a55947">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">For the acquisitions in 2019 and 2018, the values assigned to the referral relationships and non-compete agreements are being amortized to expense equally over the respective estimated lives. For referral relationships, the weighted average amortization period was <ix:nonNumeric name="usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" id="Fact_2c53ee24d1ea4569a1e916e32d301dc9" contextRef="c20190101to20191231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember" format="ixt-sec:duryear">10.54</ix:nonNumeric> and <ix:nonNumeric name="usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" id="Fact_56ec0823df464715850fe5f33d0dd915" contextRef="c20180101to20181231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember" format="ixt-sec:duryear">10.10</ix:nonNumeric> years at December 31, 2019 and December 31, 2018, respectively. For non-compete agreements, the weighted average amortization period was <ix:nonNumeric name="usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" id="Fact_044942dc07ba4597866c3f362288c218" contextRef="c20190101to20191231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" format="ixt-sec:duryear">6.00</ix:nonNumeric> and <ix:nonNumeric name="usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" id="Fact_3036c0cb73b84dbc894058b4e16a0b9a" contextRef="c20180101to20181231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" format="ixt-sec:duryear">5.16</ix:nonNumeric> years at December 31, 2019 and December 31, 2018, respectively. Generally, the values assigned to tradenames are tested annually for impairment.</div>
</ix:continuation><ix:continuation id="Text_48a61b40805447b88eb0e001fea2a55947" continuedAt="Text_48a61b40805447b88eb0e001fea2a55948">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_48a61b40805447b88eb0e001fea2a55948" continuedAt="Text_48a61b40805447b88eb0e001fea2a55949">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">For the 2020, 2019 and 2018 acquisitions, total current assets primarily represent patient accounts receivable. Total non-current assets are fixed assets, primarily equipment, used in the practices.</div>
</ix:continuation><ix:continuation id="Text_48a61b40805447b88eb0e001fea2a55949" continuedAt="Text_48a61b40805447b88eb0e001fea2a55950">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_48a61b40805447b88eb0e001fea2a55950">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The consideration paid for each of the acquisitions was derived through arm&#8217;s length negotiations. Funding for the cash portions was derived from proceeds from the Company&#8217;s revolving credit facility. The results of operations of the acquisitions have been included in the Company&#8217;s consolidated financial statements since their respective date of acquisition. Unaudited proforma consolidated financial information for the acquisitions in 2020, 2019 and 2018 acquisitions have not been included as the results, individually and in the aggregate. </div>
</ix:continuation></div>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>62</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div><br /></div>
<div><br /></div>
<div><ix:nonNumeric name="us-gaap:MinorityInterestDisclosureTextBlock" id="Text_a8d7415ad90d4efab2fc857372c8e3a1" contextRef="c20200101to20201231" escape="true" continuedAt="Text_f1a4f646bd27400e8bae0f1face5f20a1">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">4. Acquisitions and Sale of Non-Controlling Interests</div>
</ix:nonNumeric><ix:continuation id="Text_f1a4f646bd27400e8bae0f1face5f20a1" continuedAt="Text_f1a4f646bd27400e8bae0f1face5f20a2">
<div style="text-align: left;"><br /></div>
</ix:continuation><ix:continuation id="Text_f1a4f646bd27400e8bae0f1face5f20a2" continuedAt="Text_f1a4f646bd27400e8bae0f1face5f20a3">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">During </span>2020,<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> the Company acquired additional interests in </span><ix:nonFraction name="usph:NumberOfPartnershipInWhichInterestAcquired" id="Fact_571d5cafe15b4c03b079e7ae1be3fcb7" contextRef="c20200101to20201231" unitRef="U015" decimals="INF" scale="0" format="ixt-sec:numwordsen">five</ix:nonFraction><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> partnerships which are included in non-controlling interest. The additional interests purchased in each of the partnerships ranged from </span><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_48968455fbfd49629e368b7d4e1ae124" contextRef="c20201231_RangeAxis_MinimumMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">20</ix:nonFraction>%<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> to </span><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_c3b0a872b94148d3bba14f5b3a5ca013" contextRef="c20201231_RangeAxis_MaximumMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">35</ix:nonFraction>%<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">. The aggregated purchase price for these acquired interests was </span>$<ix:nonFraction name="us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent" id="Fact_e3986f0991eb44859032260278303231" contextRef="c20200101to20201231" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction> million<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">. The Company sold an interest in a partnership for </span>$<ix:nonFraction name="us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent" id="Fact_c22190a53f9446fea163fb2427e73fd8" contextRef="c20200101to20201231" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction> million<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">.</span></div>
</ix:continuation><ix:continuation id="Text_f1a4f646bd27400e8bae0f1face5f20a3" continuedAt="Text_f1a4f646bd27400e8bae0f1face5f20a4">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_f1a4f646bd27400e8bae0f1face5f20a4" continuedAt="Text_f1a4f646bd27400e8bae0f1face5f20a5">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">Also during </span>2020,<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> the Company sold </span><ix:nonFraction name="usph:NumberOfClosedClinicsSold" id="Fact_66733f1d8a044d4a979397dcb1a572f4" contextRef="c20201231" unitRef="U007" decimals="0" scale="0" format="ixt:numdotdecimal">14</ix:nonFraction><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> previously closed clinics. The aggregate sales price was </span>$<ix:nonFraction name="usph:AggregateSalePriceOfCinics" id="Fact_786d6dc2d40a4dc88a93fb49990648fa" contextRef="c20200101to20201231" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">1.1</ix:nonFraction> million<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">, of which </span>$<ix:nonFraction name="usph:CashReceivedRelatedToSaleOfClinics" id="Fact_1af9b1b3c9a443b6891fc2bcb77a1ece" contextRef="c20201231" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.7</ix:nonFraction> million<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> was paid in cash and </span>$<ix:nonFraction name="usph:NoteReceivableRelatedToSaleOfClinics" id="Fact_3354ba4cc819469e887c033c2fd87d22" contextRef="c20201231" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.4</ix:nonFraction> million<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> in a note receivable, payable in </span><ix:nonFraction name="usph:NumberOfInstallmentsForNoteReceivableInSaleConsideration" id="Fact_523e9531873947e9bc0f16bedeb1d0df" contextRef="c20200101to20201231" unitRef="U010" decimals="INF" scale="0" format="ixt-sec:numwordsen">two</ix:nonFraction><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> equal installments of principal and any accrued interest on June </span>15,<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">&#160;</span>2021<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> and </span>2022.</div>
</ix:continuation><ix:continuation id="Text_f1a4f646bd27400e8bae0f1face5f20a5" continuedAt="Text_f1a4f646bd27400e8bae0f1face5f20a6">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_f1a4f646bd27400e8bae0f1face5f20a6">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">During </span>2019,<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> the Company acquired additional interests in </span><ix:nonFraction name="usph:NumberOfPartnershipInWhichInterestAcquired" id="Fact_50d04884e4be468ba53c29674657e892" contextRef="c20190101to20191231" unitRef="U015" decimals="INF" scale="0" format="ixt-sec:numwordsen">four</ix:nonFraction><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> partnerships which are included in non-controlling interest. The additional interests purchased in each of the partnerships ranged from </span><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_bb66f6e8eaee4ac29bc0fd717646a0f1" contextRef="c20191231_RangeAxis_MinimumMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">1</ix:nonFraction>%<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> to </span><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" id="Fact_098c95bd7e65435ab46da9739f2a8bda" contextRef="c20191231_RangeAxis_MaximumMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">20</ix:nonFraction>%<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">. Also in </span>2019,<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> the Company sold a </span><ix:nonFraction name="usph:SaleOfNoncontrollingInterestPercentageInPartnershipOne" id="Fact_2f7defd77c614d86895a0d756511464e" contextRef="c20190101to20191231" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">1</ix:nonFraction>%<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> interest in a partnership. The net after-tax difference between the payments and the portion of undistributed earnings of </span>$<ix:nonFraction name="usph:TaxEffectOnSaleOfNoncontrollingInterest" id="Fact_8e2445e29d264dff836c129be1e78bca" contextRef="c20190101to20191231" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">196,000</ix:nonFraction><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> was credited to additional paid-in capital. </span></div>
</ix:continuation></div>
<div><br /></div>
<div><ix:nonNumeric name="usph:RedeemableNonControllingInterestTextBlock" id="Text_916056b9f1d7413ebf65c0b9453fee7f" contextRef="c20200101to20201231" escape="true" continuedAt="Text_4af94549396245cda69072b43ac3c14d1">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">5. Redeemable Non-Controlling Interest</div>
</ix:nonNumeric><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d1" continuedAt="Text_4af94549396245cda69072b43ac3c14d2">
<div style="text-align: left;"><br /></div>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d2" continuedAt="Text_4af94549396245cda69072b43ac3c14d3">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Since October 2017, when the Company acquires a majority interest (the &#8220;Acquisition&#8221;) in a physical therapy clinic business (referred to as &#8220;Therapy Practice&#8221;), these Acquisitions occur in a series of steps which are described below.</div>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d3" continuedAt="Text_4af94549396245cda69072b43ac3c14d4">
<div style="text-align: left;"><br /></div>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d4" continuedAt="Text_4af94549396245cda69072b43ac3c14d5">
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="zc7bdc62a54e54a708109fb2fb4f94a6d">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1.</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Prior to the Acquisition, the Therapy Practice exists as a separate legal entity (the &#8220;Seller Entity&#8221;). The Seller Entity is owned by one or more individuals (the &#8220;Selling Shareholders&#8221;) most of whom are physical therapists that work in the Therapy Practice and provide physical therapy services to patients.</div></td>
  </tr>
</table>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d5" continuedAt="Text_4af94549396245cda69072b43ac3c14d6">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d6" continuedAt="Text_4af94549396245cda69072b43ac3c14d7">
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z99217b321d1b4616ac247e23558b81cb">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2.</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In conjunction with the Acquisition, the Seller Entity contributes the Therapy Practice into a newly-formed limited partnership (&#8220;NewCo&#8221;), in exchange for one hundred percent (<ix:nonFraction name="usph:BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" id="Fact_1a1318dd20ca489cb43d8aaca68dae86" contextRef="c20201231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">100</ix:nonFraction>%) of the limited and general partnership interests in NewCo. Therefore, in this step, NewCo becomes a wholly-owned subsidiary of the Seller Entity.</div></td>
  </tr>
</table>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d7" continuedAt="Text_4af94549396245cda69072b43ac3c14d8">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d8" continuedAt="Text_4af94549396245cda69072b43ac3c14d9">
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z0671445f15e345a8bbe848867376c4df">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">3.</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company enters into an agreement (the &#8220;Purchase Agreement&#8221;) to acquire from the Seller Entity a majority (ranges from <ix:nonFraction name="usph:BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" id="Fact_da752b6ddd8142a8bfc6819396778f7e" contextRef="c20201231_BusinessAcquisitionAxis_TherapyPracticeMember_RangeAxis_MinimumMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">50</ix:nonFraction>% to <ix:nonFraction name="usph:BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" id="Fact_22dfd480522e4db9b95208fe2e9660bf" contextRef="c20201231_BusinessAcquisitionAxis_TherapyPracticeMember_RangeAxis_MaximumMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">90</ix:nonFraction>%) of the limited partnership interest and in <span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="text-decoration: underline;">all</span></span> cases <ix:nonFraction name="usph:BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" id="Fact_420cd14c37a94b7e921233be19bd4bb7" contextRef="c20201231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">100</ix:nonFraction>% of the general partnership interest in NewCo. The Company does not purchase 100% of the limited partnership interest because the Selling Shareholders, through the Seller Entity, want to maintain an ownership percentage. The consideration for the Acquisition is primarily payable in the form of cash at closing and a small <ix:nonNumeric name="usph:NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" id="Fact_34e3f17457974e71897a30be5c9e03d3" contextRef="c20200101to20201231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember" format="ixt-sec:durwordsen">two-year</ix:nonNumeric> note in lieu of an escrow (the &#8220;Purchase Price&#8221;). The Purchase Agreement does not contain any future earn-out or other contingent consideration that is payable to the Seller Entity or the Selling Shareholders.</div></td>
  </tr>
</table>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d9" continuedAt="Text_4af94549396245cda69072b43ac3c14d10">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d10" continuedAt="Text_4af94549396245cda69072b43ac3c14d11">
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="ze02633183fb54390b58ff1885d4e4783">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">4.</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company and the Seller Entity also execute a partnership agreement (the &#8220;Partnership Agreement&#8221;) for NewCo that sets forth the rights and obligations of the limited and general partners of NewCo. After the Acquisition, the Company is the general partner of NewCo.</div></td>
  </tr>
</table>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d11" continuedAt="Text_4af94549396245cda69072b43ac3c14d12">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d12" continuedAt="Text_4af94549396245cda69072b43ac3c14d13">
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z7a526d32e09d4dddad04019070607f9f">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">5.</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">As noted above, the Company does not purchase 100% of the limited partnership interests in NewCo and the Seller Entity retains a portion of the limited partnership interest in NewCo (&#8220;Seller Entity Interest&#8221;).</div></td>
  </tr>
</table>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d13" continuedAt="Text_4af94549396245cda69072b43ac3c14d14">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d14" continuedAt="Text_4af94549396245cda69072b43ac3c14d15">
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="zb058bf3e3d2847d5aedd1d3b688d4498">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">6.</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In most cases, some or all of the Selling Shareholders enter into an employment agreement (the &#8220;Employment Agreement&#8221;) with NewCo with an initial term that ranges from <span style="-sec-ix-hidden:Fact_52fb956c20c94f01b9b7ffcd0435f795">three</span> to <ix:nonNumeric name="usph:TermOfEmploymentAgreement" id="Fact_c3d56d245a9a49149bccd66c95e0160b" contextRef="c20200101to20201231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember_RangeAxis_MaximumMember" format="ixt-sec:durwordsen">five years</ix:nonNumeric> (the &#8220;Employment Term&#8221;), with automatic <ix:nonNumeric name="usph:EmploymentAgreementRenewalTerm" id="Fact_e8ec4f79f6c34537889001efa0a159c1" contextRef="c20200101to20201231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember" format="ixt-sec:durwordsen">one-year</ix:nonNumeric> renewals, unless employment is terminated prior to the end of the Employment Term. As a result, a Selling Shareholder becomes an employee (&#8220;Employed Selling Shareholder&#8221;) of NewCo. The employment of an Employed Selling Shareholder can be terminated by the Employed Selling Shareholder or NewCo, with or without cause, at any time. In a few situations, a Selling Shareholder does not become employed by NewCo and is not involved with NewCo following the closing; in those situations, such Selling Shareholders sell their entire ownership interest in the Seller Entity as of the closing of the Acquisition.</div></td>
  </tr>
</table>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d15" continuedAt="Text_4af94549396245cda69072b43ac3c14d16">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d16" continuedAt="Text_4af94549396245cda69072b43ac3c14d17">
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="zb9ec36386a1e4b0085e09d415fa38596">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">7.</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The compensation of each Employed Selling Shareholder is specified in the Employment Agreement and is customary and commensurate with his or her responsibilities based on other employees in similar capacities within NewCo, the Company and the industry.</div></td>
  </tr>
</table>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d17" continuedAt="Text_4af94549396245cda69072b43ac3c14d18">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d18" continuedAt="Text_4af94549396245cda69072b43ac3c14d19">
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z6c026b3d9d774cd0bca196d3492506cd">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">8.</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company and the Selling Shareholder (including both Employed Selling Shareholders and Selling Shareholders not employed by NewCo) execute a non-compete agreement (the &#8220;Non-Compete Agreement&#8221;) which restricts the Selling Shareholder from engaging in competing business activities for a specified period of time (the &#8220;Non-Compete Term&#8221;). A Non-Compete Agreement is executed with the Selling Shareholders in all cases. That is, even if the Selling Shareholder does not become an Employed Selling Shareholder, the Selling Shareholder is restricted from engaging in a competing business during the Non-Compete Term.</div></td>
  </tr>
</table>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d19" continuedAt="Text_4af94549396245cda69072b43ac3c14d20">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d20" continuedAt="Text_4af94549396245cda69072b43ac3c14d21">
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z1de0bf8dd2dc459597d038135831c4d3">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">9.</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Non-Compete Term commences as of the date of the Acquisition and expires on the <span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="text-decoration: underline;">later</span></span> of:</div></td>
  </tr>
</table>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d21" continuedAt="Text_4af94549396245cda69072b43ac3c14d22">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d22" continuedAt="Text_4af94549396245cda69072b43ac3c14d23">
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="zda65c3f5f9174cc199fe8dd67bd83ca9">
  <tr>
    <td style="width: 36pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">a.</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="usph:BusinessAcquisitionConsiderationPayableTermOfNote" id="Fact_a68d9aeb6bae459185d01b8cffffabfc" contextRef="c20200101to20201231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember" format="ixt-sec:durwordsen">Two years</ix:nonNumeric> after the date an Employed Selling Shareholders&#8217; employment is terminated (if the Selling Shareholder becomes an Employed Selling Shareholder) or</div></td>
  </tr>
</table>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d23" continuedAt="Text_4af94549396245cda69072b43ac3c14d24">
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="zfb76a3e74897489fa93180854bcb8faa">
  <tr>
    <td style="width: 36pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">b.</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><span style="-sec-ix-hidden:Fact_c128a6eff4b84ab0bfde32533264356c">Five</span> to <ix:nonNumeric name="usph:NonCompeteAgreementBasicTerm" id="Fact_0b29e1aaafe4464896629e8ad8086da5" contextRef="c20200101to20201231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember_RangeAxis_MaximumMember" format="ixt-sec:durwordsen">six years</ix:nonNumeric> from the date of the Acquisition, as defined in the Non-Compete Agreement, regardless of whether the Selling Shareholder is employed by NewCo.</div></td>
  </tr>
</table>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d24" continuedAt="Text_4af94549396245cda69072b43ac3c14d25">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d25" continuedAt="Text_4af94549396245cda69072b43ac3c14d26">
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="zbc85b6963e4d434897715db0819242a0">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">10.</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Non-Compete Agreement applies to a restricted region which is defined as a 15-mile radius from the Therapy Practice. That is, an Employed Selling Shareholder is permitted to engage in competing businesses or activities outside the 15-mile radius (after such Employed Selling Shareholder no longer is employed by NewCo) and a Selling Shareholder who is not employed by NewCo immediately is permitted to engage in the competing business or activities outside the 15-mile radius.</div></td>
  </tr>
</table>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d26" continuedAt="Text_4af94549396245cda69072b43ac3c14d27">
<div><br /></div>
</ix:continuation></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>63</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d27" continuedAt="Text_4af94549396245cda69072b43ac3c14d28">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d28" continuedAt="Text_4af94549396245cda69072b43ac3c14d29">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 18pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Partnership Agreement contains provisions for the redemption of the Seller Entity Interest, either at the option of the Company (the &#8220;Call Right&#8221;) or at the option of the Seller Entity (the &#8220;Put Right&#8221;) as follows:</div>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d29" continuedAt="Text_4af94549396245cda69072b43ac3c14d30">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d30" continuedAt="Text_4af94549396245cda69072b43ac3c14d31">
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="zd97299e0990f4b66ad809445b4244966">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1.</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Put Right</div></td>
  </tr>
</table>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d31" continuedAt="Text_4af94549396245cda69072b43ac3c14d32">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d32" continuedAt="Text_4af94549396245cda69072b43ac3c14d33">
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z67d0c7c361bf43cc85f4d8b2b3482dd4">
  <tr>
    <td style="width: 36pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">a.</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In the event that any Selling Shareholder&#8217;s employment is terminated under certain circumstances prior to the fifth anniversary of the Closing Date, the Seller Entity thereafter may have an irrevocable right to cause the Company to purchase from Seller Entity the Terminated Selling Shareholder&#8217;s Allocable Percentage of Seller Entity&#8217;s Interest at the purchase price described in &#8220;3&#8221; below.</div></td>
  </tr>
</table>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d33" continuedAt="Text_4af94549396245cda69072b43ac3c14d34">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d34" continuedAt="Text_4af94549396245cda69072b43ac3c14d35">
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z81aac4917b12463886deee6aa25f1d93">
  <tr>
    <td style="width: 36pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">b.</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In the event that any Selling Shareholder is not employed by NewCo as of the fifth anniversary of the Closing Date and the Company has not exercised its Call Right with respect to the Terminated Selling Shareholder&#8217;s Allocable Percentage of Seller Entity&#8217;s Interest, Seller Entity thereafter shall have the Put Right to cause the Company to purchase from Seller Entity the Terminated Selling Shareholder&#8217;s Allocable Percentage of Seller Entity&#8217;s Interest at the purchase price described in &#8220;3&#8221; below.</div></td>
  </tr>
</table>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d35" continuedAt="Text_4af94549396245cda69072b43ac3c14d36">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d36" continuedAt="Text_4af94549396245cda69072b43ac3c14d37">
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z7901e88d85124eb88f96525cee10b616">
  <tr>
    <td style="width: 36pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">c.</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In the event that any Selling Shareholder&#8217;s employment with NewCo is terminated for any reason on or after the fifth anniversary of the Closing Date, the Seller Entity shall have the Put Right, and upon the exercise of the Put Right, the Terminated Selling Shareholder&#8217;s Allocable Percentage of Seller Entity&#8217;s Interest shall be redeemed by the Company at the purchase price described in &#8220;3&#8221; below.</div></td>
  </tr>
</table>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d37" continuedAt="Text_4af94549396245cda69072b43ac3c14d38">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d38" continuedAt="Text_4af94549396245cda69072b43ac3c14d39">
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="ze305be984ed843dda348b7fbea98691b">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2.</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Call Right</div></td>
  </tr>
</table>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d39" continuedAt="Text_4af94549396245cda69072b43ac3c14d40">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d40" continuedAt="Text_4af94549396245cda69072b43ac3c14d41">
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z0a51ba759e7e4ab7af84d58fff32e8c2">
  <tr>
    <td style="width: 36pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">a.</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">If any Selling Shareholder&#8217;s employment by NewCo is terminated prior to the fifth anniversary of the Closing Date, the Company thereafter shall have an irrevocable right to purchase from Seller Entity the Terminated Selling Shareholder&#8217;s Allocable Percentage of Seller Entity&#8217;s Interest, in each case at the purchase price described in &#8220;3&#8221; below.</div></td>
  </tr>
</table>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d41" continuedAt="Text_4af94549396245cda69072b43ac3c14d42">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d42" continuedAt="Text_4af94549396245cda69072b43ac3c14d43">
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z05b9ea60733547efbda8408402826246">
  <tr>
    <td style="width: 36pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">b.</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In the event that any Selling Shareholder&#8217;s employment with NewCo is terminated for any reason on or after the fifth anniversary of the Closing Date, the Company shall have the Call Right, and upon the exercise of the Call Right, the Terminated Selling Shareholder&#8217;s Allocable Percentage of Seller Entity&#8217;s Interest shall be redeemed by the Company at the purchase price described in &#8220;3&#8221; below.</div></td>
  </tr>
</table>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d43" continuedAt="Text_4af94549396245cda69072b43ac3c14d44">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d44" continuedAt="Text_4af94549396245cda69072b43ac3c14d45">
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="zd051b3679ba0404d967210cec70f1639">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 22.5pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">3.</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">For the Put Right and the Call Right, the purchase price is derived from a formula based on a specified multiple of NewCo&#8217;s trailing twelve months of earnings before interest, taxes, depreciation, amortization, and the Company&#8217;s internal management fee, plus an Allocable Percentage of any undistributed earnings of NewCo (the &#8220;Redemption Amount&#8221;). NewCo&#8217;s earnings are distributed monthly based on available cash within NewCo&#894; therefore, the undistributed earnings amount is small, if any.</div></td>
  </tr>
</table>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d45" continuedAt="Text_4af94549396245cda69072b43ac3c14d46">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d46" continuedAt="Text_4af94549396245cda69072b43ac3c14d47">
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="zbff5a3f2289d41cf8510cf450726b116">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 22.5pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">4.</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Purchase Price for the initial equity interest purchased by the Company is also based on the same specified multiple of the trailing twelve-month earnings that is used in the Put Right and the Call Right noted above.</div></td>
  </tr>
</table>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d47" continuedAt="Text_4af94549396245cda69072b43ac3c14d48">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d48" continuedAt="Text_4af94549396245cda69072b43ac3c14d49">
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z1528515d22304d02bf65e5b330c9ce23">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 22.5pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">5.</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Put Right and the Call Right do not have an expiration date, but the Seller Entity Interest is not required to be purchased by the Company or sold by the Seller Entity.</div></td>
  </tr>
</table>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d49" continuedAt="Text_4af94549396245cda69072b43ac3c14d50">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d50" continuedAt="Text_4af94549396245cda69072b43ac3c14d51">
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z470f34023b2c4a63b1cd76aa3f152c47">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 22.5pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">6.</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Put Right and the Call Right never apply to Selling Shareholders who do not become employed by NewCo, since the Company requires that such Selling Shareholders sell their entire ownership interest in the Seller Entity at the closing of the Acquisition.</div></td>
  </tr>
</table>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d51" continuedAt="Text_4af94549396245cda69072b43ac3c14d52">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d52" continuedAt="Text_4af94549396245cda69072b43ac3c14d53">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">An Employed Selling Shareholder&#8217;s ownership of his or her equity interest in the Seller Entity predates the Acquisition and the Company&#8217;s purchase of its partnership interest in NewCo. The Employment Agreement and the Non-Compete Agreement do not contain any provision to escrow or &#8220;claw back&#8221; the equity interest in the Seller Entity held by such Employed Selling Shareholder, nor the Seller Entity Interest in NewCo, in the event of a breach of the employment or non-compete terms. More specifically, even if the Employed Selling Shareholder is terminated for &#8220;cause&#8221; by NewCo, such Employed Selling Shareholder does not forfeit his or her right to his or her full equity interest in the Seller Entity and the Seller Entity does not forfeit its right to any portion of the Seller Entity Interest. The Company&#8217;s only recourse against the Employed Selling Shareholder for breach of either the Employment Agreement or the Non-Compete Agreement is to seek damages and other legal remedies under such agreements. There are no conditions in any of the arrangements with an Employed Selling Shareholder that would result in a forfeiture of the equity interest held in the Seller Entity or of the Seller Entity Interest.</div>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d53" continuedAt="Text_4af94549396245cda69072b43ac3c14d54">
<div><br /></div>
</ix:continuation></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>64</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d54" continuedAt="Text_4af94549396245cda69072b43ac3c14d55">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d55" continuedAt="Text_4af94549396245cda69072b43ac3c14d56"><ix:nonNumeric name="us-gaap:RedeemableNoncontrollingInterestTableTextBlock" id="Text_f2c365726986418489fc737fbb6630c2" contextRef="c20200101to20201231" escape="true" continuedAt="Text_60a8fa9360d246f48a39fcf5c5b24c271">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">For the year ended December 31, 2020, 2019 and 2018, the following table details the changes in the carrying amount (fair value) of the redeemable non-controlling interests (in thousands):</div>
</ix:nonNumeric></ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d56" continuedAt="Text_4af94549396245cda69072b43ac3c14d57"><ix:continuation id="Text_60a8fa9360d246f48a39fcf5c5b24c271" continuedAt="Text_60a8fa9360d246f48a39fcf5c5b24c272">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d57" continuedAt="Text_4af94549396245cda69072b43ac3c14d58"><ix:continuation id="Text_60a8fa9360d246f48a39fcf5c5b24c272">
<table cellpadding="0" cellspacing="0" id="z5419bd02f8334e35b081255c66326369" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"></div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="10" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;">December 31, 2018</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Beginning balance</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" id="Fact_5a76fa7b98a84fc9a2a24a534f65190d" contextRef="c20191231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">137,750</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" id="Fact_ece3958ebeca42548a338b94565cad37" contextRef="c20181231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">133,943</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" id="Fact_f6a5a7d0772d462d8357854f8883e0f1" contextRef="c20171231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">102,572</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Operating results allocated to redeemable non-controlling interest partners</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" id="Fact_9a6b8c3a1d854e20b5df13a649b3d320" contextRef="c20200101to20201231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">11,175</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" id="Fact_2da09f88ad02472da7bfdf583fc97811" contextRef="c20190101to20191231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">10,659</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" id="Fact_5fe7be01599645dea67dd0ed3cd3e450" contextRef="c20180101to20181231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">8,433</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Distributions to redeemable non-controlling interest partners</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" id="Fact_2a1c0939455b4b5abf53410ea6ec5cb0" contextRef="c20200101to20201231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">12,403</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" id="Fact_b68aa11263a641b8816705dee5e52891" contextRef="c20190101to20191231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">10,221</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" id="Fact_41132853fe304b9c935732f54f107f12" contextRef="c20180101to20181231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">9,835</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Changes in the fair value of redeemable non-controlling interest</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestChangeInRedemptionValue" id="Fact_aed1beecbc634ba59611e365ce2d885c" contextRef="c20200101to20201231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,632</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestChangeInRedemptionValue" id="Fact_6abd629ff0704d95954d7801ff36e964" contextRef="c20190101to20191231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">11,893</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:MinorityInterestChangeInRedemptionValue" id="Fact_63697d38ac99418ca85ac74312332d8d" contextRef="c20180101to20181231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">24,770</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Purchases of redeemable non-controlling interest</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:ProceedsFromPaymentsToMinorityShareholders" id="Fact_8c61cc1ef7fe4a0089d1eb2f0d5ba574" contextRef="c20200101to20201231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">20,521</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:ProceedsFromPaymentsToMinorityShareholders" id="Fact_448f7571408b481ab9668e02a68c70ca" contextRef="c20190101to20191231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">8,934</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ProceedsFromPaymentsToMinorityShareholders" id="Fact_5141145e9da34c648ad5083ed7d0a20e" contextRef="c20180101to20181231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">8,145</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Acquired interest</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:PaymentsToMinorityShareholders" id="Fact_21924acb9478434785e971558fdcbf6d" contextRef="c20200101to20201231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">11,297</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:PaymentsToMinorityShareholders" id="Fact_098e40767d6142cf8d873c9cf18be3db" contextRef="c20190101to20191231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,230</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:PaymentsToMinorityShareholders" id="Fact_88121a28841645dfad67912d099b96c3" contextRef="c20180101to20181231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Reduction of non-controlling interest due to sale of USPH partnership interest</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation" id="Fact_3f539441de10477db9c9f71e8244e963" contextRef="c20200101to20201231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation" id="Fact_48920462589244f88037bf510aa881aa" contextRef="c20190101to20191231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,132</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation" id="Fact_f668f2ac762c459f95f5c6bed6a3ae97" contextRef="c20180101to20181231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Sales of redeemable non-controlling interest - temporary equity</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" id="Fact_acbc9d6b397149a5a6c3a7128073f612" contextRef="c20200101to20201231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,133</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" id="Fact_cd049f4404f34adaa215ca44ccbdebc6" contextRef="c20190101to20191231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">3,120</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" id="Fact_655e8fc913f94399ac3718f2c330db54" contextRef="c20180101to20181231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Notes receivable related to sales of redeemable non-controlling interest - temporary equity</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" id="Fact_b2c9f94f2a4f4026a870858e75753fac" contextRef="c20200101to20201231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">1,006</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" id="Fact_1714021036b74eddb561ecab891e7170" contextRef="c20190101to20191231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">2,870</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" id="Fact_f93875de3fde4985abe3347a127f0dce" contextRef="c20180101to20181231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">142</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Adjustments in notes receivable related to the the sales of redeemable non-controlling interest - temporary equity</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" id="Fact_b233bb99c57343958bd995a17ef0c887" contextRef="c20200101to20201231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">283</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" id="Fact_d1fcaeed3b984b9fa25ccb94e052d8b4" contextRef="c20190101to20191231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" id="Fact_57c00d8e2a0e4e69a5e3c1fbb1472a56" contextRef="c20180101to20181231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Other</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" id="Fact_7e21524d892547d9b9744fa5a465c23c" contextRef="c20200101to20201231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" id="Fact_73951aaa55d14f169db3ab5fdb6a9615" contextRef="c20190101to20191231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">62</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" id="Fact_e5a7990ad83244e98a8e659c27d11a70" contextRef="c20180101to20181231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Ending balance</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" id="Fact_c4701da66a06471082111b7aa4397f70" contextRef="c20201231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">132,340</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" id="Fact_98ac0d6659294fbb9b8e9a38f1b20cef" contextRef="c20191231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">137,750</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" id="Fact_3332699507a347ccbf37d6321bf4c794" contextRef="c20181231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">133,943</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
  </tr>
</table>
</ix:continuation></ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d58" continuedAt="Text_4af94549396245cda69072b43ac3c14d59">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 12pt;"><br /></div>
</ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d59" continuedAt="Text_4af94549396245cda69072b43ac3c14d60"><ix:nonNumeric name="usph:CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" id="Text_463160775cc94537b4cc96f2febf1880" contextRef="c20200101to20201231" escape="true" continuedAt="Text_4b9077d86a7f4663a0b5e3823a1bd5c91">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The following table categorizes the carrying amount (fair value) of the redeemable non-controlling interests (in thousands):</div>
</ix:nonNumeric></ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d60" continuedAt="Text_4af94549396245cda69072b43ac3c14d61"><ix:continuation id="Text_4b9077d86a7f4663a0b5e3823a1bd5c91" continuedAt="Text_4b9077d86a7f4663a0b5e3823a1bd5c92">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_4af94549396245cda69072b43ac3c14d61"><ix:continuation id="Text_4b9077d86a7f4663a0b5e3823a1bd5c92">
<table cellpadding="0" cellspacing="0" id="z670c3e5c6ec64188aa3c22deb9e2062e" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"></div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;">December 31, 2018</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Contractual time period has lapsed but holder's employment has not been terminated</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" id="Fact_8bc4b44826ba48269b7a8d568b8c7d63" contextRef="c20201231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">62,390</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" id="Fact_9c4b32eff00345fcb91f5c19e428514c" contextRef="c20191231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">51,921</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" id="Fact_579a9746333846dbb39d022db5f0e493" contextRef="c20181231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">42,624</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Contractual time period has not lapsed and holder's employment has not been terminated</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" id="Fact_b281676cbdca491a8b5b9129129c66e8" contextRef="c20201231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">69,950</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" id="Fact_6e76c1cd8e7e4105aa95aba7c789bd23" contextRef="c20191231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">85,829</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" id="Fact_552612b1c21245f0832fce8a9b5d9328" contextRef="c20181231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">91,319</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Holder's employment has terminated and contractual time period has expired</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" id="Fact_96c36c59dac04818874408aee1d90c31" contextRef="c20201231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" id="Fact_0d104ff03cc54acdae7f1b0eddb991fd" contextRef="c20191231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" id="Fact_f305be5bffa44ce5981729c4086dc559" contextRef="c20181231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Holder's employment has terminated and contractual time period has not expired</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" id="Fact_2cabd95407a04433bb6b16d972ff4f53" contextRef="c20201231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" id="Fact_870a60789574466d9b0ec742429fa77f" contextRef="c20191231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" id="Fact_2e4f0d398cd04f1ca216906a7d635127" contextRef="c20181231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" id="Fact_5f614ad42a7c4707a85ab8cf3bd493b5" contextRef="c20201231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">132,340</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" id="Fact_38ed846f3f2a406283ee34d43402fbc0" contextRef="c20191231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">137,750</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" id="Fact_1d8dea1df0764cb182c62dc3808e0dfa" contextRef="c20181231_OwnershipAxis_RedeemableNonControllingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">133,943</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
</table>
</ix:continuation></ix:continuation></div>
<div style="text-align: left;"><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>65</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div><br /></div>
<div><ix:nonNumeric name="us-gaap:GoodwillDisclosureTextBlock" id="Text_837a74d49b5a45979c597d4040a01b09" contextRef="c20200101to20201231" escape="true" continuedAt="Text_d5673019e17b4677af95a0cb55ef97c61">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">6. Goodwill</div>
</ix:nonNumeric><ix:continuation id="Text_d5673019e17b4677af95a0cb55ef97c61" continuedAt="Text_d5673019e17b4677af95a0cb55ef97c62">
<div style="text-align: left;"><br /></div>
</ix:continuation><ix:continuation id="Text_d5673019e17b4677af95a0cb55ef97c62" continuedAt="Text_d5673019e17b4677af95a0cb55ef97c63"><ix:nonNumeric name="us-gaap:ScheduleOfGoodwillTextBlock" id="Text_c0ec77a500854e33bd3bb739cea7a67b" contextRef="c20200101to20201231" escape="true" continuedAt="Text_17a222979ccf4424b34e313e7ed8de221">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The changes in the carrying amount of goodwill as of December 31, 2020 and 2019 consisted of the following (in thousands):</div>
</ix:nonNumeric></ix:continuation><ix:continuation id="Text_d5673019e17b4677af95a0cb55ef97c63" continuedAt="Text_d5673019e17b4677af95a0cb55ef97c64"><ix:continuation id="Text_17a222979ccf4424b34e313e7ed8de221" continuedAt="Text_17a222979ccf4424b34e313e7ed8de222">
<div style="text-align: left;"><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_d5673019e17b4677af95a0cb55ef97c64"><ix:continuation id="Text_17a222979ccf4424b34e313e7ed8de222">
<table cellpadding="0" cellspacing="0" id="z004ebbf23ace473ea8af3849451f0579" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"></div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Beginning balance</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Goodwill" id="Fact_d7fb50520855431f8648223d4b18e9a4" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">317,676</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Goodwill" id="Fact_90cf0ec6c1744f6aabbe826ab165c074" contextRef="c20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">293,525</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Goodwill acquired</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GoodwillAcquiredDuringPeriod" id="Fact_0937c87ddb664fec85b0dde3add6f291" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">28,540</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GoodwillAcquiredDuringPeriod" id="Fact_7fc1b8c0d6ac45449443b6b5d2fdab03" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">31,330</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Goodwill related to partnership interest sold</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" id="Fact_592ec242b42f4855a09a0a56abf90d8a" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" id="Fact_809000cb37274e7d91af1422b1b9b3a2" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">7,325</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Goodwill derecognition (write-off) related to closed clinics</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" id="Fact_3eb54263f35e41e4a64e8a3393cdc0bf" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,859</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" id="Fact_75604ceae3304bcfb3db16df7d27652b" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Goodwill adjustments for purchase price allocation of businesses acquired in prior year</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GoodwillPurchaseAccountingAdjustments" id="Fact_28a97c67b27f4fd4902f7f5ff425d733" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,289</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GoodwillPurchaseAccountingAdjustments" id="Fact_619d719ed642458f9b291cd8b0cff6c2" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">146</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Ending balance</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Goodwill" id="Fact_b908772ccad44ce58167fc0546b0b6a4" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">345,646</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Goodwill" id="Fact_87a9cf975f0b4b2f89f20ae993729b16" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">317,676</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
  </tr>
</table>
</ix:continuation></ix:continuation></div>
<div style="text-align: left;"><br /></div>
<div><ix:nonNumeric name="us-gaap:IntangibleAssetsDisclosureTextBlock" id="Text_0334ca8450ce45408725e592c37065ea" contextRef="c20200101to20201231" escape="true" continuedAt="Text_37f4537975e44bce9c6336c72b08a5451">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">7. Intangible Assets, net</div>
</ix:nonNumeric><ix:continuation id="Text_37f4537975e44bce9c6336c72b08a5451" continuedAt="Text_37f4537975e44bce9c6336c72b08a5452">
<div style="text-align: left;"><br /></div>
</ix:continuation><ix:nonNumeric name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="Text_a1ad63ad6fb14afdbacaea415de2eeff" contextRef="c20200101to20201231" escape="true" continuedAt="Text_cf0617dab47e4713a93baad1dea34d041"><ix:continuation id="Text_37f4537975e44bce9c6336c72b08a5452" continuedAt="Text_37f4537975e44bce9c6336c72b08a5453">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Intangible assets, net as of December 31, 2020, 2019 and 2018 consisted of the following (in thousands):</div>
</ix:continuation></ix:nonNumeric><ix:continuation id="Text_cf0617dab47e4713a93baad1dea34d041" continuedAt="Text_cf0617dab47e4713a93baad1dea34d042"><ix:continuation id="Text_37f4537975e44bce9c6336c72b08a5453" continuedAt="Text_37f4537975e44bce9c6336c72b08a5454">
<div style="text-align: left;"><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_cf0617dab47e4713a93baad1dea34d042"><ix:continuation id="Text_37f4537975e44bce9c6336c72b08a5454" continuedAt="Text_37f4537975e44bce9c6336c72b08a5455">
<table cellpadding="0" cellspacing="0" id="z4aa296b7bad344d8aa0f77e9db40fba3" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"></div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Tradenames</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" id="Fact_06a81963ad99459a9373a8883b15a7e1" contextRef="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">32,317</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" id="Fact_9b9713d3d6344b269370c43936ef6d09" contextRef="c20191231_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">32,049</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Referral relationships, net of accumulated amortization of $<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" id="Fact_c8a0916bb1db47099768221d1e89fb75" contextRef="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">14,522</ix:nonFraction> and $<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" id="Fact_1cd7d2f94dd14ad6a29e284d25139ebf" contextRef="c20191231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">11,677</ix:nonFraction>, respectively</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" id="Fact_927e2b7621464fd9a2ed6ae7ab33ef16" contextRef="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">22,119</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" id="Fact_d465392331ce4e9fa1ff60eda36cfc96" contextRef="c20191231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">18,367</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Non-compete agreements, net of accumulated amortization of $<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" id="Fact_36a95dd0b94b4d8db2fe7a2303223850" contextRef="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,993</ix:nonFraction> and $<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" id="Fact_8e15d2bdeed544bead07465bac2a753f" contextRef="c20191231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,424</ix:nonFraction>, respectively</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" id="Fact_7feae0def7fe47eeab8bc93c34afac6b" contextRef="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,844</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" id="Fact_e02d6c9fbea94a1fb09288006c871623" contextRef="c20191231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,172</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" id="Fact_350bb16246144f98ac9691f3e40c09b6" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">56,280</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" id="Fact_7a4a6ef0a6ce4d6189f58bd9046a4976" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">52,588</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
  </tr>
</table>
</ix:continuation></ix:continuation><ix:continuation id="Text_37f4537975e44bce9c6336c72b08a5455" continuedAt="Text_37f4537975e44bce9c6336c72b08a5456">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 12pt;"><br /></div>
</ix:continuation><ix:continuation id="Text_37f4537975e44bce9c6336c72b08a5456" continuedAt="Text_37f4537975e44bce9c6336c72b08a5457">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Tradenames, referral relationships and non-compete agreements are related to the businesses acquired. The value assigned to tradenames has an indefinite life and is tested at least annually for impairment using the relief from royalty method in conjunction with the Company&#8217;s annual goodwill impairment test. The value assigned to referral relationships is being amortized over their respective estimated useful lives which range from <ix:nonNumeric name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="Fact_59385f608bb647b3aece0bf6c8e9548c" contextRef="c20200101to20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember_RangeAxis_MinimumMember" format="ixt-sec:duryear">6</ix:nonNumeric> to <ix:nonNumeric name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="Fact_8c2f8550090b418c9b27bb22651fc668" contextRef="c20200101to20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember_RangeAxis_MaximumMember" format="ixt-sec:durwordsen">16 years</ix:nonNumeric>. Non-compete agreements are amortized over the respective term of the agreements which range from <ix:nonNumeric name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="Fact_409782829e80453abe8cc94ad688e8dc" contextRef="c20200101to20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember_RangeAxis_MinimumMember" format="ixt-sec:duryear">5</ix:nonNumeric> to <ix:nonNumeric name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="Fact_570adb39448e4c2a942224bdd4ba5f9b" contextRef="c20200101to20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember_RangeAxis_MaximumMember" format="ixt-sec:durwordsen">6 years</ix:nonNumeric>.</div>
</ix:continuation><ix:continuation id="Text_37f4537975e44bce9c6336c72b08a5457" continuedAt="Text_37f4537975e44bce9c6336c72b08a5458">
<div style="text-align: left;"><br /></div>
</ix:continuation><ix:nonNumeric name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" id="Text_d27a6e8604d64bcb94aa8b7453b005b5" contextRef="c20200101to20201231" escape="true" continuedAt="Text_1961874774f04ce59dbb18d79364ed921"><ix:continuation id="Text_37f4537975e44bce9c6336c72b08a5458" continuedAt="Text_37f4537975e44bce9c6336c72b08a5459">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The following table details the amount of amortization expense recorded for intangible assets for the years ended December 31, 2020, 2019 and 2018 (in thousands):</div>
</ix:continuation></ix:nonNumeric><ix:continuation id="Text_1961874774f04ce59dbb18d79364ed921" continuedAt="Text_1961874774f04ce59dbb18d79364ed922"><ix:continuation id="Text_37f4537975e44bce9c6336c72b08a5459" continuedAt="Text_37f4537975e44bce9c6336c72b08a54510">
<div style="text-align: left;"><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_1961874774f04ce59dbb18d79364ed922"><ix:continuation id="Text_37f4537975e44bce9c6336c72b08a54510" continuedAt="Text_37f4537975e44bce9c6336c72b08a54511">
<table cellpadding="0" cellspacing="0" id="z3d51561c2d2b4e3991aa252252acd5e0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"></div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;">Year Ended</div><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;">December 31, 2018</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Referral relationships</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" id="Fact_cecc93dc63924268af56e378aef52dba" contextRef="c20200101to20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,845</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" id="Fact_e4933741c1a94c91ba87728f26764ba7" contextRef="c20190101to20191231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,307</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" id="Fact_ce838a9047fa4044b3868f6c074d8af9" contextRef="c20180101to20181231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,161</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Non-compete agreements</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" id="Fact_2a7495e7bdc8490cbd3258608dd4831b" contextRef="c20200101to20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">569</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" id="Fact_b235bb94584c44d68bf1d86ce7cb79ee" contextRef="c20190101to20191231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">708</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" id="Fact_e641236deed648c9a23f439d628b0265" contextRef="c20180101to20181231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">616</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" id="Fact_e1cd22197f284690aebee88568562937" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">3,414</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" id="Fact_63cd01751de1419ba665792fea768b4e" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">3,015</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" id="Fact_791507cf892d4b5392a1b196172e6a9c" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,777</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
</table>
</ix:continuation></ix:continuation><ix:continuation id="Text_37f4537975e44bce9c6336c72b08a54511" continuedAt="Text_37f4537975e44bce9c6336c72b08a54512">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 12pt;"><br /></div>
</ix:continuation><ix:continuation id="Text_37f4537975e44bce9c6336c72b08a54512" continuedAt="Text_37f4537975e44bce9c6336c72b08a54513">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">For <ix:nonFraction name="usph:NumberOfAcquiredOperations" id="Fact_41001470748c49fa80d78fa537321154" contextRef="c20200101to20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember" unitRef="U017" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction> acquisition, the value assigned to tradename was being amortized over the term of the <ix:nonNumeric name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="Fact_4cc1483110004d9aae51eee4aeadb5de" contextRef="c20200101to20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember" format="ixt-sec:durwordsen">six year</ix:nonNumeric> agreement in which the Company had acquired the right to use the specific tradename.</div>
</ix:continuation><ix:continuation id="Text_37f4537975e44bce9c6336c72b08a54513" continuedAt="Text_37f4537975e44bce9c6336c72b08a54514">
<div><br /></div>
</ix:continuation><ix:nonNumeric name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="Text_18d4cbf7eaf34e98b3b0c7142a194c2f" contextRef="c20200101to20201231" escape="true" continuedAt="Text_5def31ffaefb474988a9367e56e88eb91"><ix:continuation id="Text_37f4537975e44bce9c6336c72b08a54514" continuedAt="Text_37f4537975e44bce9c6336c72b08a54515">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The remaining balances of the referral relationships and non-compete agreements is expected to be amortized as follows (in thousands):</div>
</ix:continuation></ix:nonNumeric><ix:continuation id="Text_5def31ffaefb474988a9367e56e88eb91" continuedAt="Text_5def31ffaefb474988a9367e56e88eb92"><ix:continuation id="Text_37f4537975e44bce9c6336c72b08a54515" continuedAt="Text_37f4537975e44bce9c6336c72b08a54516">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_5def31ffaefb474988a9367e56e88eb92"><ix:continuation id="Text_37f4537975e44bce9c6336c72b08a54516">
<table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z4ca35e0153f74abcaf4ae18e8b962393">
  <tr>
    <td colspan="3" style="width: 48.7%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Referral Relationships</div></td>
    <td style="width: 1.33%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="3" style="width: 48.71%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Non-Compete Agreements</div></td>
    <td style="width: 1.26%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 37.23%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Years</div></td>
    <td style="width: 1.12%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td style="width: 10.35%; vertical-align: bottom;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Annual Amount</div></td>
    <td style="width: 1.33%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td style="width: 37.23%; vertical-align: bottom; white-space: nowrap;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Years</div></td>
    <td style="width: 1.12%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td style="width: 10.35%; vertical-align: bottom;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Annual Amount</div></td>
    <td style="width: 1.26%; vertical-align: bottom;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 37.23%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Ending December 31,</div></td>
    <td style="width: 1.12%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td style="width: 10.35%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td style="width: 1.33%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td style="width: 37.23%; vertical-align: bottom; white-space: nowrap;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Ending December 31,</div></td>
    <td style="width: 1.12%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td style="width: 10.35%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td style="width: 1.26%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2021</div></td>
    <td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" id="Fact_c52364b32d554d23b2b92a8b0c4fb062" contextRef="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,946</ix:nonFraction></div></td>
    <td style="width: 1.33%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2021</div></td>
    <td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" id="Fact_3915697c5f524ffd80fbe126e7bbd9ea" contextRef="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">556</ix:nonFraction></div></td>
    <td style="width: 1.26%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2022</div></td>
    <td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" id="Fact_8a1f1116ab8248ec8ff407970e52df73" contextRef="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,886</ix:nonFraction></div></td>
    <td style="width: 1.33%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2022</div></td>
    <td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" id="Fact_18ffd7b8ddff4011bc6e287d0ed185b4" contextRef="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">403</ix:nonFraction></div></td>
    <td style="width: 1.26%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2023</div></td>
    <td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" id="Fact_75ccc3577e944a88b7e7e62d09b41d35" contextRef="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,778</ix:nonFraction></div></td>
    <td style="width: 1.33%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2023</div></td>
    <td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" id="Fact_8f5fff8898534e05bbe6ee4966213b9c" contextRef="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">335</ix:nonFraction></div></td>
    <td style="width: 1.26%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2024</div></td>
    <td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" id="Fact_c5383315f31e4f599bb41d9d2aacac47" contextRef="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,615</ix:nonFraction></div></td>
    <td style="width: 1.33%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2024</div></td>
    <td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" id="Fact_962ce853d892472abaca0443c640d838" contextRef="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">279</ix:nonFraction></div></td>
    <td style="width: 1.26%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2025</div></td>
    <td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" id="Fact_0aeb3ddb27ad42ef839810f48f4ef4c2" contextRef="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,470</ix:nonFraction></div></td>
    <td style="width: 1.33%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2025</div></td>
    <td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" id="Fact_a3ea2029b4ab4e96a36e8e6fff2b290e" contextRef="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">212</ix:nonFraction></div></td>
    <td style="width: 1.26%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Thereafter</div></td>
    <td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" id="Fact_5a767df28e9349ad9952b3cd310f593f" contextRef="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">8,424</ix:nonFraction></div></td>
    <td style="width: 1.33%; vertical-align: bottom; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>
    <td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF; white-space: nowrap;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Thereafter</div></td>
    <td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" id="Fact_9506af02c641474c9c037f18024700aa" contextRef="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">59</ix:nonFraction></div></td>
    <td style="width: 1.26%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
  </tr>
</table>
</ix:continuation></ix:continuation></div>
<div style="text-align: left;"><br /></div>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>66</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div><br /></div>
<div><ix:nonNumeric name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" id="Text_94715be10e8844b489d5b6f9d5c8f840" contextRef="c20200101to20201231" escape="true" continuedAt="Text_fa01dfc0b9474b9fb07d73514fb377a61">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">8. Accrued Expenses</div>
</ix:nonNumeric><ix:continuation id="Text_fa01dfc0b9474b9fb07d73514fb377a61" continuedAt="Text_fa01dfc0b9474b9fb07d73514fb377a62">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_fa01dfc0b9474b9fb07d73514fb377a62" continuedAt="Text_fa01dfc0b9474b9fb07d73514fb377a63"><ix:nonNumeric name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="Text_930d066ff5ea4acd87e6eaa5705b9e90" contextRef="c20200101to20201231" escape="true" continuedAt="Text_2bfcca2f0a164b6289e7655d27402b771">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Accrued expenses as of December 31, 2020 and 2019 consisted of the following (in thousands):</div>
</ix:nonNumeric></ix:continuation><ix:continuation id="Text_fa01dfc0b9474b9fb07d73514fb377a63" continuedAt="Text_fa01dfc0b9474b9fb07d73514fb377a64"><ix:continuation id="Text_2bfcca2f0a164b6289e7655d27402b771" continuedAt="Text_2bfcca2f0a164b6289e7655d27402b772">
<div style="text-align: left;"><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_fa01dfc0b9474b9fb07d73514fb377a64"><ix:continuation id="Text_2bfcca2f0a164b6289e7655d27402b772">
<table cellpadding="0" cellspacing="0" id="z5e0ab21edcc54f1d894d4c3659803307" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"></div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Salaries and related costs</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EmployeeRelatedLiabilitiesCurrent" id="Fact_c50d1fb9bf55470b9bdbb0c51a4a046d" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">24,646</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EmployeeRelatedLiabilitiesCurrent" id="Fact_aa5ce36319ac4d07995f25ec4d03b1b8" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">19,340</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Credit balances due to patients and payors</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PatientsAndPayorsRelatedLiability" id="Fact_46e1e29aaa7a48228e8df4a72cf0c3ec" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,756</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:PatientsAndPayorsRelatedLiability" id="Fact_405a79f731de4c8ba80aefb7ad7eb656" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,303</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Group health insurance claims</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AccruedInsuranceCurrent" id="Fact_3acfd6bb13a247b5bf408929a0952956" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,113</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AccruedInsuranceCurrent" id="Fact_35857c10fd504cc196d01306061fabd6" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,277</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Closure costs</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" id="Fact_9ed09af2dd5b47b397b959b11d9a6423" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,333</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" id="Fact_bfba1655d13c43b38c015950bf591e88" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">116</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Federal income taxes payable</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:TaxesPayableCurrent" id="Fact_90a281aaa5204781b5791f24c2eb5847" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,715</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:TaxesPayableCurrent" id="Fact_a8218e742e6747e7bb8227ccaeafa44b" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">MAAPP funds payable</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable" id="Fact_b2269ce242574eea88c9f051a0bb0044" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">14,054</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable" id="Fact_f6e76912f8b04aa99f6e24b0e0c45c67" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Deferred employer payroll taxes - CARES ACT</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:DeferredEmployerPayrollTaxesCARESACT" id="Fact_d1e45c40a77c45edbb2f2e5ffc7eaed5" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,170</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:DeferredEmployerPayrollTaxesCARESACT" id="Fact_8e9ee2da83e7455c8800853f10a86513" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Other</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrent" id="Fact_f7b531127fa44169b5e80050021d3ae5" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,959</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrent" id="Fact_0d7a25f86f4b4c09bd46dcb8f44342b7" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,819</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" id="Fact_1a128c7b9ef945dc916605ce7f3bb7fd" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">59,746</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" id="Fact_74e4b6075bbc4f2e97a9613dbc852ca0" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">30,855</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
</table>
</ix:continuation></ix:continuation></div>
<div style="text-align: left;"><br /></div>
<div><ix:nonNumeric name="us-gaap:DebtDisclosureTextBlock" id="Text_2abac05811524a44b4020a0ed6b452f5" contextRef="c20200101to20201231" escape="true" continuedAt="Text_e7818976d8e346ceb7f622c412c8a0781">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">9. Notes Payable</div>
</ix:nonNumeric><ix:continuation id="Text_e7818976d8e346ceb7f622c412c8a0781" continuedAt="Text_e7818976d8e346ceb7f622c412c8a0782">
<div style="text-align: left;"><br /></div>
</ix:continuation><ix:continuation id="Text_e7818976d8e346ceb7f622c412c8a0782" continuedAt="Text_e7818976d8e346ceb7f622c412c8a0783"><ix:nonNumeric name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="Text_4be35ebad5724b499e4913a8dae0d115" contextRef="c20200101to20201231" escape="true" continuedAt="Text_c5308923fe764474a5c6549b84996d4f1">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Notes payable as of December 31, 2020 and 2019 consisted of the following (in thousands):</div>
</ix:nonNumeric></ix:continuation><ix:continuation id="Text_e7818976d8e346ceb7f622c412c8a0783" continuedAt="Text_e7818976d8e346ceb7f622c412c8a0784"><ix:continuation id="Text_c5308923fe764474a5c6549b84996d4f1" continuedAt="Text_c5308923fe764474a5c6549b84996d4f2">
<div style="text-align: left;"><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_e7818976d8e346ceb7f622c412c8a0784" continuedAt="Text_e7818976d8e346ceb7f622c412c8a0785"><ix:continuation id="Text_c5308923fe764474a5c6549b84996d4f2">
<table cellpadding="0" cellspacing="0" id="z2a1752aada2b4b209bdac3644d131528" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"></div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Credit Agreement average effective interest rate of <ix:nonFraction name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" id="Fact_b8c52fdef01b498eb2e60b66fd59ce21" contextRef="c20200101to20201231_CreditFacilityAxis_RevolvingCreditFacilityMember" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">2.6</ix:nonFraction>% and <ix:nonFraction name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" id="Fact_931d4aad8463474bb9f27625be879767" contextRef="c20190101to20191231_CreditFacilityAxis_RevolvingCreditFacilityMember" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">3.9</ix:nonFraction>% in 2020 and 2019, respectively (inclusive of unused fee)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermDebt" id="Fact_acaa0c070f094d229dacbf914120eea9" contextRef="c20201231_CreditFacilityAxis_RevolvingCreditFacilityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">16,000</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermDebt" id="Fact_228f1809e55e44d3b4ec07e322063fc6" contextRef="c20191231_CreditFacilityAxis_RevolvingCreditFacilityMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">46,000</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Various notes payable with $<ix:nonFraction name="us-gaap:DebtInstrumentAnnualPrincipalPayment" id="Fact_fda2207307434239941c8fa5c983af1a" contextRef="c20201231_DebtInstrumentAxis_PromissoryNotesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,899</ix:nonFraction> plus accrued interest due in the next year, interest accrues in the range of <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" id="Fact_d903564ea8b648d68cb9911e0e8064d0" contextRef="c20201231_DebtInstrumentAxis_PromissoryNotesMember_RangeAxis_MinimumMember" unitRef="U005" decimals="4" scale="-2" format="ixt:numdotdecimal">3.25</ix:nonFraction>% through <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" id="Fact_e65b049796354fa4942ea7629e2037a2" contextRef="c20201231_DebtInstrumentAxis_PromissoryNotesMember_RangeAxis_MaximumMember" unitRef="U005" decimals="4" scale="-2" format="ixt:numdotdecimal">5.50</ix:nonFraction>% per annum</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermDebt" id="Fact_09c7650eda764baca9fb8ec33f3d59f7" contextRef="c20201231_DebtInstrumentAxis_PromissoryNotesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,495</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermDebt" id="Fact_f5c412fcfe0a4c33834e2726d6f1e7a8" contextRef="c20191231_DebtInstrumentAxis_PromissoryNotesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,089</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermDebt" id="Fact_026390bf77914947a682e4448fa72cfa" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">21,495</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermDebt" id="Fact_0ebcca7066294e3ebb6db629533c969f" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">51,089</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Less current portion</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:LongTermDebtCurrent" id="Fact_dad4c49069c64b2cb647d1014f162ea9" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,899</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:LongTermDebtCurrent" id="Fact_966fb9aee4f74e128879c45eefd08665" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">728</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Long term portion</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermDebtNoncurrent" id="Fact_8b1b78c45d5a4438a71eac59c302faea" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">16,596</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LongTermDebtNoncurrent" id="Fact_7dce55a961794ec59c2733c7dd69ca11" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">50,361</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
</table>
</ix:continuation></ix:continuation><ix:continuation id="Text_e7818976d8e346ceb7f622c412c8a0785" continuedAt="Text_e7818976d8e346ceb7f622c412c8a0786">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 12pt;"><br /></div>
</ix:continuation><ix:continuation id="Text_e7818976d8e346ceb7f622c412c8a0786" continuedAt="Text_e7818976d8e346ceb7f622c412c8a0787">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Effective December 5, 2013, the Company entered into an Amended and Restated Credit Agreement with a commitment for a $<ix:nonFraction name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" id="Fact_8a17382f9b2f4b0188df94d11748f00b" contextRef="c20131205_CreditFacilityAxis_RevolvingCreditFacilityMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">125.0</ix:nonFraction> million revolving credit facility. This agreement was amended and/or restated in August 2015, January 2016, March 2017 and November 2017 and January 2021 (hereafter referred to as &#8220;Amended Credit Agreement&#8221;). The Amended Credit Agreement is unsecured and has loan covenants, including requirements that the Company comply with a consolidated fixed charge coverage ratio and consolidated leverage ratio. Proceeds from the Amended Credit Agreement may be used for working capital, acquisitions, purchases of the Company&#8217;s common stock, dividend payments to the Company&#8217;s common stockholders, capital expenditures and other corporate purposes. The pricing grid which is based on the Company&#8217;s consolidated leverage ratio with the applicable spread over LIBOR ranging from <ix:nonFraction name="usph:DebtInstrumentBasisSpreadOnLiborVariableRate" id="Fact_de6c2adc55be427597fc075eab7a30c0" contextRef="c20201231_RangeAxis_MinimumMember" unitRef="U005" decimals="4" scale="-2" format="ixt:numdotdecimal">1.25</ix:nonFraction>% to <ix:nonFraction name="usph:DebtInstrumentBasisSpreadOnLiborVariableRate" id="Fact_82dada8a1c3f47cea713850c03aca35b" contextRef="c20201231_RangeAxis_MaximumMember" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">2.0</ix:nonFraction>% or the applicable spread over the Base Rate ranging from <ix:nonFraction name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" id="Fact_47d840c75cf84c4fa91acd7ca3a43f74" contextRef="c20200101to20201231_RangeAxis_MinimumMember" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">0.1</ix:nonFraction>% to <ix:nonFraction name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" id="Fact_5ad33158ebac4b3d93f9f550e8adcd0f" contextRef="c20200101to20201231_RangeAxis_MaximumMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">1</ix:nonFraction>%. Fees under the Amended Credit Agreement include an unused commitment fee of <ix:nonFraction name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" id="Fact_8c1339b35bca4bb7acff91cc6d136c5e" contextRef="c20200101to20201231" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">0.3</ix:nonFraction>% of the amount of funds outstanding under the Amended Credit Agreement.</div>
</ix:continuation><ix:continuation id="Text_e7818976d8e346ceb7f622c412c8a0787" continuedAt="Text_e7818976d8e346ceb7f622c412c8a0788">
<div style="text-align: left;"><br /></div>
</ix:continuation><ix:continuation id="Text_e7818976d8e346ceb7f622c412c8a0788" continuedAt="Text_e7818976d8e346ceb7f622c412c8a0789">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">The Amended Credit Agreement allows the cash and noncash consideration that the Company could pay with respect to acquisitions permitted under the Amended Credit Agreement to $</span><ix:nonFraction name="usph:CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" id="Fact_dd11a658a0fa4e94be40e05c4499a2fb" contextRef="c20160101to20160131_DebtInstrumentAxis_CreditAgreementMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">50,000,000</ix:nonFraction><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> for any fiscal year, and the amount the Company may pay in cash dividends to its shareholders in an aggregate amount not to exceed $</span><ix:nonFraction name="usph:DividendsCashAfterAmendment" id="Fact_5468cdf33d3f4bdb95a03a6270a02ffb" contextRef="c20160101to20160131_DebtInstrumentAxis_CreditAgreementMember_RangeAxis_MaximumMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">50,000,000</ix:nonFraction><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> in any fiscal year. The commitment remains at </span>$<ix:nonFraction name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" id="Fact_a6ef1187a75345a3967be3896f3849ca" contextRef="c20131205_CreditFacilityAxis_RevolvingCreditFacilityMember" unitRef="U001" decimals="-6" scale="6" format="ixt:numdotdecimal">125</ix:nonFraction> million<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">, however the accordion feature in the agreement was expanded to provide for capacity up to </span>$<ix:nonFraction name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" id="Fact_0d8d5eff832c48a98b21f9f55563b087" contextRef="c20201231_CreditFacilityAxis_RevolvingCreditFacilityMember" unitRef="U001" decimals="-6" scale="6" format="ixt:numdotdecimal">150</ix:nonFraction> million<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">, and has a maturity date of </span><ix:nonNumeric name="us-gaap:DebtInstrumentMaturityDate" id="Fact_55fde865b6194fbf8333d5d74d2c2eba" contextRef="c20200101to20201231_CreditFacilityAxis_RevolvingCreditFacilityMember" format="ixt:datemonthdayyearen">November 30, 2025</ix:nonNumeric>.<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> The Amended Credit Agreement is unsecured and includes certain financial covenants which include a consolidated fixed charge coverage ratio and a consolidated leverage ratio, as defined in the agreement.</span></div>
</ix:continuation><ix:continuation id="Text_e7818976d8e346ceb7f622c412c8a0789" continuedAt="Text_e7818976d8e346ceb7f622c412c8a07810">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt;"><br /></div>
</ix:continuation><ix:continuation id="Text_e7818976d8e346ceb7f622c412c8a07810" continuedAt="Text_e7818976d8e346ceb7f622c412c8a07811">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">On December 31, 2020, $<ix:nonFraction name="us-gaap:LongTermDebt" id="Fact_c7a5bca9fd6a418b9a765b5f57891dfb" contextRef="c20201231_CreditFacilityAxis_RevolvingCreditFacilityMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">16.0</ix:nonFraction> million was outstanding on the Amended Credit Agreement resulting in $<ix:nonFraction name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" id="Fact_587fe474f94444348bb53b99a8358322" contextRef="c20201231_CreditFacilityAxis_RevolvingCreditFacilityMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">109.0</ix:nonFraction> million of availability. As of December 31, 2020, the Company was in compliance with all of the covenants thereunder.</div>
</ix:continuation><ix:continuation id="Text_e7818976d8e346ceb7f622c412c8a07811" continuedAt="Text_e7818976d8e346ceb7f622c412c8a07812">
<div style="text-align: left;"><br /></div>
</ix:continuation><ix:continuation id="Text_e7818976d8e346ceb7f622c412c8a07812">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">The Company generally enters into various notes payable as a means of financing a portion of its acquisitions and purchasing of non-controlling interests. In conjunction with these transactions in </span>2020,<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> the Company entered into notes payable in the aggregate amount of </span>$<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" id="Fact_f75011cc2f0447ec9bea459bca20d89e" contextRef="c20201231_ShortTermDebtTypeAxis_NotesPayableMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">1.4</ix:nonFraction> million<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> of which an aggregate principal payment of </span>$<ix:nonFraction name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" id="Fact_719b2dd3d4854dc899217f777caf21b5" contextRef="c20201231_ShortTermDebtTypeAxis_NotesPayableMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.5</ix:nonFraction> million<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> is due in </span>2021<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> and </span>$<ix:nonFraction name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" id="Fact_f4899eb8d66b4fb1bd9e18a94200a63f" contextRef="c20201231_ShortTermDebtTypeAxis_NotesPayableMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.6</ix:nonFraction> million<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> is due in </span>2022.<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> Interest accrues in the range of </span><ix:nonFraction name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" id="Fact_1fa8c991ba3845f294bc006a0d371861" contextRef="c20200101to20201231_RangeAxis_MinimumMember_ShortTermDebtTypeAxis_NotesPayableMember" unitRef="U005" decimals="4" scale="-2" format="ixt:numdotdecimal">3.25</ix:nonFraction>%<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> to </span><ix:nonFraction name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" id="Fact_6ba97b5621f84348be23c32d26a58741" contextRef="c20200101to20201231_RangeAxis_MaximumMember_ShortTermDebtTypeAxis_NotesPayableMember" unitRef="U005" decimals="4" scale="-2" format="ixt:numdotdecimal">5.50</ix:nonFraction>%<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> per annum and is payable with each principal installment. The balance of the various notes payable entered into prior to </span>2020<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> was </span>$<ix:nonFraction name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" id="Fact_87acc8ef35c848c7831459c9d247183e" contextRef="c20191231_ShortTermDebtTypeAxis_NotesPayableMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">4.4</ix:nonFraction> million<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> which will be paid in </span>2021.</div>
</ix:continuation></div>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>67</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div><br /></div>
<div><br /></div>
<div><ix:nonNumeric name="us-gaap:LesseeOperatingLeasesTextBlock" id="Text_40017d27813c4da7aec8a7d4e8f3efdc" contextRef="c20200101to20201231" escape="true" continuedAt="Text_a060f030708b42f09aaf166abe51b43c1">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">10. Leases</div>
</ix:nonNumeric><ix:continuation id="Text_a060f030708b42f09aaf166abe51b43c1" continuedAt="Text_a060f030708b42f09aaf166abe51b43c2">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_a060f030708b42f09aaf166abe51b43c2" continuedAt="Text_a060f030708b42f09aaf166abe51b43c3">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company has operating leases for its corporate offices and operating facilities. The Company determines if an arrangement is a lease at the inception of a contract. Effective January 1, 2019, right-of-use assets and operating lease liabilities are included in the consolidated balance sheet. Right-of-use assets represent the Company&#8217;s right to use an underlying asset during the lease term and operating lease liabilities represent net present value of the Company&#8217;s obligation to make lease payments arising from the lease. Right-of-use assets and operating lease liabilities are recognized at commencement date based on the net present value of the fixed lease payments over the lease term. The Company&#8217;s operating lease terms are generally <ix:nonNumeric name="us-gaap:LesseeOperatingLeaseTermOfContract" id="Fact_097839ddd0424a16aaa2eec851c061cb" contextRef="c20201231_RangeAxis_MaximumMember" format="ixt-sec:durwordsen">five years</ix:nonNumeric> or less. The Company&#8217;s lease terms include options to extend or terminate the lease when it is reasonably certain that the option will be exercised. As most of the Company&#8217;s operating leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. Operating fixed lease expense is recognized on a straight-line basis over the lease term.</div>
</ix:continuation><ix:continuation id="Text_a060f030708b42f09aaf166abe51b43c3" continuedAt="Text_a060f030708b42f09aaf166abe51b43c4">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_a060f030708b42f09aaf166abe51b43c4" continuedAt="Text_a060f030708b42f09aaf166abe51b43c5">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In accordance with ASC 842, the Company records on its consolidated balance sheet leases with a term greater than 12 months. The Company has elected, in compliance with current accounting standards, not to record leases with an initial term of 12 months or less in the consolidated balance sheet. ASC 842 requires the separation of the fixed lease components from the variable lease components. The Company has elected the practical expedient to account for separate lease components of a contract as a single lease cost thus causing all fixed payments to be capitalized. Non-lease and variable cost components are not included in the measurement of the right-of-use assets or operating lease liabilities. The Company also elected the package of practical expedients permitted within ASC 842, which among other things, allows the Company to carry forward historical lease classification. Variable lease payment amounts that cannot be determined at the commencement of the lease such as increases in lease payments based on changes in index rates or usage are not included in the right-of-use assets or operating lease liabilities. These are expensed as incurred and recorded as variable lease expense.</div>
</ix:continuation><ix:continuation id="Text_a060f030708b42f09aaf166abe51b43c5" continuedAt="Text_a060f030708b42f09aaf166abe51b43c6">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_a060f030708b42f09aaf166abe51b43c6" continuedAt="Text_a060f030708b42f09aaf166abe51b43c7"><ix:nonNumeric name="us-gaap:LeaseCostTableTextBlock" id="Text_af87c7ed305e4a34a511378c828d5ea9" contextRef="c20200101to20201231" escape="true" continuedAt="Text_312f16cbd0b64a5d90e6fa7a321746bf1">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">For the years ended December 31, 2020 and 2019, the components of lease expense were as follows (in thousands):</div>
</ix:nonNumeric></ix:continuation><ix:continuation id="Text_a060f030708b42f09aaf166abe51b43c7" continuedAt="Text_a060f030708b42f09aaf166abe51b43c8"><ix:continuation id="Text_312f16cbd0b64a5d90e6fa7a321746bf1" continuedAt="Text_312f16cbd0b64a5d90e6fa7a321746bf2">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_a060f030708b42f09aaf166abe51b43c8" continuedAt="Text_a060f030708b42f09aaf166abe51b43c9"><ix:continuation id="Text_312f16cbd0b64a5d90e6fa7a321746bf2" continuedAt="Text_312f16cbd0b64a5d90e6fa7a321746bf3">
<table cellpadding="0" cellspacing="0" id="z7b37b8c0456447ddb4283356a6996986" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="6" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; text-indent: -9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended December 31,</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"></div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2020</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; text-indent: -9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2019</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Operating lease cost</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingLeaseCost" id="Fact_0121c3e8800346c6beb1696dbf71e12f" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">30,710</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingLeaseCost" id="Fact_d372687ebf434a92895b34d0f0072aa7" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">30,225</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Short-term lease cost</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShortTermLeaseCost" id="Fact_1ac83c8bbee349bfadb05fe99184ef92" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,454</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShortTermLeaseCost" id="Fact_87db5ce02ea84070a46486afa0e509f7" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,212</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Variable lease cost</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:VariableLeaseCost" id="Fact_0c8d2ef64e7845b6b3ae474c043a192a" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,752</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:VariableLeaseCost" id="Fact_0943a57795a2496f97d04263346ee9c7" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,074</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total lease cost<sup>*</sup></div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LeaseCost" id="Fact_87de7115dd224e8ab5349b8ca49d2604" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">37,916</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LeaseCost" id="Fact_bfd896794afb43ceb5f52155240c54ac" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">37,511</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
  </tr>
</table>
</ix:continuation></ix:continuation><ix:continuation id="Text_a060f030708b42f09aaf166abe51b43c9" continuedAt="Text_a060f030708b42f09aaf166abe51b43c10"><ix:continuation id="Text_312f16cbd0b64a5d90e6fa7a321746bf3" continuedAt="Text_312f16cbd0b64a5d90e6fa7a321746bf4">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_a060f030708b42f09aaf166abe51b43c10" continuedAt="Text_a060f030708b42f09aaf166abe51b43c11"><ix:continuation id="Text_312f16cbd0b64a5d90e6fa7a321746bf4">
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z90bdf9c7e6434fa18d41ce5d317f4a15">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">*</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:footnote id="Foot_aeaed244265844d580a05be145ffd595" footnoteRole="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US">Sublease income was immaterial</ix:footnote></div></td>
  </tr>
</table>
</ix:continuation></ix:continuation><ix:continuation id="Text_a060f030708b42f09aaf166abe51b43c11" continuedAt="Text_a060f030708b42f09aaf166abe51b43c12">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_a060f030708b42f09aaf166abe51b43c12" continuedAt="Text_a060f030708b42f09aaf166abe51b43c13">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Lease costs are reflected in the consolidated statements of net income in the line item &#8211; rent, supplies, contract labor and other.</div>
</ix:continuation><ix:continuation id="Text_a060f030708b42f09aaf166abe51b43c13" continuedAt="Text_a060f030708b42f09aaf166abe51b43c14">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_a060f030708b42f09aaf166abe51b43c14" continuedAt="Text_a060f030708b42f09aaf166abe51b43c15"><ix:nonNumeric name="usph:OperatingLeaseSupplementalInformationTableTextBlock" id="Text_0c2c24dd873449e8a8d63295162bb420" contextRef="c20200101to20201231" escape="true" continuedAt="Text_5ef4f98ca10e4b0b847142259affda161">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">For the years ended December 31, 2020 and 2019, supplemental cash flow information related to leases was as follows (in thousands):</div>
</ix:nonNumeric></ix:continuation><ix:continuation id="Text_a060f030708b42f09aaf166abe51b43c15" continuedAt="Text_a060f030708b42f09aaf166abe51b43c16"><ix:continuation id="Text_5ef4f98ca10e4b0b847142259affda161" continuedAt="Text_5ef4f98ca10e4b0b847142259affda162">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_a060f030708b42f09aaf166abe51b43c16" continuedAt="Text_a060f030708b42f09aaf166abe51b43c17"><ix:continuation id="Text_5ef4f98ca10e4b0b847142259affda162" continuedAt="Text_5ef4f98ca10e4b0b847142259affda163">
<table cellpadding="0" cellspacing="0" id="zefa24bda41b145dc987f251a2c72b025" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="6" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;">Year Ended December 31,</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"></div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2020</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;">2019</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Cash paid for amounts included in the measurement of operating lease liabilities (in thousands)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingLeasePayments" id="Fact_d686a17747e64ef2a1661b40b3a32037" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">30,307</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingLeasePayments" id="Fact_9cfa6be44ddb449a8bf809a0aeb85905" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">30,077</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Right-of-use assets obtained in exchange for new operating lease liabilities (in thousands)<sup>*</sup></div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" id="Fact_8f96c3837ba5401590c591d7e2b74710" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">32,710</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" id="Fact_500b5cc37a5c47c6ab25797c123a9f6e" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">113,222</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
</table>
</ix:continuation></ix:continuation><ix:continuation id="Text_a060f030708b42f09aaf166abe51b43c17" continuedAt="Text_a060f030708b42f09aaf166abe51b43c18"><ix:continuation id="Text_5ef4f98ca10e4b0b847142259affda163" continuedAt="Text_5ef4f98ca10e4b0b847142259affda164">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_a060f030708b42f09aaf166abe51b43c18" continuedAt="Text_a060f030708b42f09aaf166abe51b43c19"><ix:continuation id="Text_5ef4f98ca10e4b0b847142259affda164">
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="ze8f9e808d67d46619b49699a7a23f031">
  <tr>
    <td style="width: 18pt;"></td>
    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">*</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:footnote id="Foot_2ef12113298047418d3d8f899b71e83a" footnoteRole="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US" continuedAt="Foot_e9899792aa584367a553e010d3f6d91c1">Includes the right-of-use assets obtained in exchange for lease liabilities for the year 2019 - $<ix:nonFraction name="us-gaap:OperatingLeaseLiability" id="Fact_0d582b95588c404582b28ba39c363ef0" contextRef="c20201231_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201602Member" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">82.6</ix:nonFraction></ix:footnote><ix:continuation id="Foot_e9899792aa584367a553e010d3f6d91c1"> million which were recognized upon adoption of ASC Topic 842 at January 1, 2019.</ix:continuation></div></td>
  </tr>
</table>
</ix:continuation></ix:continuation><ix:continuation id="Text_a060f030708b42f09aaf166abe51b43c19" continuedAt="Text_a060f030708b42f09aaf166abe51b43c20">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_a060f030708b42f09aaf166abe51b43c20" continuedAt="Text_a060f030708b42f09aaf166abe51b43c21"><ix:nonNumeric name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="Text_326e73ed06524d57bc1d62ca411c161a" contextRef="c20200101to20201231" escape="true" continuedAt="Text_7e03b944e2bc4687afe2904dcc5735db1">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The aggregate future lease payments for operating leases as of December 31, 2020 were as follows (in thousands):</div>
</ix:nonNumeric></ix:continuation><ix:continuation id="Text_a060f030708b42f09aaf166abe51b43c21" continuedAt="Text_a060f030708b42f09aaf166abe51b43c22"><ix:continuation id="Text_7e03b944e2bc4687afe2904dcc5735db1" continuedAt="Text_7e03b944e2bc4687afe2904dcc5735db2">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_a060f030708b42f09aaf166abe51b43c22" continuedAt="Text_a060f030708b42f09aaf166abe51b43c23"><ix:continuation id="Text_7e03b944e2bc4687afe2904dcc5735db2">
<table cellpadding="0" cellspacing="0" id="z36a05d7ef158441a9e0ee25c617b7227" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Fiscal Year</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Amount</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2021</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" id="Fact_40ce3979383f464d98f012803e25a8f7" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">29,819</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 88%;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2022</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" id="Fact_7b3d8ca0550443b895d17dc2ce757a13" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">23,861</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2023</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" id="Fact_1f5e2b212ccd4c1290bfb6c1d48c74e5" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">17,787</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 88%;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2024</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" id="Fact_ec19bb0568ad4d8c997e37430b1071fb" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">11,487</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2025 and therafter</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" id="Fact_e6ef42f6831b406f9a759a8dce0e3ae5" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">12,294</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 88%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total lease payments</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" id="Fact_142dd3b548b34b02bb88defae9807326" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">95,248</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Less: imputed interest</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" id="Fact_a3b67cd5f28c4fbb8d31d12175a15064" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,751</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 88%; padding-bottom: 4px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 33.85pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total operating lease liabilities</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" id="Fact_55fd4415ace14b1abff63f2f364cd63d" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">89,497</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
  </tr>
</table>
</ix:continuation></ix:continuation><ix:continuation id="Text_a060f030708b42f09aaf166abe51b43c23" continuedAt="Text_a060f030708b42f09aaf166abe51b43c24">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><br /></div>
</ix:continuation><ix:continuation id="Text_a060f030708b42f09aaf166abe51b43c24" continuedAt="Text_a060f030708b42f09aaf166abe51b43c25">
<div><br /></div>
</ix:continuation></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>68</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div><ix:continuation id="Text_a060f030708b42f09aaf166abe51b43c25" continuedAt="Text_a060f030708b42f09aaf166abe51b43c26"><ix:nonNumeric name="usph:WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock" id="Text_fa5ac311840b446aa0e9da41964fecc6" contextRef="c20200101to20201231" escape="true" continuedAt="Text_edc268e11c8849eb971e9b803bcdb12b1">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Average lease terms and discount rates were as follows:</div>
</ix:nonNumeric></ix:continuation><ix:continuation id="Text_a060f030708b42f09aaf166abe51b43c26" continuedAt="Text_a060f030708b42f09aaf166abe51b43c27"><ix:continuation id="Text_edc268e11c8849eb971e9b803bcdb12b1" continuedAt="Text_edc268e11c8849eb971e9b803bcdb12b2">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_a060f030708b42f09aaf166abe51b43c27"><ix:continuation id="Text_edc268e11c8849eb971e9b803bcdb12b2">
<table cellpadding="0" cellspacing="0" id="z00c67b6139734de2b818611f02c97724" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"></div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="6" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;">Year Ended December 31,</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2020</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;">2019</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Weighted-average remaining lease term - Operating leases</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="Fact_f60d3ff5edaa4a9686a8336c9e8db008" contextRef="c20201231" format="ixt-sec:duryear">4.05</ix:nonNumeric> Years</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -7pt;"><ix:nonNumeric name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="Fact_443744d2de8c45e996a0b837e1428b48" contextRef="c20191231" format="ixt-sec:duryear">4.05</ix:nonNumeric> Years</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Weighted-average discount rate - Operating leases</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" id="Fact_f2b2109921344d88bdf54eb2f1031f8c" contextRef="c20201231" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">3.1</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">%</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" id="Fact_e64d39c530df4447823ae6f223baeb76" contextRef="c20191231" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">3.9</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">%</div></td>
  </tr>
</table>
</ix:continuation></ix:continuation></div>
<div style="text-align: left;"><br /></div>
<div><ix:nonNumeric name="us-gaap:IncomeTaxDisclosureTextBlock" id="Text_0ec53356eab049eab7ffac8a31b8364d" contextRef="c20200101to20201231" escape="true" continuedAt="Text_4ad188883ba3490baa118bbf1a703bb11">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">11. Income Taxes</div>
</ix:nonNumeric><ix:continuation id="Text_4ad188883ba3490baa118bbf1a703bb11" continuedAt="Text_4ad188883ba3490baa118bbf1a703bb12">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_4ad188883ba3490baa118bbf1a703bb12" continuedAt="Text_4ad188883ba3490baa118bbf1a703bb13"><ix:nonNumeric name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="Text_2f23527fd6cf4f6ab6cbbfce73d2c408" contextRef="c20200101to20201231" escape="true" continuedAt="Text_86149cf369e54094be3f18ce1a47d1061">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Significant components of deferred tax assets and liabilities included in the consolidated balance sheets at December 31, 2020 and 2019 were as follows (in thousands):</div>
</ix:nonNumeric></ix:continuation><ix:continuation id="Text_4ad188883ba3490baa118bbf1a703bb13" continuedAt="Text_4ad188883ba3490baa118bbf1a703bb14"><ix:continuation id="Text_86149cf369e54094be3f18ce1a47d1061" continuedAt="Text_86149cf369e54094be3f18ce1a47d1062">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_4ad188883ba3490baa118bbf1a703bb14" continuedAt="Text_4ad188883ba3490baa118bbf1a703bb15"><ix:continuation id="Text_86149cf369e54094be3f18ce1a47d1062">
<table cellpadding="0" cellspacing="0" id="z210002d42bc24598a6e0e37001fc2dac" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"></div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Deferred tax assets:</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Compensation</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" id="Fact_5f3ee2f6d3dd408695fb1fe4e65252c5" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,865</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" id="Fact_9b981484fb2240d595e81a3e5b22fa49" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,964</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Allowance for credit losses</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" id="Fact_4d6ecea9a2e54377a1f52778bf1d0ea3" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">396</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" id="Fact_2234a4978ce149f6859605e2ee6357b4" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">514</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Acquired net operating losses</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" id="Fact_1c1f3be0303046dfa351aeee7591be7c" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">558</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" id="Fact_159c43c4681e4ef8a03afa6d162d3f03" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">840</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Lease obligations - including closed clinics</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:DeferredTaxAssetsLeaseObligations" id="Fact_afafe610d21c48318be3775b692fed0b" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">23,819</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:DeferredTaxAssetsLeaseObligations" id="Fact_9918d7e926ec41d7ada14827b0829270" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">21,445</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Deferred tax assets</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" id="Fact_fe4d5bd259f74bd18f409d4c2b73a68a" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">26,638</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" id="Fact_c00e8cdcd0dd441897f9e02918e49bd1" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">24,763</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Deferred tax liabilities:</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Depreciation and amortization</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" id="Fact_00df25e7ec804305b7f8e3267ab78e7a" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">12,650</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" id="Fact_75bd0aba3d704c8eab488b55ba58d452" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">13,195</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Operating lease right-of-use assets</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" id="Fact_be3ee8b1a47a409fa1f025231f2ac4fa" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">21,419</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" id="Fact_cc1fd4103fff411eaa961ae22a2a1e1e" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">21,416</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Other</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesOther" id="Fact_62228ddd331f4bdba2ceada922d012fc" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">348</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesOther" id="Fact_a41f0932694b447ba5c39f6026f3d515" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">223</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Deferred tax liabilities</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DeferredIncomeTaxLiabilities" id="Fact_d9312ff5d82445c3ba2896e46b0ebcdb" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">34,417</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DeferredIncomeTaxLiabilities" id="Fact_e1616d6324ef4c98b80b5733ad838b0d" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">34,834</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Net deferred tax liability</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilities" id="Fact_c057de254a1a4cd4b521aff3005a549a" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">7,779</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilities" id="Fact_9a9e8822324644d0a2866ad5b673e4cd" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">10,071</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
</table>
</ix:continuation></ix:continuation><ix:continuation id="Text_4ad188883ba3490baa118bbf1a703bb15" continuedAt="Text_4ad188883ba3490baa118bbf1a703bb16">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><br /></div>
</ix:continuation><ix:continuation id="Text_4ad188883ba3490baa118bbf1a703bb16" continuedAt="Text_4ad188883ba3490baa118bbf1a703bb17">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The deferred tax assets and liabilities related to purchased interests not yet finalized may result in an immaterial adjustment.</div>
</ix:continuation><ix:continuation id="Text_4ad188883ba3490baa118bbf1a703bb17" continuedAt="Text_4ad188883ba3490baa118bbf1a703bb18">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_4ad188883ba3490baa118bbf1a703bb18" continuedAt="Text_4ad188883ba3490baa118bbf1a703bb19">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">During 2020, the Company recorded deferred tax assets of $<ix:nonFraction name="usph:DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests" id="Fact_bf328ec96c7442e2a7ad2670be2c2fb8" contextRef="c20201231" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">1.2</ix:nonFraction> million related to the revaluation of redeemable non-controlling interests and acquisitions of non-controlling interests. In addition, during 2020, the Company recorded an adjustment to the deferred tax assets of $<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" id="Fact_8844c692b660401488b7930060999c95" contextRef="c20200101to20201231" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">1.4</ix:nonFraction> million as a result of a detailed reconciliation of its federal and state taxes payable and receivable accounts along with its federal and state deferred tax asset and liability accounts with its federal and state tax returns for 2019. The offset of this adjustment was a decrease to the previously reported federal income tax receivable. As of December 31, 2020, the Company has a federal income tax payable of $<ix:nonFraction name="us-gaap:AccruedIncomeTaxesCurrent" id="Fact_cf7264dc7dc549069a74bb9c2d4cd081" contextRef="c20201231_IncomeTaxAuthorityAxis_ForeignCountryMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">5.7</ix:nonFraction> million and state tax receivables of $<ix:nonFraction name="us-gaap:DeferredIncomeTaxesAndOtherTaxReceivableCurrent" id="Fact_98a9b10e524e4e93ac0df0275d19cb87" contextRef="c20201231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.7</ix:nonFraction> million. <span style="font-size: 10pt; font-family: 'Times New Roman';">The federal income tax payable is included in </span><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">accrued liabilities</span><span style="font-size: 10pt; font-family: 'Times New Roman';"> and the tax receivable is</span> included in <span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">other current assets</span> on the accompanying consolidated balance sheets.</div>
</ix:continuation><ix:continuation id="Text_4ad188883ba3490baa118bbf1a703bb19" continuedAt="Text_4ad188883ba3490baa118bbf1a703bb110">
<div style="text-align: left;"><br /></div>
</ix:continuation><ix:continuation id="Text_4ad188883ba3490baa118bbf1a703bb110" continuedAt="Text_4ad188883ba3490baa118bbf1a703bb111"><ix:nonNumeric name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="Text_c83c1926380349c6af086855ac405b3c" contextRef="c20200101to20201231" escape="true" continuedAt="Text_a9839b84a5f74d30b184065430ef3acd1">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The differences between the federal tax rate and the Company&#8217;s effective tax rate for the years ended December 31, 2020, 2019 and 2018 were as follows (in thousands):</div>
</ix:nonNumeric></ix:continuation><ix:continuation id="Text_4ad188883ba3490baa118bbf1a703bb111" continuedAt="Text_4ad188883ba3490baa118bbf1a703bb112"><ix:continuation id="Text_a9839b84a5f74d30b184065430ef3acd1" continuedAt="Text_a9839b84a5f74d30b184065430ef3acd2">
<div style="text-align: left;"><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_4ad188883ba3490baa118bbf1a703bb112" continuedAt="Text_4ad188883ba3490baa118bbf1a703bb113"><ix:continuation id="Text_a9839b84a5f74d30b184065430ef3acd2">
<table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z21bd67f809424afe8f722f356649b1f4">
  <tr>
    <td style="width: 26.72%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"></div></td>
    <td style="width: 1.13%; vertical-align: bottom;">&#160;</td>
    <td style="width: 1.18%; vertical-align: bottom; border-bottom: #000000 2px solid;">&#160;</td>
    <td colspan="3" style="width: 21.95%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div></td>
    <td style="width: 1.11%; vertical-align: bottom;">&#160;</td>
    <td style="width: 1.14%; vertical-align: bottom; border-bottom: #000000 2px solid;">&#160;</td>
    <td colspan="3" style="width: 21.77%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div></td>
    <td style="width: 1.08%; vertical-align: bottom;">&#160;</td>
    <td style="width: 1.1%; vertical-align: bottom; border-bottom: #000000 2px solid;">&#160;</td>
    <td colspan="3" style="width: 21.78%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2018</div></td>
    <td style="width: 1.04%; vertical-align: bottom;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 26.72%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U. S. tax at statutory rate</div></td>
    <td style="width: 1.13%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 1.18%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.51%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" id="Fact_88e8f25bc018459098855b9b1bb16e1e" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">10,125</ix:nonFraction></div></td>
    <td style="width: 0.93%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 10.51%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" id="Fact_5e110eb435ca401b98610262716ccb56" contextRef="c20200101to20201231" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">21.0</ix:nonFraction>%</div></td>
    <td style="width: 1.11%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 1.14%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.52%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" id="Fact_a82f1533f7524caa9aaec20fe5196d6c" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">11,274</ix:nonFraction></div></td>
    <td style="width: 0.73%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 10.52%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" id="Fact_7571cdf489e64abeb168c44c58887647" contextRef="c20190101to20191231" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">21.0</ix:nonFraction>%</div></td>
    <td style="width: 1.08%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 1.1%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.53%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" id="Fact_5867b29647284c2b89b55d75b678b3a8" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">9,710</ix:nonFraction></div></td>
    <td style="width: 0.73%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 10.52%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" id="Fact_2e343fabc02a4ca8a054bf2629fb12b9" contextRef="c20180101to20181231" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">21.0</ix:nonFraction>%</div></td>
    <td style="width: 1.04%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 26.72%; vertical-align: bottom; background-color: #FFFFFF; white-space: nowrap;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">State income taxes, net of federal benefit</div></td>
    <td style="width: 1.13%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 1.18%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 10.51%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" id="Fact_35dac135f1c74b34830913146efeff56" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,956</ix:nonFraction></div></td>
    <td style="width: 0.93%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 10.51%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" id="Fact_0940207a923c4adb85e97487dc8b5a12" contextRef="c20200101to20201231" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">3.9</ix:nonFraction>%</div></td>
    <td style="width: 1.11%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 1.14%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 10.52%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" id="Fact_fbdaf61146144964bebe26b4b9d99a8f" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,059</ix:nonFraction></div></td>
    <td style="width: 0.73%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 10.52%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" id="Fact_6a2e8a02eb6a4a539a417904bc52f6c5" contextRef="c20190101to20191231" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">3.8</ix:nonFraction>%</div></td>
    <td style="width: 1.08%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 1.1%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 10.53%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" id="Fact_6fa111822d484abe8af1f028a4d09316" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,722</ix:nonFraction></div></td>
    <td style="width: 0.73%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 10.52%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" id="Fact_fc9336f8d4224b27932827c5c9aa53c2" contextRef="c20180101to20181231" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">3.7</ix:nonFraction>%</div></td>
    <td style="width: 1.04%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 26.72%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Excess equity compensation deduction</div></td>
    <td style="width: 1.13%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 1.18%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 10.51%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationDeductions" id="Fact_a29075a2853e410987e3cea729c1cb3d" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">99</ix:nonFraction>)</div></td>
    <td style="width: 0.93%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 10.51%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationDeductions" id="Fact_f416a44670c14dfebb4c734a086d7238" contextRef="c20200101to20201231" unitRef="U005" decimals="3" sign="-" scale="-2" format="ixt:numdotdecimal">0.0</ix:nonFraction>%</div></td>
    <td style="width: 1.11%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 1.14%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 10.52%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationDeductions" id="Fact_0dc6ba2ea47243f5beb5d6ad15cfbe03" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">871</ix:nonFraction>)</div></td>
    <td style="width: 0.73%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 10.52%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationDeductions" id="Fact_8f1758b0e66b40d5ba0c75207f2509d3" contextRef="c20190101to20191231" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">1.6</ix:nonFraction> %</div></td>
    <td style="width: 1.08%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 1.1%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 10.53%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationDeductions" id="Fact_3b9c0bef7d044a6cb29be80d1fb4c133" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">806</ix:nonFraction>)</div></td>
    <td style="width: 0.73%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 10.52%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationDeductions" id="Fact_43eca628f590439981ed8ec4ab3f4d17" contextRef="c20180101to20181231" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">1.7</ix:nonFraction> %</div></td>
    <td style="width: 1.04%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 26.72%; vertical-align: bottom; background-color: #FFFFFF; white-space: nowrap;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Non-deductible expenses</div></td>
    <td style="width: 1.13%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 1.18%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 10.51%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" id="Fact_db8ae5df419b4865a8effe574b7ac857" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,040</ix:nonFraction></div></td>
    <td style="width: 0.93%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 10.51%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" id="Fact_6d83e5f9dc214a098eac283dd6052477" contextRef="c20200101to20201231" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">2.1</ix:nonFraction>%</div></td>
    <td style="width: 1.11%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 1.14%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 10.52%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" id="Fact_80f71899e1894613890ab208550a9e35" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,185</ix:nonFraction></div></td>
    <td style="width: 0.73%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 10.52%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" id="Fact_a884acb519a14f09873f5ce8f329999b" contextRef="c20190101to20191231" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">2.2</ix:nonFraction>%</div></td>
    <td style="width: 1.08%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 1.1%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 10.53%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" id="Fact_c6678d847c8c44899246ac71f40e6b85" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">743</ix:nonFraction></div></td>
    <td style="width: 0.73%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 10.52%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" id="Fact_ec62d04ef5ff4844a548f69bea5b0122" contextRef="c20180101to20181231" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">1.6</ix:nonFraction>%</div></td>
    <td style="width: 1.04%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 26.72%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 1.13%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 1.18%; vertical-align: bottom; border-top: #000000 2px solid; border-bottom: #000000 4px double; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.51%; vertical-align: bottom; border-top: #000000 2px solid; border-bottom: #000000 4px double; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" id="Fact_c5b7cddb82974ca5bc0b09bace456b48" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">13,022</ix:nonFraction></div></td>
    <td style="width: 0.93%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 10.51%; vertical-align: bottom; border-top: #000000 2px solid; border-bottom: #000000 4px double; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" id="Fact_b74047cb1fd34e589a244cf771de19eb" contextRef="c20200101to20201231" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">27.0</ix:nonFraction>%</div></td>
    <td style="width: 1.11%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 1.14%; vertical-align: bottom; border-top: #000000 2px solid; border-bottom: #000000 4px double; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.52%; vertical-align: bottom; border-top: #000000 2px solid; border-bottom: #000000 4px double; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" id="Fact_65452e40a9404c55b03380269e192569" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">13,647</ix:nonFraction></div></td>
    <td style="width: 0.73%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 10.52%; vertical-align: bottom; border-top: #000000 2px solid; border-bottom: #000000 4px double; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" id="Fact_9eb9a22f911b4a6bbf59abf44129f54d" contextRef="c20190101to20191231" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">25.4</ix:nonFraction>%</div></td>
    <td style="width: 1.08%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 1.1%; vertical-align: bottom; border-top: #000000 2px solid; border-bottom: #000000 4px double; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.53%; vertical-align: bottom; border-top: #000000 2px solid; border-bottom: #000000 4px double; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" id="Fact_0933cb19f54349bbae941a1a9e462caf" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">11,369</ix:nonFraction></div></td>
    <td style="width: 0.73%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 10.52%; vertical-align: bottom; border-top: #000000 2px solid; border-bottom: #000000 4px double; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" id="Fact_621f3f3a517e4b6b9f11243fa8ce2dbb" contextRef="c20180101to20181231" unitRef="U005" decimals="3" scale="-2" format="ixt:numdotdecimal">24.6</ix:nonFraction>%</div></td>
    <td style="width: 1.04%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
  </tr>
</table>
</ix:continuation></ix:continuation><ix:continuation id="Text_4ad188883ba3490baa118bbf1a703bb113" continuedAt="Text_4ad188883ba3490baa118bbf1a703bb114">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><br /></div>
</ix:continuation><ix:continuation id="Text_4ad188883ba3490baa118bbf1a703bb114" continuedAt="Text_4ad188883ba3490baa118bbf1a703bb115">
<div><br /></div>
</ix:continuation></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>69</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div><ix:continuation id="Text_4ad188883ba3490baa118bbf1a703bb115" continuedAt="Text_4ad188883ba3490baa118bbf1a703bb116"><ix:nonNumeric name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="Text_c326d369b10b4edcb1a548a203c9014e" contextRef="c20200101to20201231" escape="true" continuedAt="Text_61d40ef5384d42a69ef8fd6a36e01b5a1">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Significant components of the provision for income taxes for the years ended December 31, 2020, 2019 and 2018 were as follows (in thousands):</div>
</ix:nonNumeric></ix:continuation><ix:continuation id="Text_4ad188883ba3490baa118bbf1a703bb116" continuedAt="Text_4ad188883ba3490baa118bbf1a703bb117"><ix:continuation id="Text_61d40ef5384d42a69ef8fd6a36e01b5a1" continuedAt="Text_61d40ef5384d42a69ef8fd6a36e01b5a2">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_4ad188883ba3490baa118bbf1a703bb117" continuedAt="Text_4ad188883ba3490baa118bbf1a703bb118"><ix:continuation id="Text_61d40ef5384d42a69ef8fd6a36e01b5a2">
<table cellpadding="0" cellspacing="0" id="zbf81119b8a024b268d90882988e17c64" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td valign="bottom" style="vertical-align: top; padding-bottom: 2px; white-space: nowrap;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"></div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">December 31, </span>2020</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">December 31, </span>2019</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">December 31, </span>2018</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: top; white-space: nowrap;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Current:</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: top; width: 64%; background-color: #CCEEFF; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Federal</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" id="Fact_b7ca54753bbc40a385eb65d4efe05f7c" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">10,506</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" id="Fact_2a7e186d4d13460d87c24d0339041113" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,523</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" id="Fact_9b2fb089d5494a718660099da3eb3913" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,357</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: top; width: 64%; padding-bottom: 2px; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">State</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" id="Fact_1c0e061911ae4f4eb1b32199f7c423ec" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,774</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" id="Fact_324014f5e1e7493d9706c90699d58539" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,473</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" id="Fact_c541630a2cff466480d90baf8cef364b" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,199</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: top; width: 64%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total current</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CurrentIncomeTaxExpenseBenefit" id="Fact_34893f428c4547bab8ea44c7a8703325" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">13,280</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CurrentIncomeTaxExpenseBenefit" id="Fact_5ce56f4cd618421194dbf7e31a05c857" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">8,996</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:CurrentIncomeTaxExpenseBenefit" id="Fact_ebe4468d213d4c40afa67863a4f68667" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,556</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: top; width: 64%; white-space: nowrap;"><div style="text-align: left; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Deferred:</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: top; width: 64%; background-color: #CCEEFF; white-space: nowrap;"><div style="text-align: left; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Federal</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" id="Fact_f47794a289fa443e8f42b67b85589405" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">38</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" id="Fact_8db7295a340143cf876c8301362ecebe" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">3,730</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" id="Fact_8c555085d8a6407784d596af4b42ffed" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">3,771</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: top; width: 64%; padding-bottom: 2px; white-space: nowrap;"><div style="text-align: left; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">State</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" id="Fact_59671c58a9a2494ab42e80a34ff74bc4" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">220</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" id="Fact_b7b178e59a3845c0b0cfd6d18ccc8c0d" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">921</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" id="Fact_52dd01d49051491b94857360bc900030" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,042</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: top; width: 64%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total deferred</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" id="Fact_27f90b2ad0494cee82e16ef42322ebe4" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">258</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" id="Fact_da3e388272f7454b983d9d79a079e830" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,651</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" id="Fact_95d030e3b75145b78e239c0a05d54567" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,813</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: top; width: 64%; padding-bottom: 4px; white-space: nowrap;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total income tax provision</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" id="Fact_b7e88154a1be4aa59300cc411fabb2ad" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">13,022</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" id="Fact_ee2f7a5edf4c40ec877d0e1a5a6e280d" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">13,647</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" id="Fact_333084e60be44f44a8f1e4e453e940b3" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">11,369</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
  </tr>
</table>
</ix:continuation></ix:continuation><ix:continuation id="Text_4ad188883ba3490baa118bbf1a703bb118" continuedAt="Text_4ad188883ba3490baa118bbf1a703bb119">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><br /></div>
</ix:continuation><ix:continuation id="Text_4ad188883ba3490baa118bbf1a703bb119" continuedAt="Text_4ad188883ba3490baa118bbf1a703bb120">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">For 2020, 2019 and 2018, the Company performed a detailed reconciliation of its federal and state taxes payable and receivable accounts along with its federal and state deferred tax asset and liability accounts. The adjustments were immaterial. The Company considers this reconciliation process to be an annual control.</div>
</ix:continuation><ix:continuation id="Text_4ad188883ba3490baa118bbf1a703bb120" continuedAt="Text_4ad188883ba3490baa118bbf1a703bb121">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_4ad188883ba3490baa118bbf1a703bb121" continuedAt="Text_4ad188883ba3490baa118bbf1a703bb122">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company is required to establish a valuation allowance for deferred tax assets if, based on the weight of available evidence, it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the projected future taxable income and tax planning strategies in making this assessment. Based upon the level of historical taxable income and projections for future taxable income in the periods which the deferred tax assets are deductible, management believes that a valuation allowance is not required, as it is more likely than not that the results of future operations will generate sufficient taxable income to realize the deferred tax assets.</div>
</ix:continuation><ix:continuation id="Text_4ad188883ba3490baa118bbf1a703bb122" continuedAt="Text_4ad188883ba3490baa118bbf1a703bb123">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_4ad188883ba3490baa118bbf1a703bb123" continuedAt="Text_4ad188883ba3490baa118bbf1a703bb124">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company&#8217;s U.S. federal returns remain open to examination for <span style="-sec-ix-hidden:Fact_c614eba92f724091923d077cce15bd38">2017 through 2019</span> and U.S. state jurisdictions are open for periods ranging from <span style="-sec-ix-hidden:Fact_a3d421d0c572494d8b850b77d069a61f">2016 through 2019</span>.</div>
</ix:continuation><ix:continuation id="Text_4ad188883ba3490baa118bbf1a703bb124" continuedAt="Text_4ad188883ba3490baa118bbf1a703bb125">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_4ad188883ba3490baa118bbf1a703bb125" continuedAt="Text_4ad188883ba3490baa118bbf1a703bb126">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company does not believe that it has any significant uncertain tax positions at December 31, 2020 and December 31, 2019, nor is this expected to change within the next twelve months due to the settlement and expiration of statutes of limitation.</div>
</ix:continuation><ix:continuation id="Text_4ad188883ba3490baa118bbf1a703bb126" continuedAt="Text_4ad188883ba3490baa118bbf1a703bb127">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_4ad188883ba3490baa118bbf1a703bb127">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company did <ix:nonFraction name="us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" id="Fact_f17d686007254b2ead06ecd6aa004f72" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" id="Fact_65275baa7c7e4ae9ab465ba4a2df460e" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" id="Fact_5c500b2ceb59435a9367076b6dda1601" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" id="Fact_55631d253d904abb9fbb7f5111a2e36f" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" id="Fact_2a3c18f909e34cc9915252fce094ed26" contextRef="c20181231" unitRef="U001" decimals="-3" scale="3" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" id="Fact_00dbb930dd194ec985f8cbecd430ad27" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>t have any accrued interest or penalties associated with any unrecognized tax benefits nor was any interest expense recognized during the years ended December 31, 2020, 2019 and 2018.</div>
</ix:continuation></div>
<div><br /></div>
<div><ix:nonNumeric name="us-gaap:SegmentReportingDisclosureTextBlock" id="Text_6e9da235e2794822a68fe70d324b0750" contextRef="c20200101to20201231" escape="true" continuedAt="Text_2ed316e0633e4b519beb6338c425c27d1">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">12. Segment Information</div>
</ix:nonNumeric><ix:continuation id="Text_2ed316e0633e4b519beb6338c425c27d1" continuedAt="Text_2ed316e0633e4b519beb6338c425c27d2">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_2ed316e0633e4b519beb6338c425c27d2" continuedAt="Text_2ed316e0633e4b519beb6338c425c27d3">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">The Company&#8217;s reportable segments include the physical therapy operations segment and the industrial injury prevention services segment. Also included in the physical therapy operations segment are revenues from management contract services and other services which include services the Company provides on-site, such as schools for athletic trainers</span>.</div>
</ix:continuation><ix:continuation id="Text_2ed316e0633e4b519beb6338c425c27d3" continuedAt="Text_2ed316e0633e4b519beb6338c425c27d4">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_2ed316e0633e4b519beb6338c425c27d4" continuedAt="Text_2ed316e0633e4b519beb6338c425c27d5">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">The Company evaluates performance of the segments based on gross profit. The Company has provided additional information regarding its reportable segments which contributes to the understanding of the Company and provides useful information</span>.</div>
</ix:continuation><ix:continuation id="Text_2ed316e0633e4b519beb6338c425c27d5" continuedAt="Text_2ed316e0633e4b519beb6338c425c27d6">
<div><br /></div>
</ix:continuation></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>70</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div><ix:continuation id="Text_2ed316e0633e4b519beb6338c425c27d6" continuedAt="Text_2ed316e0633e4b519beb6338c425c27d7"><ix:nonNumeric name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="Text_8b35a70c459349c187575a2f0041d55b" contextRef="c20200101to20201231" escape="true" continuedAt="Text_d6a6d3afddcb4031a33cb1fa8d6402e01">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">T<span style="font-size: 10pt; font-family: 'Times New Roman';">he following table summarizes selected financial data for the Company&#8217;s reportable segments. Prior year results presented herein have been changed to conform to the current presentation</span>.</div>
</ix:nonNumeric></ix:continuation><ix:continuation id="Text_2ed316e0633e4b519beb6338c425c27d7" continuedAt="Text_2ed316e0633e4b519beb6338c425c27d8"><ix:continuation id="Text_d6a6d3afddcb4031a33cb1fa8d6402e01" continuedAt="Text_d6a6d3afddcb4031a33cb1fa8d6402e02">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_2ed316e0633e4b519beb6338c425c27d8"><ix:continuation id="Text_d6a6d3afddcb4031a33cb1fa8d6402e02">
<table cellpadding="0" cellspacing="0" id="zea0754717f864c8688543b30b5aa363f" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31,</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31,</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31,</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"></div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2020</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> 2019</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2018</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(in thousands)</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(in thousands)</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Net operating revenues:</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Physical therapy operations</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Revenues" id="Fact_76bd81f7b88e44d48185909609e3e62d" contextRef="c20200101to20201231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">383,770</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Revenues" id="Fact_52ee4d9dad274edfb218422a828e15cd" contextRef="c20190101to20191231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">444,507</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Revenues" id="Fact_d5f9e45c972c4b1495066d70407d1eea" contextRef="c20180101to20181231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">428,445</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px;"><div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Industrial injury prevention services</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Revenues" id="Fact_9a9108960248438ebe02c782f3901e0b" contextRef="c20200101to20201231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">39,199</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Revenues" id="Fact_cb48a3d5cc464d859e4e48e203fb50fd" contextRef="c20190101to20191231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">37,462</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Revenues" id="Fact_82adba4a80074ee697f34bd852e54558" contextRef="c20180101to20181231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">25,466</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total Company</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Revenues" id="Fact_0c1a9c1d1e3a42bb982062e4b95879df" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">422,969</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Revenues" id="Fact_ff6f85a38fe942338a0d2f0e905c7231" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">481,969</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Revenues" id="Fact_34dfa5cb699549c99da0bdd43f601d3f" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">453,911</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: top; width: 64%;"><div style="text-align: left; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Gross profit:</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: top; width: 64%;"><div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Physical therapy operations (excluding closure costs)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GrossProfit" id="Fact_897e0405d22444cd9569768efe73b8de" contextRef="c20200101to20201231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsExcludingClosureCostsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">88,295</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GrossProfit" id="Fact_5d21e5f6ccf54fc5b23d155333286f23" contextRef="c20190101to20191231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsExcludingClosureCostsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">104,120</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GrossProfit" id="Fact_05d68dca9b6749efbac2b3f75ad563f3" contextRef="c20180101to20181231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsExcludingClosureCostsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">96,463</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: top; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Industrial injury prevention services</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GrossProfit" id="Fact_65840ee1d5524f0ebb19a87b31c29a4e" contextRef="c20200101to20201231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">10,086</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GrossProfit" id="Fact_5b71d245291a4653a7d691beabe0c841" contextRef="c20190101to20191231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">8,379</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GrossProfit" id="Fact_a25be442dd904fed917ce673000f912b" contextRef="c20180101to20181231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,192</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: top; width: 64%;"><div style="text-align: left; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GrossProfit" id="Fact_c9edbed54975472eb0d7cd91f34cc00c" contextRef="c20200101to20201231_ConsolidationItemsAxis_OperatingSegmentsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">98,381</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GrossProfit" id="Fact_28eaa2fd23674a4cb8bc8c4656b96b6e" contextRef="c20190101to20191231_ConsolidationItemsAxis_OperatingSegmentsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">112,499</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GrossProfit" id="Fact_973d7d9e4426437d8efe113dee9b9efd" contextRef="c20180101to20181231_ConsolidationItemsAxis_OperatingSegmentsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">101,655</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: top; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Physical therapy operations - closure costs</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RestructuringCharges" id="Fact_06439c45d2bc4bd6ae549c997ff17205" contextRef="c20200101to20201231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">3,931</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:RestructuringCharges" id="Fact_246f3e02ed194c7a8de03c1a66a8ab8f" contextRef="c20190101to20191231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">25</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="us-gaap:RestructuringCharges" id="Fact_7a9761222bb24515a66471ed52446f1f" contextRef="c20180101to20181231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">8</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: top; width: 64%; padding-bottom: 4px;"><div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Gross profit</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GrossProfit" id="Fact_c469dbbb58c24bf2913f0e6e9d887276" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">94,450</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GrossProfit" id="Fact_445b1c0714884270a19921020b8a5e42" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">112,474</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:GrossProfit" id="Fact_ad7868d5dd0b411e9e38a371b42763e0" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">101,663</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: top; width: 64%; background-color: #CCEEFF;"><div style="text-align: left; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total Assets:</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: top; width: 64%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Physical therapy operations</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Assets" id="Fact_bc058bcc884a49c9b2f26f263b5c2e73" contextRef="c20201231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">550,181</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Assets" id="Fact_ffdcda26951a41bcb8bacc8d453458b1" contextRef="c20191231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">518,027</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Assets" id="Fact_1f53dd13cb094499a1f30ce9b14e81b2" contextRef="c20181231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">421,474</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: top; width: 64%; padding-bottom: 2px;"><div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Industrial injury prevention services</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Assets" id="Fact_e08a3a23b0a84f57b8dd11abcc487fbf" contextRef="c20201231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">44,180</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Assets" id="Fact_b5f99d741d0f46c88e33ce212a566708" contextRef="c20191231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">42,818</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Assets" id="Fact_4ed612ba6045495199d7e32d506dfba1" contextRef="c20181231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">21,692</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: top; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total Company</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Assets" id="Fact_5278e6efac8d422181163d8056310166" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">594,361</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Assets" id="Fact_28f719b97d3d4b389f68003290605bb7" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">560,845</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:Assets" id="Fact_e638af0e235744ef9e2e8307b625679a" contextRef="c20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">443,166</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
</table>
</ix:continuation></ix:continuation></div>
<div style="text-align: left;"><br /></div>
<div><ix:nonNumeric name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="Text_1bf2c877ca6d48a08f86dce9ab84ac62" contextRef="c20200101to20201231" escape="true" continuedAt="Text_a293117fb5d94473ba92bb26a451e17f1">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">13. Equity Based Plans</div>
</ix:nonNumeric><ix:continuation id="Text_a293117fb5d94473ba92bb26a451e17f1" continuedAt="Text_a293117fb5d94473ba92bb26a451e17f2">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_a293117fb5d94473ba92bb26a451e17f2" continuedAt="Text_a293117fb5d94473ba92bb26a451e17f3">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company has the following equity based plans with outstanding equity grants:</div>
</ix:continuation><ix:continuation id="Text_a293117fb5d94473ba92bb26a451e17f3" continuedAt="Text_a293117fb5d94473ba92bb26a451e17f4">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_a293117fb5d94473ba92bb26a451e17f4" continuedAt="Text_a293117fb5d94473ba92bb26a451e17f5">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Amended and Restated 1999 Employee Stock Option Plan (the &#8220;Amended 1999 Plan&#8221;) permits the Company to grant to non-employee directors and employees of the Company up to <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" id="Fact_3985c2b255a0462fa6acb69da4cdd14b" contextRef="c20201231_AwardTypeAxis_NonQualifiedStockOptionsMember_RangeAxis_MaximumMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">600,000</ix:nonFraction> non-qualified options to purchase shares of common stock and restricted stock (subject to proportionate adjustments in the event of stock dividends, splits, and similar corporate transactions). The exercise prices of options granted under the Amended 1999 Plan are determined by the Compensation Committee. The period within which each option will be exercisable is determined by the Compensation Committee. The Amended 1999 Plan was approved by the shareholders of the Company at the 2008 Shareholders Meeting on May 20, 2008.</div>
</ix:continuation><ix:continuation id="Text_a293117fb5d94473ba92bb26a451e17f5" continuedAt="Text_a293117fb5d94473ba92bb26a451e17f6">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_a293117fb5d94473ba92bb26a451e17f6" continuedAt="Text_a293117fb5d94473ba92bb26a451e17f7">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Amended and Restated 2003 Stock Option Plan (the &#8220;Amended 2003 Plan&#8221;) permits the Company to grant to key employees and outside directors of the Company incentive and non-qualified options and shares of restricted stock covering up to <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" id="Fact_64e16b49f3f14e2d8590d5d8c109eee7" contextRef="c20201231_PlanNameAxis_AmendedTwoThousandThreePlanMember_RangeAxis_MaximumMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">2,100,000</ix:nonFraction> shares of common stock (subject to proportionate adjustments in the event of stock dividends, splits, and similar corporate transactions). The material terms of the Amended 2003 Plan was reapproved by the shareholders of the Company at the 2015 Shareholders Meeting on May 19, 2015 and an increase in the number of shares authorized for issuance from <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" id="Fact_441ca605604c4b299e69df28ef59e6d0" contextRef="c20160316_PlanNameAxis_AmendedTwoThousandThreePlanMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">1,750,000</ix:nonFraction> to <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" id="Fact_b967085175794e508e0bad209d803040" contextRef="c20160317_PlanNameAxis_AmendedTwoThousandThreePlanMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">2,100,000</ix:nonFraction> was approved at the 2016 Shareholders Meeting on March 17, 2016.</div>
</ix:continuation><ix:continuation id="Text_a293117fb5d94473ba92bb26a451e17f7" continuedAt="Text_a293117fb5d94473ba92bb26a451e17f8">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_a293117fb5d94473ba92bb26a451e17f8" continuedAt="Text_a293117fb5d94473ba92bb26a451e17f9"><ix:nonNumeric name="us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock" id="Text_876112127aef4da68da7304fec5c63af" contextRef="c20200101to20201231" escape="true" continuedAt="Text_f8870abc29bb49509b9487b1df6666f81">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">A cumulative summary of equity plans as of December 31, 2020 follows:</div>
</ix:nonNumeric></ix:continuation><ix:continuation id="Text_a293117fb5d94473ba92bb26a451e17f9" continuedAt="Text_a293117fb5d94473ba92bb26a451e17f10"><ix:continuation id="Text_f8870abc29bb49509b9487b1df6666f81" continuedAt="Text_f8870abc29bb49509b9487b1df6666f82">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_a293117fb5d94473ba92bb26a451e17f10" continuedAt="Text_a293117fb5d94473ba92bb26a451e17f11"><ix:continuation id="Text_f8870abc29bb49509b9487b1df6666f82">
<table cellpadding="0" cellspacing="0" id="z0fd35d71f4c741a1afb5a3fdfe7e4755" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"></div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Authorized</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Restricted<span style="font-size: 10pt; font-family: 'Times New Roman';"><br /></span>Stock Issued</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Outstanding<span style="font-size: 10pt; font-family: 'Times New Roman';"><br /></span>Stock Options</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Stock Options<span style="font-size: 10pt; font-family: 'Times New Roman';"><br /></span>Exercised</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Stock Options<span style="font-size: 10pt; font-family: 'Times New Roman';"><br /></span>Exercisable</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Shares Available<span style="font-size: 10pt; font-family: 'Times New Roman';"><br /></span>for Grant</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; white-space: nowrap;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Equity Plans</span></div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: #CCEEFF; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Amended 1999 Plan</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" id="Fact_ef6f1ae9e8e046499ef25607c94f1376" contextRef="c20201231_PlanNameAxis_AmendedNineteenNinetyNinePlanMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">600,000</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod" id="Fact_169bf999606544038f198894c7869a73" contextRef="c20201231_PlanNameAxis_AmendedNineteenNinetyNinePlanMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">416,402</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" id="Fact_a157782706e2459ea664bb327b2560fa" contextRef="c20201231_PlanNameAxis_AmendedNineteenNinetyNinePlanMember" unitRef="U002" decimals="INF" scale="0" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod" id="Fact_7c31cd6f5e15476183edffe3ddc4b19d" contextRef="c20201231_PlanNameAxis_AmendedNineteenNinetyNinePlanMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">139,791</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" id="Fact_8899542c11784f63aaf237e696ed3c26" contextRef="c20201231_PlanNameAxis_AmendedNineteenNinetyNinePlanMember" unitRef="U002" decimals="INF" scale="0" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" id="Fact_8bcd168f7124473693b589ce80b380ed" contextRef="c20201231_PlanNameAxis_AmendedNineteenNinetyNinePlanMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">7,775</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 28%; padding-bottom: 2px; white-space: nowrap;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Amended 2003 Plan</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" id="Fact_a1a362aed6f84e28941057525e1ffff5" contextRef="c20201231_PlanNameAxis_AmendedTwoThousandThreePlanMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">2,100,000</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod" id="Fact_0a091a8a67bd4d7f86c312b263185063" contextRef="c20201231_PlanNameAxis_AmendedTwoThousandThreePlanMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">1,106,977</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" id="Fact_f0ebc547108a44e290a61b2c5ab68b32" contextRef="c20201231_PlanNameAxis_AmendedTwoThousandThreePlanMember" unitRef="U002" decimals="INF" scale="0" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod" id="Fact_89f5f086e881405aa26c9d258330bca8" contextRef="c20201231_PlanNameAxis_AmendedTwoThousandThreePlanMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">778,300</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" id="Fact_808cf5ca6ea14d018bce805c369bffac" contextRef="c20201231_PlanNameAxis_AmendedTwoThousandThreePlanMember" unitRef="U002" decimals="INF" scale="0" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" id="Fact_4b87cc8c3cd34ce5b7306bb27cdb278d" contextRef="c20201231_PlanNameAxis_AmendedTwoThousandThreePlanMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">224,760</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 28%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" id="Fact_a17c223a3e114d458e1ead6a28cc5ed1" contextRef="c20201231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">2,700,000</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod" id="Fact_cd9212355cce43ff90a4505736fdb567" contextRef="c20201231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">1,523,379</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" id="Fact_5347ee97792e495da40fc60b2e86d370" contextRef="c20201231" unitRef="U002" decimals="INF" scale="0" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod" id="Fact_d1a8b771e86543889f01bb8e025730ec" contextRef="c20201231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">918,091</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" id="Fact_9e993450b5814d24862fa5a939687ebf" contextRef="c20201231" unitRef="U002" decimals="INF" scale="0" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" id="Fact_94b26a59e1f74bd7853f34bc187257e7" contextRef="c20201231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">232,535</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
</table>
</ix:continuation></ix:continuation><ix:continuation id="Text_a293117fb5d94473ba92bb26a451e17f11" continuedAt="Text_a293117fb5d94473ba92bb26a451e17f12">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><br /></div>
</ix:continuation><ix:continuation id="Text_a293117fb5d94473ba92bb26a451e17f12" continuedAt="Text_a293117fb5d94473ba92bb26a451e17f13">
<div><br /></div>
</ix:continuation></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>71</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div><ix:continuation id="Text_a293117fb5d94473ba92bb26a451e17f13" continuedAt="Text_a293117fb5d94473ba92bb26a451e17f14"><ix:nonNumeric name="us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" id="Text_4d762aba49a247b981f909ddec37c516" contextRef="c20200101to20201231" escape="true" continuedAt="Text_d494bc67d6164dd0976ae2da3adf6b701">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">During 2020, 2019 and 2018, the Company granted the following shares of restricted stock to directors, officers and employees pursuant to its equity plans as follows:</div>
</ix:nonNumeric></ix:continuation><ix:continuation id="Text_a293117fb5d94473ba92bb26a451e17f14" continuedAt="Text_a293117fb5d94473ba92bb26a451e17f15"><ix:continuation id="Text_d494bc67d6164dd0976ae2da3adf6b701" continuedAt="Text_d494bc67d6164dd0976ae2da3adf6b702">
<div style="text-align: left;"><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_a293117fb5d94473ba92bb26a451e17f15" continuedAt="Text_a293117fb5d94473ba92bb26a451e17f16"><ix:continuation id="Text_d494bc67d6164dd0976ae2da3adf6b702" continuedAt="Text_d494bc67d6164dd0976ae2da3adf6b703">
<table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; border-collapse: collapse; text-align: left; color: #000000; width: 100%; margin-left: auto; margin-right: auto;" id="z87259eaa26b8463e9d0de795ce96e698">
  <tr>
    <td style="width: 33.07%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Granted</div></td>
    <td style="width: 0.97%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td style="width: 33.21%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Number of Shares</div></td>
    <td style="width: 1.11%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="2" style="width: 30.43%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Weighted Average Fair<span style="font-size: 10pt; font-family: 'Times New Roman';"><br /></span>Value Per Share</div></td>
    <td style="width: 1.21%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 33.07%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2020</div></td>
    <td style="width: 0.97%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 33.21%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" id="Fact_fc501d60d7e64fda9e983344ba5abbaa" contextRef="c20200101to20201231_AwardTypeAxis_RestrictedStockMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">86,982</ix:nonFraction></div></td>
    <td style="width: 1.11%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 2.36%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 28.07%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" id="Fact_3ef44493ed4e4df48fa511e4e416351b" contextRef="c20200101to20201231_AwardTypeAxis_RestrictedStockMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">104.69</ix:nonFraction></div></td>
    <td style="width: 1.21%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 33.07%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2019</div></td>
    <td style="width: 0.97%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 33.21%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" id="Fact_6d7f6250feb34fd7bd3386358b98c29b" contextRef="c20190101to20191231_AwardTypeAxis_RestrictedStockMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">91,682</ix:nonFraction></div></td>
    <td style="width: 1.11%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 2.36%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 28.07%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" id="Fact_bc82d60fbf2e4afcbe8f56413e54aa9d" contextRef="c20190101to20191231_AwardTypeAxis_RestrictedStockMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">104.85</ix:nonFraction></div></td>
    <td style="width: 1.21%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 33.07%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2018</div></td>
    <td style="width: 0.97%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 33.21%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" id="Fact_503c6c46bd6948e6a064a912a9bec944" contextRef="c20180101to20181231_AwardTypeAxis_RestrictedStockMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">93,801</ix:nonFraction></div></td>
    <td style="width: 1.11%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 2.36%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 28.07%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" id="Fact_9da08f3067f543659303fc04cd8ee3c4" contextRef="c20180101to20181231_AwardTypeAxis_RestrictedStockMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">78.63</ix:nonFraction></div></td>
    <td style="width: 1.21%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
  </tr>
</table>
</ix:continuation></ix:continuation><ix:continuation id="Text_a293117fb5d94473ba92bb26a451e17f16" continuedAt="Text_a293117fb5d94473ba92bb26a451e17f17"><ix:continuation id="Text_d494bc67d6164dd0976ae2da3adf6b703" continuedAt="Text_d494bc67d6164dd0976ae2da3adf6b704">
<div style="text-align: left;"><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_a293117fb5d94473ba92bb26a451e17f17" continuedAt="Text_a293117fb5d94473ba92bb26a451e17f18"><ix:continuation id="Text_d494bc67d6164dd0976ae2da3adf6b704" continuedAt="Text_d494bc67d6164dd0976ae2da3adf6b705">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">During 2020, 2019 and 2018, the following shares were cancelled due to employee terminations prior to restrictions lapsing:</div>
</ix:continuation></ix:continuation><ix:continuation id="Text_a293117fb5d94473ba92bb26a451e17f18" continuedAt="Text_a293117fb5d94473ba92bb26a451e17f19"><ix:continuation id="Text_d494bc67d6164dd0976ae2da3adf6b705" continuedAt="Text_d494bc67d6164dd0976ae2da3adf6b706">
<div style="text-align: left;"><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_a293117fb5d94473ba92bb26a451e17f19" continuedAt="Text_a293117fb5d94473ba92bb26a451e17f20"><ix:continuation id="Text_d494bc67d6164dd0976ae2da3adf6b706">
<table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; border-collapse: collapse; text-align: left; color: #000000; width: 100%; margin-left: auto; margin-right: auto;" id="z7daa2e54ca844999961717e10e62abe6">
  <tr>
    <td style="width: 33.06%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Cancelled</div></td>
    <td style="width: 1%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td style="width: 33.04%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Number of Shares</div></td>
    <td style="width: 1.32%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="2" style="width: 30.36%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Weighted Average Fair<span style="font-size: 10pt; font-family: 'Times New Roman';"><br /></span>Value Per Share</div></td>
    <td style="width: 1.22%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 33.06%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2020</div></td>
    <td style="width: 1%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 33.04%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" id="Fact_8aa1438e9c1843a39b449f2339031598" contextRef="c20200101to20201231_AwardTypeAxis_RestrictedStockMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">10,037</ix:nonFraction></div></td>
    <td style="width: 1.32%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 2.23%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 28.13%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" id="Fact_1a3422c90a744ecc95b9b9f49b928371" contextRef="c20200101to20201231_AwardTypeAxis_RestrictedStockMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">102.52</ix:nonFraction></div></td>
    <td style="width: 1.22%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 33.06%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2019</div></td>
    <td style="width: 1%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 33.04%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" id="Fact_6d536a56576b4c7fbd9908d14a53a210" contextRef="c20190101to20191231_AwardTypeAxis_RestrictedStockMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">1,578</ix:nonFraction></div></td>
    <td style="width: 1.32%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 2.23%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 28.13%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" id="Fact_0aac4dc01b304c958419feda9de1aed1" contextRef="c20190101to20191231_AwardTypeAxis_RestrictedStockMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">87.88</ix:nonFraction></div></td>
    <td style="width: 1.22%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 33.06%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2018</div></td>
    <td style="width: 1%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 33.04%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" id="Fact_734e261301904f3889c61b2cf6fce573" contextRef="c20180101to20181231_AwardTypeAxis_RestrictedStockMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">3,867</ix:nonFraction></div></td>
    <td style="width: 1.32%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 2.23%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 28.13%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" id="Fact_3346237975354ef5a88bd0a7c92cc596" contextRef="c20180101to20181231_AwardTypeAxis_RestrictedStockMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">59.51</ix:nonFraction></div></td>
    <td style="width: 1.22%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
  </tr>
</table>
</ix:continuation></ix:continuation><ix:continuation id="Text_a293117fb5d94473ba92bb26a451e17f20" continuedAt="Text_a293117fb5d94473ba92bb26a451e17f21">
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><br /></div>
</ix:continuation><ix:continuation id="Text_a293117fb5d94473ba92bb26a451e17f21" continuedAt="Text_a293117fb5d94473ba92bb26a451e17f22">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Generally, restrictions on the stock granted to employees lapse in equal annual installments on the following <span style="-sec-ix-hidden:Fact_5193d5e0f71242e78d0ec8f60c9b56d8">four</span> anniversaries of the date of grant. For those shares granted to directors, the restrictions will lapse in equal quarterly installments during the first year after the date of grant. For those granted to officers, the restriction will lapse in equal quarterly installments during the <ix:nonNumeric name="usph:RestrictedPeriodToEmployeesOnTheStockGranted" id="Fact_4084f42379794911b400b8b7c70738de" contextRef="c20200101to20201231_TitleOfIndividualAxis_ExecutiveOfficerMember" format="ixt-sec:durwordsen">four years</ix:nonNumeric> following the date of grant.</div>
</ix:continuation><ix:continuation id="Text_a293117fb5d94473ba92bb26a451e17f22" continuedAt="Text_a293117fb5d94473ba92bb26a451e17f23">
<div style="text-align: left;"><br /></div>
</ix:continuation><ix:continuation id="Text_a293117fb5d94473ba92bb26a451e17f23" continuedAt="Text_a293117fb5d94473ba92bb26a451e17f24">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">There were <ix:nonFraction name="usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed" id="Fact_ac274efeef6e4790a0ae7f11c8858cfd" contextRef="c20201231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">127,562</ix:nonFraction> and <ix:nonFraction name="usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed" id="Fact_91fc62550d9a435dac9e88edf4bb8706" contextRef="c20191231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">150,771</ix:nonFraction> shares outstanding as of December 31, 2020 and December 31, 2019 respectively, for which restrictions had not lapsed. The restrictions will lapse in <ix:nonNumeric name="usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription" id="Fact_719eea96c71142a0a0c63af4fea1ff93" contextRef="c20200101to20201231_RangeAxis_MinimumMember">2021</ix:nonNumeric> through <ix:nonNumeric name="usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription" id="Fact_72d85f1dc0bf40d687ea220145967e95" contextRef="c20200101to20201231_RangeAxis_MaximumMember">2024</ix:nonNumeric>.</div>
</ix:continuation><ix:continuation id="Text_a293117fb5d94473ba92bb26a451e17f24" continuedAt="Text_a293117fb5d94473ba92bb26a451e17f25">
<div style="text-align: left;"><br /></div>
</ix:continuation><ix:continuation id="Text_a293117fb5d94473ba92bb26a451e17f25">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Compensation expense for grants of restricted stock is recognized based on the fair value on the date of grant. Compensation expense for restricted stock grants was $<ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_d468c9fbafe146e4b11a642937cbd845" contextRef="c20200101to20201231_AwardTypeAxis_RestrictedStockMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">7.9</ix:nonFraction> million, $<ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_91d695488a7a490cb278702369ccf928" contextRef="c20190101to20191231_AwardTypeAxis_RestrictedStockMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">5.9</ix:nonFraction> million, and $<ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_b5f0ce9ebb0149108bf660b17b558bc6" contextRef="c20180101to20181231_AwardTypeAxis_RestrictedStockMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">5.0</ix:nonFraction> million, respectively, for 2020, 2019 and 2018. As of December 31, 2020, the remaining $<ix:nonFraction name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" id="Fact_f50f56e8f05347118242893060c59058" contextRef="c20201231_AwardTypeAxis_RestrictedStockMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">8.8</ix:nonFraction> million of compensation expense will be recognized from 2021 through 2024.</div>
</ix:continuation></div>
<div><br /></div>
<div><ix:nonNumeric name="us-gaap:PreferredStockTextBlock" id="Text_20c4b75f33924f45967eddb27eb036ae" contextRef="c20200101to20201231" escape="true" continuedAt="Text_6e30fd9aa20f4f42941a7012a8c2af0c1">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">14. Preferred Stock</div>
</ix:nonNumeric><ix:continuation id="Text_6e30fd9aa20f4f42941a7012a8c2af0c1" continuedAt="Text_6e30fd9aa20f4f42941a7012a8c2af0c2">
<div style="text-align: left;"><br /></div>
</ix:continuation><ix:continuation id="Text_6e30fd9aa20f4f42941a7012a8c2af0c2" continuedAt="Text_6e30fd9aa20f4f42941a7012a8c2af0c3">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Board is empowered, without approval of the shareholders, to cause shares of preferred stock to be issued in one or more series and to establish the number of shares to be included in each such series and the rights, powers, preferences and limitations of each series. There are no provisions in the Company&#8217;s Articles of Incorporation specifying the vote required by the holders of preferred stock to take action. All such provisions would be set out in the designation of any series of preferred stock established by the Board. The bylaws of the Company specify that, when a quorum is present at any meeting, the vote of the holders of at least a majority of the outstanding shares entitled to vote who are present, in person or by proxy, shall decide any question brought before the meeting, unless a different vote is required by law or the Company&#8217;s Articles of Incorporation.</div>
</ix:continuation><ix:continuation id="Text_6e30fd9aa20f4f42941a7012a8c2af0c3" continuedAt="Text_6e30fd9aa20f4f42941a7012a8c2af0c4">
<div style="text-align: left;"><br /></div>
</ix:continuation><ix:continuation id="Text_6e30fd9aa20f4f42941a7012a8c2af0c4">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Because the Board has the power to establish the preferences and rights of each series, it may afford the holders of any series of preferred stock, preferences, powers, and rights, voting or otherwise, senior to the right of holders of common stock. The issuance of the preferred stock could have the effect of delaying or preventing a change in control of the Company. </div>
</ix:continuation></div>
<div><br /></div>
<div><ix:nonNumeric name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="Text_f267c355657444dfb60c5e06091538a8" contextRef="c20200101to20201231" escape="true" continuedAt="Text_4ce36fb2884846438ef8f9803c0c0ab31">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">15. Common Stock</div>
</ix:nonNumeric><ix:continuation id="Text_4ce36fb2884846438ef8f9803c0c0ab31" continuedAt="Text_4ce36fb2884846438ef8f9803c0c0ab32">
<div style="text-align: left;"><br /></div>
</ix:continuation><ix:continuation id="Text_4ce36fb2884846438ef8f9803c0c0ab32" continuedAt="Text_4ce36fb2884846438ef8f9803c0c0ab33">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">From September 2001 through December 31, 2008, the Board authorized the Company to purchase, in the open market or in privately negotiated transactions, up to <ix:nonFraction name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" id="Fact_65b2ed128518470c8ea8c7015ed729df" contextRef="c20081231_RangeAxis_MaximumMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">2,250,000</ix:nonFraction> shares of the Company&#8217;s common stock. In March 2009, the Board authorized the repurchase of up to <ix:nonFraction name="usph:PercentageOfRepurchaseOfCommonStock" id="Fact_099a00e2ab824221a58344111d3abee6" contextRef="c20090331_RangeAxis_MaximumMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">10</ix:nonFraction>% or approximately <ix:nonFraction name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" id="Fact_652e751e161e4ead8bc3200467199b43" contextRef="c20090331_RangeAxis_MaximumMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">1,200,000</ix:nonFraction> shares of its common stock (&#8220;March 2009 Authorization&#8221;). The Amended Credit Agreement permits share repurchases of up to $<ix:nonFraction name="usph:BankCreditAgreementToPermitShareRepurchasesOfCommonStock" id="Fact_e6d0b4410beb494bb733c659fe998dd1" contextRef="c20090331_RangeAxis_MaximumMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">15,000,000</ix:nonFraction>, subject to compliance with covenants. The Company is required to retire shares purchased under the March 2009 Authorization.</div>
</ix:continuation><ix:continuation id="Text_4ce36fb2884846438ef8f9803c0c0ab33" continuedAt="Text_4ce36fb2884846438ef8f9803c0c0ab34">
<div style="text-align: left;"><br /></div>
</ix:continuation><ix:continuation id="Text_4ce36fb2884846438ef8f9803c0c0ab34">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Under the March 2009 Authorization, the Company has purchased a total of <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodShares" id="Fact_c327c14366294579ad991f5243fc0d0f" contextRef="c20090301to20090331" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">859,499</ix:nonFraction> shares. There is <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodShares" id="Fact_d791795173ec4f9a9453291c5d6bdff2" contextRef="c20200101to20201231" unitRef="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodShares" id="Fact_660aa1198f0c43fdb8d73c3615f699d0" contextRef="c20190101to20191231" unitRef="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction> expiration date for the share repurchase program. There are currently an additional estimated <ix:nonFraction name="usph:AdditionalEstimatedRepurchaseOfCommonStock" id="Fact_f35c73e803434448aa97a58898fdeb9c" contextRef="c20200101to20201231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">124,740</ix:nonFraction> shares (based on the closing price of $<ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" id="Fact_a3703f5afc7a451b884856c26faa95ae" contextRef="c20201231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">120.25</ix:nonFraction> on December 31, 2020, the last business day in 2020) that may be purchased from time to time in the open market or private transactions depending on price, availability and the Company&#8217;s cash position. The Company did not purchase any shares of its common stock during 2020 or 2019. </div>
</ix:continuation></div>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>72</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div><br /></div>
<div><ix:nonNumeric name="us-gaap:CompensationAndEmployeeBenefitPlansTextBlock" id="Text_1ba3d1fabc4c4376a36766319fe0c516" contextRef="c20200101to20201231" escape="true" continuedAt="Text_4c9076d068fb40f58e14fb03caa310db1">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">16. Defined Contribution Plan</div>
</ix:nonNumeric><ix:continuation id="Text_4c9076d068fb40f58e14fb03caa310db1" continuedAt="Text_4c9076d068fb40f58e14fb03caa310db2">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_4c9076d068fb40f58e14fb03caa310db2">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company has several 401(k) profit sharing plans covering all employees with <ix:nonNumeric name="usph:DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan" id="Fact_8c4f206f9c214f8cb0ad18f065146a5e" contextRef="c20200101to20201231" format="ixt-sec:durwordsen">three months</ix:nonNumeric> of service. For certain plans, the Company makes matching contributions. The Company may also make discretionary contributions of up to <ix:nonFraction name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" id="Fact_fa35b081278041b38e99298a18997153" contextRef="c20200101to20201231" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">50</ix:nonFraction>% of employee contributions. The Company did <ix:nonFraction name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" id="Fact_f2c6754687324734be8acb598b3bdaa2" contextRef="c20180101to20181231" unitRef="U001" decimals="-6" scale="6" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" id="Fact_c19e2846c6f94196a89cf18153961350" contextRef="c20190101to20191231" unitRef="U001" decimals="-6" scale="6" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" id="Fact_960aa92faa0c4553942f2d89f4bb2419" contextRef="c20200101to20201231" unitRef="U001" decimals="-6" scale="6" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction>t make any discretionary contributions for the years ended December 31, 2020, 2019 and 2018. The Company matching contributions totaled $<ix:nonFraction name="usph:DefinedContributionPlanEmployerMatchingContributionAmount" id="Fact_b4afe50fce964ab3addc6cf930572013" contextRef="c20200101to20201231" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">1.9</ix:nonFraction> million, $<ix:nonFraction name="usph:DefinedContributionPlanEmployerMatchingContributionAmount" id="Fact_13c80a23309c40d5a5dd3a21d72e78f4" contextRef="c20190101to20191231" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">2.0</ix:nonFraction> million and $<ix:nonFraction name="usph:DefinedContributionPlanEmployerMatchingContributionAmount" id="Fact_4e89a35babad45dfb6943f754e1a9dc8" contextRef="c20180101to20181231" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">1.8</ix:nonFraction> million, respectively, for the years ended December 31, 2020, 2019 and 2018. </div>
</ix:continuation></div>
<div><br /></div>
<div><ix:nonNumeric name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="Text_953e716480224bbea825f6abf40f39a1" contextRef="c20200101to20201231" escape="true" continuedAt="Text_0e63e36f420d41fb8d64bf90102c01a11">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">17. Commitments and Contingencies</div>
</ix:nonNumeric><ix:continuation id="Text_0e63e36f420d41fb8d64bf90102c01a11" continuedAt="Text_0e63e36f420d41fb8d64bf90102c01a12">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_0e63e36f420d41fb8d64bf90102c01a12" continuedAt="Text_0e63e36f420d41fb8d64bf90102c01a13">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">We may be subject to litigation in the ordinary course of business.</div>
</ix:continuation><ix:continuation id="Text_0e63e36f420d41fb8d64bf90102c01a13" continuedAt="Text_0e63e36f420d41fb8d64bf90102c01a14">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_0e63e36f420d41fb8d64bf90102c01a14" continuedAt="Text_0e63e36f420d41fb8d64bf90102c01a15">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Employment Agreements</div>
</ix:continuation><ix:continuation id="Text_0e63e36f420d41fb8d64bf90102c01a15" continuedAt="Text_0e63e36f420d41fb8d64bf90102c01a16">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_0e63e36f420d41fb8d64bf90102c01a16" continuedAt="Text_0e63e36f420d41fb8d64bf90102c01a17">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">At December 31, 2020, the Company had outstanding employment agreements with <ix:nonFraction name="usph:NumberOfEmployeesCoveredUnderEmployeeAgreement" id="Fact_4cf5d82a9f4541a2a00c439f2332493a" contextRef="c20200101to20201231_TitleOfIndividualAxis_ExecutiveOfficerMember" unitRef="U018" decimals="INF" scale="0" format="ixt-sec:numwordsen">four</ix:nonFraction> of its executive officers, one of whom (Mr. McDowell) has provided notice of a planned retirement in <span style="-sec-ix-hidden:Fact_07fa882becbb4980afaa1f4e941716d5">August 2021</span>. The three remaining agreements have terms that expire <ix:nonNumeric name="usph:EmploymentAgreementsExpirationDate" id="Fact_18624bf7a9a44decae930e36928cc36f" contextRef="c20200101to20201231" format="ixt:datemonthdayyearen">December 31, 2021</ix:nonNumeric>, <ix:nonNumeric name="usph:EmploymentAgreementsExpirationDateTwo" id="Fact_ffbb8463e1af472f9812cca9373ccd2e" contextRef="c20200101to20201231" format="ixt:datemonthdayyearen">February 28, 2022</ix:nonNumeric> and <ix:nonNumeric name="usph:EmploymentAgreementsExpirationDateThree" id="Fact_535608f30e80454986e9d187fab6e4a2" contextRef="c20200101to20201231" format="ixt:datemonthdayyearen">November 8, 2022</ix:nonNumeric>, respectively; however, each of these agreements provide for an automatic <ix:nonNumeric name="usph:RenewalPeriodForEmploymentAgreement" id="Fact_7b6b5a6b9a614b75b24214f01f4716d8" contextRef="c20200101to20201231" format="ixt-sec:durwordsen">two year</ix:nonNumeric> renewal at the conclusion of the expiring term or renewal term. All of the agreements contain a provision for annual adjustment of salaries.</div>
</ix:continuation><ix:continuation id="Text_0e63e36f420d41fb8d64bf90102c01a17" continuedAt="Text_0e63e36f420d41fb8d64bf90102c01a18">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_0e63e36f420d41fb8d64bf90102c01a18">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In addition, the Company has outstanding employment agreements with most of the managing physical therapist partners of the Company&#8217;s physical therapy clinics and with certain other clinic employees which obligate subsidiaries of the Company to pay compensation of $<ix:nonFraction name="usph:EmployeeCompensationFuturePaymentDueNextFiscalYear" id="Fact_9261da79a3c541cfa458fc9e3404a94b" contextRef="c20201231" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">37.1</ix:nonFraction> million in 2021 and $<ix:nonFraction name="usph:EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter" id="Fact_5437408ea5cf46bd86ad05ec8fbb69a7" contextRef="c20201231" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">6.1</ix:nonFraction> million in the aggregate from 2022 through 2024. In addition, many of the employment agreements with the managing physical therapists provide for monthly bonus payments calculated as a percentage of each clinic&#8217;s net revenues (not in excess of operating profits) or operating profits. </div>
</ix:continuation></div>
<div><br /></div>
<div><ix:nonNumeric name="us-gaap:EarningsPerShareTextBlock" id="Text_66af2a7b65ca4d13bc4fcd446b96f01a" contextRef="c20200101to20201231" escape="true" continuedAt="Text_35e39ab7dd5e4ee78e6781f3164d626f1">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">18. Earnings Per Share</div>
</ix:nonNumeric><ix:continuation id="Text_35e39ab7dd5e4ee78e6781f3164d626f1" continuedAt="Text_35e39ab7dd5e4ee78e6781f3164d626f2">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_35e39ab7dd5e4ee78e6781f3164d626f2" continuedAt="Text_35e39ab7dd5e4ee78e6781f3164d626f3"><ix:nonNumeric name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="Text_61234a90ba0d4e71acf5d83808f98795" contextRef="c20200101to20201231" escape="true" continuedAt="Text_16335f5949dc475385caa1ab504ed90e1">
<div style="display:none;"><br /></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The computations of basic and diluted earnings per share for the years ended December 31, 2020, 2019 and 2018 are as follows (in thousands, except per share data):</div>
</ix:nonNumeric></ix:continuation><ix:continuation id="Text_35e39ab7dd5e4ee78e6781f3164d626f3" continuedAt="Text_35e39ab7dd5e4ee78e6781f3164d626f4"><ix:continuation id="Text_16335f5949dc475385caa1ab504ed90e1" continuedAt="Text_16335f5949dc475385caa1ab504ed90e2">
<div><br /></div>
</ix:continuation></ix:continuation><ix:continuation id="Text_35e39ab7dd5e4ee78e6781f3164d626f4"><ix:continuation id="Text_16335f5949dc475385caa1ab504ed90e2">
<table cellpadding="0" cellspacing="0" id="z70cf1bf066894e77938a1c395afa0aa6" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="10" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"></div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2018</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Computation of earnings per share - USPH shareholders:</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Net income attributable to USPH shareholders</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_0ab6b252d7ac4bab9fc9970db10bd550" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">35,194</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_46969e4514b74ae0848fc5eaa3babd71" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">40,039</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_77177f47e5f34bee9595b98afcaa8012" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">34,873</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Credit (charges) to retained earnings:</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Revaluation of redeemable non-controlling interest</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:ChargesToRetainedEarningsRevaluationOfNonControllingInterests" id="Fact_fd7acffd68134c9ba2ce0b06723fb0b9" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">4,632</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:ChargesToRetainedEarningsRevaluationOfNonControllingInterests" id="Fact_d5fb04dd6c6f41dca76120050e5f8a66" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">11,893</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<ix:nonFraction name="usph:ChargesToRetainedEarningsRevaluationOfNonControllingInterests" id="Fact_28e86f9d3b034b7390c095a7d375e8b2" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">24,770</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 2px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Tax effect at statutory rate (federal and state) of <ix:nonFraction name="usph:EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate" id="Fact_e8f186a3266e48e499653cf664890ee2" contextRef="c20200101to20201231" unitRef="U005" decimals="4" scale="-2" format="ixt:numdotdecimal">26.25</ix:nonFraction>%</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" id="Fact_d2bf87cd23664446980cf054fda6c8b0" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">1,216</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" id="Fact_191e006d46954a0d920eb71ed6ba9eff" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">3,121</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" id="Fact_c299e6d3935142d5a925f87378018961" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">6,502</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" id="Fact_fba7460321e0499db8b7f706b13913d7" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">31,778</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" id="Fact_20990620da0c4b90a40520547973ac41" contextRef="c20190101to20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">31,267</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="usph:IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" id="Fact_d3f0089fe57a417582698b7d08e6bf9e" contextRef="c20180101to20181231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">16,605</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Earnings per share (basic and diluted)</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" id="Fact_3240d35a26a74ad39f4d745a84cf5745" contextRef="c20200101to20201231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">2.48</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" id="Fact_b721a77640904bdfb9cd9c4e27184e35" contextRef="c20190101to20191231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">2.45</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" id="Fact_e8d01cf0a8ae4ed7bf947f5b443521af" contextRef="c20180101to20181231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">1.31</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Shares used in computation:</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 64%; padding-bottom: 4px;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Basic and diluted earnings per share - weighted-average shares</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" id="Fact_55c08d082c5245488d18a9bfbaa41391" contextRef="c20200101to20201231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">12,835</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" id="Fact_891e150d639948f597b5cc0dbfae48e8" contextRef="c20190101to20191231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">12,756</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" id="Fact_57b19fe8eeb849ed9a13334a485ab097" contextRef="c20180101to20181231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">12,666</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;">&#160;</td>
  </tr>
</table>
</ix:continuation></ix:continuation></div>
<div style="text-align: left;"><br /></div>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>73</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div><br /></div>
<div><a id="ITEM9"><!--Anchor--></a></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="zafb8d8bda3d44f2aad0930d76bfe73a5">
  <tr>
    <td style="width: 72pt; vertical-align: top; align: right;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">ITEM 9.</span></td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL</span>&#160;<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">DISCLOSURE.</span></div></td>
  </tr>
</table>
<div><br /></div>
<div style="text-align: left; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Not applicable.</div>
<div><br /></div>
<div><a id="ITEM9A"><!--Anchor--></a></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="ze80f382f246d47e5bcfe724962d7add4">
  <tr>
    <td style="width: 72pt; vertical-align: top; align: right;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">ITEM 9A.</span></td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">CONTROLS AND PROCEDURES.</div></td>
  </tr>
</table>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Evaluation of Disclosure Controls and Procedures</div>
<div><br /></div>
<div style="text-align: left; text-indent: 18pt; margin-right: 9pt; font-family: 'Times New Roman'; font-size: 10pt;">Our management, including our Chief Executive Officer and Chief Financial Officer, has conducted an evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) promulgated under the Exchange Act) as of the end of the fiscal period covered by this report. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures are effective in ensuring that the information required to be disclosed in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the rules and forms of the SEC and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding disclosure.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Management&#8217;s Report on Internal Control over Financial Reporting</div>
<div><br /></div>
<div style="text-align: left; margin-right: 3pt; font-family: 'Times New Roman'; font-size: 10pt;">Management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rule 13a-15(f) under the Exchange Act. U.S. Physical Therapy, Inc. and subsidiaries&#8217; (the &#8220;Company&#8221;) internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Internal control over financial reporting includes those policies and procedures that:</div>
<div><br /></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="ze26931b2e60b42e3b3970d8fe153621c">
  <tr>
    <td style="width: 37.95pt;"></td>
    <td style="width: 18.05pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">Pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company;</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="zbc3ddcb53ac24e269deeb84d400b9b9a">
  <tr>
    <td style="width: 37.95pt;"></td>
    <td style="width: 18.05pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of the Company&#8217;s management and directors&#894; and</div></td>
  </tr>
</table>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z860ff526d7134363b03b25f5965b27cb">
  <tr>
    <td style="width: 37.95pt;"></td>
    <td style="width: 18.05pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company&#8217;s assets that could have a material effect on the financial statements.</div></td>
  </tr>
</table>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Internal control over financial reporting cannot provide absolute assurance of achieving financial reporting objectives because of its inherent limitations. Internal control over financial reporting is a process that involves human diligence and compliance and is subject to lapses in judgment and breakdowns resulting from human failures. Internal control over financial reporting can also be circumvented by collusion or improper management override. Because of such limitations, there is a risk that material misstatements may not be prevented or detected on a timely basis by internal control over financial reporting. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. However, these inherent limitations are known features of the financial reporting process. Therefore, it is possible to design into the process safeguards to reduce, though not eliminate, the risk.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 36pt; margin-right: 2pt; font-family: 'Times New Roman'; font-size: 10pt;">Management conducted an assessment of the effectiveness of our internal control over financial reporting as of December 31, 2020. In making this assessment, management used the criteria described in Internal Control &#8212; Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on this assessment, management concluded that our internal control over financial reporting was effective as of December 31, 2020.</div>
<div><br /></div>
<div style="text-align: left; text-indent: 36pt; margin-right: 5pt; font-family: 'Times New Roman'; font-size: 10pt;">The Company&#8217;s internal control over financial reporting has been audited by Grant Thornton LLP, an independent registered public accounting firm, as stated in their report included on page 44.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Changes in Internal Control over Financial Reporting</div>
<div><br /></div>
<div style="text-align: left; text-indent: 36pt; margin-right: 4pt; font-family: 'Times New Roman'; font-size: 10pt;">There have been no changes in our internal control over financial reporting during the quarter ended December 31, 2020 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</div>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>74</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div><a id="ITEM9B"><!--Anchor--></a></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z5a9cbae2a0c84613b057d6b06e738638">
  <tr>
    <td style="width: 72pt; vertical-align: top; align: right;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">ITEM 9B.</span></td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">OTHER INFORMATION.</div></td>
  </tr>
</table>
<div><br /></div>
<div style="text-align: left; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Not applicable.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">PART III</div>
<div><br /></div>
<div><a id="ITEM10"><!--Anchor--></a></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="zf0f93ae75dfd4fc6a82b487681b952e2">
  <tr>
    <td style="width: 72pt; vertical-align: top; align: right;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">ITEM 10.</span></td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE.</div></td>
  </tr>
</table>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; font-family: 'Times New Roman'; font-size: 10pt;">The information required in response to this Item 10 is incorporated herein by reference to our definitive proxy statement relating to our 2021 Annual Meeting of Stockholders to be filed with the SEC pursuant to Regulation 14A, not later than 120 days after the end of our fiscal year covered by this report.</div>
<div><br /></div>
<div><a id="ITEM11"><!--Anchor--></a></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z9d8d85738bae469bae46207b20a11ca8">
  <tr>
    <td style="width: 72pt; vertical-align: top; align: right;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">ITEM 11.</span></td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">EXECUTIVE COMPENSATION.</div></td>
  </tr>
</table>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; font-family: 'Times New Roman'; font-size: 10pt;">The information required in response to this Item 11 is incorporated herein by reference to our definitive proxy statement relating to our 2021 Annual Meeting of Stockholders to be filed with the SEC pursuant to Regulation 14A, not later than 120 days after the end of our fiscal year covered by this report.</div>
<div><br /></div>
<div><a id="ITEM12"><!--Anchor--></a></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z2c7ca52a4bf848c38610f6a359a3fbd1">
  <tr>
    <td style="width: 72pt; vertical-align: top; align: right;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">ITEM 12.</span></td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED</span>&#160;<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">STOCKHOLDER MATTERS.</span></div></td>
  </tr>
</table>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; font-family: 'Times New Roman'; font-size: 10pt;">The information required in response to this Item 12 is incorporated herein by reference to our definitive proxy statement relating to our 2021 Annual Meeting of Stockholders to be filed with the SEC pursuant to Regulation 14A, not later than 120 days after the end of our fiscal year covered by this report.</div>
<div><br /></div>
<div><a id="ITEM13"><!--Anchor--></a></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z55991dbbc2204b9f80632bb78f00b16b">
  <tr>
    <td style="width: 72pt; vertical-align: top; align: right;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">ITEM 13.</span></td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE.</div></td>
  </tr>
</table>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; font-family: 'Times New Roman'; font-size: 10pt;">The information required in response to this Item 13 is incorporated herein by reference to our definitive proxy statement relating to our 2021 Annual Meeting of Stockholders to be filed with the SEC pursuant to Regulation 14A, not later than 120 days after the end of our fiscal year covered by this report.</div>
<div><br /></div>
<div><a id="ITEM14"><!--Anchor--></a></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z5bda7f6d046243c4843b929740f12eb7">
  <tr>
    <td style="width: 72pt; vertical-align: top; align: right;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">ITEM 14.</span></td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">PRINCIPAL ACCOUNTANT FEES AND SERVICES.</div></td>
  </tr>
</table>
<div><br /></div>
<div style="text-align: left; text-indent: 19.9pt; font-family: 'Times New Roman'; font-size: 10pt;">The information required in response to this Item 14 is incorporated herein by reference to our definitive proxy statement relating to our 2021 Annual Meeting of Stockholders to be filed with the SEC pursuant to Regulation 14A, not later than 120 days after the end of our fiscal year covered by this report.</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">PART IV</div>
<div><br /></div>
<div><a id="ITEM15"><!--Anchor--></a></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z406445eba2624626aeb1c8bedca47178">
  <tr>
    <td style="width: 72pt; vertical-align: top; align: right;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">ITEM 15.</span></td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">EXHIBITS AND FINANCIAL STATEMENT SCHEDULES.</div></td>
  </tr>
</table>
<div><br /></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z0884a443266c4bcd860da52449ae780e">
  <tr>
    <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">(a)</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="font-family: 'Times New Roman'; font-size: 10pt;">Documents filed as a part of this report:</div></td>
  </tr>
</table>
<div><br /></div>
<div style="text-align: justify; text-indent: 19.95pt; margin-right: 6pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">1.</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Financial Statements. </span>Reference is made to the Index to Financial Statements and Related Information under Item 8 in Part II<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">&#160;</span>hereof, where these documents are listed.</span></div>
<div><br /></div>
<div style="text-align: left; text-indent: 19.95pt; margin-right: 15pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">2.</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Financial Statement Schedules. </span>See page 81 for Schedule II<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">&#160;</span>&#8212;<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">&#160;</span>Valuation and Qualifying Accounts. All other schedules are<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">&#160;</span>omitted because of the absence of conditions under which they are required or because the required information is shown in the financial statements or notes thereto.</span></div>
<div><br /></div>
<div style="text-align: justify; text-indent: 19.95pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">3.</span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Exhibits. </span>The exhibits listed in List of Exhibits on the next page are filed or incorporated by reference as part of this report.</span></div>
<div><br /></div>
<div><a id="ITEM16"><!--Anchor--></a></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z167b0500b968437198340dd9bcc29fe2">
  <tr>
    <td style="width: 72pt; vertical-align: top; align: right;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">ITEM 16.</span></td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Form 10-K Summary</span><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">&#160;</span><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">&#8211;</span><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">&#160;</span>None.</div></td>
  </tr>
</table>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>75</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">EXHIBIT INDEX</div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">LIST OF EXHIBITS</div>
<div><br /></div>
<table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z24a18999c60c48a88af17e835732e144">
  <tr>
    <td style="width: 12.51%; vertical-align: bottom;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Number</div></td>
    <td style="width: 87.49%; vertical-align: bottom;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Description</div></td>
  </tr>
  <tr>
    <td style="width: 12.51%; vertical-align: top;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;&#160;</div></td>
    <td style="width: 87.49%; vertical-align: bottom;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 12.51%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="brhc10020853_ex4-1.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">3.1</a></div></td>
    <td style="width: 87.49%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Articles of Incorporation of the Company [filed as an exhibit to the Company&#8217;s Form 10-Q for the quarterly period ended June 30, 2001 and incorporated herein by reference].</div></td>
  </tr>
  <tr>
    <td style="width: 12.51%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;&#160;</div></td>
    <td style="width: 87.49%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 12.51%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000095012901502598/h89745ex3-2.txt" style="font-family: 'Times New Roman'; font-size: 10pt;">3.2</a></div></td>
    <td style="width: 87.49%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Amendment to the Articles of Incorporation of the Company [filed as an exhibit to the Company&#8217;s Form 10-Q for the quarterly period ended June 30, 2001 and incorporated herein by reference].</div></td>
  </tr>
  <tr>
    <td style="width: 12.51%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;&#160;</div></td>
    <td style="width: 87.49%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 12.51%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">3.3</div></td>
    <td style="width: 87.49%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Bylaws of the Company, as amended [filed as an exhibit to the Company&#8217;s Form 10-KSB for the year ended December 31, 1993 and incorporated herein by reference&#8212;Commission File Number&#8212;1-11151].</div></td>
  </tr>
  <tr>
    <td style="width: 12.51%; vertical-align: top; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 87.49%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 12.51%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="brhc10020853_ex4-1.htm">4.1*</a></div></td>
    <td style="width: 87.49%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Description of Company Securities [filed herewith the Company&#8217;s Form 10-K for the year ended December 31, 2019 filed with the SEC on February 28, 2020.]</div></td>
  </tr>
  <tr>
    <td style="width: 12.51%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;&#160;</div></td>
    <td style="width: 87.49%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 12.51%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000095012908002272/h55685def14a.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.1+</a></div></td>
    <td style="width: 87.49%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1999 Employee Stock Option Plan (as amended and restated May 20, 2008) [incorporated by reference to Appendix A to the Company&#8217;s Definitive Proxy Statement on Schedule 14A, filed with the SEC on April 17, 2008].</div></td>
  </tr>
  <tr>
    <td style="width: 12.51%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;&#160;</div></td>
    <td style="width: 87.49%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 12.51%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000156761916002163/h10035537x1_def14a.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.2+</a></div></td>
    <td style="width: 87.49%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U.S. Physical Therapy, Inc. 2003 Stock Incentive Plan, (as amended and restated effective March 26, 2016) [incorporated herein by reference to Appendix A to the Company's Definitive Proxy Statement on Schedule 14A filed with the SEC on April 7, 2016.]</div></td>
  </tr>
  <tr>
    <td style="width: 12.51%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;&#160;</div></td>
    <td style="width: 87.49%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 12.51%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000119312513136397/d514665dex991.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.3+</a></div></td>
    <td style="width: 87.49%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U. S. Physical Therapy, Inc. Long-Term Incentive Plan for Senior Management for 2013, effective March 27, 2013 [incorporated by reference to Exhibit 99.1 to the Company Current Report on Form 8-K filed with the SEC on April 1, 2013].</div></td>
  </tr>
  <tr>
    <td style="width: 12.51%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;&#160;</div></td>
    <td style="width: 87.49%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 12.51%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000119312513136397/d514665dex992.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.4+</a></div></td>
    <td style="width: 87.49%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U. S. Physical Therapy, Inc. Objective Cash Bonus Plan for 2013, effective March 27, 2013 [incorporated by reference to Exhibit 99.2 to the Company Current Report on Form 8-K filed with the SEC on April 1, 2013].</div></td>
  </tr>
  <tr>
    <td style="width: 12.51%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 87.49%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 12.51%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000119312513136397/d514665dex993.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.5+</a></div></td>
    <td style="width: 87.49%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U. S. Physical Therapy, Inc. Discretionary Cash Bonus Plan for 2013, effective March 27, 2013 [incorporated by reference to Exhibit 99.3 to the Company Current Report on Form 8-K filed with the SEC on April 1, 2013].</div></td>
  </tr>
  <tr>
    <td style="width: 12.51%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;&#160;</div></td>
    <td style="width: 87.49%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 12.51%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000119312514117900/d699247dex991.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.6+</a></div></td>
    <td style="width: 87.49%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U. S. Physical Therapy, Inc. Long-Term Incentive Plan for Senior Management for 2014, effective March 21, 2014 [incorporated by reference to Exhibit 99.1 to the Company Current Report on Form 8-K filed with the SEC on March 27, 2014].</div></td>
  </tr>
  <tr>
    <td style="width: 12.51%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;&#160;</div></td>
    <td style="width: 87.49%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 12.51%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000119312514117900/d699247dex992.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.7+</a></div></td>
    <td style="width: 87.49%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U. S. Physical Therapy, Inc. Discretionary Long-Term Incentive Plan for Senior Management for 2014, effective March 21, 2014 [incorporated by reference to Exhibit 99.2 to the Company Current Report on Form 8-K filed with the SEC on March 27, 2014].</div></td>
  </tr>
  <tr>
    <td style="width: 12.51%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;&#160;</div></td>
    <td style="width: 87.49%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 12.51%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000119312514117900/d699247dex993.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.8+</a></div></td>
    <td style="width: 87.49%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U. S. Physical Therapy, Inc. Objective Cash Bonus Plan for Senior Management for 2014, effective March 21, 2014 [incorporated by reference to Exhibit 99.3 to the Company Current Report on Form 8-K filed with the SEC on March 27, 2014].</div></td>
  </tr>
  <tr>
    <td style="width: 12.51%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;&#160;</div></td>
    <td style="width: 87.49%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 12.51%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000119312514117900/d699247dex994.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.9+</a></div></td>
    <td style="width: 87.49%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U. S. Physical Therapy, Inc. Discretionary Cash Bonus Plan for Senior Management for 2014, effective March 21, 2014 [incorporated by reference to Exhibit 99.4 to the Company Current Report on Form 8-K filed with the SEC on March 27, 2014].</div></td>
  </tr>
  <tr>
    <td style="width: 12.51%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;&#160;</div></td>
    <td style="width: 87.49%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 12.51%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000114036115013296/ex99_1.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.10+</a></div></td>
    <td style="width: 87.49%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U. S. Physical Therapy, Inc. Long Term Incentive Plan for Senior Management for 2015, effective March 23, 2015 [incorporated by reference to Exhibit 99.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on March 27, 2015.]</div></td>
  </tr>
</table>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>76</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div><br /></div>
<table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zfeb06fda48fc41af825e6b0c74bf1e30">
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000114036115013296/ex99_2.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.11+</a></div></td>
    <td style="width: 89.69%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U. S. Physical Therapy, Inc. Discretionary Long Term Incentive Plan for Senior Management for 2015, effective March 23, 2015 [incorporated by reference to Exhibit 99.2 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on March 27, 2015.]</div></td>
  </tr>
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;&#160;</div></td>
    <td style="width: 89.69%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000114036115013296/ex99_3.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.12+</a></div></td>
    <td style="width: 89.69%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U. S. Physical Therapy, Inc. Objective Cash Bonus Plan for Senior Management for 2015, effective March 23, 2015 [incorporated by reference to Exhibit 99.3 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on March 27, 2015.]</div></td>
  </tr>
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;&#160;</div></td>
    <td style="width: 89.69%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000114036115013296/ex99_4.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.13+</a></div></td>
    <td style="width: 89.69%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U. S. Physical Therapy, Inc. Discretionary Cash Bonus Plan for Senior Management for 2015, effective March 23, 2015 [incorporated by reference to Exhibit 99.4 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on March 27, 2015.]</div></td>
  </tr>
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;&#160;</div></td>
    <td style="width: 89.69%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000088597816000027/exhibit10-1.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.14+</a></div></td>
    <td style="width: 89.69%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U. S. Physical Therapy, Inc. Objective Long Term Incentive Plan for Senior Management for 2016, effective March 10, 2016 [incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on March 16, 2016].</div></td>
  </tr>
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;&#160;</div></td>
    <td style="width: 89.69%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000088597816000027/exhibit10-2.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.15+</a></div></td>
    <td style="width: 89.69%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U. S. Physical Therapy, Inc. Discretionary Long Term Incentive Plan for Senior Management for 2016, effective March 10, 2016 [incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on March 16, 2016].</div></td>
  </tr>
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;&#160;</div></td>
    <td style="width: 89.69%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000088597816000027/exhibit10-3.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.16+</a></div></td>
    <td style="width: 89.69%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U. S. Physical Therapy, Inc. Objective Cash Bonus Plan for Senior Management for 2016, effective March 10, 2016 [incorporated by reference to Exhibit 10.3 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on March 16, 2016].</div></td>
  </tr>
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;&#160;</div></td>
    <td style="width: 89.69%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000088597816000027/exhibit10-4.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.17+</a></div></td>
    <td style="width: 89.69%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U. S. Physical Therapy, Inc. Discretionary Cash Bonus Plan for Senior Management for 2016, effective March 10, 2016 [incorporated by reference to Exhibit 10.4 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on March 16, 2016].</div></td>
  </tr>
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;&#160;</div></td>
    <td style="width: 89.69%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000088597816000027/exhibit10-5.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.18+</a></div></td>
    <td style="width: 89.69%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Form of Restricted Stock Agreement [incorporated by reference to Exhibit 10.5 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on March 16, 2016].</div></td>
  </tr>
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;&#160;</div></td>
    <td style="width: 89.69%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000088597818000004/exhibit99-1.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.19+</a></div></td>
    <td style="width: 89.69%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U. S. Physical Therapy, Inc. Long-Term Incentive Plan for Senior Management for 2017, effective March 24, 2017 [incorporated by reference to Exhibit 99.1 to the Company&#8217;s Current Report on Form 8-K/A filed with the SEC on February 9, 2018.]</div></td>
  </tr>
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;&#160;</div></td>
    <td style="width: 89.69%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000088597817000011/exhibit99-2.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.20+</a></div></td>
    <td style="width: 89.69%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U. S. Physical Therapy, Inc. Discretionary Long &#8211;Term Incentive Plan for Senior Management for 2017, effective March 24, 2017 [incorporated by reference to Exhibit 99.2 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on March 30, 2017.]</div></td>
  </tr>
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;&#160;</div></td>
    <td style="width: 89.69%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000088597817000011/exhibit99-3.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.21+</a></div></td>
    <td style="width: 89.69%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U. S. Physical Therapy, Inc. Objective Cash Bonus Plan for Senior Management for 2017, effective March 24, 2017 [incorporated by reference to Exhibit 99.3 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on March 30, 2017.]</div></td>
  </tr>
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;&#160;</div></td>
    <td style="width: 89.69%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000088597817000011/exhibit99-4.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.22+</a><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">&#160;</span></div></td>
    <td style="width: 89.69%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U. S. Physical Therapy, Inc. Discretionary Cash Bonus Plan for Senior Management for 2017, effective March 24, 2017 [incorporated by reference to Exhibit 99.4 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on March 30, 2017.]</div></td>
  </tr>
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 89.69%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000088597818000018/exhibit99-1.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.23+</a></div></td>
    <td style="width: 89.69%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U. S. Physical Therapy, Inc. Objective Long-Term Incentive Plan for Senior Management for 2018, effective April 9, 2018 [incorporated by reference to Exhibit 99.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on April 12, 2018.]&#160;</div></td>
  </tr>
</table>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>77</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div><br /></div>
<table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zed84e68895d34df18c743c5e51d7d257">
  <tr>
    <td style="width: 11.12%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000088597818000018/exhibit99-2.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.24+</a></div></td>
    <td style="width: 88.88%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U. S. Physical Therapy, Inc. Discretionary Long-Term Incentive Plan for Senior Management for 2018, effective April 9, 2018 [incorporated by reference to Exhibit 99.2 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on April 12, 2018.]</div></td>
  </tr>
  <tr>
    <td style="width: 11.12%; vertical-align: top; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 88.88%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 11.12%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000088597818000018/exhibit99-3.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.25+</a></div></td>
    <td style="width: 88.88%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U. S. Physical Therapy, Inc. Objective Cash/RSA Bonus Plan for Senior Management for 2018, effective April 9, 2018 [incorporated by reference to Exhibit 99.3 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on April 12, 2018.]</div></td>
  </tr>
  <tr>
    <td style="width: 11.12%; vertical-align: top; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 88.88%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 11.12%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000088597818000018/exhibit99-4.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.26+</a></div></td>
    <td style="width: 88.88%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U. S. Physical Therapy, Inc. Discretionary Cash/RSA Bonus Plan for Senior Management for 2018, effective April 9, 2018 [incorporated by reference to Exhibit 99.4 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on April 12, 2018.]</div></td>
  </tr>
  <tr>
    <td style="width: 11.12%; vertical-align: top; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 88.88%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 11.12%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000114036117042646/ex99_2.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.27+</a></div></td>
    <td style="width: 88.88%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Second Amended and Restated Credit Agreement dated as of November 10, 2017 among the Company, as Borrower, Bank of America, N.A. as Administrative Agent and the Lenders Patty (incorporated by reference to Exhibit 99.2 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on November 14, 2017).</div></td>
  </tr>
  <tr>
    <td style="width: 11.12%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;&#160;</div></td>
    <td style="width: 88.88%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 11.12%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000088597816000017/exhibit10-1.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.28+</a></div></td>
    <td style="width: 88.88%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Second Amended and Restated Employment Agreement by and between the Company and Christopher J. Reading dated effective February 9, 2016 [incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K, filed with the SEC on February 12, 2016].</div></td>
  </tr>
  <tr>
    <td style="width: 11.12%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;&#160;</div></td>
    <td style="width: 88.88%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 11.12%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000088597816000017/exhibit10-2.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.29+</a></div></td>
    <td style="width: 88.88%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Second Amended and Restated Employment Agreement by and between the Company and Lawrance W. McAfee dated effective February 9, 2016 [incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K, filed with the SEC on February 12, 2016].</div></td>
  </tr>
  <tr>
    <td style="width: 11.12%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;&#160;</div></td>
    <td style="width: 88.88%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 11.12%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000088597816000017/exhibit10-3.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.30+</a></div></td>
    <td style="width: 88.88%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Amended and Restated Employment Agreement by and between the Company and Glenn D. McDowell dated effective February 9, 2016 [incorporated by reference to Exhibit 10.3 to the Company&#8217;s Current Report on Form 8-K, filed with the SEC on February 12, 2016].</div></td>
  </tr>
  <tr>
    <td style="width: 11.12%; vertical-align: top; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 88.88%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 11.12%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000088597818000006/exhibit10-1.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.31+</a></div></td>
    <td style="width: 88.88%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Employment Agreement commencing on March 1, 2018 by and between the Company and Graham Reeve [incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on March 7, 2018].</div></td>
  </tr>
  <tr>
    <td style="width: 11.12%; vertical-align: top; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 88.88%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 11.12%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000114036119004598/ex99_1.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.32+</a></div></td>
    <td style="width: 88.88%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Objective Long-Term Incentive Plan for Senior Management [incorporated by reference to Exhibit 99.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on March 8, 2019.]</div></td>
  </tr>
  <tr>
    <td style="width: 11.12%; vertical-align: top; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 88.88%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 11.12%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000114036119004598/ex99_2.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.33+</a></div></td>
    <td style="width: 88.88%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Discretionary Long-Term Incentive Plan for Senior Management [incorporated by reference to Exhibit 99.2 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on March 8, 2019.]</div></td>
  </tr>
  <tr>
    <td style="width: 11.12%; vertical-align: top; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 88.88%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 11.12%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000114036119004598/ex99_3.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.34+</a></div></td>
    <td style="width: 88.88%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Objective Cash/RSA Bonus Plan for Senior Management [incorporated by reference to Exhibit 99.3 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on March 8, 2019.]</div></td>
  </tr>
  <tr>
    <td style="width: 11.12%; vertical-align: top; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 88.88%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 11.12%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000114036119004598/ex99_4.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.35+</a></div></td>
    <td style="width: 88.88%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Discretionary Cash/RSA Bonus Plan for Senior Management [incorporated by reference to Exhibit 99.4 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on March 8, 2019.]</div></td>
  </tr>
  <tr>
    <td style="width: 11.12%; vertical-align: top; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 88.88%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 11.12%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000114036119009655/ex10_1.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.36+</a></div></td>
    <td style="width: 88.88%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Third Amended and Restated Employment Agreement by and between the Company and Christopher J. Reading dated effective May 21, 2019 [incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on March 22, 2019]</div></td>
  </tr>
</table>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>78</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div><br /></div>
<table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z54c9881618bb4c59bd50c1f1e97404b7">
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000114036119009655/ex10_2.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.37+</a></div></td>
    <td style="width: 89.69%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Third Amended and Restated Employment Agreement by and between the Company and Lawrance W. McAfee dated effective May 21, 2019 [incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on March 22, 2019]</div></td>
  </tr>
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 89.69%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000114036119009655/ex10_3.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.38+</a></div></td>
    <td style="width: 89.69%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Second Amended and Restated Employment Agreement by and between the Company and Glenn D. McDowell dated effective May 21, 2019 [incorporated by reference to Exhibit 10.3 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on March 22, 2019]</div></td>
  </tr>
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 89.69%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000114036119009655/ex10_4.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.39+</a></div></td>
    <td style="width: 89.69%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Amended &amp; Restated Employment Agreement commencing by and between the Company and Graham Reeve dated effective May 21, 2019 [incorporated by reference to Exhibit 10.4 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on March 22, 2019]</div></td>
  </tr>
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 89.69%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000114036119009655/ex10_5.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.40+</a></div></td>
    <td style="width: 89.69%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Restricted Stock Agreement [incorporated by reference to Exhibit 10.5 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on March 22, 2019]</div></td>
  </tr>
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 89.69%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000114036120005025/ex99_1.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.41+</a></div></td>
    <td style="width: 89.69%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U. S. Physical Therapy, Inc. Objective Long-Term Incentive Plan for Senior Management for 2020, effective March 3, 2020 [incorporated by reference to Exhibit 99.1 to the Company Current Report on Form 8-K filed with the SEC on March 6, 2020].</div></td>
  </tr>
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 89.69%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000114036120007017/ex10_2.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.42+</a></div></td>
    <td style="width: 89.69%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Amendment to Employment Agreement entered into as of March 26, 2020 by and between the Company and Lawrance McAfee [incorporated by reference to Exhibit 10.2 to the Company Current Report on Form 8-K filed with the SEC on March 26, 2020].</div></td>
  </tr>
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 89.69%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000114036120007017/ex10_3.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.43+</a></div></td>
    <td style="width: 89.69%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Amendment to Employment Agreement entered into as of March 26, 2020 by and between the Company and Glenn McDowell [incorporated by reference to Exhibit 10.3 to the Company Current Report on Form 8-K filed with the SEC on March 26, 2020].</div></td>
  </tr>
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 89.69%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000114036120007017/ex10_4.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.44+</a></div></td>
    <td style="width: 89.69%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Amendment to Employment Agreement entered into as of March 26, 2020 by and between the Company and Graham Reeve [incorporated by reference to Exhibit 10.4 to the Company Current Report on Form 8-K filed with the SEC on March 26, 2020].</div></td>
  </tr>
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 89.69%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000114036120005025/ex99_1.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.45+</a></div></td>
    <td style="width: 89.69%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U. S. Physical Therapy, Inc. Objective Long-Term Incentive Plan for Senior Management for 2020, effective March 3, 2020 [incorporated by reference to Exhibit 99.1 to the Company Current Report on Form 8-K filed with the SEC on March 6, 2020].</div></td>
  </tr>
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 89.69%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000114036120005025/ex99_2.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.46+</a></div></td>
    <td style="width: 89.69%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U. S. Physical Therapy, Inc. Discretionary Long-Term Incentive Plan for Senior Management for 2020, effective March 3, 2020 [incorporated by reference to Exhibit 99.2 to the Company Current Report on Form 8-K filed with the SEC on March 6, 2020].</div></td>
  </tr>
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 89.69%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000114036120005025/ex99_3.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.47+</a></div></td>
    <td style="width: 89.69%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U. S. Physical Therapy, Inc. Objective Cash/RSA Bonus Plan for Senior Management for 2020, effective March 3, 2020 [incorporated by reference to Exhibit 99.3 to the Company Current Report on Form 8-K filed with the SEC on March 6, 2020].</div></td>
  </tr>
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 89.69%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000114036120005025/ex99_4.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.48+</a></div></td>
    <td style="width: 89.69%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U. S. Physical Therapy, Inc. Discretionary Cash/RSA Bonus Plan for Senior Management for 2020, effective March 3, 2020 [incorporated by reference to Exhibit 99.4 to the Company Current Report on Form 8-K filed with the SEC on March 6, 2020].</div></td>
  </tr>
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 89.69%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000088597820000037/ex10-1.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.49+</a></div></td>
    <td style="width: 89.69%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Employment Agreement entered into as of November 9, 2020 by and between U.S. Physical Therapy and Carey Hendrickson [incorporated by reference to Exhibit 10.1 to the Company Current Report on Form 8-K filed with the SEC on September 23, 2020.]</div></td>
  </tr>
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 89.69%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 10.31%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000088597820000037/ex10-2.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.50+</a></div></td>
    <td style="width: 89.69%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Consulting Agreement entered into as of September 22, 2020 by and between U.S. Physical Therapy and Lawrence McAfee [incorporated by reference to Exhibit 10.1 to the Company Current Report on Form 8-K filed with the SEC on September 23, 2020.]</div></td>
  </tr>
</table>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>79</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div><br /></div>
<table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z1ca5bbc7f49249f98bd75189326b9e49">
  <tr>
    <td style="width: 11.79%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/885978/000114036121003360/brhc10019729_ex10-1.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">10.51+</a></div></td>
    <td style="width: 88.21%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">First Amendment to Second Amended and Restated Credit Agreement [filed by reference to Exhibit 10.1 to the Company Current Report on Form 8-K filed with the SEC on February 4, 2021.]</div></td>
  </tr>
  <tr>
    <td style="width: 11.79%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;&#160;</div></td>
    <td style="width: 88.21%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 11.79%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="brhc10020853_ex21-1.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">21.1*</a></div></td>
    <td style="width: 88.21%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">C</span>Subsidiaries of the Registrant</div></td>
  </tr>
  <tr>
    <td style="width: 11.79%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;&#160;</div></td>
    <td style="width: 88.21%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 11.79%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="brhc10020853_ex23-1.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">23.1*</a></div></td>
    <td style="width: 88.21%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Consent of Independent Registered Public Accounting Firm&#8212;Grant Thornton LLP</div></td>
  </tr>
  <tr>
    <td style="width: 11.79%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;&#160;</div></td>
    <td style="width: 88.21%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 11.79%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="brhc10020853_ex31-1.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">31.1*</a></div></td>
    <td style="width: 88.21%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Certification of Chief Executive Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended</div></td>
  </tr>
  <tr>
    <td style="width: 11.79%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;&#160;</div></td>
    <td style="width: 88.21%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 11.79%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="brhc10020853_ex31-2.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">31.2*</a></div></td>
    <td style="width: 88.21%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Certification of Chief Financial Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended</div></td>
  </tr>
  <tr>
    <td style="width: 11.79%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;&#160;</div></td>
    <td style="width: 88.21%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 11.79%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="brhc10020853_ex31-3.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">31.3*</a></div></td>
    <td style="width: 88.21%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Certification of Controller pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended</div></td>
  </tr>
  <tr>
    <td style="width: 11.79%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;&#160;</div></td>
    <td style="width: 88.21%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 11.79%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #0000FF; font-family: 'Times New Roman'; font-size: 10pt;"><a href="brhc10020853_ex32-1.htm" style="font-family: 'Times New Roman'; font-size: 10pt;">32.1*</a></div></td>
    <td style="width: 88.21%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Certification of Periodic Report of the Chief Executive Officer, Chief Financial Officer and Controller pursuant to Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</div></td>
  </tr>
  <tr>
    <td style="width: 11.79%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;&#160;</div></td>
    <td style="width: 88.21%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 11.79%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">101.INS*</div></td>
    <td style="width: 88.21%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">XBRL Instance Document</div></td>
  </tr>
  <tr>
    <td style="width: 11.79%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;&#160;</div></td>
    <td style="width: 88.21%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 11.79%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">101.SCH*</div></td>
    <td style="width: 88.21%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">XBRL Taxonomy Extension Schema Document</div></td>
  </tr>
  <tr>
    <td style="width: 11.79%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;&#160;</div></td>
    <td style="width: 88.21%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 11.79%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">101.CAL*</div></td>
    <td style="width: 88.21%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">XBRL Taxonomy Extension Calculation Linkbase Document</div></td>
  </tr>
  <tr>
    <td style="width: 11.79%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;&#160;</div></td>
    <td style="width: 88.21%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 11.79%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">101.DEF*</div></td>
    <td style="width: 88.21%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">XBRL Taxonomy Extension Definition Linkbase Document</div></td>
  </tr>
  <tr>
    <td style="width: 11.79%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;&#160;</div></td>
    <td style="width: 88.21%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 11.79%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">101.LAB*</div></td>
    <td style="width: 88.21%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">XBRL Taxonomy Extension Label Linkbase Document</div></td>
  </tr>
  <tr>
    <td style="width: 11.79%; vertical-align: top; background-color: #FFFFFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;&#160;</div></td>
    <td style="width: 88.21%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 11.79%; vertical-align: top; background-color: #CCEEFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">101.PRE*</div></td>
    <td style="width: 88.21%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">XBRL Taxonomy Extension Presentation Linkbase Document</div></td>
  </tr>
</table>
<div><br /></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="zf53d2589f03b45b3885405f80743faf9">
  <tr>
    <td style="width: 35pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">*</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Filed herewith</div></td>
  </tr>
</table>
<div><br /></div>
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="z7cb91ac3a58b460e92a9d5fd1088000c">
  <tr>
    <td style="width: 35pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">+</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Management contract or compensatory plan or arrangement.</div></td>
  </tr>
</table>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>80</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div><br /></div>
<div><br /></div>
<div><ix:nonNumeric name="srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" id="Text_1d56677262dd45f3b7d5d3ccffff37f8" contextRef="c20200101to20201231" escape="true" continuedAt="Text_d361f00a0bab4b6a8ee643c83587dff91">
<div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">FINANCIAL STATEMENT SCHEDULE*<span style="font-size: 10pt; font-family: 'Times New Roman';"><br /></span>SCHEDULE II &#8212; VALUATION AND QUALIFYING ACCOUNTS<span style="font-size: 10pt; font-family: 'Times New Roman';"><br /></span>U.S. PHYSICAL THERAPY, INC. AND SUBSIDIARIES</div>
</ix:nonNumeric><ix:continuation id="Text_d361f00a0bab4b6a8ee643c83587dff91" continuedAt="Text_d361f00a0bab4b6a8ee643c83587dff92">
<div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(In Thousands)</div>
</ix:continuation><ix:continuation id="Text_d361f00a0bab4b6a8ee643c83587dff92" continuedAt="Text_d361f00a0bab4b6a8ee643c83587dff93">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_d361f00a0bab4b6a8ee643c83587dff93" continuedAt="Text_d361f00a0bab4b6a8ee643c83587dff94">
<table cellpadding="0" cellspacing="0" id="z0dc91a2b2ca3420693ba57e50a133eae" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"></div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Balance at</div><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Beginning of Period</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Additions Charged</div><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">to Costs and Expenses</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Additions Charged</div><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">to Other Accounts</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Deductions</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Balance at</div><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">End of Period</div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">YEAR ENDED DECEMBER 31, 2020:</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Reserves and allowances deducted from asset accounts:</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="2" valign="bottom" style="vertical-align: bottom;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 40%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Allowance for credit losses<sup>(1)</sup></div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesBalance" id="Fact_bb699c43da284af58e2748b717ff4b1b" contextRef="c20191231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,698</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" id="Fact_b19a53519bab4348911ce11f977f1667" contextRef="c20200101to20201231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,623</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" id="Fact_c9284f57288c4ed9a5b4a222fc4e71e4" contextRef="c20200101to20201231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesDeductions" id="Fact_5fde58692cd0441b89744b3b76fd84f8" contextRef="c20200101to20201231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,313</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><sup>(2)</sup>&#160;</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesBalance" id="Fact_e131ad63ad1041799466edcdc9c10b29" contextRef="c20201231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,008</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 40%;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">YEAR ENDED DECEMBER 31, 2019:</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 40%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Reserves and allowances deducted from asset accounts:</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 40%;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Allowance for credit losses</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesBalance" id="Fact_50866eb3b6c24bbfb0f7835e0795cafb" contextRef="c20181231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,672</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" id="Fact_ac52836920bf4899a0f3620e5d603e80" contextRef="c20190101to20191231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,858</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" id="Fact_ae62d03c79b64b4c9914d39255367290" contextRef="c20190101to20191231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesDeductions" id="Fact_ae81df1cdd664746aa4f7c582ca0406a" contextRef="c20190101to20191231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,832</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><sup>(2)</sup>&#160;</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesBalance" id="Fact_acda1d90e3084f70a5e7d63ba76fcd72" contextRef="c20191231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,698</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 40%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">YEAR ENDED DECEMBER 31, 2018:</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 40%;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Reserves and allowances deducted from asset accounts:</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td valign="bottom" style="vertical-align: bottom; width: 40%; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Allowance for credit losses</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesBalance" id="Fact_c5e00a2974b8449ba922b73e3f7e8b5c" contextRef="c20171231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,273</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" id="Fact_0e55fc8f7d934f33b82a3e9c7e31db06" contextRef="c20180101to20181231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,603</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts" id="Fact_0d31b70118414194a243aa683dd6cd8f" contextRef="c20180101to20181231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">-</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesDeductions" id="Fact_1f7983ae02f14d5eaa69d3a489cef97f" contextRef="c20180101to20181231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,204</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><sup>(2)</sup>&#160;</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonFraction name="us-gaap:ValuationAllowancesAndReservesBalance" id="Fact_6d0626e30596466db88668abd78c404a" contextRef="c20181231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,672</ix:nonFraction></div></td>
    <td colspan="1" valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
  </tr>
</table>
</ix:continuation><ix:continuation id="Text_d361f00a0bab4b6a8ee643c83587dff94" continuedAt="Text_d361f00a0bab4b6a8ee643c83587dff95">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_d361f00a0bab4b6a8ee643c83587dff95" continuedAt="Text_d361f00a0bab4b6a8ee643c83587dff96">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><hr style="height: 2px; width: 20%; color: #000000; background-color: #000000; text-align: left; border: none; margin-left: 0px; margin-right: auto;" /></div>
</ix:continuation><ix:continuation id="Text_d361f00a0bab4b6a8ee643c83587dff96" continuedAt="Text_d361f00a0bab4b6a8ee643c83587dff97">
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="zb21ebc1e542b426880671b0df7e72f56">
  <tr>
    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(1)</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:footnote id="Foot_c1daa8198f5247f8b265a5b321d9c423" footnoteRole="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US">Related to patient accounts receivable and accounts receivable-other.</ix:footnote></div></td>
  </tr>
</table>
</ix:continuation><ix:continuation id="Text_d361f00a0bab4b6a8ee643c83587dff97" continuedAt="Text_d361f00a0bab4b6a8ee643c83587dff98">
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="zdfe066ff46504f55890afc338c74a818">
  <tr>
    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(2)</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:footnote id="Foot_48f584180c61464eac6330240454329a" footnoteRole="http://www.xbrl.org/2003/role/footnote" xml:lang="en-US">Uncollectible accounts written off, net of recoveries.</ix:footnote></div></td>
  </tr>
</table>
</ix:continuation><ix:continuation id="Text_d361f00a0bab4b6a8ee643c83587dff98" continuedAt="Text_d361f00a0bab4b6a8ee643c83587dff99">
<div><br /></div>
</ix:continuation><ix:continuation id="Text_d361f00a0bab4b6a8ee643c83587dff99">
<table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" cellpadding="0" cellspacing="0" id="za82c941ee7854b2b9941fe778592b572">
  <tr>
    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">*</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">All other schedules are omitted because of the absence of conditions under which they are required or because the required information is shown in the financial statements or notes thereto.</div></td>
  </tr>
</table>
</ix:continuation></div>
<div><br /></div>
<div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>81</span></div>
</div>
<div style="page-break-after:always;"><hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>
<div>
<div style="text-align: left; color: #0000FF; font-family: 'Times New Roman'; font-size: 8pt; font-style: italic;"><a href="#TableofContents" style="font-family: 'Times New Roman'; font-size: 8pt;">Table of Contents</a></div>
</div>
</div>
<div><br /></div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><a id="SIGNATURES"><!--Anchor--></a>SIGNATURES</div>
<div><br /></div>
<div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</div>
<div><br /></div>
<table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zb6ea856d53144354ac32f7ee35e88a5d">
  <tr>
    <td style="width: 50%; vertical-align: top;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td colspan="2" style="width: 50%; vertical-align: top;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">U.S. PHYSICAL THERAPY, INC.</div></td>
  </tr>
  <tr>
    <td style="width: 50%; vertical-align: top;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 5%; vertical-align: top;">&#160;</td>
    <td style="width: 45%; vertical-align: top;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(Registrant)</div></td>
  </tr>
  <tr>
    <td style="width: 50%; vertical-align: top;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 5%; vertical-align: top;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 45%; vertical-align: top;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 50%; vertical-align: top;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 5%; vertical-align: top;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">By:</div></td>
    <td style="width: 45%; vertical-align: top; border-bottom: #000000 2px solid;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">/s/ Carey Hendrickson</div></td>
  </tr>
  <tr>
    <td style="width: 50%; vertical-align: top;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td colspan="2" style="width: 50%; vertical-align: top;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Carey Hendrickson</div></td>
  </tr>
  <tr>
    <td style="width: 50%; vertical-align: top;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td colspan="2" style="width: 50%; vertical-align: top;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Chief Financial Officer</div></td>
  </tr>
  <tr>
    <td style="width: 50%; vertical-align: top;">&#160;</td>
    <td colspan="2" style="width: 50%; vertical-align: top;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Principal Financial Officer and Principal Accounting Officer)</div></td>
  </tr>
  <tr>
    <td style="width: 50%; vertical-align: top;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 5%; vertical-align: top;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 45%; vertical-align: top;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 50%; vertical-align: top;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 5%; vertical-align: top;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">By:</div></td>
    <td style="width: 45%; vertical-align: top; border-bottom: #000000 2px solid;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">/s/ Jon C. Bates</div></td>
  </tr>
  <tr>
    <td style="width: 50%; vertical-align: top;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td colspan="2" style="width: 50%; vertical-align: top;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Jon C. Bates</div></td>
  </tr>
  <tr>
    <td style="width: 50%; vertical-align: top;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td colspan="2" style="width: 50%; vertical-align: top;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Vice President/Controller</div></td>
  </tr>
</table>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Date: March 1, 2021</div>
<div><br /></div>
<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated as of the date indicated above.</div>
<div><br /></div>
<table cellpadding="0" cellspacing="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z9361a2d5f3f943f486fe42e12c4f43ae">
  <tr>
    <td style="width: 29.99%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 1.11%; vertical-align: bottom; border-top: #000000 2px solid;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 49.93%; vertical-align: bottom; border-right: #000000 2px solid; border-top: #000000 2px solid;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Chief Executive Officer, President and Director</div></td>
    <td style="width: 18.97%; vertical-align: bottom; border-right: #000000 2px solid; border-top: #000000 2px solid;"><div style="text-align: right; margin-right: 8pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 29.99%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-bottom: #000000 2px solid;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">/s/ Chris J. Reading</div></td>
    <td style="width: 1.11%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 49.93%; vertical-align: bottom; border-right: #000000 2px solid; border-bottom: #000000 2px solid;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(Principal Executive Officer)</div></td>
    <td style="width: 18.97%; vertical-align: bottom; border-right: #000000 2px solid; border-bottom: #000000 2px solid;"><div style="text-align: right; margin-right: 8pt; margin-left: 20pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">March 1, 2021</div></td>
  </tr>
  <tr>
    <td style="width: 29.99%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-bottom: #000000 2px solid;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Chris J. Reading</div></td>
    <td style="width: 1.11%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 49.93%; vertical-align: bottom; border-right: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
    <td style="width: 18.97%; vertical-align: bottom; border-right: #000000 2px solid; border-bottom: #000000 2px solid;"><div style="text-align: right; margin-right: 8pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 29.99%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-bottom: #000000 2px solid;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">/s/ Edward L. Kuntz</div></td>
    <td style="width: 1.11%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 49.93%; vertical-align: bottom; border-right: #000000 2px solid; border-bottom: #000000 2px solid;"><div>&#160;</div><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Chairman of the Board</div></td>
    <td style="width: 18.97%; vertical-align: bottom; border-right: #000000 2px solid; border-bottom: #000000 2px solid;"><div style="text-align: right; margin-right: 8pt; margin-left: 20pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">March 1, 2021</div></td>
  </tr>
  <tr>
    <td style="width: 29.99%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-bottom: #000000 2px solid;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Edward L. Kuntz</div></td>
    <td style="width: 1.11%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 49.93%; vertical-align: bottom; border-right: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
    <td style="width: 18.97%; vertical-align: bottom; border-right: #000000 2px solid; border-bottom: #000000 2px solid;"><div style="text-align: right; margin-right: 8pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 29.99%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-bottom: #000000 2px solid;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">/s/ Mark J. Brookner</div></td>
    <td style="width: 1.11%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 49.93%; vertical-align: bottom; border-right: #000000 2px solid; border-bottom: #000000 2px solid;"><div>&#160;</div><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Director</div></td>
    <td style="width: 18.97%; vertical-align: bottom; border-right: #000000 2px solid; border-bottom: #000000 2px solid;"><div style="text-align: right; margin-right: 8pt; margin-left: 20pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">March 1, 2021</div></td>
  </tr>
  <tr>
    <td style="width: 29.99%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-bottom: #000000 2px solid;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Mark J. Brookner</div></td>
    <td style="width: 1.11%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 49.93%; vertical-align: bottom; border-right: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
    <td style="width: 18.97%; vertical-align: bottom; border-right: #000000 2px solid; border-bottom: #000000 2px solid;"><div style="text-align: right; margin-right: 8pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 29.99%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-bottom: #000000 2px solid;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">/s/ Harry S. Chapman</div></td>
    <td style="width: 1.11%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 49.93%; vertical-align: bottom; border-right: #000000 2px solid; border-bottom: #000000 2px solid;"><div>&#160;</div><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Director</div></td>
    <td style="width: 18.97%; vertical-align: bottom; border-right: #000000 2px solid; border-bottom: #000000 2px solid;"><div style="text-align: right; margin-right: 8pt; margin-left: 20pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">March 1, 2021</div></td>
  </tr>
  <tr>
    <td style="width: 29.99%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-bottom: #000000 2px solid;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Harry S. Chapman</div></td>
    <td style="width: 1.11%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 49.93%; vertical-align: bottom; border-right: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
    <td style="width: 18.97%; vertical-align: bottom; border-right: #000000 2px solid; border-bottom: #000000 2px solid;"><div style="text-align: right; margin-right: 8pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 29.99%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-bottom: #000000 2px solid;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">/s/ Bernard A. Harris</div></td>
    <td style="width: 1.11%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 49.93%; vertical-align: bottom; border-right: #000000 2px solid; border-bottom: #000000 2px solid;"><div>&#160;</div><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Director</div></td>
    <td style="width: 18.97%; vertical-align: bottom; border-right: #000000 2px solid; border-bottom: #000000 2px solid;"><div style="text-align: right; margin-right: 8pt; margin-left: 20pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">March 1, 2021</div></td>
  </tr>
  <tr>
    <td style="width: 29.99%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-bottom: #000000 2px solid;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Dr. Bernard A. Harris, Jr.</div></td>
    <td style="width: 1.11%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 49.93%; vertical-align: bottom; border-right: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
    <td style="width: 18.97%; vertical-align: bottom; border-right: #000000 2px solid; border-bottom: #000000 2px solid;"><div style="text-align: right; margin-right: 8pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 29.99%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-bottom: #000000 2px solid;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">/s/ Kathleen A. Gilmartin</div></td>
    <td style="width: 1.11%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 49.93%; vertical-align: bottom; border-right: #000000 2px solid; border-bottom: #000000 2px solid;"><div>&#160;</div><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Director</div></td>
    <td style="width: 18.97%; vertical-align: bottom; border-right: #000000 2px solid; border-bottom: #000000 2px solid;"><div style="text-align: right; margin-right: 8pt; margin-left: 20pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">March 1, 2021</div></td>
  </tr>
  <tr>
    <td style="width: 29.99%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-bottom: #000000 2px solid;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Kathleen A. Gilmartin</div></td>
    <td style="width: 1.11%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 49.93%; vertical-align: bottom; border-right: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
    <td style="width: 18.97%; vertical-align: bottom; border-right: #000000 2px solid; border-bottom: #000000 2px solid;"><div style="text-align: right; margin-right: 8pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 29.99%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-bottom: #000000 2px solid;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">/s/ Reginald E. Swanson</div></td>
    <td style="width: 1.11%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 49.93%; vertical-align: bottom; border-right: #000000 2px solid; border-bottom: #000000 2px solid;"><div>&#160;</div><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Director</div></td>
    <td style="width: 18.97%; vertical-align: bottom; border-right: #000000 2px solid; border-bottom: #000000 2px solid;"><div style="text-align: right; margin-right: 8pt; margin-left: 20pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">March 1, 2021</div></td>
  </tr>
  <tr>
    <td style="width: 29.99%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-bottom: #000000 2px solid;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Reginald E. Swanson</div></td>
    <td style="width: 1.11%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 49.93%; vertical-align: bottom; border-right: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
    <td style="width: 18.97%; vertical-align: bottom; border-right: #000000 2px solid; border-bottom: #000000 2px solid;"><div style="text-align: right; margin-right: 8pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
  <tr>
    <td style="width: 29.99%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-bottom: #000000 2px solid;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">/s/ Clayton K. Trier</div></td>
    <td style="width: 1.11%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 49.93%; vertical-align: bottom; border-right: #000000 2px solid; border-bottom: #000000 2px solid;"><div>&#160;</div><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Director</div></td>
    <td style="width: 18.97%; vertical-align: bottom; border-right: #000000 2px solid; border-bottom: #000000 2px solid;"><div style="text-align: right; margin-right: 8pt; margin-left: 20pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">March 1, 2021</div></td>
  </tr>
  <tr>
    <td style="width: 29.99%; vertical-align: bottom; border-left: #000000 2px solid; border-right: #000000 2px solid; border-bottom: #000000 2px solid;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Clayton K. Trier</div></td>
    <td style="width: 1.11%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td style="width: 49.93%; vertical-align: bottom; border-right: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
    <td style="width: 18.97%; vertical-align: bottom; border-right: #000000 2px solid; border-bottom: #000000 2px solid;"><div style="text-align: right; margin-right: 8pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
  </tr>
</table>
<div><br /></div>
<div><br /></div>
<div>
<div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;"><span>82</span></div>
</div>
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>brhc10020853_ex4-1.htm
<DESCRIPTION>EXHIBIT 4.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using EDGARfilings PROfile 7.3.2.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div>
    <div style="text-align: right; font-weight: bold;">EXHIBIT 4.1</div>
    <div><br>
    </div>
    <div style="margin-right: 29pt;">The Company&#8217;s authorized capital stock consists of 500,000 shares of preferred stock, par value $0.01 per share (the &#8220;Preferred Stock&#8221;), and 20,000,000
      Common Stock.</div>
    <div><br>
    </div>
    <div style="margin-right: 5pt;">The following is a summary of the material provisions of the Company&#8217;s Certificate of Incorporation, as amended (the &#8220;Certificate of Incorporation&#8221;) and
      Amended and Restated By-laws (the &#8220;By-laws&#8221;), insofar as they relate to the material terms of the Common</div>
    <div><br>
    </div>
    <div style="margin-right: 9pt;">Stock. This description summarizes the material terms and provisions of the Common Stock, but it is not complete. This summary is qualified in its
      entirety by reference to the Certificate of Incorporation and By-laws, which are incorporated herein by reference.</div>
    <div><br>
    </div>
    <div style="margin-right: 8pt;">Each holder of the Common Stock is entitled to one vote for each share on all matters to be voted upon by the stockholders and there are no cumulative
      voting rights. In the event of a liquidation, dissolution or winding up of the Company, holders of the Common</div>
    <div><br>
    </div>
    <div style="margin-right: 4pt;">Stock would be entitled to share in the Company&#8217;s assets remaining after the payment of the Company&#8217;s debts and liabilities. Holders of the Common Stock
      have no preemptive or conversion rights or other subscription rights and there are no redemption or sinking fund provisions applicable to the Common Stock. The rights, preferences and privileges of the holders of the Common Stock are subject to, and
      may be adversely affected by, the rights of the holders of shares of any series of Preferred Stock that we may designate in the future.</div>
    <div><br>
    </div>
    <div style="margin-right: 10pt;">The Common Stock is not convertible into, or exchangeable for, any other class or series of the Company&#8217;s capital stock. Holders of the Common Stock do
      not have preemptive or other rights to subscribe for or purchase additional securities of the Company. Certain provisions of the Company&#8217;s articles of incorporation and bylaws may delay, discourage, prevent or render more difficult an attempt to
      obtain control of the Company, whether through a tender offer, business combination, proxy contest or otherwise. These provisions include the charter authorization of &#8220;blank check&#8221; preferred stock (as described above) and a restriction on the ability
      of stockholders to call a special meeting.</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>3
<FILENAME>brhc10020853_ex21-1.htm
<DESCRIPTION>EXHIBIT 21.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using EDGARfilings PROfile 7.3.2.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div>
    <div style="text-align: right; font-weight: bold;">Exhibit 21.1</div>
    <br>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z33ac289dabf84dd2b5a433d703f99d22">

        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Notes</div>
          </td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Name</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">DBA</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Entity Type</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">State of Formation</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Foreign Qualification</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">General Partner (LP)/Owner (corp)/Member (LLC)</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Tax ID</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2037953 Ontario, Inc.</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Corp</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Canada</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Briotix Health, LP</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Ability Health PT Management GP, LLC</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LLC</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">FL</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #4, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">81-4216526</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Ability Health Services and Rehabilitation, L.P.</div>
          </td>
          <td style="width: 17.15%; vertical-align: top;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Ability Rehabilitation</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">FL</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Ability Health PT Management GP, LLC</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">38-4017532</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Achieve Management GP, LLC</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LLC</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #4, Inc</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">47-3291851</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Achieve Physical Therapy and Performance, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Achieve Management GP, LLC</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">47-3283941</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Action Therapy Centers, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Action Physical Therapy</div>
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Houston Hand Therapy&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160; PT Professionals</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #1, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0389610</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Adams County Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">PA</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #5, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0483100</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Advance Rehabilitation &amp; Consulting, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">AL, FL &amp; GA</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Advance Rehabilitation Management GP, LLC</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">27-4414647</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Advance Rehabilitation Management GP, LLC</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LLC</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">FL</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #4, Inc</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">27-4414443</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Agape Physical Therapy &amp; Sports Rehabilitation, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">MD</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Agape Physical Therapy Management GP, LLC</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">32-0378859</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Agape Physical Therapy Management GP, LLC</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LLC</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #4, Inc</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">45-5378415</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Agility Spine &amp; Sports PT Management GP LLC</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LLC</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">82-10244870</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Agility Spine &amp; Sports Physical Therapy and Rehabilitation, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">AZ</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Agility Spine &amp; Sports PT Management GP, LLC</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">82-0901134</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">To be dissolved</div>
          </td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Ankeny Physical &amp; Sports Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">IA</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #5, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0424735</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">ARC Iowa PT Plus, LLC</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LLC</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">IA</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">ARC PT Management GP, LLC (note:&#160; owned 100% by ARC Physical Therapy Plus, LP)</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">82-5241308</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">ARC Physical Therapy Plus, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">KS, MO</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">ARC PT Management GP, LLC</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">80-0955852</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">ARC PT Management GP, LLC</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LLC</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">MO</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #4, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">46-3942987</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">ARCH Physical Therapy and Sports Medicine, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">MI</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #1, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">27-5086288</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Arrow Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Broken Arrow Physical Therapy</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">OK</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #2, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0631992</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Arrowhead Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Elite Sports Medicine &amp; Physical Therapy</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">MS</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #2, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">26-0176798</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Ashland Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">OR</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #6, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">75-3054977</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Audubon Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LA</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #6, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0622471</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Barren Ridge Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">VA</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #6, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">26-3594831</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Bayside Management GP, LLC</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LLC</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #4, Inc</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">27-4348787</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Bayside Physical Therapy &amp; Sports Rehabilitation, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">MD</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Bayside Management GP, LLC</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">27-4348871</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Beaufort Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">NC</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #3, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0639928</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Bow Physical Therapy &amp; Spine Center, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">NH</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #6, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0623486</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Brazos Valley Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #3, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0407118</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Brick Hand &amp; Rehabilitative Services, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">NJ</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #3, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0420711</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Briotix Health, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">InSite Health (6/25/2020 - Per Cyndi M. and Leon P. this dba is no longer used).</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">DE</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">AZ, CA, CO, CT, FL, GA, HI, IL, IA, IN, KS, KY, MA, MD, MI, MN, MO, MT, NV, NJ, NY, NC, OH, OK, OR, PA, SC, TX, UT, VA, WA, WI</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Briotix Management GP, LLC</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">81-1190407</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Briotix Management GP, LLC</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LLC</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">FL, MA, OH, UT</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">81-1200727</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">BTE Workforce Solutions, LLC (formerly BTE Technoligies, Inc.)</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LLC</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">DE</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">AK, AL,CO, DC, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MD, ME, MI, MN, MO,MS, MT, NC, ND, NE, NH, NJ, NM, NV, OK, PA, RI, SC, SD, TX, UT, VT, WI,
              WV, WY</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Briotix Health, LP</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">52-1165956</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">C. Foster Physical Therapists, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">C. Foster PT Management GP, LLC</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">36-4965660</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">C. Foster PT Management GP, LLC</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LLC</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #4, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">35-2689219</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Cape Cod Hand Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Cape Cod Hand &amp; Upper Extremity Therapy</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">MA</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #1, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">27-0058293</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Carolina Physical Therapy and Sports Medicine, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">SC</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Carolina PT Management GP, LLC</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">82-1408170</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Carolina PT Management GP, LLC</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LLC</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">82-1453799</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Center for Physical Rehabilitation and Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">DE</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">MI</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">CPR Management GP, LLC</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">47-4006118</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Cleveland Physical Therapy, Ltd.</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #2, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0410649</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Comprehensive Hand &amp; Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">FL</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #2, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0452158</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Coppell Spine &amp; Sports Rehab, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">North Davis/Keller Physical Therapy&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; Physical Therapy of Colleyville</div>
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Physical Therapy of North Texas&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160; Physical Therapy of Corinth&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;
              &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160; Trinity Sports &amp; Physical Therapy&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160; Physical Therapy of Flower Mound&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160; Southlake Physical
              Therapy&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160; Physical Therapy of Trophy Club&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; Heritage Trace Physical Therapy&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;
              &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160; Therapy Partners of Frisco/Little Elm&#160; &#160; &#160; &#160; &#160; Therapy Partners of North Texas</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #5, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0513962</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">CPR Management GP, LLC</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LLC</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #4, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">47-3434985</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Cross Creek Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">MS</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #4, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">35-2185612</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Crossroads Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Green Oaks Physical Therapy - Fort Worth&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; Green Oaks Physical Therapy</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #1, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0551398</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Crossroads Rehabilitation, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Crossroads Physical Therapy</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">MI</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #1, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">84-1658419</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Custom Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">NV</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #4, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">04-3708931</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Cutting Edge Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">IN</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #4, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">20-4069256</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Dearborn Physical Therapy, Ltd.</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Advanced Physical Therapy</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">MI</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #1, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0376595</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Decatur Hand and Physical Therapy Specialists, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">GA</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #4, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">20-3319149</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Dekalb Comprehensive Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">GA</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #4, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">20-3631634</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Denali Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">AK</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #5, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">20-8666329</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">DHT Hand Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Arizona Desert Hand Therapy Services&#160; &#160; &#160; &#160; Desert Hand and Physical Therapy</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">AZ</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">DHT Management GP, LLC</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">20-5881475</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">DHT Management GP, LLC</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LLC</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">AZ</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #4, Inc</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">20-5881418</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Dynamic Hand Therapy &amp; Rehabilitation, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">IL</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #4, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">20-8847486</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Eastgate Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Summit Physical Therapy</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">OH</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #4, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0637484</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Edge Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">River's Edge Physical Therapy</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">MT</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #3, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0473771</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Enid Therapy Center, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Enid Physical Therapy</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">OK</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #2, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0384228</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Everett Management, LLC</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LLC</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">WA</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U.S. Physical Therapy, Ltd.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">37-1776322</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Evergreen Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">MI</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #1, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">20-8613843</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Excel Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">AK</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Excel PT Texas GP, LLC</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">20-3951569</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Excel PT Texas GP, LLC</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LLC</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #6, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">20-3951532</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Fit2WRK, Inc.</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Corp</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U.S. Physical Therapy, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">27-1647054</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Five Rivers Therapy Services, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Peak Physical Therapy</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">AR</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #3, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">20-3785604</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Flannery Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Physical Therapy Plus</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">NJ</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #3, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0580514</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">To be dissolved</div>
          </td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Forest City Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">IL</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #4, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0525481</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Fredericksburg Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #1, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">20-3589445</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Fremont PT Management GP, LLC</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LLC</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">85-4237359</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Fremont Therapy Group, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Fremont PT Management GP, LLC</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Frisco Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">PT of Prosper</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #1, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0625171</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Gahanna Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Cornerstone Physical Therapy</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">OH</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #4, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">27-0643842</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Genesee Valley Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">MI</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #1, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">26-2299603</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Green Oaks Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #1, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">72-1531238</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Hamilton Physical Therapy Services, LP</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">NJ</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">HPTS Management GP, LLC</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">74-3145890</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Hands-On Sports Medicine, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Metro Spine and Sports Rehabilitation</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">IL</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #4, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">20-3300800</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Hanoun Medical, Inc.</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">BTE Workforce Solutions&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160; Briotix Health</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Corp</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Canada</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2037053 Ontario, Inc. (owned by Briotix Health, LP)</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Harbor Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">MD</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #6, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">20-3303737</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">To be dissolved</div>
          </td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Heritage Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">CA</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #5, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0647511</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">HH Rehab Associates, Inc.</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Genesee Valley Physical Therapy</div>
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Theramax Physical Therapy</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Corp</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">MI</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">DE</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U.S. PT - Michigan, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">38-2427228</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">High Plains Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">WY</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #4, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">41-2060941</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Highlands Physical Therapy &amp; Sports Medicine, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">NJ</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #3, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">27-3126287</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Hoeppner Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">VT</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #5, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0613907</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Houston On Demand Physical Therapy, LLC</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LLC</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Kingwood Physical Therapy, Ltd.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">85-3267403</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">HPTS Management GP, LLC</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LLC</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">NJ</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #3, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">74-3145888</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">To be dissolved</div>
            </td>
            <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">IH GP, LLC</div>
            </td>
            <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
            <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LLC</div>
            </td>
            <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
            </td>
            <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
            <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
            <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">82-4303618</div>
            </td>
          </tr>
          <tr>
            <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
            <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Indy ProCare Physical Therapy, Limited Partnership</div>
            </td>
            <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
            <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
            </td>
            <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
            </td>
            <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">IN</div>
            </td>
            <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #4, Inc.</div>
            </td>
            <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">45-4419567</div>
            </td>
          </tr>
          <tr>
            <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">To be dissolved</div>
            </td>
            <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">InSite Health Limited Partnership</div>
            </td>
            <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
            <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
            </td>
            <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">DE</div>
            </td>
            <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
            <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">IH GP, LLC</div>
            </td>
            <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">82-4365153</div>
            </td>
          </tr>
          <tr>
            <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
            <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Intermountain Physical Therapy, Limited Partnership</div>
            </td>
            <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
            <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
            </td>
            <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
            </td>
            <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">ID</div>
            </td>
            <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #6, Inc.</div>
            </td>
            <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0532873</div>
            </td>
          </tr>
          <tr>
            <td style="width: 7.76%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 26.07%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Jackson Clinics PT Management GP , LLC</div>
            </td>
            <td style="width: 17.15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 2.97%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LLC</div>
            </td>
            <td style="width: 4.78%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
            </td>
            <td style="width: 14.45%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 19.01%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #4, Inc.</div>
            </td>
            <td style="width: 7.81%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">46-4470249</div>
            </td>
          </tr>

      </table>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Jackson Clinics, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">MD, VA</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Jackson Clinics PT Management GP, LLC</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">61-1729833</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Jaco Rehab Honolulu Management GP, LLC</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LLC</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">84-3191941</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Jaco Kapolei Management GP, LLC</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LLC</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">84-3152468</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Jaco Mililani Management GP LLC</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LLC</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">84-3167120</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Jaco Waikele Management GP LLC</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LLC</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">84-3176419</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Jaco Rehab Honolulu, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">HI</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Jaco Rehab Honolulu Management GP, LLC</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">84-3255422</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Jaco Rehab Kapolei, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">HI</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Jaco Kapolei Management GP, LLC</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">84-3236943</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Jaco Rehab Mililani, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Jaco Mililani Management GP, LLC</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">84-3206751</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Jaco Rehab Waikele, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">HI</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Jaco Waikele Management GP, LLC</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">84-3226914</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Joan Ostermeier Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Sport &amp; Spine Clinic of Wittenberg</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">WI</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #1, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0556793</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Julie Emond Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Maple Valley Physical Therapy</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">VT</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #3, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0544267</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Kelly Lynch Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Sport &amp; Spine Clinic of Watertown</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">WI</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #1, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0559026</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Kennebec Physical Therapy, LLC</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LLC</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">ME</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U.S. Physical Therapy, Ltd.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">46-4456545</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Kingwood Physical Therapy, Ltd.</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Spring-Klein Physical Therapy&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; West Woodlands Physical Therapy&#160; &#160; &#160; &#160; &#160; &#160;
              &#160; &#160; &#160;&#160; Lake Conroe Sports Medicine and Rehabilitation Cypress Oaks Physical Therapy&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160; Star Therapy Services of Fairfield;&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; Grand Oaks Sports Medicine and Rehabilitation</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #2, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0384227</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Lake Houston Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Northern Oaks Orthopedic &amp; Sports PT</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #1, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">75-3050296</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Leader Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Memphis Physical Therapy</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TN</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #4, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0539465</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Withdraw PA</div>
          </td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Life Fitness Physical Therapy, LLC</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In Balance Physical Therapy&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160; Herbst Physical Therapy</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LLC</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">MD</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">PA</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U.S. Physical Therapy, Ltd.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">20-1193079</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Life Strides Physical Therapy and Rehabilitation, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">SC</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #2, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">20-5120914</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LiveWell Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #5, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">26-3700763</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Madison Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">NJ</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">MSPT Management GP, LLC&#160;</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">27-2047964</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Madison Spine, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">NJ</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">MSPT Management GP, LLC&#160;</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">90-0813058</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Max Motion Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">AZ</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #3, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">26-3988733</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Merrill Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">WI</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #1, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0512097</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Mishock Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Xcelerate Physical Therapy</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">PA</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Mishock PT Management GP, LLC</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">30-0783139</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Mishock PT Management GP, LLC</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LLC</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #4, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">46-2793533</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Mission Rehabilitation and Sports Medicine, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">RYKE Rehabilitation</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">RYKE Management GP, LLC</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">26-3747839</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Mobile Spine and Rehabilitation, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">AL</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #6, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0600186</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Momentum Physical &amp; Sports Rehabilitation, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Momentum Physical Therapy &amp; Sports Rehab</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">FL, CO, AZ</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #10, LLC</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">47-2388509</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Mountain View Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Mountain View Physical and Hand Therapy</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">OR</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #6, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0528482</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">MSPT Management GP, LLC</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LLC</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">NJ</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #4, Inc</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">27-2047906</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">National Rehab Delaware, Inc.</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Corp</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">DE</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">MO</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">National Rehab GP, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">74-2899827</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">shows tax clearance</div>
          </td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">National Rehab GP, Inc.</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Corp</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">FL,MO</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U.S. PT - Delaware, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0345539</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">National Rehab Management GP, Inc.</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Corp</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">IL</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U.S. PT - Delaware, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0345543</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">New Horizons Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">IN</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #4, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">20-2729857</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Norman Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">OK</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #4, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0420713</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">North Jersey Game On Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Madison Spine &amp; Physical Therapy</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">NJ</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #3, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">27-3885529</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">North Lake Physical Therapy and Rehab, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">OR</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">North Lake PT Management GP, LLC</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">90-0964749</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">North Lake PT Management GP, LLC</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LLC</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #4, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">46-2599705</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Northern Lights Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">ND</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #3, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">27-0342077</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Northwest PT Management GP, LLC</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LLC</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #4, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">82-2410286</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Northwoods Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">MI</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #1, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">26-1258418</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">OPR Management Services, Inc.</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Corp</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">AK, AL, AZ, CO, CT, DE, FL, GA, IA, ID, IL, IN, KS, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, OH, OK, OR, PA, SC, SD, TN,
              VA, VT, WI, WY</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U.S. Physical Therapy, Ltd.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">81-3815218</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">OSR Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">MN</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">OSR Physical Therapy Management GP, LLC</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">83-0657305</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">OSR Physical Therapy Management GP LLC</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LLC</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">83-0649952</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">To be dissolved</div>
          </td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Old Towne Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">DE</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #3, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">26-0237594</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">One to One PT Management GP LLC</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LLC</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">FL</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #4, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">84-4060850</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">One to One Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">DE</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">One to One PT Management GP, LLC</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">84-4074270</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Oregon Spine &amp; Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Peak State Physical Therapy</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">OR</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #6, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0613909</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Peak Performance PT Management GP, LLC</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LLC</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Peak Performance Physical Therapy and Fitness, LLC</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">85-3948317</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Peak Performance Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Peak Performance PT Management GP, LLC</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">85-4174416</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Pelican State Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Audubon Physical Therapy</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LA</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #6, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0433513</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Penns Wood Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">PA</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #5, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0430771</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">PerformancePro Sports Medicine and Rehabilitation, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #5, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">26-1539873</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Phoenix Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">OH</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #4, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">27-0932165</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Check with Peter if to be dissolved</div>
          </td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Physical Restoration and Sports Medicine, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">VA</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #6, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">27-0878621</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Physical Therapy Northwest, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">OR</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Northwest PT Management GP, LLC</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">82-2397360</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Physical Therapy and Spine Institute, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">IL</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #4, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0438263</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Physical Therapy Solutions, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">DE</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">VA</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">PTS GP Management, LLC</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">47-3075583</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Pinnacle Therapy Services, LLC</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LLC</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">DE</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">MO</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U.S. Physical Therapy, Ltd.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">46-3247784</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Pioneer Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">NE</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #1, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">20-3530492</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Plymouth Physical Therapy Specialists, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">MI</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #3, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0424739</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Port City Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">ME</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #3, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0585914</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Precision Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">PA</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #5, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0438265</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Premier Physical Therapy and Sports Performance, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">DE</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Premier Management GP, LLC</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">47-5385666</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Premier Management GP, LLC</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LLC</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">DE</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #4, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">47-5403407</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">ProActive Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">SD</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #3, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0600187</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">ProCare Physical Therapy Management GP, LLC</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LLC</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #4, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">46-2044643</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">ProCare PT, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">PA</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">ProCare Physical Therapy Management GP, LLC</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">90-0941849</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Progressive Physical Therapy Clinic, Ltd.</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Progressive Hand and Physical Therapy</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #1, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0387638</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">PTS GP Management, LLC</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LLC</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #4, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">47-3239903</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Quad City Physical Therapy &amp; Spine, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">IA</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #5, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">14-1921829</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">RACVA GP, LLC</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LLC</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">VA</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #4, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">37-1838302</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">R. Clair Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Clair Physical Therapy</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #1, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0478967</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Radtke Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">MN</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #5, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0574455</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Reaction Physical Therapy, LLC</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LLC</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">DE</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">OK</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U.S. Physical Therapy, Ltd.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">47-1586428</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rebound Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">OR</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rebound PT Management GP, LLC</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">81-1026078</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rebound PT Management GP, LLC</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LLC</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #4, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">81-1045143</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Red River Valley Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #5, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">20-4489003</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Redmond Ridge Management, LLC</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LLC</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">WA</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U.S. Physical Therapy, Ltd.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">61-1754288</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Regional Physical Therapy Center, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #5, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0429008</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #1, Inc.</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Corp</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">FL, MA, &amp; WI</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U.S. PT Delaware, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0345544</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #2, Inc.</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Corp</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">FL</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U.S. PT Delaware, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0379584</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Withdraw, NJ</div>
          </td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #3, Inc.</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Corp</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">MO, MT, NJ, ND, &amp; SD</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U.S. PT Delaware, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0394604</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Withdraw UT</div>
          </td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #4, Inc.</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Corp</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">OH, &amp; UT</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U.S. PT Delaware, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0418425</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #5, Inc.</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Corp</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U.S. PT Delaware, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0427607</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #6, Inc.</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Corp</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">OR</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U.S. PT Delaware, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0433511</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners Acquisition #1, Inc.</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Corp</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U.S. Physical Therapy, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0377650</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehabilitation Associates of Central Virginia, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Associates of Central Virginia (Campbell County)</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">VA</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">RACVA GP, LLC</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">81-3831622</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rice Rehabilitation Associates, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">GA</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #4, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0430769</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Riverview Physical Therapy, Limited Partnership (formerly Yarmouth Physical Therapy)</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">ME</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #3, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">27-0001262</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Dissolve LP; Withdrawn LA</div>
          </td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Riverwest Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LA</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #6, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0496362</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Roepke Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Elite Hand&#160;&amp; Upper Extremity Clinic</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">WI</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #1, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0483099</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">RYKE Management GP, LLC</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LLC</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #5, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">26-3747599</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Saginaw Valley Sport and Spine, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Sport &amp; Spine Physical Therapy and Rehab; Evergreen PT</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">MI</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #3, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0403520</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Saline Physical Therapy of Michigan, Ltd.</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Physical Therapy in Motion</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">MI</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #1, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0376594</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">San Antonio On Demand Physical Therapy, LLC</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LLC</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U.S. Physical Therapy, Ltd.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Seacoast Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">ME</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #3, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">45-2498148</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Signature Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">OK</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #2, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">20-5992649</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Snohomish Management, LLC</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LLC</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">WA</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U.S. Physical Therapy, Ltd.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">38-3953679</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">South Tulsa Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Physical Therapy of Jenks</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">OK</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #2, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0566430</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Spectrum Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Southshore Physical Therapy</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">CT</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #2, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0393448</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">GA is dissolved</div>
          </td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Spine &amp; Sport Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">GA</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #4, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0414726</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Sport &amp; Spine Clinic of Fort Atkinson, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Sport &amp; Spine Clinic of Sauk City</div>
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Sport &amp; Spine Clinic of Madison&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;
              &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160; Sport &amp; Spine Clinic of Jefferson</div>
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Sport &amp; Spine Edgerton</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">WI</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #1, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0694802</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Sport &amp; Spine Clinic, L.P.</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Sport &amp; Spine&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; Sport &amp; Spine Clinic of Edgar&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160; Sport &amp; Spine
              Minocqua&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; Sport &amp; Spine - Rib Mountain</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">DE</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">WI</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners Acquisition #1, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0376131</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Spracklen Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">NE</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #1, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0580510</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">STAR PT Management GP, LLC</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LLC</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #4, Inc</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">26-1107563</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">STAR Physical Therapy, LP</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">AR, TN, IN</div>
          </td>
          <td style="width: 19.01%; vertical-align: top;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">STAR PT Management GP, LLC</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">62-1707893</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Star Therapy Centers, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Star Therapy Services of Copperfield&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; Star Therapy Services of Cy-Fair&#160; &#160; &#160; &#160;
              &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160; Star Therapy Services of Fulshear</div>
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Star Therapy Services of Katy</div>
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Star Therapy Services of Magnolia</div>
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Star Therapy Services of Spring Cypress&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160; Star Therapy Services of Cinco
              Ranch</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #1, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0389608</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Texstar Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #5, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0669263</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Hale Hand Center, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">FL</div>
          </td>
          <td style="width: 19.01%; vertical-align: top;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #2, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0601187</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The U.S. Physical Therapy Foundation</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">NP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Qualified to fund raise in CA, FL, KS, MD, MI, TN, TX, VA</div>
          </td>
          <td style="width: 19.01%; vertical-align: top;">&#160;</td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">81-1071364</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Therapyworks Physical Therapy, LLC</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Therapyworks</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LLC</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">DE</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">IN</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U.S. Physical Therapy, Ltd.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">46-4446075</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Thibodeau Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">MI</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #1, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">26-1147899</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Thunder Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">WA</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #4, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">26-3806761</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U.S. Physical Therapy, Inc.</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Corp</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">NV</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">MI and AZ</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">N/A</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0364866</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U.S. Physical Therapy, Ltd.</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">NJ,</div>
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">NC</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">National Rehab GP, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0388092</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U.S. PT - Delaware, Inc.</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Corp</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">DE</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">FL, IL, MN, MO</div>
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">NM,</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U.S. Physical Therapy, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">51-0343523</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U.S. PT Alliance Rehabilitation Services, Inc.</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Alliance Rehabilitation Services</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Corp</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">PA</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U.S. Physical Therapy, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">26-2377769</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U.S. PT Management, Ltd.</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">WA</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">National Rehab Management GP, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0388500</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U.S. PT Michigan #1, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Genesee Valley Physical Therapy</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">MI</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #1, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0570431</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U.S. PT Michigan #2, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Physical Therapy Solutions</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">MI</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #2, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0579492</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U.S. PT Solutions, Inc.</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Physical Therapy Solutions</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Corp</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">VA</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U.S. Physical Therapy, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">26-0609553</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U.S. PT Texas, Inc.</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Kinetix Physical Therapy</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Corp</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">MS</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U.S. Physical Therapy, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">20-5125415</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">To be dissolved</div>
          </td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U.S. PT Therapy Services, Inc. (formerly U.S. Surgical Partners, Inc.)</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Capstone Physical Therapy</div>
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Carolina Hand and Wellness Center</div>
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Hand Therapy of North Texas - Frisco</div>
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Hand Therapy of North Texas - Coppell</div>
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Innovative Physical Therapy</div>
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Lake City Hand Therapy</div>
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Life Sport Physical Therapy</div>
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Life Sport Physical Therapy - Glen Ellyn</div>
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Metro Hand Rehabilitation</div>
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Missouri City Physical Therapy</div>
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Mountain View Physical Therapy of Medford</div>
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Mountain View Physical Therapy of Talent</div>
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Northern Illinois Therapy Services</div>
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Propel Physical Therapy</div>
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">ReAction Physical Therapy</div>
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Therapeutic Concepts</div>
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Tulsa Hand Therapy</div>
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Waco Sports Medicine and Rehabilitation</div>
            <div>&#160;</div>
            <div>&#160;</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Corp</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">DE</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">CA, FL, IA, IL, IN, KS, ME, MS, MO, NC, OH, OK, OR, PA, TX VA, &amp; WI</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U.S. Physical Therapy, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0613914</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U.S. PT Turnkey Services, Inc.</div>
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(formerly Surgical Management GP, Inc.</div>
          </td>
          <td style="width: 17.15%; vertical-align: top;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Hand &amp; Orthopedic Rehab Clinic</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Corp</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">IN</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U.S. Physical Therapy, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">20-2803028</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U.S. Therapy, Inc.</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">First Choice Physical Therapy</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Corp</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">IN</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U.S. PT - Delaware, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0637511</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Facilities Group, Inc.</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">University Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">VA</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #6, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76-0613913</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">USPT Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Body Basics Physical Therapy</div>
          </td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">IA</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #5, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">20-5441273</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Victory Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #5, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">20-4406904</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">West Texas Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #5, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">20-5834588</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Wright PT Management GP, LLC</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LLC</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 19.01%; vertical-align: top;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Rehab Partners #4, Inc.</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">82-3239740</div>
          </td>
        </tr>
        <tr>
          <td style="width: 7.76%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 26.07%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Wright Physical Therapy, Limited Partnership</div>
          </td>
          <td style="width: 17.15%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">&#160;</td>
          <td style="width: 2.97%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">LP</div>
          </td>
          <td style="width: 4.78%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">TX</div>
          </td>
          <td style="width: 14.45%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">ID</div>
          </td>
          <td style="width: 19.01%; vertical-align: top; border-left: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Wright PT Management GP, LLC</div>
          </td>
          <td style="width: 7.81%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">82-3255983</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zb3185dfc5f7c4e37b06680052c5c21be">

          <tr>
            <td style="width: 27.99%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Name</div>
            </td>
            <td style="width: 28.98%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">DBA</div>
            </td>
            <td style="width: 9.02%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Entity Type</div>
            </td>
            <td style="width: 10.85%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">State of Formation</div>
            </td>
            <td style="width: 12.39%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Foreign Qualification</div>
            </td>
            <td style="width: 10.76%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Tax ID</div>
            </td>
          </tr>
          <tr>
            <td style="width: 27.99%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Everett Physical Therapy and Sports Performance Center, PLLC</div>
            </td>
            <td style="width: 28.98%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Sports Physical Therapy</div>
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">SPT- Bellevue</div>
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">SPT- Kirkland</div>
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">SPT &#8211; Everett</div>
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">SPT &#8211; Factoria</div>
              <div>&#160;</div>
            </td>
            <td style="width: 9.02%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">PLLC</div>
            </td>
            <td style="width: 10.85%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">WA</div>
            </td>
            <td style="width: 12.39%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">&#160;</td>
            <td style="width: 10.76%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">47-0930529</div>
            </td>
          </tr>
          <tr>
            <td style="width: 27.99%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Redmond Ridge Physical Therapy, PLLC</div>
            </td>
            <td style="width: 28.98%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Functional Therapy Group</div>
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">FTG Duvall</div>
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">FTG Redmond Ridge</div>
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">FTG Woodinville</div>
              <div>&#160;</div>
            </td>
            <td style="width: 9.02%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">PLLC</div>
            </td>
            <td style="width: 10.85%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">WA</div>
            </td>
            <td style="width: 12.39%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">&#160;</td>
            <td style="width: 10.76%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">26-1241495</div>
            </td>
          </tr>
          <tr>
            <td style="width: 27.99%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Snohomish Physical Therapy, PLLC</div>
            </td>
            <td style="width: 28.98%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Movement Physical and Hand Therapy of Snohomish</div>
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Movement Physical and Hand Therapy of Canyon Park</div>
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">MPT Snohomish</div>
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">MPT Canyon Park</div>
              <div>&#160;</div>
            </td>
            <td style="width: 9.02%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">PLLC</div>
            </td>
            <td style="width: 10.85%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">WA</div>
            </td>
            <td style="width: 12.39%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">&#160;</td>
            <td style="width: 10.76%; vertical-align: top; border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">33-1058838</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>brhc10020853_ex23-1.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using EDGARfilings PROfile 7.3.2.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">


  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div>
    <div style="text-align: right; font-weight: bold;">EXHIBIT 23.1</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</div>
    <div><br>
    </div>
    <div>We have issued our reports dated March 1, 2021, with respect to the consolidated financial statements and internal control over financial reporting included in
      the Annual Report of U.S. Physical Therapy, Inc. on Form 10-K for the year ended December 31, 2020. We consent to the incorporation by reference of said reports in the Registration Statements of U.S. Physical Therapy, Inc. on Forms S-8 (File Nos.
      333-30071 effective June 26, 1997, 333-64159 effective September 24, 1998, 333-67678 effective August 16, 2001, 333-67680 effective August 16, 2001, 333-82932 effective February 15, 2002, 333-103057 effective February 10, 2003, 333-113592 effective
      March 15, 2004, 333-116230 effective June 4, 2004, 333-153051 effective August 15, 2008, 333-185381 effective December 11, 2012, 333-200832 effective December 10, 2014, and 333-230368 effective March 18, 2019).</div>
    <div><br>
    </div>
    <div>/s/ GRANT THORNTON LLP</div>
    <div> <br>
    </div>
    <div>Houston, Texas</div>
    <div>March 1, 2021</div>
    <div><br>
    </div>
    <div><br>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
  </div>
  <div><br>
  </div>


</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>brhc10020853_ex31-1.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using EDGARfilings PROfile 7.3.2.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div>
    <div style="text-align: right; font-weight: bold;">EXHIBIT 31.1</div>
    <div><br>
    </div>
    <div style="font-weight: bold; text-align: center;">CERTIFICATION</div>
    <div><br>
    </div>
    <div>I, Christopher J. Reading, certify that:</div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" id="zb2c86dc1eba14a0b8b4e1d560791cfb9" class="DSPFListTable">

          <tr style="vertical-align: top;">
            <td style="vertical-align: top; width: 18pt;">
              <div style="text-align: left;">1.</div>
            </td>
            <td style="align: left; vertical-align: top; width: auto;">
              <div style="text-align: left;">I have reviewed this annual report on Form 10-K of U.S. Physical Therapy, Inc.;</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" id="z279f38b47a7645728215895d8309ad97" class="DSPFListTable">

          <tr style="vertical-align: top;">
            <td style="vertical-align: top; width: 18pt;">
              <div style="text-align: left;">2.</div>
            </td>
            <td style="align: left; vertical-align: top; width: auto;">
              <div style="text-align: left;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such
                statements were made, not misleading with respect to the period covered by this report;</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" id="zf8e20510b87c4da29776300061652cb2" class="DSPFListTable">

          <tr style="vertical-align: top;">
            <td style="vertical-align: top; width: 18pt;">
              <div style="text-align: left;">3.</div>
            </td>
            <td style="align: left; vertical-align: top; width: auto;">
              <div style="text-align: left;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of
                the registrant as of, and for, the periods presented in this report;</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" id="zf43d767e139247379b12317b8121e24a" class="DSPFListTable">

          <tr style="vertical-align: top;">
            <td style="vertical-align: top; width: 18pt;">
              <div style="text-align: left;">4.</div>
            </td>
            <td style="align: left; vertical-align: top; width: auto;">
              <div style="text-align: left;">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal
                control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" id="zb74a17a5492a4acaae3121840b115b90" class="DSPFListTable">

          <tr style="vertical-align: top;">
            <td style="vertical-align: top; width: 18pt;">
              <div style="text-align: left;">(a)</div>
            </td>
            <td style="align: left; vertical-align: top; width: auto;">
              <div style="text-align: left;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including
                its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" id="z4a8414fd905b4703a41b96fbeac95db3" class="DSPFListTable">

          <tr style="vertical-align: top;">
            <td style="vertical-align: top; width: 18pt;">
              <div style="text-align: left;">(b)</div>
            </td>
            <td style="align: left; vertical-align: top; width: auto;">
              <div style="text-align: left;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability
                of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" id="z0fac94d60ac34c74bf3f328addab6f61" class="DSPFListTable">

          <tr style="vertical-align: top;">
            <td style="vertical-align: top; width: 18pt;">
              <div style="text-align: left;">(c)</div>
            </td>
            <td style="align: left; vertical-align: top; width: auto;">
              <div style="text-align: left;">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of
                the period covered by this report based on such evaluation; and</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" id="za6fa3b2f04884ce3aee7646eced89765" class="DSPFListTable">

          <tr style="vertical-align: top;">
            <td style="vertical-align: top; width: 18pt;">
              <div style="text-align: left;">(d)</div>
            </td>
            <td style="align: left; vertical-align: top; width: auto;">
              <div style="text-align: left;">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the
                case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" id="z88694603e4f244ffa0e8e65421622804" class="DSPFListTable">

          <tr style="vertical-align: top;">
            <td style="vertical-align: top; width: 18pt;">
              <div style="text-align: left;">5.</div>
            </td>
            <td style="align: left; vertical-align: top; width: auto;">
              <div style="text-align: left;">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the
                registrant&#8217;s board of directors (or persons performing the equivalent functions):</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" id="z57f5f63c41a84e06a05885452c23e7b8" class="DSPFListTable">

          <tr style="vertical-align: top;">
            <td style="vertical-align: top; width: 18pt;">
              <div style="text-align: left;">(a)</div>
            </td>
            <td style="align: left; vertical-align: top; width: auto;">
              <div style="text-align: left;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record,
                process, summarize and report financial information&#894; and</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" id="zb057fa8e666349e894551ff1b05bca61" class="DSPFListTable">

          <tr style="vertical-align: top;">
            <td style="vertical-align: top; width: 18pt;">
              <div style="text-align: left;">(b)</div>
            </td>
            <td style="align: left; vertical-align: top; width: auto;">
              <div style="text-align: left;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" id="z3404669edf414aa6989596f4182406d8" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 50%; vertical-align: top;" colspan="1">
            <div>Date: March 1, 2021</div>
          </td>
          <td style="width: 50%; vertical-align: top;">
            <div><br>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td style="width: 50%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>/s/ Christopher J. Reading</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
          <td style="width: 50%; vertical-align: top;">
            <div>Christopher J. Reading</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
          <td style="width: 50%; vertical-align: top;">
            <div>President and Chief Executive Officer</div>
            <div>(principal executive officer)</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div><br>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>6
<FILENAME>brhc10020853_ex31-2.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using EDGARfilings PROfile 7.3.2.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div style="text-align: right; font-weight: bold;">EXHIBIT 31.2</div>
  <div style="text-align: center;"><br>
  </div>
  <div style="text-align: center; font-weight: bold;">CERTIFICATION</div>
  <div><br>
  </div>
  <div>I, Carey Hendrickson, certify that:</div>
  <div><br>
  </div>
  <div>
    <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" id="z6e35cc9902d34cca9d8fff879107c8fb" class="DSPFListTable">

        <tr style="vertical-align: top;">
          <td style="vertical-align: top; width: 18pt;">
            <div style="text-align: left;">1.</div>
          </td>
          <td style="align: left; vertical-align: top; width: auto;">
            <div style="text-align: left;">I have reviewed this annual report on Form 10-K of U.S. Physical Therapy, Inc.;</div>
          </td>
        </tr>

    </table>
  </div>
  <div><br>
  </div>
  <div>
    <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" id="z52aa12c554fc4f8caf4b36da3745d07f" class="DSPFListTable">

        <tr style="vertical-align: top;">
          <td style="vertical-align: top; width: 18pt;">
            <div style="text-align: left;">2.</div>
          </td>
          <td style="align: left; vertical-align: top; width: auto;">
            <div style="text-align: left;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,
              in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</div>
          </td>
        </tr>

    </table>
  </div>
  <div><br>
  </div>
  <div>
    <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" id="z83cf4e2d01274375b965f43c53017346" class="DSPFListTable">

        <tr style="vertical-align: top;">
          <td style="vertical-align: top; width: 18pt;">
            <div style="text-align: left;">3.</div>
          </td>
          <td style="align: left; vertical-align: top; width: auto;">
            <div style="text-align: left;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial
              condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</div>
          </td>
        </tr>

    </table>
  </div>
  <div><br>
  </div>
  <div>
    <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" id="zd0aa5cbc8b8548a0aac60e0aa6491572" class="DSPFListTable">

        <tr style="vertical-align: top;">
          <td style="vertical-align: top; width: 18pt;">
            <div style="text-align: left;">4.</div>
          </td>
          <td style="align: left; vertical-align: top; width: auto;">
            <div style="text-align: left;">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act
              Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</div>
          </td>
        </tr>

    </table>
  </div>
  <div><br>
  </div>
  <div>
    <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" id="z1bfb4f104fe84fd8a4f9fd6290e7f33b" class="DSPFListTable">

        <tr style="vertical-align: top;">
          <td style="vertical-align: top; width: 18pt;">
            <div style="text-align: left;">(a)</div>
          </td>
          <td style="align: left; vertical-align: top; width: auto;">
            <div style="text-align: left;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material
              information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</div>
          </td>
        </tr>

    </table>
  </div>
  <div><br>
  </div>
  <div>
    <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" id="z7d5e648e4e774283811241dc17d048cd" class="DSPFListTable">

        <tr style="vertical-align: top;">
          <td style="vertical-align: top; width: 18pt;">
            <div style="text-align: left;">(b)</div>
          </td>
          <td style="align: left; vertical-align: top; width: auto;">
            <div style="text-align: left;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide
              reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</div>
          </td>
        </tr>

    </table>
  </div>
  <div><br>
  </div>
  <div>
    <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" id="z88cab1e5b9d04dc897434995e7d5671c" class="DSPFListTable">

        <tr style="vertical-align: top;">
          <td style="vertical-align: top; width: 18pt;">
            <div style="text-align: left;">(c)</div>
          </td>
          <td style="align: left; vertical-align: top; width: auto;">
            <div style="text-align: left;">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the
              disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</div>
          </td>
        </tr>

    </table>
  </div>
  <div><br>
  </div>
  <div>
    <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" id="zb7f804700b9b4fefaeb4cb487e4f5082" class="DSPFListTable">

        <tr style="vertical-align: top;">
          <td style="vertical-align: top; width: 18pt;">
            <div style="text-align: left;">(d)</div>
          </td>
          <td style="align: left; vertical-align: top; width: auto;">
            <div style="text-align: left;">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter
              (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#894; and</div>
          </td>
        </tr>

    </table>
  </div>
  <div><br>
  </div>
  <div>
    <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" id="z1ceab7afd53b4b729ddb471a38dc41ff" class="DSPFListTable">

        <tr style="vertical-align: top;">
          <td style="vertical-align: top; width: 18pt;">
            <div style="text-align: left;">5.</div>
          </td>
          <td style="align: left; vertical-align: top; width: auto;">
            <div style="text-align: left;">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the
              registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</div>
          </td>
        </tr>

    </table>
  </div>
  <div><br>
  </div>
  <div>
    <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" id="za333ae92de2b4b45a72243adaa443791" class="DSPFListTable">

        <tr style="vertical-align: top;">
          <td style="vertical-align: top; width: 18pt;">
            <div style="text-align: left;">(a)</div>
          </td>
          <td style="align: left; vertical-align: top; width: auto;">
            <div style="text-align: left;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to
              adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</div>
          </td>
        </tr>

    </table>
  </div>
  <div><br>
  </div>
  <div>
    <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" id="zbca40339023b446d990befd387a5cacc" class="DSPFListTable">

        <tr style="vertical-align: top;">
          <td style="vertical-align: top; width: 18pt;">
            <div style="text-align: left;">(b)</div>
          </td>
          <td style="align: left; vertical-align: top; width: auto;">
            <div style="text-align: left;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial
              reporting.</div>
          </td>
        </tr>

    </table>
  </div>
  <div><br>
  </div>
  <table cellspacing="0" cellpadding="0" border="0" id="z60865717902942099c3c63cb5d2ea5eb" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

      <tr>
        <td style="width: 50%; vertical-align: top;" colspan="1">
          <div>Date: March 1, 2021</div>
        </td>
        <td style="width: 50%; vertical-align: top;">
          <div><br>
          </div>
        </td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top; padding-bottom: 2px;" colspan="1">&#160;</td>
        <td style="width: 50%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
          <div>/s/ Carey Hendrickson</div>
        </td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
        <td style="width: 50%; vertical-align: top;">
          <div>Carey Hendrickson</div>
        </td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
        <td style="width: 50%; vertical-align: top;">
          <div>Chief Financial Officer</div>
        </td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
        <td style="width: 50%; vertical-align: top;">
          <div>(Principal Accounting Officer)</div>
        </td>
      </tr>

  </table>
  <div><br>
  </div>
  <div><br>
  </div>
  <div>
    <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.3
<SEQUENCE>7
<FILENAME>brhc10020853_ex31-3.htm
<DESCRIPTION>EXHIBIT 31.3
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using EDGARfilings PROfile 7.3.2.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div>
    <div style="text-align: right; font-weight: bold;">EXHIBIT 31.3</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">CERTIFICATION</div>
    <div><br>
    </div>
    <div>I, Jon C. Bates, certify that:</div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z2c2da117ba294a63b40656462608fd6c" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">

          <tr style="vertical-align: top;">
            <td style="vertical-align: top; width: 18pt;">
              <div style="text-align: left;">1.</div>
            </td>
            <td style="align: left; vertical-align: top; width: auto;">
              <div style="text-align: left;">I have reviewed this annual report on Form 10-K of U.S. Physical Therapy, Inc.;</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zddad28fb65094771a0246eb9b26a0c7a" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">

          <tr style="vertical-align: top;">
            <td style="vertical-align: top; width: 18pt;">
              <div style="text-align: left;">2.</div>
            </td>
            <td style="align: left; vertical-align: top; width: auto;">
              <div style="text-align: left;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such
                statements were made, not misleading with respect to the period covered by this report;</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zadfa400d2d50411580d39d0d8c71178c" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">

          <tr style="vertical-align: top;">
            <td style="vertical-align: top; width: 18pt;">
              <div style="text-align: left;">3.</div>
            </td>
            <td style="align: left; vertical-align: top; width: auto;">
              <div style="text-align: left;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of
                the registrant as of, and for, the periods presented in this report;</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z3d3ea1e62f3e4071bf30d5d96771d98a" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">

          <tr style="vertical-align: top;">
            <td style="vertical-align: top; width: 18pt;">
              <div style="text-align: left;">4.</div>
            </td>
            <td style="align: left; vertical-align: top; width: auto;">
              <div style="text-align: left;">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal
                control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z128562622889464eb2e157bf98b1e70e" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">

          <tr style="vertical-align: top;">
            <td style="vertical-align: top; width: 18pt;">
              <div style="text-align: left;">(a)</div>
            </td>
            <td style="align: left; vertical-align: top; width: auto;">
              <div style="text-align: left;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including
                its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z54665469ecd34d8997f3a0899dc0f9ca" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">

          <tr style="vertical-align: top;">
            <td style="vertical-align: top; width: 18pt;">
              <div style="text-align: left;">(b)</div>
            </td>
            <td style="align: left; vertical-align: top; width: auto;">
              <div style="text-align: left;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability
                of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zf6ed137b8c574e2785b8269645686708" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">

          <tr style="vertical-align: top;">
            <td style="vertical-align: top; width: 18pt;">
              <div style="text-align: left;">(c)</div>
            </td>
            <td style="align: left; vertical-align: top; width: auto;">
              <div style="text-align: left;">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of
                the period covered by this report based on such evaluation; and</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <div>
        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z730c144964b9455d8348b4094d19f56b" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">

              <tr style="vertical-align: top;">
                <td style="vertical-align: top; width: 18pt;">
                  <div style="text-align: left;">(d)</div>
                </td>
                <td style="align: left; vertical-align: top; width: auto;">
                  <div style="text-align: left;">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in
                    the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#894; and</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zb40b70225c824edeb180c071686c2997" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">

          <tr style="vertical-align: top;">
            <td style="vertical-align: top; width: 18pt;">
              <div style="text-align: left;">5.</div>
            </td>
            <td style="align: left; vertical-align: top; width: auto;">
              <div style="text-align: left;">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the
                registrant&#8217;s board of directors (or persons performing the equivalent functions):</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z5702299b4c8c4b3bb864adb9c4dfa3a8" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">

          <tr style="vertical-align: top;">
            <td style="vertical-align: top; width: 18pt;">
              <div style="text-align: left;">(a)</div>
            </td>
            <td style="align: left; vertical-align: top; width: auto;">
              <div style="text-align: left;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record,
                process, summarize and report financial information; and</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z87081273f53849f9b2a0a0830917fe05" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">

          <tr style="vertical-align: top;">
            <td style="vertical-align: top; width: 18pt;">
              <div style="text-align: left;">(b)</div>
            </td>
            <td style="align: left; vertical-align: top; width: auto;">
              <div style="text-align: left;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z05bcd31f09b9432dbc2f80d582ead6e0">

        <tr>
          <td colspan="1" style="width: 50%; vertical-align: top;">
            <div>Date: March 1, 2021</div>
          </td>
          <td style="width: 50%; vertical-align: top;">
            <div><br>
            </div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td colspan="1" style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td style="width: 50%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>/s/ Jon C. Bates</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">
            <div>Jon C. Bates</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">
            <div>Vice President and Corporate Controller</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div><br>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>8
<FILENAME>brhc10020853_ex32-1.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using EDGARfilings PROfile 7.3.2.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div>
    <div style="text-align: right; font-weight: bold;">EXHIBIT 32.1</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">CERTIFICATION PURSUANT TO</div>
    <div style="text-align: center; font-weight: bold;">18 U.S.C. SECTION 1350,</div>
    <div style="text-align: center; font-weight: bold;">AS ADOPTED PURSUANT TO</div>
    <div style="text-align: center; font-weight: bold;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</div>
    <div><br>
    </div>
    <div>In connection with the Annual Report of U.S. Physical Therapy, Inc. (the &#8220;registrant&#8221;) on Form 10-K for the year ending December 31, 2020 as filed with the
      Securities and Exchange Commission on the date hereof (the &#8220;report&#8221;), we, Christopher J. Reading, Carey Hendrickson and Jon C. Bates, Chief Executive Officer, Chief Financial Officer and Controller, respectively, of the registrant, certify, pursuant
      to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that to our knowledge:</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">(1) The report fully complies with the
        requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt;">(2) The information contained in the report
        fairly presents, in all material respects, the financial condition and results of operations of the registrant.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" id="z0f465b53ef1349318b7310d2c8ca2bbd" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div>March 1, 2021</div>
          </td>
          <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>/s/ Christopher J. Reading</div>
          </td>
          <td style="width: 50%; vertical-align: top; padding-bottom: 2px;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div>Christopher J. Reading</div>
          </td>
          <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div>Chief Executive Officer</div>
          </td>
          <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>/s/ Carey Hendrickson</div>
          </td>
          <td style="width: 50%; vertical-align: top; padding-bottom: 2px;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div>Carey Hendrickson</div>
          </td>
          <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div>Chief Financial Officer</div>
          </td>
          <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>/s/ Jon C. Bates</div>
          </td>
          <td style="width: 50%; vertical-align: top; padding-bottom: 2px;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div>Jon C. Bates</div>
          </td>
          <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div>Vice President and Controller</div>
          </td>
          <td style="width: 50%; vertical-align: top;" colspan="1">&#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="margin-right: 25pt;">A signed original of this written statement required by Section 906 has been provided to U. S. Physical Therapy, Inc. and will be retained by U. S.
      Physical Therapy, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.</div>
    <div>
      <div><br>
      </div>
      <br>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>usph-20201231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 7.0.0.0 Broadridge-->
<xs:schema targetNamespace="http://usph.com/20201231" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:usph="http://usph.com/20201231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="usph-20201231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="usph-20201231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="usph-20201231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="usph-20201231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://usph.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/ConsolidatedBalanceSheets" id="ConsolidatedBalanceSheets">
        <link:definition>010000 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/ConsolidatedBalanceSheetsParenthetical" id="ConsolidatedBalanceSheetsParenthetical">
        <!--Parent Role: CONSOLIDATED BALANCE SHEETS-->
        <link:definition>010100 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/ConsolidatedStatementsOfIncome" id="ConsolidatedStatementsOfIncome">
        <link:definition>020000 - Statement - CONSOLIDATED STATEMENTS OF INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/ConsolidatedStatementsOfChangesInEquity" id="ConsolidatedStatementsOfChangesInEquity">
        <link:definition>030000 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/ConsolidatedStatementsOfCashFlows" id="ConsolidatedStatementsOfCashFlows">
        <link:definition>040000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentation" id="OrganizationNatureOfOperationsAndBasisOfPresentation">
        <link:definition>060100 - Disclosure - Organization, Nature of Operations and Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/SignificantAccountingPolicies" id="SignificantAccountingPolicies">
        <link:definition>060200 - Disclosure - Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/AcquisitionsOfBusinesses" id="AcquisitionsOfBusinesses">
        <link:definition>060300 - Disclosure - Acquisitions of Businesses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterests" id="AcquisitionsAndSaleOfNoncontrollingInterests">
        <link:definition>060400 - Disclosure - Acquisitions and Sale of Non-Controlling Interests</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/RedeemableNoncontrollingInterest" id="RedeemableNoncontrollingInterest">
        <link:definition>060500 - Disclosure - Redeemable Non-Controlling Interest</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/Goodwill" id="Goodwill">
        <link:definition>060600 - Disclosure - Goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/IntangibleAssetsNet" id="IntangibleAssetsNet">
        <link:definition>060700 - Disclosure - Intangible Assets, net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/AccruedExpenses" id="AccruedExpenses">
        <link:definition>060800 - Disclosure - Accrued Expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/NotesPayable" id="NotesPayable">
        <link:definition>060900 - Disclosure - Notes Payable</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/Leases" id="Leases">
        <link:definition>061000 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/IncomeTaxes" id="IncomeTaxes">
        <link:definition>061100 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/SegmentInformation" id="SegmentInformation">
        <link:definition>061200 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/EquityBasedPlans" id="EquityBasedPlans">
        <link:definition>061300 - Disclosure - Equity Based Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/PreferredStock" id="PreferredStock">
        <link:definition>061400 - Disclosure - Preferred Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/CommonStock" id="CommonStock">
        <link:definition>061500 - Disclosure - Common Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/DefinedContributionPlan" id="DefinedContributionPlan">
        <link:definition>061600 - Disclosure - Defined Contribution Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
        <link:definition>061700 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/EarningsPerShare" id="EarningsPerShare">
        <link:definition>061800 - Disclosure - Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/ScheduleIiValuationAndQualifyingAccounts" id="ScheduleIiValuationAndQualifyingAccounts">
        <link:definition>061900 - Schedule - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/SignificantAccountingPoliciesPolicies" id="SignificantAccountingPoliciesPolicies">
        <!--Parent Role: Significant Accounting Policies-->
        <link:definition>070200 - Disclosure - Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationTables" id="OrganizationNatureOfOperationsAndBasisOfPresentationTables">
        <!--Parent Role: Organization, Nature of Operations and Basis of Presentation-->
        <link:definition>080100 - Disclosure - Organization, Nature of Operations and Basis of Presentation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/SignificantAccountingPoliciesTables" id="SignificantAccountingPoliciesTables">
        <!--Parent Role: Significant Accounting Policies-->
        <link:definition>080200 - Disclosure - Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/AcquisitionsOfBusinessesTables" id="AcquisitionsOfBusinessesTables">
        <!--Parent Role: Acquisitions of Businesses-->
        <link:definition>080300 - Disclosure - Acquisitions of Businesses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/RedeemableNoncontrollingInterestTables" id="RedeemableNoncontrollingInterestTables">
        <!--Parent Role: Redeemable Non-Controlling Interest-->
        <link:definition>080500 - Disclosure - Redeemable Non-Controlling Interest (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/GoodwillTables" id="GoodwillTables">
        <!--Parent Role: Goodwill-->
        <link:definition>080600 - Disclosure - Goodwill (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/IntangibleAssetsNetTables" id="IntangibleAssetsNetTables">
        <!--Parent Role: Intangible Assets, net-->
        <link:definition>080700 - Disclosure - Intangible Assets, net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/AccruedExpensesTables" id="AccruedExpensesTables">
        <!--Parent Role: Accrued Expenses-->
        <link:definition>080800 - Disclosure - Accrued Expenses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/NotesPayableTables" id="NotesPayableTables">
        <!--Parent Role: Notes Payable-->
        <link:definition>080900 - Disclosure - Notes Payable (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/LeasesTables" id="LeasesTables">
        <!--Parent Role: Leases-->
        <link:definition>081000 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
        <!--Parent Role: Income Taxes-->
        <link:definition>081100 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/SegmentInformationTables" id="SegmentInformationTables">
        <!--Parent Role: Segment Information-->
        <link:definition>081200 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/EquityBasedPlansTables" id="EquityBasedPlansTables">
        <!--Parent Role: Equity Based Plans-->
        <link:definition>081300 - Disclosure - Equity Based Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/EarningsPerShareTables" id="EarningsPerShareTables">
        <!--Parent Role: Earnings Per Share-->
        <link:definition>081800 - Disclosure - Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails" id="OrganizationNatureOfOperationsAndBasisOfPresentationDetails">
        <!--Parent Role: Organization, Nature of Operations and Basis of Presentation-->
        <link:definition>090100 - Disclosure - Organization, Nature of Operations and Basis of Presentation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails" id="OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails">
        <!--Parent Role: Organization, Nature of Operations and Basis of Presentation-->
        <link:definition>090102 - Disclosure - Organization, Nature of Operations and Basis of Presentation - Acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/SignificantAccountingPoliciesDetails" id="SignificantAccountingPoliciesDetails">
        <!--Parent Role: Significant Accounting Policies-->
        <link:definition>090200 - Disclosure - Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/AcquisitionsOfBusinessesDetails" id="AcquisitionsOfBusinessesDetails">
        <!--Parent Role: Acquisitions of Businesses-->
        <link:definition>090300 - Disclosure - Acquisitions of Businesses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails" id="AcquisitionsAndSaleOfNoncontrollingInterestsDetails">
        <!--Parent Role: Acquisitions and Sale of Non-Controlling Interests-->
        <link:definition>090400 - Disclosure - Acquisitions and Sale of Non-Controlling Interests (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/RedeemableNoncontrollingInterestDetails" id="RedeemableNoncontrollingInterestDetails">
        <!--Parent Role: Redeemable Non-Controlling Interest-->
        <link:definition>090500 - Disclosure - Redeemable Non-Controlling Interest (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/GoodwillDetails" id="GoodwillDetails">
        <!--Parent Role: Goodwill-->
        <link:definition>090600 - Disclosure - Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/IntangibleAssetsNetDetails" id="IntangibleAssetsNetDetails">
        <!--Parent Role: Intangible Assets, net-->
        <link:definition>090700 - Disclosure - Intangible Assets, net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails" id="IntangibleAssetsNetAmortizationExpensesDetails">
        <!--Parent Role: Intangible Assets, net-->
        <link:definition>090702 - Disclosure - Intangible Assets, net - Amortization Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails" id="IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails">
        <!--Parent Role: Intangible Assets, net-->
        <link:definition>090704 - Disclosure - Intangible Assets, net - Amortization of Referral Relationships and Non-Competition Agreements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/AccruedExpensesDetails" id="AccruedExpensesDetails">
        <!--Parent Role: Accrued Expenses-->
        <link:definition>090800 - Disclosure - Accrued Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails" id="NotesPayableSummaryOfNotesPayableDetails">
        <!--Parent Role: Notes Payable-->
        <link:definition>090900 - Disclosure - Notes Payable - Summary of Notes Payable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/NotesPayableDetails" id="NotesPayableDetails">
        <!--Parent Role: Notes Payable-->
        <link:definition>090902 - Disclosure - Notes Payable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/LeasesDetails" id="LeasesDetails">
        <!--Parent Role: Leases-->
        <link:definition>091000 - Disclosure - Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/LeasesDetailsCalc01" id="LeasesDetailsCalc01">
        <!--Parent Role: Leases (Details)-->
        <link:definition>091002 - Disclosure - Leases (Details) CALC 01</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails" id="IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails">
        <!--Parent Role: Income Taxes-->
        <link:definition>091100 - Disclosure - Income Taxes - Components of Deferred Tax Assets and Liabilities Included in Consolidated Balance Sheets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/IncomeTaxesDetails" id="IncomeTaxesDetails">
        <!--Parent Role: Income Taxes-->
        <link:definition>091102 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails" id="IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails">
        <!--Parent Role: Income Taxes-->
        <link:definition>091104 - Disclosure - Income Taxes - Differences Between Federal Tax Rate and Company's Effective Tax Rate for Results of Continuing Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails" id="IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails">
        <!--Parent Role: Income Taxes-->
        <link:definition>091106 - Disclosure - Income Taxes - Significant Components of Provision for Income Taxes for Continuing Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/SegmentInformationDetails" id="SegmentInformationDetails">
        <!--Parent Role: Segment Information-->
        <link:definition>091200 - Disclosure - Segment Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/EquityBasedPlansAmendedAndRestatedEmployeeStockOptionPlansDetails" id="EquityBasedPlansAmendedAndRestatedEmployeeStockOptionPlansDetails">
        <!--Parent Role: Equity Based Plans-->
        <link:definition>091300 - Disclosure - Equity Based Plans - Amended and Restated Employee Stock Option Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/EquityBasedPlansCumulativeSummaryOfEquityPlansDetails" id="EquityBasedPlansCumulativeSummaryOfEquityPlansDetails">
        <!--Parent Role: Equity Based Plans-->
        <link:definition>091302 - Disclosure - Equity Based Plans - Cumulative Summary of Equity Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/EquityBasedPlansRestrictedStockGrantedToDirectorsOfficersAndEmployeesPursuantToItsEquityPlansDetails" id="EquityBasedPlansRestrictedStockGrantedToDirectorsOfficersAndEmployeesPursuantToItsEquityPlansDetails">
        <!--Parent Role: Equity Based Plans-->
        <link:definition>091304 - Disclosure - Equity Based Plans - Restricted Stock Granted to Directors, Officers and Employees Pursuant to its Equity Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/EquityBasedPlansRestrictedStockCancelledDueToEmployeeTerminationsPriorToRestrictionsLapsingDetails" id="EquityBasedPlansRestrictedStockCancelledDueToEmployeeTerminationsPriorToRestrictionsLapsingDetails">
        <!--Parent Role: Equity Based Plans-->
        <link:definition>091306 - Disclosure - Equity Based Plans - Restricted Stock Cancelled Due to Employee Terminations Prior to Restrictions Lapsing (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/EquityBasedPlansDetails" id="EquityBasedPlansDetails">
        <!--Parent Role: Equity Based Plans-->
        <link:definition>091308 - Disclosure - Equity Based Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/CommonStockDetails" id="CommonStockDetails">
        <!--Parent Role: Common Stock-->
        <link:definition>091500 - Disclosure - Common Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/DefinedContributionPlanDetails" id="DefinedContributionPlanDetails">
        <!--Parent Role: Defined Contribution Plan-->
        <link:definition>091600 - Disclosure - Defined Contribution Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/CommitmentsAndContingenciesDetails" id="CommitmentsAndContingenciesDetails">
        <!--Parent Role: Commitments and Contingencies-->
        <link:definition>091700 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/EarningsPerShareDetails" id="EarningsPerShareDetails">
        <!--Parent Role: Earnings Per Share-->
        <link:definition>091800 - Disclosure - Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/ScheduleIiValuationAndQualifyingAccountsDetails" id="ScheduleIiValuationAndQualifyingAccountsDetails">
        <!--Parent Role: SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS-->
        <link:definition>091900 - Schedule - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2020-01-31" schemaLocation="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2020-01-31" schemaLocation="https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2017-01-31" schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2020-01-31" schemaLocation="https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2018-01-31" schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd" />
  <xs:element name="RedeemableNonControllingInterestAbstract" id="usph_RedeemableNonControllingInterestAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="RedeemableNonControllingInterestTextBlock" id="usph_RedeemableNonControllingInterestTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock" id="usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PurchaseOfPartnershipInterestsRedeemableNonControllingInterests" id="usph_PurchaseOfPartnershipInterestsRedeemableNonControllingInterests" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" id="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="SaleOfNonControllingInterestNetOfTaxAndPurchases" id="usph_SaleOfNonControllingInterestNetOfTaxAndPurchases" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="RevaluationOfRedeemableNonControllingInterestNetOfTax" id="usph_RevaluationOfRedeemableNonControllingInterestNetOfTax" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" id="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" id="usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="NonCompeteAgreementBasicTerm" id="usph_NonCompeteAgreementBasicTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" id="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="TermOfEmploymentAgreement" id="usph_TermOfEmploymentAgreement" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" id="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" id="usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" id="usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" id="usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="CarryingAmountOfRedeemableNonControllingInterestAbstract" id="usph_CarryingAmountOfRedeemableNonControllingInterestAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" id="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" id="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" id="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="BusinessAcquisitionConsiderationPayableTermOfNote" id="usph_BusinessAcquisitionConsiderationPayableTermOfNote" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="RedeemableNonControllingInterestMember" id="usph_RedeemableNonControllingInterestMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" id="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="EmploymentAgreementRenewalTerm" id="usph_EmploymentAgreementRenewalTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" id="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="TherapyPracticeMember" id="usph_TherapyPracticeMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" id="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" id="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" id="usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="CashReceivedRelatedToSaleOfClinics" id="usph_CashReceivedRelatedToSaleOfClinics" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="SaleOfNoncontrollingInterestPercentageInPartnershipOne" id="usph_SaleOfNoncontrollingInterestPercentageInPartnershipOne" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="NumberOfInstallmentsForNoteReceivableInSaleConsideration" id="usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="AggregateSalePriceOfCinics" id="usph_AggregateSalePriceOfCinics" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="TaxEffectOnSaleOfNoncontrollingInterest" id="usph_TaxEffectOnSaleOfNoncontrollingInterest" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="NumberOfPartnershipInWhichInterestAcquired" id="usph_NumberOfPartnershipInWhichInterestAcquired" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="NumberOfClosedClinicsSold" id="usph_NumberOfClosedClinicsSold" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="NoteReceivableRelatedToSaleOfClinics" id="usph_NoteReceivableRelatedToSaleOfClinics" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" id="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="RentSuppliesContractLaborAndOther" id="usph_RentSuppliesContractLaborAndOther" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="InterestExpenseDebtAndOther" id="usph_InterestExpenseDebtAndOther" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="NetPatientRevenuesMember" id="usph_NetPatientRevenuesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ReliefFunds" id="usph_ReliefFunds" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" id="usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="NotesPayableMember" id="usph_NotesPayableMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="CreditAgreementMember" id="usph_CreditAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" id="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="DebtInstrumentBasisSpreadOnLiborVariableRate" id="usph_DebtInstrumentBasisSpreadOnLiborVariableRate" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="DividendsCashAfterAmendment" id="usph_DividendsCashAfterAmendment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="NumberOfManagementContracts" id="usph_NumberOfManagementContracts" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ManagementContractsMember" id="usph_ManagementContractsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="SeptemberTwoThousandNineteenAcquisitionMember" id="usph_SeptemberTwoThousandNineteenAcquisitionMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="NovemberTwoThousandTwentyAcquisitionMember" id="usph_NovemberTwoThousandTwentyAcquisitionMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ClinicPracticeMember" id="usph_ClinicPracticeMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="August2018AcquisitionMember" id="usph_August2018AcquisitionMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="SeptemberTwoThousandTwentyAcquisitionMember" id="usph_SeptemberTwoThousandTwentyAcquisitionMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="FebruaryTwoThousandTwentyAcquisitionMember" id="usph_FebruaryTwoThousandTwentyAcquisitionMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="RemainingContractTerm" id="usph_RemainingContractTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="CashPaidDuringPeriodForAbstract" id="usph_CashPaidDuringPeriodForAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="GainOnSaleOfPartnershipInterestNetOfTax" id="usph_GainOnSaleOfPartnershipInterestNetOfTax" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity" id="usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity" id="usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="PaymentsToAcquireRedeemableNonControllingInterest" id="usph_PaymentsToAcquireRedeemableNonControllingInterest" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="PurchaseOfBusinessSellerFinancingPortion" id="usph_PurchaseOfBusinessSellerFinancingPortion" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="MedicareAcceleratedAndAdvancePaymentFunds" id="usph_MedicareAcceleratedAndAdvancePaymentFunds" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="ReferralRelationshipMember" id="usph_ReferralRelationshipMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="SupplementalInformationRelatedToOperatingLeasesAbstract" id="usph_SupplementalInformationRelatedToOperatingLeasesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="AverageLeaseTermsAndDiscountRatesAbstract" id="usph_AverageLeaseTermsAndDiscountRatesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="PatientsAndPayorsRelatedLiability" id="usph_PatientsAndPayorsRelatedLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable" id="usph_MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="DeferredEmployerPayrollTaxesCARESACT" id="usph_DeferredEmployerPayrollTaxesCARESACT" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="NumberOfAcquiredOperations" id="usph_NumberOfAcquiredOperations" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PreferredStockAbstract" id="usph_PreferredStockAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="AmendedNineteenNinetyNinePlanMember" id="usph_AmendedNineteenNinetyNinePlanMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod" id="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod" id="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="AmendedTwoThousandThreePlanMember" id="usph_AmendedTwoThousandThreePlanMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" id="usph_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="DeferredTaxAssetsLeaseObligations" id="usph_DeferredTaxAssetsLeaseObligations" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="IncomeTaxExaminationAbstract" id="usph_IncomeTaxExaminationAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests" id="usph_DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock" id="usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="OperatingLeaseSupplementalInformationTableTextBlock" id="usph_OperatingLeaseSupplementalInformationTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="NonQualifiedStockOptionsMember" id="usph_NonQualifiedStockOptionsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="PromissoryNotesMember" id="usph_PromissoryNotesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="AdditionalEstimatedRepurchaseOfCommonStock" id="usph_AdditionalEstimatedRepurchaseOfCommonStock" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PercentageOfRepurchaseOfCommonStock" id="usph_PercentageOfRepurchaseOfCommonStock" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="BankCreditAgreementToPermitShareRepurchasesOfCommonStock" id="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="PhysicalTherapyOperationsMember" id="usph_PhysicalTherapyOperationsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="OtherRevenuesMember" id="usph_OtherRevenuesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="IndustrialInjuryPreventionServicesRevenuesMember" id="usph_IndustrialInjuryPreventionServicesRevenuesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="DepreciationAmortizationImpairmentTable" id="usph_DepreciationAmortizationImpairmentTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="Year2019Member" id="usph_Year2019Member" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="Year2018Member" id="usph_Year2018Member" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" id="usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="FromTwoThousandNineteenThroughTwoThousandTwentyFourMember" id="usph_FromTwoThousandNineteenThroughTwoThousandTwentyFourMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ManagementContractRevenuesMember" id="usph_ManagementContractRevenuesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="Year2017Member" id="usph_Year2017Member" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="EmployeeMember" id="usph_EmployeeMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="DepreciationAmortizationImpairmentLineItems" id="usph_DepreciationAmortizationImpairmentLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="NonControllingInterestRedeemableAbstract" id="usph_NonControllingInterestRedeemableAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" id="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="MedicareReimbursementAbstract" id="usph_MedicareReimbursementAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" id="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="MaximumContractualAllowanceReserveEstimate" id="usph_MaximumContractualAllowanceReserveEstimate" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PercentageOfPaymentForOutpatientTherapyServices" id="usph_PercentageOfPaymentForOutpatientTherapyServices" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="NetRevenueFromMedicare" id="usph_NetRevenueFromMedicare" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="ReductionInMedicareSpendingPercentage" id="usph_ReductionInMedicareSpendingPercentage" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PercentageOfPracticeExpenseComponentOfRelativeValueUnit" id="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="EstimatedPercentageOfDecreaseInPayment" id="usph_EstimatedPercentageOfDecreaseInPayment" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="AnnualLimitOccupationalTherapyServices" id="usph_AnnualLimitOccupationalTherapyServices" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="ExpectedReductionInMedicareSpendingPercentage" id="usph_ExpectedReductionInMedicareSpendingPercentage" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="PercentageOfMedicarePaymentIncrease" id="usph_PercentageOfMedicarePaymentIncrease" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PercentageOfBonusPayment" id="usph_PercentageOfBonusPayment" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="CombinedPhysicalTherapySpeechLanguagePathologyExpenses" id="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" id="usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" id="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices" id="usph_AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" id="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" id="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="AmountOfReductionsInFederalSpending" id="usph_AmountOfReductionsInFederalSpending" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="NumberOfRegions" id="usph_NumberOfRegions" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="SeptemberTwoThousandTwentyMember" id="usph_SeptemberTwoThousandTwentyMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="AugustTwoThousandNineteenMember" id="usph_AugustTwoThousandNineteenMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="AugustTwoThousandTwentyMember" id="usph_AugustTwoThousandTwentyMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="SeptemberTwoThousandTwentyOneMember" id="usph_SeptemberTwoThousandTwentyOneMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="BusinessAcquisitionPayableToShareholdersOfSeller" id="usph_BusinessAcquisitionPayableToShareholdersOfSeller" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="NumberOfOnsiteClientLocations" id="usph_NumberOfOnsiteClientLocations" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="NumberOfBusinessesMerged" id="usph_NumberOfBusinessesMerged" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" id="usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="NumberOfStatesOfNetworkServices" id="usph_NumberOfStatesOfNetworkServices" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" id="usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="PaymentsToAcquireBusinessesConsideration" id="usph_PaymentsToAcquireBusinessesConsideration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" id="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" id="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="LeadingProviderOfIndustrialInjuryPreventionMember" id="usph_LeadingProviderOfIndustrialInjuryPreventionMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="AcquisitionOfFiveClinicPracticesMember" id="usph_AcquisitionOfFiveClinicPracticesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="AprilTwoThousandNineteenAcquisitionMember" id="usph_AprilTwoThousandNineteenAcquisitionMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ManagementAndServicesContractsMember" id="usph_ManagementAndServicesContractsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" id="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" id="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="PercentageOfCombinedBusinessInterestOwned" id="usph_PercentageOfCombinedBusinessInterestOwned" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="NotesPayableOneMember" id="usph_NotesPayableOneMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="NotesPayableTwoMember" id="usph_NotesPayableTwoMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="EmploymentAgreementsAbstract" id="usph_EmploymentAgreementsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter" id="usph_EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="RenewalPeriodForEmploymentAgreement" id="usph_RenewalPeriodForEmploymentAgreement" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="EmploymentAgreementsExpirationDate" id="usph_EmploymentAgreementsExpirationDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="EmploymentAgreementsExpirationDateTwo" id="usph_EmploymentAgreementsExpirationDateTwo" type="xbrli:dateItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="NumberOfEmployeesCoveredUnderEmployeeAgreement" id="usph_NumberOfEmployeesCoveredUnderEmployeeAgreement" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="EmploymentAgreementsExpirationDateThree" id="usph_EmploymentAgreementsExpirationDateThree" type="xbrli:dateItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="EmploymentAgreementsRetirementDate" id="usph_EmploymentAgreementsRetirementDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="EmployeeCompensationFuturePaymentDueNextFiscalYear" id="usph_EmployeeCompensationFuturePaymentDueNextFiscalYear" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate" id="usph_EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="CreditChargesToRetainedEarningsAbstract" id="usph_CreditChargesToRetainedEarningsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" id="usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" id="usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="ChargesToRetainedEarningsRevaluationOfNonControllingInterests" id="usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="PublicHealthAndSocialServicesEmergencyFundMember" id="usph_PublicHealthAndSocialServicesEmergencyFundMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="NumberOfOperatingClinicLocations" id="usph_NumberOfOperatingClinicLocations" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="NumberOfClinicsOperatesAsASatelliteClinicWithExistingPartnerships" id="usph_NumberOfClinicsOperatesAsASatelliteClinicWithExistingPartnerships" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="CashAndCashEquivalentsAndAccruedLiabilities" id="usph_CashAndCashEquivalentsAndAccruedLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="GrantsAndOtherFunds" id="usph_GrantsAndOtherFunds" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="NumberOfClinicsOperated" id="usph_NumberOfClinicsOperated" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="PercentageOfEmployeesFurloughedOrTerminated" id="usph_PercentageOfEmployeesFurloughedOrTerminated" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="AveragePhysicalTherapyPatientsVolumesPerDayPerClinic" id="usph_AveragePhysicalTherapyPatientsVolumesPerDayPerClinic" type="xbrli:decimalItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PercentageOfGeneralPartnershipInterestOwned" id="usph_PercentageOfGeneralPartnershipInterestOwned" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PercentageOfLimitedPartnershipInterestOwned" id="usph_PercentageOfLimitedPartnershipInterestOwned" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="NumberOfThirdPartyFacilities" id="usph_NumberOfThirdPartyFacilities" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="MarchTwoThousandSeventeenAcquisitionMember" id="usph_MarchTwoThousandSeventeenAcquisitionMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="MedicareAcceleratedAndAdvancePaymentsProgramMember" id="usph_MedicareAcceleratedAndAdvancePaymentsProgramMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="NumberOfFurloughedEmployeesReturned" id="usph_NumberOfFurloughedEmployeesReturned" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan" id="usph_DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="DefinedContributionPlanEmployerMatchingContributionAmount" id="usph_DefinedContributionPlanEmployerMatchingContributionAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="RedeemableNonControllingInterestsPolicyTextBlock" id="usph_RedeemableNonControllingInterestsPolicyTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="SelfInsuranceProgramPolicyPolicyTextBlock" id="usph_SelfInsuranceProgramPolicyPolicyTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="RestrictedStockPolicyPolicyTextBlock" id="usph_RestrictedStockPolicyPolicyTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="NonControllingInterestsPolicyPolicyTextBlock" id="usph_NonControllingInterestsPolicyPolicyTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PhysicalTherapyOperationsExcludingClosureCostsMember" id="usph_PhysicalTherapyOperationsExcludingClosureCostsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="RestrictedPeriodToEmployeesOnTheStockGranted" id="usph_RestrictedPeriodToEmployeesOnTheStockGranted" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription" id="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed" id="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="EmployeesMember" id="usph_EmployeesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>10
<FILENAME>usph-20201231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 7.0.0.0 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://usph.com/role/EarningsPerShareDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#EarningsPerShareDetails" />
  <link:roleRef roleURI="http://usph.com/role/IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails" />
  <link:roleRef roleURI="http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails" />
  <link:roleRef roleURI="http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails" />
  <link:roleRef roleURI="http://usph.com/role/LeasesDetailsCalc01" xlink:type="simple" xlink:href="usph-20201231.xsd#LeasesDetailsCalc01" />
  <link:roleRef roleURI="http://usph.com/role/LeasesDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#LeasesDetails" />
  <link:roleRef roleURI="http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#NotesPayableSummaryOfNotesPayableDetails" />
  <link:roleRef roleURI="http://usph.com/role/AccruedExpensesDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#AccruedExpensesDetails" />
  <link:roleRef roleURI="http://usph.com/role/RedeemableNoncontrollingInterestDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#RedeemableNoncontrollingInterestDetails" />
  <link:roleRef roleURI="http://usph.com/role/AcquisitionsOfBusinessesDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#AcquisitionsOfBusinessesDetails" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="simple" xlink:href="usph-20201231.xsd#ConsolidatedStatementsOfCashFlows" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedStatementsOfIncome" xlink:type="simple" xlink:href="usph-20201231.xsd#ConsolidatedStatementsOfIncome" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="usph-20201231.xsd#ConsolidatedBalanceSheets" />
  <link:calculationLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedBalanceSheets">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="Assets" xlink:title="Assets" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="PropertyPlantAndEquipmentGross" xlink:title="PropertyPlantAndEquipmentGross" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsGross" xlink:label="LeaseholdImprovementsGross" xlink:title="LeaseholdImprovementsGross" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="PropertyPlantAndEquipmentGross" xlink:to="LeaseholdImprovementsGross" xlink:title="calculation: PropertyPlantAndEquipmentGross to LeaseholdImprovementsGross" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesGross" xlink:label="FurnitureAndFixturesGross" xlink:title="FurnitureAndFixturesGross" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="PropertyPlantAndEquipmentGross" xlink:to="FurnitureAndFixturesGross" xlink:title="calculation: PropertyPlantAndEquipmentGross to FurnitureAndFixturesGross" order="1.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="PropertyPlantAndEquipmentNet" xlink:to="PropertyPlantAndEquipmentGross" xlink:title="calculation: PropertyPlantAndEquipmentNet to PropertyPlantAndEquipmentGross" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="PropertyPlantAndEquipmentNet" xlink:to="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="calculation: PropertyPlantAndEquipmentNet to AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="2.0" weight="-1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="PropertyPlantAndEquipmentNet" xlink:title="calculation: Assets to PropertyPlantAndEquipmentNet" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="IntangibleAssetsNetExcludingGoodwill" xlink:title="IntangibleAssetsNetExcludingGoodwill" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="IntangibleAssetsNetExcludingGoodwill" xlink:title="calculation: Assets to IntangibleAssetsNetExcludingGoodwill" order="6.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="OtherAssetsNoncurrent" xlink:title="OtherAssetsNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="OtherAssetsNoncurrent" xlink:title="calculation: Assets to OtherAssetsNoncurrent" order="7.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:label="Goodwill" xlink:title="Goodwill" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="Goodwill" xlink:title="calculation: Assets to Goodwill" order="5.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="OperatingLeaseRightOfUseAsset" xlink:title="OperatingLeaseRightOfUseAsset" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="OperatingLeaseRightOfUseAsset" xlink:title="calculation: Assets to OperatingLeaseRightOfUseAsset" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="AssetsCurrent" xlink:title="AssetsCurrent" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="AccountsAndOtherReceivablesNetCurrent" xlink:title="AccountsAndOtherReceivablesNetCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetsCurrent" xlink:to="AccountsAndOtherReceivablesNetCurrent" xlink:title="calculation: AssetsCurrent to AccountsAndOtherReceivablesNetCurrent" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="AccountsReceivableNetCurrent" xlink:title="AccountsReceivableNetCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetsCurrent" xlink:to="AccountsReceivableNetCurrent" xlink:title="calculation: AssetsCurrent to AccountsReceivableNetCurrent" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="OtherAssetsCurrent" xlink:title="OtherAssetsCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetsCurrent" xlink:to="OtherAssetsCurrent" xlink:title="calculation: AssetsCurrent to OtherAssetsCurrent" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="CashAndCashEquivalentsAtCarryingValue" xlink:title="CashAndCashEquivalentsAtCarryingValue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetsCurrent" xlink:to="CashAndCashEquivalentsAtCarryingValue" xlink:title="calculation: AssetsCurrent to CashAndCashEquivalentsAtCarryingValue" order="1.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="AssetsCurrent" xlink:title="calculation: Assets to AssetsCurrent" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="LiabilitiesAndStockholdersEquity" xlink:title="LiabilitiesAndStockholdersEquity" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:label="Liabilities" xlink:title="Liabilities" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermNotesPayable" xlink:label="LongTermNotesPayable" xlink:title="LongTermNotesPayable" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="LongTermNotesPayable" xlink:title="calculation: Liabilities to LongTermNotesPayable" order="6.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="DeferredIncomeTaxLiabilitiesNet" xlink:title="DeferredIncomeTaxLiabilitiesNet" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="DeferredIncomeTaxLiabilitiesNet" xlink:title="calculation: Liabilities to DeferredIncomeTaxLiabilitiesNet" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="OperatingLeaseLiabilityNoncurrent" xlink:title="OperatingLeaseLiabilityNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="OperatingLeaseLiabilityNoncurrent" xlink:title="calculation: Liabilities to OperatingLeaseLiabilityNoncurrent" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermLineOfCredit" xlink:label="LongTermLineOfCredit" xlink:title="LongTermLineOfCredit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="LongTermLineOfCredit" xlink:title="calculation: Liabilities to LongTermLineOfCredit" order="7.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="OtherLiabilitiesNoncurrent" xlink:title="OtherLiabilitiesNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="OtherLiabilitiesNoncurrent" xlink:title="calculation: Liabilities to OtherLiabilitiesNoncurrent" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="LiabilitiesCurrent" xlink:title="LiabilitiesCurrent" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesCurrent" xlink:to="AccruedLiabilitiesCurrent" xlink:title="calculation: LiabilitiesCurrent to AccruedLiabilitiesCurrent" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="AccountsPayableTradeCurrent" xlink:title="AccountsPayableTradeCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesCurrent" xlink:to="AccountsPayableTradeCurrent" xlink:title="calculation: LiabilitiesCurrent to AccountsPayableTradeCurrent" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="OperatingLeaseLiabilityCurrent" xlink:title="OperatingLeaseLiabilityCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesCurrent" xlink:to="OperatingLeaseLiabilityCurrent" xlink:title="calculation: LiabilitiesCurrent to OperatingLeaseLiabilityCurrent" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="LongTermDebtCurrent" xlink:title="LongTermDebtCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesCurrent" xlink:to="LongTermDebtCurrent" xlink:title="calculation: LiabilitiesCurrent to LongTermDebtCurrent" order="4.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="LiabilitiesCurrent" xlink:title="calculation: Liabilities to LiabilitiesCurrent" order="5.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent" xlink:label="DeferredRentCreditNoncurrent" xlink:title="DeferredRentCreditNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="DeferredRentCreditNoncurrent" xlink:title="calculation: Liabilities to DeferredRentCreditNoncurrent" order="8.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="Liabilities" xlink:title="calculation: LiabilitiesAndStockholdersEquity to Liabilities" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest" xlink:label="MinorityInterest" xlink:title="MinorityInterest" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="MinorityInterest" xlink:title="calculation: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest to MinorityInterest" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="PreferredStockValue" xlink:title="PreferredStockValue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquity" xlink:to="PreferredStockValue" xlink:title="calculation: StockholdersEquity to PreferredStockValue" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="RetainedEarningsAccumulatedDeficit" xlink:title="RetainedEarningsAccumulatedDeficit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquity" xlink:to="RetainedEarningsAccumulatedDeficit" xlink:title="calculation: StockholdersEquity to RetainedEarningsAccumulatedDeficit" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="TreasuryStockValue" xlink:title="TreasuryStockValue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquity" xlink:to="TreasuryStockValue" xlink:title="calculation: StockholdersEquity to TreasuryStockValue" order="5.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="CommonStockValue" xlink:title="CommonStockValue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquity" xlink:to="CommonStockValue" xlink:title="calculation: StockholdersEquity to CommonStockValue" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="AdditionalPaidInCapital" xlink:title="AdditionalPaidInCapital" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquity" xlink:to="AdditionalPaidInCapital" xlink:title="calculation: StockholdersEquity to AdditionalPaidInCapital" order="3.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="StockholdersEquity" xlink:title="calculation: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest to StockholdersEquity" order="1.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="calculation: LiabilitiesAndStockholdersEquity to StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:title="RedeemableNoncontrollingInterestEquityCarryingAmount" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:title="calculation: LiabilitiesAndStockholdersEquity to RedeemableNoncontrollingInterestEquityCarryingAmount" order="5.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="CommitmentsAndContingencies" xlink:title="CommitmentsAndContingencies" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="CommitmentsAndContingencies" xlink:title="calculation: LiabilitiesAndStockholdersEquity to CommitmentsAndContingencies" order="4.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedStatementsOfIncome">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="NonoperatingIncomeExpense" xlink:title="NonoperatingIncomeExpense" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="GainsLossesOnExtinguishmentOfDebt" xlink:title="GainsLossesOnExtinguishmentOfDebt" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NonoperatingIncomeExpense" xlink:to="GainsLossesOnExtinguishmentOfDebt" xlink:title="calculation: NonoperatingIncomeExpense to GainsLossesOnExtinguishmentOfDebt" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndOtherIncome" xlink:label="InterestAndOtherIncome" xlink:title="InterestAndOtherIncome" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NonoperatingIncomeExpense" xlink:to="InterestAndOtherIncome" xlink:title="calculation: NonoperatingIncomeExpense to InterestAndOtherIncome" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_InterestExpenseDebtAndOther" xlink:label="InterestExpenseDebtAndOther" xlink:title="InterestExpenseDebtAndOther" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NonoperatingIncomeExpense" xlink:to="InterestExpenseDebtAndOther" xlink:title="calculation: NonoperatingIncomeExpense to InterestExpenseDebtAndOther" order="4.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ReliefFunds" xlink:label="ReliefFunds" xlink:title="ReliefFunds" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NonoperatingIncomeExpense" xlink:to="ReliefFunds" xlink:title="calculation: NonoperatingIncomeExpense to ReliefFunds" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfInterestInProjects" xlink:label="GainLossOnSaleOfInterestInProjects" xlink:title="GainLossOnSaleOfInterestInProjects" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NonoperatingIncomeExpense" xlink:to="GainLossOnSaleOfInterestInProjects" xlink:title="calculation: NonoperatingIncomeExpense to GainLossOnSaleOfInterestInProjects" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="NetIncomeLossAttributableToNoncontrollingInterest" xlink:title="NetIncomeLossAttributableToNoncontrollingInterest" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:label="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:title="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:title="calculation: NetIncomeLossAttributableToNoncontrollingInterest to NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:label="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:title="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:title="calculation: NetIncomeLossAttributableToNoncontrollingInterest to NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" order="1.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetIncomeLoss" xlink:to="NetIncomeLossAttributableToNoncontrollingInterest" xlink:title="calculation: NetIncomeLoss to NetIncomeLossAttributableToNoncontrollingInterest" order="2.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="ProfitLoss" xlink:title="ProfitLoss" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="GainsLossesOnExtinguishmentOfDebt" xlink:title="calculation: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to GainsLossesOnExtinguishmentOfDebt" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="OperatingIncomeLoss" xlink:title="OperatingIncomeLoss" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="SellingGeneralAndAdministrativeExpense" xlink:title="SellingGeneralAndAdministrativeExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OperatingIncomeLoss" xlink:to="SellingGeneralAndAdministrativeExpense" xlink:title="calculation: OperatingIncomeLoss to SellingGeneralAndAdministrativeExpense" order="2.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit" xlink:label="GrossProfit" xlink:title="GrossProfit" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:title="RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="GrossProfit" xlink:to="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:title="calculation: GrossProfit to RevenueFromContractWithCustomerExcludingAssessedTax" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="CostsAndExpenses" xlink:title="CostsAndExpenses" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_RentSuppliesContractLaborAndOther" xlink:label="RentSuppliesContractLaborAndOther" xlink:title="RentSuppliesContractLaborAndOther" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CostsAndExpenses" xlink:to="RentSuppliesContractLaborAndOther" xlink:title="calculation: CostsAndExpenses to RentSuppliesContractLaborAndOther" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="GoodwillImpairmentLoss" xlink:title="GoodwillImpairmentLoss" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CostsAndExpenses" xlink:to="GoodwillImpairmentLoss" xlink:title="calculation: CostsAndExpenses to GoodwillImpairmentLoss" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="RestructuringCharges" xlink:title="RestructuringCharges" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CostsAndExpenses" xlink:to="RestructuringCharges" xlink:title="calculation: CostsAndExpenses to RestructuringCharges" order="5.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="LaborAndRelatedExpense" xlink:title="LaborAndRelatedExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CostsAndExpenses" xlink:to="LaborAndRelatedExpense" xlink:title="calculation: CostsAndExpenses to LaborAndRelatedExpense" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="ProvisionForDoubtfulAccounts" xlink:title="ProvisionForDoubtfulAccounts" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CostsAndExpenses" xlink:to="ProvisionForDoubtfulAccounts" xlink:title="calculation: CostsAndExpenses to ProvisionForDoubtfulAccounts" order="4.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="GrossProfit" xlink:to="CostsAndExpenses" xlink:title="calculation: GrossProfit to CostsAndExpenses" order="2.0" weight="-1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OperatingIncomeLoss" xlink:to="GrossProfit" xlink:title="calculation: OperatingIncomeLoss to GrossProfit" order="1.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="OperatingIncomeLoss" xlink:title="calculation: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to OperatingIncomeLoss" order="1.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="GainLossOnSaleOfInterestInProjects" xlink:title="calculation: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to GainLossOnSaleOfInterestInProjects" order="2.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="InterestAndOtherIncome" xlink:title="calculation: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to InterestAndOtherIncome" order="3.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="ReliefFunds" xlink:title="calculation: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to ReliefFunds" order="6.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="InterestExpenseDebtAndOther" xlink:title="calculation: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to InterestExpenseDebtAndOther" order="5.0" weight="-1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ProfitLoss" xlink:to="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="calculation: ProfitLoss to IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ProfitLoss" xlink:to="IncomeTaxExpenseBenefit" xlink:title="calculation: ProfitLoss to IncomeTaxExpenseBenefit" order="1.0" weight="-1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetIncomeLoss" xlink:to="ProfitLoss" xlink:title="calculation: NetIncomeLoss to ProfitLoss" order="1.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedStatementsOfCashFlows">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="NetCashProvidedByUsedInInvestingActivities" xlink:title="NetCashProvidedByUsedInInvestingActivities" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:label="ProceedsFromDivestitureOfBusinesses" xlink:title="ProceedsFromDivestitureOfBusinesses" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="ProceedsFromDivestitureOfBusinesses" xlink:title="calculation: NetCashProvidedByUsedInInvestingActivities to ProceedsFromDivestitureOfBusinesses" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="PaymentsToAcquireBusinessesNetOfCashAcquired" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="calculation: NetCashProvidedByUsedInInvestingActivities to PaymentsToAcquireBusinessesNetOfCashAcquired" order="2.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PaymentsToAcquireRedeemableNonControllingInterest" xlink:label="PaymentsToAcquireRedeemableNonControllingInterest" xlink:title="PaymentsToAcquireRedeemableNonControllingInterest" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="PaymentsToAcquireRedeemableNonControllingInterest" xlink:title="calculation: NetCashProvidedByUsedInInvestingActivities to PaymentsToAcquireRedeemableNonControllingInterest" order="5.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" xlink:label="ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" xlink:title="ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" xlink:title="calculation: NetCashProvidedByUsedInInvestingActivities to ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="PaymentsToAcquireProductiveAssets" xlink:title="PaymentsToAcquireProductiveAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="PaymentsToAcquireProductiveAssets" xlink:title="calculation: NetCashProvidedByUsedInInvestingActivities to PaymentsToAcquireProductiveAssets" order="1.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:label="PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:title="PaymentsToAcquireInterestInSubsidiariesAndAffiliates" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:title="calculation: NetCashProvidedByUsedInInvestingActivities to PaymentsToAcquireInterestInSubsidiariesAndAffiliates" order="6.0" weight="-1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="NetCashProvidedByUsedInInvestingActivities" xlink:title="calculation: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect to NetCashProvidedByUsedInInvestingActivities" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="NetCashProvidedByUsedInFinancingActivities" xlink:title="NetCashProvidedByUsedInFinancingActivities" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="RepaymentsOfLinesOfCredit" xlink:title="RepaymentsOfLinesOfCredit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="RepaymentsOfLinesOfCredit" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to RepaymentsOfLinesOfCredit" order="6.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="ProceedsFromLinesOfCredit" xlink:title="ProceedsFromLinesOfCredit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="ProceedsFromLinesOfCredit" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to ProceedsFromLinesOfCredit" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_MedicareAcceleratedAndAdvancePaymentFunds" xlink:label="MedicareAcceleratedAndAdvancePaymentFunds" xlink:title="MedicareAcceleratedAndAdvancePaymentFunds" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="MedicareAcceleratedAndAdvancePaymentFunds" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to MedicareAcceleratedAndAdvancePaymentFunds" order="5.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:label="ProceedsFromPaymentsForOtherFinancingActivities" xlink:title="ProceedsFromPaymentsForOtherFinancingActivities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="ProceedsFromPaymentsForOtherFinancingActivities" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to ProceedsFromPaymentsForOtherFinancingActivities" order="10.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="RepaymentsOfNotesPayable" xlink:title="RepaymentsOfNotesPayable" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="RepaymentsOfNotesPayable" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to RepaymentsOfNotesPayable" order="7.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="PaymentsOfDividendsMinorityInterest" xlink:title="PaymentsOfDividendsMinorityInterest" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="PaymentsOfDividendsMinorityInterest" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to PaymentsOfDividendsMinorityInterest" order="1.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock" xlink:label="PaymentsOfDividendsCommonStock" xlink:title="PaymentsOfDividendsCommonStock" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="PaymentsOfDividendsCommonStock" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to PaymentsOfDividendsCommonStock" order="2.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:label="PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:title="PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" order="9.0" weight="-1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="NetCashProvidedByUsedInFinancingActivities" xlink:title="calculation: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect to NetCashProvidedByUsedInFinancingActivities" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="NetCashProvidedByUsedInOperatingActivities" xlink:title="NetCashProvidedByUsedInOperatingActivities" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="ProfitLoss" xlink:title="ProfitLoss" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="ProfitLoss" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to ProfitLoss" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:label="IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:title="IncreaseDecreaseInOtherNoncurrentLiabilities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInOtherNoncurrentLiabilities" order="20.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="DepreciationDepletionAndAmortization" xlink:title="DepreciationDepletionAndAmortization" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="DepreciationDepletionAndAmortization" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to DepreciationDepletionAndAmortization" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="DeferredIncomeTaxExpenseBenefit" xlink:title="DeferredIncomeTaxExpenseBenefit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="DeferredIncomeTaxExpenseBenefit" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to DeferredIncomeTaxExpenseBenefit" order="13.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="ProvisionForDoubtfulAccounts" xlink:title="ProvisionForDoubtfulAccounts" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="ProvisionForDoubtfulAccounts" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to ProvisionForDoubtfulAccounts" order="5.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="GoodwillImpairmentLoss" xlink:title="GoodwillImpairmentLoss" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="GoodwillImpairmentLoss" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to GoodwillImpairmentLoss" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:label="OtherOperatingActivitiesCashFlowStatement" xlink:title="OtherOperatingActivitiesCashFlowStatement" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="OtherOperatingActivitiesCashFlowStatement" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to OtherOperatingActivitiesCashFlowStatement" order="11.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="IncreaseDecreaseInOtherOperatingAssets" xlink:title="IncreaseDecreaseInOtherOperatingAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInOtherOperatingAssets" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInOtherOperatingAssets" order="18.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_GainOnSaleOfPartnershipInterestNetOfTax" xlink:label="GainOnSaleOfPartnershipInterestNetOfTax" xlink:title="GainOnSaleOfPartnershipInterestNetOfTax" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="GainOnSaleOfPartnershipInterestNetOfTax" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to GainOnSaleOfPartnershipInterestNetOfTax" order="9.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="IncreaseDecreaseInAccountsReceivable" xlink:title="IncreaseDecreaseInAccountsReceivable" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInAccountsReceivable" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInAccountsReceivable" order="16.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="ShareBasedCompensation" xlink:title="ShareBasedCompensation" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="ShareBasedCompensation" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to ShareBasedCompensation" order="7.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="19.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" xlink:label="IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" xlink:title="IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" order="17.0" weight="-1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="NetCashProvidedByUsedInOperatingActivities" xlink:title="calculation: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect to NetCashProvidedByUsedInOperatingActivities" order="1.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://usph.com/role/AcquisitionsOfBusinessesDetails">
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:label="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:title="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:title="calculation: BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:title="calculation: BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:title="calculation: BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" order="0.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://usph.com/role/RedeemableNoncontrollingInterestDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:title="RedeemableNoncontrollingInterestEquityCarryingAmount" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:label="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:title="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:title="calculation: RedeemableNoncontrollingInterestEquityCarryingAmount to ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:label="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:title="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:title="calculation: RedeemableNoncontrollingInterestEquityCarryingAmount to ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:label="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:title="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:title="calculation: RedeemableNoncontrollingInterestEquityCarryingAmount to HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:label="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:title="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:title="calculation: RedeemableNoncontrollingInterestEquityCarryingAmount to HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" order="3.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://usph.com/role/AccruedExpensesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PatientsAndPayorsRelatedLiability" xlink:label="PatientsAndPayorsRelatedLiability" xlink:title="PatientsAndPayorsRelatedLiability" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="PatientsAndPayorsRelatedLiability" xlink:title="calculation: AccruedLiabilitiesCurrent to PatientsAndPayorsRelatedLiability" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedInsuranceCurrent" xlink:label="AccruedInsuranceCurrent" xlink:title="AccruedInsuranceCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="AccruedInsuranceCurrent" xlink:title="calculation: AccruedLiabilitiesCurrent to AccruedInsuranceCurrent" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_DeferredEmployerPayrollTaxesCARESACT" xlink:label="DeferredEmployerPayrollTaxesCARESACT" xlink:title="DeferredEmployerPayrollTaxesCARESACT" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="DeferredEmployerPayrollTaxesCARESACT" xlink:title="calculation: AccruedLiabilitiesCurrent to DeferredEmployerPayrollTaxesCARESACT" order="9.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="OtherAccruedLiabilitiesCurrent" xlink:title="OtherAccruedLiabilitiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="OtherAccruedLiabilitiesCurrent" xlink:title="calculation: AccruedLiabilitiesCurrent to OtherAccruedLiabilitiesCurrent" order="5.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="EmployeeRelatedLiabilitiesCurrent" xlink:title="EmployeeRelatedLiabilitiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="EmployeeRelatedLiabilitiesCurrent" xlink:title="calculation: AccruedLiabilitiesCurrent to EmployeeRelatedLiabilitiesCurrent" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable" xlink:label="MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable" xlink:title="MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable" xlink:title="calculation: AccruedLiabilitiesCurrent to MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable" order="8.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxesPayableCurrent" xlink:label="TaxesPayableCurrent" xlink:title="TaxesPayableCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="TaxesPayableCurrent" xlink:title="calculation: AccruedLiabilitiesCurrent to TaxesPayableCurrent" order="7.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:label="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:title="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:title="calculation: AccruedLiabilitiesCurrent to LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" order="6.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt" xlink:label="LongTermDebt" xlink:title="LongTermDebt" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="LongTermDebtCurrent" xlink:title="LongTermDebtCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LongTermDebt" xlink:to="LongTermDebtCurrent" xlink:title="calculation: LongTermDebt to LongTermDebtCurrent" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="LongTermDebtNoncurrent" xlink:title="LongTermDebtNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LongTermDebt" xlink:to="LongTermDebtNoncurrent" xlink:title="calculation: LongTermDebt to LongTermDebtNoncurrent" order="1.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://usph.com/role/LeasesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" order="6.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost" xlink:label="LeaseCost" xlink:title="LeaseCost" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost" xlink:label="VariableLeaseCost" xlink:title="VariableLeaseCost" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LeaseCost" xlink:to="VariableLeaseCost" xlink:title="calculation: LeaseCost to VariableLeaseCost" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermLeaseCost" xlink:label="ShortTermLeaseCost" xlink:title="ShortTermLeaseCost" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LeaseCost" xlink:to="ShortTermLeaseCost" xlink:title="calculation: LeaseCost to ShortTermLeaseCost" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="OperatingLeaseCost" xlink:title="OperatingLeaseCost" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LeaseCost" xlink:to="OperatingLeaseCost" xlink:title="calculation: LeaseCost to OperatingLeaseCost" order="1.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://usph.com/role/LeasesDetailsCalc01">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability" xlink:title="OperatingLeaseLiability" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="OperatingLeaseLiability" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to OperatingLeaseLiability" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="2.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="DeferredTaxLiabilities" xlink:title="DeferredTaxLiabilities" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="DeferredIncomeTaxLiabilities" xlink:title="DeferredIncomeTaxLiabilities" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:title="DeferredTaxLiabilitiesPropertyPlantAndEquipment" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredIncomeTaxLiabilities" xlink:to="DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:title="calculation: DeferredIncomeTaxLiabilities to DeferredTaxLiabilitiesPropertyPlantAndEquipment" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" xlink:label="DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" xlink:title="DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredIncomeTaxLiabilities" xlink:to="DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" xlink:title="calculation: DeferredIncomeTaxLiabilities to DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther" xlink:label="DeferredTaxLiabilitiesOther" xlink:title="DeferredTaxLiabilitiesOther" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredIncomeTaxLiabilities" xlink:to="DeferredTaxLiabilitiesOther" xlink:title="calculation: DeferredIncomeTaxLiabilities to DeferredTaxLiabilitiesOther" order="2.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxLiabilities" xlink:to="DeferredIncomeTaxLiabilities" xlink:title="calculation: DeferredTaxLiabilities to DeferredIncomeTaxLiabilities" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="DeferredTaxAssetsGross" xlink:title="DeferredTaxAssetsGross" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:label="DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:title="DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxAssetsGross" xlink:to="DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:title="calculation: DeferredTaxAssetsGross to DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:label="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:title="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxAssetsGross" xlink:to="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:title="calculation: DeferredTaxAssetsGross to DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_DeferredTaxAssetsLeaseObligations" xlink:label="DeferredTaxAssetsLeaseObligations" xlink:title="DeferredTaxAssetsLeaseObligations" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxAssetsGross" xlink:to="DeferredTaxAssetsLeaseObligations" xlink:title="calculation: DeferredTaxAssetsGross to DeferredTaxAssetsLeaseObligations" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="DeferredTaxAssetsOperatingLossCarryforwards" xlink:title="DeferredTaxAssetsOperatingLossCarryforwards" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxAssetsGross" xlink:to="DeferredTaxAssetsOperatingLossCarryforwards" xlink:title="calculation: DeferredTaxAssetsGross to DeferredTaxAssetsOperatingLossCarryforwards" order="4.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxLiabilities" xlink:to="DeferredTaxAssetsGross" xlink:title="calculation: DeferredTaxLiabilities to DeferredTaxAssetsGross" order="1.0" weight="-1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:label="IncomeTaxReconciliationNondeductibleExpense" xlink:title="IncomeTaxReconciliationNondeductibleExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeTaxExpenseBenefit" xlink:to="IncomeTaxReconciliationNondeductibleExpense" xlink:title="calculation: IncomeTaxExpenseBenefit to IncomeTaxReconciliationNondeductibleExpense" order="8.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:title="IncomeTaxReconciliationStateAndLocalIncomeTaxes" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeTaxExpenseBenefit" xlink:to="IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:title="calculation: IncomeTaxExpenseBenefit to IncomeTaxReconciliationStateAndLocalIncomeTaxes" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:title="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeTaxExpenseBenefit" xlink:to="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:title="calculation: IncomeTaxExpenseBenefit to IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:title="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeTaxExpenseBenefit" xlink:to="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:title="calculation: IncomeTaxExpenseBenefit to EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="9.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationDeductions" xlink:label="IncomeTaxReconciliationDeductions" xlink:title="IncomeTaxReconciliationDeductions" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeTaxExpenseBenefit" xlink:to="IncomeTaxReconciliationDeductions" xlink:title="calculation: IncomeTaxExpenseBenefit to IncomeTaxReconciliationDeductions" order="4.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="EffectiveIncomeTaxRateContinuingOperations" xlink:title="EffectiveIncomeTaxRateContinuingOperations" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:label="EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:title="EffectiveIncomeTaxRateReconciliationNondeductibleExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="EffectiveIncomeTaxRateContinuingOperations" xlink:to="EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:title="calculation: EffectiveIncomeTaxRateContinuingOperations to EffectiveIncomeTaxRateReconciliationNondeductibleExpense" order="7.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDeductions" xlink:label="EffectiveIncomeTaxRateReconciliationDeductions" xlink:title="EffectiveIncomeTaxRateReconciliationDeductions" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="EffectiveIncomeTaxRateContinuingOperations" xlink:to="EffectiveIncomeTaxRateReconciliationDeductions" xlink:title="calculation: EffectiveIncomeTaxRateContinuingOperations to EffectiveIncomeTaxRateReconciliationDeductions" order="5.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:title="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="EffectiveIncomeTaxRateContinuingOperations" xlink:to="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:title="calculation: EffectiveIncomeTaxRateContinuingOperations to EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="1.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="EffectiveIncomeTaxRateContinuingOperations" xlink:to="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:title="calculation: EffectiveIncomeTaxRateContinuingOperations to EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="3.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://usph.com/role/IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="CurrentIncomeTaxExpenseBenefit" xlink:title="CurrentIncomeTaxExpenseBenefit" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="CurrentFederalTaxExpenseBenefit" xlink:title="CurrentFederalTaxExpenseBenefit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CurrentIncomeTaxExpenseBenefit" xlink:to="CurrentFederalTaxExpenseBenefit" xlink:title="calculation: CurrentIncomeTaxExpenseBenefit to CurrentFederalTaxExpenseBenefit" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="CurrentStateAndLocalTaxExpenseBenefit" xlink:title="CurrentStateAndLocalTaxExpenseBenefit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CurrentIncomeTaxExpenseBenefit" xlink:to="CurrentStateAndLocalTaxExpenseBenefit" xlink:title="calculation: CurrentIncomeTaxExpenseBenefit to CurrentStateAndLocalTaxExpenseBenefit" order="2.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeTaxExpenseBenefit" xlink:to="CurrentIncomeTaxExpenseBenefit" xlink:title="calculation: IncomeTaxExpenseBenefit to CurrentIncomeTaxExpenseBenefit" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="DeferredIncomeTaxExpenseBenefit" xlink:title="DeferredIncomeTaxExpenseBenefit" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:title="DeferredStateAndLocalIncomeTaxExpenseBenefit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredIncomeTaxExpenseBenefit" xlink:to="DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:title="calculation: DeferredIncomeTaxExpenseBenefit to DeferredStateAndLocalIncomeTaxExpenseBenefit" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="DeferredFederalIncomeTaxExpenseBenefit" xlink:title="DeferredFederalIncomeTaxExpenseBenefit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredIncomeTaxExpenseBenefit" xlink:to="DeferredFederalIncomeTaxExpenseBenefit" xlink:title="calculation: DeferredIncomeTaxExpenseBenefit to DeferredFederalIncomeTaxExpenseBenefit" order="1.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeTaxExpenseBenefit" xlink:to="DeferredIncomeTaxExpenseBenefit" xlink:title="calculation: IncomeTaxExpenseBenefit to DeferredIncomeTaxExpenseBenefit" order="2.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://usph.com/role/EarningsPerShareDetails">
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" xlink:label="IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" xlink:title="IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" xlink:to="NetIncomeLoss" xlink:title="calculation: IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests to NetIncomeLoss" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" xlink:label="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" xlink:title="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" xlink:to="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" xlink:title="calculation: IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests to IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" order="3.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests" xlink:label="ChargesToRetainedEarningsRevaluationOfNonControllingInterests" xlink:title="ChargesToRetainedEarningsRevaluationOfNonControllingInterests" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" xlink:to="ChargesToRetainedEarningsRevaluationOfNonControllingInterests" xlink:title="calculation: IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests to ChargesToRetainedEarningsRevaluationOfNonControllingInterests" order="2.0" weight="1.0" />
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>11
<FILENAME>usph-20201231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 7.0.0.0 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:t1="http://xbrl.org/2005/xbrldt">
  <link:roleRef roleURI="http://usph.com/role/ScheduleIiValuationAndQualifyingAccountsDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#ScheduleIiValuationAndQualifyingAccountsDetails" />
  <link:roleRef roleURI="http://usph.com/role/EarningsPerShareDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#EarningsPerShareDetails" />
  <link:roleRef roleURI="http://usph.com/role/CommitmentsAndContingenciesDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#CommitmentsAndContingenciesDetails" />
  <link:roleRef roleURI="http://usph.com/role/DefinedContributionPlanDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#DefinedContributionPlanDetails" />
  <link:roleRef roleURI="http://usph.com/role/CommonStockDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#CommonStockDetails" />
  <link:roleRef roleURI="http://usph.com/role/EquityBasedPlansDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#EquityBasedPlansDetails" />
  <link:roleRef roleURI="http://usph.com/role/EquityBasedPlansRestrictedStockCancelledDueToEmployeeTerminationsPriorToRestrictionsLapsingDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#EquityBasedPlansRestrictedStockCancelledDueToEmployeeTerminationsPriorToRestrictionsLapsingDetails" />
  <link:roleRef roleURI="http://usph.com/role/EquityBasedPlansRestrictedStockGrantedToDirectorsOfficersAndEmployeesPursuantToItsEquityPlansDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#EquityBasedPlansRestrictedStockGrantedToDirectorsOfficersAndEmployeesPursuantToItsEquityPlansDetails" />
  <link:roleRef roleURI="http://usph.com/role/EquityBasedPlansCumulativeSummaryOfEquityPlansDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#EquityBasedPlansCumulativeSummaryOfEquityPlansDetails" />
  <link:roleRef roleURI="http://usph.com/role/EquityBasedPlansAmendedAndRestatedEmployeeStockOptionPlansDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#EquityBasedPlansAmendedAndRestatedEmployeeStockOptionPlansDetails" />
  <link:roleRef roleURI="http://usph.com/role/SegmentInformationDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#SegmentInformationDetails" />
  <link:roleRef roleURI="http://usph.com/role/IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails" />
  <link:roleRef roleURI="http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails" />
  <link:roleRef roleURI="http://usph.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#IncomeTaxesDetails" />
  <link:roleRef roleURI="http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails" />
  <link:roleRef roleURI="http://usph.com/role/LeasesDetailsCalc01" xlink:type="simple" xlink:href="usph-20201231.xsd#LeasesDetailsCalc01" />
  <link:roleRef roleURI="http://usph.com/role/LeasesDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#LeasesDetails" />
  <link:roleRef roleURI="http://usph.com/role/NotesPayableDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#NotesPayableDetails" />
  <link:roleRef roleURI="http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#NotesPayableSummaryOfNotesPayableDetails" />
  <link:roleRef roleURI="http://usph.com/role/AccruedExpensesDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#AccruedExpensesDetails" />
  <link:roleRef roleURI="http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails" />
  <link:roleRef roleURI="http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#IntangibleAssetsNetAmortizationExpensesDetails" />
  <link:roleRef roleURI="http://usph.com/role/IntangibleAssetsNetDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#IntangibleAssetsNetDetails" />
  <link:roleRef roleURI="http://usph.com/role/GoodwillDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#GoodwillDetails" />
  <link:roleRef roleURI="http://usph.com/role/RedeemableNoncontrollingInterestDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#RedeemableNoncontrollingInterestDetails" />
  <link:roleRef roleURI="http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#AcquisitionsAndSaleOfNoncontrollingInterestsDetails" />
  <link:roleRef roleURI="http://usph.com/role/AcquisitionsOfBusinessesDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#AcquisitionsOfBusinessesDetails" />
  <link:roleRef roleURI="http://usph.com/role/SignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#SignificantAccountingPoliciesDetails" />
  <link:roleRef roleURI="http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails" />
  <link:roleRef roleURI="http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#OrganizationNatureOfOperationsAndBasisOfPresentationDetails" />
  <link:roleRef roleURI="http://usph.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="usph-20201231.xsd#EarningsPerShareTables" />
  <link:roleRef roleURI="http://usph.com/role/EquityBasedPlansTables" xlink:type="simple" xlink:href="usph-20201231.xsd#EquityBasedPlansTables" />
  <link:roleRef roleURI="http://usph.com/role/SegmentInformationTables" xlink:type="simple" xlink:href="usph-20201231.xsd#SegmentInformationTables" />
  <link:roleRef roleURI="http://usph.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="usph-20201231.xsd#IncomeTaxesTables" />
  <link:roleRef roleURI="http://usph.com/role/LeasesTables" xlink:type="simple" xlink:href="usph-20201231.xsd#LeasesTables" />
  <link:roleRef roleURI="http://usph.com/role/NotesPayableTables" xlink:type="simple" xlink:href="usph-20201231.xsd#NotesPayableTables" />
  <link:roleRef roleURI="http://usph.com/role/AccruedExpensesTables" xlink:type="simple" xlink:href="usph-20201231.xsd#AccruedExpensesTables" />
  <link:roleRef roleURI="http://usph.com/role/IntangibleAssetsNetTables" xlink:type="simple" xlink:href="usph-20201231.xsd#IntangibleAssetsNetTables" />
  <link:roleRef roleURI="http://usph.com/role/GoodwillTables" xlink:type="simple" xlink:href="usph-20201231.xsd#GoodwillTables" />
  <link:roleRef roleURI="http://usph.com/role/RedeemableNoncontrollingInterestTables" xlink:type="simple" xlink:href="usph-20201231.xsd#RedeemableNoncontrollingInterestTables" />
  <link:roleRef roleURI="http://usph.com/role/AcquisitionsOfBusinessesTables" xlink:type="simple" xlink:href="usph-20201231.xsd#AcquisitionsOfBusinessesTables" />
  <link:roleRef roleURI="http://usph.com/role/SignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="usph-20201231.xsd#SignificantAccountingPoliciesTables" />
  <link:roleRef roleURI="http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationTables" xlink:type="simple" xlink:href="usph-20201231.xsd#OrganizationNatureOfOperationsAndBasisOfPresentationTables" />
  <link:roleRef roleURI="http://usph.com/role/SignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="usph-20201231.xsd#SignificantAccountingPoliciesPolicies" />
  <link:roleRef roleURI="http://usph.com/role/ScheduleIiValuationAndQualifyingAccounts" xlink:type="simple" xlink:href="usph-20201231.xsd#ScheduleIiValuationAndQualifyingAccounts" />
  <link:roleRef roleURI="http://usph.com/role/EarningsPerShare" xlink:type="simple" xlink:href="usph-20201231.xsd#EarningsPerShare" />
  <link:roleRef roleURI="http://usph.com/role/CommitmentsAndContingencies" xlink:type="simple" xlink:href="usph-20201231.xsd#CommitmentsAndContingencies" />
  <link:roleRef roleURI="http://usph.com/role/DefinedContributionPlan" xlink:type="simple" xlink:href="usph-20201231.xsd#DefinedContributionPlan" />
  <link:roleRef roleURI="http://usph.com/role/CommonStock" xlink:type="simple" xlink:href="usph-20201231.xsd#CommonStock" />
  <link:roleRef roleURI="http://usph.com/role/PreferredStock" xlink:type="simple" xlink:href="usph-20201231.xsd#PreferredStock" />
  <link:roleRef roleURI="http://usph.com/role/EquityBasedPlans" xlink:type="simple" xlink:href="usph-20201231.xsd#EquityBasedPlans" />
  <link:roleRef roleURI="http://usph.com/role/SegmentInformation" xlink:type="simple" xlink:href="usph-20201231.xsd#SegmentInformation" />
  <link:roleRef roleURI="http://usph.com/role/IncomeTaxes" xlink:type="simple" xlink:href="usph-20201231.xsd#IncomeTaxes" />
  <link:roleRef roleURI="http://usph.com/role/Leases" xlink:type="simple" xlink:href="usph-20201231.xsd#Leases" />
  <link:roleRef roleURI="http://usph.com/role/NotesPayable" xlink:type="simple" xlink:href="usph-20201231.xsd#NotesPayable" />
  <link:roleRef roleURI="http://usph.com/role/AccruedExpenses" xlink:type="simple" xlink:href="usph-20201231.xsd#AccruedExpenses" />
  <link:roleRef roleURI="http://usph.com/role/IntangibleAssetsNet" xlink:type="simple" xlink:href="usph-20201231.xsd#IntangibleAssetsNet" />
  <link:roleRef roleURI="http://usph.com/role/Goodwill" xlink:type="simple" xlink:href="usph-20201231.xsd#Goodwill" />
  <link:roleRef roleURI="http://usph.com/role/RedeemableNoncontrollingInterest" xlink:type="simple" xlink:href="usph-20201231.xsd#RedeemableNoncontrollingInterest" />
  <link:roleRef roleURI="http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterests" xlink:type="simple" xlink:href="usph-20201231.xsd#AcquisitionsAndSaleOfNoncontrollingInterests" />
  <link:roleRef roleURI="http://usph.com/role/AcquisitionsOfBusinesses" xlink:type="simple" xlink:href="usph-20201231.xsd#AcquisitionsOfBusinesses" />
  <link:roleRef roleURI="http://usph.com/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="usph-20201231.xsd#SignificantAccountingPolicies" />
  <link:roleRef roleURI="http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentation" xlink:type="simple" xlink:href="usph-20201231.xsd#OrganizationNatureOfOperationsAndBasisOfPresentation" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="simple" xlink:href="usph-20201231.xsd#ConsolidatedStatementsOfCashFlows" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedStatementsOfChangesInEquity" xlink:type="simple" xlink:href="usph-20201231.xsd#ConsolidatedStatementsOfChangesInEquity" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedStatementsOfIncome" xlink:type="simple" xlink:href="usph-20201231.xsd#ConsolidatedStatementsOfIncome" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="usph-20201231.xsd#ConsolidatedBalanceSheetsParenthetical" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="usph-20201231.xsd#ConsolidatedBalanceSheets" />
  <link:roleRef roleURI="http://usph.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="usph-20201231.xsd#DocumentAndEntityInformation" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/DocumentAndEntityInformation" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedBalanceSheets" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedBalanceSheetsParenthetical" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedStatementsOfIncome">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="StatementLineItems" xlink:title="StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="RevenuesAbstract" xlink:title="RevenuesAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="RevenuesAbstract" xlink:title="definition: StatementLineItems to RevenuesAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="CostsAndExpensesAbstract" xlink:title="CostsAndExpensesAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="CostsAndExpensesAbstract" xlink:title="definition: StatementLineItems to CostsAndExpensesAbstract" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit" xlink:label="GrossProfit" xlink:title="GrossProfit" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="GrossProfit" xlink:title="definition: StatementLineItems to GrossProfit" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="SellingGeneralAndAdministrativeExpense" xlink:title="SellingGeneralAndAdministrativeExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="SellingGeneralAndAdministrativeExpense" xlink:title="definition: StatementLineItems to SellingGeneralAndAdministrativeExpense" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="OperatingIncomeLoss" xlink:title="OperatingIncomeLoss" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="OperatingIncomeLoss" xlink:title="definition: StatementLineItems to OperatingIncomeLoss" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="OtherNonoperatingIncomeExpenseAbstract" xlink:title="OtherNonoperatingIncomeExpenseAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="OtherNonoperatingIncomeExpenseAbstract" xlink:title="definition: StatementLineItems to OtherNonoperatingIncomeExpenseAbstract" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="definition: StatementLineItems to IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="IncomeTaxExpenseBenefit" xlink:title="definition: StatementLineItems to IncomeTaxExpenseBenefit" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="ProfitLoss" xlink:title="ProfitLoss" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="ProfitLoss" xlink:title="definition: StatementLineItems to ProfitLoss" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" xlink:label="MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" xlink:title="MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" xlink:title="definition: StatementLineItems to MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="NetIncomeLoss" xlink:title="definition: StatementLineItems to NetIncomeLoss" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="EarningsPerShareBasicAndDiluted" xlink:title="EarningsPerShareBasicAndDiluted" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="EarningsPerShareBasicAndDiluted" xlink:title="definition: StatementLineItems to EarningsPerShareBasicAndDiluted" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:title="WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:title="definition: StatementLineItems to WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared" xlink:label="CommonStockDividendsPerShareDeclared" xlink:title="CommonStockDividendsPerShareDeclared" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="CommonStockDividendsPerShareDeclared" xlink:title="definition: StatementLineItems to CommonStockDividendsPerShareDeclared" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:label="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:title="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:title="definition: StatementLineItems to NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:label="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:title="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:title="definition: StatementLineItems to NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="NetIncomeLossAttributableToNoncontrollingInterest" xlink:title="NetIncomeLossAttributableToNoncontrollingInterest" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="NetIncomeLossAttributableToNoncontrollingInterest" xlink:title="definition: StatementLineItems to NetIncomeLossAttributableToNoncontrollingInterest" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ReliefFunds" xlink:label="ReliefFunds" xlink:title="ReliefFunds" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="ReliefFunds" xlink:title="definition: StatementLineItems to ReliefFunds" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfInterestInProjects" xlink:label="GainLossOnSaleOfInterestInProjects" xlink:title="GainLossOnSaleOfInterestInProjects" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="GainLossOnSaleOfInterestInProjects" xlink:title="definition: StatementLineItems to GainLossOnSaleOfInterestInProjects" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="GainsLossesOnExtinguishmentOfDebt" xlink:title="GainsLossesOnExtinguishmentOfDebt" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="GainsLossesOnExtinguishmentOfDebt" xlink:title="definition: StatementLineItems to GainsLossesOnExtinguishmentOfDebt" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndOtherIncome" xlink:label="InterestAndOtherIncome" xlink:title="InterestAndOtherIncome" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="InterestAndOtherIncome" xlink:title="definition: StatementLineItems to InterestAndOtherIncome" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_InterestExpenseDebtAndOther" xlink:label="InterestExpenseDebtAndOther" xlink:title="InterestExpenseDebtAndOther" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="InterestExpenseDebtAndOther" xlink:title="definition: StatementLineItems to InterestExpenseDebtAndOther" order="22.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="NonoperatingIncomeExpense" xlink:title="NonoperatingIncomeExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="NonoperatingIncomeExpense" xlink:title="definition: StatementLineItems to NonoperatingIncomeExpense" order="23.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="LaborAndRelatedExpense" xlink:title="LaborAndRelatedExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="LaborAndRelatedExpense" xlink:title="definition: StatementLineItems to LaborAndRelatedExpense" order="24.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_RentSuppliesContractLaborAndOther" xlink:label="RentSuppliesContractLaborAndOther" xlink:title="RentSuppliesContractLaborAndOther" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="RentSuppliesContractLaborAndOther" xlink:title="definition: StatementLineItems to RentSuppliesContractLaborAndOther" order="25.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="ProvisionForDoubtfulAccounts" xlink:title="ProvisionForDoubtfulAccounts" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="ProvisionForDoubtfulAccounts" xlink:title="definition: StatementLineItems to ProvisionForDoubtfulAccounts" order="26.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="RestructuringCharges" xlink:title="RestructuringCharges" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="RestructuringCharges" xlink:title="definition: StatementLineItems to RestructuringCharges" order="27.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="GoodwillImpairmentLoss" xlink:title="GoodwillImpairmentLoss" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="GoodwillImpairmentLoss" xlink:title="definition: StatementLineItems to GoodwillImpairmentLoss" order="28.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="CostsAndExpenses" xlink:title="CostsAndExpenses" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="CostsAndExpenses" xlink:title="definition: StatementLineItems to CostsAndExpenses" order="29.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:title="RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:title="definition: StatementLineItems to RevenueFromContractWithCustomerExcludingAssessedTax" order="30.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="StatementTable" xlink:title="StatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="StatementLineItems" xlink:to="StatementTable" xlink:title="definition: StatementLineItems to StatementTable" order="31.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="ProductOrServiceAxis" xlink:title="ProductOrServiceAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="StatementTable" xlink:to="ProductOrServiceAxis" xlink:title="definition: StatementTable to ProductOrServiceAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="ProductsAndServicesDomain" xlink:title="ProductsAndServicesDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ProductOrServiceAxis" xlink:to="ProductsAndServicesDomain" xlink:title="definition: ProductOrServiceAxis to ProductsAndServicesDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="ProductsAndServicesDomain_2" xlink:title="ProductsAndServicesDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ProductOrServiceAxis" xlink:to="ProductsAndServicesDomain_2" xlink:title="definition: ProductOrServiceAxis to ProductsAndServicesDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NetPatientRevenuesMember" xlink:label="NetPatientRevenuesMember" xlink:title="NetPatientRevenuesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ProductsAndServicesDomain" xlink:to="NetPatientRevenuesMember" xlink:title="definition: ProductsAndServicesDomain to NetPatientRevenuesMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" xlink:label="OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" xlink:title="OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ProductsAndServicesDomain" xlink:to="OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" xlink:title="definition: ProductsAndServicesDomain to OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedStatementsOfChangesInEquity">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="StatementLineItems" xlink:title="StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="IncreaseDecreaseInStockholdersEquityRollForward" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="definition: StatementLineItems to IncreaseDecreaseInStockholdersEquityRollForward" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="definition: StatementLineItems to StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="SharesOutstanding" xlink:title="SharesOutstanding" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="SharesOutstanding" xlink:title="definition: StatementLineItems to SharesOutstanding" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:label="StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:title="StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:title="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_RevaluationOfRedeemableNonControllingInterestNetOfTax" xlink:label="RevaluationOfRedeemableNonControllingInterestNetOfTax" xlink:title="RevaluationOfRedeemableNonControllingInterestNetOfTax" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="RevaluationOfRedeemableNonControllingInterestNetOfTax" xlink:title="definition: StatementLineItems to RevaluationOfRedeemableNonControllingInterestNetOfTax" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" xlink:label="RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" xlink:title="RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" xlink:title="definition: StatementLineItems to RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="definition: StatementLineItems to AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" xlink:label="TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" xlink:title="TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" xlink:title="definition: StatementLineItems to TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PurchaseOfPartnershipInterestsRedeemableNonControllingInterests" xlink:label="PurchaseOfPartnershipInterestsRedeemableNonControllingInterests" xlink:title="PurchaseOfPartnershipInterestsRedeemableNonControllingInterests" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="PurchaseOfPartnershipInterestsRedeemableNonControllingInterests" xlink:title="definition: StatementLineItems to PurchaseOfPartnershipInterestsRedeemableNonControllingInterests" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_SaleOfNonControllingInterestNetOfTaxAndPurchases" xlink:label="SaleOfNonControllingInterestNetOfTaxAndPurchases" xlink:title="SaleOfNonControllingInterestNetOfTaxAndPurchases" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="SaleOfNonControllingInterestNetOfTaxAndPurchases" xlink:title="definition: StatementLineItems to SaleOfNonControllingInterestNetOfTaxAndPurchases" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsCommonStockCash" xlink:label="DividendsCommonStockCash" xlink:title="DividendsCommonStockCash" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="DividendsCommonStockCash" xlink:title="definition: StatementLineItems to DividendsCommonStockCash" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:title="MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:title="definition: StatementLineItems to MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityOther" xlink:label="StockholdersEquityOther" xlink:title="StockholdersEquityOther" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockholdersEquityOther" xlink:title="definition: StatementLineItems to StockholdersEquityOther" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:label="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:title="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:title="definition: StatementLineItems to NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="NetIncomeLoss" xlink:title="definition: StatementLineItems to NetIncomeLoss" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="StatementTable" xlink:title="StatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="StatementLineItems" xlink:to="StatementTable" xlink:title="definition: StatementLineItems to StatementTable" order="17.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="StatementTable" xlink:to="StatementEquityComponentsAxis" xlink:title="definition: StatementTable to StatementEquityComponentsAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain" xlink:title="definition: StatementEquityComponentsAxis to EquityComponentDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain_2" xlink:title="EquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain_2" xlink:title="definition: StatementEquityComponentsAxis to EquityComponentDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="CommonStockMember" xlink:title="definition: EquityComponentDomain to CommonStockMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="AdditionalPaidInCapitalMember" xlink:title="AdditionalPaidInCapitalMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="AdditionalPaidInCapitalMember" xlink:title="definition: EquityComponentDomain to AdditionalPaidInCapitalMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="RetainedEarningsMember" xlink:title="RetainedEarningsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="RetainedEarningsMember" xlink:title="definition: EquityComponentDomain to RetainedEarningsMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="TreasuryStockMember" xlink:title="TreasuryStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="TreasuryStockMember" xlink:title="definition: EquityComponentDomain to TreasuryStockMember" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ParentMember" xlink:label="ParentMember" xlink:title="ParentMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="ParentMember" xlink:title="definition: EquityComponentDomain to ParentMember" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="NoncontrollingInterestMember" xlink:title="NoncontrollingInterestMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="NoncontrollingInterestMember" xlink:title="definition: EquityComponentDomain to NoncontrollingInterestMember" order="6.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedStatementsOfCashFlows" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentation" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/SignificantAccountingPolicies" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/AcquisitionsOfBusinesses" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterests" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/RedeemableNoncontrollingInterest" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/Goodwill" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/IntangibleAssetsNet" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/AccruedExpenses" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/NotesPayable" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/Leases" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/IncomeTaxes" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/SegmentInformation" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/EquityBasedPlans" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/PreferredStock" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/CommonStock" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/DefinedContributionPlan" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/CommitmentsAndContingencies" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/EarningsPerShare" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/ScheduleIiValuationAndQualifyingAccounts" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/SignificantAccountingPoliciesPolicies" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/SignificantAccountingPoliciesTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/AcquisitionsOfBusinessesTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/RedeemableNoncontrollingInterestTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/GoodwillTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/IntangibleAssetsNetTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/AccruedExpensesTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/NotesPayableTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/LeasesTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/IncomeTaxesTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/SegmentInformationTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/EquityBasedPlansTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/EarningsPerShareTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:label="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:title="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:label="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:title="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:title="definition: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems to ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments" xlink:label="NumberOfReportableSegments" xlink:title="NumberOfReportableSegments" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="NumberOfReportableSegments" xlink:title="definition: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems to NumberOfReportableSegments" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PercentageOfGeneralPartnershipInterestOwned" xlink:label="PercentageOfGeneralPartnershipInterestOwned" xlink:title="PercentageOfGeneralPartnershipInterestOwned" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="PercentageOfGeneralPartnershipInterestOwned" xlink:title="definition: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems to PercentageOfGeneralPartnershipInterestOwned" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PercentageOfLimitedPartnershipInterestOwned" xlink:label="PercentageOfLimitedPartnershipInterestOwned" xlink:title="PercentageOfLimitedPartnershipInterestOwned" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="PercentageOfLimitedPartnershipInterestOwned" xlink:title="definition: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems to PercentageOfLimitedPartnershipInterestOwned" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfOperatingClinicLocations" xlink:label="NumberOfOperatingClinicLocations" xlink:title="NumberOfOperatingClinicLocations" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="NumberOfOperatingClinicLocations" xlink:title="definition: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems to NumberOfOperatingClinicLocations" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfClinicsOperated" xlink:label="NumberOfClinicsOperated" xlink:title="NumberOfClinicsOperated" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="NumberOfClinicsOperated" xlink:title="definition: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems to NumberOfClinicsOperated" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfStatesInWhichEntityOperates" xlink:label="NumberOfStatesInWhichEntityOperates" xlink:title="NumberOfStatesInWhichEntityOperates" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="NumberOfStatesInWhichEntityOperates" xlink:title="definition: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems to NumberOfStatesInWhichEntityOperates" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfThirdPartyFacilities" xlink:label="NumberOfThirdPartyFacilities" xlink:title="NumberOfThirdPartyFacilities" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="NumberOfThirdPartyFacilities" xlink:title="definition: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems to NumberOfThirdPartyFacilities" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfBusinessesAcquired" xlink:label="NumberOfBusinessesAcquired" xlink:title="NumberOfBusinessesAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="NumberOfBusinessesAcquired" xlink:title="definition: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems to NumberOfBusinessesAcquired" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfClinicsOperatesAsASatelliteClinicWithExistingPartnerships" xlink:label="NumberOfClinicsOperatesAsASatelliteClinicWithExistingPartnerships" xlink:title="NumberOfClinicsOperatesAsASatelliteClinicWithExistingPartnerships" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="NumberOfClinicsOperatesAsASatelliteClinicWithExistingPartnerships" xlink:title="definition: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems to NumberOfClinicsOperatesAsASatelliteClinicWithExistingPartnerships" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfClosedClinicsSold" xlink:label="NumberOfClosedClinicsSold" xlink:title="NumberOfClosedClinicsSold" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="NumberOfClosedClinicsSold" xlink:title="definition: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems to NumberOfClosedClinicsSold" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_AggregateSalePriceOfCinics" xlink:label="AggregateSalePriceOfCinics" xlink:title="AggregateSalePriceOfCinics" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="AggregateSalePriceOfCinics" xlink:title="definition: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems to AggregateSalePriceOfCinics" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_CashReceivedRelatedToSaleOfClinics" xlink:label="CashReceivedRelatedToSaleOfClinics" xlink:title="CashReceivedRelatedToSaleOfClinics" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="CashReceivedRelatedToSaleOfClinics" xlink:title="definition: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems to CashReceivedRelatedToSaleOfClinics" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NoteReceivableRelatedToSaleOfClinics" xlink:label="NoteReceivableRelatedToSaleOfClinics" xlink:title="NoteReceivableRelatedToSaleOfClinics" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="NoteReceivableRelatedToSaleOfClinics" xlink:title="definition: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems to NoteReceivableRelatedToSaleOfClinics" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration" xlink:label="NumberOfInstallmentsForNoteReceivableInSaleConsideration" xlink:title="NumberOfInstallmentsForNoteReceivableInSaleConsideration" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="NumberOfInstallmentsForNoteReceivableInSaleConsideration" xlink:title="definition: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems to NumberOfInstallmentsForNoteReceivableInSaleConsideration" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="definition: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems to BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfBusinessesMerged" xlink:label="NumberOfBusinessesMerged" xlink:title="NumberOfBusinessesMerged" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="NumberOfBusinessesMerged" xlink:title="definition: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems to NumberOfBusinessesMerged" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PercentageOfCombinedBusinessInterestOwned" xlink:label="PercentageOfCombinedBusinessInterestOwned" xlink:title="PercentageOfCombinedBusinessInterestOwned" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="PercentageOfCombinedBusinessInterestOwned" xlink:title="definition: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems to PercentageOfCombinedBusinessInterestOwned" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfStatesOfNetworkServices" xlink:label="NumberOfStatesOfNetworkServices" xlink:title="NumberOfStatesOfNetworkServices" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="NumberOfStatesOfNetworkServices" xlink:title="definition: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems to NumberOfStatesOfNetworkServices" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfOnsiteClientLocations" xlink:label="NumberOfOnsiteClientLocations" xlink:title="NumberOfOnsiteClientLocations" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="NumberOfOnsiteClientLocations" xlink:title="definition: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems to NumberOfOnsiteClientLocations" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_AveragePhysicalTherapyPatientsVolumesPerDayPerClinic" xlink:label="AveragePhysicalTherapyPatientsVolumesPerDayPerClinic" xlink:title="AveragePhysicalTherapyPatientsVolumesPerDayPerClinic" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="AveragePhysicalTherapyPatientsVolumesPerDayPerClinic" xlink:title="definition: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems to AveragePhysicalTherapyPatientsVolumesPerDayPerClinic" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PercentageOfEmployeesFurloughedOrTerminated" xlink:label="PercentageOfEmployeesFurloughedOrTerminated" xlink:title="PercentageOfEmployeesFurloughedOrTerminated" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="PercentageOfEmployeesFurloughedOrTerminated" xlink:title="definition: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems to PercentageOfEmployeesFurloughedOrTerminated" order="22.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityNumberOfEmployees" xlink:label="EntityNumberOfEmployees" xlink:title="EntityNumberOfEmployees" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="EntityNumberOfEmployees" xlink:title="definition: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems to EntityNumberOfEmployees" order="23.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfFurloughedEmployeesReturned" xlink:label="NumberOfFurloughedEmployeesReturned" xlink:title="NumberOfFurloughedEmployeesReturned" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="NumberOfFurloughedEmployeesReturned" xlink:title="definition: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems to NumberOfFurloughedEmployeesReturned" order="24.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_CashAndCashEquivalentsAndAccruedLiabilities" xlink:label="CashAndCashEquivalentsAndAccruedLiabilities" xlink:title="CashAndCashEquivalentsAndAccruedLiabilities" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="CashAndCashEquivalentsAndAccruedLiabilities" xlink:title="definition: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems to CashAndCashEquivalentsAndAccruedLiabilities" order="25.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_GrantsAndOtherFunds" xlink:label="GrantsAndOtherFunds" xlink:title="GrantsAndOtherFunds" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="GrantsAndOtherFunds" xlink:title="definition: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems to GrantsAndOtherFunds" order="26.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrantsReceivable" xlink:label="GrantsReceivable" xlink:title="GrantsReceivable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="GrantsReceivable" xlink:title="definition: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems to GrantsReceivable" order="27.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ReliefFunds" xlink:label="ReliefFunds" xlink:title="ReliefFunds" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="ReliefFunds" xlink:title="definition: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems to ReliefFunds" order="28.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:label="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:title="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:title="definition: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems to ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" order="29.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="BusinessAcquisitionAxis" xlink:title="definition: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable to BusinessAcquisitionAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain_2" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain_2" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ClinicPracticeMember" xlink:label="ClinicPracticeMember" xlink:title="ClinicPracticeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="ClinicPracticeMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to ClinicPracticeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_LeadingProviderOfIndustrialInjuryPreventionMember" xlink:label="LeadingProviderOfIndustrialInjuryPreventionMember" xlink:title="LeadingProviderOfIndustrialInjuryPreventionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="LeadingProviderOfIndustrialInjuryPreventionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to LeadingProviderOfIndustrialInjuryPreventionMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ManagementContractsMember" xlink:label="ManagementContractsMember" xlink:title="ManagementContractsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="ManagementContractsMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to ManagementContractsMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_AprilTwoThousandNineteenAcquisitionMember" xlink:label="AprilTwoThousandNineteenAcquisitionMember" xlink:title="AprilTwoThousandNineteenAcquisitionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="AprilTwoThousandNineteenAcquisitionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to AprilTwoThousandNineteenAcquisitionMember" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_MarchTwoThousandSeventeenAcquisitionMember" xlink:label="MarchTwoThousandSeventeenAcquisitionMember" xlink:title="MarchTwoThousandSeventeenAcquisitionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="MarchTwoThousandSeventeenAcquisitionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to MarchTwoThousandSeventeenAcquisitionMember" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="RangeAxis" xlink:title="definition: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable to RangeAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis" xlink:label="UnusualOrInfrequentItemAxis" xlink:title="UnusualOrInfrequentItemAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="UnusualOrInfrequentItemAxis" xlink:title="definition: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable to UnusualOrInfrequentItemAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain" xlink:label="UnusualOrInfrequentItemDomain" xlink:title="UnusualOrInfrequentItemDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="UnusualOrInfrequentItemAxis" xlink:to="UnusualOrInfrequentItemDomain" xlink:title="definition: UnusualOrInfrequentItemAxis to UnusualOrInfrequentItemDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain" xlink:label="UnusualOrInfrequentItemDomain_2" xlink:title="UnusualOrInfrequentItemDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="UnusualOrInfrequentItemAxis" xlink:to="UnusualOrInfrequentItemDomain_2" xlink:title="definition: UnusualOrInfrequentItemAxis to UnusualOrInfrequentItemDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_MedicareAcceleratedAndAdvancePaymentsProgramMember" xlink:label="MedicareAcceleratedAndAdvancePaymentsProgramMember" xlink:title="MedicareAcceleratedAndAdvancePaymentsProgramMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="UnusualOrInfrequentItemDomain" xlink:to="MedicareAcceleratedAndAdvancePaymentsProgramMember" xlink:title="definition: UnusualOrInfrequentItemDomain to MedicareAcceleratedAndAdvancePaymentsProgramMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PublicHealthAndSocialServicesEmergencyFundMember" xlink:label="PublicHealthAndSocialServicesEmergencyFundMember" xlink:title="PublicHealthAndSocialServicesEmergencyFundMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="UnusualOrInfrequentItemDomain" xlink:to="PublicHealthAndSocialServicesEmergencyFundMember" xlink:title="definition: UnusualOrInfrequentItemDomain to PublicHealthAndSocialServicesEmergencyFundMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfManagementContracts" xlink:label="NumberOfManagementContracts" xlink:title="NumberOfManagementContracts" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="NumberOfManagementContracts" xlink:title="definition: BusinessAcquisitionLineItems to NumberOfManagementContracts" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_RemainingContractTerm" xlink:label="RemainingContractTerm" xlink:title="RemainingContractTerm" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="RemainingContractTerm" xlink:title="definition: BusinessAcquisitionLineItems to RemainingContractTerm" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfPartnershipInWhichInterestAcquired" xlink:label="NumberOfPartnershipInWhichInterestAcquired" xlink:title="NumberOfPartnershipInWhichInterestAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="NumberOfPartnershipInWhichInterestAcquired" xlink:title="definition: BusinessAcquisitionLineItems to NumberOfPartnershipInWhichInterestAcquired" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:label="BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:title="BusinessAcquisitionDateOfAcquisitionAgreement1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionDateOfAcquisitionAgreement1" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfBusinessesAcquired" xlink:label="NumberOfBusinessesAcquired" xlink:title="NumberOfBusinessesAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="NumberOfBusinessesAcquired" xlink:title="definition: BusinessAcquisitionLineItems to NumberOfBusinessesAcquired" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="BusinessAcquisitionLineItems" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="definition: BusinessAcquisitionLineItems to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="8.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain_2" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain_2" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NovemberTwoThousandTwentyAcquisitionMember" xlink:label="NovemberTwoThousandTwentyAcquisitionMember" xlink:title="NovemberTwoThousandTwentyAcquisitionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="NovemberTwoThousandTwentyAcquisitionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to NovemberTwoThousandTwentyAcquisitionMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_SeptemberTwoThousandTwentyAcquisitionMember" xlink:label="SeptemberTwoThousandTwentyAcquisitionMember" xlink:title="SeptemberTwoThousandTwentyAcquisitionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="SeptemberTwoThousandTwentyAcquisitionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to SeptemberTwoThousandTwentyAcquisitionMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_FebruaryTwoThousandTwentyAcquisitionMember" xlink:label="FebruaryTwoThousandTwentyAcquisitionMember" xlink:title="FebruaryTwoThousandTwentyAcquisitionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="FebruaryTwoThousandTwentyAcquisitionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to FebruaryTwoThousandTwentyAcquisitionMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_SeptemberTwoThousandNineteenAcquisitionMember" xlink:label="SeptemberTwoThousandNineteenAcquisitionMember" xlink:title="SeptemberTwoThousandNineteenAcquisitionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="SeptemberTwoThousandNineteenAcquisitionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to SeptemberTwoThousandNineteenAcquisitionMember" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_August2018AcquisitionMember" xlink:label="August2018AcquisitionMember" xlink:title="August2018AcquisitionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="August2018AcquisitionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to August2018AcquisitionMember" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ManagementContractsMember" xlink:label="ManagementContractsMember" xlink:title="ManagementContractsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="ManagementContractsMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to ManagementContractsMember" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ClinicPracticeMember" xlink:label="ClinicPracticeMember" xlink:title="ClinicPracticeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="ClinicPracticeMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to ClinicPracticeMember" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="RangeAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to RangeAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/SignificantAccountingPoliciesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:label="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:title="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementsAbstract" xlink:label="DeferredCompensationArrangementsAbstract" xlink:title="DeferredCompensationArrangementsAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="DeferredCompensationArrangementsAbstract" xlink:title="definition: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to DeferredCompensationArrangementsAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" xlink:label="DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" xlink:title="DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" xlink:title="definition: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:label="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:title="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:title="definition: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" order="3.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="TitleOfIndividualAxis" xlink:title="TitleOfIndividualAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="TitleOfIndividualAxis" xlink:title="definition: ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable to TitleOfIndividualAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="TitleOfIndividualAxis" xlink:to="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="definition: TitleOfIndividualAxis to TitleOfIndividualWithRelationshipToEntityDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain_2" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="TitleOfIndividualAxis" xlink:to="TitleOfIndividualWithRelationshipToEntityDomain_2" xlink:title="definition: TitleOfIndividualAxis to TitleOfIndividualWithRelationshipToEntityDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_EmployeeMember" xlink:label="EmployeeMember" xlink:title="EmployeeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="EmployeeMember" xlink:title="definition: TitleOfIndividualWithRelationshipToEntityDomain to EmployeeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_DirectorMember" xlink:label="DirectorMember" xlink:title="DirectorMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="DirectorMember" xlink:title="definition: TitleOfIndividualWithRelationshipToEntityDomain to DirectorMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OfficerMember" xlink:label="OfficerMember" xlink:title="OfficerMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="OfficerMember" xlink:title="definition: TitleOfIndividualWithRelationshipToEntityDomain to OfficerMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_DepreciationAmortizationImpairmentLineItems" xlink:label="DepreciationAmortizationImpairmentLineItems" xlink:title="DepreciationAmortizationImpairmentLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="PropertyPlantAndEquipmentAbstract" xlink:title="PropertyPlantAndEquipmentAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="PropertyPlantAndEquipmentAbstract" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to PropertyPlantAndEquipmentAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationGoodwillAbstract" xlink:label="BusinessCombinationGoodwillAbstract" xlink:title="BusinessCombinationGoodwillAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="BusinessCombinationGoodwillAbstract" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to BusinessCombinationGoodwillAbstract" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NonControllingInterestRedeemableAbstract" xlink:label="NonControllingInterestRedeemableAbstract" xlink:title="NonControllingInterestRedeemableAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="NonControllingInterestRedeemableAbstract" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to NonControllingInterestRedeemableAbstract" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_MedicareReimbursementAbstract" xlink:label="MedicareReimbursementAbstract" xlink:title="MedicareReimbursementAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="MedicareReimbursementAbstract" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to MedicareReimbursementAbstract" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="IncomeTaxDisclosureAbstract" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to IncomeTaxDisclosureAbstract" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:label="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:title="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="SubsequentEventsAbstract" xlink:title="SubsequentEventsAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="SubsequentEventsAbstract" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to SubsequentEventsAbstract" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="LineOfCreditFacilityMaximumBorrowingCapacity" xlink:title="LineOfCreditFacilityMaximumBorrowingCapacity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="LineOfCreditFacilityMaximumBorrowingCapacity" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to LineOfCreditFacilityMaximumBorrowingCapacity" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="DebtInstrumentMaturityDate" xlink:title="DebtInstrumentMaturityDate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="DebtInstrumentMaturityDate" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to DebtInstrumentMaturityDate" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="DebtInstrumentFaceAmount" xlink:title="DebtInstrumentFaceAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="DebtInstrumentFaceAmount" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to DebtInstrumentFaceAmount" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="OperatingLeaseRightOfUseAsset" xlink:title="OperatingLeaseRightOfUseAsset" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="OperatingLeaseRightOfUseAsset" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to OperatingLeaseRightOfUseAsset" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability" xlink:title="OperatingLeaseLiability" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="OperatingLeaseLiability" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to OperatingLeaseLiability" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:title="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" xlink:label="InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" xlink:title="InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PercentageOfMedicarePaymentIncrease" xlink:label="PercentageOfMedicarePaymentIncrease" xlink:title="PercentageOfMedicarePaymentIncrease" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="PercentageOfMedicarePaymentIncrease" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to PercentageOfMedicarePaymentIncrease" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_EstimatedPercentageOfDecreaseInPayment" xlink:label="EstimatedPercentageOfDecreaseInPayment" xlink:title="EstimatedPercentageOfDecreaseInPayment" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="EstimatedPercentageOfDecreaseInPayment" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to EstimatedPercentageOfDecreaseInPayment" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PercentageOfBonusPayment" xlink:label="PercentageOfBonusPayment" xlink:title="PercentageOfBonusPayment" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="PercentageOfBonusPayment" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to PercentageOfBonusPayment" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" xlink:label="PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" xlink:title="PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_AmountOfReductionsInFederalSpending" xlink:label="AmountOfReductionsInFederalSpending" xlink:title="AmountOfReductionsInFederalSpending" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="AmountOfReductionsInFederalSpending" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to AmountOfReductionsInFederalSpending" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ReductionInMedicareSpendingPercentage" xlink:label="ReductionInMedicareSpendingPercentage" xlink:title="ReductionInMedicareSpendingPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="ReductionInMedicareSpendingPercentage" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to ReductionInMedicareSpendingPercentage" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ExpectedReductionInMedicareSpendingPercentage" xlink:label="ExpectedReductionInMedicareSpendingPercentage" xlink:title="ExpectedReductionInMedicareSpendingPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="ExpectedReductionInMedicareSpendingPercentage" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to ExpectedReductionInMedicareSpendingPercentage" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices" xlink:label="AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices" xlink:title="AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices" order="22.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_AnnualLimitOccupationalTherapyServices" xlink:label="AnnualLimitOccupationalTherapyServices" xlink:title="AnnualLimitOccupationalTherapyServices" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="AnnualLimitOccupationalTherapyServices" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to AnnualLimitOccupationalTherapyServices" order="23.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:label="CombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:title="CombinedPhysicalTherapySpeechLanguagePathologyExpenses" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="CombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to CombinedPhysicalTherapySpeechLanguagePathologyExpenses" order="24.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:label="ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:title="ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" order="25.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit" xlink:label="PercentageOfPracticeExpenseComponentOfRelativeValueUnit" xlink:title="PercentageOfPracticeExpenseComponentOfRelativeValueUnit" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="PercentageOfPracticeExpenseComponentOfRelativeValueUnit" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to PercentageOfPracticeExpenseComponentOfRelativeValueUnit" order="26.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" xlink:label="PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" xlink:title="PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" order="27.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PercentageOfPaymentForOutpatientTherapyServices" xlink:label="PercentageOfPaymentForOutpatientTherapyServices" xlink:title="PercentageOfPaymentForOutpatientTherapyServices" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="PercentageOfPaymentForOutpatientTherapyServices" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to PercentageOfPaymentForOutpatientTherapyServices" order="28.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NetRevenueFromMedicare" xlink:label="NetRevenueFromMedicare" xlink:title="NetRevenueFromMedicare" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="NetRevenueFromMedicare" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to NetRevenueFromMedicare" order="29.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" xlink:label="DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" xlink:title="DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" order="30.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" xlink:label="DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" xlink:title="DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" order="31.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_MaximumContractualAllowanceReserveEstimate" xlink:label="MaximumContractualAllowanceReserveEstimate" xlink:title="MaximumContractualAllowanceReserveEstimate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="MaximumContractualAllowanceReserveEstimate" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to MaximumContractualAllowanceReserveEstimate" order="32.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:label="RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:title="RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" order="33.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="NumberOfOperatingSegments" xlink:title="NumberOfOperatingSegments" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="NumberOfOperatingSegments" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to NumberOfOperatingSegments" order="34.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfRegions" xlink:label="NumberOfRegions" xlink:title="NumberOfRegions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="NumberOfRegions" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to NumberOfRegions" order="35.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="GoodwillImpairmentLoss" xlink:title="GoodwillImpairmentLoss" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="GoodwillImpairmentLoss" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to GoodwillImpairmentLoss" order="36.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="PropertyPlantAndEquipmentUsefulLife" xlink:title="PropertyPlantAndEquipmentUsefulLife" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="PropertyPlantAndEquipmentUsefulLife" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to PropertyPlantAndEquipmentUsefulLife" order="37.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_DepreciationAmortizationImpairmentTable" xlink:label="DepreciationAmortizationImpairmentTable" xlink:title="DepreciationAmortizationImpairmentTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="DepreciationAmortizationImpairmentTable" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to DepreciationAmortizationImpairmentTable" order="38.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DepreciationAmortizationImpairmentTable" xlink:to="RangeAxis" xlink:title="definition: DepreciationAmortizationImpairmentTable to RangeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="PropertyPlantAndEquipmentByTypeAxis" xlink:title="PropertyPlantAndEquipmentByTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DepreciationAmortizationImpairmentTable" xlink:to="PropertyPlantAndEquipmentByTypeAxis" xlink:title="definition: DepreciationAmortizationImpairmentTable to PropertyPlantAndEquipmentByTypeAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="PropertyPlantAndEquipmentTypeDomain" xlink:title="PropertyPlantAndEquipmentTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="PropertyPlantAndEquipmentByTypeAxis" xlink:to="PropertyPlantAndEquipmentTypeDomain" xlink:title="definition: PropertyPlantAndEquipmentByTypeAxis to PropertyPlantAndEquipmentTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="PropertyPlantAndEquipmentTypeDomain_2" xlink:title="PropertyPlantAndEquipmentTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="PropertyPlantAndEquipmentByTypeAxis" xlink:to="PropertyPlantAndEquipmentTypeDomain_2" xlink:title="definition: PropertyPlantAndEquipmentByTypeAxis to PropertyPlantAndEquipmentTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="FurnitureAndFixturesMember" xlink:title="FurnitureAndFixturesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="FurnitureAndFixturesMember" xlink:title="definition: PropertyPlantAndEquipmentTypeDomain to FurnitureAndFixturesMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:label="ComputerSoftwareIntangibleAssetMember" xlink:title="ComputerSoftwareIntangibleAssetMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="ComputerSoftwareIntangibleAssetMember" xlink:title="definition: PropertyPlantAndEquipmentTypeDomain to ComputerSoftwareIntangibleAssetMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="LeaseholdImprovementsMember" xlink:title="LeaseholdImprovementsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="LeaseholdImprovementsMember" xlink:title="definition: PropertyPlantAndEquipmentTypeDomain to LeaseholdImprovementsMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis" xlink:label="UnusualOrInfrequentItemAxis" xlink:title="UnusualOrInfrequentItemAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DepreciationAmortizationImpairmentTable" xlink:to="UnusualOrInfrequentItemAxis" xlink:title="definition: DepreciationAmortizationImpairmentTable to UnusualOrInfrequentItemAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain" xlink:label="UnusualOrInfrequentItemDomain" xlink:title="UnusualOrInfrequentItemDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="UnusualOrInfrequentItemAxis" xlink:to="UnusualOrInfrequentItemDomain" xlink:title="definition: UnusualOrInfrequentItemAxis to UnusualOrInfrequentItemDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain" xlink:label="UnusualOrInfrequentItemDomain_2" xlink:title="UnusualOrInfrequentItemDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="UnusualOrInfrequentItemAxis" xlink:to="UnusualOrInfrequentItemDomain_2" xlink:title="definition: UnusualOrInfrequentItemAxis to UnusualOrInfrequentItemDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_Year2017Member" xlink:label="Year2017Member" xlink:title="Year2017Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="UnusualOrInfrequentItemDomain" xlink:to="Year2017Member" xlink:title="definition: UnusualOrInfrequentItemDomain to Year2017Member" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_Year2018Member" xlink:label="Year2018Member" xlink:title="Year2018Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="UnusualOrInfrequentItemDomain" xlink:to="Year2018Member" xlink:title="definition: UnusualOrInfrequentItemDomain to Year2018Member" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_Year2019Member" xlink:label="Year2019Member" xlink:title="Year2019Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="UnusualOrInfrequentItemDomain" xlink:to="Year2019Member" xlink:title="definition: UnusualOrInfrequentItemDomain to Year2019Member" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_FromTwoThousandNineteenThroughTwoThousandTwentyFourMember" xlink:label="FromTwoThousandNineteenThroughTwoThousandTwentyFourMember" xlink:title="FromTwoThousandNineteenThroughTwoThousandTwentyFourMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="UnusualOrInfrequentItemDomain" xlink:to="FromTwoThousandNineteenThroughTwoThousandTwentyFourMember" xlink:title="definition: UnusualOrInfrequentItemDomain to FromTwoThousandNineteenThroughTwoThousandTwentyFourMember" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" xlink:label="FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" xlink:title="FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="UnusualOrInfrequentItemDomain" xlink:to="FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" xlink:title="definition: UnusualOrInfrequentItemDomain to FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="AdjustmentsForNewAccountingPronouncementsAxis" xlink:title="AdjustmentsForNewAccountingPronouncementsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DepreciationAmortizationImpairmentTable" xlink:to="AdjustmentsForNewAccountingPronouncementsAxis" xlink:title="definition: DepreciationAmortizationImpairmentTable to AdjustmentsForNewAccountingPronouncementsAxis" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="TypeOfAdoptionMember" xlink:title="TypeOfAdoptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="TypeOfAdoptionMember" xlink:title="definition: AdjustmentsForNewAccountingPronouncementsAxis to TypeOfAdoptionMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="TypeOfAdoptionMember_2" xlink:title="TypeOfAdoptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="TypeOfAdoptionMember_2" xlink:title="definition: AdjustmentsForNewAccountingPronouncementsAxis to TypeOfAdoptionMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="AccountingStandardsUpdate201602Member" xlink:title="AccountingStandardsUpdate201602Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="TypeOfAdoptionMember" xlink:to="AccountingStandardsUpdate201602Member" xlink:title="definition: TypeOfAdoptionMember to AccountingStandardsUpdate201602Member" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis" xlink:label="StatementScenarioAxis" xlink:title="StatementScenarioAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DepreciationAmortizationImpairmentTable" xlink:to="StatementScenarioAxis" xlink:title="definition: DepreciationAmortizationImpairmentTable to StatementScenarioAxis" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="ScenarioUnspecifiedDomain" xlink:title="ScenarioUnspecifiedDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementScenarioAxis" xlink:to="ScenarioUnspecifiedDomain" xlink:title="definition: StatementScenarioAxis to ScenarioUnspecifiedDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="ScenarioUnspecifiedDomain_2" xlink:title="ScenarioUnspecifiedDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementScenarioAxis" xlink:to="ScenarioUnspecifiedDomain_2" xlink:title="definition: StatementScenarioAxis to ScenarioUnspecifiedDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember" xlink:label="ScenarioForecastMember" xlink:title="ScenarioForecastMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ScenarioUnspecifiedDomain" xlink:to="ScenarioForecastMember" xlink:title="definition: ScenarioUnspecifiedDomain to ScenarioForecastMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="DebtInstrumentAxis" xlink:title="DebtInstrumentAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DepreciationAmortizationImpairmentTable" xlink:to="DebtInstrumentAxis" xlink:title="definition: DepreciationAmortizationImpairmentTable to DebtInstrumentAxis" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain" xlink:title="DebtInstrumentNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="DebtInstrumentAxis" xlink:to="DebtInstrumentNameDomain" xlink:title="definition: DebtInstrumentAxis to DebtInstrumentNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain_2" xlink:title="DebtInstrumentNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="DebtInstrumentAxis" xlink:to="DebtInstrumentNameDomain_2" xlink:title="definition: DebtInstrumentAxis to DebtInstrumentNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_CreditAgreementMember" xlink:label="CreditAgreementMember" xlink:title="CreditAgreementMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentNameDomain" xlink:to="CreditAgreementMember" xlink:title="definition: DebtInstrumentNameDomain to CreditAgreementMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DepreciationAmortizationImpairmentTable" xlink:to="SubsequentEventTypeAxis" xlink:title="definition: DepreciationAmortizationImpairmentTable to SubsequentEventTypeAxis" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="SubsequentEventTypeAxis" xlink:to="SubsequentEventTypeDomain" xlink:title="definition: SubsequentEventTypeAxis to SubsequentEventTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain_2" xlink:title="SubsequentEventTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="SubsequentEventTypeAxis" xlink:to="SubsequentEventTypeDomain_2" xlink:title="definition: SubsequentEventTypeAxis to SubsequentEventTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="SubsequentEventMember" xlink:title="SubsequentEventMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventTypeDomain" xlink:to="SubsequentEventMember" xlink:title="definition: SubsequentEventTypeDomain to SubsequentEventMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="DisaggregationOfRevenueLineItems" xlink:title="DisaggregationOfRevenueLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="RevenueFromContractWithCustomerAbstract" xlink:title="RevenueFromContractWithCustomerAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="RevenueFromContractWithCustomerAbstract" xlink:title="definition: DisaggregationOfRevenueLineItems to RevenueFromContractWithCustomerAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:title="RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:title="definition: DisaggregationOfRevenueLineItems to RevenueFromContractWithCustomerExcludingAssessedTax" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="DisaggregationOfRevenueTable" xlink:title="DisaggregationOfRevenueTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="DisaggregationOfRevenueTable" xlink:title="definition: DisaggregationOfRevenueLineItems to DisaggregationOfRevenueTable" order="3.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="ProductOrServiceAxis" xlink:title="ProductOrServiceAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DisaggregationOfRevenueTable" xlink:to="ProductOrServiceAxis" xlink:title="definition: DisaggregationOfRevenueTable to ProductOrServiceAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="ProductsAndServicesDomain" xlink:title="ProductsAndServicesDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ProductOrServiceAxis" xlink:to="ProductsAndServicesDomain" xlink:title="definition: ProductOrServiceAxis to ProductsAndServicesDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="ProductsAndServicesDomain_2" xlink:title="ProductsAndServicesDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ProductOrServiceAxis" xlink:to="ProductsAndServicesDomain_2" xlink:title="definition: ProductOrServiceAxis to ProductsAndServicesDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NetPatientRevenuesMember" xlink:label="NetPatientRevenuesMember" xlink:title="NetPatientRevenuesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ProductsAndServicesDomain" xlink:to="NetPatientRevenuesMember" xlink:title="definition: ProductsAndServicesDomain to NetPatientRevenuesMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ManagementContractRevenuesMember" xlink:label="ManagementContractRevenuesMember" xlink:title="ManagementContractRevenuesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ProductsAndServicesDomain" xlink:to="ManagementContractRevenuesMember" xlink:title="definition: ProductsAndServicesDomain to ManagementContractRevenuesMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_OtherRevenuesMember" xlink:label="OtherRevenuesMember" xlink:title="OtherRevenuesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ProductsAndServicesDomain" xlink:to="OtherRevenuesMember" xlink:title="definition: ProductsAndServicesDomain to OtherRevenuesMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PhysicalTherapyOperationsMember" xlink:label="PhysicalTherapyOperationsMember" xlink:title="PhysicalTherapyOperationsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ProductsAndServicesDomain" xlink:to="PhysicalTherapyOperationsMember" xlink:title="definition: ProductsAndServicesDomain to PhysicalTherapyOperationsMember" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_IndustrialInjuryPreventionServicesRevenuesMember" xlink:label="IndustrialInjuryPreventionServicesRevenuesMember" xlink:title="IndustrialInjuryPreventionServicesRevenuesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ProductsAndServicesDomain" xlink:to="IndustrialInjuryPreventionServicesRevenuesMember" xlink:title="definition: ProductsAndServicesDomain to IndustrialInjuryPreventionServicesRevenuesMember" order="5.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/AcquisitionsOfBusinessesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:label="BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:title="BusinessAcquisitionDateOfAcquisitionAgreement1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionDateOfAcquisitionAgreement1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfBusinessesAcquired" xlink:label="NumberOfBusinessesAcquired" xlink:title="NumberOfBusinessesAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="NumberOfBusinessesAcquired" xlink:title="definition: BusinessAcquisitionLineItems to NumberOfBusinessesAcquired" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfManagementContracts" xlink:label="NumberOfManagementContracts" xlink:title="NumberOfManagementContracts" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="NumberOfManagementContracts" xlink:title="definition: BusinessAcquisitionLineItems to NumberOfManagementContracts" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_RemainingContractTerm" xlink:label="RemainingContractTerm" xlink:title="RemainingContractTerm" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="RemainingContractTerm" xlink:title="definition: BusinessAcquisitionLineItems to RemainingContractTerm" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfPartnershipInWhichInterestAcquired" xlink:label="NumberOfPartnershipInWhichInterestAcquired" xlink:title="NumberOfPartnershipInWhichInterestAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="NumberOfPartnershipInWhichInterestAcquired" xlink:title="definition: BusinessAcquisitionLineItems to NumberOfPartnershipInWhichInterestAcquired" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="BusinessCombinationConsiderationTransferred1" xlink:title="BusinessCombinationConsiderationTransferred1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationConsiderationTransferred1" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationConsiderationTransferred1" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="PaymentsToAcquireBusinessesGross" xlink:title="PaymentsToAcquireBusinessesGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="PaymentsToAcquireBusinessesGross" xlink:title="definition: BusinessAcquisitionLineItems to PaymentsToAcquireBusinessesGross" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" xlink:label="BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" xlink:title="BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:label="DebtInstrumentAnnualPrincipalPayment" xlink:title="DebtInstrumentAnnualPrincipalPayment" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="DebtInstrumentAnnualPrincipalPayment" xlink:title="definition: BusinessAcquisitionLineItems to DebtInstrumentAnnualPrincipalPayment" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="DebtInstrumentInterestRateStatedPercentage" xlink:title="DebtInstrumentInterestRateStatedPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="DebtInstrumentInterestRateStatedPercentage" xlink:title="definition: BusinessAcquisitionLineItems to DebtInstrumentInterestRateStatedPercentage" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="PaymentsToAcquireBusinessesNetOfCashAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="definition: BusinessAcquisitionLineItems to PaymentsToAcquireBusinessesNetOfCashAcquired" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_BusinessAcquisitionPayableToShareholdersOfSeller" xlink:label="BusinessAcquisitionPayableToShareholdersOfSeller" xlink:title="BusinessAcquisitionPayableToShareholdersOfSeller" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionPayableToShareholdersOfSeller" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionPayableToShareholdersOfSeller" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:label="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:title="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionCostOfAcquiredEntityDebtIssued" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PaymentsToAcquireBusinessesConsideration" xlink:label="PaymentsToAcquireBusinessesConsideration" xlink:title="PaymentsToAcquireBusinessesConsideration" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="PaymentsToAcquireBusinessesConsideration" xlink:title="definition: BusinessAcquisitionLineItems to PaymentsToAcquireBusinessesConsideration" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:label="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:title="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:title="definition: BusinessAcquisitionLineItems to EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="CashAcquiredFromAcquisition" xlink:title="CashAcquiredFromAcquisition" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="CashAcquiredFromAcquisition" xlink:title="definition: BusinessAcquisitionLineItems to CashAcquiredFromAcquisition" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfStatesOfNetworkServices" xlink:label="NumberOfStatesOfNetworkServices" xlink:title="NumberOfStatesOfNetworkServices" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="NumberOfStatesOfNetworkServices" xlink:title="definition: BusinessAcquisitionLineItems to NumberOfStatesOfNetworkServices" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfOnsiteClientLocations" xlink:label="NumberOfOnsiteClientLocations" xlink:title="NumberOfOnsiteClientLocations" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="NumberOfOnsiteClientLocations" xlink:title="definition: BusinessAcquisitionLineItems to NumberOfOnsiteClientLocations" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" xlink:label="BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" xlink:title="BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfBusinessesMerged" xlink:label="NumberOfBusinessesMerged" xlink:title="NumberOfBusinessesMerged" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="NumberOfBusinessesMerged" xlink:title="definition: BusinessAcquisitionLineItems to NumberOfBusinessesMerged" order="22.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PercentageOfCombinedBusinessInterestOwned" xlink:label="PercentageOfCombinedBusinessInterestOwned" xlink:title="PercentageOfCombinedBusinessInterestOwned" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="PercentageOfCombinedBusinessInterestOwned" xlink:title="definition: BusinessAcquisitionLineItems to PercentageOfCombinedBusinessInterestOwned" order="23.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" order="24.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" order="25.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" order="26.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:label="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:title="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" order="27.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" order="28.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" order="29.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" order="30.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:label="BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:title="BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" order="31.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:label="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:title="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" order="32.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="BusinessAcquisitionLineItems" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="definition: BusinessAcquisitionLineItems to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="33.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain_2" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain_2" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NovemberTwoThousandTwentyAcquisitionMember" xlink:label="NovemberTwoThousandTwentyAcquisitionMember" xlink:title="NovemberTwoThousandTwentyAcquisitionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="NovemberTwoThousandTwentyAcquisitionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to NovemberTwoThousandTwentyAcquisitionMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_SeptemberTwoThousandTwentyAcquisitionMember" xlink:label="SeptemberTwoThousandTwentyAcquisitionMember" xlink:title="SeptemberTwoThousandTwentyAcquisitionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="SeptemberTwoThousandTwentyAcquisitionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to SeptemberTwoThousandTwentyAcquisitionMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_FebruaryTwoThousandTwentyAcquisitionMember" xlink:label="FebruaryTwoThousandTwentyAcquisitionMember" xlink:title="FebruaryTwoThousandTwentyAcquisitionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="FebruaryTwoThousandTwentyAcquisitionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to FebruaryTwoThousandTwentyAcquisitionMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_SeptemberTwoThousandNineteenAcquisitionMember" xlink:label="SeptemberTwoThousandNineteenAcquisitionMember" xlink:title="SeptemberTwoThousandNineteenAcquisitionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="SeptemberTwoThousandNineteenAcquisitionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to SeptemberTwoThousandNineteenAcquisitionMember" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_August2018AcquisitionMember" xlink:label="August2018AcquisitionMember" xlink:title="August2018AcquisitionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="August2018AcquisitionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to August2018AcquisitionMember" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ManagementAndServicesContractsMember" xlink:label="ManagementAndServicesContractsMember" xlink:title="ManagementAndServicesContractsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="ManagementAndServicesContractsMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to ManagementAndServicesContractsMember" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ManagementContractsMember" xlink:label="ManagementContractsMember" xlink:title="ManagementContractsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="ManagementContractsMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to ManagementContractsMember" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:label="SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:title="SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_AprilTwoThousandNineteenAcquisitionMember" xlink:label="AprilTwoThousandNineteenAcquisitionMember" xlink:title="AprilTwoThousandNineteenAcquisitionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="AprilTwoThousandNineteenAcquisitionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to AprilTwoThousandNineteenAcquisitionMember" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_LeadingProviderOfIndustrialInjuryPreventionMember" xlink:label="LeadingProviderOfIndustrialInjuryPreventionMember" xlink:title="LeadingProviderOfIndustrialInjuryPreventionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="LeadingProviderOfIndustrialInjuryPreventionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to LeadingProviderOfIndustrialInjuryPreventionMember" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ClinicPracticeMember" xlink:label="ClinicPracticeMember" xlink:title="ClinicPracticeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="ClinicPracticeMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to ClinicPracticeMember" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_AcquisitionOfFiveClinicPracticesMember" xlink:label="AcquisitionOfFiveClinicPracticesMember" xlink:title="AcquisitionOfFiveClinicPracticesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="AcquisitionOfFiveClinicPracticesMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to AcquisitionOfFiveClinicPracticesMember" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="ShortTermDebtTypeAxis" xlink:title="ShortTermDebtTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="ShortTermDebtTypeAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to ShortTermDebtTypeAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="ShortTermDebtTypeDomain" xlink:title="ShortTermDebtTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ShortTermDebtTypeAxis" xlink:to="ShortTermDebtTypeDomain" xlink:title="definition: ShortTermDebtTypeAxis to ShortTermDebtTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="ShortTermDebtTypeDomain_2" xlink:title="ShortTermDebtTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ShortTermDebtTypeAxis" xlink:to="ShortTermDebtTypeDomain_2" xlink:title="definition: ShortTermDebtTypeAxis to ShortTermDebtTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NotesPayableOneMember" xlink:label="NotesPayableOneMember" xlink:title="NotesPayableOneMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShortTermDebtTypeDomain" xlink:to="NotesPayableOneMember" xlink:title="definition: ShortTermDebtTypeDomain to NotesPayableOneMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NotesPayableTwoMember" xlink:label="NotesPayableTwoMember" xlink:title="NotesPayableTwoMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShortTermDebtTypeDomain" xlink:to="NotesPayableTwoMember" xlink:title="definition: ShortTermDebtTypeDomain to NotesPayableTwoMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis" xlink:label="StatementScenarioAxis" xlink:title="StatementScenarioAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="StatementScenarioAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to StatementScenarioAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="ScenarioUnspecifiedDomain" xlink:title="ScenarioUnspecifiedDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementScenarioAxis" xlink:to="ScenarioUnspecifiedDomain" xlink:title="definition: StatementScenarioAxis to ScenarioUnspecifiedDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="ScenarioUnspecifiedDomain_2" xlink:title="ScenarioUnspecifiedDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementScenarioAxis" xlink:to="ScenarioUnspecifiedDomain_2" xlink:title="definition: StatementScenarioAxis to ScenarioUnspecifiedDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_SeptemberTwoThousandTwentyMember" xlink:label="SeptemberTwoThousandTwentyMember" xlink:title="SeptemberTwoThousandTwentyMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ScenarioUnspecifiedDomain" xlink:to="SeptemberTwoThousandTwentyMember" xlink:title="definition: ScenarioUnspecifiedDomain to SeptemberTwoThousandTwentyMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_SeptemberTwoThousandTwentyOneMember" xlink:label="SeptemberTwoThousandTwentyOneMember" xlink:title="SeptemberTwoThousandTwentyOneMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ScenarioUnspecifiedDomain" xlink:to="SeptemberTwoThousandTwentyOneMember" xlink:title="definition: ScenarioUnspecifiedDomain to SeptemberTwoThousandTwentyOneMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_AugustTwoThousandNineteenMember" xlink:label="AugustTwoThousandNineteenMember" xlink:title="AugustTwoThousandNineteenMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ScenarioUnspecifiedDomain" xlink:to="AugustTwoThousandNineteenMember" xlink:title="definition: ScenarioUnspecifiedDomain to AugustTwoThousandNineteenMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_AugustTwoThousandTwentyMember" xlink:label="AugustTwoThousandTwentyMember" xlink:title="AugustTwoThousandTwentyMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ScenarioUnspecifiedDomain" xlink:to="AugustTwoThousandTwentyMember" xlink:title="definition: ScenarioUnspecifiedDomain to AugustTwoThousandTwentyMember" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="StatementBusinessSegmentsAxis" xlink:title="StatementBusinessSegmentsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="StatementBusinessSegmentsAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to StatementBusinessSegmentsAxis" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="SegmentDomain" xlink:title="SegmentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementBusinessSegmentsAxis" xlink:to="SegmentDomain" xlink:title="definition: StatementBusinessSegmentsAxis to SegmentDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="SegmentDomain_2" xlink:title="SegmentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementBusinessSegmentsAxis" xlink:to="SegmentDomain_2" xlink:title="definition: StatementBusinessSegmentsAxis to SegmentDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PhysicalTherapyOperationsMember" xlink:label="PhysicalTherapyOperationsMember" xlink:title="PhysicalTherapyOperationsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SegmentDomain" xlink:to="PhysicalTherapyOperationsMember" xlink:title="definition: SegmentDomain to PhysicalTherapyOperationsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to FiniteLivedIntangibleAssetsByMajorClassAxis" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="definition: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain_2" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain_2" xlink:title="definition: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ReferralRelationshipMember" xlink:label="ReferralRelationshipMember" xlink:title="ReferralRelationshipMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="ReferralRelationshipMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to ReferralRelationshipMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="NoncompeteAgreementsMember" xlink:title="NoncompeteAgreementsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="NoncompeteAgreementsMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to NoncompeteAgreementsMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="RangeAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to RangeAxis" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfPartnershipInWhichInterestAcquired" xlink:label="NumberOfPartnershipInWhichInterestAcquired" xlink:title="NumberOfPartnershipInWhichInterestAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="NumberOfPartnershipInWhichInterestAcquired" xlink:title="definition: BusinessAcquisitionLineItems to NumberOfPartnershipInWhichInterestAcquired" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent" xlink:label="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent" xlink:title="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent" xlink:title="definition: BusinessAcquisitionLineItems to ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent" xlink:label="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent" xlink:title="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent" xlink:title="definition: BusinessAcquisitionLineItems to ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfClosedClinicsSold" xlink:label="NumberOfClosedClinicsSold" xlink:title="NumberOfClosedClinicsSold" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="NumberOfClosedClinicsSold" xlink:title="definition: BusinessAcquisitionLineItems to NumberOfClosedClinicsSold" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_AggregateSalePriceOfCinics" xlink:label="AggregateSalePriceOfCinics" xlink:title="AggregateSalePriceOfCinics" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="AggregateSalePriceOfCinics" xlink:title="definition: BusinessAcquisitionLineItems to AggregateSalePriceOfCinics" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_CashReceivedRelatedToSaleOfClinics" xlink:label="CashReceivedRelatedToSaleOfClinics" xlink:title="CashReceivedRelatedToSaleOfClinics" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="CashReceivedRelatedToSaleOfClinics" xlink:title="definition: BusinessAcquisitionLineItems to CashReceivedRelatedToSaleOfClinics" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NoteReceivableRelatedToSaleOfClinics" xlink:label="NoteReceivableRelatedToSaleOfClinics" xlink:title="NoteReceivableRelatedToSaleOfClinics" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="NoteReceivableRelatedToSaleOfClinics" xlink:title="definition: BusinessAcquisitionLineItems to NoteReceivableRelatedToSaleOfClinics" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration" xlink:label="NumberOfInstallmentsForNoteReceivableInSaleConsideration" xlink:title="NumberOfInstallmentsForNoteReceivableInSaleConsideration" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="NumberOfInstallmentsForNoteReceivableInSaleConsideration" xlink:title="definition: BusinessAcquisitionLineItems to NumberOfInstallmentsForNoteReceivableInSaleConsideration" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_SaleOfNoncontrollingInterestPercentageInPartnershipOne" xlink:label="SaleOfNoncontrollingInterestPercentageInPartnershipOne" xlink:title="SaleOfNoncontrollingInterestPercentageInPartnershipOne" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="SaleOfNoncontrollingInterestPercentageInPartnershipOne" xlink:title="definition: BusinessAcquisitionLineItems to SaleOfNoncontrollingInterestPercentageInPartnershipOne" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_TaxEffectOnSaleOfNoncontrollingInterest" xlink:label="TaxEffectOnSaleOfNoncontrollingInterest" xlink:title="TaxEffectOnSaleOfNoncontrollingInterest" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="TaxEffectOnSaleOfNoncontrollingInterest" xlink:title="definition: BusinessAcquisitionLineItems to TaxEffectOnSaleOfNoncontrollingInterest" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="BusinessAcquisitionLineItems" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="definition: BusinessAcquisitionLineItems to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="13.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="RangeAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to RangeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/RedeemableNoncontrollingInterestDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestLineItems" xlink:label="RedeemableNoncontrollingInterestLineItems" xlink:title="RedeemableNoncontrollingInterestLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:label="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:title="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:label="CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:title="CarryingAmountOfRedeemableNonControllingInterestAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to CarryingAmountOfRedeemableNonControllingInterestAbstract" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:label="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:title="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:label="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:title="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:label="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:title="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:label="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:title="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:title="RedeemableNoncontrollingInterestEquityCarryingAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to RedeemableNoncontrollingInterestEquityCarryingAmount" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:label="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:title="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" xlink:label="DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" xlink:title="DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestChangeInRedemptionValue" xlink:label="MinorityInterestChangeInRedemptionValue" xlink:title="MinorityInterestChangeInRedemptionValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="MinorityInterestChangeInRedemptionValue" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to MinorityInterestChangeInRedemptionValue" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsToMinorityShareholders" xlink:label="ProceedsFromPaymentsToMinorityShareholders" xlink:title="ProceedsFromPaymentsToMinorityShareholders" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="ProceedsFromPaymentsToMinorityShareholders" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to ProceedsFromPaymentsToMinorityShareholders" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToMinorityShareholders" xlink:label="PaymentsToMinorityShareholders" xlink:title="PaymentsToMinorityShareholders" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="PaymentsToMinorityShareholders" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to PaymentsToMinorityShareholders" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation" xlink:label="NoncontrollingInterestDecreaseFromDeconsolidation" xlink:title="NoncontrollingInterestDecreaseFromDeconsolidation" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="NoncontrollingInterestDecreaseFromDeconsolidation" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to NoncontrollingInterestDecreaseFromDeconsolidation" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:label="ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:label="NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" xlink:label="DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:label="NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:title="NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable" xlink:label="RedeemableNoncontrollingInterestByLegalEntityTable" xlink:title="RedeemableNoncontrollingInterestByLegalEntityTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="RedeemableNoncontrollingInterestByLegalEntityTable" xlink:title="definition: RedeemableNoncontrollingInterestLineItems to RedeemableNoncontrollingInterestByLegalEntityTable" order="18.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis" xlink:label="OwnershipAxis" xlink:title="OwnershipAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="RedeemableNoncontrollingInterestByLegalEntityTable" xlink:to="OwnershipAxis" xlink:title="definition: RedeemableNoncontrollingInterestByLegalEntityTable to OwnershipAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain" xlink:label="OwnershipDomain" xlink:title="OwnershipDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="OwnershipAxis" xlink:to="OwnershipDomain" xlink:title="definition: OwnershipAxis to OwnershipDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain" xlink:label="OwnershipDomain_2" xlink:title="OwnershipDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="OwnershipAxis" xlink:to="OwnershipDomain_2" xlink:title="definition: OwnershipAxis to OwnershipDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_RedeemableNonControllingInterestMember" xlink:label="RedeemableNonControllingInterestMember" xlink:title="RedeemableNonControllingInterestMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="OwnershipDomain" xlink:to="RedeemableNonControllingInterestMember" xlink:title="definition: OwnershipDomain to RedeemableNonControllingInterestMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" xlink:label="BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" xlink:title="BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" xlink:label="BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" xlink:title="BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" xlink:label="BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" xlink:title="BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_BusinessAcquisitionConsiderationPayableTermOfNote" xlink:label="BusinessAcquisitionConsiderationPayableTermOfNote" xlink:title="BusinessAcquisitionConsiderationPayableTermOfNote" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionConsiderationPayableTermOfNote" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionConsiderationPayableTermOfNote" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_TermOfEmploymentAgreement" xlink:label="TermOfEmploymentAgreement" xlink:title="TermOfEmploymentAgreement" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="TermOfEmploymentAgreement" xlink:title="definition: BusinessAcquisitionLineItems to TermOfEmploymentAgreement" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_EmploymentAgreementRenewalTerm" xlink:label="EmploymentAgreementRenewalTerm" xlink:title="EmploymentAgreementRenewalTerm" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="EmploymentAgreementRenewalTerm" xlink:title="definition: BusinessAcquisitionLineItems to EmploymentAgreementRenewalTerm" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" xlink:label="NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" xlink:title="NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" xlink:title="definition: BusinessAcquisitionLineItems to NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NonCompeteAgreementBasicTerm" xlink:label="NonCompeteAgreementBasicTerm" xlink:title="NonCompeteAgreementBasicTerm" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="NonCompeteAgreementBasicTerm" xlink:title="definition: BusinessAcquisitionLineItems to NonCompeteAgreementBasicTerm" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="BusinessAcquisitionLineItems" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="definition: BusinessAcquisitionLineItems to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="10.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain_2" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain_2" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_TherapyPracticeMember" xlink:label="TherapyPracticeMember" xlink:title="TherapyPracticeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="TherapyPracticeMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to TherapyPracticeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="ConsolidatedEntitiesAxis" xlink:title="ConsolidatedEntitiesAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="ConsolidatedEntitiesAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to ConsolidatedEntitiesAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="ConsolidatedEntitiesDomain" xlink:title="ConsolidatedEntitiesDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ConsolidatedEntitiesAxis" xlink:to="ConsolidatedEntitiesDomain" xlink:title="definition: ConsolidatedEntitiesAxis to ConsolidatedEntitiesDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="ConsolidatedEntitiesDomain_2" xlink:title="ConsolidatedEntitiesDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ConsolidatedEntitiesAxis" xlink:to="ConsolidatedEntitiesDomain_2" xlink:title="definition: ConsolidatedEntitiesAxis to ConsolidatedEntitiesDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SubsidiariesMember" xlink:label="SubsidiariesMember" xlink:title="SubsidiariesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConsolidatedEntitiesDomain" xlink:to="SubsidiariesMember" xlink:title="definition: ConsolidatedEntitiesDomain to SubsidiariesMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="RangeAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to RangeAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/GoodwillDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/IntangibleAssetsNetDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="FiniteLivedIntangibleAssetsLineItems" xlink:title="FiniteLivedIntangibleAssetsLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:label="FiniteLivedIntangibleAssetsNetAbstract" xlink:title="FiniteLivedIntangibleAssetsNetAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsNetAbstract" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsNetAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="IntangibleAssetsNetExcludingGoodwill" xlink:title="IntangibleAssetsNetExcludingGoodwill" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="IntangibleAssetsNetExcludingGoodwill" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to IntangibleAssetsNetExcludingGoodwill" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:title="FiniteLivedIntangibleAssetsAccumulatedAmortization" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAccumulatedAmortization" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="FiniteLivedIntangibleAssetUsefulLife" xlink:title="FiniteLivedIntangibleAssetUsefulLife" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetUsefulLife" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetUsefulLife" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="ScheduleOfFiniteLivedIntangibleAssetsTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to ScheduleOfFiniteLivedIntangibleAssetsTable" order="5.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="definition: ScheduleOfFiniteLivedIntangibleAssetsTable to FiniteLivedIntangibleAssetsByMajorClassAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="definition: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain_2" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain_2" xlink:title="definition: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksMember" xlink:label="TrademarksMember" xlink:title="TrademarksMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="TrademarksMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to TrademarksMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ReferralRelationshipMember" xlink:label="ReferralRelationshipMember" xlink:title="ReferralRelationshipMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="ReferralRelationshipMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to ReferralRelationshipMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="NoncompeteAgreementsMember" xlink:title="NoncompeteAgreementsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="NoncompeteAgreementsMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to NoncompeteAgreementsMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="RangeAxis" xlink:title="definition: ScheduleOfFiniteLivedIntangibleAssetsTable to RangeAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="FiniteLivedIntangibleAssetsLineItems" xlink:title="FiniteLivedIntangibleAssetsLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfDeferredChargesAbstract" xlink:label="AmortizationOfDeferredChargesAbstract" xlink:title="AmortizationOfDeferredChargesAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="AmortizationOfDeferredChargesAbstract" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to AmortizationOfDeferredChargesAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="AmortizationOfIntangibleAssets" xlink:title="AmortizationOfIntangibleAssets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="AmortizationOfIntangibleAssets" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to AmortizationOfIntangibleAssets" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfAcquiredOperations" xlink:label="NumberOfAcquiredOperations" xlink:title="NumberOfAcquiredOperations" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="NumberOfAcquiredOperations" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to NumberOfAcquiredOperations" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="FiniteLivedIntangibleAssetUsefulLife" xlink:title="FiniteLivedIntangibleAssetUsefulLife" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetUsefulLife" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetUsefulLife" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="ScheduleOfFiniteLivedIntangibleAssetsTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to ScheduleOfFiniteLivedIntangibleAssetsTable" order="5.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="definition: ScheduleOfFiniteLivedIntangibleAssetsTable to FiniteLivedIntangibleAssetsByMajorClassAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="definition: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain_2" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain_2" xlink:title="definition: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ReferralRelationshipMember" xlink:label="ReferralRelationshipMember" xlink:title="ReferralRelationshipMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="ReferralRelationshipMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to ReferralRelationshipMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="NoncompeteAgreementsMember" xlink:title="NoncompeteAgreementsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="NoncompeteAgreementsMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to NoncompeteAgreementsMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksMember" xlink:label="TrademarksMember" xlink:title="TrademarksMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="TrademarksMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to TrademarksMember" order="3.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="FiniteLivedIntangibleAssetsLineItems" xlink:title="FiniteLivedIntangibleAssetsLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:label="FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:title="FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="ScheduleOfFiniteLivedIntangibleAssetsTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to ScheduleOfFiniteLivedIntangibleAssetsTable" order="8.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="definition: ScheduleOfFiniteLivedIntangibleAssetsTable to FiniteLivedIntangibleAssetsByMajorClassAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="definition: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain_2" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain_2" xlink:title="definition: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ReferralRelationshipMember" xlink:label="ReferralRelationshipMember" xlink:title="ReferralRelationshipMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="ReferralRelationshipMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to ReferralRelationshipMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="NoncompeteAgreementsMember" xlink:title="NoncompeteAgreementsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="NoncompeteAgreementsMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to NoncompeteAgreementsMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/AccruedExpensesDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="DebtInstrumentLineItems" xlink:title="DebtInstrumentLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentsAbstract" xlink:label="DebtInstrumentsAbstract" xlink:title="DebtInstrumentsAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentsAbstract" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentsAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt" xlink:label="LongTermDebt" xlink:title="LongTermDebt" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LongTermDebt" xlink:title="definition: DebtInstrumentLineItems to LongTermDebt" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="LongTermDebtCurrent" xlink:title="LongTermDebtCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LongTermDebtCurrent" xlink:title="definition: DebtInstrumentLineItems to LongTermDebtCurrent" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="LongTermDebtNoncurrent" xlink:title="LongTermDebtNoncurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LongTermDebtNoncurrent" xlink:title="definition: DebtInstrumentLineItems to LongTermDebtNoncurrent" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:label="LineOfCreditFacilityInterestRateDuringPeriod" xlink:title="LineOfCreditFacilityInterestRateDuringPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LineOfCreditFacilityInterestRateDuringPeriod" xlink:title="definition: DebtInstrumentLineItems to LineOfCreditFacilityInterestRateDuringPeriod" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:label="DebtInstrumentAnnualPrincipalPayment" xlink:title="DebtInstrumentAnnualPrincipalPayment" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentAnnualPrincipalPayment" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentAnnualPrincipalPayment" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="DebtInstrumentInterestRateStatedPercentage" xlink:title="DebtInstrumentInterestRateStatedPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentInterestRateStatedPercentage" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentInterestRateStatedPercentage" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="DebtInstrumentTable" xlink:title="DebtInstrumentTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentTable" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentTable" order="8.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="DebtInstrumentAxis" xlink:title="DebtInstrumentAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DebtInstrumentTable" xlink:to="DebtInstrumentAxis" xlink:title="definition: DebtInstrumentTable to DebtInstrumentAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain" xlink:title="DebtInstrumentNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="DebtInstrumentAxis" xlink:to="DebtInstrumentNameDomain" xlink:title="definition: DebtInstrumentAxis to DebtInstrumentNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain_2" xlink:title="DebtInstrumentNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="DebtInstrumentAxis" xlink:to="DebtInstrumentNameDomain_2" xlink:title="definition: DebtInstrumentAxis to DebtInstrumentNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PromissoryNotesMember" xlink:label="PromissoryNotesMember" xlink:title="PromissoryNotesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentNameDomain" xlink:to="PromissoryNotesMember" xlink:title="definition: DebtInstrumentNameDomain to PromissoryNotesMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="CreditFacilityAxis" xlink:title="CreditFacilityAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DebtInstrumentTable" xlink:to="CreditFacilityAxis" xlink:title="definition: DebtInstrumentTable to CreditFacilityAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="CreditFacilityDomain" xlink:title="CreditFacilityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="CreditFacilityAxis" xlink:to="CreditFacilityDomain" xlink:title="definition: CreditFacilityAxis to CreditFacilityDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="CreditFacilityDomain_2" xlink:title="CreditFacilityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="CreditFacilityAxis" xlink:to="CreditFacilityDomain_2" xlink:title="definition: CreditFacilityAxis to CreditFacilityDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="RevolvingCreditFacilityMember" xlink:title="RevolvingCreditFacilityMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="CreditFacilityDomain" xlink:to="RevolvingCreditFacilityMember" xlink:title="definition: CreditFacilityDomain to RevolvingCreditFacilityMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DebtInstrumentTable" xlink:to="RangeAxis" xlink:title="definition: DebtInstrumentTable to RangeAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/NotesPayableDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="DebtInstrumentLineItems" xlink:title="DebtInstrumentLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentsAbstract" xlink:label="DebtInstrumentsAbstract" xlink:title="DebtInstrumentsAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentsAbstract" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentsAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="LineOfCreditFacilityMaximumBorrowingCapacity" xlink:title="LineOfCreditFacilityMaximumBorrowingCapacity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LineOfCreditFacilityMaximumBorrowingCapacity" xlink:title="definition: DebtInstrumentLineItems to LineOfCreditFacilityMaximumBorrowingCapacity" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="DebtInstrumentMaturityDate" xlink:title="DebtInstrumentMaturityDate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentMaturityDate" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentMaturityDate" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_DebtInstrumentBasisSpreadOnLiborVariableRate" xlink:label="DebtInstrumentBasisSpreadOnLiborVariableRate" xlink:title="DebtInstrumentBasisSpreadOnLiborVariableRate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentBasisSpreadOnLiborVariableRate" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentBasisSpreadOnLiborVariableRate" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="DebtInstrumentBasisSpreadOnVariableRate1" xlink:title="DebtInstrumentBasisSpreadOnVariableRate1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentBasisSpreadOnVariableRate1" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentBasisSpreadOnVariableRate1" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:label="LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:title="LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:title="definition: DebtInstrumentLineItems to LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" xlink:label="CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" xlink:title="CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" xlink:title="definition: DebtInstrumentLineItems to CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_DividendsCashAfterAmendment" xlink:label="DividendsCashAfterAmendment" xlink:title="DividendsCashAfterAmendment" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="DividendsCashAfterAmendment" xlink:title="definition: DebtInstrumentLineItems to DividendsCashAfterAmendment" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:label="LineOfCreditFacilityRemainingBorrowingCapacity" xlink:title="LineOfCreditFacilityRemainingBorrowingCapacity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LineOfCreditFacilityRemainingBorrowingCapacity" xlink:title="definition: DebtInstrumentLineItems to LineOfCreditFacilityRemainingBorrowingCapacity" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="DebtInstrumentFaceAmount" xlink:title="DebtInstrumentFaceAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentFaceAmount" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentFaceAmount" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:label="LineOfCreditFacilityInterestRateDuringPeriod" xlink:title="LineOfCreditFacilityInterestRateDuringPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LineOfCreditFacilityInterestRateDuringPeriod" xlink:title="definition: DebtInstrumentLineItems to LineOfCreditFacilityInterestRateDuringPeriod" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="definition: DebtInstrumentLineItems to LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="definition: DebtInstrumentLineItems to LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="DebtInstrumentTable" xlink:title="DebtInstrumentTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentTable" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentTable" order="14.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="DebtInstrumentAxis" xlink:title="DebtInstrumentAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DebtInstrumentTable" xlink:to="DebtInstrumentAxis" xlink:title="definition: DebtInstrumentTable to DebtInstrumentAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain" xlink:title="DebtInstrumentNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="DebtInstrumentAxis" xlink:to="DebtInstrumentNameDomain" xlink:title="definition: DebtInstrumentAxis to DebtInstrumentNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain_2" xlink:title="DebtInstrumentNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="DebtInstrumentAxis" xlink:to="DebtInstrumentNameDomain_2" xlink:title="definition: DebtInstrumentAxis to DebtInstrumentNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_CreditAgreementMember" xlink:label="CreditAgreementMember" xlink:title="CreditAgreementMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentNameDomain" xlink:to="CreditAgreementMember" xlink:title="definition: DebtInstrumentNameDomain to CreditAgreementMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="CreditFacilityAxis" xlink:title="CreditFacilityAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DebtInstrumentTable" xlink:to="CreditFacilityAxis" xlink:title="definition: DebtInstrumentTable to CreditFacilityAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="CreditFacilityDomain" xlink:title="CreditFacilityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="CreditFacilityAxis" xlink:to="CreditFacilityDomain" xlink:title="definition: CreditFacilityAxis to CreditFacilityDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="CreditFacilityDomain_2" xlink:title="CreditFacilityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="CreditFacilityAxis" xlink:to="CreditFacilityDomain_2" xlink:title="definition: CreditFacilityAxis to CreditFacilityDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="RevolvingCreditFacilityMember" xlink:title="RevolvingCreditFacilityMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="CreditFacilityDomain" xlink:to="RevolvingCreditFacilityMember" xlink:title="definition: CreditFacilityDomain to RevolvingCreditFacilityMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DebtInstrumentTable" xlink:to="RangeAxis" xlink:title="definition: DebtInstrumentTable to RangeAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="ShortTermDebtTypeAxis" xlink:title="ShortTermDebtTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DebtInstrumentTable" xlink:to="ShortTermDebtTypeAxis" xlink:title="definition: DebtInstrumentTable to ShortTermDebtTypeAxis" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="ShortTermDebtTypeDomain" xlink:title="ShortTermDebtTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ShortTermDebtTypeAxis" xlink:to="ShortTermDebtTypeDomain" xlink:title="definition: ShortTermDebtTypeAxis to ShortTermDebtTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="ShortTermDebtTypeDomain_2" xlink:title="ShortTermDebtTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ShortTermDebtTypeAxis" xlink:to="ShortTermDebtTypeDomain_2" xlink:title="definition: ShortTermDebtTypeAxis to ShortTermDebtTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NotesPayableMember" xlink:label="NotesPayableMember" xlink:title="NotesPayableMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShortTermDebtTypeDomain" xlink:to="NotesPayableMember" xlink:title="definition: ShortTermDebtTypeDomain to NotesPayableMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/LeasesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="LesseeLeaseDescriptionLineItems" xlink:title="LesseeLeaseDescriptionLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseDescriptionAbstract" xlink:label="LesseeOperatingLeaseDescriptionAbstract" xlink:title="LesseeOperatingLeaseDescriptionAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeOperatingLeaseDescriptionAbstract" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeOperatingLeaseDescriptionAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostAbstract" xlink:label="LeaseCostAbstract" xlink:title="LeaseCostAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LeaseCostAbstract" xlink:title="definition: LesseeLeaseDescriptionLineItems to LeaseCostAbstract" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_SupplementalInformationRelatedToOperatingLeasesAbstract" xlink:label="SupplementalInformationRelatedToOperatingLeasesAbstract" xlink:title="SupplementalInformationRelatedToOperatingLeasesAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="SupplementalInformationRelatedToOperatingLeasesAbstract" xlink:title="definition: LesseeLeaseDescriptionLineItems to SupplementalInformationRelatedToOperatingLeasesAbstract" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:title="OperatingLeaseLiabilitiesPaymentsDueAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:title="definition: LesseeLeaseDescriptionLineItems to OperatingLeaseLiabilitiesPaymentsDueAbstract" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_AverageLeaseTermsAndDiscountRatesAbstract" xlink:label="AverageLeaseTermsAndDiscountRatesAbstract" xlink:title="AverageLeaseTermsAndDiscountRatesAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="AverageLeaseTermsAndDiscountRatesAbstract" xlink:title="definition: LesseeLeaseDescriptionLineItems to AverageLeaseTermsAndDiscountRatesAbstract" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:title="OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:title="definition: LesseeLeaseDescriptionLineItems to OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="OperatingLeaseWeightedAverageDiscountRatePercent" xlink:title="OperatingLeaseWeightedAverageDiscountRatePercent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="OperatingLeaseWeightedAverageDiscountRatePercent" xlink:title="definition: LesseeLeaseDescriptionLineItems to OperatingLeaseWeightedAverageDiscountRatePercent" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeOperatingLeaseLiabilityPaymentsDue" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability" xlink:title="OperatingLeaseLiability" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="OperatingLeaseLiability" xlink:title="definition: LesseeLeaseDescriptionLineItems to OperatingLeaseLiability" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="OperatingLeasePayments" xlink:title="OperatingLeasePayments" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="OperatingLeasePayments" xlink:title="definition: LesseeLeaseDescriptionLineItems to OperatingLeasePayments" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:title="RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:title="definition: LesseeLeaseDescriptionLineItems to RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="OperatingLeaseCost" xlink:title="OperatingLeaseCost" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="OperatingLeaseCost" xlink:title="definition: LesseeLeaseDescriptionLineItems to OperatingLeaseCost" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermLeaseCost" xlink:label="ShortTermLeaseCost" xlink:title="ShortTermLeaseCost" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="ShortTermLeaseCost" xlink:title="definition: LesseeLeaseDescriptionLineItems to ShortTermLeaseCost" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost" xlink:label="VariableLeaseCost" xlink:title="VariableLeaseCost" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="VariableLeaseCost" xlink:title="definition: LesseeLeaseDescriptionLineItems to VariableLeaseCost" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost" xlink:label="LeaseCost" xlink:title="LeaseCost" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LeaseCost" xlink:title="definition: LesseeLeaseDescriptionLineItems to LeaseCost" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="LesseeOperatingLeaseTermOfContract" xlink:title="LesseeOperatingLeaseTermOfContract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeOperatingLeaseTermOfContract" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeOperatingLeaseTermOfContract" order="22.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="LesseeLeaseDescriptionTable" xlink:title="LesseeLeaseDescriptionTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeLeaseDescriptionTable" xlink:title="definition: LesseeLeaseDescriptionLineItems to LesseeLeaseDescriptionTable" order="23.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="LesseeLeaseDescriptionTable" xlink:to="RangeAxis" xlink:title="definition: LesseeLeaseDescriptionTable to RangeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="AdjustmentsForNewAccountingPronouncementsAxis" xlink:title="AdjustmentsForNewAccountingPronouncementsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="LesseeLeaseDescriptionTable" xlink:to="AdjustmentsForNewAccountingPronouncementsAxis" xlink:title="definition: LesseeLeaseDescriptionTable to AdjustmentsForNewAccountingPronouncementsAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="TypeOfAdoptionMember" xlink:title="TypeOfAdoptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="TypeOfAdoptionMember" xlink:title="definition: AdjustmentsForNewAccountingPronouncementsAxis to TypeOfAdoptionMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="TypeOfAdoptionMember_2" xlink:title="TypeOfAdoptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="TypeOfAdoptionMember_2" xlink:title="definition: AdjustmentsForNewAccountingPronouncementsAxis to TypeOfAdoptionMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="AccountingStandardsUpdate201602Member" xlink:title="AccountingStandardsUpdate201602Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="TypeOfAdoptionMember" xlink:to="AccountingStandardsUpdate201602Member" xlink:title="definition: TypeOfAdoptionMember to AccountingStandardsUpdate201602Member" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/LeasesDetailsCalc01" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/IncomeTaxesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationLineItems" xlink:label="IncomeTaxExaminationLineItems" xlink:title="IncomeTaxExaminationLineItems" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_IncomeTaxExaminationAbstract" xlink:label="IncomeTaxExaminationAbstract" xlink:title="IncomeTaxExaminationAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeTaxExaminationLineItems" xlink:to="IncomeTaxExaminationAbstract" xlink:title="definition: IncomeTaxExaminationLineItems to IncomeTaxExaminationAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests" xlink:label="DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests" xlink:title="DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeTaxExaminationLineItems" xlink:to="DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests" xlink:title="definition: IncomeTaxExaminationLineItems to DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:label="IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:title="IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeTaxExaminationLineItems" xlink:to="IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:title="definition: IncomeTaxExaminationLineItems to IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="AccruedIncomeTaxesCurrent" xlink:title="AccruedIncomeTaxesCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeTaxExaminationLineItems" xlink:to="AccruedIncomeTaxesCurrent" xlink:title="definition: IncomeTaxExaminationLineItems to AccruedIncomeTaxesCurrent" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxesAndOtherTaxReceivableCurrent" xlink:label="DeferredIncomeTaxesAndOtherTaxReceivableCurrent" xlink:title="DeferredIncomeTaxesAndOtherTaxReceivableCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeTaxExaminationLineItems" xlink:to="DeferredIncomeTaxesAndOtherTaxReceivableCurrent" xlink:title="definition: IncomeTaxExaminationLineItems to DeferredIncomeTaxesAndOtherTaxReceivableCurrent" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:title="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeTaxExaminationLineItems" xlink:to="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:title="definition: IncomeTaxExaminationLineItems to UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" xlink:label="UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" xlink:title="UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeTaxExaminationLineItems" xlink:to="UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" xlink:title="definition: IncomeTaxExaminationLineItems to UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationYearUnderExamination" xlink:label="IncomeTaxExaminationYearUnderExamination" xlink:title="IncomeTaxExaminationYearUnderExamination" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeTaxExaminationLineItems" xlink:to="IncomeTaxExaminationYearUnderExamination" xlink:title="definition: IncomeTaxExaminationLineItems to IncomeTaxExaminationYearUnderExamination" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationTable" xlink:label="IncomeTaxExaminationTable" xlink:title="IncomeTaxExaminationTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="IncomeTaxExaminationLineItems" xlink:to="IncomeTaxExaminationTable" xlink:title="definition: IncomeTaxExaminationLineItems to IncomeTaxExaminationTable" order="9.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="IncomeTaxAuthorityAxis" xlink:title="IncomeTaxAuthorityAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="IncomeTaxExaminationTable" xlink:to="IncomeTaxAuthorityAxis" xlink:title="definition: IncomeTaxExaminationTable to IncomeTaxAuthorityAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="IncomeTaxAuthorityDomain" xlink:title="IncomeTaxAuthorityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="IncomeTaxAuthorityAxis" xlink:to="IncomeTaxAuthorityDomain" xlink:title="definition: IncomeTaxAuthorityAxis to IncomeTaxAuthorityDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="IncomeTaxAuthorityDomain_2" xlink:title="IncomeTaxAuthorityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="IncomeTaxAuthorityAxis" xlink:to="IncomeTaxAuthorityDomain_2" xlink:title="definition: IncomeTaxAuthorityAxis to IncomeTaxAuthorityDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="ForeignCountryMember" xlink:title="ForeignCountryMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeTaxAuthorityDomain" xlink:to="ForeignCountryMember" xlink:title="definition: IncomeTaxAuthorityDomain to ForeignCountryMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="StateAndLocalJurisdictionMember" xlink:title="StateAndLocalJurisdictionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeTaxAuthorityDomain" xlink:to="StateAndLocalJurisdictionMember" xlink:title="definition: IncomeTaxAuthorityDomain to StateAndLocalJurisdictionMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="IncomeTaxExaminationTable" xlink:to="RangeAxis" xlink:title="definition: IncomeTaxExaminationTable to RangeAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/SegmentInformationDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="SegmentReportingInformationLineItems" xlink:title="SegmentReportingInformationLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:label="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:title="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SegmentReportingInformationLineItems" xlink:to="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:title="definition: SegmentReportingInformationLineItems to SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="Revenues" xlink:title="Revenues" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SegmentReportingInformationLineItems" xlink:to="Revenues" xlink:title="definition: SegmentReportingInformationLineItems to Revenues" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit" xlink:label="GrossProfit" xlink:title="GrossProfit" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SegmentReportingInformationLineItems" xlink:to="GrossProfit" xlink:title="definition: SegmentReportingInformationLineItems to GrossProfit" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="RestructuringCharges" xlink:title="RestructuringCharges" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SegmentReportingInformationLineItems" xlink:to="RestructuringCharges" xlink:title="definition: SegmentReportingInformationLineItems to RestructuringCharges" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="Assets" xlink:title="Assets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SegmentReportingInformationLineItems" xlink:to="Assets" xlink:title="definition: SegmentReportingInformationLineItems to Assets" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="ScheduleOfSegmentReportingInformationBySegmentTable" xlink:title="ScheduleOfSegmentReportingInformationBySegmentTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="SegmentReportingInformationLineItems" xlink:to="ScheduleOfSegmentReportingInformationBySegmentTable" xlink:title="definition: SegmentReportingInformationLineItems to ScheduleOfSegmentReportingInformationBySegmentTable" order="6.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis" xlink:label="ConsolidationItemsAxis" xlink:title="ConsolidationItemsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="ConsolidationItemsAxis" xlink:title="definition: ScheduleOfSegmentReportingInformationBySegmentTable to ConsolidationItemsAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="ConsolidationItemsDomain" xlink:title="ConsolidationItemsDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ConsolidationItemsAxis" xlink:to="ConsolidationItemsDomain" xlink:title="definition: ConsolidationItemsAxis to ConsolidationItemsDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="ConsolidationItemsDomain_2" xlink:title="ConsolidationItemsDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ConsolidationItemsAxis" xlink:to="ConsolidationItemsDomain_2" xlink:title="definition: ConsolidationItemsAxis to ConsolidationItemsDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="OperatingSegmentsMember" xlink:title="OperatingSegmentsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ConsolidationItemsDomain" xlink:to="OperatingSegmentsMember" xlink:title="definition: ConsolidationItemsDomain to OperatingSegmentsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="StatementBusinessSegmentsAxis" xlink:title="StatementBusinessSegmentsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="StatementBusinessSegmentsAxis" xlink:title="definition: ScheduleOfSegmentReportingInformationBySegmentTable to StatementBusinessSegmentsAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="SegmentDomain" xlink:title="SegmentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementBusinessSegmentsAxis" xlink:to="SegmentDomain" xlink:title="definition: StatementBusinessSegmentsAxis to SegmentDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="SegmentDomain_2" xlink:title="SegmentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementBusinessSegmentsAxis" xlink:to="SegmentDomain_2" xlink:title="definition: StatementBusinessSegmentsAxis to SegmentDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PhysicalTherapyOperationsMember" xlink:label="PhysicalTherapyOperationsMember" xlink:title="PhysicalTherapyOperationsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SegmentDomain" xlink:to="PhysicalTherapyOperationsMember" xlink:title="definition: SegmentDomain to PhysicalTherapyOperationsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_IndustrialInjuryPreventionServicesRevenuesMember" xlink:label="IndustrialInjuryPreventionServicesRevenuesMember" xlink:title="IndustrialInjuryPreventionServicesRevenuesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SegmentDomain" xlink:to="IndustrialInjuryPreventionServicesRevenuesMember" xlink:title="definition: SegmentDomain to IndustrialInjuryPreventionServicesRevenuesMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PhysicalTherapyOperationsExcludingClosureCostsMember" xlink:label="PhysicalTherapyOperationsExcludingClosureCostsMember" xlink:title="PhysicalTherapyOperationsExcludingClosureCostsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SegmentDomain" xlink:to="PhysicalTherapyOperationsExcludingClosureCostsMember" xlink:title="definition: SegmentDomain to PhysicalTherapyOperationsExcludingClosureCostsMember" order="3.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/EquityBasedPlansAmendedAndRestatedEmployeeStockOptionPlansDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAbstract" xlink:label="ShareBasedCompensationAbstract" xlink:title="ShareBasedCompensationAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="4.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="RangeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to RangeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="PlanNameAxis" xlink:title="PlanNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="PlanNameAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to PlanNameAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="PlanNameDomain" xlink:title="PlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="PlanNameAxis" xlink:to="PlanNameDomain" xlink:title="definition: PlanNameAxis to PlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="PlanNameDomain_2" xlink:title="PlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="PlanNameAxis" xlink:to="PlanNameDomain_2" xlink:title="definition: PlanNameAxis to PlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_AmendedTwoThousandThreePlanMember" xlink:label="AmendedTwoThousandThreePlanMember" xlink:title="AmendedTwoThousandThreePlanMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PlanNameDomain" xlink:to="AmendedTwoThousandThreePlanMember" xlink:title="definition: PlanNameDomain to AmendedTwoThousandThreePlanMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NonQualifiedStockOptionsMember" xlink:label="NonQualifiedStockOptionsMember" xlink:title="NonQualifiedStockOptionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="NonQualifiedStockOptionsMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to NonQualifiedStockOptionsMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/EquityBasedPlansCumulativeSummaryOfEquityPlansDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAbstract" xlink:label="ShareBasedCompensationAbstract" xlink:title="ShareBasedCompensationAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="8.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="PlanNameAxis" xlink:title="PlanNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="PlanNameAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to PlanNameAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="PlanNameDomain" xlink:title="PlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="PlanNameAxis" xlink:to="PlanNameDomain" xlink:title="definition: PlanNameAxis to PlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="PlanNameDomain_2" xlink:title="PlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="PlanNameAxis" xlink:to="PlanNameDomain_2" xlink:title="definition: PlanNameAxis to PlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_AmendedNineteenNinetyNinePlanMember" xlink:label="AmendedNineteenNinetyNinePlanMember" xlink:title="AmendedNineteenNinetyNinePlanMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PlanNameDomain" xlink:to="AmendedNineteenNinetyNinePlanMember" xlink:title="definition: PlanNameDomain to AmendedNineteenNinetyNinePlanMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_AmendedTwoThousandThreePlanMember" xlink:label="AmendedTwoThousandThreePlanMember" xlink:title="AmendedTwoThousandThreePlanMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PlanNameDomain" xlink:to="AmendedTwoThousandThreePlanMember" xlink:title="definition: PlanNameDomain to AmendedTwoThousandThreePlanMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/EquityBasedPlansRestrictedStockGrantedToDirectorsOfficersAndEmployeesPursuantToItsEquityPlansDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAbstract" xlink:label="ShareBasedCompensationAbstract" xlink:title="ShareBasedCompensationAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="4.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="RestrictedStockMember" xlink:title="RestrictedStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/EquityBasedPlansRestrictedStockCancelledDueToEmployeeTerminationsPriorToRestrictionsLapsingDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAbstract" xlink:label="ShareBasedCompensationAbstract" xlink:title="ShareBasedCompensationAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="4.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="RestrictedStockMember" xlink:title="RestrictedStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/EquityBasedPlansDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAbstract" xlink:label="ShareBasedCompensationAbstract" xlink:title="ShareBasedCompensationAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_RestrictedPeriodToEmployeesOnTheStockGranted" xlink:label="RestrictedPeriodToEmployeesOnTheStockGranted" xlink:title="RestrictedPeriodToEmployeesOnTheStockGranted" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="RestrictedPeriodToEmployeesOnTheStockGranted" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to RestrictedPeriodToEmployeesOnTheStockGranted" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="AllocatedShareBasedCompensationExpense" xlink:title="AllocatedShareBasedCompensationExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="AllocatedShareBasedCompensationExpense" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to AllocatedShareBasedCompensationExpense" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="7.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="RangeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to RangeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="TitleOfIndividualAxis" xlink:title="TitleOfIndividualAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="TitleOfIndividualAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to TitleOfIndividualAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="TitleOfIndividualAxis" xlink:to="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="definition: TitleOfIndividualAxis to TitleOfIndividualWithRelationshipToEntityDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain_2" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="TitleOfIndividualAxis" xlink:to="TitleOfIndividualWithRelationshipToEntityDomain_2" xlink:title="definition: TitleOfIndividualAxis to TitleOfIndividualWithRelationshipToEntityDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_EmployeesMember" xlink:label="EmployeesMember" xlink:title="EmployeesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="EmployeesMember" xlink:title="definition: TitleOfIndividualWithRelationshipToEntityDomain to EmployeesMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ExecutiveOfficerMember" xlink:label="ExecutiveOfficerMember" xlink:title="ExecutiveOfficerMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="ExecutiveOfficerMember" xlink:title="definition: TitleOfIndividualWithRelationshipToEntityDomain to ExecutiveOfficerMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="RestrictedStockMember" xlink:title="RestrictedStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/CommonStockDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems" xlink:label="EquityClassOfTreasuryStockLineItems" xlink:title="EquityClassOfTreasuryStockLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDisclosuresAbstract" xlink:label="ClassOfStockDisclosuresAbstract" xlink:title="ClassOfStockDisclosuresAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityClassOfTreasuryStockLineItems" xlink:to="ClassOfStockDisclosuresAbstract" xlink:title="definition: EquityClassOfTreasuryStockLineItems to ClassOfStockDisclosuresAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:label="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityClassOfTreasuryStockLineItems" xlink:to="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="definition: EquityClassOfTreasuryStockLineItems to StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PercentageOfRepurchaseOfCommonStock" xlink:label="PercentageOfRepurchaseOfCommonStock" xlink:title="PercentageOfRepurchaseOfCommonStock" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityClassOfTreasuryStockLineItems" xlink:to="PercentageOfRepurchaseOfCommonStock" xlink:title="definition: EquityClassOfTreasuryStockLineItems to PercentageOfRepurchaseOfCommonStock" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock" xlink:label="BankCreditAgreementToPermitShareRepurchasesOfCommonStock" xlink:title="BankCreditAgreementToPermitShareRepurchasesOfCommonStock" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityClassOfTreasuryStockLineItems" xlink:to="BankCreditAgreementToPermitShareRepurchasesOfCommonStock" xlink:title="definition: EquityClassOfTreasuryStockLineItems to BankCreditAgreementToPermitShareRepurchasesOfCommonStock" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="StockRepurchasedDuringPeriodShares" xlink:title="StockRepurchasedDuringPeriodShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityClassOfTreasuryStockLineItems" xlink:to="StockRepurchasedDuringPeriodShares" xlink:title="definition: EquityClassOfTreasuryStockLineItems to StockRepurchasedDuringPeriodShares" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_AdditionalEstimatedRepurchaseOfCommonStock" xlink:label="AdditionalEstimatedRepurchaseOfCommonStock" xlink:title="AdditionalEstimatedRepurchaseOfCommonStock" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityClassOfTreasuryStockLineItems" xlink:to="AdditionalEstimatedRepurchaseOfCommonStock" xlink:title="definition: EquityClassOfTreasuryStockLineItems to AdditionalEstimatedRepurchaseOfCommonStock" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="SharesIssuedPricePerShare" xlink:title="SharesIssuedPricePerShare" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityClassOfTreasuryStockLineItems" xlink:to="SharesIssuedPricePerShare" xlink:title="definition: EquityClassOfTreasuryStockLineItems to SharesIssuedPricePerShare" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfTreasuryStockTable" xlink:label="ClassOfTreasuryStockTable" xlink:title="ClassOfTreasuryStockTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="EquityClassOfTreasuryStockLineItems" xlink:to="ClassOfTreasuryStockTable" xlink:title="definition: EquityClassOfTreasuryStockLineItems to ClassOfTreasuryStockTable" order="8.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ClassOfTreasuryStockTable" xlink:to="RangeAxis" xlink:title="definition: ClassOfTreasuryStockTable to RangeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/DefinedContributionPlanDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/CommitmentsAndContingenciesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:label="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:title="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_EmploymentAgreementsAbstract" xlink:label="EmploymentAgreementsAbstract" xlink:title="EmploymentAgreementsAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="EmploymentAgreementsAbstract" xlink:title="definition: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to EmploymentAgreementsAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfEmployeesCoveredUnderEmployeeAgreement" xlink:label="NumberOfEmployeesCoveredUnderEmployeeAgreement" xlink:title="NumberOfEmployeesCoveredUnderEmployeeAgreement" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="NumberOfEmployeesCoveredUnderEmployeeAgreement" xlink:title="definition: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to NumberOfEmployeesCoveredUnderEmployeeAgreement" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_EmploymentAgreementsRetirementDate" xlink:label="EmploymentAgreementsRetirementDate" xlink:title="EmploymentAgreementsRetirementDate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="EmploymentAgreementsRetirementDate" xlink:title="definition: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to EmploymentAgreementsRetirementDate" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_EmploymentAgreementsExpirationDate" xlink:label="EmploymentAgreementsExpirationDate" xlink:title="EmploymentAgreementsExpirationDate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="EmploymentAgreementsExpirationDate" xlink:title="definition: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to EmploymentAgreementsExpirationDate" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_EmploymentAgreementsExpirationDateTwo" xlink:label="EmploymentAgreementsExpirationDateTwo" xlink:title="EmploymentAgreementsExpirationDateTwo" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="EmploymentAgreementsExpirationDateTwo" xlink:title="definition: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to EmploymentAgreementsExpirationDateTwo" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_EmploymentAgreementsExpirationDateThree" xlink:label="EmploymentAgreementsExpirationDateThree" xlink:title="EmploymentAgreementsExpirationDateThree" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="EmploymentAgreementsExpirationDateThree" xlink:title="definition: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to EmploymentAgreementsExpirationDateThree" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_RenewalPeriodForEmploymentAgreement" xlink:label="RenewalPeriodForEmploymentAgreement" xlink:title="RenewalPeriodForEmploymentAgreement" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="RenewalPeriodForEmploymentAgreement" xlink:title="definition: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to RenewalPeriodForEmploymentAgreement" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_EmployeeCompensationFuturePaymentDueNextFiscalYear" xlink:label="EmployeeCompensationFuturePaymentDueNextFiscalYear" xlink:title="EmployeeCompensationFuturePaymentDueNextFiscalYear" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="EmployeeCompensationFuturePaymentDueNextFiscalYear" xlink:title="definition: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to EmployeeCompensationFuturePaymentDueNextFiscalYear" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter" xlink:label="EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter" xlink:title="EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter" xlink:title="definition: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:label="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:title="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:title="definition: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" order="10.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="TitleOfIndividualAxis" xlink:title="TitleOfIndividualAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="TitleOfIndividualAxis" xlink:title="definition: ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable to TitleOfIndividualAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="TitleOfIndividualAxis" xlink:to="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="definition: TitleOfIndividualAxis to TitleOfIndividualWithRelationshipToEntityDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain_2" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="TitleOfIndividualAxis" xlink:to="TitleOfIndividualWithRelationshipToEntityDomain_2" xlink:title="definition: TitleOfIndividualAxis to TitleOfIndividualWithRelationshipToEntityDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ExecutiveOfficerMember" xlink:label="ExecutiveOfficerMember" xlink:title="ExecutiveOfficerMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="ExecutiveOfficerMember" xlink:title="definition: TitleOfIndividualWithRelationshipToEntityDomain to ExecutiveOfficerMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/EarningsPerShareDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/ScheduleIiValuationAndQualifyingAccountsDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:label="ValuationAndQualifyingAccountsDisclosureLineItems" xlink:title="ValuationAndQualifyingAccountsDisclosureLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:label="MovementInValuationAllowancesAndReservesRollForward" xlink:title="MovementInValuationAllowancesAndReservesRollForward" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="MovementInValuationAllowancesAndReservesRollForward" xlink:title="definition: ValuationAndQualifyingAccountsDisclosureLineItems to MovementInValuationAllowancesAndReservesRollForward" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="ValuationAllowancesAndReservesBalance" xlink:title="ValuationAllowancesAndReservesBalance" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="ValuationAllowancesAndReservesBalance" xlink:title="definition: ValuationAndQualifyingAccountsDisclosureLineItems to ValuationAllowancesAndReservesBalance" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:label="ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:title="ValuationAllowancesAndReservesChargedToCostAndExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:title="definition: ValuationAndQualifyingAccountsDisclosureLineItems to ValuationAllowancesAndReservesChargedToCostAndExpense" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:label="ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:title="ValuationAllowancesAndReservesChargedToOtherAccounts" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:title="definition: ValuationAndQualifyingAccountsDisclosureLineItems to ValuationAllowancesAndReservesChargedToOtherAccounts" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions" xlink:label="ValuationAllowancesAndReservesDeductions" xlink:title="ValuationAllowancesAndReservesDeductions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="ValuationAllowancesAndReservesDeductions" xlink:title="definition: ValuationAndQualifyingAccountsDisclosureLineItems to ValuationAllowancesAndReservesDeductions" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:label="ValuationAndQualifyingAccountsDisclosureTable" xlink:title="ValuationAndQualifyingAccountsDisclosureTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="ValuationAndQualifyingAccountsDisclosureTable" xlink:title="definition: ValuationAndQualifyingAccountsDisclosureLineItems to ValuationAndQualifyingAccountsDisclosureTable" order="6.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:label="ValuationAllowancesAndReservesTypeAxis" xlink:title="ValuationAllowancesAndReservesTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ValuationAndQualifyingAccountsDisclosureTable" xlink:to="ValuationAllowancesAndReservesTypeAxis" xlink:title="definition: ValuationAndQualifyingAccountsDisclosureTable to ValuationAllowancesAndReservesTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:label="ValuationAllowancesAndReservesDomain" xlink:title="ValuationAllowancesAndReservesDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ValuationAllowancesAndReservesTypeAxis" xlink:to="ValuationAllowancesAndReservesDomain" xlink:title="definition: ValuationAllowancesAndReservesTypeAxis to ValuationAllowancesAndReservesDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:label="ValuationAllowancesAndReservesDomain_2" xlink:title="ValuationAllowancesAndReservesDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ValuationAllowancesAndReservesTypeAxis" xlink:to="ValuationAllowancesAndReservesDomain_2" xlink:title="definition: ValuationAllowancesAndReservesTypeAxis to ValuationAllowancesAndReservesDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForCreditLossMember" xlink:label="AllowanceForCreditLossMember" xlink:title="AllowanceForCreditLossMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ValuationAllowancesAndReservesDomain" xlink:to="AllowanceForCreditLossMember" xlink:title="definition: ValuationAllowancesAndReservesDomain to AllowanceForCreditLossMember" order="1.0" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>usph-20201231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 7.0.0.0 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AwardTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US" id="us-gaap_AwardTypeAxis_lbl">Award Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:title="label: AwardTypeAxis to us-gaap_AwardTypeAxis_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AwardTypeAxis_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AwardTypeAxis_lbl1" xml:lang="en-US" id="us-gaap_AwardTypeAxis_lbl1">Award Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl1" xlink:title="label: AwardTypeAxis to us-gaap_AwardTypeAxis_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="AccountingStandardsUpdate201602Member" xlink:title="AccountingStandardsUpdate201602Member" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdate201602Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccountingStandardsUpdate201602Member_lbl" xml:lang="en-US" id="us-gaap_AccountingStandardsUpdate201602Member_lbl">ASU 2016-02 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountingStandardsUpdate201602Member" xlink:to="us-gaap_AccountingStandardsUpdate201602Member_lbl" xlink:title="label: AccountingStandardsUpdate201602Member to us-gaap_AccountingStandardsUpdate201602Member_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US" id="us-gaap_AccountingPoliciesAbstract_lbl">Significant Accounting Policies [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:title="label: AccountingPoliciesAbstract to us-gaap_AccountingPoliciesAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:title="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl">Accrued Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:title="label: AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock to us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl1">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl1" xlink:title="label: AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock to us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:label="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:title="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_lbl" xml:lang="en-US" id="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_lbl">Payables and Accruals [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_lbl" xlink:title="label: AccountsPayableAndAccruedLiabilitiesCurrentAbstract to us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_lbl1" xml:lang="en-US" id="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_lbl1">Accounts Payable and Accrued Liabilities, Current [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_lbl1" xlink:title="label: AccountsPayableAndAccruedLiabilitiesCurrentAbstract to us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="AccountsPayableTradeCurrent" xlink:title="AccountsPayableTradeCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsPayableTradeCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccountsPayableTradeCurrent_lbl" xml:lang="en-US" id="us-gaap_AccountsPayableTradeCurrent_lbl">Accounts payable - trade</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableTradeCurrent" xlink:to="us-gaap_AccountsPayableTradeCurrent_lbl" xlink:title="label: AccountsPayableTradeCurrent to us-gaap_AccountsPayableTradeCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsPayableTradeCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccountsPayableTradeCurrent_lbl1" xml:lang="en-US" id="us-gaap_AccountsPayableTradeCurrent_lbl1">Accounts Payable, Trade, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableTradeCurrent" xlink:to="us-gaap_AccountsPayableTradeCurrent_lbl1" xlink:title="label: AccountsPayableTradeCurrent to us-gaap_AccountsPayableTradeCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="AccountsAndOtherReceivablesNetCurrent" xlink:title="AccountsAndOtherReceivablesNetCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl" xml:lang="en-US" id="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl">Accounts receivable - other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsAndOtherReceivablesNetCurrent" xlink:to="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl" xlink:title="label: AccountsAndOtherReceivablesNetCurrent to us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl1" xml:lang="en-US" id="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl1">Accounts and Other Receivables, Net, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsAndOtherReceivablesNetCurrent" xlink:to="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl1" xlink:title="label: AccountsAndOtherReceivablesNetCurrent to us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="AccountsReceivableNetCurrent" xlink:title="AccountsReceivableNetCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US" id="us-gaap_AccountsReceivableNetCurrent_lbl">Patient accounts receivable, less allowance for credit losses of $2,008 and $2,698, respectively</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:title="label: AccountsReceivableNetCurrent to us-gaap_AccountsReceivableNetCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccountsReceivableNetCurrent_lbl1" xml:lang="en-US" id="us-gaap_AccountsReceivableNetCurrent_lbl1">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl1" xlink:title="label: AccountsReceivableNetCurrent to us-gaap_AccountsReceivableNetCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedInsuranceCurrent" xlink:label="AccruedInsuranceCurrent" xlink:title="AccruedInsuranceCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccruedInsuranceCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_AccruedInsuranceCurrent_lbl" xml:lang="en-US" id="us-gaap_AccruedInsuranceCurrent_lbl">Group health insurance claims</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedInsuranceCurrent" xlink:to="us-gaap_AccruedInsuranceCurrent_lbl" xlink:title="label: AccruedInsuranceCurrent to us-gaap_AccruedInsuranceCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccruedInsuranceCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccruedInsuranceCurrent_lbl1" xml:lang="en-US" id="us-gaap_AccruedInsuranceCurrent_lbl1">Accrued Insurance, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedInsuranceCurrent" xlink:to="us-gaap_AccruedInsuranceCurrent_lbl1" xlink:title="label: AccruedInsuranceCurrent to us-gaap_AccruedInsuranceCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US" id="us-gaap_AccruedLiabilitiesCurrent_lbl">Accrued expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:title="label: AccruedLiabilitiesCurrent to us-gaap_AccruedLiabilitiesCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_AccruedLiabilitiesCurrent_lbl1" xml:lang="en-US" id="us-gaap_AccruedLiabilitiesCurrent_lbl1">Total</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl1" xlink:title="label: AccruedLiabilitiesCurrent to us-gaap_AccruedLiabilitiesCurrent_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccruedLiabilitiesCurrent_lbl2" xml:lang="en-US" id="us-gaap_AccruedLiabilitiesCurrent_lbl2">Accrued Liabilities, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl2" xlink:title="label: AccruedLiabilitiesCurrent to us-gaap_AccruedLiabilitiesCurrent_lbl2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="AccruedIncomeTaxesCurrent" xlink:title="AccruedIncomeTaxesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccruedIncomeTaxesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccruedIncomeTaxesCurrent_lbl" xml:lang="en-US" id="us-gaap_AccruedIncomeTaxesCurrent_lbl">Tax payable included in accrued liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedIncomeTaxesCurrent" xlink:to="us-gaap_AccruedIncomeTaxesCurrent_lbl" xlink:title="label: AccruedIncomeTaxesCurrent to us-gaap_AccruedIncomeTaxesCurrent_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US" id="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl">Less accumulated depreciation and amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:title="label: AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment to us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl1" xml:lang="en-US" id="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl1">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl1" xlink:title="label: AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment to us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="AdditionalPaidInCapitalMember" xlink:title="AdditionalPaidInCapitalMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US" id="us-gaap_AdditionalPaidInCapitalMember_lbl">Additional Paid-In Capital [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:title="label: AdditionalPaidInCapitalMember to us-gaap_AdditionalPaidInCapitalMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AdditionalPaidInCapitalMember_lbl1" xml:lang="en-US" id="us-gaap_AdditionalPaidInCapitalMember_lbl1">Additional Paid-in Capital [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl1" xlink:title="label: AdditionalPaidInCapitalMember to us-gaap_AdditionalPaidInCapitalMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="AdditionalPaidInCapital" xlink:title="AdditionalPaidInCapital" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US" id="us-gaap_AdditionalPaidInCapital_lbl">Additional paid-in capital</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:title="label: AdditionalPaidInCapital to us-gaap_AdditionalPaidInCapital_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapital_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AdditionalPaidInCapital_lbl1" xml:lang="en-US" id="us-gaap_AdditionalPaidInCapital_lbl1">Additional Paid in Capital</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl1" xlink:title="label: AdditionalPaidInCapital to us-gaap_AdditionalPaidInCapital_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US" id="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl">Adjustments to reconcile net income including non-controlling interests to net cash provided by operating activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:title="label: AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xml:lang="en-US" id="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl1">Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xlink:title="label: AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xml:lang="en-US" id="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl">Compensation expense - equity-based awards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:title="label: AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue to us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl1" xml:lang="en-US" id="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl1">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl1" xlink:title="label: AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue to us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="AdjustmentsForNewAccountingPronouncementsAxis" xlink:title="AdjustmentsForNewAccountingPronouncementsAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xml:lang="en-US" id="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xlink:title="label: AdjustmentsForNewAccountingPronouncementsAxis to us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="AllocatedShareBasedCompensationExpense" xlink:title="AllocatedShareBasedCompensationExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US" id="us-gaap_AllocatedShareBasedCompensationExpense_lbl">Compensation expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:title="label: AllocatedShareBasedCompensationExpense to us-gaap_AllocatedShareBasedCompensationExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AllocatedShareBasedCompensationExpense_lbl1" xml:lang="en-US" id="us-gaap_AllocatedShareBasedCompensationExpense_lbl1">Share-based Payment Arrangement, Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl1" xlink:title="label: AllocatedShareBasedCompensationExpense to us-gaap_AllocatedShareBasedCompensationExpense_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="AllowanceForDoubtfulAccountsReceivableCurrent" xlink:title="AllowanceForDoubtfulAccountsReceivableCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xml:lang="en-US" id="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl">Allowance for credit losses, patient accounts receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xlink:title="label: AllowanceForDoubtfulAccountsReceivableCurrent to us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl1" xml:lang="en-US" id="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl1">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl1" xlink:title="label: AllowanceForDoubtfulAccountsReceivableCurrent to us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForCreditLossMember" xlink:label="AllowanceForCreditLossMember" xlink:title="AllowanceForCreditLossMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AllowanceForCreditLossMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AllowanceForCreditLossMember_lbl" xml:lang="en-US" id="us-gaap_AllowanceForCreditLossMember_lbl">Allowance for Credit Losses [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AllowanceForCreditLossMember" xlink:to="us-gaap_AllowanceForCreditLossMember_lbl" xlink:title="label: AllowanceForCreditLossMember to us-gaap_AllowanceForCreditLossMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="AmortizationOfIntangibleAssets" xlink:title="AmortizationOfIntangibleAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US" id="us-gaap_AmortizationOfIntangibleAssets_lbl">Total amortization expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:title="label: AmortizationOfIntangibleAssets to us-gaap_AmortizationOfIntangibleAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AmortizationOfIntangibleAssets_lbl1" xml:lang="en-US" id="us-gaap_AmortizationOfIntangibleAssets_lbl1">Amortization of Intangible Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl1" xlink:title="label: AmortizationOfIntangibleAssets to us-gaap_AmortizationOfIntangibleAssets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfDeferredChargesAbstract" xlink:label="AmortizationOfDeferredChargesAbstract" xlink:title="AmortizationOfDeferredChargesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AmortizationOfDeferredChargesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AmortizationOfDeferredChargesAbstract_lbl" xml:lang="en-US" id="us-gaap_AmortizationOfDeferredChargesAbstract_lbl">Amortization of Deferred Charges [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmortizationOfDeferredChargesAbstract" xlink:to="us-gaap_AmortizationOfDeferredChargesAbstract_lbl" xlink:title="label: AmortizationOfDeferredChargesAbstract to us-gaap_AmortizationOfDeferredChargesAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="AssetsAbstract" xlink:title="AssetsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AssetsAbstract_lbl" xml:lang="en-US" id="us-gaap_AssetsAbstract_lbl">ASSETS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:title="label: AssetsAbstract to us-gaap_AssetsAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetsAbstract_lbl1" xml:lang="en-US" id="us-gaap_AssetsAbstract_lbl1">Assets [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl1" xlink:title="label: AssetsAbstract to us-gaap_AssetsAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="Assets" xlink:title="Assets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_Assets_lbl" xml:lang="en-US" id="us-gaap_Assets_lbl">Total assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Assets" xlink:to="us-gaap_Assets_lbl" xlink:title="label: Assets to us-gaap_Assets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Assets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_Assets_lbl1" xml:lang="en-US" id="us-gaap_Assets_lbl1">Total assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Assets" xlink:to="us-gaap_Assets_lbl1" xlink:title="label: Assets to us-gaap_Assets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="AssetsCurrent" xlink:title="AssetsCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_AssetsCurrent_lbl" xml:lang="en-US" id="us-gaap_AssetsCurrent_lbl">Total current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:title="label: AssetsCurrent to us-gaap_AssetsCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetsCurrent_lbl1" xml:lang="en-US" id="us-gaap_AssetsCurrent_lbl1">Assets, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl1" xlink:title="label: AssetsCurrent to us-gaap_AssetsCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="AssetsCurrentAbstract" xlink:title="AssetsCurrentAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US" id="us-gaap_AssetsCurrentAbstract_lbl">Current assets:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:title="label: AssetsCurrentAbstract to us-gaap_AssetsCurrentAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetsCurrentAbstract_lbl1" xml:lang="en-US" id="us-gaap_AssetsCurrentAbstract_lbl1">Assets, Current [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl1" xlink:title="label: AssetsCurrentAbstract to us-gaap_AssetsCurrentAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:label="BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:title="BusinessAcquisitionDateOfAcquisitionAgreement1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_lbl" xml:lang="en-US" id="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_lbl">Acquisition date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:to="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_lbl" xlink:title="label: BusinessAcquisitionDateOfAcquisitionAgreement1 to us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_lbl1" xml:lang="en-US" id="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_lbl1">Business Acquisition, Date of Acquisition Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:to="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_lbl1" xlink:title="label: BusinessAcquisitionDateOfAcquisitionAgreement1 to us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="BusinessCombinationConsiderationTransferred1" xlink:title="BusinessCombinationConsiderationTransferred1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationConsiderationTransferred1_lbl">Aggregate purchase price for the acquired clinic practices</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xlink:title="label: BusinessCombinationConsiderationTransferred1 to us-gaap_BusinessCombinationConsiderationTransferred1_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationConsiderationTransferred1_lbl1" xml:lang="en-US" id="us-gaap_BusinessCombinationConsiderationTransferred1_lbl1">Business Combination, Consideration Transferred</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1_lbl1" xlink:title="label: BusinessCombinationConsiderationTransferred1 to us-gaap_BusinessCombinationConsiderationTransferred1_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl">Total non-current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl1" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl1">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl1" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl">Total current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl1" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl1">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl1" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationGoodwillAbstract" xlink:label="BusinessCombinationGoodwillAbstract" xlink:title="BusinessCombinationGoodwillAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationGoodwillAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessCombinationGoodwillAbstract_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationGoodwillAbstract_lbl">Goodwill [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationGoodwillAbstract" xlink:to="us-gaap_BusinessCombinationGoodwillAbstract_lbl" xlink:title="label: BusinessCombinationGoodwillAbstract to us-gaap_BusinessCombinationGoodwillAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationGoodwillAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationGoodwillAbstract_lbl1" xml:lang="en-US" id="us-gaap_BusinessCombinationGoodwillAbstract_lbl1">Business Combination, Goodwill [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationGoodwillAbstract" xlink:to="us-gaap_BusinessCombinationGoodwillAbstract_lbl1" xlink:title="label: BusinessCombinationGoodwillAbstract to us-gaap_BusinessCombinationGoodwillAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xml:lang="en-US" id="us-gaap_BusinessAcquisitionAcquireeDomain_lbl">Business Acquisition, Acquiree [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xlink:title="label: BusinessAcquisitionAcquireeDomain to us-gaap_BusinessAcquisitionAcquireeDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xml:lang="en-US" id="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl">Percentage of interest acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xlink:title="label: BusinessAcquisitionPercentageOfVotingInterestsAcquired to us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl1" xml:lang="en-US" id="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl1">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl1" xlink:title="label: BusinessAcquisitionPercentageOfVotingInterestsAcquired to us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessAcquisitionLineItems_lbl" xml:lang="en-US" id="us-gaap_BusinessAcquisitionLineItems_lbl">Business Acquisition [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionLineItems_lbl" xlink:title="label: BusinessAcquisitionLineItems to us-gaap_BusinessAcquisitionLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" xlink:title="BusinessCombinationsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationsAbstract_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationsAbstract_lbl">Acquisitions of Businesses [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationsAbstract" xlink:to="us-gaap_BusinessCombinationsAbstract_lbl" xlink:title="label: BusinessCombinationsAbstract to us-gaap_BusinessCombinationsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US" id="us-gaap_BusinessAcquisitionAxis_lbl">Business Acquisition [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl" xlink:title="label: BusinessAcquisitionAxis to us-gaap_BusinessAcquisitionAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:label="BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:title="BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_lbl" xml:lang="en-US" id="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_lbl">Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:to="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_lbl" xlink:title="label: BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount to us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_lbl1" xml:lang="en-US" id="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_lbl1">Business Acquisition, Goodwill, Expected Tax Deductible Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:to="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_lbl1" xlink:title="label: BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount to us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationDescriptionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationDescriptionAbstract_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationDescriptionAbstract_lbl">Business Combination, Description [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="us-gaap_BusinessCombinationDescriptionAbstract_lbl" xlink:title="label: BusinessCombinationDescriptionAbstract to us-gaap_BusinessCombinationDescriptionAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl">Total liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl1" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl1">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl1" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="BusinessCombinationDisclosureTextBlock" xlink:title="BusinessCombinationDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationDisclosureTextBlock_lbl">Acquisitions of Businesses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationDisclosureTextBlock" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xlink:title="label: BusinessCombinationDisclosureTextBlock to us-gaap_BusinessCombinationDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_BusinessCombinationDisclosureTextBlock_lbl1">Business Combination Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationDisclosureTextBlock" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock_lbl1" xlink:title="label: BusinessCombinationDisclosureTextBlock to us-gaap_BusinessCombinationDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="CashAndCashEquivalentsAtCarryingValue" xlink:title="CashAndCashEquivalentsAtCarryingValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US" id="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl">Cash and cash equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:title="label: CashAndCashEquivalentsAtCarryingValue to us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1" xml:lang="en-US" id="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1" xlink:title="label: CashAndCashEquivalentsAtCarryingValue to us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US" id="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl">Net increase in cash and cash equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:title="label: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect to us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl1" xml:lang="en-US" id="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl1">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl1" xlink:title="label: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect to us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="CashAcquiredFromAcquisition" xlink:title="CashAcquiredFromAcquisition" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashAcquiredFromAcquisition_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashAcquiredFromAcquisition_lbl" xml:lang="en-US" id="us-gaap_CashAcquiredFromAcquisition_lbl">Net of cash acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAcquiredFromAcquisition" xlink:to="us-gaap_CashAcquiredFromAcquisition_lbl" xlink:title="label: CashAcquiredFromAcquisition to us-gaap_CashAcquiredFromAcquisition_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US" id="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl">Cash and cash equivalents - end of period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:title="label: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents to us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1" xml:lang="en-US" id="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1">Cash and cash equivalents - beginning of period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1" xlink:title="label: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents to us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl2" xml:lang="en-US" id="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl2">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl2" xlink:title="label: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents to us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="CashAndCashEquivalentsPolicyTextBlock" xlink:title="CashAndCashEquivalentsPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl">Cash Equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:title="label: CashAndCashEquivalentsPolicyTextBlock to us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl1">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl1" xlink:title="label: CashAndCashEquivalentsPolicyTextBlock to us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:title="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xml:lang="en-US" id="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl">Non-cash investing and financing transactions during the period:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:title="label: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl1" xml:lang="en-US" id="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl1">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl1" xlink:title="label: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfTreasuryStockTable" xlink:label="ClassOfTreasuryStockTable" xlink:title="ClassOfTreasuryStockTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfTreasuryStockTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfTreasuryStockTable_lbl" xml:lang="en-US" id="us-gaap_ClassOfTreasuryStockTable_lbl">Class of Treasury Stock [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfTreasuryStockTable" xlink:to="us-gaap_ClassOfTreasuryStockTable_lbl" xlink:title="label: ClassOfTreasuryStockTable to us-gaap_ClassOfTreasuryStockTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDisclosuresAbstract" xlink:label="ClassOfStockDisclosuresAbstract" xlink:title="ClassOfStockDisclosuresAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfStockDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfStockDisclosuresAbstract_lbl" xml:lang="en-US" id="us-gaap_ClassOfStockDisclosuresAbstract_lbl">Class of Stock Disclosures [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfStockDisclosuresAbstract" xlink:to="us-gaap_ClassOfStockDisclosuresAbstract_lbl" xlink:title="label: ClassOfStockDisclosuresAbstract to us-gaap_ClassOfStockDisclosuresAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="CommitmentsAndContingencies" xlink:title="CommitmentsAndContingencies" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US" id="us-gaap_CommitmentsAndContingencies_lbl">Commitments and Contingencies (Note 17)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:title="label: CommitmentsAndContingencies to us-gaap_CommitmentsAndContingencies_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommitmentsAndContingencies_lbl1" xml:lang="en-US" id="us-gaap_CommitmentsAndContingencies_lbl1">Commitments and Contingencies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl1" xlink:title="label: CommitmentsAndContingencies to us-gaap_CommitmentsAndContingencies_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="CommitmentsAndContingenciesDisclosureTextBlock" xlink:title="CommitmentsAndContingenciesDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl">Commitments and Contingencies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:title="label: CommitmentsAndContingenciesDisclosureTextBlock to us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl1">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl1" xlink:title="label: CommitmentsAndContingenciesDisclosureTextBlock to us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="CommitmentsAndContingenciesDisclosureAbstract" xlink:title="CommitmentsAndContingenciesDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US" id="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl">Commitments and Contingencies [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:title="label: CommitmentsAndContingenciesDisclosureAbstract to us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommonStockMember_lbl" xml:lang="en-US" id="us-gaap_CommonStockMember_lbl">Common Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:title="label: CommonStockMember to us-gaap_CommonStockMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockMember_lbl1" xml:lang="en-US" id="us-gaap_CommonStockMember_lbl1">Common Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl1" xlink:title="label: CommonStockMember to us-gaap_CommonStockMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared" xlink:label="CommonStockDividendsPerShareDeclared" xlink:title="CommonStockDividendsPerShareDeclared" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockDividendsPerShareDeclared_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommonStockDividendsPerShareDeclared_lbl" xml:lang="en-US" id="us-gaap_CommonStockDividendsPerShareDeclared_lbl">Dividends declared per common share (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockDividendsPerShareDeclared" xlink:to="us-gaap_CommonStockDividendsPerShareDeclared_lbl" xlink:title="label: CommonStockDividendsPerShareDeclared to us-gaap_CommonStockDividendsPerShareDeclared_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockDividendsPerShareDeclared_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockDividendsPerShareDeclared_lbl1" xml:lang="en-US" id="us-gaap_CommonStockDividendsPerShareDeclared_lbl1">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockDividendsPerShareDeclared" xlink:to="us-gaap_CommonStockDividendsPerShareDeclared_lbl1" xlink:title="label: CommonStockDividendsPerShareDeclared to us-gaap_CommonStockDividendsPerShareDeclared_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="CommonStockParOrStatedValuePerShare" xlink:title="CommonStockParOrStatedValuePerShare" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US" id="us-gaap_CommonStockParOrStatedValuePerShare_lbl">Common stock, par value (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:title="label: CommonStockParOrStatedValuePerShare to us-gaap_CommonStockParOrStatedValuePerShare_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockParOrStatedValuePerShare_lbl1" xml:lang="en-US" id="us-gaap_CommonStockParOrStatedValuePerShare_lbl1">Common Stock, Par or Stated Value Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl1" xlink:title="label: CommonStockParOrStatedValuePerShare to us-gaap_CommonStockParOrStatedValuePerShare_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="CommonStockSharesIssued" xlink:title="CommonStockSharesIssued" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US" id="us-gaap_CommonStockSharesIssued_lbl">Common stock, shares issued (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:title="label: CommonStockSharesIssued to us-gaap_CommonStockSharesIssued_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockSharesIssued_lbl1" xml:lang="en-US" id="us-gaap_CommonStockSharesIssued_lbl1">Common Stock, Shares, Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl1" xlink:title="label: CommonStockSharesIssued to us-gaap_CommonStockSharesIssued_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="CommonStockSharesAuthorized" xlink:title="CommonStockSharesAuthorized" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US" id="us-gaap_CommonStockSharesAuthorized_lbl">Common stock, shares authorized (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:title="label: CommonStockSharesAuthorized to us-gaap_CommonStockSharesAuthorized_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockSharesAuthorized_lbl1" xml:lang="en-US" id="us-gaap_CommonStockSharesAuthorized_lbl1">Common Stock, Shares Authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl1" xlink:title="label: CommonStockSharesAuthorized to us-gaap_CommonStockSharesAuthorized_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="CommonStockValue" xlink:title="CommonStockValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommonStockValue_lbl" xml:lang="en-US" id="us-gaap_CommonStockValue_lbl">Common stock, $.01 par value, 20,000,000 shares authorized, 15,066,282 and 14,989,337 shares issued, respectively</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:title="label: CommonStockValue to us-gaap_CommonStockValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockValue_lbl1" xml:lang="en-US" id="us-gaap_CommonStockValue_lbl1">Common Stock, Value, Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl1" xlink:title="label: CommonStockValue to us-gaap_CommonStockValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:label="CompensationAndEmployeeBenefitPlansTextBlock" xlink:title="CompensationAndEmployeeBenefitPlansTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_lbl" xml:lang="en-US" id="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_lbl">Defined Contribution Plan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CompensationAndEmployeeBenefitPlansTextBlock" xlink:to="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_lbl" xlink:title="label: CompensationAndEmployeeBenefitPlansTextBlock to us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_lbl1" xml:lang="en-US" id="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_lbl1">Compensation and Employee Benefit Plans [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CompensationAndEmployeeBenefitPlansTextBlock" xlink:to="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_lbl1" xlink:title="label: CompensationAndEmployeeBenefitPlansTextBlock to us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="CompensationAndRetirementDisclosureAbstract" xlink:title="CompensationAndRetirementDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl" xml:lang="en-US" id="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl">Defined Contribution Plan [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl" xlink:title="label: CompensationAndRetirementDisclosureAbstract to us-gaap_CompensationAndRetirementDisclosureAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:label="ComponentsOfDeferredTaxAssetsAbstract" xlink:title="ComponentsOfDeferredTaxAssetsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl" xml:lang="en-US" id="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl">Deferred tax assets [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl" xlink:title="label: ComponentsOfDeferredTaxAssetsAbstract to us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl1" xml:lang="en-US" id="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl1">Components of Deferred Tax Assets [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl1" xlink:title="label: ComponentsOfDeferredTaxAssetsAbstract to us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:label="ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:title="ComponentsOfDeferredTaxLiabilitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_lbl" xml:lang="en-US" id="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_lbl">Deferred tax liabilities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_lbl" xlink:title="label: ComponentsOfDeferredTaxLiabilitiesAbstract to us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_lbl1" xml:lang="en-US" id="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_lbl1">Components of Deferred Tax Liabilities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_lbl1" xlink:title="label: ComponentsOfDeferredTaxLiabilitiesAbstract to us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:label="ComputerSoftwareIntangibleAssetMember" xlink:title="ComputerSoftwareIntangibleAssetMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ComputerSoftwareIntangibleAssetMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ComputerSoftwareIntangibleAssetMember_lbl" xml:lang="en-US" id="us-gaap_ComputerSoftwareIntangibleAssetMember_lbl">Software [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ComputerSoftwareIntangibleAssetMember" xlink:to="us-gaap_ComputerSoftwareIntangibleAssetMember_lbl" xlink:title="label: ComputerSoftwareIntangibleAssetMember to us-gaap_ComputerSoftwareIntangibleAssetMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ComputerSoftwareIntangibleAssetMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ComputerSoftwareIntangibleAssetMember_lbl1" xml:lang="en-US" id="us-gaap_ComputerSoftwareIntangibleAssetMember_lbl1">Computer Software, Intangible Asset [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ComputerSoftwareIntangibleAssetMember" xlink:to="us-gaap_ComputerSoftwareIntangibleAssetMember_lbl1" xlink:title="label: ComputerSoftwareIntangibleAssetMember to us-gaap_ComputerSoftwareIntangibleAssetMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:label="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:title="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_lbl" xml:lang="en-US" id="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_lbl">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_lbl" xlink:title="label: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable to us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:label="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:title="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract_lbl" xml:lang="en-US" id="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract_lbl">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Change Due to Net Income Attributable to Parent and Effects of Changes, Net [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:to="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract_lbl" xlink:title="label: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract to us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent" xlink:label="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent" xlink:title="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent_lbl" xml:lang="en-US" id="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent_lbl">Cash proceeds from sale of non-controlling interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent" xlink:to="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent_lbl" xlink:title="label: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent to us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent_lbl1" xml:lang="en-US" id="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent_lbl1">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Sale of Interest by Parent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent" xlink:to="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent_lbl1" xlink:title="label: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent to us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:label="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:title="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_lbl" xml:lang="en-US" id="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_lbl">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_lbl" xlink:title="label: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems to us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent" xlink:label="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent" xlink:title="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent_lbl" xml:lang="en-US" id="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent_lbl">Purchase price for additional non controlling interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent" xlink:to="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent_lbl" xlink:title="label: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent to us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock" xlink:label="ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock" xlink:title="ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock_lbl">Contractual Allowances</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock" xlink:to="us-gaap_ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock_lbl" xlink:title="label: ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock to us-gaap_ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock_lbl1">Contractual Adjustments and Third Party Settlements, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock" xlink:to="us-gaap_ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock_lbl1" xlink:title="label: ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock to us-gaap_ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="CostsAndExpensesAbstract" xlink:title="CostsAndExpensesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CostsAndExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CostsAndExpensesAbstract_lbl" xml:lang="en-US" id="us-gaap_CostsAndExpensesAbstract_lbl">Operating costs:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CostsAndExpensesAbstract" xlink:to="us-gaap_CostsAndExpensesAbstract_lbl" xlink:title="label: CostsAndExpensesAbstract to us-gaap_CostsAndExpensesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CostsAndExpensesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CostsAndExpensesAbstract_lbl1" xml:lang="en-US" id="us-gaap_CostsAndExpensesAbstract_lbl1">Costs and Expenses [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CostsAndExpensesAbstract" xlink:to="us-gaap_CostsAndExpensesAbstract_lbl1" xlink:title="label: CostsAndExpensesAbstract to us-gaap_CostsAndExpensesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="CostsAndExpenses" xlink:title="CostsAndExpenses" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CostsAndExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_CostsAndExpenses_lbl" xml:lang="en-US" id="us-gaap_CostsAndExpenses_lbl">Total operating costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl" xlink:title="label: CostsAndExpenses to us-gaap_CostsAndExpenses_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CostsAndExpenses_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CostsAndExpenses_lbl1" xml:lang="en-US" id="us-gaap_CostsAndExpenses_lbl1">Costs and Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl1" xlink:title="label: CostsAndExpenses to us-gaap_CostsAndExpenses_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="CreditFacilityDomain" xlink:title="CreditFacilityDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CreditFacilityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CreditFacilityDomain_lbl" xml:lang="en-US" id="us-gaap_CreditFacilityDomain_lbl">Credit Facility [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CreditFacilityDomain" xlink:to="us-gaap_CreditFacilityDomain_lbl" xlink:title="label: CreditFacilityDomain to us-gaap_CreditFacilityDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="CreditFacilityAxis" xlink:title="CreditFacilityAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CreditFacilityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CreditFacilityAxis_lbl" xml:lang="en-US" id="us-gaap_CreditFacilityAxis_lbl">Credit Facility [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityAxis_lbl" xlink:title="label: CreditFacilityAxis to us-gaap_CreditFacilityAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="CurrentFederalTaxExpenseBenefit" xlink:title="CurrentFederalTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xml:lang="en-US" id="us-gaap_CurrentFederalTaxExpenseBenefit_lbl">Federal</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:title="label: CurrentFederalTaxExpenseBenefit to us-gaap_CurrentFederalTaxExpenseBenefit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CurrentFederalTaxExpenseBenefit_lbl1" xml:lang="en-US" id="us-gaap_CurrentFederalTaxExpenseBenefit_lbl1">Current Federal Tax Expense (Benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl1" xlink:title="label: CurrentFederalTaxExpenseBenefit to us-gaap_CurrentFederalTaxExpenseBenefit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="CurrentStateAndLocalTaxExpenseBenefit" xlink:title="CurrentStateAndLocalTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xml:lang="en-US" id="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl">State</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:title="label: CurrentStateAndLocalTaxExpenseBenefit to us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl1" xml:lang="en-US" id="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl1">Current State and Local Tax Expense (Benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl1" xlink:title="label: CurrentStateAndLocalTaxExpenseBenefit to us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="CurrentIncomeTaxExpenseBenefit" xlink:title="CurrentIncomeTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xml:lang="en-US" id="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl">Total current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:title="label: CurrentIncomeTaxExpenseBenefit to us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl1" xml:lang="en-US" id="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl1">Current Income Tax Expense (Benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl1" xlink:title="label: CurrentIncomeTaxExpenseBenefit to us-gaap_CurrentIncomeTaxExpenseBenefit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:title="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xml:lang="en-US" id="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl">Current [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:title="label: CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract to us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1" xml:lang="en-US" id="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1" xlink:title="label: CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract to us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="DisaggregationOfRevenueTable" xlink:title="DisaggregationOfRevenueTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisaggregationOfRevenueTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisaggregationOfRevenueTable_lbl" xml:lang="en-US" id="us-gaap_DisaggregationOfRevenueTable_lbl">Disaggregation of Revenue [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueTable_lbl" xlink:title="label: DisaggregationOfRevenueTable to us-gaap_DisaggregationOfRevenueTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="DisaggregationOfRevenueLineItems" xlink:title="DisaggregationOfRevenueLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisaggregationOfRevenueLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisaggregationOfRevenueLineItems_lbl" xml:lang="en-US" id="us-gaap_DisaggregationOfRevenueLineItems_lbl">Disaggregation of Revenue [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueLineItems_lbl" xlink:title="label: DisaggregationOfRevenueLineItems to us-gaap_DisaggregationOfRevenueLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="DisaggregationOfRevenueTableTextBlock" xlink:title="DisaggregationOfRevenueTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl">Disaggregation of Revenue, Categories</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisaggregationOfRevenueTableTextBlock" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xlink:title="label: DisaggregationOfRevenueTableTextBlock to us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="DebtDisclosureAbstract" xlink:title="DebtDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US" id="us-gaap_DebtDisclosureAbstract_lbl">Notes Payable [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xlink:title="label: DebtDisclosureAbstract to us-gaap_DebtDisclosureAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="DebtInstrumentBasisSpreadOnVariableRate1" xlink:title="DebtInstrumentBasisSpreadOnVariableRate1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl">Spread on variable rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" xlink:title="label: DebtInstrumentBasisSpreadOnVariableRate1 to us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl1" xml:lang="en-US" id="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl1">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl1" xlink:title="label: DebtInstrumentBasisSpreadOnVariableRate1 to us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="DebtInstrumentFaceAmount" xlink:title="DebtInstrumentFaceAmount" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentFaceAmount_lbl">Aggregate amount of notes payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:title="label: DebtInstrumentFaceAmount to us-gaap_DebtInstrumentFaceAmount_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DebtInstrumentFaceAmount_lbl1" xml:lang="en-US" id="us-gaap_DebtInstrumentFaceAmount_lbl1">Aggregate amount of notes payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl1" xlink:title="label: DebtInstrumentFaceAmount to us-gaap_DebtInstrumentFaceAmount_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentFaceAmount_lbl2" xml:lang="en-US" id="us-gaap_DebtInstrumentFaceAmount_lbl2">Debt Instrument, Face Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl2" xlink:title="label: DebtInstrumentFaceAmount to us-gaap_DebtInstrumentFaceAmount_lbl2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="DebtInstrumentTable" xlink:title="DebtInstrumentTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentTable_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentTable_lbl">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable_lbl" xlink:title="label: DebtInstrumentTable to us-gaap_DebtInstrumentTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="DebtInstrumentAxis" xlink:title="DebtInstrumentAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentAxis_lbl">Debt Instrument [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" xlink:title="label: DebtInstrumentAxis to us-gaap_DebtInstrumentAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:label="DebtInstrumentAnnualPrincipalPayment" xlink:title="DebtInstrumentAnnualPrincipalPayment" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl">Annual installments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentAnnualPrincipalPayment" xlink:to="us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl" xlink:title="label: DebtInstrumentAnnualPrincipalPayment to us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl1" xml:lang="en-US" id="us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl1">Principal installments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentAnnualPrincipalPayment" xlink:to="us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl1" xlink:title="label: DebtInstrumentAnnualPrincipalPayment to us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="DebtDisclosureTextBlock" xlink:title="DebtDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_DebtDisclosureTextBlock_lbl">Notes Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl" xlink:title="label: DebtDisclosureTextBlock to us-gaap_DebtDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_DebtDisclosureTextBlock_lbl1">Debt Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl1" xlink:title="label: DebtDisclosureTextBlock to us-gaap_DebtDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="DebtInstrumentLineItems" xlink:title="DebtInstrumentLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentLineItems_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentLineItems_lbl">Debt Instrument [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl" xlink:title="label: DebtInstrumentLineItems to us-gaap_DebtInstrumentLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain" xlink:title="DebtInstrumentNameDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentNameDomain_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentNameDomain_lbl">Debt Instrument, Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentNameDomain" xlink:to="us-gaap_DebtInstrumentNameDomain_lbl" xlink:title="label: DebtInstrumentNameDomain to us-gaap_DebtInstrumentNameDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="DebtInstrumentInterestRateStatedPercentage" xlink:title="DebtInstrumentInterestRateStatedPercentage" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl">Percentage of interest accrued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:title="label: DebtInstrumentInterestRateStatedPercentage to us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl1" xml:lang="en-US" id="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl1">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl1" xlink:title="label: DebtInstrumentInterestRateStatedPercentage to us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentsAbstract" xlink:label="DebtInstrumentsAbstract" xlink:title="DebtInstrumentsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentsAbstract_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentsAbstract_lbl">Debt Instruments [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentsAbstract" xlink:to="us-gaap_DebtInstrumentsAbstract_lbl" xlink:title="label: DebtInstrumentsAbstract to us-gaap_DebtInstrumentsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="DebtInstrumentMaturityDate" xlink:title="DebtInstrumentMaturityDate" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DebtInstrumentMaturityDate_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentMaturityDate_lbl">Revolving credit facility maturity date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:title="label: DebtInstrumentMaturityDate to us-gaap_DebtInstrumentMaturityDate_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentMaturityDate_lbl1" xml:lang="en-US" id="us-gaap_DebtInstrumentMaturityDate_lbl1">Debt Instrument, Maturity Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl1" xlink:title="label: DebtInstrumentMaturityDate to us-gaap_DebtInstrumentMaturityDate_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" xlink:label="DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" xlink:title="DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1_lbl" xml:lang="en-US" id="us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1_lbl">Period in which restrictions lapse on stock granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1_lbl" xlink:title="label: DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1 to us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="DeferredIncomeTaxLiabilitiesNet" xlink:title="DeferredIncomeTaxLiabilitiesNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl" xml:lang="en-US" id="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl">Deferred taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredIncomeTaxLiabilitiesNet" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl" xlink:title="label: DeferredIncomeTaxLiabilitiesNet to us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:label="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:title="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_lbl" xml:lang="en-US" id="us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_lbl">Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_lbl" xlink:title="label: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxesAndOtherTaxReceivableCurrent" xlink:label="DeferredIncomeTaxesAndOtherTaxReceivableCurrent" xlink:title="DeferredIncomeTaxesAndOtherTaxReceivableCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxesAndOtherTaxReceivableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DeferredIncomeTaxesAndOtherTaxReceivableCurrent_lbl" xml:lang="en-US" id="us-gaap_DeferredIncomeTaxesAndOtherTaxReceivableCurrent_lbl">Tax receivable included in other current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredIncomeTaxesAndOtherTaxReceivableCurrent" xlink:to="us-gaap_DeferredIncomeTaxesAndOtherTaxReceivableCurrent_lbl" xlink:title="label: DeferredIncomeTaxesAndOtherTaxReceivableCurrent to us-gaap_DeferredIncomeTaxesAndOtherTaxReceivableCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxesAndOtherTaxReceivableCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredIncomeTaxesAndOtherTaxReceivableCurrent_lbl1" xml:lang="en-US" id="us-gaap_DeferredIncomeTaxesAndOtherTaxReceivableCurrent_lbl1">Deferred Income Taxes and Other Tax Receivable, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredIncomeTaxesAndOtherTaxReceivableCurrent" xlink:to="us-gaap_DeferredIncomeTaxesAndOtherTaxReceivableCurrent_lbl1" xlink:title="label: DeferredIncomeTaxesAndOtherTaxReceivableCurrent to us-gaap_DeferredIncomeTaxesAndOtherTaxReceivableCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementsAbstract" xlink:label="DeferredCompensationArrangementsAbstract" xlink:title="DeferredCompensationArrangementsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredCompensationArrangementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredCompensationArrangementsAbstract_lbl" xml:lang="en-US" id="us-gaap_DeferredCompensationArrangementsAbstract_lbl">Restricted Stock [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredCompensationArrangementsAbstract" xlink:to="us-gaap_DeferredCompensationArrangementsAbstract_lbl" xlink:title="label: DeferredCompensationArrangementsAbstract to us-gaap_DeferredCompensationArrangementsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="DeferredFederalIncomeTaxExpenseBenefit" xlink:title="DeferredFederalIncomeTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US" id="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl">Federal</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:title="label: DeferredFederalIncomeTaxExpenseBenefit to us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl1" xml:lang="en-US" id="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl1">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl1" xlink:title="label: DeferredFederalIncomeTaxExpenseBenefit to us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="DeferredIncomeTaxLiabilities" xlink:title="DeferredIncomeTaxLiabilities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:title="us-gaap_DeferredIncomeTaxLiabilities_lbl" xml:lang="en-US" id="us-gaap_DeferredIncomeTaxLiabilities_lbl">Deferred tax liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_lbl" xlink:title="label: DeferredIncomeTaxLiabilities to us-gaap_DeferredIncomeTaxLiabilities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredIncomeTaxLiabilities_lbl1" xml:lang="en-US" id="us-gaap_DeferredIncomeTaxLiabilities_lbl1">Deferred Tax Liabilities, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_lbl1" xlink:title="label: DeferredIncomeTaxLiabilities to us-gaap_DeferredIncomeTaxLiabilities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="DeferredIncomeTaxExpenseBenefit" xlink:title="DeferredIncomeTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xml:lang="en-US" id="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl">Deferred income taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:title="label: DeferredIncomeTaxExpenseBenefit to us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl1" xml:lang="en-US" id="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl1">Total deferred</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl1" xlink:title="label: DeferredIncomeTaxExpenseBenefit to us-gaap_DeferredIncomeTaxExpenseBenefit_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl2" xml:lang="en-US" id="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl2">Deferred Income Tax Expense (Benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl2" xlink:title="label: DeferredIncomeTaxExpenseBenefit to us-gaap_DeferredIncomeTaxExpenseBenefit_lbl2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:title="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xml:lang="en-US" id="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl">Deferred [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:title="label: DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract to us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1" xml:lang="en-US" id="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1" xlink:title="label: DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract to us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent" xlink:label="DeferredRentCreditNoncurrent" xlink:title="DeferredRentCreditNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredRentCreditNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DeferredRentCreditNoncurrent_lbl" xml:lang="en-US" id="us-gaap_DeferredRentCreditNoncurrent_lbl">Deferred rent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredRentCreditNoncurrent" xlink:to="us-gaap_DeferredRentCreditNoncurrent_lbl" xlink:title="label: DeferredRentCreditNoncurrent to us-gaap_DeferredRentCreditNoncurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredRentCreditNoncurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredRentCreditNoncurrent_lbl1" xml:lang="en-US" id="us-gaap_DeferredRentCreditNoncurrent_lbl1">Deferred Rent Credit, Noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredRentCreditNoncurrent" xlink:to="us-gaap_DeferredRentCreditNoncurrent_lbl1" xlink:title="label: DeferredRentCreditNoncurrent to us-gaap_DeferredRentCreditNoncurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="DeferredTaxAssetsGross" xlink:title="DeferredTaxAssetsGross" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsGross_lbl">Deferred tax assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl" xlink:title="label: DeferredTaxAssetsGross to us-gaap_DeferredTaxAssetsGross_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxAssetsGross_lbl1" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsGross_lbl1">Deferred Tax Assets, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl1" xlink:title="label: DeferredTaxAssetsGross to us-gaap_DeferredTaxAssetsGross_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:title="DeferredStateAndLocalIncomeTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US" id="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl">State</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:title="label: DeferredStateAndLocalIncomeTaxExpenseBenefit to us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl1" xml:lang="en-US" id="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl1">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl1" xlink:title="label: DeferredStateAndLocalIncomeTaxExpenseBenefit to us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="DeferredTaxAssetsOperatingLossCarryforwards" xlink:title="DeferredTaxAssetsOperatingLossCarryforwards" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl">Acquired net operating losses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:title="label: DeferredTaxAssetsOperatingLossCarryforwards to us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:label="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:title="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_lbl" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_lbl">Compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_lbl" xlink:title="label: DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits to us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_lbl1" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_lbl1">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_lbl1" xlink:title="label: DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits to us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:label="DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:title="DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_lbl" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_lbl">Allowance for credit losses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_lbl" xlink:title="label: DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts to us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_lbl1" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_lbl1">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_lbl1" xlink:title="label: DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts to us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="DeferredTaxLiabilities" xlink:title="DeferredTaxLiabilities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:title="us-gaap_DeferredTaxLiabilities_lbl" xml:lang="en-US" id="us-gaap_DeferredTaxLiabilities_lbl">Net deferred tax liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_lbl" xlink:title="label: DeferredTaxLiabilities to us-gaap_DeferredTaxLiabilities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxLiabilities_lbl1" xml:lang="en-US" id="us-gaap_DeferredTaxLiabilities_lbl1">Deferred Tax Liabilities, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_lbl1" xlink:title="label: DeferredTaxLiabilities to us-gaap_DeferredTaxLiabilities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther" xlink:label="DeferredTaxLiabilitiesOther" xlink:title="DeferredTaxLiabilitiesOther" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesOther_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_DeferredTaxLiabilitiesOther_lbl" xml:lang="en-US" id="us-gaap_DeferredTaxLiabilitiesOther_lbl">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxLiabilitiesOther" xlink:to="us-gaap_DeferredTaxLiabilitiesOther_lbl" xlink:title="label: DeferredTaxLiabilitiesOther to us-gaap_DeferredTaxLiabilitiesOther_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesOther_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxLiabilitiesOther_lbl1" xml:lang="en-US" id="us-gaap_DeferredTaxLiabilitiesOther_lbl1">Deferred Tax Liabilities, Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxLiabilitiesOther" xlink:to="us-gaap_DeferredTaxLiabilitiesOther_lbl1" xlink:title="label: DeferredTaxLiabilitiesOther to us-gaap_DeferredTaxLiabilitiesOther_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:title="DeferredTaxLiabilitiesPropertyPlantAndEquipment" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl" xml:lang="en-US" id="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl">Depreciation and amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl" xlink:title="label: DeferredTaxLiabilitiesPropertyPlantAndEquipment to us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl1" xml:lang="en-US" id="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl1">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl1" xlink:title="label: DeferredTaxLiabilitiesPropertyPlantAndEquipment to us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:label="DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:title="DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_lbl" xml:lang="en-US" id="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_lbl">Maximum employer contribution as a percentage of employee contribution</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:to="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_lbl" xlink:title="label: DefinedContributionPlanEmployerMatchingContributionPercentOfMatch to us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_lbl1" xml:lang="en-US" id="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_lbl1">Defined Contribution Plan, Employer Matching Contribution, Percent of Match</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:to="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_lbl1" xlink:title="label: DefinedContributionPlanEmployerMatchingContributionPercentOfMatch to us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:label="DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:title="DefinedContributionPlanEmployerDiscretionaryContributionAmount" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl" xml:lang="en-US" id="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl">Contribution expense recognized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:to="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl" xlink:title="label: DefinedContributionPlanEmployerDiscretionaryContributionAmount to us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl1" xml:lang="en-US" id="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl1">Defined Contribution Plan, Employer Discretionary Contribution Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:to="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl1" xlink:title="label: DefinedContributionPlanEmployerDiscretionaryContributionAmount to us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="DepreciationDepletionAndAmortization" xlink:title="DepreciationDepletionAndAmortization" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US" id="us-gaap_DepreciationDepletionAndAmortization_lbl">Depreciation and amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:title="label: DepreciationDepletionAndAmortization to us-gaap_DepreciationDepletionAndAmortization_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DepreciationDepletionAndAmortization_lbl1" xml:lang="en-US" id="us-gaap_DepreciationDepletionAndAmortization_lbl1">Depreciation, Depletion and Amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl1" xlink:title="label: DepreciationDepletionAndAmortization to us-gaap_DepreciationDepletionAndAmortization_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xml:lang="en-US" id="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl">Equity Based Plans [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:title="label: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:title="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US" id="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl">Equity Based Plans</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:title="label: DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock to us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl1" xml:lang="en-US" id="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl1">Share-based Payment Arrangement [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl1" xlink:title="label: DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock to us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsCommonStockCash" xlink:label="DividendsCommonStockCash" xlink:title="DividendsCommonStockCash" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DividendsCommonStockCash_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_DividendsCommonStockCash_lbl" xml:lang="en-US" id="us-gaap_DividendsCommonStockCash_lbl">Dividends paid to USPT shareholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DividendsCommonStockCash" xlink:to="us-gaap_DividendsCommonStockCash_lbl" xlink:title="label: DividendsCommonStockCash to us-gaap_DividendsCommonStockCash_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DividendsCommonStockCash_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DividendsCommonStockCash_lbl1" xml:lang="en-US" id="us-gaap_DividendsCommonStockCash_lbl1">Dividends, Common Stock, Cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DividendsCommonStockCash" xlink:to="us-gaap_DividendsCommonStockCash_lbl1" xlink:title="label: DividendsCommonStockCash to us-gaap_DividendsCommonStockCash_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="EarningsPerShareTextBlock" xlink:title="EarningsPerShareTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EarningsPerShareTextBlock_lbl" xml:lang="en-US" id="us-gaap_EarningsPerShareTextBlock_lbl">Earnings Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl" xlink:title="label: EarningsPerShareTextBlock to us-gaap_EarningsPerShareTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EarningsPerShareTextBlock_lbl1" xml:lang="en-US" id="us-gaap_EarningsPerShareTextBlock_lbl1">Earnings Per Share [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl1" xlink:title="label: EarningsPerShareTextBlock to us-gaap_EarningsPerShareTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="EarningsPerShareBasicAndDiluted" xlink:title="EarningsPerShareBasicAndDiluted" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US" id="us-gaap_EarningsPerShareBasicAndDiluted_lbl">Basic and diluted earnings per share attributable to USPH shareholders (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:title="label: EarningsPerShareBasicAndDiluted to us-gaap_EarningsPerShareBasicAndDiluted_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EarningsPerShareBasicAndDiluted_lbl1" xml:lang="en-US" id="us-gaap_EarningsPerShareBasicAndDiluted_lbl1">Earnings per share (basic and diluted) (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl1" xlink:title="label: EarningsPerShareBasicAndDiluted to us-gaap_EarningsPerShareBasicAndDiluted_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" xlink:title="EarningsPerShareAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US" id="us-gaap_EarningsPerShareAbstract_lbl">Earnings Per Share [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl" xlink:title="label: EarningsPerShareAbstract to us-gaap_EarningsPerShareAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:label="EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:title="EffectiveIncomeTaxRateReconciliationNondeductibleExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_lbl" xml:lang="en-US" id="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_lbl">Nondeductible expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_lbl" xlink:title="label: EffectiveIncomeTaxRateReconciliationNondeductibleExpense to us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_lbl1" xml:lang="en-US" id="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_lbl1">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_lbl1" xlink:title="label: EffectiveIncomeTaxRateReconciliationNondeductibleExpense to us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDeductions" xlink:label="EffectiveIncomeTaxRateReconciliationDeductions" xlink:title="EffectiveIncomeTaxRateReconciliationDeductions" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationDeductions_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_EffectiveIncomeTaxRateReconciliationDeductions_lbl" xml:lang="en-US" id="us-gaap_EffectiveIncomeTaxRateReconciliationDeductions_lbl">Excess equity compensation deduction</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationDeductions" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationDeductions_lbl" xlink:title="label: EffectiveIncomeTaxRateReconciliationDeductions to us-gaap_EffectiveIncomeTaxRateReconciliationDeductions_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationDeductions_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EffectiveIncomeTaxRateReconciliationDeductions_lbl1" xml:lang="en-US" id="us-gaap_EffectiveIncomeTaxRateReconciliationDeductions_lbl1">Effective Income Tax Rate Reconciliation, Deduction, Percent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationDeductions" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationDeductions_lbl1" xlink:title="label: EffectiveIncomeTaxRateReconciliationDeductions to us-gaap_EffectiveIncomeTaxRateReconciliationDeductions_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:title="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US" id="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl">U.S. tax at statutory rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:title="label: EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate to us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl1" xml:lang="en-US" id="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl1">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl1" xlink:title="label: EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate to us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:title="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US" id="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl">State income taxes, net of federal benefit and tax reform</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:title="label: EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes to us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl1" xml:lang="en-US" id="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl1">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl1" xlink:title="label: EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes to us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="EffectiveIncomeTaxRateContinuingOperations" xlink:title="EffectiveIncomeTaxRateContinuingOperations" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US" id="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl">Total</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:title="label: EffectiveIncomeTaxRateContinuingOperations to us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl1" xml:lang="en-US" id="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl1">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl1" xlink:title="label: EffectiveIncomeTaxRateContinuingOperations to us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl" xml:lang="en-US" id="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl">Compensation not yet recognized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl" xlink:title="label: EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions to us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl1" xml:lang="en-US" id="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl1">Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl1" xlink:title="label: EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions to us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="EmployeeRelatedLiabilitiesCurrent" xlink:title="EmployeeRelatedLiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US" id="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl">Salaries and related costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:title="label: EmployeeRelatedLiabilitiesCurrent to us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl1" xml:lang="en-US" id="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl1">Employee-related Liabilities, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl1" xlink:title="label: EmployeeRelatedLiabilitiesCurrent to us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EquityComponentDomain_lbl" xml:lang="en-US" id="us-gaap_EquityComponentDomain_lbl">Equity Component [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl" xlink:title="label: EquityComponentDomain to us-gaap_EquityComponentDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="EquityAbstract" xlink:title="EquityAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EquityAbstract_lbl" xml:lang="en-US" id="us-gaap_EquityAbstract_lbl">Common Stock [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:title="label: EquityAbstract to us-gaap_EquityAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems" xlink:label="EquityClassOfTreasuryStockLineItems" xlink:title="EquityClassOfTreasuryStockLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityClassOfTreasuryStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EquityClassOfTreasuryStockLineItems_lbl" xml:lang="en-US" id="us-gaap_EquityClassOfTreasuryStockLineItems_lbl">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityClassOfTreasuryStockLineItems" xlink:to="us-gaap_EquityClassOfTreasuryStockLineItems_lbl" xlink:title="label: EquityClassOfTreasuryStockLineItems to us-gaap_EquityClassOfTreasuryStockLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="FairValueOfFinancialInstrumentsPolicy" xlink:title="FairValueOfFinancialInstrumentsPolicy" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US" id="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl">Fair Values of Financial Instruments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:title="label: FairValueOfFinancialInstrumentsPolicy to us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl1" xml:lang="en-US" id="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl1">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl1" xlink:title="label: FairValueOfFinancialInstrumentsPolicy to us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts" xlink:label="FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts" xlink:title="FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts_lbl" xml:lang="en-US" id="us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts_lbl">Allowance for Credit Losses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts" xlink:to="us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts_lbl" xlink:title="label: FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts to us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:title="label: FiniteLivedIntangibleAssetsByMajorClassAxis to us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_lbl">Amortization Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_lbl" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_lbl1">Finite-lived Intangible Assets Amortization Expense [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_lbl1" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl">2021</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl1" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl1">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl1" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl">Thereafter</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl1" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl1">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl1" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xlink:title="label: FiniteLivedIntangibleAssetsMajorClassNameDomain to us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl">2022</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl1" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl1">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl1" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl">2023</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearThree to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl1" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl1">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl1" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearThree to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:title="FiniteLivedIntangibleAssetsAccumulatedAmortization" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl">Accumulated amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:title="label: FiniteLivedIntangibleAssetsAccumulatedAmortization to us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl1" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl1">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl1" xlink:title="label: FiniteLivedIntangibleAssetsAccumulatedAmortization to us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:label="FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:title="FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_lbl">Preliminary Purchase Prices Allocation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:to="us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_lbl" xlink:title="label: FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock to us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_lbl1">Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:to="us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_lbl1" xlink:title="label: FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock to us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl">2024</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearFour to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl1" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl1">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl1" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearFour to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:label="FiniteLivedIntangibleAssetsNetAbstract" xlink:title="FiniteLivedIntangibleAssetsNetAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNetAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsNetAbstract_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsNetAbstract_lbl">Finite-Lived Intangible Assets, Net [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsNetAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNetAbstract_lbl" xlink:title="label: FiniteLivedIntangibleAssetsNetAbstract to us-gaap_FiniteLivedIntangibleAssetsNetAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="FiniteLivedIntangibleAssetsLineItems" xlink:title="FiniteLivedIntangibleAssetsLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl">Finite Lived Intangible Assets [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xlink:title="label: FiniteLivedIntangibleAssetsLineItems to us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="FiniteLivedIntangibleAssetUsefulLife" xlink:title="FiniteLivedIntangibleAssetUsefulLife" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl">Estimated useful life</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xlink:title="label: FiniteLivedIntangibleAssetUsefulLife to us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl1" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl1">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl1" xlink:title="label: FiniteLivedIntangibleAssetUsefulLife to us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:label="FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:title="FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_lbl">Finite-Lived Intangible Assets, Amortization Expense, Maturity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_lbl" xlink:title="label: FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract to us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl">2025</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearFive to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl1" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl1">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl1" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearFive to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="ForeignCountryMember" xlink:title="ForeignCountryMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ForeignCountryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ForeignCountryMember_lbl" xml:lang="en-US" id="us-gaap_ForeignCountryMember_lbl">Federal [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ForeignCountryMember" xlink:to="us-gaap_ForeignCountryMember_lbl" xlink:title="label: ForeignCountryMember to us-gaap_ForeignCountryMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesGross" xlink:label="FurnitureAndFixturesGross" xlink:title="FurnitureAndFixturesGross" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FurnitureAndFixturesGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FurnitureAndFixturesGross_lbl" xml:lang="en-US" id="us-gaap_FurnitureAndFixturesGross_lbl">Furniture and equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FurnitureAndFixturesGross" xlink:to="us-gaap_FurnitureAndFixturesGross_lbl" xlink:title="label: FurnitureAndFixturesGross to us-gaap_FurnitureAndFixturesGross_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FurnitureAndFixturesGross_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FurnitureAndFixturesGross_lbl1" xml:lang="en-US" id="us-gaap_FurnitureAndFixturesGross_lbl1">Furniture and Fixtures, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FurnitureAndFixturesGross" xlink:to="us-gaap_FurnitureAndFixturesGross_lbl1" xlink:title="label: FurnitureAndFixturesGross to us-gaap_FurnitureAndFixturesGross_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="FurnitureAndFixturesMember" xlink:title="FurnitureAndFixturesMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FurnitureAndFixturesMember_lbl" xml:lang="en-US" id="us-gaap_FurnitureAndFixturesMember_lbl">Furniture &amp; Equipment [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl" xlink:title="label: FurnitureAndFixturesMember to us-gaap_FurnitureAndFixturesMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FurnitureAndFixturesMember_lbl1" xml:lang="en-US" id="us-gaap_FurnitureAndFixturesMember_lbl1">Furniture and Fixtures [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl1" xlink:title="label: FurnitureAndFixturesMember to us-gaap_FurnitureAndFixturesMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfInterestInProjects" xlink:label="GainLossOnSaleOfInterestInProjects" xlink:title="GainLossOnSaleOfInterestInProjects" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GainLossOnSaleOfInterestInProjects_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_GainLossOnSaleOfInterestInProjects_lbl" xml:lang="en-US" id="us-gaap_GainLossOnSaleOfInterestInProjects_lbl">Gain on sale of partnership interest and clinics</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainLossOnSaleOfInterestInProjects" xlink:to="us-gaap_GainLossOnSaleOfInterestInProjects_lbl" xlink:title="label: GainLossOnSaleOfInterestInProjects to us-gaap_GainLossOnSaleOfInterestInProjects_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GainLossOnSaleOfInterestInProjects_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GainLossOnSaleOfInterestInProjects_lbl1" xml:lang="en-US" id="us-gaap_GainLossOnSaleOfInterestInProjects_lbl1">Gain (Loss) on Sale of Interest in Projects</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainLossOnSaleOfInterestInProjects" xlink:to="us-gaap_GainLossOnSaleOfInterestInProjects_lbl1" xlink:title="label: GainLossOnSaleOfInterestInProjects to us-gaap_GainLossOnSaleOfInterestInProjects_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="GainsLossesOnExtinguishmentOfDebt" xlink:title="GainsLossesOnExtinguishmentOfDebt" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xml:lang="en-US" id="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl">Gain on derecognition of debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xlink:title="label: GainsLossesOnExtinguishmentOfDebt to us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl1" xml:lang="en-US" id="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl1">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl1" xlink:title="label: GainsLossesOnExtinguishmentOfDebt to us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="GoodwillImpairmentLoss" xlink:title="GoodwillImpairmentLoss" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillImpairmentLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GoodwillImpairmentLoss_lbl" xml:lang="en-US" id="us-gaap_GoodwillImpairmentLoss_lbl">Closure costs - derecognition of goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillImpairmentLoss" xlink:to="us-gaap_GoodwillImpairmentLoss_lbl" xlink:title="label: GoodwillImpairmentLoss to us-gaap_GoodwillImpairmentLoss_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillImpairmentLoss_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_GoodwillImpairmentLoss_lbl1" xml:lang="en-US" id="us-gaap_GoodwillImpairmentLoss_lbl1">Write-off of goodwill - closed clinics</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillImpairmentLoss" xlink:to="us-gaap_GoodwillImpairmentLoss_lbl1" xlink:title="label: GoodwillImpairmentLoss to us-gaap_GoodwillImpairmentLoss_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillImpairmentLoss_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_GoodwillImpairmentLoss_lbl2" xml:lang="en-US" id="us-gaap_GoodwillImpairmentLoss_lbl2">Goodwill derecognition (write-off) related to closed clinics</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillImpairmentLoss" xlink:to="us-gaap_GoodwillImpairmentLoss_lbl2" xlink:title="label: GoodwillImpairmentLoss to us-gaap_GoodwillImpairmentLoss_lbl2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:label="GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:title="GoodwillWrittenOffRelatedToSaleOfBusinessUnit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_lbl" xml:lang="en-US" id="us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_lbl">Goodwill related to partnership interest sold</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:to="us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_lbl" xlink:title="label: GoodwillWrittenOffRelatedToSaleOfBusinessUnit to us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_lbl1" xml:lang="en-US" id="us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_lbl1">Goodwill, Written off Related to Sale of Business Unit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:to="us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_lbl1" xlink:title="label: GoodwillWrittenOffRelatedToSaleOfBusinessUnit to us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="GoodwillAcquiredDuringPeriod" xlink:title="GoodwillAcquiredDuringPeriod" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillAcquiredDuringPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_GoodwillAcquiredDuringPeriod_lbl" xml:lang="en-US" id="us-gaap_GoodwillAcquiredDuringPeriod_lbl">Goodwill acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillAcquiredDuringPeriod" xlink:to="us-gaap_GoodwillAcquiredDuringPeriod_lbl" xlink:title="label: GoodwillAcquiredDuringPeriod to us-gaap_GoodwillAcquiredDuringPeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillAcquiredDuringPeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GoodwillAcquiredDuringPeriod_lbl1" xml:lang="en-US" id="us-gaap_GoodwillAcquiredDuringPeriod_lbl1">Goodwill, Acquired During Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillAcquiredDuringPeriod" xlink:to="us-gaap_GoodwillAcquiredDuringPeriod_lbl1" xlink:title="label: GoodwillAcquiredDuringPeriod to us-gaap_GoodwillAcquiredDuringPeriod_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillDisclosureTextBlock" xlink:label="GoodwillDisclosureTextBlock" xlink:title="GoodwillDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_GoodwillDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_GoodwillDisclosureTextBlock_lbl">Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillDisclosureTextBlock" xlink:to="us-gaap_GoodwillDisclosureTextBlock_lbl" xlink:title="label: GoodwillDisclosureTextBlock to us-gaap_GoodwillDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GoodwillDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_GoodwillDisclosureTextBlock_lbl1">Goodwill Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillDisclosureTextBlock" xlink:to="us-gaap_GoodwillDisclosureTextBlock_lbl1" xlink:title="label: GoodwillDisclosureTextBlock to us-gaap_GoodwillDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:label="Goodwill" xlink:title="Goodwill" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Goodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_Goodwill_lbl" xml:lang="en-US" id="us-gaap_Goodwill_lbl">Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Goodwill" xlink:to="us-gaap_Goodwill_lbl" xlink:title="label: Goodwill to us-gaap_Goodwill_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Goodwill_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_Goodwill_lbl1" xml:lang="en-US" id="us-gaap_Goodwill_lbl1">Ending balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Goodwill" xlink:to="us-gaap_Goodwill_lbl1" xlink:title="label: Goodwill to us-gaap_Goodwill_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Goodwill_lbl2" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_Goodwill_lbl2" xml:lang="en-US" id="us-gaap_Goodwill_lbl2">Beginning balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Goodwill" xlink:to="us-gaap_Goodwill_lbl2" xlink:title="label: Goodwill to us-gaap_Goodwill_lbl2" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Goodwill_lbl3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_Goodwill_lbl3" xml:lang="en-US" id="us-gaap_Goodwill_lbl3">Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Goodwill" xlink:to="us-gaap_Goodwill_lbl3" xlink:title="label: Goodwill to us-gaap_Goodwill_lbl3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:label="GoodwillPurchaseAccountingAdjustments" xlink:title="GoodwillPurchaseAccountingAdjustments" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillPurchaseAccountingAdjustments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_GoodwillPurchaseAccountingAdjustments_lbl" xml:lang="en-US" id="us-gaap_GoodwillPurchaseAccountingAdjustments_lbl">Goodwill adjustments for purchase price allocation of businesses acquired in prior year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillPurchaseAccountingAdjustments" xlink:to="us-gaap_GoodwillPurchaseAccountingAdjustments_lbl" xlink:title="label: GoodwillPurchaseAccountingAdjustments to us-gaap_GoodwillPurchaseAccountingAdjustments_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillPurchaseAccountingAdjustments_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GoodwillPurchaseAccountingAdjustments_lbl1" xml:lang="en-US" id="us-gaap_GoodwillPurchaseAccountingAdjustments_lbl1">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillPurchaseAccountingAdjustments" xlink:to="us-gaap_GoodwillPurchaseAccountingAdjustments_lbl1" xlink:title="label: GoodwillPurchaseAccountingAdjustments to us-gaap_GoodwillPurchaseAccountingAdjustments_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward" xlink:label="GoodwillRollForward" xlink:title="GoodwillRollForward" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_GoodwillRollForward_lbl" xml:lang="en-US" id="us-gaap_GoodwillRollForward_lbl">Goodwill [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillRollForward" xlink:to="us-gaap_GoodwillRollForward_lbl" xlink:title="label: GoodwillRollForward to us-gaap_GoodwillRollForward_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillRollForward_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GoodwillRollForward_lbl1" xml:lang="en-US" id="us-gaap_GoodwillRollForward_lbl1">Goodwill [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillRollForward" xlink:to="us-gaap_GoodwillRollForward_lbl1" xlink:title="label: GoodwillRollForward to us-gaap_GoodwillRollForward_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:title="GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US" id="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl">Goodwill [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:title="label: GoodwillAndIntangibleAssetsDisclosureAbstract to us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:title="GoodwillAndIntangibleAssetsPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl">Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xlink:title="label: GoodwillAndIntangibleAssetsPolicyTextBlock to us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl1">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl1" xlink:title="label: GoodwillAndIntangibleAssetsPolicyTextBlock to us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrantsReceivable" xlink:label="GrantsReceivable" xlink:title="GrantsReceivable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GrantsReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GrantsReceivable_lbl" xml:lang="en-US" id="us-gaap_GrantsReceivable_lbl">Funds received</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GrantsReceivable" xlink:to="us-gaap_GrantsReceivable_lbl" xlink:title="label: GrantsReceivable to us-gaap_GrantsReceivable_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit" xlink:label="GrossProfit" xlink:title="GrossProfit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GrossProfit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_GrossProfit_lbl" xml:lang="en-US" id="us-gaap_GrossProfit_lbl">Gross profit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GrossProfit" xlink:to="us-gaap_GrossProfit_lbl" xlink:title="label: GrossProfit to us-gaap_GrossProfit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GrossProfit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GrossProfit_lbl1" xml:lang="en-US" id="us-gaap_GrossProfit_lbl1">Gross profit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GrossProfit" xlink:to="us-gaap_GrossProfit_lbl1" xlink:title="label: GrossProfit to us-gaap_GrossProfit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:title="ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl">Long-Lived Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:title="label: ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock to us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl1">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl1" xlink:title="label: ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock to us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:label="ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:title="ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_lbl">Impairment of Long-Lived Assets and Long-Lived Assets to be Disposed of</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_lbl" xlink:title="label: ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock to us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_lbl1">Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_lbl1" xlink:title="label: ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock to us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="IncomeTaxAuthorityAxis" xlink:title="IncomeTaxAuthorityAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxAuthorityAxis_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxAuthorityAxis_lbl">Income Tax Authority [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:title="label: IncomeTaxAuthorityAxis to us-gaap_IncomeTaxAuthorityAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US" id="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl">Income before taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:title="label: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1" xml:lang="en-US" id="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1" xlink:title="label: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxDisclosureAbstract_lbl">Income Taxes [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:title="label: IncomeTaxDisclosureAbstract to us-gaap_IncomeTaxDisclosureAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeTaxDisclosureAbstract_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxDisclosureAbstract_lbl1">Income Taxes [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl1" xlink:title="label: IncomeTaxDisclosureAbstract to us-gaap_IncomeTaxDisclosureAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationYearUnderExamination" xlink:label="IncomeTaxExaminationYearUnderExamination" xlink:title="IncomeTaxExaminationYearUnderExamination" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxExaminationYearUnderExamination_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeTaxExaminationYearUnderExamination_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxExaminationYearUnderExamination_lbl">Periods open for examination</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxExaminationYearUnderExamination" xlink:to="us-gaap_IncomeTaxExaminationYearUnderExamination_lbl" xlink:title="label: IncomeTaxExaminationYearUnderExamination to us-gaap_IncomeTaxExaminationYearUnderExamination_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxExaminationYearUnderExamination_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxExaminationYearUnderExamination_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxExaminationYearUnderExamination_lbl1">Income Tax Examination, Year under Examination</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxExaminationYearUnderExamination" xlink:to="us-gaap_IncomeTaxExaminationYearUnderExamination_lbl1" xlink:title="label: IncomeTaxExaminationYearUnderExamination to us-gaap_IncomeTaxExaminationYearUnderExamination_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:label="IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:title="IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_lbl">Adjustment to deferred tax assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:to="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_lbl" xlink:title="label: IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability to us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="IncomeStatementAbstract" xlink:title="IncomeStatementAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US" id="us-gaap_IncomeStatementAbstract_lbl">CONSOLIDATED STATEMENTS OF INCOME [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:title="label: IncomeStatementAbstract to us-gaap_IncomeStatementAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationTable" xlink:label="IncomeTaxExaminationTable" xlink:title="IncomeTaxExaminationTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxExaminationTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxExaminationTable_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxExaminationTable_lbl">Income Tax Examination [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxExaminationTable" xlink:to="us-gaap_IncomeTaxExaminationTable_lbl" xlink:title="label: IncomeTaxExaminationTable to us-gaap_IncomeTaxExaminationTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="IncomeTaxDisclosureTextBlock" xlink:title="IncomeTaxDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxDisclosureTextBlock_lbl">Income Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:title="label: IncomeTaxDisclosureTextBlock to us-gaap_IncomeTaxDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxDisclosureTextBlock_lbl1">Income Tax Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl1" xlink:title="label: IncomeTaxDisclosureTextBlock to us-gaap_IncomeTaxDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationLineItems" xlink:label="IncomeTaxExaminationLineItems" xlink:title="IncomeTaxExaminationLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxExaminationLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxExaminationLineItems_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxExaminationLineItems_lbl">Income Tax Examination [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxExaminationLineItems" xlink:to="us-gaap_IncomeTaxExaminationLineItems_lbl" xlink:title="label: IncomeTaxExaminationLineItems to us-gaap_IncomeTaxExaminationLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="IncomeTaxAuthorityDomain" xlink:title="IncomeTaxAuthorityDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxAuthorityDomain_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxAuthorityDomain_lbl">Income Tax Authority [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxAuthorityDomain" xlink:to="us-gaap_IncomeTaxAuthorityDomain_lbl" xlink:title="label: IncomeTaxAuthorityDomain to us-gaap_IncomeTaxAuthorityDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:title="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl">U.S. tax at statutory rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xlink:title="label: IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate to us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl1">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl1" xlink:title="label: IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate to us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationDeductions" xlink:label="IncomeTaxReconciliationDeductions" xlink:title="IncomeTaxReconciliationDeductions" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationDeductions_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_IncomeTaxReconciliationDeductions_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxReconciliationDeductions_lbl">Excess equity compensation deduction</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxReconciliationDeductions" xlink:to="us-gaap_IncomeTaxReconciliationDeductions_lbl" xlink:title="label: IncomeTaxReconciliationDeductions to us-gaap_IncomeTaxReconciliationDeductions_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationDeductions_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxReconciliationDeductions_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxReconciliationDeductions_lbl1">Effective Income Tax Rate Reconciliation, Deduction, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxReconciliationDeductions" xlink:to="us-gaap_IncomeTaxReconciliationDeductions_lbl1" xlink:title="label: IncomeTaxReconciliationDeductions to us-gaap_IncomeTaxReconciliationDeductions_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:label="IncomeTaxReconciliationNondeductibleExpense" xlink:title="IncomeTaxReconciliationNondeductibleExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl">Non-deductible expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxReconciliationNondeductibleExpense" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl" xlink:title="label: IncomeTaxReconciliationNondeductibleExpense to us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl1">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxReconciliationNondeductibleExpense" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl1" xlink:title="label: IncomeTaxReconciliationNondeductibleExpense to us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxExpenseBenefit_lbl">Provision for income taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:title="label: IncomeTaxExpenseBenefit to us-gaap_IncomeTaxExpenseBenefit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_IncomeTaxExpenseBenefit_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxExpenseBenefit_lbl1">Total income tax provision</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl1" xlink:title="label: IncomeTaxExpenseBenefit to us-gaap_IncomeTaxExpenseBenefit_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxExpenseBenefit_lbl2" xml:lang="en-US" id="us-gaap_IncomeTaxExpenseBenefit_lbl2">Income Tax Expense (Benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl2" xlink:title="label: IncomeTaxExpenseBenefit to us-gaap_IncomeTaxExpenseBenefit_lbl2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:title="IncomeTaxReconciliationStateAndLocalIncomeTaxes" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl">State income taxes, net of federal benefit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xlink:title="label: IncomeTaxReconciliationStateAndLocalIncomeTaxes to us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl1">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl1" xlink:title="label: IncomeTaxReconciliationStateAndLocalIncomeTaxes to us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="IncomeTaxPolicyTextBlock" xlink:title="IncomeTaxPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxPolicyTextBlock_lbl">Income Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:title="label: IncomeTaxPolicyTextBlock to us-gaap_IncomeTaxPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxPolicyTextBlock_lbl1">Income Tax, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl1" xlink:title="label: IncomeTaxPolicyTextBlock to us-gaap_IncomeTaxPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="IncomeTaxesPaidNet" xlink:title="IncomeTaxesPaidNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeTaxesPaidNet_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxesPaidNet_lbl">Income taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl" xlink:title="label: IncomeTaxesPaidNet to us-gaap_IncomeTaxesPaidNet_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxesPaidNet_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxesPaidNet_lbl1">Income Taxes Paid, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl1" xlink:title="label: IncomeTaxesPaidNet to us-gaap_IncomeTaxesPaidNet_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:label="IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:title="IncreaseDecreaseInOtherNoncurrentLiabilities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_lbl">Increase (decrease) in other long-term liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_lbl" xlink:title="label: IncreaseDecreaseInOtherNoncurrentLiabilities to us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" xlink:label="IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" xlink:title="IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_lbl">Decrease (increase) in accounts receivable - other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_lbl" xlink:title="label: IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets to us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_lbl1">Increase (Decrease) in Accounts Receivable and Other Operating Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_lbl1" xlink:title="label: IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets to us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl">Increase (decrease) in accounts payable and accrued expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:title="label: IncreaseDecreaseInAccountsPayableAndAccruedLiabilities to us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl1">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl1" xlink:title="label: IncreaseDecreaseInAccountsPayableAndAccruedLiabilities to us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="IncreaseDecreaseInAccountsReceivable" xlink:title="IncreaseDecreaseInAccountsReceivable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl">Decrease (increase) in patient accounts receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:title="label: IncreaseDecreaseInAccountsReceivable to us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl1">Increase (Decrease) in Accounts Receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl1" xlink:title="label: IncreaseDecreaseInAccountsReceivable to us-gaap_IncreaseDecreaseInAccountsReceivable_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="IncreaseDecreaseInOtherOperatingAssets" xlink:title="IncreaseDecreaseInOtherOperatingAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl">Decrease (increase) in other assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xlink:title="label: IncreaseDecreaseInOtherOperatingAssets to us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl1">Increase (Decrease) in Other Operating Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl1" xlink:title="label: IncreaseDecreaseInOtherOperatingAssets to us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl">Changes in operating assets and liabilities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:title="label: IncreaseDecreaseInOperatingCapitalAbstract to us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1" xlink:title="label: IncreaseDecreaseInOperatingCapitalAbstract to us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="IncreaseDecreaseInStockholdersEquityRollForward" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" xlink:title="label: IncreaseDecreaseInStockholdersEquityRollForward to us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:title="IntangibleAssetsNetExcludingGoodwillAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_lbl" xml:lang="en-US" id="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_lbl">Intangible Assets, net [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_lbl" xlink:title="label: IntangibleAssetsNetExcludingGoodwillAbstract to us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="IntangibleAssetsNetExcludingGoodwill" xlink:title="IntangibleAssetsNetExcludingGoodwill" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US" id="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl">Other identifiable intangible assets, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:title="label: IntangibleAssetsNetExcludingGoodwill to us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl1" xml:lang="en-US" id="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl1">Total</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl1" xlink:title="label: IntangibleAssetsNetExcludingGoodwill to us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl2" xml:lang="en-US" id="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl2">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl2" xlink:title="label: IntangibleAssetsNetExcludingGoodwill to us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="IntangibleAssetsDisclosureTextBlock" xlink:title="IntangibleAssetsDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl">Intangible Assets, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xlink:title="label: IntangibleAssetsDisclosureTextBlock to us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl1">Intangible Assets Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl1" xlink:title="label: IntangibleAssetsDisclosureTextBlock to us-gaap_IntangibleAssetsDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndOtherIncome" xlink:label="InterestAndOtherIncome" xlink:title="InterestAndOtherIncome" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InterestAndOtherIncome_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_InterestAndOtherIncome_lbl" xml:lang="en-US" id="us-gaap_InterestAndOtherIncome_lbl">Interest and other income, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestAndOtherIncome" xlink:to="us-gaap_InterestAndOtherIncome_lbl" xlink:title="label: InterestAndOtherIncome to us-gaap_InterestAndOtherIncome_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InterestAndOtherIncome_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InterestAndOtherIncome_lbl1" xml:lang="en-US" id="us-gaap_InterestAndOtherIncome_lbl1">Interest and Other Income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestAndOtherIncome" xlink:to="us-gaap_InterestAndOtherIncome_lbl1" xlink:title="label: InterestAndOtherIncome to us-gaap_InterestAndOtherIncome_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" xlink:label="InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" xlink:title="InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations_lbl" xml:lang="en-US" id="us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations_lbl">Interest expense recognized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" xlink:to="us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations_lbl" xlink:title="label: InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations to us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations_lbl1" xml:lang="en-US" id="us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations_lbl1">Interest Expense on Prepetition Liabilities Recognized in Statement of Operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" xlink:to="us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations_lbl1" xlink:title="label: InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations to us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="InterestPaidNet" xlink:title="InterestPaidNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InterestPaidNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_InterestPaidNet_lbl" xml:lang="en-US" id="us-gaap_InterestPaidNet_lbl">Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:title="label: InterestPaidNet to us-gaap_InterestPaidNet_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InterestPaidNet_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InterestPaidNet_lbl1" xml:lang="en-US" id="us-gaap_InterestPaidNet_lbl1">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl1" xlink:title="label: InterestPaidNet to us-gaap_InterestPaidNet_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="LesseeOperatingLeaseTermOfContract" xlink:title="LesseeOperatingLeaseTermOfContract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseTermOfContract_lbl">Lease term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseTermOfContract" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:title="label: LesseeOperatingLeaseTermOfContract to us-gaap_LesseeOperatingLeaseTermOfContract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl">2023</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueYearThree to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="LesseeLeaseDescriptionTable" xlink:title="LesseeLeaseDescriptionTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeLeaseDescriptionTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeLeaseDescriptionTable_lbl" xml:lang="en-US" id="us-gaap_LesseeLeaseDescriptionTable_lbl">Lessee, Lease, Description [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeLeaseDescriptionTable" xlink:to="us-gaap_LesseeLeaseDescriptionTable_lbl" xlink:title="label: LesseeLeaseDescriptionTable to us-gaap_LesseeLeaseDescriptionTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl">Less: imputed interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityUndiscountedExcessAmount to us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl1" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl1">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl1" xlink:title="label: LesseeOperatingLeaseLiabilityUndiscountedExcessAmount to us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl">2025 and therafter</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl">2024</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueYearFour to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="LesseeLeaseDescriptionLineItems" xlink:title="LesseeLeaseDescriptionLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeLeaseDescriptionLineItems_lbl" xml:lang="en-US" id="us-gaap_LesseeLeaseDescriptionLineItems_lbl">Lessee, Lease, Description [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeLeaseDescriptionLineItems_lbl" xlink:title="label: LesseeLeaseDescriptionLineItems to us-gaap_LesseeLeaseDescriptionLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseDescriptionAbstract" xlink:label="LesseeOperatingLeaseDescriptionAbstract" xlink:title="LesseeOperatingLeaseDescriptionAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseDescriptionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseDescriptionAbstract_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseDescriptionAbstract_lbl">Operating Lease [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="us-gaap_LesseeOperatingLeaseDescriptionAbstract_lbl" xlink:title="label: LesseeOperatingLeaseDescriptionAbstract to us-gaap_LesseeOperatingLeaseDescriptionAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl">Total lease payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDue to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl1" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl1">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl1" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDue to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:title="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl">Future Lease Payments for Operating Leases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityMaturityTableTextBlock to us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="LesseeOperatingLeasesTextBlock" xlink:title="LesseeOperatingLeasesTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeasesTextBlock_lbl">Leases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:title="label: LesseeOperatingLeasesTextBlock to us-gaap_LesseeOperatingLeasesTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl">2022</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueYearTwo to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl">2021</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="LaborAndRelatedExpense" xlink:title="LaborAndRelatedExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LaborAndRelatedExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LaborAndRelatedExpense_lbl" xml:lang="en-US" id="us-gaap_LaborAndRelatedExpense_lbl">Salaries and related costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LaborAndRelatedExpense" xlink:to="us-gaap_LaborAndRelatedExpense_lbl" xlink:title="label: LaborAndRelatedExpense to us-gaap_LaborAndRelatedExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LaborAndRelatedExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LaborAndRelatedExpense_lbl1" xml:lang="en-US" id="us-gaap_LaborAndRelatedExpense_lbl1">Labor and Related Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LaborAndRelatedExpense" xlink:to="us-gaap_LaborAndRelatedExpense_lbl1" xlink:title="label: LaborAndRelatedExpense to us-gaap_LaborAndRelatedExpense_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostAbstract" xlink:label="LeaseCostAbstract" xlink:title="LeaseCostAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseCostAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LeaseCostAbstract_lbl" xml:lang="en-US" id="us-gaap_LeaseCostAbstract_lbl">Components of Lease Expense [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseCostAbstract" xlink:to="us-gaap_LeaseCostAbstract_lbl" xlink:title="label: LeaseCostAbstract to us-gaap_LeaseCostAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost" xlink:label="LeaseCost" xlink:title="LeaseCost" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_LeaseCost_lbl" xml:lang="en-US" id="us-gaap_LeaseCost_lbl">Total lease cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseCost" xlink:to="us-gaap_LeaseCost_lbl" xlink:title="label: LeaseCost to us-gaap_LeaseCost_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseCost_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LeaseCost_lbl1" xml:lang="en-US" id="us-gaap_LeaseCost_lbl1">Lease, Cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseCost" xlink:to="us-gaap_LeaseCost_lbl1" xlink:title="label: LeaseCost to us-gaap_LeaseCost_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="LeaseCostTableTextBlock" xlink:title="LeaseCostTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LeaseCostTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_LeaseCostTableTextBlock_lbl">Components of Lease Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl" xlink:title="label: LeaseCostTableTextBlock to us-gaap_LeaseCostTableTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsGross" xlink:label="LeaseholdImprovementsGross" xlink:title="LeaseholdImprovementsGross" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LeaseholdImprovementsGross_lbl" xml:lang="en-US" id="us-gaap_LeaseholdImprovementsGross_lbl">Leasehold improvements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseholdImprovementsGross" xlink:to="us-gaap_LeaseholdImprovementsGross_lbl" xlink:title="label: LeaseholdImprovementsGross to us-gaap_LeaseholdImprovementsGross_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsGross_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LeaseholdImprovementsGross_lbl1" xml:lang="en-US" id="us-gaap_LeaseholdImprovementsGross_lbl1">Leasehold Improvements, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseholdImprovementsGross" xlink:to="us-gaap_LeaseholdImprovementsGross_lbl1" xlink:title="label: LeaseholdImprovementsGross to us-gaap_LeaseholdImprovementsGross_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="LeaseholdImprovementsMember" xlink:title="LeaseholdImprovementsMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LeaseholdImprovementsMember_lbl" xml:lang="en-US" id="us-gaap_LeaseholdImprovementsMember_lbl">Leasehold Improvements [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl" xlink:title="label: LeaseholdImprovementsMember to us-gaap_LeaseholdImprovementsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LeaseholdImprovementsMember_lbl1" xml:lang="en-US" id="us-gaap_LeaseholdImprovementsMember_lbl1">Leasehold Improvements [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl1" xlink:title="label: LeaseholdImprovementsMember to us-gaap_LeaseholdImprovementsMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeasesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LeasesAbstract_lbl" xml:lang="en-US" id="us-gaap_LeasesAbstract_lbl">LEASES [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeasesAbstract" xlink:to="us-gaap_LeasesAbstract_lbl" xlink:title="label: LeasesAbstract to us-gaap_LeasesAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="LiabilitiesAndStockholdersEquity" xlink:title="LiabilitiesAndStockholdersEquity" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesAndStockholdersEquity_lbl">Total liabilities, redeemable non-controlling interests, USPH shareholders' equity and non-controlling interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:title="label: LiabilitiesAndStockholdersEquity to us-gaap_LiabilitiesAndStockholdersEquity_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesAndStockholdersEquity_lbl1" xml:lang="en-US" id="us-gaap_LiabilitiesAndStockholdersEquity_lbl1">Liabilities and Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl1" xlink:title="label: LiabilitiesAndStockholdersEquity to us-gaap_LiabilitiesAndStockholdersEquity_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="LiabilitiesAndStockholdersEquityAbstract" xlink:title="LiabilitiesAndStockholdersEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl">LIABILITIES, REDEEMABLE NON-CONTROLLING INTERESTS, USPH SHAREHOLDERS' EQUITY AND NON-CONTROLLING INTERESTS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:title="label: LiabilitiesAndStockholdersEquityAbstract to us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl1" xml:lang="en-US" id="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl1">Liabilities and Equity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl1" xlink:title="label: LiabilitiesAndStockholdersEquityAbstract to us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:label="Liabilities" xlink:title="Liabilities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_Liabilities_lbl" xml:lang="en-US" id="us-gaap_Liabilities_lbl">Total liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:title="label: Liabilities to us-gaap_Liabilities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_Liabilities_lbl1" xml:lang="en-US" id="us-gaap_Liabilities_lbl1">Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Liabilities" xlink:to="us-gaap_Liabilities_lbl1" xlink:title="label: Liabilities to us-gaap_Liabilities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:label="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:title="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_lbl">Closure costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_lbl" xlink:title="label: LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent to us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="LiabilitiesCurrent" xlink:title="LiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesCurrent_lbl">Total current liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:title="label: LiabilitiesCurrent to us-gaap_LiabilitiesCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesCurrent_lbl1" xml:lang="en-US" id="us-gaap_LiabilitiesCurrent_lbl1">Liabilities, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl1" xlink:title="label: LiabilitiesCurrent to us-gaap_LiabilitiesCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="LiabilitiesCurrentAbstract" xlink:title="LiabilitiesCurrentAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesCurrentAbstract_lbl">Current liabilities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:title="label: LiabilitiesCurrentAbstract to us-gaap_LiabilitiesCurrentAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesCurrentAbstract_lbl1" xml:lang="en-US" id="us-gaap_LiabilitiesCurrentAbstract_lbl1">Liabilities, Current [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl1" xlink:title="label: LiabilitiesCurrentAbstract to us-gaap_LiabilitiesCurrentAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:label="LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:title="LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_lbl" xml:lang="en-US" id="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_lbl">Percentage of unused commitment fee</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:to="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_lbl" xlink:title="label: LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage to us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_lbl1" xml:lang="en-US" id="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_lbl1">Line of Credit Facility, Unused Capacity, Commitment Fee Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:to="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_lbl1" xlink:title="label: LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage to us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="LineOfCreditFacilityMaximumBorrowingCapacity" xlink:title="LineOfCreditFacilityMaximumBorrowingCapacity" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xml:lang="en-US" id="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl">Revolving credit facility commitment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xlink:title="label: LineOfCreditFacilityMaximumBorrowingCapacity to us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl1" xml:lang="en-US" id="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl1">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl1" xlink:title="label: LineOfCreditFacilityMaximumBorrowingCapacity to us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:label="LineOfCreditFacilityInterestRateDuringPeriod" xlink:title="LineOfCreditFacilityInterestRateDuringPeriod" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl" xml:lang="en-US" id="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl">Average effective interest rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LineOfCreditFacilityInterestRateDuringPeriod" xlink:to="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl" xlink:title="label: LineOfCreditFacilityInterestRateDuringPeriod to us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl1" xml:lang="en-US" id="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl1">Line of Credit Facility, Interest Rate During Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LineOfCreditFacilityInterestRateDuringPeriod" xlink:to="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl1" xlink:title="label: LineOfCreditFacilityInterestRateDuringPeriod to us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:label="LineOfCreditFacilityRemainingBorrowingCapacity" xlink:title="LineOfCreditFacilityRemainingBorrowingCapacity" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl" xml:lang="en-US" id="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl">Remaining revolving credit outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl" xlink:title="label: LineOfCreditFacilityRemainingBorrowingCapacity to us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl1" xml:lang="en-US" id="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl1">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl1" xlink:title="label: LineOfCreditFacilityRemainingBorrowingCapacity to us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt" xlink:label="LongTermDebt" xlink:title="LongTermDebt" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_LongTermDebt_lbl" xml:lang="en-US" id="us-gaap_LongTermDebt_lbl">Payments/Long term debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl" xlink:title="label: LongTermDebt to us-gaap_LongTermDebt_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebt_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongTermDebt_lbl1" xml:lang="en-US" id="us-gaap_LongTermDebt_lbl1">Long-term Debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl1" xlink:title="label: LongTermDebt to us-gaap_LongTermDebt_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xml:lang="en-US" id="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl">Aggregate principal payment due in 2022</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl1" xml:lang="en-US" id="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl1">Long-Term Debt, Maturity, Year Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl1" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="LongTermDebtNoncurrent" xlink:title="LongTermDebtNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LongTermDebtNoncurrent_lbl" xml:lang="en-US" id="us-gaap_LongTermDebtNoncurrent_lbl">Long term portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebtNoncurrent_lbl" xlink:title="label: LongTermDebtNoncurrent to us-gaap_LongTermDebtNoncurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongTermDebtNoncurrent_lbl1" xml:lang="en-US" id="us-gaap_LongTermDebtNoncurrent_lbl1">Long-term Debt, Excluding Current Maturities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebtNoncurrent_lbl1" xlink:title="label: LongTermDebtNoncurrent to us-gaap_LongTermDebtNoncurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="LongTermDebtCurrent" xlink:title="LongTermDebtCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LongTermDebtCurrent_lbl" xml:lang="en-US" id="us-gaap_LongTermDebtCurrent_lbl">Current portion of notes payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_lbl" xlink:title="label: LongTermDebtCurrent to us-gaap_LongTermDebtCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtCurrent_lbl1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_LongTermDebtCurrent_lbl1" xml:lang="en-US" id="us-gaap_LongTermDebtCurrent_lbl1">Less current portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_lbl1" xlink:title="label: LongTermDebtCurrent to us-gaap_LongTermDebtCurrent_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtCurrent_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongTermDebtCurrent_lbl2" xml:lang="en-US" id="us-gaap_LongTermDebtCurrent_lbl2">Long-term Debt, Current Maturities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_lbl2" xlink:title="label: LongTermDebtCurrent to us-gaap_LongTermDebtCurrent_lbl2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xml:lang="en-US" id="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl">Aggregate principal payment due in 2021</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermLineOfCredit" xlink:label="LongTermLineOfCredit" xlink:title="LongTermLineOfCredit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermLineOfCredit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LongTermLineOfCredit_lbl" xml:lang="en-US" id="us-gaap_LongTermLineOfCredit_lbl">Revolving line of credit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermLineOfCredit" xlink:to="us-gaap_LongTermLineOfCredit_lbl" xlink:title="label: LongTermLineOfCredit to us-gaap_LongTermLineOfCredit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermLineOfCredit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongTermLineOfCredit_lbl1" xml:lang="en-US" id="us-gaap_LongTermLineOfCredit_lbl1">Long-term Line of Credit, Noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermLineOfCredit" xlink:to="us-gaap_LongTermLineOfCredit_lbl1" xlink:title="label: LongTermLineOfCredit to us-gaap_LongTermLineOfCredit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermNotesPayable" xlink:label="LongTermNotesPayable" xlink:title="LongTermNotesPayable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermNotesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LongTermNotesPayable_lbl" xml:lang="en-US" id="us-gaap_LongTermNotesPayable_lbl">Notes payable, net of current portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermNotesPayable" xlink:to="us-gaap_LongTermNotesPayable_lbl" xlink:title="label: LongTermNotesPayable to us-gaap_LongTermNotesPayable_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermNotesPayable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongTermNotesPayable_lbl1" xml:lang="en-US" id="us-gaap_LongTermNotesPayable_lbl1">Notes Payable, Noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermNotesPayable" xlink:to="us-gaap_LongTermNotesPayable_lbl1" xlink:title="label: LongTermNotesPayable to us-gaap_LongTermNotesPayable_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" xlink:label="MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" xlink:title="MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract_lbl" xml:lang="en-US" id="us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract_lbl">Less: net income attributable to non-controlling interests:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" xlink:to="us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract_lbl" xlink:title="label: MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract to us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:title="MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl" xml:lang="en-US" id="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl">Distributions to non-controlling interest partners - permanent equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl" xlink:title="label: MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders to us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl1" xml:lang="en-US" id="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl1">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl1" xlink:title="label: MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders to us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest" xlink:label="MinorityInterest" xlink:title="MinorityInterest" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MinorityInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_MinorityInterest_lbl" xml:lang="en-US" id="us-gaap_MinorityInterest_lbl">Non-controlling interests - permanent equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinorityInterest" xlink:to="us-gaap_MinorityInterest_lbl" xlink:title="label: MinorityInterest to us-gaap_MinorityInterest_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MinorityInterest_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MinorityInterest_lbl1" xml:lang="en-US" id="us-gaap_MinorityInterest_lbl1">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinorityInterest" xlink:to="us-gaap_MinorityInterest_lbl1" xlink:title="label: MinorityInterest to us-gaap_MinorityInterest_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDisclosureTextBlock" xlink:label="MinorityInterestDisclosureTextBlock" xlink:title="MinorityInterestDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MinorityInterestDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MinorityInterestDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_MinorityInterestDisclosureTextBlock_lbl">Acquisitions and Sale of Non-Controlling Interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinorityInterestDisclosureTextBlock" xlink:to="us-gaap_MinorityInterestDisclosureTextBlock_lbl" xlink:title="label: MinorityInterestDisclosureTextBlock to us-gaap_MinorityInterestDisclosureTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestChangeInRedemptionValue" xlink:label="MinorityInterestChangeInRedemptionValue" xlink:title="MinorityInterestChangeInRedemptionValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MinorityInterestChangeInRedemptionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_MinorityInterestChangeInRedemptionValue_lbl" xml:lang="en-US" id="us-gaap_MinorityInterestChangeInRedemptionValue_lbl">Changes in the fair value of redeemable non-controlling interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinorityInterestChangeInRedemptionValue" xlink:to="us-gaap_MinorityInterestChangeInRedemptionValue_lbl" xlink:title="label: MinorityInterestChangeInRedemptionValue to us-gaap_MinorityInterestChangeInRedemptionValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MinorityInterestChangeInRedemptionValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MinorityInterestChangeInRedemptionValue_lbl1" xml:lang="en-US" id="us-gaap_MinorityInterestChangeInRedemptionValue_lbl1">Noncontrolling Interest, Change in Redemption Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinorityInterestChangeInRedemptionValue" xlink:to="us-gaap_MinorityInterestChangeInRedemptionValue_lbl1" xlink:title="label: MinorityInterestChangeInRedemptionValue to us-gaap_MinorityInterestChangeInRedemptionValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:label="MovementInValuationAllowancesAndReservesRollForward" xlink:title="MovementInValuationAllowancesAndReservesRollForward" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MovementInValuationAllowancesAndReservesRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MovementInValuationAllowancesAndReservesRollForward_lbl" xml:lang="en-US" id="us-gaap_MovementInValuationAllowancesAndReservesRollForward_lbl">Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MovementInValuationAllowancesAndReservesRollForward" xlink:to="us-gaap_MovementInValuationAllowancesAndReservesRollForward_lbl" xlink:title="label: MovementInValuationAllowancesAndReservesRollForward to us-gaap_MovementInValuationAllowancesAndReservesRollForward_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="NetCashProvidedByUsedInOperatingActivities" xlink:title="NetCashProvidedByUsedInOperatingActivities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl">Net cash provided by operating activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:title="label: NetCashProvidedByUsedInOperatingActivities to us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1" xlink:title="label: NetCashProvidedByUsedInOperatingActivities to us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US" id="us-gaap_NetIncomeLoss_lbl">Net income attributable to USPH shareholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:title="label: NetIncomeLoss to us-gaap_NetIncomeLoss_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NetIncomeLoss_lbl1" xml:lang="en-US" id="us-gaap_NetIncomeLoss_lbl1">Net income attributable to USPH shareholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl1" xlink:title="label: NetIncomeLoss to us-gaap_NetIncomeLoss_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NetIncomeLoss_lbl2" xml:lang="en-US" id="us-gaap_NetIncomeLoss_lbl2">Net income attributable to USPH shareholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl2" xlink:title="label: NetIncomeLoss to us-gaap_NetIncomeLoss_lbl2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl">INVESTING ACTIVITIES</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:title="label: NetCashProvidedByUsedInInvestingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl1">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl1" xlink:title="label: NetCashProvidedByUsedInInvestingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl">OPERATING ACTIVITIES</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:title="label: NetCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl1">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xlink:title="label: NetCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="NetCashProvidedByUsedInInvestingActivities" xlink:title="NetCashProvidedByUsedInInvestingActivities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl">Net cash used in investing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:title="label: NetCashProvidedByUsedInInvestingActivities to us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl1">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl1" xlink:title="label: NetCashProvidedByUsedInInvestingActivities to us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="NetCashProvidedByUsedInFinancingActivities" xlink:title="NetCashProvidedByUsedInFinancingActivities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl">Net cash used in financing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:title="label: NetCashProvidedByUsedInFinancingActivities to us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1" xlink:title="label: NetCashProvidedByUsedInFinancingActivities to us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl">FINANCING ACTIVITIES</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:title="label: NetCashProvidedByUsedInFinancingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl1">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl1" xlink:title="label: NetCashProvidedByUsedInFinancingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:label="NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:title="NetIncomeLossAvailableToCommonStockholdersBasicAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl" xml:lang="en-US" id="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl">Computation of earnings per share - USPH shareholders [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl" xlink:title="label: NetIncomeLossAvailableToCommonStockholdersBasicAbstract to us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl1" xml:lang="en-US" id="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl1">Net Income (Loss) Available to Common Stockholders, Basic [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl1" xlink:title="label: NetIncomeLossAvailableToCommonStockholdersBasicAbstract to us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="NetIncomeLossAttributableToNoncontrollingInterest" xlink:title="NetIncomeLossAttributableToNoncontrollingInterest" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:title="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xml:lang="en-US" id="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl">Net income attributable to non-controlling interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xlink:title="label: NetIncomeLossAttributableToNoncontrollingInterest to us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl1" xml:lang="en-US" id="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl1">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl1" xlink:title="label: NetIncomeLossAttributableToNoncontrollingInterest to us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:title="NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl">Recently Adopted Accounting Guidance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:title="label: NewAccountingPronouncementsPolicyPolicyTextBlock to us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:label="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:title="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_lbl" xml:lang="en-US" id="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_lbl">Recently Adopted Accounting Guidance [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_lbl" xlink:title="label: NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract to us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" xlink:label="NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" xlink:title="NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1_lbl" xml:lang="en-US" id="us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1_lbl">Notes receivables related to sale of partnership interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" xlink:to="us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1_lbl" xlink:title="label: NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1 to us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionPayablesAssumed1" xlink:label="NoncashOrPartNoncashAcquisitionPayablesAssumed1" xlink:title="NoncashOrPartNoncashAcquisitionPayablesAssumed1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NoncashOrPartNoncashAcquisitionPayablesAssumed1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NoncashOrPartNoncashAcquisitionPayablesAssumed1_lbl" xml:lang="en-US" id="us-gaap_NoncashOrPartNoncashAcquisitionPayablesAssumed1_lbl">Purchase of business - payable to common shareholders of acquired business</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncashOrPartNoncashAcquisitionPayablesAssumed1" xlink:to="us-gaap_NoncashOrPartNoncashAcquisitionPayablesAssumed1_lbl" xlink:title="label: NoncashOrPartNoncashAcquisitionPayablesAssumed1 to us-gaap_NoncashOrPartNoncashAcquisitionPayablesAssumed1_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="NoncompeteAgreementsMember" xlink:title="NoncompeteAgreementsMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NoncompeteAgreementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NoncompeteAgreementsMember_lbl" xml:lang="en-US" id="us-gaap_NoncompeteAgreementsMember_lbl">Non-compete Agreements [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncompeteAgreementsMember" xlink:to="us-gaap_NoncompeteAgreementsMember_lbl" xlink:title="label: NoncompeteAgreementsMember to us-gaap_NoncompeteAgreementsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NoncompeteAgreementsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NoncompeteAgreementsMember_lbl1" xml:lang="en-US" id="us-gaap_NoncompeteAgreementsMember_lbl1">Non-compete Agreements [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncompeteAgreementsMember" xlink:to="us-gaap_NoncompeteAgreementsMember_lbl1" xlink:title="label: NoncompeteAgreementsMember to us-gaap_NoncompeteAgreementsMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="NonoperatingIncomeExpense" xlink:title="NonoperatingIncomeExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US" id="us-gaap_NonoperatingIncomeExpense_lbl">Total other income and expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:title="label: NonoperatingIncomeExpense to us-gaap_NonoperatingIncomeExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NonoperatingIncomeExpense_lbl1" xml:lang="en-US" id="us-gaap_NonoperatingIncomeExpense_lbl1">Nonoperating Income (Expense)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl1" xlink:title="label: NonoperatingIncomeExpense to us-gaap_NonoperatingIncomeExpense_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments" xlink:label="NumberOfReportableSegments" xlink:title="NumberOfReportableSegments" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NumberOfReportableSegments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NumberOfReportableSegments_lbl" xml:lang="en-US" id="us-gaap_NumberOfReportableSegments_lbl">Number of reportable segments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfReportableSegments" xlink:to="us-gaap_NumberOfReportableSegments_lbl" xlink:title="label: NumberOfReportableSegments to us-gaap_NumberOfReportableSegments_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NumberOfReportableSegments_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NumberOfReportableSegments_lbl1" xml:lang="en-US" id="us-gaap_NumberOfReportableSegments_lbl1">Number of Reportable Segments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfReportableSegments" xlink:to="us-gaap_NumberOfReportableSegments_lbl1" xlink:title="label: NumberOfReportableSegments to us-gaap_NumberOfReportableSegments_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="NumberOfOperatingSegments" xlink:title="NumberOfOperatingSegments" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NumberOfOperatingSegments_lbl" xml:lang="en-US" id="us-gaap_NumberOfOperatingSegments_lbl">Number of business segments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfOperatingSegments" xlink:to="us-gaap_NumberOfOperatingSegments_lbl" xlink:title="label: NumberOfOperatingSegments to us-gaap_NumberOfOperatingSegments_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfStatesInWhichEntityOperates" xlink:label="NumberOfStatesInWhichEntityOperates" xlink:title="NumberOfStatesInWhichEntityOperates" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NumberOfStatesInWhichEntityOperates_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NumberOfStatesInWhichEntityOperates_lbl" xml:lang="en-US" id="us-gaap_NumberOfStatesInWhichEntityOperates_lbl">Number of states where clinics are operated</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfStatesInWhichEntityOperates" xlink:to="us-gaap_NumberOfStatesInWhichEntityOperates_lbl" xlink:title="label: NumberOfStatesInWhichEntityOperates to us-gaap_NumberOfStatesInWhichEntityOperates_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NumberOfStatesInWhichEntityOperates_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NumberOfStatesInWhichEntityOperates_lbl1" xml:lang="en-US" id="us-gaap_NumberOfStatesInWhichEntityOperates_lbl1">Number of States in which Entity Operates</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfStatesInWhichEntityOperates" xlink:to="us-gaap_NumberOfStatesInWhichEntityOperates_lbl1" xlink:title="label: NumberOfStatesInWhichEntityOperates to us-gaap_NumberOfStatesInWhichEntityOperates_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfBusinessesAcquired" xlink:label="NumberOfBusinessesAcquired" xlink:title="NumberOfBusinessesAcquired" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NumberOfBusinessesAcquired_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NumberOfBusinessesAcquired_lbl" xml:lang="en-US" id="us-gaap_NumberOfBusinessesAcquired_lbl">Number of clinics</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfBusinessesAcquired" xlink:to="us-gaap_NumberOfBusinessesAcquired_lbl" xlink:title="label: NumberOfBusinessesAcquired to us-gaap_NumberOfBusinessesAcquired_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NumberOfBusinessesAcquired_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_NumberOfBusinessesAcquired_lbl1" xml:lang="en-US" id="us-gaap_NumberOfBusinessesAcquired_lbl1">Number of businesses acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfBusinessesAcquired" xlink:to="us-gaap_NumberOfBusinessesAcquired_lbl1" xlink:title="label: NumberOfBusinessesAcquired to us-gaap_NumberOfBusinessesAcquired_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="NoncontrollingInterestAbstract" xlink:title="NoncontrollingInterestAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NoncontrollingInterestAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NoncontrollingInterestAbstract_lbl" xml:lang="en-US" id="us-gaap_NoncontrollingInterestAbstract_lbl">Acquisitions and Sale of Non-Controlling Interests [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncontrollingInterestAbstract" xlink:to="us-gaap_NoncontrollingInterestAbstract_lbl" xlink:title="label: NoncontrollingInterestAbstract to us-gaap_NoncontrollingInterestAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="NoncontrollingInterestMember" xlink:title="NoncontrollingInterestMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NoncontrollingInterestMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NoncontrollingInterestMember_lbl" xml:lang="en-US" id="us-gaap_NoncontrollingInterestMember_lbl">Non-Controlling Interests [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncontrollingInterestMember" xlink:to="us-gaap_NoncontrollingInterestMember_lbl" xlink:title="label: NoncontrollingInterestMember to us-gaap_NoncontrollingInterestMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NoncontrollingInterestMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NoncontrollingInterestMember_lbl1" xml:lang="en-US" id="us-gaap_NoncontrollingInterestMember_lbl1">Noncontrolling Interest [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncontrollingInterestMember" xlink:to="us-gaap_NoncontrollingInterestMember_lbl1" xlink:title="label: NoncontrollingInterestMember to us-gaap_NoncontrollingInterestMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation" xlink:label="NoncontrollingInterestDecreaseFromDeconsolidation" xlink:title="NoncontrollingInterestDecreaseFromDeconsolidation" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation_lbl" xml:lang="en-US" id="us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation_lbl">Reduction of non-controlling interest due to sale of USPH partnership interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncontrollingInterestDecreaseFromDeconsolidation" xlink:to="us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation_lbl" xlink:title="label: NoncontrollingInterestDecreaseFromDeconsolidation to us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation_lbl1" xml:lang="en-US" id="us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation_lbl1">Noncontrolling Interest, Decrease from Deconsolidation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncontrollingInterestDecreaseFromDeconsolidation" xlink:to="us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation_lbl1" xlink:title="label: NoncontrollingInterestDecreaseFromDeconsolidation to us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:label="NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:title="NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_lbl" xml:lang="en-US" id="us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_lbl">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:to="us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_lbl" xlink:title="label: NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable to us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_lbl1" xml:lang="en-US" id="us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_lbl1">Noncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, Redeemable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:to="us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_lbl1" xlink:title="label: NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable to us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="OperatingLeasePayments" xlink:title="OperatingLeasePayments" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeasePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeasePayments_lbl" xml:lang="en-US" id="us-gaap_OperatingLeasePayments_lbl">Cash paid for amounts included in the measurement of operating lease liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl" xlink:title="label: OperatingLeasePayments to us-gaap_OperatingLeasePayments_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:title="OperatingLeaseLiabilitiesPaymentsDueAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl">Future Lease Payments for Operating Leases [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" xlink:title="label: OperatingLeaseLiabilitiesPaymentsDueAbstract to us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="OperatingLeaseWeightedAverageDiscountRatePercent" xlink:title="OperatingLeaseWeightedAverageDiscountRatePercent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl">Weighted-average discount rate - Operating leases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:title="label: OperatingLeaseWeightedAverageDiscountRatePercent to us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability" xlink:title="OperatingLeaseLiability" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseLiability_lbl">Total operating lease liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl" xlink:title="label: OperatingLeaseLiability to us-gaap_OperatingLeaseLiability_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseLiability_lbl1" xml:lang="en-US" id="us-gaap_OperatingLeaseLiability_lbl1">Lease Liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl1" xlink:title="label: OperatingLeaseLiability to us-gaap_OperatingLeaseLiability_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="OperatingLeaseLiabilityNoncurrent" xlink:title="OperatingLeaseLiabilityNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl">Operating lease liabilities, net of current portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:title="label: OperatingLeaseLiabilityNoncurrent to us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="OperatingLeaseLiabilityCurrent" xlink:title="OperatingLeaseLiabilityCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilityCurrent_lbl">Current portion of operating lease liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:title="label: OperatingLeaseLiabilityCurrent to us-gaap_OperatingLeaseLiabilityCurrent_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="OperatingSegmentsMember" xlink:title="OperatingSegmentsMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingSegmentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingSegmentsMember_lbl" xml:lang="en-US" id="us-gaap_OperatingSegmentsMember_lbl">Reportable Segments [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingSegmentsMember" xlink:to="us-gaap_OperatingSegmentsMember_lbl" xlink:title="label: OperatingSegmentsMember to us-gaap_OperatingSegmentsMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="OperatingLeaseCost" xlink:title="OperatingLeaseCost" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseCost_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseCost_lbl">Operating lease cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl" xlink:title="label: OperatingLeaseCost to us-gaap_OperatingLeaseCost_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="OperatingLeaseRightOfUseAsset" xlink:title="OperatingLeaseRightOfUseAsset" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseRightOfUseAsset_lbl">Operating lease right-of-use assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:title="label: OperatingLeaseRightOfUseAsset to us-gaap_OperatingLeaseRightOfUseAsset_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:title="OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl">Weighted-average remaining lease term - Operating leases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:title="label: OperatingLeaseWeightedAverageRemainingLeaseTerm1 to us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="OperatingIncomeLoss" xlink:title="OperatingIncomeLoss" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US" id="us-gaap_OperatingIncomeLoss_lbl">Operating income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:title="label: OperatingIncomeLoss to us-gaap_OperatingIncomeLoss_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingIncomeLoss_lbl1" xml:lang="en-US" id="us-gaap_OperatingIncomeLoss_lbl1">Operating Income (Loss)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl1" xlink:title="label: OperatingIncomeLoss to us-gaap_OperatingIncomeLoss_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl">Organization, Nature of Operations and Basis of Presentation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:title="label: OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock to us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl1">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl1" xlink:title="label: OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock to us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US" id="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl">Organization, Nature of Operations and Basis of Presentation [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:title="label: OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:label="OtherOperatingActivitiesCashFlowStatement" xlink:title="OtherOperatingActivitiesCashFlowStatement" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherOperatingActivitiesCashFlowStatement_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherOperatingActivitiesCashFlowStatement_lbl" xml:lang="en-US" id="us-gaap_OtherOperatingActivitiesCashFlowStatement_lbl">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherOperatingActivitiesCashFlowStatement" xlink:to="us-gaap_OtherOperatingActivitiesCashFlowStatement_lbl" xlink:title="label: OtherOperatingActivitiesCashFlowStatement to us-gaap_OtherOperatingActivitiesCashFlowStatement_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="OtherAssetsCurrent" xlink:title="OtherAssetsCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OtherAssetsCurrent_lbl" xml:lang="en-US" id="us-gaap_OtherAssetsCurrent_lbl">Other current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_lbl" xlink:title="label: OtherAssetsCurrent to us-gaap_OtherAssetsCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherAssetsCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherAssetsCurrent_lbl1" xml:lang="en-US" id="us-gaap_OtherAssetsCurrent_lbl1">Other Assets, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_lbl1" xlink:title="label: OtherAssetsCurrent to us-gaap_OtherAssetsCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="OtherAssetsNoncurrent" xlink:title="OtherAssetsNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US" id="us-gaap_OtherAssetsNoncurrent_lbl">Other assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl" xlink:title="label: OtherAssetsNoncurrent to us-gaap_OtherAssetsNoncurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherAssetsNoncurrent_lbl1" xml:lang="en-US" id="us-gaap_OtherAssetsNoncurrent_lbl1">Other Assets, Noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl1" xlink:title="label: OtherAssetsNoncurrent to us-gaap_OtherAssetsNoncurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="OtherLiabilitiesNoncurrent" xlink:title="OtherLiabilitiesNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OtherLiabilitiesNoncurrent_lbl" xml:lang="en-US" id="us-gaap_OtherLiabilitiesNoncurrent_lbl">Other long-term liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:title="label: OtherLiabilitiesNoncurrent to us-gaap_OtherLiabilitiesNoncurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherLiabilitiesNoncurrent_lbl1" xml:lang="en-US" id="us-gaap_OtherLiabilitiesNoncurrent_lbl1">Other Liabilities, Noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl1" xlink:title="label: OtherLiabilitiesNoncurrent to us-gaap_OtherLiabilitiesNoncurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="OtherNonoperatingIncomeExpenseAbstract" xlink:title="OtherNonoperatingIncomeExpenseAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US" id="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl">Other income and expense:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl" xlink:title="label: OtherNonoperatingIncomeExpenseAbstract to us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl1" xml:lang="en-US" id="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl1">Other Nonoperating Income (Expense) [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl1" xlink:title="label: OtherNonoperatingIncomeExpenseAbstract to us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="OtherAccruedLiabilitiesCurrent" xlink:title="OtherAccruedLiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US" id="us-gaap_OtherAccruedLiabilitiesCurrent_lbl">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:title="label: OtherAccruedLiabilitiesCurrent to us-gaap_OtherAccruedLiabilitiesCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherAccruedLiabilitiesCurrent_lbl1" xml:lang="en-US" id="us-gaap_OtherAccruedLiabilitiesCurrent_lbl1">Other Accrued Liabilities, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl1" xlink:title="label: OtherAccruedLiabilitiesCurrent to us-gaap_OtherAccruedLiabilitiesCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ParentMember" xlink:label="ParentMember" xlink:title="ParentMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ParentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ParentMember_lbl" xml:lang="en-US" id="us-gaap_ParentMember_lbl">Total Shareholders' Equity [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ParentMember" xlink:to="us-gaap_ParentMember_lbl" xlink:title="label: ParentMember to us-gaap_ParentMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ParentMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ParentMember_lbl1" xml:lang="en-US" id="us-gaap_ParentMember_lbl1">Parent [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ParentMember" xlink:to="us-gaap_ParentMember_lbl1" xlink:title="label: ParentMember to us-gaap_ParentMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="PayablesAndAccrualsAbstract" xlink:title="PayablesAndAccrualsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US" id="us-gaap_PayablesAndAccrualsAbstract_lbl">Accrued Expenses [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:title="label: PayablesAndAccrualsAbstract to us-gaap_PayablesAndAccrualsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:label="PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:title="PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_lbl" xml:lang="en-US" id="us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_lbl">Payments to settle mandatorily redeemable non-controlling interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:to="us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_lbl" xlink:title="label: PaymentsForRepurchaseOfRedeemableNoncontrollingInterest to us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_lbl1" xml:lang="en-US" id="us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_lbl1">Payments for Repurchase of Redeemable Noncontrolling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:to="us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_lbl1" xlink:title="label: PaymentsForRepurchaseOfRedeemableNoncontrollingInterest to us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock" xlink:label="PaymentsOfDividendsCommonStock" xlink:title="PaymentsOfDividendsCommonStock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsOfDividendsCommonStock_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_PaymentsOfDividendsCommonStock_lbl" xml:lang="en-US" id="us-gaap_PaymentsOfDividendsCommonStock_lbl">Cash dividends paid to shareholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsOfDividendsCommonStock" xlink:to="us-gaap_PaymentsOfDividendsCommonStock_lbl" xlink:title="label: PaymentsOfDividendsCommonStock to us-gaap_PaymentsOfDividendsCommonStock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsOfDividendsCommonStock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsOfDividendsCommonStock_lbl1" xml:lang="en-US" id="us-gaap_PaymentsOfDividendsCommonStock_lbl1">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsOfDividendsCommonStock" xlink:to="us-gaap_PaymentsOfDividendsCommonStock_lbl1" xlink:title="label: PaymentsOfDividendsCommonStock to us-gaap_PaymentsOfDividendsCommonStock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="PaymentsToAcquireBusinessesGross" xlink:title="PaymentsToAcquireBusinessesGross" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PaymentsToAcquireBusinessesGross_lbl" xml:lang="en-US" id="us-gaap_PaymentsToAcquireBusinessesGross_lbl">Cash paid for acquisition of interest in clinic</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireBusinessesGross" xlink:to="us-gaap_PaymentsToAcquireBusinessesGross_lbl" xlink:title="label: PaymentsToAcquireBusinessesGross to us-gaap_PaymentsToAcquireBusinessesGross_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsToAcquireBusinessesGross_lbl1" xml:lang="en-US" id="us-gaap_PaymentsToAcquireBusinessesGross_lbl1">Payments to Acquire Businesses, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireBusinessesGross" xlink:to="us-gaap_PaymentsToAcquireBusinessesGross_lbl1" xlink:title="label: PaymentsToAcquireBusinessesGross to us-gaap_PaymentsToAcquireBusinessesGross_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="PaymentsToAcquireBusinessesNetOfCashAcquired" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl" xml:lang="en-US" id="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl">Cash paid, net of cash acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl" xlink:title="label: PaymentsToAcquireBusinessesNetOfCashAcquired to us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl1" xml:lang="en-US" id="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl1">Purchase of majority interest in businesses, net of cash acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl1" xlink:title="label: PaymentsToAcquireBusinessesNetOfCashAcquired to us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl2" xml:lang="en-US" id="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl2">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl2" xlink:title="label: PaymentsToAcquireBusinessesNetOfCashAcquired to us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="PaymentsOfDividendsMinorityInterest" xlink:title="PaymentsOfDividendsMinorityInterest" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_PaymentsOfDividendsMinorityInterest_lbl" xml:lang="en-US" id="us-gaap_PaymentsOfDividendsMinorityInterest_lbl">Distributions to non-controlling interests, permanent and temporary equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsOfDividendsMinorityInterest" xlink:to="us-gaap_PaymentsOfDividendsMinorityInterest_lbl" xlink:title="label: PaymentsOfDividendsMinorityInterest to us-gaap_PaymentsOfDividendsMinorityInterest_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsOfDividendsMinorityInterest_lbl1" xml:lang="en-US" id="us-gaap_PaymentsOfDividendsMinorityInterest_lbl1">Payments of Ordinary Dividends, Noncontrolling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsOfDividendsMinorityInterest" xlink:to="us-gaap_PaymentsOfDividendsMinorityInterest_lbl1" xlink:title="label: PaymentsOfDividendsMinorityInterest to us-gaap_PaymentsOfDividendsMinorityInterest_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:label="PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:title="PaymentsToAcquireInterestInSubsidiariesAndAffiliates" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_lbl" xml:lang="en-US" id="us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_lbl">Purchase of non-controlling interest, permanent equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:to="us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_lbl" xlink:title="label: PaymentsToAcquireInterestInSubsidiariesAndAffiliates to us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_lbl1" xml:lang="en-US" id="us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_lbl1">Payments to Acquire Interest in Subsidiaries and Affiliates</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:to="us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_lbl1" xlink:title="label: PaymentsToAcquireInterestInSubsidiariesAndAffiliates to us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="PaymentsToAcquireProductiveAssets" xlink:title="PaymentsToAcquireProductiveAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xml:lang="en-US" id="us-gaap_PaymentsToAcquireProductiveAssets_lbl">Purchase of fixed assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireProductiveAssets" xlink:to="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xlink:title="label: PaymentsToAcquireProductiveAssets to us-gaap_PaymentsToAcquireProductiveAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsToAcquireProductiveAssets_lbl1" xml:lang="en-US" id="us-gaap_PaymentsToAcquireProductiveAssets_lbl1">Payments to Acquire Productive Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireProductiveAssets" xlink:to="us-gaap_PaymentsToAcquireProductiveAssets_lbl1" xlink:title="label: PaymentsToAcquireProductiveAssets to us-gaap_PaymentsToAcquireProductiveAssets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToMinorityShareholders" xlink:label="PaymentsToMinorityShareholders" xlink:title="PaymentsToMinorityShareholders" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToMinorityShareholders_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsToMinorityShareholders_lbl" xml:lang="en-US" id="us-gaap_PaymentsToMinorityShareholders_lbl">Acquired interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToMinorityShareholders" xlink:to="us-gaap_PaymentsToMinorityShareholders_lbl" xlink:title="label: PaymentsToMinorityShareholders to us-gaap_PaymentsToMinorityShareholders_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="PlanNameAxis" xlink:title="PlanNameAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PlanNameAxis_lbl" xml:lang="en-US" id="us-gaap_PlanNameAxis_lbl">Plan Name [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" xlink:title="label: PlanNameAxis to us-gaap_PlanNameAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="PlanNameDomain" xlink:title="PlanNameDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PlanNameDomain_lbl" xml:lang="en-US" id="us-gaap_PlanNameDomain_lbl">Plan Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PlanNameDomain" xlink:to="us-gaap_PlanNameDomain_lbl" xlink:title="label: PlanNameDomain to us-gaap_PlanNameDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockTextBlock" xlink:label="PreferredStockTextBlock" xlink:title="PreferredStockTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PreferredStockTextBlock_lbl" xml:lang="en-US" id="us-gaap_PreferredStockTextBlock_lbl">Preferred Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockTextBlock" xlink:to="us-gaap_PreferredStockTextBlock_lbl" xlink:title="label: PreferredStockTextBlock to us-gaap_PreferredStockTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockTextBlock_lbl1" xml:lang="en-US" id="us-gaap_PreferredStockTextBlock_lbl1">Preferred Stock [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockTextBlock" xlink:to="us-gaap_PreferredStockTextBlock_lbl1" xlink:title="label: PreferredStockTextBlock to us-gaap_PreferredStockTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="PreferredStockSharesIssued" xlink:title="PreferredStockSharesIssued" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US" id="us-gaap_PreferredStockSharesIssued_lbl">Preferred stock, shares issued (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:title="label: PreferredStockSharesIssued to us-gaap_PreferredStockSharesIssued_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockSharesIssued_lbl1" xml:lang="en-US" id="us-gaap_PreferredStockSharesIssued_lbl1">Preferred Stock, Shares Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl1" xlink:title="label: PreferredStockSharesIssued to us-gaap_PreferredStockSharesIssued_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="PreferredStockValue" xlink:title="PreferredStockValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PreferredStockValue_lbl" xml:lang="en-US" id="us-gaap_PreferredStockValue_lbl">Preferred stock, $.01 par value, 500,000 shares authorized, no shares issued and outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:title="label: PreferredStockValue to us-gaap_PreferredStockValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockValue_lbl1" xml:lang="en-US" id="us-gaap_PreferredStockValue_lbl1">Preferred Stock, Value, Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl1" xlink:title="label: PreferredStockValue to us-gaap_PreferredStockValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="PreferredStockSharesOutstanding" xlink:title="PreferredStockSharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US" id="us-gaap_PreferredStockSharesOutstanding_lbl">Preferred stock, shares outstanding (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:title="label: PreferredStockSharesOutstanding to us-gaap_PreferredStockSharesOutstanding_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockSharesOutstanding_lbl1" xml:lang="en-US" id="us-gaap_PreferredStockSharesOutstanding_lbl1">Preferred Stock, Shares Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl1" xlink:title="label: PreferredStockSharesOutstanding to us-gaap_PreferredStockSharesOutstanding_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="PreferredStockParOrStatedValuePerShare" xlink:title="PreferredStockParOrStatedValuePerShare" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US" id="us-gaap_PreferredStockParOrStatedValuePerShare_lbl">Preferred stock, par value (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:title="label: PreferredStockParOrStatedValuePerShare to us-gaap_PreferredStockParOrStatedValuePerShare_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockParOrStatedValuePerShare_lbl1" xml:lang="en-US" id="us-gaap_PreferredStockParOrStatedValuePerShare_lbl1">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl1" xlink:title="label: PreferredStockParOrStatedValuePerShare to us-gaap_PreferredStockParOrStatedValuePerShare_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="PreferredStockSharesAuthorized" xlink:title="PreferredStockSharesAuthorized" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US" id="us-gaap_PreferredStockSharesAuthorized_lbl">Preferred stock, shares authorized (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:title="label: PreferredStockSharesAuthorized to us-gaap_PreferredStockSharesAuthorized_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockSharesAuthorized_lbl1" xml:lang="en-US" id="us-gaap_PreferredStockSharesAuthorized_lbl1">Preferred Stock, Shares Authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl1" xlink:title="label: PreferredStockSharesAuthorized to us-gaap_PreferredStockSharesAuthorized_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:label="ProceedsFromPaymentsForOtherFinancingActivities" xlink:title="ProceedsFromPaymentsForOtherFinancingActivities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl" xlink:title="label: ProceedsFromPaymentsForOtherFinancingActivities to us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl1" xml:lang="en-US" id="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl1">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl1" xlink:title="label: ProceedsFromPaymentsForOtherFinancingActivities to us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsToMinorityShareholders" xlink:label="ProceedsFromPaymentsToMinorityShareholders" xlink:title="ProceedsFromPaymentsToMinorityShareholders" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromPaymentsToMinorityShareholders_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromPaymentsToMinorityShareholders_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromPaymentsToMinorityShareholders_lbl">Purchases of redeemable non-controlling interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromPaymentsToMinorityShareholders" xlink:to="us-gaap_ProceedsFromPaymentsToMinorityShareholders_lbl" xlink:title="label: ProceedsFromPaymentsToMinorityShareholders to us-gaap_ProceedsFromPaymentsToMinorityShareholders_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:label="ProceedsFromDivestitureOfBusinesses" xlink:title="ProceedsFromDivestitureOfBusinesses" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromDivestitureOfBusinesses_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromDivestitureOfBusinesses_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromDivestitureOfBusinesses_lbl">Proceeds on sales of partnership interest, clinics and fixed assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromDivestitureOfBusinesses" xlink:to="us-gaap_ProceedsFromDivestitureOfBusinesses_lbl" xlink:title="label: ProceedsFromDivestitureOfBusinesses to us-gaap_ProceedsFromDivestitureOfBusinesses_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" xlink:label="ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" xlink:title="ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates_lbl">Proceeds on sale of redeemable non-controlling interest, temporary equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" xlink:to="us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates_lbl" xlink:title="label: ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates to us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates_lbl1" xml:lang="en-US" id="us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates_lbl1">Proceeds from Divestiture of Interest in Subsidiaries and Affiliates</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" xlink:to="us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates_lbl1" xlink:title="label: ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates to us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="ProceedsFromLinesOfCredit" xlink:title="ProceedsFromLinesOfCredit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromLinesOfCredit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ProceedsFromLinesOfCredit_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromLinesOfCredit_lbl">Proceeds from revolving line of credit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromLinesOfCredit" xlink:to="us-gaap_ProceedsFromLinesOfCredit_lbl" xlink:title="label: ProceedsFromLinesOfCredit to us-gaap_ProceedsFromLinesOfCredit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromLinesOfCredit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromLinesOfCredit_lbl1" xml:lang="en-US" id="us-gaap_ProceedsFromLinesOfCredit_lbl1">Proceeds from Lines of Credit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromLinesOfCredit" xlink:to="us-gaap_ProceedsFromLinesOfCredit_lbl1" xlink:title="label: ProceedsFromLinesOfCredit to us-gaap_ProceedsFromLinesOfCredit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders" xlink:label="ProceedsFromMinorityShareholders" xlink:title="ProceedsFromMinorityShareholders" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromMinorityShareholders_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ProceedsFromMinorityShareholders_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromMinorityShareholders_lbl">Notes receivable related to sale of partnership interest - redeemable non-controlling interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromMinorityShareholders" xlink:to="us-gaap_ProceedsFromMinorityShareholders_lbl" xlink:title="label: ProceedsFromMinorityShareholders to us-gaap_ProceedsFromMinorityShareholders_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromMinorityShareholders_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromMinorityShareholders_lbl1" xml:lang="en-US" id="us-gaap_ProceedsFromMinorityShareholders_lbl1">Proceeds from Noncontrolling Interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromMinorityShareholders" xlink:to="us-gaap_ProceedsFromMinorityShareholders_lbl1" xlink:title="label: ProceedsFromMinorityShareholders to us-gaap_ProceedsFromMinorityShareholders_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="ProfitLoss" xlink:title="ProfitLoss" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_ProfitLoss_lbl" xml:lang="en-US" id="us-gaap_ProfitLoss_lbl">Net income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl" xlink:title="label: ProfitLoss to us-gaap_ProfitLoss_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ProfitLoss_lbl1" xml:lang="en-US" id="us-gaap_ProfitLoss_lbl1">Net income including non-controlling interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl1" xlink:title="label: ProfitLoss to us-gaap_ProfitLoss_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProfitLoss_lbl2" xml:lang="en-US" id="us-gaap_ProfitLoss_lbl2">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl2" xlink:title="label: ProfitLoss to us-gaap_ProfitLoss_lbl2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="PropertyPlantAndEquipmentUsefulLife" xlink:title="PropertyPlantAndEquipmentUsefulLife" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl">Estimated useful lives</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:title="label: PropertyPlantAndEquipmentUsefulLife to us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl1" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl1">Property, Plant and Equipment, Useful Life</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl1" xlink:title="label: PropertyPlantAndEquipmentUsefulLife to us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="PropertyPlantAndEquipmentByTypeAxis" xlink:title="PropertyPlantAndEquipmentByTypeAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:title="label: PropertyPlantAndEquipmentByTypeAxis to us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="PropertyPlantAndEquipmentAbstract" xlink:title="PropertyPlantAndEquipmentAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentAbstract_lbl">Long-Lived Assets [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:title="label: PropertyPlantAndEquipmentAbstract to us-gaap_PropertyPlantAndEquipmentAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="PropertyPlantAndEquipmentTypeDomain" xlink:title="PropertyPlantAndEquipmentTypeDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:title="label: PropertyPlantAndEquipmentTypeDomain to us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="PropertyPlantAndEquipmentGross" xlink:title="PropertyPlantAndEquipmentGross" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentGross_lbl">Fixed assets, gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:title="label: PropertyPlantAndEquipmentGross to us-gaap_PropertyPlantAndEquipmentGross_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentGross_lbl1" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentGross_lbl1">Property, Plant and Equipment, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl1" xlink:title="label: PropertyPlantAndEquipmentGross to us-gaap_PropertyPlantAndEquipmentGross_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentNet_lbl">Fixed assets, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:title="label: PropertyPlantAndEquipmentNet to us-gaap_PropertyPlantAndEquipmentNet_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentNet_lbl1" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentNet_lbl1">Property, Plant and Equipment, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl1" xlink:title="label: PropertyPlantAndEquipmentNet to us-gaap_PropertyPlantAndEquipmentNet_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:label="PropertyPlantAndEquipmentNetAbstract" xlink:title="PropertyPlantAndEquipmentNetAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl">Fixed assets:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentNetAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl" xlink:title="label: PropertyPlantAndEquipmentNetAbstract to us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl1" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl1">Property, Plant and Equipment, Net [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentNetAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl1" xlink:title="label: PropertyPlantAndEquipmentNetAbstract to us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="ProvisionForDoubtfulAccounts" xlink:title="ProvisionForDoubtfulAccounts" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ProvisionForDoubtfulAccounts_lbl" xml:lang="en-US" id="us-gaap_ProvisionForDoubtfulAccounts_lbl">Provision for credit losses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProvisionForDoubtfulAccounts" xlink:to="us-gaap_ProvisionForDoubtfulAccounts_lbl" xlink:title="label: ProvisionForDoubtfulAccounts to us-gaap_ProvisionForDoubtfulAccounts_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProvisionForDoubtfulAccounts_lbl1" xml:lang="en-US" id="us-gaap_ProvisionForDoubtfulAccounts_lbl1">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProvisionForDoubtfulAccounts" xlink:to="us-gaap_ProvisionForDoubtfulAccounts_lbl1" xlink:title="label: ProvisionForDoubtfulAccounts to us-gaap_ProvisionForDoubtfulAccounts_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:title="RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xml:lang="en-US" id="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl">Right-of-use assets obtained in exchange for new operating lease liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xlink:title="label: RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability to us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable" xlink:label="RedeemableNoncontrollingInterestByLegalEntityTable" xlink:title="RedeemableNoncontrollingInterestByLegalEntityTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable_lbl" xml:lang="en-US" id="us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable_lbl">Redeemable Noncontrolling Interest, by Legal Entity [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNoncontrollingInterestByLegalEntityTable" xlink:to="us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable_lbl" xlink:title="label: RedeemableNoncontrollingInterestByLegalEntityTable to us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestLineItems" xlink:label="RedeemableNoncontrollingInterestLineItems" xlink:title="RedeemableNoncontrollingInterestLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RedeemableNoncontrollingInterestLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RedeemableNoncontrollingInterestLineItems_lbl" xml:lang="en-US" id="us-gaap_RedeemableNoncontrollingInterestLineItems_lbl">Redeemable Noncontrolling Interest [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="us-gaap_RedeemableNoncontrollingInterestLineItems_lbl" xlink:title="label: RedeemableNoncontrollingInterestLineItems to us-gaap_RedeemableNoncontrollingInterestLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:label="RedeemableNoncontrollingInterestTableTextBlock" xlink:title="RedeemableNoncontrollingInterestTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RedeemableNoncontrollingInterestTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RedeemableNoncontrollingInterestTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_RedeemableNoncontrollingInterestTableTextBlock_lbl">Changes in Carrying Amount (Fair Value) of Redeemable Non-Controlling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNoncontrollingInterestTableTextBlock" xlink:to="us-gaap_RedeemableNoncontrollingInterestTableTextBlock_lbl" xlink:title="label: RedeemableNoncontrollingInterestTableTextBlock to us-gaap_RedeemableNoncontrollingInterestTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RedeemableNoncontrollingInterestTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RedeemableNoncontrollingInterestTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_RedeemableNoncontrollingInterestTableTextBlock_lbl1">Redeemable Noncontrolling Interest [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNoncontrollingInterestTableTextBlock" xlink:to="us-gaap_RedeemableNoncontrollingInterestTableTextBlock_lbl1" xlink:title="label: RedeemableNoncontrollingInterestTableTextBlock to us-gaap_RedeemableNoncontrollingInterestTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:title="RedeemableNoncontrollingInterestEquityCarryingAmount" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl" xml:lang="en-US" id="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl">Redeemable non-controlling interests - temporary equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl" xlink:title="label: RedeemableNoncontrollingInterestEquityCarryingAmount to us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl1" xml:lang="en-US" id="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl1">Redeemable non-controlling interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl1" xlink:title="label: RedeemableNoncontrollingInterestEquityCarryingAmount to us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl2" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl2" xml:lang="en-US" id="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl2">Beginning balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl2" xlink:title="label: RedeemableNoncontrollingInterestEquityCarryingAmount to us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl2" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl3" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl3" xml:lang="en-US" id="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl3">Ending balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl3" xlink:title="label: RedeemableNoncontrollingInterestEquityCarryingAmount to us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:label="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:title="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmountAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmountAbstract_lbl" xml:lang="en-US" id="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmountAbstract_lbl">Changes in Carrying Amount (Fair Value) of Redeemable Non-Controlling Interests [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmountAbstract_lbl" xlink:title="label: RedeemableNoncontrollingInterestEquityCarryingAmountAbstract to us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmountAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="RepaymentsOfLinesOfCredit" xlink:title="RepaymentsOfLinesOfCredit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RepaymentsOfLinesOfCredit_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_RepaymentsOfLinesOfCredit_lbl" xml:lang="en-US" id="us-gaap_RepaymentsOfLinesOfCredit_lbl">Payments on revolving line of credit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RepaymentsOfLinesOfCredit" xlink:to="us-gaap_RepaymentsOfLinesOfCredit_lbl" xlink:title="label: RepaymentsOfLinesOfCredit to us-gaap_RepaymentsOfLinesOfCredit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RepaymentsOfLinesOfCredit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RepaymentsOfLinesOfCredit_lbl1" xml:lang="en-US" id="us-gaap_RepaymentsOfLinesOfCredit_lbl1">Repayments of Lines of Credit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RepaymentsOfLinesOfCredit" xlink:to="us-gaap_RepaymentsOfLinesOfCredit_lbl1" xlink:title="label: RepaymentsOfLinesOfCredit to us-gaap_RepaymentsOfLinesOfCredit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="RepaymentsOfNotesPayable" xlink:title="RepaymentsOfNotesPayable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_RepaymentsOfNotesPayable_lbl" xml:lang="en-US" id="us-gaap_RepaymentsOfNotesPayable_lbl">Principal payments on notes payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_lbl" xlink:title="label: RepaymentsOfNotesPayable to us-gaap_RepaymentsOfNotesPayable_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RepaymentsOfNotesPayable_lbl1" xml:lang="en-US" id="us-gaap_RepaymentsOfNotesPayable_lbl1">Repayments of Notes Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_lbl1" xlink:title="label: RepaymentsOfNotesPayable to us-gaap_RepaymentsOfNotesPayable_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="RestrictedStockMember" xlink:title="RestrictedStockMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RestrictedStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RestrictedStockMember_lbl" xml:lang="en-US" id="us-gaap_RestrictedStockMember_lbl">Restricted Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedStockMember" xlink:to="us-gaap_RestrictedStockMember_lbl" xlink:title="label: RestrictedStockMember to us-gaap_RestrictedStockMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RestrictedStockMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RestrictedStockMember_lbl1" xml:lang="en-US" id="us-gaap_RestrictedStockMember_lbl1">Restricted Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedStockMember" xlink:to="us-gaap_RestrictedStockMember_lbl1" xlink:title="label: RestrictedStockMember to us-gaap_RestrictedStockMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="RestructuringCharges" xlink:title="RestructuringCharges" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RestructuringCharges_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RestructuringCharges_lbl" xml:lang="en-US" id="us-gaap_RestructuringCharges_lbl">Closure costs - lease and other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestructuringCharges" xlink:to="us-gaap_RestructuringCharges_lbl" xlink:title="label: RestructuringCharges to us-gaap_RestructuringCharges_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RestructuringCharges_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_RestructuringCharges_lbl1" xml:lang="en-US" id="us-gaap_RestructuringCharges_lbl1">Closure costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestructuringCharges" xlink:to="us-gaap_RestructuringCharges_lbl1" xlink:title="label: RestructuringCharges to us-gaap_RestructuringCharges_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RestructuringCharges_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RestructuringCharges_lbl2" xml:lang="en-US" id="us-gaap_RestructuringCharges_lbl2">Restructuring Charges</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestructuringCharges" xlink:to="us-gaap_RestructuringCharges_lbl2" xlink:title="label: RestructuringCharges to us-gaap_RestructuringCharges_lbl2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="RetainedEarningsAccumulatedDeficit" xlink:title="RetainedEarningsAccumulatedDeficit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US" id="us-gaap_RetainedEarningsAccumulatedDeficit_lbl">Retained earnings</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:title="label: RetainedEarningsAccumulatedDeficit to us-gaap_RetainedEarningsAccumulatedDeficit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RetainedEarningsAccumulatedDeficit_lbl1" xml:lang="en-US" id="us-gaap_RetainedEarningsAccumulatedDeficit_lbl1">Retained Earnings (Accumulated Deficit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl1" xlink:title="label: RetainedEarningsAccumulatedDeficit to us-gaap_RetainedEarningsAccumulatedDeficit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="RetainedEarningsMember" xlink:title="RetainedEarningsMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US" id="us-gaap_RetainedEarningsMember_lbl">Retained Earnings [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:title="label: RetainedEarningsMember to us-gaap_RetainedEarningsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RetainedEarningsMember_lbl1" xml:lang="en-US" id="us-gaap_RetainedEarningsMember_lbl1">Retained Earnings [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl1" xlink:title="label: RetainedEarningsMember to us-gaap_RetainedEarningsMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="RevenueFromContractWithCustomerAbstract" xlink:title="RevenueFromContractWithCustomerAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RevenueFromContractWithCustomerAbstract_lbl" xml:lang="en-US" id="us-gaap_RevenueFromContractWithCustomerAbstract_lbl">Revenue Recognition [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerAbstract_lbl" xlink:title="label: RevenueFromContractWithCustomerAbstract to us-gaap_RevenueFromContractWithCustomerAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RevenueFromContractWithCustomerAbstract_lbl1" xml:lang="en-US" id="us-gaap_RevenueFromContractWithCustomerAbstract_lbl1">Revenue from Contract with Customer [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerAbstract_lbl1" xlink:title="label: RevenueFromContractWithCustomerAbstract to us-gaap_RevenueFromContractWithCustomerAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="RevenueFromContractWithCustomerPolicyTextBlock" xlink:title="RevenueFromContractWithCustomerPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl">Revenue Recognition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xlink:title="label: RevenueFromContractWithCustomerPolicyTextBlock to us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl1">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl1" xlink:title="label: RevenueFromContractWithCustomerPolicyTextBlock to us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:title="RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xml:lang="en-US" id="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl">Net revenues</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:title="label: RevenueFromContractWithCustomerExcludingAssessedTax to us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl1" xml:lang="en-US" id="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl1">Revenue related to the various categories</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl1" xlink:title="label: RevenueFromContractWithCustomerExcludingAssessedTax to us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl2" xml:lang="en-US" id="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl2">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl2" xlink:title="label: RevenueFromContractWithCustomerExcludingAssessedTax to us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="RevenuesAbstract" xlink:title="RevenuesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RevenuesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RevenuesAbstract_lbl" xml:lang="en-US" id="us-gaap_RevenuesAbstract_lbl">Revenues [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevenuesAbstract" xlink:to="us-gaap_RevenuesAbstract_lbl" xlink:title="label: RevenuesAbstract to us-gaap_RevenuesAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="Revenues" xlink:title="Revenues" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Revenues_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_Revenues_lbl" xml:lang="en-US" id="us-gaap_Revenues_lbl">Net operating revenues</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Revenues" xlink:to="us-gaap_Revenues_lbl" xlink:title="label: Revenues to us-gaap_Revenues_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="RevolvingCreditFacilityMember" xlink:title="RevolvingCreditFacilityMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RevolvingCreditFacilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_RevolvingCreditFacilityMember_lbl" xml:lang="en-US" id="us-gaap_RevolvingCreditFacilityMember_lbl">Credit Facility [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevolvingCreditFacilityMember" xlink:to="us-gaap_RevolvingCreditFacilityMember_lbl" xlink:title="label: RevolvingCreditFacilityMember to us-gaap_RevolvingCreditFacilityMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RevolvingCreditFacilityMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RevolvingCreditFacilityMember_lbl1" xml:lang="en-US" id="us-gaap_RevolvingCreditFacilityMember_lbl1">Revolving Credit Facility [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevolvingCreditFacilityMember" xlink:to="us-gaap_RevolvingCreditFacilityMember_lbl1" xlink:title="label: RevolvingCreditFacilityMember to us-gaap_RevolvingCreditFacilityMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:title="ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl">Amortization of Referral Relationships and Non Competition Agreements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xlink:title="label: ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock to us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl1">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl1" xlink:title="label: ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock to us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:label="ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:title="ScheduleOfShareBasedCompensationActivityTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl">Cumulative Summary of Equity Plans</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl" xlink:title="label: ScheduleOfShareBasedCompensationActivityTableTextBlock to us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl1">Share-based Payment Arrangement, Activity [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl1" xlink:title="label: ScheduleOfShareBasedCompensationActivityTableTextBlock to us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:label="ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:title="ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl">Restricted Stock Granted and Cancelled</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl" xlink:title="label: ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock to us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl1">Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl1" xlink:title="label: ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock to us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:title="ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl">Significant Components of Provision for Income Taxes for Continuing Operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:title="label: ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock to us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl1">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl1" xlink:title="label: ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock to us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:title="ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl">Components of Deferred Tax Assets and Liabilities Included in Consolidated Balance Sheets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:title="label: ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock to us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl1">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl1" xlink:title="label: ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock to us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:title="ScheduleOfAccruedLiabilitiesTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl">Accrued Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:title="label: ScheduleOfAccruedLiabilitiesTableTextBlock to us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl1">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl1" xlink:title="label: ScheduleOfAccruedLiabilitiesTableTextBlock to us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="ScheduleOfFiniteLivedIntangibleAssetsTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl">Schedule of Finite Lived Intangible Assets [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xlink:title="label: ScheduleOfFiniteLivedIntangibleAssetsTable to us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:title="ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl">Computations of Basic and Diluted Earnings Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:title="label: ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock to us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl1">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl1" xlink:title="label: ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock to us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:title="ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl">Intangible Assets, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xlink:title="label: ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock to us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl1">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl1" xlink:title="label: ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock to us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:title="ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl">Differences Between Federal Tax Rate and Company's Effective Tax Rate for Results of Continuing Operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:title="label: ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock to us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl1">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl1" xlink:title="label: ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock to us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xlink:title="label: ScheduleOfBusinessAcquisitionsByAcquisitionTable to us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_lbl">Clinic Acquisition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_lbl" xlink:title="label: ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock to us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_lbl1">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_lbl1" xlink:title="label: ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock to us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:label="ScheduleOfDebtInstrumentsTextBlock" xlink:title="ScheduleOfDebtInstrumentsTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl">Credit Agreement and Notes Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfDebtInstrumentsTextBlock" xlink:to="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl" xlink:title="label: ScheduleOfDebtInstrumentsTextBlock to us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl1">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfDebtInstrumentsTextBlock" xlink:to="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl1" xlink:title="label: ScheduleOfDebtInstrumentsTextBlock to us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:label="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:title="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_lbl">Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_lbl" xlink:title="label: ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable to us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="ScheduleOfGoodwillTextBlock" xlink:title="ScheduleOfGoodwillTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfGoodwillTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfGoodwillTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfGoodwillTextBlock_lbl">Changes in Carrying Amount of Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfGoodwillTextBlock" xlink:to="us-gaap_ScheduleOfGoodwillTextBlock_lbl" xlink:title="label: ScheduleOfGoodwillTextBlock to us-gaap_ScheduleOfGoodwillTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfGoodwillTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfGoodwillTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfGoodwillTextBlock_lbl1">Schedule of Goodwill [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfGoodwillTextBlock" xlink:to="us-gaap_ScheduleOfGoodwillTextBlock_lbl1" xlink:title="label: ScheduleOfGoodwillTextBlock to us-gaap_ScheduleOfGoodwillTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="ScheduleOfSegmentReportingInformationBySegmentTable" xlink:title="ScheduleOfSegmentReportingInformationBySegmentTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl" xlink:title="label: ScheduleOfSegmentReportingInformationBySegmentTable to us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:title="ScheduleOfSegmentReportingInformationBySegmentTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl">Selected Financial Data for Reportable Segments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xlink:title="label: ScheduleOfSegmentReportingInformationBySegmentTextBlock to us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:title="label: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl1">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl1" xlink:title="label: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="SegmentReportingPolicyPolicyTextBlock" xlink:title="SegmentReportingPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl">Segment Reporting</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:title="label: SegmentReportingPolicyPolicyTextBlock to us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl1">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl1" xlink:title="label: SegmentReportingPolicyPolicyTextBlock to us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="SegmentReportingInformationLineItems" xlink:title="SegmentReportingInformationLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SegmentReportingInformationLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SegmentReportingInformationLineItems_lbl" xml:lang="en-US" id="us-gaap_SegmentReportingInformationLineItems_lbl">Segment Reporting Information [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SegmentReportingInformationLineItems" xlink:to="us-gaap_SegmentReportingInformationLineItems_lbl" xlink:title="label: SegmentReportingInformationLineItems to us-gaap_SegmentReportingInformationLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="SegmentDomain" xlink:title="SegmentDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SegmentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SegmentDomain_lbl" xml:lang="en-US" id="us-gaap_SegmentDomain_lbl">Segments [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SegmentDomain" xlink:to="us-gaap_SegmentDomain_lbl" xlink:title="label: SegmentDomain to us-gaap_SegmentDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="SegmentReportingAbstract" xlink:title="SegmentReportingAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SegmentReportingAbstract_lbl" xml:lang="en-US" id="us-gaap_SegmentReportingAbstract_lbl">Segment Information [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl" xlink:title="label: SegmentReportingAbstract to us-gaap_SegmentReportingAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:label="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:title="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract_lbl" xml:lang="en-US" id="us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract_lbl">Segment Information [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:to="us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract_lbl" xlink:title="label: SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract to us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract_lbl1" xml:lang="en-US" id="us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract_lbl1">Segment Reporting, Disclosure of Entity's Reportable Segments [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:to="us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract_lbl1" xlink:title="label: SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract to us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="SegmentReportingDisclosureTextBlock" xlink:title="SegmentReportingDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_SegmentReportingDisclosureTextBlock_lbl">Segment Information</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:title="label: SegmentReportingDisclosureTextBlock to us-gaap_SegmentReportingDisclosureTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="SellingGeneralAndAdministrativeExpense" xlink:title="SellingGeneralAndAdministrativeExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US" id="us-gaap_SellingGeneralAndAdministrativeExpense_lbl">Corporate office costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:title="label: SellingGeneralAndAdministrativeExpense to us-gaap_SellingGeneralAndAdministrativeExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SellingGeneralAndAdministrativeExpense_lbl1" xml:lang="en-US" id="us-gaap_SellingGeneralAndAdministrativeExpense_lbl1">Selling, General and Administrative Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl1" xlink:title="label: SellingGeneralAndAdministrativeExpense to us-gaap_SellingGeneralAndAdministrativeExpense_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:label="SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:title="SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_lbl" xml:lang="en-US" id="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_lbl">Acquisitions [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:to="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_lbl" xlink:title="label: SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember to us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAbstract" xlink:label="ShareBasedCompensationAbstract" xlink:title="ShareBasedCompensationAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationAbstract_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationAbstract_lbl">Share-based Compensation [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationAbstract" xlink:to="us-gaap_ShareBasedCompensationAbstract_lbl" xlink:title="label: ShareBasedCompensationAbstract to us-gaap_ShareBasedCompensationAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="ShareBasedCompensation" xlink:title="ShareBasedCompensation" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensation_lbl">Equity-based awards compensation expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:title="label: ShareBasedCompensation to us-gaap_ShareBasedCompensation_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensation_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensation_lbl1">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl1" xlink:title="label: ShareBasedCompensation to us-gaap_ShareBasedCompensation_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl1">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl">Weighted average fair value (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl">Number of shares (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl">Number of shares (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl">Weighted average fair value (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl">Shares available for grant (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl1">Number of common shares available for grant (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl2" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl2">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl">Authorized (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl1">Number of shares authorized (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl2" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl2">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl">Stock options exercisable (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl">Equity Award [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl1">Equity Award [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl1" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl">Outstanding stock options (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="SharesOutstanding" xlink:title="SharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_SharesOutstanding_lbl" xml:lang="en-US" id="us-gaap_SharesOutstanding_lbl">Ending balance (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:title="label: SharesOutstanding to us-gaap_SharesOutstanding_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_SharesOutstanding_lbl1" xml:lang="en-US" id="us-gaap_SharesOutstanding_lbl1">Beginning balance (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl1" xlink:title="label: SharesOutstanding to us-gaap_SharesOutstanding_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharesOutstanding_lbl2" xml:lang="en-US" id="us-gaap_SharesOutstanding_lbl2">Shares, Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl2" xlink:title="label: SharesOutstanding to us-gaap_SharesOutstanding_lbl2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="SharesIssuedPricePerShare" xlink:title="SharesIssuedPricePerShare" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharesIssuedPricePerShare_lbl" xml:lang="en-US" id="us-gaap_SharesIssuedPricePerShare_lbl">Closing price (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl" xlink:title="label: SharesIssuedPricePerShare to us-gaap_SharesIssuedPricePerShare_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="ShortTermDebtTypeDomain" xlink:title="ShortTermDebtTypeDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShortTermDebtTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShortTermDebtTypeDomain_lbl" xml:lang="en-US" id="us-gaap_ShortTermDebtTypeDomain_lbl">Short-term Debt, Type [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShortTermDebtTypeDomain" xlink:to="us-gaap_ShortTermDebtTypeDomain_lbl" xlink:title="label: ShortTermDebtTypeDomain to us-gaap_ShortTermDebtTypeDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermLeaseCost" xlink:label="ShortTermLeaseCost" xlink:title="ShortTermLeaseCost" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShortTermLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShortTermLeaseCost_lbl" xml:lang="en-US" id="us-gaap_ShortTermLeaseCost_lbl">Short-term lease cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShortTermLeaseCost" xlink:to="us-gaap_ShortTermLeaseCost_lbl" xlink:title="label: ShortTermLeaseCost to us-gaap_ShortTermLeaseCost_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="ShortTermDebtTypeAxis" xlink:title="ShortTermDebtTypeAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShortTermDebtTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShortTermDebtTypeAxis_lbl" xml:lang="en-US" id="us-gaap_ShortTermDebtTypeAxis_lbl">Short-term Debt, Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeAxis_lbl" xlink:title="label: ShortTermDebtTypeAxis to us-gaap_ShortTermDebtTypeAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="SignificantAccountingPoliciesTextBlock" xlink:title="SignificantAccountingPoliciesTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US" id="us-gaap_SignificantAccountingPoliciesTextBlock_lbl">Significant Accounting Policies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:title="label: SignificantAccountingPoliciesTextBlock to us-gaap_SignificantAccountingPoliciesTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SignificantAccountingPoliciesTextBlock_lbl1" xml:lang="en-US" id="us-gaap_SignificantAccountingPoliciesTextBlock_lbl1">Significant Accounting Policies [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl1" xlink:title="label: SignificantAccountingPoliciesTextBlock to us-gaap_SignificantAccountingPoliciesTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="StateAndLocalJurisdictionMember" xlink:title="StateAndLocalJurisdictionMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StateAndLocalJurisdictionMember_lbl" xml:lang="en-US" id="us-gaap_StateAndLocalJurisdictionMember_lbl">State [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StateAndLocalJurisdictionMember" xlink:to="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:title="label: StateAndLocalJurisdictionMember to us-gaap_StateAndLocalJurisdictionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StateAndLocalJurisdictionMember_lbl1" xml:lang="en-US" id="us-gaap_StateAndLocalJurisdictionMember_lbl1">State and Local Jurisdiction [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StateAndLocalJurisdictionMember" xlink:to="us-gaap_StateAndLocalJurisdictionMember_lbl1" xlink:title="label: StateAndLocalJurisdictionMember to us-gaap_StateAndLocalJurisdictionMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="StatementOfFinancialPositionAbstract" xlink:title="StatementOfFinancialPositionAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US" id="us-gaap_StatementOfFinancialPositionAbstract_lbl">CONSOLIDATED BALANCE SHEETS [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:title="label: StatementOfFinancialPositionAbstract to us-gaap_StatementOfFinancialPositionAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="StatementTable" xlink:title="StatementTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementTable_lbl" xml:lang="en-US" id="us-gaap_StatementTable_lbl">Statement [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:title="label: StatementTable to us-gaap_StatementTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="StatementBusinessSegmentsAxis" xlink:title="StatementBusinessSegmentsAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementBusinessSegmentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementBusinessSegmentsAxis_lbl" xml:lang="en-US" id="us-gaap_StatementBusinessSegmentsAxis_lbl">Segments [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementBusinessSegmentsAxis" xlink:to="us-gaap_StatementBusinessSegmentsAxis_lbl" xlink:title="label: StatementBusinessSegmentsAxis to us-gaap_StatementBusinessSegmentsAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="StatementLineItems" xlink:title="StatementLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementLineItems_lbl" xml:lang="en-US" id="us-gaap_StatementLineItems_lbl">Statement [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:title="label: StatementLineItems to us-gaap_StatementLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="StatementOfCashFlowsAbstract" xlink:title="StatementOfCashFlowsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US" id="us-gaap_StatementOfCashFlowsAbstract_lbl">CONSOLIDATED STATEMENTS OF CASH FLOWS [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:title="label: StatementOfCashFlowsAbstract to us-gaap_StatementOfCashFlowsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US" id="us-gaap_StatementEquityComponentsAxis_lbl">Equity Components [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:title="label: StatementEquityComponentsAxis to us-gaap_StatementEquityComponentsAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="StatementOfStockholdersEquityAbstract" xlink:title="StatementOfStockholdersEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xml:lang="en-US" id="us-gaap_StatementOfStockholdersEquityAbstract_lbl">CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:title="label: StatementOfStockholdersEquityAbstract to us-gaap_StatementOfStockholdersEquityAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:label="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl" xml:lang="en-US" id="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl">Common stock authorized by the Board of Directors (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:to="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl" xlink:title="label: StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased to us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl1" xml:lang="en-US" id="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl1">Stock Repurchase Program, Number of Shares Authorized to be Repurchased</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:to="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl1" xlink:title="label: StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased to us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:title="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl">Issuance of restricted stock, net of cancellations (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" xlink:title="label: StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures to us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl1" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl1">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl1" xlink:title="label: StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures to us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:label="StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:title="StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl">Issuance of restricted stock, net of cancellations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl" xlink:title="label: StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures to us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl1" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl1">Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl1" xlink:title="label: StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures to us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="StockRepurchasedDuringPeriodShares" xlink:title="StockRepurchasedDuringPeriodShares" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xml:lang="en-US" id="us-gaap_StockRepurchasedDuringPeriodShares_lbl">Total purchased shares (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockRepurchasedDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xlink:title="label: StockRepurchasedDuringPeriodShares to us-gaap_StockRepurchasedDuringPeriodShares_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockRepurchasedDuringPeriodShares_lbl1" xml:lang="en-US" id="us-gaap_StockRepurchasedDuringPeriodShares_lbl1">Stock Repurchased During Period, Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockRepurchasedDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares_lbl1" xlink:title="label: StockRepurchasedDuringPeriodShares to us-gaap_StockRepurchasedDuringPeriodShares_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:title="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_lbl" xml:lang="en-US" id="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_lbl">Equity:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_lbl" xlink:title="label: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract to us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_lbl1" xml:lang="en-US" id="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_lbl1">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_lbl1" xlink:title="label: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract to us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="StockholdersEquityNoteDisclosureTextBlock" xlink:title="StockholdersEquityNoteDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl">Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:title="label: StockholdersEquityNoteDisclosureTextBlock to us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl1">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl1" xlink:title="label: StockholdersEquityNoteDisclosureTextBlock to us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityOther" xlink:label="StockholdersEquityOther" xlink:title="StockholdersEquityOther" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityOther_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockholdersEquityOther_lbl" xml:lang="en-US" id="us-gaap_StockholdersEquityOther_lbl">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityOther" xlink:to="us-gaap_StockholdersEquityOther_lbl" xlink:title="label: StockholdersEquityOther to us-gaap_StockholdersEquityOther_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityOther_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockholdersEquityOther_lbl1" xml:lang="en-US" id="us-gaap_StockholdersEquityOther_lbl1">Stockholders' Equity, Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityOther" xlink:to="us-gaap_StockholdersEquityOther_lbl1" xlink:title="label: StockholdersEquityOther to us-gaap_StockholdersEquityOther_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US" id="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl">Ending balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:title="label: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest to us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl1" xml:lang="en-US" id="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl1">Beginning balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl1" xlink:title="label: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest to us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl2" xml:lang="en-US" id="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl2">Total USPH shareholders' equity and non-controlling interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl2" xlink:title="label: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest to us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl2" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl3" xml:lang="en-US" id="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl3">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl3" xlink:title="label: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest to us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_StockholdersEquity_lbl" xml:lang="en-US" id="us-gaap_StockholdersEquity_lbl">Total USPH shareholders' equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:title="label: StockholdersEquity to us-gaap_StockholdersEquity_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockholdersEquity_lbl1" xml:lang="en-US" id="us-gaap_StockholdersEquity_lbl1">Stockholders' Equity Attributable to Parent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl1" xlink:title="label: StockholdersEquity to us-gaap_StockholdersEquity_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="StockholdersEquityAbstract" xlink:title="StockholdersEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US" id="us-gaap_StockholdersEquityAbstract_lbl">U.S. Physical Therapy, Inc. ("USPH") shareholders' equity:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:title="label: StockholdersEquityAbstract to us-gaap_StockholdersEquityAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockholdersEquityAbstract_lbl1" xml:lang="en-US" id="us-gaap_StockholdersEquityAbstract_lbl1">U. S. Physical Therapy, Inc. shareholders' equity:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl1" xlink:title="label: StockholdersEquityAbstract to us-gaap_StockholdersEquityAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US" id="us-gaap_SubsequentEventTypeAxis_lbl">Subsequent Event Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:title="label: SubsequentEventTypeAxis to us-gaap_SubsequentEventTypeAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventTypeDomain_lbl" xml:lang="en-US" id="us-gaap_SubsequentEventTypeDomain_lbl">Subsequent Event Type [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl" xlink:title="label: SubsequentEventTypeDomain to us-gaap_SubsequentEventTypeDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="SubsequentEventMember" xlink:title="SubsequentEventMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US" id="us-gaap_SubsequentEventMember_lbl">Subsequent Event [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:title="label: SubsequentEventMember to us-gaap_SubsequentEventMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="SubsequentEventsAbstract" xlink:title="SubsequentEventsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US" id="us-gaap_SubsequentEventsAbstract_lbl">Subsequent Event [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:title="label: SubsequentEventsAbstract to us-gaap_SubsequentEventsAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventsAbstract_lbl1" xml:lang="en-US" id="us-gaap_SubsequentEventsAbstract_lbl1">Subsequent Events [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl1" xlink:title="label: SubsequentEventsAbstract to us-gaap_SubsequentEventsAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:label="SubsequentEventsPolicyPolicyTextBlock" xlink:title="SubsequentEventsPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SubsequentEventsPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_SubsequentEventsPolicyPolicyTextBlock_lbl">Subsequent Event</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventsPolicyPolicyTextBlock" xlink:to="us-gaap_SubsequentEventsPolicyPolicyTextBlock_lbl" xlink:title="label: SubsequentEventsPolicyPolicyTextBlock to us-gaap_SubsequentEventsPolicyPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventsPolicyPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventsPolicyPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_SubsequentEventsPolicyPolicyTextBlock_lbl1">Subsequent Events, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventsPolicyPolicyTextBlock" xlink:to="us-gaap_SubsequentEventsPolicyPolicyTextBlock_lbl1" xlink:title="label: SubsequentEventsPolicyPolicyTextBlock to us-gaap_SubsequentEventsPolicyPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="SupplementalCashFlowInformationAbstract" xlink:title="SupplementalCashFlowInformationAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US" id="us-gaap_SupplementalCashFlowInformationAbstract_lbl">SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:title="label: SupplementalCashFlowInformationAbstract to us-gaap_SupplementalCashFlowInformationAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SupplementalCashFlowInformationAbstract_lbl1" xml:lang="en-US" id="us-gaap_SupplementalCashFlowInformationAbstract_lbl1">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl1" xlink:title="label: SupplementalCashFlowInformationAbstract to us-gaap_SupplementalCashFlowInformationAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxesPayableCurrent" xlink:label="TaxesPayableCurrent" xlink:title="TaxesPayableCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TaxesPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_TaxesPayableCurrent_lbl" xml:lang="en-US" id="us-gaap_TaxesPayableCurrent_lbl">Federal income taxes payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TaxesPayableCurrent" xlink:to="us-gaap_TaxesPayableCurrent_lbl" xlink:title="label: TaxesPayableCurrent to us-gaap_TaxesPayableCurrent_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksMember" xlink:label="TrademarksMember" xlink:title="TrademarksMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TrademarksMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_TrademarksMember_lbl" xml:lang="en-US" id="us-gaap_TrademarksMember_lbl">Tradenames [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TrademarksMember" xlink:to="us-gaap_TrademarksMember_lbl" xlink:title="label: TrademarksMember to us-gaap_TrademarksMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TrademarksMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_TrademarksMember_lbl1" xml:lang="en-US" id="us-gaap_TrademarksMember_lbl1">Trademarks [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TrademarksMember" xlink:to="us-gaap_TrademarksMember_lbl1" xlink:title="label: TrademarksMember to us-gaap_TrademarksMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="TreasuryStockShares" xlink:title="TreasuryStockShares" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TreasuryStockShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_TreasuryStockShares_lbl" xml:lang="en-US" id="us-gaap_TreasuryStockShares_lbl">Treasury stock, shares (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TreasuryStockShares" xlink:to="us-gaap_TreasuryStockShares_lbl" xlink:title="label: TreasuryStockShares to us-gaap_TreasuryStockShares_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TreasuryStockShares_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_TreasuryStockShares_lbl1" xml:lang="en-US" id="us-gaap_TreasuryStockShares_lbl1">Treasury Stock, Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TreasuryStockShares" xlink:to="us-gaap_TreasuryStockShares_lbl1" xlink:title="label: TreasuryStockShares to us-gaap_TreasuryStockShares_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="TreasuryStockValue" xlink:title="TreasuryStockValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TreasuryStockValue_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_TreasuryStockValue_lbl" xml:lang="en-US" id="us-gaap_TreasuryStockValue_lbl">Treasury stock at cost, 2,214,737 shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_lbl" xlink:title="label: TreasuryStockValue to us-gaap_TreasuryStockValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TreasuryStockValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_TreasuryStockValue_lbl1" xml:lang="en-US" id="us-gaap_TreasuryStockValue_lbl1">Treasury Stock, Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_lbl1" xlink:title="label: TreasuryStockValue to us-gaap_TreasuryStockValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="TreasuryStockMember" xlink:title="TreasuryStockMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TreasuryStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_TreasuryStockMember_lbl" xml:lang="en-US" id="us-gaap_TreasuryStockMember_lbl">Treasury Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TreasuryStockMember" xlink:to="us-gaap_TreasuryStockMember_lbl" xlink:title="label: TreasuryStockMember to us-gaap_TreasuryStockMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TreasuryStockMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_TreasuryStockMember_lbl1" xml:lang="en-US" id="us-gaap_TreasuryStockMember_lbl1">Treasury Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TreasuryStockMember" xlink:to="us-gaap_TreasuryStockMember_lbl1" xlink:title="label: TreasuryStockMember to us-gaap_TreasuryStockMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="TypeOfAdoptionMember" xlink:title="TypeOfAdoptionMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TypeOfAdoptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_TypeOfAdoptionMember_lbl" xml:lang="en-US" id="us-gaap_TypeOfAdoptionMember_lbl">Type of Adoption [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TypeOfAdoptionMember" xlink:to="us-gaap_TypeOfAdoptionMember_lbl" xlink:title="label: TypeOfAdoptionMember to us-gaap_TypeOfAdoptionMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" xlink:label="UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" xlink:title="UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_lbl" xml:lang="en-US" id="us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_lbl">Interest expense recognized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" xlink:to="us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_lbl" xlink:title="label: UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense to us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_lbl1" xml:lang="en-US" id="us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_lbl1">Unrecognized Tax Benefits, Interest on Income Taxes Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" xlink:to="us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_lbl1" xlink:title="label: UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense to us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:title="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xml:lang="en-US" id="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl">Accrued interest and penalties associated with any unrecognized tax benefits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xlink:title="label: UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued to us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl1" xml:lang="en-US" id="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl1">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl1" xlink:title="label: UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued to us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain" xlink:label="UnusualOrInfrequentItemDomain" xlink:title="UnusualOrInfrequentItemDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UnusualOrInfrequentItemDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_UnusualOrInfrequentItemDomain_lbl" xml:lang="en-US" id="us-gaap_UnusualOrInfrequentItemDomain_lbl">Unusual or Infrequent Item, or Both [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnusualOrInfrequentItemDomain" xlink:to="us-gaap_UnusualOrInfrequentItemDomain_lbl" xlink:title="label: UnusualOrInfrequentItemDomain to us-gaap_UnusualOrInfrequentItemDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis" xlink:label="UnusualOrInfrequentItemAxis" xlink:title="UnusualOrInfrequentItemAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UnusualOrInfrequentItemAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_UnusualOrInfrequentItemAxis_lbl" xml:lang="en-US" id="us-gaap_UnusualOrInfrequentItemAxis_lbl">Unusual or Infrequent Item, or Both [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnusualOrInfrequentItemAxis" xlink:to="us-gaap_UnusualOrInfrequentItemAxis_lbl" xlink:title="label: UnusualOrInfrequentItemAxis to us-gaap_UnusualOrInfrequentItemAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="UseOfEstimates" xlink:title="UseOfEstimates" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_UseOfEstimates_lbl" xml:lang="en-US" id="us-gaap_UseOfEstimates_lbl">Use of Estimates</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:title="label: UseOfEstimates to us-gaap_UseOfEstimates_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_UseOfEstimates_lbl1" xml:lang="en-US" id="us-gaap_UseOfEstimates_lbl1">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl1" xlink:title="label: UseOfEstimates to us-gaap_UseOfEstimates_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:label="ValuationAllowancesAndReservesTypeAxis" xlink:title="ValuationAllowancesAndReservesTypeAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ValuationAllowancesAndReservesTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ValuationAllowancesAndReservesTypeAxis_lbl" xml:lang="en-US" id="us-gaap_ValuationAllowancesAndReservesTypeAxis_lbl">Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ValuationAllowancesAndReservesTypeAxis" xlink:to="us-gaap_ValuationAllowancesAndReservesTypeAxis_lbl" xlink:title="label: ValuationAllowancesAndReservesTypeAxis to us-gaap_ValuationAllowancesAndReservesTypeAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:label="ValuationAllowancesAndReservesDomain" xlink:title="ValuationAllowancesAndReservesDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ValuationAllowancesAndReservesDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ValuationAllowancesAndReservesDomain_lbl" xml:lang="en-US" id="us-gaap_ValuationAllowancesAndReservesDomain_lbl">Valuation Allowances and Reserves [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ValuationAllowancesAndReservesDomain" xlink:to="us-gaap_ValuationAllowancesAndReservesDomain_lbl" xlink:title="label: ValuationAllowancesAndReservesDomain to us-gaap_ValuationAllowancesAndReservesDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="ValuationAllowancesAndReservesBalance" xlink:title="ValuationAllowancesAndReservesBalance" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ValuationAllowancesAndReservesBalance_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_ValuationAllowancesAndReservesBalance_lbl" xml:lang="en-US" id="us-gaap_ValuationAllowancesAndReservesBalance_lbl">Beginning Balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ValuationAllowancesAndReservesBalance" xlink:to="us-gaap_ValuationAllowancesAndReservesBalance_lbl" xlink:title="label: ValuationAllowancesAndReservesBalance to us-gaap_ValuationAllowancesAndReservesBalance_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ValuationAllowancesAndReservesBalance_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_ValuationAllowancesAndReservesBalance_lbl1" xml:lang="en-US" id="us-gaap_ValuationAllowancesAndReservesBalance_lbl1">Ending Balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ValuationAllowancesAndReservesBalance" xlink:to="us-gaap_ValuationAllowancesAndReservesBalance_lbl1" xlink:title="label: ValuationAllowancesAndReservesBalance to us-gaap_ValuationAllowancesAndReservesBalance_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ValuationAllowancesAndReservesBalance_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ValuationAllowancesAndReservesBalance_lbl2" xml:lang="en-US" id="us-gaap_ValuationAllowancesAndReservesBalance_lbl2">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ValuationAllowancesAndReservesBalance" xlink:to="us-gaap_ValuationAllowancesAndReservesBalance_lbl2" xlink:title="label: ValuationAllowancesAndReservesBalance to us-gaap_ValuationAllowancesAndReservesBalance_lbl2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:label="ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:title="ValuationAllowancesAndReservesChargedToOtherAccounts" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_lbl" xml:lang="en-US" id="us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_lbl">Additions Charged to Other Accounts</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:to="us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_lbl" xlink:title="label: ValuationAllowancesAndReservesChargedToOtherAccounts to us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:label="ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:title="ValuationAllowancesAndReservesChargedToCostAndExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_lbl" xml:lang="en-US" id="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_lbl">Additions Charged to Cost and Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_lbl" xlink:title="label: ValuationAllowancesAndReservesChargedToCostAndExpense to us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_lbl1" xml:lang="en-US" id="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_lbl1">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_lbl1" xlink:title="label: ValuationAllowancesAndReservesChargedToCostAndExpense to us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions" xlink:label="ValuationAllowancesAndReservesDeductions" xlink:title="ValuationAllowancesAndReservesDeductions" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ValuationAllowancesAndReservesDeductions_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ValuationAllowancesAndReservesDeductions_lbl" xml:lang="en-US" id="us-gaap_ValuationAllowancesAndReservesDeductions_lbl">Deductions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ValuationAllowancesAndReservesDeductions" xlink:to="us-gaap_ValuationAllowancesAndReservesDeductions_lbl" xlink:title="label: ValuationAllowancesAndReservesDeductions to us-gaap_ValuationAllowancesAndReservesDeductions_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost" xlink:label="VariableLeaseCost" xlink:title="VariableLeaseCost" />
    <link:label xlink:type="resource" xlink:label="us-gaap_VariableLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_VariableLeaseCost_lbl" xml:lang="en-US" id="us-gaap_VariableLeaseCost_lbl">Variable lease cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VariableLeaseCost" xlink:to="us-gaap_VariableLeaseCost_lbl" xlink:title="label: VariableLeaseCost to us-gaap_VariableLeaseCost_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:title="WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xml:lang="en-US" id="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl">Shares used in computation - basic and diluted (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:title="label: WeightedAverageNumberOfShareOutstandingBasicAndDiluted to us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl1" xml:lang="en-US" id="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl1">Basic and diluted earnings per share - weighted-average shares (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl1" xlink:title="label: WeightedAverageNumberOfShareOutstandingBasicAndDiluted to us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl2" xml:lang="en-US" id="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl2">Weighted Average Number of Shares Outstanding, Basic and Diluted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl2" xlink:title="label: WeightedAverageNumberOfShareOutstandingBasicAndDiluted to us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="WeightedAverageNumberOfSharesOutstandingAbstract" xlink:title="WeightedAverageNumberOfSharesOutstandingAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xml:lang="en-US" id="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl">Shares used in computation [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xlink:title="label: WeightedAverageNumberOfSharesOutstandingAbstract to us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl1" xml:lang="en-US" id="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl1">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl1" xlink:title="label: WeightedAverageNumberOfSharesOutstandingAbstract to us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="ConsolidatedEntitiesDomain" xlink:title="ConsolidatedEntitiesDomain" />
    <link:label xlink:type="resource" xlink:label="srt_ConsolidatedEntitiesDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_ConsolidatedEntitiesDomain_lbl" xml:lang="en-US" id="srt_ConsolidatedEntitiesDomain_lbl">Consolidated Entities [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConsolidatedEntitiesDomain" xlink:to="srt_ConsolidatedEntitiesDomain_lbl" xlink:title="label: ConsolidatedEntitiesDomain to srt_ConsolidatedEntitiesDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="ConsolidatedEntitiesAxis" xlink:title="ConsolidatedEntitiesAxis" />
    <link:label xlink:type="resource" xlink:label="srt_ConsolidatedEntitiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_ConsolidatedEntitiesAxis_lbl" xml:lang="en-US" id="srt_ConsolidatedEntitiesAxis_lbl">Consolidated Entities [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesAxis_lbl" xlink:title="label: ConsolidatedEntitiesAxis to srt_ConsolidatedEntitiesAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis" xlink:label="ConsolidationItemsAxis" xlink:title="ConsolidationItemsAxis" />
    <link:label xlink:type="resource" xlink:label="srt_ConsolidationItemsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_ConsolidationItemsAxis_lbl" xml:lang="en-US" id="srt_ConsolidationItemsAxis_lbl">Consolidation Items [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConsolidationItemsAxis" xlink:to="srt_ConsolidationItemsAxis_lbl" xlink:title="label: ConsolidationItemsAxis to srt_ConsolidationItemsAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="ConsolidationItemsDomain" xlink:title="ConsolidationItemsDomain" />
    <link:label xlink:type="resource" xlink:label="srt_ConsolidationItemsDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_ConsolidationItemsDomain_lbl" xml:lang="en-US" id="srt_ConsolidationItemsDomain_lbl">Consolidation Items [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConsolidationItemsDomain" xlink:to="srt_ConsolidationItemsDomain_lbl" xlink:title="label: ConsolidationItemsDomain to srt_ConsolidationItemsDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_DirectorMember" xlink:label="DirectorMember" xlink:title="DirectorMember" />
    <link:label xlink:type="resource" xlink:label="srt_DirectorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_DirectorMember_lbl" xml:lang="en-US" id="srt_DirectorMember_lbl">Director [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DirectorMember" xlink:to="srt_DirectorMember_lbl" xlink:title="label: DirectorMember to srt_DirectorMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ExecutiveOfficerMember" xlink:label="ExecutiveOfficerMember" xlink:title="ExecutiveOfficerMember" />
    <link:label xlink:type="resource" xlink:label="srt_ExecutiveOfficerMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="srt_ExecutiveOfficerMember_lbl" xml:lang="en-US" id="srt_ExecutiveOfficerMember_lbl">Executive Officer [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ExecutiveOfficerMember" xlink:to="srt_ExecutiveOfficerMember_lbl" xlink:title="label: ExecutiveOfficerMember to srt_ExecutiveOfficerMember_lbl" />
    <link:label xlink:type="resource" xlink:label="srt_ExecutiveOfficerMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_ExecutiveOfficerMember_lbl1" xml:lang="en-US" id="srt_ExecutiveOfficerMember_lbl1">Executive Officer [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ExecutiveOfficerMember" xlink:to="srt_ExecutiveOfficerMember_lbl1" xlink:title="label: ExecutiveOfficerMember to srt_ExecutiveOfficerMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:label xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="srt_MaximumMember_lbl" xml:lang="en-US" id="srt_MaximumMember_lbl">Maximum [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MaximumMember" xlink:to="srt_MaximumMember_lbl" xlink:title="label: MaximumMember to srt_MaximumMember_lbl" />
    <link:label xlink:type="resource" xlink:label="srt_MaximumMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_MaximumMember_lbl1" xml:lang="en-US" id="srt_MaximumMember_lbl1">Maximum [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MaximumMember" xlink:to="srt_MaximumMember_lbl1" xlink:title="label: MaximumMember to srt_MaximumMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:label xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="srt_MinimumMember_lbl" xml:lang="en-US" id="srt_MinimumMember_lbl">Minimum [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinimumMember" xlink:to="srt_MinimumMember_lbl" xlink:title="label: MinimumMember to srt_MinimumMember_lbl" />
    <link:label xlink:type="resource" xlink:label="srt_MinimumMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_MinimumMember_lbl1" xml:lang="en-US" id="srt_MinimumMember_lbl1">Minimum [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinimumMember" xlink:to="srt_MinimumMember_lbl1" xlink:title="label: MinimumMember to srt_MinimumMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain" xlink:label="OwnershipDomain" xlink:title="OwnershipDomain" />
    <link:label xlink:type="resource" xlink:label="srt_OwnershipDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_OwnershipDomain_lbl" xml:lang="en-US" id="srt_OwnershipDomain_lbl">Ownership [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OwnershipDomain" xlink:to="srt_OwnershipDomain_lbl" xlink:title="label: OwnershipDomain to srt_OwnershipDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis" xlink:label="OwnershipAxis" xlink:title="OwnershipAxis" />
    <link:label xlink:type="resource" xlink:label="srt_OwnershipAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_OwnershipAxis_lbl" xml:lang="en-US" id="srt_OwnershipAxis_lbl">Ownership [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OwnershipAxis" xlink:to="srt_OwnershipAxis_lbl" xlink:title="label: OwnershipAxis to srt_OwnershipAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OfficerMember" xlink:label="OfficerMember" xlink:title="OfficerMember" />
    <link:label xlink:type="resource" xlink:label="srt_OfficerMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_OfficerMember_lbl" xml:lang="en-US" id="srt_OfficerMember_lbl">Officer [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OfficerMember" xlink:to="srt_OfficerMember_lbl" xlink:title="label: OfficerMember to srt_OfficerMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="ProductsAndServicesDomain" xlink:title="ProductsAndServicesDomain" />
    <link:label xlink:type="resource" xlink:label="srt_ProductsAndServicesDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_ProductsAndServicesDomain_lbl" xml:lang="en-US" id="srt_ProductsAndServicesDomain_lbl">Products and Services [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProductsAndServicesDomain" xlink:to="srt_ProductsAndServicesDomain_lbl" xlink:title="label: ProductsAndServicesDomain to srt_ProductsAndServicesDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="ProductOrServiceAxis" xlink:title="ProductOrServiceAxis" />
    <link:label xlink:type="resource" xlink:label="srt_ProductOrServiceAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_ProductOrServiceAxis_lbl" xml:lang="en-US" id="srt_ProductOrServiceAxis_lbl">Products and Services [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl" xlink:title="label: ProductOrServiceAxis to srt_ProductOrServiceAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:label xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_RangeAxis_lbl" xml:lang="en-US" id="srt_RangeAxis_lbl">Statistical Measurement [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:title="label: RangeAxis to srt_RangeAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:label xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_RangeMember_lbl" xml:lang="en-US" id="srt_RangeMember_lbl">Statistical Measurement [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RangeMember" xlink:to="srt_RangeMember_lbl" xlink:title="label: RangeMember to srt_RangeMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="ScenarioUnspecifiedDomain" xlink:title="ScenarioUnspecifiedDomain" />
    <link:label xlink:type="resource" xlink:label="srt_ScenarioUnspecifiedDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_ScenarioUnspecifiedDomain_lbl" xml:lang="en-US" id="srt_ScenarioUnspecifiedDomain_lbl">Scenario [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioUnspecifiedDomain_lbl" xlink:title="label: ScenarioUnspecifiedDomain to srt_ScenarioUnspecifiedDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember" xlink:label="ScenarioForecastMember" xlink:title="ScenarioForecastMember" />
    <link:label xlink:type="resource" xlink:label="srt_ScenarioForecastMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_ScenarioForecastMember_lbl" xml:lang="en-US" id="srt_ScenarioForecastMember_lbl">Forecast [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScenarioForecastMember" xlink:to="srt_ScenarioForecastMember_lbl" xlink:title="label: ScenarioForecastMember to srt_ScenarioForecastMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:label="ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:title="ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_lbl" xml:lang="en-US" id="srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_lbl">SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:to="srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_lbl" xlink:title="label: ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock to srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_lbl1" xml:lang="en-US" id="srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_lbl1">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:to="srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_lbl1" xlink:title="label: ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock to srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis" xlink:label="StatementScenarioAxis" xlink:title="StatementScenarioAxis" />
    <link:label xlink:type="resource" xlink:label="srt_StatementScenarioAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_StatementScenarioAxis_lbl" xml:lang="en-US" id="srt_StatementScenarioAxis_lbl">Scenario [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl" xlink:title="label: StatementScenarioAxis to srt_StatementScenarioAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SubsidiariesMember" xlink:label="SubsidiariesMember" xlink:title="SubsidiariesMember" />
    <link:label xlink:type="resource" xlink:label="srt_SubsidiariesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_SubsidiariesMember_lbl" xml:lang="en-US" id="srt_SubsidiariesMember_lbl">NewCo. [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsidiariesMember" xlink:to="srt_SubsidiariesMember_lbl" xlink:title="label: SubsidiariesMember to srt_SubsidiariesMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="TitleOfIndividualAxis" xlink:title="TitleOfIndividualAxis" />
    <link:label xlink:type="resource" xlink:label="srt_TitleOfIndividualAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US" id="srt_TitleOfIndividualAxis_lbl">Title of Individual [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" xlink:title="label: TitleOfIndividualAxis to srt_TitleOfIndividualAxis_lbl" />
    <link:label xlink:type="resource" xlink:label="srt_TitleOfIndividualAxis_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="srt_TitleOfIndividualAxis_lbl1" xml:lang="en-US" id="srt_TitleOfIndividualAxis_lbl1">Title of Individual [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl1" xlink:title="label: TitleOfIndividualAxis to srt_TitleOfIndividualAxis_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:label xlink:type="resource" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xml:lang="en-US" id="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl">Relationship to Entity [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xlink:title="label: TitleOfIndividualWithRelationshipToEntityDomain to srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" />
    <link:label xlink:type="resource" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl1" xml:lang="en-US" id="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl1">Relationship to Entity [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl1" xlink:title="label: TitleOfIndividualWithRelationshipToEntityDomain to srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract" xlink:label="ValuationAndQualifyingAccountsAbstract" xlink:title="ValuationAndQualifyingAccountsAbstract" />
    <link:label xlink:type="resource" xlink:label="srt_ValuationAndQualifyingAccountsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_ValuationAndQualifyingAccountsAbstract_lbl" xml:lang="en-US" id="srt_ValuationAndQualifyingAccountsAbstract_lbl">SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ValuationAndQualifyingAccountsAbstract" xlink:to="srt_ValuationAndQualifyingAccountsAbstract_lbl" xlink:title="label: ValuationAndQualifyingAccountsAbstract to srt_ValuationAndQualifyingAccountsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:label="ValuationAndQualifyingAccountsDisclosureLineItems" xlink:title="ValuationAndQualifyingAccountsDisclosureLineItems" />
    <link:label xlink:type="resource" xlink:label="srt_ValuationAndQualifyingAccountsDisclosureLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_ValuationAndQualifyingAccountsDisclosureLineItems_lbl" xml:lang="en-US" id="srt_ValuationAndQualifyingAccountsDisclosureLineItems_lbl">Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="srt_ValuationAndQualifyingAccountsDisclosureLineItems_lbl" xlink:title="label: ValuationAndQualifyingAccountsDisclosureLineItems to srt_ValuationAndQualifyingAccountsDisclosureLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:label="ValuationAndQualifyingAccountsDisclosureTable" xlink:title="ValuationAndQualifyingAccountsDisclosureTable" />
    <link:label xlink:type="resource" xlink:label="srt_ValuationAndQualifyingAccountsDisclosureTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_ValuationAndQualifyingAccountsDisclosureTable_lbl" xml:lang="en-US" id="srt_ValuationAndQualifyingAccountsDisclosureTable_lbl">Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ValuationAndQualifyingAccountsDisclosureTable" xlink:to="srt_ValuationAndQualifyingAccountsDisclosureTable_lbl" xlink:title="label: ValuationAndQualifyingAccountsDisclosureTable to srt_ValuationAndQualifyingAccountsDisclosureTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract_lbl" xml:lang="en-US" id="dei_CoverAbstract_lbl">Cover page.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:title="label: CoverAbstract to dei_CoverAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine1_lbl">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine2_lbl">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag_lbl" xml:lang="en-US" id="dei_AmendmentFlag_lbl">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:title="label: AmendmentFlag to dei_AmendmentFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode_lbl" xml:lang="en-US" id="dei_CityAreaCode_lbl">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:title="label: CityAreaCode to dei_CityAreaCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" id="dei_EntityAddressCityOrTown_lbl">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="CurrentFiscalYearEndDate" xlink:title="CurrentFiscalYearEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US" id="dei_CurrentFiscalYearEndDate_lbl">Current Fiscal Year End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:title="label: CurrentFiscalYearEndDate to dei_CurrentFiscalYearEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" id="dei_DocumentPeriodEndDate_lbl">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode_lbl">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber_lbl" xml:lang="en-US" id="dei_LocalPhoneNumber_lbl">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" id="dei_EntityAddressPostalZipCode_lbl">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" id="dei_EntityAddressStateOrProvince_lbl">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle_lbl" xml:lang="en-US" id="dei_Security12bTitle_lbl">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:title="label: Security12bTitle to dei_Security12bTitle_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol_lbl" xml:lang="en-US" id="dei_TradingSymbol_lbl">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:title="label: TradingSymbol to dei_TradingSymbol_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName_lbl" xml:lang="en-US" id="dei_SecurityExchangeName_lbl">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="EntityWellKnownSeasonedIssuer" xlink:title="EntityWellKnownSeasonedIssuer" />
    <link:label xlink:type="resource" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US" id="dei_EntityWellKnownSeasonedIssuer_lbl">Entity Well-known Seasoned Issuer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:title="label: EntityWellKnownSeasonedIssuer to dei_EntityWellKnownSeasonedIssuer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="EntityVoluntaryFilers" xlink:title="EntityVoluntaryFilers" />
    <link:label xlink:type="resource" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US" id="dei_EntityVoluntaryFilers_lbl">Entity Voluntary Filers</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:title="label: EntityVoluntaryFilers to dei_EntityVoluntaryFilers_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="EntityCurrentReportingStatus" xlink:title="EntityCurrentReportingStatus" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US" id="dei_EntityCurrentReportingStatus_lbl">Entity Current Reporting Status</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:title="label: EntityCurrentReportingStatus to dei_EntityCurrentReportingStatus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory" xlink:label="EntityFilerCategory" xlink:title="EntityFilerCategory" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFilerCategory_lbl" xml:lang="en-US" id="dei_EntityFilerCategory_lbl">Entity Filer Category</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:title="label: EntityFilerCategory to dei_EntityFilerCategory_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPublicFloat" xlink:label="EntityPublicFloat" xlink:title="EntityPublicFloat" />
    <link:label xlink:type="resource" xlink:label="dei_EntityPublicFloat_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityPublicFloat_lbl" xml:lang="en-US" id="dei_EntityPublicFloat_lbl">Entity Public Float</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:title="label: EntityPublicFloat to dei_EntityPublicFloat_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="dei_EntityRegistrantName_lbl">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="dei_EntityCentralIndexKey_lbl">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber_lbl">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="EntityCommonStockSharesOutstanding" xlink:title="EntityCommonStockSharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US" id="dei_EntityCommonStockSharesOutstanding_lbl">Entity Common Stock, Shares Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:title="label: EntityCommonStockSharesOutstanding to dei_EntityCommonStockSharesOutstanding_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalYearFocus_lbl">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus_lbl">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType_lbl" xml:lang="en-US" id="dei_DocumentType_lbl">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType_lbl" xlink:title="label: DocumentType to dei_DocumentType_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAnnualReport" xlink:label="DocumentAnnualReport" xlink:title="DocumentAnnualReport" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentAnnualReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentAnnualReport_lbl" xml:lang="en-US" id="dei_DocumentAnnualReport_lbl">Document Annual Report</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:title="label: DocumentAnnualReport to dei_DocumentAnnualReport_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport" xlink:label="DocumentTransitionReport" xlink:title="DocumentTransitionReport" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentTransitionReport_lbl" xml:lang="en-US" id="dei_DocumentTransitionReport_lbl">Document Transition Report</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:title="label: DocumentTransitionReport to dei_DocumentTransitionReport_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="EntityInteractiveDataCurrent" xlink:title="EntityInteractiveDataCurrent" />
    <link:label xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US" id="dei_EntityInteractiveDataCurrent_lbl">Entity Interactive Data Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:title="label: EntityInteractiveDataCurrent to dei_EntityInteractiveDataCurrent_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityNumberOfEmployees" xlink:label="EntityNumberOfEmployees" xlink:title="EntityNumberOfEmployees" />
    <link:label xlink:type="resource" xlink:label="dei_EntityNumberOfEmployees_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityNumberOfEmployees_lbl" xml:lang="en-US" id="dei_EntityNumberOfEmployees_lbl">Number of full and part-time workforce</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityNumberOfEmployees" xlink:to="dei_EntityNumberOfEmployees_lbl" xlink:title="label: EntityNumberOfEmployees to dei_EntityNumberOfEmployees_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber_lbl" xml:lang="en-US" id="dei_EntityFileNumber_lbl">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:title="label: EntityFileNumber to dei_EntityFileNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany" xlink:label="EntityShellCompany" xlink:title="EntityShellCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityShellCompany_lbl" xml:lang="en-US" id="dei_EntityShellCompany_lbl">Entity Shell Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:title="label: EntityShellCompany to dei_EntityShellCompany_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany_lbl">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness" xlink:label="EntitySmallBusiness" xlink:title="EntitySmallBusiness" />
    <link:label xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntitySmallBusiness_lbl" xml:lang="en-US" id="dei_EntitySmallBusiness_lbl">Entity Small Business</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:title="label: EntitySmallBusiness to dei_EntitySmallBusiness_lbl" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_EmployeesMember" xlink:label="EmployeesMember" xlink:title="EmployeesMember" />
    <link:label xlink:type="resource" xlink:label="usph_EmployeesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_EmployeesMember_lbl" xml:lang="en-US" id="usph_EmployeesMember_lbl">An individual who works part-time or full-time under a contract of employment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeesMember" xlink:to="usph_EmployeesMember_lbl" xlink:title="label: EmployeesMember to usph_EmployeesMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_EmployeesMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_EmployeesMember_lbl1" xml:lang="en-US" id="usph_EmployeesMember_lbl1">Employees [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeesMember" xlink:to="usph_EmployeesMember_lbl1" xlink:title="label: EmployeesMember to usph_EmployeesMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_EmployeesMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_EmployeesMember_lbl2" xml:lang="en-US" id="usph_EmployeesMember_lbl2">Employees [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeesMember" xlink:to="usph_EmployeesMember_lbl2" xlink:title="label: EmployeesMember to usph_EmployeesMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed" />
    <link:label xlink:type="resource" xlink:label="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed_lbl" xml:lang="en-US" id="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed_lbl">Number of shares outstanding for which restrictions had not lapsed.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed" xlink:to="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed to usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed_lbl1" xml:lang="en-US" id="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed_lbl1">Share Based Compensation Arrangement By Share Based Payment Award For Shares Outstanding Restrictions Had Not Lapsed</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed" xlink:to="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed to usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed_lbl2" xml:lang="en-US" id="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed_lbl2">Shares outstanding for which restrictions had not lapsed (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed" xlink:to="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed to usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription" />
    <link:label xlink:type="resource" xlink:label="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription_lbl" xml:lang="en-US" id="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription_lbl">Description of restriction lapse grant to employees.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription" xlink:to="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription to usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription_lbl1" xml:lang="en-US" id="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription_lbl1">Share Based Compensation Arrangement By Share Based Payment Award Restriction Lapse Period Description</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription" xlink:to="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription to usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription_lbl2" xml:lang="en-US" id="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription_lbl2">Restrictions will lapse in</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription" xlink:to="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription to usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_RestrictedPeriodToEmployeesOnTheStockGranted" xlink:label="RestrictedPeriodToEmployeesOnTheStockGranted" xlink:title="RestrictedPeriodToEmployeesOnTheStockGranted" />
    <link:label xlink:type="resource" xlink:label="usph_RestrictedPeriodToEmployeesOnTheStockGranted_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_RestrictedPeriodToEmployeesOnTheStockGranted_lbl" xml:lang="en-US" id="usph_RestrictedPeriodToEmployeesOnTheStockGranted_lbl">Restricted period to employees on the stock granted during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedPeriodToEmployeesOnTheStockGranted" xlink:to="usph_RestrictedPeriodToEmployeesOnTheStockGranted_lbl" xlink:title="label: RestrictedPeriodToEmployeesOnTheStockGranted to usph_RestrictedPeriodToEmployeesOnTheStockGranted_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_RestrictedPeriodToEmployeesOnTheStockGranted_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_RestrictedPeriodToEmployeesOnTheStockGranted_lbl1" xml:lang="en-US" id="usph_RestrictedPeriodToEmployeesOnTheStockGranted_lbl1">Restricted period to employees on the stock granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedPeriodToEmployeesOnTheStockGranted" xlink:to="usph_RestrictedPeriodToEmployeesOnTheStockGranted_lbl1" xlink:title="label: RestrictedPeriodToEmployeesOnTheStockGranted to usph_RestrictedPeriodToEmployeesOnTheStockGranted_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_RestrictedPeriodToEmployeesOnTheStockGranted_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_RestrictedPeriodToEmployeesOnTheStockGranted_lbl2" xml:lang="en-US" id="usph_RestrictedPeriodToEmployeesOnTheStockGranted_lbl2">Restricted period on the stock granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedPeriodToEmployeesOnTheStockGranted" xlink:to="usph_RestrictedPeriodToEmployeesOnTheStockGranted_lbl2" xlink:title="label: RestrictedPeriodToEmployeesOnTheStockGranted to usph_RestrictedPeriodToEmployeesOnTheStockGranted_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PhysicalTherapyOperationsExcludingClosureCostsMember" xlink:label="PhysicalTherapyOperationsExcludingClosureCostsMember" xlink:title="PhysicalTherapyOperationsExcludingClosureCostsMember" />
    <link:label xlink:type="resource" xlink:label="usph_PhysicalTherapyOperationsExcludingClosureCostsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PhysicalTherapyOperationsExcludingClosureCostsMember_lbl" xml:lang="en-US" id="usph_PhysicalTherapyOperationsExcludingClosureCostsMember_lbl">Physical therapy operations excluding closure cost consist of net revenue from physical therapy and occupational therapy clinics that provide pre-and post-operative care and treatment for orthopedic related disorders, sports-related injuries, preventive care, rehabilitation of injured workers and neurological injuries.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PhysicalTherapyOperationsExcludingClosureCostsMember" xlink:to="usph_PhysicalTherapyOperationsExcludingClosureCostsMember_lbl" xlink:title="label: PhysicalTherapyOperationsExcludingClosureCostsMember to usph_PhysicalTherapyOperationsExcludingClosureCostsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PhysicalTherapyOperationsExcludingClosureCostsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PhysicalTherapyOperationsExcludingClosureCostsMember_lbl1" xml:lang="en-US" id="usph_PhysicalTherapyOperationsExcludingClosureCostsMember_lbl1">Physical Therapy Operations Excluding Closure Costs [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PhysicalTherapyOperationsExcludingClosureCostsMember" xlink:to="usph_PhysicalTherapyOperationsExcludingClosureCostsMember_lbl1" xlink:title="label: PhysicalTherapyOperationsExcludingClosureCostsMember to usph_PhysicalTherapyOperationsExcludingClosureCostsMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PhysicalTherapyOperationsExcludingClosureCostsMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PhysicalTherapyOperationsExcludingClosureCostsMember_lbl2" xml:lang="en-US" id="usph_PhysicalTherapyOperationsExcludingClosureCostsMember_lbl2">Physical Therapy Operations (Excluding Closure Costs) [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PhysicalTherapyOperationsExcludingClosureCostsMember" xlink:to="usph_PhysicalTherapyOperationsExcludingClosureCostsMember_lbl2" xlink:title="label: PhysicalTherapyOperationsExcludingClosureCostsMember to usph_PhysicalTherapyOperationsExcludingClosureCostsMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NonControllingInterestsPolicyPolicyTextBlock" xlink:label="NonControllingInterestsPolicyPolicyTextBlock" xlink:title="NonControllingInterestsPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="usph_NonControllingInterestsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NonControllingInterestsPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="usph_NonControllingInterestsPolicyPolicyTextBlock_lbl">Disclosure of accounting policy for non-controlling interests.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonControllingInterestsPolicyPolicyTextBlock" xlink:to="usph_NonControllingInterestsPolicyPolicyTextBlock_lbl" xlink:title="label: NonControllingInterestsPolicyPolicyTextBlock to usph_NonControllingInterestsPolicyPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NonControllingInterestsPolicyPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NonControllingInterestsPolicyPolicyTextBlock_lbl1" xml:lang="en-US" id="usph_NonControllingInterestsPolicyPolicyTextBlock_lbl1">Non controlling Interests Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonControllingInterestsPolicyPolicyTextBlock" xlink:to="usph_NonControllingInterestsPolicyPolicyTextBlock_lbl1" xlink:title="label: NonControllingInterestsPolicyPolicyTextBlock to usph_NonControllingInterestsPolicyPolicyTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NonControllingInterestsPolicyPolicyTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NonControllingInterestsPolicyPolicyTextBlock_lbl2" xml:lang="en-US" id="usph_NonControllingInterestsPolicyPolicyTextBlock_lbl2">Non-Controlling Interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonControllingInterestsPolicyPolicyTextBlock" xlink:to="usph_NonControllingInterestsPolicyPolicyTextBlock_lbl2" xlink:title="label: NonControllingInterestsPolicyPolicyTextBlock to usph_NonControllingInterestsPolicyPolicyTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_RestrictedStockPolicyPolicyTextBlock" xlink:label="RestrictedStockPolicyPolicyTextBlock" xlink:title="RestrictedStockPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="usph_RestrictedStockPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_RestrictedStockPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="usph_RestrictedStockPolicyPolicyTextBlock_lbl">Disclosure of accounting policy for restricted stock.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedStockPolicyPolicyTextBlock" xlink:to="usph_RestrictedStockPolicyPolicyTextBlock_lbl" xlink:title="label: RestrictedStockPolicyPolicyTextBlock to usph_RestrictedStockPolicyPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_RestrictedStockPolicyPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_RestrictedStockPolicyPolicyTextBlock_lbl1" xml:lang="en-US" id="usph_RestrictedStockPolicyPolicyTextBlock_lbl1">Restricted Stock Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedStockPolicyPolicyTextBlock" xlink:to="usph_RestrictedStockPolicyPolicyTextBlock_lbl1" xlink:title="label: RestrictedStockPolicyPolicyTextBlock to usph_RestrictedStockPolicyPolicyTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_RestrictedStockPolicyPolicyTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_RestrictedStockPolicyPolicyTextBlock_lbl2" xml:lang="en-US" id="usph_RestrictedStockPolicyPolicyTextBlock_lbl2">Restricted Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedStockPolicyPolicyTextBlock" xlink:to="usph_RestrictedStockPolicyPolicyTextBlock_lbl2" xlink:title="label: RestrictedStockPolicyPolicyTextBlock to usph_RestrictedStockPolicyPolicyTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_SelfInsuranceProgramPolicyPolicyTextBlock" xlink:label="SelfInsuranceProgramPolicyPolicyTextBlock" xlink:title="SelfInsuranceProgramPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl">Disclosure of accounting policy for self-insurance program.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SelfInsuranceProgramPolicyPolicyTextBlock" xlink:to="usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl" xlink:title="label: SelfInsuranceProgramPolicyPolicyTextBlock to usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl1" xml:lang="en-US" id="usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl1">Self Insurance Program Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SelfInsuranceProgramPolicyPolicyTextBlock" xlink:to="usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl1" xlink:title="label: SelfInsuranceProgramPolicyPolicyTextBlock to usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl2" xml:lang="en-US" id="usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl2">Self-Insurance Program</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SelfInsuranceProgramPolicyPolicyTextBlock" xlink:to="usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl2" xlink:title="label: SelfInsuranceProgramPolicyPolicyTextBlock to usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_RedeemableNonControllingInterestsPolicyTextBlock" xlink:label="RedeemableNonControllingInterestsPolicyTextBlock" xlink:title="RedeemableNonControllingInterestsPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl" xml:lang="en-US" id="usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl">Disclosure of accounting policy for redeemable non-controlling interests.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNonControllingInterestsPolicyTextBlock" xlink:to="usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl" xlink:title="label: RedeemableNonControllingInterestsPolicyTextBlock to usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl1" xml:lang="en-US" id="usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl1">Redeemable Non Controlling Interests [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNonControllingInterestsPolicyTextBlock" xlink:to="usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl1" xlink:title="label: RedeemableNonControllingInterestsPolicyTextBlock to usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl2" xml:lang="en-US" id="usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl2">Redeemable Non-Controlling Interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNonControllingInterestsPolicyTextBlock" xlink:to="usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl2" xlink:title="label: RedeemableNonControllingInterestsPolicyTextBlock to usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_DefinedContributionPlanEmployerMatchingContributionAmount" xlink:label="DefinedContributionPlanEmployerMatchingContributionAmount" xlink:title="DefinedContributionPlanEmployerMatchingContributionAmount" />
    <link:label xlink:type="resource" xlink:label="usph_DefinedContributionPlanEmployerMatchingContributionAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_DefinedContributionPlanEmployerMatchingContributionAmount_lbl" xml:lang="en-US" id="usph_DefinedContributionPlanEmployerMatchingContributionAmount_lbl">Amount of matching contributions made by an employer to a defined contribution plan.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanEmployerMatchingContributionAmount" xlink:to="usph_DefinedContributionPlanEmployerMatchingContributionAmount_lbl" xlink:title="label: DefinedContributionPlanEmployerMatchingContributionAmount to usph_DefinedContributionPlanEmployerMatchingContributionAmount_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_DefinedContributionPlanEmployerMatchingContributionAmount_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_DefinedContributionPlanEmployerMatchingContributionAmount_lbl1" xml:lang="en-US" id="usph_DefinedContributionPlanEmployerMatchingContributionAmount_lbl1">Defined Contribution Plan, Employer Matching Contribution Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanEmployerMatchingContributionAmount" xlink:to="usph_DefinedContributionPlanEmployerMatchingContributionAmount_lbl1" xlink:title="label: DefinedContributionPlanEmployerMatchingContributionAmount to usph_DefinedContributionPlanEmployerMatchingContributionAmount_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_DefinedContributionPlanEmployerMatchingContributionAmount_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_DefinedContributionPlanEmployerMatchingContributionAmount_lbl2" xml:lang="en-US" id="usph_DefinedContributionPlanEmployerMatchingContributionAmount_lbl2">Employer matching contribution amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanEmployerMatchingContributionAmount" xlink:to="usph_DefinedContributionPlanEmployerMatchingContributionAmount_lbl2" xlink:title="label: DefinedContributionPlanEmployerMatchingContributionAmount to usph_DefinedContributionPlanEmployerMatchingContributionAmount_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan" xlink:label="DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan" xlink:title="DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan" />
    <link:label xlink:type="resource" xlink:label="usph_DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan_lbl" xml:lang="en-US" id="usph_DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan_lbl">Period consider for new employees to cover under defined contribution plan.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan" xlink:to="usph_DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan_lbl" xlink:title="label: DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan to usph_DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan_lbl1" xml:lang="en-US" id="usph_DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan_lbl1">Defined Contribution Plan Period For New Employees Covered Under Plan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan" xlink:to="usph_DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan_lbl1" xlink:title="label: DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan to usph_DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan_lbl2" xml:lang="en-US" id="usph_DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan_lbl2">Required time period for employees for profit sharing plan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan" xlink:to="usph_DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan_lbl2" xlink:title="label: DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan to usph_DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfFurloughedEmployeesReturned" xlink:label="NumberOfFurloughedEmployeesReturned" xlink:title="NumberOfFurloughedEmployeesReturned" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfFurloughedEmployeesReturned_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NumberOfFurloughedEmployeesReturned_lbl" xml:lang="en-US" id="usph_NumberOfFurloughedEmployeesReturned_lbl">Number of furloughed employees returned to work.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfFurloughedEmployeesReturned" xlink:to="usph_NumberOfFurloughedEmployeesReturned_lbl" xlink:title="label: NumberOfFurloughedEmployeesReturned to usph_NumberOfFurloughedEmployeesReturned_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfFurloughedEmployeesReturned_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NumberOfFurloughedEmployeesReturned_lbl1" xml:lang="en-US" id="usph_NumberOfFurloughedEmployeesReturned_lbl1">Number of Furloughed Employees Returned</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfFurloughedEmployeesReturned" xlink:to="usph_NumberOfFurloughedEmployeesReturned_lbl1" xlink:title="label: NumberOfFurloughedEmployeesReturned to usph_NumberOfFurloughedEmployeesReturned_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfFurloughedEmployeesReturned_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NumberOfFurloughedEmployeesReturned_lbl2" xml:lang="en-US" id="usph_NumberOfFurloughedEmployeesReturned_lbl2">Number of furloughed employees returned</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfFurloughedEmployeesReturned" xlink:to="usph_NumberOfFurloughedEmployeesReturned_lbl2" xlink:title="label: NumberOfFurloughedEmployeesReturned to usph_NumberOfFurloughedEmployeesReturned_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_MedicareAcceleratedAndAdvancePaymentsProgramMember" xlink:label="MedicareAcceleratedAndAdvancePaymentsProgramMember" xlink:title="MedicareAcceleratedAndAdvancePaymentsProgramMember" />
    <link:label xlink:type="resource" xlink:label="usph_MedicareAcceleratedAndAdvancePaymentsProgramMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_MedicareAcceleratedAndAdvancePaymentsProgramMember_lbl" xml:lang="en-US" id="usph_MedicareAcceleratedAndAdvancePaymentsProgramMember_lbl">Emergency financial aid grants to cover expenses related to the disruption of campus operations due to COVID-19.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MedicareAcceleratedAndAdvancePaymentsProgramMember" xlink:to="usph_MedicareAcceleratedAndAdvancePaymentsProgramMember_lbl" xlink:title="label: MedicareAcceleratedAndAdvancePaymentsProgramMember to usph_MedicareAcceleratedAndAdvancePaymentsProgramMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_MedicareAcceleratedAndAdvancePaymentsProgramMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_MedicareAcceleratedAndAdvancePaymentsProgramMember_lbl1" xml:lang="en-US" id="usph_MedicareAcceleratedAndAdvancePaymentsProgramMember_lbl1">Medicare Accelerated and Advance Payments Program [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MedicareAcceleratedAndAdvancePaymentsProgramMember" xlink:to="usph_MedicareAcceleratedAndAdvancePaymentsProgramMember_lbl1" xlink:title="label: MedicareAcceleratedAndAdvancePaymentsProgramMember to usph_MedicareAcceleratedAndAdvancePaymentsProgramMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_MedicareAcceleratedAndAdvancePaymentsProgramMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_MedicareAcceleratedAndAdvancePaymentsProgramMember_lbl2" xml:lang="en-US" id="usph_MedicareAcceleratedAndAdvancePaymentsProgramMember_lbl2">Medicare Accelerated and Advance Payments Program [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MedicareAcceleratedAndAdvancePaymentsProgramMember" xlink:to="usph_MedicareAcceleratedAndAdvancePaymentsProgramMember_lbl2" xlink:title="label: MedicareAcceleratedAndAdvancePaymentsProgramMember to usph_MedicareAcceleratedAndAdvancePaymentsProgramMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_MarchTwoThousandSeventeenAcquisitionMember" xlink:label="MarchTwoThousandSeventeenAcquisitionMember" xlink:title="MarchTwoThousandSeventeenAcquisitionMember" />
    <link:label xlink:type="resource" xlink:label="usph_MarchTwoThousandSeventeenAcquisitionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_MarchTwoThousandSeventeenAcquisitionMember_lbl" xml:lang="en-US" id="usph_MarchTwoThousandSeventeenAcquisitionMember_lbl">Date of business acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MarchTwoThousandSeventeenAcquisitionMember" xlink:to="usph_MarchTwoThousandSeventeenAcquisitionMember_lbl" xlink:title="label: MarchTwoThousandSeventeenAcquisitionMember to usph_MarchTwoThousandSeventeenAcquisitionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_MarchTwoThousandSeventeenAcquisitionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_MarchTwoThousandSeventeenAcquisitionMember_lbl1" xml:lang="en-US" id="usph_MarchTwoThousandSeventeenAcquisitionMember_lbl1">March Two Thousand Seventeen Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MarchTwoThousandSeventeenAcquisitionMember" xlink:to="usph_MarchTwoThousandSeventeenAcquisitionMember_lbl1" xlink:title="label: MarchTwoThousandSeventeenAcquisitionMember to usph_MarchTwoThousandSeventeenAcquisitionMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_MarchTwoThousandSeventeenAcquisitionMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_MarchTwoThousandSeventeenAcquisitionMember_lbl2" xml:lang="en-US" id="usph_MarchTwoThousandSeventeenAcquisitionMember_lbl2">March 2017 Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MarchTwoThousandSeventeenAcquisitionMember" xlink:to="usph_MarchTwoThousandSeventeenAcquisitionMember_lbl2" xlink:title="label: MarchTwoThousandSeventeenAcquisitionMember to usph_MarchTwoThousandSeventeenAcquisitionMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfThirdPartyFacilities" xlink:label="NumberOfThirdPartyFacilities" xlink:title="NumberOfThirdPartyFacilities" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfThirdPartyFacilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NumberOfThirdPartyFacilities_lbl" xml:lang="en-US" id="usph_NumberOfThirdPartyFacilities_lbl">Number of third party facilities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfThirdPartyFacilities" xlink:to="usph_NumberOfThirdPartyFacilities_lbl" xlink:title="label: NumberOfThirdPartyFacilities to usph_NumberOfThirdPartyFacilities_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfThirdPartyFacilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NumberOfThirdPartyFacilities_lbl1" xml:lang="en-US" id="usph_NumberOfThirdPartyFacilities_lbl1">Number Of Third Party Facilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfThirdPartyFacilities" xlink:to="usph_NumberOfThirdPartyFacilities_lbl1" xlink:title="label: NumberOfThirdPartyFacilities to usph_NumberOfThirdPartyFacilities_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfThirdPartyFacilities_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NumberOfThirdPartyFacilities_lbl2" xml:lang="en-US" id="usph_NumberOfThirdPartyFacilities_lbl2">Number of third party facilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfThirdPartyFacilities" xlink:to="usph_NumberOfThirdPartyFacilities_lbl2" xlink:title="label: NumberOfThirdPartyFacilities to usph_NumberOfThirdPartyFacilities_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PercentageOfLimitedPartnershipInterestOwned" xlink:label="PercentageOfLimitedPartnershipInterestOwned" xlink:title="PercentageOfLimitedPartnershipInterestOwned" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfLimitedPartnershipInterestOwned_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PercentageOfLimitedPartnershipInterestOwned_lbl" xml:lang="en-US" id="usph_PercentageOfLimitedPartnershipInterestOwned_lbl">Percentage of limited partnership interest owned during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfLimitedPartnershipInterestOwned" xlink:to="usph_PercentageOfLimitedPartnershipInterestOwned_lbl" xlink:title="label: PercentageOfLimitedPartnershipInterestOwned to usph_PercentageOfLimitedPartnershipInterestOwned_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfLimitedPartnershipInterestOwned_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PercentageOfLimitedPartnershipInterestOwned_lbl1" xml:lang="en-US" id="usph_PercentageOfLimitedPartnershipInterestOwned_lbl1">Percentage Of Limited Partnership Interest Owned</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfLimitedPartnershipInterestOwned" xlink:to="usph_PercentageOfLimitedPartnershipInterestOwned_lbl1" xlink:title="label: PercentageOfLimitedPartnershipInterestOwned to usph_PercentageOfLimitedPartnershipInterestOwned_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfLimitedPartnershipInterestOwned_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PercentageOfLimitedPartnershipInterestOwned_lbl2" xml:lang="en-US" id="usph_PercentageOfLimitedPartnershipInterestOwned_lbl2">Percentage of limited partnership interest owned</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfLimitedPartnershipInterestOwned" xlink:to="usph_PercentageOfLimitedPartnershipInterestOwned_lbl2" xlink:title="label: PercentageOfLimitedPartnershipInterestOwned to usph_PercentageOfLimitedPartnershipInterestOwned_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PercentageOfGeneralPartnershipInterestOwned" xlink:label="PercentageOfGeneralPartnershipInterestOwned" xlink:title="PercentageOfGeneralPartnershipInterestOwned" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfGeneralPartnershipInterestOwned_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PercentageOfGeneralPartnershipInterestOwned_lbl" xml:lang="en-US" id="usph_PercentageOfGeneralPartnershipInterestOwned_lbl">Percentage of general partnership interest owned during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfGeneralPartnershipInterestOwned" xlink:to="usph_PercentageOfGeneralPartnershipInterestOwned_lbl" xlink:title="label: PercentageOfGeneralPartnershipInterestOwned to usph_PercentageOfGeneralPartnershipInterestOwned_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfGeneralPartnershipInterestOwned_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PercentageOfGeneralPartnershipInterestOwned_lbl1" xml:lang="en-US" id="usph_PercentageOfGeneralPartnershipInterestOwned_lbl1">Percentage Of General Partnership Interest Owned</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfGeneralPartnershipInterestOwned" xlink:to="usph_PercentageOfGeneralPartnershipInterestOwned_lbl1" xlink:title="label: PercentageOfGeneralPartnershipInterestOwned to usph_PercentageOfGeneralPartnershipInterestOwned_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfGeneralPartnershipInterestOwned_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PercentageOfGeneralPartnershipInterestOwned_lbl2" xml:lang="en-US" id="usph_PercentageOfGeneralPartnershipInterestOwned_lbl2">Percentage of general partnership interest owned</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfGeneralPartnershipInterestOwned" xlink:to="usph_PercentageOfGeneralPartnershipInterestOwned_lbl2" xlink:title="label: PercentageOfGeneralPartnershipInterestOwned to usph_PercentageOfGeneralPartnershipInterestOwned_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_AveragePhysicalTherapyPatientsVolumesPerDayPerClinic" xlink:label="AveragePhysicalTherapyPatientsVolumesPerDayPerClinic" xlink:title="AveragePhysicalTherapyPatientsVolumesPerDayPerClinic" />
    <link:label xlink:type="resource" xlink:label="usph_AveragePhysicalTherapyPatientsVolumesPerDayPerClinic_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_AveragePhysicalTherapyPatientsVolumesPerDayPerClinic_lbl" xml:lang="en-US" id="usph_AveragePhysicalTherapyPatientsVolumesPerDayPerClinic_lbl">The average number of physical therapy patient volumes per day per clinic</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AveragePhysicalTherapyPatientsVolumesPerDayPerClinic" xlink:to="usph_AveragePhysicalTherapyPatientsVolumesPerDayPerClinic_lbl" xlink:title="label: AveragePhysicalTherapyPatientsVolumesPerDayPerClinic to usph_AveragePhysicalTherapyPatientsVolumesPerDayPerClinic_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_AveragePhysicalTherapyPatientsVolumesPerDayPerClinic_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_AveragePhysicalTherapyPatientsVolumesPerDayPerClinic_lbl1" xml:lang="en-US" id="usph_AveragePhysicalTherapyPatientsVolumesPerDayPerClinic_lbl1">Average Physical Therapy Patients Volumes per Day per Clinic</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AveragePhysicalTherapyPatientsVolumesPerDayPerClinic" xlink:to="usph_AveragePhysicalTherapyPatientsVolumesPerDayPerClinic_lbl1" xlink:title="label: AveragePhysicalTherapyPatientsVolumesPerDayPerClinic to usph_AveragePhysicalTherapyPatientsVolumesPerDayPerClinic_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_AveragePhysicalTherapyPatientsVolumesPerDayPerClinic_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_AveragePhysicalTherapyPatientsVolumesPerDayPerClinic_lbl2" xml:lang="en-US" id="usph_AveragePhysicalTherapyPatientsVolumesPerDayPerClinic_lbl2">Average physical therapy patient volumes per day per clinic</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AveragePhysicalTherapyPatientsVolumesPerDayPerClinic" xlink:to="usph_AveragePhysicalTherapyPatientsVolumesPerDayPerClinic_lbl2" xlink:title="label: AveragePhysicalTherapyPatientsVolumesPerDayPerClinic to usph_AveragePhysicalTherapyPatientsVolumesPerDayPerClinic_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PercentageOfEmployeesFurloughedOrTerminated" xlink:label="PercentageOfEmployeesFurloughedOrTerminated" xlink:title="PercentageOfEmployeesFurloughedOrTerminated" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfEmployeesFurloughedOrTerminated_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PercentageOfEmployeesFurloughedOrTerminated_lbl" xml:lang="en-US" id="usph_PercentageOfEmployeesFurloughedOrTerminated_lbl">The percentage of employees furloughed or terminated due to pandemic.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfEmployeesFurloughedOrTerminated" xlink:to="usph_PercentageOfEmployeesFurloughedOrTerminated_lbl" xlink:title="label: PercentageOfEmployeesFurloughedOrTerminated to usph_PercentageOfEmployeesFurloughedOrTerminated_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfEmployeesFurloughedOrTerminated_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PercentageOfEmployeesFurloughedOrTerminated_lbl1" xml:lang="en-US" id="usph_PercentageOfEmployeesFurloughedOrTerminated_lbl1">Percentage of Employees Furloughed or Terminated</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfEmployeesFurloughedOrTerminated" xlink:to="usph_PercentageOfEmployeesFurloughedOrTerminated_lbl1" xlink:title="label: PercentageOfEmployeesFurloughedOrTerminated to usph_PercentageOfEmployeesFurloughedOrTerminated_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfEmployeesFurloughedOrTerminated_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PercentageOfEmployeesFurloughedOrTerminated_lbl2" xml:lang="en-US" id="usph_PercentageOfEmployeesFurloughedOrTerminated_lbl2">Percentage of employees furloughed or terminated</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfEmployeesFurloughedOrTerminated" xlink:to="usph_PercentageOfEmployeesFurloughedOrTerminated_lbl2" xlink:title="label: PercentageOfEmployeesFurloughedOrTerminated to usph_PercentageOfEmployeesFurloughedOrTerminated_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfClinicsOperated" xlink:label="NumberOfClinicsOperated" xlink:title="NumberOfClinicsOperated" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfClinicsOperated_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NumberOfClinicsOperated_lbl" xml:lang="en-US" id="usph_NumberOfClinicsOperated_lbl">Number of clinics operated during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfClinicsOperated" xlink:to="usph_NumberOfClinicsOperated_lbl" xlink:title="label: NumberOfClinicsOperated to usph_NumberOfClinicsOperated_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfClinicsOperated_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NumberOfClinicsOperated_lbl1" xml:lang="en-US" id="usph_NumberOfClinicsOperated_lbl1">Number Of Clinics Operated</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfClinicsOperated" xlink:to="usph_NumberOfClinicsOperated_lbl1" xlink:title="label: NumberOfClinicsOperated to usph_NumberOfClinicsOperated_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfClinicsOperated_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NumberOfClinicsOperated_lbl2" xml:lang="en-US" id="usph_NumberOfClinicsOperated_lbl2">Number of clinics operated</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfClinicsOperated" xlink:to="usph_NumberOfClinicsOperated_lbl2" xlink:title="label: NumberOfClinicsOperated to usph_NumberOfClinicsOperated_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_GrantsAndOtherFunds" xlink:label="GrantsAndOtherFunds" xlink:title="GrantsAndOtherFunds" />
    <link:label xlink:type="resource" xlink:label="usph_GrantsAndOtherFunds_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_GrantsAndOtherFunds_lbl" xml:lang="en-US" id="usph_GrantsAndOtherFunds_lbl">Carrying amount as of the balance sheet date of amounts due under the terms of grants and other funds.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GrantsAndOtherFunds" xlink:to="usph_GrantsAndOtherFunds_lbl" xlink:title="label: GrantsAndOtherFunds to usph_GrantsAndOtherFunds_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_GrantsAndOtherFunds_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_GrantsAndOtherFunds_lbl1" xml:lang="en-US" id="usph_GrantsAndOtherFunds_lbl1">Grants and Other Funds</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GrantsAndOtherFunds" xlink:to="usph_GrantsAndOtherFunds_lbl1" xlink:title="label: GrantsAndOtherFunds to usph_GrantsAndOtherFunds_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_GrantsAndOtherFunds_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_GrantsAndOtherFunds_lbl2" xml:lang="en-US" id="usph_GrantsAndOtherFunds_lbl2">Grants and other funds</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GrantsAndOtherFunds" xlink:to="usph_GrantsAndOtherFunds_lbl2" xlink:title="label: GrantsAndOtherFunds to usph_GrantsAndOtherFunds_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_CashAndCashEquivalentsAndAccruedLiabilities" xlink:label="CashAndCashEquivalentsAndAccruedLiabilities" xlink:title="CashAndCashEquivalentsAndAccruedLiabilities" />
    <link:label xlink:type="resource" xlink:label="usph_CashAndCashEquivalentsAndAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_CashAndCashEquivalentsAndAccruedLiabilities_lbl" xml:lang="en-US" id="usph_CashAndCashEquivalentsAndAccruedLiabilities_lbl">Carrying value as of the balance sheet date of obligations incurred and Cash and cash equivalents and accrued liabilities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndCashEquivalentsAndAccruedLiabilities" xlink:to="usph_CashAndCashEquivalentsAndAccruedLiabilities_lbl" xlink:title="label: CashAndCashEquivalentsAndAccruedLiabilities to usph_CashAndCashEquivalentsAndAccruedLiabilities_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_CashAndCashEquivalentsAndAccruedLiabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_CashAndCashEquivalentsAndAccruedLiabilities_lbl1" xml:lang="en-US" id="usph_CashAndCashEquivalentsAndAccruedLiabilities_lbl1">Cash and cash equivalents and accrued liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndCashEquivalentsAndAccruedLiabilities" xlink:to="usph_CashAndCashEquivalentsAndAccruedLiabilities_lbl1" xlink:title="label: CashAndCashEquivalentsAndAccruedLiabilities to usph_CashAndCashEquivalentsAndAccruedLiabilities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfClinicsOperatesAsASatelliteClinicWithExistingPartnerships" xlink:label="NumberOfClinicsOperatesAsASatelliteClinicWithExistingPartnerships" xlink:title="NumberOfClinicsOperatesAsASatelliteClinicWithExistingPartnerships" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfClinicsOperatesAsASatelliteClinicWithExistingPartnerships_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NumberOfClinicsOperatesAsASatelliteClinicWithExistingPartnerships_lbl" xml:lang="en-US" id="usph_NumberOfClinicsOperatesAsASatelliteClinicWithExistingPartnerships_lbl">Number of clinics operates as a satellite clinic with existing partnerships during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfClinicsOperatesAsASatelliteClinicWithExistingPartnerships" xlink:to="usph_NumberOfClinicsOperatesAsASatelliteClinicWithExistingPartnerships_lbl" xlink:title="label: NumberOfClinicsOperatesAsASatelliteClinicWithExistingPartnerships to usph_NumberOfClinicsOperatesAsASatelliteClinicWithExistingPartnerships_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfClinicsOperatesAsASatelliteClinicWithExistingPartnerships_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NumberOfClinicsOperatesAsASatelliteClinicWithExistingPartnerships_lbl1" xml:lang="en-US" id="usph_NumberOfClinicsOperatesAsASatelliteClinicWithExistingPartnerships_lbl1">Number Of Clinics Operates As a Satellite Clinic With Existing Partnerships</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfClinicsOperatesAsASatelliteClinicWithExistingPartnerships" xlink:to="usph_NumberOfClinicsOperatesAsASatelliteClinicWithExistingPartnerships_lbl1" xlink:title="label: NumberOfClinicsOperatesAsASatelliteClinicWithExistingPartnerships to usph_NumberOfClinicsOperatesAsASatelliteClinicWithExistingPartnerships_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfClinicsOperatesAsASatelliteClinicWithExistingPartnerships_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NumberOfClinicsOperatesAsASatelliteClinicWithExistingPartnerships_lbl2" xml:lang="en-US" id="usph_NumberOfClinicsOperatesAsASatelliteClinicWithExistingPartnerships_lbl2">Number of clinics that operate as a satellite clinic with existing partnerships</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfClinicsOperatesAsASatelliteClinicWithExistingPartnerships" xlink:to="usph_NumberOfClinicsOperatesAsASatelliteClinicWithExistingPartnerships_lbl2" xlink:title="label: NumberOfClinicsOperatesAsASatelliteClinicWithExistingPartnerships to usph_NumberOfClinicsOperatesAsASatelliteClinicWithExistingPartnerships_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfOperatingClinicLocations" xlink:label="NumberOfOperatingClinicLocations" xlink:title="NumberOfOperatingClinicLocations" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfOperatingClinicLocations_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NumberOfOperatingClinicLocations_lbl" xml:lang="en-US" id="usph_NumberOfOperatingClinicLocations_lbl">Number of operating clinic locations during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfOperatingClinicLocations" xlink:to="usph_NumberOfOperatingClinicLocations_lbl" xlink:title="label: NumberOfOperatingClinicLocations to usph_NumberOfOperatingClinicLocations_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfOperatingClinicLocations_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NumberOfOperatingClinicLocations_lbl1" xml:lang="en-US" id="usph_NumberOfOperatingClinicLocations_lbl1">Number of Operating Clinic Locations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfOperatingClinicLocations" xlink:to="usph_NumberOfOperatingClinicLocations_lbl1" xlink:title="label: NumberOfOperatingClinicLocations to usph_NumberOfOperatingClinicLocations_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfOperatingClinicLocations_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NumberOfOperatingClinicLocations_lbl2" xml:lang="en-US" id="usph_NumberOfOperatingClinicLocations_lbl2">Number of operating clinic locations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfOperatingClinicLocations" xlink:to="usph_NumberOfOperatingClinicLocations_lbl2" xlink:title="label: NumberOfOperatingClinicLocations to usph_NumberOfOperatingClinicLocations_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PublicHealthAndSocialServicesEmergencyFundMember" xlink:label="PublicHealthAndSocialServicesEmergencyFundMember" xlink:title="PublicHealthAndSocialServicesEmergencyFundMember" />
    <link:label xlink:type="resource" xlink:label="usph_PublicHealthAndSocialServicesEmergencyFundMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PublicHealthAndSocialServicesEmergencyFundMember_lbl" xml:lang="en-US" id="usph_PublicHealthAndSocialServicesEmergencyFundMember_lbl">Emergency financial aid grants to cover expenses related to the disruption of campus operations due to COVID-19.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PublicHealthAndSocialServicesEmergencyFundMember" xlink:to="usph_PublicHealthAndSocialServicesEmergencyFundMember_lbl" xlink:title="label: PublicHealthAndSocialServicesEmergencyFundMember to usph_PublicHealthAndSocialServicesEmergencyFundMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PublicHealthAndSocialServicesEmergencyFundMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PublicHealthAndSocialServicesEmergencyFundMember_lbl1" xml:lang="en-US" id="usph_PublicHealthAndSocialServicesEmergencyFundMember_lbl1">Public Health and Social Services Emergency Fund [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PublicHealthAndSocialServicesEmergencyFundMember" xlink:to="usph_PublicHealthAndSocialServicesEmergencyFundMember_lbl1" xlink:title="label: PublicHealthAndSocialServicesEmergencyFundMember to usph_PublicHealthAndSocialServicesEmergencyFundMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PublicHealthAndSocialServicesEmergencyFundMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PublicHealthAndSocialServicesEmergencyFundMember_lbl2" xml:lang="en-US" id="usph_PublicHealthAndSocialServicesEmergencyFundMember_lbl2">Public Health and Social Services Emergency Fund [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PublicHealthAndSocialServicesEmergencyFundMember" xlink:to="usph_PublicHealthAndSocialServicesEmergencyFundMember_lbl2" xlink:title="label: PublicHealthAndSocialServicesEmergencyFundMember to usph_PublicHealthAndSocialServicesEmergencyFundMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests" xlink:label="ChargesToRetainedEarningsRevaluationOfNonControllingInterests" xlink:title="ChargesToRetainedEarningsRevaluationOfNonControllingInterests" />
    <link:label xlink:type="resource" xlink:label="usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests_lbl" xml:lang="en-US" id="usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests_lbl">The amount of income (loss) from revaluation of redeemable noncontrolling interest.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ChargesToRetainedEarningsRevaluationOfNonControllingInterests" xlink:to="usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests_lbl" xlink:title="label: ChargesToRetainedEarningsRevaluationOfNonControllingInterests to usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests_lbl1" xml:lang="en-US" id="usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests_lbl1">Charges To Retained Earnings Revaluation Of Non Controlling Interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ChargesToRetainedEarningsRevaluationOfNonControllingInterests" xlink:to="usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests_lbl1" xlink:title="label: ChargesToRetainedEarningsRevaluationOfNonControllingInterests to usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests_lbl2" xml:lang="en-US" id="usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests_lbl2">Revaluation of redeemable non-controlling interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ChargesToRetainedEarningsRevaluationOfNonControllingInterests" xlink:to="usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests_lbl2" xlink:title="label: ChargesToRetainedEarningsRevaluationOfNonControllingInterests to usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" xlink:label="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" xlink:title="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" />
    <link:label xlink:type="resource" xlink:label="usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate_lbl" xml:lang="en-US" id="usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate_lbl">The amount of income tax expense or benefit for the period computed by applying the domestic federal and state statutory tax rates to pretax income.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" xlink:to="usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate_lbl" xlink:title="label: IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate to usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate_lbl1" xml:lang="en-US" id="usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate_lbl1">Income Tax Reconciliation Income Tax Expense Benefit At Federal and State Statutory Income Tax Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" xlink:to="usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate_lbl1" xlink:title="label: IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate to usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate_lbl2" xml:lang="en-US" id="usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate_lbl2">Tax effect at statutory rate (federal and state) of 26.25%</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" xlink:to="usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate_lbl2" xlink:title="label: IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate to usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" xlink:label="IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" xlink:title="IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" />
    <link:label xlink:type="resource" xlink:label="usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests_lbl" xml:lang="en-US" id="usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests_lbl">The portion of profit or loss for the period, net of income taxes, which is attributable to the parent after revaluation of noncontrolling interest.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" xlink:to="usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests_lbl" xlink:title="label: IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests to usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests_lbl1" xml:lang="en-US" id="usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests_lbl1">Income Loss From Operations After Revaluation Of NonControlling Interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" xlink:to="usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests_lbl1" xlink:title="label: IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests to usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests_lbl2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests_lbl2" xml:lang="en-US" id="usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests_lbl2">Net income attributable to common shareholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" xlink:to="usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests_lbl2" xlink:title="label: IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests to usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_CreditChargesToRetainedEarningsAbstract" xlink:label="CreditChargesToRetainedEarningsAbstract" xlink:title="CreditChargesToRetainedEarningsAbstract" />
    <link:label xlink:type="resource" xlink:label="usph_CreditChargesToRetainedEarningsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_CreditChargesToRetainedEarningsAbstract_lbl1" xml:lang="en-US" id="usph_CreditChargesToRetainedEarningsAbstract_lbl1">Credit Charges To Retained Earnings [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CreditChargesToRetainedEarningsAbstract" xlink:to="usph_CreditChargesToRetainedEarningsAbstract_lbl1" xlink:title="label: CreditChargesToRetainedEarningsAbstract to usph_CreditChargesToRetainedEarningsAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_CreditChargesToRetainedEarningsAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_CreditChargesToRetainedEarningsAbstract_lbl2" xml:lang="en-US" id="usph_CreditChargesToRetainedEarningsAbstract_lbl2">Credit (Charges) To Retained Earnings [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CreditChargesToRetainedEarningsAbstract" xlink:to="usph_CreditChargesToRetainedEarningsAbstract_lbl2" xlink:title="label: CreditChargesToRetainedEarningsAbstract to usph_CreditChargesToRetainedEarningsAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate" xlink:label="EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate" xlink:title="EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate" />
    <link:label xlink:type="resource" xlink:label="usph_EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate_lbl" xml:lang="en-US" id="usph_EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate_lbl">Percentage of domestic federal and state statutory tax rate applicable to pretax income (loss).</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate" xlink:to="usph_EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate_lbl" xlink:title="label: EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate to usph_EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate_lbl1" xml:lang="en-US" id="usph_EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate_lbl1">Effective Income Tax Rate Reconciliation At Federal and State Statutory Income Tax Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate" xlink:to="usph_EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate_lbl1" xlink:title="label: EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate to usph_EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate_lbl2" xml:lang="en-US" id="usph_EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate_lbl2">Federal and state statutory income tax rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate" xlink:to="usph_EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate_lbl2" xlink:title="label: EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate to usph_EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_EmployeeCompensationFuturePaymentDueNextFiscalYear" xlink:label="EmployeeCompensationFuturePaymentDueNextFiscalYear" xlink:title="EmployeeCompensationFuturePaymentDueNextFiscalYear" />
    <link:label xlink:type="resource" xlink:label="usph_EmployeeCompensationFuturePaymentDueNextFiscalYear_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_EmployeeCompensationFuturePaymentDueNextFiscalYear_lbl" xml:lang="en-US" id="usph_EmployeeCompensationFuturePaymentDueNextFiscalYear_lbl">Amount of required minimum payments for employee agreements in excess of one year due in the next fiscal year following the latest fiscal year.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeCompensationFuturePaymentDueNextFiscalYear" xlink:to="usph_EmployeeCompensationFuturePaymentDueNextFiscalYear_lbl" xlink:title="label: EmployeeCompensationFuturePaymentDueNextFiscalYear to usph_EmployeeCompensationFuturePaymentDueNextFiscalYear_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_EmployeeCompensationFuturePaymentDueNextFiscalYear_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_EmployeeCompensationFuturePaymentDueNextFiscalYear_lbl1" xml:lang="en-US" id="usph_EmployeeCompensationFuturePaymentDueNextFiscalYear_lbl1">Employee Compensation Future Payment Due Next Fiscal Year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeCompensationFuturePaymentDueNextFiscalYear" xlink:to="usph_EmployeeCompensationFuturePaymentDueNextFiscalYear_lbl1" xlink:title="label: EmployeeCompensationFuturePaymentDueNextFiscalYear to usph_EmployeeCompensationFuturePaymentDueNextFiscalYear_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_EmployeeCompensationFuturePaymentDueNextFiscalYear_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_EmployeeCompensationFuturePaymentDueNextFiscalYear_lbl2" xml:lang="en-US" id="usph_EmployeeCompensationFuturePaymentDueNextFiscalYear_lbl2">Future compensation - 2021</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeCompensationFuturePaymentDueNextFiscalYear" xlink:to="usph_EmployeeCompensationFuturePaymentDueNextFiscalYear_lbl2" xlink:title="label: EmployeeCompensationFuturePaymentDueNextFiscalYear to usph_EmployeeCompensationFuturePaymentDueNextFiscalYear_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_EmploymentAgreementsRetirementDate" xlink:label="EmploymentAgreementsRetirementDate" xlink:title="EmploymentAgreementsRetirementDate" />
    <link:label xlink:type="resource" xlink:label="usph_EmploymentAgreementsRetirementDate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_EmploymentAgreementsRetirementDate_lbl" xml:lang="en-US" id="usph_EmploymentAgreementsRetirementDate_lbl">Retirement date of one of the employee in employment agreements.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmploymentAgreementsRetirementDate" xlink:to="usph_EmploymentAgreementsRetirementDate_lbl" xlink:title="label: EmploymentAgreementsRetirementDate to usph_EmploymentAgreementsRetirementDate_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_EmploymentAgreementsRetirementDate_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_EmploymentAgreementsRetirementDate_lbl1" xml:lang="en-US" id="usph_EmploymentAgreementsRetirementDate_lbl1">Employment Agreements Retirement Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmploymentAgreementsRetirementDate" xlink:to="usph_EmploymentAgreementsRetirementDate_lbl1" xlink:title="label: EmploymentAgreementsRetirementDate to usph_EmploymentAgreementsRetirementDate_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_EmploymentAgreementsRetirementDate_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_EmploymentAgreementsRetirementDate_lbl2" xml:lang="en-US" id="usph_EmploymentAgreementsRetirementDate_lbl2">Retirement date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmploymentAgreementsRetirementDate" xlink:to="usph_EmploymentAgreementsRetirementDate_lbl2" xlink:title="label: EmploymentAgreementsRetirementDate to usph_EmploymentAgreementsRetirementDate_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_EmploymentAgreementsExpirationDateThree" xlink:label="EmploymentAgreementsExpirationDateThree" xlink:title="EmploymentAgreementsExpirationDateThree" />
    <link:label xlink:type="resource" xlink:label="usph_EmploymentAgreementsExpirationDateThree_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_EmploymentAgreementsExpirationDateThree_lbl" xml:lang="en-US" id="usph_EmploymentAgreementsExpirationDateThree_lbl">Expiration date of the employment agreements three.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmploymentAgreementsExpirationDateThree" xlink:to="usph_EmploymentAgreementsExpirationDateThree_lbl" xlink:title="label: EmploymentAgreementsExpirationDateThree to usph_EmploymentAgreementsExpirationDateThree_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_EmploymentAgreementsExpirationDateThree_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_EmploymentAgreementsExpirationDateThree_lbl1" xml:lang="en-US" id="usph_EmploymentAgreementsExpirationDateThree_lbl1">Employment Agreements Expiration Date Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmploymentAgreementsExpirationDateThree" xlink:to="usph_EmploymentAgreementsExpirationDateThree_lbl1" xlink:title="label: EmploymentAgreementsExpirationDateThree to usph_EmploymentAgreementsExpirationDateThree_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_EmploymentAgreementsExpirationDateThree_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_EmploymentAgreementsExpirationDateThree_lbl2" xml:lang="en-US" id="usph_EmploymentAgreementsExpirationDateThree_lbl2">Expiration date of employment agreement, three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmploymentAgreementsExpirationDateThree" xlink:to="usph_EmploymentAgreementsExpirationDateThree_lbl2" xlink:title="label: EmploymentAgreementsExpirationDateThree to usph_EmploymentAgreementsExpirationDateThree_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfEmployeesCoveredUnderEmployeeAgreement" xlink:label="NumberOfEmployeesCoveredUnderEmployeeAgreement" xlink:title="NumberOfEmployeesCoveredUnderEmployeeAgreement" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfEmployeesCoveredUnderEmployeeAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NumberOfEmployeesCoveredUnderEmployeeAgreement_lbl" xml:lang="en-US" id="usph_NumberOfEmployeesCoveredUnderEmployeeAgreement_lbl">Number of employees covered under employee agreement during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfEmployeesCoveredUnderEmployeeAgreement" xlink:to="usph_NumberOfEmployeesCoveredUnderEmployeeAgreement_lbl" xlink:title="label: NumberOfEmployeesCoveredUnderEmployeeAgreement to usph_NumberOfEmployeesCoveredUnderEmployeeAgreement_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfEmployeesCoveredUnderEmployeeAgreement_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NumberOfEmployeesCoveredUnderEmployeeAgreement_lbl1" xml:lang="en-US" id="usph_NumberOfEmployeesCoveredUnderEmployeeAgreement_lbl1">Number Of Employees Covered Under Employee Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfEmployeesCoveredUnderEmployeeAgreement" xlink:to="usph_NumberOfEmployeesCoveredUnderEmployeeAgreement_lbl1" xlink:title="label: NumberOfEmployeesCoveredUnderEmployeeAgreement to usph_NumberOfEmployeesCoveredUnderEmployeeAgreement_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfEmployeesCoveredUnderEmployeeAgreement_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NumberOfEmployeesCoveredUnderEmployeeAgreement_lbl2" xml:lang="en-US" id="usph_NumberOfEmployeesCoveredUnderEmployeeAgreement_lbl2">Number of officers with the company had employee agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfEmployeesCoveredUnderEmployeeAgreement" xlink:to="usph_NumberOfEmployeesCoveredUnderEmployeeAgreement_lbl2" xlink:title="label: NumberOfEmployeesCoveredUnderEmployeeAgreement to usph_NumberOfEmployeesCoveredUnderEmployeeAgreement_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_EmploymentAgreementsExpirationDateTwo" xlink:label="EmploymentAgreementsExpirationDateTwo" xlink:title="EmploymentAgreementsExpirationDateTwo" />
    <link:label xlink:type="resource" xlink:label="usph_EmploymentAgreementsExpirationDateTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_EmploymentAgreementsExpirationDateTwo_lbl" xml:lang="en-US" id="usph_EmploymentAgreementsExpirationDateTwo_lbl">Expiration date of the employment agreements two.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmploymentAgreementsExpirationDateTwo" xlink:to="usph_EmploymentAgreementsExpirationDateTwo_lbl" xlink:title="label: EmploymentAgreementsExpirationDateTwo to usph_EmploymentAgreementsExpirationDateTwo_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_EmploymentAgreementsExpirationDateTwo_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_EmploymentAgreementsExpirationDateTwo_lbl1" xml:lang="en-US" id="usph_EmploymentAgreementsExpirationDateTwo_lbl1">Employment Agreements Expiration Date Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmploymentAgreementsExpirationDateTwo" xlink:to="usph_EmploymentAgreementsExpirationDateTwo_lbl1" xlink:title="label: EmploymentAgreementsExpirationDateTwo to usph_EmploymentAgreementsExpirationDateTwo_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_EmploymentAgreementsExpirationDateTwo_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_EmploymentAgreementsExpirationDateTwo_lbl2" xml:lang="en-US" id="usph_EmploymentAgreementsExpirationDateTwo_lbl2">Expiration date of employment agreement, two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmploymentAgreementsExpirationDateTwo" xlink:to="usph_EmploymentAgreementsExpirationDateTwo_lbl2" xlink:title="label: EmploymentAgreementsExpirationDateTwo to usph_EmploymentAgreementsExpirationDateTwo_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_EmploymentAgreementsExpirationDate" xlink:label="EmploymentAgreementsExpirationDate" xlink:title="EmploymentAgreementsExpirationDate" />
    <link:label xlink:type="resource" xlink:label="usph_EmploymentAgreementsExpirationDate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_EmploymentAgreementsExpirationDate_lbl" xml:lang="en-US" id="usph_EmploymentAgreementsExpirationDate_lbl">Expiration date of the employment agreements.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmploymentAgreementsExpirationDate" xlink:to="usph_EmploymentAgreementsExpirationDate_lbl" xlink:title="label: EmploymentAgreementsExpirationDate to usph_EmploymentAgreementsExpirationDate_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_EmploymentAgreementsExpirationDate_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_EmploymentAgreementsExpirationDate_lbl1" xml:lang="en-US" id="usph_EmploymentAgreementsExpirationDate_lbl1">Employment Agreements Expiration Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmploymentAgreementsExpirationDate" xlink:to="usph_EmploymentAgreementsExpirationDate_lbl1" xlink:title="label: EmploymentAgreementsExpirationDate to usph_EmploymentAgreementsExpirationDate_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_EmploymentAgreementsExpirationDate_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_EmploymentAgreementsExpirationDate_lbl2" xml:lang="en-US" id="usph_EmploymentAgreementsExpirationDate_lbl2">Expiration date of employment agreement, one</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmploymentAgreementsExpirationDate" xlink:to="usph_EmploymentAgreementsExpirationDate_lbl2" xlink:title="label: EmploymentAgreementsExpirationDate to usph_EmploymentAgreementsExpirationDate_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_RenewalPeriodForEmploymentAgreement" xlink:label="RenewalPeriodForEmploymentAgreement" xlink:title="RenewalPeriodForEmploymentAgreement" />
    <link:label xlink:type="resource" xlink:label="usph_RenewalPeriodForEmploymentAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_RenewalPeriodForEmploymentAgreement_lbl" xml:lang="en-US" id="usph_RenewalPeriodForEmploymentAgreement_lbl">Employment agreement renewal period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RenewalPeriodForEmploymentAgreement" xlink:to="usph_RenewalPeriodForEmploymentAgreement_lbl" xlink:title="label: RenewalPeriodForEmploymentAgreement to usph_RenewalPeriodForEmploymentAgreement_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_RenewalPeriodForEmploymentAgreement_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_RenewalPeriodForEmploymentAgreement_lbl1" xml:lang="en-US" id="usph_RenewalPeriodForEmploymentAgreement_lbl1">Renewal Period For Employment Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RenewalPeriodForEmploymentAgreement" xlink:to="usph_RenewalPeriodForEmploymentAgreement_lbl1" xlink:title="label: RenewalPeriodForEmploymentAgreement to usph_RenewalPeriodForEmploymentAgreement_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_RenewalPeriodForEmploymentAgreement_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_RenewalPeriodForEmploymentAgreement_lbl2" xml:lang="en-US" id="usph_RenewalPeriodForEmploymentAgreement_lbl2">Renewal period of employment agreements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RenewalPeriodForEmploymentAgreement" xlink:to="usph_RenewalPeriodForEmploymentAgreement_lbl2" xlink:title="label: RenewalPeriodForEmploymentAgreement to usph_RenewalPeriodForEmploymentAgreement_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter" xlink:label="EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter" xlink:title="EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter" />
    <link:label xlink:type="resource" xlink:label="usph_EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter_lbl" xml:lang="en-US" id="usph_EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter_lbl">Amount of required minimum payments for employee agreements in excess of one year due after next fiscal year following the latest fiscal year.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter" xlink:to="usph_EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter_lbl" xlink:title="label: EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter to usph_EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter_lbl1" xml:lang="en-US" id="usph_EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter_lbl1">Employee Compensation Future Payment Due Next Fiscal Year Thereafter</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter" xlink:to="usph_EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter_lbl1" xlink:title="label: EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter to usph_EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter_lbl2" xml:lang="en-US" id="usph_EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter_lbl2">Future compensation - 2022 through 2024</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter" xlink:to="usph_EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter_lbl2" xlink:title="label: EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter to usph_EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_EmploymentAgreementsAbstract" xlink:label="EmploymentAgreementsAbstract" xlink:title="EmploymentAgreementsAbstract" />
    <link:label xlink:type="resource" xlink:label="usph_EmploymentAgreementsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_EmploymentAgreementsAbstract_lbl1" xml:lang="en-US" id="usph_EmploymentAgreementsAbstract_lbl1">Employment Agreements [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmploymentAgreementsAbstract" xlink:to="usph_EmploymentAgreementsAbstract_lbl1" xlink:title="label: EmploymentAgreementsAbstract to usph_EmploymentAgreementsAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_EmploymentAgreementsAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_EmploymentAgreementsAbstract_lbl2" xml:lang="en-US" id="usph_EmploymentAgreementsAbstract_lbl2">Employee Agreements [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmploymentAgreementsAbstract" xlink:to="usph_EmploymentAgreementsAbstract_lbl2" xlink:title="label: EmploymentAgreementsAbstract to usph_EmploymentAgreementsAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NotesPayableTwoMember" xlink:label="NotesPayableTwoMember" xlink:title="NotesPayableTwoMember" />
    <link:label xlink:type="resource" xlink:label="usph_NotesPayableTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NotesPayableTwoMember_lbl" xml:lang="en-US" id="usph_NotesPayableTwoMember_lbl">A written promise to pay a note to a third party.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesPayableTwoMember" xlink:to="usph_NotesPayableTwoMember_lbl" xlink:title="label: NotesPayableTwoMember to usph_NotesPayableTwoMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NotesPayableTwoMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NotesPayableTwoMember_lbl1" xml:lang="en-US" id="usph_NotesPayableTwoMember_lbl1">Notes Payable Two [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesPayableTwoMember" xlink:to="usph_NotesPayableTwoMember_lbl1" xlink:title="label: NotesPayableTwoMember to usph_NotesPayableTwoMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NotesPayableTwoMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NotesPayableTwoMember_lbl2" xml:lang="en-US" id="usph_NotesPayableTwoMember_lbl2">Notes Payable Two [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesPayableTwoMember" xlink:to="usph_NotesPayableTwoMember_lbl2" xlink:title="label: NotesPayableTwoMember to usph_NotesPayableTwoMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NotesPayableOneMember" xlink:label="NotesPayableOneMember" xlink:title="NotesPayableOneMember" />
    <link:label xlink:type="resource" xlink:label="usph_NotesPayableOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NotesPayableOneMember_lbl" xml:lang="en-US" id="usph_NotesPayableOneMember_lbl">A written promise to pay a note to a third party.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesPayableOneMember" xlink:to="usph_NotesPayableOneMember_lbl" xlink:title="label: NotesPayableOneMember to usph_NotesPayableOneMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NotesPayableOneMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NotesPayableOneMember_lbl1" xml:lang="en-US" id="usph_NotesPayableOneMember_lbl1">Notes Payable One [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesPayableOneMember" xlink:to="usph_NotesPayableOneMember_lbl1" xlink:title="label: NotesPayableOneMember to usph_NotesPayableOneMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NotesPayableOneMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NotesPayableOneMember_lbl2" xml:lang="en-US" id="usph_NotesPayableOneMember_lbl2">Notes Payable One [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesPayableOneMember" xlink:to="usph_NotesPayableOneMember_lbl2" xlink:title="label: NotesPayableOneMember to usph_NotesPayableOneMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl" xml:lang="en-US" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl">The amount of tradename recognized as of the acquisition date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:to="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename to usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl1" xml:lang="en-US" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl1">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Tradename</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:to="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl1" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename to usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl2" xml:lang="en-US" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl2">Tradename</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:to="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl2" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename to usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PercentageOfCombinedBusinessInterestOwned" xlink:label="PercentageOfCombinedBusinessInterestOwned" xlink:title="PercentageOfCombinedBusinessInterestOwned" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfCombinedBusinessInterestOwned_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PercentageOfCombinedBusinessInterestOwned_lbl" xml:lang="en-US" id="usph_PercentageOfCombinedBusinessInterestOwned_lbl">Percentage of combined business interest owned during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfCombinedBusinessInterestOwned" xlink:to="usph_PercentageOfCombinedBusinessInterestOwned_lbl" xlink:title="label: PercentageOfCombinedBusinessInterestOwned to usph_PercentageOfCombinedBusinessInterestOwned_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfCombinedBusinessInterestOwned_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PercentageOfCombinedBusinessInterestOwned_lbl1" xml:lang="en-US" id="usph_PercentageOfCombinedBusinessInterestOwned_lbl1">Percentage of Combined Business Interest Owned</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfCombinedBusinessInterestOwned" xlink:to="usph_PercentageOfCombinedBusinessInterestOwned_lbl1" xlink:title="label: PercentageOfCombinedBusinessInterestOwned to usph_PercentageOfCombinedBusinessInterestOwned_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfCombinedBusinessInterestOwned_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PercentageOfCombinedBusinessInterestOwned_lbl2" xml:lang="en-US" id="usph_PercentageOfCombinedBusinessInterestOwned_lbl2">Percentage of combined business interest owned</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfCombinedBusinessInterestOwned" xlink:to="usph_PercentageOfCombinedBusinessInterestOwned_lbl2" xlink:title="label: PercentageOfCombinedBusinessInterestOwned to usph_PercentageOfCombinedBusinessInterestOwned_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:label="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:title="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl" xml:lang="en-US" id="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl">Amount of net tangible asset acquired at the acquisition date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:to="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl" xlink:title="label: BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset to usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl1" xml:lang="en-US" id="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl1">Business Acquisition Purchase Price Allocation Net Tangible Asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:to="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl1" xlink:title="label: BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset to usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl2" xml:lang="en-US" id="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl2">Net tangible assets acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:to="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl2" xlink:title="label: BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset to usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:label="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:title="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl" xml:lang="en-US" id="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl">This element represents the fair value of the redeemable noncontrolling interest in the acquiree at the acquisition date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:to="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl" xlink:title="label: BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests to usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl1" xml:lang="en-US" id="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl1">Business Combination Acquisition Fair Value of Redeemable Non-Controlling Interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:to="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl1" xlink:title="label: BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests to usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl2" xml:lang="en-US" id="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl2">Fair value of non-controlling interest (classified as redeemable non-controlling interests)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:to="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl2" xlink:title="label: BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests to usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ManagementAndServicesContractsMember" xlink:label="ManagementAndServicesContractsMember" xlink:title="ManagementAndServicesContractsMember" />
    <link:label xlink:type="resource" xlink:label="usph_ManagementAndServicesContractsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ManagementAndServicesContractsMember_lbl" xml:lang="en-US" id="usph_ManagementAndServicesContractsMember_lbl">Acquisition of part of a company which holds management and service contracts.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ManagementAndServicesContractsMember" xlink:to="usph_ManagementAndServicesContractsMember_lbl" xlink:title="label: ManagementAndServicesContractsMember to usph_ManagementAndServicesContractsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ManagementAndServicesContractsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ManagementAndServicesContractsMember_lbl1" xml:lang="en-US" id="usph_ManagementAndServicesContractsMember_lbl1">Management and Services Contracts [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ManagementAndServicesContractsMember" xlink:to="usph_ManagementAndServicesContractsMember_lbl1" xlink:title="label: ManagementAndServicesContractsMember to usph_ManagementAndServicesContractsMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ManagementAndServicesContractsMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ManagementAndServicesContractsMember_lbl2" xml:lang="en-US" id="usph_ManagementAndServicesContractsMember_lbl2">Management and Services Contracts [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ManagementAndServicesContractsMember" xlink:to="usph_ManagementAndServicesContractsMember_lbl2" xlink:title="label: ManagementAndServicesContractsMember to usph_ManagementAndServicesContractsMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_AprilTwoThousandNineteenAcquisitionMember" xlink:label="AprilTwoThousandNineteenAcquisitionMember" xlink:title="AprilTwoThousandNineteenAcquisitionMember" />
    <link:label xlink:type="resource" xlink:label="usph_AprilTwoThousandNineteenAcquisitionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_AprilTwoThousandNineteenAcquisitionMember_lbl" xml:lang="en-US" id="usph_AprilTwoThousandNineteenAcquisitionMember_lbl">Date of business acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AprilTwoThousandNineteenAcquisitionMember" xlink:to="usph_AprilTwoThousandNineteenAcquisitionMember_lbl" xlink:title="label: AprilTwoThousandNineteenAcquisitionMember to usph_AprilTwoThousandNineteenAcquisitionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_AprilTwoThousandNineteenAcquisitionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_AprilTwoThousandNineteenAcquisitionMember_lbl1" xml:lang="en-US" id="usph_AprilTwoThousandNineteenAcquisitionMember_lbl1">April Two Thousand Nineteen Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AprilTwoThousandNineteenAcquisitionMember" xlink:to="usph_AprilTwoThousandNineteenAcquisitionMember_lbl1" xlink:title="label: AprilTwoThousandNineteenAcquisitionMember to usph_AprilTwoThousandNineteenAcquisitionMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_AprilTwoThousandNineteenAcquisitionMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_AprilTwoThousandNineteenAcquisitionMember_lbl2" xml:lang="en-US" id="usph_AprilTwoThousandNineteenAcquisitionMember_lbl2">April 2019 Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AprilTwoThousandNineteenAcquisitionMember" xlink:to="usph_AprilTwoThousandNineteenAcquisitionMember_lbl2" xlink:title="label: AprilTwoThousandNineteenAcquisitionMember to usph_AprilTwoThousandNineteenAcquisitionMember_lbl2" />
    <link:label xlink:type="resource" xlink:label="usph_AprilTwoThousandNineteenAcquisitionMember_lbl3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_AprilTwoThousandNineteenAcquisitionMember_lbl3" xml:lang="en-US" id="usph_AprilTwoThousandNineteenAcquisitionMember_lbl3">April 2019 Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AprilTwoThousandNineteenAcquisitionMember" xlink:to="usph_AprilTwoThousandNineteenAcquisitionMember_lbl3" xlink:title="label: AprilTwoThousandNineteenAcquisitionMember to usph_AprilTwoThousandNineteenAcquisitionMember_lbl3" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_AcquisitionOfFiveClinicPracticesMember" xlink:label="AcquisitionOfFiveClinicPracticesMember" xlink:title="AcquisitionOfFiveClinicPracticesMember" />
    <link:label xlink:type="resource" xlink:label="usph_AcquisitionOfFiveClinicPracticesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_AcquisitionOfFiveClinicPracticesMember_lbl" xml:lang="en-US" id="usph_AcquisitionOfFiveClinicPracticesMember_lbl">Acquisition of five clinic practices for an aggregate amount of cash.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AcquisitionOfFiveClinicPracticesMember" xlink:to="usph_AcquisitionOfFiveClinicPracticesMember_lbl" xlink:title="label: AcquisitionOfFiveClinicPracticesMember to usph_AcquisitionOfFiveClinicPracticesMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_AcquisitionOfFiveClinicPracticesMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_AcquisitionOfFiveClinicPracticesMember_lbl1" xml:lang="en-US" id="usph_AcquisitionOfFiveClinicPracticesMember_lbl1">Acquisition of Five Clinic Practices [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AcquisitionOfFiveClinicPracticesMember" xlink:to="usph_AcquisitionOfFiveClinicPracticesMember_lbl1" xlink:title="label: AcquisitionOfFiveClinicPracticesMember to usph_AcquisitionOfFiveClinicPracticesMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_AcquisitionOfFiveClinicPracticesMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_AcquisitionOfFiveClinicPracticesMember_lbl2" xml:lang="en-US" id="usph_AcquisitionOfFiveClinicPracticesMember_lbl2">Acquisition of Five Clinic Practices [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AcquisitionOfFiveClinicPracticesMember" xlink:to="usph_AcquisitionOfFiveClinicPracticesMember_lbl2" xlink:title="label: AcquisitionOfFiveClinicPracticesMember to usph_AcquisitionOfFiveClinicPracticesMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_LeadingProviderOfIndustrialInjuryPreventionMember" xlink:label="LeadingProviderOfIndustrialInjuryPreventionMember" xlink:title="LeadingProviderOfIndustrialInjuryPreventionMember" />
    <link:label xlink:type="resource" xlink:label="usph_LeadingProviderOfIndustrialInjuryPreventionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_LeadingProviderOfIndustrialInjuryPreventionMember_lbl" xml:lang="en-US" id="usph_LeadingProviderOfIndustrialInjuryPreventionMember_lbl">Acquisition of part of a company which provides services include onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeadingProviderOfIndustrialInjuryPreventionMember" xlink:to="usph_LeadingProviderOfIndustrialInjuryPreventionMember_lbl" xlink:title="label: LeadingProviderOfIndustrialInjuryPreventionMember to usph_LeadingProviderOfIndustrialInjuryPreventionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_LeadingProviderOfIndustrialInjuryPreventionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_LeadingProviderOfIndustrialInjuryPreventionMember_lbl1" xml:lang="en-US" id="usph_LeadingProviderOfIndustrialInjuryPreventionMember_lbl1">Leading Provider of Industrial Injury Prevention [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeadingProviderOfIndustrialInjuryPreventionMember" xlink:to="usph_LeadingProviderOfIndustrialInjuryPreventionMember_lbl1" xlink:title="label: LeadingProviderOfIndustrialInjuryPreventionMember to usph_LeadingProviderOfIndustrialInjuryPreventionMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_LeadingProviderOfIndustrialInjuryPreventionMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_LeadingProviderOfIndustrialInjuryPreventionMember_lbl2" xml:lang="en-US" id="usph_LeadingProviderOfIndustrialInjuryPreventionMember_lbl2">IIPS [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeadingProviderOfIndustrialInjuryPreventionMember" xlink:to="usph_LeadingProviderOfIndustrialInjuryPreventionMember_lbl2" xlink:title="label: LeadingProviderOfIndustrialInjuryPreventionMember to usph_LeadingProviderOfIndustrialInjuryPreventionMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:label="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:title="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl" xml:lang="en-US" id="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl">The amount of business acquisition cost of acquired entity debt issued on the date of acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:to="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl" xlink:title="label: BusinessAcquisitionCostOfAcquiredEntityDebtIssued to usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl1" xml:lang="en-US" id="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl1">Business Acquisition Cost Of Acquired Entity Debt Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:to="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl1" xlink:title="label: BusinessAcquisitionCostOfAcquiredEntityDebtIssued to usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl2" xml:lang="en-US" id="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl2">Seller notes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:to="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl2" xlink:title="label: BusinessAcquisitionCostOfAcquiredEntityDebtIssued to usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" xlink:label="BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" xlink:title="BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl" xml:lang="en-US" id="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl">Useful life of acquired finite-lived intangible assets in business combination, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" xlink:to="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl" xlink:title="label: BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife to usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl1" xml:lang="en-US" id="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl1">Business Combination, Acquired Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" xlink:to="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl1" xlink:title="label: BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife to usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl2" xml:lang="en-US" id="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl2">Estimated useful lives of acquired intangibles</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" xlink:to="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl2" xlink:title="label: BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife to usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl" xml:lang="en-US" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl">The amount of non-competition agreements recognized as of the acquisition date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:to="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements to usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl1" xml:lang="en-US" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl1">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Non Competition Agreements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:to="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl1" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements to usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl2" xml:lang="en-US" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl2">Non-compete</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:to="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl2" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements to usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PaymentsToAcquireBusinessesConsideration" xlink:label="PaymentsToAcquireBusinessesConsideration" xlink:title="PaymentsToAcquireBusinessesConsideration" />
    <link:label xlink:type="resource" xlink:label="usph_PaymentsToAcquireBusinessesConsideration_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PaymentsToAcquireBusinessesConsideration_lbl" xml:lang="en-US" id="usph_PaymentsToAcquireBusinessesConsideration_lbl">Payments to acquire businesses total consideration.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireBusinessesConsideration" xlink:to="usph_PaymentsToAcquireBusinessesConsideration_lbl" xlink:title="label: PaymentsToAcquireBusinessesConsideration to usph_PaymentsToAcquireBusinessesConsideration_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PaymentsToAcquireBusinessesConsideration_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PaymentsToAcquireBusinessesConsideration_lbl1" xml:lang="en-US" id="usph_PaymentsToAcquireBusinessesConsideration_lbl1">Payments To Acquire Businesses Consideration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireBusinessesConsideration" xlink:to="usph_PaymentsToAcquireBusinessesConsideration_lbl1" xlink:title="label: PaymentsToAcquireBusinessesConsideration to usph_PaymentsToAcquireBusinessesConsideration_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PaymentsToAcquireBusinessesConsideration_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_PaymentsToAcquireBusinessesConsideration_lbl2" xml:lang="en-US" id="usph_PaymentsToAcquireBusinessesConsideration_lbl2">Total consideration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireBusinessesConsideration" xlink:to="usph_PaymentsToAcquireBusinessesConsideration_lbl2" xlink:title="label: PaymentsToAcquireBusinessesConsideration to usph_PaymentsToAcquireBusinessesConsideration_lbl2" />
    <link:label xlink:type="resource" xlink:label="usph_PaymentsToAcquireBusinessesConsideration_lbl3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PaymentsToAcquireBusinessesConsideration_lbl3" xml:lang="en-US" id="usph_PaymentsToAcquireBusinessesConsideration_lbl3">Total consideration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireBusinessesConsideration" xlink:to="usph_PaymentsToAcquireBusinessesConsideration_lbl3" xlink:title="label: PaymentsToAcquireBusinessesConsideration to usph_PaymentsToAcquireBusinessesConsideration_lbl3" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl" xml:lang="en-US" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl">Amount of referral relationships at the acquisition date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:to="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships to usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl1" xml:lang="en-US" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl1">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Referral Relationships</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:to="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl1" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships to usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl2" xml:lang="en-US" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl2">Referral relationships</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:to="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl2" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships to usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:label="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:title="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" />
    <link:label xlink:type="resource" xlink:label="usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract_lbl1" xml:lang="en-US" id="usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract_lbl1">Estimated Fair Value Of Net Tangible Assets Acquired [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract_lbl1" xlink:title="label: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract_lbl2" xml:lang="en-US" id="usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract_lbl2">Estimated fair value of net tangible assets acquired [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract_lbl2" xlink:title="label: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfStatesOfNetworkServices" xlink:label="NumberOfStatesOfNetworkServices" xlink:title="NumberOfStatesOfNetworkServices" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfStatesOfNetworkServices_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NumberOfStatesOfNetworkServices_lbl" xml:lang="en-US" id="usph_NumberOfStatesOfNetworkServices_lbl">This element represents number of states of network services provided by the company.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfStatesOfNetworkServices" xlink:to="usph_NumberOfStatesOfNetworkServices_lbl" xlink:title="label: NumberOfStatesOfNetworkServices to usph_NumberOfStatesOfNetworkServices_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfStatesOfNetworkServices_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NumberOfStatesOfNetworkServices_lbl1" xml:lang="en-US" id="usph_NumberOfStatesOfNetworkServices_lbl1">Number of States of Network Services</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfStatesOfNetworkServices" xlink:to="usph_NumberOfStatesOfNetworkServices_lbl1" xlink:title="label: NumberOfStatesOfNetworkServices to usph_NumberOfStatesOfNetworkServices_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfStatesOfNetworkServices_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NumberOfStatesOfNetworkServices_lbl2" xml:lang="en-US" id="usph_NumberOfStatesOfNetworkServices_lbl2">Number of states of network services</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfStatesOfNetworkServices" xlink:to="usph_NumberOfStatesOfNetworkServices_lbl2" xlink:title="label: NumberOfStatesOfNetworkServices to usph_NumberOfStatesOfNetworkServices_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" xlink:label="BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" xlink:title="BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration_lbl" xml:lang="en-US" id="usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration_lbl">Business acquisition number of installments for payment of purchase consideration.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" xlink:to="usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration_lbl" xlink:title="label: BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration to usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration_lbl1" xml:lang="en-US" id="usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration_lbl1">Business Acquisition Number Of Installments For Payment Of Purchase Consideration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" xlink:to="usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration_lbl1" xlink:title="label: BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration to usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration_lbl2" xml:lang="en-US" id="usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration_lbl2">Number of installments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" xlink:to="usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration_lbl2" xlink:title="label: BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration to usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfBusinessesMerged" xlink:label="NumberOfBusinessesMerged" xlink:title="NumberOfBusinessesMerged" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfBusinessesMerged_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NumberOfBusinessesMerged_lbl" xml:lang="en-US" id="usph_NumberOfBusinessesMerged_lbl">Number of businesses merged during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfBusinessesMerged" xlink:to="usph_NumberOfBusinessesMerged_lbl" xlink:title="label: NumberOfBusinessesMerged to usph_NumberOfBusinessesMerged_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfBusinessesMerged_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NumberOfBusinessesMerged_lbl1" xml:lang="en-US" id="usph_NumberOfBusinessesMerged_lbl1">Number of Businesses Merged</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfBusinessesMerged" xlink:to="usph_NumberOfBusinessesMerged_lbl1" xlink:title="label: NumberOfBusinessesMerged to usph_NumberOfBusinessesMerged_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfBusinessesMerged_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NumberOfBusinessesMerged_lbl2" xml:lang="en-US" id="usph_NumberOfBusinessesMerged_lbl2">Number of businesses merged</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfBusinessesMerged" xlink:to="usph_NumberOfBusinessesMerged_lbl2" xlink:title="label: NumberOfBusinessesMerged to usph_NumberOfBusinessesMerged_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfOnsiteClientLocations" xlink:label="NumberOfOnsiteClientLocations" xlink:title="NumberOfOnsiteClientLocations" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfOnsiteClientLocations_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NumberOfOnsiteClientLocations_lbl" xml:lang="en-US" id="usph_NumberOfOnsiteClientLocations_lbl">Number of client locations that included in total operated states that are providing industrial injury prevention services.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfOnsiteClientLocations" xlink:to="usph_NumberOfOnsiteClientLocations_lbl" xlink:title="label: NumberOfOnsiteClientLocations to usph_NumberOfOnsiteClientLocations_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfOnsiteClientLocations_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NumberOfOnsiteClientLocations_lbl1" xml:lang="en-US" id="usph_NumberOfOnsiteClientLocations_lbl1">Number of Onsite Client Locations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfOnsiteClientLocations" xlink:to="usph_NumberOfOnsiteClientLocations_lbl1" xlink:title="label: NumberOfOnsiteClientLocations to usph_NumberOfOnsiteClientLocations_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfOnsiteClientLocations_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NumberOfOnsiteClientLocations_lbl2" xml:lang="en-US" id="usph_NumberOfOnsiteClientLocations_lbl2">Number of onsite client locations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfOnsiteClientLocations" xlink:to="usph_NumberOfOnsiteClientLocations_lbl2" xlink:title="label: NumberOfOnsiteClientLocations to usph_NumberOfOnsiteClientLocations_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_BusinessAcquisitionPayableToShareholdersOfSeller" xlink:label="BusinessAcquisitionPayableToShareholdersOfSeller" xlink:title="BusinessAcquisitionPayableToShareholdersOfSeller" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPayableToShareholdersOfSeller_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessAcquisitionPayableToShareholdersOfSeller_lbl" xml:lang="en-US" id="usph_BusinessAcquisitionPayableToShareholdersOfSeller_lbl">The amount payable to shareholders of seller in business acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPayableToShareholdersOfSeller" xlink:to="usph_BusinessAcquisitionPayableToShareholdersOfSeller_lbl" xlink:title="label: BusinessAcquisitionPayableToShareholdersOfSeller to usph_BusinessAcquisitionPayableToShareholdersOfSeller_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPayableToShareholdersOfSeller_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessAcquisitionPayableToShareholdersOfSeller_lbl1" xml:lang="en-US" id="usph_BusinessAcquisitionPayableToShareholdersOfSeller_lbl1">Business Acquisition,Payable to Shareholders of Seller</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPayableToShareholdersOfSeller" xlink:to="usph_BusinessAcquisitionPayableToShareholdersOfSeller_lbl1" xlink:title="label: BusinessAcquisitionPayableToShareholdersOfSeller to usph_BusinessAcquisitionPayableToShareholdersOfSeller_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPayableToShareholdersOfSeller_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_BusinessAcquisitionPayableToShareholdersOfSeller_lbl2" xml:lang="en-US" id="usph_BusinessAcquisitionPayableToShareholdersOfSeller_lbl2">Payable to shareholders of seller</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPayableToShareholdersOfSeller" xlink:to="usph_BusinessAcquisitionPayableToShareholdersOfSeller_lbl2" xlink:title="label: BusinessAcquisitionPayableToShareholdersOfSeller to usph_BusinessAcquisitionPayableToShareholdersOfSeller_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_SeptemberTwoThousandTwentyOneMember" xlink:label="SeptemberTwoThousandTwentyOneMember" xlink:title="SeptemberTwoThousandTwentyOneMember" />
    <link:label xlink:type="resource" xlink:label="usph_SeptemberTwoThousandTwentyOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_SeptemberTwoThousandTwentyOneMember_lbl" xml:lang="en-US" id="usph_SeptemberTwoThousandTwentyOneMember_lbl">Refers to the principal installment plus accrued interest payable date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeptemberTwoThousandTwentyOneMember" xlink:to="usph_SeptemberTwoThousandTwentyOneMember_lbl" xlink:title="label: SeptemberTwoThousandTwentyOneMember to usph_SeptemberTwoThousandTwentyOneMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_SeptemberTwoThousandTwentyOneMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_SeptemberTwoThousandTwentyOneMember_lbl1" xml:lang="en-US" id="usph_SeptemberTwoThousandTwentyOneMember_lbl1">September Two Thousand Twenty One [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeptemberTwoThousandTwentyOneMember" xlink:to="usph_SeptemberTwoThousandTwentyOneMember_lbl1" xlink:title="label: SeptemberTwoThousandTwentyOneMember to usph_SeptemberTwoThousandTwentyOneMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_SeptemberTwoThousandTwentyOneMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_SeptemberTwoThousandTwentyOneMember_lbl2" xml:lang="en-US" id="usph_SeptemberTwoThousandTwentyOneMember_lbl2">September 2021 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeptemberTwoThousandTwentyOneMember" xlink:to="usph_SeptemberTwoThousandTwentyOneMember_lbl2" xlink:title="label: SeptemberTwoThousandTwentyOneMember to usph_SeptemberTwoThousandTwentyOneMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_AugustTwoThousandTwentyMember" xlink:label="AugustTwoThousandTwentyMember" xlink:title="AugustTwoThousandTwentyMember" />
    <link:label xlink:type="resource" xlink:label="usph_AugustTwoThousandTwentyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_AugustTwoThousandTwentyMember_lbl" xml:lang="en-US" id="usph_AugustTwoThousandTwentyMember_lbl">Refers to the principal installment plus accrued interest payable date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AugustTwoThousandTwentyMember" xlink:to="usph_AugustTwoThousandTwentyMember_lbl" xlink:title="label: AugustTwoThousandTwentyMember to usph_AugustTwoThousandTwentyMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_AugustTwoThousandTwentyMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_AugustTwoThousandTwentyMember_lbl1" xml:lang="en-US" id="usph_AugustTwoThousandTwentyMember_lbl1">August Two Thousand Twenty [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AugustTwoThousandTwentyMember" xlink:to="usph_AugustTwoThousandTwentyMember_lbl1" xlink:title="label: AugustTwoThousandTwentyMember to usph_AugustTwoThousandTwentyMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_AugustTwoThousandTwentyMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_AugustTwoThousandTwentyMember_lbl2" xml:lang="en-US" id="usph_AugustTwoThousandTwentyMember_lbl2">August 2020 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AugustTwoThousandTwentyMember" xlink:to="usph_AugustTwoThousandTwentyMember_lbl2" xlink:title="label: AugustTwoThousandTwentyMember to usph_AugustTwoThousandTwentyMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_AugustTwoThousandNineteenMember" xlink:label="AugustTwoThousandNineteenMember" xlink:title="AugustTwoThousandNineteenMember" />
    <link:label xlink:type="resource" xlink:label="usph_AugustTwoThousandNineteenMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_AugustTwoThousandNineteenMember_lbl" xml:lang="en-US" id="usph_AugustTwoThousandNineteenMember_lbl">Refers to the principal installment plus accrued interest payable date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AugustTwoThousandNineteenMember" xlink:to="usph_AugustTwoThousandNineteenMember_lbl" xlink:title="label: AugustTwoThousandNineteenMember to usph_AugustTwoThousandNineteenMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_AugustTwoThousandNineteenMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_AugustTwoThousandNineteenMember_lbl1" xml:lang="en-US" id="usph_AugustTwoThousandNineteenMember_lbl1">August Two Thousand Nineteen [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AugustTwoThousandNineteenMember" xlink:to="usph_AugustTwoThousandNineteenMember_lbl1" xlink:title="label: AugustTwoThousandNineteenMember to usph_AugustTwoThousandNineteenMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_AugustTwoThousandNineteenMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_AugustTwoThousandNineteenMember_lbl2" xml:lang="en-US" id="usph_AugustTwoThousandNineteenMember_lbl2">August 2019 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AugustTwoThousandNineteenMember" xlink:to="usph_AugustTwoThousandNineteenMember_lbl2" xlink:title="label: AugustTwoThousandNineteenMember to usph_AugustTwoThousandNineteenMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_SeptemberTwoThousandTwentyMember" xlink:label="SeptemberTwoThousandTwentyMember" xlink:title="SeptemberTwoThousandTwentyMember" />
    <link:label xlink:type="resource" xlink:label="usph_SeptemberTwoThousandTwentyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_SeptemberTwoThousandTwentyMember_lbl" xml:lang="en-US" id="usph_SeptemberTwoThousandTwentyMember_lbl">Refers to the principal installment plus accrued interest payable date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeptemberTwoThousandTwentyMember" xlink:to="usph_SeptemberTwoThousandTwentyMember_lbl" xlink:title="label: SeptemberTwoThousandTwentyMember to usph_SeptemberTwoThousandTwentyMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_SeptemberTwoThousandTwentyMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_SeptemberTwoThousandTwentyMember_lbl1" xml:lang="en-US" id="usph_SeptemberTwoThousandTwentyMember_lbl1">September Two Thousand Twenty [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeptemberTwoThousandTwentyMember" xlink:to="usph_SeptemberTwoThousandTwentyMember_lbl1" xlink:title="label: SeptemberTwoThousandTwentyMember to usph_SeptemberTwoThousandTwentyMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_SeptemberTwoThousandTwentyMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_SeptemberTwoThousandTwentyMember_lbl2" xml:lang="en-US" id="usph_SeptemberTwoThousandTwentyMember_lbl2">September 2020 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeptemberTwoThousandTwentyMember" xlink:to="usph_SeptemberTwoThousandTwentyMember_lbl2" xlink:title="label: SeptemberTwoThousandTwentyMember to usph_SeptemberTwoThousandTwentyMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfRegions" xlink:label="NumberOfRegions" xlink:title="NumberOfRegions" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfRegions_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NumberOfRegions_lbl" xml:lang="en-US" id="usph_NumberOfRegions_lbl">Number of regions of the entity operates.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfRegions" xlink:to="usph_NumberOfRegions_lbl" xlink:title="label: NumberOfRegions to usph_NumberOfRegions_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfRegions_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NumberOfRegions_lbl1" xml:lang="en-US" id="usph_NumberOfRegions_lbl1">Number of regions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfRegions" xlink:to="usph_NumberOfRegions_lbl1" xlink:title="label: NumberOfRegions to usph_NumberOfRegions_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfRegions_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NumberOfRegions_lbl2" xml:lang="en-US" id="usph_NumberOfRegions_lbl2">Number of regions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfRegions" xlink:to="usph_NumberOfRegions_lbl2" xlink:title="label: NumberOfRegions to usph_NumberOfRegions_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_AmountOfReductionsInFederalSpending" xlink:label="AmountOfReductionsInFederalSpending" xlink:title="AmountOfReductionsInFederalSpending" />
    <link:label xlink:type="resource" xlink:label="usph_AmountOfReductionsInFederalSpending_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_AmountOfReductionsInFederalSpending_lbl" xml:lang="en-US" id="usph_AmountOfReductionsInFederalSpending_lbl">Amount of reductions in federal spending during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmountOfReductionsInFederalSpending" xlink:to="usph_AmountOfReductionsInFederalSpending_lbl" xlink:title="label: AmountOfReductionsInFederalSpending to usph_AmountOfReductionsInFederalSpending_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_AmountOfReductionsInFederalSpending_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_AmountOfReductionsInFederalSpending_lbl1" xml:lang="en-US" id="usph_AmountOfReductionsInFederalSpending_lbl1">Amount Of Reductions In Federal Spending</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmountOfReductionsInFederalSpending" xlink:to="usph_AmountOfReductionsInFederalSpending_lbl1" xlink:title="label: AmountOfReductionsInFederalSpending to usph_AmountOfReductionsInFederalSpending_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_AmountOfReductionsInFederalSpending_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_AmountOfReductionsInFederalSpending_lbl2" xml:lang="en-US" id="usph_AmountOfReductionsInFederalSpending_lbl2">Reductions in federal spending</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmountOfReductionsInFederalSpending" xlink:to="usph_AmountOfReductionsInFederalSpending_lbl2" xlink:title="label: AmountOfReductionsInFederalSpending to usph_AmountOfReductionsInFederalSpending_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" xlink:label="DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" xlink:title="DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" />
    <link:label xlink:type="resource" xlink:label="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl" xml:lang="en-US" id="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl">Difference between net revenues and corresponding cash collections reflected percentage of net revenues.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" xlink:to="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl" xlink:title="label: DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues to usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl1" xml:lang="en-US" id="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl1">Difference Between Net Revenues And Corresponding Cash Collections Reflected Percentage Of Net Revenues</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" xlink:to="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl1" xlink:title="label: DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues to usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl2" xml:lang="en-US" id="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl2">Difference between net revenues and corresponding cash collections, approximately of net revenues</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" xlink:to="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl2" xlink:title="label: DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues to usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" xlink:label="PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" xlink:title="PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl" xml:lang="en-US" id="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl">Percentage reduction for service in office or other non institutional settings during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" xlink:to="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl" xlink:title="label: PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings to usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl1" xml:lang="en-US" id="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl1">Percentage Reduction For Service In Office Or Other Non Institutional Settings</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" xlink:to="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl1" xlink:title="label: PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings to usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl2" xml:lang="en-US" id="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl2">Percentage reduction for service</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" xlink:to="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl2" xlink:title="label: PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings to usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices" xlink:label="AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices" xlink:title="AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices" />
    <link:label xlink:type="resource" xlink:label="usph_AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices_lbl" xml:lang="en-US" id="usph_AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices_lbl">Annual Limit on physical therapy and speech language pathology services during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices" xlink:to="usph_AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices_lbl" xlink:title="label: AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices to usph_AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices_lbl1" xml:lang="en-US" id="usph_AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices_lbl1">Annual Limit On Physical Therapy And Speech Language Pathology Services</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices" xlink:to="usph_AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices_lbl1" xlink:title="label: AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices to usph_AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices_lbl2" xml:lang="en-US" id="usph_AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices_lbl2">Annual limit on physical therapy and speech language pathology services</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices" xlink:to="usph_AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices_lbl2" xlink:title="label: AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices to usph_AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" xlink:label="PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" xlink:title="PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" />
    <link:label xlink:type="resource" xlink:label="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl" xml:lang="en-US" id="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl">This element represents the period of federal debt ceiling in connection with deficit reductions, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" xlink:to="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl" xlink:title="label: PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions to usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl1" xml:lang="en-US" id="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl1">Period Of Federal Debt Ceiling In Connection With Deficit Reductions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" xlink:to="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl1" xlink:title="label: PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions to usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl2" xml:lang="en-US" id="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl2">Federal debt ceiling in connection with deficit reductions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" xlink:to="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl2" xlink:title="label: PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions to usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:label="ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:title="ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" />
    <link:label xlink:type="resource" xlink:label="usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl" xml:lang="en-US" id="usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl">Reduction in Combined physical therapy/speech language pathology expenses during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:to="usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl" xlink:title="label: ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses to usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl1" xml:lang="en-US" id="usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl1">Reduction In Combined Physical Therapy Speech Language Pathology Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:to="usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl1" xlink:title="label: ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses to usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl2" xml:lang="en-US" id="usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl2">Reduction in combined physical therapy/speech language pathology expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:to="usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl2" xlink:title="label: ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses to usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:label="CombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:title="CombinedPhysicalTherapySpeechLanguagePathologyExpenses" />
    <link:label xlink:type="resource" xlink:label="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl" xml:lang="en-US" id="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl">Combined physical therapy/speech language pathology expenses during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:to="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl" xlink:title="label: CombinedPhysicalTherapySpeechLanguagePathologyExpenses to usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl1" xml:lang="en-US" id="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl1">Combined Physical Therapy Speech Language Pathology Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:to="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl1" xlink:title="label: CombinedPhysicalTherapySpeechLanguagePathologyExpenses to usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl2" xml:lang="en-US" id="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl2">Combined physical therapy/speech language pathology expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:to="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl2" xlink:title="label: CombinedPhysicalTherapySpeechLanguagePathologyExpenses to usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PercentageOfBonusPayment" xlink:label="PercentageOfBonusPayment" xlink:title="PercentageOfBonusPayment" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfBonusPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PercentageOfBonusPayment_lbl" xml:lang="en-US" id="usph_PercentageOfBonusPayment_lbl">Refers to percentage of bonus payment proposed by the agency.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfBonusPayment" xlink:to="usph_PercentageOfBonusPayment_lbl" xlink:title="label: PercentageOfBonusPayment to usph_PercentageOfBonusPayment_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfBonusPayment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PercentageOfBonusPayment_lbl1" xml:lang="en-US" id="usph_PercentageOfBonusPayment_lbl1">Percentage Of Bonus Payment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfBonusPayment" xlink:to="usph_PercentageOfBonusPayment_lbl1" xlink:title="label: PercentageOfBonusPayment to usph_PercentageOfBonusPayment_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfBonusPayment_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PercentageOfBonusPayment_lbl2" xml:lang="en-US" id="usph_PercentageOfBonusPayment_lbl2">Percentage of bonus payment by APM</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfBonusPayment" xlink:to="usph_PercentageOfBonusPayment_lbl2" xlink:title="label: PercentageOfBonusPayment to usph_PercentageOfBonusPayment_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PercentageOfMedicarePaymentIncrease" xlink:label="PercentageOfMedicarePaymentIncrease" xlink:title="PercentageOfMedicarePaymentIncrease" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfMedicarePaymentIncrease_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PercentageOfMedicarePaymentIncrease_lbl" xml:lang="en-US" id="usph_PercentageOfMedicarePaymentIncrease_lbl">Percentage of Medicare payment increase during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfMedicarePaymentIncrease" xlink:to="usph_PercentageOfMedicarePaymentIncrease_lbl" xlink:title="label: PercentageOfMedicarePaymentIncrease to usph_PercentageOfMedicarePaymentIncrease_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfMedicarePaymentIncrease_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PercentageOfMedicarePaymentIncrease_lbl1" xml:lang="en-US" id="usph_PercentageOfMedicarePaymentIncrease_lbl1">Percentage Of Medicare Payment increase</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfMedicarePaymentIncrease" xlink:to="usph_PercentageOfMedicarePaymentIncrease_lbl1" xlink:title="label: PercentageOfMedicarePaymentIncrease to usph_PercentageOfMedicarePaymentIncrease_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfMedicarePaymentIncrease_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PercentageOfMedicarePaymentIncrease_lbl2" xml:lang="en-US" id="usph_PercentageOfMedicarePaymentIncrease_lbl2">Percentage of increase in Medicare payment rates</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfMedicarePaymentIncrease" xlink:to="usph_PercentageOfMedicarePaymentIncrease_lbl2" xlink:title="label: PercentageOfMedicarePaymentIncrease to usph_PercentageOfMedicarePaymentIncrease_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ExpectedReductionInMedicareSpendingPercentage" xlink:label="ExpectedReductionInMedicareSpendingPercentage" xlink:title="ExpectedReductionInMedicareSpendingPercentage" />
    <link:label xlink:type="resource" xlink:label="usph_ExpectedReductionInMedicareSpendingPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ExpectedReductionInMedicareSpendingPercentage_lbl" xml:lang="en-US" id="usph_ExpectedReductionInMedicareSpendingPercentage_lbl">Expected reduction in Medicare spending percentage during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ExpectedReductionInMedicareSpendingPercentage" xlink:to="usph_ExpectedReductionInMedicareSpendingPercentage_lbl" xlink:title="label: ExpectedReductionInMedicareSpendingPercentage to usph_ExpectedReductionInMedicareSpendingPercentage_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ExpectedReductionInMedicareSpendingPercentage_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ExpectedReductionInMedicareSpendingPercentage_lbl1" xml:lang="en-US" id="usph_ExpectedReductionInMedicareSpendingPercentage_lbl1">Expected Reduction In Medicare Spending Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ExpectedReductionInMedicareSpendingPercentage" xlink:to="usph_ExpectedReductionInMedicareSpendingPercentage_lbl1" xlink:title="label: ExpectedReductionInMedicareSpendingPercentage to usph_ExpectedReductionInMedicareSpendingPercentage_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ExpectedReductionInMedicareSpendingPercentage_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ExpectedReductionInMedicareSpendingPercentage_lbl2" xml:lang="en-US" id="usph_ExpectedReductionInMedicareSpendingPercentage_lbl2">Expected reduction in Medicare spending percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ExpectedReductionInMedicareSpendingPercentage" xlink:to="usph_ExpectedReductionInMedicareSpendingPercentage_lbl2" xlink:title="label: ExpectedReductionInMedicareSpendingPercentage to usph_ExpectedReductionInMedicareSpendingPercentage_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_AnnualLimitOccupationalTherapyServices" xlink:label="AnnualLimitOccupationalTherapyServices" xlink:title="AnnualLimitOccupationalTherapyServices" />
    <link:label xlink:type="resource" xlink:label="usph_AnnualLimitOccupationalTherapyServices_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_AnnualLimitOccupationalTherapyServices_lbl" xml:lang="en-US" id="usph_AnnualLimitOccupationalTherapyServices_lbl">Annual Limit occupational therapy services during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AnnualLimitOccupationalTherapyServices" xlink:to="usph_AnnualLimitOccupationalTherapyServices_lbl" xlink:title="label: AnnualLimitOccupationalTherapyServices to usph_AnnualLimitOccupationalTherapyServices_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_AnnualLimitOccupationalTherapyServices_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_AnnualLimitOccupationalTherapyServices_lbl1" xml:lang="en-US" id="usph_AnnualLimitOccupationalTherapyServices_lbl1">Annual Limit Occupational Therapy Services</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AnnualLimitOccupationalTherapyServices" xlink:to="usph_AnnualLimitOccupationalTherapyServices_lbl1" xlink:title="label: AnnualLimitOccupationalTherapyServices to usph_AnnualLimitOccupationalTherapyServices_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_AnnualLimitOccupationalTherapyServices_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_AnnualLimitOccupationalTherapyServices_lbl2" xml:lang="en-US" id="usph_AnnualLimitOccupationalTherapyServices_lbl2">Annual limit occupational therapy services</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AnnualLimitOccupationalTherapyServices" xlink:to="usph_AnnualLimitOccupationalTherapyServices_lbl2" xlink:title="label: AnnualLimitOccupationalTherapyServices to usph_AnnualLimitOccupationalTherapyServices_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_EstimatedPercentageOfDecreaseInPayment" xlink:label="EstimatedPercentageOfDecreaseInPayment" xlink:title="EstimatedPercentageOfDecreaseInPayment" />
    <link:label xlink:type="resource" xlink:label="usph_EstimatedPercentageOfDecreaseInPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_EstimatedPercentageOfDecreaseInPayment_lbl" xml:lang="en-US" id="usph_EstimatedPercentageOfDecreaseInPayment_lbl">Estimated percentage of decrease in payment during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EstimatedPercentageOfDecreaseInPayment" xlink:to="usph_EstimatedPercentageOfDecreaseInPayment_lbl" xlink:title="label: EstimatedPercentageOfDecreaseInPayment to usph_EstimatedPercentageOfDecreaseInPayment_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_EstimatedPercentageOfDecreaseInPayment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_EstimatedPercentageOfDecreaseInPayment_lbl1" xml:lang="en-US" id="usph_EstimatedPercentageOfDecreaseInPayment_lbl1">Estimated Percentage of Decrease in Payment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EstimatedPercentageOfDecreaseInPayment" xlink:to="usph_EstimatedPercentageOfDecreaseInPayment_lbl1" xlink:title="label: EstimatedPercentageOfDecreaseInPayment to usph_EstimatedPercentageOfDecreaseInPayment_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_EstimatedPercentageOfDecreaseInPayment_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_EstimatedPercentageOfDecreaseInPayment_lbl2" xml:lang="en-US" id="usph_EstimatedPercentageOfDecreaseInPayment_lbl2">Estimated percentage of decrease in payment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EstimatedPercentageOfDecreaseInPayment" xlink:to="usph_EstimatedPercentageOfDecreaseInPayment_lbl2" xlink:title="label: EstimatedPercentageOfDecreaseInPayment to usph_EstimatedPercentageOfDecreaseInPayment_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit" xlink:label="PercentageOfPracticeExpenseComponentOfRelativeValueUnit" xlink:title="PercentageOfPracticeExpenseComponentOfRelativeValueUnit" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl" xml:lang="en-US" id="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl">Percentage of practice expense component of relative value unit during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfPracticeExpenseComponentOfRelativeValueUnit" xlink:to="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl" xlink:title="label: PercentageOfPracticeExpenseComponentOfRelativeValueUnit to usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl1" xml:lang="en-US" id="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl1">Percentage Of Practice Expense Component Of Relative Value Unit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfPracticeExpenseComponentOfRelativeValueUnit" xlink:to="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl1" xlink:title="label: PercentageOfPracticeExpenseComponentOfRelativeValueUnit to usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl2" xml:lang="en-US" id="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl2">Percentage of practice expense component</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfPracticeExpenseComponentOfRelativeValueUnit" xlink:to="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl2" xlink:title="label: PercentageOfPracticeExpenseComponentOfRelativeValueUnit to usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ReductionInMedicareSpendingPercentage" xlink:label="ReductionInMedicareSpendingPercentage" xlink:title="ReductionInMedicareSpendingPercentage" />
    <link:label xlink:type="resource" xlink:label="usph_ReductionInMedicareSpendingPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ReductionInMedicareSpendingPercentage_lbl" xml:lang="en-US" id="usph_ReductionInMedicareSpendingPercentage_lbl">Reduction in Medicare spending percentage during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReductionInMedicareSpendingPercentage" xlink:to="usph_ReductionInMedicareSpendingPercentage_lbl" xlink:title="label: ReductionInMedicareSpendingPercentage to usph_ReductionInMedicareSpendingPercentage_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ReductionInMedicareSpendingPercentage_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ReductionInMedicareSpendingPercentage_lbl1" xml:lang="en-US" id="usph_ReductionInMedicareSpendingPercentage_lbl1">Reduction In Medicare Spending Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReductionInMedicareSpendingPercentage" xlink:to="usph_ReductionInMedicareSpendingPercentage_lbl1" xlink:title="label: ReductionInMedicareSpendingPercentage to usph_ReductionInMedicareSpendingPercentage_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ReductionInMedicareSpendingPercentage_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ReductionInMedicareSpendingPercentage_lbl2" xml:lang="en-US" id="usph_ReductionInMedicareSpendingPercentage_lbl2">Medicare spending cut percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReductionInMedicareSpendingPercentage" xlink:to="usph_ReductionInMedicareSpendingPercentage_lbl2" xlink:title="label: ReductionInMedicareSpendingPercentage to usph_ReductionInMedicareSpendingPercentage_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NetRevenueFromMedicare" xlink:label="NetRevenueFromMedicare" xlink:title="NetRevenueFromMedicare" />
    <link:label xlink:type="resource" xlink:label="usph_NetRevenueFromMedicare_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NetRevenueFromMedicare_lbl" xml:lang="en-US" id="usph_NetRevenueFromMedicare_lbl">Net revenue from Medicare.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetRevenueFromMedicare" xlink:to="usph_NetRevenueFromMedicare_lbl" xlink:title="label: NetRevenueFromMedicare to usph_NetRevenueFromMedicare_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NetRevenueFromMedicare_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NetRevenueFromMedicare_lbl1" xml:lang="en-US" id="usph_NetRevenueFromMedicare_lbl1">Net revenue from Medicare</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetRevenueFromMedicare" xlink:to="usph_NetRevenueFromMedicare_lbl1" xlink:title="label: NetRevenueFromMedicare to usph_NetRevenueFromMedicare_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NetRevenueFromMedicare_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NetRevenueFromMedicare_lbl2" xml:lang="en-US" id="usph_NetRevenueFromMedicare_lbl2">Net patient revenue from Medicare accounts</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetRevenueFromMedicare" xlink:to="usph_NetRevenueFromMedicare_lbl2" xlink:title="label: NetRevenueFromMedicare to usph_NetRevenueFromMedicare_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PercentageOfPaymentForOutpatientTherapyServices" xlink:label="PercentageOfPaymentForOutpatientTherapyServices" xlink:title="PercentageOfPaymentForOutpatientTherapyServices" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfPaymentForOutpatientTherapyServices_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PercentageOfPaymentForOutpatientTherapyServices_lbl" xml:lang="en-US" id="usph_PercentageOfPaymentForOutpatientTherapyServices_lbl">Refers to the percentage of payment for outpatient therapy services to the therapy assistant.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfPaymentForOutpatientTherapyServices" xlink:to="usph_PercentageOfPaymentForOutpatientTherapyServices_lbl" xlink:title="label: PercentageOfPaymentForOutpatientTherapyServices to usph_PercentageOfPaymentForOutpatientTherapyServices_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfPaymentForOutpatientTherapyServices_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PercentageOfPaymentForOutpatientTherapyServices_lbl1" xml:lang="en-US" id="usph_PercentageOfPaymentForOutpatientTherapyServices_lbl1">Percentage of Payment for Outpatient Therapy Services</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfPaymentForOutpatientTherapyServices" xlink:to="usph_PercentageOfPaymentForOutpatientTherapyServices_lbl1" xlink:title="label: PercentageOfPaymentForOutpatientTherapyServices to usph_PercentageOfPaymentForOutpatientTherapyServices_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfPaymentForOutpatientTherapyServices_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PercentageOfPaymentForOutpatientTherapyServices_lbl2" xml:lang="en-US" id="usph_PercentageOfPaymentForOutpatientTherapyServices_lbl2">Percentage of payment for outpatient therapy services</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfPaymentForOutpatientTherapyServices" xlink:to="usph_PercentageOfPaymentForOutpatientTherapyServices_lbl2" xlink:title="label: PercentageOfPaymentForOutpatientTherapyServices to usph_PercentageOfPaymentForOutpatientTherapyServices_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_MaximumContractualAllowanceReserveEstimate" xlink:label="MaximumContractualAllowanceReserveEstimate" xlink:title="MaximumContractualAllowanceReserveEstimate" />
    <link:label xlink:type="resource" xlink:label="usph_MaximumContractualAllowanceReserveEstimate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_MaximumContractualAllowanceReserveEstimate_lbl" xml:lang="en-US" id="usph_MaximumContractualAllowanceReserveEstimate_lbl">Maximum contractual allowance reserve estimate.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MaximumContractualAllowanceReserveEstimate" xlink:to="usph_MaximumContractualAllowanceReserveEstimate_lbl" xlink:title="label: MaximumContractualAllowanceReserveEstimate to usph_MaximumContractualAllowanceReserveEstimate_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_MaximumContractualAllowanceReserveEstimate_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_MaximumContractualAllowanceReserveEstimate_lbl1" xml:lang="en-US" id="usph_MaximumContractualAllowanceReserveEstimate_lbl1">Maximum Contractual Allowance Reserve Estimate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MaximumContractualAllowanceReserveEstimate" xlink:to="usph_MaximumContractualAllowanceReserveEstimate_lbl1" xlink:title="label: MaximumContractualAllowanceReserveEstimate to usph_MaximumContractualAllowanceReserveEstimate_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_MaximumContractualAllowanceReserveEstimate_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_MaximumContractualAllowanceReserveEstimate_lbl2" xml:lang="en-US" id="usph_MaximumContractualAllowanceReserveEstimate_lbl2">Maximum contractual allowance reserve estimate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MaximumContractualAllowanceReserveEstimate" xlink:to="usph_MaximumContractualAllowanceReserveEstimate_lbl2" xlink:title="label: MaximumContractualAllowanceReserveEstimate to usph_MaximumContractualAllowanceReserveEstimate_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" xlink:label="DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" xlink:title="DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" />
    <link:label xlink:type="resource" xlink:label="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl" xml:lang="en-US" id="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl">Maximum difference between actual aggregate contractual reserve percentage as compared to estimated contractual allowance reserve percentage.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" xlink:to="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl" xlink:title="label: DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage to usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl1" xml:lang="en-US" id="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl1">Difference Between Actual Aggregate Contractual Reserve Percentages As Compared To Estimated Contractual Allowance Reserve Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" xlink:to="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl1" xlink:title="label: DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage to usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl2" xml:lang="en-US" id="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl2">Difference between actual aggregate contractual reserve and estimated contractual allowance reserve percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" xlink:to="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl2" xlink:title="label: DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage to usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_MedicareReimbursementAbstract" xlink:label="MedicareReimbursementAbstract" xlink:title="MedicareReimbursementAbstract" />
    <link:label xlink:type="resource" xlink:label="usph_MedicareReimbursementAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_MedicareReimbursementAbstract_lbl1" xml:lang="en-US" id="usph_MedicareReimbursementAbstract_lbl1">Medicare Reimbursement [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MedicareReimbursementAbstract" xlink:to="usph_MedicareReimbursementAbstract_lbl1" xlink:title="label: MedicareReimbursementAbstract to usph_MedicareReimbursementAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_MedicareReimbursementAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_MedicareReimbursementAbstract_lbl2" xml:lang="en-US" id="usph_MedicareReimbursementAbstract_lbl2">Medicare Reimbursement [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MedicareReimbursementAbstract" xlink:to="usph_MedicareReimbursementAbstract_lbl2" xlink:title="label: MedicareReimbursementAbstract to usph_MedicareReimbursementAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:label="RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:title="RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" />
    <link:label xlink:type="resource" xlink:label="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl" xml:lang="en-US" id="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl">Refers to the commencement period of redemption rights for redeemable non controlling interest.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:to="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl" xlink:title="label: RedeemableNonControllingInterestRedemptionRightsCommencementPeriod to usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl1" xml:lang="en-US" id="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl1">Redeemable Non-controlling Interest, Redemption Rights, Commencement Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:to="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl1" xlink:title="label: RedeemableNonControllingInterestRedemptionRightsCommencementPeriod to usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl2" xml:lang="en-US" id="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl2">Redeemable non-controlling interest, redemption rights, commencement period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:to="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl2" xlink:title="label: RedeemableNonControllingInterestRedemptionRightsCommencementPeriod to usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NonControllingInterestRedeemableAbstract" xlink:label="NonControllingInterestRedeemableAbstract" xlink:title="NonControllingInterestRedeemableAbstract" />
    <link:label xlink:type="resource" xlink:label="usph_NonControllingInterestRedeemableAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NonControllingInterestRedeemableAbstract_lbl1" xml:lang="en-US" id="usph_NonControllingInterestRedeemableAbstract_lbl1">Non-Controlling Interest, Redeemable [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonControllingInterestRedeemableAbstract" xlink:to="usph_NonControllingInterestRedeemableAbstract_lbl1" xlink:title="label: NonControllingInterestRedeemableAbstract to usph_NonControllingInterestRedeemableAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NonControllingInterestRedeemableAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_NonControllingInterestRedeemableAbstract_lbl2" xml:lang="en-US" id="usph_NonControllingInterestRedeemableAbstract_lbl2">Redeemable Non-Controlling Interests [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonControllingInterestRedeemableAbstract" xlink:to="usph_NonControllingInterestRedeemableAbstract_lbl2" xlink:title="label: NonControllingInterestRedeemableAbstract to usph_NonControllingInterestRedeemableAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_DepreciationAmortizationImpairmentLineItems" xlink:label="DepreciationAmortizationImpairmentLineItems" xlink:title="DepreciationAmortizationImpairmentLineItems" />
    <link:label xlink:type="resource" xlink:label="usph_DepreciationAmortizationImpairmentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_DepreciationAmortizationImpairmentLineItems_lbl" xml:lang="en-US" id="usph_DepreciationAmortizationImpairmentLineItems_lbl">Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="usph_DepreciationAmortizationImpairmentLineItems_lbl" xlink:title="label: DepreciationAmortizationImpairmentLineItems to usph_DepreciationAmortizationImpairmentLineItems_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_DepreciationAmortizationImpairmentLineItems_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_DepreciationAmortizationImpairmentLineItems_lbl1" xml:lang="en-US" id="usph_DepreciationAmortizationImpairmentLineItems_lbl1">Depreciation Amortization Impairment [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="usph_DepreciationAmortizationImpairmentLineItems_lbl1" xlink:title="label: DepreciationAmortizationImpairmentLineItems to usph_DepreciationAmortizationImpairmentLineItems_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_EmployeeMember" xlink:label="EmployeeMember" xlink:title="EmployeeMember" />
    <link:label xlink:type="resource" xlink:label="usph_EmployeeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_EmployeeMember_lbl" xml:lang="en-US" id="usph_EmployeeMember_lbl">Person who is employed by the company.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeMember" xlink:to="usph_EmployeeMember_lbl" xlink:title="label: EmployeeMember to usph_EmployeeMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_EmployeeMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_EmployeeMember_lbl1" xml:lang="en-US" id="usph_EmployeeMember_lbl1">Employee [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeMember" xlink:to="usph_EmployeeMember_lbl1" xlink:title="label: EmployeeMember to usph_EmployeeMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_Year2017Member" xlink:label="Year2017Member" xlink:title="Year2017Member" />
    <link:label xlink:type="resource" xlink:label="usph_Year2017Member_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_Year2017Member_lbl" xml:lang="en-US" id="usph_Year2017Member_lbl">Medicare payment year.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Year2017Member" xlink:to="usph_Year2017Member_lbl" xlink:title="label: Year2017Member to usph_Year2017Member_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_Year2017Member_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_Year2017Member_lbl1" xml:lang="en-US" id="usph_Year2017Member_lbl1">Year 2017 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Year2017Member" xlink:to="usph_Year2017Member_lbl1" xlink:title="label: Year2017Member to usph_Year2017Member_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ManagementContractRevenuesMember" xlink:label="ManagementContractRevenuesMember" xlink:title="ManagementContractRevenuesMember" />
    <link:label xlink:type="resource" xlink:label="usph_ManagementContractRevenuesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ManagementContractRevenuesMember_lbl" xml:lang="en-US" id="usph_ManagementContractRevenuesMember_lbl">Management contract revenues are derived from contractual arrangements whereby the Company manages a clinic for third party owners. Revenues are determined based on the number of visits conducted at the clinic and recognized when services are performed.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ManagementContractRevenuesMember" xlink:to="usph_ManagementContractRevenuesMember_lbl" xlink:title="label: ManagementContractRevenuesMember to usph_ManagementContractRevenuesMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ManagementContractRevenuesMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ManagementContractRevenuesMember_lbl1" xml:lang="en-US" id="usph_ManagementContractRevenuesMember_lbl1">Management Contract Revenues [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ManagementContractRevenuesMember" xlink:to="usph_ManagementContractRevenuesMember_lbl1" xlink:title="label: ManagementContractRevenuesMember to usph_ManagementContractRevenuesMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_FromTwoThousandNineteenThroughTwoThousandTwentyFourMember" xlink:label="FromTwoThousandNineteenThroughTwoThousandTwentyFourMember" xlink:title="FromTwoThousandNineteenThroughTwoThousandTwentyFourMember" />
    <link:label xlink:type="resource" xlink:label="usph_FromTwoThousandNineteenThroughTwoThousandTwentyFourMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_FromTwoThousandNineteenThroughTwoThousandTwentyFourMember_lbl" xml:lang="en-US" id="usph_FromTwoThousandNineteenThroughTwoThousandTwentyFourMember_lbl">Insurance products service years.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FromTwoThousandNineteenThroughTwoThousandTwentyFourMember" xlink:to="usph_FromTwoThousandNineteenThroughTwoThousandTwentyFourMember_lbl" xlink:title="label: FromTwoThousandNineteenThroughTwoThousandTwentyFourMember to usph_FromTwoThousandNineteenThroughTwoThousandTwentyFourMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_FromTwoThousandNineteenThroughTwoThousandTwentyFourMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_FromTwoThousandNineteenThroughTwoThousandTwentyFourMember_lbl1" xml:lang="en-US" id="usph_FromTwoThousandNineteenThroughTwoThousandTwentyFourMember_lbl1">From Two Thousand Nineteen Through Two Thousand Twenty Four [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FromTwoThousandNineteenThroughTwoThousandTwentyFourMember" xlink:to="usph_FromTwoThousandNineteenThroughTwoThousandTwentyFourMember_lbl1" xlink:title="label: FromTwoThousandNineteenThroughTwoThousandTwentyFourMember to usph_FromTwoThousandNineteenThroughTwoThousandTwentyFourMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_FromTwoThousandNineteenThroughTwoThousandTwentyFourMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_FromTwoThousandNineteenThroughTwoThousandTwentyFourMember_lbl2" xml:lang="en-US" id="usph_FromTwoThousandNineteenThroughTwoThousandTwentyFourMember_lbl2">From 2019 through 2024 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FromTwoThousandNineteenThroughTwoThousandTwentyFourMember" xlink:to="usph_FromTwoThousandNineteenThroughTwoThousandTwentyFourMember_lbl2" xlink:title="label: FromTwoThousandNineteenThroughTwoThousandTwentyFourMember to usph_FromTwoThousandNineteenThroughTwoThousandTwentyFourMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" xlink:label="FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" xlink:title="FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" />
    <link:label xlink:type="resource" xlink:label="usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember_lbl" xml:lang="en-US" id="usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember_lbl">Insurance products service years.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" xlink:to="usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember_lbl" xlink:title="label: FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember to usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember_lbl1" xml:lang="en-US" id="usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember_lbl1">From Two Thousand Twenty Through Two Thousand Twenty Five [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" xlink:to="usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember_lbl1" xlink:title="label: FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember to usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember_lbl2" xml:lang="en-US" id="usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember_lbl2">From 2020 through 2025 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" xlink:to="usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember_lbl2" xlink:title="label: FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember to usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_Year2018Member" xlink:label="Year2018Member" xlink:title="Year2018Member" />
    <link:label xlink:type="resource" xlink:label="usph_Year2018Member_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_Year2018Member_lbl" xml:lang="en-US" id="usph_Year2018Member_lbl">Medicare payment year.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Year2018Member" xlink:to="usph_Year2018Member_lbl" xlink:title="label: Year2018Member to usph_Year2018Member_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_Year2018Member_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_Year2018Member_lbl1" xml:lang="en-US" id="usph_Year2018Member_lbl1">Year2018 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Year2018Member" xlink:to="usph_Year2018Member_lbl1" xlink:title="label: Year2018Member to usph_Year2018Member_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_Year2018Member_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_Year2018Member_lbl2" xml:lang="en-US" id="usph_Year2018Member_lbl2">Year 2018 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Year2018Member" xlink:to="usph_Year2018Member_lbl2" xlink:title="label: Year2018Member to usph_Year2018Member_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_Year2019Member" xlink:label="Year2019Member" xlink:title="Year2019Member" />
    <link:label xlink:type="resource" xlink:label="usph_Year2019Member_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_Year2019Member_lbl" xml:lang="en-US" id="usph_Year2019Member_lbl">Medicare payment year.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Year2019Member" xlink:to="usph_Year2019Member_lbl" xlink:title="label: Year2019Member to usph_Year2019Member_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_Year2019Member_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_Year2019Member_lbl1" xml:lang="en-US" id="usph_Year2019Member_lbl1">Year2019 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Year2019Member" xlink:to="usph_Year2019Member_lbl1" xlink:title="label: Year2019Member to usph_Year2019Member_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_Year2019Member_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_Year2019Member_lbl2" xml:lang="en-US" id="usph_Year2019Member_lbl2">Year 2019 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Year2019Member" xlink:to="usph_Year2019Member_lbl2" xlink:title="label: Year2019Member to usph_Year2019Member_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_DepreciationAmortizationImpairmentTable" xlink:label="DepreciationAmortizationImpairmentTable" xlink:title="DepreciationAmortizationImpairmentTable" />
    <link:label xlink:type="resource" xlink:label="usph_DepreciationAmortizationImpairmentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_DepreciationAmortizationImpairmentTable_lbl" xml:lang="en-US" id="usph_DepreciationAmortizationImpairmentTable_lbl">A table or schedule providing information pertaining to depreciation amortization impairment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DepreciationAmortizationImpairmentTable" xlink:to="usph_DepreciationAmortizationImpairmentTable_lbl" xlink:title="label: DepreciationAmortizationImpairmentTable to usph_DepreciationAmortizationImpairmentTable_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_DepreciationAmortizationImpairmentTable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_DepreciationAmortizationImpairmentTable_lbl1" xml:lang="en-US" id="usph_DepreciationAmortizationImpairmentTable_lbl1">Depreciation Amortization Impairment [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DepreciationAmortizationImpairmentTable" xlink:to="usph_DepreciationAmortizationImpairmentTable_lbl1" xlink:title="label: DepreciationAmortizationImpairmentTable to usph_DepreciationAmortizationImpairmentTable_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_IndustrialInjuryPreventionServicesRevenuesMember" xlink:label="IndustrialInjuryPreventionServicesRevenuesMember" xlink:title="IndustrialInjuryPreventionServicesRevenuesMember" />
    <link:label xlink:type="resource" xlink:label="usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl" xml:lang="en-US" id="usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl">Revenues from the industrial injury prevention business are derived from onsite services provided to clients' employees including injury prevention, rehabilitation, ergonomic assessments and performance optimization. Revenues are determined based on the number of hours and respective rate for services provided. The Company has agreements with third-party payers that provide for payments to the Company at amounts different from its established rates. The allowance for estimated contractual adjustments is based on terms of payer contracts and historical collection and write-off experience.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IndustrialInjuryPreventionServicesRevenuesMember" xlink:to="usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl" xlink:title="label: IndustrialInjuryPreventionServicesRevenuesMember to usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl1" xml:lang="en-US" id="usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl1">Industrial Injury Prevention Services Revenues [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IndustrialInjuryPreventionServicesRevenuesMember" xlink:to="usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl1" xlink:title="label: IndustrialInjuryPreventionServicesRevenuesMember to usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl2" xml:lang="en-US" id="usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl2">Industrial Injury Prevention Services Revenues [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IndustrialInjuryPreventionServicesRevenuesMember" xlink:to="usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl2" xlink:title="label: IndustrialInjuryPreventionServicesRevenuesMember to usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl2" />
    <link:label xlink:type="resource" xlink:label="usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl3" xml:lang="en-US" id="usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl3">Industrial Injury Prevention Services [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IndustrialInjuryPreventionServicesRevenuesMember" xlink:to="usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl3" xlink:title="label: IndustrialInjuryPreventionServicesRevenuesMember to usph_IndustrialInjuryPreventionServicesRevenuesMember_lbl3" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_OtherRevenuesMember" xlink:label="OtherRevenuesMember" xlink:title="OtherRevenuesMember" />
    <link:label xlink:type="resource" xlink:label="usph_OtherRevenuesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_OtherRevenuesMember_lbl" xml:lang="en-US" id="usph_OtherRevenuesMember_lbl">Other revenues include services provided on-site, such as schools and industrial worksites, for physical or occupational therapy services, and athletic trainers and gym membership fees. Contract terms and rates are agreed to in advance between the Company and the third parties. Services are typically performed over the contract period and revenue is recorded in accordance with the contract terms. If the services are paid in advance, revenue is deferred over the period of the agreement and recognized when the services are performed.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherRevenuesMember" xlink:to="usph_OtherRevenuesMember_lbl" xlink:title="label: OtherRevenuesMember to usph_OtherRevenuesMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_OtherRevenuesMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_OtherRevenuesMember_lbl1" xml:lang="en-US" id="usph_OtherRevenuesMember_lbl1">Other Revenues [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherRevenuesMember" xlink:to="usph_OtherRevenuesMember_lbl1" xlink:title="label: OtherRevenuesMember to usph_OtherRevenuesMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PhysicalTherapyOperationsMember" xlink:label="PhysicalTherapyOperationsMember" xlink:title="PhysicalTherapyOperationsMember" />
    <link:label xlink:type="resource" xlink:label="usph_PhysicalTherapyOperationsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PhysicalTherapyOperationsMember_lbl" xml:lang="en-US" id="usph_PhysicalTherapyOperationsMember_lbl">Physical therapy operations consist of physical therapy and occupational therapy clinics that provide pre-and post-operative care and treatment for orthopedic related disorders, sports-related injuries, preventive care, rehabilitation of injured workers and neurological injuries. Services provided by industrial injury prevention services segment include onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PhysicalTherapyOperationsMember" xlink:to="usph_PhysicalTherapyOperationsMember_lbl" xlink:title="label: PhysicalTherapyOperationsMember to usph_PhysicalTherapyOperationsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PhysicalTherapyOperationsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PhysicalTherapyOperationsMember_lbl1" xml:lang="en-US" id="usph_PhysicalTherapyOperationsMember_lbl1">Physical Therapy Operations [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PhysicalTherapyOperationsMember" xlink:to="usph_PhysicalTherapyOperationsMember_lbl1" xlink:title="label: PhysicalTherapyOperationsMember to usph_PhysicalTherapyOperationsMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PhysicalTherapyOperationsMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PhysicalTherapyOperationsMember_lbl2" xml:lang="en-US" id="usph_PhysicalTherapyOperationsMember_lbl2">Physical Therapy Operations [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PhysicalTherapyOperationsMember" xlink:to="usph_PhysicalTherapyOperationsMember_lbl2" xlink:title="label: PhysicalTherapyOperationsMember to usph_PhysicalTherapyOperationsMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock" xlink:label="BankCreditAgreementToPermitShareRepurchasesOfCommonStock" xlink:title="BankCreditAgreementToPermitShareRepurchasesOfCommonStock" />
    <link:label xlink:type="resource" xlink:label="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl" xml:lang="en-US" id="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl">Bank credit agreement to permit share repurchases of common stock during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BankCreditAgreementToPermitShareRepurchasesOfCommonStock" xlink:to="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl" xlink:title="label: BankCreditAgreementToPermitShareRepurchasesOfCommonStock to usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl1" xml:lang="en-US" id="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl1">Bank Credit Agreement To Permit Share Repurchases Of Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BankCreditAgreementToPermitShareRepurchasesOfCommonStock" xlink:to="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl1" xlink:title="label: BankCreditAgreementToPermitShareRepurchasesOfCommonStock to usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl2" xml:lang="en-US" id="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl2">Bank credit agreement to permit share repurchases of common stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BankCreditAgreementToPermitShareRepurchasesOfCommonStock" xlink:to="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl2" xlink:title="label: BankCreditAgreementToPermitShareRepurchasesOfCommonStock to usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PercentageOfRepurchaseOfCommonStock" xlink:label="PercentageOfRepurchaseOfCommonStock" xlink:title="PercentageOfRepurchaseOfCommonStock" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfRepurchaseOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PercentageOfRepurchaseOfCommonStock_lbl" xml:lang="en-US" id="usph_PercentageOfRepurchaseOfCommonStock_lbl">Percentage of repurchase of common stock during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfRepurchaseOfCommonStock" xlink:to="usph_PercentageOfRepurchaseOfCommonStock_lbl" xlink:title="label: PercentageOfRepurchaseOfCommonStock to usph_PercentageOfRepurchaseOfCommonStock_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfRepurchaseOfCommonStock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PercentageOfRepurchaseOfCommonStock_lbl1" xml:lang="en-US" id="usph_PercentageOfRepurchaseOfCommonStock_lbl1">Percentage Of Repurchase Of Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfRepurchaseOfCommonStock" xlink:to="usph_PercentageOfRepurchaseOfCommonStock_lbl1" xlink:title="label: PercentageOfRepurchaseOfCommonStock to usph_PercentageOfRepurchaseOfCommonStock_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfRepurchaseOfCommonStock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PercentageOfRepurchaseOfCommonStock_lbl2" xml:lang="en-US" id="usph_PercentageOfRepurchaseOfCommonStock_lbl2">Percentage of repurchase of common stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfRepurchaseOfCommonStock" xlink:to="usph_PercentageOfRepurchaseOfCommonStock_lbl2" xlink:title="label: PercentageOfRepurchaseOfCommonStock to usph_PercentageOfRepurchaseOfCommonStock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_AdditionalEstimatedRepurchaseOfCommonStock" xlink:label="AdditionalEstimatedRepurchaseOfCommonStock" xlink:title="AdditionalEstimatedRepurchaseOfCommonStock" />
    <link:label xlink:type="resource" xlink:label="usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl" xml:lang="en-US" id="usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl">Additional estimated repurchase of common stock during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalEstimatedRepurchaseOfCommonStock" xlink:to="usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl" xlink:title="label: AdditionalEstimatedRepurchaseOfCommonStock to usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl1" xml:lang="en-US" id="usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl1">Additional Estimated Repurchase Of Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalEstimatedRepurchaseOfCommonStock" xlink:to="usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl1" xlink:title="label: AdditionalEstimatedRepurchaseOfCommonStock to usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl2" xml:lang="en-US" id="usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl2">Additional estimated shares (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalEstimatedRepurchaseOfCommonStock" xlink:to="usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl2" xlink:title="label: AdditionalEstimatedRepurchaseOfCommonStock to usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PromissoryNotesMember" xlink:label="PromissoryNotesMember" xlink:title="PromissoryNotesMember" />
    <link:label xlink:type="resource" xlink:label="usph_PromissoryNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PromissoryNotesMember_lbl" xml:lang="en-US" id="usph_PromissoryNotesMember_lbl">A written promise to pay a note to a third party.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PromissoryNotesMember" xlink:to="usph_PromissoryNotesMember_lbl" xlink:title="label: PromissoryNotesMember to usph_PromissoryNotesMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PromissoryNotesMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PromissoryNotesMember_lbl1" xml:lang="en-US" id="usph_PromissoryNotesMember_lbl1">Promissory Notes [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PromissoryNotesMember" xlink:to="usph_PromissoryNotesMember_lbl1" xlink:title="label: PromissoryNotesMember to usph_PromissoryNotesMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PromissoryNotesMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PromissoryNotesMember_lbl2" xml:lang="en-US" id="usph_PromissoryNotesMember_lbl2">3.25% through 5.50% Notes Payable due in Next Year [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PromissoryNotesMember" xlink:to="usph_PromissoryNotesMember_lbl2" xlink:title="label: PromissoryNotesMember to usph_PromissoryNotesMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NonQualifiedStockOptionsMember" xlink:label="NonQualifiedStockOptionsMember" xlink:title="NonQualifiedStockOptionsMember" />
    <link:label xlink:type="resource" xlink:label="usph_NonQualifiedStockOptionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NonQualifiedStockOptionsMember_lbl" xml:lang="en-US" id="usph_NonQualifiedStockOptionsMember_lbl">Non-qualified stock options are stock options which do not qualify for the special treatment accorded to incentive stock options.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonQualifiedStockOptionsMember" xlink:to="usph_NonQualifiedStockOptionsMember_lbl" xlink:title="label: NonQualifiedStockOptionsMember to usph_NonQualifiedStockOptionsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NonQualifiedStockOptionsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NonQualifiedStockOptionsMember_lbl1" xml:lang="en-US" id="usph_NonQualifiedStockOptionsMember_lbl1">Non Qualified Stock Options [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonQualifiedStockOptionsMember" xlink:to="usph_NonQualifiedStockOptionsMember_lbl1" xlink:title="label: NonQualifiedStockOptionsMember to usph_NonQualifiedStockOptionsMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NonQualifiedStockOptionsMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NonQualifiedStockOptionsMember_lbl2" xml:lang="en-US" id="usph_NonQualifiedStockOptionsMember_lbl2">Non Qualified Stock Options [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonQualifiedStockOptionsMember" xlink:to="usph_NonQualifiedStockOptionsMember_lbl2" xlink:title="label: NonQualifiedStockOptionsMember to usph_NonQualifiedStockOptionsMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_OperatingLeaseSupplementalInformationTableTextBlock" xlink:label="OperatingLeaseSupplementalInformationTableTextBlock" xlink:title="OperatingLeaseSupplementalInformationTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="usph_OperatingLeaseSupplementalInformationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_OperatingLeaseSupplementalInformationTableTextBlock_lbl" xml:lang="en-US" id="usph_OperatingLeaseSupplementalInformationTableTextBlock_lbl">Tabular disclosure of supplemental information related to leases.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseSupplementalInformationTableTextBlock" xlink:to="usph_OperatingLeaseSupplementalInformationTableTextBlock_lbl" xlink:title="label: OperatingLeaseSupplementalInformationTableTextBlock to usph_OperatingLeaseSupplementalInformationTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_OperatingLeaseSupplementalInformationTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_OperatingLeaseSupplementalInformationTableTextBlock_lbl1" xml:lang="en-US" id="usph_OperatingLeaseSupplementalInformationTableTextBlock_lbl1">Operating Lease, Supplemental Information [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseSupplementalInformationTableTextBlock" xlink:to="usph_OperatingLeaseSupplementalInformationTableTextBlock_lbl1" xlink:title="label: OperatingLeaseSupplementalInformationTableTextBlock to usph_OperatingLeaseSupplementalInformationTableTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_OperatingLeaseSupplementalInformationTableTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_OperatingLeaseSupplementalInformationTableTextBlock_lbl2" xml:lang="en-US" id="usph_OperatingLeaseSupplementalInformationTableTextBlock_lbl2">Supplemental Information Related to Leases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseSupplementalInformationTableTextBlock" xlink:to="usph_OperatingLeaseSupplementalInformationTableTextBlock_lbl2" xlink:title="label: OperatingLeaseSupplementalInformationTableTextBlock to usph_OperatingLeaseSupplementalInformationTableTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock" xlink:label="WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock" xlink:title="WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock_lbl" xml:lang="en-US" id="usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock_lbl">Tabular disclosure of information related to weighted average lease terms and discount rates.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock" xlink:to="usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock_lbl" xlink:title="label: WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock to usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock_lbl1" xml:lang="en-US" id="usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock_lbl1">Weighted Average Lease Terms and Discount Rates [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock" xlink:to="usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock_lbl1" xlink:title="label: WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock to usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock_lbl2" xml:lang="en-US" id="usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock_lbl2">Average Lease Terms and Discount Rates</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock" xlink:to="usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock_lbl2" xlink:title="label: WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock to usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests" xlink:label="DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests" xlink:title="DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests" />
    <link:label xlink:type="resource" xlink:label="usph_DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests_lbl" xml:lang="en-US" id="usph_DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests_lbl">Value of deferred tax assets related to revaluation of redeemable non-controlling interests and acquisitions of non-controlling interests.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests" xlink:to="usph_DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests_lbl" xlink:title="label: DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests to usph_DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests_lbl1" xml:lang="en-US" id="usph_DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests_lbl1">Deferred Tax Assets Related to Redeemable Non-controlling Interests and Acquisitions of Non-controlling Interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests" xlink:to="usph_DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests_lbl1" xlink:title="label: DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests to usph_DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests_lbl2" xml:lang="en-US" id="usph_DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests_lbl2">Deferred tax assets, related to revaluation and acquisition of redeemable non-controlling interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests" xlink:to="usph_DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests_lbl2" xlink:title="label: DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests to usph_DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_IncomeTaxExaminationAbstract" xlink:label="IncomeTaxExaminationAbstract" xlink:title="IncomeTaxExaminationAbstract" />
    <link:label xlink:type="resource" xlink:label="usph_IncomeTaxExaminationAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_IncomeTaxExaminationAbstract_lbl1" xml:lang="en-US" id="usph_IncomeTaxExaminationAbstract_lbl1">Income Tax Examination [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxExaminationAbstract" xlink:to="usph_IncomeTaxExaminationAbstract_lbl1" xlink:title="label: IncomeTaxExaminationAbstract to usph_IncomeTaxExaminationAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_DeferredTaxAssetsLeaseObligations" xlink:label="DeferredTaxAssetsLeaseObligations" xlink:title="DeferredTaxAssetsLeaseObligations" />
    <link:label xlink:type="resource" xlink:label="usph_DeferredTaxAssetsLeaseObligations_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_DeferredTaxAssetsLeaseObligations_lbl" xml:lang="en-US" id="usph_DeferredTaxAssetsLeaseObligations_lbl">Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from the lease obligations.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsLeaseObligations" xlink:to="usph_DeferredTaxAssetsLeaseObligations_lbl" xlink:title="label: DeferredTaxAssetsLeaseObligations to usph_DeferredTaxAssetsLeaseObligations_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_DeferredTaxAssetsLeaseObligations_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_DeferredTaxAssetsLeaseObligations_lbl1" xml:lang="en-US" id="usph_DeferredTaxAssetsLeaseObligations_lbl1">Deferred Tax Assets Lease Obligations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsLeaseObligations" xlink:to="usph_DeferredTaxAssetsLeaseObligations_lbl1" xlink:title="label: DeferredTaxAssetsLeaseObligations to usph_DeferredTaxAssetsLeaseObligations_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_DeferredTaxAssetsLeaseObligations_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_DeferredTaxAssetsLeaseObligations_lbl2" xml:lang="en-US" id="usph_DeferredTaxAssetsLeaseObligations_lbl2">Lease obligations - including closed clinics</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsLeaseObligations" xlink:to="usph_DeferredTaxAssetsLeaseObligations_lbl2" xlink:title="label: DeferredTaxAssetsLeaseObligations to usph_DeferredTaxAssetsLeaseObligations_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" xlink:label="DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" xlink:title="DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" />
    <link:label xlink:type="resource" xlink:label="usph_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets_lbl" xml:lang="en-US" id="usph_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets_lbl">Amount of deferred tax liability attributable to operating lease right-of-use assets.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" xlink:to="usph_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets_lbl" xlink:title="label: DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets to usph_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets_lbl1" xml:lang="en-US" id="usph_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets_lbl1">Deferred Tax Liabilities Operating Lease Right-of-use Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" xlink:to="usph_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets_lbl1" xlink:title="label: DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets to usph_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="usph_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets_lbl2" xml:lang="en-US" id="usph_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets_lbl2">Operating lease right-of-use assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" xlink:to="usph_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets_lbl2" xlink:title="label: DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets to usph_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_AmendedTwoThousandThreePlanMember" xlink:label="AmendedTwoThousandThreePlanMember" xlink:title="AmendedTwoThousandThreePlanMember" />
    <link:label xlink:type="resource" xlink:label="usph_AmendedTwoThousandThreePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_AmendedTwoThousandThreePlanMember_lbl" xml:lang="en-US" id="usph_AmendedTwoThousandThreePlanMember_lbl">Name of the equity-based compensation arrangement plan.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendedTwoThousandThreePlanMember" xlink:to="usph_AmendedTwoThousandThreePlanMember_lbl" xlink:title="label: AmendedTwoThousandThreePlanMember to usph_AmendedTwoThousandThreePlanMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_AmendedTwoThousandThreePlanMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_AmendedTwoThousandThreePlanMember_lbl1" xml:lang="en-US" id="usph_AmendedTwoThousandThreePlanMember_lbl1">Amended Two Thousand Three Plan [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendedTwoThousandThreePlanMember" xlink:to="usph_AmendedTwoThousandThreePlanMember_lbl1" xlink:title="label: AmendedTwoThousandThreePlanMember to usph_AmendedTwoThousandThreePlanMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_AmendedTwoThousandThreePlanMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_AmendedTwoThousandThreePlanMember_lbl2" xml:lang="en-US" id="usph_AmendedTwoThousandThreePlanMember_lbl2">Amended 2003 Plan [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendedTwoThousandThreePlanMember" xlink:to="usph_AmendedTwoThousandThreePlanMember_lbl2" xlink:title="label: AmendedTwoThousandThreePlanMember to usph_AmendedTwoThousandThreePlanMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod" />
    <link:label xlink:type="resource" xlink:label="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod_lbl" xml:lang="en-US" id="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod_lbl">Number of share options (or share units) exercised for the cumulative period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod" xlink:to="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod to usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod_lbl1" xml:lang="en-US" id="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises For the Cumulative Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod" xlink:to="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod to usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod_lbl2" xml:lang="en-US" id="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod_lbl2">Stock options exercised (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod" xlink:to="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod to usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod" />
    <link:label xlink:type="resource" xlink:label="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod_lbl" xml:lang="en-US" id="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod_lbl">The number of grants made for the cumulative period on restricted stock units plan.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod" xlink:to="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod to usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod_lbl1" xml:lang="en-US" id="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod_lbl1">Share-based Compensation Arrangement by Share-based Payment Award Restricted Stock Grants For The Cumulative Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod" xlink:to="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod to usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod_lbl2" xml:lang="en-US" id="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod_lbl2">Restricted stock issued (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod" xlink:to="usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod to usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_AmendedNineteenNinetyNinePlanMember" xlink:label="AmendedNineteenNinetyNinePlanMember" xlink:title="AmendedNineteenNinetyNinePlanMember" />
    <link:label xlink:type="resource" xlink:label="usph_AmendedNineteenNinetyNinePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_AmendedNineteenNinetyNinePlanMember_lbl" xml:lang="en-US" id="usph_AmendedNineteenNinetyNinePlanMember_lbl">Name of the equity-based compensation arrangement plan.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendedNineteenNinetyNinePlanMember" xlink:to="usph_AmendedNineteenNinetyNinePlanMember_lbl" xlink:title="label: AmendedNineteenNinetyNinePlanMember to usph_AmendedNineteenNinetyNinePlanMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_AmendedNineteenNinetyNinePlanMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_AmendedNineteenNinetyNinePlanMember_lbl1" xml:lang="en-US" id="usph_AmendedNineteenNinetyNinePlanMember_lbl1">Amended Nineteen Ninety Nine Plan [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendedNineteenNinetyNinePlanMember" xlink:to="usph_AmendedNineteenNinetyNinePlanMember_lbl1" xlink:title="label: AmendedNineteenNinetyNinePlanMember to usph_AmendedNineteenNinetyNinePlanMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_AmendedNineteenNinetyNinePlanMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_AmendedNineteenNinetyNinePlanMember_lbl2" xml:lang="en-US" id="usph_AmendedNineteenNinetyNinePlanMember_lbl2">Amended 1999 Plan [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendedNineteenNinetyNinePlanMember" xlink:to="usph_AmendedNineteenNinetyNinePlanMember_lbl2" xlink:title="label: AmendedNineteenNinetyNinePlanMember to usph_AmendedNineteenNinetyNinePlanMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PreferredStockAbstract" xlink:label="PreferredStockAbstract" xlink:title="PreferredStockAbstract" />
    <link:label xlink:type="resource" xlink:label="usph_PreferredStockAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PreferredStockAbstract_lbl1" xml:lang="en-US" id="usph_PreferredStockAbstract_lbl1">Preferred Stock [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockAbstract" xlink:to="usph_PreferredStockAbstract_lbl1" xlink:title="label: PreferredStockAbstract to usph_PreferredStockAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfAcquiredOperations" xlink:label="NumberOfAcquiredOperations" xlink:title="NumberOfAcquiredOperations" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfAcquiredOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NumberOfAcquiredOperations_lbl" xml:lang="en-US" id="usph_NumberOfAcquiredOperations_lbl">Refers to number of acquired operations during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfAcquiredOperations" xlink:to="usph_NumberOfAcquiredOperations_lbl" xlink:title="label: NumberOfAcquiredOperations to usph_NumberOfAcquiredOperations_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfAcquiredOperations_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NumberOfAcquiredOperations_lbl1" xml:lang="en-US" id="usph_NumberOfAcquiredOperations_lbl1">Number of Acquired Operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfAcquiredOperations" xlink:to="usph_NumberOfAcquiredOperations_lbl1" xlink:title="label: NumberOfAcquiredOperations to usph_NumberOfAcquiredOperations_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfAcquiredOperations_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NumberOfAcquiredOperations_lbl2" xml:lang="en-US" id="usph_NumberOfAcquiredOperations_lbl2">Number of acquired operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfAcquiredOperations" xlink:to="usph_NumberOfAcquiredOperations_lbl2" xlink:title="label: NumberOfAcquiredOperations to usph_NumberOfAcquiredOperations_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_DeferredEmployerPayrollTaxesCARESACT" xlink:label="DeferredEmployerPayrollTaxesCARESACT" xlink:title="DeferredEmployerPayrollTaxesCARESACT" />
    <link:label xlink:type="resource" xlink:label="usph_DeferredEmployerPayrollTaxesCARESACT_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_DeferredEmployerPayrollTaxesCARESACT_lbl" xml:lang="en-US" id="usph_DeferredEmployerPayrollTaxesCARESACT_lbl">Amount of deferred employer payroll taxes - CARES ACT.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredEmployerPayrollTaxesCARESACT" xlink:to="usph_DeferredEmployerPayrollTaxesCARESACT_lbl" xlink:title="label: DeferredEmployerPayrollTaxesCARESACT to usph_DeferredEmployerPayrollTaxesCARESACT_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_DeferredEmployerPayrollTaxesCARESACT_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_DeferredEmployerPayrollTaxesCARESACT_lbl1" xml:lang="en-US" id="usph_DeferredEmployerPayrollTaxesCARESACT_lbl1">Deferred employer payroll taxes - CARES ACT</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredEmployerPayrollTaxesCARESACT" xlink:to="usph_DeferredEmployerPayrollTaxesCARESACT_lbl1" xlink:title="label: DeferredEmployerPayrollTaxesCARESACT to usph_DeferredEmployerPayrollTaxesCARESACT_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_DeferredEmployerPayrollTaxesCARESACT_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_DeferredEmployerPayrollTaxesCARESACT_lbl2" xml:lang="en-US" id="usph_DeferredEmployerPayrollTaxesCARESACT_lbl2">Deferred employer payroll taxes - CARES ACT</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredEmployerPayrollTaxesCARESACT" xlink:to="usph_DeferredEmployerPayrollTaxesCARESACT_lbl2" xlink:title="label: DeferredEmployerPayrollTaxesCARESACT to usph_DeferredEmployerPayrollTaxesCARESACT_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable" xlink:label="MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable" xlink:title="MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable" />
    <link:label xlink:type="resource" xlink:label="usph_MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable_lbl" xml:lang="en-US" id="usph_MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable_lbl">Amount of funds from the CARES Act allowed for qualified healthcare providers to receive advanced payments under the existing Medicare Accelerated and Advance Payments Program ("MAAPP funds") during the COVID-19 pandemic</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable" xlink:to="usph_MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable_lbl" xlink:title="label: MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable to usph_MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable_lbl1" xml:lang="en-US" id="usph_MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable_lbl1">Medicare Accelerated and Advance Payments Program Funds Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable" xlink:to="usph_MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable_lbl1" xlink:title="label: MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable to usph_MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable_lbl2" xml:lang="en-US" id="usph_MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable_lbl2">MAAPP Funds Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable" xlink:to="usph_MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable_lbl2" xlink:title="label: MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable to usph_MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PatientsAndPayorsRelatedLiability" xlink:label="PatientsAndPayorsRelatedLiability" xlink:title="PatientsAndPayorsRelatedLiability" />
    <link:label xlink:type="resource" xlink:label="usph_PatientsAndPayorsRelatedLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PatientsAndPayorsRelatedLiability_lbl" xml:lang="en-US" id="usph_PatientsAndPayorsRelatedLiability_lbl">Carrying value as of the balance sheet date of obligations incurred due to patients and payors . Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PatientsAndPayorsRelatedLiability" xlink:to="usph_PatientsAndPayorsRelatedLiability_lbl" xlink:title="label: PatientsAndPayorsRelatedLiability to usph_PatientsAndPayorsRelatedLiability_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PatientsAndPayorsRelatedLiability_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PatientsAndPayorsRelatedLiability_lbl1" xml:lang="en-US" id="usph_PatientsAndPayorsRelatedLiability_lbl1">Patients And Payors Related Liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PatientsAndPayorsRelatedLiability" xlink:to="usph_PatientsAndPayorsRelatedLiability_lbl1" xlink:title="label: PatientsAndPayorsRelatedLiability to usph_PatientsAndPayorsRelatedLiability_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PatientsAndPayorsRelatedLiability_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_PatientsAndPayorsRelatedLiability_lbl2" xml:lang="en-US" id="usph_PatientsAndPayorsRelatedLiability_lbl2">Credit balances due to patients and payors</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PatientsAndPayorsRelatedLiability" xlink:to="usph_PatientsAndPayorsRelatedLiability_lbl2" xlink:title="label: PatientsAndPayorsRelatedLiability to usph_PatientsAndPayorsRelatedLiability_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_AverageLeaseTermsAndDiscountRatesAbstract" xlink:label="AverageLeaseTermsAndDiscountRatesAbstract" xlink:title="AverageLeaseTermsAndDiscountRatesAbstract" />
    <link:label xlink:type="resource" xlink:label="usph_AverageLeaseTermsAndDiscountRatesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_AverageLeaseTermsAndDiscountRatesAbstract_lbl1" xml:lang="en-US" id="usph_AverageLeaseTermsAndDiscountRatesAbstract_lbl1">Average Lease Terms and Discount Rates [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AverageLeaseTermsAndDiscountRatesAbstract" xlink:to="usph_AverageLeaseTermsAndDiscountRatesAbstract_lbl1" xlink:title="label: AverageLeaseTermsAndDiscountRatesAbstract to usph_AverageLeaseTermsAndDiscountRatesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_SupplementalInformationRelatedToOperatingLeasesAbstract" xlink:label="SupplementalInformationRelatedToOperatingLeasesAbstract" xlink:title="SupplementalInformationRelatedToOperatingLeasesAbstract" />
    <link:label xlink:type="resource" xlink:label="usph_SupplementalInformationRelatedToOperatingLeasesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_SupplementalInformationRelatedToOperatingLeasesAbstract_lbl1" xml:lang="en-US" id="usph_SupplementalInformationRelatedToOperatingLeasesAbstract_lbl1">Supplemental Information Related to Operating Leases [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SupplementalInformationRelatedToOperatingLeasesAbstract" xlink:to="usph_SupplementalInformationRelatedToOperatingLeasesAbstract_lbl1" xlink:title="label: SupplementalInformationRelatedToOperatingLeasesAbstract to usph_SupplementalInformationRelatedToOperatingLeasesAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_SupplementalInformationRelatedToOperatingLeasesAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_SupplementalInformationRelatedToOperatingLeasesAbstract_lbl2" xml:lang="en-US" id="usph_SupplementalInformationRelatedToOperatingLeasesAbstract_lbl2">Supplemental Information Related to Leases [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SupplementalInformationRelatedToOperatingLeasesAbstract" xlink:to="usph_SupplementalInformationRelatedToOperatingLeasesAbstract_lbl2" xlink:title="label: SupplementalInformationRelatedToOperatingLeasesAbstract to usph_SupplementalInformationRelatedToOperatingLeasesAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ReferralRelationshipMember" xlink:label="ReferralRelationshipMember" xlink:title="ReferralRelationshipMember" />
    <link:label xlink:type="resource" xlink:label="usph_ReferralRelationshipMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ReferralRelationshipMember_lbl" xml:lang="en-US" id="usph_ReferralRelationshipMember_lbl">Referral relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReferralRelationshipMember" xlink:to="usph_ReferralRelationshipMember_lbl" xlink:title="label: ReferralRelationshipMember to usph_ReferralRelationshipMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ReferralRelationshipMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ReferralRelationshipMember_lbl1" xml:lang="en-US" id="usph_ReferralRelationshipMember_lbl1">Referral Relationship [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReferralRelationshipMember" xlink:to="usph_ReferralRelationshipMember_lbl1" xlink:title="label: ReferralRelationshipMember to usph_ReferralRelationshipMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ReferralRelationshipMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ReferralRelationshipMember_lbl2" xml:lang="en-US" id="usph_ReferralRelationshipMember_lbl2">Referral Relationships [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReferralRelationshipMember" xlink:to="usph_ReferralRelationshipMember_lbl2" xlink:title="label: ReferralRelationshipMember to usph_ReferralRelationshipMember_lbl2" />
    <link:label xlink:type="resource" xlink:label="usph_ReferralRelationshipMember_lbl3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_ReferralRelationshipMember_lbl3" xml:lang="en-US" id="usph_ReferralRelationshipMember_lbl3">Referral Relationships [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReferralRelationshipMember" xlink:to="usph_ReferralRelationshipMember_lbl3" xlink:title="label: ReferralRelationshipMember to usph_ReferralRelationshipMember_lbl3" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_MedicareAcceleratedAndAdvancePaymentFunds" xlink:label="MedicareAcceleratedAndAdvancePaymentFunds" xlink:title="MedicareAcceleratedAndAdvancePaymentFunds" />
    <link:label xlink:type="resource" xlink:label="usph_MedicareAcceleratedAndAdvancePaymentFunds_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_MedicareAcceleratedAndAdvancePaymentFunds_lbl" xml:lang="en-US" id="usph_MedicareAcceleratedAndAdvancePaymentFunds_lbl">Amount of medicare accelerated and advance payment funds.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MedicareAcceleratedAndAdvancePaymentFunds" xlink:to="usph_MedicareAcceleratedAndAdvancePaymentFunds_lbl" xlink:title="label: MedicareAcceleratedAndAdvancePaymentFunds to usph_MedicareAcceleratedAndAdvancePaymentFunds_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_MedicareAcceleratedAndAdvancePaymentFunds_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_MedicareAcceleratedAndAdvancePaymentFunds_lbl1" xml:lang="en-US" id="usph_MedicareAcceleratedAndAdvancePaymentFunds_lbl1">Medicare Accelerated and Advance Payment Funds</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MedicareAcceleratedAndAdvancePaymentFunds" xlink:to="usph_MedicareAcceleratedAndAdvancePaymentFunds_lbl1" xlink:title="label: MedicareAcceleratedAndAdvancePaymentFunds to usph_MedicareAcceleratedAndAdvancePaymentFunds_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_MedicareAcceleratedAndAdvancePaymentFunds_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_MedicareAcceleratedAndAdvancePaymentFunds_lbl2" xml:lang="en-US" id="usph_MedicareAcceleratedAndAdvancePaymentFunds_lbl2">Medicare accelerated and advance payment funds</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MedicareAcceleratedAndAdvancePaymentFunds" xlink:to="usph_MedicareAcceleratedAndAdvancePaymentFunds_lbl2" xlink:title="label: MedicareAcceleratedAndAdvancePaymentFunds to usph_MedicareAcceleratedAndAdvancePaymentFunds_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PurchaseOfBusinessSellerFinancingPortion" xlink:label="PurchaseOfBusinessSellerFinancingPortion" xlink:title="PurchaseOfBusinessSellerFinancingPortion" />
    <link:label xlink:type="resource" xlink:label="usph_PurchaseOfBusinessSellerFinancingPortion_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PurchaseOfBusinessSellerFinancingPortion_lbl" xml:lang="en-US" id="usph_PurchaseOfBusinessSellerFinancingPortion_lbl">Purchase of business - seller financing portion in noncash investing or financing activities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PurchaseOfBusinessSellerFinancingPortion" xlink:to="usph_PurchaseOfBusinessSellerFinancingPortion_lbl" xlink:title="label: PurchaseOfBusinessSellerFinancingPortion to usph_PurchaseOfBusinessSellerFinancingPortion_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PurchaseOfBusinessSellerFinancingPortion_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PurchaseOfBusinessSellerFinancingPortion_lbl1" xml:lang="en-US" id="usph_PurchaseOfBusinessSellerFinancingPortion_lbl1">Purchase Of Business Seller Financing Portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PurchaseOfBusinessSellerFinancingPortion" xlink:to="usph_PurchaseOfBusinessSellerFinancingPortion_lbl1" xlink:title="label: PurchaseOfBusinessSellerFinancingPortion to usph_PurchaseOfBusinessSellerFinancingPortion_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PurchaseOfBusinessSellerFinancingPortion_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PurchaseOfBusinessSellerFinancingPortion_lbl2" xml:lang="en-US" id="usph_PurchaseOfBusinessSellerFinancingPortion_lbl2">Purchase of businesses - seller financing portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PurchaseOfBusinessSellerFinancingPortion" xlink:to="usph_PurchaseOfBusinessSellerFinancingPortion_lbl2" xlink:title="label: PurchaseOfBusinessSellerFinancingPortion to usph_PurchaseOfBusinessSellerFinancingPortion_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PaymentsToAcquireRedeemableNonControllingInterest" xlink:label="PaymentsToAcquireRedeemableNonControllingInterest" xlink:title="PaymentsToAcquireRedeemableNonControllingInterest" />
    <link:label xlink:type="resource" xlink:label="usph_PaymentsToAcquireRedeemableNonControllingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PaymentsToAcquireRedeemableNonControllingInterest_lbl" xml:lang="en-US" id="usph_PaymentsToAcquireRedeemableNonControllingInterest_lbl">The cash outflow associated with the acquisition of a redeemable non-controlling interest.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireRedeemableNonControllingInterest" xlink:to="usph_PaymentsToAcquireRedeemableNonControllingInterest_lbl" xlink:title="label: PaymentsToAcquireRedeemableNonControllingInterest to usph_PaymentsToAcquireRedeemableNonControllingInterest_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PaymentsToAcquireRedeemableNonControllingInterest_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PaymentsToAcquireRedeemableNonControllingInterest_lbl1" xml:lang="en-US" id="usph_PaymentsToAcquireRedeemableNonControllingInterest_lbl1">Payments to Acquire Redeemable Non-controlling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireRedeemableNonControllingInterest" xlink:to="usph_PaymentsToAcquireRedeemableNonControllingInterest_lbl1" xlink:title="label: PaymentsToAcquireRedeemableNonControllingInterest to usph_PaymentsToAcquireRedeemableNonControllingInterest_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PaymentsToAcquireRedeemableNonControllingInterest_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="usph_PaymentsToAcquireRedeemableNonControllingInterest_lbl2" xml:lang="en-US" id="usph_PaymentsToAcquireRedeemableNonControllingInterest_lbl2">Purchase of redeemable non-controlling interest, temporary equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireRedeemableNonControllingInterest" xlink:to="usph_PaymentsToAcquireRedeemableNonControllingInterest_lbl2" xlink:title="label: PaymentsToAcquireRedeemableNonControllingInterest to usph_PaymentsToAcquireRedeemableNonControllingInterest_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity" xlink:label="NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity" />
    <link:label xlink:type="resource" xlink:label="usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity_lbl" xml:lang="en-US" id="usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity_lbl">The amount of business acquisition cost of acquired entity debt issued (temporary equity) on the date of acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity" xlink:to="usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity_lbl" xlink:title="label: NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity to usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity_lbl1" xml:lang="en-US" id="usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity_lbl1">Notes Payable Related To Purchase Of Redeemable Non Controlling Interest, Temporary Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity" xlink:to="usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity_lbl1" xlink:title="label: NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity to usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity_lbl2" xml:lang="en-US" id="usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity_lbl2">Notes payable related to purchase of redeemable non-controlling interest, temporary equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity" xlink:to="usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity_lbl2" xlink:title="label: NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity to usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity" xlink:label="NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity" xlink:title="NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity" />
    <link:label xlink:type="resource" xlink:label="usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity_lbl" xml:lang="en-US" id="usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity_lbl">The amount of business acquisition cost of acquired entity debt issued on the date of acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity" xlink:to="usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity_lbl" xlink:title="label: NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity to usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity_lbl1" xml:lang="en-US" id="usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity_lbl1">Notes Payable Related to Purchase of Non-Controlling Interest, Permanent Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity" xlink:to="usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity_lbl1" xlink:title="label: NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity to usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity_lbl2" xml:lang="en-US" id="usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity_lbl2">Notes payable related to purchase of non-controlling interest, permanent equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity" xlink:to="usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity_lbl2" xlink:title="label: NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity to usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_GainOnSaleOfPartnershipInterestNetOfTax" xlink:label="GainOnSaleOfPartnershipInterestNetOfTax" xlink:title="GainOnSaleOfPartnershipInterestNetOfTax" />
    <link:label xlink:type="resource" xlink:label="usph_GainOnSaleOfPartnershipInterestNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_GainOnSaleOfPartnershipInterestNetOfTax_lbl" xml:lang="en-US" id="usph_GainOnSaleOfPartnershipInterestNetOfTax_lbl">After tax amount of gain on sale or disposal of partnership interest.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainOnSaleOfPartnershipInterestNetOfTax" xlink:to="usph_GainOnSaleOfPartnershipInterestNetOfTax_lbl" xlink:title="label: GainOnSaleOfPartnershipInterestNetOfTax to usph_GainOnSaleOfPartnershipInterestNetOfTax_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_GainOnSaleOfPartnershipInterestNetOfTax_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_GainOnSaleOfPartnershipInterestNetOfTax_lbl1" xml:lang="en-US" id="usph_GainOnSaleOfPartnershipInterestNetOfTax_lbl1">Gain on Sale of Partnership Interest, Net of Tax</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainOnSaleOfPartnershipInterestNetOfTax" xlink:to="usph_GainOnSaleOfPartnershipInterestNetOfTax_lbl1" xlink:title="label: GainOnSaleOfPartnershipInterestNetOfTax to usph_GainOnSaleOfPartnershipInterestNetOfTax_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_GainOnSaleOfPartnershipInterestNetOfTax_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="usph_GainOnSaleOfPartnershipInterestNetOfTax_lbl2" xml:lang="en-US" id="usph_GainOnSaleOfPartnershipInterestNetOfTax_lbl2">Gain on sale of partnership interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainOnSaleOfPartnershipInterestNetOfTax" xlink:to="usph_GainOnSaleOfPartnershipInterestNetOfTax_lbl2" xlink:title="label: GainOnSaleOfPartnershipInterestNetOfTax to usph_GainOnSaleOfPartnershipInterestNetOfTax_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_CashPaidDuringPeriodForAbstract" xlink:label="CashPaidDuringPeriodForAbstract" xlink:title="CashPaidDuringPeriodForAbstract" />
    <link:label xlink:type="resource" xlink:label="usph_CashPaidDuringPeriodForAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_CashPaidDuringPeriodForAbstract_lbl1" xml:lang="en-US" id="usph_CashPaidDuringPeriodForAbstract_lbl1">Cash Paid During Period For [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashPaidDuringPeriodForAbstract" xlink:to="usph_CashPaidDuringPeriodForAbstract_lbl1" xlink:title="label: CashPaidDuringPeriodForAbstract to usph_CashPaidDuringPeriodForAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_CashPaidDuringPeriodForAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_CashPaidDuringPeriodForAbstract_lbl2" xml:lang="en-US" id="usph_CashPaidDuringPeriodForAbstract_lbl2">Cash paid during the period for:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashPaidDuringPeriodForAbstract" xlink:to="usph_CashPaidDuringPeriodForAbstract_lbl2" xlink:title="label: CashPaidDuringPeriodForAbstract to usph_CashPaidDuringPeriodForAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_RemainingContractTerm" xlink:label="RemainingContractTerm" xlink:title="RemainingContractTerm" />
    <link:label xlink:type="resource" xlink:label="usph_RemainingContractTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_RemainingContractTerm_lbl" xml:lang="en-US" id="usph_RemainingContractTerm_lbl">Remaining term of contract, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RemainingContractTerm" xlink:to="usph_RemainingContractTerm_lbl" xlink:title="label: RemainingContractTerm to usph_RemainingContractTerm_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_RemainingContractTerm_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_RemainingContractTerm_lbl1" xml:lang="en-US" id="usph_RemainingContractTerm_lbl1">Remaining Contract Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RemainingContractTerm" xlink:to="usph_RemainingContractTerm_lbl1" xlink:title="label: RemainingContractTerm to usph_RemainingContractTerm_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_RemainingContractTerm_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_RemainingContractTerm_lbl2" xml:lang="en-US" id="usph_RemainingContractTerm_lbl2">Remaining contract term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RemainingContractTerm" xlink:to="usph_RemainingContractTerm_lbl2" xlink:title="label: RemainingContractTerm to usph_RemainingContractTerm_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_FebruaryTwoThousandTwentyAcquisitionMember" xlink:label="FebruaryTwoThousandTwentyAcquisitionMember" xlink:title="FebruaryTwoThousandTwentyAcquisitionMember" />
    <link:label xlink:type="resource" xlink:label="usph_FebruaryTwoThousandTwentyAcquisitionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_FebruaryTwoThousandTwentyAcquisitionMember_lbl" xml:lang="en-US" id="usph_FebruaryTwoThousandTwentyAcquisitionMember_lbl">Date of business acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FebruaryTwoThousandTwentyAcquisitionMember" xlink:to="usph_FebruaryTwoThousandTwentyAcquisitionMember_lbl" xlink:title="label: FebruaryTwoThousandTwentyAcquisitionMember to usph_FebruaryTwoThousandTwentyAcquisitionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_FebruaryTwoThousandTwentyAcquisitionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_FebruaryTwoThousandTwentyAcquisitionMember_lbl1" xml:lang="en-US" id="usph_FebruaryTwoThousandTwentyAcquisitionMember_lbl1">February Two Thousand Twenty Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FebruaryTwoThousandTwentyAcquisitionMember" xlink:to="usph_FebruaryTwoThousandTwentyAcquisitionMember_lbl1" xlink:title="label: FebruaryTwoThousandTwentyAcquisitionMember to usph_FebruaryTwoThousandTwentyAcquisitionMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_FebruaryTwoThousandTwentyAcquisitionMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_FebruaryTwoThousandTwentyAcquisitionMember_lbl2" xml:lang="en-US" id="usph_FebruaryTwoThousandTwentyAcquisitionMember_lbl2">February 2020 Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FebruaryTwoThousandTwentyAcquisitionMember" xlink:to="usph_FebruaryTwoThousandTwentyAcquisitionMember_lbl2" xlink:title="label: FebruaryTwoThousandTwentyAcquisitionMember to usph_FebruaryTwoThousandTwentyAcquisitionMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_SeptemberTwoThousandTwentyAcquisitionMember" xlink:label="SeptemberTwoThousandTwentyAcquisitionMember" xlink:title="SeptemberTwoThousandTwentyAcquisitionMember" />
    <link:label xlink:type="resource" xlink:label="usph_SeptemberTwoThousandTwentyAcquisitionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_SeptemberTwoThousandTwentyAcquisitionMember_lbl" xml:lang="en-US" id="usph_SeptemberTwoThousandTwentyAcquisitionMember_lbl">Date of business acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeptemberTwoThousandTwentyAcquisitionMember" xlink:to="usph_SeptemberTwoThousandTwentyAcquisitionMember_lbl" xlink:title="label: SeptemberTwoThousandTwentyAcquisitionMember to usph_SeptemberTwoThousandTwentyAcquisitionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_SeptemberTwoThousandTwentyAcquisitionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_SeptemberTwoThousandTwentyAcquisitionMember_lbl1" xml:lang="en-US" id="usph_SeptemberTwoThousandTwentyAcquisitionMember_lbl1">September Two Thousand Twenty Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeptemberTwoThousandTwentyAcquisitionMember" xlink:to="usph_SeptemberTwoThousandTwentyAcquisitionMember_lbl1" xlink:title="label: SeptemberTwoThousandTwentyAcquisitionMember to usph_SeptemberTwoThousandTwentyAcquisitionMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_SeptemberTwoThousandTwentyAcquisitionMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_SeptemberTwoThousandTwentyAcquisitionMember_lbl2" xml:lang="en-US" id="usph_SeptemberTwoThousandTwentyAcquisitionMember_lbl2">September 2020 Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeptemberTwoThousandTwentyAcquisitionMember" xlink:to="usph_SeptemberTwoThousandTwentyAcquisitionMember_lbl2" xlink:title="label: SeptemberTwoThousandTwentyAcquisitionMember to usph_SeptemberTwoThousandTwentyAcquisitionMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_August2018AcquisitionMember" xlink:label="August2018AcquisitionMember" xlink:title="August2018AcquisitionMember" />
    <link:label xlink:type="resource" xlink:label="usph_August2018AcquisitionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_August2018AcquisitionMember_lbl" xml:lang="en-US" id="usph_August2018AcquisitionMember_lbl">Date of business acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="August2018AcquisitionMember" xlink:to="usph_August2018AcquisitionMember_lbl" xlink:title="label: August2018AcquisitionMember to usph_August2018AcquisitionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_August2018AcquisitionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_August2018AcquisitionMember_lbl1" xml:lang="en-US" id="usph_August2018AcquisitionMember_lbl1">August Two Thousand Eighteen Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="August2018AcquisitionMember" xlink:to="usph_August2018AcquisitionMember_lbl1" xlink:title="label: August2018AcquisitionMember to usph_August2018AcquisitionMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_August2018AcquisitionMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_August2018AcquisitionMember_lbl2" xml:lang="en-US" id="usph_August2018AcquisitionMember_lbl2">August 2018 Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="August2018AcquisitionMember" xlink:to="usph_August2018AcquisitionMember_lbl2" xlink:title="label: August2018AcquisitionMember to usph_August2018AcquisitionMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ClinicPracticeMember" xlink:label="ClinicPracticeMember" xlink:title="ClinicPracticeMember" />
    <link:label xlink:type="resource" xlink:label="usph_ClinicPracticeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ClinicPracticeMember_lbl" xml:lang="en-US" id="usph_ClinicPracticeMember_lbl">Acquisition of part of a company which provides clinic practice services.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClinicPracticeMember" xlink:to="usph_ClinicPracticeMember_lbl" xlink:title="label: ClinicPracticeMember to usph_ClinicPracticeMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ClinicPracticeMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ClinicPracticeMember_lbl1" xml:lang="en-US" id="usph_ClinicPracticeMember_lbl1">Clinic Practice [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClinicPracticeMember" xlink:to="usph_ClinicPracticeMember_lbl1" xlink:title="label: ClinicPracticeMember to usph_ClinicPracticeMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NovemberTwoThousandTwentyAcquisitionMember" xlink:label="NovemberTwoThousandTwentyAcquisitionMember" xlink:title="NovemberTwoThousandTwentyAcquisitionMember" />
    <link:label xlink:type="resource" xlink:label="usph_NovemberTwoThousandTwentyAcquisitionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NovemberTwoThousandTwentyAcquisitionMember_lbl" xml:lang="en-US" id="usph_NovemberTwoThousandTwentyAcquisitionMember_lbl">Date of business acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NovemberTwoThousandTwentyAcquisitionMember" xlink:to="usph_NovemberTwoThousandTwentyAcquisitionMember_lbl" xlink:title="label: NovemberTwoThousandTwentyAcquisitionMember to usph_NovemberTwoThousandTwentyAcquisitionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NovemberTwoThousandTwentyAcquisitionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NovemberTwoThousandTwentyAcquisitionMember_lbl1" xml:lang="en-US" id="usph_NovemberTwoThousandTwentyAcquisitionMember_lbl1">November Two Thousand Twenty Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NovemberTwoThousandTwentyAcquisitionMember" xlink:to="usph_NovemberTwoThousandTwentyAcquisitionMember_lbl1" xlink:title="label: NovemberTwoThousandTwentyAcquisitionMember to usph_NovemberTwoThousandTwentyAcquisitionMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NovemberTwoThousandTwentyAcquisitionMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NovemberTwoThousandTwentyAcquisitionMember_lbl2" xml:lang="en-US" id="usph_NovemberTwoThousandTwentyAcquisitionMember_lbl2">November 2020 Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NovemberTwoThousandTwentyAcquisitionMember" xlink:to="usph_NovemberTwoThousandTwentyAcquisitionMember_lbl2" xlink:title="label: NovemberTwoThousandTwentyAcquisitionMember to usph_NovemberTwoThousandTwentyAcquisitionMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_SeptemberTwoThousandNineteenAcquisitionMember" xlink:label="SeptemberTwoThousandNineteenAcquisitionMember" xlink:title="SeptemberTwoThousandNineteenAcquisitionMember" />
    <link:label xlink:type="resource" xlink:label="usph_SeptemberTwoThousandNineteenAcquisitionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_SeptemberTwoThousandNineteenAcquisitionMember_lbl" xml:lang="en-US" id="usph_SeptemberTwoThousandNineteenAcquisitionMember_lbl">Date of business acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeptemberTwoThousandNineteenAcquisitionMember" xlink:to="usph_SeptemberTwoThousandNineteenAcquisitionMember_lbl" xlink:title="label: SeptemberTwoThousandNineteenAcquisitionMember to usph_SeptemberTwoThousandNineteenAcquisitionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_SeptemberTwoThousandNineteenAcquisitionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_SeptemberTwoThousandNineteenAcquisitionMember_lbl1" xml:lang="en-US" id="usph_SeptemberTwoThousandNineteenAcquisitionMember_lbl1">September Two Thousand Nineteen Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeptemberTwoThousandNineteenAcquisitionMember" xlink:to="usph_SeptemberTwoThousandNineteenAcquisitionMember_lbl1" xlink:title="label: SeptemberTwoThousandNineteenAcquisitionMember to usph_SeptemberTwoThousandNineteenAcquisitionMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_SeptemberTwoThousandNineteenAcquisitionMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_SeptemberTwoThousandNineteenAcquisitionMember_lbl2" xml:lang="en-US" id="usph_SeptemberTwoThousandNineteenAcquisitionMember_lbl2">September 2019 Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeptemberTwoThousandNineteenAcquisitionMember" xlink:to="usph_SeptemberTwoThousandNineteenAcquisitionMember_lbl2" xlink:title="label: SeptemberTwoThousandNineteenAcquisitionMember to usph_SeptemberTwoThousandNineteenAcquisitionMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ManagementContractsMember" xlink:label="ManagementContractsMember" xlink:title="ManagementContractsMember" />
    <link:label xlink:type="resource" xlink:label="usph_ManagementContractsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ManagementContractsMember_lbl" xml:lang="en-US" id="usph_ManagementContractsMember_lbl">Acquisition of part of a company which holds management contracts.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ManagementContractsMember" xlink:to="usph_ManagementContractsMember_lbl" xlink:title="label: ManagementContractsMember to usph_ManagementContractsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ManagementContractsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ManagementContractsMember_lbl1" xml:lang="en-US" id="usph_ManagementContractsMember_lbl1">Management Contracts [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ManagementContractsMember" xlink:to="usph_ManagementContractsMember_lbl1" xlink:title="label: ManagementContractsMember to usph_ManagementContractsMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ManagementContractsMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ManagementContractsMember_lbl2" xml:lang="en-US" id="usph_ManagementContractsMember_lbl2">Management Contracts [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ManagementContractsMember" xlink:to="usph_ManagementContractsMember_lbl2" xlink:title="label: ManagementContractsMember to usph_ManagementContractsMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfManagementContracts" xlink:label="NumberOfManagementContracts" xlink:title="NumberOfManagementContracts" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfManagementContracts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NumberOfManagementContracts_lbl" xml:lang="en-US" id="usph_NumberOfManagementContracts_lbl">The number of management contracts during period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfManagementContracts" xlink:to="usph_NumberOfManagementContracts_lbl" xlink:title="label: NumberOfManagementContracts to usph_NumberOfManagementContracts_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfManagementContracts_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NumberOfManagementContracts_lbl1" xml:lang="en-US" id="usph_NumberOfManagementContracts_lbl1">Number of Management Contracts</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfManagementContracts" xlink:to="usph_NumberOfManagementContracts_lbl1" xlink:title="label: NumberOfManagementContracts to usph_NumberOfManagementContracts_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfManagementContracts_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NumberOfManagementContracts_lbl2" xml:lang="en-US" id="usph_NumberOfManagementContracts_lbl2">Number of management contracts</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfManagementContracts" xlink:to="usph_NumberOfManagementContracts_lbl2" xlink:title="label: NumberOfManagementContracts to usph_NumberOfManagementContracts_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_DividendsCashAfterAmendment" xlink:label="DividendsCashAfterAmendment" xlink:title="DividendsCashAfterAmendment" />
    <link:label xlink:type="resource" xlink:label="usph_DividendsCashAfterAmendment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_DividendsCashAfterAmendment_lbl" xml:lang="en-US" id="usph_DividendsCashAfterAmendment_lbl">Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DividendsCashAfterAmendment" xlink:to="usph_DividendsCashAfterAmendment_lbl" xlink:title="label: DividendsCashAfterAmendment to usph_DividendsCashAfterAmendment_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_DividendsCashAfterAmendment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_DividendsCashAfterAmendment_lbl1" xml:lang="en-US" id="usph_DividendsCashAfterAmendment_lbl1">Dividends Cash After Amendment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DividendsCashAfterAmendment" xlink:to="usph_DividendsCashAfterAmendment_lbl1" xlink:title="label: DividendsCashAfterAmendment to usph_DividendsCashAfterAmendment_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_DividendsCashAfterAmendment_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_DividendsCashAfterAmendment_lbl2" xml:lang="en-US" id="usph_DividendsCashAfterAmendment_lbl2">Cash dividends after amendment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DividendsCashAfterAmendment" xlink:to="usph_DividendsCashAfterAmendment_lbl2" xlink:title="label: DividendsCashAfterAmendment to usph_DividendsCashAfterAmendment_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_DebtInstrumentBasisSpreadOnLiborVariableRate" xlink:label="DebtInstrumentBasisSpreadOnLiborVariableRate" xlink:title="DebtInstrumentBasisSpreadOnLiborVariableRate" />
    <link:label xlink:type="resource" xlink:label="usph_DebtInstrumentBasisSpreadOnLiborVariableRate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_DebtInstrumentBasisSpreadOnLiborVariableRate_lbl" xml:lang="en-US" id="usph_DebtInstrumentBasisSpreadOnLiborVariableRate_lbl">The percentage points added to the reference rate to compute the variable rate on the debt instrument.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentBasisSpreadOnLiborVariableRate" xlink:to="usph_DebtInstrumentBasisSpreadOnLiborVariableRate_lbl" xlink:title="label: DebtInstrumentBasisSpreadOnLiborVariableRate to usph_DebtInstrumentBasisSpreadOnLiborVariableRate_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_DebtInstrumentBasisSpreadOnLiborVariableRate_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_DebtInstrumentBasisSpreadOnLiborVariableRate_lbl1" xml:lang="en-US" id="usph_DebtInstrumentBasisSpreadOnLiborVariableRate_lbl1">Debt Instrument Basis Spread On Libor Variable Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentBasisSpreadOnLiborVariableRate" xlink:to="usph_DebtInstrumentBasisSpreadOnLiborVariableRate_lbl1" xlink:title="label: DebtInstrumentBasisSpreadOnLiborVariableRate to usph_DebtInstrumentBasisSpreadOnLiborVariableRate_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_DebtInstrumentBasisSpreadOnLiborVariableRate_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_DebtInstrumentBasisSpreadOnLiborVariableRate_lbl2" xml:lang="en-US" id="usph_DebtInstrumentBasisSpreadOnLiborVariableRate_lbl2">Spread on Libor variable rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentBasisSpreadOnLiborVariableRate" xlink:to="usph_DebtInstrumentBasisSpreadOnLiborVariableRate_lbl2" xlink:title="label: DebtInstrumentBasisSpreadOnLiborVariableRate to usph_DebtInstrumentBasisSpreadOnLiborVariableRate_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" xlink:label="CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" xlink:title="CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" />
    <link:label xlink:type="resource" xlink:label="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl" xml:lang="en-US" id="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl">Amount of cash and noncash consideration that could pay with respect to acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" xlink:to="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl" xlink:title="label: CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement to usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl1" xml:lang="en-US" id="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl1">Cash And Noncash Consideration With Respect To Acquisition After Amendement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" xlink:to="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl1" xlink:title="label: CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement to usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl2" xml:lang="en-US" id="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl2">Cash and noncash consideration with respect to acquisition after amendment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" xlink:to="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl2" xlink:title="label: CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement to usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_CreditAgreementMember" xlink:label="CreditAgreementMember" xlink:title="CreditAgreementMember" />
    <link:label xlink:type="resource" xlink:label="usph_CreditAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_CreditAgreementMember_lbl" xml:lang="en-US" id="usph_CreditAgreementMember_lbl">A credit agreement is a legal contract in which a bank arranges to loan a customer a certain amount of money for a specified amount of time.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CreditAgreementMember" xlink:to="usph_CreditAgreementMember_lbl" xlink:title="label: CreditAgreementMember to usph_CreditAgreementMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_CreditAgreementMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_CreditAgreementMember_lbl1" xml:lang="en-US" id="usph_CreditAgreementMember_lbl1">Credit Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CreditAgreementMember" xlink:to="usph_CreditAgreementMember_lbl1" xlink:title="label: CreditAgreementMember to usph_CreditAgreementMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NotesPayableMember" xlink:label="NotesPayableMember" xlink:title="NotesPayableMember" />
    <link:label xlink:type="resource" xlink:label="usph_NotesPayableMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NotesPayableMember_lbl" xml:lang="en-US" id="usph_NotesPayableMember_lbl">A written promise to pay a note.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesPayableMember" xlink:to="usph_NotesPayableMember_lbl" xlink:title="label: NotesPayableMember to usph_NotesPayableMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NotesPayableMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NotesPayableMember_lbl1" xml:lang="en-US" id="usph_NotesPayableMember_lbl1">Notes Payable [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesPayableMember" xlink:to="usph_NotesPayableMember_lbl1" xlink:title="label: NotesPayableMember to usph_NotesPayableMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" xlink:label="OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" xlink:title="OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" />
    <link:label xlink:type="resource" xlink:label="usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember_lbl" xml:lang="en-US" id="usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember_lbl">Other revenues includes management contract revenues, industrial injury prevention services revenues and services provided on-site, such as schools and industrial worksites, for physical or occupational therapy services, and athletic trainers and gym membership fees. Contract terms and rates are agreed to in advance between the Company and the third parties. Services are typically performed over the contract period and revenue is recorded in accordance with the contract terms. If the services are paid in advance, revenue is deferred over the period of the agreement and recognized when the services are performed.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" xlink:to="usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember_lbl" xlink:title="label: OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember to usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember_lbl1" xml:lang="en-US" id="usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember_lbl1">Other Revenues Including Management Contract Revenues and Industrial Injury Prevention Services Revenues [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" xlink:to="usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember_lbl1" xlink:title="label: OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember to usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember_lbl2" xml:lang="en-US" id="usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember_lbl2">Other Revenues [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" xlink:to="usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember_lbl2" xlink:title="label: OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember to usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ReliefFunds" xlink:label="ReliefFunds" xlink:title="ReliefFunds" />
    <link:label xlink:type="resource" xlink:label="usph_ReliefFunds_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ReliefFunds_lbl" xml:lang="en-US" id="usph_ReliefFunds_lbl">Relief funds relates to social welfare, a fund of money set up to provide aid for people in need, especially in disaster areas.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReliefFunds" xlink:to="usph_ReliefFunds_lbl" xlink:title="label: ReliefFunds to usph_ReliefFunds_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ReliefFunds_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ReliefFunds_lbl1" xml:lang="en-US" id="usph_ReliefFunds_lbl1">Relief Funds</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReliefFunds" xlink:to="usph_ReliefFunds_lbl1" xlink:title="label: ReliefFunds to usph_ReliefFunds_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ReliefFunds_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ReliefFunds_lbl2" xml:lang="en-US" id="usph_ReliefFunds_lbl2">Relief funds</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReliefFunds" xlink:to="usph_ReliefFunds_lbl2" xlink:title="label: ReliefFunds to usph_ReliefFunds_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NetPatientRevenuesMember" xlink:label="NetPatientRevenuesMember" xlink:title="NetPatientRevenuesMember" />
    <link:label xlink:type="resource" xlink:label="usph_NetPatientRevenuesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NetPatientRevenuesMember_lbl" xml:lang="en-US" id="usph_NetPatientRevenuesMember_lbl">Net patient revenues (patient revenues less estimated contractual adjustments) are reported at the estimated net realizable amounts from third-party payors, patients and others for services rendered.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetPatientRevenuesMember" xlink:to="usph_NetPatientRevenuesMember_lbl" xlink:title="label: NetPatientRevenuesMember to usph_NetPatientRevenuesMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NetPatientRevenuesMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NetPatientRevenuesMember_lbl1" xml:lang="en-US" id="usph_NetPatientRevenuesMember_lbl1">Net Patient Revenues [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetPatientRevenuesMember" xlink:to="usph_NetPatientRevenuesMember_lbl1" xlink:title="label: NetPatientRevenuesMember to usph_NetPatientRevenuesMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NetPatientRevenuesMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NetPatientRevenuesMember_lbl2" xml:lang="en-US" id="usph_NetPatientRevenuesMember_lbl2">Net Patient Revenues [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetPatientRevenuesMember" xlink:to="usph_NetPatientRevenuesMember_lbl2" xlink:title="label: NetPatientRevenuesMember to usph_NetPatientRevenuesMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_InterestExpenseDebtAndOther" xlink:label="InterestExpenseDebtAndOther" xlink:title="InterestExpenseDebtAndOther" />
    <link:label xlink:type="resource" xlink:label="usph_InterestExpenseDebtAndOther_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_InterestExpenseDebtAndOther_lbl" xml:lang="en-US" id="usph_InterestExpenseDebtAndOther_lbl">Debt related expenses and other expenses associated with nonoperating financing activities of the entity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestExpenseDebtAndOther" xlink:to="usph_InterestExpenseDebtAndOther_lbl" xlink:title="label: InterestExpenseDebtAndOther to usph_InterestExpenseDebtAndOther_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_InterestExpenseDebtAndOther_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_InterestExpenseDebtAndOther_lbl1" xml:lang="en-US" id="usph_InterestExpenseDebtAndOther_lbl1">Interest Expense, Debt and Other Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestExpenseDebtAndOther" xlink:to="usph_InterestExpenseDebtAndOther_lbl1" xlink:title="label: InterestExpenseDebtAndOther to usph_InterestExpenseDebtAndOther_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_InterestExpenseDebtAndOther_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="usph_InterestExpenseDebtAndOther_lbl2" xml:lang="en-US" id="usph_InterestExpenseDebtAndOther_lbl2">Interest expense - debt and other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestExpenseDebtAndOther" xlink:to="usph_InterestExpenseDebtAndOther_lbl2" xlink:title="label: InterestExpenseDebtAndOther to usph_InterestExpenseDebtAndOther_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_RentSuppliesContractLaborAndOther" xlink:label="RentSuppliesContractLaborAndOther" xlink:title="RentSuppliesContractLaborAndOther" />
    <link:label xlink:type="resource" xlink:label="usph_RentSuppliesContractLaborAndOther_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_RentSuppliesContractLaborAndOther_lbl" xml:lang="en-US" id="usph_RentSuppliesContractLaborAndOther_lbl">Amount of expense related to rent, supplies, contract labor and other.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RentSuppliesContractLaborAndOther" xlink:to="usph_RentSuppliesContractLaborAndOther_lbl" xlink:title="label: RentSuppliesContractLaborAndOther to usph_RentSuppliesContractLaborAndOther_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_RentSuppliesContractLaborAndOther_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_RentSuppliesContractLaborAndOther_lbl1" xml:lang="en-US" id="usph_RentSuppliesContractLaborAndOther_lbl1">Rent Supplies Contract Labor And Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RentSuppliesContractLaborAndOther" xlink:to="usph_RentSuppliesContractLaborAndOther_lbl1" xlink:title="label: RentSuppliesContractLaborAndOther to usph_RentSuppliesContractLaborAndOther_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_RentSuppliesContractLaborAndOther_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_RentSuppliesContractLaborAndOther_lbl2" xml:lang="en-US" id="usph_RentSuppliesContractLaborAndOther_lbl2">Rent, supplies, contract labor and other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RentSuppliesContractLaborAndOther" xlink:to="usph_RentSuppliesContractLaborAndOther_lbl2" xlink:title="label: RentSuppliesContractLaborAndOther to usph_RentSuppliesContractLaborAndOther_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" xlink:label="CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" xlink:title="CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl" xml:lang="en-US" id="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl">Tabular disclosure of carrying amount of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" xlink:to="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl" xlink:title="label: CarryingAmountOfRedeemableNonControllingInterestTableTextBlock to usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl1" xml:lang="en-US" id="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl1">Carrying Amount of Redeemable Non-Controlling Interest [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" xlink:to="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl1" xlink:title="label: CarryingAmountOfRedeemableNonControllingInterestTableTextBlock to usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl2" xml:lang="en-US" id="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl2">Carrying Amount of (Fair Value) Redeemable Non-Controlling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" xlink:to="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl2" xlink:title="label: CarryingAmountOfRedeemableNonControllingInterestTableTextBlock to usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NoteReceivableRelatedToSaleOfClinics" xlink:label="NoteReceivableRelatedToSaleOfClinics" xlink:title="NoteReceivableRelatedToSaleOfClinics" />
    <link:label xlink:type="resource" xlink:label="usph_NoteReceivableRelatedToSaleOfClinics_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NoteReceivableRelatedToSaleOfClinics_lbl" xml:lang="en-US" id="usph_NoteReceivableRelatedToSaleOfClinics_lbl">Note receivable related to sale of discontinued clinics</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoteReceivableRelatedToSaleOfClinics" xlink:to="usph_NoteReceivableRelatedToSaleOfClinics_lbl" xlink:title="label: NoteReceivableRelatedToSaleOfClinics to usph_NoteReceivableRelatedToSaleOfClinics_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NoteReceivableRelatedToSaleOfClinics_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NoteReceivableRelatedToSaleOfClinics_lbl1" xml:lang="en-US" id="usph_NoteReceivableRelatedToSaleOfClinics_lbl1">Note Receivable Related to Sale of Clinics</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoteReceivableRelatedToSaleOfClinics" xlink:to="usph_NoteReceivableRelatedToSaleOfClinics_lbl1" xlink:title="label: NoteReceivableRelatedToSaleOfClinics to usph_NoteReceivableRelatedToSaleOfClinics_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NoteReceivableRelatedToSaleOfClinics_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NoteReceivableRelatedToSaleOfClinics_lbl2" xml:lang="en-US" id="usph_NoteReceivableRelatedToSaleOfClinics_lbl2">Note receivable related to sale of closed clinics</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoteReceivableRelatedToSaleOfClinics" xlink:to="usph_NoteReceivableRelatedToSaleOfClinics_lbl2" xlink:title="label: NoteReceivableRelatedToSaleOfClinics to usph_NoteReceivableRelatedToSaleOfClinics_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfClosedClinicsSold" xlink:label="NumberOfClosedClinicsSold" xlink:title="NumberOfClosedClinicsSold" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfClosedClinicsSold_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NumberOfClosedClinicsSold_lbl" xml:lang="en-US" id="usph_NumberOfClosedClinicsSold_lbl">Number of closed clinics sold during the period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfClosedClinicsSold" xlink:to="usph_NumberOfClosedClinicsSold_lbl" xlink:title="label: NumberOfClosedClinicsSold to usph_NumberOfClosedClinicsSold_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfClosedClinicsSold_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NumberOfClosedClinicsSold_lbl1" xml:lang="en-US" id="usph_NumberOfClosedClinicsSold_lbl1">Number of Closed Clinics Sold</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfClosedClinicsSold" xlink:to="usph_NumberOfClosedClinicsSold_lbl1" xlink:title="label: NumberOfClosedClinicsSold to usph_NumberOfClosedClinicsSold_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfClosedClinicsSold_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NumberOfClosedClinicsSold_lbl2" xml:lang="en-US" id="usph_NumberOfClosedClinicsSold_lbl2">Number of closed clinics sold</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfClosedClinicsSold" xlink:to="usph_NumberOfClosedClinicsSold_lbl2" xlink:title="label: NumberOfClosedClinicsSold to usph_NumberOfClosedClinicsSold_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfPartnershipInWhichInterestAcquired" xlink:label="NumberOfPartnershipInWhichInterestAcquired" xlink:title="NumberOfPartnershipInWhichInterestAcquired" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfPartnershipInWhichInterestAcquired_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NumberOfPartnershipInWhichInterestAcquired_lbl" xml:lang="en-US" id="usph_NumberOfPartnershipInWhichInterestAcquired_lbl">Number of partnership in which interest acquired during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfPartnershipInWhichInterestAcquired" xlink:to="usph_NumberOfPartnershipInWhichInterestAcquired_lbl" xlink:title="label: NumberOfPartnershipInWhichInterestAcquired to usph_NumberOfPartnershipInWhichInterestAcquired_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfPartnershipInWhichInterestAcquired_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NumberOfPartnershipInWhichInterestAcquired_lbl1" xml:lang="en-US" id="usph_NumberOfPartnershipInWhichInterestAcquired_lbl1">Number Of Partnership In Which Interest Acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfPartnershipInWhichInterestAcquired" xlink:to="usph_NumberOfPartnershipInWhichInterestAcquired_lbl1" xlink:title="label: NumberOfPartnershipInWhichInterestAcquired to usph_NumberOfPartnershipInWhichInterestAcquired_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfPartnershipInWhichInterestAcquired_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_NumberOfPartnershipInWhichInterestAcquired_lbl2" xml:lang="en-US" id="usph_NumberOfPartnershipInWhichInterestAcquired_lbl2">Number of partnerships</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfPartnershipInWhichInterestAcquired" xlink:to="usph_NumberOfPartnershipInWhichInterestAcquired_lbl2" xlink:title="label: NumberOfPartnershipInWhichInterestAcquired to usph_NumberOfPartnershipInWhichInterestAcquired_lbl2" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfPartnershipInWhichInterestAcquired_lbl3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NumberOfPartnershipInWhichInterestAcquired_lbl3" xml:lang="en-US" id="usph_NumberOfPartnershipInWhichInterestAcquired_lbl3">Number of partnerships in which interest acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfPartnershipInWhichInterestAcquired" xlink:to="usph_NumberOfPartnershipInWhichInterestAcquired_lbl3" xlink:title="label: NumberOfPartnershipInWhichInterestAcquired to usph_NumberOfPartnershipInWhichInterestAcquired_lbl3" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_TaxEffectOnSaleOfNoncontrollingInterest" xlink:label="TaxEffectOnSaleOfNoncontrollingInterest" xlink:title="TaxEffectOnSaleOfNoncontrollingInterest" />
    <link:label xlink:type="resource" xlink:label="usph_TaxEffectOnSaleOfNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_TaxEffectOnSaleOfNoncontrollingInterest_lbl" xml:lang="en-US" id="usph_TaxEffectOnSaleOfNoncontrollingInterest_lbl">Refers to amount of tax effected on noncontrolling interest sale price during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TaxEffectOnSaleOfNoncontrollingInterest" xlink:to="usph_TaxEffectOnSaleOfNoncontrollingInterest_lbl" xlink:title="label: TaxEffectOnSaleOfNoncontrollingInterest to usph_TaxEffectOnSaleOfNoncontrollingInterest_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_TaxEffectOnSaleOfNoncontrollingInterest_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_TaxEffectOnSaleOfNoncontrollingInterest_lbl1" xml:lang="en-US" id="usph_TaxEffectOnSaleOfNoncontrollingInterest_lbl1">Tax Effect on Sale of Noncontrolling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TaxEffectOnSaleOfNoncontrollingInterest" xlink:to="usph_TaxEffectOnSaleOfNoncontrollingInterest_lbl1" xlink:title="label: TaxEffectOnSaleOfNoncontrollingInterest to usph_TaxEffectOnSaleOfNoncontrollingInterest_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_TaxEffectOnSaleOfNoncontrollingInterest_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_TaxEffectOnSaleOfNoncontrollingInterest_lbl2" xml:lang="en-US" id="usph_TaxEffectOnSaleOfNoncontrollingInterest_lbl2">Tax effect on sale price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TaxEffectOnSaleOfNoncontrollingInterest" xlink:to="usph_TaxEffectOnSaleOfNoncontrollingInterest_lbl2" xlink:title="label: TaxEffectOnSaleOfNoncontrollingInterest to usph_TaxEffectOnSaleOfNoncontrollingInterest_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_AggregateSalePriceOfCinics" xlink:label="AggregateSalePriceOfCinics" xlink:title="AggregateSalePriceOfCinics" />
    <link:label xlink:type="resource" xlink:label="usph_AggregateSalePriceOfCinics_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_AggregateSalePriceOfCinics_lbl" xml:lang="en-US" id="usph_AggregateSalePriceOfCinics_lbl">Sale price of the clinics sold which were discontinued.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AggregateSalePriceOfCinics" xlink:to="usph_AggregateSalePriceOfCinics_lbl" xlink:title="label: AggregateSalePriceOfCinics to usph_AggregateSalePriceOfCinics_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_AggregateSalePriceOfCinics_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_AggregateSalePriceOfCinics_lbl1" xml:lang="en-US" id="usph_AggregateSalePriceOfCinics_lbl1">Aggregate Sale Price of Clinics</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AggregateSalePriceOfCinics" xlink:to="usph_AggregateSalePriceOfCinics_lbl1" xlink:title="label: AggregateSalePriceOfCinics to usph_AggregateSalePriceOfCinics_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_AggregateSalePriceOfCinics_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_AggregateSalePriceOfCinics_lbl2" xml:lang="en-US" id="usph_AggregateSalePriceOfCinics_lbl2">Aggregate sale price of clinics</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AggregateSalePriceOfCinics" xlink:to="usph_AggregateSalePriceOfCinics_lbl2" xlink:title="label: AggregateSalePriceOfCinics to usph_AggregateSalePriceOfCinics_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration" xlink:label="NumberOfInstallmentsForNoteReceivableInSaleConsideration" xlink:title="NumberOfInstallmentsForNoteReceivableInSaleConsideration" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration_lbl" xml:lang="en-US" id="usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration_lbl">The number of installments for note receivable in sale consideration.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfInstallmentsForNoteReceivableInSaleConsideration" xlink:to="usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration_lbl" xlink:title="label: NumberOfInstallmentsForNoteReceivableInSaleConsideration to usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration_lbl1" xml:lang="en-US" id="usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration_lbl1">Number of Installments for Note Receivable in Sale Consideration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfInstallmentsForNoteReceivableInSaleConsideration" xlink:to="usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration_lbl1" xlink:title="label: NumberOfInstallmentsForNoteReceivableInSaleConsideration to usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration_lbl2" xml:lang="en-US" id="usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration_lbl2">Number of installments for note receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfInstallmentsForNoteReceivableInSaleConsideration" xlink:to="usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration_lbl2" xlink:title="label: NumberOfInstallmentsForNoteReceivableInSaleConsideration to usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration_lbl2" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration_lbl3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration_lbl3" xml:lang="en-US" id="usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration_lbl3">Number of installments for note receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfInstallmentsForNoteReceivableInSaleConsideration" xlink:to="usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration_lbl3" xlink:title="label: NumberOfInstallmentsForNoteReceivableInSaleConsideration to usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration_lbl3" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_SaleOfNoncontrollingInterestPercentageInPartnershipOne" xlink:label="SaleOfNoncontrollingInterestPercentageInPartnershipOne" xlink:title="SaleOfNoncontrollingInterestPercentageInPartnershipOne" />
    <link:label xlink:type="resource" xlink:label="usph_SaleOfNoncontrollingInterestPercentageInPartnershipOne_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_SaleOfNoncontrollingInterestPercentageInPartnershipOne_lbl" xml:lang="en-US" id="usph_SaleOfNoncontrollingInterestPercentageInPartnershipOne_lbl">Refers to noncontrolling percentage sold by an entity during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfNoncontrollingInterestPercentageInPartnershipOne" xlink:to="usph_SaleOfNoncontrollingInterestPercentageInPartnershipOne_lbl" xlink:title="label: SaleOfNoncontrollingInterestPercentageInPartnershipOne to usph_SaleOfNoncontrollingInterestPercentageInPartnershipOne_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_SaleOfNoncontrollingInterestPercentageInPartnershipOne_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_SaleOfNoncontrollingInterestPercentageInPartnershipOne_lbl1" xml:lang="en-US" id="usph_SaleOfNoncontrollingInterestPercentageInPartnershipOne_lbl1">Sale of Noncontrolling Interest Percentage in Partnership One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfNoncontrollingInterestPercentageInPartnershipOne" xlink:to="usph_SaleOfNoncontrollingInterestPercentageInPartnershipOne_lbl1" xlink:title="label: SaleOfNoncontrollingInterestPercentageInPartnershipOne to usph_SaleOfNoncontrollingInterestPercentageInPartnershipOne_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_SaleOfNoncontrollingInterestPercentageInPartnershipOne_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_SaleOfNoncontrollingInterestPercentageInPartnershipOne_lbl2" xml:lang="en-US" id="usph_SaleOfNoncontrollingInterestPercentageInPartnershipOne_lbl2">Sale of non-controlling interest percentage in partnership one</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfNoncontrollingInterestPercentageInPartnershipOne" xlink:to="usph_SaleOfNoncontrollingInterestPercentageInPartnershipOne_lbl2" xlink:title="label: SaleOfNoncontrollingInterestPercentageInPartnershipOne to usph_SaleOfNoncontrollingInterestPercentageInPartnershipOne_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_CashReceivedRelatedToSaleOfClinics" xlink:label="CashReceivedRelatedToSaleOfClinics" xlink:title="CashReceivedRelatedToSaleOfClinics" />
    <link:label xlink:type="resource" xlink:label="usph_CashReceivedRelatedToSaleOfClinics_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_CashReceivedRelatedToSaleOfClinics_lbl" xml:lang="en-US" id="usph_CashReceivedRelatedToSaleOfClinics_lbl">Cash received related to sale of discontinued clinics.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashReceivedRelatedToSaleOfClinics" xlink:to="usph_CashReceivedRelatedToSaleOfClinics_lbl" xlink:title="label: CashReceivedRelatedToSaleOfClinics to usph_CashReceivedRelatedToSaleOfClinics_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_CashReceivedRelatedToSaleOfClinics_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_CashReceivedRelatedToSaleOfClinics_lbl1" xml:lang="en-US" id="usph_CashReceivedRelatedToSaleOfClinics_lbl1">Cash Received Related to Sale of Clinics</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashReceivedRelatedToSaleOfClinics" xlink:to="usph_CashReceivedRelatedToSaleOfClinics_lbl1" xlink:title="label: CashReceivedRelatedToSaleOfClinics to usph_CashReceivedRelatedToSaleOfClinics_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_CashReceivedRelatedToSaleOfClinics_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_CashReceivedRelatedToSaleOfClinics_lbl2" xml:lang="en-US" id="usph_CashReceivedRelatedToSaleOfClinics_lbl2">Cash received related to sale of closed clinics</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashReceivedRelatedToSaleOfClinics" xlink:to="usph_CashReceivedRelatedToSaleOfClinics_lbl2" xlink:title="label: CashReceivedRelatedToSaleOfClinics to usph_CashReceivedRelatedToSaleOfClinics_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" xlink:label="DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" />
    <link:label xlink:type="resource" xlink:label="usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity_lbl" xml:lang="en-US" id="usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity_lbl">The amount of reduction in notes receivable from sale of redeemable non-controlling interest attributable to temporary equity interest.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" xlink:to="usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity_lbl" xlink:title="label: DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity to usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity_lbl1" xml:lang="en-US" id="usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity_lbl1">Decrease in Note Receivable form sales of redeemable non-controlling interest - temporary equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" xlink:to="usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity_lbl1" xlink:title="label: DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity to usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity_lbl2" xml:lang="en-US" id="usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity_lbl2">Adjustments in notes receivable related to the sales of redeemable non-controlling interest - temporary equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" xlink:to="usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity_lbl2" xlink:title="label: DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity to usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" xlink:label="BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" xlink:title="BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl" xml:lang="en-US" id="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl">Refers to the percentage of general partnership interest acquired in the business combination.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" xlink:to="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl" xlink:title="label: BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired to usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl1" xml:lang="en-US" id="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl1">Business Acquisition, Percentage of General Partnership Interest Acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" xlink:to="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl1" xlink:title="label: BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired to usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl2" xml:lang="en-US" id="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl2">Business acquisition, percentage of general partnership interest acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" xlink:to="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl2" xlink:title="label: BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired to usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:label="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:title="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" />
    <link:label xlink:type="resource" xlink:label="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl" xml:lang="en-US" id="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl">Refers to amount of contractual time period had lapsed but holder's employment had not been terminated as of balance sheet date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:to="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl" xlink:title="label: ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated to usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl1" xml:lang="en-US" id="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl1">Contractual Time Period Has Lapsed But Holders Employment Has Not Been Terminated</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:to="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl1" xlink:title="label: ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated to usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl2" xml:lang="en-US" id="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl2">Contractual time period has lapsed but holder's employment has not been terminated</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:to="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl2" xlink:title="label: ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated to usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_TherapyPracticeMember" xlink:label="TherapyPracticeMember" xlink:title="TherapyPracticeMember" />
    <link:label xlink:type="resource" xlink:label="usph_TherapyPracticeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_TherapyPracticeMember_lbl" xml:lang="en-US" id="usph_TherapyPracticeMember_lbl">Refers to the acquiree entity Therapy Practice.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TherapyPracticeMember" xlink:to="usph_TherapyPracticeMember_lbl" xlink:title="label: TherapyPracticeMember to usph_TherapyPracticeMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_TherapyPracticeMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_TherapyPracticeMember_lbl1" xml:lang="en-US" id="usph_TherapyPracticeMember_lbl1">Therapy Practice [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TherapyPracticeMember" xlink:to="usph_TherapyPracticeMember_lbl1" xlink:title="label: TherapyPracticeMember to usph_TherapyPracticeMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_TherapyPracticeMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_TherapyPracticeMember_lbl2" xml:lang="en-US" id="usph_TherapyPracticeMember_lbl2">Therapy Practice [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TherapyPracticeMember" xlink:to="usph_TherapyPracticeMember_lbl2" xlink:title="label: TherapyPracticeMember to usph_TherapyPracticeMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:label="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:title="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" />
    <link:label xlink:type="resource" xlink:label="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl" xml:lang="en-US" id="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl">Refers to amount of contractual time period had not lapsed and holder's employment had not been terminated as of balance sheet date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:to="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl" xlink:title="label: ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated to usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl1" xml:lang="en-US" id="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl1">Contractual Time Period Has Not Lapsed And Holders Employment Has Not Been Terminated</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:to="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl1" xlink:title="label: ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated to usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl2" xml:lang="en-US" id="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl2">Contractual time period has not lapsed and holder's employment has not been terminated</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:to="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl2" xlink:title="label: ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated to usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_EmploymentAgreementRenewalTerm" xlink:label="EmploymentAgreementRenewalTerm" xlink:title="EmploymentAgreementRenewalTerm" />
    <link:label xlink:type="resource" xlink:label="usph_EmploymentAgreementRenewalTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_EmploymentAgreementRenewalTerm_lbl" xml:lang="en-US" id="usph_EmploymentAgreementRenewalTerm_lbl">Refers to the renewal term of the employment agreement with the subsidiary entity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmploymentAgreementRenewalTerm" xlink:to="usph_EmploymentAgreementRenewalTerm_lbl" xlink:title="label: EmploymentAgreementRenewalTerm to usph_EmploymentAgreementRenewalTerm_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_EmploymentAgreementRenewalTerm_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_EmploymentAgreementRenewalTerm_lbl1" xml:lang="en-US" id="usph_EmploymentAgreementRenewalTerm_lbl1">Employment Agreement Renewal Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmploymentAgreementRenewalTerm" xlink:to="usph_EmploymentAgreementRenewalTerm_lbl1" xlink:title="label: EmploymentAgreementRenewalTerm to usph_EmploymentAgreementRenewalTerm_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_EmploymentAgreementRenewalTerm_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_EmploymentAgreementRenewalTerm_lbl2" xml:lang="en-US" id="usph_EmploymentAgreementRenewalTerm_lbl2">Employment agreement renewal term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmploymentAgreementRenewalTerm" xlink:to="usph_EmploymentAgreementRenewalTerm_lbl2" xlink:title="label: EmploymentAgreementRenewalTerm to usph_EmploymentAgreementRenewalTerm_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:label="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:title="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" />
    <link:label xlink:type="resource" xlink:label="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl" xml:lang="en-US" id="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl">Amount of Net Income (Loss) attributable to redeemable noncontrolling interest temporary equity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:to="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl" xlink:title="label: NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity to usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl1" xml:lang="en-US" id="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl1">Net Income Loss Attributable To Redeemable Noncontrolling Interest temporary Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:to="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl1" xlink:title="label: NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity to usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl2" xml:lang="en-US" id="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl2">Redeemable non-controlling interests - temporary equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:to="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl2" xlink:title="label: NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity to usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl2" />
    <link:label xlink:type="resource" xlink:label="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl3" xml:lang="en-US" id="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl3">Operating results allocated to redeemable non-controlling interest partners</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:to="usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl3" xlink:title="label: NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity to usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity_lbl3" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_RedeemableNonControllingInterestMember" xlink:label="RedeemableNonControllingInterestMember" xlink:title="RedeemableNonControllingInterestMember" />
    <link:label xlink:type="resource" xlink:label="usph_RedeemableNonControllingInterestMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_RedeemableNonControllingInterestMember_lbl" xml:lang="en-US" id="usph_RedeemableNonControllingInterestMember_lbl">Represents the upper bound of a range for the estimate of fair value as of the reporting date of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNonControllingInterestMember" xlink:to="usph_RedeemableNonControllingInterestMember_lbl" xlink:title="label: RedeemableNonControllingInterestMember to usph_RedeemableNonControllingInterestMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_RedeemableNonControllingInterestMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_RedeemableNonControllingInterestMember_lbl1" xml:lang="en-US" id="usph_RedeemableNonControllingInterestMember_lbl1">Redeemable Non-Controlling Interest [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNonControllingInterestMember" xlink:to="usph_RedeemableNonControllingInterestMember_lbl1" xlink:title="label: RedeemableNonControllingInterestMember to usph_RedeemableNonControllingInterestMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_RedeemableNonControllingInterestMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_RedeemableNonControllingInterestMember_lbl2" xml:lang="en-US" id="usph_RedeemableNonControllingInterestMember_lbl2">Redeemable Non-Controlling Interest [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNonControllingInterestMember" xlink:to="usph_RedeemableNonControllingInterestMember_lbl2" xlink:title="label: RedeemableNonControllingInterestMember to usph_RedeemableNonControllingInterestMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_BusinessAcquisitionConsiderationPayableTermOfNote" xlink:label="BusinessAcquisitionConsiderationPayableTermOfNote" xlink:title="BusinessAcquisitionConsiderationPayableTermOfNote" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl" xml:lang="en-US" id="usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl">Refers to the term of the note issued for consideration payable for the acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionConsiderationPayableTermOfNote" xlink:to="usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl" xlink:title="label: BusinessAcquisitionConsiderationPayableTermOfNote to usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl1" xml:lang="en-US" id="usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl1">Business Acquisition Consideration Payable, Term of Note</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionConsiderationPayableTermOfNote" xlink:to="usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl1" xlink:title="label: BusinessAcquisitionConsiderationPayableTermOfNote to usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl2" xml:lang="en-US" id="usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl2">Business acquisition, consideration payable, term of note</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionConsiderationPayableTermOfNote" xlink:to="usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl2" xlink:title="label: BusinessAcquisitionConsiderationPayableTermOfNote to usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:label="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:title="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" />
    <link:label xlink:type="resource" xlink:label="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl" xml:lang="en-US" id="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl">Refers to holder's employment has terminated and contractual time period has not expired.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:to="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl" xlink:title="label: HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired to usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl1" xml:lang="en-US" id="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl1">Holders Employment Has Terminated and Contractual Time Period Has Not Expired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:to="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl1" xlink:title="label: HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired to usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl2" xml:lang="en-US" id="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl2">Holder's employment has terminated and contractual time period has not expired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:to="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl2" xlink:title="label: HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired to usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" xlink:label="NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" xlink:title="NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" />
    <link:label xlink:type="resource" xlink:label="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl" xml:lang="en-US" id="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl">Refers to the term of non-compete agreement under the condition if an Employed Selling Shareholders' employment is terminated (if the Selling Shareholder becomes an Employed Selling Shareholder).</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" xlink:to="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl" xlink:title="label: NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder to usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl1" xml:lang="en-US" id="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl1">Non-Compete Agreement Term under Condition of Termination of Employment of Employed Selling Shareholder</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" xlink:to="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl1" xlink:title="label: NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder to usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl2" xml:lang="en-US" id="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl2">Non-Compete agreement term under condition of termination of employment of employed selling shareholder</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" xlink:to="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl2" xlink:title="label: NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder to usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:label="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:title="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" />
    <link:label xlink:type="resource" xlink:label="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl" xml:lang="en-US" id="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl">Refers to holder's employment has terminated and contractual time period has expired.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:to="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl" xlink:title="label: HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired to usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl1" xml:lang="en-US" id="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl1">Holders Employment Has Terminated and Contractual Time Period Has Expired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:to="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl1" xlink:title="label: HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired to usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl2" xml:lang="en-US" id="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl2">Holder's employment has terminated and contractual time period has expired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:to="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl2" xlink:title="label: HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired to usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:label="CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:title="CarryingAmountOfRedeemableNonControllingInterestAbstract" />
    <link:label xlink:type="resource" xlink:label="usph_CarryingAmountOfRedeemableNonControllingInterestAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_CarryingAmountOfRedeemableNonControllingInterestAbstract_lbl1" xml:lang="en-US" id="usph_CarryingAmountOfRedeemableNonControllingInterestAbstract_lbl1">Carrying Amount of Redeemable Non-Controlling Interest [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:to="usph_CarryingAmountOfRedeemableNonControllingInterestAbstract_lbl1" xlink:title="label: CarryingAmountOfRedeemableNonControllingInterestAbstract to usph_CarryingAmountOfRedeemableNonControllingInterestAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_CarryingAmountOfRedeemableNonControllingInterestAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_CarryingAmountOfRedeemableNonControllingInterestAbstract_lbl2" xml:lang="en-US" id="usph_CarryingAmountOfRedeemableNonControllingInterestAbstract_lbl2">Carrying Amount (Fair Value) of Redeemable Non-Controlling Interest [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:to="usph_CarryingAmountOfRedeemableNonControllingInterestAbstract_lbl2" xlink:title="label: CarryingAmountOfRedeemableNonControllingInterestAbstract to usph_CarryingAmountOfRedeemableNonControllingInterestAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:label="NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" />
    <link:label xlink:type="resource" xlink:label="usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl" xml:lang="en-US" id="usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl">The amount of notes receivable from sale of redeemable non-controlling interest attributable to temporary equity interest.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:to="usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl" xlink:title="label: NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity to usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl1" xml:lang="en-US" id="usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl1">Notes Receivable Related to Sale of Redeemable Non-controlling Interest Temporary Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:to="usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl1" xlink:title="label: NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity to usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl2" xml:lang="en-US" id="usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl2">Notes receivable related to sales of redeemable non-controlling interest - temporary equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:to="usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl2" xlink:title="label: NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity to usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:label="ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" />
    <link:label xlink:type="resource" xlink:label="usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl" xml:lang="en-US" id="usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl">The cash inflow associated with the sale of redeemable non-controlling interest attributable to temporary equity interest.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:to="usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl" xlink:title="label: ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity to usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl1" xml:lang="en-US" id="usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl1">Proceeds from Sale of Redeemable Non-controlling Interest Temporary Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:to="usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl1" xlink:title="label: ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity to usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl2" xml:lang="en-US" id="usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl2">Sales of redeemable non-controlling interest - temporary equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:to="usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl2" xlink:title="label: ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity to usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" xlink:label="DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" xlink:title="DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" />
    <link:label xlink:type="resource" xlink:label="usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests_lbl" xml:lang="en-US" id="usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests_lbl">The distributions during the period for redemption of mandatorily redeemable noncontrolling interests.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" xlink:to="usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests_lbl" xlink:title="label: DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests to usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests_lbl1" xml:lang="en-US" id="usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests_lbl1">Distributions to Limited Partners and Redeemable Noncontrolling Interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" xlink:to="usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests_lbl1" xlink:title="label: DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests to usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests_lbl2" xml:lang="en-US" id="usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests_lbl2">Distributions to redeemable non-controlling interest partners</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" xlink:to="usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests_lbl2" xlink:title="label: DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests to usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" xlink:label="BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" xlink:title="BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl" xml:lang="en-US" id="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl">Refers to the percentage of equity interest in subsidiary contributed for acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" xlink:to="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl" xlink:title="label: BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed to usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl1" xml:lang="en-US" id="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl1">Business Acquisition Percentage Of Equity Interest In Subsidiary Contributed</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" xlink:to="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl1" xlink:title="label: BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed to usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl2" xml:lang="en-US" id="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl2">Percentage of equity interest of subsidiary contributed for acquisition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" xlink:to="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl2" xlink:title="label: BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed to usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_TermOfEmploymentAgreement" xlink:label="TermOfEmploymentAgreement" xlink:title="TermOfEmploymentAgreement" />
    <link:label xlink:type="resource" xlink:label="usph_TermOfEmploymentAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_TermOfEmploymentAgreement_lbl" xml:lang="en-US" id="usph_TermOfEmploymentAgreement_lbl">Refers to the term of employment agreement with the subsidiary entity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TermOfEmploymentAgreement" xlink:to="usph_TermOfEmploymentAgreement_lbl" xlink:title="label: TermOfEmploymentAgreement to usph_TermOfEmploymentAgreement_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_TermOfEmploymentAgreement_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_TermOfEmploymentAgreement_lbl1" xml:lang="en-US" id="usph_TermOfEmploymentAgreement_lbl1">Term of Employment Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TermOfEmploymentAgreement" xlink:to="usph_TermOfEmploymentAgreement_lbl1" xlink:title="label: TermOfEmploymentAgreement to usph_TermOfEmploymentAgreement_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_TermOfEmploymentAgreement_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_TermOfEmploymentAgreement_lbl2" xml:lang="en-US" id="usph_TermOfEmploymentAgreement_lbl2">Employment agreement term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TermOfEmploymentAgreement" xlink:to="usph_TermOfEmploymentAgreement_lbl2" xlink:title="label: TermOfEmploymentAgreement to usph_TermOfEmploymentAgreement_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" xlink:label="BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" xlink:title="BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl" xml:lang="en-US" id="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl">Refers to the percentage of limited partnership interest acquired in the business combination.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" xlink:to="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl" xlink:title="label: BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired to usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl1" xml:lang="en-US" id="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl1">Business Acquisition, Percentage of Limited Partnership Interest Acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" xlink:to="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl1" xlink:title="label: BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired to usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl2" xml:lang="en-US" id="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl2">Business acquisition, percentage of limited partnership acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" xlink:to="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl2" xlink:title="label: BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired to usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NonCompeteAgreementBasicTerm" xlink:label="NonCompeteAgreementBasicTerm" xlink:title="NonCompeteAgreementBasicTerm" />
    <link:label xlink:type="resource" xlink:label="usph_NonCompeteAgreementBasicTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NonCompeteAgreementBasicTerm_lbl" xml:lang="en-US" id="usph_NonCompeteAgreementBasicTerm_lbl">Refers to the term of non-compete agreement regardless of whether the Selling Shareholder is employed by the subsidiary entity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonCompeteAgreementBasicTerm" xlink:to="usph_NonCompeteAgreementBasicTerm_lbl" xlink:title="label: NonCompeteAgreementBasicTerm to usph_NonCompeteAgreementBasicTerm_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NonCompeteAgreementBasicTerm_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NonCompeteAgreementBasicTerm_lbl1" xml:lang="en-US" id="usph_NonCompeteAgreementBasicTerm_lbl1">Non-Compete Agreement Term under Condition Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonCompeteAgreementBasicTerm" xlink:to="usph_NonCompeteAgreementBasicTerm_lbl1" xlink:title="label: NonCompeteAgreementBasicTerm to usph_NonCompeteAgreementBasicTerm_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NonCompeteAgreementBasicTerm_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NonCompeteAgreementBasicTerm_lbl2" xml:lang="en-US" id="usph_NonCompeteAgreementBasicTerm_lbl2">Non-Compete agreement term regardless of whether the selling shareholder is employed</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonCompeteAgreementBasicTerm" xlink:to="usph_NonCompeteAgreementBasicTerm_lbl2" xlink:title="label: NonCompeteAgreementBasicTerm to usph_NonCompeteAgreementBasicTerm_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" xlink:label="RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" xlink:title="RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" />
    <link:label xlink:type="resource" xlink:label="usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares_lbl" xml:lang="en-US" id="usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares_lbl">Number of shares issued during the period related to redeemable non-controlling interest.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" xlink:to="usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares_lbl" xlink:title="label: RevaluationOfRedeemableNonControllingInterestNetOfTaxShares to usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares_lbl1" xml:lang="en-US" id="usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares_lbl1">Revaluation of Redeemable Non-controlling Interest Net of Tax, Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" xlink:to="usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares_lbl1" xlink:title="label: RevaluationOfRedeemableNonControllingInterestNetOfTaxShares to usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares_lbl2" xml:lang="en-US" id="usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares_lbl2">Revaluation of redeemable non-controlling interest, net of tax (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" xlink:to="usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares_lbl2" xlink:title="label: RevaluationOfRedeemableNonControllingInterestNetOfTaxShares to usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:label="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:title="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" />
    <link:label xlink:type="resource" xlink:label="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl" xml:lang="en-US" id="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl">Amount of Net Income (Loss) attributable to noncontrolling interest permanent equity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:to="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl" xlink:title="label: NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity to usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl1" xml:lang="en-US" id="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl1">Net Income Loss Attributable To Noncontrolling Interest, Permanent Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:to="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl1" xlink:title="label: NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity to usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl2" xml:lang="en-US" id="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl2">Net income attributable to non-controlling interest - permanent equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:to="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl2" xlink:title="label: NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity to usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl2" />
    <link:label xlink:type="resource" xlink:label="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl3" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl3" xml:lang="en-US" id="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl3">Non-controlling interests - permanent equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:to="usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl3" xlink:title="label: NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity to usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity_lbl3" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_RevaluationOfRedeemableNonControllingInterestNetOfTax" xlink:label="RevaluationOfRedeemableNonControllingInterestNetOfTax" xlink:title="RevaluationOfRedeemableNonControllingInterestNetOfTax" />
    <link:label xlink:type="resource" xlink:label="usph_RevaluationOfRedeemableNonControllingInterestNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_RevaluationOfRedeemableNonControllingInterestNetOfTax_lbl" xml:lang="en-US" id="usph_RevaluationOfRedeemableNonControllingInterestNetOfTax_lbl">Amount of distributions during the period on mandatorily redeemable securities net of tax.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevaluationOfRedeemableNonControllingInterestNetOfTax" xlink:to="usph_RevaluationOfRedeemableNonControllingInterestNetOfTax_lbl" xlink:title="label: RevaluationOfRedeemableNonControllingInterestNetOfTax to usph_RevaluationOfRedeemableNonControllingInterestNetOfTax_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_RevaluationOfRedeemableNonControllingInterestNetOfTax_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_RevaluationOfRedeemableNonControllingInterestNetOfTax_lbl1" xml:lang="en-US" id="usph_RevaluationOfRedeemableNonControllingInterestNetOfTax_lbl1">Revaluation of Redeemable Non-controlling Interest Net of Tax</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevaluationOfRedeemableNonControllingInterestNetOfTax" xlink:to="usph_RevaluationOfRedeemableNonControllingInterestNetOfTax_lbl1" xlink:title="label: RevaluationOfRedeemableNonControllingInterestNetOfTax to usph_RevaluationOfRedeemableNonControllingInterestNetOfTax_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_RevaluationOfRedeemableNonControllingInterestNetOfTax_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_RevaluationOfRedeemableNonControllingInterestNetOfTax_lbl2" xml:lang="en-US" id="usph_RevaluationOfRedeemableNonControllingInterestNetOfTax_lbl2">Revaluation of redeemable non-controlling interest, net of tax</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevaluationOfRedeemableNonControllingInterestNetOfTax" xlink:to="usph_RevaluationOfRedeemableNonControllingInterestNetOfTax_lbl2" xlink:title="label: RevaluationOfRedeemableNonControllingInterestNetOfTax to usph_RevaluationOfRedeemableNonControllingInterestNetOfTax_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_SaleOfNonControllingInterestNetOfTaxAndPurchases" xlink:label="SaleOfNonControllingInterestNetOfTaxAndPurchases" xlink:title="SaleOfNonControllingInterestNetOfTaxAndPurchases" />
    <link:label xlink:type="resource" xlink:label="usph_SaleOfNonControllingInterestNetOfTaxAndPurchases_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_SaleOfNonControllingInterestNetOfTaxAndPurchases_lbl" xml:lang="en-US" id="usph_SaleOfNonControllingInterestNetOfTaxAndPurchases_lbl">Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest or decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfNonControllingInterestNetOfTaxAndPurchases" xlink:to="usph_SaleOfNonControllingInterestNetOfTaxAndPurchases_lbl" xlink:title="label: SaleOfNonControllingInterestNetOfTaxAndPurchases to usph_SaleOfNonControllingInterestNetOfTaxAndPurchases_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_SaleOfNonControllingInterestNetOfTaxAndPurchases_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_SaleOfNonControllingInterestNetOfTaxAndPurchases_lbl1" xml:lang="en-US" id="usph_SaleOfNonControllingInterestNetOfTaxAndPurchases_lbl1">Sale of non-controlling interest, net of tax and purchases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfNonControllingInterestNetOfTaxAndPurchases" xlink:to="usph_SaleOfNonControllingInterestNetOfTaxAndPurchases_lbl1" xlink:title="label: SaleOfNonControllingInterestNetOfTaxAndPurchases to usph_SaleOfNonControllingInterestNetOfTaxAndPurchases_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_SaleOfNonControllingInterestNetOfTaxAndPurchases_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_SaleOfNonControllingInterestNetOfTaxAndPurchases_lbl2" xml:lang="en-US" id="usph_SaleOfNonControllingInterestNetOfTaxAndPurchases_lbl2">Sale of non-controlling interest, net of purchases and tax</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfNonControllingInterestNetOfTaxAndPurchases" xlink:to="usph_SaleOfNonControllingInterestNetOfTaxAndPurchases_lbl2" xlink:title="label: SaleOfNonControllingInterestNetOfTaxAndPurchases to usph_SaleOfNonControllingInterestNetOfTaxAndPurchases_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" xlink:label="TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" xlink:title="TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" />
    <link:label xlink:type="resource" xlink:label="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl" xml:lang="en-US" id="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl">Refers to transfer of compensation liability for certain stock issued pursuant to incentive plans.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" xlink:to="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl" xlink:title="label: TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans to usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl1" xml:lang="en-US" id="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl1">Transfer Of Compensation Liability For Certain Stock Issued Pursuant To Incentive Plans</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" xlink:to="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl1" xlink:title="label: TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans to usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl2" xml:lang="en-US" id="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl2">Transfer of compensation liability for certain stock issued pursuant to long-term incentive plans</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" xlink:to="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl2" xlink:title="label: TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans to usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PurchaseOfPartnershipInterestsRedeemableNonControllingInterests" xlink:label="PurchaseOfPartnershipInterestsRedeemableNonControllingInterests" xlink:title="PurchaseOfPartnershipInterestsRedeemableNonControllingInterests" />
    <link:label xlink:type="resource" xlink:label="usph_PurchaseOfPartnershipInterestsRedeemableNonControllingInterests_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PurchaseOfPartnershipInterestsRedeemableNonControllingInterests_lbl" xml:lang="en-US" id="usph_PurchaseOfPartnershipInterestsRedeemableNonControllingInterests_lbl">Decrease in redeemable noncontrolling interest through purchasing of interests from noncontrolling shareholders.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PurchaseOfPartnershipInterestsRedeemableNonControllingInterests" xlink:to="usph_PurchaseOfPartnershipInterestsRedeemableNonControllingInterests_lbl" xlink:title="label: PurchaseOfPartnershipInterestsRedeemableNonControllingInterests to usph_PurchaseOfPartnershipInterestsRedeemableNonControllingInterests_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PurchaseOfPartnershipInterestsRedeemableNonControllingInterests_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PurchaseOfPartnershipInterestsRedeemableNonControllingInterests_lbl1" xml:lang="en-US" id="usph_PurchaseOfPartnershipInterestsRedeemableNonControllingInterests_lbl1">Purchase of partnership interests - redeemable non-controlling interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PurchaseOfPartnershipInterestsRedeemableNonControllingInterests" xlink:to="usph_PurchaseOfPartnershipInterestsRedeemableNonControllingInterests_lbl1" xlink:title="label: PurchaseOfPartnershipInterestsRedeemableNonControllingInterests to usph_PurchaseOfPartnershipInterestsRedeemableNonControllingInterests_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock" xlink:label="ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock" xlink:title="ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock_lbl" xml:lang="en-US" id="usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock_lbl">Tabular disclosure of business combination completed within the physical therapy operations segment during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock" xlink:to="usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock_lbl" xlink:title="label: ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock to usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock_lbl1" xml:lang="en-US" id="usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock_lbl1">Schedule of Business Acquisitions Within Physical Therapy Operations Segment [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock" xlink:to="usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock_lbl1" xlink:title="label: ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock to usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock_lbl2" xml:lang="en-US" id="usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock_lbl2">Acquisitions Within Physical Therapy Operations Segment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock" xlink:to="usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock_lbl2" xlink:title="label: ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock to usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_RedeemableNonControllingInterestTextBlock" xlink:label="RedeemableNonControllingInterestTextBlock" xlink:title="RedeemableNonControllingInterestTextBlock" />
    <link:label xlink:type="resource" xlink:label="usph_RedeemableNonControllingInterestTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_RedeemableNonControllingInterestTextBlock_lbl" xml:lang="en-US" id="usph_RedeemableNonControllingInterestTextBlock_lbl">The entire disclosure for a redeemable non-controlling interest.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNonControllingInterestTextBlock" xlink:to="usph_RedeemableNonControllingInterestTextBlock_lbl" xlink:title="label: RedeemableNonControllingInterestTextBlock to usph_RedeemableNonControllingInterestTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_RedeemableNonControllingInterestTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_RedeemableNonControllingInterestTextBlock_lbl1" xml:lang="en-US" id="usph_RedeemableNonControllingInterestTextBlock_lbl1">Redeemable Non-Controlling Interest [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNonControllingInterestTextBlock" xlink:to="usph_RedeemableNonControllingInterestTextBlock_lbl1" xlink:title="label: RedeemableNonControllingInterestTextBlock to usph_RedeemableNonControllingInterestTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_RedeemableNonControllingInterestTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_RedeemableNonControllingInterestTextBlock_lbl2" xml:lang="en-US" id="usph_RedeemableNonControllingInterestTextBlock_lbl2">Redeemable Non-Controlling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNonControllingInterestTextBlock" xlink:to="usph_RedeemableNonControllingInterestTextBlock_lbl2" xlink:title="label: RedeemableNonControllingInterestTextBlock to usph_RedeemableNonControllingInterestTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_RedeemableNonControllingInterestAbstract" xlink:label="RedeemableNonControllingInterestAbstract" xlink:title="RedeemableNonControllingInterestAbstract" />
    <link:label xlink:type="resource" xlink:label="usph_RedeemableNonControllingInterestAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_RedeemableNonControllingInterestAbstract_lbl1" xml:lang="en-US" id="usph_RedeemableNonControllingInterestAbstract_lbl1">Redeemable Non-Controlling Interest [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNonControllingInterestAbstract" xlink:to="usph_RedeemableNonControllingInterestAbstract_lbl1" xlink:title="label: RedeemableNonControllingInterestAbstract to usph_RedeemableNonControllingInterestAbstract_lbl1" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>usph-20201231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 7.0.0.0 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://usph.com/role/ScheduleIiValuationAndQualifyingAccountsDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#ScheduleIiValuationAndQualifyingAccountsDetails" />
  <link:roleRef roleURI="http://usph.com/role/EarningsPerShareDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#EarningsPerShareDetails" />
  <link:roleRef roleURI="http://usph.com/role/CommitmentsAndContingenciesDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#CommitmentsAndContingenciesDetails" />
  <link:roleRef roleURI="http://usph.com/role/DefinedContributionPlanDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#DefinedContributionPlanDetails" />
  <link:roleRef roleURI="http://usph.com/role/CommonStockDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#CommonStockDetails" />
  <link:roleRef roleURI="http://usph.com/role/EquityBasedPlansDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#EquityBasedPlansDetails" />
  <link:roleRef roleURI="http://usph.com/role/EquityBasedPlansRestrictedStockCancelledDueToEmployeeTerminationsPriorToRestrictionsLapsingDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#EquityBasedPlansRestrictedStockCancelledDueToEmployeeTerminationsPriorToRestrictionsLapsingDetails" />
  <link:roleRef roleURI="http://usph.com/role/EquityBasedPlansRestrictedStockGrantedToDirectorsOfficersAndEmployeesPursuantToItsEquityPlansDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#EquityBasedPlansRestrictedStockGrantedToDirectorsOfficersAndEmployeesPursuantToItsEquityPlansDetails" />
  <link:roleRef roleURI="http://usph.com/role/EquityBasedPlansCumulativeSummaryOfEquityPlansDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#EquityBasedPlansCumulativeSummaryOfEquityPlansDetails" />
  <link:roleRef roleURI="http://usph.com/role/EquityBasedPlansAmendedAndRestatedEmployeeStockOptionPlansDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#EquityBasedPlansAmendedAndRestatedEmployeeStockOptionPlansDetails" />
  <link:roleRef roleURI="http://usph.com/role/SegmentInformationDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#SegmentInformationDetails" />
  <link:roleRef roleURI="http://usph.com/role/IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails" />
  <link:roleRef roleURI="http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails" />
  <link:roleRef roleURI="http://usph.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#IncomeTaxesDetails" />
  <link:roleRef roleURI="http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails" />
  <link:roleRef roleURI="http://usph.com/role/LeasesDetailsCalc01" xlink:type="simple" xlink:href="usph-20201231.xsd#LeasesDetailsCalc01" />
  <link:roleRef roleURI="http://usph.com/role/LeasesDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#LeasesDetails" />
  <link:roleRef roleURI="http://usph.com/role/NotesPayableDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#NotesPayableDetails" />
  <link:roleRef roleURI="http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#NotesPayableSummaryOfNotesPayableDetails" />
  <link:roleRef roleURI="http://usph.com/role/AccruedExpensesDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#AccruedExpensesDetails" />
  <link:roleRef roleURI="http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails" />
  <link:roleRef roleURI="http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#IntangibleAssetsNetAmortizationExpensesDetails" />
  <link:roleRef roleURI="http://usph.com/role/IntangibleAssetsNetDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#IntangibleAssetsNetDetails" />
  <link:roleRef roleURI="http://usph.com/role/GoodwillDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#GoodwillDetails" />
  <link:roleRef roleURI="http://usph.com/role/RedeemableNoncontrollingInterestDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#RedeemableNoncontrollingInterestDetails" />
  <link:roleRef roleURI="http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#AcquisitionsAndSaleOfNoncontrollingInterestsDetails" />
  <link:roleRef roleURI="http://usph.com/role/AcquisitionsOfBusinessesDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#AcquisitionsOfBusinessesDetails" />
  <link:roleRef roleURI="http://usph.com/role/SignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#SignificantAccountingPoliciesDetails" />
  <link:roleRef roleURI="http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails" />
  <link:roleRef roleURI="http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails" xlink:type="simple" xlink:href="usph-20201231.xsd#OrganizationNatureOfOperationsAndBasisOfPresentationDetails" />
  <link:roleRef roleURI="http://usph.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="usph-20201231.xsd#EarningsPerShareTables" />
  <link:roleRef roleURI="http://usph.com/role/EquityBasedPlansTables" xlink:type="simple" xlink:href="usph-20201231.xsd#EquityBasedPlansTables" />
  <link:roleRef roleURI="http://usph.com/role/SegmentInformationTables" xlink:type="simple" xlink:href="usph-20201231.xsd#SegmentInformationTables" />
  <link:roleRef roleURI="http://usph.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="usph-20201231.xsd#IncomeTaxesTables" />
  <link:roleRef roleURI="http://usph.com/role/LeasesTables" xlink:type="simple" xlink:href="usph-20201231.xsd#LeasesTables" />
  <link:roleRef roleURI="http://usph.com/role/NotesPayableTables" xlink:type="simple" xlink:href="usph-20201231.xsd#NotesPayableTables" />
  <link:roleRef roleURI="http://usph.com/role/AccruedExpensesTables" xlink:type="simple" xlink:href="usph-20201231.xsd#AccruedExpensesTables" />
  <link:roleRef roleURI="http://usph.com/role/IntangibleAssetsNetTables" xlink:type="simple" xlink:href="usph-20201231.xsd#IntangibleAssetsNetTables" />
  <link:roleRef roleURI="http://usph.com/role/GoodwillTables" xlink:type="simple" xlink:href="usph-20201231.xsd#GoodwillTables" />
  <link:roleRef roleURI="http://usph.com/role/RedeemableNoncontrollingInterestTables" xlink:type="simple" xlink:href="usph-20201231.xsd#RedeemableNoncontrollingInterestTables" />
  <link:roleRef roleURI="http://usph.com/role/AcquisitionsOfBusinessesTables" xlink:type="simple" xlink:href="usph-20201231.xsd#AcquisitionsOfBusinessesTables" />
  <link:roleRef roleURI="http://usph.com/role/SignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="usph-20201231.xsd#SignificantAccountingPoliciesTables" />
  <link:roleRef roleURI="http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationTables" xlink:type="simple" xlink:href="usph-20201231.xsd#OrganizationNatureOfOperationsAndBasisOfPresentationTables" />
  <link:roleRef roleURI="http://usph.com/role/SignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="usph-20201231.xsd#SignificantAccountingPoliciesPolicies" />
  <link:roleRef roleURI="http://usph.com/role/ScheduleIiValuationAndQualifyingAccounts" xlink:type="simple" xlink:href="usph-20201231.xsd#ScheduleIiValuationAndQualifyingAccounts" />
  <link:roleRef roleURI="http://usph.com/role/EarningsPerShare" xlink:type="simple" xlink:href="usph-20201231.xsd#EarningsPerShare" />
  <link:roleRef roleURI="http://usph.com/role/CommitmentsAndContingencies" xlink:type="simple" xlink:href="usph-20201231.xsd#CommitmentsAndContingencies" />
  <link:roleRef roleURI="http://usph.com/role/DefinedContributionPlan" xlink:type="simple" xlink:href="usph-20201231.xsd#DefinedContributionPlan" />
  <link:roleRef roleURI="http://usph.com/role/CommonStock" xlink:type="simple" xlink:href="usph-20201231.xsd#CommonStock" />
  <link:roleRef roleURI="http://usph.com/role/PreferredStock" xlink:type="simple" xlink:href="usph-20201231.xsd#PreferredStock" />
  <link:roleRef roleURI="http://usph.com/role/EquityBasedPlans" xlink:type="simple" xlink:href="usph-20201231.xsd#EquityBasedPlans" />
  <link:roleRef roleURI="http://usph.com/role/SegmentInformation" xlink:type="simple" xlink:href="usph-20201231.xsd#SegmentInformation" />
  <link:roleRef roleURI="http://usph.com/role/IncomeTaxes" xlink:type="simple" xlink:href="usph-20201231.xsd#IncomeTaxes" />
  <link:roleRef roleURI="http://usph.com/role/Leases" xlink:type="simple" xlink:href="usph-20201231.xsd#Leases" />
  <link:roleRef roleURI="http://usph.com/role/NotesPayable" xlink:type="simple" xlink:href="usph-20201231.xsd#NotesPayable" />
  <link:roleRef roleURI="http://usph.com/role/AccruedExpenses" xlink:type="simple" xlink:href="usph-20201231.xsd#AccruedExpenses" />
  <link:roleRef roleURI="http://usph.com/role/IntangibleAssetsNet" xlink:type="simple" xlink:href="usph-20201231.xsd#IntangibleAssetsNet" />
  <link:roleRef roleURI="http://usph.com/role/Goodwill" xlink:type="simple" xlink:href="usph-20201231.xsd#Goodwill" />
  <link:roleRef roleURI="http://usph.com/role/RedeemableNoncontrollingInterest" xlink:type="simple" xlink:href="usph-20201231.xsd#RedeemableNoncontrollingInterest" />
  <link:roleRef roleURI="http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterests" xlink:type="simple" xlink:href="usph-20201231.xsd#AcquisitionsAndSaleOfNoncontrollingInterests" />
  <link:roleRef roleURI="http://usph.com/role/AcquisitionsOfBusinesses" xlink:type="simple" xlink:href="usph-20201231.xsd#AcquisitionsOfBusinesses" />
  <link:roleRef roleURI="http://usph.com/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="usph-20201231.xsd#SignificantAccountingPolicies" />
  <link:roleRef roleURI="http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentation" xlink:type="simple" xlink:href="usph-20201231.xsd#OrganizationNatureOfOperationsAndBasisOfPresentation" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="simple" xlink:href="usph-20201231.xsd#ConsolidatedStatementsOfCashFlows" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedStatementsOfChangesInEquity" xlink:type="simple" xlink:href="usph-20201231.xsd#ConsolidatedStatementsOfChangesInEquity" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedStatementsOfIncome" xlink:type="simple" xlink:href="usph-20201231.xsd#ConsolidatedStatementsOfIncome" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="usph-20201231.xsd#ConsolidatedBalanceSheetsParenthetical" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="usph-20201231.xsd#ConsolidatedBalanceSheets" />
  <link:roleRef roleURI="http://usph.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="usph-20201231.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="CurrentFiscalYearEndDate" xlink:title="CurrentFiscalYearEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CurrentFiscalYearEndDate" xlink:title="presentation: CoverAbstract to CurrentFiscalYearEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAnnualReport" xlink:label="DocumentAnnualReport" xlink:title="DocumentAnnualReport" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentAnnualReport" xlink:title="presentation: CoverAbstract to DocumentAnnualReport" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport" xlink:label="DocumentTransitionReport" xlink:title="DocumentTransitionReport" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentTransitionReport" xlink:title="presentation: CoverAbstract to DocumentTransitionReport" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFileNumber" xlink:title="presentation: CoverAbstract to EntityFileNumber" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: CoverAbstract to EntityIncorporationStateCountryCode" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: CoverAbstract to EntityTaxIdentificationNumber" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine1" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine2" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: CoverAbstract to EntityAddressCityOrTown" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: CoverAbstract to EntityAddressPostalZipCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CityAreaCode" xlink:title="presentation: CoverAbstract to CityAreaCode" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="LocalPhoneNumber" xlink:title="presentation: CoverAbstract to LocalPhoneNumber" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="Security12bTitle" xlink:title="presentation: CoverAbstract to Security12bTitle" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="TradingSymbol" xlink:title="presentation: CoverAbstract to TradingSymbol" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SecurityExchangeName" xlink:title="presentation: CoverAbstract to SecurityExchangeName" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="EntityWellKnownSeasonedIssuer" xlink:title="EntityWellKnownSeasonedIssuer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityWellKnownSeasonedIssuer" xlink:title="presentation: CoverAbstract to EntityWellKnownSeasonedIssuer" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="EntityVoluntaryFilers" xlink:title="EntityVoluntaryFilers" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityVoluntaryFilers" xlink:title="presentation: CoverAbstract to EntityVoluntaryFilers" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="EntityCurrentReportingStatus" xlink:title="EntityCurrentReportingStatus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCurrentReportingStatus" xlink:title="presentation: CoverAbstract to EntityCurrentReportingStatus" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="EntityInteractiveDataCurrent" xlink:title="EntityInteractiveDataCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityInteractiveDataCurrent" xlink:title="presentation: CoverAbstract to EntityInteractiveDataCurrent" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory" xlink:label="EntityFilerCategory" xlink:title="EntityFilerCategory" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFilerCategory" xlink:title="presentation: CoverAbstract to EntityFilerCategory" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness" xlink:label="EntitySmallBusiness" xlink:title="EntitySmallBusiness" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntitySmallBusiness" xlink:title="presentation: CoverAbstract to EntitySmallBusiness" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="29.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany" xlink:label="EntityShellCompany" xlink:title="EntityShellCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityShellCompany" xlink:title="presentation: CoverAbstract to EntityShellCompany" order="30.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPublicFloat" xlink:label="EntityPublicFloat" xlink:title="EntityPublicFloat" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityPublicFloat" xlink:title="presentation: CoverAbstract to EntityPublicFloat" order="31.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="EntityCommonStockSharesOutstanding" xlink:title="EntityCommonStockSharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCommonStockSharesOutstanding" xlink:title="presentation: CoverAbstract to EntityCommonStockSharesOutstanding" order="32.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedBalanceSheets">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="StatementOfFinancialPositionAbstract" xlink:title="StatementOfFinancialPositionAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="AssetsAbstract" xlink:title="AssetsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="AssetsCurrentAbstract" xlink:title="AssetsCurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="CashAndCashEquivalentsAtCarryingValue" xlink:title="CashAndCashEquivalentsAtCarryingValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="CashAndCashEquivalentsAtCarryingValue" xlink:title="presentation: AssetsCurrentAbstract to CashAndCashEquivalentsAtCarryingValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="AccountsReceivableNetCurrent" xlink:title="AccountsReceivableNetCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="AccountsReceivableNetCurrent" xlink:title="presentation: AssetsCurrentAbstract to AccountsReceivableNetCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="AccountsAndOtherReceivablesNetCurrent" xlink:title="AccountsAndOtherReceivablesNetCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="AccountsAndOtherReceivablesNetCurrent" xlink:title="presentation: AssetsCurrentAbstract to AccountsAndOtherReceivablesNetCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="OtherAssetsCurrent" xlink:title="OtherAssetsCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="OtherAssetsCurrent" xlink:title="presentation: AssetsCurrentAbstract to OtherAssetsCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="AssetsCurrent" xlink:title="AssetsCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="AssetsCurrent" xlink:title="presentation: AssetsCurrentAbstract to AssetsCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="AssetsCurrentAbstract" xlink:title="presentation: AssetsAbstract to AssetsCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:label="PropertyPlantAndEquipmentNetAbstract" xlink:title="PropertyPlantAndEquipmentNetAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesGross" xlink:label="FurnitureAndFixturesGross" xlink:title="FurnitureAndFixturesGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentNetAbstract" xlink:to="FurnitureAndFixturesGross" xlink:title="presentation: PropertyPlantAndEquipmentNetAbstract to FurnitureAndFixturesGross" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsGross" xlink:label="LeaseholdImprovementsGross" xlink:title="LeaseholdImprovementsGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentNetAbstract" xlink:to="LeaseholdImprovementsGross" xlink:title="presentation: PropertyPlantAndEquipmentNetAbstract to LeaseholdImprovementsGross" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="PropertyPlantAndEquipmentGross" xlink:title="PropertyPlantAndEquipmentGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentNetAbstract" xlink:to="PropertyPlantAndEquipmentGross" xlink:title="presentation: PropertyPlantAndEquipmentNetAbstract to PropertyPlantAndEquipmentGross" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentNetAbstract" xlink:to="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="presentation: PropertyPlantAndEquipmentNetAbstract to AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentNetAbstract" xlink:to="PropertyPlantAndEquipmentNet" xlink:title="presentation: PropertyPlantAndEquipmentNetAbstract to PropertyPlantAndEquipmentNet" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="PropertyPlantAndEquipmentNetAbstract" xlink:title="presentation: AssetsAbstract to PropertyPlantAndEquipmentNetAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="OperatingLeaseRightOfUseAsset" xlink:title="OperatingLeaseRightOfUseAsset" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="OperatingLeaseRightOfUseAsset" xlink:title="presentation: AssetsAbstract to OperatingLeaseRightOfUseAsset" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:label="Goodwill" xlink:title="Goodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="Goodwill" xlink:title="presentation: AssetsAbstract to Goodwill" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="IntangibleAssetsNetExcludingGoodwill" xlink:title="IntangibleAssetsNetExcludingGoodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="IntangibleAssetsNetExcludingGoodwill" xlink:title="presentation: AssetsAbstract to IntangibleAssetsNetExcludingGoodwill" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="OtherAssetsNoncurrent" xlink:title="OtherAssetsNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="OtherAssetsNoncurrent" xlink:title="presentation: AssetsAbstract to OtherAssetsNoncurrent" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="Assets" xlink:title="Assets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="Assets" xlink:title="presentation: AssetsAbstract to Assets" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="AssetsAbstract" xlink:title="presentation: StatementOfFinancialPositionAbstract to AssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="LiabilitiesAndStockholdersEquityAbstract" xlink:title="LiabilitiesAndStockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="LiabilitiesCurrentAbstract" xlink:title="LiabilitiesCurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="AccountsPayableTradeCurrent" xlink:title="AccountsPayableTradeCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="AccountsPayableTradeCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to AccountsPayableTradeCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="AccruedLiabilitiesCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to AccruedLiabilitiesCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="OperatingLeaseLiabilityCurrent" xlink:title="OperatingLeaseLiabilityCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="OperatingLeaseLiabilityCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to OperatingLeaseLiabilityCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="LongTermDebtCurrent" xlink:title="LongTermDebtCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="LongTermDebtCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to LongTermDebtCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="LiabilitiesCurrent" xlink:title="LiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="LiabilitiesCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to LiabilitiesCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="LiabilitiesCurrentAbstract" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to LiabilitiesCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermNotesPayable" xlink:label="LongTermNotesPayable" xlink:title="LongTermNotesPayable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="LongTermNotesPayable" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to LongTermNotesPayable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermLineOfCredit" xlink:label="LongTermLineOfCredit" xlink:title="LongTermLineOfCredit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="LongTermLineOfCredit" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to LongTermLineOfCredit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="DeferredIncomeTaxLiabilitiesNet" xlink:title="DeferredIncomeTaxLiabilitiesNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="DeferredIncomeTaxLiabilitiesNet" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to DeferredIncomeTaxLiabilitiesNet" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent" xlink:label="DeferredRentCreditNoncurrent" xlink:title="DeferredRentCreditNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="DeferredRentCreditNoncurrent" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to DeferredRentCreditNoncurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="OperatingLeaseLiabilityNoncurrent" xlink:title="OperatingLeaseLiabilityNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="OperatingLeaseLiabilityNoncurrent" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to OperatingLeaseLiabilityNoncurrent" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="OtherLiabilitiesNoncurrent" xlink:title="OtherLiabilitiesNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="OtherLiabilitiesNoncurrent" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to OtherLiabilitiesNoncurrent" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:label="Liabilities" xlink:title="Liabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="Liabilities" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to Liabilities" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:title="RedeemableNoncontrollingInterestEquityCarryingAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to RedeemableNoncontrollingInterestEquityCarryingAmount" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="CommitmentsAndContingencies" xlink:title="CommitmentsAndContingencies" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="CommitmentsAndContingencies" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to CommitmentsAndContingencies" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="StockholdersEquityAbstract" xlink:title="StockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="PreferredStockValue" xlink:title="PreferredStockValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="PreferredStockValue" xlink:title="presentation: StockholdersEquityAbstract to PreferredStockValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="CommonStockValue" xlink:title="CommonStockValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="CommonStockValue" xlink:title="presentation: StockholdersEquityAbstract to CommonStockValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="AdditionalPaidInCapital" xlink:title="AdditionalPaidInCapital" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="AdditionalPaidInCapital" xlink:title="presentation: StockholdersEquityAbstract to AdditionalPaidInCapital" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="RetainedEarningsAccumulatedDeficit" xlink:title="RetainedEarningsAccumulatedDeficit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="RetainedEarningsAccumulatedDeficit" xlink:title="presentation: StockholdersEquityAbstract to RetainedEarningsAccumulatedDeficit" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="TreasuryStockValue" xlink:title="TreasuryStockValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="TreasuryStockValue" xlink:title="presentation: StockholdersEquityAbstract to TreasuryStockValue" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="StockholdersEquity" xlink:title="presentation: StockholdersEquityAbstract to StockholdersEquity" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="StockholdersEquityAbstract" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to StockholdersEquityAbstract" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest" xlink:label="MinorityInterest" xlink:title="MinorityInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="MinorityInterest" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to MinorityInterest" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="LiabilitiesAndStockholdersEquity" xlink:title="LiabilitiesAndStockholdersEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="LiabilitiesAndStockholdersEquity" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to LiabilitiesAndStockholdersEquity" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="LiabilitiesAndStockholdersEquityAbstract" xlink:title="presentation: StatementOfFinancialPositionAbstract to LiabilitiesAndStockholdersEquityAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedBalanceSheetsParenthetical">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="StatementOfFinancialPositionAbstract" xlink:title="StatementOfFinancialPositionAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="AssetsAbstract" xlink:title="AssetsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="AssetsCurrentAbstract" xlink:title="AssetsCurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="AllowanceForDoubtfulAccountsReceivableCurrent" xlink:title="AllowanceForDoubtfulAccountsReceivableCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="AllowanceForDoubtfulAccountsReceivableCurrent" xlink:title="presentation: AssetsCurrentAbstract to AllowanceForDoubtfulAccountsReceivableCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="AssetsCurrentAbstract" xlink:title="presentation: AssetsAbstract to AssetsCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="AssetsAbstract" xlink:title="presentation: StatementOfFinancialPositionAbstract to AssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="LiabilitiesAndStockholdersEquityAbstract" xlink:title="LiabilitiesAndStockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:title="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="StockholdersEquityAbstract" xlink:title="StockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="PreferredStockParOrStatedValuePerShare" xlink:title="PreferredStockParOrStatedValuePerShare" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="PreferredStockParOrStatedValuePerShare" xlink:title="presentation: StockholdersEquityAbstract to PreferredStockParOrStatedValuePerShare" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="PreferredStockSharesAuthorized" xlink:title="PreferredStockSharesAuthorized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="PreferredStockSharesAuthorized" xlink:title="presentation: StockholdersEquityAbstract to PreferredStockSharesAuthorized" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="PreferredStockSharesIssued" xlink:title="PreferredStockSharesIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="PreferredStockSharesIssued" xlink:title="presentation: StockholdersEquityAbstract to PreferredStockSharesIssued" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="PreferredStockSharesOutstanding" xlink:title="PreferredStockSharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="PreferredStockSharesOutstanding" xlink:title="presentation: StockholdersEquityAbstract to PreferredStockSharesOutstanding" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="CommonStockParOrStatedValuePerShare" xlink:title="CommonStockParOrStatedValuePerShare" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="CommonStockParOrStatedValuePerShare" xlink:title="presentation: StockholdersEquityAbstract to CommonStockParOrStatedValuePerShare" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="CommonStockSharesAuthorized" xlink:title="CommonStockSharesAuthorized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="CommonStockSharesAuthorized" xlink:title="presentation: StockholdersEquityAbstract to CommonStockSharesAuthorized" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="CommonStockSharesIssued" xlink:title="CommonStockSharesIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="CommonStockSharesIssued" xlink:title="presentation: StockholdersEquityAbstract to CommonStockSharesIssued" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="TreasuryStockShares" xlink:title="TreasuryStockShares" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="TreasuryStockShares" xlink:title="presentation: StockholdersEquityAbstract to TreasuryStockShares" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="StockholdersEquityAbstract" xlink:title="presentation: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract to StockholdersEquityAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="LiabilitiesAndStockholdersEquityAbstract" xlink:title="presentation: StatementOfFinancialPositionAbstract to LiabilitiesAndStockholdersEquityAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedStatementsOfIncome">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="IncomeStatementAbstract" xlink:title="IncomeStatementAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="StatementTable" xlink:title="StatementTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="ProductOrServiceAxis" xlink:title="ProductOrServiceAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="ProductsAndServicesDomain" xlink:title="ProductsAndServicesDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NetPatientRevenuesMember" xlink:label="NetPatientRevenuesMember" xlink:title="NetPatientRevenuesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProductsAndServicesDomain" xlink:to="NetPatientRevenuesMember" xlink:title="presentation: ProductsAndServicesDomain to NetPatientRevenuesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" xlink:label="OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" xlink:title="OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProductsAndServicesDomain" xlink:to="OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" xlink:title="presentation: ProductsAndServicesDomain to OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProductOrServiceAxis" xlink:to="ProductsAndServicesDomain" xlink:title="presentation: ProductOrServiceAxis to ProductsAndServicesDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementTable" xlink:to="ProductOrServiceAxis" xlink:title="presentation: StatementTable to ProductOrServiceAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="StatementLineItems" xlink:title="StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="RevenuesAbstract" xlink:title="RevenuesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:title="RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenuesAbstract" xlink:to="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:title="presentation: RevenuesAbstract to RevenueFromContractWithCustomerExcludingAssessedTax" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="RevenuesAbstract" xlink:title="presentation: StatementLineItems to RevenuesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="CostsAndExpensesAbstract" xlink:title="CostsAndExpensesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="LaborAndRelatedExpense" xlink:title="LaborAndRelatedExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CostsAndExpensesAbstract" xlink:to="LaborAndRelatedExpense" xlink:title="presentation: CostsAndExpensesAbstract to LaborAndRelatedExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_RentSuppliesContractLaborAndOther" xlink:label="RentSuppliesContractLaborAndOther" xlink:title="RentSuppliesContractLaborAndOther" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CostsAndExpensesAbstract" xlink:to="RentSuppliesContractLaborAndOther" xlink:title="presentation: CostsAndExpensesAbstract to RentSuppliesContractLaborAndOther" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="ProvisionForDoubtfulAccounts" xlink:title="ProvisionForDoubtfulAccounts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CostsAndExpensesAbstract" xlink:to="ProvisionForDoubtfulAccounts" xlink:title="presentation: CostsAndExpensesAbstract to ProvisionForDoubtfulAccounts" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="RestructuringCharges" xlink:title="RestructuringCharges" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CostsAndExpensesAbstract" xlink:to="RestructuringCharges" xlink:title="presentation: CostsAndExpensesAbstract to RestructuringCharges" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="GoodwillImpairmentLoss" xlink:title="GoodwillImpairmentLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CostsAndExpensesAbstract" xlink:to="GoodwillImpairmentLoss" xlink:title="presentation: CostsAndExpensesAbstract to GoodwillImpairmentLoss" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="CostsAndExpenses" xlink:title="CostsAndExpenses" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CostsAndExpensesAbstract" xlink:to="CostsAndExpenses" xlink:title="presentation: CostsAndExpensesAbstract to CostsAndExpenses" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="CostsAndExpensesAbstract" xlink:title="presentation: StatementLineItems to CostsAndExpensesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit" xlink:label="GrossProfit" xlink:title="GrossProfit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="GrossProfit" xlink:title="presentation: StatementLineItems to GrossProfit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="SellingGeneralAndAdministrativeExpense" xlink:title="SellingGeneralAndAdministrativeExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="SellingGeneralAndAdministrativeExpense" xlink:title="presentation: StatementLineItems to SellingGeneralAndAdministrativeExpense" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="OperatingIncomeLoss" xlink:title="OperatingIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="OperatingIncomeLoss" xlink:title="presentation: StatementLineItems to OperatingIncomeLoss" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="OtherNonoperatingIncomeExpenseAbstract" xlink:title="OtherNonoperatingIncomeExpenseAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ReliefFunds" xlink:label="ReliefFunds" xlink:title="ReliefFunds" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherNonoperatingIncomeExpenseAbstract" xlink:to="ReliefFunds" xlink:title="presentation: OtherNonoperatingIncomeExpenseAbstract to ReliefFunds" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfInterestInProjects" xlink:label="GainLossOnSaleOfInterestInProjects" xlink:title="GainLossOnSaleOfInterestInProjects" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherNonoperatingIncomeExpenseAbstract" xlink:to="GainLossOnSaleOfInterestInProjects" xlink:title="presentation: OtherNonoperatingIncomeExpenseAbstract to GainLossOnSaleOfInterestInProjects" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="GainsLossesOnExtinguishmentOfDebt" xlink:title="GainsLossesOnExtinguishmentOfDebt" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherNonoperatingIncomeExpenseAbstract" xlink:to="GainsLossesOnExtinguishmentOfDebt" xlink:title="presentation: OtherNonoperatingIncomeExpenseAbstract to GainsLossesOnExtinguishmentOfDebt" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndOtherIncome" xlink:label="InterestAndOtherIncome" xlink:title="InterestAndOtherIncome" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherNonoperatingIncomeExpenseAbstract" xlink:to="InterestAndOtherIncome" xlink:title="presentation: OtherNonoperatingIncomeExpenseAbstract to InterestAndOtherIncome" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_InterestExpenseDebtAndOther" xlink:label="InterestExpenseDebtAndOther" xlink:title="InterestExpenseDebtAndOther" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherNonoperatingIncomeExpenseAbstract" xlink:to="InterestExpenseDebtAndOther" xlink:title="presentation: OtherNonoperatingIncomeExpenseAbstract to InterestExpenseDebtAndOther" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="NonoperatingIncomeExpense" xlink:title="NonoperatingIncomeExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherNonoperatingIncomeExpenseAbstract" xlink:to="NonoperatingIncomeExpense" xlink:title="presentation: OtherNonoperatingIncomeExpenseAbstract to NonoperatingIncomeExpense" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="OtherNonoperatingIncomeExpenseAbstract" xlink:title="presentation: StatementLineItems to OtherNonoperatingIncomeExpenseAbstract" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="presentation: StatementLineItems to IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="IncomeTaxExpenseBenefit" xlink:title="presentation: StatementLineItems to IncomeTaxExpenseBenefit" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="ProfitLoss" xlink:title="ProfitLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="ProfitLoss" xlink:title="presentation: StatementLineItems to ProfitLoss" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" xlink:label="MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" xlink:title="MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:label="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:title="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" xlink:to="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:title="presentation: MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract to NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:label="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:title="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" xlink:to="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:title="presentation: MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract to NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="NetIncomeLossAttributableToNoncontrollingInterest" xlink:title="NetIncomeLossAttributableToNoncontrollingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" xlink:to="NetIncomeLossAttributableToNoncontrollingInterest" xlink:title="presentation: MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract to NetIncomeLossAttributableToNoncontrollingInterest" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" xlink:title="presentation: StatementLineItems to MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="NetIncomeLoss" xlink:title="presentation: StatementLineItems to NetIncomeLoss" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="EarningsPerShareBasicAndDiluted" xlink:title="EarningsPerShareBasicAndDiluted" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="EarningsPerShareBasicAndDiluted" xlink:title="presentation: StatementLineItems to EarningsPerShareBasicAndDiluted" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:title="WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:title="presentation: StatementLineItems to WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared" xlink:label="CommonStockDividendsPerShareDeclared" xlink:title="CommonStockDividendsPerShareDeclared" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="CommonStockDividendsPerShareDeclared" xlink:title="presentation: StatementLineItems to CommonStockDividendsPerShareDeclared" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementTable" xlink:to="StatementLineItems" xlink:title="presentation: StatementTable to StatementLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="StatementTable" xlink:title="presentation: IncomeStatementAbstract to StatementTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedStatementsOfChangesInEquity">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="StatementOfStockholdersEquityAbstract" xlink:title="StatementOfStockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="StatementTable" xlink:title="StatementTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="CommonStockMember" xlink:title="presentation: StatementEquityComponentsAxis to CommonStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="AdditionalPaidInCapitalMember" xlink:title="AdditionalPaidInCapitalMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="AdditionalPaidInCapitalMember" xlink:title="presentation: StatementEquityComponentsAxis to AdditionalPaidInCapitalMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="RetainedEarningsMember" xlink:title="RetainedEarningsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="RetainedEarningsMember" xlink:title="presentation: StatementEquityComponentsAxis to RetainedEarningsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="TreasuryStockMember" xlink:title="TreasuryStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="TreasuryStockMember" xlink:title="presentation: StatementEquityComponentsAxis to TreasuryStockMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ParentMember" xlink:label="ParentMember" xlink:title="ParentMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="ParentMember" xlink:title="presentation: StatementEquityComponentsAxis to ParentMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="NoncontrollingInterestMember" xlink:title="NoncontrollingInterestMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="NoncontrollingInterestMember" xlink:title="presentation: StatementEquityComponentsAxis to NoncontrollingInterestMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain" xlink:title="presentation: StatementEquityComponentsAxis to EquityComponentDomain" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementTable" xlink:to="StatementEquityComponentsAxis" xlink:title="presentation: StatementTable to StatementEquityComponentsAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="StatementLineItems" xlink:title="StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="IncreaseDecreaseInStockholdersEquityRollForward" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="SharesOutstanding" xlink:title="SharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="SharesOutstanding" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to SharesOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:label="StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:title="StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:title="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_RevaluationOfRedeemableNonControllingInterestNetOfTax" xlink:label="RevaluationOfRedeemableNonControllingInterestNetOfTax" xlink:title="RevaluationOfRedeemableNonControllingInterestNetOfTax" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="RevaluationOfRedeemableNonControllingInterestNetOfTax" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to RevaluationOfRedeemableNonControllingInterestNetOfTax" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" xlink:label="RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" xlink:title="RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to RevaluationOfRedeemableNonControllingInterestNetOfTaxShares" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" xlink:label="TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" xlink:title="TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PurchaseOfPartnershipInterestsRedeemableNonControllingInterests" xlink:label="PurchaseOfPartnershipInterestsRedeemableNonControllingInterests" xlink:title="PurchaseOfPartnershipInterestsRedeemableNonControllingInterests" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="PurchaseOfPartnershipInterestsRedeemableNonControllingInterests" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to PurchaseOfPartnershipInterestsRedeemableNonControllingInterests" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_SaleOfNonControllingInterestNetOfTaxAndPurchases" xlink:label="SaleOfNonControllingInterestNetOfTaxAndPurchases" xlink:title="SaleOfNonControllingInterestNetOfTaxAndPurchases" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="SaleOfNonControllingInterestNetOfTaxAndPurchases" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to SaleOfNonControllingInterestNetOfTaxAndPurchases" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsCommonStockCash" xlink:label="DividendsCommonStockCash" xlink:title="DividendsCommonStockCash" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="DividendsCommonStockCash" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to DividendsCommonStockCash" order="10.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:title="MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" order="11.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityOther" xlink:label="StockholdersEquityOther" xlink:title="StockholdersEquityOther" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockholdersEquityOther" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockholdersEquityOther" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:label="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:title="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="NetIncomeLoss" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to NetIncomeLoss" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" xlink:title="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="SharesOutstanding_2" xlink:title="SharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="SharesOutstanding_2" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to SharesOutstanding" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="presentation: StatementLineItems to IncreaseDecreaseInStockholdersEquityRollForward" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementTable" xlink:to="StatementLineItems" xlink:title="presentation: StatementTable to StatementLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfStockholdersEquityAbstract" xlink:to="StatementTable" xlink:title="presentation: StatementOfStockholdersEquityAbstract to StatementTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedStatementsOfCashFlows">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="StatementOfCashFlowsAbstract" xlink:title="StatementOfCashFlowsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="ProfitLoss" xlink:title="ProfitLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="ProfitLoss" xlink:title="presentation: NetCashProvidedByUsedInOperatingActivitiesAbstract to ProfitLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="DepreciationDepletionAndAmortization" xlink:title="DepreciationDepletionAndAmortization" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="DepreciationDepletionAndAmortization" xlink:title="presentation: AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to DepreciationDepletionAndAmortization" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="ProvisionForDoubtfulAccounts" xlink:title="ProvisionForDoubtfulAccounts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="ProvisionForDoubtfulAccounts" xlink:title="presentation: AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to ProvisionForDoubtfulAccounts" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="ShareBasedCompensation" xlink:title="ShareBasedCompensation" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="ShareBasedCompensation" xlink:title="presentation: AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to ShareBasedCompensation" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="DeferredIncomeTaxExpenseBenefit" xlink:title="DeferredIncomeTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="DeferredIncomeTaxExpenseBenefit" xlink:title="presentation: AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to DeferredIncomeTaxExpenseBenefit" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_GainOnSaleOfPartnershipInterestNetOfTax" xlink:label="GainOnSaleOfPartnershipInterestNetOfTax" xlink:title="GainOnSaleOfPartnershipInterestNetOfTax" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="GainOnSaleOfPartnershipInterestNetOfTax" xlink:title="presentation: AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to GainOnSaleOfPartnershipInterestNetOfTax" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="GoodwillImpairmentLoss" xlink:title="GoodwillImpairmentLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="GoodwillImpairmentLoss" xlink:title="presentation: AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to GoodwillImpairmentLoss" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:label="OtherOperatingActivitiesCashFlowStatement" xlink:title="OtherOperatingActivitiesCashFlowStatement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="OtherOperatingActivitiesCashFlowStatement" xlink:title="presentation: AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to OtherOperatingActivitiesCashFlowStatement" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="presentation: NetCashProvidedByUsedInOperatingActivitiesAbstract to AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="IncreaseDecreaseInAccountsReceivable" xlink:title="IncreaseDecreaseInAccountsReceivable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInAccountsReceivable" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInAccountsReceivable" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" xlink:label="IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" xlink:title="IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="IncreaseDecreaseInOtherOperatingAssets" xlink:title="IncreaseDecreaseInOtherOperatingAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInOtherOperatingAssets" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInOtherOperatingAssets" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:label="IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:title="IncreaseDecreaseInOtherNoncurrentLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInOtherNoncurrentLiabilities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="presentation: NetCashProvidedByUsedInOperatingActivitiesAbstract to IncreaseDecreaseInOperatingCapitalAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="NetCashProvidedByUsedInOperatingActivities" xlink:title="NetCashProvidedByUsedInOperatingActivities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="NetCashProvidedByUsedInOperatingActivities" xlink:title="presentation: NetCashProvidedByUsedInOperatingActivitiesAbstract to NetCashProvidedByUsedInOperatingActivities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="PaymentsToAcquireProductiveAssets" xlink:title="PaymentsToAcquireProductiveAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="PaymentsToAcquireProductiveAssets" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to PaymentsToAcquireProductiveAssets" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="PaymentsToAcquireBusinessesNetOfCashAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to PaymentsToAcquireBusinessesNetOfCashAcquired" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PaymentsToAcquireRedeemableNonControllingInterest" xlink:label="PaymentsToAcquireRedeemableNonControllingInterest" xlink:title="PaymentsToAcquireRedeemableNonControllingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="PaymentsToAcquireRedeemableNonControllingInterest" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to PaymentsToAcquireRedeemableNonControllingInterest" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:label="PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:title="PaymentsToAcquireInterestInSubsidiariesAndAffiliates" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to PaymentsToAcquireInterestInSubsidiariesAndAffiliates" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" xlink:label="ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" xlink:title="ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:label="ProceedsFromDivestitureOfBusinesses" xlink:title="ProceedsFromDivestitureOfBusinesses" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="ProceedsFromDivestitureOfBusinesses" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to ProceedsFromDivestitureOfBusinesses" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="NetCashProvidedByUsedInInvestingActivities" xlink:title="NetCashProvidedByUsedInInvestingActivities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="NetCashProvidedByUsedInInvestingActivities" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to NetCashProvidedByUsedInInvestingActivities" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to NetCashProvidedByUsedInInvestingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="PaymentsOfDividendsMinorityInterest" xlink:title="PaymentsOfDividendsMinorityInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="PaymentsOfDividendsMinorityInterest" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to PaymentsOfDividendsMinorityInterest" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock" xlink:label="PaymentsOfDividendsCommonStock" xlink:title="PaymentsOfDividendsCommonStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="PaymentsOfDividendsCommonStock" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to PaymentsOfDividendsCommonStock" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="ProceedsFromLinesOfCredit" xlink:title="ProceedsFromLinesOfCredit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromLinesOfCredit" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to ProceedsFromLinesOfCredit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="RepaymentsOfLinesOfCredit" xlink:title="RepaymentsOfLinesOfCredit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="RepaymentsOfLinesOfCredit" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to RepaymentsOfLinesOfCredit" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:label="PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:title="PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="RepaymentsOfNotesPayable" xlink:title="RepaymentsOfNotesPayable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="RepaymentsOfNotesPayable" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to RepaymentsOfNotesPayable" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_MedicareAcceleratedAndAdvancePaymentFunds" xlink:label="MedicareAcceleratedAndAdvancePaymentFunds" xlink:title="MedicareAcceleratedAndAdvancePaymentFunds" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="MedicareAcceleratedAndAdvancePaymentFunds" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to MedicareAcceleratedAndAdvancePaymentFunds" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:label="ProceedsFromPaymentsForOtherFinancingActivities" xlink:title="ProceedsFromPaymentsForOtherFinancingActivities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromPaymentsForOtherFinancingActivities" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to ProceedsFromPaymentsForOtherFinancingActivities" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="NetCashProvidedByUsedInFinancingActivities" xlink:title="NetCashProvidedByUsedInFinancingActivities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="NetCashProvidedByUsedInFinancingActivities" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to NetCashProvidedByUsedInFinancingActivities" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to NetCashProvidedByUsedInFinancingActivitiesAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:title="presentation: StatementOfCashFlowsAbstract to CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:title="presentation: StatementOfCashFlowsAbstract to CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xlink:title="presentation: StatementOfCashFlowsAbstract to CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="SupplementalCashFlowInformationAbstract" xlink:title="SupplementalCashFlowInformationAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_CashPaidDuringPeriodForAbstract" xlink:label="CashPaidDuringPeriodForAbstract" xlink:title="CashPaidDuringPeriodForAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="IncomeTaxesPaidNet" xlink:title="IncomeTaxesPaidNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashPaidDuringPeriodForAbstract" xlink:to="IncomeTaxesPaidNet" xlink:title="presentation: CashPaidDuringPeriodForAbstract to IncomeTaxesPaidNet" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="InterestPaidNet" xlink:title="InterestPaidNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashPaidDuringPeriodForAbstract" xlink:to="InterestPaidNet" xlink:title="presentation: CashPaidDuringPeriodForAbstract to InterestPaidNet" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SupplementalCashFlowInformationAbstract" xlink:to="CashPaidDuringPeriodForAbstract" xlink:title="presentation: SupplementalCashFlowInformationAbstract to CashPaidDuringPeriodForAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="SupplementalCashFlowInformationAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to SupplementalCashFlowInformationAbstract" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:title="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PurchaseOfBusinessSellerFinancingPortion" xlink:label="PurchaseOfBusinessSellerFinancingPortion" xlink:title="PurchaseOfBusinessSellerFinancingPortion" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="PurchaseOfBusinessSellerFinancingPortion" xlink:title="presentation: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to PurchaseOfBusinessSellerFinancingPortion" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionPayablesAssumed1" xlink:label="NoncashOrPartNoncashAcquisitionPayablesAssumed1" xlink:title="NoncashOrPartNoncashAcquisitionPayablesAssumed1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="NoncashOrPartNoncashAcquisitionPayablesAssumed1" xlink:title="presentation: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to NoncashOrPartNoncashAcquisitionPayablesAssumed1" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity" xlink:label="NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="presentation: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity" xlink:label="NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity" xlink:title="NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity" xlink:title="presentation: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders" xlink:label="ProceedsFromMinorityShareholders" xlink:title="ProceedsFromMinorityShareholders" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="ProceedsFromMinorityShareholders" xlink:title="presentation: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to ProceedsFromMinorityShareholders" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" xlink:label="NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" xlink:title="NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" xlink:title="presentation: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentation">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:title="presentation: OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/SignificantAccountingPolicies">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="SignificantAccountingPoliciesTextBlock" xlink:title="SignificantAccountingPoliciesTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="SignificantAccountingPoliciesTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to SignificantAccountingPoliciesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/AcquisitionsOfBusinesses">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" xlink:title="BusinessCombinationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="BusinessCombinationDisclosureTextBlock" xlink:title="BusinessCombinationDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="BusinessCombinationDisclosureTextBlock" xlink:title="presentation: BusinessCombinationsAbstract to BusinessCombinationDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterests">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="NoncontrollingInterestAbstract" xlink:title="NoncontrollingInterestAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDisclosureTextBlock" xlink:label="MinorityInterestDisclosureTextBlock" xlink:title="MinorityInterestDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NoncontrollingInterestAbstract" xlink:to="MinorityInterestDisclosureTextBlock" xlink:title="presentation: NoncontrollingInterestAbstract to MinorityInterestDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/RedeemableNoncontrollingInterest">
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_RedeemableNonControllingInterestAbstract" xlink:label="RedeemableNonControllingInterestAbstract" xlink:title="RedeemableNonControllingInterestAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_RedeemableNonControllingInterestTextBlock" xlink:label="RedeemableNonControllingInterestTextBlock" xlink:title="RedeemableNonControllingInterestTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNonControllingInterestAbstract" xlink:to="RedeemableNonControllingInterestTextBlock" xlink:title="presentation: RedeemableNonControllingInterestAbstract to RedeemableNonControllingInterestTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/Goodwill">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:title="GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillDisclosureTextBlock" xlink:label="GoodwillDisclosureTextBlock" xlink:title="GoodwillDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="GoodwillDisclosureTextBlock" xlink:title="presentation: GoodwillAndIntangibleAssetsDisclosureAbstract to GoodwillDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/IntangibleAssetsNet">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:title="IntangibleAssetsNetExcludingGoodwillAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="IntangibleAssetsDisclosureTextBlock" xlink:title="IntangibleAssetsDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="IntangibleAssetsDisclosureTextBlock" xlink:title="presentation: IntangibleAssetsNetExcludingGoodwillAbstract to IntangibleAssetsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/AccruedExpenses">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="PayablesAndAccrualsAbstract" xlink:title="PayablesAndAccrualsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:title="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:title="presentation: PayablesAndAccrualsAbstract to AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/NotesPayable">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="DebtDisclosureAbstract" xlink:title="DebtDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="DebtDisclosureTextBlock" xlink:title="DebtDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDisclosureAbstract" xlink:to="DebtDisclosureTextBlock" xlink:title="presentation: DebtDisclosureAbstract to DebtDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/Leases">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="LesseeOperatingLeasesTextBlock" xlink:title="LesseeOperatingLeasesTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="LesseeOperatingLeasesTextBlock" xlink:title="presentation: LeasesAbstract to LesseeOperatingLeasesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/IncomeTaxes">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="IncomeTaxDisclosureTextBlock" xlink:title="IncomeTaxDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="IncomeTaxDisclosureTextBlock" xlink:title="presentation: IncomeTaxDisclosureAbstract to IncomeTaxDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/SegmentInformation">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="SegmentReportingAbstract" xlink:title="SegmentReportingAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="SegmentReportingDisclosureTextBlock" xlink:title="SegmentReportingDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentReportingAbstract" xlink:to="SegmentReportingDisclosureTextBlock" xlink:title="presentation: SegmentReportingAbstract to SegmentReportingDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/EquityBasedPlans">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:title="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/PreferredStock">
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PreferredStockAbstract" xlink:label="PreferredStockAbstract" xlink:title="PreferredStockAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockTextBlock" xlink:label="PreferredStockTextBlock" xlink:title="PreferredStockTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PreferredStockAbstract" xlink:to="PreferredStockTextBlock" xlink:title="presentation: PreferredStockAbstract to PreferredStockTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/CommonStock">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="EquityAbstract" xlink:title="EquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="StockholdersEquityNoteDisclosureTextBlock" xlink:title="StockholdersEquityNoteDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="StockholdersEquityNoteDisclosureTextBlock" xlink:title="presentation: EquityAbstract to StockholdersEquityNoteDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/DefinedContributionPlan">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="CompensationAndRetirementDisclosureAbstract" xlink:title="CompensationAndRetirementDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:label="CompensationAndEmployeeBenefitPlansTextBlock" xlink:title="CompensationAndEmployeeBenefitPlansTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CompensationAndRetirementDisclosureAbstract" xlink:to="CompensationAndEmployeeBenefitPlansTextBlock" xlink:title="presentation: CompensationAndRetirementDisclosureAbstract to CompensationAndEmployeeBenefitPlansTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/CommitmentsAndContingencies">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="CommitmentsAndContingenciesDisclosureAbstract" xlink:title="CommitmentsAndContingenciesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="CommitmentsAndContingenciesDisclosureTextBlock" xlink:title="CommitmentsAndContingenciesDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsAndContingenciesDisclosureAbstract" xlink:to="CommitmentsAndContingenciesDisclosureTextBlock" xlink:title="presentation: CommitmentsAndContingenciesDisclosureAbstract to CommitmentsAndContingenciesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/EarningsPerShare">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" xlink:title="EarningsPerShareAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="EarningsPerShareTextBlock" xlink:title="EarningsPerShareTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="EarningsPerShareTextBlock" xlink:title="presentation: EarningsPerShareAbstract to EarningsPerShareTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/ScheduleIiValuationAndQualifyingAccounts">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract" xlink:label="ValuationAndQualifyingAccountsAbstract" xlink:title="ValuationAndQualifyingAccountsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:label="ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:title="ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ValuationAndQualifyingAccountsAbstract" xlink:to="ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:title="presentation: ValuationAndQualifyingAccountsAbstract to ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/SignificantAccountingPoliciesPolicies">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="CashAndCashEquivalentsPolicyTextBlock" xlink:title="CashAndCashEquivalentsPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="CashAndCashEquivalentsPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to CashAndCashEquivalentsPolicyTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:title="ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:label="ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:title="ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:title="GoodwillAndIntangibleAssetsPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to GoodwillAndIntangibleAssetsPolicyTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_RedeemableNonControllingInterestsPolicyTextBlock" xlink:label="RedeemableNonControllingInterestsPolicyTextBlock" xlink:title="RedeemableNonControllingInterestsPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="RedeemableNonControllingInterestsPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to RedeemableNonControllingInterestsPolicyTextBlock" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NonControllingInterestsPolicyPolicyTextBlock" xlink:label="NonControllingInterestsPolicyPolicyTextBlock" xlink:title="NonControllingInterestsPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="NonControllingInterestsPolicyPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to NonControllingInterestsPolicyPolicyTextBlock" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="RevenueFromContractWithCustomerPolicyTextBlock" xlink:title="RevenueFromContractWithCustomerPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="RevenueFromContractWithCustomerPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to RevenueFromContractWithCustomerPolicyTextBlock" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock" xlink:label="ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock" xlink:title="ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts" xlink:label="FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts" xlink:title="FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts" xlink:title="presentation: AccountingPoliciesAbstract to FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="IncomeTaxPolicyTextBlock" xlink:title="IncomeTaxPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="IncomeTaxPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to IncomeTaxPolicyTextBlock" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="FairValueOfFinancialInstrumentsPolicy" xlink:title="FairValueOfFinancialInstrumentsPolicy" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="FairValueOfFinancialInstrumentsPolicy" xlink:title="presentation: AccountingPoliciesAbstract to FairValueOfFinancialInstrumentsPolicy" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="SegmentReportingPolicyPolicyTextBlock" xlink:title="SegmentReportingPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="SegmentReportingPolicyPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to SegmentReportingPolicyPolicyTextBlock" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="UseOfEstimates" xlink:title="UseOfEstimates" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="UseOfEstimates" xlink:title="presentation: AccountingPoliciesAbstract to UseOfEstimates" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_SelfInsuranceProgramPolicyPolicyTextBlock" xlink:label="SelfInsuranceProgramPolicyPolicyTextBlock" xlink:title="SelfInsuranceProgramPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="SelfInsuranceProgramPolicyPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to SelfInsuranceProgramPolicyPolicyTextBlock" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_RestrictedStockPolicyPolicyTextBlock" xlink:label="RestrictedStockPolicyPolicyTextBlock" xlink:title="RestrictedStockPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="RestrictedStockPolicyPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to RestrictedStockPolicyPolicyTextBlock" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:title="NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to NewAccountingPronouncementsPolicyPolicyTextBlock" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:label="SubsequentEventsPolicyPolicyTextBlock" xlink:title="SubsequentEventsPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="SubsequentEventsPolicyPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to SubsequentEventsPolicyPolicyTextBlock" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock" xlink:label="ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock" xlink:title="ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock" xlink:title="presentation: OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/SignificantAccountingPoliciesTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="DisaggregationOfRevenueTableTextBlock" xlink:title="DisaggregationOfRevenueTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="DisaggregationOfRevenueTableTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to DisaggregationOfRevenueTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/AcquisitionsOfBusinessesTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" xlink:title="BusinessCombinationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:title="presentation: BusinessCombinationsAbstract to ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:label="FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:title="FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:title="presentation: BusinessCombinationsAbstract to FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/RedeemableNoncontrollingInterestTables">
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_RedeemableNonControllingInterestAbstract" xlink:label="RedeemableNonControllingInterestAbstract" xlink:title="RedeemableNonControllingInterestAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:label="RedeemableNoncontrollingInterestTableTextBlock" xlink:title="RedeemableNoncontrollingInterestTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNonControllingInterestAbstract" xlink:to="RedeemableNoncontrollingInterestTableTextBlock" xlink:title="presentation: RedeemableNonControllingInterestAbstract to RedeemableNoncontrollingInterestTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" xlink:label="CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" xlink:title="CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNonControllingInterestAbstract" xlink:to="CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" xlink:title="presentation: RedeemableNonControllingInterestAbstract to CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/GoodwillTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:title="GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="ScheduleOfGoodwillTextBlock" xlink:title="ScheduleOfGoodwillTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="ScheduleOfGoodwillTextBlock" xlink:title="presentation: GoodwillAndIntangibleAssetsDisclosureAbstract to ScheduleOfGoodwillTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/IntangibleAssetsNetTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:title="IntangibleAssetsNetExcludingGoodwillAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:title="ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:title="presentation: IntangibleAssetsNetExcludingGoodwillAbstract to ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:title="presentation: IntangibleAssetsNetExcludingGoodwillAbstract to FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:title="ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:title="presentation: IntangibleAssetsNetExcludingGoodwillAbstract to ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/AccruedExpensesTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="PayablesAndAccrualsAbstract" xlink:title="PayablesAndAccrualsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:title="ScheduleOfAccruedLiabilitiesTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:title="presentation: PayablesAndAccrualsAbstract to ScheduleOfAccruedLiabilitiesTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/NotesPayableTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="DebtDisclosureAbstract" xlink:title="DebtDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:label="ScheduleOfDebtInstrumentsTextBlock" xlink:title="ScheduleOfDebtInstrumentsTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDisclosureAbstract" xlink:to="ScheduleOfDebtInstrumentsTextBlock" xlink:title="presentation: DebtDisclosureAbstract to ScheduleOfDebtInstrumentsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/LeasesTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="LeaseCostTableTextBlock" xlink:title="LeaseCostTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="LeaseCostTableTextBlock" xlink:title="presentation: LeasesAbstract to LeaseCostTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_OperatingLeaseSupplementalInformationTableTextBlock" xlink:label="OperatingLeaseSupplementalInformationTableTextBlock" xlink:title="OperatingLeaseSupplementalInformationTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="OperatingLeaseSupplementalInformationTableTextBlock" xlink:title="presentation: LeasesAbstract to OperatingLeaseSupplementalInformationTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:title="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:title="presentation: LeasesAbstract to LesseeOperatingLeaseLiabilityMaturityTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock" xlink:label="WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock" xlink:title="WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock" xlink:title="presentation: LeasesAbstract to WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/IncomeTaxesTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:title="ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:title="presentation: IncomeTaxDisclosureAbstract to ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:title="ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:title="presentation: IncomeTaxDisclosureAbstract to ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:title="ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:title="presentation: IncomeTaxDisclosureAbstract to ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/SegmentInformationTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="SegmentReportingAbstract" xlink:title="SegmentReportingAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:title="ScheduleOfSegmentReportingInformationBySegmentTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentReportingAbstract" xlink:to="ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:title="presentation: SegmentReportingAbstract to ScheduleOfSegmentReportingInformationBySegmentTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/EquityBasedPlansTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:label="ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:title="ScheduleOfShareBasedCompensationActivityTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationActivityTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:label="ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:title="ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/EarningsPerShareTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" xlink:title="EarningsPerShareAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:title="ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:title="presentation: EarningsPerShareAbstract to ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:label="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:title="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ClinicPracticeMember" xlink:label="ClinicPracticeMember" xlink:title="ClinicPracticeMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="ClinicPracticeMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to ClinicPracticeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_LeadingProviderOfIndustrialInjuryPreventionMember" xlink:label="LeadingProviderOfIndustrialInjuryPreventionMember" xlink:title="LeadingProviderOfIndustrialInjuryPreventionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="LeadingProviderOfIndustrialInjuryPreventionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to LeadingProviderOfIndustrialInjuryPreventionMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ManagementContractsMember" xlink:label="ManagementContractsMember" xlink:title="ManagementContractsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="ManagementContractsMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to ManagementContractsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_AprilTwoThousandNineteenAcquisitionMember" xlink:label="AprilTwoThousandNineteenAcquisitionMember" xlink:title="AprilTwoThousandNineteenAcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="AprilTwoThousandNineteenAcquisitionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to AprilTwoThousandNineteenAcquisitionMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_MarchTwoThousandSeventeenAcquisitionMember" xlink:label="MarchTwoThousandSeventeenAcquisitionMember" xlink:title="MarchTwoThousandSeventeenAcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="MarchTwoThousandSeventeenAcquisitionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to MarchTwoThousandSeventeenAcquisitionMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="presentation: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="BusinessAcquisitionAxis" xlink:title="presentation: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable to BusinessAcquisitionAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="RangeAxis" xlink:title="presentation: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable to RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis" xlink:label="UnusualOrInfrequentItemAxis" xlink:title="UnusualOrInfrequentItemAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain" xlink:label="UnusualOrInfrequentItemDomain" xlink:title="UnusualOrInfrequentItemDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_MedicareAcceleratedAndAdvancePaymentsProgramMember" xlink:label="MedicareAcceleratedAndAdvancePaymentsProgramMember" xlink:title="MedicareAcceleratedAndAdvancePaymentsProgramMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="UnusualOrInfrequentItemDomain" xlink:to="MedicareAcceleratedAndAdvancePaymentsProgramMember" xlink:title="presentation: UnusualOrInfrequentItemDomain to MedicareAcceleratedAndAdvancePaymentsProgramMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PublicHealthAndSocialServicesEmergencyFundMember" xlink:label="PublicHealthAndSocialServicesEmergencyFundMember" xlink:title="PublicHealthAndSocialServicesEmergencyFundMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="UnusualOrInfrequentItemDomain" xlink:to="PublicHealthAndSocialServicesEmergencyFundMember" xlink:title="presentation: UnusualOrInfrequentItemDomain to PublicHealthAndSocialServicesEmergencyFundMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="UnusualOrInfrequentItemAxis" xlink:to="UnusualOrInfrequentItemDomain" xlink:title="presentation: UnusualOrInfrequentItemAxis to UnusualOrInfrequentItemDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="UnusualOrInfrequentItemAxis" xlink:title="presentation: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable to UnusualOrInfrequentItemAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:label="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:title="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:label="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:title="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments" xlink:label="NumberOfReportableSegments" xlink:title="NumberOfReportableSegments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:to="NumberOfReportableSegments" xlink:title="presentation: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract to NumberOfReportableSegments" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PercentageOfGeneralPartnershipInterestOwned" xlink:label="PercentageOfGeneralPartnershipInterestOwned" xlink:title="PercentageOfGeneralPartnershipInterestOwned" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:to="PercentageOfGeneralPartnershipInterestOwned" xlink:title="presentation: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract to PercentageOfGeneralPartnershipInterestOwned" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PercentageOfLimitedPartnershipInterestOwned" xlink:label="PercentageOfLimitedPartnershipInterestOwned" xlink:title="PercentageOfLimitedPartnershipInterestOwned" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:to="PercentageOfLimitedPartnershipInterestOwned" xlink:title="presentation: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract to PercentageOfLimitedPartnershipInterestOwned" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfOperatingClinicLocations" xlink:label="NumberOfOperatingClinicLocations" xlink:title="NumberOfOperatingClinicLocations" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:to="NumberOfOperatingClinicLocations" xlink:title="presentation: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract to NumberOfOperatingClinicLocations" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfClinicsOperated" xlink:label="NumberOfClinicsOperated" xlink:title="NumberOfClinicsOperated" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:to="NumberOfClinicsOperated" xlink:title="presentation: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract to NumberOfClinicsOperated" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfStatesInWhichEntityOperates" xlink:label="NumberOfStatesInWhichEntityOperates" xlink:title="NumberOfStatesInWhichEntityOperates" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:to="NumberOfStatesInWhichEntityOperates" xlink:title="presentation: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract to NumberOfStatesInWhichEntityOperates" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfThirdPartyFacilities" xlink:label="NumberOfThirdPartyFacilities" xlink:title="NumberOfThirdPartyFacilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:to="NumberOfThirdPartyFacilities" xlink:title="presentation: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract to NumberOfThirdPartyFacilities" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfBusinessesAcquired" xlink:label="NumberOfBusinessesAcquired" xlink:title="NumberOfBusinessesAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:to="NumberOfBusinessesAcquired" xlink:title="presentation: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract to NumberOfBusinessesAcquired" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfClinicsOperatesAsASatelliteClinicWithExistingPartnerships" xlink:label="NumberOfClinicsOperatesAsASatelliteClinicWithExistingPartnerships" xlink:title="NumberOfClinicsOperatesAsASatelliteClinicWithExistingPartnerships" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:to="NumberOfClinicsOperatesAsASatelliteClinicWithExistingPartnerships" xlink:title="presentation: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract to NumberOfClinicsOperatesAsASatelliteClinicWithExistingPartnerships" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfClosedClinicsSold" xlink:label="NumberOfClosedClinicsSold" xlink:title="NumberOfClosedClinicsSold" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:to="NumberOfClosedClinicsSold" xlink:title="presentation: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract to NumberOfClosedClinicsSold" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_AggregateSalePriceOfCinics" xlink:label="AggregateSalePriceOfCinics" xlink:title="AggregateSalePriceOfCinics" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:to="AggregateSalePriceOfCinics" xlink:title="presentation: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract to AggregateSalePriceOfCinics" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_CashReceivedRelatedToSaleOfClinics" xlink:label="CashReceivedRelatedToSaleOfClinics" xlink:title="CashReceivedRelatedToSaleOfClinics" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:to="CashReceivedRelatedToSaleOfClinics" xlink:title="presentation: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract to CashReceivedRelatedToSaleOfClinics" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NoteReceivableRelatedToSaleOfClinics" xlink:label="NoteReceivableRelatedToSaleOfClinics" xlink:title="NoteReceivableRelatedToSaleOfClinics" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:to="NoteReceivableRelatedToSaleOfClinics" xlink:title="presentation: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract to NoteReceivableRelatedToSaleOfClinics" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration" xlink:label="NumberOfInstallmentsForNoteReceivableInSaleConsideration" xlink:title="NumberOfInstallmentsForNoteReceivableInSaleConsideration" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:to="NumberOfInstallmentsForNoteReceivableInSaleConsideration" xlink:title="presentation: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract to NumberOfInstallmentsForNoteReceivableInSaleConsideration" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:to="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="presentation: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract to BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfBusinessesMerged" xlink:label="NumberOfBusinessesMerged" xlink:title="NumberOfBusinessesMerged" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:to="NumberOfBusinessesMerged" xlink:title="presentation: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract to NumberOfBusinessesMerged" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PercentageOfCombinedBusinessInterestOwned" xlink:label="PercentageOfCombinedBusinessInterestOwned" xlink:title="PercentageOfCombinedBusinessInterestOwned" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:to="PercentageOfCombinedBusinessInterestOwned" xlink:title="presentation: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract to PercentageOfCombinedBusinessInterestOwned" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfStatesOfNetworkServices" xlink:label="NumberOfStatesOfNetworkServices" xlink:title="NumberOfStatesOfNetworkServices" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:to="NumberOfStatesOfNetworkServices" xlink:title="presentation: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract to NumberOfStatesOfNetworkServices" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfOnsiteClientLocations" xlink:label="NumberOfOnsiteClientLocations" xlink:title="NumberOfOnsiteClientLocations" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:to="NumberOfOnsiteClientLocations" xlink:title="presentation: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract to NumberOfOnsiteClientLocations" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_AveragePhysicalTherapyPatientsVolumesPerDayPerClinic" xlink:label="AveragePhysicalTherapyPatientsVolumesPerDayPerClinic" xlink:title="AveragePhysicalTherapyPatientsVolumesPerDayPerClinic" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:to="AveragePhysicalTherapyPatientsVolumesPerDayPerClinic" xlink:title="presentation: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract to AveragePhysicalTherapyPatientsVolumesPerDayPerClinic" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PercentageOfEmployeesFurloughedOrTerminated" xlink:label="PercentageOfEmployeesFurloughedOrTerminated" xlink:title="PercentageOfEmployeesFurloughedOrTerminated" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:to="PercentageOfEmployeesFurloughedOrTerminated" xlink:title="presentation: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract to PercentageOfEmployeesFurloughedOrTerminated" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityNumberOfEmployees" xlink:label="EntityNumberOfEmployees" xlink:title="EntityNumberOfEmployees" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:to="EntityNumberOfEmployees" xlink:title="presentation: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract to EntityNumberOfEmployees" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfFurloughedEmployeesReturned" xlink:label="NumberOfFurloughedEmployeesReturned" xlink:title="NumberOfFurloughedEmployeesReturned" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:to="NumberOfFurloughedEmployeesReturned" xlink:title="presentation: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract to NumberOfFurloughedEmployeesReturned" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_CashAndCashEquivalentsAndAccruedLiabilities" xlink:label="CashAndCashEquivalentsAndAccruedLiabilities" xlink:title="CashAndCashEquivalentsAndAccruedLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:to="CashAndCashEquivalentsAndAccruedLiabilities" xlink:title="presentation: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract to CashAndCashEquivalentsAndAccruedLiabilities" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_GrantsAndOtherFunds" xlink:label="GrantsAndOtherFunds" xlink:title="GrantsAndOtherFunds" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:to="GrantsAndOtherFunds" xlink:title="presentation: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract to GrantsAndOtherFunds" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrantsReceivable" xlink:label="GrantsReceivable" xlink:title="GrantsReceivable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:to="GrantsReceivable" xlink:title="presentation: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract to GrantsReceivable" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ReliefFunds" xlink:label="ReliefFunds" xlink:title="ReliefFunds" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:to="ReliefFunds" xlink:title="presentation: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract to ReliefFunds" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" xlink:title="presentation: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems to ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:title="presentation: ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable to ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:title="presentation: OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NovemberTwoThousandTwentyAcquisitionMember" xlink:label="NovemberTwoThousandTwentyAcquisitionMember" xlink:title="NovemberTwoThousandTwentyAcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="NovemberTwoThousandTwentyAcquisitionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to NovemberTwoThousandTwentyAcquisitionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_SeptemberTwoThousandTwentyAcquisitionMember" xlink:label="SeptemberTwoThousandTwentyAcquisitionMember" xlink:title="SeptemberTwoThousandTwentyAcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="SeptemberTwoThousandTwentyAcquisitionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to SeptemberTwoThousandTwentyAcquisitionMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_FebruaryTwoThousandTwentyAcquisitionMember" xlink:label="FebruaryTwoThousandTwentyAcquisitionMember" xlink:title="FebruaryTwoThousandTwentyAcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="FebruaryTwoThousandTwentyAcquisitionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to FebruaryTwoThousandTwentyAcquisitionMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_SeptemberTwoThousandNineteenAcquisitionMember" xlink:label="SeptemberTwoThousandNineteenAcquisitionMember" xlink:title="SeptemberTwoThousandNineteenAcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="SeptemberTwoThousandNineteenAcquisitionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to SeptemberTwoThousandNineteenAcquisitionMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_August2018AcquisitionMember" xlink:label="August2018AcquisitionMember" xlink:title="August2018AcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="August2018AcquisitionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to August2018AcquisitionMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ManagementContractsMember" xlink:label="ManagementContractsMember" xlink:title="ManagementContractsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="ManagementContractsMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to ManagementContractsMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ClinicPracticeMember" xlink:label="ClinicPracticeMember" xlink:title="ClinicPracticeMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="ClinicPracticeMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to ClinicPracticeMember" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="presentation: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="RangeAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:label="BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:title="BusinessAcquisitionDateOfAcquisitionAgreement1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionDateOfAcquisitionAgreement1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfBusinessesAcquired" xlink:label="NumberOfBusinessesAcquired" xlink:title="NumberOfBusinessesAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="NumberOfBusinessesAcquired" xlink:title="presentation: BusinessCombinationDescriptionAbstract to NumberOfBusinessesAcquired" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="presentation: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfManagementContracts" xlink:label="NumberOfManagementContracts" xlink:title="NumberOfManagementContracts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="NumberOfManagementContracts" xlink:title="presentation: BusinessAcquisitionLineItems to NumberOfManagementContracts" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_RemainingContractTerm" xlink:label="RemainingContractTerm" xlink:title="RemainingContractTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="RemainingContractTerm" xlink:title="presentation: BusinessAcquisitionLineItems to RemainingContractTerm" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfPartnershipInWhichInterestAcquired" xlink:label="NumberOfPartnershipInWhichInterestAcquired" xlink:title="NumberOfPartnershipInWhichInterestAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="NumberOfPartnershipInWhichInterestAcquired" xlink:title="presentation: BusinessAcquisitionLineItems to NumberOfPartnershipInWhichInterestAcquired" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionLineItems" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="presentation: OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/SignificantAccountingPoliciesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="DisaggregationOfRevenueTable" xlink:title="DisaggregationOfRevenueTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="ProductOrServiceAxis" xlink:title="ProductOrServiceAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="ProductsAndServicesDomain" xlink:title="ProductsAndServicesDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NetPatientRevenuesMember" xlink:label="NetPatientRevenuesMember" xlink:title="NetPatientRevenuesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProductsAndServicesDomain" xlink:to="NetPatientRevenuesMember" xlink:title="presentation: ProductsAndServicesDomain to NetPatientRevenuesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ManagementContractRevenuesMember" xlink:label="ManagementContractRevenuesMember" xlink:title="ManagementContractRevenuesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProductsAndServicesDomain" xlink:to="ManagementContractRevenuesMember" xlink:title="presentation: ProductsAndServicesDomain to ManagementContractRevenuesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_OtherRevenuesMember" xlink:label="OtherRevenuesMember" xlink:title="OtherRevenuesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProductsAndServicesDomain" xlink:to="OtherRevenuesMember" xlink:title="presentation: ProductsAndServicesDomain to OtherRevenuesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PhysicalTherapyOperationsMember" xlink:label="PhysicalTherapyOperationsMember" xlink:title="PhysicalTherapyOperationsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProductsAndServicesDomain" xlink:to="PhysicalTherapyOperationsMember" xlink:title="presentation: ProductsAndServicesDomain to PhysicalTherapyOperationsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_IndustrialInjuryPreventionServicesRevenuesMember" xlink:label="IndustrialInjuryPreventionServicesRevenuesMember" xlink:title="IndustrialInjuryPreventionServicesRevenuesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProductsAndServicesDomain" xlink:to="IndustrialInjuryPreventionServicesRevenuesMember" xlink:title="presentation: ProductsAndServicesDomain to IndustrialInjuryPreventionServicesRevenuesMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProductOrServiceAxis" xlink:to="ProductsAndServicesDomain" xlink:title="presentation: ProductOrServiceAxis to ProductsAndServicesDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisaggregationOfRevenueTable" xlink:to="ProductOrServiceAxis" xlink:title="presentation: DisaggregationOfRevenueTable to ProductOrServiceAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="DisaggregationOfRevenueLineItems" xlink:title="DisaggregationOfRevenueLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="RevenueFromContractWithCustomerAbstract" xlink:title="RevenueFromContractWithCustomerAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:title="RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueFromContractWithCustomerAbstract" xlink:to="RevenueFromContractWithCustomerExcludingAssessedTax" xlink:title="presentation: RevenueFromContractWithCustomerAbstract to RevenueFromContractWithCustomerExcludingAssessedTax" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisaggregationOfRevenueLineItems" xlink:to="RevenueFromContractWithCustomerAbstract" xlink:title="presentation: DisaggregationOfRevenueLineItems to RevenueFromContractWithCustomerAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisaggregationOfRevenueTable" xlink:to="DisaggregationOfRevenueLineItems" xlink:title="presentation: DisaggregationOfRevenueTable to DisaggregationOfRevenueLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="DisaggregationOfRevenueTable" xlink:title="presentation: AccountingPoliciesAbstract to DisaggregationOfRevenueTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_DepreciationAmortizationImpairmentTable" xlink:label="DepreciationAmortizationImpairmentTable" xlink:title="DepreciationAmortizationImpairmentTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentTable" xlink:to="RangeAxis" xlink:title="presentation: DepreciationAmortizationImpairmentTable to RangeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="PropertyPlantAndEquipmentByTypeAxis" xlink:title="PropertyPlantAndEquipmentByTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="PropertyPlantAndEquipmentTypeDomain" xlink:title="PropertyPlantAndEquipmentTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="FurnitureAndFixturesMember" xlink:title="FurnitureAndFixturesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="FurnitureAndFixturesMember" xlink:title="presentation: PropertyPlantAndEquipmentTypeDomain to FurnitureAndFixturesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:label="ComputerSoftwareIntangibleAssetMember" xlink:title="ComputerSoftwareIntangibleAssetMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="ComputerSoftwareIntangibleAssetMember" xlink:title="presentation: PropertyPlantAndEquipmentTypeDomain to ComputerSoftwareIntangibleAssetMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="LeaseholdImprovementsMember" xlink:title="LeaseholdImprovementsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="LeaseholdImprovementsMember" xlink:title="presentation: PropertyPlantAndEquipmentTypeDomain to LeaseholdImprovementsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentByTypeAxis" xlink:to="PropertyPlantAndEquipmentTypeDomain" xlink:title="presentation: PropertyPlantAndEquipmentByTypeAxis to PropertyPlantAndEquipmentTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentTable" xlink:to="PropertyPlantAndEquipmentByTypeAxis" xlink:title="presentation: DepreciationAmortizationImpairmentTable to PropertyPlantAndEquipmentByTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis" xlink:label="UnusualOrInfrequentItemAxis" xlink:title="UnusualOrInfrequentItemAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain" xlink:label="UnusualOrInfrequentItemDomain" xlink:title="UnusualOrInfrequentItemDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_Year2017Member" xlink:label="Year2017Member" xlink:title="Year2017Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="UnusualOrInfrequentItemDomain" xlink:to="Year2017Member" xlink:title="presentation: UnusualOrInfrequentItemDomain to Year2017Member" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_Year2018Member" xlink:label="Year2018Member" xlink:title="Year2018Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="UnusualOrInfrequentItemDomain" xlink:to="Year2018Member" xlink:title="presentation: UnusualOrInfrequentItemDomain to Year2018Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_Year2019Member" xlink:label="Year2019Member" xlink:title="Year2019Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="UnusualOrInfrequentItemDomain" xlink:to="Year2019Member" xlink:title="presentation: UnusualOrInfrequentItemDomain to Year2019Member" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_FromTwoThousandNineteenThroughTwoThousandTwentyFourMember" xlink:label="FromTwoThousandNineteenThroughTwoThousandTwentyFourMember" xlink:title="FromTwoThousandNineteenThroughTwoThousandTwentyFourMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="UnusualOrInfrequentItemDomain" xlink:to="FromTwoThousandNineteenThroughTwoThousandTwentyFourMember" xlink:title="presentation: UnusualOrInfrequentItemDomain to FromTwoThousandNineteenThroughTwoThousandTwentyFourMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" xlink:label="FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" xlink:title="FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="UnusualOrInfrequentItemDomain" xlink:to="FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" xlink:title="presentation: UnusualOrInfrequentItemDomain to FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="UnusualOrInfrequentItemAxis" xlink:to="UnusualOrInfrequentItemDomain" xlink:title="presentation: UnusualOrInfrequentItemAxis to UnusualOrInfrequentItemDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentTable" xlink:to="UnusualOrInfrequentItemAxis" xlink:title="presentation: DepreciationAmortizationImpairmentTable to UnusualOrInfrequentItemAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="AdjustmentsForNewAccountingPronouncementsAxis" xlink:title="AdjustmentsForNewAccountingPronouncementsAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="TypeOfAdoptionMember" xlink:title="TypeOfAdoptionMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="AccountingStandardsUpdate201602Member" xlink:title="AccountingStandardsUpdate201602Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TypeOfAdoptionMember" xlink:to="AccountingStandardsUpdate201602Member" xlink:title="presentation: TypeOfAdoptionMember to AccountingStandardsUpdate201602Member" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="TypeOfAdoptionMember" xlink:title="presentation: AdjustmentsForNewAccountingPronouncementsAxis to TypeOfAdoptionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentTable" xlink:to="AdjustmentsForNewAccountingPronouncementsAxis" xlink:title="presentation: DepreciationAmortizationImpairmentTable to AdjustmentsForNewAccountingPronouncementsAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis" xlink:label="StatementScenarioAxis" xlink:title="StatementScenarioAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="ScenarioUnspecifiedDomain" xlink:title="ScenarioUnspecifiedDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember" xlink:label="ScenarioForecastMember" xlink:title="ScenarioForecastMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScenarioUnspecifiedDomain" xlink:to="ScenarioForecastMember" xlink:title="presentation: ScenarioUnspecifiedDomain to ScenarioForecastMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementScenarioAxis" xlink:to="ScenarioUnspecifiedDomain" xlink:title="presentation: StatementScenarioAxis to ScenarioUnspecifiedDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentTable" xlink:to="StatementScenarioAxis" xlink:title="presentation: DepreciationAmortizationImpairmentTable to StatementScenarioAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="DebtInstrumentAxis" xlink:title="DebtInstrumentAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain" xlink:title="DebtInstrumentNameDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_CreditAgreementMember" xlink:label="CreditAgreementMember" xlink:title="CreditAgreementMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentNameDomain" xlink:to="CreditAgreementMember" xlink:title="presentation: DebtInstrumentNameDomain to CreditAgreementMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentAxis" xlink:to="DebtInstrumentNameDomain" xlink:title="presentation: DebtInstrumentAxis to DebtInstrumentNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentTable" xlink:to="DebtInstrumentAxis" xlink:title="presentation: DepreciationAmortizationImpairmentTable to DebtInstrumentAxis" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="SubsequentEventMember" xlink:title="SubsequentEventMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTypeDomain" xlink:to="SubsequentEventMember" xlink:title="presentation: SubsequentEventTypeDomain to SubsequentEventMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTypeAxis" xlink:to="SubsequentEventTypeDomain" xlink:title="presentation: SubsequentEventTypeAxis to SubsequentEventTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentTable" xlink:to="SubsequentEventTypeAxis" xlink:title="presentation: DepreciationAmortizationImpairmentTable to SubsequentEventTypeAxis" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_DepreciationAmortizationImpairmentLineItems" xlink:label="DepreciationAmortizationImpairmentLineItems" xlink:title="DepreciationAmortizationImpairmentLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="PropertyPlantAndEquipmentAbstract" xlink:title="PropertyPlantAndEquipmentAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="PropertyPlantAndEquipmentUsefulLife" xlink:title="PropertyPlantAndEquipmentUsefulLife" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentAbstract" xlink:to="PropertyPlantAndEquipmentUsefulLife" xlink:title="presentation: PropertyPlantAndEquipmentAbstract to PropertyPlantAndEquipmentUsefulLife" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="PropertyPlantAndEquipmentAbstract" xlink:title="presentation: DepreciationAmortizationImpairmentLineItems to PropertyPlantAndEquipmentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationGoodwillAbstract" xlink:label="BusinessCombinationGoodwillAbstract" xlink:title="BusinessCombinationGoodwillAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="NumberOfOperatingSegments" xlink:title="NumberOfOperatingSegments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationGoodwillAbstract" xlink:to="NumberOfOperatingSegments" xlink:title="presentation: BusinessCombinationGoodwillAbstract to NumberOfOperatingSegments" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfRegions" xlink:label="NumberOfRegions" xlink:title="NumberOfRegions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationGoodwillAbstract" xlink:to="NumberOfRegions" xlink:title="presentation: BusinessCombinationGoodwillAbstract to NumberOfRegions" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="GoodwillImpairmentLoss" xlink:title="GoodwillImpairmentLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationGoodwillAbstract" xlink:to="GoodwillImpairmentLoss" xlink:title="presentation: BusinessCombinationGoodwillAbstract to GoodwillImpairmentLoss" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="BusinessCombinationGoodwillAbstract" xlink:title="presentation: DepreciationAmortizationImpairmentLineItems to BusinessCombinationGoodwillAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NonControllingInterestRedeemableAbstract" xlink:label="NonControllingInterestRedeemableAbstract" xlink:title="NonControllingInterestRedeemableAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:label="RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:title="RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonControllingInterestRedeemableAbstract" xlink:to="RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:title="presentation: NonControllingInterestRedeemableAbstract to RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="NonControllingInterestRedeemableAbstract" xlink:title="presentation: DepreciationAmortizationImpairmentLineItems to NonControllingInterestRedeemableAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_MedicareReimbursementAbstract" xlink:label="MedicareReimbursementAbstract" xlink:title="MedicareReimbursementAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PercentageOfMedicarePaymentIncrease" xlink:label="PercentageOfMedicarePaymentIncrease" xlink:title="PercentageOfMedicarePaymentIncrease" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="PercentageOfMedicarePaymentIncrease" xlink:title="presentation: MedicareReimbursementAbstract to PercentageOfMedicarePaymentIncrease" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_EstimatedPercentageOfDecreaseInPayment" xlink:label="EstimatedPercentageOfDecreaseInPayment" xlink:title="EstimatedPercentageOfDecreaseInPayment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="EstimatedPercentageOfDecreaseInPayment" xlink:title="presentation: MedicareReimbursementAbstract to EstimatedPercentageOfDecreaseInPayment" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PercentageOfBonusPayment" xlink:label="PercentageOfBonusPayment" xlink:title="PercentageOfBonusPayment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="PercentageOfBonusPayment" xlink:title="presentation: MedicareReimbursementAbstract to PercentageOfBonusPayment" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" xlink:label="PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" xlink:title="PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" xlink:title="presentation: MedicareReimbursementAbstract to PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_AmountOfReductionsInFederalSpending" xlink:label="AmountOfReductionsInFederalSpending" xlink:title="AmountOfReductionsInFederalSpending" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="AmountOfReductionsInFederalSpending" xlink:title="presentation: MedicareReimbursementAbstract to AmountOfReductionsInFederalSpending" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ReductionInMedicareSpendingPercentage" xlink:label="ReductionInMedicareSpendingPercentage" xlink:title="ReductionInMedicareSpendingPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="ReductionInMedicareSpendingPercentage" xlink:title="presentation: MedicareReimbursementAbstract to ReductionInMedicareSpendingPercentage" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ExpectedReductionInMedicareSpendingPercentage" xlink:label="ExpectedReductionInMedicareSpendingPercentage" xlink:title="ExpectedReductionInMedicareSpendingPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="ExpectedReductionInMedicareSpendingPercentage" xlink:title="presentation: MedicareReimbursementAbstract to ExpectedReductionInMedicareSpendingPercentage" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices" xlink:label="AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices" xlink:title="AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices" xlink:title="presentation: MedicareReimbursementAbstract to AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_AnnualLimitOccupationalTherapyServices" xlink:label="AnnualLimitOccupationalTherapyServices" xlink:title="AnnualLimitOccupationalTherapyServices" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="AnnualLimitOccupationalTherapyServices" xlink:title="presentation: MedicareReimbursementAbstract to AnnualLimitOccupationalTherapyServices" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:label="CombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:title="CombinedPhysicalTherapySpeechLanguagePathologyExpenses" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="CombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:title="presentation: MedicareReimbursementAbstract to CombinedPhysicalTherapySpeechLanguagePathologyExpenses" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:label="ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:title="ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:title="presentation: MedicareReimbursementAbstract to ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit" xlink:label="PercentageOfPracticeExpenseComponentOfRelativeValueUnit" xlink:title="PercentageOfPracticeExpenseComponentOfRelativeValueUnit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="PercentageOfPracticeExpenseComponentOfRelativeValueUnit" xlink:title="presentation: MedicareReimbursementAbstract to PercentageOfPracticeExpenseComponentOfRelativeValueUnit" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" xlink:label="PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" xlink:title="PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" xlink:title="presentation: MedicareReimbursementAbstract to PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PercentageOfPaymentForOutpatientTherapyServices" xlink:label="PercentageOfPaymentForOutpatientTherapyServices" xlink:title="PercentageOfPaymentForOutpatientTherapyServices" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="PercentageOfPaymentForOutpatientTherapyServices" xlink:title="presentation: MedicareReimbursementAbstract to PercentageOfPaymentForOutpatientTherapyServices" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NetRevenueFromMedicare" xlink:label="NetRevenueFromMedicare" xlink:title="NetRevenueFromMedicare" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="NetRevenueFromMedicare" xlink:title="presentation: MedicareReimbursementAbstract to NetRevenueFromMedicare" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" xlink:label="DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" xlink:title="DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" xlink:title="presentation: MedicareReimbursementAbstract to DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" xlink:label="DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" xlink:title="DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" xlink:title="presentation: MedicareReimbursementAbstract to DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_MaximumContractualAllowanceReserveEstimate" xlink:label="MaximumContractualAllowanceReserveEstimate" xlink:title="MaximumContractualAllowanceReserveEstimate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MedicareReimbursementAbstract" xlink:to="MaximumContractualAllowanceReserveEstimate" xlink:title="presentation: MedicareReimbursementAbstract to MaximumContractualAllowanceReserveEstimate" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="MedicareReimbursementAbstract" xlink:title="presentation: DepreciationAmortizationImpairmentLineItems to MedicareReimbursementAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:title="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:title="presentation: IncomeTaxDisclosureAbstract to UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" xlink:label="InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" xlink:title="InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" xlink:title="presentation: IncomeTaxDisclosureAbstract to InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="IncomeTaxDisclosureAbstract" xlink:title="presentation: DepreciationAmortizationImpairmentLineItems to IncomeTaxDisclosureAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:label="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:title="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="OperatingLeaseRightOfUseAsset" xlink:title="OperatingLeaseRightOfUseAsset" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="OperatingLeaseRightOfUseAsset" xlink:title="presentation: NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract to OperatingLeaseRightOfUseAsset" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability" xlink:title="OperatingLeaseLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="OperatingLeaseLiability" xlink:title="presentation: NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract to OperatingLeaseLiability" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:title="presentation: DepreciationAmortizationImpairmentLineItems to NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="SubsequentEventsAbstract" xlink:title="SubsequentEventsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="LineOfCreditFacilityMaximumBorrowingCapacity" xlink:title="LineOfCreditFacilityMaximumBorrowingCapacity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsAbstract" xlink:to="LineOfCreditFacilityMaximumBorrowingCapacity" xlink:title="presentation: SubsequentEventsAbstract to LineOfCreditFacilityMaximumBorrowingCapacity" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="DebtInstrumentMaturityDate" xlink:title="DebtInstrumentMaturityDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsAbstract" xlink:to="DebtInstrumentMaturityDate" xlink:title="presentation: SubsequentEventsAbstract to DebtInstrumentMaturityDate" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="DebtInstrumentFaceAmount" xlink:title="DebtInstrumentFaceAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsAbstract" xlink:to="DebtInstrumentFaceAmount" xlink:title="presentation: SubsequentEventsAbstract to DebtInstrumentFaceAmount" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="SubsequentEventsAbstract" xlink:title="presentation: DepreciationAmortizationImpairmentLineItems to SubsequentEventsAbstract" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentTable" xlink:to="DepreciationAmortizationImpairmentLineItems" xlink:title="presentation: DepreciationAmortizationImpairmentTable to DepreciationAmortizationImpairmentLineItems" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="DepreciationAmortizationImpairmentTable" xlink:title="presentation: AccountingPoliciesAbstract to DepreciationAmortizationImpairmentTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:label="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:title="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="TitleOfIndividualAxis" xlink:title="TitleOfIndividualAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_EmployeeMember" xlink:label="EmployeeMember" xlink:title="EmployeeMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="EmployeeMember" xlink:title="presentation: TitleOfIndividualWithRelationshipToEntityDomain to EmployeeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_DirectorMember" xlink:label="DirectorMember" xlink:title="DirectorMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="DirectorMember" xlink:title="presentation: TitleOfIndividualWithRelationshipToEntityDomain to DirectorMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OfficerMember" xlink:label="OfficerMember" xlink:title="OfficerMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="OfficerMember" xlink:title="presentation: TitleOfIndividualWithRelationshipToEntityDomain to OfficerMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TitleOfIndividualAxis" xlink:to="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="presentation: TitleOfIndividualAxis to TitleOfIndividualWithRelationshipToEntityDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="TitleOfIndividualAxis" xlink:title="presentation: ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable to TitleOfIndividualAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:label="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:title="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementsAbstract" xlink:label="DeferredCompensationArrangementsAbstract" xlink:title="DeferredCompensationArrangementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" xlink:label="DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" xlink:title="DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredCompensationArrangementsAbstract" xlink:to="DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" xlink:title="presentation: DeferredCompensationArrangementsAbstract to DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="DeferredCompensationArrangementsAbstract" xlink:title="presentation: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to DeferredCompensationArrangementsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:title="presentation: ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable to DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:title="presentation: AccountingPoliciesAbstract to ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/AcquisitionsOfBusinessesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" xlink:title="BusinessCombinationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NovemberTwoThousandTwentyAcquisitionMember" xlink:label="NovemberTwoThousandTwentyAcquisitionMember" xlink:title="NovemberTwoThousandTwentyAcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="NovemberTwoThousandTwentyAcquisitionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to NovemberTwoThousandTwentyAcquisitionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_SeptemberTwoThousandTwentyAcquisitionMember" xlink:label="SeptemberTwoThousandTwentyAcquisitionMember" xlink:title="SeptemberTwoThousandTwentyAcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="SeptemberTwoThousandTwentyAcquisitionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to SeptemberTwoThousandTwentyAcquisitionMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_FebruaryTwoThousandTwentyAcquisitionMember" xlink:label="FebruaryTwoThousandTwentyAcquisitionMember" xlink:title="FebruaryTwoThousandTwentyAcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="FebruaryTwoThousandTwentyAcquisitionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to FebruaryTwoThousandTwentyAcquisitionMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_SeptemberTwoThousandNineteenAcquisitionMember" xlink:label="SeptemberTwoThousandNineteenAcquisitionMember" xlink:title="SeptemberTwoThousandNineteenAcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="SeptemberTwoThousandNineteenAcquisitionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to SeptemberTwoThousandNineteenAcquisitionMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_August2018AcquisitionMember" xlink:label="August2018AcquisitionMember" xlink:title="August2018AcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="August2018AcquisitionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to August2018AcquisitionMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ManagementAndServicesContractsMember" xlink:label="ManagementAndServicesContractsMember" xlink:title="ManagementAndServicesContractsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="ManagementAndServicesContractsMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to ManagementAndServicesContractsMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ManagementContractsMember" xlink:label="ManagementContractsMember" xlink:title="ManagementContractsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="ManagementContractsMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to ManagementContractsMember" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:label="SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:title="SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_AprilTwoThousandNineteenAcquisitionMember" xlink:label="AprilTwoThousandNineteenAcquisitionMember" xlink:title="AprilTwoThousandNineteenAcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="AprilTwoThousandNineteenAcquisitionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to AprilTwoThousandNineteenAcquisitionMember" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_LeadingProviderOfIndustrialInjuryPreventionMember" xlink:label="LeadingProviderOfIndustrialInjuryPreventionMember" xlink:title="LeadingProviderOfIndustrialInjuryPreventionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="LeadingProviderOfIndustrialInjuryPreventionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to LeadingProviderOfIndustrialInjuryPreventionMember" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ClinicPracticeMember" xlink:label="ClinicPracticeMember" xlink:title="ClinicPracticeMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="ClinicPracticeMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to ClinicPracticeMember" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_AcquisitionOfFiveClinicPracticesMember" xlink:label="AcquisitionOfFiveClinicPracticesMember" xlink:title="AcquisitionOfFiveClinicPracticesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="AcquisitionOfFiveClinicPracticesMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to AcquisitionOfFiveClinicPracticesMember" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="presentation: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="ShortTermDebtTypeAxis" xlink:title="ShortTermDebtTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="ShortTermDebtTypeDomain" xlink:title="ShortTermDebtTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NotesPayableOneMember" xlink:label="NotesPayableOneMember" xlink:title="NotesPayableOneMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShortTermDebtTypeDomain" xlink:to="NotesPayableOneMember" xlink:title="presentation: ShortTermDebtTypeDomain to NotesPayableOneMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NotesPayableTwoMember" xlink:label="NotesPayableTwoMember" xlink:title="NotesPayableTwoMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShortTermDebtTypeDomain" xlink:to="NotesPayableTwoMember" xlink:title="presentation: ShortTermDebtTypeDomain to NotesPayableTwoMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShortTermDebtTypeAxis" xlink:to="ShortTermDebtTypeDomain" xlink:title="presentation: ShortTermDebtTypeAxis to ShortTermDebtTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="ShortTermDebtTypeAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to ShortTermDebtTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis" xlink:label="StatementScenarioAxis" xlink:title="StatementScenarioAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="ScenarioUnspecifiedDomain" xlink:title="ScenarioUnspecifiedDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_SeptemberTwoThousandTwentyMember" xlink:label="SeptemberTwoThousandTwentyMember" xlink:title="SeptemberTwoThousandTwentyMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScenarioUnspecifiedDomain" xlink:to="SeptemberTwoThousandTwentyMember" xlink:title="presentation: ScenarioUnspecifiedDomain to SeptemberTwoThousandTwentyMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_SeptemberTwoThousandTwentyOneMember" xlink:label="SeptemberTwoThousandTwentyOneMember" xlink:title="SeptemberTwoThousandTwentyOneMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScenarioUnspecifiedDomain" xlink:to="SeptemberTwoThousandTwentyOneMember" xlink:title="presentation: ScenarioUnspecifiedDomain to SeptemberTwoThousandTwentyOneMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_AugustTwoThousandNineteenMember" xlink:label="AugustTwoThousandNineteenMember" xlink:title="AugustTwoThousandNineteenMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScenarioUnspecifiedDomain" xlink:to="AugustTwoThousandNineteenMember" xlink:title="presentation: ScenarioUnspecifiedDomain to AugustTwoThousandNineteenMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_AugustTwoThousandTwentyMember" xlink:label="AugustTwoThousandTwentyMember" xlink:title="AugustTwoThousandTwentyMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScenarioUnspecifiedDomain" xlink:to="AugustTwoThousandTwentyMember" xlink:title="presentation: ScenarioUnspecifiedDomain to AugustTwoThousandTwentyMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementScenarioAxis" xlink:to="ScenarioUnspecifiedDomain" xlink:title="presentation: StatementScenarioAxis to ScenarioUnspecifiedDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="StatementScenarioAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to StatementScenarioAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="StatementBusinessSegmentsAxis" xlink:title="StatementBusinessSegmentsAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="SegmentDomain" xlink:title="SegmentDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PhysicalTherapyOperationsMember" xlink:label="PhysicalTherapyOperationsMember" xlink:title="PhysicalTherapyOperationsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentDomain" xlink:to="PhysicalTherapyOperationsMember" xlink:title="presentation: SegmentDomain to PhysicalTherapyOperationsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementBusinessSegmentsAxis" xlink:to="SegmentDomain" xlink:title="presentation: StatementBusinessSegmentsAxis to SegmentDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="StatementBusinessSegmentsAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to StatementBusinessSegmentsAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ReferralRelationshipMember" xlink:label="ReferralRelationshipMember" xlink:title="ReferralRelationshipMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="ReferralRelationshipMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to ReferralRelationshipMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="NoncompeteAgreementsMember" xlink:title="NoncompeteAgreementsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="NoncompeteAgreementsMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to NoncompeteAgreementsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="presentation: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to FiniteLivedIntangibleAssetsByMajorClassAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="RangeAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to RangeAxis" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:label="BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:title="BusinessAcquisitionDateOfAcquisitionAgreement1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionDateOfAcquisitionAgreement1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfBusinessesAcquired" xlink:label="NumberOfBusinessesAcquired" xlink:title="NumberOfBusinessesAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="NumberOfBusinessesAcquired" xlink:title="presentation: BusinessCombinationDescriptionAbstract to NumberOfBusinessesAcquired" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfManagementContracts" xlink:label="NumberOfManagementContracts" xlink:title="NumberOfManagementContracts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="NumberOfManagementContracts" xlink:title="presentation: BusinessCombinationDescriptionAbstract to NumberOfManagementContracts" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_RemainingContractTerm" xlink:label="RemainingContractTerm" xlink:title="RemainingContractTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="RemainingContractTerm" xlink:title="presentation: BusinessCombinationDescriptionAbstract to RemainingContractTerm" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfPartnershipInWhichInterestAcquired" xlink:label="NumberOfPartnershipInWhichInterestAcquired" xlink:title="NumberOfPartnershipInWhichInterestAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="NumberOfPartnershipInWhichInterestAcquired" xlink:title="presentation: BusinessCombinationDescriptionAbstract to NumberOfPartnershipInWhichInterestAcquired" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="BusinessCombinationConsiderationTransferred1" xlink:title="BusinessCombinationConsiderationTransferred1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessCombinationConsiderationTransferred1" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessCombinationConsiderationTransferred1" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="PaymentsToAcquireBusinessesGross" xlink:title="PaymentsToAcquireBusinessesGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="PaymentsToAcquireBusinessesGross" xlink:title="presentation: BusinessCombinationDescriptionAbstract to PaymentsToAcquireBusinessesGross" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" xlink:label="BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" xlink:title="BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:label="DebtInstrumentAnnualPrincipalPayment" xlink:title="DebtInstrumentAnnualPrincipalPayment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="DebtInstrumentAnnualPrincipalPayment" xlink:title="presentation: BusinessCombinationDescriptionAbstract to DebtInstrumentAnnualPrincipalPayment" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="DebtInstrumentInterestRateStatedPercentage" xlink:title="DebtInstrumentInterestRateStatedPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="DebtInstrumentInterestRateStatedPercentage" xlink:title="presentation: BusinessCombinationDescriptionAbstract to DebtInstrumentInterestRateStatedPercentage" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="PaymentsToAcquireBusinessesNetOfCashAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="presentation: BusinessCombinationDescriptionAbstract to PaymentsToAcquireBusinessesNetOfCashAcquired" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_BusinessAcquisitionPayableToShareholdersOfSeller" xlink:label="BusinessAcquisitionPayableToShareholdersOfSeller" xlink:title="BusinessAcquisitionPayableToShareholdersOfSeller" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionPayableToShareholdersOfSeller" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionPayableToShareholdersOfSeller" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:label="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:title="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionCostOfAcquiredEntityDebtIssued" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PaymentsToAcquireBusinessesConsideration" xlink:label="PaymentsToAcquireBusinessesConsideration" xlink:title="PaymentsToAcquireBusinessesConsideration" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="PaymentsToAcquireBusinessesConsideration" xlink:title="presentation: BusinessCombinationDescriptionAbstract to PaymentsToAcquireBusinessesConsideration" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:label="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:title="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:label="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:title="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:label="BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:title="BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:label="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:title="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" order="8.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="PaymentsToAcquireBusinessesConsideration" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to PaymentsToAcquireBusinessesConsideration" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:title="presentation: BusinessCombinationDescriptionAbstract to EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="CashAcquiredFromAcquisition" xlink:title="CashAcquiredFromAcquisition" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="CashAcquiredFromAcquisition" xlink:title="presentation: BusinessCombinationDescriptionAbstract to CashAcquiredFromAcquisition" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfStatesOfNetworkServices" xlink:label="NumberOfStatesOfNetworkServices" xlink:title="NumberOfStatesOfNetworkServices" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="NumberOfStatesOfNetworkServices" xlink:title="presentation: BusinessCombinationDescriptionAbstract to NumberOfStatesOfNetworkServices" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfOnsiteClientLocations" xlink:label="NumberOfOnsiteClientLocations" xlink:title="NumberOfOnsiteClientLocations" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="NumberOfOnsiteClientLocations" xlink:title="presentation: BusinessCombinationDescriptionAbstract to NumberOfOnsiteClientLocations" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" xlink:label="BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" xlink:title="BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfBusinessesMerged" xlink:label="NumberOfBusinessesMerged" xlink:title="NumberOfBusinessesMerged" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="NumberOfBusinessesMerged" xlink:title="presentation: BusinessCombinationDescriptionAbstract to NumberOfBusinessesMerged" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PercentageOfCombinedBusinessInterestOwned" xlink:label="PercentageOfCombinedBusinessInterestOwned" xlink:title="PercentageOfCombinedBusinessInterestOwned" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="PercentageOfCombinedBusinessInterestOwned" xlink:title="presentation: BusinessCombinationDescriptionAbstract to PercentageOfCombinedBusinessInterestOwned" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="presentation: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionLineItems" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionLineItems" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="presentation: BusinessCombinationsAbstract to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="NoncontrollingInterestAbstract" xlink:title="NoncontrollingInterestAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="RangeAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to RangeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfPartnershipInWhichInterestAcquired" xlink:label="NumberOfPartnershipInWhichInterestAcquired" xlink:title="NumberOfPartnershipInWhichInterestAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="NumberOfPartnershipInWhichInterestAcquired" xlink:title="presentation: BusinessCombinationDescriptionAbstract to NumberOfPartnershipInWhichInterestAcquired" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent" xlink:label="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent" xlink:title="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent" xlink:title="presentation: BusinessCombinationDescriptionAbstract to ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent" xlink:label="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent" xlink:title="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent" xlink:title="presentation: BusinessCombinationDescriptionAbstract to ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfClosedClinicsSold" xlink:label="NumberOfClosedClinicsSold" xlink:title="NumberOfClosedClinicsSold" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="NumberOfClosedClinicsSold" xlink:title="presentation: BusinessCombinationDescriptionAbstract to NumberOfClosedClinicsSold" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_AggregateSalePriceOfCinics" xlink:label="AggregateSalePriceOfCinics" xlink:title="AggregateSalePriceOfCinics" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="AggregateSalePriceOfCinics" xlink:title="presentation: BusinessCombinationDescriptionAbstract to AggregateSalePriceOfCinics" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_CashReceivedRelatedToSaleOfClinics" xlink:label="CashReceivedRelatedToSaleOfClinics" xlink:title="CashReceivedRelatedToSaleOfClinics" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="CashReceivedRelatedToSaleOfClinics" xlink:title="presentation: BusinessCombinationDescriptionAbstract to CashReceivedRelatedToSaleOfClinics" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NoteReceivableRelatedToSaleOfClinics" xlink:label="NoteReceivableRelatedToSaleOfClinics" xlink:title="NoteReceivableRelatedToSaleOfClinics" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="NoteReceivableRelatedToSaleOfClinics" xlink:title="presentation: BusinessCombinationDescriptionAbstract to NoteReceivableRelatedToSaleOfClinics" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration" xlink:label="NumberOfInstallmentsForNoteReceivableInSaleConsideration" xlink:title="NumberOfInstallmentsForNoteReceivableInSaleConsideration" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="NumberOfInstallmentsForNoteReceivableInSaleConsideration" xlink:title="presentation: BusinessCombinationDescriptionAbstract to NumberOfInstallmentsForNoteReceivableInSaleConsideration" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_SaleOfNoncontrollingInterestPercentageInPartnershipOne" xlink:label="SaleOfNoncontrollingInterestPercentageInPartnershipOne" xlink:title="SaleOfNoncontrollingInterestPercentageInPartnershipOne" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="SaleOfNoncontrollingInterestPercentageInPartnershipOne" xlink:title="presentation: BusinessCombinationDescriptionAbstract to SaleOfNoncontrollingInterestPercentageInPartnershipOne" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_TaxEffectOnSaleOfNoncontrollingInterest" xlink:label="TaxEffectOnSaleOfNoncontrollingInterest" xlink:title="TaxEffectOnSaleOfNoncontrollingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="TaxEffectOnSaleOfNoncontrollingInterest" xlink:title="presentation: BusinessCombinationDescriptionAbstract to TaxEffectOnSaleOfNoncontrollingInterest" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="presentation: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionLineItems" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NoncontrollingInterestAbstract" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="presentation: NoncontrollingInterestAbstract to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/RedeemableNoncontrollingInterestDetails">
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_RedeemableNonControllingInterestAbstract" xlink:label="RedeemableNonControllingInterestAbstract" xlink:title="RedeemableNonControllingInterestAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_TherapyPracticeMember" xlink:label="TherapyPracticeMember" xlink:title="TherapyPracticeMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="TherapyPracticeMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to TherapyPracticeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="presentation: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="ConsolidatedEntitiesAxis" xlink:title="ConsolidatedEntitiesAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="ConsolidatedEntitiesDomain" xlink:title="ConsolidatedEntitiesDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SubsidiariesMember" xlink:label="SubsidiariesMember" xlink:title="SubsidiariesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidatedEntitiesDomain" xlink:to="SubsidiariesMember" xlink:title="presentation: ConsolidatedEntitiesDomain to SubsidiariesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidatedEntitiesAxis" xlink:to="ConsolidatedEntitiesDomain" xlink:title="presentation: ConsolidatedEntitiesAxis to ConsolidatedEntitiesDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="ConsolidatedEntitiesAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="RangeAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="BusinessCombinationDescriptionAbstract" xlink:title="BusinessCombinationDescriptionAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" xlink:label="BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" xlink:title="BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" xlink:label="BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" xlink:title="BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" xlink:label="BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" xlink:title="BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_BusinessAcquisitionConsiderationPayableTermOfNote" xlink:label="BusinessAcquisitionConsiderationPayableTermOfNote" xlink:title="BusinessAcquisitionConsiderationPayableTermOfNote" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="BusinessAcquisitionConsiderationPayableTermOfNote" xlink:title="presentation: BusinessCombinationDescriptionAbstract to BusinessAcquisitionConsiderationPayableTermOfNote" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_TermOfEmploymentAgreement" xlink:label="TermOfEmploymentAgreement" xlink:title="TermOfEmploymentAgreement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="TermOfEmploymentAgreement" xlink:title="presentation: BusinessCombinationDescriptionAbstract to TermOfEmploymentAgreement" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_EmploymentAgreementRenewalTerm" xlink:label="EmploymentAgreementRenewalTerm" xlink:title="EmploymentAgreementRenewalTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="EmploymentAgreementRenewalTerm" xlink:title="presentation: BusinessCombinationDescriptionAbstract to EmploymentAgreementRenewalTerm" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" xlink:label="NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" xlink:title="NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" xlink:title="presentation: BusinessCombinationDescriptionAbstract to NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NonCompeteAgreementBasicTerm" xlink:label="NonCompeteAgreementBasicTerm" xlink:title="NonCompeteAgreementBasicTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationDescriptionAbstract" xlink:to="NonCompeteAgreementBasicTerm" xlink:title="presentation: BusinessCombinationDescriptionAbstract to NonCompeteAgreementBasicTerm" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationDescriptionAbstract" xlink:title="presentation: BusinessAcquisitionLineItems to BusinessCombinationDescriptionAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionLineItems" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNonControllingInterestAbstract" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="presentation: RedeemableNonControllingInterestAbstract to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable" xlink:label="RedeemableNoncontrollingInterestByLegalEntityTable" xlink:title="RedeemableNoncontrollingInterestByLegalEntityTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis" xlink:label="OwnershipAxis" xlink:title="OwnershipAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain" xlink:label="OwnershipDomain" xlink:title="OwnershipDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_RedeemableNonControllingInterestMember" xlink:label="RedeemableNonControllingInterestMember" xlink:title="RedeemableNonControllingInterestMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OwnershipDomain" xlink:to="RedeemableNonControllingInterestMember" xlink:title="presentation: OwnershipDomain to RedeemableNonControllingInterestMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OwnershipAxis" xlink:to="OwnershipDomain" xlink:title="presentation: OwnershipAxis to OwnershipDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNoncontrollingInterestByLegalEntityTable" xlink:to="OwnershipAxis" xlink:title="presentation: RedeemableNoncontrollingInterestByLegalEntityTable to OwnershipAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestLineItems" xlink:label="RedeemableNoncontrollingInterestLineItems" xlink:title="RedeemableNoncontrollingInterestLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:label="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:title="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:title="RedeemableNoncontrollingInterestEquityCarryingAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:to="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:title="presentation: RedeemableNoncontrollingInterestEquityCarryingAmountAbstract to RedeemableNoncontrollingInterestEquityCarryingAmount" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:label="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:title="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:to="NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" xlink:title="presentation: RedeemableNoncontrollingInterestEquityCarryingAmountAbstract to NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" xlink:label="DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" xlink:title="DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:to="DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" xlink:title="presentation: RedeemableNoncontrollingInterestEquityCarryingAmountAbstract to DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestChangeInRedemptionValue" xlink:label="MinorityInterestChangeInRedemptionValue" xlink:title="MinorityInterestChangeInRedemptionValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:to="MinorityInterestChangeInRedemptionValue" xlink:title="presentation: RedeemableNoncontrollingInterestEquityCarryingAmountAbstract to MinorityInterestChangeInRedemptionValue" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsToMinorityShareholders" xlink:label="ProceedsFromPaymentsToMinorityShareholders" xlink:title="ProceedsFromPaymentsToMinorityShareholders" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:to="ProceedsFromPaymentsToMinorityShareholders" xlink:title="presentation: RedeemableNoncontrollingInterestEquityCarryingAmountAbstract to ProceedsFromPaymentsToMinorityShareholders" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToMinorityShareholders" xlink:label="PaymentsToMinorityShareholders" xlink:title="PaymentsToMinorityShareholders" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:to="PaymentsToMinorityShareholders" xlink:title="presentation: RedeemableNoncontrollingInterestEquityCarryingAmountAbstract to PaymentsToMinorityShareholders" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation" xlink:label="NoncontrollingInterestDecreaseFromDeconsolidation" xlink:title="NoncontrollingInterestDecreaseFromDeconsolidation" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:to="NoncontrollingInterestDecreaseFromDeconsolidation" xlink:title="presentation: RedeemableNoncontrollingInterestEquityCarryingAmountAbstract to NoncontrollingInterestDecreaseFromDeconsolidation" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:label="ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:to="ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="presentation: RedeemableNoncontrollingInterestEquityCarryingAmountAbstract to ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:label="NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:to="NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="presentation: RedeemableNoncontrollingInterestEquityCarryingAmountAbstract to NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" xlink:label="DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:to="DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" xlink:title="presentation: RedeemableNoncontrollingInterestEquityCarryingAmountAbstract to DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:label="NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:title="NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:to="NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:title="presentation: RedeemableNoncontrollingInterestEquityCarryingAmountAbstract to NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="RedeemableNoncontrollingInterestEquityCarryingAmount_2" xlink:title="RedeemableNoncontrollingInterestEquityCarryingAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:to="RedeemableNoncontrollingInterestEquityCarryingAmount_2" xlink:title="presentation: RedeemableNoncontrollingInterestEquityCarryingAmountAbstract to RedeemableNoncontrollingInterestEquityCarryingAmount" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" xlink:title="presentation: RedeemableNoncontrollingInterestLineItems to RedeemableNoncontrollingInterestEquityCarryingAmountAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:label="CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:title="CarryingAmountOfRedeemableNonControllingInterestAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:label="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:title="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:to="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:title="presentation: CarryingAmountOfRedeemableNonControllingInterestAbstract to ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:label="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:title="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:to="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:title="presentation: CarryingAmountOfRedeemableNonControllingInterestAbstract to ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:label="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:title="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:to="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:title="presentation: CarryingAmountOfRedeemableNonControllingInterestAbstract to HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:label="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:title="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:to="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:title="presentation: CarryingAmountOfRedeemableNonControllingInterestAbstract to HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:to="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:title="presentation: CarryingAmountOfRedeemableNonControllingInterestAbstract to RedeemableNoncontrollingInterestEquityCarryingAmount" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNoncontrollingInterestLineItems" xlink:to="CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:title="presentation: RedeemableNoncontrollingInterestLineItems to CarryingAmountOfRedeemableNonControllingInterestAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNoncontrollingInterestByLegalEntityTable" xlink:to="RedeemableNoncontrollingInterestLineItems" xlink:title="presentation: RedeemableNoncontrollingInterestByLegalEntityTable to RedeemableNoncontrollingInterestLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RedeemableNonControllingInterestAbstract" xlink:to="RedeemableNoncontrollingInterestByLegalEntityTable" xlink:title="presentation: RedeemableNonControllingInterestAbstract to RedeemableNoncontrollingInterestByLegalEntityTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/GoodwillDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:title="GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward" xlink:label="GoodwillRollForward" xlink:title="GoodwillRollForward" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:label="Goodwill" xlink:title="Goodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillRollForward" xlink:to="Goodwill" xlink:title="presentation: GoodwillRollForward to Goodwill" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="GoodwillAcquiredDuringPeriod" xlink:title="GoodwillAcquiredDuringPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillRollForward" xlink:to="GoodwillAcquiredDuringPeriod" xlink:title="presentation: GoodwillRollForward to GoodwillAcquiredDuringPeriod" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:label="GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:title="GoodwillWrittenOffRelatedToSaleOfBusinessUnit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillRollForward" xlink:to="GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:title="presentation: GoodwillRollForward to GoodwillWrittenOffRelatedToSaleOfBusinessUnit" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="GoodwillImpairmentLoss" xlink:title="GoodwillImpairmentLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillRollForward" xlink:to="GoodwillImpairmentLoss" xlink:title="presentation: GoodwillRollForward to GoodwillImpairmentLoss" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:label="GoodwillPurchaseAccountingAdjustments" xlink:title="GoodwillPurchaseAccountingAdjustments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillRollForward" xlink:to="GoodwillPurchaseAccountingAdjustments" xlink:title="presentation: GoodwillRollForward to GoodwillPurchaseAccountingAdjustments" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:label="Goodwill_2" xlink:title="Goodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillRollForward" xlink:to="Goodwill_2" xlink:title="presentation: GoodwillRollForward to Goodwill" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="GoodwillRollForward" xlink:title="presentation: GoodwillAndIntangibleAssetsDisclosureAbstract to GoodwillRollForward" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/IntangibleAssetsNetDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:title="IntangibleAssetsNetExcludingGoodwillAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="ScheduleOfFiniteLivedIntangibleAssetsTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksMember" xlink:label="TrademarksMember" xlink:title="TrademarksMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="TrademarksMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to TrademarksMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ReferralRelationshipMember" xlink:label="ReferralRelationshipMember" xlink:title="ReferralRelationshipMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="ReferralRelationshipMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to ReferralRelationshipMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="NoncompeteAgreementsMember" xlink:title="NoncompeteAgreementsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="NoncompeteAgreementsMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to NoncompeteAgreementsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="presentation: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="presentation: ScheduleOfFiniteLivedIntangibleAssetsTable to FiniteLivedIntangibleAssetsByMajorClassAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="RangeAxis" xlink:title="presentation: ScheduleOfFiniteLivedIntangibleAssetsTable to RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="FiniteLivedIntangibleAssetsLineItems" xlink:title="FiniteLivedIntangibleAssetsLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:label="FiniteLivedIntangibleAssetsNetAbstract" xlink:title="FiniteLivedIntangibleAssetsNetAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="IntangibleAssetsNetExcludingGoodwill" xlink:title="IntangibleAssetsNetExcludingGoodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsNetAbstract" xlink:to="IntangibleAssetsNetExcludingGoodwill" xlink:title="presentation: FiniteLivedIntangibleAssetsNetAbstract to IntangibleAssetsNetExcludingGoodwill" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:title="FiniteLivedIntangibleAssetsAccumulatedAmortization" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsNetAbstract" xlink:to="FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:title="presentation: FiniteLivedIntangibleAssetsNetAbstract to FiniteLivedIntangibleAssetsAccumulatedAmortization" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="FiniteLivedIntangibleAssetUsefulLife" xlink:title="FiniteLivedIntangibleAssetUsefulLife" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsNetAbstract" xlink:to="FiniteLivedIntangibleAssetUsefulLife" xlink:title="presentation: FiniteLivedIntangibleAssetsNetAbstract to FiniteLivedIntangibleAssetUsefulLife" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsNetAbstract" xlink:title="presentation: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsNetAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="FiniteLivedIntangibleAssetsLineItems" xlink:title="presentation: ScheduleOfFiniteLivedIntangibleAssetsTable to FiniteLivedIntangibleAssetsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="presentation: IntangibleAssetsNetExcludingGoodwillAbstract to ScheduleOfFiniteLivedIntangibleAssetsTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:title="IntangibleAssetsNetExcludingGoodwillAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="ScheduleOfFiniteLivedIntangibleAssetsTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ReferralRelationshipMember" xlink:label="ReferralRelationshipMember" xlink:title="ReferralRelationshipMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="ReferralRelationshipMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to ReferralRelationshipMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="NoncompeteAgreementsMember" xlink:title="NoncompeteAgreementsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="NoncompeteAgreementsMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to NoncompeteAgreementsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksMember" xlink:label="TrademarksMember" xlink:title="TrademarksMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="TrademarksMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to TrademarksMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="presentation: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="presentation: ScheduleOfFiniteLivedIntangibleAssetsTable to FiniteLivedIntangibleAssetsByMajorClassAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="FiniteLivedIntangibleAssetsLineItems" xlink:title="FiniteLivedIntangibleAssetsLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfDeferredChargesAbstract" xlink:label="AmortizationOfDeferredChargesAbstract" xlink:title="AmortizationOfDeferredChargesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="AmortizationOfIntangibleAssets" xlink:title="AmortizationOfIntangibleAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AmortizationOfDeferredChargesAbstract" xlink:to="AmortizationOfIntangibleAssets" xlink:title="presentation: AmortizationOfDeferredChargesAbstract to AmortizationOfIntangibleAssets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfAcquiredOperations" xlink:label="NumberOfAcquiredOperations" xlink:title="NumberOfAcquiredOperations" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AmortizationOfDeferredChargesAbstract" xlink:to="NumberOfAcquiredOperations" xlink:title="presentation: AmortizationOfDeferredChargesAbstract to NumberOfAcquiredOperations" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="FiniteLivedIntangibleAssetUsefulLife" xlink:title="FiniteLivedIntangibleAssetUsefulLife" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AmortizationOfDeferredChargesAbstract" xlink:to="FiniteLivedIntangibleAssetUsefulLife" xlink:title="presentation: AmortizationOfDeferredChargesAbstract to FiniteLivedIntangibleAssetUsefulLife" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="AmortizationOfDeferredChargesAbstract" xlink:title="presentation: FiniteLivedIntangibleAssetsLineItems to AmortizationOfDeferredChargesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="FiniteLivedIntangibleAssetsLineItems" xlink:title="presentation: ScheduleOfFiniteLivedIntangibleAssetsTable to FiniteLivedIntangibleAssetsLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="presentation: IntangibleAssetsNetExcludingGoodwillAbstract to ScheduleOfFiniteLivedIntangibleAssetsTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:title="IntangibleAssetsNetExcludingGoodwillAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="ScheduleOfFiniteLivedIntangibleAssetsTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ReferralRelationshipMember" xlink:label="ReferralRelationshipMember" xlink:title="ReferralRelationshipMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="ReferralRelationshipMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to ReferralRelationshipMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="NoncompeteAgreementsMember" xlink:title="NoncompeteAgreementsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="NoncompeteAgreementsMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to NoncompeteAgreementsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="presentation: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="presentation: ScheduleOfFiniteLivedIntangibleAssetsTable to FiniteLivedIntangibleAssetsByMajorClassAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="FiniteLivedIntangibleAssetsLineItems" xlink:title="FiniteLivedIntangibleAssetsLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:label="FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:title="FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:title="presentation: FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract to FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:title="presentation: FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract to FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:title="presentation: FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract to FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:title="presentation: FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract to FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:title="presentation: FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract to FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:title="presentation: FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract to FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:title="presentation: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="FiniteLivedIntangibleAssetsLineItems" xlink:title="presentation: ScheduleOfFiniteLivedIntangibleAssetsTable to FiniteLivedIntangibleAssetsLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="presentation: IntangibleAssetsNetExcludingGoodwillAbstract to ScheduleOfFiniteLivedIntangibleAssetsTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/AccruedExpensesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="PayablesAndAccrualsAbstract" xlink:title="PayablesAndAccrualsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:label="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:title="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="EmployeeRelatedLiabilitiesCurrent" xlink:title="EmployeeRelatedLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="EmployeeRelatedLiabilitiesCurrent" xlink:title="presentation: AccountsPayableAndAccruedLiabilitiesCurrentAbstract to EmployeeRelatedLiabilitiesCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PatientsAndPayorsRelatedLiability" xlink:label="PatientsAndPayorsRelatedLiability" xlink:title="PatientsAndPayorsRelatedLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="PatientsAndPayorsRelatedLiability" xlink:title="presentation: AccountsPayableAndAccruedLiabilitiesCurrentAbstract to PatientsAndPayorsRelatedLiability" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedInsuranceCurrent" xlink:label="AccruedInsuranceCurrent" xlink:title="AccruedInsuranceCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="AccruedInsuranceCurrent" xlink:title="presentation: AccountsPayableAndAccruedLiabilitiesCurrentAbstract to AccruedInsuranceCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:label="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:title="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:title="presentation: AccountsPayableAndAccruedLiabilitiesCurrentAbstract to LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxesPayableCurrent" xlink:label="TaxesPayableCurrent" xlink:title="TaxesPayableCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="TaxesPayableCurrent" xlink:title="presentation: AccountsPayableAndAccruedLiabilitiesCurrentAbstract to TaxesPayableCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable" xlink:label="MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable" xlink:title="MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable" xlink:title="presentation: AccountsPayableAndAccruedLiabilitiesCurrentAbstract to MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_DeferredEmployerPayrollTaxesCARESACT" xlink:label="DeferredEmployerPayrollTaxesCARESACT" xlink:title="DeferredEmployerPayrollTaxesCARESACT" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="DeferredEmployerPayrollTaxesCARESACT" xlink:title="presentation: AccountsPayableAndAccruedLiabilitiesCurrentAbstract to DeferredEmployerPayrollTaxesCARESACT" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="OtherAccruedLiabilitiesCurrent" xlink:title="OtherAccruedLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="OtherAccruedLiabilitiesCurrent" xlink:title="presentation: AccountsPayableAndAccruedLiabilitiesCurrentAbstract to OtherAccruedLiabilitiesCurrent" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="AccruedLiabilitiesCurrent" xlink:title="presentation: AccountsPayableAndAccruedLiabilitiesCurrentAbstract to AccruedLiabilitiesCurrent" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:title="presentation: PayablesAndAccrualsAbstract to AccountsPayableAndAccruedLiabilitiesCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="DebtDisclosureAbstract" xlink:title="DebtDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="DebtInstrumentTable" xlink:title="DebtInstrumentTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="DebtInstrumentAxis" xlink:title="DebtInstrumentAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain" xlink:title="DebtInstrumentNameDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PromissoryNotesMember" xlink:label="PromissoryNotesMember" xlink:title="PromissoryNotesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentNameDomain" xlink:to="PromissoryNotesMember" xlink:title="presentation: DebtInstrumentNameDomain to PromissoryNotesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentAxis" xlink:to="DebtInstrumentNameDomain" xlink:title="presentation: DebtInstrumentAxis to DebtInstrumentNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="DebtInstrumentAxis" xlink:title="presentation: DebtInstrumentTable to DebtInstrumentAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="CreditFacilityAxis" xlink:title="CreditFacilityAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="CreditFacilityDomain" xlink:title="CreditFacilityDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="RevolvingCreditFacilityMember" xlink:title="RevolvingCreditFacilityMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CreditFacilityDomain" xlink:to="RevolvingCreditFacilityMember" xlink:title="presentation: CreditFacilityDomain to RevolvingCreditFacilityMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CreditFacilityAxis" xlink:to="CreditFacilityDomain" xlink:title="presentation: CreditFacilityAxis to CreditFacilityDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="CreditFacilityAxis" xlink:title="presentation: DebtInstrumentTable to CreditFacilityAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="RangeAxis" xlink:title="presentation: DebtInstrumentTable to RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="DebtInstrumentLineItems" xlink:title="DebtInstrumentLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentsAbstract" xlink:label="DebtInstrumentsAbstract" xlink:title="DebtInstrumentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt" xlink:label="LongTermDebt" xlink:title="LongTermDebt" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="LongTermDebt" xlink:title="presentation: DebtInstrumentsAbstract to LongTermDebt" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="LongTermDebtCurrent" xlink:title="LongTermDebtCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="LongTermDebtCurrent" xlink:title="presentation: DebtInstrumentsAbstract to LongTermDebtCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="LongTermDebtNoncurrent" xlink:title="LongTermDebtNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="LongTermDebtNoncurrent" xlink:title="presentation: DebtInstrumentsAbstract to LongTermDebtNoncurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:label="LineOfCreditFacilityInterestRateDuringPeriod" xlink:title="LineOfCreditFacilityInterestRateDuringPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="LineOfCreditFacilityInterestRateDuringPeriod" xlink:title="presentation: DebtInstrumentsAbstract to LineOfCreditFacilityInterestRateDuringPeriod" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:label="DebtInstrumentAnnualPrincipalPayment" xlink:title="DebtInstrumentAnnualPrincipalPayment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="DebtInstrumentAnnualPrincipalPayment" xlink:title="presentation: DebtInstrumentsAbstract to DebtInstrumentAnnualPrincipalPayment" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="DebtInstrumentInterestRateStatedPercentage" xlink:title="DebtInstrumentInterestRateStatedPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="DebtInstrumentInterestRateStatedPercentage" xlink:title="presentation: DebtInstrumentsAbstract to DebtInstrumentInterestRateStatedPercentage" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentsAbstract" xlink:title="presentation: DebtInstrumentLineItems to DebtInstrumentsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="DebtInstrumentLineItems" xlink:title="presentation: DebtInstrumentTable to DebtInstrumentLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDisclosureAbstract" xlink:to="DebtInstrumentTable" xlink:title="presentation: DebtDisclosureAbstract to DebtInstrumentTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/NotesPayableDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="DebtDisclosureAbstract" xlink:title="DebtDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="DebtInstrumentTable" xlink:title="DebtInstrumentTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="DebtInstrumentAxis" xlink:title="DebtInstrumentAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain" xlink:title="DebtInstrumentNameDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_CreditAgreementMember" xlink:label="CreditAgreementMember" xlink:title="CreditAgreementMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentNameDomain" xlink:to="CreditAgreementMember" xlink:title="presentation: DebtInstrumentNameDomain to CreditAgreementMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentAxis" xlink:to="DebtInstrumentNameDomain" xlink:title="presentation: DebtInstrumentAxis to DebtInstrumentNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="DebtInstrumentAxis" xlink:title="presentation: DebtInstrumentTable to DebtInstrumentAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="CreditFacilityAxis" xlink:title="CreditFacilityAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="CreditFacilityDomain" xlink:title="CreditFacilityDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="RevolvingCreditFacilityMember" xlink:title="RevolvingCreditFacilityMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CreditFacilityDomain" xlink:to="RevolvingCreditFacilityMember" xlink:title="presentation: CreditFacilityDomain to RevolvingCreditFacilityMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CreditFacilityAxis" xlink:to="CreditFacilityDomain" xlink:title="presentation: CreditFacilityAxis to CreditFacilityDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="CreditFacilityAxis" xlink:title="presentation: DebtInstrumentTable to CreditFacilityAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="RangeAxis" xlink:title="presentation: DebtInstrumentTable to RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="ShortTermDebtTypeAxis" xlink:title="ShortTermDebtTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="ShortTermDebtTypeDomain" xlink:title="ShortTermDebtTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NotesPayableMember" xlink:label="NotesPayableMember" xlink:title="NotesPayableMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShortTermDebtTypeDomain" xlink:to="NotesPayableMember" xlink:title="presentation: ShortTermDebtTypeDomain to NotesPayableMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShortTermDebtTypeAxis" xlink:to="ShortTermDebtTypeDomain" xlink:title="presentation: ShortTermDebtTypeAxis to ShortTermDebtTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="ShortTermDebtTypeAxis" xlink:title="presentation: DebtInstrumentTable to ShortTermDebtTypeAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="DebtInstrumentLineItems" xlink:title="DebtInstrumentLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentsAbstract" xlink:label="DebtInstrumentsAbstract" xlink:title="DebtInstrumentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="LineOfCreditFacilityMaximumBorrowingCapacity" xlink:title="LineOfCreditFacilityMaximumBorrowingCapacity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="LineOfCreditFacilityMaximumBorrowingCapacity" xlink:title="presentation: DebtInstrumentsAbstract to LineOfCreditFacilityMaximumBorrowingCapacity" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="DebtInstrumentMaturityDate" xlink:title="DebtInstrumentMaturityDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="DebtInstrumentMaturityDate" xlink:title="presentation: DebtInstrumentsAbstract to DebtInstrumentMaturityDate" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_DebtInstrumentBasisSpreadOnLiborVariableRate" xlink:label="DebtInstrumentBasisSpreadOnLiborVariableRate" xlink:title="DebtInstrumentBasisSpreadOnLiborVariableRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="DebtInstrumentBasisSpreadOnLiborVariableRate" xlink:title="presentation: DebtInstrumentsAbstract to DebtInstrumentBasisSpreadOnLiborVariableRate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="DebtInstrumentBasisSpreadOnVariableRate1" xlink:title="DebtInstrumentBasisSpreadOnVariableRate1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="DebtInstrumentBasisSpreadOnVariableRate1" xlink:title="presentation: DebtInstrumentsAbstract to DebtInstrumentBasisSpreadOnVariableRate1" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:label="LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:title="LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:title="presentation: DebtInstrumentsAbstract to LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" xlink:label="CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" xlink:title="CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" xlink:title="presentation: DebtInstrumentsAbstract to CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_DividendsCashAfterAmendment" xlink:label="DividendsCashAfterAmendment" xlink:title="DividendsCashAfterAmendment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="DividendsCashAfterAmendment" xlink:title="presentation: DebtInstrumentsAbstract to DividendsCashAfterAmendment" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:label="LineOfCreditFacilityRemainingBorrowingCapacity" xlink:title="LineOfCreditFacilityRemainingBorrowingCapacity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="LineOfCreditFacilityRemainingBorrowingCapacity" xlink:title="presentation: DebtInstrumentsAbstract to LineOfCreditFacilityRemainingBorrowingCapacity" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="DebtInstrumentFaceAmount" xlink:title="DebtInstrumentFaceAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="DebtInstrumentFaceAmount" xlink:title="presentation: DebtInstrumentsAbstract to DebtInstrumentFaceAmount" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:label="LineOfCreditFacilityInterestRateDuringPeriod" xlink:title="LineOfCreditFacilityInterestRateDuringPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="LineOfCreditFacilityInterestRateDuringPeriod" xlink:title="presentation: DebtInstrumentsAbstract to LineOfCreditFacilityInterestRateDuringPeriod" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="presentation: DebtInstrumentsAbstract to LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentsAbstract" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="presentation: DebtInstrumentsAbstract to LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentsAbstract" xlink:title="presentation: DebtInstrumentLineItems to DebtInstrumentsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="DebtInstrumentLineItems" xlink:title="presentation: DebtInstrumentTable to DebtInstrumentLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDisclosureAbstract" xlink:to="DebtInstrumentTable" xlink:title="presentation: DebtDisclosureAbstract to DebtInstrumentTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/LeasesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="LesseeLeaseDescriptionTable" xlink:title="LesseeLeaseDescriptionTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeLeaseDescriptionTable" xlink:to="RangeAxis" xlink:title="presentation: LesseeLeaseDescriptionTable to RangeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="AdjustmentsForNewAccountingPronouncementsAxis" xlink:title="AdjustmentsForNewAccountingPronouncementsAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="TypeOfAdoptionMember" xlink:title="TypeOfAdoptionMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="AccountingStandardsUpdate201602Member" xlink:title="AccountingStandardsUpdate201602Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TypeOfAdoptionMember" xlink:to="AccountingStandardsUpdate201602Member" xlink:title="presentation: TypeOfAdoptionMember to AccountingStandardsUpdate201602Member" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="TypeOfAdoptionMember" xlink:title="presentation: AdjustmentsForNewAccountingPronouncementsAxis to TypeOfAdoptionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeLeaseDescriptionTable" xlink:to="AdjustmentsForNewAccountingPronouncementsAxis" xlink:title="presentation: LesseeLeaseDescriptionTable to AdjustmentsForNewAccountingPronouncementsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="LesseeLeaseDescriptionLineItems" xlink:title="LesseeLeaseDescriptionLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseDescriptionAbstract" xlink:label="LesseeOperatingLeaseDescriptionAbstract" xlink:title="LesseeOperatingLeaseDescriptionAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="LesseeOperatingLeaseTermOfContract" xlink:title="LesseeOperatingLeaseTermOfContract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeOperatingLeaseDescriptionAbstract" xlink:to="LesseeOperatingLeaseTermOfContract" xlink:title="presentation: LesseeOperatingLeaseDescriptionAbstract to LesseeOperatingLeaseTermOfContract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LesseeOperatingLeaseDescriptionAbstract" xlink:title="presentation: LesseeLeaseDescriptionLineItems to LesseeOperatingLeaseDescriptionAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostAbstract" xlink:label="LeaseCostAbstract" xlink:title="LeaseCostAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="OperatingLeaseCost" xlink:title="OperatingLeaseCost" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeaseCostAbstract" xlink:to="OperatingLeaseCost" xlink:title="presentation: LeaseCostAbstract to OperatingLeaseCost" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermLeaseCost" xlink:label="ShortTermLeaseCost" xlink:title="ShortTermLeaseCost" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeaseCostAbstract" xlink:to="ShortTermLeaseCost" xlink:title="presentation: LeaseCostAbstract to ShortTermLeaseCost" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost" xlink:label="VariableLeaseCost" xlink:title="VariableLeaseCost" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeaseCostAbstract" xlink:to="VariableLeaseCost" xlink:title="presentation: LeaseCostAbstract to VariableLeaseCost" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost" xlink:label="LeaseCost" xlink:title="LeaseCost" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeaseCostAbstract" xlink:to="LeaseCost" xlink:title="presentation: LeaseCostAbstract to LeaseCost" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="LeaseCostAbstract" xlink:title="presentation: LesseeLeaseDescriptionLineItems to LeaseCostAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_SupplementalInformationRelatedToOperatingLeasesAbstract" xlink:label="SupplementalInformationRelatedToOperatingLeasesAbstract" xlink:title="SupplementalInformationRelatedToOperatingLeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="OperatingLeasePayments" xlink:title="OperatingLeasePayments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SupplementalInformationRelatedToOperatingLeasesAbstract" xlink:to="OperatingLeasePayments" xlink:title="presentation: SupplementalInformationRelatedToOperatingLeasesAbstract to OperatingLeasePayments" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:title="RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SupplementalInformationRelatedToOperatingLeasesAbstract" xlink:to="RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:title="presentation: SupplementalInformationRelatedToOperatingLeasesAbstract to RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="SupplementalInformationRelatedToOperatingLeasesAbstract" xlink:title="presentation: LesseeLeaseDescriptionLineItems to SupplementalInformationRelatedToOperatingLeasesAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:title="OperatingLeaseLiabilitiesPaymentsDueAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDue" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability" xlink:title="OperatingLeaseLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="OperatingLeaseLiability" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to OperatingLeaseLiability" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:title="presentation: LesseeLeaseDescriptionLineItems to OperatingLeaseLiabilitiesPaymentsDueAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_AverageLeaseTermsAndDiscountRatesAbstract" xlink:label="AverageLeaseTermsAndDiscountRatesAbstract" xlink:title="AverageLeaseTermsAndDiscountRatesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:title="OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AverageLeaseTermsAndDiscountRatesAbstract" xlink:to="OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:title="presentation: AverageLeaseTermsAndDiscountRatesAbstract to OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="OperatingLeaseWeightedAverageDiscountRatePercent" xlink:title="OperatingLeaseWeightedAverageDiscountRatePercent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AverageLeaseTermsAndDiscountRatesAbstract" xlink:to="OperatingLeaseWeightedAverageDiscountRatePercent" xlink:title="presentation: AverageLeaseTermsAndDiscountRatesAbstract to OperatingLeaseWeightedAverageDiscountRatePercent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeLeaseDescriptionLineItems" xlink:to="AverageLeaseTermsAndDiscountRatesAbstract" xlink:title="presentation: LesseeLeaseDescriptionLineItems to AverageLeaseTermsAndDiscountRatesAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LesseeLeaseDescriptionTable" xlink:to="LesseeLeaseDescriptionLineItems" xlink:title="presentation: LesseeLeaseDescriptionTable to LesseeLeaseDescriptionLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="LesseeLeaseDescriptionTable" xlink:title="presentation: LeasesAbstract to LesseeLeaseDescriptionTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/LeasesDetailsCalc01" />
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:label="ComponentsOfDeferredTaxAssetsAbstract" xlink:title="ComponentsOfDeferredTaxAssetsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:label="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:title="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfDeferredTaxAssetsAbstract" xlink:to="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:title="presentation: ComponentsOfDeferredTaxAssetsAbstract to DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:label="DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:title="DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfDeferredTaxAssetsAbstract" xlink:to="DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:title="presentation: ComponentsOfDeferredTaxAssetsAbstract to DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="DeferredTaxAssetsOperatingLossCarryforwards" xlink:title="DeferredTaxAssetsOperatingLossCarryforwards" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfDeferredTaxAssetsAbstract" xlink:to="DeferredTaxAssetsOperatingLossCarryforwards" xlink:title="presentation: ComponentsOfDeferredTaxAssetsAbstract to DeferredTaxAssetsOperatingLossCarryforwards" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_DeferredTaxAssetsLeaseObligations" xlink:label="DeferredTaxAssetsLeaseObligations" xlink:title="DeferredTaxAssetsLeaseObligations" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfDeferredTaxAssetsAbstract" xlink:to="DeferredTaxAssetsLeaseObligations" xlink:title="presentation: ComponentsOfDeferredTaxAssetsAbstract to DeferredTaxAssetsLeaseObligations" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="DeferredTaxAssetsGross" xlink:title="DeferredTaxAssetsGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfDeferredTaxAssetsAbstract" xlink:to="DeferredTaxAssetsGross" xlink:title="presentation: ComponentsOfDeferredTaxAssetsAbstract to DeferredTaxAssetsGross" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="ComponentsOfDeferredTaxAssetsAbstract" xlink:title="presentation: IncomeTaxDisclosureAbstract to ComponentsOfDeferredTaxAssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:label="ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:title="ComponentsOfDeferredTaxLiabilitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:title="DeferredTaxLiabilitiesPropertyPlantAndEquipment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:title="presentation: ComponentsOfDeferredTaxLiabilitiesAbstract to DeferredTaxLiabilitiesPropertyPlantAndEquipment" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" xlink:label="DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" xlink:title="DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" xlink:title="presentation: ComponentsOfDeferredTaxLiabilitiesAbstract to DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther" xlink:label="DeferredTaxLiabilitiesOther" xlink:title="DeferredTaxLiabilitiesOther" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="DeferredTaxLiabilitiesOther" xlink:title="presentation: ComponentsOfDeferredTaxLiabilitiesAbstract to DeferredTaxLiabilitiesOther" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="DeferredIncomeTaxLiabilities" xlink:title="DeferredIncomeTaxLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="DeferredIncomeTaxLiabilities" xlink:title="presentation: ComponentsOfDeferredTaxLiabilitiesAbstract to DeferredIncomeTaxLiabilities" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:title="presentation: IncomeTaxDisclosureAbstract to ComponentsOfDeferredTaxLiabilitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="DeferredTaxLiabilities" xlink:title="DeferredTaxLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="DeferredTaxLiabilities" xlink:title="presentation: IncomeTaxDisclosureAbstract to DeferredTaxLiabilities" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/IncomeTaxesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationTable" xlink:label="IncomeTaxExaminationTable" xlink:title="IncomeTaxExaminationTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="IncomeTaxAuthorityAxis" xlink:title="IncomeTaxAuthorityAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="IncomeTaxAuthorityDomain" xlink:title="IncomeTaxAuthorityDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="ForeignCountryMember" xlink:title="ForeignCountryMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxAuthorityDomain" xlink:to="ForeignCountryMember" xlink:title="presentation: IncomeTaxAuthorityDomain to ForeignCountryMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="StateAndLocalJurisdictionMember" xlink:title="StateAndLocalJurisdictionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxAuthorityDomain" xlink:to="StateAndLocalJurisdictionMember" xlink:title="presentation: IncomeTaxAuthorityDomain to StateAndLocalJurisdictionMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxAuthorityAxis" xlink:to="IncomeTaxAuthorityDomain" xlink:title="presentation: IncomeTaxAuthorityAxis to IncomeTaxAuthorityDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExaminationTable" xlink:to="IncomeTaxAuthorityAxis" xlink:title="presentation: IncomeTaxExaminationTable to IncomeTaxAuthorityAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExaminationTable" xlink:to="RangeAxis" xlink:title="presentation: IncomeTaxExaminationTable to RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationLineItems" xlink:label="IncomeTaxExaminationLineItems" xlink:title="IncomeTaxExaminationLineItems" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_IncomeTaxExaminationAbstract" xlink:label="IncomeTaxExaminationAbstract" xlink:title="IncomeTaxExaminationAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests" xlink:label="DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests" xlink:title="DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExaminationAbstract" xlink:to="DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests" xlink:title="presentation: IncomeTaxExaminationAbstract to DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:label="IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:title="IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExaminationAbstract" xlink:to="IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:title="presentation: IncomeTaxExaminationAbstract to IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="AccruedIncomeTaxesCurrent" xlink:title="AccruedIncomeTaxesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExaminationAbstract" xlink:to="AccruedIncomeTaxesCurrent" xlink:title="presentation: IncomeTaxExaminationAbstract to AccruedIncomeTaxesCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxesAndOtherTaxReceivableCurrent" xlink:label="DeferredIncomeTaxesAndOtherTaxReceivableCurrent" xlink:title="DeferredIncomeTaxesAndOtherTaxReceivableCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExaminationAbstract" xlink:to="DeferredIncomeTaxesAndOtherTaxReceivableCurrent" xlink:title="presentation: IncomeTaxExaminationAbstract to DeferredIncomeTaxesAndOtherTaxReceivableCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:title="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExaminationAbstract" xlink:to="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:title="presentation: IncomeTaxExaminationAbstract to UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" xlink:label="UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" xlink:title="UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExaminationAbstract" xlink:to="UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" xlink:title="presentation: IncomeTaxExaminationAbstract to UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationYearUnderExamination" xlink:label="IncomeTaxExaminationYearUnderExamination" xlink:title="IncomeTaxExaminationYearUnderExamination" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExaminationAbstract" xlink:to="IncomeTaxExaminationYearUnderExamination" xlink:title="presentation: IncomeTaxExaminationAbstract to IncomeTaxExaminationYearUnderExamination" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExaminationLineItems" xlink:to="IncomeTaxExaminationAbstract" xlink:title="presentation: IncomeTaxExaminationLineItems to IncomeTaxExaminationAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExaminationTable" xlink:to="IncomeTaxExaminationLineItems" xlink:title="presentation: IncomeTaxExaminationTable to IncomeTaxExaminationLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="IncomeTaxExaminationTable" xlink:title="presentation: IncomeTaxDisclosureAbstract to IncomeTaxExaminationTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:title="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:title="presentation: IncomeTaxDisclosureAbstract to IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:title="IncomeTaxReconciliationStateAndLocalIncomeTaxes" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:title="presentation: IncomeTaxDisclosureAbstract to IncomeTaxReconciliationStateAndLocalIncomeTaxes" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationDeductions" xlink:label="IncomeTaxReconciliationDeductions" xlink:title="IncomeTaxReconciliationDeductions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="IncomeTaxReconciliationDeductions" xlink:title="presentation: IncomeTaxDisclosureAbstract to IncomeTaxReconciliationDeductions" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:label="IncomeTaxReconciliationNondeductibleExpense" xlink:title="IncomeTaxReconciliationNondeductibleExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="IncomeTaxReconciliationNondeductibleExpense" xlink:title="presentation: IncomeTaxDisclosureAbstract to IncomeTaxReconciliationNondeductibleExpense" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="IncomeTaxExpenseBenefit" xlink:title="presentation: IncomeTaxDisclosureAbstract to IncomeTaxExpenseBenefit" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:title="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:title="presentation: IncomeTaxDisclosureAbstract to EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:title="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:title="presentation: IncomeTaxDisclosureAbstract to EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDeductions" xlink:label="EffectiveIncomeTaxRateReconciliationDeductions" xlink:title="EffectiveIncomeTaxRateReconciliationDeductions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="EffectiveIncomeTaxRateReconciliationDeductions" xlink:title="presentation: IncomeTaxDisclosureAbstract to EffectiveIncomeTaxRateReconciliationDeductions" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:label="EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:title="EffectiveIncomeTaxRateReconciliationNondeductibleExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:title="presentation: IncomeTaxDisclosureAbstract to EffectiveIncomeTaxRateReconciliationNondeductibleExpense" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="EffectiveIncomeTaxRateContinuingOperations" xlink:title="EffectiveIncomeTaxRateContinuingOperations" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="EffectiveIncomeTaxRateContinuingOperations" xlink:title="presentation: IncomeTaxDisclosureAbstract to EffectiveIncomeTaxRateContinuingOperations" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:title="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="CurrentFederalTaxExpenseBenefit" xlink:title="CurrentFederalTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="CurrentFederalTaxExpenseBenefit" xlink:title="presentation: CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract to CurrentFederalTaxExpenseBenefit" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="CurrentStateAndLocalTaxExpenseBenefit" xlink:title="CurrentStateAndLocalTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="CurrentStateAndLocalTaxExpenseBenefit" xlink:title="presentation: CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract to CurrentStateAndLocalTaxExpenseBenefit" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="CurrentIncomeTaxExpenseBenefit" xlink:title="CurrentIncomeTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="CurrentIncomeTaxExpenseBenefit" xlink:title="presentation: CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract to CurrentIncomeTaxExpenseBenefit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:title="presentation: IncomeTaxDisclosureAbstract to CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:title="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="DeferredFederalIncomeTaxExpenseBenefit" xlink:title="DeferredFederalIncomeTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="DeferredFederalIncomeTaxExpenseBenefit" xlink:title="presentation: DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract to DeferredFederalIncomeTaxExpenseBenefit" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:title="DeferredStateAndLocalIncomeTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:title="presentation: DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract to DeferredStateAndLocalIncomeTaxExpenseBenefit" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="DeferredIncomeTaxExpenseBenefit" xlink:title="DeferredIncomeTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="DeferredIncomeTaxExpenseBenefit" xlink:title="presentation: DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract to DeferredIncomeTaxExpenseBenefit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:title="presentation: IncomeTaxDisclosureAbstract to DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="IncomeTaxExpenseBenefit" xlink:title="presentation: IncomeTaxDisclosureAbstract to IncomeTaxExpenseBenefit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/SegmentInformationDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="SegmentReportingAbstract" xlink:title="SegmentReportingAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="ScheduleOfSegmentReportingInformationBySegmentTable" xlink:title="ScheduleOfSegmentReportingInformationBySegmentTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis" xlink:label="ConsolidationItemsAxis" xlink:title="ConsolidationItemsAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="ConsolidationItemsDomain" xlink:title="ConsolidationItemsDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="OperatingSegmentsMember" xlink:title="OperatingSegmentsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationItemsDomain" xlink:to="OperatingSegmentsMember" xlink:title="presentation: ConsolidationItemsDomain to OperatingSegmentsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidationItemsAxis" xlink:to="ConsolidationItemsDomain" xlink:title="presentation: ConsolidationItemsAxis to ConsolidationItemsDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="ConsolidationItemsAxis" xlink:title="presentation: ScheduleOfSegmentReportingInformationBySegmentTable to ConsolidationItemsAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="StatementBusinessSegmentsAxis" xlink:title="StatementBusinessSegmentsAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="SegmentDomain" xlink:title="SegmentDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PhysicalTherapyOperationsMember" xlink:label="PhysicalTherapyOperationsMember" xlink:title="PhysicalTherapyOperationsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentDomain" xlink:to="PhysicalTherapyOperationsMember" xlink:title="presentation: SegmentDomain to PhysicalTherapyOperationsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_IndustrialInjuryPreventionServicesRevenuesMember" xlink:label="IndustrialInjuryPreventionServicesRevenuesMember" xlink:title="IndustrialInjuryPreventionServicesRevenuesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentDomain" xlink:to="IndustrialInjuryPreventionServicesRevenuesMember" xlink:title="presentation: SegmentDomain to IndustrialInjuryPreventionServicesRevenuesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PhysicalTherapyOperationsExcludingClosureCostsMember" xlink:label="PhysicalTherapyOperationsExcludingClosureCostsMember" xlink:title="PhysicalTherapyOperationsExcludingClosureCostsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentDomain" xlink:to="PhysicalTherapyOperationsExcludingClosureCostsMember" xlink:title="presentation: SegmentDomain to PhysicalTherapyOperationsExcludingClosureCostsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementBusinessSegmentsAxis" xlink:to="SegmentDomain" xlink:title="presentation: StatementBusinessSegmentsAxis to SegmentDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="StatementBusinessSegmentsAxis" xlink:title="presentation: ScheduleOfSegmentReportingInformationBySegmentTable to StatementBusinessSegmentsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="SegmentReportingInformationLineItems" xlink:title="SegmentReportingInformationLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:label="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:title="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="Revenues" xlink:title="Revenues" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:to="Revenues" xlink:title="presentation: SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract to Revenues" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit" xlink:label="GrossProfit" xlink:title="GrossProfit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:to="GrossProfit" xlink:title="presentation: SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract to GrossProfit" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="RestructuringCharges" xlink:title="RestructuringCharges" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:to="RestructuringCharges" xlink:title="presentation: SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract to RestructuringCharges" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="Assets" xlink:title="Assets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:to="Assets" xlink:title="presentation: SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract to Assets" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentReportingInformationLineItems" xlink:to="SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" xlink:title="presentation: SegmentReportingInformationLineItems to SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="SegmentReportingInformationLineItems" xlink:title="presentation: ScheduleOfSegmentReportingInformationBySegmentTable to SegmentReportingInformationLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentReportingAbstract" xlink:to="ScheduleOfSegmentReportingInformationBySegmentTable" xlink:title="presentation: SegmentReportingAbstract to ScheduleOfSegmentReportingInformationBySegmentTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/EquityBasedPlansAmendedAndRestatedEmployeeStockOptionPlansDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="RangeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to RangeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="PlanNameAxis" xlink:title="PlanNameAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="PlanNameDomain" xlink:title="PlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_AmendedTwoThousandThreePlanMember" xlink:label="AmendedTwoThousandThreePlanMember" xlink:title="AmendedTwoThousandThreePlanMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PlanNameDomain" xlink:to="AmendedTwoThousandThreePlanMember" xlink:title="presentation: PlanNameDomain to AmendedTwoThousandThreePlanMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PlanNameAxis" xlink:to="PlanNameDomain" xlink:title="presentation: PlanNameAxis to PlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="PlanNameAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to PlanNameAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NonQualifiedStockOptionsMember" xlink:label="NonQualifiedStockOptionsMember" xlink:title="NonQualifiedStockOptionsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="NonQualifiedStockOptionsMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to NonQualifiedStockOptionsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="presentation: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAbstract" xlink:label="ShareBasedCompensationAbstract" xlink:title="ShareBasedCompensationAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:title="presentation: ShareBasedCompensationAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="presentation: ShareBasedCompensationAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/EquityBasedPlansCumulativeSummaryOfEquityPlansDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="PlanNameAxis" xlink:title="PlanNameAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="PlanNameDomain" xlink:title="PlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_AmendedNineteenNinetyNinePlanMember" xlink:label="AmendedNineteenNinetyNinePlanMember" xlink:title="AmendedNineteenNinetyNinePlanMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PlanNameDomain" xlink:to="AmendedNineteenNinetyNinePlanMember" xlink:title="presentation: PlanNameDomain to AmendedNineteenNinetyNinePlanMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_AmendedTwoThousandThreePlanMember" xlink:label="AmendedTwoThousandThreePlanMember" xlink:title="AmendedTwoThousandThreePlanMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PlanNameDomain" xlink:to="AmendedTwoThousandThreePlanMember" xlink:title="presentation: PlanNameDomain to AmendedTwoThousandThreePlanMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PlanNameAxis" xlink:to="PlanNameDomain" xlink:title="presentation: PlanNameAxis to PlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="PlanNameAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to PlanNameAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAbstract" xlink:label="ShareBasedCompensationAbstract" xlink:title="ShareBasedCompensationAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:title="presentation: ShareBasedCompensationAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod" xlink:title="presentation: ShareBasedCompensationAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="presentation: ShareBasedCompensationAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod" xlink:title="presentation: ShareBasedCompensationAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:title="presentation: ShareBasedCompensationAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="presentation: ShareBasedCompensationAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/EquityBasedPlansRestrictedStockGrantedToDirectorsOfficersAndEmployeesPursuantToItsEquityPlansDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="RestrictedStockMember" xlink:title="RestrictedStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="presentation: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAbstract" xlink:label="ShareBasedCompensationAbstract" xlink:title="ShareBasedCompensationAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="presentation: ShareBasedCompensationAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="presentation: ShareBasedCompensationAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/EquityBasedPlansRestrictedStockCancelledDueToEmployeeTerminationsPriorToRestrictionsLapsingDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="RestrictedStockMember" xlink:title="RestrictedStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="presentation: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAbstract" xlink:label="ShareBasedCompensationAbstract" xlink:title="ShareBasedCompensationAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:title="presentation: ShareBasedCompensationAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:title="presentation: ShareBasedCompensationAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/EquityBasedPlansDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="RangeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to RangeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="TitleOfIndividualAxis" xlink:title="TitleOfIndividualAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_EmployeesMember" xlink:label="EmployeesMember" xlink:title="EmployeesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="EmployeesMember" xlink:title="presentation: TitleOfIndividualWithRelationshipToEntityDomain to EmployeesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ExecutiveOfficerMember" xlink:label="ExecutiveOfficerMember" xlink:title="ExecutiveOfficerMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="ExecutiveOfficerMember" xlink:title="presentation: TitleOfIndividualWithRelationshipToEntityDomain to ExecutiveOfficerMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TitleOfIndividualAxis" xlink:to="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="presentation: TitleOfIndividualAxis to TitleOfIndividualWithRelationshipToEntityDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="TitleOfIndividualAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to TitleOfIndividualAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="RestrictedStockMember" xlink:title="RestrictedStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="presentation: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAbstract" xlink:label="ShareBasedCompensationAbstract" xlink:title="ShareBasedCompensationAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_RestrictedPeriodToEmployeesOnTheStockGranted" xlink:label="RestrictedPeriodToEmployeesOnTheStockGranted" xlink:title="RestrictedPeriodToEmployeesOnTheStockGranted" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationAbstract" xlink:to="RestrictedPeriodToEmployeesOnTheStockGranted" xlink:title="presentation: ShareBasedCompensationAbstract to RestrictedPeriodToEmployeesOnTheStockGranted" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed" xlink:title="presentation: ShareBasedCompensationAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription" xlink:title="presentation: ShareBasedCompensationAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="AllocatedShareBasedCompensationExpense" xlink:title="AllocatedShareBasedCompensationExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationAbstract" xlink:to="AllocatedShareBasedCompensationExpense" xlink:title="presentation: ShareBasedCompensationAbstract to AllocatedShareBasedCompensationExpense" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationAbstract" xlink:to="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:title="presentation: ShareBasedCompensationAbstract to EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/CommonStockDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="EquityAbstract" xlink:title="EquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfTreasuryStockTable" xlink:label="ClassOfTreasuryStockTable" xlink:title="ClassOfTreasuryStockTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfTreasuryStockTable" xlink:to="RangeAxis" xlink:title="presentation: ClassOfTreasuryStockTable to RangeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems" xlink:label="EquityClassOfTreasuryStockLineItems" xlink:title="EquityClassOfTreasuryStockLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDisclosuresAbstract" xlink:label="ClassOfStockDisclosuresAbstract" xlink:title="ClassOfStockDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:label="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDisclosuresAbstract" xlink:to="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="presentation: ClassOfStockDisclosuresAbstract to StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_PercentageOfRepurchaseOfCommonStock" xlink:label="PercentageOfRepurchaseOfCommonStock" xlink:title="PercentageOfRepurchaseOfCommonStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDisclosuresAbstract" xlink:to="PercentageOfRepurchaseOfCommonStock" xlink:title="presentation: ClassOfStockDisclosuresAbstract to PercentageOfRepurchaseOfCommonStock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock" xlink:label="BankCreditAgreementToPermitShareRepurchasesOfCommonStock" xlink:title="BankCreditAgreementToPermitShareRepurchasesOfCommonStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDisclosuresAbstract" xlink:to="BankCreditAgreementToPermitShareRepurchasesOfCommonStock" xlink:title="presentation: ClassOfStockDisclosuresAbstract to BankCreditAgreementToPermitShareRepurchasesOfCommonStock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="StockRepurchasedDuringPeriodShares" xlink:title="StockRepurchasedDuringPeriodShares" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDisclosuresAbstract" xlink:to="StockRepurchasedDuringPeriodShares" xlink:title="presentation: ClassOfStockDisclosuresAbstract to StockRepurchasedDuringPeriodShares" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_AdditionalEstimatedRepurchaseOfCommonStock" xlink:label="AdditionalEstimatedRepurchaseOfCommonStock" xlink:title="AdditionalEstimatedRepurchaseOfCommonStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDisclosuresAbstract" xlink:to="AdditionalEstimatedRepurchaseOfCommonStock" xlink:title="presentation: ClassOfStockDisclosuresAbstract to AdditionalEstimatedRepurchaseOfCommonStock" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="SharesIssuedPricePerShare" xlink:title="SharesIssuedPricePerShare" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDisclosuresAbstract" xlink:to="SharesIssuedPricePerShare" xlink:title="presentation: ClassOfStockDisclosuresAbstract to SharesIssuedPricePerShare" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityClassOfTreasuryStockLineItems" xlink:to="ClassOfStockDisclosuresAbstract" xlink:title="presentation: EquityClassOfTreasuryStockLineItems to ClassOfStockDisclosuresAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfTreasuryStockTable" xlink:to="EquityClassOfTreasuryStockLineItems" xlink:title="presentation: ClassOfTreasuryStockTable to EquityClassOfTreasuryStockLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="ClassOfTreasuryStockTable" xlink:title="presentation: EquityAbstract to ClassOfTreasuryStockTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/DefinedContributionPlanDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="CompensationAndRetirementDisclosureAbstract" xlink:title="CompensationAndRetirementDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan" xlink:label="DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan" xlink:title="DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CompensationAndRetirementDisclosureAbstract" xlink:to="DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan" xlink:title="presentation: CompensationAndRetirementDisclosureAbstract to DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:label="DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:title="DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CompensationAndRetirementDisclosureAbstract" xlink:to="DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:title="presentation: CompensationAndRetirementDisclosureAbstract to DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:label="DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:title="DefinedContributionPlanEmployerDiscretionaryContributionAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CompensationAndRetirementDisclosureAbstract" xlink:to="DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:title="presentation: CompensationAndRetirementDisclosureAbstract to DefinedContributionPlanEmployerDiscretionaryContributionAmount" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_DefinedContributionPlanEmployerMatchingContributionAmount" xlink:label="DefinedContributionPlanEmployerMatchingContributionAmount" xlink:title="DefinedContributionPlanEmployerMatchingContributionAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CompensationAndRetirementDisclosureAbstract" xlink:to="DefinedContributionPlanEmployerMatchingContributionAmount" xlink:title="presentation: CompensationAndRetirementDisclosureAbstract to DefinedContributionPlanEmployerMatchingContributionAmount" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/CommitmentsAndContingenciesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="CommitmentsAndContingenciesDisclosureAbstract" xlink:title="CommitmentsAndContingenciesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:label="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:title="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="TitleOfIndividualAxis" xlink:title="TitleOfIndividualAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ExecutiveOfficerMember" xlink:label="ExecutiveOfficerMember" xlink:title="ExecutiveOfficerMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="ExecutiveOfficerMember" xlink:title="presentation: TitleOfIndividualWithRelationshipToEntityDomain to ExecutiveOfficerMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TitleOfIndividualAxis" xlink:to="TitleOfIndividualWithRelationshipToEntityDomain" xlink:title="presentation: TitleOfIndividualAxis to TitleOfIndividualWithRelationshipToEntityDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="TitleOfIndividualAxis" xlink:title="presentation: ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable to TitleOfIndividualAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:label="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:title="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_EmploymentAgreementsAbstract" xlink:label="EmploymentAgreementsAbstract" xlink:title="EmploymentAgreementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_NumberOfEmployeesCoveredUnderEmployeeAgreement" xlink:label="NumberOfEmployeesCoveredUnderEmployeeAgreement" xlink:title="NumberOfEmployeesCoveredUnderEmployeeAgreement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EmploymentAgreementsAbstract" xlink:to="NumberOfEmployeesCoveredUnderEmployeeAgreement" xlink:title="presentation: EmploymentAgreementsAbstract to NumberOfEmployeesCoveredUnderEmployeeAgreement" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_EmploymentAgreementsRetirementDate" xlink:label="EmploymentAgreementsRetirementDate" xlink:title="EmploymentAgreementsRetirementDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EmploymentAgreementsAbstract" xlink:to="EmploymentAgreementsRetirementDate" xlink:title="presentation: EmploymentAgreementsAbstract to EmploymentAgreementsRetirementDate" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_EmploymentAgreementsExpirationDate" xlink:label="EmploymentAgreementsExpirationDate" xlink:title="EmploymentAgreementsExpirationDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EmploymentAgreementsAbstract" xlink:to="EmploymentAgreementsExpirationDate" xlink:title="presentation: EmploymentAgreementsAbstract to EmploymentAgreementsExpirationDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_EmploymentAgreementsExpirationDateTwo" xlink:label="EmploymentAgreementsExpirationDateTwo" xlink:title="EmploymentAgreementsExpirationDateTwo" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EmploymentAgreementsAbstract" xlink:to="EmploymentAgreementsExpirationDateTwo" xlink:title="presentation: EmploymentAgreementsAbstract to EmploymentAgreementsExpirationDateTwo" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_EmploymentAgreementsExpirationDateThree" xlink:label="EmploymentAgreementsExpirationDateThree" xlink:title="EmploymentAgreementsExpirationDateThree" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EmploymentAgreementsAbstract" xlink:to="EmploymentAgreementsExpirationDateThree" xlink:title="presentation: EmploymentAgreementsAbstract to EmploymentAgreementsExpirationDateThree" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_RenewalPeriodForEmploymentAgreement" xlink:label="RenewalPeriodForEmploymentAgreement" xlink:title="RenewalPeriodForEmploymentAgreement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EmploymentAgreementsAbstract" xlink:to="RenewalPeriodForEmploymentAgreement" xlink:title="presentation: EmploymentAgreementsAbstract to RenewalPeriodForEmploymentAgreement" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_EmployeeCompensationFuturePaymentDueNextFiscalYear" xlink:label="EmployeeCompensationFuturePaymentDueNextFiscalYear" xlink:title="EmployeeCompensationFuturePaymentDueNextFiscalYear" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EmploymentAgreementsAbstract" xlink:to="EmployeeCompensationFuturePaymentDueNextFiscalYear" xlink:title="presentation: EmploymentAgreementsAbstract to EmployeeCompensationFuturePaymentDueNextFiscalYear" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter" xlink:label="EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter" xlink:title="EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EmploymentAgreementsAbstract" xlink:to="EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter" xlink:title="presentation: EmploymentAgreementsAbstract to EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="EmploymentAgreementsAbstract" xlink:title="presentation: DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems to EmploymentAgreementsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:title="presentation: ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable to DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsAndContingenciesDisclosureAbstract" xlink:to="ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:title="presentation: CommitmentsAndContingenciesDisclosureAbstract to ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/EarningsPerShareDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" xlink:title="EarningsPerShareAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:label="NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:title="NetIncomeLossAvailableToCommonStockholdersBasicAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="NetIncomeLoss" xlink:title="presentation: NetIncomeLossAvailableToCommonStockholdersBasicAbstract to NetIncomeLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_CreditChargesToRetainedEarningsAbstract" xlink:label="CreditChargesToRetainedEarningsAbstract" xlink:title="CreditChargesToRetainedEarningsAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests" xlink:label="ChargesToRetainedEarningsRevaluationOfNonControllingInterests" xlink:title="ChargesToRetainedEarningsRevaluationOfNonControllingInterests" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CreditChargesToRetainedEarningsAbstract" xlink:to="ChargesToRetainedEarningsRevaluationOfNonControllingInterests" xlink:title="presentation: CreditChargesToRetainedEarningsAbstract to ChargesToRetainedEarningsRevaluationOfNonControllingInterests" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" xlink:label="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" xlink:title="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CreditChargesToRetainedEarningsAbstract" xlink:to="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" xlink:title="presentation: CreditChargesToRetainedEarningsAbstract to IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" xlink:label="IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" xlink:title="IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CreditChargesToRetainedEarningsAbstract" xlink:to="IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" xlink:title="presentation: CreditChargesToRetainedEarningsAbstract to IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="CreditChargesToRetainedEarningsAbstract" xlink:title="presentation: NetIncomeLossAvailableToCommonStockholdersBasicAbstract to CreditChargesToRetainedEarningsAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:title="presentation: EarningsPerShareAbstract to NetIncomeLossAvailableToCommonStockholdersBasicAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="EarningsPerShareBasicAndDiluted" xlink:title="EarningsPerShareBasicAndDiluted" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="EarningsPerShareBasicAndDiluted" xlink:title="presentation: EarningsPerShareAbstract to EarningsPerShareBasicAndDiluted" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="WeightedAverageNumberOfSharesOutstandingAbstract" xlink:title="WeightedAverageNumberOfSharesOutstandingAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:title="WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:title="presentation: WeightedAverageNumberOfSharesOutstandingAbstract to WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="WeightedAverageNumberOfSharesOutstandingAbstract" xlink:title="presentation: EarningsPerShareAbstract to WeightedAverageNumberOfSharesOutstandingAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20201231.xsd#usph_EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate" xlink:label="EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate" xlink:title="EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate" xlink:title="presentation: EarningsPerShareAbstract to EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/ScheduleIiValuationAndQualifyingAccountsDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract" xlink:label="ValuationAndQualifyingAccountsAbstract" xlink:title="ValuationAndQualifyingAccountsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:label="ValuationAndQualifyingAccountsDisclosureTable" xlink:title="ValuationAndQualifyingAccountsDisclosureTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:label="ValuationAllowancesAndReservesTypeAxis" xlink:title="ValuationAllowancesAndReservesTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:label="ValuationAllowancesAndReservesDomain" xlink:title="ValuationAllowancesAndReservesDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForCreditLossMember" xlink:label="AllowanceForCreditLossMember" xlink:title="AllowanceForCreditLossMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ValuationAllowancesAndReservesDomain" xlink:to="AllowanceForCreditLossMember" xlink:title="presentation: ValuationAllowancesAndReservesDomain to AllowanceForCreditLossMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ValuationAllowancesAndReservesTypeAxis" xlink:to="ValuationAllowancesAndReservesDomain" xlink:title="presentation: ValuationAllowancesAndReservesTypeAxis to ValuationAllowancesAndReservesDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ValuationAndQualifyingAccountsDisclosureTable" xlink:to="ValuationAllowancesAndReservesTypeAxis" xlink:title="presentation: ValuationAndQualifyingAccountsDisclosureTable to ValuationAllowancesAndReservesTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:label="ValuationAndQualifyingAccountsDisclosureLineItems" xlink:title="ValuationAndQualifyingAccountsDisclosureLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:label="MovementInValuationAllowancesAndReservesRollForward" xlink:title="MovementInValuationAllowancesAndReservesRollForward" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="ValuationAllowancesAndReservesBalance" xlink:title="ValuationAllowancesAndReservesBalance" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MovementInValuationAllowancesAndReservesRollForward" xlink:to="ValuationAllowancesAndReservesBalance" xlink:title="presentation: MovementInValuationAllowancesAndReservesRollForward to ValuationAllowancesAndReservesBalance" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:label="ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:title="ValuationAllowancesAndReservesChargedToCostAndExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MovementInValuationAllowancesAndReservesRollForward" xlink:to="ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:title="presentation: MovementInValuationAllowancesAndReservesRollForward to ValuationAllowancesAndReservesChargedToCostAndExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:label="ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:title="ValuationAllowancesAndReservesChargedToOtherAccounts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MovementInValuationAllowancesAndReservesRollForward" xlink:to="ValuationAllowancesAndReservesChargedToOtherAccounts" xlink:title="presentation: MovementInValuationAllowancesAndReservesRollForward to ValuationAllowancesAndReservesChargedToOtherAccounts" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions" xlink:label="ValuationAllowancesAndReservesDeductions" xlink:title="ValuationAllowancesAndReservesDeductions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MovementInValuationAllowancesAndReservesRollForward" xlink:to="ValuationAllowancesAndReservesDeductions" xlink:title="presentation: MovementInValuationAllowancesAndReservesRollForward to ValuationAllowancesAndReservesDeductions" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="ValuationAllowancesAndReservesBalance_2" xlink:title="ValuationAllowancesAndReservesBalance" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MovementInValuationAllowancesAndReservesRollForward" xlink:to="ValuationAllowancesAndReservesBalance_2" xlink:title="presentation: MovementInValuationAllowancesAndReservesRollForward to ValuationAllowancesAndReservesBalance" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="MovementInValuationAllowancesAndReservesRollForward" xlink:title="presentation: ValuationAndQualifyingAccountsDisclosureLineItems to MovementInValuationAllowancesAndReservesRollForward" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ValuationAndQualifyingAccountsDisclosureTable" xlink:to="ValuationAndQualifyingAccountsDisclosureLineItems" xlink:title="presentation: ValuationAndQualifyingAccountsDisclosureTable to ValuationAndQualifyingAccountsDisclosureLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ValuationAndQualifyingAccountsAbstract" xlink:to="ValuationAndQualifyingAccountsDisclosureTable" xlink:title="presentation: ValuationAndQualifyingAccountsAbstract to ValuationAndQualifyingAccountsDisclosureTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>image0.jpg
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" () M # 2(  A$! Q$!_\0
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M^_\  "?_ .(K0HH S_[9M?\ GE??^ $__P 11_;-K_SROO\ P G_ /B*T**
M,_\ MFU_YY7W_@!/_P#$4?VS:_\ /*^_\ )__B*T** ,_P#MFU_YY7W_ ( 3
M_P#Q%']LVO\ SROO_ "?_P"(K0HH S_[9M?^>5]_X 3_ /Q%']LVO_/*^_\
M "?_ .(K0HH S_[9M?\ GE??^ $__P 11_;-K_SROO\ P G_ /B*T** ,_\
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M_@!/_P#$4?VS:_\ /*^_\ )__B*T** ,_P#MFU_YY7W_ ( 3_P#Q%']LVO\
MSROO_ "?_P"(K0HH S_[9M?^>5]_X 3_ /Q%']LVO_/*^_\  "?_ .(K0HH
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M_P"(K0HH S_[9M?^>5]_X 3_ /Q%']LVO_/*^_\  "?_ .(K0HH S_[9M?\
MGE??^ $__P 11_;-K_SROO\ P G_ /B*T** ,_\ MFU_YY7W_@!/_P#$4?VS
M:_\ /*^_\ )__B*T** ,_P#MFU_YY7W_ ( 3_P#Q%']LVO\ SROO_ "?_P"(
MK0HH S_[9M?^>5]_X 3_ /Q%']LVO_/*^_\  "?_ .(K0HH S_[9M?\ GE??
M^ $__P 11_;-K_SROO\ P G_ /B*T** ,_\ MFU_YY7W_@!/_P#$4?VS:_\
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M5Y>Z?J6E1VT,+2)!<:=)(_RKD@N)U')!_AX]Z -^BN?^Q^,/^@[H?_@FF_\
MDJC['XP_Z#NA_P#@FF_^2J .@HKG_L?C#_H.Z'_X)IO_ )*H^Q^,/^@[H?\
MX)IO_DJ@#H**Y_['XP_Z#NA_^":;_P"2J/L?C#_H.Z'_ .":;_Y*H Z"BN?^
MQ^,/^@[H?_@FF_\ DJC['XP_Z#NA_P#@FF_^2J .@HKG_L?C#_H.Z'_X)IO_
M )*H^Q^,/^@[H?\ X)IO_DJ@#H**Y_['XP_Z#NA_^":;_P"2J/L?C#_H.Z'_
M .":;_Y*H Z"BN?^Q^,/^@[H?_@FF_\ DJC['XP_Z#NA_P#@FF_^2J .@HKG
M_L?C#_H.Z'_X)IO_ )*H^Q^,/^@[H?\ X)IO_DJ@#H**Y_['XP_Z#NA_^":;
M_P"2J/L?C#_H.Z'_ .":;_Y*H Z"BN?^Q^,/^@[H?_@FF_\ DJC['XP_Z#NA
M_P#@FF_^2J .@HKG_L?C#_H.Z'_X)IO_ )*H^Q^,/^@[H?\ X)IO_DJ@#H**
MY_['XP_Z#NA_^":;_P"2J/L?C#_H.Z'_ .":;_Y*H Z"BN?^Q^,/^@[H?_@F
MF_\ DJC['XP_Z#NA_P#@FF_^2J .@HKG_L?C#_H.Z'_X)IO_ )*H^Q^,/^@[
MH?\ X)IO_DJ@#H**Y_['XP_Z#NA_^":;_P"2J/L?C#_H.Z'_ .":;_Y*H Z"
MBN?^Q^,/^@[H?_@FF_\ DJC['XP_Z#NA_P#@FF_^2J .@HKG_L?C#_H.Z'_X
M)IO_ )*H^Q^,/^@[H?\ X)IO_DJ@#H**Y_['XP_Z#NA_^":;_P"2J/L?C#_H
M.Z'_ .":;_Y*H Z"BN?^Q^,/^@[H?_@FF_\ DJC['XP_Z#NA_P#@FF_^2J .
M@HKG_L?C#_H.Z'_X)IO_ )*H^Q^,/^@[H?\ X)IO_DJ@#H**Y_['XP_Z#NA_
M^":;_P"2J/L?C#_H.Z'_ .":;_Y*H Z"BN?^Q^,/^@[H?_@FF_\ DJC['XP_
MZ#NA_P#@FF_^2J .@HKG_L?C#_H.Z'_X)IO_ )*H^Q^,/^@[H?\ X)IO_DJ@
M#H**Y_['XP_Z#NA_^":;_P"2J/L?C#_H.Z'_ .":;_Y*H Z"BN?^Q^,/^@[H
M?_@FF_\ DJC['XP_Z#NA_P#@FF_^2J .@HKG_L?C#_H.Z'_X)IO_ )*H^Q^,
M/^@[H?\ X)IO_DJ@#H**Y_['XP_Z#NA_^":;_P"2J/L?C#_H.Z'_ .":;_Y*
MH Z"BN?^Q^,/^@[H?_@FF_\ DJC['XP_Z#NA_P#@FF_^2J .@HKG_L?C#_H.
MZ'_X)IO_ )*H^Q^,/^@[H?\ X)IO_DJ@#H**Y_['XP_Z#NA_^":;_P"2J/L?
MC#_H.Z'_ .":;_Y*H Z"BN?^Q^,/^@[H?_@FF_\ DJC['XP_Z#NA_P#@FF_^
M2J .@HKG_L?C#_H.Z'_X)IO_ )*H^Q^,/^@[H?\ X)IO_DJ@#H**Y_['XP_Z
M#NA_^":;_P"2J/L?C#_H.Z'_ .":;_Y*H Z"BN?^Q^,/^@[H?_@FF_\ DJC[
M'XP_Z#NA_P#@FF_^2J .@HKG_L?C#_H.Z'_X)IO_ )*I1:>+\C.N:'COC1I?
M_DJ@#?HHHH **** "N?\"?\ )//#/_8*M?\ T4M=!7/^!/\ DGGAG_L%6O\
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M6[C';DYXZ4 7*S]>_P"1>U/_ *])?_0#6A6?KW_(O:G_ ->DO_H!H T****
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M[.NO^@S??]\0?_&ZT** ,_\ LZZ_Z#-]_P!\0?\ QNC^SKK_ *#-]_WQ!_\
M&ZT** ,_^SKK_H,WW_?$'_QNC^SKK_H,WW_?$'_QNM"B@#/_ +.NO^@S??\
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M^;+_ .1Z/^$>U3_H<]<_[\V7_P CT =!17/_ /"/:I_T.>N?]^;+_P"1Z/\
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MSUS_ +\V7_R/0!T%%<__ ,(]JG_0YZY_WYLO_D>C_A'M4_Z'/7/^_-E_\CT
M=!17/_\ "/:I_P!#GKG_ 'YLO_D>C_A'M4_Z'/7/^_-E_P#(] '045S_ /PC
MVJ?]#GKG_?FR_P#D>C_A'M4_Z'/7/^_-E_\ (] '045S_P#PCVJ?]#GKG_?F
MR_\ D>JNHV,ND6C7>H^/]5M+=>LDZV*+GTR;?K[4TFW9 =517F-MK6H:U%(W
MAG6_%FKJN0MQ]FL;>W)_ZZ26XS_P$-5_3_#GC^YR^J>-9;.-N/L\%M;S.!_U
MU\E,'Z+^-:>QDOCT]?\ +<5SMK[4++3+9KF_NX+6!>LD\@11^)KGG\=V=U&#
MH.G:CKA)*A[*#$(/O*^U/R)K*G^%%C>7@N[[Q#K=],OW3>_9KD+_ +HDA8#\
M*W4\-:C&BI'XPUM$4855@L0 /_ >C]U'S_!?Y_D&I6=/&^J,A672]"MV&64*
M;R<?C\J _@WU-.'@+2KBY%SK%Q?ZS-G.+^X+19_ZY+MCQ[;<59_X1[5/^ASU
MS_OS9?\ R/1_PCVJ?]#GKG_?FR_^1Z/;27PZ>G^>X6-JVM+:RA$-I;Q01#HD
M2!5'X"IJY_\ X1[5/^ASUS_OS9?_ "/1_P (]JG_ $.>N?\ ?FR_^1ZRO<9T
M%%<__P (]JG_ $.>N?\ ?FR_^1Z/^$>U3_H<]<_[\V7_ ,CT =!17/\ _"/:
MI_T.>N?]^;+_ .1Z/^$>U3_H<]<_[\V7_P CT =!17/_ /"/:I_T.>N?]^;+
M_P"1Z/\ A'M4_P"ASUS_ +\V7_R/0!T%%<__ ,(]JG_0YZY_WYLO_D>C_A'M
M4_Z'/7/^_-E_\CT =!17/_\ "/:I_P!#GKG_ 'YLO_D>C_A'M4_Z'/7/^_-E
M_P#(] '045S_ /PCVJ?]#GKG_?FR_P#D>C_A'M4_Z'/7/^_-E_\ (] '045S
M_P#PCVJ?]#GKG_?FR_\ D>C_ (1[5/\ H<]<_P"_-E_\CT =!17/_P#"/:I_
MT.>N?]^;+_Y'I1X>U,$'_A,M</L8;+_Y'H WZ*** "BBB@ KG_ G_)//#/\
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M8\<8-;OA?4-0U32?M=_+I$Q=SY,FDW+3PL@QSN('.=PX]* -JL_7O^1>U/\
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MF(N5C:5EXV8ZS-GZ#WS/_9]UG_D,WW_?$'_QNM"B@ HHHH **** "N?\"?\
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M7/\ P?7O_P >K,9T%%<__P (;I?_ #]:Y_X/KW_X]1_PANE_\_6N?^#Z]_\
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M_!]>_P#QZK45'9&%2M4JN]23?JSH**Y__A#=+_Y^M<_\'U[_ /'J/^$-TO\
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MO#=WJ]W#JWBIDFN(V$EMIL;DV]F1T/\ TT?_ &B..P'6NKHHJ)S<MQA1114
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M* "BBB@ HHHH ***H:IK>F:);^?J=_!:H>GFN 6]E'4GV%-)MV0%^O-OB?\
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M)_R3SPS_ -@JU_\ 12T =!6?IW_']JW_ %]K_P"B8JT*S]._X_M6_P"OM?\
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MQK7_ )ZWW_@?/_\ %T?V-:_\];[_ ,#Y_P#XNM"B@#/_ +&M?^>M]_X'S_\
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M=G\!@>U=+12=635EHO(+&?\ V-:_\];[_P #Y_\ XNC^QK7_ )ZWW_@?/_\
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M .QK7_GK??\ @?/_ /%T?V-:_P#/6^_\#Y__ (NM"B@#/_L:U_YZWW_@?/\
M_%T?V-:_\];[_P #Y_\ XNM"B@#/_L:U_P">M]_X'S__ !=']C6O_/6^_P#
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M^ Z?X4?V%H__ $";'_P'3_"@#0HK/_L+1_\ H$V/_@.G^%']A:/_ - FQ_\
M =/\* -"BL_^PM'_ .@38_\ @.G^%']A:/\ ] FQ_P# =/\ "@#0HK/_ +"T
M?_H$V/\ X#I_A1_86C_] FQ_\!T_PH T**S_ .PM'_Z!-C_X#I_A1_86C_\
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MBL_^WM'_ .@K8_\ @0G^-']O:/\ ]!6Q_P# A/\ &@#0HK/_ +>T?_H*V/\
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MO:/_ -!6Q_\  A/\: -"BL_^WM'_ .@K8_\ @0G^-']O:/\ ]!6Q_P# A/\
M&@#0HK/_ +>T?_H*V/\ X$)_C1_;NC_]!6Q_\"$_QH T**** "BBB@ KG_ G
M_)//#/\ V"K7_P!%+705S_@3_DGGAG_L%6O_ **6@#H*S]._X_M6_P"OM?\
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MY5I:QF21L9./0#N2> /4T 7JR/%=C<:IX.US3[1/,N;K3YX(4+ ;G:-E49/
MY(ZU%J/BS3-,T:QU.;[3)'?[!:PP0-+-,67< J*"2=H)_"I] \16'B2RDNK
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M6Z3PAUDV/TW*0RG\" : *GAO15\/^'[331*9I(DS-.WWII3R[GW+$FM6BB@
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M #ZZY_X(;W_XS7044 <__P )EI?_ #ZZY_X(;W_XS1_PF6E_\^NN?^"&]_\
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M6?BG3;V]AM(XM3CEF)$9N=*N8$)"EB-\D84' /?M6S6?J/\ Q_:3_P!?;?\
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M!<7MIILY@F<'='A&88_'FL:Z\*:#H7PHU>^TO2X+6ZN-"<32Q@Y?,63G\>:
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M?^B9:T* "BBB@ HHHH **** "BBB@ HHHH **** "N?\"?\ )//#/_8*M?\
MT4M=!7/^!/\ DGGAG_L%6O\ Z*6@#H*S]._X_M6_Z^U_]$Q5H5GZ=_Q_:M_U
M]K_Z)BH T**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@#/F_Y&&R_Z]+C_P!#AK0K/F_Y&&R_Z]+C_P!#AK0H **** "BBB@
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH SYO^1ALO\
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M%9^G?\?VK?\ 7VO_ *)BH T**** "BBB@ HHHH **** "BBB@ HHHH ****
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MX QG(&>IKN_ OC3_ (2E]0M)+G3KNXL?+9KG3B_DR*^['RORK#:01D]CGG
M.QHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#/U'_C^TG_K
M[;_T3+6A6?J/_']I/_7VW_HF6M"@ HHHH **** "BBB@ HHHH **** "BBB@
M KG_  )_R3SPS_V"K7_T4M=!7/\ @3_DGGAG_L%6O_HI: .@K/T[_C^U;_K[
M7_T3%6A6?IW_ !_:M_U]K_Z)BH T**** "BBB@ HHHH **** "BBB@ HHHH
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M=_Q_:M_U]K_Z)BH T**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@#/F_Y&&R_Z]+C_P!#AK0K/F_Y&&R_Z]+C_P!#AK0H ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MG4[&ZOF(CB6*9)"I/5B 3P!G\<58\.>.])U70K:ZO]1L;.[(VS0RW"(0PX)
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M0S@XQ_#WS7244 <E=^%-8UC3-3L=9\2F:.\LC:*MK9B!$SUD(+,68]#R!C.
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M2EBT1 !8@9P"<>QJ/_A._!__ $->A_\ @QA_^*KH** .?_X3OP?_ -#7H?\
MX,8?_BJ/^$[\'_\ 0UZ'_P"#&'_XJN@HH Y__A._!_\ T->A_P#@QA_^*H_X
M3OP?_P!#7H?_ (,8?_BJZ"B@#G_^$[\'_P#0UZ'_ .#&'_XJC_A._!__ $->
MA_\ @QA_^*KH** .?_X3OP?_ -#7H?\ X,8?_BJ/^$[\'_\ 0UZ'_P"#&'_X
MJN@HH Y__A._!_\ T->A_P#@QA_^*H_X3OP?_P!#7H?_ (,8?_BJZ"B@#G_^
M$[\'_P#0UZ'_ .#&'_XJC_A._!__ $->A_\ @QA_^*KH** .?_X3OP?_ -#7
MH?\ X,8?_BJ/^$[\'_\ 0UZ'_P"#&'_XJN@HH Y__A._!_\ T->A_P#@QA_^
M*H_X3OP?_P!#7H?_ (,8?_BJZ"B@#G_^$[\'_P#0UZ'_ .#&'_XJC_A._!__
M $->A_\ @QA_^*KH** .?_X3OP?_ -#7H?\ X,8?_BJ/^$[\'_\ 0UZ'_P"#
M&'_XJN@HH Y__A._!_\ T->A_P#@QA_^*H_X3OP?_P!#7H?_ (,8?_BJZ"B@
M#G_^$[\'_P#0UZ'_ .#&'_XJC_A._!__ $->A_\ @QA_^*KH** .?_X3OP?_
M -#7H?\ X,8?_BJ/^$[\'_\ 0UZ'_P"#&'_XJN@HH Y__A._!_\ T->A_P#@
MQA_^*H_X3OP?_P!#7H?_ (,8?_BJZ"B@#G_^$[\'_P#0UZ'_ .#&'_XJC_A.
M_!__ $->A_\ @QA_^*KH** .?_X3OP?_ -#7H?\ X,8?_BJ/^$[\'_\ 0UZ'
M_P"#&'_XJN@HH Y__A._!_\ T->A_P#@QA_^*H_X3OP?_P!#7H?_ (,8?_BJ
MZ"B@#G_^$[\'_P#0UZ'_ .#&'_XJC_A._!__ $->A_\ @QA_^*KH** .?_X3
MOP?_ -#7H?\ X,8?_BJ/^$[\'_\ 0UZ'_P"#&'_XJN@HH Y__A._!_\ T->A
M_P#@QA_^*H_X3OP?_P!#7H?_ (,8?_BJZ"B@#G_^$[\'_P#0UZ'_ .#&'_XJ
MC_A._!__ $->A_\ @QA_^*KH** .?_X3OP?_ -#7H?\ X,8?_BJ/^$[\'_\
M0UZ'_P"#&'_XJN@HH Y__A._!_\ T->A_P#@QA_^*H_X3OP?_P!#7H?_ (,8
M?_BJZ"B@#G_^$[\'_P#0UZ'_ .#&'_XJC_A._!__ $->A_\ @QA_^*KH** .
M9/BCP]JVL:1:Z;KNF7EP;EF$5M=QR/@0RY.%).*Z:BB@ HHHH **** "BBB@
M HHHH **** "BBB@ KG_  )_R3SPS_V"K7_T4M=!7/\ @3_DGGAG_L%6O_HI
M: .@K/T[_C^U;_K[7_T3%6A6?IW_ !_:M_U]K_Z)BH T**** "BBB@ HHHH
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M]1_PANE_\_6N?^#Z]_\ CU=!10!S_P#PANE_\_6N?^#Z]_\ CU'_  ANE_\
M/UKG_@^O?_CU=!10!S__  ANE_\ /UKG_@^O?_CU'_"&Z7_S]:Y_X/KW_P"/
M5T%% '/_ /"&Z7_S]:Y_X/KW_P"/4?\ "&Z7_P _6N?^#Z]_^/5T%% '/_\
M"&Z7_P _6N?^#Z]_^/4?\(;I?_/UKG_@^O?_ (]7044 <_\ \(;I?_/UKG_@
M^O?_ (]1_P (;I?_ #]:Y_X/KW_X]7044 <__P (;I?_ #]:Y_X/KW_X]1_P
MANE_\_6N?^#Z]_\ CU=!10!S_P#PANE_\_6N?^#Z]_\ CU'_  ANE_\ /UKG
M_@^O?_CU=!10!S__  ANE_\ /UKG_@^O?_CU'_"&Z7_S]:Y_X/KW_P"/5T%%
M '/_ /"&Z7_S]:Y_X/KW_P"/4?\ "&Z7_P _6N?^#Z]_^/5T%% '/_\ "&Z7
M_P _6N?^#Z]_^/4?\(;I?_/UKG_@^O?_ (]7044 <_\ \(;I?_/UKG_@^O?_
M (]1_P (;I?_ #]:Y_X/KW_X]7044 <__P (;I?_ #]:Y_X/KW_X]1_PANE_
M\_6N?^#Z]_\ CU=!10!S_P#PANE_\_6N?^#Z]_\ CU'_  ANE_\ /UKG_@^O
M?_CU=!10!S__  ANE_\ /UKG_@^O?_CU'_"&Z7_S]:Y_X/KW_P"/5T%% '/_
M /"&Z7_S]:Y_X/KW_P"/4?\ "&Z7_P _6N?^#Z]_^/5T%% '/_\ "&Z7_P _
M6N?^#Z]_^/4?\(;I?_/UKG_@^O?_ (]7044 <_\ \(;I?_/UKG_@^O?_ (]1
M_P (;I?_ #]:Y_X/KW_X]7044 <__P (;I?_ #]:Y_X/KW_X]1_PANE_\_6N
M?^#Z]_\ CU=!10!S_P#PANE_\_6N?^#Z]_\ CU'_  ANE_\ /UKG_@^O?_CU
M=!10!S__  ANE_\ /UKG_@^O?_CU'_"&Z7_S]:Y_X/KW_P"/5T%% '/_ /"&
MZ7_S]:Y_X/KW_P"/4?\ "&Z7_P _6N?^#Z]_^/5T%% '/_\ "&Z7_P _6N?^
M#Z]_^/4?\(;I?_/UKG_@^O?_ (]7044 <_\ \(;I?_/UKG_@^O?_ (]1_P (
M;I?_ #]:Y_X/KW_X]7044 <__P (;I?_ #]:Y_X/KW_X]1_PANE_\_6N?^#Z
M]_\ CU=!10!S_P#PANE_\_6N?^#Z]_\ CU'_  ANE_\ /UKG_@^O?_CU=!10
M!S__  ANE_\ /UKG_@^O?_CU'_"&Z7_S]:Y_X/KW_P"/5T%% '/_ /"&Z7_S
M]:Y_X/KW_P"/4?\ "&Z7_P _6N?^#Z]_^/5T%% '/_\ "&Z7_P _6N?^#Z]_
M^/4?\(;I?_/UKG_@^O?_ (]7044 <_\ \(;I?_/UKG_@^O?_ (]1_P (;I?_
M #]:Y_X/KW_X]7044 <__P (;I?_ #]:Y_X/KW_X]1_PANE_\_6N?^#Z]_\
MCU=!10!S_P#PANE_\_6N?^#Z]_\ CU'_  ANE_\ /UKG_@^O?_CU=!10!S__
M  ANE_\ /UKG_@^O?_CU'_"&Z7_S]:Y_X/KW_P"/5T%% '/_ /"&Z7_S]:Y_
MX/KW_P"/4?\ "&Z7_P _6N?^#Z]_^/5T%% '/_\ "&Z7_P _6N?^#Z]_^/4?
M\(;I?_/UKG_@^O?_ (]7044 <_\ \(;I?_/UKG_@^O?_ (]1_P (;I?_ #]:
MY_X/KW_X]7044 <__P (;I?_ #]:Y_X/KW_X]1_PANE_\_6N?^#Z]_\ CU=!
M10!S_P#PANE_\_6N?^#Z]_\ CU'_  ANE_\ /UKG_@^O?_CU=!10!S__  AN
ME_\ /UKG_@^O?_CU'_"&Z7_S]:Y_X/KW_P"/5T%% '/_ /"&Z7_S]:Y_X/KW
M_P"/4?\ "&Z7_P _6N?^#Z]_^/5T%% '/_\ "&Z7_P _6N?^#Z]_^/5L6-E;
=Z;I]M86D?E6MM$L,*9)VHH 49/)P .M6** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>image00002.jpg
<TEXT>
begin 644 image00002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" .Q!?<# 2(  A$! Q$!_\0
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MBB@ HHHH **** "BBB@ HHHH **** "BBB@ J-OO&I*C;[QJ9;$RV&T445)
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #EZ4M(O2EH*04444QA
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 (:*#10(**** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ IR?>_"FTY/O?A0MQK<DHHHK0T"BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH !UIU-'6G4T-!1113&%%%% !1110 4444
M %%%% !1110 4444 %%%% !2KUI*5>M (?1115&@4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110!5HHHK(Y0HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "I!T%1U(.@IH<0HHHJB@HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** &]Z*.]%0(**** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ J-OO&I*C;[QJ9;$RV&T445) 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% #EZ4M(O2EH*04444QA1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 (:*#10(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IR?>
M_"FTY/O?A0MQK<DHHHK0T"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH !UIU-'6G4T-!1113&%%%% !1110 4444 %%%% !1110 4444 %%%% !2
MKUI*5>M (?1115&@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110!5HHHK(Y0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "I!T%1
MU(.@IH<0HHHJB@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &]Z*
M.]%0(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J-OO&I*C;[QJ
M9;$RV&T445) 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #EZ4M(
MO2EH*04444QA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 (:*#10(**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ IR?>_"FTY/O?A0MQK<DHHHK0T"BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH !UIU-'6G4T-!1113&%%%
M% !1110 4444 %%%% !1110 4444 %%%% !2KUI*5>M (?1115&@4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110!5HHHK(Y0HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "I!T%1U(.@IH<0HHHJB@HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** &]Z*.]%0(**** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ J-OO&I*C;[QJ9;$RV&T445) 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% #EZ4M(O2EH*04444QA1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 (:*#10(**** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ IR?>_"FTY/O?A0MQK<DHHHK0T"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH !UIU-'6G4T-!1113&%%%% !1110 4444 %%%% !1110
M4444 %%%% !2KUI*5>M (?1115&@4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110!5HHHK(Y0HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "I!T%1U(.@IH<0HHHJB@HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** &]Z*.]%0(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MJ-OO&I*C;[QJ9;$RV&T445) 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% #EZ4M(O2EH*04444QA1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 (:*#10
M(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IR?>_"FTY/O?A0MQ
MK<DHHHK0T"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH !UIU-'6G
M4T-!1113&%%%% !1110 4444 %%%% !1110 4444 %%%% !2KUI*5>M (?11
M15&@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!5HHHK(Y0
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "I!T%1U(.@IH<0HHHJ
MB@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &]Z*.]%0(**** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ J-OO&I*C;[QJ9;$RV&T445)
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M'_H.ZG_X%R?XT?\ "4>(?^@[J?\ X%R?XT<X<Z/IBBOF?_A*/$/_ $'=3_\
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M@YCZ0HKYO_X2;7_^@YJ7_@7)_C1_PDVO_P#0<U+_ ,"Y/\:.8.8^D**^;_\
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M_P"$I\0_]![5/_ R3_&C_A*?$/\ T'M4_P# R3_&CG#VB/IJBOF7_A*?$/\
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M_"2:[_T&M1_\"G_QH_X237?^@UJ/_@4_^-'.'M$?1-%?.W_"2:[_ -!K4?\
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M*H.MZD?^WM_\:M_\)'KG_09U'_P*?_&J3N5&5SZ$HKY[_P"$CUS_ *#.H_\
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M4 %.3K3:<G6FMP6X^BBBK- HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 1R]JCJ27M4=4MBUL%%%%,84444 %%%%
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MHHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !5FT_C_"JU6;3^/\*
M+5%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 1R]JCJ27M4=
M4MBUL%%%%,84444 %%%% !1110 4444 %%%% !1110 4444 %.3K3:<G6FMP
M6X^BBBK- HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** )(/\ 7+5R
MJ<'^N6KE7'8TAL%%%%44%%%% !1110 4444 %%%% !1110 4444 %%%% !70
M^!O^1QL/^VG_ *+:N>KH? W_ ".-A_VT_P#1;4#/9****LH**** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH TJ***9(4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !7SCXE_Y&K6/^OZ;_P!#-?1U?./B7_D:M8_Z
M_IO_ $,UG,BH9=%%%9F04444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% %&3_6-]33:=)_K&^IIM02%%%% @HHHH **** "BBB@ HHHH **** "BBB@
M HHHH *<.E-IPZ4F)BT445(@HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** (I/O?A3*?)][\*92)"BBBD 4444 %%%% !1110 4444 %%%% !1110
M 4444 %6;3^/\*K59M/X_P * +5%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 1R]JCJ27M4=4MBUL%%%%,84444 %%%% !1110 4444 %%%
M% !1110 4444 %.3K3:<G6FMP6X^BBBK- HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** )(/]<M7*IP?ZY:N5<=C2&P4445104444 %%%% !1110
M4444 %%%% !1110 4444 %=#X&_Y'&P_[:?^BVKGJZ'P-_R.-A_VT_\ 1;4#
M/9****LH**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH TJ**
M*9(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7SCXE_Y&K6/^OZ
M;_T,U]'5\X^)?^1JUC_K^F_]#-9S(J&711169D%%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110!1D_UC?4TVG2?ZQOJ:;4$A1110(**** "BBB@ HH
MHH **** "BBB@ HHHH **** "G#I3:<.E)B8M%%%2(**** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@"*3[WX4RGR?>_"F4B0HHHI %%%% !1110 44
M44 %%%% !1110 4444 %%%% !5FT_C_"JU6;3^/\* +5%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 1R]JCJ27M4=4MBUL%%%%,84444 %%
M%% !1110 4444 %%%% !1110 4444 %.3K3:<G6FMP6X^BBBK- HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** )(/]<M7*IP?ZY:N5<=C2&P44451
M04444 %%%% !1110 4444 %%%% !1110 4444 %=#X&_Y'&P_P"VG_HMJYZN
MA\#?\CC8?]M/_1;4#/9****LH**** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH TJ***9(4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !7SCXE_P"1JUC_ *_IO_0S7T=7SCXE_P"1JUC_ *_IO_0S6<R*AET445F9
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 49/\ 6-]33:=)_K&^
MIIM02%%%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH *<.E-IPZ4F)B
MT445(@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** (I/O?A3*?)][
M\*92)"BBBD 4444 %%%% !1110 4444 %%%% !1110 4444 %6;3^/\ "JU6
M;3^/\* +5%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 1R]J
MCJ27M4=4MBUL%%%%,84444 %%%% !1110 4444 %%%% !1110 4444 %.3K3
M:<G6FMP6X^BBBK- HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** )(
M/]<M7*IP?ZY:N5<=C2&P4445104444 %%%% !1110 4444 %%%% !1110 44
M44 %=#X&_P"1QL/^VG_HMJYZNA\#?\CC8?\ ;3_T6U SV2BBBK*"BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** +VX^M&X^M)147,;L7<?6C
M<?6DHHN%V+N/K1N/K2447"[%W'UHW'UI**+A=B[CZT;CZTE%%PNQ=Q]:-Q]:
M2BBX78NX^M&X^M)11<+L7<?6C<?6DHHN%V+N/K1N/K2447"[%W'UKGKGP)X:
MO+J:ZN--WS3.9)&\^098G). V.IKH*>.E/<:UW.7_P"%=^%?^@5_Y,2__%4?
M\*[\*_\ 0*_\F)?_ (JNHHHLAV1R_P#PKOPK_P! K_R8E_\ BJ/^%=^%?^@5
M_P"3$O\ \574446061R__"N_"O\ T"O_ "8E_P#BJ/\ A7?A7_H%?^3$O_Q5
M=1119!9'+_\ "N_"O_0*_P#)B7_XJC_A7?A7_H%?^3$O_P 574446061R_\
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M/"/_ $"/_)F7_P"*H_X5IX1_Z!'_ ),R_P#Q5=9119!9')_\*T\(_P#0(_\
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ME_T"?_)F7_XJNKHHL@Y5V.4_X5MX2_Z!/_DS+_\ %4?\*V\)?] G_P F9?\
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M*_\ 0+_\F)?_ (JNHHHL@Y5V.7_X5YX5_P"@7_Y,2_\ Q5'_  KSPK_T"_\
MR8E_^*KJ**+(.5=CE_\ A7GA7_H%_P#DQ+_\51_PKSPK_P! O_R8E_\ BJZB
MBBR#E78Y?_A7GA7_ *!?_DQ+_P#%4?\ "O/"O_0+_P#)B7_XJNHHHL@Y5V.7
M_P"%>>%?^@7_ .3$O_Q5'_"O/"O_ $"__)B7_P"*KJ**+(.5=CE_^%>>%?\
MH%_^3$O_ ,51_P *\\*_] O_ ,F)?_BJZBBBR#E78YC_ (5SX4;KI7_DQ+_\
M51_PK?PE_P! G_R8E_\ BJZE:6J212BNQRO_  K?PE_T"?\ R8E_^*H_X5OX
M2_Z!/_DQ+_\ %5U5%%D'*NQRO_"M_"7_ $"?_)B7_P"*H_X5OX2_Z!/_ ),2
M_P#Q5=5119!RKL<K_P *W\)?] G_ ,F)?_BJ/^%;^$O^@3_Y,2__ !5=5119
M!RKL<K_PK?PE_P! G_R8E_\ BJ/^%;^$O^@3_P"3$O\ \5754460<J['*_\
M"M_"7_0)_P#)B7_XJC_A6_A+_H$_^3$O_P 5754460<J['*_\*W\)?\ 0)_\
MF)?_ (JC_A6_A+_H$_\ DQ+_ /%5U5%%D'*NQRO_  K?PE_T"?\ R8E_^*H_
MX5OX2_Z!/_DQ+_\ %5U5%%D'*NQRO_"M_"7_ $"?_)B7_P"*H_X5OX2_Z!/_
M ),2_P#Q5=5119!RKL<K_P *W\)?] G_ ,F)?_BJ3_A7'A,=-*_\F)?_ (JN
MKI&Z46061RO_  KKPK_T"O\ R8E_^*H_X5UX5_Z!7_DQ+_\ %5U%%(5CE_\
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M !1110 4444 %%%% !1110 4444 %%%% !2'K2TAZTF E%%%( HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** &/UIM.?K3:A[F;W"BBB@04444 %%
M%% !1110 4444 %%%% !1110 4444 %.7O3:<O>A#6XZBBBF:!1110 4444
M%%%% !1110 4444 %%%% !1110 4444 .6EI%I:I#04444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !2-TI:1NE #:***D04444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% "CK3J:.M.JX[%(****H84444 %%%% !1110 4
M444 %%%% !1110 4444 %.3[XIM.3[XH6XUN34445H:!1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% %6BBBLCF"BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH *>.E,IXZ4T-!1113&%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 E%%%2(**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ I#UI:0]:3 2BBBD 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% #'ZTVG/UIM0]S-[A1110(**** "BBB@ HHHH **** "BBB@ HHH
MH **** "G+WIM.7O0AK<=1113- HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** '+2TBTM4AH**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ I&Z4M(W2@!M%%%2(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M!1UIU-'6G5<=BD%%%%4,**** "BBB@ HHHH **** "BBB@ HHHH **** "G)
M]\4VG)]\4+<:W)J***T- HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@"K11161S!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M/'2F4\=*:&@HHHIC"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 2
MBBBI$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4AZTM(>M)@)1
M112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!C]:;3GZTVH>YF
M]PHHHH$%%%% !1110 4444 %%%% !1110 4444 %%%% !3E[TVG+WH0UN.HH
MHIF@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #EI:1:6J0T%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4C=*6D;I0 VBBBI$%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 HZTZFCK3JN.Q2"BBBJ&%%%
M% !1110 4444 %%%% !1110 4444 %%%% !3D^^*;3D^^*%N-;DU%%%:&@44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!5HHHK(Y@HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "GCI3*>.E-#04444QA1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 )1114B"BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *0]:6D/6DP$HHHI %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 Q^M-IS]:;4/<S>X4444""BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ IR]Z;3E[T(:W'4444S0**** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@!RTM(M+5(:"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *1NE+2-TH ;1114B"BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH 4=:=31UIU7'8I!1115#"BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ IR??%-IR??%"W&MR:BBBM#0**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH JT445D<P4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !3QTIE/'2FAH****8PHHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** $HHHJ1!1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %(>M+2'K28"4444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M 8_6FTY^M-J'N9O<****!!1110 4444 %%%% !1110 4444 %%%% !1110 4
MY>]-IR]Z$-;CJ***9H%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M Y:6D6EJD-!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(W2EI&
MZ4 -HHHJ1!1110 4444 %%%% !1110 4444 %%%% !1110 4444 *.M.IHZT
MZKCL4@HHHJAA1110 4444 %%%% !1110 4444 %%%% !1110 4Y/OBFTY/OB
MA;C6Y-1116AH%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[7_^?/3/^_4G_P 71=!S(]IHKQ;_ (6]K_\ SYZ9_P!^I/\ XNC_ (6]K_\
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MT>RT5XU_PMK7O^?33?\ OW)_\71_PMK7O^?33?\ OW)_\71S(.='LM%>-?\
M"VM>_P"?33?^_<G_ ,71_P +:U[_ )]--_[]R?\ Q=',@YT>RT5XU_PMK7O^
M?33?^_<G_P 71_PMK7O^?33?^_<G_P 71S(.='LM%>-?\+:U[_GTTW_OW)_\
M71_PMK7O^?33?^_<G_Q=',@YT>RT5XU_PMK7O^?33?\ OW)_\71_PMK7O^?3
M3?\ OW)_\71S(.='LM%>-?\ "VM>_P"?33?^_<G_ ,71_P +:U[_ )]--_[]
MR?\ Q=',@YT>SK2UX?<_&/Q#;[=EGI9W9SF*3_XNJ_\ PNOQ)_SY:5_WZD_^
M.4U)%*2/>**\'_X77XD_Y\M*_P"_4G_QRC_A=?B3_GRTK_OU)_\ '*?,@YD>
M\45X/_PNOQ)_SY:5_P!^I/\ XY1_PNOQ)_SY:5_WZD_^.4<R#F1[Q17@_P#P
MNOQ)_P ^6E?]^I/_ (Y1_P +K\2?\^6E?]^I/_CE',@YD>\45X/_ ,+K\2?\
M^6E?]^I/_CE'_"Z_$G_/EI7_ 'ZD_P#CE',@YD>\45X/_P +K\2?\^6E?]^I
M/_CE'_"Z_$G_ #Y:5_WZD_\ CE',@YD>\45X/_PNOQ)_SY:5_P!^I/\ XY1_
MPNOQ)_SY:5_WZD_^.4<R#F1[Q17@_P#PNOQ)_P ^6E?]^I/_ (Y1_P +K\2?
M\^6E?]^I/_CE',@YD>\45X/_ ,+K\2?\^6E?]^I/_CE'_"Z_$G_/EI7_ 'ZD
M_P#CE',@YD>\4C=*\(_X77XD_P"?+2O^_4G_ ,<KK?AW\0=6\7>()]/U"WLH
MHH[5I@;='#;@Z#NQXPQHO<?,GH>D45)Y8]Z/+'O3Y6/E9'14GECWH\L>]'*P
MY61T5)Y8]Z/+'O1RL.5D=%2>6/>CRQ[T<K#E9'14GECWH\L>]'*PY61T5)Y8
M]Z/+'O1RL.5D=%2>6/>CRQ[T<K#E9'14GECWH\L>]'*PY61T5)Y8]Z/+'O1R
ML.5C!UIU.$8SWIWECWJXQ=BE%D=%2>6/>CRQ[T[,KE9'14GECWH\L>]%F'*R
M.BI/+'O1Y8]Z+,.5D=%2>6/>CRQ[T68<K(Z*D\L>]'ECWHLPY61T5)Y8]Z/+
M'O19ARLCHJ3RQ[T>6/>BS#E9'14GECWH\L>]%F'*R.G)]\4[RQ[TJH V>:$F
M"3N/HI:*LT$HI:* $HI:* $HI:* $HI:* $HI:* $HI:* $HI:* $HI:* $H
MI:* (:***1B%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\O>*O
M^1PUO_K_ )__ $8U?4-?+WBK_D<-;_Z_Y_\ T8U9S(J&111169D%%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110!,OW1]*6D7[H^E+4DA1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %68O]6*K59B_P!6*3!CZ***0@HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** *\_WQ]*BJ6?[X^E14A!1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %2P_P 515+#_%0!+111
M0,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"CJ'_+/\?Z52J[J'
M_+/\?Z52JEL4M@HHHIC"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KTG
MX)?\CG>?]@]__1D=>;5Z3\$O^1SO/^P>_P#Z,CIQW*CN>]T445N= 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% "CK3J:.M.IHI!1113&%%%% !1
M110 4444 %%%% !1110 4444 %%%% !0.M% ZTP'4444#"BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** (:***1B%%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 5\O>*O^1PUO\ Z_Y__1C5]0U\O>*O^1PUO_K_
M )__ $8U9S(J&111169D%%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10!,OW1]*6D7[H^E+4DA1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %68O\ 5BJU68O]6*3!CZ***0@HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** *\_WQ]*BJ6?[X^E14A!1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %2P_Q5%4L/\5 $M%%% PHHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** *.H?\L_Q_I5*KNH?\L_Q_I5*J6Q2V"BBBF,**** "BBB@ HH
MHH **** "BBB@ HHHH **** "O2?@E_R.=Y_V#W_ /1D=>;5Z3\$O^1SO/\
ML'O_ .C(Z<=RH[GO=%%%;G0%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 HZTZFCK3J:*04444QA1110 4444 %%%% !1110 4444 %%%% !1110
M 4#K10.M,!U%%% PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@"&BBBD8A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?+WBK_
M )'#6_\ K_G_ /1C5]0U\O>*O^1PUO\ Z_Y__1C5G,BH9%%%%9F04444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% $R_='TI:1?NCZ4M22%%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 59B_U8JM5F+_5BDP8^BBBD(***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"O/\ ?'TJ*I9_OCZ5%2$%
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5+#_%452P_Q4 2T444
M#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH HZA_RS_'^E4JNZA_
MRS_'^E4JI;%+8****8PHHHH **** "BBB@ HHHH **** "BBB@ HHHH *])^
M"7_(YWG_ &#W_P#1D=>;5Z3\$O\ D<[S_L'O_P"C(Z<=RH[GO=%%%;G0%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 HZTZFCK3J:*04444QA111
M0 4444 %%%% !1110 4444 %%%% !1110 4#K10.M,!U%%% PHHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@"&BBBD8A1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %?+WBK_D<-;_Z_Y_\ T8U?4-?+WBK_ )'#
M6_\ K_G_ /1C5G,BH9%%%%9F04444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% $R_='TI:1?NCZ4M22%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 59B_U8JM5F+_5BDP8^BBBD(**** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@"O/]\?2HJEG^^/I45(04444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !4L/\515+#_ !4 2T444#"BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH HZA_P L_P ?Z52J[J'_ "S_ !_I5*J6Q2V"BBBF,***
M* "BBB@ HHHH **** "BBB@ HHHH **** "O2?@E_P CG>?]@]__ $9'7FU>
MD_!+_D<[S_L'O_Z,CIQW*CN>]T445N= 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% "CK3J:.M.IHI!1113&%%%% !1110 4444 %%%% !1110 4
M444 %%%% !0.M% ZTP'4444#"BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** (:***1B%%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 5\O>*O^1PUO_K_ )__ $8U?4-?+WBK_D<-;_Z_Y_\ T8U9S(J&111169D%
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110!,OW1]*6D7[H^E+4DA1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %68O]6*K59B_P!6*3!C
MZ***0@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *\_WQ]*BJ6?[
MX^E14A!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %2P_P 515+#
M_%0!+1110,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"CJ'_+/\
M?Z52J[J'_+/\?Z52JEL4M@HHHIC"BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ KTGX)?\CG>?]@]__1D=>;5Z3\$O^1SO/^P>_P#Z,CIQW*CN>]T445N=
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "CK3J:.M.IHI!1113
M&%%%% !1110 4444 %%%% !1110 4444 %%%% !0.M% ZTP'4444#"BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** (:***1B%%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 5\O>*O^1PUO\ Z_Y__1C5]0U\O>*O
M^1PUO_K_ )__ $8U9S(J&111169D%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!,OW1]*6D7[H^E+4DA1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %68O\ 5BJU68O]6*3!CZ***0@HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** *\_WQ]*BJ6?[X^E14A!1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %2P_Q5%4L/\5 $M%%% PHHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** *.H?\L_Q_I5*KNH?\L_Q_I5*J6Q2V"BBBF,****
M"BBB@ HHHH **** "BBB@ HHHH **** "O2?@E_R.=Y_V#W_ /1D=>;5Z3\$
MO^1SO/\ L'O_ .C(Z<=RH[GO=%%%;G0%%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 HZTZFCK3J:*04444QA1110 4444 %%%% !1110 4444 %%
M%% !1110 4#K10.M,!U%%% PHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@"'-&:2BI,!<T9I** %S1FDHH 7-&:2B@!<T9I** %S1FDHH 7
M-&:2B@!<T9I** %S1FDHH 7-?-?B?3]_BS67\W&Z^G.-O^V?>OI.OGGQ'_R-
M&K?]?LW_ *&:B9$SG?[-_P"FO_CO_P!>C^S?^FO_ ([_ /7J_169F4/[-_Z:
M_P#CO_UZ/[-_Z:_^._\ UZOT4 4/[-_Z:_\ CO\ ]>C^S?\ IK_X[_\ 7J_1
M0!0_LW_IK_X[_P#7H_LW_IK_ ..__7J_10!0_LW_ *:_^.__ %Z/[-_Z:_\
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M6CS?]G]:CHIW"[)/-_V?UH\W_9_6HZ*+A=DGF_[/ZT>;_L_K4=%%PNR3S?\
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M1110 4444 %,D^[^-/IDGW?QH$R*BBBI)"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH ='_K!5BJ\?\ K!5BKCL:1V"BBBJ*"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ I5^\*2E7[PH0$E%%%64%%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 5Z***S, HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "OGGQ'_R-&K?]?LW_ *&:^AJ^>?$?_(T:M_U^S?\
MH9J)D3,RBBBLS,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#/D_
MUK_[QIM.D_UK_P"\:;2)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *A?[YJ:H7^^:3 ;1112$%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110!8@^X?K4M10?</UJ6@84444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !36[4ZFMVH&-HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%%
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MBB@ HHHH **** "E7[PI*5?O"A 24445904444 %%%% !1110 4444 %%%%
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MOP8_YC?_ &P_]J5ZM7E/P8_YC?\ VP_]J5ZM6L=CHA\(4445104444 %%%%
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MY\1_\C1JW_7[-_Z&:B9$S,HHHK,S"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH SY/\ 6O\ [QIM.D_UK_[QIM(D**** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ J%_OFIJA?[YI,!M%%%(04444 %%%% !1110 4444
M%%%% !1110 4444 %%%% %B#[A^M2U%!]P_6I:!A1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %-;M3J:W:@8VBBBF 4444 %%%% !1110 4444
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M\*JUS_G[T[_OX_\ \11_PJK7/^?O3O\ OX__ ,119ARL\VD_UK_[QIM>@/\
M"/7R['[7IO)_YZR?_$4W_A46O_\ /YIO_?V3_P"(J;,FS.!HKOO^%1:__P _
MFF_]_9/_ (BC_A46O_\ /YIO_?V3_P"(HLPLS@:*[[_A46O_ //YIO\ W]D_
M^(H_X5%K_P#S^:;_ -_9/_B*+,+,X&BN^_X5%K__ #^:;_W]D_\ B*/^%1:_
M_P _FF_]_9/_ (BBS"S.!HKOO^%1:_\ \_FF_P#?V3_XBC_A46O_ //YIO\
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M%1Z__P _>F_]_9/_ (BC_A4>O_\ /WIO_?V3_P"(HY6'*S@:*[[_ (5'K_\
MS]Z;_P!_9/\ XBC_ (5'K_\ S]Z;_P!_9/\ XBCE8<K.!HKOO^%1Z_\ \_>F
M_P#?V3_XBC_A4>O_ //WIO\ W]D_^(HY6'*S@::W:O0/^%1Z_P#\_>F_]_9/
M_B*0_"+7S_R^:9_W]D_^(HY6'*SSZBN__P"%0^(/^?S3/^_LG_Q%'_"H?$'_
M #^:9_W]D_\ B*?*Q\K. HKO_P#A4/B#_G\TS_O[)_\ $4?\*A\0?\_FF?\
M?V3_ .(HY6'*S@**[_\ X5#X@_Y_-,_[^R?_ !%'_"H?$'_/YIG_ ']D_P#B
M*.5ARLX"BN__ .%0^(/^?S3/^_LG_P 11_PJ'Q!_S^:9_P!_9/\ XBCE8<K.
M HKO_P#A4/B#_G\TS_O[)_\ $4?\*A\0?\_FF?\ ?V3_ .(HY6'*S@**[_\
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M "BBB@ HHHH **** "BBB@!1TI:0=*6F4%%%% !1110 4444 %%%% !1110
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M HHHH **** "BBB@ HHHH **** "BBB@",]310>IHJ" HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "G#I3:<.E,$%%%% PHHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** %'2EI!TI:904444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444P"BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH !2T@I:!A1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %.3K3:<G6A#6X^BBBK- HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M***  =:=31UIU4AH****8!1110 4444 %%%% !1110 4444 %%%% !1110 4
MC?=-+2-]TT 1T444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% %2BBBN4X0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "IU^
MZ/I4%3K]T?2JB7 6BBBK+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH C/4T4'J:*@@**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IP
MZ4VG#I3!!1110,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!1TI
M:0=*6F4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%,
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****  4M(*6@84444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !3DZTVG)UH0UN/HHHJS0**** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ '6G4T=:=5(:"BBBF 4444 %%
M%% !1110 4444 %%%% !1110 4444 %(WW32TC?=- $=%%%(84444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110!4HHHKE.$**** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ J=?NCZ5!4Z_='TJHEP%HHHJRPHHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** (SU-%!ZFBH("BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH *<.E-IPZ4P04444#"BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH 4=*6D'2EIE!1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1113 **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ %+2"EH&%%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4Y.M-IR=:$-;CZ***LT"BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH !UIU-'6G52&@HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%%
M !2-]TTM(WW30!'1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 5****Y3A"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
MG7[H^E05.OW1]*J)<!:***LL**** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@",]310>IHJ" HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3\&?]!G_ ,E9O_B*/^%I^#/^@S_Y*S?_ !%?-M%'.PYV?27_  M/P9_T&?\
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MPL/PK_T%/_)>7_XFC_A8?A7_ *"G_DO+_P#$UX311<.9GNW_  L/PK_T%/\
MR7E_^)H_X6'X5_Z"G_DO+_\ $UX311<.9GNW_"P_"O\ T%/_ "7E_P#B:/\
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MHH"Q%L;THJ6B@+%6BBBL#F"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *^5/%O_ ".>N_\ 80N/_1C5]5U\J>+?^1SUW_L(7'_HQJF1%0QZ***@
MR"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH W(/^/>+_ '!_*I*C
M@_X]XO\ <'\JDH&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4X
M=*;3ATH 6BBBF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'LGP
MF_Y%6Z_Z_7_] 2N\K@_A-_R*MU_U^O\ ^@)7>5:V-H[!1113&%%%% !1110
M4444 %%%% !1110 4444 %%%% !3EIM.6FMQK<6BBBJ*"BBB@ HHHH ****
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M %%%% !3ATIM.'2@!:***8!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 >R?";_D5;K_ *_7_P#0$KO*X/X3?\BK=?\ 7Z__ * E=Y5K8VCL%%%%
M,84444 %%%% !1110 4444 %%%% !1110 4444 %.6FTY::W&MQ:***HH***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!12T@I:!H****8PHHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *CE^X/K4E1R_<'UH$0T444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444T4@HHHIC"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ J2'_7+4=20_ZY:!ENBBBF4%%%% !1110
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M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 5:***P.4****
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M%%% !1110!5HHHK Y0HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MI?\ @))_A1_PC.O?] 34O_ 23_"@+&716I_PC.O?] 34O_ 23_"C_A&=>_Z
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MI_PC6O?] 34O_ 1_\*/^$:U[_H":E_X"/_A18+,RZ*U/^$:U[_H":E_X"/\
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M*** "BBB@ I:2EH*04444#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MI&^Z:6D;[IH CHHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 0T445S'(%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4WO
M3J;WH!A1112$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 \=**!
MTHJB@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "EI*6FAA1113
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHI""BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *<O>FTY>]-;C6XZBBBJ- HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** $:FTYJ;0(**** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ I\?WOPIE/C^]^%"W!;DE%%%66%%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4M)2T%(****!A1110 4444 %%%
M% !1110 4444 %%%% !1110 4C?=-+2-]TT 1T444P"BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** (:***YCD"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *;WIU-[T PHHHI""BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH >.E% Z45104444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !2TE+30PHHHI@%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444A!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %.7O3
M:<O>FMQK<=1115&@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "-
M3:<U-H$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4^/[WX4RGQ
M_>_"A;@MR2BBBK+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *6
MDI:"D%%%% PHHHH **** "BBB@ HHHH **** "BBB@ HHHH *1ONFEI&^Z:
M(Z***8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $-%%%<
MQR!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %-[TZF]Z 84444A
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 /'2B@=**HH**** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ I:2EIH84444P"BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH ****0@HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "G+WIM.7O36XUN.HHHJC0**** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@!&IM.:FT""BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH *?'][\*93X_O?A0MP6Y)1115EA1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %+24M!2"BBB@84444 %%%% !1110 4444 %%%%
M !1110 4444 %(WW32TC?=- $=%%%, HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@"&BBBN8Y HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "F]Z=3>] ,****0@HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** 'CI10.E%44%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4M)2TT,****8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%(
M04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !3E[TVG+WIK<:W'44
M451H%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 C4VG-3:!!1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %/C^]^%,I\?WOPH6X+<DHH
MHJRPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "EI*6@I!1110,*
M*** "BBB@ HHHH **** "BBB@ HHHH **** "D;[II:1ONF@".BBBF 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!#1117,<@4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !3>].IO>@&%%%%(04444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% #QTHH'2BJ*"BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH *6DI::&%%%%, HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBBD(**** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ IR]Z;3E[TUN-;CJ***HT"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH 1J;3FIM @HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "GQ_>_"F4^/[WX4+<%N24445984444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !2TE+04@HHHH&%%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% "4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 4Z***Y#C"BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH *^;/$_P#R-FL_]?T__H9KZ3KYL\3_ /(V:S_U_3_^AFID14,JBBBH
M,@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** 'CI10.E%46%%%%,
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *]_^&__ "(.F?\ ;7_T:]>
M5[_\-_\ D0=,_P"VO_HUZJ&Y<-SJJ***U-0HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** %'2EI!TI:92"BBBF,**** "BBB@ HHHH **** "BBB@
M HHHH **** "@44"@!:***!A1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 *M.IJTZJ6Q2V"BBBF 4444 %%%% !1110 4444 %%%% !1110 4444
M %*.M)2CK0,6BBBF,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MI:2EH&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 )1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!3HHHKD.,****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KYL\3_P#(V:S_ -?T_P#Z
M&:^DZ^;/$_\ R-FL_P#7]/\ ^AFID14,JBBBH,@HHHH **** "BBB@ HHHH
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M%% !1110 4444 %%%% !1110!3HHHKD.,**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ KYL\3_\ (V:S_P!?T_\ Z&:^DZ^;/$__ "-FL_\ 7]/_
M .AFID14,JBBBH,@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** 'C
MI10.E%46%%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH *]_\ AO\
M\B#IG_;7_P!&O7@%>_\ PW_Y$'3/^VO_ *->JAN7#<ZJBBBM34**** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@!1TI:0=*6F4@HHHIC"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ H%% H 6BBB@84444 %%%% !1110 4444
M%%%% !1110 4444 %%%% "K3J:M.JEL4M@HHHI@%%%% !1110 4444 %%%%
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MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH >.E%%%46%%%%, HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *]_^&_\ R(.F?]M?_1KT454-RX;G
M54445J:A1110 4444 %%%% !1110 4444 %%%% !1110 4444 *.E+113*04
M444QA1110 4444 %%%% !1110 4444 %%%% !1110 4"BB@!:***!A1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 *M.HHJEL4M@HHHI@%%%% !11
M10 4444 %%%% !1110 4444 %%%% !2CK110,6BBBF,**** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ I:**!A1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% "4444 %%%% !1110 4444 %%%% !1110 4444 %%%
,% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>brhc10020853_10k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:usph="http://usph.com/20201231"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="usph-20201231.xsd" xlink:type="simple"/>
    <context id="c20200101to20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="c20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <instant>2021-03-01</instant>
        </period>
    </context>
    <context id="c20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20190101to20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c20190101to20191231_ProductOrServiceAxis_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c20180101to20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="c20190101to20191231_ProductOrServiceAxis_NetPatientRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:NetPatientRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_ProductOrServiceAxis_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20180101to20181231_ProductOrServiceAxis_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="c20180101to20181231_ProductOrServiceAxis_NetPatientRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:NetPatientRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_ProductOrServiceAxis_NetPatientRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:NetPatientRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20171231_StatementEquityComponentsAxis_ParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="c20171231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="c20171231_StatementEquityComponentsAxis_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="c20171231_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="c20171231_StatementEquityComponentsAxis_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="c20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="c20171231_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="c20180101to20181231_StatementEquityComponentsAxis_ParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20180101to20181231_StatementEquityComponentsAxis_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="c20190101to20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20180101to20181231_StatementEquityComponentsAxis_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="c20190101to20191231_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c20180101to20181231_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_StatementEquityComponentsAxis_ParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20190101to20191231_StatementEquityComponentsAxis_ParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20180101to20181231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20180101to20181231_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c20190101to20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c20191231_StatementEquityComponentsAxis_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c20191231_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c20181231_StatementEquityComponentsAxis_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="c20191231_StatementEquityComponentsAxis_ParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c20191231_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c20181231_StatementEquityComponentsAxis_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="c20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20181231_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="c20201231_StatementEquityComponentsAxis_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="c20201231_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20181231_StatementEquityComponentsAxis_ParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="c20201231_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20181231_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="c20201231_StatementEquityComponentsAxis_ParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20181231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="c20200101to20201231_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_RangeAxis_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20201231_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20180831to20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:LeadingProviderOfIndustrialInjuryPreventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-11</instant>
        </period>
    </context>
    <context id="c20170331_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:LeadingProviderOfIndustrialInjuryPreventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-03-31</instant>
        </period>
    </context>
    <context id="c20180430_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:LeadingProviderOfIndustrialInjuryPreventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-04-30</instant>
        </period>
    </context>
    <context id="c20180430to20180430_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:LeadingProviderOfIndustrialInjuryPreventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c20190411to20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:LeadingProviderOfIndustrialInjuryPreventionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-11</startDate>
            <endDate>2019-04-11</endDate>
        </period>
    </context>
    <context id="c20200101to20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="c20200401to20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="c20200701to20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="c20201001to20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="c20200502">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <instant>2020-05-02</instant>
        </period>
    </context>
    <context id="c20201231_UnusualOrInfrequentItemAxis_MedicareAcceleratedAndAdvancePaymentsProgramMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">usph:MedicareAcceleratedAndAdvancePaymentsProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20201231_UnusualOrInfrequentItemAxis_PublicHealthAndSocialServicesEmergencyFundMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">usph:PublicHealthAndSocialServicesEmergencyFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20200101to20201231_UnusualOrInfrequentItemAxis_PublicHealthAndSocialServicesEmergencyFundMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">usph:PublicHealthAndSocialServicesEmergencyFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_BusinessAcquisitionAxis_FebruaryTwoThousandTwentyAcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:FebruaryTwoThousandTwentyAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_BusinessAcquisitionAxis_SeptemberTwoThousandNineteenAcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:SeptemberTwoThousandNineteenAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_BusinessAcquisitionAxis_NovemberTwoThousandTwentyAcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:NovemberTwoThousandTwentyAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_BusinessAcquisitionAxis_SeptemberTwoThousandTwentyAcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:SeptemberTwoThousandTwentyAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_BusinessAcquisitionAxis_August2018AcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:August2018AcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20200930_BusinessAcquisitionAxis_SeptemberTwoThousandTwentyAcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:SeptemberTwoThousandTwentyAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="c20201130_BusinessAcquisitionAxis_NovemberTwoThousandTwentyAcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:NovemberTwoThousandTwentyAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-30</instant>
        </period>
    </context>
    <context id="c20190930_BusinessAcquisitionAxis_SeptemberTwoThousandNineteenAcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:SeptemberTwoThousandNineteenAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="c20200227_BusinessAcquisitionAxis_FebruaryTwoThousandTwentyAcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:FebruaryTwoThousandTwentyAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-27</instant>
        </period>
    </context>
    <context id="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-27</instant>
        </period>
    </context>
    <context id="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-27</instant>
        </period>
    </context>
    <context id="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-27</instant>
        </period>
    </context>
    <context id="c20180831_BusinessAcquisitionAxis_August2018AcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:August2018AcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="c20200930to20200930_BusinessAcquisitionAxis_SeptemberTwoThousandTwentyAcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:SeptemberTwoThousandTwentyAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-30</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="c20180831to20180831_BusinessAcquisitionAxis_August2018AcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:August2018AcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="c20190930to20190930_BusinessAcquisitionAxis_SeptemberTwoThousandNineteenAcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:SeptemberTwoThousandNineteenAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-30</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="c20201130to20201130_BusinessAcquisitionAxis_NovemberTwoThousandTwentyAcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:NovemberTwoThousandTwentyAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-30</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="c20200227to20200227_BusinessAcquisitionAxis_ClinicPracticeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-27</startDate>
            <endDate>2020-02-27</endDate>
        </period>
    </context>
    <context id="c20200227to20200227_BusinessAcquisitionAxis_FebruaryTwoThousandTwentyAcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:FebruaryTwoThousandTwentyAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-27</startDate>
            <endDate>2020-02-27</endDate>
        </period>
    </context>
    <context id="c20200930to20200930_BusinessAcquisitionAxis_ManagementContractsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ManagementContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-30</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_ProductOrServiceAxis_OtherRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:OtherRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20190101to20191231_ProductOrServiceAxis_OtherRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:OtherRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c20190101to20191231_ProductOrServiceAxis_ManagementContractRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:ManagementContractRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c20180101to20181231_ProductOrServiceAxis_OtherRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:OtherRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="c20180101to20181231_ProductOrServiceAxis_IndustrialInjuryPreventionServicesRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:IndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_ProductOrServiceAxis_IndustrialInjuryPreventionServicesRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:IndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20190101to20191231_ProductOrServiceAxis_IndustrialInjuryPreventionServicesRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:IndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c20180101to20181231_ProductOrServiceAxis_ManagementContractRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:ManagementContractRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_ProductOrServiceAxis_PhysicalTherapyOperationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20190101to20191231_ProductOrServiceAxis_PhysicalTherapyOperationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c20180101to20181231_ProductOrServiceAxis_PhysicalTherapyOperationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_ProductOrServiceAxis_ManagementContractRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">usph:ManagementContractRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember_RangeAxis_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember_RangeAxis_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_PropertyPlantAndEquipmentByTypeAxis_ComputerSoftwareIntangibleAssetMember_RangeAxis_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_PropertyPlantAndEquipmentByTypeAxis_ComputerSoftwareIntangibleAssetMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_UnusualOrInfrequentItemAxis_Year2019Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">usph:Year2019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_UnusualOrInfrequentItemAxis_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">usph:FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_UnusualOrInfrequentItemAxis_Year2018Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">usph:Year2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20201227to20201227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2020-12-27</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_UnusualOrInfrequentItemAxis_FromTwoThousandNineteenThroughTwoThousandTwentyFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">usph:FromTwoThousandNineteenThroughTwoThousandTwentyFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20180209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <instant>2018-02-09</instant>
        </period>
    </context>
    <context id="c20151102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <instant>2015-11-02</instant>
        </period>
    </context>
    <context id="c20130401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <instant>2013-04-01</instant>
        </period>
    </context>
    <context id="c20210331_StatementScenarioAxis_ScenarioForecastMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c20200101to20201231_RangeAxis_MaximumMember_UnusualOrInfrequentItemAxis_Year2017Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">usph:Year2017Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20201231_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201602Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20210129_DebtInstrumentAxis_CreditAgreementMember_SubsequentEventTypeAxis_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usph:CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-29</instant>
        </period>
    </context>
    <context id="c20200101to20201231_DebtInstrumentAxis_CreditAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usph:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20210129to20210129_DebtInstrumentAxis_CreditAgreementMember_SubsequentEventTypeAxis_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usph:CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-29</startDate>
            <endDate>2021-01-29</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_TitleOfIndividualAxis_DirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_TitleOfIndividualAxis_OfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:OfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_TitleOfIndividualAxis_EmployeeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">usph:EmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20201130_BusinessAcquisitionAxis_ClinicPracticeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-30</instant>
        </period>
    </context>
    <context id="c20201231_BusinessAcquisitionAxis_SeptemberTwoThousandTwentyAcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:SeptemberTwoThousandTwentyAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20201231_BusinessAcquisitionAxis_FebruaryTwoThousandTwentyAcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:FebruaryTwoThousandTwentyAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20200930_BusinessAcquisitionAxis_ManagementContractsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ManagementContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="c20201231_BusinessAcquisitionAxis_SeptemberTwoThousandNineteenAcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:SeptemberTwoThousandNineteenAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20190411_BusinessAcquisitionAxis_AprilTwoThousandNineteenAcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:AprilTwoThousandNineteenAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-11</instant>
        </period>
    </context>
    <context id="c20201231_BusinessAcquisitionAxis_August2018AcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:August2018AcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20201231_BusinessAcquisitionAxis_NovemberTwoThousandTwentyAcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:NovemberTwoThousandTwentyAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20201130to20201130_BusinessAcquisitionAxis_ClinicPracticeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ClinicPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-30</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="c20180101to20181231_BusinessAcquisitionAxis_AcquisitionOfFiveClinicPracticesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:AcquisitionOfFiveClinicPracticesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="c20200930to20200930_BusinessAcquisitionAxis_ManagementAndServicesContractsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ManagementAndServicesContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-30</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_BusinessAcquisitionAxis_ManagementContractsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ManagementContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_BusinessAcquisitionAxis_ManagementAndServicesContractsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ManagementAndServicesContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20190411to20190411_BusinessAcquisitionAxis_AprilTwoThousandNineteenAcquisitionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:AprilTwoThousandNineteenAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-11</startDate>
            <endDate>2019-04-11</endDate>
        </period>
    </context>
    <context id="c20190930to20190930_BusinessAcquisitionAxis_SeptemberTwoThousandNineteenAcquisitionMember_StatementScenarioAxis_SeptemberTwoThousandTwentyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">usph:SeptemberTwoThousandTwentyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:SeptemberTwoThousandNineteenAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-30</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="c20190930to20190930_BusinessAcquisitionAxis_SeptemberTwoThousandNineteenAcquisitionMember_StatementScenarioAxis_SeptemberTwoThousandTwentyOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">usph:SeptemberTwoThousandTwentyOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:SeptemberTwoThousandNineteenAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-30</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="c20180831_BusinessAcquisitionAxis_August2018AcquisitionMember_StatementScenarioAxis_AugustTwoThousandTwentyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">usph:AugustTwoThousandTwentyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:August2018AcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="c20180831_BusinessAcquisitionAxis_August2018AcquisitionMember_StatementScenarioAxis_AugustTwoThousandNineteenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">usph:AugustTwoThousandNineteenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:August2018AcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="c20181231_BusinessAcquisitionAxis_AcquisitionOfFiveClinicPracticesMember_StatementScenarioAxis_AugustTwoThousandNineteenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">usph:AugustTwoThousandNineteenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:AcquisitionOfFiveClinicPracticesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="c20200930_BusinessAcquisitionAxis_ManagementContractsMember_ShortTermDebtTypeAxis_NotesPayableOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ManagementContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">usph:NotesPayableOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="c20200101to20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20190101to20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c20190930to20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-30</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="c20180430to20180430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <startDate>2018-04-30</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="c20200930_BusinessAcquisitionAxis_ManagementContractsMember_ShortTermDebtTypeAxis_NotesPayableTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:ManagementContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">usph:NotesPayableTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="c20181231_BusinessAcquisitionAxis_AcquisitionOfFiveClinicPracticesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:AcquisitionOfFiveClinicPracticesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20180430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <instant>2018-04-30</instant>
        </period>
    </context>
    <context id="c20200101to20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20180101to20181231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">usph:ReferralRelationshipMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="c20180101to20181231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">usph:ReferralRelationshipMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20190101to20191231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c20190101to20191231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">usph:ReferralRelationshipMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c20191231_RangeAxis_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c20201231_RangeAxis_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20191231_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c20201231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TherapyPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20201231_BusinessAcquisitionAxis_TherapyPracticeMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TherapyPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20201231_BusinessAcquisitionAxis_TherapyPracticeMember_RangeAxis_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TherapyPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20200101to20201231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TherapyPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TherapyPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember_RangeAxis_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TherapyPracticeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20171231_OwnershipAxis_RedeemableNonControllingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">usph:RedeemableNonControllingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="c20191231_OwnershipAxis_RedeemableNonControllingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">usph:RedeemableNonControllingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c20181231_OwnershipAxis_RedeemableNonControllingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">usph:RedeemableNonControllingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="c20190101to20191231_OwnershipAxis_RedeemableNonControllingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">usph:RedeemableNonControllingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_OwnershipAxis_RedeemableNonControllingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">usph:RedeemableNonControllingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20180101to20181231_OwnershipAxis_RedeemableNonControllingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">usph:RedeemableNonControllingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="c20201231_OwnershipAxis_RedeemableNonControllingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">usph:RedeemableNonControllingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20191231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c20191231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">usph:ReferralRelationshipMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c20191231_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">usph:ReferralRelationshipMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20200101to20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember_RangeAxis_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">usph:ReferralRelationshipMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember_RangeAxis_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">usph:ReferralRelationshipMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20191231_CreditFacilityAxis_RevolvingCreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c20201231_CreditFacilityAxis_RevolvingCreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20191231_DebtInstrumentAxis_PromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usph:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c20201231_DebtInstrumentAxis_PromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usph:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20190101to20191231_CreditFacilityAxis_RevolvingCreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_CreditFacilityAxis_RevolvingCreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20201231_DebtInstrumentAxis_PromissoryNotesMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usph:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20201231_DebtInstrumentAxis_PromissoryNotesMember_RangeAxis_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usph:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20131205_CreditFacilityAxis_RevolvingCreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-12-05</instant>
        </period>
    </context>
    <context id="c20160101to20160131_DebtInstrumentAxis_CreditAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usph:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-01-01</startDate>
            <endDate>2016-01-31</endDate>
        </period>
    </context>
    <context id="c20160101to20160131_DebtInstrumentAxis_CreditAgreementMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usph:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-01-01</startDate>
            <endDate>2016-01-31</endDate>
        </period>
    </context>
    <context id="c20201231_ShortTermDebtTypeAxis_NotesPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">usph:NotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20200101to20201231_RangeAxis_MaximumMember_ShortTermDebtTypeAxis_NotesPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">usph:NotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_RangeAxis_MinimumMember_ShortTermDebtTypeAxis_NotesPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">usph:NotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20191231_ShortTermDebtTypeAxis_NotesPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">usph:NotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c20201231_IncomeTaxAuthorityAxis_ForeignCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20201231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20200101to20201231_IncomeTaxAuthorityAxis_ForeignCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20180101to20181231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="c20180101to20181231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:IndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="c20190101to20191231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:IndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:IndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20190101to20191231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20180101to20181231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsExcludingClosureCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsExcludingClosureCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_ConsolidationItemsAxis_OperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsExcludingClosureCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsExcludingClosureCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20190101to20191231_ConsolidationItemsAxis_OperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c20190101to20191231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsExcludingClosureCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsExcludingClosureCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c20180101to20181231_ConsolidationItemsAxis_OperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="c20201231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20181231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:IndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="c20191231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c20201231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:IndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20191231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:IndustrialInjuryPreventionServicesRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c20181231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">usph:PhysicalTherapyOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="c20160317_PlanNameAxis_AmendedTwoThousandThreePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">usph:AmendedTwoThousandThreePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-03-17</instant>
        </period>
    </context>
    <context id="c20201231_AwardTypeAxis_NonQualifiedStockOptionsMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">usph:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20160316_PlanNameAxis_AmendedTwoThousandThreePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">usph:AmendedTwoThousandThreePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-03-16</instant>
        </period>
    </context>
    <context id="c20201231_PlanNameAxis_AmendedTwoThousandThreePlanMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">usph:AmendedTwoThousandThreePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20201231_PlanNameAxis_AmendedTwoThousandThreePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">usph:AmendedTwoThousandThreePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20201231_PlanNameAxis_AmendedNineteenNinetyNinePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">usph:AmendedNineteenNinetyNinePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20180101to20181231_AwardTypeAxis_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="c20190101to20191231_AwardTypeAxis_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_AwardTypeAxis_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_TitleOfIndividualAxis_ExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_TitleOfIndividualAxis_EmployeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">usph:EmployeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20201231_AwardTypeAxis_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20090331_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2009-03-31</instant>
        </period>
    </context>
    <context id="c20081231_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2008-12-31</instant>
        </period>
    </context>
    <context id="c20090301to20090331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
        </entity>
        <period>
            <startDate>2009-03-01</startDate>
            <endDate>2009-03-31</endDate>
        </period>
    </context>
    <context id="c20171231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="c20191231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c20181231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="c20200101to20201231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20180101to20181231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="c20190101to20191231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c20201231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885978</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <unit id="U001">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="U002">
        <measure>shares</measure>
    </unit>
    <unit id="U003">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="U004">
        <measure>usph:Segment</measure>
    </unit>
    <unit id="U005">
        <measure>pure</measure>
    </unit>
    <unit id="U006">
        <measure>usph:Location</measure>
    </unit>
    <unit id="U007">
        <measure>usph:Clinic</measure>
    </unit>
    <unit id="U008">
        <measure>usph:State</measure>
    </unit>
    <unit id="U009">
        <measure>usph:Facility</measure>
    </unit>
    <unit id="U010">
        <measure>usph:Installment</measure>
    </unit>
    <unit id="U011">
        <measure>usph:Business</measure>
    </unit>
    <unit id="U012">
        <measure>usph:Volume</measure>
    </unit>
    <unit id="U013">
        <measure>usph:Employee</measure>
    </unit>
    <unit id="U014">
        <measure>usph:Contract</measure>
    </unit>
    <unit id="U015">
        <measure>usph:Partnership</measure>
    </unit>
    <unit id="U016">
        <measure>usph:Region</measure>
    </unit>
    <unit id="U017">
        <measure>usph:Operation</measure>
    </unit>
    <unit id="U018">
        <measure>usph:Officer</measure>
    </unit>
    <dei:EntityRegistrantName
      contextRef="c20200101to20201231"
      id="Fact_f2da9d2421674ebe8d6c38534d4d877f">U S PHYSICAL THERAPY INC /NV</dei:EntityRegistrantName>
    <dei:EntityCentralIndexKey
      contextRef="c20200101to20201231"
      id="Fact_e45ab1e1281a419992201107edbe2d66">0000885978</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="c20200101to20201231"
      id="Fact_9738d431d7564b778d3953c83e90c37d">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:AmendmentFlag
      contextRef="c20200101to20201231"
      id="Fact_ef07dff40cb44c63bf4ee4594cac7983">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="c20200101to20201231"
      id="Fact_97b65cfe11054ae3a64529f51da52532">2020</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="c20200101to20201231"
      id="Fact_7ca76cb7cf70452fa0f11d9f553f73c6">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20200101to20201231"
      id="Fact_555251a9a4f249158279069f9fa10a71">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressStateOrProvince
      contextRef="c20200101to20201231"
      id="Fact_e48ef9b1762e421fa2a66cdc7e8e4662">TX</dei:EntityAddressStateOrProvince>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="c20200101to20201231_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember_RangeAxis_MinimumMember"
      id="Fact_82099ea63dd944a793bca0b3ef182707">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="c20200101to20201231_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember_RangeAxis_MinimumMember"
      id="Fact_d794a755570f470987cd83402baa1e26">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="c20200101to20201231_PropertyPlantAndEquipmentByTypeAxis_ComputerSoftwareIntangibleAssetMember_RangeAxis_MinimumMember"
      id="Fact_c914f2e353b54597a7cd8a612b794874">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <usph:RedeemableNonControllingInterestRedemptionRightsCommencementPeriod
      contextRef="c20200101to20201231_RangeAxis_MinimumMember"
      id="Fact_74434238a9e847afae6e8bd50f9c3ecb">P3Y</usph:RedeemableNonControllingInterestRedemptionRightsCommencementPeriod>
    <us-gaap:DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1
      contextRef="c20200101to20201231_TitleOfIndividualAxis_DirectorMember"
      id="Fact_d66bd8ac9de54f2492bfbf867e9180fc">P1Y</us-gaap:DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1>
    <us-gaap:DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1
      contextRef="c20200101to20201231_TitleOfIndividualAxis_EmployeeMember"
      id="Fact_e171b1cb7c524fee994efb673b5c1ee0">P4Y</us-gaap:DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20200101to20201231_BusinessAcquisitionAxis_SeptemberTwoThousandTwentyAcquisitionMember"
      id="Fact_29c0aadade644e9a962b7bfbcb82c179"
      unitRef="U007"
      xsi:nil="true"/>
    <usph:TermOfEmploymentAgreement
      contextRef="c20200101to20201231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember_RangeAxis_MinimumMember"
      id="Fact_52fb956c20c94f01b9b7ffcd0435f795">P3Y</usph:TermOfEmploymentAgreement>
    <usph:NonCompeteAgreementBasicTerm
      contextRef="c20200101to20201231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember_RangeAxis_MinimumMember"
      id="Fact_c128a6eff4b84ab0bfde32533264356c">P5Y</usph:NonCompeteAgreementBasicTerm>
    <us-gaap:IncomeTaxExaminationYearUnderExamination
      contextRef="c20200101to20201231_IncomeTaxAuthorityAxis_ForeignCountryMember"
      id="Fact_c614eba92f724091923d077cce15bd38">2017 2018 2019</us-gaap:IncomeTaxExaminationYearUnderExamination>
    <us-gaap:IncomeTaxExaminationYearUnderExamination
      contextRef="c20200101to20201231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember"
      id="Fact_a3d421d0c572494d8b850b77d069a61f">2016 2017 2018 2019</us-gaap:IncomeTaxExaminationYearUnderExamination>
    <usph:RestrictedPeriodToEmployeesOnTheStockGranted
      contextRef="c20200101to20201231_TitleOfIndividualAxis_EmployeesMember"
      id="Fact_5193d5e0f71242e78d0ec8f60c9b56d8">P4Y</usph:RestrictedPeriodToEmployeesOnTheStockGranted>
    <usph:EmploymentAgreementsRetirementDate
      contextRef="c20200101to20201231"
      id="Fact_07fa882becbb4980afaa1f4e941716d5">2021-08-31</usph:EmploymentAgreementsRetirementDate>
    <dei:DocumentType
      contextRef="c20200101to20201231"
      id="Fact_5f2506a0b8034f10b4ae5a6c0ad93ab1">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="c20200101to20201231"
      id="Fact_622920f4c0b94da3b709f753b4c52de4">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="c20200101to20201231"
      id="Fact_b415b2d8269f4592b0818122a6c85fc5">2020-12-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="c20200101to20201231"
      id="Fact_5faa561af39a4008b749bd32c2e002fd">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="c20200101to20201231"
      id="Fact_fcb5ba67bf1d4778b2c57f69cd6bef4a">1-11151</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20200101to20201231"
      id="Fact_cd283d3f79ed4c21ad91859b63101f0b">76-0364866</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20200101to20201231"
      id="Fact_e46170a6442241bbb38ea0fbcadc7742">1300 WEST SAM HOUSTON PARKWAY SOUTH</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="c20200101to20201231"
      id="Fact_34ec21b8954a4b32b064d93d9514f745">SUITE 300</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="c20200101to20201231"
      id="Fact_71a088f56e9f4bb5a4302f52ad550eab">HOUSTON</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode
      contextRef="c20200101to20201231"
      id="Fact_1e6f912f18c94ddd809626ccf11d1777">77042</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20200101to20201231"
      id="Fact_49a6a1097c3d4234a2d39f6ff5281844">713</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20200101to20201231"
      id="Fact_33984dda15a4462ea4944784e7494132">297-7000</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="c20200101to20201231"
      id="Fact_aeef2e992004459980f9c95231e65b9a">Common Stock, $.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20200101to20201231"
      id="Fact_9467b6550fe944788d34f504711ecd34">USPH</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20200101to20201231"
      id="Fact_93e7680d211142e5ab04ab235fefd5e5">NYSE</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="c20200101to20201231"
      id="Fact_0c03ea6ce46849278312505e990c1e4e">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="c20200101to20201231"
      id="Fact_127aefd2421c41179b770c1773e41392">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="c20200101to20201231"
      id="Fact_f68c618b669d4a70b4d5813aeffbfca5">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="c20200101to20201231"
      id="Fact_fc660aa9cdaa447ea0411ee8a0f8a7e2">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="c20200101to20201231"
      id="Fact_65c71415128e4218a76d852519a4ba8c">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="c20200101to20201231"
      id="Fact_4cabba4230d94b3c9fdb7a5ec9b01d48">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20200101to20201231"
      id="Fact_027d1fe547434fbba7cdd63572ca7ac1">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="c20200101to20201231"
      id="Fact_dd853894d9c84ab1be2ee8ecf448a09c">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="c20200630"
      decimals="-5"
      id="Fact_1831e346d0e347899a382a4775eddb1b"
      unitRef="U001">565300000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="c20210301"
      decimals="INF"
      id="Fact_a15106f84d2b46c7b0733af2b0f00bca"
      unitRef="U002">12897096</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="c20201231"
      decimals="-3"
      id="Fact_2ce2d5105c7b4dc28dc233e436489a8f"
      unitRef="U001">32918000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="c20191231"
      decimals="-3"
      id="Fact_05bade75101f4225bd86ecb6d0e494d6"
      unitRef="U001">23548000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_6b920a7b30204a83a34a0b072d0c975e"
      unitRef="U001">2008000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="c20191231"
      decimals="-3"
      id="Fact_d365d56031ec4deab5ddb4e95063a4f1"
      unitRef="U001">2698000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_7fe3ae65f699406595ff153fdedc0e83"
      unitRef="U001">41906000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="c20191231"
      decimals="-3"
      id="Fact_dea4543ee9e847f596c2355be0405581"
      unitRef="U001">46228000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsAndOtherReceivablesNetCurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_d4af189555f446769a4ab47c9114f959"
      unitRef="U001">9039000</us-gaap:AccountsAndOtherReceivablesNetCurrent>
    <us-gaap:AccountsAndOtherReceivablesNetCurrent
      contextRef="c20191231"
      decimals="-3"
      id="Fact_0969a7f302e64132bafa6b306a4469db"
      unitRef="U001">9823000</us-gaap:AccountsAndOtherReceivablesNetCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_bf4b5518a96a442aa6e5155f352e4931"
      unitRef="U001">3773000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="c20191231"
      decimals="-3"
      id="Fact_f9d3bae1d6b044f9bdca267945d446cf"
      unitRef="U001">5787000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_9c42641ce4ca4bf992926b523e516cb7"
      unitRef="U001">87636000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="c20191231"
      decimals="-3"
      id="Fact_fc0f93d3d0fc4ce08c3fca87fed34ba2"
      unitRef="U001">85386000</us-gaap:AssetsCurrent>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="c20201231"
      decimals="-3"
      id="Fact_f1d90ca3b0d64579b9569dad07437d1e"
      unitRef="U001">55426000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="c20191231"
      decimals="-3"
      id="Fact_9ef119e111d442a38a490351866dac13"
      unitRef="U001">54942000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="c20201231"
      decimals="-3"
      id="Fact_442c99afe67a44349e10142b8afe9b16"
      unitRef="U001">35320000</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="c20191231"
      decimals="-3"
      id="Fact_77ee5b7915634df2963ec38be67dd419"
      unitRef="U001">33247000</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="c20201231"
      decimals="-3"
      id="Fact_daa7f1d8eb1b4fb6a33557b392b32e75"
      unitRef="U001">90746000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="c20191231"
      decimals="-3"
      id="Fact_2f7e6f7be46046d0870f2e3ee61463bb"
      unitRef="U001">88189000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="c20201231"
      decimals="-3"
      id="Fact_f52e0122f4cf4daa9aed6baa2a9d0fc5"
      unitRef="U001">69081000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="c20191231"
      decimals="-3"
      id="Fact_35f64a30bfe54397a1bafd73b9c406f5"
      unitRef="U001">66099000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="c20201231"
      decimals="-3"
      id="Fact_d67b9a45298040939fe0f8ae2bb3a76f"
      unitRef="U001">21665000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="c20191231"
      decimals="-3"
      id="Fact_f16d84cf150f40f9ad4136baab4d6d0c"
      unitRef="U001">22090000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="c20201231"
      decimals="-3"
      id="Fact_789cf4b05c3a41979723e3f06166d40b"
      unitRef="U001">81595000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="c20191231"
      decimals="-3"
      id="Fact_af30bcff1ef440bb930a11abe8db7d1c"
      unitRef="U001">81586000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="c20201231"
      decimals="-3"
      id="Fact_33d4620d152b4f588ff917afe3eb01aa"
      unitRef="U001">345646000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="c20191231"
      decimals="-3"
      id="Fact_3fbed941dc8b432884104ba029c5c926"
      unitRef="U001">317676000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="c20201231"
      decimals="-3"
      id="Fact_bfd7c6f1e4dd448ea716065aa8d9c18e"
      unitRef="U001">56280000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="c20191231"
      decimals="-3"
      id="Fact_a79f2d798b4a49528e12a1a917c67a1f"
      unitRef="U001">52588000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_2d9dff42930e40a4ae33352c57ea3fb0"
      unitRef="U001">1539000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="c20191231"
      decimals="-3"
      id="Fact_513b098804b341729fcc92b16a304b6e"
      unitRef="U001">1519000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="c20201231"
      decimals="-3"
      id="Fact_2e900d70673745e68e79e37c1b39b23b"
      unitRef="U001">594361000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="c20191231"
      decimals="-3"
      id="Fact_e60e3ebb34dc4f398fcced329287a18e"
      unitRef="U001">560845000</us-gaap:Assets>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_16d722628c304cd6b771c39940c3ab32"
      unitRef="U001">1335000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="c20191231"
      decimals="-3"
      id="Fact_fc8b850a65cf4c94808447bff5cee5ad"
      unitRef="U001">2494000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_59c6efc0e5254574ac8b52145204d515"
      unitRef="U001">59746000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="c20191231"
      decimals="-3"
      id="Fact_7f721b421c4e49e3ac23616b60cd6d2d"
      unitRef="U001">30855000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_7528e83538fa44a686c97c6d7f45046b"
      unitRef="U001">27512000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="c20191231"
      decimals="-3"
      id="Fact_559302aefaac443e84392ed642cab1bb"
      unitRef="U001">26486000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_4c30ec4007054809919a6939047345f6"
      unitRef="U001">4899000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="c20191231"
      decimals="-3"
      id="Fact_c3ba565395b147a497f11f3c2bbc7687"
      unitRef="U001">728000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_c0bb6ede3f4841f99e2d812c7cb73fca"
      unitRef="U001">93492000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="c20191231"
      decimals="-3"
      id="Fact_572f2ccbb3d24855849448caec530103"
      unitRef="U001">60563000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermNotesPayable
      contextRef="c20201231"
      decimals="-3"
      id="Fact_a1b6c782a1544ec29dae0d15d66ba078"
      unitRef="U001">596000</us-gaap:LongTermNotesPayable>
    <us-gaap:LongTermNotesPayable
      contextRef="c20191231"
      decimals="-3"
      id="Fact_6d5d2017a2a14cbd8d94fdc5169747a0"
      unitRef="U001">4361000</us-gaap:LongTermNotesPayable>
    <us-gaap:LongTermLineOfCredit
      contextRef="c20201231"
      decimals="-3"
      id="Fact_e727a06037a1462c9a9a27dcab9008cf"
      unitRef="U001">16000000</us-gaap:LongTermLineOfCredit>
    <us-gaap:LongTermLineOfCredit
      contextRef="c20191231"
      decimals="-3"
      id="Fact_fd624ba6d8674b0491f8e7569ff13a60"
      unitRef="U001">46000000</us-gaap:LongTermLineOfCredit>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="c20201231"
      decimals="-3"
      id="Fact_d05c866eccd5474caa69f057e9e2ad9e"
      unitRef="U001">7779000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="c20191231"
      decimals="-3"
      id="Fact_445f572077104ea9bb6aff4222768cee"
      unitRef="U001">10071000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_aa0942dfda90437b927a5e77709391c4"
      unitRef="U001">61985000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="c20191231"
      decimals="-3"
      id="Fact_c4377a58ffc64541a0fc681366b50add"
      unitRef="U001">60258000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_e502a01909f74f448dedd223e84cb516"
      unitRef="U001">4539000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="c20191231"
      decimals="-3"
      id="Fact_6d442207476d4d74af37aa78d2757010"
      unitRef="U001">141000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="c20201231"
      decimals="-3"
      id="Fact_e323b6f938af4b73bf9e6b318459627e"
      unitRef="U001">184391000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="c20191231"
      decimals="-3"
      id="Fact_1804dd88c3be496d94b195b791f3c6c8"
      unitRef="U001">181394000</us-gaap:Liabilities>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="c20201231"
      decimals="-3"
      id="Fact_dc76525c9c3540e9a00130be00622ca5"
      unitRef="U001">132340000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="c20191231"
      decimals="-3"
      id="Fact_fa94725061404027a4a9d8cec3dc80f9"
      unitRef="U001">137750000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:CommitmentsAndContingencies
      contextRef="c20201231"
      id="Fact_f51bdff43632426686f66c4c43387d1d"
      unitRef="U001"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="c20191231"
      id="Fact_6f923232041d44f586caab32061eacfa"
      unitRef="U001"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c20191231"
      decimals="2"
      id="Fact_533717d3ecf644b689249608603441a0"
      unitRef="U003">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c20201231"
      decimals="2"
      id="Fact_2f8dcac6aa0b4a7a91b8290b1b4f078a"
      unitRef="U003">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c20201231"
      decimals="0"
      id="Fact_55f9a2b40e244bac9734f259a2f092fa"
      unitRef="U002">500000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c20191231"
      decimals="0"
      id="Fact_e4969dea983746029ed7c008889aad23"
      unitRef="U002">500000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c20201231"
      decimals="INF"
      id="Fact_445d545663f340c3b29cb24fff1339a8"
      unitRef="U002">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c20191231"
      decimals="INF"
      id="Fact_9e907d0793014e1a8f5e41ff7dfe33c9"
      unitRef="U002">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c20201231"
      decimals="INF"
      id="Fact_7a2e0a6634e14018aa4627ac4ac73ebd"
      unitRef="U002">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c20191231"
      decimals="INF"
      id="Fact_6969c36e3f3f40ce95dd91607ef09a0b"
      unitRef="U002">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="c20201231"
      decimals="-3"
      id="Fact_22ee4fb801cc489cb72c297acf3c0ee8"
      unitRef="U001">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="c20191231"
      decimals="-3"
      id="Fact_5cc2b9910a794bd685adac6113855292"
      unitRef="U001">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c20201231"
      decimals="2"
      id="Fact_23df58c641ef47d3b8ab61c72122c7b3"
      unitRef="U003">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c20191231"
      decimals="2"
      id="Fact_7729113373134ace9784335566bd5dea"
      unitRef="U003">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c20191231"
      decimals="0"
      id="Fact_bf3d1d5431f84e74a721b9cf003ab13b"
      unitRef="U002">20000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c20201231"
      decimals="0"
      id="Fact_b5f9c671d2234ee8b496fae75090a7f6"
      unitRef="U002">20000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="c20201231"
      decimals="0"
      id="Fact_c6172ad2dab0462284b448937cfa778f"
      unitRef="U002">15066282</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="c20191231"
      decimals="0"
      id="Fact_5306c9d2f0be43e2874b69c7b0d19fb2"
      unitRef="U002">14989337</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="c20201231"
      decimals="-3"
      id="Fact_14d1307248364171959a49cf82445478"
      unitRef="U001">151000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="c20191231"
      decimals="-3"
      id="Fact_637938b9d07340fe9525e8d03e2f3d66"
      unitRef="U001">150000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="c20201231"
      decimals="-3"
      id="Fact_c43e3fae9f8141c1ae9272c4e591adf5"
      unitRef="U001">95622000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="c20191231"
      decimals="-3"
      id="Fact_5e97ad0fa1a640d39c62198739354026"
      unitRef="U001">87383000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="c20201231"
      decimals="-3"
      id="Fact_36769be17bbc446a9560ebef73fddc1d"
      unitRef="U001">212015000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="c20191231"
      decimals="-3"
      id="Fact_b9798d73605243dc9ed81d125b7c9b47"
      unitRef="U001">184352000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockShares
      contextRef="c20201231"
      decimals="0"
      id="Fact_7a6c599fd0f544529201120d61801a08"
      unitRef="U002">2214737</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="c20191231"
      decimals="0"
      id="Fact_75ac6df5c07e40c1b74dac393f776266"
      unitRef="U002">2214737</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="c20201231"
      decimals="-3"
      id="Fact_ade910b159cb44d2862fa6e1691bc879"
      unitRef="U001">31628000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="c20191231"
      decimals="-3"
      id="Fact_350010c45bd04c989aefd046a151ee84"
      unitRef="U001">31628000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity
      contextRef="c20201231"
      decimals="-3"
      id="Fact_4b0f79582bed43e6861baf5074a2ad68"
      unitRef="U001">276160000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20191231"
      decimals="-3"
      id="Fact_51e985b0b53d4356a4f86b0c23542f8a"
      unitRef="U001">240257000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="c20201231"
      decimals="-3"
      id="Fact_644db5a6fe8d4c2dbd3a870f7764a784"
      unitRef="U001">1470000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="c20191231"
      decimals="-3"
      id="Fact_e059b9d1754349bcafab4a127948934f"
      unitRef="U001">1444000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20201231"
      decimals="-3"
      id="Fact_3ca81ed110b945db8e535902354c9df1"
      unitRef="U001">277630000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20191231"
      decimals="-3"
      id="Fact_150345a2b01a4be19f74969975f156bc"
      unitRef="U001">241701000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="c20201231"
      decimals="-3"
      id="Fact_d9c7daef913840919caa962c18b140a8"
      unitRef="U001">594361000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="c20191231"
      decimals="-3"
      id="Fact_566c9d007e0b42cab75eeef97e82b2c5"
      unitRef="U001">560845000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20200101to20201231_ProductOrServiceAxis_NetPatientRevenuesMember"
      decimals="-3"
      id="Fact_e35c9967bb9f4dd0b0204873f5680460"
      unitRef="U001">373340000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20190101to20191231_ProductOrServiceAxis_NetPatientRevenuesMember"
      decimals="-3"
      id="Fact_7ad59bf422cc49eb8655247753eb9c6f"
      unitRef="U001">433345000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20180101to20181231_ProductOrServiceAxis_NetPatientRevenuesMember"
      decimals="-3"
      id="Fact_770be3cf31534bc69d1a71a5aa7407c7"
      unitRef="U001">417703000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20200101to20201231_ProductOrServiceAxis_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember"
      decimals="-3"
      id="Fact_00042d1941d245cc89cdeb1d8eceb009"
      unitRef="U001">49629000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20190101to20191231_ProductOrServiceAxis_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember"
      decimals="-3"
      id="Fact_e8811db838ab4cc0bf0d9729e13f6fb5"
      unitRef="U001">48624000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20180101to20181231_ProductOrServiceAxis_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember"
      decimals="-3"
      id="Fact_65682071f9e241dda91e9425e8d0e987"
      unitRef="U001">36208000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_6ce856a4fb56458592e0ba2e79cf86b5"
      unitRef="U001">422969000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_c5dda4651d6d42dabbb350296d0b02af"
      unitRef="U001">481969000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_97ca2440635c46a6b04ca7f62cc528d3"
      unitRef="U001">453911000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:LaborAndRelatedExpense
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_61def78b225b4c30a5cb11c226fe1036"
      unitRef="U001">235629000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_9e6121bed2844723aa8fc8d6fd1c09a1"
      unitRef="U001">274233000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_a14809dd412949f89d2b60ccb841ca6b"
      unitRef="U001">259228000</us-gaap:LaborAndRelatedExpense>
    <usph:RentSuppliesContractLaborAndOther
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_65191cada3724f26af3313be7972cc22"
      unitRef="U001">84336000</usph:RentSuppliesContractLaborAndOther>
    <usph:RentSuppliesContractLaborAndOther
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_a2d5ea7b395e42fbab658c2dc675a38b"
      unitRef="U001">90379000</usph:RentSuppliesContractLaborAndOther>
    <usph:RentSuppliesContractLaborAndOther
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_ab34ea46a55d490da607b55e8dd20267"
      unitRef="U001">88426000</usph:RentSuppliesContractLaborAndOther>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_ba0b2faa79014c53a03219397ae2999a"
      unitRef="U001">4623000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_3a2c59168e04419397ea50e3c1acfe5b"
      unitRef="U001">4858000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_a6c41c88b78540a78f27357bd130f0c5"
      unitRef="U001">4603000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:RestructuringCharges
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_f50737667fe349dc8e394ee71d4582d4"
      unitRef="U001">2072000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_feb32cd04e904fa68d1d28abbadbbce3"
      unitRef="U001">25000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_fadd9a615cbf448889894ab46a2163be"
      unitRef="U001">-9000</us-gaap:RestructuringCharges>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_718aab7d5e95400f9f9a3fd2279ee369"
      unitRef="U001">1859000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_817d4b0b29484fe5ad372109012ea095"
      unitRef="U001">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_1ac475118fc84568a9b88bb9e74750a8"
      unitRef="U001">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:CostsAndExpenses
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_356252ae6bd84f93883aee6dd172838e"
      unitRef="U001">328519000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_badc1a42bbd043cda9b49a3fbb78c88d"
      unitRef="U001">369495000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_5fa9cf00b4724588af5f6416f755625b"
      unitRef="U001">352248000</us-gaap:CostsAndExpenses>
    <us-gaap:GrossProfit
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_8aa965161a974bd7977f8e27c43a46db"
      unitRef="U001">94450000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_519be4070e5c4ab1a3ddb9049660d266"
      unitRef="U001">112474000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_6669eddc33e24d509545e52a263ee948"
      unitRef="U001">101663000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_dc4d6615516547ccbaf131801ad2b43c"
      unitRef="U001">42037000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_339e858f87bc4a5d8088f523f3ce04a7"
      unitRef="U001">45049000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_a40c8d642e464b7087190a436a6e6001"
      unitRef="U001">41349000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_232585ea62b3409ea2fa980846a4e095"
      unitRef="U001">52413000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_cb5eee5f9927401eb5e41adf051f3f4d"
      unitRef="U001">67425000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_6d793eb1111c421294c3b7c204ed8726"
      unitRef="U001">60314000</us-gaap:OperatingIncomeLoss>
    <usph:ReliefFunds
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_0dd041d1d5434432b48526438ab4920b"
      unitRef="U001">13501000</usph:ReliefFunds>
    <usph:ReliefFunds
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_2d0e9091e77b4d89a326543a7e603d0b"
      unitRef="U001">0</usph:ReliefFunds>
    <usph:ReliefFunds
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_eeae2d8bded34765b962710c07cc0399"
      unitRef="U001">0</usph:ReliefFunds>
    <us-gaap:GainLossOnSaleOfInterestInProjects
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_11b6a467e6f44604b8b221056cfc8ecb"
      unitRef="U001">1091000</us-gaap:GainLossOnSaleOfInterestInProjects>
    <us-gaap:GainLossOnSaleOfInterestInProjects
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_a9640dd66b1645599f70a042c075754f"
      unitRef="U001">5514000</us-gaap:GainLossOnSaleOfInterestInProjects>
    <us-gaap:GainLossOnSaleOfInterestInProjects
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_36494e685a0e4653a371a30c3bc29263"
      unitRef="U001">0</us-gaap:GainLossOnSaleOfInterestInProjects>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_126b099faf3c4303b54211f64fc37e4d"
      unitRef="U001">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_07ca9e6121504d3dad8a10d713599707"
      unitRef="U001">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_7e64e762420747d28b35ef7096a8fdff"
      unitRef="U001">1846000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:InterestAndOtherIncome
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_47a6948804e6421aa7c5569ddfb6f432"
      unitRef="U001">142000</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_6673f1ddb6de4e3e88cef8bffb09c538"
      unitRef="U001">46000</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_0fb4e652a83d40ca9380dd08c22e143c"
      unitRef="U001">93000</us-gaap:InterestAndOtherIncome>
    <usph:InterestExpenseDebtAndOther
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_5edcd5c5fc24482ea39a16479f7f01cc"
      unitRef="U001">1634000</usph:InterestExpenseDebtAndOther>
    <usph:InterestExpenseDebtAndOther
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_6c0bf53b06c24910b90862697a113664"
      unitRef="U001">2079000</usph:InterestExpenseDebtAndOther>
    <usph:InterestExpenseDebtAndOther
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_114139eb1d40479b920e5abfd30dfde3"
      unitRef="U001">2042000</usph:InterestExpenseDebtAndOther>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_1ecc0a48dcab42f28074ebd74a033757"
      unitRef="U001">13100000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_0fac39fce89a4f02b908280d94c0dbea"
      unitRef="U001">3481000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_a5241686e8e3460b967a8f55b9422da3"
      unitRef="U001">-103000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_c265a78c41644118bf05f565239b1b7a"
      unitRef="U001">65513000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_d33c361e91fa42ec9279c95e7045f44b"
      unitRef="U001">70906000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_3f1829e853174cad87037a0923a0853b"
      unitRef="U001">60211000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_ed64e716c78c408395d255cf5ff6f76c"
      unitRef="U001">13022000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_275eae87f6164f3cbf8a9de99e43c183"
      unitRef="U001">13647000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_28ae1dac79474472b8b70839a93cd2b9"
      unitRef="U001">11369000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_29155edc6b2641ed8c87262ae24397ca"
      unitRef="U001">52491000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_6f9b95ec0bc34e92aa05c9fcaec0fa9f"
      unitRef="U001">57259000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_d69789a070424537a32da77e2c0a7173"
      unitRef="U001">48842000</us-gaap:ProfitLoss>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_088facc727da4e8dae55d74920778473"
      unitRef="U001">6122000</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_8175e81b6b48483ab14eab2cae8ef10b"
      unitRef="U001">6561000</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_dcea8686fab849c88225d1bf710e3485"
      unitRef="U001">5536000</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_438b4fecd99746a995c3c21718f20cb3"
      unitRef="U001">11175000</usph:NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity>
    <usph:NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_70cea6ef71224e2eadc5867ad8e2e3b3"
      unitRef="U001">10659000</usph:NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity>
    <usph:NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_51c2b86a0f3c441daa44495c7520799b"
      unitRef="U001">8433000</usph:NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_7f61bf9462694815bd16de14e473ed79"
      unitRef="U001">17297000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_834f06bee5924c12b3ca4785b8102173"
      unitRef="U001">17220000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_e03a86e004484de3aa213f2bb2d7b4de"
      unitRef="U001">13969000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_31bdbfb4915f47acb8218bf15a52ad49"
      unitRef="U001">35194000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_dd6f30fb2a9346cd878ccf29d188cf37"
      unitRef="U001">40039000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_13ad099f58fb4769a198359989747e09"
      unitRef="U001">34873000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="c20200101to20201231"
      decimals="2"
      id="Fact_c585bb89c2ac4e25a129f456266e225e"
      unitRef="U003">2.48</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="c20190101to20191231"
      decimals="2"
      id="Fact_ab4ab6f15414421da7be1eb830722efd"
      unitRef="U003">2.45</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="c20180101to20181231"
      decimals="2"
      id="Fact_0172f895a68642baba3a75c813fc1554"
      unitRef="U003">1.31</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_52a84381861042c5b5aa644dda136413"
      unitRef="U002">12835000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_6beed9c77fc048a1a38adcc0b7461c9a"
      unitRef="U002">12756000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_c0469b8922514ae794bc545d836ff24a"
      unitRef="U002">12666000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c20200101to20201231"
      decimals="2"
      id="Fact_012f9768e29b4bf2be07d6b5d4720ae9"
      unitRef="U003">0.32</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c20190101to20191231"
      decimals="2"
      id="Fact_482dee4cca2448898c010e7bd16cc319"
      unitRef="U003">1.14</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c20180101to20181231"
      decimals="2"
      id="Fact_6896edea7afa4e1593c24d01ff57d231"
      unitRef="U003">0.92</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:SharesOutstanding
      contextRef="c20171231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_f83d1c0691e5479f9b523544afe15332"
      unitRef="U002">14809000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20171231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_785fd350be414c27a44c27ca72cf45a1"
      unitRef="U001">148000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20171231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_7e352e549c6e441fbef6007e2a1fefca"
      unitRef="U001">73940000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20171231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_4312cc04e3974531b02d3117342264c5"
      unitRef="U001">162406000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="c20171231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_27c7420849724d44be51d6630cbf3dc2"
      unitRef="U002">-2215000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20171231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_c1c6aaec27504359aed8a8c9b8eb694c"
      unitRef="U001">-31628000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20171231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_72d470802917488cb4ddaa481edbb992"
      unitRef="U001">204866000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20171231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_d2c23374fa364405993f70ce658c1b93"
      unitRef="U001">1204000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20171231"
      decimals="-3"
      id="Fact_1befc4da3b9941dbaace34d4cd9a7c3f"
      unitRef="U001">206070000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_c41034e530d94d4c89eb8205193aae40"
      unitRef="U002">90000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_5a83464f42c54a82a1776bdff0720ede"
      unitRef="U001">1000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_99c8243ce9fa42c3a69995618ddded14"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_582ca17769554fab94e8ad4bb8c3dcc2"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_e2a97c06e0b84ac3badf01d7f77cead8"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_f5b8f2a6252e40f6a6d8f2a794348aa4"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_9fe6844a20a24aad91d532abd5ef92e4"
      unitRef="U001">1000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_0566adc9664d42d0b9b3af67d87db3a6"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_7ae29ff14cf94b74b14e52d12ceacb4f"
      unitRef="U001">1000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTaxShares
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_45d68bdf28734cec8337203f23dcd3f0"
      unitRef="U002">0</usph:RevaluationOfRedeemableNonControllingInterestNetOfTaxShares>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_78b2d56c333f42ab96a92f971fa3765d"
      unitRef="U001">0</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_f6e604376a964b4a97a0d47272d71f5e"
      unitRef="U001">0</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_22d5e8143ef74d338632b150c670e69b"
      unitRef="U001">-18268000</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTaxShares
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_222ccc34cd5f4258b204c2f36bc7f6c1"
      unitRef="U002">0</usph:RevaluationOfRedeemableNonControllingInterestNetOfTaxShares>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_188b85854ebe4752bf2644c6efaba986"
      unitRef="U001">0</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_4f244c49e0b443169c4ef16fc8ce7936"
      unitRef="U001">-18268000</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_41e1cc8b1e714ed7ac8c034c1cac923f"
      unitRef="U001">0</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_2d2c8b14be784a43b2ebdda1a91f8978"
      unitRef="U001">-18268000</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_d4dd4eac340d49ef97a0b8d520073d28"
      unitRef="U001">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_4d52a212f6324f289699435b35292b64"
      unitRef="U001">5939000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_eef8f4fbf54547ce9cd24ccef0016531"
      unitRef="U001">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_fcb1c70e24004eee9ba68398ba0f9206"
      unitRef="U001">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_9886660aab334f018cd30c5260157631"
      unitRef="U001">5939000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_84a5d527a51d4d3d9affdc9c198f8924"
      unitRef="U001">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_58891e2c2fa147029756bd062babf481"
      unitRef="U001">5939000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_814ff93eb0af482b95ce3c98660ae883"
      unitRef="U001">0</usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans>
    <usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_7efef34746e249babfdb69a5fb30485c"
      unitRef="U001">373000</usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans>
    <usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_a07cb379ee34480ca3a2e5640b46fec2"
      unitRef="U001">0</usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans>
    <usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_a41b9228c43c4c34b56eaf28788a9961"
      unitRef="U001">0</usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans>
    <usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_c86bdbff5e954fe4b22ecbbd7b2f049f"
      unitRef="U001">373000</usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans>
    <usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_e541bd54d3e248a5b257a44b7ec93be9"
      unitRef="U001">0</usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans>
    <usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_dfd9729acbce4790abc1171175801f29"
      unitRef="U001">373000</usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans>
    <usph:SaleOfNonControllingInterestNetOfTaxAndPurchases
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_e14d559ac74e49d4adf17d7c7a852c32"
      unitRef="U001">0</usph:SaleOfNonControllingInterestNetOfTaxAndPurchases>
    <usph:SaleOfNonControllingInterestNetOfTaxAndPurchases
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_88daaa2d7ccc4a16b5d3efa00ec12703"
      unitRef="U001">-224000</usph:SaleOfNonControllingInterestNetOfTaxAndPurchases>
    <usph:SaleOfNonControllingInterestNetOfTaxAndPurchases
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_7caaadbb0be144549ec3fa448c6ca4f3"
      unitRef="U001">0</usph:SaleOfNonControllingInterestNetOfTaxAndPurchases>
    <usph:SaleOfNonControllingInterestNetOfTaxAndPurchases
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_8ca26989ad6f42babeb271299d7c0463"
      unitRef="U001">0</usph:SaleOfNonControllingInterestNetOfTaxAndPurchases>
    <usph:SaleOfNonControllingInterestNetOfTaxAndPurchases
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_ecebe879e5714097a9a58c5eb3321d29"
      unitRef="U001">-224000</usph:SaleOfNonControllingInterestNetOfTaxAndPurchases>
    <usph:SaleOfNonControllingInterestNetOfTaxAndPurchases
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_80bf2673caa04e2f854d569302b934dd"
      unitRef="U001">-48000</usph:SaleOfNonControllingInterestNetOfTaxAndPurchases>
    <usph:SaleOfNonControllingInterestNetOfTaxAndPurchases
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_9c558c9878f04cbdb3b4bee473371003"
      unitRef="U001">-272000</usph:SaleOfNonControllingInterestNetOfTaxAndPurchases>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_c4cb5df92e5449ada53bb6a32b50afe1"
      unitRef="U001">0</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_0a1c0df69a7a4fc6a407d3c7ab5df1d4"
      unitRef="U001">0</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_c8496b9f57c54211a9b7db34cc824158"
      unitRef="U001">11664000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_e2c4da697e984235a2ae0cb7ee540485"
      unitRef="U001">0</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_8bb85119d7d3450c88cbe63dc35ff156"
      unitRef="U001">11664000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_aaeab31d4d5b4713b7a82c3e65688df4"
      unitRef="U001">0</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_5fe7630b42cb400485e8db70eff2f864"
      unitRef="U001">11664000</us-gaap:DividendsCommonStockCash>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_0e0f991709624c65b419e58136b56939"
      unitRef="U001">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_d35495ae9a7b411d8c5194173803cc80"
      unitRef="U001">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_dc07b82449924af8811482ff6a5e5e89"
      unitRef="U001">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_d267f6142a0f418dba781946684168fc"
      unitRef="U001">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_68bdb48497da4234a2de4bcfaba7e085"
      unitRef="U001">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_e1c8464bad4f4efd80623bc858874933"
      unitRef="U001">5812000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_486710db13f241518b5502f14d9d3288"
      unitRef="U001">5812000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:StockholdersEquityOther
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_ef52e274790444f2b8a80098b13232da"
      unitRef="U001">0</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_05c27d301c21402db5c08c897d291e58"
      unitRef="U001">0</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_188ffdc526824e81a6634e50d8c07601"
      unitRef="U001">49000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_31955495fe2a4e3eb5b193f3c4dad57a"
      unitRef="U001">0</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_3a79bdb7185e4057b2a84cbf1e665246"
      unitRef="U001">49000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_080ea18b407f458489dccaae58993f19"
      unitRef="U001">50000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_9a2041ef82984acdab3c3a5ce78c7865"
      unitRef="U001">99000</us-gaap:StockholdersEquityOther>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_e87f49f678ff44a99b53d903f49c34fe"
      unitRef="U001">0</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_053dfe1e6ca946069d17ecd1e6674698"
      unitRef="U001">0</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_d3cd1f182f3b49feb893afcad0b6e130"
      unitRef="U001">0</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_b4a76cb5f5464f1681667832a46094ee"
      unitRef="U001">0</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_d077ca2f47184d78bfc90db118b77943"
      unitRef="U001">0</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_843e806a1e03474694c78867584a9727"
      unitRef="U001">5536000</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_fffd2ede8c194e97b75982fe818c1009"
      unitRef="U001">5536000</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <us-gaap:NetIncomeLoss
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_af4ee5e789074be3969bd62e6288224d"
      unitRef="U001">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_8dab10a1a0c8491c931054dcd987c02f"
      unitRef="U001">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_f8ddb88bb7284bf4bb277f3cc6fc20c1"
      unitRef="U001">34873000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_de9b290c82754f5cbda8e291ec8b91e9"
      unitRef="U001">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_43e1fd5fa46b40b2be7931b5ef310914"
      unitRef="U001">34873000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20180101to20181231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_15bce0f434a84f978718b6ff6bbe5e25"
      unitRef="U001">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_035f5af1410243c1857de6b4cfe0524b"
      unitRef="U001">34873000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="c20181231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_d328c16690f14d1c9179925509c779d9"
      unitRef="U002">14899000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20181231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_9ca7273bd1f349ecba616edcac8f263c"
      unitRef="U001">149000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20181231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_19ec2f70a2d14d4187cf0264549666d4"
      unitRef="U001">80028000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20181231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_f5bf7b724d4f407fbc3b90b795e52b09"
      unitRef="U001">167396000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="c20181231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_c5f6934f13144d18b2bc12960d84e0de"
      unitRef="U002">-2215000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20181231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_164ebc8c07ce44859fefd2d54eac8c43"
      unitRef="U001">-31628000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20181231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_4597971c648e4d088b915c455a5c01b8"
      unitRef="U001">215945000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20181231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_b0b0817c72c741a49bd69f231ba0cf18"
      unitRef="U001">930000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20181231"
      decimals="-3"
      id="Fact_13b0682169d144fcb6eebc6cdf90bb81"
      unitRef="U001">216875000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_9d19eeb28dd44a2083aa4a0449473ca5"
      unitRef="U002">90000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_aed065bf5dcd4cc7b062346cafbe3e7f"
      unitRef="U001">1000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_627fbc1991ad4cc38b113547795cb610"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_31b293cd305d43a8a008271f36ed6d7e"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_b66262c821654082bebb4b22255686a5"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_65d76d958e0f487c8cb57a8808b6b40b"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_aa6fb3875abd4ff0832fd267df2ab1dc"
      unitRef="U001">1000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_01a7e47d25e84fd0b0950334d9e79a23"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_393a1a99d3104397b4c72b1ee6592c48"
      unitRef="U001">1000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTaxShares
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_6ced11221b9248cbbf5426d610fcdfbc"
      unitRef="U002">0</usph:RevaluationOfRedeemableNonControllingInterestNetOfTaxShares>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_8d1b16311de34bc5b6f8d6f86ed376ea"
      unitRef="U001">0</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_5769d2fb4ecb4815838a5c41043627cf"
      unitRef="U001">0</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_d512cf7b90204bcdaf0e8408c1535ab8"
      unitRef="U001">-8771000</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTaxShares
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_516f1f1584324518b11515ed80640945"
      unitRef="U002">0</usph:RevaluationOfRedeemableNonControllingInterestNetOfTaxShares>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_60f01d53931046bd8cc89ffa9d636763"
      unitRef="U001">0</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_3bfbc83f7dcd45baba40d58b5eb6dd1e"
      unitRef="U001">-8771000</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_c77b493a63d64b1fbfa44915456e4e61"
      unitRef="U001">0</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_7fde35ed85274d4ab82449be7cef6e19"
      unitRef="U001">-8771000</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_1277c008ae2841d0ae7fe8255a4555f9"
      unitRef="U001">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_eb3f85f224f24c2993aa0c2ed4f5efc7"
      unitRef="U001">6985000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_6e16dab575e14c1993afa95e95032840"
      unitRef="U001">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_107bd6ea897f41eeb9bb3c440a0060a0"
      unitRef="U001">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_af7662f9cfc049aba219a15b353af83a"
      unitRef="U001">6985000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_c62f9ada6a924df1a9e4e7c3dd7e1c60"
      unitRef="U001">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_90041b9c73534d0086debe52d9084cc8"
      unitRef="U001">6985000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_c47e8dede2124c08a3ed8fd7f8eacdbf"
      unitRef="U001">0</usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans>
    <usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_a23bce2be4804b4da28e72a8f5f06c9b"
      unitRef="U001">636000</usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans>
    <usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_684cfb4c1aa3432284d5185838e87ff1"
      unitRef="U001">0</usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans>
    <usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_0795acc34576457fbfac13c448d606aa"
      unitRef="U001">0</usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans>
    <usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_46b8c0101a6545b1a037cd32602d2386"
      unitRef="U001">636000</usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans>
    <usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_3560d2756fe948eea8c18fd1e4e1425b"
      unitRef="U001">0</usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans>
    <usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_d2ac7756549c42fb8bd94b66481270ed"
      unitRef="U001">636000</usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans>
    <usph:PurchaseOfPartnershipInterestsRedeemableNonControllingInterests
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_9aea48b0516249a4b3d50a6f6d75caa5"
      unitRef="U001">0</usph:PurchaseOfPartnershipInterestsRedeemableNonControllingInterests>
    <usph:PurchaseOfPartnershipInterestsRedeemableNonControllingInterests
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_4f0d23f93caa4bd5aac363d52cc5cc14"
      unitRef="U001">-266000</usph:PurchaseOfPartnershipInterestsRedeemableNonControllingInterests>
    <usph:PurchaseOfPartnershipInterestsRedeemableNonControllingInterests
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_cdfb7092e94b453c91763aabf28dcff3"
      unitRef="U001">0</usph:PurchaseOfPartnershipInterestsRedeemableNonControllingInterests>
    <usph:PurchaseOfPartnershipInterestsRedeemableNonControllingInterests
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_9bf4c46c090a4ff192875f1d7b82f5f2"
      unitRef="U001">0</usph:PurchaseOfPartnershipInterestsRedeemableNonControllingInterests>
    <usph:PurchaseOfPartnershipInterestsRedeemableNonControllingInterests
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_c2241718c2a94bce83f3fb14c7ea4047"
      unitRef="U001">-266000</usph:PurchaseOfPartnershipInterestsRedeemableNonControllingInterests>
    <usph:PurchaseOfPartnershipInterestsRedeemableNonControllingInterests
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_87995c773bf64a7e9d9f84181ecc4591"
      unitRef="U001">-26000</usph:PurchaseOfPartnershipInterestsRedeemableNonControllingInterests>
    <usph:PurchaseOfPartnershipInterestsRedeemableNonControllingInterests
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_e8901c4d30e349b6bbccf2160cc69e46"
      unitRef="U001">-292000</usph:PurchaseOfPartnershipInterestsRedeemableNonControllingInterests>
    <usph:SaleOfNonControllingInterestNetOfTaxAndPurchases
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_5f3c5917723d434bbe0bdffa5837779c"
      unitRef="U001">0</usph:SaleOfNonControllingInterestNetOfTaxAndPurchases>
    <usph:SaleOfNonControllingInterestNetOfTaxAndPurchases
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_d9ea9d5ed30146879fb1af4f93b39666"
      unitRef="U001">0</usph:SaleOfNonControllingInterestNetOfTaxAndPurchases>
    <usph:SaleOfNonControllingInterestNetOfTaxAndPurchases
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_2e353296e9754d7fb5f5852448b7e3b7"
      unitRef="U001">196000</usph:SaleOfNonControllingInterestNetOfTaxAndPurchases>
    <usph:SaleOfNonControllingInterestNetOfTaxAndPurchases
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_0a9977d7ea654862bf088ae1be4435ac"
      unitRef="U001">0</usph:SaleOfNonControllingInterestNetOfTaxAndPurchases>
    <usph:SaleOfNonControllingInterestNetOfTaxAndPurchases
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_7a525a26c43e48769fd3aaa9be8ecb10"
      unitRef="U001">196000</usph:SaleOfNonControllingInterestNetOfTaxAndPurchases>
    <usph:SaleOfNonControllingInterestNetOfTaxAndPurchases
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_6e28b9f10804496aa31f7bcb9975f8bd"
      unitRef="U001">0</usph:SaleOfNonControllingInterestNetOfTaxAndPurchases>
    <usph:SaleOfNonControllingInterestNetOfTaxAndPurchases
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_4918ba63b46843b6a78a9499c34a08c6"
      unitRef="U001">196000</usph:SaleOfNonControllingInterestNetOfTaxAndPurchases>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_d6442e09148c46019c080ff9826226be"
      unitRef="U001">0</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_f065a82ff86748469be2a7c1f450f4da"
      unitRef="U001">0</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_6d22dde1877e4b40a2d887a3e3f68258"
      unitRef="U001">14555000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_52d830115c33444e827188977e76c174"
      unitRef="U001">0</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_7f67e2ea1d01449bb2651603699d60c5"
      unitRef="U001">14555000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_f09b1cad120d4932b468bd7a27b6b1cd"
      unitRef="U001">0</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_75bfb5d85126419fba9fc98c26de27bb"
      unitRef="U001">14555000</us-gaap:DividendsCommonStockCash>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_a4e0d42e85f14da7b2fb7fa1c781440e"
      unitRef="U001">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_dda90d7fe7b4491d9e39acaa532ead6f"
      unitRef="U001">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_32b0f66524b547f19aa9d1081c78b0c5"
      unitRef="U001">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_cb11cb4ca5614e1da6a088a92b5b5c42"
      unitRef="U001">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_9af08121669748fbb157a8b9b1e37959"
      unitRef="U001">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_0b7697055b6148c9b70309464938dc4b"
      unitRef="U001">6014000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_bc859fe506e64c42857be43e2f163395"
      unitRef="U001">6014000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:StockholdersEquityOther
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_602e25321e9f47558197c645c62ded24"
      unitRef="U001">0</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_18ee574153154452ba35ce1f0bf25a6f"
      unitRef="U001">0</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_69d8ec44d7624447af2f0a0f3a519519"
      unitRef="U001">47000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_d29252d168b24ed0a6045989e5d8a921"
      unitRef="U001">0</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_876e99729a7945e9ba04dbda9ca490d4"
      unitRef="U001">47000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_c8c35df23d6f495290845dde87d42f72"
      unitRef="U001">-7000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_586613367d9a4359995036473d46a9be"
      unitRef="U001">40000</us-gaap:StockholdersEquityOther>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_97cc82717e94464d83cc8d1be4fecc56"
      unitRef="U001">0</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_bdd3679a44784736938427b876bd47f9"
      unitRef="U001">0</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_b5d2bbb4dccd4c8b891de03abbd3ab5f"
      unitRef="U001">0</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_3c5b91ab11454f1f887df73814798122"
      unitRef="U001">0</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_9fb83d0c89af473da9d1b0ca3deacd98"
      unitRef="U001">0</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_185a429f3489476c9dc1a7d79cbb756e"
      unitRef="U001">6561000</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_1029402fafdb44f8aba784f2b387a1cd"
      unitRef="U001">6561000</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <us-gaap:NetIncomeLoss
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_d76100fb65384b5d9a630e86f2cad8e9"
      unitRef="U001">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_66eb3505956545edb9be468aeac02ecd"
      unitRef="U001">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_670a8706b48540a8a206fce257c58bbf"
      unitRef="U001">40039000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_4f579fa22a4e4b6b90523bcec4a05bd8"
      unitRef="U001">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_db7194d6ceb34189adb94cf43fb4b62f"
      unitRef="U001">40039000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20190101to20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_41f429a79d49438f9e927c0d9def0a56"
      unitRef="U001">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_31671a1bcee0461e89aa645ac5ab9bd4"
      unitRef="U001">40039000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="c20191231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_c62df02de46b43cf96ee3dc2a881e91f"
      unitRef="U002">14989000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20191231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_4f5534e7c46e4024b5b82adf4a8c4b81"
      unitRef="U001">150000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_5253cdd4963f4b1eb45700924bf837ed"
      unitRef="U001">87383000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20191231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_253b2ed6a4af4ea985449d5be4056bf4"
      unitRef="U001">184352000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="c20191231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_071baf6ebe6c4b0aa6e4bf340828dc05"
      unitRef="U002">-2215000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20191231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_247466b354454eb7b07926c334751cbb"
      unitRef="U001">-31628000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20191231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_62e87ff0164f4fb7aee303b113ff0b9e"
      unitRef="U001">240257000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_af40a826b6e0414688597bd21bd7dc9a"
      unitRef="U001">1444000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20191231"
      decimals="-3"
      id="Fact_a00c2f95a2cf4cf8b062b42e5ca1253c"
      unitRef="U001">241701000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_cf42913a55e644359dcddeed67a8ffa0"
      unitRef="U002">76000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_67f9fa07af8d478f829053eae3bb43f7"
      unitRef="U001">1000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_e4a1dfde09cc42a98226738b47cef8fb"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_e64fd0edcc2b4518be1e96ea7cf082e6"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_582dbbc940ff435caa2317186cf5b151"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_1840a95365e34d7e899c7be37a34b4b2"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_93550e8c87ad481ebe78c822ed2d3e4c"
      unitRef="U001">1000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_e007e9971a6d40589c59ae8177060dfc"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_dd744078131b4659b99594c6c4d1f174"
      unitRef="U001">1000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTaxShares
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_ff05884ca7094c4699aec85d40af0883"
      unitRef="U002">0</usph:RevaluationOfRedeemableNonControllingInterestNetOfTaxShares>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_5892ee2c49ba48ed99824d677400b273"
      unitRef="U001">0</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_fc7dcd3164164c31afd8dfc3eafb956e"
      unitRef="U001">0</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_0918aad158e246539b023dd9578f1235"
      unitRef="U001">-3415000</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTaxShares
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_26325bd617884128812992661f625abe"
      unitRef="U002">0</usph:RevaluationOfRedeemableNonControllingInterestNetOfTaxShares>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_31fae65b0b6f4947922ae25b4a4e8435"
      unitRef="U001">0</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_8f4cefb69896453e88e5c2d1387ea5ca"
      unitRef="U001">-3415000</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_c5355d138d734584ad25dc988b928882"
      unitRef="U001">0</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <usph:RevaluationOfRedeemableNonControllingInterestNetOfTax
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_84459a894a664d5fb02f174297ef8b1c"
      unitRef="U001">-3415000</usph:RevaluationOfRedeemableNonControllingInterestNetOfTax>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_d7093df019cd454aa16f6b48d9d9fd7f"
      unitRef="U001">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_aad311e2898e44a59fdeefdf327bddbf"
      unitRef="U001">7917000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_2df06227d43d43aa9adccf6536ab9383"
      unitRef="U001">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_7d14099e155a49fda06db6739eaa7285"
      unitRef="U001">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_6295cf23268044b9948d41b02daf63f5"
      unitRef="U001">7917000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_b876d48d80e34daca7c704cb32695b3f"
      unitRef="U001">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_9874b51c369f4b88804dbe5702c59e0b"
      unitRef="U001">7917000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_eb638845c7634740a27faf93270c0473"
      unitRef="U001">0</usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans>
    <usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_1d43842204264e65987bdefbaa935ca4"
      unitRef="U001">486000</usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans>
    <usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_1b68911bf92b45a2a2c88a0a52ce1bc9"
      unitRef="U001">0</usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans>
    <usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_ccd8a1d32107492e8d6a87aac6542775"
      unitRef="U001">0</usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans>
    <usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_1384706a20f743c48553ea235ef3179a"
      unitRef="U001">486000</usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans>
    <usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_d745f30492994cc4b88aa8e0485b2c50"
      unitRef="U001">0</usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans>
    <usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_10231e3d07c949afa6785156d7797be3"
      unitRef="U001">486000</usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans>
    <usph:PurchaseOfPartnershipInterestsRedeemableNonControllingInterests
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_6e75d5e95d70484d871ffb7dbb298518"
      unitRef="U001">0</usph:PurchaseOfPartnershipInterestsRedeemableNonControllingInterests>
    <usph:PurchaseOfPartnershipInterestsRedeemableNonControllingInterests
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_b32194e2227d496c9e239e09f826e7b7"
      unitRef="U001">0</usph:PurchaseOfPartnershipInterestsRedeemableNonControllingInterests>
    <usph:PurchaseOfPartnershipInterestsRedeemableNonControllingInterests
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_0b8e27211ea54645a17777b1fa19d292"
      unitRef="U001">0</usph:PurchaseOfPartnershipInterestsRedeemableNonControllingInterests>
    <usph:PurchaseOfPartnershipInterestsRedeemableNonControllingInterests
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_3d978d1a74f34f5ebfa3ecd4aeb67b7d"
      unitRef="U001">0</usph:PurchaseOfPartnershipInterestsRedeemableNonControllingInterests>
    <usph:PurchaseOfPartnershipInterestsRedeemableNonControllingInterests
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_f00bf1fba39d4d3999f1adf92e4be5ef"
      unitRef="U001">0</usph:PurchaseOfPartnershipInterestsRedeemableNonControllingInterests>
    <usph:PurchaseOfPartnershipInterestsRedeemableNonControllingInterests
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_4d53478be8df46469af58fc2dc0c1a9e"
      unitRef="U001">-168000</usph:PurchaseOfPartnershipInterestsRedeemableNonControllingInterests>
    <usph:PurchaseOfPartnershipInterestsRedeemableNonControllingInterests
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_f765f04716f843f2b626339ebdaa0428"
      unitRef="U001">-168000</usph:PurchaseOfPartnershipInterestsRedeemableNonControllingInterests>
    <usph:SaleOfNonControllingInterestNetOfTaxAndPurchases
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_89551c498ee8406aac635ce703654284"
      unitRef="U001">0</usph:SaleOfNonControllingInterestNetOfTaxAndPurchases>
    <usph:SaleOfNonControllingInterestNetOfTaxAndPurchases
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_35a0998a7af4481981770be1ff6b24f6"
      unitRef="U001">-164000</usph:SaleOfNonControllingInterestNetOfTaxAndPurchases>
    <usph:SaleOfNonControllingInterestNetOfTaxAndPurchases
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_777d872e493f45a5bebd5e11ff97d69a"
      unitRef="U001">0</usph:SaleOfNonControllingInterestNetOfTaxAndPurchases>
    <usph:SaleOfNonControllingInterestNetOfTaxAndPurchases
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_75fc178a488d44209855cb20d9735566"
      unitRef="U001">0</usph:SaleOfNonControllingInterestNetOfTaxAndPurchases>
    <usph:SaleOfNonControllingInterestNetOfTaxAndPurchases
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_bb18618307444c84856d8bbce8dbb5ed"
      unitRef="U001">-164000</usph:SaleOfNonControllingInterestNetOfTaxAndPurchases>
    <usph:SaleOfNonControllingInterestNetOfTaxAndPurchases
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_93ac07d13721455d8646413f98787da2"
      unitRef="U001">0</usph:SaleOfNonControllingInterestNetOfTaxAndPurchases>
    <usph:SaleOfNonControllingInterestNetOfTaxAndPurchases
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_dae39a2b30b8404fa9705fc2cfc0ed71"
      unitRef="U001">-164000</usph:SaleOfNonControllingInterestNetOfTaxAndPurchases>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_182e92d62d91443ab601e8e0cfb4f0ba"
      unitRef="U001">0</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_be79880261fc4b4eaeec33c823ce2f5f"
      unitRef="U001">0</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_0d2b59d354ba4fcb86b3014ca0b2b562"
      unitRef="U001">4110000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_e7a36e13f94f4178bc3bd8037f92c428"
      unitRef="U001">0</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_150d7264ab794f6f9b0873ef83bdcc51"
      unitRef="U001">4110000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_6b6344a7eae045aa888c4d7ffdb74eb3"
      unitRef="U001">0</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_92a123a181cd46c095b75cb3c12fa114"
      unitRef="U001">4110000</us-gaap:DividendsCommonStockCash>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_fc481bda61ee4018aa01c5e9afbb96c0"
      unitRef="U001">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_944d05de06b24937b838152975921e6b"
      unitRef="U001">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_a3170e893b134c799f923abbc6e41bb4"
      unitRef="U001">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_518aa71bfc7440d981372a63429a8dcb"
      unitRef="U001">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_c962f31058784e05b76fda26ae522e33"
      unitRef="U001">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_113a3b878d674d2c8444d3520c6352c7"
      unitRef="U001">5928000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_8b5bf3cf105d4916badc8dd2b94c840a"
      unitRef="U001">5928000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:StockholdersEquityOther
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_c079de163135413ba02e5b375d8cacfc"
      unitRef="U001">0</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_af6d38fe6e334977be5a6a54cca2da5b"
      unitRef="U001">0</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_0ebaed835131442484433b04edcb3c34"
      unitRef="U001">-6000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_31eddebb3946476a904d6ae58cc12273"
      unitRef="U001">0</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_963d4e277372411fba094dfaaa94d983"
      unitRef="U001">-6000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_6fccdedb59ef40f986601b7baf124ffc"
      unitRef="U001">0</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_79334fa36db140c5bc35755214242f96"
      unitRef="U001">-6000</us-gaap:StockholdersEquityOther>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_1816d44652cb4004b6b146b381bdc92c"
      unitRef="U001">0</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_7008171cc8a546a4830214db364922ca"
      unitRef="U001">0</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_6a10a7df05864a22bde89c3ba3c587ab"
      unitRef="U001">0</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_c7745a0af1aa45749fa2f7c32a1856a2"
      unitRef="U001">0</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_2b0dd70d26c84e8e92034be7cda11096"
      unitRef="U001">0</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_f1e4f738368c4a1694baa8ffe4f1f928"
      unitRef="U001">6122000</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_2257dafe8fc447d68c1a80ff8b1295e2"
      unitRef="U001">6122000</usph:NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity>
    <us-gaap:NetIncomeLoss
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_f7fea1e16b664519918f0b20fa6c0d9b"
      unitRef="U001">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_d7903201039048dabeef595b18583fdb"
      unitRef="U001">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_45908be2d7d84705915e7b8687c1900c"
      unitRef="U001">35194000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_7e5eec8b906e45edbf13590cbdb93e6a"
      unitRef="U001">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_84e8dc4c82474e5eb7968656326d7ee9"
      unitRef="U001">35194000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_c2dba2d021664012885f15c3d3cf7e82"
      unitRef="U001">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_aad493baac264f568bebb0b28544e99c"
      unitRef="U001">35194000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="c20201231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_a4c0f34763d6493eb99228b836735c74"
      unitRef="U002">15065000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20201231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_469c6a1adf164acbb793c7104ce62ae7"
      unitRef="U001">151000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_7a243a23836f40b39feb8dfafcef9eb4"
      unitRef="U001">95622000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20201231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_f364babd46e24017aa41080fcdea0df2"
      unitRef="U001">212015000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="c20201231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_efc50bb202fd410c985e96282918f90d"
      unitRef="U002">-2215000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20201231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_12f3cc337ad84867be6922cf0b92fa4a"
      unitRef="U001">-31628000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20201231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_58dbce2609844ea6a88213097aafc19d"
      unitRef="U001">276160000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_0d3d3f870fd245e3a182ab16587a6740"
      unitRef="U001">1470000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20201231"
      decimals="-3"
      id="Fact_05694e8141664bfea5ec2c409dbf48ea"
      unitRef="U001">277630000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_3d4a40ab76a5449a86d374f557d3ff08"
      unitRef="U001">52491000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_110c1ad1248f4ff8810d630583bb6b3b"
      unitRef="U001">57259000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_014b2e9f759d4c5882a9da49cba14788"
      unitRef="U001">48842000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_4672ed17ad464edc99bfbee3501fbb7a"
      unitRef="U001">10533000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_92714c1cf35f4d8cbf6337e51ff84532"
      unitRef="U001">10095000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_e50a1241c15644018f3d24f4c051d626"
      unitRef="U001">9755000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_13b24af077fe4156ad4bc13afea48f97"
      unitRef="U001">4623000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_c15655b1110742aabc6a68877f9eb2c2"
      unitRef="U001">4858000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_a3f4e6e667a94155b94f7f82c0e6da78"
      unitRef="U001">4603000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ShareBasedCompensation
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_06ec87c57d7842088b7d3f32bbdb65dc"
      unitRef="U001">7917000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_8b006ccbdc1248069ef9b990ea4a9a70"
      unitRef="U001">6985000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_deb0d11f02524c07b5f451cdced3af1c"
      unitRef="U001">5939000</us-gaap:ShareBasedCompensation>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_4d91369e230344a0ab6c3004c49cff6a"
      unitRef="U001">-258000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_205e29714f9f447393313e699733b8ee"
      unitRef="U001">4651000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_6a0494c2f6c14b39a8f3b4c38fd3dead"
      unitRef="U001">4813000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <usph:GainOnSaleOfPartnershipInterestNetOfTax
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_38b62a4c171d4c91ae5403dd60968a9b"
      unitRef="U001">1091000</usph:GainOnSaleOfPartnershipInterestNetOfTax>
    <usph:GainOnSaleOfPartnershipInterestNetOfTax
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_bbb564ee12ff4879ae96bb53a6aeb5b7"
      unitRef="U001">5514000</usph:GainOnSaleOfPartnershipInterestNetOfTax>
    <usph:GainOnSaleOfPartnershipInterestNetOfTax
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_02530686b78d445ea31761f5aef7c518"
      unitRef="U001">1846000</usph:GainOnSaleOfPartnershipInterestNetOfTax>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_db0c6a524a334fd993e5ef36fe325567"
      unitRef="U001">1859000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_1ad790cbe34a4fe790df481e3610568e"
      unitRef="U001">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_7e4616547c774f0c94845fee3c26c590"
      unitRef="U001">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_ccc42a650f4c4929b831af1779d6ae8d"
      unitRef="U001">281000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_0183991bb8494e0a8366bc67e3d108ac"
      unitRef="U001">96000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_8d0f41a22de4425b942c6615d6549d22"
      unitRef="U001">167000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_2df6ba5dc0c3477fb7b04f7d7705296b"
      unitRef="U001">-899000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_9a0028af42554e1c87e772ebcc8e03f6"
      unitRef="U001">6376000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_76ef5d3d8b2147388a9be7da273b7694"
      unitRef="U001">3434000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_eb28d8e06cd544399c4a30da4e0f777f"
      unitRef="U001">-1661000</us-gaap:IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_ed8d42707579460e80c38b96e79c94ed"
      unitRef="U001">2499000</us-gaap:IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_e551a6b1aa8e4b0f948432666e4b6090"
      unitRef="U001">1087000</us-gaap:IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_32210e2e686b4ee9a1f3f3fe85a96fba"
      unitRef="U001">-4161000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_673b4340a5d84908afb8713a1d17689c"
      unitRef="U001">1878000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_19940dde9e284c78a55289eeac947aa3"
      unitRef="U001">-345000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_d4b63a138c8e4df980b940233c616546"
      unitRef="U001">12427000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_83b6ed74eaad43b7be580bad0cd724b6"
      unitRef="U001">-4209000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_fb2a9304db70499299c806767ad3cff0"
      unitRef="U001">4876000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_1174c618ff0b4b4c94c821196acf95a1"
      unitRef="U001">4492000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_92ed1fb97a00448facf969aacbb46f4c"
      unitRef="U001">-1020000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_abce45fb6f6e494da594563e19bcd0ba"
      unitRef="U001">32000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_1f573f4974b446df9f0c199882efc21a"
      unitRef="U001">99995000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_e203ae84474b499ca8419a3ccc6a435e"
      unitRef="U001">62448000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_306c0d9b1c0a4ef7b29e0d058bcadea4"
      unitRef="U001">73005000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_df07545d6eff49cf9daccdcf04cb774f"
      unitRef="U001">7639000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_d7e73fba2b024792b408fe9b33be63aa"
      unitRef="U001">10189000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_eae80edeefd24c6e82ff91a345b7da25"
      unitRef="U001">7193000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_e93d024bbc694bf9a5e871e4726d16b2"
      unitRef="U001">23907000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_b21a92c21735462e8a28eb97e03e2191"
      unitRef="U001">30597000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_c3f7980a75e34c3c8ffa4b0111118bed"
      unitRef="U001">16367000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <usph:PaymentsToAcquireRedeemableNonControllingInterest
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_eb7e2c00dd7d40e7b64712a335793f09"
      unitRef="U001">20385000</usph:PaymentsToAcquireRedeemableNonControllingInterest>
    <usph:PaymentsToAcquireRedeemableNonControllingInterest
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_7070a3005c70497595ff76b71faa19e7"
      unitRef="U001">8651000</usph:PaymentsToAcquireRedeemableNonControllingInterest>
    <usph:PaymentsToAcquireRedeemableNonControllingInterest
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_e9a27e610baa48ab95a9d44d01610111"
      unitRef="U001">0</usph:PaymentsToAcquireRedeemableNonControllingInterest>
    <us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_89814b35c0ca46f2aeb84dcac31b5fb7"
      unitRef="U001">238000</us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates>
    <us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_4e2cdc01bbdd485d81ca6d43620870f9"
      unitRef="U001">428000</us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates>
    <us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_f4b5372a112e46ecbd66bd1d2f8f8c6c"
      unitRef="U001">350000</us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates>
    <us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_6a56dc796b5a4c64ac80b3a24b9678c0"
      unitRef="U001">127000</us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates>
    <us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_4a4673b00e6044848ed4c8b76618f4cb"
      unitRef="U001">207000</us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates>
    <us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_623e1f7906e9428d8c74c7eb6d6fcbf9"
      unitRef="U001">0</us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_a82ac8b47d7447028bf08d914bbe402e"
      unitRef="U001">839000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_80ac043b20684994a820796b8ed45cee"
      unitRef="U001">11665000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_a8b16a7b3beb4e10ae1859a2ee9d65e8"
      unitRef="U001">1000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_c141bb06aeb04ce79c0da6f890b0956a"
      unitRef="U001">-51203000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_5a65d112dfa34888a73979be2ee57e37"
      unitRef="U001">-37993000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_781a26f700e94f39aa52dc9b21ca1f3a"
      unitRef="U001">-23909000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_ccae4839fe90447b8629301b080a132b"
      unitRef="U001">18331000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_8b7f159a4b70462f9c6fcbd115aee702"
      unitRef="U001">16235000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_11483e389dbc41b8b7fc2cb70b33f83e"
      unitRef="U001">15646000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_c4e54b8ba125470da87843ab4ad05b6c"
      unitRef="U001">4110000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_509e395458894ed29b04268c4dc346da"
      unitRef="U001">14555000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_ebfd6ec3b53249dabf9a88937b796ad3"
      unitRef="U001">11664000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_46f036fb8b8040819014852d8f40083a"
      unitRef="U001">214000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_1063e64d3b034383958133fbf6250a64"
      unitRef="U001">145000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_2e9000ac72e143c5b1b7b96b5248003d"
      unitRef="U001">103000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_d20c4172db0545448aa0dac7df0da45a"
      unitRef="U001">244000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_32c533b4bc034f3298f5bf72db390201"
      unitRef="U001">137000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_782d6fd000d04598bcf62194917f1570"
      unitRef="U001">119000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_67c4548cd2084db19e676d3050a99e1b"
      unitRef="U001">0</us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest>
    <us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_943ff3b5778d4125a7e0b6d70bc71b90"
      unitRef="U001">0</us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest>
    <us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_d13898c21b9b449dbcbe43f216177231"
      unitRef="U001">265000</us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_d562c8f30fb940ffb63872f5700fea66"
      unitRef="U001">1037000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_b7a62c277b8846e58648e15f46f9135f"
      unitRef="U001">1433000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_604a89f4931f4f4ab181d253d5f5e48d"
      unitRef="U001">4044000</us-gaap:RepaymentsOfNotesPayable>
    <usph:MedicareAcceleratedAndAdvancePaymentFunds
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_c251aeb49d5b4c6a9126f2d8f1c9303f"
      unitRef="U001">14054000</usph:MedicareAcceleratedAndAdvancePaymentFunds>
    <usph:MedicareAcceleratedAndAdvancePaymentFunds
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_0e0b284ad9b14d99886adfb439f8abc5"
      unitRef="U001">0</usph:MedicareAcceleratedAndAdvancePaymentFunds>
    <usph:MedicareAcceleratedAndAdvancePaymentFunds
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_5a5b4b116e6e4e379c5a72f1a07f3e68"
      unitRef="U001">0</usph:MedicareAcceleratedAndAdvancePaymentFunds>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_1bd3d9a074944d0492ec27021b5ae304"
      unitRef="U001">2000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_de03d0b606cd415ea4ff6a460900168a"
      unitRef="U001">-52000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_7c729fd7e707460db8d50ab3a560cb0c"
      unitRef="U001">-42000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_955b20996ae94f349727f3b9ed3ac9bf"
      unitRef="U001">-39422000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_bc82fd15bec84132ac47fbd449afb665"
      unitRef="U001">-24275000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_e7c3fdfd0bc14f51a7b38823ddf044d4"
      unitRef="U001">-47661000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_42e39c09a0f74e0796a97902e96517a8"
      unitRef="U001">9370000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_24e07632d20d48098616db6f4db73ea5"
      unitRef="U001">180000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_d997254f4e684801b9e7f851e8c16348"
      unitRef="U001">1435000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c20191231"
      decimals="-3"
      id="Fact_777f00e897fb4b248155bf5045914fe1"
      unitRef="U001">23548000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c20181231"
      decimals="-3"
      id="Fact_f67a26f46be2436f9912b296f8908faa"
      unitRef="U001">23368000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c20171231"
      decimals="-3"
      id="Fact_10c889bea641463c94b9e4dc89634c50"
      unitRef="U001">21933000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c20201231"
      decimals="-3"
      id="Fact_f504fdbea1fc49dabdc52956c195c950"
      unitRef="U001">32918000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c20191231"
      decimals="-3"
      id="Fact_25bb31a1a11449b4a7017b729498d3dd"
      unitRef="U001">23548000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c20181231"
      decimals="-3"
      id="Fact_5697f6d3605441a195686b92a609d85f"
      unitRef="U001">23368000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_b167ddfd15494b91a79965fb35f05fb8"
      unitRef="U001">7677000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_80127d333db4455aa0423641961abdd1"
      unitRef="U001">9856000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_1a889cf355d94e5490baed6b0342b745"
      unitRef="U001">9183000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_3d6f57ffeba14e5e92570007a015215a"
      unitRef="U001">1202000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_8551ccd229604176936a6d07e6c0cc76"
      unitRef="U001">1890000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_3f97c0f442d249c8bfaddb23b8828ded"
      unitRef="U001">2357000</us-gaap:InterestPaidNet>
    <usph:PurchaseOfBusinessSellerFinancingPortion
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_b665651e2b8c43c88762ae6c61f0a693"
      unitRef="U001">1121000</usph:PurchaseOfBusinessSellerFinancingPortion>
    <usph:PurchaseOfBusinessSellerFinancingPortion
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_adefb4a410934e9db42b839f5e2c6a85"
      unitRef="U001">4300000</usph:PurchaseOfBusinessSellerFinancingPortion>
    <usph:PurchaseOfBusinessSellerFinancingPortion
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_407dd64e763945b3b7662da0ff0bd736"
      unitRef="U001">950000</usph:PurchaseOfBusinessSellerFinancingPortion>
    <us-gaap:NoncashOrPartNoncashAcquisitionPayablesAssumed1
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_ac0f3fdfc24a418c9498f237ec1b2c6e"
      unitRef="U001">0</us-gaap:NoncashOrPartNoncashAcquisitionPayablesAssumed1>
    <us-gaap:NoncashOrPartNoncashAcquisitionPayablesAssumed1
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_0c8824a0eb5a4bf6ab02e09ada5ddf8b"
      unitRef="U001">502000</us-gaap:NoncashOrPartNoncashAcquisitionPayablesAssumed1>
    <us-gaap:NoncashOrPartNoncashAcquisitionPayablesAssumed1
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_dbd16575d6a44f7ba76a1a836546d989"
      unitRef="U001">0</us-gaap:NoncashOrPartNoncashAcquisitionPayablesAssumed1>
    <usph:NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity
      contextRef="c20201231"
      decimals="-3"
      id="Fact_8d7731e274ec4054b8493bc7ab3e110b"
      unitRef="U001">136000</usph:NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity>
    <usph:NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity
      contextRef="c20191231"
      decimals="-3"
      id="Fact_3ec938d5f2eb40b890475746c4bc0d95"
      unitRef="U001">283000</usph:NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity>
    <usph:NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity
      contextRef="c20181231"
      decimals="-3"
      id="Fact_ce1c8e6995ab4291805b77630e9ebedf"
      unitRef="U001">0</usph:NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity>
    <usph:NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity
      contextRef="c20201231"
      decimals="-3"
      id="Fact_ec3c095f5a32498fa251a708195e9a3b"
      unitRef="U001">699000</usph:NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity>
    <usph:NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity
      contextRef="c20191231"
      decimals="-3"
      id="Fact_570d4dde67c349b3b373c4ed2b9586fe"
      unitRef="U001">103000</usph:NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity>
    <usph:NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity
      contextRef="c20181231"
      decimals="-3"
      id="Fact_f1a7b66bc9da4be6ab500609d92deb4e"
      unitRef="U001">0</usph:NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity>
    <us-gaap:ProceedsFromMinorityShareholders
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_aa6dbc596724477b8a729d3f0cc2ce44"
      unitRef="U001">0</us-gaap:ProceedsFromMinorityShareholders>
    <us-gaap:ProceedsFromMinorityShareholders
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_1dadb3586c04495eac0d194c3e7fd04d"
      unitRef="U001">2870000</us-gaap:ProceedsFromMinorityShareholders>
    <us-gaap:ProceedsFromMinorityShareholders
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_11df266f82824b78a84d6e43f96bdc97"
      unitRef="U001">0</us-gaap:ProceedsFromMinorityShareholders>
    <us-gaap:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_64dfddccb9534d81ac6a365b681c63da"
      unitRef="U001">994000</us-gaap:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1>
    <us-gaap:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_1fd864a38bb64910a63b1fec8c34fdd8"
      unitRef="U001">0</us-gaap:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1>
    <us-gaap:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_cceb83364f2a45048bde038801c89602"
      unitRef="U001">0</us-gaap:NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="c20200101to20201231"
      id="Text_740229741e4a4bce838119035adbdd2a">
&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;1. Organization, Nature of Operations and Basis of Presentation&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The consolidated financial statements include the accounts of U.S. Physical Therapy, Inc. and its subsidiaries (the &#x201c;Company&#x201d;). All significant intercompany transactions and balances have been eliminated.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company operates its business through two reportable business segments. The Company&#x2019;s reportable segments include the physical therapy operations segment and the industrial injury prevention services segment. The Company&#x2019;s physical therapy operations consist of physical therapy and occupational therapy clinics that provide pre-and post-operative care and treatment for orthopedic related disorders, sports-related injuries, preventive care, rehabilitation of injured workers and neurological injuries. The industrial injury prevention services segment includes onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments. Prior to the second quarter of 2020, the Company operated as a single segment.&#160; All prior year segment information has been reclassified to conform to the 2020 segment presentation. See Note 12. Segment Information.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Physical Therapy Operations&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The physical therapy operations segment primarily operates through subsidiary clinic partnerships, in which the Company generally owns a 1% general partnership interest in all the Clinic Partnerships. Our limited partnership interests typically range from 10% to 99% in the Clinic Partnerships. The managing therapist of each clinic owns, directly or indirectly, the remaining limited partnership interest in most of the clinics (hereinafter referred to as &#x201c;Clinic Partnerships&#x201d;). To a lesser extent, the Company operates some clinics, through wholly-owned subsidiaries, under profit sharing arrangements with therapists (hereinafter referred to as &#x201c;Wholly-Owned Facilities&#x201d;).&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company continues to seek to attract for employment physical therapists who have established relationships with physicians and other referral sources, by offering these therapists a competitive salary and incentives based on the profitability of the clinic that they manage. For multi-site clinic practices in which a controlling interest is acquired by the Company, the prior owners typically continue on as employees to manage the clinic operations, retaining a non-controlling ownership interest in the clinics and receiving a competitive salary for managing the clinic operations. In addition, the Company has developed satellite clinic facilities as part of existing Clinic Partnerships and Wholly-Owned Facilities, with the result that a substantial number of Clinic Partnerships and Wholly-Owned Facilities operate more than one clinic location.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;As of December 31, 2020, the Company owned and/or operated 554 clinics in 39 states. The clinics&#x2019; business primarily originates from physician referrals. The principal sources of payment for the clinics&#x2019; services are managed care programs, commercial health insurance, Medicare/Medicaid, workers&#x2019; compensation insurance and proceeds from personal injury cases. In addition to the Company&#x2019;s ownership and operation of outpatient physical therapy clinics, it also manages physical therapy facilities for third parties, such as physicians and hospitals, with 38 such third-party facilities under management as of December 31, 2020.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 27.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;During the last three years, the Company completed the following acquisitions within its physical therapy operations segment:&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="z329b3aa4a904444f99fe9105ae0bad7b" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;"&gt;
  &lt;tr&gt;
    &lt;td style="width: 34.03%; vertical-align: bottom; border-bottom: #000000 2px solid;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Acquisition&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.78%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 25.28%; vertical-align: bottom; border-bottom: #000000 2px solid;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Date&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.5%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 16.67%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;% Interest&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;&lt;/span&gt;Acquired&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.5%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 16.25%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Number of&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;&lt;/span&gt;Clinics&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 34.03%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 2.78%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 25.28%; vertical-align: bottom; border-top: #000000 2px solid;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 2.5%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 16.67%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 2.5%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 16.25%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 34.03%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;November 2020 Acquisition&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.78%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 25.28%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;November 30, 2020&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.5%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 16.67%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;75%&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.5%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 16.25%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;3&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 34.03%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;September 2020 Acquisition&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.78%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 25.28%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;September 30, 2020&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.5%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 16.67%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;70%&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.5%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 16.25%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;*&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 34.03%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;February 2020 Acquisition&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.78%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 25.28%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;February 27, 2020&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.5%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 16.67%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;65%&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.5%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;**&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 16.25%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;4&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 34.03%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;September 2019 Acquisition&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.78%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 25.28%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;September 30, 2019&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.5%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 16.67%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;67%&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.5%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 16.25%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;11&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 34.03%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;August 2018 Acquisition&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.78%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 25.28%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;August 31, 2018&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.5%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 16.67%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;70%&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.5%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 16.25%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;4&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" id="z70c8f2b5b53b4524bb7ccfe492028040" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;
  &lt;tr&gt;
    &lt;td style="width: 27pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;*&lt;/td&gt;
    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The business includes six management and services contracts which had a remaining term of approximately five years as of the date acquired.&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" id="z46f47f69a0da4fb98e548c6918a6352a" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;
  &lt;tr&gt;
    &lt;td style="width: 27pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;**&lt;/td&gt;
    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The four clinics are in four separate partnerships. The Company's interest in the four partnerships range from 10.0% to 83.8%, with an overall 65.0% based on the initial purchase transaction.&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Also during 2019, we purchased the assets and business of one physical therapy clinic in a separate transaction. The clinic operates as a satellite clinic of one of the existing partnerships. Besides the August 2018 multi-clinic acquisition, we acquired five separate clinic practices that year through several of our majority owned Clinic Partnerships. These practices operate as satellites of the respective existing Clinic Partnerships.&lt;/div&gt;

&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;During the year ended December 31, 2020, the Company sold 14 previously closed clinics. The aggregate sales price was $1.1 million, of which $0.7 million was paid in cash and $0.4 million in a note receivable, payable in two equal installments of principal and any accrued interest on June 15, 2021 and 2022.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company intends to continue to pursue additional acquisition opportunities, develop new clinics and open satellite clinics.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Clinic Partnerships&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;For non-acquired Clinic Partnerships, the earnings and liabilities attributable to the non-controlling interests, typically owned by the managing therapist, directly or indirectly, are recorded within the balance sheets and income statements as non-controlling interests &#x2013; permanent equity. For acquired Clinic Partnerships with redeemable non-controlling interests, the earnings attributable to the redeemable non-controlling interests are recorded within the consolidated statements of income line item &#x2013; &lt;span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;net income attributable to redeemable non-controlling interests &#x2013; temporary equity&lt;/span&gt; and the equity interests are recorded on the consolidated balance sheet as &lt;span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;redeemable non-controlling interests &#x2013; temporary equity&lt;/span&gt;.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Effective December 31, 2017, the Company entered into amendments to its acquired limited partnership agreements replacing the mandatory redemption features. No monetary consideration was paid to the partners to amend the agreements. The amended limited partnership agreements provide that, upon certain events, the Company has a call right (the &#x201c;Call Right&#x201d;) and the selling entity has a put right (the &#x201c;Put Right&#x201d;) for the purchase and sale of the limited partnership interest held by the partner. Once triggered, the Put Right and the Call Right do not expire, even upon an individual partner&#x2019;s death, and contain no mandatory redemption feature. The purchase price of the partner&#x2019;s limited partnership interest upon the exercise of either the Put Right or the Call Right is calculated per the terms of the respective agreements. The Company accounted for the amendment of its limited partnership agreements as an extinguishment of the outstanding Seller Entity Interests, as defined in Note 5, classified as liabilities through the issuance of new Seller Entity Interests classified in temporary equity. Pursuant to ASC 470-50-40-2, the Company removed the outstanding liability-classified Seller Entity Interests at their carrying amounts, recognized the new temporary-equity-classified Seller Entity Interests at their fair value, and recorded no gain or loss on extinguishment as management believes the redemption value (i.e. the carrying amount) and fair value are the same. In summary, the redemption values of the mandatorily redeemable non-controlling interest (previously classified as liabilities) were reclassified as redeemable non-controlling interest (temporary equity) at fair value on the December 31, 2017 consolidated balance sheet. See Note 5 - Redeemable Non-Controlling Interests &#x2013; for further discussion.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Wholly-Owned Facilities&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;For Wholly-Owned Facilities with profit sharing arrangements, an appropriate accrual is recorded for the amount of profit sharing due the clinic partners/directors. The amount is expensed as compensation and included in clinic operating costs&#x2014;salaries and related costs. The respective liability is included in current liabilities&#x2014;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;accrued expenses&lt;/span&gt; on the consolidated balance sheets.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Industrial Injury Prevention Services&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;In March 2017, the Company acquired a 55% interest in the initial industrial injury prevention business. On April 30, 2018, the Company acquired a 65% interest in another business in the industrial injury prevention sector. On April 30, 2018, the Company combined the two businesses.&#160; After the combination, the Company owned a 59.45% interest in the combined business, Briotix Health, Limited Partnership (&#x201c;Briotix Health&#x201d;), which is the Company&#x2019;s industrial injury prevention operation.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;On April 11, 2019, the Company acquired 100% of a third provider of industrial injury prevention services. The acquired company specializes in delivering injury prevention and care, post offer employment testing, functional capacity evaluations and return-to-work services. It performs these services across a network in 45 states including onsite at eleven client locations. After the acquisition, the business was then combined with Briotix Health increasing the Company&#x2019;s ownership position in the partnership to approximately 76.0%.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Services provided in the industrial injury prevention services segment include onsite injury prevention and rehabilitation, performance optimization, post offer employment testing, functional capacity evaluations, and ergonomic assessments. The majority of these services are contracted with and paid for directly by employers, including a number of Fortune 500 companies. Other clients include large insurers and their contractors. The Company performs these services through Industrial Sports Medicine Professionals, consisting of both physical therapists and specialized certified athletic trainers (ATCs).&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Impact of COVID-19&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;As previously disclosed in a series of filings with the SEC and further described in detail in our Quarterly Reports on Form 10-Q for the first three quarters of 2020, the Company&#x2019;s results have been negatively impacted by the effects of the COVID-19 pandemic. Management has taken a number of steps to reduce costs, make up for operating losses incurred in March and April, and increase profits subsequently. The Company continues to experience somewhat lower physical therapy patient volumes; however revenues improved significantly in the 2020 fourth quarter compared to the 2020 second and third quarters. The Company&#x2019;s average physical therapy patient volumes per day per clinic were 26.2, 18.9, 25.8, and 27.7, respectively, in the first four quarters of 2020. The Company&#x2019;s industrial injury prevention business was less affected by the pandemic in 2020.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;In March, with the onset of the COVID-19 pandemic, the Company began to furlough or terminate approximately 40% of its 5,500 full and part-time workforce. Since early May, approximately 1,200 of the furloughed employees have returned to work on a full or part-time basis.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;As of the filing of this annual report, the Company continues to experience lower physical therapy revenues. As stay at home orders and other restrictions have been lifted, we have seen our physical therapy volumes trending upwards. Should stay at home orders or other restrictions be reenacted, the Company could see its Company&#x2019;s patient volume and revenues decline again.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company has put preparedness plans in place at its facilities to maintain continuity of operations, while also taking steps to keep employees and patients safe. In line with recommendations to reduce large gatherings and increase social distancing, the Company has, where practical, transitioned a large number of office-based employees to a remote work environment.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Medicare Accelerated and Advance Payment Program (&#x201c;MAAPP Funds&#x201d;)&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 27pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #212529;"&gt;In response to the COVID-19 pandemic, the federal government approved the Coronavirus Aid, Relief, and Economic Security Act (&#x201c;CARES Act&#x201d;). The CARES Act allowed for qualified healthcare providers to receive advanced payments under the existing MAAPP Funds during the COVID-19 pandemic. Under this program, healthcare providers could choose to receive advanced payments for future Medicare services provided. The Company applied for and received approval from&lt;/span&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #222222;"&gt;&#160;&lt;/span&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #212529;"&gt;Centers for Medicare &amp;amp; Medicaid Services (&#x201c;CMS&#x201d;) in April 2020. T&lt;/span&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #211D1E;"&gt;he Company recorded these payments as a liability until all performance obligations have been met as the payments were made on behalf of patients before services were provided. Currently, MAAPP funds received are required to be applied to future Medicare billings commencing in August 2021, with all such remaining amounts required to be repaid by January 2024. Beginning January 2024, any unpaid balance will begin accruing interest.&lt;/span&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #212529;"&gt; The Company currently intends to repay funds prior to August 2021. Included in cash and cash equivalents and accrued liabilities at December 31, 2020 is $&lt;/span&gt;14.1&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #212529;"&gt; million of MAAPP Funds.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Relief Funds&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The CARES Act also provided additional waivers, reimbursement, grants and other funds to assist health care providers during the COVID-19 pandemic, including $100.0 billion in appropriations for the Public Health and Social Services Emergency Fund, also referred to as the Provider Relief Fund, to be used for preventing, preparing, and responding to the coronavirus, and for reimbursing eligible health care providers for lost revenues and health care related expenses that are attributable to COVID-19.&lt;/div&gt;

&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Through December 31, 2020, the Company&#x2019;s consolidated subsidiaries received approximately $13.5 million of payments under the CARES Act (&#x201c;Relief Funds&#x201d;). For the year ended December 31, 2020, the Company has recognized approximately $13.5 million, as Other income &#x2013; Relief Funds on the accompany consolidated statement of operations. These funds are not required to be repaid upon attestation and compliance with certain terms and conditions, which could change materially based on evolving grant compliance provisions and guidance provided by the U.S. Department of Health and Human Services. Currently, the Company can attest and comply with the terms and conditions of the grant guidance.&#160; The Company will continue to monitor the evolving guidelines and may record adjustments as additional information is released.&lt;/div&gt;
</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="c20200101to20201231"
      decimals="INF"
      id="Fact_16d5f19e7d704b479cc15f58ac30301e"
      unitRef="U004">2</us-gaap:NumberOfReportableSegments>
    <usph:PercentageOfGeneralPartnershipInterestOwned
      contextRef="c20200101to20201231"
      decimals="2"
      id="Fact_d8561842ba9944388f9c45bce79b67d4"
      unitRef="U005">0.01</usph:PercentageOfGeneralPartnershipInterestOwned>
    <usph:PercentageOfLimitedPartnershipInterestOwned
      contextRef="c20200101to20201231_RangeAxis_MinimumMember"
      decimals="2"
      id="Fact_caf7b1fe8e354b0283e159539052ea66"
      unitRef="U005">0.10</usph:PercentageOfLimitedPartnershipInterestOwned>
    <usph:PercentageOfLimitedPartnershipInterestOwned
      contextRef="c20200101to20201231_RangeAxis_MaximumMember"
      decimals="2"
      id="Fact_e7aeb478d9034cc9b159dff2cb9ed204"
      unitRef="U005">0.99</usph:PercentageOfLimitedPartnershipInterestOwned>
    <usph:NumberOfOperatingClinicLocations
      contextRef="c20201231_RangeAxis_MaximumMember"
      decimals="INF"
      id="Fact_df3f5aab4e544df7803635c0683c9dcb"
      unitRef="U006">1</usph:NumberOfOperatingClinicLocations>
    <usph:NumberOfClinicsOperated
      contextRef="c20201231"
      decimals="0"
      id="Fact_41532647d1444e54a6be2338db501131"
      unitRef="U007">554</usph:NumberOfClinicsOperated>
    <us-gaap:NumberOfStatesInWhichEntityOperates
      contextRef="c20201231"
      decimals="0"
      id="Fact_49da464d43b44b91a61043567807c87b"
      unitRef="U008">39</us-gaap:NumberOfStatesInWhichEntityOperates>
    <usph:NumberOfThirdPartyFacilities
      contextRef="c20200101to20201231"
      decimals="0"
      id="Fact_38449ebfd6b8475186988c2ff1be7d75"
      unitRef="U009">38</usph:NumberOfThirdPartyFacilities>
    <usph:ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock
      contextRef="c20200101to20201231"
      id="Text_2899ee22700e400f9a51e1b4daeab2d6">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 27.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;During the last three years, the Company completed the following acquisitions within its physical therapy operations segment:&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="z329b3aa4a904444f99fe9105ae0bad7b" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;"&gt;
  &lt;tr&gt;
    &lt;td style="width: 34.03%; vertical-align: bottom; border-bottom: #000000 2px solid;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Acquisition&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.78%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 25.28%; vertical-align: bottom; border-bottom: #000000 2px solid;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Date&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.5%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 16.67%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;% Interest&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;&lt;/span&gt;Acquired&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.5%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 16.25%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Number of&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;&lt;/span&gt;Clinics&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 34.03%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 2.78%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 25.28%; vertical-align: bottom; border-top: #000000 2px solid;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 2.5%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 16.67%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 2.5%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 16.25%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 34.03%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;November 2020 Acquisition&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.78%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 25.28%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;November 30, 2020&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.5%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 16.67%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;75%&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.5%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 16.25%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;3&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 34.03%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;September 2020 Acquisition&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.78%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 25.28%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;September 30, 2020&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.5%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 16.67%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;70%&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.5%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 16.25%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;*&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 34.03%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;February 2020 Acquisition&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.78%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 25.28%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;February 27, 2020&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.5%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 16.67%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;65%&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.5%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;**&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 16.25%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;4&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 34.03%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;September 2019 Acquisition&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.78%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 25.28%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;September 30, 2019&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.5%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 16.67%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;67%&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.5%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 16.25%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;11&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 34.03%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;August 2018 Acquisition&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.78%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 25.28%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;August 31, 2018&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.5%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 16.67%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;70%&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.5%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 16.25%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;4&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" id="z70c8f2b5b53b4524bb7ccfe492028040" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;
  &lt;tr&gt;
    &lt;td style="width: 27pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;*&lt;/td&gt;
    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The business includes six management and services contracts which had a remaining term of approximately five years as of the date acquired.&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" id="z46f47f69a0da4fb98e548c6918a6352a" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;
  &lt;tr&gt;
    &lt;td style="width: 27pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;**&lt;/td&gt;
    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The four clinics are in four separate partnerships. The Company's interest in the four partnerships range from 10.0% to 83.8%, with an overall 65.0% based on the initial purchase transaction.&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;
</usph:ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock>
    <us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1
      contextRef="c20200101to20201231_BusinessAcquisitionAxis_NovemberTwoThousandTwentyAcquisitionMember"
      id="Fact_fb0bd85c77954fe5ad38e626357a93c3">2020-11-30</us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20201130_BusinessAcquisitionAxis_NovemberTwoThousandTwentyAcquisitionMember"
      decimals="2"
      id="Fact_796590de33b64f9b88175afeae13776d"
      unitRef="U005">0.75</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20201130to20201130_BusinessAcquisitionAxis_NovemberTwoThousandTwentyAcquisitionMember"
      decimals="0"
      id="Fact_d00ee5ee40154adbb16c4f32d3f125fa"
      unitRef="U007">3</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1
      contextRef="c20200101to20201231_BusinessAcquisitionAxis_SeptemberTwoThousandTwentyAcquisitionMember"
      id="Fact_89660600b9624992880d61e795a03e25">2020-09-30</us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20200930_BusinessAcquisitionAxis_SeptemberTwoThousandTwentyAcquisitionMember"
      decimals="2"
      id="Fact_ea6ef6bf1dbb4ecc89b878a2f31f7b20"
      unitRef="U005">0.70</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20200930to20200930_BusinessAcquisitionAxis_SeptemberTwoThousandTwentyAcquisitionMember"
      id="Fact_74729e999361491e8eb1757c704e74be"
      unitRef="U007"
      xsi:nil="true"/>
    <us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1
      contextRef="c20200101to20201231_BusinessAcquisitionAxis_FebruaryTwoThousandTwentyAcquisitionMember"
      id="Fact_2ca6f4248b784b7eb286542bcfc7519e">2020-02-27</us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20200227_BusinessAcquisitionAxis_FebruaryTwoThousandTwentyAcquisitionMember"
      decimals="2"
      id="Fact_be63fda669ef48c48951108c9fa8d90d"
      unitRef="U005">0.65</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20200227to20200227_BusinessAcquisitionAxis_FebruaryTwoThousandTwentyAcquisitionMember"
      decimals="0"
      id="Fact_b984ea6b9b9f4c38a04b5eb4a1c4fa24"
      unitRef="U007">4</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1
      contextRef="c20200101to20201231_BusinessAcquisitionAxis_SeptemberTwoThousandNineteenAcquisitionMember"
      id="Fact_c49c1388fbfe44a0903c42e91de35023">2019-09-30</us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20190930_BusinessAcquisitionAxis_SeptemberTwoThousandNineteenAcquisitionMember"
      decimals="2"
      id="Fact_cc4f495c2b5d4d3aab9559bb5cb0c321"
      unitRef="U005">0.67</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20190930to20190930_BusinessAcquisitionAxis_SeptemberTwoThousandNineteenAcquisitionMember"
      decimals="0"
      id="Fact_4b25800a56fc43858041d726d134d1e8"
      unitRef="U007">11</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1
      contextRef="c20200101to20201231_BusinessAcquisitionAxis_August2018AcquisitionMember"
      id="Fact_c7e1cb913c204ea382b7756a9dc60372">2018-08-31</us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20180831_BusinessAcquisitionAxis_August2018AcquisitionMember"
      decimals="2"
      id="Fact_b45a638e89da4f9c8a47b2c4d386bafa"
      unitRef="U005">0.70</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20180831to20180831_BusinessAcquisitionAxis_August2018AcquisitionMember"
      decimals="0"
      id="Fact_759ad8ba50df45b5ac9e49977955c2f5"
      unitRef="U007">4</us-gaap:NumberOfBusinessesAcquired>
    <usph:NumberOfManagementContracts
      contextRef="c20200930to20200930_BusinessAcquisitionAxis_ManagementContractsMember"
      decimals="INF"
      id="Fact_eaf3f38d456349518b47f7ccea240f58"
      unitRef="U014">6</usph:NumberOfManagementContracts>
    <usph:RemainingContractTerm
      contextRef="c20200930to20200930_BusinessAcquisitionAxis_ManagementContractsMember"
      id="Fact_0548ae892f53427394e458c284fc7aa6">P5Y</usph:RemainingContractTerm>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20200227to20200227_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="INF"
      id="Fact_3635a43d868a48c5aa247136b7e14a27"
      unitRef="U007">4</us-gaap:NumberOfBusinessesAcquired>
    <usph:NumberOfPartnershipInWhichInterestAcquired
      contextRef="c20200227to20200227_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="INF"
      id="Fact_208002b0c43040c39ba07a0bf93db577"
      unitRef="U015">4</usph:NumberOfPartnershipInWhichInterestAcquired>
    <usph:NumberOfPartnershipInWhichInterestAcquired
      contextRef="c20200227to20200227_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="INF"
      id="Fact_841f049d97e1418fb2a3a7c85659f6b8"
      unitRef="U015">4</usph:NumberOfPartnershipInWhichInterestAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MinimumMember"
      decimals="3"
      id="Fact_ffe23fc52fd24e85960b6feb72b3981b"
      unitRef="U005">0.100</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MaximumMember"
      decimals="3"
      id="Fact_e6648510a8224088825d4123d59b0419"
      unitRef="U005">0.838</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="3"
      id="Fact_0f36062692be44299e3de4292ebe8313"
      unitRef="U005">0.650</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20190101to20191231"
      decimals="INF"
      id="Fact_40193de58a8246759d8fc232bf9167c5"
      unitRef="U007">1</us-gaap:NumberOfBusinessesAcquired>
    <usph:NumberOfClinicsOperatesAsASatelliteClinicWithExistingPartnerships
      contextRef="c20190101to20191231"
      decimals="INF"
      id="Fact_d7f7b6d4db644d69918beceaf42e3bf5"
      unitRef="U007">1</usph:NumberOfClinicsOperatesAsASatelliteClinicWithExistingPartnerships>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20180831to20180831"
      decimals="INF"
      id="Fact_f32329daf3ca4cb69e7007d2e6111dd9"
      unitRef="U007">5</us-gaap:NumberOfBusinessesAcquired>
    <usph:NumberOfClosedClinicsSold
      contextRef="c20201231"
      decimals="0"
      id="Fact_a97655b2f17c43c7b1599105ec47c51d"
      unitRef="U007">14</usph:NumberOfClosedClinicsSold>
    <usph:AggregateSalePriceOfCinics
      contextRef="c20200101to20201231"
      decimals="-5"
      id="Fact_b55d0220d44d4d6c95bbb07771156303"
      unitRef="U001">1100000</usph:AggregateSalePriceOfCinics>
    <usph:CashReceivedRelatedToSaleOfClinics
      contextRef="c20201231"
      decimals="-5"
      id="Fact_d63eabcc819744eeb79b1947dbe595fb"
      unitRef="U001">700000</usph:CashReceivedRelatedToSaleOfClinics>
    <usph:NoteReceivableRelatedToSaleOfClinics
      contextRef="c20201231"
      decimals="-5"
      id="Fact_763b8020dce84abe8d6227d83a587a0d"
      unitRef="U001">400000</usph:NoteReceivableRelatedToSaleOfClinics>
    <usph:NumberOfInstallmentsForNoteReceivableInSaleConsideration
      contextRef="c20200101to20201231"
      decimals="INF"
      id="Fact_b49b36e8e161440080018d9682ac31ab"
      unitRef="U010">2</usph:NumberOfInstallmentsForNoteReceivableInSaleConsideration>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20170331_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="2"
      id="Fact_23ebf9b6926f4a34847f938978965ff7"
      unitRef="U005">0.55</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20180430_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="2"
      id="Fact_21150a54f49147d781c5787c67efe985"
      unitRef="U005">0.65</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <usph:NumberOfBusinessesMerged
      contextRef="c20180430to20180430_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="INF"
      id="Fact_a5fb3821a94f45e3906d3eeb26caa790"
      unitRef="U011">2</usph:NumberOfBusinessesMerged>
    <usph:PercentageOfCombinedBusinessInterestOwned
      contextRef="c20180430to20180430_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="4"
      id="Fact_30c467607d914e83adbbbceab24953e4"
      unitRef="U005">0.5945</usph:PercentageOfCombinedBusinessInterestOwned>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="2"
      id="Fact_e8239b7779744b42bddecc311959b2ea"
      unitRef="U005">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <usph:NumberOfStatesOfNetworkServices
      contextRef="c20190411to20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="0"
      id="Fact_e344a66cc474439b8c548811351c98fa"
      unitRef="U008">45</usph:NumberOfStatesOfNetworkServices>
    <usph:NumberOfOnsiteClientLocations
      contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="INF"
      id="Fact_d00deb3d891642f4aa4fa2fee6086eee"
      unitRef="U006">11</usph:NumberOfOnsiteClientLocations>
    <usph:PercentageOfCombinedBusinessInterestOwned
      contextRef="c20190411to20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="3"
      id="Fact_06039fa2c858468db6bdfcc3323e42aa"
      unitRef="U005">0.760</usph:PercentageOfCombinedBusinessInterestOwned>
    <usph:AveragePhysicalTherapyPatientsVolumesPerDayPerClinic
      contextRef="c20200101to20200331"
      decimals="1"
      id="Fact_6e61fdd14e554039a8746e0c97e9f8d9"
      unitRef="U012">26.2</usph:AveragePhysicalTherapyPatientsVolumesPerDayPerClinic>
    <usph:AveragePhysicalTherapyPatientsVolumesPerDayPerClinic
      contextRef="c20200401to20200630"
      decimals="1"
      id="Fact_a5d61f502b7b473a89447502ea03e5b9"
      unitRef="U012">18.9</usph:AveragePhysicalTherapyPatientsVolumesPerDayPerClinic>
    <usph:AveragePhysicalTherapyPatientsVolumesPerDayPerClinic
      contextRef="c20200701to20200930"
      decimals="1"
      id="Fact_0ddf92dce4304181bff2b85a958deeee"
      unitRef="U012">25.8</usph:AveragePhysicalTherapyPatientsVolumesPerDayPerClinic>
    <usph:AveragePhysicalTherapyPatientsVolumesPerDayPerClinic
      contextRef="c20201001to20201231"
      decimals="1"
      id="Fact_ba4f8dcbca61401d9b673bdb5c7fdbe0"
      unitRef="U012">27.7</usph:AveragePhysicalTherapyPatientsVolumesPerDayPerClinic>
    <usph:PercentageOfEmployeesFurloughedOrTerminated
      contextRef="c20200101to20200331"
      decimals="2"
      id="Fact_1b8f84e167d648b58e5e215d9bb0fb14"
      unitRef="U005">0.40</usph:PercentageOfEmployeesFurloughedOrTerminated>
    <dei:EntityNumberOfEmployees
      contextRef="c20200331"
      decimals="0"
      id="Fact_ecd27b620ea247a99e821c0bc52d4d3e"
      unitRef="U013">5500</dei:EntityNumberOfEmployees>
    <usph:NumberOfFurloughedEmployeesReturned
      contextRef="c20200502"
      decimals="0"
      id="Fact_fd21e9f43a4943e4a8bd9436337a348e"
      unitRef="U013">1200</usph:NumberOfFurloughedEmployeesReturned>
    <usph:CashAndCashEquivalentsAndAccruedLiabilities
      contextRef="c20201231_UnusualOrInfrequentItemAxis_MedicareAcceleratedAndAdvancePaymentsProgramMember"
      decimals="-5"
      id="Fact_51efc329adf94088ae2328b26dd67e91"
      unitRef="U001">14100000</usph:CashAndCashEquivalentsAndAccruedLiabilities>
    <usph:GrantsAndOtherFunds
      contextRef="c20201231_UnusualOrInfrequentItemAxis_PublicHealthAndSocialServicesEmergencyFundMember"
      decimals="-8"
      id="Fact_7d120d9c1d9849eaa24bf6662cc085e7"
      unitRef="U001">100000000000.0</usph:GrantsAndOtherFunds>
    <us-gaap:GrantsReceivable
      contextRef="c20201231_UnusualOrInfrequentItemAxis_PublicHealthAndSocialServicesEmergencyFundMember"
      decimals="-5"
      id="Fact_3041df8fef544458842ee063d7a71bb7"
      unitRef="U001">13500000</us-gaap:GrantsReceivable>
    <usph:ReliefFunds
      contextRef="c20200101to20201231_UnusualOrInfrequentItemAxis_PublicHealthAndSocialServicesEmergencyFundMember"
      decimals="-5"
      id="Fact_04c69dd76927408eb54d39c55e68df0f"
      unitRef="U001">13500000</usph:ReliefFunds>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="c20200101to20201231"
      id="Text_dd60cb8835484300b0c375d0823aefe8">
&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;2. Significant Accounting Policies&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Cash Equivalents&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company maintains its cash and cash equivalents at financial institutions. The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. The combined account balances at several institutions typically exceed Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;) insurance coverage and, as a result, there is a concentration of credit risk related to amounts on deposit in excess of FDIC insurance coverage. Management believes that this risk is not significant.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Long-Lived Assets&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Fixed assets are stated at cost. Depreciation is computed on the straight-line method over the estimated useful lives of the related assets. Estimated useful lives for furniture and equipment range from &lt;span style="-sec-ix-hidden:Fact_82099ea63dd944a793bca0b3ef182707"&gt;three&lt;/span&gt; to eight years and for software purchased from &lt;span style="-sec-ix-hidden:Fact_c914f2e353b54597a7cd8a612b794874"&gt;three&lt;/span&gt; to seven years. Leasehold improvements are amortized over the shorter of the related lease term or estimated useful lives of the assets, which is generally &lt;span style="-sec-ix-hidden:Fact_d794a755570f470987cd83402baa1e26"&gt;three&lt;/span&gt; to five years.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Impairment of Long-Lived Assets and Long-Lived Assets to Be Disposed Of&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company reviews property and equipment and intangible assets with finite lives for impairment upon the occurrence of certain events or circumstances that indicate the related amounts may be impaired. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Goodwill&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt;Goodwill represents the excess of the amount paid and fair value of the non-controlling interests over the fair value of the acquired business assets, which include certain identifiable intangible assets. Historically, goodwill has been derived from acquisitions and, prior to 2009&lt;/span&gt;,&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; from the purchase of some or all of a particular local management&#x2019;s equity interest in an existing clinic. Effective January 1, 2009&lt;/span&gt;,&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; if the purchase price of a non-controlling interest by the Company exceeds or is less than the book value at the time of purchase, any excess or shortfall is recognized as an adjustment to additional paid-in capital.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Goodwill and other indefinite-lived intangible assets are not amortized, but are instead subject to periodic impairment evaluations. The fair value of goodwill and other identifiable intangible assets with indefinite lives are evaluated for impairment at least annually and upon the occurrence of certain events or conditions, and are written down to fair value if considered impaired. These events or conditions include, but are not limited to: a significant adverse change in the business environment, regulatory environment, or legal factors; a current period operating or cash flow loss combined with a history of such losses or a projection of continuing losses; or a sale or disposition of a significant portion of a reporting unit. The occurrence of one of these events or conditions could significantly impact an impairment assessment, necessitating an impairment charge. The Company evaluates indefinite lived tradenames using the relief from royalty method in conjunction with its annual goodwill impairment test.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt;The Company operates a &lt;/span&gt;two&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; segment business which is made up of various clinics within partnerships, and the other is industrial injury prevention services business. The partnerships are components of regions and are aggregated to the operating segment level for the purpose of determining the Company&#x2019;s reporting units when performing its annual goodwill impairment test. In 2020, 2019 and 2018&lt;/span&gt;,&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; there were &lt;/span&gt;six&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; regions. In addition to the six regions, in 2020 and 2019&lt;/span&gt;,&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; the impairment analysis included a separate analysis for the industrial injury prevention business, as a separate reporting unit.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;As part of the impairment analysis, the Company is first required to assess qualitatively if it can conclude whether goodwill is more likely than not impaired. If goodwill is more likely than not impaired, the Company is then required to complete a quantitative analysis of whether a reporting unit&#x2019;s fair value is less than its carrying amount. In evaluating whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, the Company considers relevant events or circumstances that affect the fair value or carrying amount of a reporting unit. The Company considers both the income and market approach in determining the fair value of its reporting units when performing a quantitative analysis.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;An impairment loss generally would be recognized when the carrying amount of the net assets of a reporting unit, inclusive of goodwill and other identifiable intangible assets, exceeds the estimated fair value of the reporting unit. The evaluation of goodwill in 2020, 2019 and 2018 did not result in any goodwill amounts that were deemed impaired.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt;Based on the economic conditions experienced in 2020 and the decline in patient visits due to the pandemic, the Company evaluated whether events or circumstances indicated that it was more likely than not that the fair value of the reporting units were reduced below their carrying value as of December 31, 2020&lt;/span&gt;.&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; As a result of the assessment, the Company determined that it was not more likely than not that goodwill and tradenames of the reporting units were impaired as of December 31, 2020&lt;/span&gt;.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company will continue to monitor for any triggering events or other indicators of impairment.&#160; Due to the uncertainty of the current economic conditions resulting from the COVID-19 pandemic, the Company will continue to review its carrying amounts of goodwill and other intangibles quarterly.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt;For the year ended December 31, 2020&lt;/span&gt;,&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; the Company derecognized (wrote-off) goodwill in the amount of &lt;/span&gt;$1.9 million&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; related to closed clinics due to COVID-19&lt;/span&gt;.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Redeemable Non-Controlling Interests&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The non-controlling interests that are reflected as redeemable non-controlling interests in the consolidated financial statements consist of those in which the owners and the Company have certain redemption rights, whether currently exercisable or not, and which currently, or in the future, require that the Company purchase or the owner sell the non-controlling interest held by the owner, if certain conditions are met. The purchase price is derived at a predetermined formula based on a multiple of trailing twelve months earnings performance as defined in the respective limited partnership agreements. The redemption rights can be triggered by the owner or the Company at such time as both of the following events have occurred: 1) termination of the owner&#x2019;s employment, regardless of the reason for such termination, and 2) the passage of specified number of years after the closing of the transaction, typically &lt;span style="-sec-ix-hidden:Fact_74434238a9e847afae6e8bd50f9c3ecb"&gt;three&lt;/span&gt; to five years, as defined in the limited partnership agreement. The redemption rights are not automatic or mandatory (even upon death) and require either the owner or the Company to exercise its rights when the conditions triggering the redemption rights have been satisfied.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;On the date the Company acquires a controlling interest in a partnership, and the limited partnership agreement for such partnership contains redemption rights not under the control of the Company, the fair value of the non-controlling interest is recorded in the consolidated balance sheet under the caption &#x2013; Redeemable non-controlling interests. Then, in each reporting period thereafter until it is purchased by the Company, the redeemable non-controlling interest is adjusted to the greater of its then current redemption value or initial carrying value, based on the predetermined formula defined in the respective limited partnership agreement. As a result, the value of the non-controlling interest is not adjusted below its initial carrying value. The Company records any adjustment in the redemption value, net of tax, directly to retained earnings and are not reflected in the consolidated statements of income. Although the adjustments are not reflected in the consolidated statements of income, current accounting rules require that the Company reflects the adjustments, net of tax, in the earnings per share calculation. The amount of net income attributable to redeemable non-controlling interest owners is included in consolidated net income on the face of the consolidated statements of net income. Management believes the redemption value (i.e. the carrying amount) and fair value are the same.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Non-Controlling Interests&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company recognizes non-controlling interests, in which the Company has no obligation but the right to purchase the non-controlling interests, as permanent equity in the consolidated financial statements separate from the parent entity&#x2019;s equity. The amount of net income attributable to non-controlling interests is included in consolidated net income on the face of the statements of net income. Changes in a parent entity&#x2019;s ownership interest in a subsidiary that do not result in deconsolidation are treated as equity transactions if the parent entity retains its controlling financial interest. The Company recognizes a gain or loss in net income when a subsidiary is deconsolidated. Such gain or loss is measured using the fair value of the non-controlling equity investment on the deconsolidation date.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;When the purchase price of a non-controlling interest by the Company exceeds the book value at the time of purchase, any excess or shortfall is recognized as an adjustment to additional paid-in capital. Additionally, operating losses are allocated to non-controlling interests even when such allocation creates a deficit balance for the non-controlling interest partner.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Revenue Recognition&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;In May 2014, March 2016, April 2016, and December 2016, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2014-09, Revenue from Contracts with Customers, ASU 2016-08, Revenue from Contracts with Customers, Principal versus Agent Considerations, ASU 2016-10, Revenue from Contracts with Customers, Identifying Performance Obligations and Licensing, ASU 2016-12, Revenue from Contracts with Customers, Narrow Scope Improvements and Practical Expedients, and ASU 2016-20, Technical Corrections and Improvements to Topic 606, Revenue from Contracts with Customer (collectively the &#x201c;standards&#x201d;), respectively, which supersede most of the current revenue recognition requirements (&#x201c;ASC 606&#x201d;). The core principle of the new guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company implemented the new standards beginning January 1, 2018 using a modified retrospective transition method. The principal change relates to how the new standard requires healthcare providers to estimate the amount of variable consideration to be included in the transaction price up to an amount which is probable that a significant reversal will not occur. The most common forms of variable consideration the Company experiences are amounts for services provided that are ultimately not realizable from a customer. There were no changes to revenues or other revenues upon implementation. Under the new standards, the Company&#x2019;s estimate for unrealizable amounts will continue to be recognized as a reduction to revenue. The bad debt expense historically reported will not materially change.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;For ASC 606, there is an implied contract between us and the patient upon each patient visit. Separate contractual arrangements exist between us and third-party payors (e.g. insurers, managed care programs, government programs, workers' compensation) which establish the amounts the third parties pay on behalf of the patients for covered services rendered. While these agreements are not considered contracts with the customer, they are used for determining the transaction price for services provided to the patients covered by the third party payors. The payor contracts do not indicate performance obligations for us, but indicate reimbursement rates for patients who are covered by those payors when the services are provided. At that time, the Company is obligated to provide services for the reimbursement rates stipulated in the payor contracts. The execution of the contract alone does not indicate a performance obligation. For self-paying customers, the performance obligation exists when we provide the services at established rates. The difference between the Company&#x2019;s established rate and the anticipated reimbursement rate is accounted for as an offset to revenue &#x2013; contractual allowance.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The following table details the revenue related to the various categories (in thousands).&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="z8c0b8e1e67b64cb6b6522cc37bfa309c" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Year Ended&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2020&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2019&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2018&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Net patient revenues&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;373,340&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;433,345&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;417,703&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Management contract revenues&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;8,410&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;8,676&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;8,339&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Other revenues&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,020&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,486&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,403&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 17.65pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Physical therapy operations&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;383,770&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;444,507&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;428,445&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Industrial injury prevention services revenues&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;39,199&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;37,462&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;25,466&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;422,969&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;481,969&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;453,911&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Patient revenues&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Revenues are recognized in the period in which services are rendered. Net patient revenues consists of revenues for physical therapy and occupational therapy clinics that provide pre-and post-operative care and treatment for orthopedic related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries. Net patient revenues (patient revenues less estimated contractual adjustments) are recognized at the estimated net realizable amounts from third-party payors, patients and others in exchange for services rendered when obligations under the terms of the contract are satisfied. There is an implied contract between us and the patient upon each patient visit. Generally, this occurs as the Company provides physical and occupational therapy services, as each service provided is distinct and future services rendered are not dependent on previously rendered services. The Company has agreements with third-party payors that provide for payments to the Company at amounts different from its established rates.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"&gt;Medicare Reimbursement&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Medicare program reimburses outpatient rehabilitation providers based on the Medicare Physician Fee Schedule (&#x2018;&#x2018;MPFS&#x2019;&#x2019;). For services provided in 2018, a 0.5% increase was applied to the fee schedule payment rates; for services provided in 2019, a 0.25% increase was applied to the fee schedule payment rates before applying the mandatory budget neutrality adjustment. For services provided in 2020 through 2025, a 0.0% percent update will be applied each year to the fee schedule payment rates, before applying the mandatory budget neutrality adjustment. However, in the 2020 MPFS Final Rule, CMS proposed an increase to the code values for office/outpatient evaluation and management (E/M) codes and cuts to other codes to maintain budget neutrality of the MPFS. This change in code valuations was to become effective January 1, 2021.&#160; Under the 2021 MPFS Final Rule, reimbursement for the codes applicable to physical/occupational therapy services were to be reduced by approximately 9% in the aggregate. &lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt;The &lt;/span&gt;9%&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; reduction in payment was addressed by the Consolidated Appropriations Act, &lt;/span&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;2021&lt;/span&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; (&#x201c;Act&#x201d;) signed into law on December &lt;/span&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;27,&lt;/span&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt;&#160;&lt;/span&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;2020.&lt;/span&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt;&#160; Based on various provisions in the Act, the Company now estimates that the Medicare rate reduction for the full year of &lt;/span&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;2021&lt;/span&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; will be approximately &lt;/span&gt;3.5%&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; in aggregate.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Beginning in 2021, payments to individual therapists (Physical/Occupational Therapist in Private Practice) paid under the fee schedule may be subject to adjustment based on performance in the Merit Based Incentive Payment System (&#x201c;MIPS&#x201d;), which measures performance based on certain quality metrics, resource use, and meaningful use of electronic health records. Under the MIPS requirements, a provider's performance is assessed according to established performance standards each year and then is used to determine an adjustment factor that is applied to the professional's payment for the corresponding payment year. The provider&#x2019;s MIPS performance in 2019 will determine the payment adjustment in 2021. Each year from 2019 through 2024, professionals who receive a significant share of their revenues through an alternate payment model (&#x201c;APM&#x201d;), (such as accountable care organizations or bundled payment arrangements) that involves risk of financial losses and a quality measurement component will receive a 5% bonus in the corresponding payment year. The bonus payment for APM participation is intended to encourage participation and testing of new APMs and to promote the alignment of incentives across payors. The specifics of the MIPS and APM adjustments will be subject to future notice and comment rule-making.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Budget Control Act of 2011 increased the federal debt ceiling in connection with deficit reductions over the next ten years, and requires automatic reductions in federal spending by approximately $1.2 trillion. Payments to Medicare providers are subject to these automatic spending reductions, subject to a 2% cap. On April 1, 2013, a 2% reduction to Medicare payments was implemented. The Bipartisan Budget Act of 2015, enacted on November 2, 2015, extended the 2% reductions to Medicare payments through fiscal year 2025. The Bipartisan Budget Act of 2018, enacted on February 9, 2018, extends the 2% reductions to Medicare payments through fiscal year 2027. &lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;The Coronavirus Aid, Relief, and Economic Security (CARES) Act suspended the &lt;/span&gt;2%&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; payment reduction Medicare payments for dates of service from May 1, 2020, through December 31, 2020. The Consolidated Appropriations Act, 2021 further suspended the &lt;/span&gt;2%&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; payment reduction until March 31, 2021.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Historically, the total amount paid by Medicare in any one year for outpatient physical therapy, occupational therapy, and/or speech-language pathology services provided to any Medicare beneficiary was subject to an annual dollar limit (i.e., the &#x201c;Therapy Cap&#x201d; or &#x201c;Limit&#x201d;). For 2017, the annual Limit on outpatient therapy services was $1,980 for combined Physical Therapy and Speech Language Pathology services and $1,980 for Occupational Therapy services. As a result of Bipartisan Budget Act of 2018, the Therapy Caps have been eliminated, effective as of January 1, 2018.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Under the Middle Class Tax Relief and Job Creation Act of 2012 (&#x201c;MCTRA&#x201d;), since October 1, 2012, patients who met or exceeded $3,700 in therapy expenditures during a calendar year have been subject to a manual medical review to determine whether applicable payment criteria are satisfied. The $3,700 threshold is applied to Physical Therapy and Speech Language Pathology Services; a separate $3,700 threshold is applied to the Occupational Therapy. The MACRA directed CMS to modify the manual medical review process such that those reviews will no longer apply to all claims exceeding the $3,700 threshold and instead will be determined on a targeted basis based on a variety of factors that CMS considers appropriate. The Bipartisan Budget Act of 2018 extends the targeted medical review indefinitely, but reduces the threshold to $3,000 through December 31, 2027. For 2028, the threshold amount will be increased by the percentage increase in the Medicare Economic Index (&#x201c;MEI&#x201d;) for 2028 and in subsequent years the threshold amount will increase based on the corresponding percentage increase in the MEI for such subsequent year.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt;CMS adopted a multiple procedure payment reduction (&#x201c;MPPR&#x201d;) for therapy services in the final update to the MPFS for calendar year 2011. The MPPR applied to all outpatient therapy services paid under Medicare Part B &#x2014; occupational therapy, physical therapy and speech-language pathology. Under the policy, the Medicare program pays &lt;/span&gt;100%&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; of the practice expense component of the Relative Value Unit (&#x201c;RVU&#x201d;) for the therapy procedure with the highest practice expense RVU, then reduces the payment for the practice expense component for the second and subsequent therapy procedures or units of service furnished during the same day for the same patient, regardless of whether those therapy services are furnished in separate sessions. Since 2013, the practice expense component for the second and subsequent therapy service furnished during the same day for the same patient was reduced by &lt;/span&gt;50%&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt;. &lt;/span&gt;In addition, the MCTRA directed CMS to implement a claims-based data collection program to gather additional data on patient function during the course of therapy in order to better understand patient conditions and outcomes. All practice settings that provide outpatient therapy services are required to include this data on the claim form. Since 2013, therapists have been required to report new codes and modifiers on the claim form that reflect a patient&#x2019;s functional limitations and goals at initial evaluation, periodically throughout care, and at discharge. Reporting of these functional limitation codes and modifiers are required on the claim for payment.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Medicare claims for outpatient therapy services furnished by therapy assistants on or after January 1, 2020 must include a modifier indicating the service was furnished by a therapy assistant. Outpatient therapy services furnished on or after January 1, 2022 in whole or part by a therapy assistant will be paid at an amount equal to 85% of the payment amount otherwise applicable for the service.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Statutes, regulations, and payment rules governing the delivery of therapy services to Medicare beneficiaries are complex and subject to interpretation. We believe that we are in compliance, in all material respects, with all applicable laws and regulations and are not aware of any pending or threatened investigations involving allegations of potential wrongdoing that would have a material effect on the our financial statements as of December 31, 2020. Compliance with such laws and regulations can be subject to future government review and interpretation, as well as significant regulatory action including fines, penalties, and exclusion from the Medicare program. For year ended December 31, 2020, net patient revenues from Medicare were approximately $101.6 million.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Given the history of frequent revisions to the Medicare program and its reimbursement rates and rules, we may not continue to receive reimbursement rates from Medicare that sufficiently compensate us for our services or, in some instances, cover our operating costs. Limits on reimbursement rates or the scope of services being reimbursed could have a material adverse effect on our revenue, financial condition and results of operations. Additionally, any delay or default by the federal or state governments in making Medicare and/or Medicaid reimbursement payments could materially and, adversely, affect our business, financial condition and results of operations.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Management Contract Revenues&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Management contract revenues, which are included in other revenues, are derived from contractual arrangements whereby the Company manages a clinic for third party owners. The Company does not have any ownership interest in these clinics. Typically, revenues are determined based on the number of visits conducted at the clinic and recognized at a point in time when services are performed. Costs, typically salaries for the Company&#x2019;s employees, are recorded when incurred.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Industrial Injury Prevention Services Revenues&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Revenue from the industrial injury prevention business, which are also included in other revenues in the consolidated statements of net income, are derived from onsite services we provide to clients&#x2019; employees including injury prevention, rehabilitation, ergonomic assessments and performance optimization. Revenue from the Company&#x2019;s industrial injury prevention business is recognized when obligations under the terms of the contract are satisfied. Revenues are recognized at an amount equal to the consideration the company expects to receive in exchange for providing injury prevention services to its clients. The revenue is determined and recognized based on the number of hours and respective rate for services provided in a given period.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Other Revenues&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Additionally, other revenues include services the Company provides on-site at locations such as schools and industrial worksites for physical or occupational therapy services, athletic trainers and gym membership fees. Contract terms and rates are agreed to in advance between the Company and the third parties. Services are typically performed over the contract period and revenue is recorded at the point of service. If the services are paid in advance, revenue is recorded as a contract liability over the period of the agreement and recognized at the point in time, when the services are performed.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Contractual Allowances&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The allowance for estimated contractual adjustments is based on terms of payor contracts and historical collection and write-off experience. Contractual allowances result from the differences between the rates charged for services performed and expected reimbursements by both insurance companies and government sponsored healthcare programs for such services. Medicare regulations and the various third party payors and managed care contracts are often complex and may include multiple reimbursement mechanisms payable for the services provided in Company clinics. The Company estimates contractual allowances based on its interpretation of the applicable regulations, payor contracts and historical calculations. Each month the Company estimates its contractual allowance for each clinic based on payor contracts and the historical collection experience of the clinic and applies an appropriate contractual allowance reserve percentage to the gross accounts receivable balances for each payor of the clinic. Based on the Company&#x2019;s historical experience, calculating the contractual allowance reserve percentage at the payor level is sufficient to allow the Company to provide the necessary detail and accuracy with its collectability estimates. However, the services authorized and provided and related reimbursement are subject to interpretation that could result in payments that differ from the Company&#x2019;s estimates. Payor terms are periodically revised necessitating continual review and assessment of the estimates made by management. The Company&#x2019;s billing system does not capture the exact change in its contractual allowance reserve estimate from period to period in order to assess the accuracy of its revenues and hence its contractual allowance reserves. Management regularly compares its cash collections to corresponding net revenues measured both in the aggregate and on a clinic-by-clinic basis. In the aggregate, historically the difference between net revenues and corresponding cash collections for any fiscal year has generally reflected a difference within approximately 1% to 1.5% of net revenues. Additionally, analysis of subsequent periods&#x2019; contractual write-offs on a payor basis reflects a difference within approximately 1% to 1.5% between the actual aggregate contractual reserve percentage as compared to the estimated contractual allowance reserve percentage associated with the same period end balance. As a result, the Company believes that a change in the contractual allowance reserve estimate would not likely be more than 1% to 1.5% of gross billings included in accounts receivable at December 31, 2020.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Allowance for Credit Losses&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company determines allowances for credit losses based on the specific agings and payor classifications at each clinic. The provision for credit losses is included in operating costs in the statements of net income. Patient accounts receivable, which are stated at the historical carrying amount net of contractual allowances, write-offs and allowance for credit losses, includes only those amounts the Company estimates to be collectible.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Income Taxes&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount to be recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company did not have any accrued interest or penalties associated with any unrecognized tax benefits nor was any interest expense recognized during the twelve months ended December 31, 2020, 2019 and 2018. The Company will book any interest or penalties, if required, in interest and other expense, as appropriate.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Fair Values of Financial Instruments&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The carrying amounts reported in the balance sheets for cash and cash equivalents, accounts receivable, accounts payable and notes payable approximate their fair values due to the short-term maturity of these financial instruments. The carrying amount under the Amended Credit Agreement and the redemption value of Redeemable non-controlling interests approximate the respective fair values. The fair value of the Company&#x2019;s redeemable non-controlling interests is determined based on &#x201c;Level 3&#x201d; inputs. The interest rate on the Amended Credit Agreement, which is tied to LIBOR, is set at various short-term intervals, as detailed in the Amended Credit Agreement.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Segment Reporting&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt;Operating segments are components of an enterprise for which separate financial information is available that is evaluated regularly by chief operating decision makers in determining the allocation of resources and in assessing performance. &lt;/span&gt;The Company currently operates through two segments: physical therapy operations and industrial injury prevention services.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Use of Estimates&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;In preparing the Company&#x2019;s consolidated financial statements, management makes certain estimates and assumptions, especially in relation to, but not limited to, goodwill impairment, tradenames, allocations of purchase price, allowance for receivables, tax provision and contractual allowances, that affect the amounts reported in the consolidated financial statements and related disclosures. Actual results may differ from these estimates.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Self-Insurance Program&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company utilizes a self-insurance plan for its employee group health and dental insurance coverage administered by a third party. Predetermined loss limits have been arranged with the insurance company to minimize the Company&#x2019;s maximum liability and cash outlay. Accrued expenses include the estimated incurred but unreported costs to settle unpaid claims and estimated future claims. Management believes that the current accrued amounts are sufficient to pay claims arising from self-insurance claims incurred through December 31, 2020.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Restricted Stock&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Restricted stock issued to employees and directors is subject to continued employment or continued service on the board, respectively. Generally, restrictions on the stock granted to employees lapse in equal annual installments on the following &lt;span style="-sec-ix-hidden:Fact_e171b1cb7c524fee994efb673b5c1ee0"&gt;four&lt;/span&gt; anniversaries of the date of grant. For those shares granted to directors, the restrictions will lapse in equal quarterly installments during the &lt;span style="-sec-ix-hidden:Fact_d66bd8ac9de54f2492bfbf867e9180fc"&gt;first&lt;/span&gt; year after the date of grant. For those granted to officers, the restriction will lapse in equal quarterly installments during the four years following the date of grant. Compensation expense for grants of restricted stock is recognized based on the fair value per share on the date of grant amortized over the vesting period. The Company recognizes any forfeitures as they occur. The restricted stock issued is included in basic and diluted shares for the earnings per share computation.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Recently Adopted Accounting Guidance&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;In February 2016, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2016-02, Leases (Topic 842) (&#x201c;ASC 842&#x201d;), which amended prior accounting standards for leases.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company implemented the new lease standard, ASC Topic 842 &#x2013; Leases as of January 1, 2019 using the transition method in ASU 2018-11 issued in July 2018 which allows the Company to initially apply the new leases standard at adoption date and recognize a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. There was no adjustment required to retained earnings upon adoption. Accordingly, no retrospective adjustments were made to the comparative periods presented. The Company elected certain of the practical expedients permitted, including the expedient that allows the Company to retain its existing lease assessment and classification.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Adoption of ASC 842 resulted in an increase to total assets and liabilities due to the recording of operating lease right-of-use assets (&#x201c;ROU&#x201d;) and operating lease liabilities of approximately $78.0 million and $82.6 million respectively, as of January 1, 2019 for operating leases as a lessee. The adoption did not materially impact the Company&#x2019;s consolidated statement of income or cash flows. See Footnote 10 - Leases for further discussion of leases.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;In August 2018, the Securities Exchange Commission (&#x201c;SEC&#x201d;) issued Final Rule 33-10532, Disclosure Update and Simplification, which amends certain disclosure requirements that were redundant, duplicative, overlapping or superseded by other SEC disclosure requirements. The amendments generally eliminated or otherwise reduced certain disclosure requirements of various SEC rules and regulations. However, in some cases, the amendments require additional information to be disclosed, including changes in stockholders&#x2019; equity in interim periods. The rule is effective 30 days after its publication in the Federal Register. The rule was posted on October 4, 2018. On September 25, 2018, the SEC released guidance advising it will not object to a registrant adopting the requirement to include changes in stockholders&#x2019; equity in the Form 10-Q for the first quarter beginning after the effective date of the rule. The Company adopted this guidance in its Form 10-Q for the period ended March 31, 2019.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;In June 2016, the FASB issued ASU 2016-13, Financial Instruments &#x2013; Credit Losses, which added a new impairment model (known as the current expected credit loss (CECL) model) that is based on expected losses rather than incurred losses. Under the new guidance, an entity recognizes as an allowance its estimate of expected credit losses. The CECL model applies to most debt instruments, including trade receivables. The CECL model does not have a minimum threshold for recognition of impairment losses and entities will need to measure expected credit losses on assets that have a low risk of loss. The standard is required to be applied using the modified retrospective approach with a cumulative-effect adjustment to retained earnings, if any, upon adoption.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company completed the adoption of ASU 2016-13, &lt;span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;Financial Instruments &#x2013; Credit Losses&lt;/span&gt;&#160; on January 1, 2020. The financial instruments subject to ASU 2016-13 are the Company&#x2019;s accounts receivable derived from contracts with customers. A significant portion of the Company&#x2019;s accounts receivable are from highly-solvent, creditworthy payors including governmental programs such as Medicare and Medicaid, and highly regulated commercial insurers. The Company&#x2019;s estimate of expected credit losses as of January 1, 2020, using its expected credit loss evaluation process, resulted in no adjustments to the allowance for credit losses and no cumulative-effect adjustment to retained earnings on the adoption date of the standard.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;In January 2017, the FASB issued ASU 2017-04, &lt;span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;Simplifying the Test for Goodwill Impairment (Topic 350),&lt;/span&gt; which eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment charge. ASU 2017-04 is effective prospectively for fiscal years, and the interim periods within those years, beginning after December 15, 2019. The Company completed the adoption of the standard effective January 1, 2020 and there was no impact to goodwill from the Company&#x2019;s adoption of this change.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Recently Issued Accounting Guidance&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. This ASU provides temporary optional expedients and exceptions to the guidance on contract modifications and hedge accounting to ease the financial reporting burdens of the expected market transition from the London Interbank Offered Rate (&#x201c;LIBOR&#x201d;) and other interbank offered rates to alternative reference rates. The new guidance was effective upon issuance, and the Company is allowed to elect to apply the amendments prospectively through December 31, 2022. Borrowings under the Amended Credit Agreement bear interest based on LIBOR or an alternate base rate. Provisions within the agreement currently provide the Company with the ability to replace LIBOR with a different reference rate in the event LIBOR ceases to exist.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;In August 2020, the FASB issued ASU 2020-06&#160;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;Debt&#x2014;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity &lt;/span&gt;which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity&#x2019;s own equity. As part of this update, convertible instruments are to be included in diluted earnings per share using the if-converted method, rather than the treasury stock method. Further, contracts which can be settled in cash or shares, excluding liability-classified share-based payment awards, are to be included in diluted earnings per share on an if-converted basis if the effect is dilutive, regardless of whether the entity or the counterparty can choose between cash and share settlement. The share-settlement presumption may not be rebutted based on past experience or a stated policy.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;This pronouncement is effective for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2021. The Company plans to adopt this pronouncement as of January 1, 2022. The use of either the modified retrospective or fully retrospective method of transition is permitted. The Company is currently evaluating the impact of the adoption of ASU 2020-06 on the Company's consolidated financial statements.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;In December 2019, the FASB issued ASU 2019-12,&#160;Income Taxes (Topic 740) &#x2013; Simplifying the Accounting for Income Taxes (&#x201c;ASU 2019-12&#x201d;). The objective of ASU 2019-12 is to simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740 and to provide more consistent application to improve the comparability of financial statements. The amendments in this ASU are effective for fiscal years beginning after December 15, 2020, and early adoption is permitted. We are currently evaluating the impact this guidance may have on our consolidated financial statements and related footnote disclosures.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Subsequent Event&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;On January 29, 2021, the Company, entered into the First Amendment to Second Amended and Restated Credit Agreement (hereafter referred to as &#x201c;Amended Credit Agreement&#x201d;) extending the maturity date from November 30, 2021 to November 30, 2025. The commitment under the Amended Credit Agreement remains at $125 million, however the accordion feature in the agreement was expanded to provide for capacity up to $150 million. See Note 9 for more information on the Amended Credit Agreement.&lt;/div&gt;
</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="c20200101to20201231"
      id="Text_f654e6e9d34c410f8184c36d01fea70c">
&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Cash Equivalents&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company maintains its cash and cash equivalents at financial institutions. The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. The combined account balances at several institutions typically exceed Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;) insurance coverage and, as a result, there is a concentration of credit risk related to amounts on deposit in excess of FDIC insurance coverage. Management believes that this risk is not significant.&lt;/div&gt;
</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock
      contextRef="c20200101to20201231"
      id="Text_82478d6cd0114cd88193d5a5cad28fdb">
&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Long-Lived Assets&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Fixed assets are stated at cost. Depreciation is computed on the straight-line method over the estimated useful lives of the related assets. Estimated useful lives for furniture and equipment range from &lt;span style="-sec-ix-hidden:Fact_82099ea63dd944a793bca0b3ef182707"&gt;three&lt;/span&gt; to eight years and for software purchased from &lt;span style="-sec-ix-hidden:Fact_c914f2e353b54597a7cd8a612b794874"&gt;three&lt;/span&gt; to seven years. Leasehold improvements are amortized over the shorter of the related lease term or estimated useful lives of the assets, which is generally &lt;span style="-sec-ix-hidden:Fact_d794a755570f470987cd83402baa1e26"&gt;three&lt;/span&gt; to five years.&lt;/div&gt;
</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="c20200101to20201231_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember_RangeAxis_MaximumMember"
      id="Fact_19d1a963bce6491ba0e785cd1568213f">P8Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="c20200101to20201231_PropertyPlantAndEquipmentByTypeAxis_ComputerSoftwareIntangibleAssetMember_RangeAxis_MaximumMember"
      id="Fact_a1883202b29d49a9889f9e0df8891930">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="c20200101to20201231_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember_RangeAxis_MaximumMember"
      id="Fact_6141ef64f1024cc9b8d39878b3642033">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock
      contextRef="c20200101to20201231"
      id="Text_0e89c96f275d420791e129ad72bb61c7">
&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Impairment of Long-Lived Assets and Long-Lived Assets to Be Disposed Of&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company reviews property and equipment and intangible assets with finite lives for impairment upon the occurrence of certain events or circumstances that indicate the related amounts may be impaired. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.&lt;/div&gt;
</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock
      contextRef="c20200101to20201231"
      id="Text_6e277d5e92864848a5a510a2dc14f342">
&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Goodwill&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt;Goodwill represents the excess of the amount paid and fair value of the non-controlling interests over the fair value of the acquired business assets, which include certain identifiable intangible assets. Historically, goodwill has been derived from acquisitions and, prior to 2009&lt;/span&gt;,&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; from the purchase of some or all of a particular local management&#x2019;s equity interest in an existing clinic. Effective January 1, 2009&lt;/span&gt;,&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; if the purchase price of a non-controlling interest by the Company exceeds or is less than the book value at the time of purchase, any excess or shortfall is recognized as an adjustment to additional paid-in capital.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Goodwill and other indefinite-lived intangible assets are not amortized, but are instead subject to periodic impairment evaluations. The fair value of goodwill and other identifiable intangible assets with indefinite lives are evaluated for impairment at least annually and upon the occurrence of certain events or conditions, and are written down to fair value if considered impaired. These events or conditions include, but are not limited to: a significant adverse change in the business environment, regulatory environment, or legal factors; a current period operating or cash flow loss combined with a history of such losses or a projection of continuing losses; or a sale or disposition of a significant portion of a reporting unit. The occurrence of one of these events or conditions could significantly impact an impairment assessment, necessitating an impairment charge. The Company evaluates indefinite lived tradenames using the relief from royalty method in conjunction with its annual goodwill impairment test.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt;The Company operates a &lt;/span&gt;two&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; segment business which is made up of various clinics within partnerships, and the other is industrial injury prevention services business. The partnerships are components of regions and are aggregated to the operating segment level for the purpose of determining the Company&#x2019;s reporting units when performing its annual goodwill impairment test. In 2020, 2019 and 2018&lt;/span&gt;,&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; there were &lt;/span&gt;six&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; regions. In addition to the six regions, in 2020 and 2019&lt;/span&gt;,&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; the impairment analysis included a separate analysis for the industrial injury prevention business, as a separate reporting unit.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;As part of the impairment analysis, the Company is first required to assess qualitatively if it can conclude whether goodwill is more likely than not impaired. If goodwill is more likely than not impaired, the Company is then required to complete a quantitative analysis of whether a reporting unit&#x2019;s fair value is less than its carrying amount. In evaluating whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, the Company considers relevant events or circumstances that affect the fair value or carrying amount of a reporting unit. The Company considers both the income and market approach in determining the fair value of its reporting units when performing a quantitative analysis.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;An impairment loss generally would be recognized when the carrying amount of the net assets of a reporting unit, inclusive of goodwill and other identifiable intangible assets, exceeds the estimated fair value of the reporting unit. The evaluation of goodwill in 2020, 2019 and 2018 did not result in any goodwill amounts that were deemed impaired.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt;Based on the economic conditions experienced in 2020 and the decline in patient visits due to the pandemic, the Company evaluated whether events or circumstances indicated that it was more likely than not that the fair value of the reporting units were reduced below their carrying value as of December 31, 2020&lt;/span&gt;.&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; As a result of the assessment, the Company determined that it was not more likely than not that goodwill and tradenames of the reporting units were impaired as of December 31, 2020&lt;/span&gt;.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company will continue to monitor for any triggering events or other indicators of impairment.&#160; Due to the uncertainty of the current economic conditions resulting from the COVID-19 pandemic, the Company will continue to review its carrying amounts of goodwill and other intangibles quarterly.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt;For the year ended December 31, 2020&lt;/span&gt;,&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; the Company derecognized (wrote-off) goodwill in the amount of &lt;/span&gt;$1.9 million&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; related to closed clinics due to COVID-19&lt;/span&gt;.&lt;/div&gt;
</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="c20200101to20201231"
      decimals="INF"
      id="Fact_3512773c39804d5bb7e82aff520b97ef"
      unitRef="U004">2</us-gaap:NumberOfOperatingSegments>
    <usph:NumberOfRegions
      contextRef="c20180101to20181231"
      decimals="INF"
      id="Fact_6b67e9fb5f084286bc76babfd92350dc"
      unitRef="U016">6</usph:NumberOfRegions>
    <usph:NumberOfRegions
      contextRef="c20190101to20191231"
      decimals="INF"
      id="Fact_24374ec3d07b423d929dd87f5452d1ad"
      unitRef="U016">6</usph:NumberOfRegions>
    <usph:NumberOfRegions
      contextRef="c20200101to20201231"
      decimals="INF"
      id="Fact_0847d4d192ef478d850e942cc9b26058"
      unitRef="U016">6</usph:NumberOfRegions>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="c20200101to20201231"
      decimals="-5"
      id="Fact_f5b604ece7fb42bdbbab7830c4664ca5"
      unitRef="U001">1900000</us-gaap:GoodwillImpairmentLoss>
    <usph:RedeemableNonControllingInterestsPolicyTextBlock
      contextRef="c20200101to20201231"
      id="Text_b6c58a5603fd4c7e8fa3b0bc88dda8b1">
&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Redeemable Non-Controlling Interests&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The non-controlling interests that are reflected as redeemable non-controlling interests in the consolidated financial statements consist of those in which the owners and the Company have certain redemption rights, whether currently exercisable or not, and which currently, or in the future, require that the Company purchase or the owner sell the non-controlling interest held by the owner, if certain conditions are met. The purchase price is derived at a predetermined formula based on a multiple of trailing twelve months earnings performance as defined in the respective limited partnership agreements. The redemption rights can be triggered by the owner or the Company at such time as both of the following events have occurred: 1) termination of the owner&#x2019;s employment, regardless of the reason for such termination, and 2) the passage of specified number of years after the closing of the transaction, typically &lt;span style="-sec-ix-hidden:Fact_74434238a9e847afae6e8bd50f9c3ecb"&gt;three&lt;/span&gt; to five years, as defined in the limited partnership agreement. The redemption rights are not automatic or mandatory (even upon death) and require either the owner or the Company to exercise its rights when the conditions triggering the redemption rights have been satisfied.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;On the date the Company acquires a controlling interest in a partnership, and the limited partnership agreement for such partnership contains redemption rights not under the control of the Company, the fair value of the non-controlling interest is recorded in the consolidated balance sheet under the caption &#x2013; Redeemable non-controlling interests. Then, in each reporting period thereafter until it is purchased by the Company, the redeemable non-controlling interest is adjusted to the greater of its then current redemption value or initial carrying value, based on the predetermined formula defined in the respective limited partnership agreement. As a result, the value of the non-controlling interest is not adjusted below its initial carrying value. The Company records any adjustment in the redemption value, net of tax, directly to retained earnings and are not reflected in the consolidated statements of income. Although the adjustments are not reflected in the consolidated statements of income, current accounting rules require that the Company reflects the adjustments, net of tax, in the earnings per share calculation. The amount of net income attributable to redeemable non-controlling interest owners is included in consolidated net income on the face of the consolidated statements of net income. Management believes the redemption value (i.e. the carrying amount) and fair value are the same.&lt;/div&gt;
</usph:RedeemableNonControllingInterestsPolicyTextBlock>
    <usph:RedeemableNonControllingInterestRedemptionRightsCommencementPeriod
      contextRef="c20200101to20201231_RangeAxis_MaximumMember"
      id="Fact_0ee28dc40f114fa6a737957c7f31d0bc">P5Y</usph:RedeemableNonControllingInterestRedemptionRightsCommencementPeriod>
    <usph:NonControllingInterestsPolicyPolicyTextBlock
      contextRef="c20200101to20201231"
      id="Text_c31070a799ae47149a2ffcab8e9d302c">
&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Non-Controlling Interests&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company recognizes non-controlling interests, in which the Company has no obligation but the right to purchase the non-controlling interests, as permanent equity in the consolidated financial statements separate from the parent entity&#x2019;s equity. The amount of net income attributable to non-controlling interests is included in consolidated net income on the face of the statements of net income. Changes in a parent entity&#x2019;s ownership interest in a subsidiary that do not result in deconsolidation are treated as equity transactions if the parent entity retains its controlling financial interest. The Company recognizes a gain or loss in net income when a subsidiary is deconsolidated. Such gain or loss is measured using the fair value of the non-controlling equity investment on the deconsolidation date.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;When the purchase price of a non-controlling interest by the Company exceeds the book value at the time of purchase, any excess or shortfall is recognized as an adjustment to additional paid-in capital. Additionally, operating losses are allocated to non-controlling interests even when such allocation creates a deficit balance for the non-controlling interest partner.&lt;/div&gt;
</usph:NonControllingInterestsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="c20200101to20201231"
      id="Text_4d84eb0d57fb44068add3e471f7e1fb2">
&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Revenue Recognition&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;In May 2014, March 2016, April 2016, and December 2016, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2014-09, Revenue from Contracts with Customers, ASU 2016-08, Revenue from Contracts with Customers, Principal versus Agent Considerations, ASU 2016-10, Revenue from Contracts with Customers, Identifying Performance Obligations and Licensing, ASU 2016-12, Revenue from Contracts with Customers, Narrow Scope Improvements and Practical Expedients, and ASU 2016-20, Technical Corrections and Improvements to Topic 606, Revenue from Contracts with Customer (collectively the &#x201c;standards&#x201d;), respectively, which supersede most of the current revenue recognition requirements (&#x201c;ASC 606&#x201d;). The core principle of the new guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company implemented the new standards beginning January 1, 2018 using a modified retrospective transition method. The principal change relates to how the new standard requires healthcare providers to estimate the amount of variable consideration to be included in the transaction price up to an amount which is probable that a significant reversal will not occur. The most common forms of variable consideration the Company experiences are amounts for services provided that are ultimately not realizable from a customer. There were no changes to revenues or other revenues upon implementation. Under the new standards, the Company&#x2019;s estimate for unrealizable amounts will continue to be recognized as a reduction to revenue. The bad debt expense historically reported will not materially change.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;For ASC 606, there is an implied contract between us and the patient upon each patient visit. Separate contractual arrangements exist between us and third-party payors (e.g. insurers, managed care programs, government programs, workers' compensation) which establish the amounts the third parties pay on behalf of the patients for covered services rendered. While these agreements are not considered contracts with the customer, they are used for determining the transaction price for services provided to the patients covered by the third party payors. The payor contracts do not indicate performance obligations for us, but indicate reimbursement rates for patients who are covered by those payors when the services are provided. At that time, the Company is obligated to provide services for the reimbursement rates stipulated in the payor contracts. The execution of the contract alone does not indicate a performance obligation. For self-paying customers, the performance obligation exists when we provide the services at established rates. The difference between the Company&#x2019;s established rate and the anticipated reimbursement rate is accounted for as an offset to revenue &#x2013; contractual allowance.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The following table details the revenue related to the various categories (in thousands).&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="z8c0b8e1e67b64cb6b6522cc37bfa309c" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Year Ended&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2020&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2019&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2018&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Net patient revenues&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;373,340&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;433,345&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;417,703&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Management contract revenues&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;8,410&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;8,676&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;8,339&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Other revenues&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,020&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,486&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,403&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 17.65pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Physical therapy operations&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;383,770&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;444,507&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;428,445&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Industrial injury prevention services revenues&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;39,199&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;37,462&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;25,466&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;422,969&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;481,969&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;453,911&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Patient revenues&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Revenues are recognized in the period in which services are rendered. Net patient revenues consists of revenues for physical therapy and occupational therapy clinics that provide pre-and post-operative care and treatment for orthopedic related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries. Net patient revenues (patient revenues less estimated contractual adjustments) are recognized at the estimated net realizable amounts from third-party payors, patients and others in exchange for services rendered when obligations under the terms of the contract are satisfied. There is an implied contract between us and the patient upon each patient visit. Generally, this occurs as the Company provides physical and occupational therapy services, as each service provided is distinct and future services rendered are not dependent on previously rendered services. The Company has agreements with third-party payors that provide for payments to the Company at amounts different from its established rates.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"&gt;Medicare Reimbursement&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Medicare program reimburses outpatient rehabilitation providers based on the Medicare Physician Fee Schedule (&#x2018;&#x2018;MPFS&#x2019;&#x2019;). For services provided in 2018, a 0.5% increase was applied to the fee schedule payment rates; for services provided in 2019, a 0.25% increase was applied to the fee schedule payment rates before applying the mandatory budget neutrality adjustment. For services provided in 2020 through 2025, a 0.0% percent update will be applied each year to the fee schedule payment rates, before applying the mandatory budget neutrality adjustment. However, in the 2020 MPFS Final Rule, CMS proposed an increase to the code values for office/outpatient evaluation and management (E/M) codes and cuts to other codes to maintain budget neutrality of the MPFS. This change in code valuations was to become effective January 1, 2021.&#160; Under the 2021 MPFS Final Rule, reimbursement for the codes applicable to physical/occupational therapy services were to be reduced by approximately 9% in the aggregate. &lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt;The &lt;/span&gt;9%&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; reduction in payment was addressed by the Consolidated Appropriations Act, &lt;/span&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;2021&lt;/span&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; (&#x201c;Act&#x201d;) signed into law on December &lt;/span&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;27,&lt;/span&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt;&#160;&lt;/span&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;2020.&lt;/span&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt;&#160; Based on various provisions in the Act, the Company now estimates that the Medicare rate reduction for the full year of &lt;/span&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;2021&lt;/span&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; will be approximately &lt;/span&gt;3.5%&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; in aggregate.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Beginning in 2021, payments to individual therapists (Physical/Occupational Therapist in Private Practice) paid under the fee schedule may be subject to adjustment based on performance in the Merit Based Incentive Payment System (&#x201c;MIPS&#x201d;), which measures performance based on certain quality metrics, resource use, and meaningful use of electronic health records. Under the MIPS requirements, a provider's performance is assessed according to established performance standards each year and then is used to determine an adjustment factor that is applied to the professional's payment for the corresponding payment year. The provider&#x2019;s MIPS performance in 2019 will determine the payment adjustment in 2021. Each year from 2019 through 2024, professionals who receive a significant share of their revenues through an alternate payment model (&#x201c;APM&#x201d;), (such as accountable care organizations or bundled payment arrangements) that involves risk of financial losses and a quality measurement component will receive a 5% bonus in the corresponding payment year. The bonus payment for APM participation is intended to encourage participation and testing of new APMs and to promote the alignment of incentives across payors. The specifics of the MIPS and APM adjustments will be subject to future notice and comment rule-making.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Budget Control Act of 2011 increased the federal debt ceiling in connection with deficit reductions over the next ten years, and requires automatic reductions in federal spending by approximately $1.2 trillion. Payments to Medicare providers are subject to these automatic spending reductions, subject to a 2% cap. On April 1, 2013, a 2% reduction to Medicare payments was implemented. The Bipartisan Budget Act of 2015, enacted on November 2, 2015, extended the 2% reductions to Medicare payments through fiscal year 2025. The Bipartisan Budget Act of 2018, enacted on February 9, 2018, extends the 2% reductions to Medicare payments through fiscal year 2027. &lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;The Coronavirus Aid, Relief, and Economic Security (CARES) Act suspended the &lt;/span&gt;2%&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; payment reduction Medicare payments for dates of service from May 1, 2020, through December 31, 2020. The Consolidated Appropriations Act, 2021 further suspended the &lt;/span&gt;2%&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; payment reduction until March 31, 2021.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Historically, the total amount paid by Medicare in any one year for outpatient physical therapy, occupational therapy, and/or speech-language pathology services provided to any Medicare beneficiary was subject to an annual dollar limit (i.e., the &#x201c;Therapy Cap&#x201d; or &#x201c;Limit&#x201d;). For 2017, the annual Limit on outpatient therapy services was $1,980 for combined Physical Therapy and Speech Language Pathology services and $1,980 for Occupational Therapy services. As a result of Bipartisan Budget Act of 2018, the Therapy Caps have been eliminated, effective as of January 1, 2018.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Under the Middle Class Tax Relief and Job Creation Act of 2012 (&#x201c;MCTRA&#x201d;), since October 1, 2012, patients who met or exceeded $3,700 in therapy expenditures during a calendar year have been subject to a manual medical review to determine whether applicable payment criteria are satisfied. The $3,700 threshold is applied to Physical Therapy and Speech Language Pathology Services; a separate $3,700 threshold is applied to the Occupational Therapy. The MACRA directed CMS to modify the manual medical review process such that those reviews will no longer apply to all claims exceeding the $3,700 threshold and instead will be determined on a targeted basis based on a variety of factors that CMS considers appropriate. The Bipartisan Budget Act of 2018 extends the targeted medical review indefinitely, but reduces the threshold to $3,000 through December 31, 2027. For 2028, the threshold amount will be increased by the percentage increase in the Medicare Economic Index (&#x201c;MEI&#x201d;) for 2028 and in subsequent years the threshold amount will increase based on the corresponding percentage increase in the MEI for such subsequent year.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt;CMS adopted a multiple procedure payment reduction (&#x201c;MPPR&#x201d;) for therapy services in the final update to the MPFS for calendar year 2011. The MPPR applied to all outpatient therapy services paid under Medicare Part B &#x2014; occupational therapy, physical therapy and speech-language pathology. Under the policy, the Medicare program pays &lt;/span&gt;100%&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; of the practice expense component of the Relative Value Unit (&#x201c;RVU&#x201d;) for the therapy procedure with the highest practice expense RVU, then reduces the payment for the practice expense component for the second and subsequent therapy procedures or units of service furnished during the same day for the same patient, regardless of whether those therapy services are furnished in separate sessions. Since 2013, the practice expense component for the second and subsequent therapy service furnished during the same day for the same patient was reduced by &lt;/span&gt;50%&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt;. &lt;/span&gt;In addition, the MCTRA directed CMS to implement a claims-based data collection program to gather additional data on patient function during the course of therapy in order to better understand patient conditions and outcomes. All practice settings that provide outpatient therapy services are required to include this data on the claim form. Since 2013, therapists have been required to report new codes and modifiers on the claim form that reflect a patient&#x2019;s functional limitations and goals at initial evaluation, periodically throughout care, and at discharge. Reporting of these functional limitation codes and modifiers are required on the claim for payment.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Medicare claims for outpatient therapy services furnished by therapy assistants on or after January 1, 2020 must include a modifier indicating the service was furnished by a therapy assistant. Outpatient therapy services furnished on or after January 1, 2022 in whole or part by a therapy assistant will be paid at an amount equal to 85% of the payment amount otherwise applicable for the service.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Statutes, regulations, and payment rules governing the delivery of therapy services to Medicare beneficiaries are complex and subject to interpretation. We believe that we are in compliance, in all material respects, with all applicable laws and regulations and are not aware of any pending or threatened investigations involving allegations of potential wrongdoing that would have a material effect on the our financial statements as of December 31, 2020. Compliance with such laws and regulations can be subject to future government review and interpretation, as well as significant regulatory action including fines, penalties, and exclusion from the Medicare program. For year ended December 31, 2020, net patient revenues from Medicare were approximately $101.6 million.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Given the history of frequent revisions to the Medicare program and its reimbursement rates and rules, we may not continue to receive reimbursement rates from Medicare that sufficiently compensate us for our services or, in some instances, cover our operating costs. Limits on reimbursement rates or the scope of services being reimbursed could have a material adverse effect on our revenue, financial condition and results of operations. Additionally, any delay or default by the federal or state governments in making Medicare and/or Medicaid reimbursement payments could materially and, adversely, affect our business, financial condition and results of operations.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Management Contract Revenues&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Management contract revenues, which are included in other revenues, are derived from contractual arrangements whereby the Company manages a clinic for third party owners. The Company does not have any ownership interest in these clinics. Typically, revenues are determined based on the number of visits conducted at the clinic and recognized at a point in time when services are performed. Costs, typically salaries for the Company&#x2019;s employees, are recorded when incurred.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Industrial Injury Prevention Services Revenues&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Revenue from the industrial injury prevention business, which are also included in other revenues in the consolidated statements of net income, are derived from onsite services we provide to clients&#x2019; employees including injury prevention, rehabilitation, ergonomic assessments and performance optimization. Revenue from the Company&#x2019;s industrial injury prevention business is recognized when obligations under the terms of the contract are satisfied. Revenues are recognized at an amount equal to the consideration the company expects to receive in exchange for providing injury prevention services to its clients. The revenue is determined and recognized based on the number of hours and respective rate for services provided in a given period.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Other Revenues&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Additionally, other revenues include services the Company provides on-site at locations such as schools and industrial worksites for physical or occupational therapy services, athletic trainers and gym membership fees. Contract terms and rates are agreed to in advance between the Company and the third parties. Services are typically performed over the contract period and revenue is recorded at the point of service. If the services are paid in advance, revenue is recorded as a contract liability over the period of the agreement and recognized at the point in time, when the services are performed.&lt;/div&gt;
</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="c20200101to20201231"
      id="Text_60a8c81cb7334ff3be592479d26af01b">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The following table details the revenue related to the various categories (in thousands).&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="z8c0b8e1e67b64cb6b6522cc37bfa309c" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Year Ended&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2020&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2019&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2018&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Net patient revenues&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;373,340&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;433,345&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;417,703&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Management contract revenues&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;8,410&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;8,676&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;8,339&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Other revenues&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,020&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,486&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,403&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 17.65pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Physical therapy operations&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;383,770&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;444,507&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;428,445&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Industrial injury prevention services revenues&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;39,199&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;37,462&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;25,466&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;422,969&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;481,969&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;453,911&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;
</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20200101to20201231_ProductOrServiceAxis_NetPatientRevenuesMember"
      decimals="-3"
      id="Fact_7d15d9f7b77b4199add83e4e16fdb322"
      unitRef="U001">373340000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20190101to20191231_ProductOrServiceAxis_NetPatientRevenuesMember"
      decimals="-3"
      id="Fact_470b1becb47c45a3994093def0561fdf"
      unitRef="U001">433345000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20180101to20181231_ProductOrServiceAxis_NetPatientRevenuesMember"
      decimals="-3"
      id="Fact_b00d080f62d24b45aba3a04bc1d30534"
      unitRef="U001">417703000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20200101to20201231_ProductOrServiceAxis_ManagementContractRevenuesMember"
      decimals="-3"
      id="Fact_8fb2c4e8bfbb44deaf6c8a8b5290fbd2"
      unitRef="U001">8410000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20190101to20191231_ProductOrServiceAxis_ManagementContractRevenuesMember"
      decimals="-3"
      id="Fact_dba7330725544719ad5b3d5b208e8384"
      unitRef="U001">8676000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20180101to20181231_ProductOrServiceAxis_ManagementContractRevenuesMember"
      decimals="-3"
      id="Fact_e63fec09320a4e3b9c36d4ac0655f27d"
      unitRef="U001">8339000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20200101to20201231_ProductOrServiceAxis_OtherRevenuesMember"
      decimals="-3"
      id="Fact_e986d39788034d52a705fa40894dc971"
      unitRef="U001">2020000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20190101to20191231_ProductOrServiceAxis_OtherRevenuesMember"
      decimals="-3"
      id="Fact_6f6de22f96704808aa3490beffbb7e4a"
      unitRef="U001">2486000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20180101to20181231_ProductOrServiceAxis_OtherRevenuesMember"
      decimals="-3"
      id="Fact_0c61ed87a7264de79a4cb06d6d391dcf"
      unitRef="U001">2403000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20200101to20201231_ProductOrServiceAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_13919e12e38c4ab1b03012221e4c8ba9"
      unitRef="U001">383770000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20190101to20191231_ProductOrServiceAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_dae883461d7346ab89e2edfbc38ca1c7"
      unitRef="U001">444507000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20180101to20181231_ProductOrServiceAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_09cfbabaf4054929aced42d683ade9b6"
      unitRef="U001">428445000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20200101to20201231_ProductOrServiceAxis_IndustrialInjuryPreventionServicesRevenuesMember"
      decimals="-3"
      id="Fact_ba78a2856c8e41898d43daa36e229854"
      unitRef="U001">39199000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20190101to20191231_ProductOrServiceAxis_IndustrialInjuryPreventionServicesRevenuesMember"
      decimals="-3"
      id="Fact_53436a8b2963429284c4f18074428a33"
      unitRef="U001">37462000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20180101to20181231_ProductOrServiceAxis_IndustrialInjuryPreventionServicesRevenuesMember"
      decimals="-3"
      id="Fact_08e2bff9eb484919b7f29ad319f0413a"
      unitRef="U001">25466000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_f44d9fbbb77349578c17f58254b5694a"
      unitRef="U001">422969000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_48fba03a28d344e1ba39c354a972e545"
      unitRef="U001">481969000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_1bfae90c78024cbda4133f6858f83473"
      unitRef="U001">453911000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <usph:PercentageOfMedicarePaymentIncrease
      contextRef="c20200101to20201231_UnusualOrInfrequentItemAxis_Year2018Member"
      decimals="3"
      id="Fact_55d8101f79b54e519637ca6f493943a7"
      unitRef="U005">0.005</usph:PercentageOfMedicarePaymentIncrease>
    <usph:PercentageOfMedicarePaymentIncrease
      contextRef="c20200101to20201231_UnusualOrInfrequentItemAxis_Year2019Member"
      decimals="4"
      id="Fact_8dd8a88490184f15871b658d9ab6268a"
      unitRef="U005">0.0025</usph:PercentageOfMedicarePaymentIncrease>
    <usph:PercentageOfMedicarePaymentIncrease
      contextRef="c20200101to20201231_UnusualOrInfrequentItemAxis_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember"
      decimals="3"
      id="Fact_3c8d539ce8704abca3c617612aeefe90"
      unitRef="U005">0.000</usph:PercentageOfMedicarePaymentIncrease>
    <usph:EstimatedPercentageOfDecreaseInPayment
      contextRef="c20201227to20201227"
      decimals="2"
      id="Fact_d305fe06fc7647f991bf0269995882b2"
      unitRef="U005">0.09</usph:EstimatedPercentageOfDecreaseInPayment>
    <usph:EstimatedPercentageOfDecreaseInPayment
      contextRef="c20201227to20201227"
      decimals="2"
      id="Fact_97eab72864054614b9a0a38b8dc21685"
      unitRef="U005">0.09</usph:EstimatedPercentageOfDecreaseInPayment>
    <usph:EstimatedPercentageOfDecreaseInPayment
      contextRef="c20200101to20201231"
      decimals="3"
      id="Fact_653042824c33400abe3873c1cd2eb78f"
      unitRef="U005">0.035</usph:EstimatedPercentageOfDecreaseInPayment>
    <usph:PercentageOfBonusPayment
      contextRef="c20200101to20201231_UnusualOrInfrequentItemAxis_FromTwoThousandNineteenThroughTwoThousandTwentyFourMember"
      decimals="2"
      id="Fact_1eb1093db0b94d5f92319badaa306101"
      unitRef="U005">0.05</usph:PercentageOfBonusPayment>
    <usph:PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions
      contextRef="c20200101to20201231"
      id="Fact_bc91d93becfd4b939d7adf7eef9c1564">P10Y</usph:PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions>
    <usph:AmountOfReductionsInFederalSpending
      contextRef="c20200101to20201231"
      decimals="-11"
      id="Fact_a8437730cce14fcdb9ff08527ff24bae"
      unitRef="U001">1200000000000</usph:AmountOfReductionsInFederalSpending>
    <usph:ReductionInMedicareSpendingPercentage
      contextRef="c20200101to20201231"
      decimals="2"
      id="Fact_7766973703ec41d78f6dd4cf98b60bd1"
      unitRef="U005">0.02</usph:ReductionInMedicareSpendingPercentage>
    <usph:ExpectedReductionInMedicareSpendingPercentage
      contextRef="c20130401"
      decimals="2"
      id="Fact_99efd21eb1454bb58038291f19499e9b"
      unitRef="U005">0.02</usph:ExpectedReductionInMedicareSpendingPercentage>
    <usph:ExpectedReductionInMedicareSpendingPercentage
      contextRef="c20151102"
      decimals="2"
      id="Fact_c7600ea77d5a4a1ea57c3c9bfec86257"
      unitRef="U005">0.02</usph:ExpectedReductionInMedicareSpendingPercentage>
    <usph:ExpectedReductionInMedicareSpendingPercentage
      contextRef="c20180209"
      decimals="2"
      id="Fact_3ea905d1f5184b7e8f5e29f3db8f9f0b"
      unitRef="U005">0.02</usph:ExpectedReductionInMedicareSpendingPercentage>
    <usph:ExpectedReductionInMedicareSpendingPercentage
      contextRef="c20201231"
      decimals="2"
      id="Fact_69d5c80cb2be4b39949c529928910a1f"
      unitRef="U005">0.02</usph:ExpectedReductionInMedicareSpendingPercentage>
    <usph:ExpectedReductionInMedicareSpendingPercentage
      contextRef="c20210331_StatementScenarioAxis_ScenarioForecastMember"
      decimals="2"
      id="Fact_8560d06d39e346d3a71905c3e98e2bae"
      unitRef="U005">0.02</usph:ExpectedReductionInMedicareSpendingPercentage>
    <usph:AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices
      contextRef="c20200101to20201231_RangeAxis_MaximumMember_UnusualOrInfrequentItemAxis_Year2017Member"
      decimals="0"
      id="Fact_b6e707cdbfff41cb8fee3c35c6d9a199"
      unitRef="U001">1980</usph:AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices>
    <usph:AnnualLimitOccupationalTherapyServices
      contextRef="c20200101to20201231_RangeAxis_MaximumMember_UnusualOrInfrequentItemAxis_Year2017Member"
      decimals="0"
      id="Fact_201edd422af141bd9baebe16318b73c6"
      unitRef="U001">1980</usph:AnnualLimitOccupationalTherapyServices>
    <usph:CombinedPhysicalTherapySpeechLanguagePathologyExpenses
      contextRef="c20200101to20201231"
      decimals="0"
      id="Fact_e4e6f5b412cf49a3b7bfe95f680edc83"
      unitRef="U001">3700</usph:CombinedPhysicalTherapySpeechLanguagePathologyExpenses>
    <usph:CombinedPhysicalTherapySpeechLanguagePathologyExpenses
      contextRef="c20200101to20201231"
      decimals="0"
      id="Fact_baefb9408d9748279ad759a3661488bd"
      unitRef="U001">3700</usph:CombinedPhysicalTherapySpeechLanguagePathologyExpenses>
    <usph:CombinedPhysicalTherapySpeechLanguagePathologyExpenses
      contextRef="c20200101to20201231"
      decimals="0"
      id="Fact_b6c4a0ce89c742978eac930f06e87577"
      unitRef="U001">3700</usph:CombinedPhysicalTherapySpeechLanguagePathologyExpenses>
    <usph:CombinedPhysicalTherapySpeechLanguagePathologyExpenses
      contextRef="c20200101to20201231"
      decimals="0"
      id="Fact_724021545e294470a1fdee7749ee6350"
      unitRef="U001">3700</usph:CombinedPhysicalTherapySpeechLanguagePathologyExpenses>
    <usph:ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses
      contextRef="c20200101to20201231"
      decimals="0"
      id="Fact_10987fdc52dd4264b56b4f3c57785ad8"
      unitRef="U001">3000</usph:ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses>
    <usph:PercentageOfPracticeExpenseComponentOfRelativeValueUnit
      contextRef="c20200101to20201231"
      decimals="2"
      id="Fact_af6895816b7b45a7b32f347361ac9fe8"
      unitRef="U005">1</usph:PercentageOfPracticeExpenseComponentOfRelativeValueUnit>
    <usph:PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings
      contextRef="c20200101to20201231"
      decimals="2"
      id="Fact_cb29fd23afc44bc192568609fd3ba508"
      unitRef="U005">0.50</usph:PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings>
    <usph:PercentageOfPaymentForOutpatientTherapyServices
      contextRef="c20200101to20201231"
      decimals="2"
      id="Fact_e847ee5f09ba478f8e42a36a52371ae3"
      unitRef="U005">0.85</usph:PercentageOfPaymentForOutpatientTherapyServices>
    <usph:NetRevenueFromMedicare
      contextRef="c20200101to20201231"
      decimals="-5"
      id="Fact_f4ebeb7701bd4a838252c0a679d069d5"
      unitRef="U001">101600000</usph:NetRevenueFromMedicare>
    <us-gaap:ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock
      contextRef="c20200101to20201231"
      id="Text_82a6d009eac84f93b353ec5577075163">
&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Contractual Allowances&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The allowance for estimated contractual adjustments is based on terms of payor contracts and historical collection and write-off experience. Contractual allowances result from the differences between the rates charged for services performed and expected reimbursements by both insurance companies and government sponsored healthcare programs for such services. Medicare regulations and the various third party payors and managed care contracts are often complex and may include multiple reimbursement mechanisms payable for the services provided in Company clinics. The Company estimates contractual allowances based on its interpretation of the applicable regulations, payor contracts and historical calculations. Each month the Company estimates its contractual allowance for each clinic based on payor contracts and the historical collection experience of the clinic and applies an appropriate contractual allowance reserve percentage to the gross accounts receivable balances for each payor of the clinic. Based on the Company&#x2019;s historical experience, calculating the contractual allowance reserve percentage at the payor level is sufficient to allow the Company to provide the necessary detail and accuracy with its collectability estimates. However, the services authorized and provided and related reimbursement are subject to interpretation that could result in payments that differ from the Company&#x2019;s estimates. Payor terms are periodically revised necessitating continual review and assessment of the estimates made by management. The Company&#x2019;s billing system does not capture the exact change in its contractual allowance reserve estimate from period to period in order to assess the accuracy of its revenues and hence its contractual allowance reserves. Management regularly compares its cash collections to corresponding net revenues measured both in the aggregate and on a clinic-by-clinic basis. In the aggregate, historically the difference between net revenues and corresponding cash collections for any fiscal year has generally reflected a difference within approximately 1% to 1.5% of net revenues. Additionally, analysis of subsequent periods&#x2019; contractual write-offs on a payor basis reflects a difference within approximately 1% to 1.5% between the actual aggregate contractual reserve percentage as compared to the estimated contractual allowance reserve percentage associated with the same period end balance. As a result, the Company believes that a change in the contractual allowance reserve estimate would not likely be more than 1% to 1.5% of gross billings included in accounts receivable at December 31, 2020.&lt;/div&gt;
</us-gaap:ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock>
    <usph:DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues
      contextRef="c20200101to20201231_RangeAxis_MinimumMember"
      decimals="2"
      id="Fact_735d2b583918424a8c7cf9c6e59abdf8"
      unitRef="U005">0.01</usph:DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues>
    <usph:DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues
      contextRef="c20200101to20201231_RangeAxis_MaximumMember"
      decimals="3"
      id="Fact_710ed313f3b742449e6986013017f86e"
      unitRef="U005">0.015</usph:DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues>
    <usph:DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage
      contextRef="c20200101to20201231_RangeAxis_MinimumMember"
      decimals="2"
      id="Fact_abb0edecd76e42958911800b5e23f240"
      unitRef="U005">0.01</usph:DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage>
    <usph:DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage
      contextRef="c20200101to20201231_RangeAxis_MaximumMember"
      decimals="3"
      id="Fact_2d77fc8668c743d8a3e0b731707afe23"
      unitRef="U005">0.015</usph:DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage>
    <usph:MaximumContractualAllowanceReserveEstimate
      contextRef="c20200101to20201231_RangeAxis_MinimumMember"
      decimals="2"
      id="Fact_feaa9786f1b348aa92993a3ad1d3dde5"
      unitRef="U005">0.01</usph:MaximumContractualAllowanceReserveEstimate>
    <usph:MaximumContractualAllowanceReserveEstimate
      contextRef="c20200101to20201231_RangeAxis_MaximumMember"
      decimals="3"
      id="Fact_34050b62d3ac4198b86ddace8d745012"
      unitRef="U005">0.015</usph:MaximumContractualAllowanceReserveEstimate>
    <us-gaap:FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts
      contextRef="c20200101to20201231"
      id="Text_36fd587d12c04cefbe52ae0b96d83dc1">
&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Allowance for Credit Losses&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company determines allowances for credit losses based on the specific agings and payor classifications at each clinic. The provision for credit losses is included in operating costs in the statements of net income. Patient accounts receivable, which are stated at the historical carrying amount net of contractual allowances, write-offs and allowance for credit losses, includes only those amounts the Company estimates to be collectible.&lt;/div&gt;
</us-gaap:FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="c20200101to20201231"
      id="Text_499b9437e84f4f86943adb15b90ed92d">
&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Income Taxes&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount to be recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company did not have any accrued interest or penalties associated with any unrecognized tax benefits nor was any interest expense recognized during the twelve months ended December 31, 2020, 2019 and 2018. The Company will book any interest or penalties, if required, in interest and other expense, as appropriate.&lt;/div&gt;
</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="c20191231"
      decimals="-3"
      id="Fact_e42c06d7349b4065a0a5af72b08f344f"
      unitRef="U001">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="c20181231"
      decimals="-3"
      id="Fact_baaf3ff90cf44b20a88a92d3be31e64e"
      unitRef="U001">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="c20201231"
      decimals="-3"
      id="Fact_b6afa75754ea4f08af3eac2e360dc356"
      unitRef="U001">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_a4734842251b46f3ac49474f6792f2d3"
      unitRef="U001">0</us-gaap:InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations>
    <us-gaap:InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_7a6a308e051c41c99a92c335d8a7dd39"
      unitRef="U001">0</us-gaap:InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations>
    <us-gaap:InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_200af74610e7409dadacedb241ef6b07"
      unitRef="U001">0</us-gaap:InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="c20200101to20201231"
      id="Text_fab030a786d84d99b984fa4de13e2ae9">
&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Fair Values of Financial Instruments&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The carrying amounts reported in the balance sheets for cash and cash equivalents, accounts receivable, accounts payable and notes payable approximate their fair values due to the short-term maturity of these financial instruments. The carrying amount under the Amended Credit Agreement and the redemption value of Redeemable non-controlling interests approximate the respective fair values. The fair value of the Company&#x2019;s redeemable non-controlling interests is determined based on &#x201c;Level 3&#x201d; inputs. The interest rate on the Amended Credit Agreement, which is tied to LIBOR, is set at various short-term intervals, as detailed in the Amended Credit Agreement.&lt;/div&gt;
</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="c20200101to20201231"
      id="Text_f41d6361623e42e1ae6a35d3551953a7">
&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Segment Reporting&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt;Operating segments are components of an enterprise for which separate financial information is available that is evaluated regularly by chief operating decision makers in determining the allocation of resources and in assessing performance. &lt;/span&gt;The Company currently operates through two segments: physical therapy operations and industrial injury prevention services.&lt;/div&gt;
</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="c20200101to20201231"
      id="Text_9419282af8d04821b335d3e40b9355b7">
&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Use of Estimates&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;In preparing the Company&#x2019;s consolidated financial statements, management makes certain estimates and assumptions, especially in relation to, but not limited to, goodwill impairment, tradenames, allocations of purchase price, allowance for receivables, tax provision and contractual allowances, that affect the amounts reported in the consolidated financial statements and related disclosures. Actual results may differ from these estimates.&lt;/div&gt;
</us-gaap:UseOfEstimates>
    <usph:SelfInsuranceProgramPolicyPolicyTextBlock
      contextRef="c20200101to20201231"
      id="Text_7d4be4693df34678bbf20b78780bbe72">
&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Self-Insurance Program&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company utilizes a self-insurance plan for its employee group health and dental insurance coverage administered by a third party. Predetermined loss limits have been arranged with the insurance company to minimize the Company&#x2019;s maximum liability and cash outlay. Accrued expenses include the estimated incurred but unreported costs to settle unpaid claims and estimated future claims. Management believes that the current accrued amounts are sufficient to pay claims arising from self-insurance claims incurred through December 31, 2020.&lt;/div&gt;
</usph:SelfInsuranceProgramPolicyPolicyTextBlock>
    <usph:RestrictedStockPolicyPolicyTextBlock
      contextRef="c20200101to20201231"
      id="Text_ca0fc14eecc64d74b297a6d12a3ff19a">
&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Restricted Stock&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Restricted stock issued to employees and directors is subject to continued employment or continued service on the board, respectively. Generally, restrictions on the stock granted to employees lapse in equal annual installments on the following &lt;span style="-sec-ix-hidden:Fact_e171b1cb7c524fee994efb673b5c1ee0"&gt;four&lt;/span&gt; anniversaries of the date of grant. For those shares granted to directors, the restrictions will lapse in equal quarterly installments during the &lt;span style="-sec-ix-hidden:Fact_d66bd8ac9de54f2492bfbf867e9180fc"&gt;first&lt;/span&gt; year after the date of grant. For those granted to officers, the restriction will lapse in equal quarterly installments during the four years following the date of grant. Compensation expense for grants of restricted stock is recognized based on the fair value per share on the date of grant amortized over the vesting period. The Company recognizes any forfeitures as they occur. The restricted stock issued is included in basic and diluted shares for the earnings per share computation.&lt;/div&gt;
</usph:RestrictedStockPolicyPolicyTextBlock>
    <us-gaap:DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1
      contextRef="c20200101to20201231_TitleOfIndividualAxis_OfficerMember"
      id="Fact_decb0cbb01da4c6cbe4a3c50d6feff8c">P4Y</us-gaap:DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="c20200101to20201231"
      id="Text_3b238b06a0a24633b2bc213616210fea">
&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Recently Adopted Accounting Guidance&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;In February 2016, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2016-02, Leases (Topic 842) (&#x201c;ASC 842&#x201d;), which amended prior accounting standards for leases.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company implemented the new lease standard, ASC Topic 842 &#x2013; Leases as of January 1, 2019 using the transition method in ASU 2018-11 issued in July 2018 which allows the Company to initially apply the new leases standard at adoption date and recognize a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. There was no adjustment required to retained earnings upon adoption. Accordingly, no retrospective adjustments were made to the comparative periods presented. The Company elected certain of the practical expedients permitted, including the expedient that allows the Company to retain its existing lease assessment and classification.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Adoption of ASC 842 resulted in an increase to total assets and liabilities due to the recording of operating lease right-of-use assets (&#x201c;ROU&#x201d;) and operating lease liabilities of approximately $78.0 million and $82.6 million respectively, as of January 1, 2019 for operating leases as a lessee. The adoption did not materially impact the Company&#x2019;s consolidated statement of income or cash flows. See Footnote 10 - Leases for further discussion of leases.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;In August 2018, the Securities Exchange Commission (&#x201c;SEC&#x201d;) issued Final Rule 33-10532, Disclosure Update and Simplification, which amends certain disclosure requirements that were redundant, duplicative, overlapping or superseded by other SEC disclosure requirements. The amendments generally eliminated or otherwise reduced certain disclosure requirements of various SEC rules and regulations. However, in some cases, the amendments require additional information to be disclosed, including changes in stockholders&#x2019; equity in interim periods. The rule is effective 30 days after its publication in the Federal Register. The rule was posted on October 4, 2018. On September 25, 2018, the SEC released guidance advising it will not object to a registrant adopting the requirement to include changes in stockholders&#x2019; equity in the Form 10-Q for the first quarter beginning after the effective date of the rule. The Company adopted this guidance in its Form 10-Q for the period ended March 31, 2019.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;In June 2016, the FASB issued ASU 2016-13, Financial Instruments &#x2013; Credit Losses, which added a new impairment model (known as the current expected credit loss (CECL) model) that is based on expected losses rather than incurred losses. Under the new guidance, an entity recognizes as an allowance its estimate of expected credit losses. The CECL model applies to most debt instruments, including trade receivables. The CECL model does not have a minimum threshold for recognition of impairment losses and entities will need to measure expected credit losses on assets that have a low risk of loss. The standard is required to be applied using the modified retrospective approach with a cumulative-effect adjustment to retained earnings, if any, upon adoption.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company completed the adoption of ASU 2016-13, &lt;span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;Financial Instruments &#x2013; Credit Losses&lt;/span&gt;&#160; on January 1, 2020. The financial instruments subject to ASU 2016-13 are the Company&#x2019;s accounts receivable derived from contracts with customers. A significant portion of the Company&#x2019;s accounts receivable are from highly-solvent, creditworthy payors including governmental programs such as Medicare and Medicaid, and highly regulated commercial insurers. The Company&#x2019;s estimate of expected credit losses as of January 1, 2020, using its expected credit loss evaluation process, resulted in no adjustments to the allowance for credit losses and no cumulative-effect adjustment to retained earnings on the adoption date of the standard.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;In January 2017, the FASB issued ASU 2017-04, &lt;span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;Simplifying the Test for Goodwill Impairment (Topic 350),&lt;/span&gt; which eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment charge. ASU 2017-04 is effective prospectively for fiscal years, and the interim periods within those years, beginning after December 15, 2019. The Company completed the adoption of the standard effective January 1, 2020 and there was no impact to goodwill from the Company&#x2019;s adoption of this change.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Recently Issued Accounting Guidance&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. This ASU provides temporary optional expedients and exceptions to the guidance on contract modifications and hedge accounting to ease the financial reporting burdens of the expected market transition from the London Interbank Offered Rate (&#x201c;LIBOR&#x201d;) and other interbank offered rates to alternative reference rates. The new guidance was effective upon issuance, and the Company is allowed to elect to apply the amendments prospectively through December 31, 2022. Borrowings under the Amended Credit Agreement bear interest based on LIBOR or an alternate base rate. Provisions within the agreement currently provide the Company with the ability to replace LIBOR with a different reference rate in the event LIBOR ceases to exist.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;In August 2020, the FASB issued ASU 2020-06&#160;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;Debt&#x2014;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity &lt;/span&gt;which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity&#x2019;s own equity. As part of this update, convertible instruments are to be included in diluted earnings per share using the if-converted method, rather than the treasury stock method. Further, contracts which can be settled in cash or shares, excluding liability-classified share-based payment awards, are to be included in diluted earnings per share on an if-converted basis if the effect is dilutive, regardless of whether the entity or the counterparty can choose between cash and share settlement. The share-settlement presumption may not be rebutted based on past experience or a stated policy.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;This pronouncement is effective for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2021. The Company plans to adopt this pronouncement as of January 1, 2022. The use of either the modified retrospective or fully retrospective method of transition is permitted. The Company is currently evaluating the impact of the adoption of ASU 2020-06 on the Company's consolidated financial statements.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;In December 2019, the FASB issued ASU 2019-12,&#160;Income Taxes (Topic 740) &#x2013; Simplifying the Accounting for Income Taxes (&#x201c;ASU 2019-12&#x201d;). The objective of ASU 2019-12 is to simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740 and to provide more consistent application to improve the comparability of financial statements. The amendments in this ASU are effective for fiscal years beginning after December 15, 2020, and early adoption is permitted. We are currently evaluating the impact this guidance may have on our consolidated financial statements and related footnote disclosures.&lt;/div&gt;
</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="c20201231_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201602Member"
      decimals="-5"
      id="Fact_6a3b94af9bd443bf80feeca9badde6dd"
      unitRef="U001">78000000.0</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="c20201231_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201602Member"
      decimals="-5"
      id="Fact_7e43e5cacb054a9484c433d9ed8ad8b7"
      unitRef="U001">82600000</us-gaap:OperatingLeaseLiability>
    <us-gaap:SubsequentEventsPolicyPolicyTextBlock
      contextRef="c20200101to20201231"
      id="Text_ab44d1b7266b41689f34baf05a01821e">
&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Subsequent Event&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;On January 29, 2021, the Company, entered into the First Amendment to Second Amended and Restated Credit Agreement (hereafter referred to as &#x201c;Amended Credit Agreement&#x201d;) extending the maturity date from November 30, 2021 to November 30, 2025. The commitment under the Amended Credit Agreement remains at $125 million, however the accordion feature in the agreement was expanded to provide for capacity up to $150 million. See Note 9 for more information on the Amended Credit Agreement.&lt;/div&gt;
</us-gaap:SubsequentEventsPolicyPolicyTextBlock>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="c20210129to20210129_DebtInstrumentAxis_CreditAgreementMember_SubsequentEventTypeAxis_SubsequentEventMember"
      id="Fact_3c066b5e24634ed1b00358519b10f9d1">2021-11-30</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="c20200101to20201231_DebtInstrumentAxis_CreditAgreementMember"
      id="Fact_88af0ea6de7b4cf4a02c5962e39597b8">2025-11-30</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="c20210129_DebtInstrumentAxis_CreditAgreementMember_SubsequentEventTypeAxis_SubsequentEventMember"
      decimals="-6"
      id="Fact_bd8e4eafc51b48218eedd2c2e071add4"
      unitRef="U001">125000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c20210129_DebtInstrumentAxis_CreditAgreementMember_SubsequentEventTypeAxis_SubsequentEventMember"
      decimals="-6"
      id="Fact_85842de4d97f47688caed73f8663c0a0"
      unitRef="U001">150000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="c20200101to20201231"
      id="Text_27186a00161449d7ada7cce8030f6001">
&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;3. Acquisitions of Businesses&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;During 2020, 2019 and 2018, the Company acquired a majority interest in the following physical therapy practices:&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="zf55e47efd599479e982bad9962730ad0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;"&gt;
  &lt;tr&gt;
    &lt;td style="width: 39.03%; vertical-align: bottom; border-bottom: #000000 2px solid;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Acquisition&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 3.06%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 22.92%; vertical-align: bottom; border-bottom: #000000 2px solid;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Date&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.78%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 14.72%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;% Interest&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;&lt;/span&gt;Acquired&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.92%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 14.58%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Number of&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;&lt;/span&gt;Clinics&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 39.03%; vertical-align: bottom;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;November 2020 Acquisition&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 3.06%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 22.92%; vertical-align: bottom; border-top: #000000 2px solid;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;November 30, 2020&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.78%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 14.72%; vertical-align: bottom;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;75%&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.92%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 14.58%; vertical-align: bottom;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;3&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 39.03%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;September 2020 Acquisition&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 3.06%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 22.92%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;September 30, 2020&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.78%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 14.72%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;70%&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.92%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 14.58%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="-sec-ix-hidden:Fact_29c0aadade644e9a962b7bfbcb82c179"&gt;*&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 39.03%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;February 2020 Acquisition&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 3.06%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 22.92%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;February 27, 2020&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.78%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 14.72%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;65%&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.92%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;**&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 14.58%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;4&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 39.03%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;September 2019 Acquisition&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 3.06%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 22.92%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;September 30, 2019&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.78%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 14.72%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;67%&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.92%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 14.58%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;11&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 39.03%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;August 2018 Acquisition&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 3.06%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 22.92%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;August 31, 2018&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.78%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 14.72%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;70%&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.92%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 14.58%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;4&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt;*&#160; &#160; &lt;/span&gt;The business includes six management and services contracts which had a remaining term of approximately five years as of the date acquired.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt;**&#160;&#160; &lt;/span&gt;The four clinics are in four separate partnerships.&#160; The Company's interest in the four partnerships range from 10.0% to 83.8%, with an overall 65.0% based on the initial purchase transaction.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;On November 30, 2020, the Company acquired a 75% interest in a three-clinic physical therapy practice. The purchase price for the 75% interest was $9.1 million, of which $8.8 million was paid in cash and $0.3 million in the form of a seller note that is payable in two principal installments totaling $162,500 each. The first principal payment plus accrued interest will be paid on November 2021 with the second installment to be paid in November 2022. The note accrues interest at 3.25% per annum.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;On September 30, 2020, the Company acquired a 70% interest in an entity which holds six-management contracts that have been in place for a number of years. Currently, these contracts have a five year term. The purchase price for the 70% interest was approximately $4.2 million, with $3.7 million payable in cash and $0.5 million in notes payable. One of the notes payable of $0.2 million is payable, with any accrued interest at 5% per annum, on September 30, 2021.&#160; The remaining note of $0.3 million was paid in November 2020.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;On February 27, 2020, the Company acquired interests in a four-clinic physical therapy practice. The four clinics are operated in four separate partnerships.&#160; The Company&#x2019;s interests in the four partnerships range from 10.0% to 83.8%, with an overall 65.0% based on the initial purchase transaction. The aggregate purchase price was $12.3 million, of which $11.9 million was paid in cash and $0.3 million in the form of a seller note.&#160; The note accrues interest at 4.75% per annum and the principal and interest is payable on February 2022.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The purchase price for the 2020 physical therapy operations acquisitions has been preliminarily allocated as follows (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="za1a0966005394e48a9d620aafba9caf2" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Cash paid, net of cash acquired ($500)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;23,907&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Seller note&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,121&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total consideration&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;25,028&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Estimated fair value of net tangible assets acquired:&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total current assets&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,271&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total non-current assets&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;134&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total liabilities&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(555&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -15.85pt; margin-left: 33.85pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Net tangible assets acquired&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;850&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Referral relationships&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,597&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Non-compete&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,012&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Tradename&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,326&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Goodwill&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;28,540&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Fair value of non-controlling interest (classified as redeemable non-controlling interests)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(11,297&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;25,028&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;On September 30, 2019, the Company acquired a 67% interest in an eleven-clinic physical therapy practice. The purchase price for the 67% interest was $12.4 million ($12.6 million less cash acquired of $0.2 million), of which $12.3 million was paid in cash and $0.3 million in a seller note payable in two principal installments totaling $150,000 each, plus accrued interest. A payment of $150,000 plus accrued interest was paid in September 2020 and a second payment is due in September 2021. The note accrues interest at 5.0% per annum.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;On April 11, 2019, the Company acquired a company that is a provider of industrial injury prevention services. The acquired company specializes in delivering injury prevention and care, post offer employment testing, functional capacity evaluations and return-to-work services. It performs these services across a network of 45 states including onsite at eleven client locations. The acquired business was then combined with Briotix Health, the Company&#x2019;s industrial injury prevention operation, increasing the Company&#x2019;s ownership position in the Briotix Health partnership to approximately 76.0%. The purchase price for the acquired company was $22.9 million ($23.6 million less cash acquired of $0.7 million), which consisted of $18.9 million in cash, (of which $0.5 million will be paid to certain shareholders), and a $4.0 million seller note. The note accrues interest at 5.5% and the principal and accrued interest is payable, on April 9, 2021.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The results of operations of the acquired clinics have been included in the Company&#x2019;s consolidated financial statements since the date of their respective acquisition. The Company intends to continue to pursue additional acquisition opportunities, develop new clinics and open satellite clinics.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The purchase price for the 2019 acquisitions were allocated as follows (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="z0200ec8ec07146f3bd1815fa975597c6" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;IIPS*&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt; Physical Therapy Operations&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Total&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Cash paid, net of cash acquired ($890)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;18,428&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;12,170&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;30,598&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Payable to shareholders of seller&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;485&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;485&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Seller note&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,000&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;300&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,300&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total consideration&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;22,913&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;12,470&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;35,383&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Estimated fair value of net tangible assets acquired:&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total current assets&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,641&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;650&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,291&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total non-current assets&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;848&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;394&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,242&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total liabilities&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(2,978&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(191&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(3,169&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -15.85pt; margin-left: 33.85pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Net tangible assets acquired&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(489&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;853&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;364&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Referral relationships&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,400&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,600&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;6,000&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Non-compete&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;250&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;270&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;520&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Tradename&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,300&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;740&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,040&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Goodwill&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;18,452&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;14,237&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;32,689&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Fair value of non-controlling interest (classified as redeemable non-controlling interests)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(6,230&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(6,230&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;22,913&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;12,470&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;35,383&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;* Industrial injury prevention services&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;On August 31, 2018, the Company acquired a 70% interest in a four-clinic physical therapy practice. The purchase price for the 70% interest was $7.3 million in cash and $0.4 million in a seller note that was payable in two principal installments totaling $200,000 each, plus accrued interest. The first installment was paid in cash in August 2019 and the second installment was paid in August 2020.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;On April 30, 2018, the Company acquired a 65% interest in another business in the industrial injury prevention sector. The aggregate purchase price for the 65% interest was $8.6 million in cash and $400,000 in a seller note that was paid on April 30, 2019. On April 30, 2018, the Company combined its two businesses. After the combination, the Company owned a 59.45% interest in the combined business, Briotix Health. See discussion above regarding an additional acquisition on April 11, 2019 in the industrial injury prevention business.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;In addition, during 2018, the Company, through several of its majority owned Clinic Partnerships, acquired five separate clinic practices. These practices operate as satellites of the existing Clinic Partnership. The aggregate purchase price was $1.0 million inclusive of cash of $850,000 and a note payable of $150,000. The note accrued interest at 4.5% and the principal and accrued interest, was paid in cash on August 31, 2019.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The purchase price for the 2018 acquisitions were allocated as follows (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="z4cea7993c4404e908d071694d5887404" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Cash paid, net of cash acquired ($372)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;16,367&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Seller note&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;950&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total consideration&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;17,317&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Estimated fair value of net tangible assets acquired:&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total current assets&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,633&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total non-current assets&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;305&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total liabilities&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(525&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Net tangible assets acquired&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,413&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Referral relationships&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,926&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Non-compete&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;298&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Tradename&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;990&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Goodwill&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;19,835&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Fair value of non-controlling interest (classified as redeemable non-controlling interests)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(8,145&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;17,317&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The finalized purchase prices plus the fair value of the non-controlling interests for the acquisitions in 2019 and 2018 were allocated to the fair value of the assets acquired, inclusive of identifiable intangible assets, i.e. trade names, referral relationships and non-compete agreements, and liabilities assumed based on the fair values at the acquisition date, with the amount exceeding the fair values being recorded as goodwill. For the acquisitions in 2020, the Company is in the process of completing its formal valuation analysis to identify and determine the fair value of tangible and identifiable intangible assets acquired and the liabilities assumed. Thus, the final allocation of the purchase price may differ from the preliminary estimates used at December 31, 2020 based on additional information obtained and completion of the valuation of the identifiable intangible assets. Changes in the estimated valuation of the tangible assets acquired, the completion of the valuation of identifiable intangible assets and the completion by the Company of the identification of any unrecorded pre-acquisition contingencies, where the liability is probable and the amount can be reasonably estimated, will likely result in adjustments to goodwill. The Company does not expect the adjustments to be material.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;For the acquisitions in 2020, the values assigned to the referral relationships and non-compete agreements are being amortized to expense equally over the respective estimated lives. For referral relationships, the amortization period is 11.0 years. For non-compete agreements, the amortization period is 6.0 years. The values assigned to tradenames are tested annually for impairment.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;For the acquisitions in 2019 and 2018, the values assigned to the referral relationships and non-compete agreements are being amortized to expense equally over the respective estimated lives. For referral relationships, the weighted average amortization period was 10.54 and 10.10 years at December 31, 2019 and December 31, 2018, respectively. For non-compete agreements, the weighted average amortization period was 6.00 and 5.16 years at December 31, 2019 and December 31, 2018, respectively. Generally, the values assigned to tradenames are tested annually for impairment.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;For the 2020, 2019 and 2018 acquisitions, total current assets primarily represent patient accounts receivable. Total non-current assets are fixed assets, primarily equipment, used in the practices.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The consideration paid for each of the acquisitions was derived through arm&#x2019;s length negotiations. Funding for the cash portions was derived from proceeds from the Company&#x2019;s revolving credit facility. The results of operations of the acquisitions have been included in the Company&#x2019;s consolidated financial statements since their respective date of acquisition. Unaudited proforma consolidated financial information for the acquisitions in 2020, 2019 and 2018 acquisitions have not been included as the results, individually and in the aggregate. &lt;/div&gt;
</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
      contextRef="c20200101to20201231"
      id="Text_26c49011939c4398a618e5abaeeecb97">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;During 2020, 2019 and 2018, the Company acquired a majority interest in the following physical therapy practices:&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="zf55e47efd599479e982bad9962730ad0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;"&gt;
  &lt;tr&gt;
    &lt;td style="width: 39.03%; vertical-align: bottom; border-bottom: #000000 2px solid;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Acquisition&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 3.06%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 22.92%; vertical-align: bottom; border-bottom: #000000 2px solid;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Date&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.78%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 14.72%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;% Interest&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;&lt;/span&gt;Acquired&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.92%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 14.58%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Number of&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;&lt;/span&gt;Clinics&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 39.03%; vertical-align: bottom;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;November 2020 Acquisition&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 3.06%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 22.92%; vertical-align: bottom; border-top: #000000 2px solid;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;November 30, 2020&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.78%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 14.72%; vertical-align: bottom;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;75%&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.92%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 14.58%; vertical-align: bottom;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;3&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 39.03%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;September 2020 Acquisition&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 3.06%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 22.92%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;September 30, 2020&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.78%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 14.72%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;70%&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.92%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 14.58%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="-sec-ix-hidden:Fact_29c0aadade644e9a962b7bfbcb82c179"&gt;*&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 39.03%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;February 2020 Acquisition&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 3.06%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 22.92%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;February 27, 2020&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.78%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 14.72%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;65%&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.92%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;**&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 14.58%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;4&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 39.03%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;September 2019 Acquisition&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 3.06%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 22.92%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;September 30, 2019&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.78%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 14.72%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;67%&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.92%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 14.58%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;11&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 39.03%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;August 2018 Acquisition&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 3.06%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 22.92%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;August 31, 2018&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.78%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 14.72%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;70%&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 2.92%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 14.58%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;4&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt;*&#160; &#160; &lt;/span&gt;The business includes six management and services contracts which had a remaining term of approximately five years as of the date acquired.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt;**&#160;&#160; &lt;/span&gt;The four clinics are in four separate partnerships.&#160; The Company's interest in the four partnerships range from 10.0% to 83.8%, with an overall 65.0% based on the initial purchase transaction.&lt;/div&gt;
</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1
      contextRef="c20200101to20201231_BusinessAcquisitionAxis_NovemberTwoThousandTwentyAcquisitionMember"
      id="Fact_8cc617e77b2341aba28c923aeb808266">2020-11-30</us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20201231_BusinessAcquisitionAxis_NovemberTwoThousandTwentyAcquisitionMember"
      decimals="2"
      id="Fact_ff759822b2cf4e63a369407031450679"
      unitRef="U005">0.75</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20200101to20201231_BusinessAcquisitionAxis_NovemberTwoThousandTwentyAcquisitionMember"
      decimals="0"
      id="Fact_7effcacf8a9b4fcb88e2d01c3383440e"
      unitRef="U007">3</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1
      contextRef="c20200101to20201231_BusinessAcquisitionAxis_SeptemberTwoThousandTwentyAcquisitionMember"
      id="Fact_e245152f416a4ee7ab45cd34b0016d12">2020-09-30</us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20201231_BusinessAcquisitionAxis_SeptemberTwoThousandTwentyAcquisitionMember"
      decimals="2"
      id="Fact_f12369ff56344b0dbf644b88d74dbd01"
      unitRef="U005">0.70</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1
      contextRef="c20200101to20201231_BusinessAcquisitionAxis_FebruaryTwoThousandTwentyAcquisitionMember"
      id="Fact_820f42ef16464009a185c09fb7295238">2020-02-27</us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20201231_BusinessAcquisitionAxis_FebruaryTwoThousandTwentyAcquisitionMember"
      decimals="2"
      id="Fact_0320094539f74ee99f3fbef241f00d39"
      unitRef="U005">0.65</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20200101to20201231_BusinessAcquisitionAxis_FebruaryTwoThousandTwentyAcquisitionMember"
      decimals="0"
      id="Fact_33b9ee538a0648e98415f462fe900865"
      unitRef="U007">4</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1
      contextRef="c20200101to20201231_BusinessAcquisitionAxis_SeptemberTwoThousandNineteenAcquisitionMember"
      id="Fact_2fdcb59510004222884c22d3c0f43911">2019-09-30</us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20201231_BusinessAcquisitionAxis_SeptemberTwoThousandNineteenAcquisitionMember"
      decimals="2"
      id="Fact_7b588b69747c47199e33ce2a68c5d23b"
      unitRef="U005">0.67</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20200101to20201231_BusinessAcquisitionAxis_SeptemberTwoThousandNineteenAcquisitionMember"
      decimals="0"
      id="Fact_366c31ed1d7d453aab63052acfeebdfd"
      unitRef="U007">11</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1
      contextRef="c20200101to20201231_BusinessAcquisitionAxis_August2018AcquisitionMember"
      id="Fact_cf0376377e99455ba2125a8b4d9c3e7d">2018-08-31</us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20201231_BusinessAcquisitionAxis_August2018AcquisitionMember"
      decimals="2"
      id="Fact_a50a8121e7f14faab5cf59fdf0bb9c6f"
      unitRef="U005">0.70</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20200101to20201231_BusinessAcquisitionAxis_August2018AcquisitionMember"
      decimals="0"
      id="Fact_479ffaa695ba4e708eb3a716514358b6"
      unitRef="U007">4</us-gaap:NumberOfBusinessesAcquired>
    <usph:NumberOfManagementContracts
      contextRef="c20200930to20200930_BusinessAcquisitionAxis_ManagementAndServicesContractsMember"
      decimals="INF"
      id="Fact_a937be94f3554d02a7c3445463d89281"
      unitRef="U014">6</usph:NumberOfManagementContracts>
    <usph:RemainingContractTerm
      contextRef="c20200101to20201231_BusinessAcquisitionAxis_ManagementAndServicesContractsMember"
      id="Fact_9adb28d8758e4f12b149cfdb5a66f7d9">P5Y</usph:RemainingContractTerm>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20200227to20200227_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="INF"
      id="Fact_ce6bef34a7ee440f8359ff11eb5321bb"
      unitRef="U007">4</us-gaap:NumberOfBusinessesAcquired>
    <usph:NumberOfPartnershipInWhichInterestAcquired
      contextRef="c20200227to20200227_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="INF"
      id="Fact_19e56ea82f62430f9e9094120e17254b"
      unitRef="U015">4</usph:NumberOfPartnershipInWhichInterestAcquired>
    <usph:NumberOfPartnershipInWhichInterestAcquired
      contextRef="c20200227to20200227_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="INF"
      id="Fact_a30b5bc6f6d74c0fba36f0154dc78f22"
      unitRef="U015">4</usph:NumberOfPartnershipInWhichInterestAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MinimumMember"
      decimals="3"
      id="Fact_ecb4b7689056458682d5e2ba644d8d3c"
      unitRef="U005">0.100</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MaximumMember"
      decimals="3"
      id="Fact_62be7f93bd514451aabe2787ecf045eb"
      unitRef="U005">0.838</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="3"
      id="Fact_1073cde8e9024d1590350271777ef5e7"
      unitRef="U005">0.650</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20201130_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="2"
      id="Fact_fba4a08401d44bdf885492deafa4e2fc"
      unitRef="U005">0.75</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20201130to20201130_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="INF"
      id="Fact_8a08c6f41a9c4d5db89abe7642d2054a"
      unitRef="U007">3</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20201130_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="2"
      id="Fact_ceb2c7240053487086cdf85b6ca6a0a6"
      unitRef="U005">0.75</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="c20201130to20201130_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="-5"
      id="Fact_3b11b9a7fd954bb5b57cfc93199d7923"
      unitRef="U001">9100000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="c20201130to20201130_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="-5"
      id="Fact_dd9e4850aa114d76aca61dfd85573448"
      unitRef="U001">8800000</us-gaap:PaymentsToAcquireBusinessesGross>
    <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued
      contextRef="c20201130_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="-5"
      id="Fact_69f91d3fc6064a4db3d5f2b908af14a1"
      unitRef="U001">300000</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
    <usph:BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration
      contextRef="c20201130to20201130_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="INF"
      id="Fact_6065646e07e14dc19e21b487270b7ea1"
      unitRef="U010">2</usph:BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration>
    <us-gaap:DebtInstrumentAnnualPrincipalPayment
      contextRef="c20201130_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="0"
      id="Fact_a3bef9f39abb47eba3184ad8200754cb"
      unitRef="U001">162500</us-gaap:DebtInstrumentAnnualPrincipalPayment>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c20201130_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="4"
      id="Fact_c19d8976ed8646eca5ee57c5ea5a0372"
      unitRef="U005">0.0325</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20200930_BusinessAcquisitionAxis_ManagementContractsMember"
      decimals="2"
      id="Fact_566e201b0848416dbab04346a6a773dc"
      unitRef="U005">0.70</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <usph:NumberOfManagementContracts
      contextRef="c20200930to20200930_BusinessAcquisitionAxis_ManagementContractsMember"
      decimals="INF"
      id="Fact_9be31bb77df84eb79f46543135f43946"
      unitRef="U014">6</usph:NumberOfManagementContracts>
    <usph:RemainingContractTerm
      contextRef="c20200101to20201231_BusinessAcquisitionAxis_ManagementContractsMember"
      id="Fact_686208299a8f46edb3f17203cbe99d71">P5Y</usph:RemainingContractTerm>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20200930_BusinessAcquisitionAxis_ManagementContractsMember"
      decimals="2"
      id="Fact_65dfc2538f304229ba2bd09b497418e1"
      unitRef="U005">0.70</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="c20200930to20200930_BusinessAcquisitionAxis_ManagementContractsMember"
      decimals="-5"
      id="Fact_72dd7e912e664a2eab2a5a192f0a2845"
      unitRef="U001">4200000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="c20200930to20200930_BusinessAcquisitionAxis_ManagementContractsMember"
      decimals="-5"
      id="Fact_2207a399bcc543798b9719a7b2ae7d52"
      unitRef="U001">3700000</us-gaap:PaymentsToAcquireBusinessesGross>
    <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued
      contextRef="c20200930_BusinessAcquisitionAxis_ManagementContractsMember"
      decimals="-5"
      id="Fact_7453b569457545f5b831a8547015d119"
      unitRef="U001">500000</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
    <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued
      contextRef="c20200930_BusinessAcquisitionAxis_ManagementContractsMember_ShortTermDebtTypeAxis_NotesPayableOneMember"
      decimals="-5"
      id="Fact_6050a2913a4e46329f71b31b71e58215"
      unitRef="U001">200000</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c20200930_BusinessAcquisitionAxis_ManagementContractsMember_ShortTermDebtTypeAxis_NotesPayableOneMember"
      decimals="2"
      id="Fact_0dd2ef7911084e28a03a0f69464bf2cd"
      unitRef="U005">0.05</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued
      contextRef="c20200930_BusinessAcquisitionAxis_ManagementContractsMember_ShortTermDebtTypeAxis_NotesPayableTwoMember"
      decimals="-5"
      id="Fact_0d6d705473a2414a9354438da247069d"
      unitRef="U001">300000</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20200227to20200227_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="INF"
      id="Fact_4284c5d2ef6f4ae1bc3917b13fbe5bc3"
      unitRef="U007">4</us-gaap:NumberOfBusinessesAcquired>
    <usph:NumberOfPartnershipInWhichInterestAcquired
      contextRef="c20200227to20200227_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="INF"
      id="Fact_f6e868a352ee470ab4dd704b10f8f69b"
      unitRef="U015">4</usph:NumberOfPartnershipInWhichInterestAcquired>
    <usph:NumberOfPartnershipInWhichInterestAcquired
      contextRef="c20200227to20200227_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="INF"
      id="Fact_637db30992a8494bbff1da37f33b69ec"
      unitRef="U015">4</usph:NumberOfPartnershipInWhichInterestAcquired>
    <usph:NumberOfPartnershipInWhichInterestAcquired
      contextRef="c20200227to20200227_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="INF"
      id="Fact_1d265c000845400b95c3ba94f093ea54"
      unitRef="U015">4</usph:NumberOfPartnershipInWhichInterestAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MinimumMember"
      decimals="3"
      id="Fact_a1462a7f8dea45039c8e8deba602e150"
      unitRef="U005">0.100</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember_RangeAxis_MaximumMember"
      decimals="3"
      id="Fact_4bdb9a298d814169b8e8a59d19aaef7d"
      unitRef="U005">0.838</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="3"
      id="Fact_9d1802cc99c547c79b57b176265d8de7"
      unitRef="U005">0.650</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="c20200227to20200227_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="-5"
      id="Fact_c78cab37b9434ad59fbea83717026db1"
      unitRef="U001">12300000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="c20200227to20200227_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="-5"
      id="Fact_d89abe25309a43a8871f8f619bc3b387"
      unitRef="U001">11900000</us-gaap:PaymentsToAcquireBusinessesGross>
    <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued
      contextRef="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="-5"
      id="Fact_e6bc523e6e834ed1ac9ddfc7fdc6669c"
      unitRef="U001">300000</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c20200227_BusinessAcquisitionAxis_ClinicPracticeMember"
      decimals="4"
      id="Fact_3fab593f97614d5bacc404f565a80c44"
      unitRef="U005">0.0475</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock
      contextRef="c20200101to20201231"
      id="Text_49f8a361ae8444528e465d9c221ad2d2">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The purchase price for the 2020 physical therapy operations acquisitions has been preliminarily allocated as follows (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="za1a0966005394e48a9d620aafba9caf2" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Cash paid, net of cash acquired ($500)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;23,907&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Seller note&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,121&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total consideration&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;25,028&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Estimated fair value of net tangible assets acquired:&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total current assets&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,271&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total non-current assets&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;134&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total liabilities&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(555&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -15.85pt; margin-left: 33.85pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Net tangible assets acquired&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;850&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Referral relationships&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,597&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Non-compete&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,012&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Tradename&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,326&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Goodwill&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;28,540&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Fair value of non-controlling interest (classified as redeemable non-controlling interests)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(11,297&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;25,028&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The purchase price for the 2019 acquisitions were allocated as follows (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="z0200ec8ec07146f3bd1815fa975597c6" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;IIPS*&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt; Physical Therapy Operations&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Total&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Cash paid, net of cash acquired ($890)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;18,428&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;12,170&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;30,598&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Payable to shareholders of seller&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;485&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;485&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Seller note&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,000&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;300&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,300&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total consideration&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;22,913&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;12,470&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;35,383&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Estimated fair value of net tangible assets acquired:&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total current assets&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,641&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;650&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,291&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total non-current assets&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;848&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;394&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,242&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total liabilities&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(2,978&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(191&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(3,169&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -15.85pt; margin-left: 33.85pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Net tangible assets acquired&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(489&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;853&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;364&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Referral relationships&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,400&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,600&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;6,000&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Non-compete&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;250&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;270&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;520&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Tradename&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,300&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;740&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,040&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Goodwill&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;18,452&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;14,237&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;32,689&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Fair value of non-controlling interest (classified as redeemable non-controlling interests)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(6,230&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(6,230&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;22,913&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;12,470&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;35,383&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;* Industrial injury prevention services&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The purchase price for the 2018 acquisitions were allocated as follows (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="z4cea7993c4404e908d071694d5887404" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Cash paid, net of cash acquired ($372)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;16,367&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Seller note&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;950&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total consideration&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;17,317&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Estimated fair value of net tangible assets acquired:&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total current assets&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,633&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total non-current assets&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;305&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total liabilities&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(525&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Net tangible assets acquired&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,413&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Referral relationships&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,926&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Non-compete&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;298&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Tradename&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;990&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Goodwill&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;19,835&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Fair value of non-controlling interest (classified as redeemable non-controlling interests)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(8,145&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;17,317&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;
</us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="c20200101to20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_8704f0e048314626b8e414348851e84b"
      unitRef="U001">500000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="c20200101to20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_3488c1bfe9a049d4b4b784d52cdad4e8"
      unitRef="U001">23907000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued
      contextRef="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_7ee80fd8a32a47388762fc64bfa8db3c"
      unitRef="U001">1121000</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
    <usph:PaymentsToAcquireBusinessesConsideration
      contextRef="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_a9c481a8edc547eb8653efaee3994407"
      unitRef="U001">25028000</usph:PaymentsToAcquireBusinessesConsideration>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_161ea83d639545b69fbbb15074e18d02"
      unitRef="U001">1271000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets
      contextRef="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_308119415bef4bd28b0945a23579d370"
      unitRef="U001">134000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_69c0e622550f46acade32f0be0312131"
      unitRef="U001">-555000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <usph:BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset
      contextRef="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_180cc378e7b742659e1c8be65f2d97ea"
      unitRef="U001">850000</usph:BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset>
    <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships
      contextRef="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_4bfdfed0a8834966a7a96a1bac1d0fb8"
      unitRef="U001">3597000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships>
    <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements
      contextRef="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_c30390cef0ef4525a8b620fb28628f26"
      unitRef="U001">1012000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements>
    <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename
      contextRef="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_4e07f7e8fa6b41a2badeb9fe98f3fd16"
      unitRef="U001">2326000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_5b60ac81d10843fc9b70cdc503b0dfb1"
      unitRef="U001">28540000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests
      contextRef="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_097e01a6b9474f4fa46e5ec70f58af1b"
      unitRef="U001">11297000</usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests>
    <usph:PaymentsToAcquireBusinessesConsideration
      contextRef="c20201231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_02bf68e439bc431db5076d92008d3123"
      unitRef="U001">25028000</usph:PaymentsToAcquireBusinessesConsideration>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20190930_BusinessAcquisitionAxis_SeptemberTwoThousandNineteenAcquisitionMember"
      decimals="2"
      id="Fact_ce9d9458ef4b40ee94e827b692cf6b2a"
      unitRef="U005">0.67</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20190930to20190930_BusinessAcquisitionAxis_SeptemberTwoThousandNineteenAcquisitionMember"
      decimals="INF"
      id="Fact_65c9850dba784e418d944b3efd2d59a8"
      unitRef="U007">11</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20201231_BusinessAcquisitionAxis_SeptemberTwoThousandNineteenAcquisitionMember"
      decimals="2"
      id="Fact_4c59dc06cb39436191d2f1cce4f785f2"
      unitRef="U005">0.67</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="c20190930to20190930_BusinessAcquisitionAxis_SeptemberTwoThousandNineteenAcquisitionMember"
      decimals="-5"
      id="Fact_598b6cbd115b40cd8d7ad2670c8c19c8"
      unitRef="U001">12400000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="c20190930to20190930_BusinessAcquisitionAxis_SeptemberTwoThousandNineteenAcquisitionMember"
      decimals="-5"
      id="Fact_38ab62f464d14d66922b1cf9bf1bbf1d"
      unitRef="U001">12600000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="c20190930to20190930_BusinessAcquisitionAxis_SeptemberTwoThousandNineteenAcquisitionMember"
      decimals="-5"
      id="Fact_a98b83e1b4094fb7a53a69d7214df153"
      unitRef="U001">200000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="c20190930to20190930_BusinessAcquisitionAxis_SeptemberTwoThousandNineteenAcquisitionMember"
      decimals="-5"
      id="Fact_13b13bc51d2b4ecf8f6a4980d09a4ed3"
      unitRef="U001">12300000</us-gaap:PaymentsToAcquireBusinessesGross>
    <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued
      contextRef="c20190930_BusinessAcquisitionAxis_SeptemberTwoThousandNineteenAcquisitionMember"
      decimals="-5"
      id="Fact_d78a3d303b4c4294b24977f0dd681bbd"
      unitRef="U001">300000</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
    <usph:BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration
      contextRef="c20190930to20190930_BusinessAcquisitionAxis_SeptemberTwoThousandNineteenAcquisitionMember"
      decimals="INF"
      id="Fact_5a0506ba2e0f4ff5b3689213c119ab0b"
      unitRef="U010">2</usph:BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="c20190930to20190930_BusinessAcquisitionAxis_SeptemberTwoThousandNineteenAcquisitionMember_StatementScenarioAxis_SeptemberTwoThousandTwentyMember"
      decimals="0"
      id="Fact_7dd16eb3f00a4588af2a31d7f1aed6c3"
      unitRef="U001">150000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="c20190930to20190930_BusinessAcquisitionAxis_SeptemberTwoThousandNineteenAcquisitionMember_StatementScenarioAxis_SeptemberTwoThousandTwentyOneMember"
      decimals="0"
      id="Fact_47bf72b50618414a97c4713b2c265aec"
      unitRef="U001">150000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c20190930_BusinessAcquisitionAxis_SeptemberTwoThousandNineteenAcquisitionMember"
      decimals="3"
      id="Fact_6382adcd3c02474bae0c9126bb640bbb"
      unitRef="U005">0.050</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <usph:NumberOfStatesOfNetworkServices
      contextRef="c20190411to20190411_BusinessAcquisitionAxis_AprilTwoThousandNineteenAcquisitionMember"
      decimals="INF"
      id="Fact_b7c0864afe2341d7ab3647cf3d2f0044"
      unitRef="U008">45</usph:NumberOfStatesOfNetworkServices>
    <usph:NumberOfOnsiteClientLocations
      contextRef="c20190411_BusinessAcquisitionAxis_AprilTwoThousandNineteenAcquisitionMember"
      decimals="INF"
      id="Fact_4f770873933743e8821cdb9b330f5f81"
      unitRef="U006">11</usph:NumberOfOnsiteClientLocations>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20190411_BusinessAcquisitionAxis_AprilTwoThousandNineteenAcquisitionMember"
      decimals="3"
      id="Fact_b29d5a235d3d4ee3abd9015ce1500fc9"
      unitRef="U005">0.760</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="c20190411to20190411_BusinessAcquisitionAxis_AprilTwoThousandNineteenAcquisitionMember"
      decimals="-5"
      id="Fact_da40d395126d49b29575bee2ec47ff4f"
      unitRef="U001">22900000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="c20190411to20190411_BusinessAcquisitionAxis_AprilTwoThousandNineteenAcquisitionMember"
      decimals="-5"
      id="Fact_5c2071460fd34bf9897aae6b8246aeff"
      unitRef="U001">23600000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="c20190411to20190411_BusinessAcquisitionAxis_AprilTwoThousandNineteenAcquisitionMember"
      decimals="-5"
      id="Fact_ec214afe139b4f9ab54ee742a30c76a3"
      unitRef="U001">700000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="c20190411to20190411_BusinessAcquisitionAxis_AprilTwoThousandNineteenAcquisitionMember"
      decimals="-5"
      id="Fact_c4761e8a09334f9fb6422683089ed4ae"
      unitRef="U001">18900000</us-gaap:PaymentsToAcquireBusinessesGross>
    <usph:BusinessAcquisitionPayableToShareholdersOfSeller
      contextRef="c20190411_BusinessAcquisitionAxis_AprilTwoThousandNineteenAcquisitionMember"
      decimals="-5"
      id="Fact_b88c3caad01d4c9f8339212d6929314d"
      unitRef="U001">500000</usph:BusinessAcquisitionPayableToShareholdersOfSeller>
    <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued
      contextRef="c20190411_BusinessAcquisitionAxis_AprilTwoThousandNineteenAcquisitionMember"
      decimals="-5"
      id="Fact_8645919ffc0f4251a069bf7682728b2f"
      unitRef="U001">4000000.0</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c20190411_BusinessAcquisitionAxis_AprilTwoThousandNineteenAcquisitionMember"
      decimals="3"
      id="Fact_f7495f017ef34730a32152fa21cee643"
      unitRef="U005">0.055</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_7ebc4389c00540a9997a48ce11a451fd"
      unitRef="U001">890000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="c20190411to20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_a9bd169930b446c6aabd97b8503b9e92"
      unitRef="U001">18428000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="c20190930to20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_5caa5c1496224092953567fc37f46c5c"
      unitRef="U001">12170000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="c20190101to20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_3820623257be4d75958716daf5e6a83f"
      unitRef="U001">30598000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <usph:BusinessAcquisitionPayableToShareholdersOfSeller
      contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_97c36c006efd4508940b439ef40e5fd4"
      unitRef="U001">485000</usph:BusinessAcquisitionPayableToShareholdersOfSeller>
    <usph:BusinessAcquisitionPayableToShareholdersOfSeller
      contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_887f58f0b6b14343a0c101e38ad063f5"
      unitRef="U001">0</usph:BusinessAcquisitionPayableToShareholdersOfSeller>
    <usph:BusinessAcquisitionPayableToShareholdersOfSeller
      contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_5750ed2f7dd0447699bbdacd43dfe0a1"
      unitRef="U001">485000</usph:BusinessAcquisitionPayableToShareholdersOfSeller>
    <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued
      contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_71db7b39649a460f8cbeab4608e180da"
      unitRef="U001">4000000</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
    <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued
      contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_975faa083fb54489ab87d7031f5819bc"
      unitRef="U001">300000</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
    <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued
      contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_d7790b95065e483984fd48c5746c9485"
      unitRef="U001">4300000</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
    <usph:PaymentsToAcquireBusinessesConsideration
      contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_69f109e55bc142d7adbb5f8d48c32af4"
      unitRef="U001">22913000</usph:PaymentsToAcquireBusinessesConsideration>
    <usph:PaymentsToAcquireBusinessesConsideration
      contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_c82e0cdb0a47486d9eebc40bc01e7f53"
      unitRef="U001">12470000</usph:PaymentsToAcquireBusinessesConsideration>
    <usph:PaymentsToAcquireBusinessesConsideration
      contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_caef6a914d5a427bade4c185cb3c7e10"
      unitRef="U001">35383000</usph:PaymentsToAcquireBusinessesConsideration>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_eee67263780a49acaa0581ec533a3e2a"
      unitRef="U001">1641000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_621a82666ed642d9ba9757af756b55a8"
      unitRef="U001">650000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_34d6552bbfed48e68b6ea25e4780c4fe"
      unitRef="U001">2291000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets
      contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_3b1220179ecd4076b3fbc66ee0581ec9"
      unitRef="U001">848000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets
      contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_e9734a1bf0d64ea589d20dbcac27b227"
      unitRef="U001">394000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets
      contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_d82c91f477494f59ae77862359e74789"
      unitRef="U001">1242000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_8cff895473e241e59d08ae7680b476bc"
      unitRef="U001">-2978000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_79d2a1744e4f432fae7bb19628341aca"
      unitRef="U001">-191000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_aafb5ad8a15a4be58dd750bce359549c"
      unitRef="U001">-3169000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <usph:BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset
      contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_1c91e22e04a04be59bf9c144d53a2b33"
      unitRef="U001">-489000</usph:BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset>
    <usph:BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset
      contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_2cf7bb08fb2941d9a675563050f8d65b"
      unitRef="U001">853000</usph:BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset>
    <usph:BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset
      contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_1935f97c2fb7488380293114c64da9bc"
      unitRef="U001">364000</usph:BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset>
    <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships
      contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_f4ccac10433342e882be0539ab3cc980"
      unitRef="U001">3400000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships>
    <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships
      contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_619f046a6fd44300bef3988cba09df5d"
      unitRef="U001">2600000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships>
    <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships
      contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_a594f8c9d56c4369870c95ee343976bc"
      unitRef="U001">6000000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships>
    <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements
      contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_cf8bc979288c40a7972a4f53552b1ec9"
      unitRef="U001">250000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements>
    <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements
      contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_2fbcfb6519264127bc3d9ecbf691956a"
      unitRef="U001">270000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements>
    <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements
      contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_644347ef1709479390f677ee9ad52093"
      unitRef="U001">520000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements>
    <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename
      contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_6d1cfd3236f143b99ad407ad2c842c35"
      unitRef="U001">1300000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename>
    <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename
      contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_3a3cca8d04ea4135b82dd10e71ec5a2c"
      unitRef="U001">740000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename>
    <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename
      contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_9b6b4f5601fc4b88a2660d9bb08f2b7f"
      unitRef="U001">2040000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_69726b880894406db2f8a42ee390913d"
      unitRef="U001">18452000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_76b8e6ad46874e0fa7bdc985ad270524"
      unitRef="U001">14237000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_b54cb154402849b3ac75f20b20009ab3"
      unitRef="U001">32689000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests
      contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_4aa84586d91a445394a1e77ae4ad8e6a"
      unitRef="U001">0</usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests>
    <usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests
      contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_5528639f17314b21b3424b6aae8df023"
      unitRef="U001">6230000</usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests>
    <usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests
      contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_94a9d235bbfe4d16802371f21e5cfc4a"
      unitRef="U001">6230000</usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests>
    <usph:PaymentsToAcquireBusinessesConsideration
      contextRef="c20190411_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-3"
      id="Fact_0146285d8d254416a7685fa0372d43c7"
      unitRef="U001">22913000</usph:PaymentsToAcquireBusinessesConsideration>
    <usph:PaymentsToAcquireBusinessesConsideration
      contextRef="c20190930_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_9d8ec51540754a98a640e58301dc6d10"
      unitRef="U001">12470000</usph:PaymentsToAcquireBusinessesConsideration>
    <usph:PaymentsToAcquireBusinessesConsideration
      contextRef="c20191231_BusinessAcquisitionAxis_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-3"
      id="Fact_014c586bbc124c9f8465e1b9177bcf03"
      unitRef="U001">35383000</usph:PaymentsToAcquireBusinessesConsideration>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20180831_BusinessAcquisitionAxis_August2018AcquisitionMember"
      decimals="2"
      id="Fact_937e3830bd704aa696d2f8d440f8f775"
      unitRef="U005">0.70</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20180831to20180831_BusinessAcquisitionAxis_August2018AcquisitionMember"
      decimals="INF"
      id="Fact_586b04b8d4d3474489f54d609c7c4539"
      unitRef="U007">4</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20180831_BusinessAcquisitionAxis_August2018AcquisitionMember"
      decimals="2"
      id="Fact_9e30a4eeb49a4d5ab0942a1a69bb2c7f"
      unitRef="U005">0.70</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="c20180831to20180831_BusinessAcquisitionAxis_August2018AcquisitionMember"
      decimals="-5"
      id="Fact_d700af96fcb745bebb4ebae8da88b659"
      unitRef="U001">7300000</us-gaap:PaymentsToAcquireBusinessesGross>
    <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued
      contextRef="c20180831_BusinessAcquisitionAxis_August2018AcquisitionMember"
      decimals="-5"
      id="Fact_7aaa1a13bb3c4b84a3a9b7a77ea297b5"
      unitRef="U001">400000</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
    <usph:BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration
      contextRef="c20180831to20180831_BusinessAcquisitionAxis_August2018AcquisitionMember"
      decimals="INF"
      id="Fact_ad4a9d9d6d3844189d496246cde3ad91"
      unitRef="U010">2</usph:BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration>
    <us-gaap:DebtInstrumentAnnualPrincipalPayment
      contextRef="c20180831_BusinessAcquisitionAxis_August2018AcquisitionMember_StatementScenarioAxis_AugustTwoThousandNineteenMember"
      decimals="0"
      id="Fact_3f5f1f5a01cd4559aab746b2ca08444e"
      unitRef="U001">200000</us-gaap:DebtInstrumentAnnualPrincipalPayment>
    <us-gaap:DebtInstrumentAnnualPrincipalPayment
      contextRef="c20180831_BusinessAcquisitionAxis_August2018AcquisitionMember_StatementScenarioAxis_AugustTwoThousandTwentyMember"
      decimals="0"
      id="Fact_3a43b50e52f84c6a9fd361e3761dc9f4"
      unitRef="U001">200000</us-gaap:DebtInstrumentAnnualPrincipalPayment>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20180430_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="2"
      id="Fact_747f09436dca419e94907ea697c31aa7"
      unitRef="U005">0.65</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20180430_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="2"
      id="Fact_f44994f73b1a4be1bde963730300b54a"
      unitRef="U005">0.65</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="c20180430to20180430_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="-5"
      id="Fact_c89822b9024e4e4d8432377978e816f5"
      unitRef="U001">8600000</us-gaap:PaymentsToAcquireBusinessesGross>
    <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued
      contextRef="c20180430_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="0"
      id="Fact_71fb14386fb440f8b03aabcceecd00cf"
      unitRef="U001">400000</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
    <usph:NumberOfBusinessesMerged
      contextRef="c20180430to20180430_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="INF"
      id="Fact_05dfc44e2d7c4b45a906498e5bc48b14"
      unitRef="U011">2</usph:NumberOfBusinessesMerged>
    <usph:PercentageOfCombinedBusinessInterestOwned
      contextRef="c20180430to20180430_BusinessAcquisitionAxis_LeadingProviderOfIndustrialInjuryPreventionMember"
      decimals="4"
      id="Fact_c7a8cf2d85f544c694aa688fc95cb935"
      unitRef="U005">0.5945</usph:PercentageOfCombinedBusinessInterestOwned>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="c20180101to20181231_BusinessAcquisitionAxis_AcquisitionOfFiveClinicPracticesMember"
      decimals="INF"
      id="Fact_3f32217e494847779b3c1d8453c3a06d"
      unitRef="U007">5</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="c20180101to20181231_BusinessAcquisitionAxis_AcquisitionOfFiveClinicPracticesMember"
      decimals="-5"
      id="Fact_b682b95ebdac4d5abfb31ed27f89ab0c"
      unitRef="U001">1000000.0</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="c20180101to20181231_BusinessAcquisitionAxis_AcquisitionOfFiveClinicPracticesMember"
      decimals="0"
      id="Fact_c0aeb2c5683b42adaa3b0bdc6a67aef5"
      unitRef="U001">850000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued
      contextRef="c20181231_BusinessAcquisitionAxis_AcquisitionOfFiveClinicPracticesMember"
      decimals="0"
      id="Fact_108a3c6c32f24864a6031b3e0e18aefc"
      unitRef="U001">150000</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c20181231_BusinessAcquisitionAxis_AcquisitionOfFiveClinicPracticesMember_StatementScenarioAxis_AugustTwoThousandNineteenMember"
      decimals="3"
      id="Fact_a48ecd5a8c024fdda960774e2b9928b4"
      unitRef="U005">0.045</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="c20180430to20180430"
      decimals="-3"
      id="Fact_a3e51969ca0f4e00ae14106e81e6d1c4"
      unitRef="U001">372000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="c20180430to20180430"
      decimals="-3"
      id="Fact_a7eae685111448d385f635bff4c72a92"
      unitRef="U001">16367000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued
      contextRef="c20180430"
      decimals="-3"
      id="Fact_f1f3884cc4ab4d5b851733be8f204f28"
      unitRef="U001">950000</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
    <usph:PaymentsToAcquireBusinessesConsideration
      contextRef="c20180430"
      decimals="-3"
      id="Fact_5e456a02d1664d2d881c3d17b5461f15"
      unitRef="U001">17317000</usph:PaymentsToAcquireBusinessesConsideration>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="c20180430"
      decimals="-3"
      id="Fact_94d47e04479f4382bee778eefa658517"
      unitRef="U001">1633000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets
      contextRef="c20180430"
      decimals="-3"
      id="Fact_52f0fd903b3747e2a8beaeb40614dbf8"
      unitRef="U001">305000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="c20180430"
      decimals="-3"
      id="Fact_2a3cf53d95e942fb88945c19980eebef"
      unitRef="U001">-525000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <usph:BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset
      contextRef="c20180430"
      decimals="-3"
      id="Fact_2575a5505ca745ce8e8ccaaede4f84bb"
      unitRef="U001">1413000</usph:BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset>
    <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships
      contextRef="c20180430"
      decimals="-3"
      id="Fact_5ccfac19cb4a452bb0830ec063da4a2d"
      unitRef="U001">2926000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships>
    <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements
      contextRef="c20180430"
      decimals="-3"
      id="Fact_f276473a887d4495bac2a5c4f4f7b483"
      unitRef="U001">298000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements>
    <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename
      contextRef="c20180430"
      decimals="-3"
      id="Fact_9a3c7be172ed488b97aea96ebdf90652"
      unitRef="U001">990000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="c20180430"
      decimals="-3"
      id="Fact_f823fd9ea9e34c9aa5488b9d66f69fd5"
      unitRef="U001">19835000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests
      contextRef="c20180430"
      decimals="-3"
      id="Fact_642bed6482a648aca23c9beae41e9433"
      unitRef="U001">8145000</usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests>
    <usph:PaymentsToAcquireBusinessesConsideration
      contextRef="c20180430"
      decimals="-3"
      id="Fact_9f9a36d8d34c4eedaf9299b5173eef27"
      unitRef="U001">17317000</usph:PaymentsToAcquireBusinessesConsideration>
    <usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife
      contextRef="c20200101to20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember"
      id="Fact_77705a39aaf74c1cab4032e9a344912d">P11Y</usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife>
    <usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife
      contextRef="c20200101to20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"
      id="Fact_3e5827b618f44c66985365b15a91851a">P6Y</usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife>
    <usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife
      contextRef="c20190101to20191231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember"
      id="Fact_2c53ee24d1ea4569a1e916e32d301dc9">P10Y6M14D</usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife>
    <usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife
      contextRef="c20180101to20181231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember"
      id="Fact_56ec0823df464715850fe5f33d0dd915">P10Y1M6D</usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife>
    <usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife
      contextRef="c20190101to20191231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"
      id="Fact_044942dc07ba4597866c3f362288c218">P6Y</usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife>
    <usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife
      contextRef="c20180101to20181231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"
      id="Fact_3036c0cb73b84dbc894058b4e16a0b9a">P5Y1M28D</usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:MinorityInterestDisclosureTextBlock
      contextRef="c20200101to20201231"
      id="Text_a8d7415ad90d4efab2fc857372c8e3a1">
&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;4. Acquisitions and Sale of Non-Controlling Interests&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt;During &lt;/span&gt;2020,&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; the Company acquired additional interests in &lt;/span&gt;five&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; partnerships which are included in non-controlling interest. The additional interests purchased in each of the partnerships ranged from &lt;/span&gt;20%&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; to &lt;/span&gt;35%&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt;. The aggregated purchase price for these acquired interests was &lt;/span&gt;$0.3 million&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt;. The Company sold an interest in a partnership for &lt;/span&gt;$0.1 million&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt;.&lt;/span&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt;Also during &lt;/span&gt;2020,&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; the Company sold &lt;/span&gt;14&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; previously closed clinics. The aggregate sales price was &lt;/span&gt;$1.1 million&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt;, of which &lt;/span&gt;$0.7 million&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; was paid in cash and &lt;/span&gt;$0.4 million&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; in a note receivable, payable in &lt;/span&gt;two&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; equal installments of principal and any accrued interest on June &lt;/span&gt;15,&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt;&#160;&lt;/span&gt;2021&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; and &lt;/span&gt;2022.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt;During &lt;/span&gt;2019,&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; the Company acquired additional interests in &lt;/span&gt;four&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; partnerships which are included in non-controlling interest. The additional interests purchased in each of the partnerships ranged from &lt;/span&gt;1%&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; to &lt;/span&gt;20%&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt;. Also in &lt;/span&gt;2019,&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; the Company sold a &lt;/span&gt;1%&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; interest in a partnership. The net after-tax difference between the payments and the portion of undistributed earnings of &lt;/span&gt;$196,000&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; was credited to additional paid-in capital. &lt;/span&gt;&lt;/div&gt;
</us-gaap:MinorityInterestDisclosureTextBlock>
    <usph:NumberOfPartnershipInWhichInterestAcquired
      contextRef="c20200101to20201231"
      decimals="INF"
      id="Fact_571d5cafe15b4c03b079e7ae1be3fcb7"
      unitRef="U015">5</usph:NumberOfPartnershipInWhichInterestAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20201231_RangeAxis_MinimumMember"
      decimals="2"
      id="Fact_48968455fbfd49629e368b7d4e1ae124"
      unitRef="U005">0.20</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20201231_RangeAxis_MaximumMember"
      decimals="2"
      id="Fact_c3b0a872b94148d3bba14f5b3a5ca013"
      unitRef="U005">0.35</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent
      contextRef="c20200101to20201231"
      decimals="-5"
      id="Fact_e3986f0991eb44859032260278303231"
      unitRef="U001">300000</us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent>
    <us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent
      contextRef="c20200101to20201231"
      decimals="-5"
      id="Fact_c22190a53f9446fea163fb2427e73fd8"
      unitRef="U001">100000</us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent>
    <usph:NumberOfClosedClinicsSold
      contextRef="c20201231"
      decimals="0"
      id="Fact_66733f1d8a044d4a979397dcb1a572f4"
      unitRef="U007">14</usph:NumberOfClosedClinicsSold>
    <usph:AggregateSalePriceOfCinics
      contextRef="c20200101to20201231"
      decimals="-5"
      id="Fact_786d6dc2d40a4dc88a93fb49990648fa"
      unitRef="U001">1100000</usph:AggregateSalePriceOfCinics>
    <usph:CashReceivedRelatedToSaleOfClinics
      contextRef="c20201231"
      decimals="-5"
      id="Fact_1af9b1b3c9a443b6891fc2bcb77a1ece"
      unitRef="U001">700000</usph:CashReceivedRelatedToSaleOfClinics>
    <usph:NoteReceivableRelatedToSaleOfClinics
      contextRef="c20201231"
      decimals="-5"
      id="Fact_3354ba4cc819469e887c033c2fd87d22"
      unitRef="U001">400000</usph:NoteReceivableRelatedToSaleOfClinics>
    <usph:NumberOfInstallmentsForNoteReceivableInSaleConsideration
      contextRef="c20200101to20201231"
      decimals="INF"
      id="Fact_523e9531873947e9bc0f16bedeb1d0df"
      unitRef="U010">2</usph:NumberOfInstallmentsForNoteReceivableInSaleConsideration>
    <usph:NumberOfPartnershipInWhichInterestAcquired
      contextRef="c20190101to20191231"
      decimals="INF"
      id="Fact_50d04884e4be468ba53c29674657e892"
      unitRef="U015">4</usph:NumberOfPartnershipInWhichInterestAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20191231_RangeAxis_MinimumMember"
      decimals="2"
      id="Fact_bb66f6e8eaee4ac29bc0fd717646a0f1"
      unitRef="U005">0.01</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c20191231_RangeAxis_MaximumMember"
      decimals="2"
      id="Fact_098c95bd7e65435ab46da9739f2a8bda"
      unitRef="U005">0.20</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <usph:SaleOfNoncontrollingInterestPercentageInPartnershipOne
      contextRef="c20190101to20191231"
      decimals="2"
      id="Fact_2f7defd77c614d86895a0d756511464e"
      unitRef="U005">0.01</usph:SaleOfNoncontrollingInterestPercentageInPartnershipOne>
    <usph:TaxEffectOnSaleOfNoncontrollingInterest
      contextRef="c20190101to20191231"
      decimals="0"
      id="Fact_8e2445e29d264dff836c129be1e78bca"
      unitRef="U001">196000</usph:TaxEffectOnSaleOfNoncontrollingInterest>
    <usph:RedeemableNonControllingInterestTextBlock
      contextRef="c20200101to20201231"
      id="Text_916056b9f1d7413ebf65c0b9453fee7f">
&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;5. Redeemable Non-Controlling Interest&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Since October 2017, when the Company acquires a majority interest (the &#x201c;Acquisition&#x201d;) in a physical therapy clinic business (referred to as &#x201c;Therapy Practice&#x201d;), these Acquisitions occur in a series of steps which are described below.&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" id="zc7bdc62a54e54a708109fb2fb4f94a6d" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;
  &lt;tr&gt;
    &lt;td style="width: 18pt;"/&gt;
    &lt;td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1.&lt;/td&gt;
    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Prior to the Acquisition, the Therapy Practice exists as a separate legal entity (the &#x201c;Seller Entity&#x201d;). The Seller Entity is owned by one or more individuals (the &#x201c;Selling Shareholders&#x201d;) most of whom are physical therapists that work in the Therapy Practice and provide physical therapy services to patients.&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" id="z99217b321d1b4616ac247e23558b81cb" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;
  &lt;tr&gt;
    &lt;td style="width: 18pt;"/&gt;
    &lt;td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2.&lt;/td&gt;
    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;In conjunction with the Acquisition, the Seller Entity contributes the Therapy Practice into a newly-formed limited partnership (&#x201c;NewCo&#x201d;), in exchange for one hundred percent (100%) of the limited and general partnership interests in NewCo. Therefore, in this step, NewCo becomes a wholly-owned subsidiary of the Seller Entity.&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" id="z0671445f15e345a8bbe848867376c4df" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;
  &lt;tr&gt;
    &lt;td style="width: 18pt;"/&gt;
    &lt;td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;3.&lt;/td&gt;
    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company enters into an agreement (the &#x201c;Purchase Agreement&#x201d;) to acquire from the Seller Entity a majority (ranges from 50% to 90%) of the limited partnership interest and in &lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;span style="text-decoration: underline;"&gt;all&lt;/span&gt;&lt;/span&gt; cases 100% of the general partnership interest in NewCo. The Company does not purchase 100% of the limited partnership interest because the Selling Shareholders, through the Seller Entity, want to maintain an ownership percentage. The consideration for the Acquisition is primarily payable in the form of cash at closing and a small two-year note in lieu of an escrow (the &#x201c;Purchase Price&#x201d;). The Purchase Agreement does not contain any future earn-out or other contingent consideration that is payable to the Seller Entity or the Selling Shareholders.&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" id="ze02633183fb54390b58ff1885d4e4783" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;
  &lt;tr&gt;
    &lt;td style="width: 18pt;"/&gt;
    &lt;td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;4.&lt;/td&gt;
    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company and the Seller Entity also execute a partnership agreement (the &#x201c;Partnership Agreement&#x201d;) for NewCo that sets forth the rights and obligations of the limited and general partners of NewCo. After the Acquisition, the Company is the general partner of NewCo.&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" id="z7a526d32e09d4dddad04019070607f9f" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;
  &lt;tr&gt;
    &lt;td style="width: 18pt;"/&gt;
    &lt;td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;5.&lt;/td&gt;
    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;As noted above, the Company does not purchase 100% of the limited partnership interests in NewCo and the Seller Entity retains a portion of the limited partnership interest in NewCo (&#x201c;Seller Entity Interest&#x201d;).&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" id="zb058bf3e3d2847d5aedd1d3b688d4498" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;
  &lt;tr&gt;
    &lt;td style="width: 18pt;"/&gt;
    &lt;td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;6.&lt;/td&gt;
    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;In most cases, some or all of the Selling Shareholders enter into an employment agreement (the &#x201c;Employment Agreement&#x201d;) with NewCo with an initial term that ranges from &lt;span style="-sec-ix-hidden:Fact_52fb956c20c94f01b9b7ffcd0435f795"&gt;three&lt;/span&gt; to five years (the &#x201c;Employment Term&#x201d;), with automatic one-year renewals, unless employment is terminated prior to the end of the Employment Term. As a result, a Selling Shareholder becomes an employee (&#x201c;Employed Selling Shareholder&#x201d;) of NewCo. The employment of an Employed Selling Shareholder can be terminated by the Employed Selling Shareholder or NewCo, with or without cause, at any time. In a few situations, a Selling Shareholder does not become employed by NewCo and is not involved with NewCo following the closing; in those situations, such Selling Shareholders sell their entire ownership interest in the Seller Entity as of the closing of the Acquisition.&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" id="zb9ec36386a1e4b0085e09d415fa38596" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;
  &lt;tr&gt;
    &lt;td style="width: 18pt;"/&gt;
    &lt;td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;7.&lt;/td&gt;
    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The compensation of each Employed Selling Shareholder is specified in the Employment Agreement and is customary and commensurate with his or her responsibilities based on other employees in similar capacities within NewCo, the Company and the industry.&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" id="z6c026b3d9d774cd0bca196d3492506cd" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;
  &lt;tr&gt;
    &lt;td style="width: 18pt;"/&gt;
    &lt;td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;8.&lt;/td&gt;
    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company and the Selling Shareholder (including both Employed Selling Shareholders and Selling Shareholders not employed by NewCo) execute a non-compete agreement (the &#x201c;Non-Compete Agreement&#x201d;) which restricts the Selling Shareholder from engaging in competing business activities for a specified period of time (the &#x201c;Non-Compete Term&#x201d;). A Non-Compete Agreement is executed with the Selling Shareholders in all cases. That is, even if the Selling Shareholder does not become an Employed Selling Shareholder, the Selling Shareholder is restricted from engaging in a competing business during the Non-Compete Term.&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" id="z1de0bf8dd2dc459597d038135831c4d3" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;
  &lt;tr&gt;
    &lt;td style="width: 18pt;"/&gt;
    &lt;td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;9.&lt;/td&gt;
    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Non-Compete Term commences as of the date of the Acquisition and expires on the &lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;span style="text-decoration: underline;"&gt;later&lt;/span&gt;&lt;/span&gt; of:&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" id="zda65c3f5f9174cc199fe8dd67bd83ca9" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;
  &lt;tr&gt;
    &lt;td style="width: 36pt;"/&gt;
    &lt;td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;a.&lt;/td&gt;
    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Two years after the date an Employed Selling Shareholders&#x2019; employment is terminated (if the Selling Shareholder becomes an Employed Selling Shareholder) or&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" id="zfb76a3e74897489fa93180854bcb8faa" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;
  &lt;tr&gt;
    &lt;td style="width: 36pt;"/&gt;
    &lt;td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;b.&lt;/td&gt;
    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="-sec-ix-hidden:Fact_c128a6eff4b84ab0bfde32533264356c"&gt;Five&lt;/span&gt; to six years from the date of the Acquisition, as defined in the Non-Compete Agreement, regardless of whether the Selling Shareholder is employed by NewCo.&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" id="zbc85b6963e4d434897715db0819242a0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;
  &lt;tr&gt;
    &lt;td style="width: 18pt;"/&gt;
    &lt;td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;10.&lt;/td&gt;
    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Non-Compete Agreement applies to a restricted region which is defined as a 15-mile radius from the Therapy Practice. That is, an Employed Selling Shareholder is permitted to engage in competing businesses or activities outside the 15-mile radius (after such Employed Selling Shareholder no longer is employed by NewCo) and a Selling Shareholder who is not employed by NewCo immediately is permitted to engage in the competing business or activities outside the 15-mile radius.&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 18pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Partnership Agreement contains provisions for the redemption of the Seller Entity Interest, either at the option of the Company (the &#x201c;Call Right&#x201d;) or at the option of the Seller Entity (the &#x201c;Put Right&#x201d;) as follows:&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" id="zd97299e0990f4b66ad809445b4244966" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;
  &lt;tr&gt;
    &lt;td style="width: 18pt;"/&gt;
    &lt;td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1.&lt;/td&gt;
    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Put Right&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" id="z67d0c7c361bf43cc85f4d8b2b3482dd4" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;
  &lt;tr&gt;
    &lt;td style="width: 36pt;"/&gt;
    &lt;td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;a.&lt;/td&gt;
    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;In the event that any Selling Shareholder&#x2019;s employment is terminated under certain circumstances prior to the fifth anniversary of the Closing Date, the Seller Entity thereafter may have an irrevocable right to cause the Company to purchase from Seller Entity the Terminated Selling Shareholder&#x2019;s Allocable Percentage of Seller Entity&#x2019;s Interest at the purchase price described in &#x201c;3&#x201d; below.&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" id="z81aac4917b12463886deee6aa25f1d93" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;
  &lt;tr&gt;
    &lt;td style="width: 36pt;"/&gt;
    &lt;td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;b.&lt;/td&gt;
    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;In the event that any Selling Shareholder is not employed by NewCo as of the fifth anniversary of the Closing Date and the Company has not exercised its Call Right with respect to the Terminated Selling Shareholder&#x2019;s Allocable Percentage of Seller Entity&#x2019;s Interest, Seller Entity thereafter shall have the Put Right to cause the Company to purchase from Seller Entity the Terminated Selling Shareholder&#x2019;s Allocable Percentage of Seller Entity&#x2019;s Interest at the purchase price described in &#x201c;3&#x201d; below.&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" id="z7901e88d85124eb88f96525cee10b616" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;
  &lt;tr&gt;
    &lt;td style="width: 36pt;"/&gt;
    &lt;td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;c.&lt;/td&gt;
    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;In the event that any Selling Shareholder&#x2019;s employment with NewCo is terminated for any reason on or after the fifth anniversary of the Closing Date, the Seller Entity shall have the Put Right, and upon the exercise of the Put Right, the Terminated Selling Shareholder&#x2019;s Allocable Percentage of Seller Entity&#x2019;s Interest shall be redeemed by the Company at the purchase price described in &#x201c;3&#x201d; below.&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" id="ze305be984ed843dda348b7fbea98691b" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;
  &lt;tr&gt;
    &lt;td style="width: 18pt;"/&gt;
    &lt;td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2.&lt;/td&gt;
    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Call Right&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" id="z0a51ba759e7e4ab7af84d58fff32e8c2" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;
  &lt;tr&gt;
    &lt;td style="width: 36pt;"/&gt;
    &lt;td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;a.&lt;/td&gt;
    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;If any Selling Shareholder&#x2019;s employment by NewCo is terminated prior to the fifth anniversary of the Closing Date, the Company thereafter shall have an irrevocable right to purchase from Seller Entity the Terminated Selling Shareholder&#x2019;s Allocable Percentage of Seller Entity&#x2019;s Interest, in each case at the purchase price described in &#x201c;3&#x201d; below.&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" id="z05b9ea60733547efbda8408402826246" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;
  &lt;tr&gt;
    &lt;td style="width: 36pt;"/&gt;
    &lt;td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;b.&lt;/td&gt;
    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;In the event that any Selling Shareholder&#x2019;s employment with NewCo is terminated for any reason on or after the fifth anniversary of the Closing Date, the Company shall have the Call Right, and upon the exercise of the Call Right, the Terminated Selling Shareholder&#x2019;s Allocable Percentage of Seller Entity&#x2019;s Interest shall be redeemed by the Company at the purchase price described in &#x201c;3&#x201d; below.&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" id="zd051b3679ba0404d967210cec70f1639" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;
  &lt;tr&gt;
    &lt;td style="width: 18pt;"/&gt;
    &lt;td style="width: 22.5pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;3.&lt;/td&gt;
    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;For the Put Right and the Call Right, the purchase price is derived from a formula based on a specified multiple of NewCo&#x2019;s trailing twelve months of earnings before interest, taxes, depreciation, amortization, and the Company&#x2019;s internal management fee, plus an Allocable Percentage of any undistributed earnings of NewCo (the &#x201c;Redemption Amount&#x201d;). NewCo&#x2019;s earnings are distributed monthly based on available cash within NewCo&#x37e; therefore, the undistributed earnings amount is small, if any.&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" id="zbff5a3f2289d41cf8510cf450726b116" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;
  &lt;tr&gt;
    &lt;td style="width: 18pt;"/&gt;
    &lt;td style="width: 22.5pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;4.&lt;/td&gt;
    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Purchase Price for the initial equity interest purchased by the Company is also based on the same specified multiple of the trailing twelve-month earnings that is used in the Put Right and the Call Right noted above.&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" id="z1528515d22304d02bf65e5b330c9ce23" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;
  &lt;tr&gt;
    &lt;td style="width: 18pt;"/&gt;
    &lt;td style="width: 22.5pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;5.&lt;/td&gt;
    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Put Right and the Call Right do not have an expiration date, but the Seller Entity Interest is not required to be purchased by the Company or sold by the Seller Entity.&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" id="z470f34023b2c4a63b1cd76aa3f152c47" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;
  &lt;tr&gt;
    &lt;td style="width: 18pt;"/&gt;
    &lt;td style="width: 22.5pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;6.&lt;/td&gt;
    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Put Right and the Call Right never apply to Selling Shareholders who do not become employed by NewCo, since the Company requires that such Selling Shareholders sell their entire ownership interest in the Seller Entity at the closing of the Acquisition.&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;An Employed Selling Shareholder&#x2019;s ownership of his or her equity interest in the Seller Entity predates the Acquisition and the Company&#x2019;s purchase of its partnership interest in NewCo. The Employment Agreement and the Non-Compete Agreement do not contain any provision to escrow or &#x201c;claw back&#x201d; the equity interest in the Seller Entity held by such Employed Selling Shareholder, nor the Seller Entity Interest in NewCo, in the event of a breach of the employment or non-compete terms. More specifically, even if the Employed Selling Shareholder is terminated for &#x201c;cause&#x201d; by NewCo, such Employed Selling Shareholder does not forfeit his or her right to his or her full equity interest in the Seller Entity and the Seller Entity does not forfeit its right to any portion of the Seller Entity Interest. The Company&#x2019;s only recourse against the Employed Selling Shareholder for breach of either the Employment Agreement or the Non-Compete Agreement is to seek damages and other legal remedies under such agreements. There are no conditions in any of the arrangements with an Employed Selling Shareholder that would result in a forfeiture of the equity interest held in the Seller Entity or of the Seller Entity Interest.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;For the year ended December 31, 2020, 2019 and 2018, the following table details the changes in the carrying amount (fair value) of the redeemable non-controlling interests (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="z5419bd02f8334e35b081255c66326369" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Year Ended&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2020&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2019&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;"&gt;December 31, 2018&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Beginning balance&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;137,750&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;133,943&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;102,572&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Operating results allocated to redeemable non-controlling interest partners&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;11,175&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;10,659&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;8,433&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Distributions to redeemable non-controlling interest partners&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(12,403&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(10,221&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(9,835&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Changes in the fair value of redeemable non-controlling interest&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,632&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;11,893&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;24,770&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Purchases of redeemable non-controlling interest&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(20,521&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(8,934&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;8,145&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Acquired interest&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;11,297&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;6,230&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Reduction of non-controlling interest due to sale of USPH partnership interest&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(6,132&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Sales of redeemable non-controlling interest - temporary equity&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,133&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,120&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Notes receivable related to sales of redeemable non-controlling interest - temporary equity&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(1,006&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(2,870&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(142&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Adjustments in notes receivable related to the the sales of redeemable non-controlling interest - temporary equity&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;283&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Other&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;62&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Ending balance&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;132,340&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;137,750&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;133,943&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 12pt;"&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The following table categorizes the carrying amount (fair value) of the redeemable non-controlling interests (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="z670c3e5c6ec64188aa3c22deb9e2062e" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2020&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2019&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;"&gt;December 31, 2018&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Contractual time period has lapsed but holder's employment has not been terminated&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;62,390&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;51,921&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;42,624&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Contractual time period has not lapsed and holder's employment has not been terminated&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;69,950&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;85,829&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;91,319&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Holder's employment has terminated and contractual time period has expired&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Holder's employment has terminated and contractual time period has not expired&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;132,340&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;137,750&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;133,943&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;
</usph:RedeemableNonControllingInterestTextBlock>
    <usph:BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed
      contextRef="c20201231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember"
      decimals="2"
      id="Fact_1a1318dd20ca489cb43d8aaca68dae86"
      unitRef="U005">1</usph:BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed>
    <usph:BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired
      contextRef="c20201231_BusinessAcquisitionAxis_TherapyPracticeMember_RangeAxis_MinimumMember"
      decimals="2"
      id="Fact_da752b6ddd8142a8bfc6819396778f7e"
      unitRef="U005">0.50</usph:BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired>
    <usph:BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired
      contextRef="c20201231_BusinessAcquisitionAxis_TherapyPracticeMember_RangeAxis_MaximumMember"
      decimals="2"
      id="Fact_22dfd480522e4db9b95208fe2e9660bf"
      unitRef="U005">0.90</usph:BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired>
    <usph:BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired
      contextRef="c20201231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember"
      decimals="2"
      id="Fact_420cd14c37a94b7e921233be19bd4bb7"
      unitRef="U005">1</usph:BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired>
    <usph:NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder
      contextRef="c20200101to20201231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember"
      id="Fact_34e3f17457974e71897a30be5c9e03d3">P2Y</usph:NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder>
    <usph:TermOfEmploymentAgreement
      contextRef="c20200101to20201231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember_RangeAxis_MaximumMember"
      id="Fact_c3d56d245a9a49149bccd66c95e0160b">P5Y</usph:TermOfEmploymentAgreement>
    <usph:EmploymentAgreementRenewalTerm
      contextRef="c20200101to20201231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember"
      id="Fact_e8ec4f79f6c34537889001efa0a159c1">P1Y</usph:EmploymentAgreementRenewalTerm>
    <usph:BusinessAcquisitionConsiderationPayableTermOfNote
      contextRef="c20200101to20201231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember"
      id="Fact_a68d9aeb6bae459185d01b8cffffabfc">P2Y</usph:BusinessAcquisitionConsiderationPayableTermOfNote>
    <usph:NonCompeteAgreementBasicTerm
      contextRef="c20200101to20201231_BusinessAcquisitionAxis_TherapyPracticeMember_ConsolidatedEntitiesAxis_SubsidiariesMember_RangeAxis_MaximumMember"
      id="Fact_0b29e1aaafe4464896629e8ad8086da5">P6Y</usph:NonCompeteAgreementBasicTerm>
    <us-gaap:RedeemableNoncontrollingInterestTableTextBlock
      contextRef="c20200101to20201231"
      id="Text_f2c365726986418489fc737fbb6630c2">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;For the year ended December 31, 2020, 2019 and 2018, the following table details the changes in the carrying amount (fair value) of the redeemable non-controlling interests (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="z5419bd02f8334e35b081255c66326369" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Year Ended&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2020&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2019&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;"&gt;December 31, 2018&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Beginning balance&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;137,750&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;133,943&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;102,572&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Operating results allocated to redeemable non-controlling interest partners&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;11,175&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;10,659&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;8,433&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Distributions to redeemable non-controlling interest partners&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(12,403&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(10,221&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(9,835&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Changes in the fair value of redeemable non-controlling interest&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,632&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;11,893&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;24,770&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Purchases of redeemable non-controlling interest&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(20,521&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(8,934&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;8,145&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Acquired interest&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;11,297&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;6,230&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Reduction of non-controlling interest due to sale of USPH partnership interest&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(6,132&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Sales of redeemable non-controlling interest - temporary equity&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,133&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,120&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Notes receivable related to sales of redeemable non-controlling interest - temporary equity&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(1,006&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(2,870&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(142&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Adjustments in notes receivable related to the the sales of redeemable non-controlling interest - temporary equity&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;283&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Other&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;62&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Ending balance&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;132,340&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;137,750&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;133,943&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;
</us-gaap:RedeemableNoncontrollingInterestTableTextBlock>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="c20191231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_5a76fa7b98a84fc9a2a24a534f65190d"
      unitRef="U001">137750000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="c20181231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_ece3958ebeca42548a338b94565cad37"
      unitRef="U001">133943000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="c20171231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_f6a5a7d0772d462d8357854f8883e0f1"
      unitRef="U001">102572000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <usph:NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity
      contextRef="c20200101to20201231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_9a6b8c3a1d854e20b5df13a649b3d320"
      unitRef="U001">11175000</usph:NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity>
    <usph:NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity
      contextRef="c20190101to20191231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_2da09f88ad02472da7bfdf583fc97811"
      unitRef="U001">10659000</usph:NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity>
    <usph:NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity
      contextRef="c20180101to20181231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_5fe7be01599645dea67dd0ed3cd3e450"
      unitRef="U001">8433000</usph:NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity>
    <usph:DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests
      contextRef="c20200101to20201231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_2a1c0939455b4b5abf53410ea6ec5cb0"
      unitRef="U001">12403000</usph:DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests>
    <usph:DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests
      contextRef="c20190101to20191231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_b68aa11263a641b8816705dee5e52891"
      unitRef="U001">10221000</usph:DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests>
    <usph:DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests
      contextRef="c20180101to20181231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_41132853fe304b9c935732f54f107f12"
      unitRef="U001">9835000</usph:DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="c20200101to20201231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_aed1beecbc634ba59611e365ce2d885c"
      unitRef="U001">4632000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="c20190101to20191231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_6abd629ff0704d95954d7801ff36e964"
      unitRef="U001">11893000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="c20180101to20181231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_63697d38ac99418ca85ac74312332d8d"
      unitRef="U001">24770000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:ProceedsFromPaymentsToMinorityShareholders
      contextRef="c20200101to20201231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_8c61cc1ef7fe4a0089d1eb2f0d5ba574"
      unitRef="U001">-20521000</us-gaap:ProceedsFromPaymentsToMinorityShareholders>
    <us-gaap:ProceedsFromPaymentsToMinorityShareholders
      contextRef="c20190101to20191231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_448f7571408b481ab9668e02a68c70ca"
      unitRef="U001">-8934000</us-gaap:ProceedsFromPaymentsToMinorityShareholders>
    <us-gaap:ProceedsFromPaymentsToMinorityShareholders
      contextRef="c20180101to20181231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_5141145e9da34c648ad5083ed7d0a20e"
      unitRef="U001">8145000</us-gaap:ProceedsFromPaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="c20200101to20201231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_21924acb9478434785e971558fdcbf6d"
      unitRef="U001">11297000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="c20190101to20191231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_098e40767d6142cf8d873c9cf18be3db"
      unitRef="U001">6230000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="c20180101to20181231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_88121a28841645dfad67912d099b96c3"
      unitRef="U001">0</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation
      contextRef="c20200101to20201231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_3f539441de10477db9c9f71e8244e963"
      unitRef="U001">0</us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation>
    <us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation
      contextRef="c20190101to20191231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_48920462589244f88037bf510aa881aa"
      unitRef="U001">6132000</us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation>
    <us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation
      contextRef="c20180101to20181231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_f668f2ac762c459f95f5c6bed6a3ae97"
      unitRef="U001">0</us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation>
    <usph:ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity
      contextRef="c20200101to20201231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_acbc9d6b397149a5a6c3a7128073f612"
      unitRef="U001">1133000</usph:ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity>
    <usph:ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity
      contextRef="c20190101to20191231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_cd049f4404f34adaa215ca44ccbdebc6"
      unitRef="U001">3120000</usph:ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity>
    <usph:ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity
      contextRef="c20180101to20181231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_655e8fc913f94399ac3718f2c330db54"
      unitRef="U001">0</usph:ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity>
    <usph:NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity
      contextRef="c20200101to20201231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_b2c9f94f2a4f4026a870858e75753fac"
      unitRef="U001">-1006000</usph:NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity>
    <usph:NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity
      contextRef="c20190101to20191231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_1714021036b74eddb561ecab891e7170"
      unitRef="U001">-2870000</usph:NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity>
    <usph:NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity
      contextRef="c20180101to20181231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_f93875de3fde4985abe3347a127f0dce"
      unitRef="U001">-142000</usph:NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity>
    <usph:DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity
      contextRef="c20200101to20201231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_b233bb99c57343958bd995a17ef0c887"
      unitRef="U001">283000</usph:DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity>
    <usph:DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity
      contextRef="c20190101to20191231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_d1fcaeed3b984b9fa25ccb94e052d8b4"
      unitRef="U001">0</usph:DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity>
    <usph:DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity
      contextRef="c20180101to20181231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_57c00d8e2a0e4e69a5e3c1fbb1472a56"
      unitRef="U001">0</usph:DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity>
    <us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
      contextRef="c20200101to20201231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_7e21524d892547d9b9744fa5a465c23c"
      unitRef="U001">0</us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable>
    <us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
      contextRef="c20190101to20191231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_73951aaa55d14f169db3ab5fdb6a9615"
      unitRef="U001">62000</us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable>
    <us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
      contextRef="c20180101to20181231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_e5a7990ad83244e98a8e659c27d11a70"
      unitRef="U001">0</us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="c20201231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_c4701da66a06471082111b7aa4397f70"
      unitRef="U001">132340000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="c20191231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_98ac0d6659294fbb9b8e9a38f1b20cef"
      unitRef="U001">137750000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="c20181231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_3332699507a347ccbf37d6321bf4c794"
      unitRef="U001">133943000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <usph:CarryingAmountOfRedeemableNonControllingInterestTableTextBlock
      contextRef="c20200101to20201231"
      id="Text_463160775cc94537b4cc96f2febf1880">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The following table categorizes the carrying amount (fair value) of the redeemable non-controlling interests (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="z670c3e5c6ec64188aa3c22deb9e2062e" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2020&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2019&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;"&gt;December 31, 2018&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Contractual time period has lapsed but holder's employment has not been terminated&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;62,390&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;51,921&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;42,624&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Contractual time period has not lapsed and holder's employment has not been terminated&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;69,950&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;85,829&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;91,319&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Holder's employment has terminated and contractual time period has expired&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Holder's employment has terminated and contractual time period has not expired&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;132,340&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;137,750&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;133,943&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;
</usph:CarryingAmountOfRedeemableNonControllingInterestTableTextBlock>
    <usph:ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated
      contextRef="c20201231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_8bc4b44826ba48269b7a8d568b8c7d63"
      unitRef="U001">62390000</usph:ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated>
    <usph:ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated
      contextRef="c20191231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_9c4b32eff00345fcb91f5c19e428514c"
      unitRef="U001">51921000</usph:ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated>
    <usph:ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated
      contextRef="c20181231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_579a9746333846dbb39d022db5f0e493"
      unitRef="U001">42624000</usph:ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated>
    <usph:ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated
      contextRef="c20201231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_b281676cbdca491a8b5b9129129c66e8"
      unitRef="U001">69950000</usph:ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated>
    <usph:ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated
      contextRef="c20191231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_6e76c1cd8e7e4105aa95aba7c789bd23"
      unitRef="U001">85829000</usph:ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated>
    <usph:ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated
      contextRef="c20181231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_552612b1c21245f0832fce8a9b5d9328"
      unitRef="U001">91319000</usph:ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated>
    <usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired
      contextRef="c20201231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_96c36c59dac04818874408aee1d90c31"
      unitRef="U001">0</usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired>
    <usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired
      contextRef="c20191231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_0d104ff03cc54acdae7f1b0eddb991fd"
      unitRef="U001">0</usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired>
    <usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired
      contextRef="c20181231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_f305be5bffa44ce5981729c4086dc559"
      unitRef="U001">0</usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired>
    <usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired
      contextRef="c20201231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_2cabd95407a04433bb6b16d972ff4f53"
      unitRef="U001">0</usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired>
    <usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired
      contextRef="c20191231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_870a60789574466d9b0ec742429fa77f"
      unitRef="U001">0</usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired>
    <usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired
      contextRef="c20181231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_2e4f0d398cd04f1ca216906a7d635127"
      unitRef="U001">0</usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="c20201231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_5f614ad42a7c4707a85ab8cf3bd493b5"
      unitRef="U001">132340000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="c20191231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_38ed846f3f2a406283ee34d43402fbc0"
      unitRef="U001">137750000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="c20181231_OwnershipAxis_RedeemableNonControllingInterestMember"
      decimals="-3"
      id="Fact_1d8dea1df0764cb182c62dc3808e0dfa"
      unitRef="U001">133943000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:GoodwillDisclosureTextBlock
      contextRef="c20200101to20201231"
      id="Text_837a74d49b5a45979c597d4040a01b09">
&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;6. Goodwill&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The changes in the carrying amount of goodwill as of December 31, 2020 and 2019 consisted of the following (in thousands):&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="z004ebbf23ace473ea8af3849451f0579" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Year Ended&lt;/div&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2020&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Year Ended&lt;/div&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2019&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Beginning balance&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;317,676&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;293,525&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Goodwill acquired&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;28,540&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;31,330&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Goodwill related to partnership interest sold&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(7,325&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Goodwill derecognition (write-off) related to closed clinics&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(1,859&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Goodwill adjustments for purchase price allocation of businesses acquired in prior year&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,289&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;146&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Ending balance&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;345,646&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;317,676&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;
</us-gaap:GoodwillDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="c20200101to20201231"
      id="Text_c0ec77a500854e33bd3bb739cea7a67b">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The changes in the carrying amount of goodwill as of December 31, 2020 and 2019 consisted of the following (in thousands):&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="z004ebbf23ace473ea8af3849451f0579" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Year Ended&lt;/div&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2020&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Year Ended&lt;/div&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2019&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Beginning balance&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;317,676&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;293,525&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Goodwill acquired&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;28,540&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;31,330&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Goodwill related to partnership interest sold&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(7,325&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Goodwill derecognition (write-off) related to closed clinics&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(1,859&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Goodwill adjustments for purchase price allocation of businesses acquired in prior year&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,289&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;146&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Ending balance&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;345,646&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;317,676&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;
</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="c20191231"
      decimals="-3"
      id="Fact_d7fb50520855431f8648223d4b18e9a4"
      unitRef="U001">317676000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="c20181231"
      decimals="-3"
      id="Fact_90cf0ec6c1744f6aabbe826ab165c074"
      unitRef="U001">293525000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_0937c87ddb664fec85b0dde3add6f291"
      unitRef="U001">28540000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_7fc1b8c0d6ac45449443b6b5d2fdab03"
      unitRef="U001">31330000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_592ec242b42f4855a09a0a56abf90d8a"
      unitRef="U001">0</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_809000cb37274e7d91af1422b1b9b3a2"
      unitRef="U001">7325000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_3eb54263f35e41e4a64e8a3393cdc0bf"
      unitRef="U001">1859000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_75604ceae3304bcfb3db16df7d27652b"
      unitRef="U001">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_28a97c67b27f4fd4902f7f5ff425d733"
      unitRef="U001">1289000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_619d719ed642458f9b291cd8b0cff6c2"
      unitRef="U001">146000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:Goodwill
      contextRef="c20201231"
      decimals="-3"
      id="Fact_b908772ccad44ce58167fc0546b0b6a4"
      unitRef="U001">345646000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="c20191231"
      decimals="-3"
      id="Fact_87a9cf975f0b4b2f89f20ae993729b16"
      unitRef="U001">317676000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsDisclosureTextBlock
      contextRef="c20200101to20201231"
      id="Text_0334ca8450ce45408725e592c37065ea">
&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;7. Intangible Assets, net&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Intangible assets, net as of December 31, 2020, 2019 and 2018 consisted of the following (in thousands):&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="z4aa296b7bad344d8aa0f77e9db40fba3" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2020&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2019&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Tradenames&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;32,317&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;32,049&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Referral relationships, net of accumulated amortization of $14,522 and $11,677, respectively&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;22,119&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;18,367&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Non-compete agreements, net of accumulated amortization of $5,993 and $5,424, respectively&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,844&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,172&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;56,280&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;52,588&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 12pt;"&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Tradenames, referral relationships and non-compete agreements are related to the businesses acquired. The value assigned to tradenames has an indefinite life and is tested at least annually for impairment using the relief from royalty method in conjunction with the Company&#x2019;s annual goodwill impairment test. The value assigned to referral relationships is being amortized over their respective estimated useful lives which range from 6 to 16 years. Non-compete agreements are amortized over the respective term of the agreements which range from 5 to 6 years.&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The following table details the amount of amortization expense recorded for intangible assets for the years ended December 31, 2020, 2019 and 2018 (in thousands):&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="z3d51561c2d2b4e3991aa252252acd5e0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Year Ended&lt;/div&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2020&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Year Ended&lt;/div&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2019&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;"&gt;Year Ended&lt;/div&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;"&gt;December 31, 2018&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Referral relationships&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,845&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,307&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,161&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Non-compete agreements&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;569&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;708&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;616&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,414&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,015&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,777&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 12pt;"&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;For one acquisition, the value assigned to tradename was being amortized over the term of the six year agreement in which the Company had acquired the right to use the specific tradename.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The remaining balances of the referral relationships and non-compete agreements is expected to be amortized as follows (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="z4ca35e0153f74abcaf4ae18e8b962393" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;"&gt;
  &lt;tr&gt;
    &lt;td colspan="3" style="width: 48.7%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Referral Relationships&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.33%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="width: 48.71%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Non-Compete Agreements&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.26%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 37.23%; vertical-align: bottom;"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Years&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.12%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.35%; vertical-align: bottom;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Annual Amount&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.33%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 37.23%; vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Years&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.12%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.35%; vertical-align: bottom;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Annual Amount&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.26%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 37.23%; vertical-align: bottom;"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Ending December 31,&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.12%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.35%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1.33%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 37.23%; vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Ending December 31,&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.12%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.35%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1.26%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2021&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,946&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.33%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2021&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;556&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.26%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2022&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,886&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.33%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2022&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;403&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.26%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2023&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,778&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.33%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2023&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;335&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.26%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2024&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,615&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.33%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2024&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;279&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.26%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2025&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,470&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.33%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2025&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;212&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.26%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Thereafter&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;8,424&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.33%; vertical-align: bottom; background-color: #FFFFFF; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF; white-space: nowrap;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Thereafter&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;59&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.26%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;
</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="c20200101to20201231"
      id="Text_a1ad63ad6fb14afdbacaea415de2eeff">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Intangible assets, net as of December 31, 2020, 2019 and 2018 consisted of the following (in thousands):&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="z4aa296b7bad344d8aa0f77e9db40fba3" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2020&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2019&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Tradenames&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;32,317&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;32,049&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Referral relationships, net of accumulated amortization of $14,522 and $11,677, respectively&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;22,119&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;18,367&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Non-compete agreements, net of accumulated amortization of $5,993 and $5,424, respectively&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,844&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,172&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;56,280&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;52,588&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;
</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember"
      decimals="-3"
      id="Fact_06a81963ad99459a9373a8883b15a7e1"
      unitRef="U001">32317000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="c20191231_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember"
      decimals="-3"
      id="Fact_9b9713d3d6344b269370c43936ef6d09"
      unitRef="U001">32049000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember"
      decimals="-3"
      id="Fact_c8a0916bb1db47099768221d1e89fb75"
      unitRef="U001">14522000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="c20191231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember"
      decimals="-3"
      id="Fact_1cd7d2f94dd14ad6a29e284d25139ebf"
      unitRef="U001">11677000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember"
      decimals="-3"
      id="Fact_927e2b7621464fd9a2ed6ae7ab33ef16"
      unitRef="U001">22119000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="c20191231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember"
      decimals="-3"
      id="Fact_d465392331ce4e9fa1ff60eda36cfc96"
      unitRef="U001">18367000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"
      decimals="-3"
      id="Fact_36a95dd0b94b4d8db2fe7a2303223850"
      unitRef="U001">5993000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="c20191231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"
      decimals="-3"
      id="Fact_8e15d2bdeed544bead07465bac2a753f"
      unitRef="U001">5424000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"
      decimals="-3"
      id="Fact_7feae0def7fe47eeab8bc93c34afac6b"
      unitRef="U001">1844000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="c20191231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"
      decimals="-3"
      id="Fact_e02d6c9fbea94a1fb09288006c871623"
      unitRef="U001">2172000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="c20201231"
      decimals="-3"
      id="Fact_350bb16246144f98ac9691f3e40c09b6"
      unitRef="U001">56280000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="c20191231"
      decimals="-3"
      id="Fact_7a4a6ef0a6ce4d6189f58bd9046a4976"
      unitRef="U001">52588000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="c20200101to20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember_RangeAxis_MinimumMember"
      id="Fact_59385f608bb647b3aece0bf6c8e9548c">P6Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="c20200101to20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember_RangeAxis_MaximumMember"
      id="Fact_8c2f8550090b418c9b27bb22651fc668">P16Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="c20200101to20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember_RangeAxis_MinimumMember"
      id="Fact_409782829e80453abe8cc94ad688e8dc">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="c20200101to20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember_RangeAxis_MaximumMember"
      id="Fact_570adb39448e4c2a942224bdd4ba5f9b">P6Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock
      contextRef="c20200101to20201231"
      id="Text_d27a6e8604d64bcb94aa8b7453b005b5">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The following table details the amount of amortization expense recorded for intangible assets for the years ended December 31, 2020, 2019 and 2018 (in thousands):&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="z3d51561c2d2b4e3991aa252252acd5e0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Year Ended&lt;/div&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2020&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Year Ended&lt;/div&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2019&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;"&gt;Year Ended&lt;/div&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;"&gt;December 31, 2018&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Referral relationships&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,845&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,307&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,161&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Non-compete agreements&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;569&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;708&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;616&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,414&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,015&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,777&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;
</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="c20200101to20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember"
      decimals="-3"
      id="Fact_cecc93dc63924268af56e378aef52dba"
      unitRef="U001">2845000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="c20190101to20191231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember"
      decimals="-3"
      id="Fact_e4933741c1a94c91ba87728f26764ba7"
      unitRef="U001">2307000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="c20180101to20181231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember"
      decimals="-3"
      id="Fact_ce838a9047fa4044b3868f6c074d8af9"
      unitRef="U001">2161000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="c20200101to20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"
      decimals="-3"
      id="Fact_2a7495e7bdc8490cbd3258608dd4831b"
      unitRef="U001">569000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="c20190101to20191231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"
      decimals="-3"
      id="Fact_b235bb94584c44d68bf1d86ce7cb79ee"
      unitRef="U001">708000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="c20180101to20181231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"
      decimals="-3"
      id="Fact_e641236deed648c9a23f439d628b0265"
      unitRef="U001">616000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_e1cd22197f284690aebee88568562937"
      unitRef="U001">3414000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_63cd01751de1419ba665792fea768b4e"
      unitRef="U001">3015000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_791507cf892d4b5392a1b196172e6a9c"
      unitRef="U001">2777000</us-gaap:AmortizationOfIntangibleAssets>
    <usph:NumberOfAcquiredOperations
      contextRef="c20200101to20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember"
      decimals="INF"
      id="Fact_41001470748c49fa80d78fa537321154"
      unitRef="U017">1</usph:NumberOfAcquiredOperations>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="c20200101to20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember"
      id="Fact_4cc1483110004d9aae51eee4aeadb5de">P6Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="c20200101to20201231"
      id="Text_18d4cbf7eaf34e98b3b0c7142a194c2f">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The remaining balances of the referral relationships and non-compete agreements is expected to be amortized as follows (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="z4ca35e0153f74abcaf4ae18e8b962393" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;"&gt;
  &lt;tr&gt;
    &lt;td colspan="3" style="width: 48.7%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Referral Relationships&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.33%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="width: 48.71%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Non-Compete Agreements&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.26%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 37.23%; vertical-align: bottom;"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Years&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.12%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.35%; vertical-align: bottom;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Annual Amount&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.33%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 37.23%; vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Years&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.12%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.35%; vertical-align: bottom;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Annual Amount&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.26%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 37.23%; vertical-align: bottom;"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Ending December 31,&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.12%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.35%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1.33%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 37.23%; vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Ending December 31,&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.12%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.35%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1.26%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2021&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,946&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.33%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2021&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;556&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.26%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2022&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,886&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.33%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2022&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;403&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.26%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2023&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,778&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.33%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2023&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;335&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.26%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2024&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,615&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.33%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2024&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;279&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.26%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2025&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,470&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.33%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2025&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;212&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.26%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Thereafter&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;8,424&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.33%; vertical-align: bottom; background-color: #FFFFFF; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF; white-space: nowrap;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Thereafter&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;59&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.26%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;
</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember"
      decimals="-3"
      id="Fact_c52364b32d554d23b2b92a8b0c4fb062"
      unitRef="U001">2946000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"
      decimals="-3"
      id="Fact_3915697c5f524ffd80fbe126e7bbd9ea"
      unitRef="U001">556000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember"
      decimals="-3"
      id="Fact_8a1f1116ab8248ec8ff407970e52df73"
      unitRef="U001">2886000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"
      decimals="-3"
      id="Fact_18ffd7b8ddff4011bc6e287d0ed185b4"
      unitRef="U001">403000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember"
      decimals="-3"
      id="Fact_75ccc3577e944a88b7e7e62d09b41d35"
      unitRef="U001">2778000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"
      decimals="-3"
      id="Fact_8f5fff8898534e05bbe6ee4966213b9c"
      unitRef="U001">335000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember"
      decimals="-3"
      id="Fact_c5383315f31e4f599bb41d9d2aacac47"
      unitRef="U001">2615000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"
      decimals="-3"
      id="Fact_962ce853d892472abaca0443c640d838"
      unitRef="U001">279000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember"
      decimals="-3"
      id="Fact_0aeb3ddb27ad42ef839810f48f4ef4c2"
      unitRef="U001">2470000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"
      decimals="-3"
      id="Fact_a3ea2029b4ab4e96a36e8e6fff2b290e"
      unitRef="U001">212000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember"
      decimals="-3"
      id="Fact_5a767df28e9349ad9952b3cd310f593f"
      unitRef="U001">8424000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember"
      decimals="-3"
      id="Fact_9506af02c641474c9c037f18024700aa"
      unitRef="U001">59000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
      contextRef="c20200101to20201231"
      id="Text_94715be10e8844b489d5b6f9d5c8f840">
&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;8. Accrued Expenses&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Accrued expenses as of December 31, 2020 and 2019 consisted of the following (in thousands):&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="z5e0ab21edcc54f1d894d4c3659803307" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2020&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2019&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Salaries and related costs&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;24,646&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;19,340&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Credit balances due to patients and payors&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;5,756&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,303&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Group health insurance claims&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,113&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,277&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Closure costs&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,333&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;116&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Federal income taxes payable&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;5,715&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;MAAPP funds payable&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;14,054&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Deferred employer payroll taxes - CARES ACT&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,170&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Other&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,959&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,819&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;59,746&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;30,855&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;
</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="c20200101to20201231"
      id="Text_930d066ff5ea4acd87e6eaa5705b9e90">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Accrued expenses as of December 31, 2020 and 2019 consisted of the following (in thousands):&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="z5e0ab21edcc54f1d894d4c3659803307" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2020&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2019&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Salaries and related costs&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;24,646&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;19,340&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Credit balances due to patients and payors&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;5,756&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,303&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Group health insurance claims&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,113&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,277&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Closure costs&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,333&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;116&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Federal income taxes payable&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;5,715&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;MAAPP funds payable&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;14,054&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Deferred employer payroll taxes - CARES ACT&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,170&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Other&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,959&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,819&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;59,746&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;30,855&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;
</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_c50d1fb9bf55470b9bdbb0c51a4a046d"
      unitRef="U001">24646000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="c20191231"
      decimals="-3"
      id="Fact_aa5ce36319ac4d07995f25ec4d03b1b8"
      unitRef="U001">19340000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <usph:PatientsAndPayorsRelatedLiability
      contextRef="c20201231"
      decimals="-3"
      id="Fact_46e1e29aaa7a48228e8df4a72cf0c3ec"
      unitRef="U001">5756000</usph:PatientsAndPayorsRelatedLiability>
    <usph:PatientsAndPayorsRelatedLiability
      contextRef="c20191231"
      decimals="-3"
      id="Fact_405a79f731de4c8ba80aefb7ad7eb656"
      unitRef="U001">4303000</usph:PatientsAndPayorsRelatedLiability>
    <us-gaap:AccruedInsuranceCurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_3acfd6bb13a247b5bf408929a0952956"
      unitRef="U001">2113000</us-gaap:AccruedInsuranceCurrent>
    <us-gaap:AccruedInsuranceCurrent
      contextRef="c20191231"
      decimals="-3"
      id="Fact_35857c10fd504cc196d01306061fabd6"
      unitRef="U001">2277000</us-gaap:AccruedInsuranceCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_9ed09af2dd5b47b397b959b11d9a6423"
      unitRef="U001">1333000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="c20191231"
      decimals="-3"
      id="Fact_bfba1655d13c43b38c015950bf591e88"
      unitRef="U001">116000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_90a281aaa5204781b5791f24c2eb5847"
      unitRef="U001">5715000</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="c20191231"
      decimals="-3"
      id="Fact_a8218e742e6747e7bb8227ccaeafa44b"
      unitRef="U001">0</us-gaap:TaxesPayableCurrent>
    <usph:MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable
      contextRef="c20201231"
      decimals="-3"
      id="Fact_b2269ce242574eea88c9f051a0bb0044"
      unitRef="U001">14054000</usph:MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable>
    <usph:MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable
      contextRef="c20191231"
      decimals="-3"
      id="Fact_f6e76912f8b04aa99f6e24b0e0c45c67"
      unitRef="U001">0</usph:MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable>
    <usph:DeferredEmployerPayrollTaxesCARESACT
      contextRef="c20201231"
      decimals="-3"
      id="Fact_d1e45c40a77c45edbb2f2e5ffc7eaed5"
      unitRef="U001">4170000</usph:DeferredEmployerPayrollTaxesCARESACT>
    <usph:DeferredEmployerPayrollTaxesCARESACT
      contextRef="c20191231"
      decimals="-3"
      id="Fact_8e9ee2da83e7455c8800853f10a86513"
      unitRef="U001">0</usph:DeferredEmployerPayrollTaxesCARESACT>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_f7b531127fa44169b5e80050021d3ae5"
      unitRef="U001">1959000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="c20191231"
      decimals="-3"
      id="Fact_0d7a25f86f4b4c09bd46dcb8f44342b7"
      unitRef="U001">4819000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_1a128c7b9ef945dc916605ce7f3bb7fd"
      unitRef="U001">59746000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="c20191231"
      decimals="-3"
      id="Fact_74e4b6075bbc4f2e97a9613dbc852ca0"
      unitRef="U001">30855000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="c20200101to20201231"
      id="Text_2abac05811524a44b4020a0ed6b452f5">
&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;9. Notes Payable&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Notes payable as of December 31, 2020 and 2019 consisted of the following (in thousands):&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="z2a1752aada2b4b209bdac3644d131528" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2020&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2019&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Credit Agreement average effective interest rate of 2.6% and 3.9% in 2020 and 2019, respectively (inclusive of unused fee)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;16,000&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;46,000&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Various notes payable with $4,899 plus accrued interest due in the next year, interest accrues in the range of 3.25% through 5.50% per annum&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;5,495&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;5,089&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;21,495&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;51,089&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Less current portion&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(4,899&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(728&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Long term portion&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;16,596&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;50,361&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 12pt;"&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Effective December 5, 2013, the Company entered into an Amended and Restated Credit Agreement with a commitment for a $125.0 million revolving credit facility. This agreement was amended and/or restated in August 2015, January 2016, March 2017 and November 2017 and January 2021 (hereafter referred to as &#x201c;Amended Credit Agreement&#x201d;). The Amended Credit Agreement is unsecured and has loan covenants, including requirements that the Company comply with a consolidated fixed charge coverage ratio and consolidated leverage ratio. Proceeds from the Amended Credit Agreement may be used for working capital, acquisitions, purchases of the Company&#x2019;s common stock, dividend payments to the Company&#x2019;s common stockholders, capital expenditures and other corporate purposes. The pricing grid which is based on the Company&#x2019;s consolidated leverage ratio with the applicable spread over LIBOR ranging from 1.25% to 2.0% or the applicable spread over the Base Rate ranging from 0.1% to 1%. Fees under the Amended Credit Agreement include an unused commitment fee of 0.3% of the amount of funds outstanding under the Amended Credit Agreement.&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt;The Amended Credit Agreement allows the cash and noncash consideration that the Company could pay with respect to acquisitions permitted under the Amended Credit Agreement to $&lt;/span&gt;50,000,000&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; for any fiscal year, and the amount the Company may pay in cash dividends to its shareholders in an aggregate amount not to exceed $&lt;/span&gt;50,000,000&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; in any fiscal year. The commitment remains at &lt;/span&gt;$125 million&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt;, however the accordion feature in the agreement was expanded to provide for capacity up to &lt;/span&gt;$150 million&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt;, and has a maturity date of &lt;/span&gt;November 30, 2025.&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; The Amended Credit Agreement is unsecured and includes certain financial covenants which include a consolidated fixed charge coverage ratio and a consolidated leverage ratio, as defined in the agreement.&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt;"&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;On December 31, 2020, $16.0 million was outstanding on the Amended Credit Agreement resulting in $109.0 million of availability. As of December 31, 2020, the Company was in compliance with all of the covenants thereunder.&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt;The Company generally enters into various notes payable as a means of financing a portion of its acquisitions and purchasing of non-controlling interests. In conjunction with these transactions in &lt;/span&gt;2020,&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; the Company entered into notes payable in the aggregate amount of &lt;/span&gt;$1.4 million&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; of which an aggregate principal payment of &lt;/span&gt;$0.5 million&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; is due in &lt;/span&gt;2021&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; and &lt;/span&gt;$0.6 million&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; is due in &lt;/span&gt;2022.&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; Interest accrues in the range of &lt;/span&gt;3.25%&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; to &lt;/span&gt;5.50%&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; per annum and is payable with each principal installment. The balance of the various notes payable entered into prior to &lt;/span&gt;2020&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; was &lt;/span&gt;$4.4 million&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt; which will be paid in &lt;/span&gt;2021.&lt;/div&gt;
</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="c20200101to20201231"
      id="Text_4be35ebad5724b499e4913a8dae0d115">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Notes payable as of December 31, 2020 and 2019 consisted of the following (in thousands):&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="z2a1752aada2b4b209bdac3644d131528" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2020&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2019&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Credit Agreement average effective interest rate of 2.6% and 3.9% in 2020 and 2019, respectively (inclusive of unused fee)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;16,000&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;46,000&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Various notes payable with $4,899 plus accrued interest due in the next year, interest accrues in the range of 3.25% through 5.50% per annum&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;5,495&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;5,089&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;21,495&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;51,089&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Less current portion&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(4,899&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(728&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Long term portion&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;16,596&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;50,361&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;
</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="c20200101to20201231_CreditFacilityAxis_RevolvingCreditFacilityMember"
      decimals="3"
      id="Fact_b8c52fdef01b498eb2e60b66fd59ce21"
      unitRef="U005">0.026</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="c20190101to20191231_CreditFacilityAxis_RevolvingCreditFacilityMember"
      decimals="3"
      id="Fact_931d4aad8463474bb9f27625be879767"
      unitRef="U005">0.039</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LongTermDebt
      contextRef="c20201231_CreditFacilityAxis_RevolvingCreditFacilityMember"
      decimals="-3"
      id="Fact_acaa0c070f094d229dacbf914120eea9"
      unitRef="U001">16000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="c20191231_CreditFacilityAxis_RevolvingCreditFacilityMember"
      decimals="-3"
      id="Fact_228f1809e55e44d3b4ec07e322063fc6"
      unitRef="U001">46000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentAnnualPrincipalPayment
      contextRef="c20201231_DebtInstrumentAxis_PromissoryNotesMember"
      decimals="-3"
      id="Fact_fda2207307434239941c8fa5c983af1a"
      unitRef="U001">4899000</us-gaap:DebtInstrumentAnnualPrincipalPayment>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c20201231_DebtInstrumentAxis_PromissoryNotesMember_RangeAxis_MinimumMember"
      decimals="4"
      id="Fact_d903564ea8b648d68cb9911e0e8064d0"
      unitRef="U005">0.0325</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c20201231_DebtInstrumentAxis_PromissoryNotesMember_RangeAxis_MaximumMember"
      decimals="4"
      id="Fact_e65b049796354fa4942ea7629e2037a2"
      unitRef="U005">0.0550</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="c20201231_DebtInstrumentAxis_PromissoryNotesMember"
      decimals="-3"
      id="Fact_09c7650eda764baca9fb8ec33f3d59f7"
      unitRef="U001">5495000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="c20191231_DebtInstrumentAxis_PromissoryNotesMember"
      decimals="-3"
      id="Fact_f5c412fcfe0a4c33834e2726d6f1e7a8"
      unitRef="U001">5089000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="c20201231"
      decimals="-3"
      id="Fact_026390bf77914947a682e4448fa72cfa"
      unitRef="U001">21495000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="c20191231"
      decimals="-3"
      id="Fact_0ebcca7066294e3ebb6db629533c969f"
      unitRef="U001">51089000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtCurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_dad4c49069c64b2cb647d1014f162ea9"
      unitRef="U001">4899000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="c20191231"
      decimals="-3"
      id="Fact_966fb9aee4f74e128879c45eefd08665"
      unitRef="U001">728000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_8b1b78c45d5a4438a71eac59c302faea"
      unitRef="U001">16596000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="c20191231"
      decimals="-3"
      id="Fact_7dce55a961794ec59c2733c7dd69ca11"
      unitRef="U001">50361000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="c20131205_CreditFacilityAxis_RevolvingCreditFacilityMember"
      decimals="-5"
      id="Fact_8a17382f9b2f4b0188df94d11748f00b"
      unitRef="U001">125000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <usph:DebtInstrumentBasisSpreadOnLiborVariableRate
      contextRef="c20201231_RangeAxis_MinimumMember"
      decimals="4"
      id="Fact_de6c2adc55be427597fc075eab7a30c0"
      unitRef="U005">0.0125</usph:DebtInstrumentBasisSpreadOnLiborVariableRate>
    <usph:DebtInstrumentBasisSpreadOnLiborVariableRate
      contextRef="c20201231_RangeAxis_MaximumMember"
      decimals="3"
      id="Fact_82dada8a1c3f47cea713850c03aca35b"
      unitRef="U005">0.020</usph:DebtInstrumentBasisSpreadOnLiborVariableRate>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c20200101to20201231_RangeAxis_MinimumMember"
      decimals="3"
      id="Fact_47d840c75cf84c4fa91acd7ca3a43f74"
      unitRef="U005">0.001</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c20200101to20201231_RangeAxis_MaximumMember"
      decimals="2"
      id="Fact_5ad33158ebac4b3d93f9f550e8adcd0f"
      unitRef="U005">0.01</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="c20200101to20201231"
      decimals="3"
      id="Fact_8c1339b35bca4bb7acff91cc6d136c5e"
      unitRef="U005">0.003</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <usph:CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement
      contextRef="c20160101to20160131_DebtInstrumentAxis_CreditAgreementMember"
      decimals="0"
      id="Fact_dd11a658a0fa4e94be40e05c4499a2fb"
      unitRef="U001">50000000</usph:CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement>
    <usph:DividendsCashAfterAmendment
      contextRef="c20160101to20160131_DebtInstrumentAxis_CreditAgreementMember_RangeAxis_MaximumMember"
      decimals="0"
      id="Fact_5468cdf33d3f4bdb95a03a6270a02ffb"
      unitRef="U001">50000000</usph:DividendsCashAfterAmendment>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="c20131205_CreditFacilityAxis_RevolvingCreditFacilityMember"
      decimals="-6"
      id="Fact_a6ef1187a75345a3967be3896f3849ca"
      unitRef="U001">125000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="c20201231_CreditFacilityAxis_RevolvingCreditFacilityMember"
      decimals="-6"
      id="Fact_0d8d5eff832c48a98b21f9f55563b087"
      unitRef="U001">150000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="c20200101to20201231_CreditFacilityAxis_RevolvingCreditFacilityMember"
      id="Fact_55fde865b6194fbf8333d5d74d2c2eba">2025-11-30</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:LongTermDebt
      contextRef="c20201231_CreditFacilityAxis_RevolvingCreditFacilityMember"
      decimals="-5"
      id="Fact_c7a5bca9fd6a418b9a765b5f57891dfb"
      unitRef="U001">16000000.0</us-gaap:LongTermDebt>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="c20201231_CreditFacilityAxis_RevolvingCreditFacilityMember"
      decimals="-5"
      id="Fact_587fe474f94444348bb53b99a8358322"
      unitRef="U001">109000000.0</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c20201231_ShortTermDebtTypeAxis_NotesPayableMember"
      decimals="-5"
      id="Fact_f75011cc2f0447ec9bea459bca20d89e"
      unitRef="U001">1400000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="c20201231_ShortTermDebtTypeAxis_NotesPayableMember"
      decimals="-5"
      id="Fact_719b2dd3d4854dc899217f777caf21b5"
      unitRef="U001">500000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="c20201231_ShortTermDebtTypeAxis_NotesPayableMember"
      decimals="-5"
      id="Fact_f4899eb8d66b4fb1bd9e18a94200a63f"
      unitRef="U001">600000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="c20200101to20201231_RangeAxis_MinimumMember_ShortTermDebtTypeAxis_NotesPayableMember"
      decimals="4"
      id="Fact_1fa8c991ba3845f294bc006a0d371861"
      unitRef="U005">0.0325</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="c20200101to20201231_RangeAxis_MaximumMember_ShortTermDebtTypeAxis_NotesPayableMember"
      decimals="4"
      id="Fact_6ba97b5621f84348be23c32d26a58741"
      unitRef="U005">0.0550</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="c20191231_ShortTermDebtTypeAxis_NotesPayableMember"
      decimals="-5"
      id="Fact_87acc8ef35c848c7831459c9d247183e"
      unitRef="U001">4400000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="c20200101to20201231"
      id="Text_40017d27813c4da7aec8a7d4e8f3efdc">
&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;10. Leases&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company has operating leases for its corporate offices and operating facilities. The Company determines if an arrangement is a lease at the inception of a contract. Effective January 1, 2019, right-of-use assets and operating lease liabilities are included in the consolidated balance sheet. Right-of-use assets represent the Company&#x2019;s right to use an underlying asset during the lease term and operating lease liabilities represent net present value of the Company&#x2019;s obligation to make lease payments arising from the lease. Right-of-use assets and operating lease liabilities are recognized at commencement date based on the net present value of the fixed lease payments over the lease term. The Company&#x2019;s operating lease terms are generally five years or less. The Company&#x2019;s lease terms include options to extend or terminate the lease when it is reasonably certain that the option will be exercised. As most of the Company&#x2019;s operating leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. Operating fixed lease expense is recognized on a straight-line basis over the lease term.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;In accordance with ASC 842, the Company records on its consolidated balance sheet leases with a term greater than 12 months. The Company has elected, in compliance with current accounting standards, not to record leases with an initial term of 12 months or less in the consolidated balance sheet. ASC 842 requires the separation of the fixed lease components from the variable lease components. The Company has elected the practical expedient to account for separate lease components of a contract as a single lease cost thus causing all fixed payments to be capitalized. Non-lease and variable cost components are not included in the measurement of the right-of-use assets or operating lease liabilities. The Company also elected the package of practical expedients permitted within ASC 842, which among other things, allows the Company to carry forward historical lease classification. Variable lease payment amounts that cannot be determined at the commencement of the lease such as increases in lease payments based on changes in index rates or usage are not included in the right-of-use assets or operating lease liabilities. These are expensed as incurred and recorded as variable lease expense.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;For the years ended December 31, 2020 and 2019, the components of lease expense were as follows (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="z7b37b8c0456447ddb4283356a6996986" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; text-indent: -9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Year Ended December 31,&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;2020&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; text-indent: -9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;2019&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Operating lease cost&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;30,710&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;30,225&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Short-term lease cost&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,454&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,212&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Variable lease cost&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;5,752&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;6,074&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total lease cost&lt;sup&gt;*&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;37,916&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;37,511&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" id="z90bdf9c7e6434fa18d41ce5d317f4a15" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;
  &lt;tr&gt;
    &lt;td style="width: 18pt;"/&gt;
    &lt;td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;*&lt;/td&gt;
    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Sublease income was immaterial&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Lease costs are reflected in the consolidated statements of net income in the line item &#x2013; rent, supplies, contract labor and other.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;For the years ended December 31, 2020 and 2019, supplemental cash flow information related to leases was as follows (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="zefa24bda41b145dc987f251a2c72b025" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;"&gt;Year Ended December 31,&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;2020&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;"&gt;2019&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Cash paid for amounts included in the measurement of operating lease liabilities (in thousands)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;30,307&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;30,077&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Right-of-use assets obtained in exchange for new operating lease liabilities (in thousands)&lt;sup&gt;*&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;32,710&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;113,222&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" id="ze8f9e808d67d46619b49699a7a23f031" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;
  &lt;tr&gt;
    &lt;td style="width: 18pt;"/&gt;
    &lt;td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;*&lt;/td&gt;
    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Includes the right-of-use assets obtained in exchange for lease liabilities for the year 2019 - $82.6 million which were recognized upon adoption of ASC Topic 842 at January 1, 2019.&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The aggregate future lease payments for operating leases as of December 31, 2020 were as follows (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="z36a05d7ef158441a9e0ee25c617b7227" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Fiscal Year&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Amount&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2021&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;29,819&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%;" valign="bottom"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2022&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;23,861&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2023&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;17,787&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%;" valign="bottom"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2024&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;11,487&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2025 and therafter&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;12,294&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total lease payments&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;95,248&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Less: imputed interest&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;5,751&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 4px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 33.85pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total operating lease liabilities&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;89,497&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Average lease terms and discount rates were as follows:&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="z00c67b6139734de2b818611f02c97724" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;"&gt;Year Ended December 31,&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;2020&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;"&gt;2019&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Weighted-average remaining lease term - Operating leases&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;4.05 Years&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -7pt;"&gt;4.05 Years&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Weighted-average discount rate - Operating leases&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;3.1&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;3.9&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;
</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="c20201231_RangeAxis_MaximumMember"
      id="Fact_097839ddd0424a16aaa2eec851c061cb">P5Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="c20200101to20201231"
      id="Text_af87c7ed305e4a34a511378c828d5ea9">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;For the years ended December 31, 2020 and 2019, the components of lease expense were as follows (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="z7b37b8c0456447ddb4283356a6996986" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; text-indent: -9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Year Ended December 31,&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;2020&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; text-indent: -9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;2019&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Operating lease cost&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;30,710&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;30,225&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Short-term lease cost&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,454&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,212&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Variable lease cost&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;5,752&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;6,074&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total lease cost&lt;sup&gt;*&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;37,916&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;37,511&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" id="z90bdf9c7e6434fa18d41ce5d317f4a15" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;
  &lt;tr&gt;
    &lt;td style="width: 18pt;"/&gt;
    &lt;td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;*&lt;/td&gt;
    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Sublease income was immaterial&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;
</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_0121c3e8800346c6beb1696dbf71e12f"
      unitRef="U001">30710000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_d372687ebf434a92895b34d0f0072aa7"
      unitRef="U001">30225000</us-gaap:OperatingLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_1ac83c8bbee349bfadb05fe99184ef92"
      unitRef="U001">1454000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_87db5ce02ea84070a46486afa0e509f7"
      unitRef="U001">1212000</us-gaap:ShortTermLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_0c8d2ef64e7845b6b3ae474c043a192a"
      unitRef="U001">5752000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_0943a57795a2496f97d04263346ee9c7"
      unitRef="U001">6074000</us-gaap:VariableLeaseCost>
    <us-gaap:LeaseCost
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_87de7115dd224e8ab5349b8ca49d2604"
      unitRef="U001">37916000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_bfd896794afb43ceb5f52155240c54ac"
      unitRef="U001">37511000</us-gaap:LeaseCost>
    <usph:OperatingLeaseSupplementalInformationTableTextBlock
      contextRef="c20200101to20201231"
      id="Text_0c2c24dd873449e8a8d63295162bb420">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;For the years ended December 31, 2020 and 2019, supplemental cash flow information related to leases was as follows (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="zefa24bda41b145dc987f251a2c72b025" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;"&gt;Year Ended December 31,&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;2020&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;"&gt;2019&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Cash paid for amounts included in the measurement of operating lease liabilities (in thousands)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;30,307&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;30,077&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Right-of-use assets obtained in exchange for new operating lease liabilities (in thousands)&lt;sup&gt;*&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;32,710&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;113,222&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" id="ze8f9e808d67d46619b49699a7a23f031" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;
  &lt;tr&gt;
    &lt;td style="width: 18pt;"/&gt;
    &lt;td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;*&lt;/td&gt;
    &lt;td style="width: auto; vertical-align: top; text-align: justify;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Includes the right-of-use assets obtained in exchange for lease liabilities for the year 2019 - $82.6 million which were recognized upon adoption of ASC Topic 842 at January 1, 2019.&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;
</usph:OperatingLeaseSupplementalInformationTableTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_d686a17747e64ef2a1661b40b3a32037"
      unitRef="U001">30307000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_9cfa6be44ddb449a8bf809a0aeb85905"
      unitRef="U001">30077000</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_8f96c3837ba5401590c591d7e2b74710"
      unitRef="U001">32710000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_500b5cc37a5c47c6ab25797c123a9f6e"
      unitRef="U001">113222000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="c20201231_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201602Member"
      decimals="-5"
      id="Fact_0d582b95588c404582b28ba39c363ef0"
      unitRef="U001">82600000</us-gaap:OperatingLeaseLiability>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="c20200101to20201231"
      id="Text_326e73ed06524d57bc1d62ca411c161a">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The aggregate future lease payments for operating leases as of December 31, 2020 were as follows (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="z36a05d7ef158441a9e0ee25c617b7227" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Fiscal Year&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Amount&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2021&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;29,819&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%;" valign="bottom"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2022&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;23,861&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2023&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;17,787&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%;" valign="bottom"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2024&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;11,487&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2025 and therafter&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;12,294&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total lease payments&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;95,248&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Less: imputed interest&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;5,751&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 88%; padding-bottom: 4px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 33.85pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total operating lease liabilities&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;89,497&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;
</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="c20201231"
      decimals="-3"
      id="Fact_40ce3979383f464d98f012803e25a8f7"
      unitRef="U001">29819000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="c20201231"
      decimals="-3"
      id="Fact_7b3d8ca0550443b895d17dc2ce757a13"
      unitRef="U001">23861000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="c20201231"
      decimals="-3"
      id="Fact_1f5e2b212ccd4c1290bfb6c1d48c74e5"
      unitRef="U001">17787000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="c20201231"
      decimals="-3"
      id="Fact_ec19bb0568ad4d8c997e37430b1071fb"
      unitRef="U001">11487000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="c20201231"
      decimals="-3"
      id="Fact_e6ef42f6831b406f9a759a8dce0e3ae5"
      unitRef="U001">12294000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="c20201231"
      decimals="-3"
      id="Fact_142dd3b548b34b02bb88defae9807326"
      unitRef="U001">95248000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="c20201231"
      decimals="-3"
      id="Fact_a3b67cd5f28c4fbb8d31d12175a15064"
      unitRef="U001">5751000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="c20201231"
      decimals="-3"
      id="Fact_55fd4415ace14b1abff63f2f364cd63d"
      unitRef="U001">89497000</us-gaap:OperatingLeaseLiability>
    <usph:WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock
      contextRef="c20200101to20201231"
      id="Text_fa5ac311840b446aa0e9da41964fecc6">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Average lease terms and discount rates were as follows:&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="z00c67b6139734de2b818611f02c97724" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;"&gt;Year Ended December 31,&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;2020&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;"&gt;2019&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Weighted-average remaining lease term - Operating leases&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;4.05 Years&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -7pt;"&gt;4.05 Years&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; background-color: #FFFFFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; background-color: #FFFFFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Weighted-average discount rate - Operating leases&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;3.1&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;3.9&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;%&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;
</usph:WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="c20201231"
      id="Fact_f60d3ff5edaa4a9686a8336c9e8db008">P4Y18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="c20191231"
      id="Fact_443744d2de8c45e996a0b837e1428b48">P4Y18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="c20201231"
      decimals="3"
      id="Fact_f2b2109921344d88bdf54eb2f1031f8c"
      unitRef="U005">0.031</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="c20191231"
      decimals="3"
      id="Fact_e64d39c530df4447823ae6f223baeb76"
      unitRef="U005">0.039</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="c20200101to20201231"
      id="Text_0ec53356eab049eab7ffac8a31b8364d">
&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;11. Income Taxes&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Significant components of deferred tax assets and liabilities included in the consolidated balance sheets at December 31, 2020 and 2019 were as follows (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="z210002d42bc24598a6e0e37001fc2dac" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2020&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2019&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom;" valign="bottom"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Deferred tax assets:&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Compensation&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,865&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,964&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Allowance for credit losses&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;396&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;514&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Acquired net operating losses&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;558&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;840&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Lease obligations - including closed clinics&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;23,819&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;21,445&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Deferred tax assets&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;26,638&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;24,763&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Deferred tax liabilities:&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Depreciation and amortization&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(12,650&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(13,195&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Operating lease right-of-use assets&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(21,419&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(21,416&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Other&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(348&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(223&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Deferred tax liabilities&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(34,417&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(34,834&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Net deferred tax liability&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(7,779&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(10,071&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The deferred tax assets and liabilities related to purchased interests not yet finalized may result in an immaterial adjustment.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;During 2020, the Company recorded deferred tax assets of $1.2 million related to the revaluation of redeemable non-controlling interests and acquisitions of non-controlling interests. In addition, during 2020, the Company recorded an adjustment to the deferred tax assets of $1.4 million as a result of a detailed reconciliation of its federal and state taxes payable and receivable accounts along with its federal and state deferred tax asset and liability accounts with its federal and state tax returns for 2019. The offset of this adjustment was a decrease to the previously reported federal income tax receivable. As of December 31, 2020, the Company has a federal income tax payable of $5.7 million and state tax receivables of $0.7 million. &lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;The federal income tax payable is included in &lt;/span&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;accrued liabilities&lt;/span&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt; and the tax receivable is&lt;/span&gt; included in &lt;span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;other current assets&lt;/span&gt; on the accompanying consolidated balance sheets.&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The differences between the federal tax rate and the Company&#x2019;s effective tax rate for the years ended December 31, 2020, 2019 and 2018 were as follows (in thousands):&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="z21bd67f809424afe8f722f356649b1f4" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;"&gt;
  &lt;tr&gt;
    &lt;td style="width: 26.72%; vertical-align: bottom;"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/&gt;&lt;/td&gt;
    &lt;td style="width: 1.13%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1.18%; vertical-align: bottom; border-bottom: #000000 2px solid;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="width: 21.95%; vertical-align: bottom; border-bottom: #000000 2px solid;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2020&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.11%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1.14%; vertical-align: bottom; border-bottom: #000000 2px solid;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="width: 21.77%; vertical-align: bottom; border-bottom: #000000 2px solid;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2019&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.08%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1.1%; vertical-align: bottom; border-bottom: #000000 2px solid;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="width: 21.78%; vertical-align: bottom; border-bottom: #000000 2px solid;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2018&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.04%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 26.72%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;U. S. tax at statutory rate&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.13%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1.18%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 10.51%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;10,125&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 0.93%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.51%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;21.0%&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.11%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1.14%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 10.52%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;11,274&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 0.73%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.52%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;21.0%&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.08%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1.1%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 10.53%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;9,710&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 0.73%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.52%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;21.0%&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.04%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 26.72%; vertical-align: bottom; background-color: #FFFFFF; white-space: nowrap;"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;State income taxes, net of federal benefit&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.13%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1.18%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.51%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,956&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 0.93%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.51%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;3.9%&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.11%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1.14%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.52%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,059&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 0.73%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.52%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;3.8%&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.08%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1.1%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.53%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,722&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 0.73%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.52%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;3.7%&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.04%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 26.72%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Excess equity compensation deduction&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.13%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1.18%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.51%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(99)&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 0.93%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.51%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;0.0%&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.11%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1.14%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.52%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(871)&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 0.73%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.52%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-1.6 %&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.08%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1.1%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.53%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(806)&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 0.73%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.52%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-1.7 %&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.04%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 26.72%; vertical-align: bottom; background-color: #FFFFFF; white-space: nowrap;"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Non-deductible expenses&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.13%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1.18%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.51%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,040&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 0.93%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.51%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2.1%&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.11%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1.14%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.52%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,185&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 0.73%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.52%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2.2%&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.08%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1.1%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.53%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;743&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 0.73%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.52%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1.6%&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.04%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 26.72%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1.13%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1.18%; vertical-align: bottom; border-top: #000000 2px solid; border-bottom: #000000 4px double; background-color: #CCEEFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 10.51%; vertical-align: bottom; border-top: #000000 2px solid; border-bottom: #000000 4px double; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;13,022&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 0.93%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.51%; vertical-align: bottom; border-top: #000000 2px solid; border-bottom: #000000 4px double; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;27.0%&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.11%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1.14%; vertical-align: bottom; border-top: #000000 2px solid; border-bottom: #000000 4px double; background-color: #CCEEFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 10.52%; vertical-align: bottom; border-top: #000000 2px solid; border-bottom: #000000 4px double; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;13,647&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 0.73%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.52%; vertical-align: bottom; border-top: #000000 2px solid; border-bottom: #000000 4px double; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;25.4%&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.08%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1.1%; vertical-align: bottom; border-top: #000000 2px solid; border-bottom: #000000 4px double; background-color: #CCEEFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 10.53%; vertical-align: bottom; border-top: #000000 2px solid; border-bottom: #000000 4px double; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;11,369&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 0.73%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.52%; vertical-align: bottom; border-top: #000000 2px solid; border-bottom: #000000 4px double; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;24.6%&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.04%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Significant components of the provision for income taxes for the years ended December 31, 2020, 2019 and 2018 were as follows (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="zbf81119b8a024b268d90882988e17c64" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt;December 31, &lt;/span&gt;2020&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt;December 31, &lt;/span&gt;2019&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt;December 31, &lt;/span&gt;2018&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Current:&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Federal&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;10,506&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;6,523&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;5,357&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 64%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;State&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,774&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,473&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,199&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 64%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total current&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;13,280&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;8,996&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;6,556&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 64%; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: left; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Deferred:&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: left; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Federal&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(38&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,730&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,771&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 64%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: left; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;State&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;(220&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;921&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,042&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 64%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total deferred&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;(258&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,651&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,813&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 64%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total income tax provision&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;13,022&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;13,647&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;11,369&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;For 2020, 2019 and 2018, the Company performed a detailed reconciliation of its federal and state taxes payable and receivable accounts along with its federal and state deferred tax asset and liability accounts. The adjustments were immaterial. The Company considers this reconciliation process to be an annual control.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company is required to establish a valuation allowance for deferred tax assets if, based on the weight of available evidence, it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the projected future taxable income and tax planning strategies in making this assessment. Based upon the level of historical taxable income and projections for future taxable income in the periods which the deferred tax assets are deductible, management believes that a valuation allowance is not required, as it is more likely than not that the results of future operations will generate sufficient taxable income to realize the deferred tax assets.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company&#x2019;s U.S. federal returns remain open to examination for &lt;span style="-sec-ix-hidden:Fact_c614eba92f724091923d077cce15bd38"&gt;2017 through 2019&lt;/span&gt; and U.S. state jurisdictions are open for periods ranging from &lt;span style="-sec-ix-hidden:Fact_a3d421d0c572494d8b850b77d069a61f"&gt;2016 through 2019&lt;/span&gt;.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company does not believe that it has any significant uncertain tax positions at December 31, 2020 and December 31, 2019, nor is this expected to change within the next twelve months due to the settlement and expiration of statutes of limitation.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company did not have any accrued interest or penalties associated with any unrecognized tax benefits nor was any interest expense recognized during the years ended December 31, 2020, 2019 and 2018.&lt;/div&gt;
</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="c20200101to20201231"
      id="Text_2f23527fd6cf4f6ab6cbbfce73d2c408">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Significant components of deferred tax assets and liabilities included in the consolidated balance sheets at December 31, 2020 and 2019 were as follows (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="z210002d42bc24598a6e0e37001fc2dac" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2020&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2019&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom;" valign="bottom"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Deferred tax assets:&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Compensation&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,865&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,964&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Allowance for credit losses&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;396&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;514&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Acquired net operating losses&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;558&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;840&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Lease obligations - including closed clinics&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;23,819&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;21,445&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Deferred tax assets&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;26,638&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;24,763&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Deferred tax liabilities:&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Depreciation and amortization&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(12,650&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(13,195&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Operating lease right-of-use assets&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(21,419&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(21,416&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Other&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(348&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(223&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Deferred tax liabilities&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(34,417&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(34,834&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Net deferred tax liability&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(7,779&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(10,071&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;
</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
      contextRef="c20201231"
      decimals="-3"
      id="Fact_5f3ee2f6d3dd408695fb1fe4e65252c5"
      unitRef="U001">1865000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
      contextRef="c20191231"
      decimals="-3"
      id="Fact_9b981484fb2240d595e81a3e5b22fa49"
      unitRef="U001">1964000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="c20201231"
      decimals="-3"
      id="Fact_4d6ecea9a2e54377a1f52778bf1d0ea3"
      unitRef="U001">396000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="c20191231"
      decimals="-3"
      id="Fact_2234a4978ce149f6859605e2ee6357b4"
      unitRef="U001">514000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="c20201231"
      decimals="-3"
      id="Fact_1c1f3be0303046dfa351aeee7591be7c"
      unitRef="U001">558000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="c20191231"
      decimals="-3"
      id="Fact_159c43c4681e4ef8a03afa6d162d3f03"
      unitRef="U001">840000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <usph:DeferredTaxAssetsLeaseObligations
      contextRef="c20201231"
      decimals="-3"
      id="Fact_afafe610d21c48318be3775b692fed0b"
      unitRef="U001">23819000</usph:DeferredTaxAssetsLeaseObligations>
    <usph:DeferredTaxAssetsLeaseObligations
      contextRef="c20191231"
      decimals="-3"
      id="Fact_9918d7e926ec41d7ada14827b0829270"
      unitRef="U001">21445000</usph:DeferredTaxAssetsLeaseObligations>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="c20201231"
      decimals="-3"
      id="Fact_fe4d5bd259f74bd18f409d4c2b73a68a"
      unitRef="U001">26638000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="c20191231"
      decimals="-3"
      id="Fact_c00e8cdcd0dd441897f9e02918e49bd1"
      unitRef="U001">24763000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="c20201231"
      decimals="-3"
      id="Fact_00df25e7ec804305b7f8e3267ab78e7a"
      unitRef="U001">12650000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="c20191231"
      decimals="-3"
      id="Fact_75bd0aba3d704c8eab488b55ba58d452"
      unitRef="U001">13195000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <usph:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets
      contextRef="c20201231"
      decimals="-3"
      id="Fact_be3ee8b1a47a409fa1f025231f2ac4fa"
      unitRef="U001">21419000</usph:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets>
    <usph:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets
      contextRef="c20191231"
      decimals="-3"
      id="Fact_cc1fd4103fff411eaa961ae22a2a1e1e"
      unitRef="U001">21416000</usph:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="c20201231"
      decimals="-3"
      id="Fact_62228ddd331f4bdba2ceada922d012fc"
      unitRef="U001">348000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="c20191231"
      decimals="-3"
      id="Fact_a41f0932694b447ba5c39f6026f3d515"
      unitRef="U001">223000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="c20201231"
      decimals="-3"
      id="Fact_d9312ff5d82445c3ba2896e46b0ebcdb"
      unitRef="U001">34417000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="c20191231"
      decimals="-3"
      id="Fact_e1616d6324ef4c98b80b5733ad838b0d"
      unitRef="U001">34834000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="c20201231"
      decimals="-3"
      id="Fact_c057de254a1a4cd4b521aff3005a549a"
      unitRef="U001">7779000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="c20191231"
      decimals="-3"
      id="Fact_9a9e8822324644d0a2866ad5b673e4cd"
      unitRef="U001">10071000</us-gaap:DeferredTaxLiabilities>
    <usph:DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests
      contextRef="c20201231"
      decimals="-5"
      id="Fact_bf328ec96c7442e2a7ad2670be2c2fb8"
      unitRef="U001">1200000</usph:DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests>
    <us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
      contextRef="c20200101to20201231"
      decimals="-5"
      id="Fact_8844c692b660401488b7930060999c95"
      unitRef="U001">1400000</us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="c20201231_IncomeTaxAuthorityAxis_ForeignCountryMember"
      decimals="-5"
      id="Fact_cf7264dc7dc549069a74bb9c2d4cd081"
      unitRef="U001">5700000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:DeferredIncomeTaxesAndOtherTaxReceivableCurrent
      contextRef="c20201231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember"
      decimals="-5"
      id="Fact_98a9b10e524e4e93ac0df0275d19cb87"
      unitRef="U001">700000</us-gaap:DeferredIncomeTaxesAndOtherTaxReceivableCurrent>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="c20200101to20201231"
      id="Text_c83c1926380349c6af086855ac405b3c">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The differences between the federal tax rate and the Company&#x2019;s effective tax rate for the years ended December 31, 2020, 2019 and 2018 were as follows (in thousands):&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="z21bd67f809424afe8f722f356649b1f4" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;"&gt;
  &lt;tr&gt;
    &lt;td style="width: 26.72%; vertical-align: bottom;"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/&gt;&lt;/td&gt;
    &lt;td style="width: 1.13%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1.18%; vertical-align: bottom; border-bottom: #000000 2px solid;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="width: 21.95%; vertical-align: bottom; border-bottom: #000000 2px solid;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2020&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.11%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1.14%; vertical-align: bottom; border-bottom: #000000 2px solid;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="width: 21.77%; vertical-align: bottom; border-bottom: #000000 2px solid;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2019&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.08%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1.1%; vertical-align: bottom; border-bottom: #000000 2px solid;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="width: 21.78%; vertical-align: bottom; border-bottom: #000000 2px solid;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2018&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.04%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 26.72%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;U. S. tax at statutory rate&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.13%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1.18%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 10.51%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;10,125&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 0.93%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.51%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;21.0%&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.11%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1.14%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 10.52%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;11,274&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 0.73%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.52%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;21.0%&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.08%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1.1%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 10.53%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;9,710&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 0.73%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.52%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;21.0%&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.04%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 26.72%; vertical-align: bottom; background-color: #FFFFFF; white-space: nowrap;"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;State income taxes, net of federal benefit&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.13%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1.18%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.51%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,956&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 0.93%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.51%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;3.9%&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.11%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1.14%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.52%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,059&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 0.73%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.52%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;3.8%&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.08%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1.1%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.53%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,722&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 0.73%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.52%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;3.7%&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.04%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 26.72%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Excess equity compensation deduction&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.13%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1.18%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.51%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(99)&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 0.93%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.51%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;0.0%&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.11%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1.14%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.52%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(871)&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 0.73%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.52%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-1.6 %&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.08%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1.1%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.53%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(806)&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 0.73%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.52%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-1.7 %&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.04%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 26.72%; vertical-align: bottom; background-color: #FFFFFF; white-space: nowrap;"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Non-deductible expenses&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.13%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1.18%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.51%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,040&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 0.93%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.51%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2.1%&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.11%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1.14%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.52%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,185&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 0.73%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.52%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2.2%&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.08%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1.1%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.53%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;743&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 0.73%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.52%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1.6%&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.04%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 26.72%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1.13%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1.18%; vertical-align: bottom; border-top: #000000 2px solid; border-bottom: #000000 4px double; background-color: #CCEEFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 10.51%; vertical-align: bottom; border-top: #000000 2px solid; border-bottom: #000000 4px double; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;13,022&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 0.93%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.51%; vertical-align: bottom; border-top: #000000 2px solid; border-bottom: #000000 4px double; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;27.0%&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.11%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1.14%; vertical-align: bottom; border-top: #000000 2px solid; border-bottom: #000000 4px double; background-color: #CCEEFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 10.52%; vertical-align: bottom; border-top: #000000 2px solid; border-bottom: #000000 4px double; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;13,647&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 0.73%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.52%; vertical-align: bottom; border-top: #000000 2px solid; border-bottom: #000000 4px double; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;25.4%&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.08%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1.1%; vertical-align: bottom; border-top: #000000 2px solid; border-bottom: #000000 4px double; background-color: #CCEEFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 10.53%; vertical-align: bottom; border-top: #000000 2px solid; border-bottom: #000000 4px double; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;11,369&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 0.73%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10.52%; vertical-align: bottom; border-top: #000000 2px solid; border-bottom: #000000 4px double; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;24.6%&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.04%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;
</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_88e8f25bc018459098855b9b1bb16e1e"
      unitRef="U001">10125000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="c20200101to20201231"
      decimals="3"
      id="Fact_5e110eb435ca401b98610262716ccb56"
      unitRef="U005">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_a82f1533f7524caa9aaec20fe5196d6c"
      unitRef="U001">11274000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="c20190101to20191231"
      decimals="3"
      id="Fact_7571cdf489e64abeb168c44c58887647"
      unitRef="U005">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_5867b29647284c2b89b55d75b678b3a8"
      unitRef="U001">9710000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="c20180101to20181231"
      decimals="3"
      id="Fact_2e343fabc02a4ca8a054bf2629fb12b9"
      unitRef="U005">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_35dac135f1c74b34830913146efeff56"
      unitRef="U001">1956000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="c20200101to20201231"
      decimals="3"
      id="Fact_0940207a923c4adb85e97487dc8b5a12"
      unitRef="U005">0.039</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_fbdaf61146144964bebe26b4b9d99a8f"
      unitRef="U001">2059000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="c20190101to20191231"
      decimals="3"
      id="Fact_6a2e8a02eb6a4a539a417904bc52f6c5"
      unitRef="U005">0.038</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_6fa111822d484abe8af1f028a4d09316"
      unitRef="U001">1722000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="c20180101to20181231"
      decimals="3"
      id="Fact_fc9336f8d4224b27932827c5c9aa53c2"
      unitRef="U005">0.037</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationDeductions
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_a29075a2853e410987e3cea729c1cb3d"
      unitRef="U001">99000</us-gaap:IncomeTaxReconciliationDeductions>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDeductions
      contextRef="c20200101to20201231"
      decimals="3"
      id="Fact_f416a44670c14dfebb4c734a086d7238"
      unitRef="U005">-0.000</us-gaap:EffectiveIncomeTaxRateReconciliationDeductions>
    <us-gaap:IncomeTaxReconciliationDeductions
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_0dc6ba2ea47243f5beb5d6ad15cfbe03"
      unitRef="U001">871000</us-gaap:IncomeTaxReconciliationDeductions>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDeductions
      contextRef="c20190101to20191231"
      decimals="3"
      id="Fact_8f1758b0e66b40d5ba0c75207f2509d3"
      unitRef="U005">0.016</us-gaap:EffectiveIncomeTaxRateReconciliationDeductions>
    <us-gaap:IncomeTaxReconciliationDeductions
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_3b9c0bef7d044a6cb29be80d1fb4c133"
      unitRef="U001">806000</us-gaap:IncomeTaxReconciliationDeductions>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDeductions
      contextRef="c20180101to20181231"
      decimals="3"
      id="Fact_43eca628f590439981ed8ec4ab3f4d17"
      unitRef="U005">0.017</us-gaap:EffectiveIncomeTaxRateReconciliationDeductions>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_db8ae5df419b4865a8effe574b7ac857"
      unitRef="U001">1040000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="c20200101to20201231"
      decimals="3"
      id="Fact_6d83e5f9dc214a098eac283dd6052477"
      unitRef="U005">0.021</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_80f71899e1894613890ab208550a9e35"
      unitRef="U001">1185000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="c20190101to20191231"
      decimals="3"
      id="Fact_a884acb519a14f09873f5ce8f329999b"
      unitRef="U005">0.022</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_c6678d847c8c44899246ac71f40e6b85"
      unitRef="U001">743000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="c20180101to20181231"
      decimals="3"
      id="Fact_ec62d04ef5ff4844a548f69bea5b0122"
      unitRef="U005">0.016</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_c5b7cddb82974ca5bc0b09bace456b48"
      unitRef="U001">13022000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="c20200101to20201231"
      decimals="3"
      id="Fact_b74047cb1fd34e589a244cf771de19eb"
      unitRef="U005">0.270</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_65452e40a9404c55b03380269e192569"
      unitRef="U001">13647000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="c20190101to20191231"
      decimals="3"
      id="Fact_9eb9a22f911b4a6bbf59abf44129f54d"
      unitRef="U005">0.254</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_0933cb19f54349bbae941a1a9e462caf"
      unitRef="U001">11369000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="c20180101to20181231"
      decimals="3"
      id="Fact_621f3f3a517e4b6b9f11243fa8ce2dbb"
      unitRef="U005">0.246</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="c20200101to20201231"
      id="Text_c326d369b10b4edcb1a548a203c9014e">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Significant components of the provision for income taxes for the years ended December 31, 2020, 2019 and 2018 were as follows (in thousands):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="zbf81119b8a024b268d90882988e17c64" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt;December 31, &lt;/span&gt;2020&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt;December 31, &lt;/span&gt;2019&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"&gt;December 31, &lt;/span&gt;2018&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Current:&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Federal&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;10,506&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;6,523&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;5,357&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 64%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;State&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,774&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,473&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,199&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 64%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total current&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;13,280&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;8,996&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;6,556&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 64%; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: left; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Deferred:&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: left; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Federal&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(38&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,730&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,771&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 64%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: left; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;State&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;(220&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;921&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,042&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 64%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total deferred&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;(258&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,651&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,813&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 64%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total income tax provision&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;13,022&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;13,647&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;11,369&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;
</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_b7ca54753bbc40a385eb65d4efe05f7c"
      unitRef="U001">10506000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_2a7e186d4d13460d87c24d0339041113"
      unitRef="U001">6523000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_9b2fb089d5494a718660099da3eb3913"
      unitRef="U001">5357000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_1c0e061911ae4f4eb1b32199f7c423ec"
      unitRef="U001">2774000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_324014f5e1e7493d9706c90699d58539"
      unitRef="U001">2473000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_c541630a2cff466480d90baf8cef364b"
      unitRef="U001">1199000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_34893f428c4547bab8ea44c7a8703325"
      unitRef="U001">13280000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_5ce56f4cd618421194dbf7e31a05c857"
      unitRef="U001">8996000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_ebe4468d213d4c40afa67863a4f68667"
      unitRef="U001">6556000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_f47794a289fa443e8f42b67b85589405"
      unitRef="U001">-38000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_8db7295a340143cf876c8301362ecebe"
      unitRef="U001">3730000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_8c555085d8a6407784d596af4b42ffed"
      unitRef="U001">3771000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_59671c58a9a2494ab42e80a34ff74bc4"
      unitRef="U001">-220000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_b7b178e59a3845c0b0cfd6d18ccc8c0d"
      unitRef="U001">921000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_52dd01d49051491b94857360bc900030"
      unitRef="U001">1042000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_27f90b2ad0494cee82e16ef42322ebe4"
      unitRef="U001">-258000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_da3e388272f7454b983d9d79a079e830"
      unitRef="U001">4651000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_95d030e3b75145b78e239c0a05d54567"
      unitRef="U001">4813000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_b7e88154a1be4aa59300cc411fabb2ad"
      unitRef="U001">13022000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_ee2f7a5edf4c40ec877d0e1a5a6e280d"
      unitRef="U001">13647000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_333084e60be44f44a8f1e4e453e940b3"
      unitRef="U001">11369000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_f17d686007254b2ead06ecd6aa004f72"
      unitRef="U001">0</us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense>
    <us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_65275baa7c7e4ae9ab465ba4a2df460e"
      unitRef="U001">0</us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense>
    <us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_5c500b2ceb59435a9367076b6dda1601"
      unitRef="U001">0</us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="c20201231"
      decimals="-3"
      id="Fact_55631d253d904abb9fbb7f5111a2e36f"
      unitRef="U001">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="c20181231"
      decimals="-3"
      id="Fact_2a3c18f909e34cc9915252fce094ed26"
      unitRef="U001">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="c20191231"
      decimals="-3"
      id="Fact_00dbb930dd194ec985f8cbecd430ad27"
      unitRef="U001">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="c20200101to20201231"
      id="Text_6e9da235e2794822a68fe70d324b0750">
&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;12. Segment Information&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;The Company&#x2019;s reportable segments include the physical therapy operations segment and the industrial injury prevention services segment. Also included in the physical therapy operations segment are revenues from management contract services and other services which include services the Company provides on-site, such as schools for athletic trainers&lt;/span&gt;.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;The Company evaluates performance of the segments based on gross profit. The Company has provided additional information regarding its reportable segments which contributes to the understanding of the Company and provides useful information&lt;/span&gt;.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;T&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;he following table summarizes selected financial data for the Company&#x2019;s reportable segments. Prior year results presented herein have been changed to conform to the current presentation&lt;/span&gt;.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="zea0754717f864c8688543b30b5aa363f" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31,&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31,&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31,&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;2020&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt; 2019&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;2018&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;(in thousands)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;(in thousands)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom;" valign="bottom"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Net operating revenues:&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Physical therapy operations&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;383,770&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;444,507&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;428,445&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Industrial injury prevention services&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;39,199&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;37,462&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;25,466&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total Company&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;422,969&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;481,969&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;453,911&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 64%;" valign="bottom"&gt;&lt;div style="text-align: left; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Gross profit:&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 64%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Physical therapy operations (excluding closure costs)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;88,295&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;104,120&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;96,463&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Industrial injury prevention services&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;10,086&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;8,379&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;5,192&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 64%;" valign="bottom"&gt;&lt;div style="text-align: left; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;98,381&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;112,499&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;101,655&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Physical therapy operations - closure costs&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,931&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;25&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(8&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 64%; padding-bottom: 4px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Gross profit&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;94,450&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;112,474&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;101,663&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total Assets:&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Physical therapy operations&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;550,181&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;518,027&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;421,474&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 64%; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Industrial injury prevention services&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;44,180&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;42,818&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;21,692&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total Company&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;594,361&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;560,845&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;443,166&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;
</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="c20200101to20201231"
      id="Text_8b35a70c459349c187575a2f0041d55b">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;T&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;he following table summarizes selected financial data for the Company&#x2019;s reportable segments. Prior year results presented herein have been changed to conform to the current presentation&lt;/span&gt;.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="zea0754717f864c8688543b30b5aa363f" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31,&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31,&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31,&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;2020&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt; 2019&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;2018&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;(in thousands)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;(in thousands)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom;" valign="bottom"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Net operating revenues:&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Physical therapy operations&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;383,770&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;444,507&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;428,445&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Industrial injury prevention services&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;39,199&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;37,462&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;25,466&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total Company&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;422,969&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;481,969&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;453,911&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 64%;" valign="bottom"&gt;&lt;div style="text-align: left; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Gross profit:&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 64%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Physical therapy operations (excluding closure costs)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;88,295&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;104,120&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;96,463&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Industrial injury prevention services&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;10,086&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;8,379&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;5,192&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 64%;" valign="bottom"&gt;&lt;div style="text-align: left; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;98,381&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;112,499&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;101,655&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Physical therapy operations - closure costs&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,931&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;25&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(8&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 64%; padding-bottom: 4px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Gross profit&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;94,450&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;112,474&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;101,663&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total Assets:&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Physical therapy operations&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;550,181&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;518,027&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;421,474&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 64%; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Industrial injury prevention services&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;44,180&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;42,818&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;21,692&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Total Company&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;594,361&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;560,845&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;443,166&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;
</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Revenues
      contextRef="c20200101to20201231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_76bd81f7b88e44d48185909609e3e62d"
      unitRef="U001">383770000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="c20190101to20191231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_52ee4d9dad274edfb218422a828e15cd"
      unitRef="U001">444507000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="c20180101to20181231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_d5f9e45c972c4b1495066d70407d1eea"
      unitRef="U001">428445000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="c20200101to20201231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember"
      decimals="-3"
      id="Fact_9a9108960248438ebe02c782f3901e0b"
      unitRef="U001">39199000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="c20190101to20191231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember"
      decimals="-3"
      id="Fact_cb48a3d5cc464d859e4e48e203fb50fd"
      unitRef="U001">37462000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="c20180101to20181231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember"
      decimals="-3"
      id="Fact_82adba4a80074ee697f34bd852e54558"
      unitRef="U001">25466000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_0c1a9c1d1e3a42bb982062e4b95879df"
      unitRef="U001">422969000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_ff6f85a38fe942338a0d2f0e905c7231"
      unitRef="U001">481969000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_34dfa5cb699549c99da0bdd43f601d3f"
      unitRef="U001">453911000</us-gaap:Revenues>
    <us-gaap:GrossProfit
      contextRef="c20200101to20201231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsExcludingClosureCostsMember"
      decimals="-3"
      id="Fact_897e0405d22444cd9569768efe73b8de"
      unitRef="U001">88295000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="c20190101to20191231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsExcludingClosureCostsMember"
      decimals="-3"
      id="Fact_5d21e5f6ccf54fc5b23d155333286f23"
      unitRef="U001">104120000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="c20180101to20181231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsExcludingClosureCostsMember"
      decimals="-3"
      id="Fact_05d68dca9b6749efbac2b3f75ad563f3"
      unitRef="U001">96463000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="c20200101to20201231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember"
      decimals="-3"
      id="Fact_65840ee1d5524f0ebb19a87b31c29a4e"
      unitRef="U001">10086000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="c20190101to20191231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember"
      decimals="-3"
      id="Fact_5b71d245291a4653a7d691beabe0c841"
      unitRef="U001">8379000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="c20180101to20181231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember"
      decimals="-3"
      id="Fact_a25be442dd904fed917ce673000f912b"
      unitRef="U001">5192000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="c20200101to20201231_ConsolidationItemsAxis_OperatingSegmentsMember"
      decimals="-3"
      id="Fact_c9edbed54975472eb0d7cd91f34cc00c"
      unitRef="U001">98381000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="c20190101to20191231_ConsolidationItemsAxis_OperatingSegmentsMember"
      decimals="-3"
      id="Fact_28eaa2fd23674a4cb8bc8c4656b96b6e"
      unitRef="U001">112499000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="c20180101to20181231_ConsolidationItemsAxis_OperatingSegmentsMember"
      decimals="-3"
      id="Fact_973d7d9e4426437d8efe113dee9b9efd"
      unitRef="U001">101655000</us-gaap:GrossProfit>
    <us-gaap:RestructuringCharges
      contextRef="c20200101to20201231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_06439c45d2bc4bd6ae549c997ff17205"
      unitRef="U001">3931000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="c20190101to20191231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_246f3e02ed194c7a8de03c1a66a8ab8f"
      unitRef="U001">25000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="c20180101to20181231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_7a9761222bb24515a66471ed52446f1f"
      unitRef="U001">-8000</us-gaap:RestructuringCharges>
    <us-gaap:GrossProfit
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_c469dbbb58c24bf2913f0e6e9d887276"
      unitRef="U001">94450000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_445b1c0714884270a19921020b8a5e42"
      unitRef="U001">112474000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_ad7868d5dd0b411e9e38a371b42763e0"
      unitRef="U001">101663000</us-gaap:GrossProfit>
    <us-gaap:Assets
      contextRef="c20201231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_bc058bcc884a49c9b2f26f263b5c2e73"
      unitRef="U001">550181000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="c20191231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_ffdcda26951a41bcb8bacc8d453458b1"
      unitRef="U001">518027000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="c20181231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_PhysicalTherapyOperationsMember"
      decimals="-3"
      id="Fact_1f53dd13cb094499a1f30ce9b14e81b2"
      unitRef="U001">421474000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="c20201231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember"
      decimals="-3"
      id="Fact_e08a3a23b0a84f57b8dd11abcc487fbf"
      unitRef="U001">44180000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="c20191231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember"
      decimals="-3"
      id="Fact_b5f99d741d0f46c88e33ce212a566708"
      unitRef="U001">42818000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="c20181231_ConsolidationItemsAxis_OperatingSegmentsMember_StatementBusinessSegmentsAxis_IndustrialInjuryPreventionServicesRevenuesMember"
      decimals="-3"
      id="Fact_4ed612ba6045495199d7e32d506dfba1"
      unitRef="U001">21692000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="c20201231"
      decimals="-3"
      id="Fact_5278e6efac8d422181163d8056310166"
      unitRef="U001">594361000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="c20191231"
      decimals="-3"
      id="Fact_28f719b97d3d4b389f68003290605bb7"
      unitRef="U001">560845000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="c20181231"
      decimals="-3"
      id="Fact_e638af0e235744ef9e2e8307b625679a"
      unitRef="U001">443166000</us-gaap:Assets>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="c20200101to20201231"
      id="Text_1bf2c877ca6d48a08f86dce9ab84ac62">
&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;13. Equity Based Plans&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company has the following equity based plans with outstanding equity grants:&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Amended and Restated 1999 Employee Stock Option Plan (the &#x201c;Amended 1999 Plan&#x201d;) permits the Company to grant to non-employee directors and employees of the Company up to 600,000 non-qualified options to purchase shares of common stock and restricted stock (subject to proportionate adjustments in the event of stock dividends, splits, and similar corporate transactions). The exercise prices of options granted under the Amended 1999 Plan are determined by the Compensation Committee. The period within which each option will be exercisable is determined by the Compensation Committee. The Amended 1999 Plan was approved by the shareholders of the Company at the 2008 Shareholders Meeting on May 20, 2008.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Amended and Restated 2003 Stock Option Plan (the &#x201c;Amended 2003 Plan&#x201d;) permits the Company to grant to key employees and outside directors of the Company incentive and non-qualified options and shares of restricted stock covering up to 2,100,000 shares of common stock (subject to proportionate adjustments in the event of stock dividends, splits, and similar corporate transactions). The material terms of the Amended 2003 Plan was reapproved by the shareholders of the Company at the 2015 Shareholders Meeting on May 19, 2015 and an increase in the number of shares authorized for issuance from 1,750,000 to 2,100,000 was approved at the 2016 Shareholders Meeting on March 17, 2016.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;A cumulative summary of equity plans as of December 31, 2020 follows:&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="z0fd35d71f4c741a1afb5a3fdfe7e4755" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Authorized&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Restricted&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;&lt;/span&gt;Stock Issued&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Outstanding&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;&lt;/span&gt;Stock Options&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Stock Options&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;&lt;/span&gt;Exercised&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Stock Options&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;&lt;/span&gt;Exercisable&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Shares Available&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;&lt;/span&gt;for Grant&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Equity Plans&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 28%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Amended 1999 Plan&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;600,000&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;416,402&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;139,791&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;7,775&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 28%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Amended 2003 Plan&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,100,000&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,106,977&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;778,300&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;224,760&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 28%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,700,000&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,523,379&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;918,091&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;232,535&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;During 2020, 2019 and 2018, the Company granted the following shares of restricted stock to directors, officers and employees pursuant to its equity plans as follows:&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="z87259eaa26b8463e9d0de795ce96e698" style="font-family: 'Times New Roman'; font-size: 10pt; border-collapse: collapse; text-align: left; color: #000000; width: 100%; margin-left: auto; margin-right: auto;"&gt;
  &lt;tr&gt;
    &lt;td style="width: 33.07%; vertical-align: bottom; border-bottom: #000000 2px solid;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Year Granted&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 0.97%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 33.21%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Number of Shares&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.11%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="width: 30.43%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Weighted Average Fair&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;&lt;/span&gt;Value Per Share&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.21%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 33.07%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2020&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 0.97%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 33.21%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;86,982&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.11%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 2.36%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 28.07%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;104.69&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.21%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 33.07%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2019&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 0.97%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 33.21%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;91,682&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.11%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 2.36%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 28.07%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;104.85&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.21%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 33.07%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2018&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 0.97%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 33.21%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;93,801&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.11%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 2.36%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 28.07%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;78.63&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.21%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;During 2020, 2019 and 2018, the following shares were cancelled due to employee terminations prior to restrictions lapsing:&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="z7daa2e54ca844999961717e10e62abe6" style="font-family: 'Times New Roman'; font-size: 10pt; border-collapse: collapse; text-align: left; color: #000000; width: 100%; margin-left: auto; margin-right: auto;"&gt;
  &lt;tr&gt;
    &lt;td style="width: 33.06%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Year Cancelled&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 33.04%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Number of Shares&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.32%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="width: 30.36%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Weighted Average Fair&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;&lt;/span&gt;Value Per Share&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.22%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 33.06%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2020&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 33.04%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;10,037&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.32%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 2.23%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 28.13%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;102.52&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.22%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 33.06%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2019&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 33.04%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,578&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.32%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 2.23%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 28.13%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;87.88&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.22%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 33.06%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2018&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 33.04%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,867&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.32%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 2.23%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 28.13%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;59.51&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.22%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Generally, restrictions on the stock granted to employees lapse in equal annual installments on the following &lt;span style="-sec-ix-hidden:Fact_5193d5e0f71242e78d0ec8f60c9b56d8"&gt;four&lt;/span&gt; anniversaries of the date of grant. For those shares granted to directors, the restrictions will lapse in equal quarterly installments during the first year after the date of grant. For those granted to officers, the restriction will lapse in equal quarterly installments during the four years following the date of grant.&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;There were 127,562 and 150,771 shares outstanding as of December 31, 2020 and December 31, 2019 respectively, for which restrictions had not lapsed. The restrictions will lapse in 2021 through 2024.&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Compensation expense for grants of restricted stock is recognized based on the fair value on the date of grant. Compensation expense for restricted stock grants was $7.9 million, $5.9 million, and $5.0 million, respectively, for 2020, 2019 and 2018. As of December 31, 2020, the remaining $8.8 million of compensation expense will be recognized from 2021 through 2024.&lt;/div&gt;
</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c20201231_AwardTypeAxis_NonQualifiedStockOptionsMember_RangeAxis_MaximumMember"
      decimals="0"
      id="Fact_3985c2b255a0462fa6acb69da4cdd14b"
      unitRef="U002">600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c20201231_PlanNameAxis_AmendedTwoThousandThreePlanMember_RangeAxis_MaximumMember"
      decimals="0"
      id="Fact_64e16b49f3f14e2d8590d5d8c109eee7"
      unitRef="U002">2100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c20160316_PlanNameAxis_AmendedTwoThousandThreePlanMember"
      decimals="0"
      id="Fact_441ca605604c4b299e69df28ef59e6d0"
      unitRef="U002">1750000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c20160317_PlanNameAxis_AmendedTwoThousandThreePlanMember"
      decimals="0"
      id="Fact_b967085175794e508e0bad209d803040"
      unitRef="U002">2100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock
      contextRef="c20200101to20201231"
      id="Text_876112127aef4da68da7304fec5c63af">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;A cumulative summary of equity plans as of December 31, 2020 follows:&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="z0fd35d71f4c741a1afb5a3fdfe7e4755" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Authorized&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Restricted&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;&lt;/span&gt;Stock Issued&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Outstanding&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;&lt;/span&gt;Stock Options&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Stock Options&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;&lt;/span&gt;Exercised&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Stock Options&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;&lt;/span&gt;Exercisable&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Shares Available&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;&lt;/span&gt;for Grant&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;span style="text-decoration: underline;"&gt;Equity Plans&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 28%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Amended 1999 Plan&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;600,000&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;416,402&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;139,791&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;7,775&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 28%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Amended 2003 Plan&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,100,000&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,106,977&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;778,300&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;224,760&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 28%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,700,000&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,523,379&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;918,091&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;232,535&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;
</us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c20201231_PlanNameAxis_AmendedNineteenNinetyNinePlanMember"
      decimals="0"
      id="Fact_ef6f1ae9e8e046499ef25607c94f1376"
      unitRef="U002">600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod
      contextRef="c20201231_PlanNameAxis_AmendedNineteenNinetyNinePlanMember"
      decimals="0"
      id="Fact_169bf999606544038f198894c7869a73"
      unitRef="U002">416402</usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c20201231_PlanNameAxis_AmendedNineteenNinetyNinePlanMember"
      decimals="INF"
      id="Fact_a157782706e2459ea664bb327b2560fa"
      unitRef="U002">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod
      contextRef="c20201231_PlanNameAxis_AmendedNineteenNinetyNinePlanMember"
      decimals="0"
      id="Fact_7c31cd6f5e15476183edffe3ddc4b19d"
      unitRef="U002">139791</usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="c20201231_PlanNameAxis_AmendedNineteenNinetyNinePlanMember"
      decimals="INF"
      id="Fact_8899542c11784f63aaf237e696ed3c26"
      unitRef="U002">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c20201231_PlanNameAxis_AmendedNineteenNinetyNinePlanMember"
      decimals="0"
      id="Fact_8bcd168f7124473693b589ce80b380ed"
      unitRef="U002">7775</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c20201231_PlanNameAxis_AmendedTwoThousandThreePlanMember"
      decimals="0"
      id="Fact_a1a362aed6f84e28941057525e1ffff5"
      unitRef="U002">2100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod
      contextRef="c20201231_PlanNameAxis_AmendedTwoThousandThreePlanMember"
      decimals="0"
      id="Fact_0a091a8a67bd4d7f86c312b263185063"
      unitRef="U002">1106977</usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c20201231_PlanNameAxis_AmendedTwoThousandThreePlanMember"
      decimals="INF"
      id="Fact_f0ebc547108a44e290a61b2c5ab68b32"
      unitRef="U002">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod
      contextRef="c20201231_PlanNameAxis_AmendedTwoThousandThreePlanMember"
      decimals="0"
      id="Fact_89f5f086e881405aa26c9d258330bca8"
      unitRef="U002">778300</usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="c20201231_PlanNameAxis_AmendedTwoThousandThreePlanMember"
      decimals="INF"
      id="Fact_808cf5ca6ea14d018bce805c369bffac"
      unitRef="U002">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c20201231_PlanNameAxis_AmendedTwoThousandThreePlanMember"
      decimals="0"
      id="Fact_4b87cc8c3cd34ce5b7306bb27cdb278d"
      unitRef="U002">224760</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c20201231"
      decimals="0"
      id="Fact_a17c223a3e114d458e1ead6a28cc5ed1"
      unitRef="U002">2700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod
      contextRef="c20201231"
      decimals="0"
      id="Fact_cd9212355cce43ff90a4505736fdb567"
      unitRef="U002">1523379</usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c20201231"
      decimals="INF"
      id="Fact_5347ee97792e495da40fc60b2e86d370"
      unitRef="U002">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod
      contextRef="c20201231"
      decimals="0"
      id="Fact_d1a8b771e86543889f01bb8e025730ec"
      unitRef="U002">918091</usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="c20201231"
      decimals="INF"
      id="Fact_9e993450b5814d24862fa5a939687ebf"
      unitRef="U002">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c20201231"
      decimals="0"
      id="Fact_94b26a59e1f74bd7853f34bc187257e7"
      unitRef="U002">232535</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
      contextRef="c20200101to20201231"
      id="Text_4d762aba49a247b981f909ddec37c516">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;During 2020, 2019 and 2018, the Company granted the following shares of restricted stock to directors, officers and employees pursuant to its equity plans as follows:&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="z87259eaa26b8463e9d0de795ce96e698" style="font-family: 'Times New Roman'; font-size: 10pt; border-collapse: collapse; text-align: left; color: #000000; width: 100%; margin-left: auto; margin-right: auto;"&gt;
  &lt;tr&gt;
    &lt;td style="width: 33.07%; vertical-align: bottom; border-bottom: #000000 2px solid;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Year Granted&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 0.97%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 33.21%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Number of Shares&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.11%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="width: 30.43%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Weighted Average Fair&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;&lt;/span&gt;Value Per Share&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.21%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 33.07%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2020&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 0.97%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 33.21%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;86,982&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.11%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 2.36%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 28.07%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;104.69&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.21%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 33.07%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2019&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 0.97%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 33.21%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;91,682&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.11%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 2.36%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 28.07%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;104.85&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.21%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 33.07%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2018&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 0.97%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 33.21%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;93,801&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.11%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 2.36%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 28.07%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;78.63&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.21%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;During 2020, 2019 and 2018, the following shares were cancelled due to employee terminations prior to restrictions lapsing:&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="z7daa2e54ca844999961717e10e62abe6" style="font-family: 'Times New Roman'; font-size: 10pt; border-collapse: collapse; text-align: left; color: #000000; width: 100%; margin-left: auto; margin-right: auto;"&gt;
  &lt;tr&gt;
    &lt;td style="width: 33.06%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Year Cancelled&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 33.04%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Number of Shares&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.32%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="width: 30.36%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Weighted Average Fair&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;&lt;/span&gt;Value Per Share&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.22%; vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 33.06%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2020&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 33.04%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;10,037&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.32%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 2.23%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 28.13%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;102.52&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.22%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 33.06%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2019&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 33.04%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,578&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.32%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 2.23%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 28.13%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;87.88&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.22%; vertical-align: bottom; background-color: #FFFFFF;"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 33.06%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2018&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 33.04%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,867&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.32%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 2.23%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 28.13%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;59.51&lt;/div&gt;&lt;/td&gt;
    &lt;td style="width: 1.22%; vertical-align: bottom; background-color: #CCEEFF;"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;
</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c20200101to20201231_AwardTypeAxis_RestrictedStockMember"
      decimals="0"
      id="Fact_fc501d60d7e64fda9e983344ba5abbaa"
      unitRef="U002">86982</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c20200101to20201231_AwardTypeAxis_RestrictedStockMember"
      decimals="2"
      id="Fact_3ef44493ed4e4df48fa511e4e416351b"
      unitRef="U003">104.69</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c20190101to20191231_AwardTypeAxis_RestrictedStockMember"
      decimals="0"
      id="Fact_6d7f6250feb34fd7bd3386358b98c29b"
      unitRef="U002">91682</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c20190101to20191231_AwardTypeAxis_RestrictedStockMember"
      decimals="2"
      id="Fact_bc82d60fbf2e4afcbe8f56413e54aa9d"
      unitRef="U003">104.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c20180101to20181231_AwardTypeAxis_RestrictedStockMember"
      decimals="0"
      id="Fact_503c6c46bd6948e6a064a912a9bec944"
      unitRef="U002">93801</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c20180101to20181231_AwardTypeAxis_RestrictedStockMember"
      decimals="2"
      id="Fact_9da08f3067f543659303fc04cd8ee3c4"
      unitRef="U003">78.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c20200101to20201231_AwardTypeAxis_RestrictedStockMember"
      decimals="0"
      id="Fact_8aa1438e9c1843a39b449f2339031598"
      unitRef="U002">10037</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c20200101to20201231_AwardTypeAxis_RestrictedStockMember"
      decimals="2"
      id="Fact_1a3422c90a744ecc95b9b9f49b928371"
      unitRef="U003">102.52</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c20190101to20191231_AwardTypeAxis_RestrictedStockMember"
      decimals="0"
      id="Fact_6d536a56576b4c7fbd9908d14a53a210"
      unitRef="U002">1578</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c20190101to20191231_AwardTypeAxis_RestrictedStockMember"
      decimals="2"
      id="Fact_0aac4dc01b304c958419feda9de1aed1"
      unitRef="U003">87.88</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c20180101to20181231_AwardTypeAxis_RestrictedStockMember"
      decimals="0"
      id="Fact_734e261301904f3889c61b2cf6fce573"
      unitRef="U002">3867</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c20180101to20181231_AwardTypeAxis_RestrictedStockMember"
      decimals="2"
      id="Fact_3346237975354ef5a88bd0a7c92cc596"
      unitRef="U003">59.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <usph:RestrictedPeriodToEmployeesOnTheStockGranted
      contextRef="c20200101to20201231_TitleOfIndividualAxis_ExecutiveOfficerMember"
      id="Fact_4084f42379794911b400b8b7c70738de">P4Y</usph:RestrictedPeriodToEmployeesOnTheStockGranted>
    <usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed
      contextRef="c20201231"
      decimals="0"
      id="Fact_ac274efeef6e4790a0ae7f11c8858cfd"
      unitRef="U002">127562</usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed>
    <usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed
      contextRef="c20191231"
      decimals="0"
      id="Fact_91fc62550d9a435dac9e88edf4bb8706"
      unitRef="U002">150771</usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed>
    <usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription
      contextRef="c20200101to20201231_RangeAxis_MinimumMember"
      id="Fact_719eea96c71142a0a0c63af4fea1ff93">2021</usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription>
    <usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription
      contextRef="c20200101to20201231_RangeAxis_MaximumMember"
      id="Fact_72d85f1dc0bf40d687ea220145967e95">2024</usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20200101to20201231_AwardTypeAxis_RestrictedStockMember"
      decimals="-5"
      id="Fact_d468c9fbafe146e4b11a642937cbd845"
      unitRef="U001">7900000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20190101to20191231_AwardTypeAxis_RestrictedStockMember"
      decimals="-5"
      id="Fact_91d695488a7a490cb278702369ccf928"
      unitRef="U001">5900000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20180101to20181231_AwardTypeAxis_RestrictedStockMember"
      decimals="-5"
      id="Fact_b5f0ce9ebb0149108bf660b17b558bc6"
      unitRef="U001">5000000.0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="c20201231_AwardTypeAxis_RestrictedStockMember"
      decimals="-5"
      id="Fact_f50f56e8f05347118242893060c59058"
      unitRef="U001">8800000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:PreferredStockTextBlock
      contextRef="c20200101to20201231"
      id="Text_20c4b75f33924f45967eddb27eb036ae">
&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;14. Preferred Stock&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Board is empowered, without approval of the shareholders, to cause shares of preferred stock to be issued in one or more series and to establish the number of shares to be included in each such series and the rights, powers, preferences and limitations of each series. There are no provisions in the Company&#x2019;s Articles of Incorporation specifying the vote required by the holders of preferred stock to take action. All such provisions would be set out in the designation of any series of preferred stock established by the Board. The bylaws of the Company specify that, when a quorum is present at any meeting, the vote of the holders of at least a majority of the outstanding shares entitled to vote who are present, in person or by proxy, shall decide any question brought before the meeting, unless a different vote is required by law or the Company&#x2019;s Articles of Incorporation.&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Because the Board has the power to establish the preferences and rights of each series, it may afford the holders of any series of preferred stock, preferences, powers, and rights, voting or otherwise, senior to the right of holders of common stock. The issuance of the preferred stock could have the effect of delaying or preventing a change in control of the Company. &lt;/div&gt;
</us-gaap:PreferredStockTextBlock>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="c20200101to20201231"
      id="Text_f267c355657444dfb60c5e06091538a8">
&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;15. Common Stock&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;From September 2001 through December 31, 2008, the Board authorized the Company to purchase, in the open market or in privately negotiated transactions, up to 2,250,000 shares of the Company&#x2019;s common stock. In March 2009, the Board authorized the repurchase of up to 10% or approximately 1,200,000 shares of its common stock (&#x201c;March 2009 Authorization&#x201d;). The Amended Credit Agreement permits share repurchases of up to $15,000,000, subject to compliance with covenants. The Company is required to retire shares purchased under the March 2009 Authorization.&lt;/div&gt;

&lt;div style="text-align: left;"&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Under the March 2009 Authorization, the Company has purchased a total of 859,499 shares. There is no expiration date for the share repurchase program. There are currently an additional estimated 124,740 shares (based on the closing price of $120.25 on December 31, 2020, the last business day in 2020) that may be purchased from time to time in the open market or private transactions depending on price, availability and the Company&#x2019;s cash position. The Company did not purchase any shares of its common stock during 2020 or 2019. &lt;/div&gt;
</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="c20081231_RangeAxis_MaximumMember"
      decimals="0"
      id="Fact_65b2ed128518470c8ea8c7015ed729df"
      unitRef="U002">2250000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <usph:PercentageOfRepurchaseOfCommonStock
      contextRef="c20090331_RangeAxis_MaximumMember"
      decimals="2"
      id="Fact_099a00e2ab824221a58344111d3abee6"
      unitRef="U005">0.10</usph:PercentageOfRepurchaseOfCommonStock>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="c20090331_RangeAxis_MaximumMember"
      decimals="0"
      id="Fact_652e751e161e4ead8bc3200467199b43"
      unitRef="U002">1200000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <usph:BankCreditAgreementToPermitShareRepurchasesOfCommonStock
      contextRef="c20090331_RangeAxis_MaximumMember"
      decimals="0"
      id="Fact_e6d0b4410beb494bb733c659fe998dd1"
      unitRef="U001">15000000</usph:BankCreditAgreementToPermitShareRepurchasesOfCommonStock>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="c20090301to20090331"
      decimals="0"
      id="Fact_c327c14366294579ad991f5243fc0d0f"
      unitRef="U002">859499</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="c20200101to20201231"
      decimals="INF"
      id="Fact_d791795173ec4f9a9453291c5d6bdff2"
      unitRef="U002">0</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="c20190101to20191231"
      decimals="INF"
      id="Fact_660aa1198f0c43fdb8d73c3615f699d0"
      unitRef="U002">0</us-gaap:StockRepurchasedDuringPeriodShares>
    <usph:AdditionalEstimatedRepurchaseOfCommonStock
      contextRef="c20200101to20201231"
      decimals="0"
      id="Fact_f35c73e803434448aa97a58898fdeb9c"
      unitRef="U002">124740</usph:AdditionalEstimatedRepurchaseOfCommonStock>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c20201231"
      decimals="2"
      id="Fact_a3703f5afc7a451b884856c26faa95ae"
      unitRef="U003">120.25</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:CompensationAndEmployeeBenefitPlansTextBlock
      contextRef="c20200101to20201231"
      id="Text_1ba3d1fabc4c4376a36766319fe0c516">
&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;16. Defined Contribution Plan&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company has several 401(k) profit sharing plans covering all employees with three months of service. For certain plans, the Company makes matching contributions. The Company may also make discretionary contributions of up to 50% of employee contributions. The Company did not make any discretionary contributions for the years ended December 31, 2020, 2019 and 2018. The Company matching contributions totaled $1.9 million, $2.0 million and $1.8 million, respectively, for the years ended December 31, 2020, 2019 and 2018. &lt;/div&gt;
</us-gaap:CompensationAndEmployeeBenefitPlansTextBlock>
    <usph:DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan
      contextRef="c20200101to20201231"
      id="Fact_8c4f206f9c214f8cb0ad18f065146a5e">P3M</usph:DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
      contextRef="c20200101to20201231"
      decimals="2"
      id="Fact_fa35b081278041b38e99298a18997153"
      unitRef="U005">0.50</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="c20180101to20181231"
      decimals="-6"
      id="Fact_f2c6754687324734be8acb598b3bdaa2"
      unitRef="U001">0</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="c20190101to20191231"
      decimals="-6"
      id="Fact_c19e2846c6f94196a89cf18153961350"
      unitRef="U001">0</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="c20200101to20201231"
      decimals="-6"
      id="Fact_960aa92faa0c4553942f2d89f4bb2419"
      unitRef="U001">0</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <usph:DefinedContributionPlanEmployerMatchingContributionAmount
      contextRef="c20200101to20201231"
      decimals="-5"
      id="Fact_b4afe50fce964ab3addc6cf930572013"
      unitRef="U001">1900000</usph:DefinedContributionPlanEmployerMatchingContributionAmount>
    <usph:DefinedContributionPlanEmployerMatchingContributionAmount
      contextRef="c20190101to20191231"
      decimals="-5"
      id="Fact_13c80a23309c40d5a5dd3a21d72e78f4"
      unitRef="U001">2000000.0</usph:DefinedContributionPlanEmployerMatchingContributionAmount>
    <usph:DefinedContributionPlanEmployerMatchingContributionAmount
      contextRef="c20180101to20181231"
      decimals="-5"
      id="Fact_4e89a35babad45dfb6943f754e1a9dc8"
      unitRef="U001">1800000</usph:DefinedContributionPlanEmployerMatchingContributionAmount>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="c20200101to20201231"
      id="Text_953e716480224bbea825f6abf40f39a1">
&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;17. Commitments and Contingencies&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;We may be subject to litigation in the ordinary course of business.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"&gt;Employment Agreements&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;At December 31, 2020, the Company had outstanding employment agreements with four of its executive officers, one of whom (Mr. McDowell) has provided notice of a planned retirement in &lt;span style="-sec-ix-hidden:Fact_07fa882becbb4980afaa1f4e941716d5"&gt;August 2021&lt;/span&gt;. The three remaining agreements have terms that expire December 31, 2021, February 28, 2022 and November 8, 2022, respectively; however, each of these agreements provide for an automatic two year renewal at the conclusion of the expiring term or renewal term. All of the agreements contain a provision for annual adjustment of salaries.&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;In addition, the Company has outstanding employment agreements with most of the managing physical therapist partners of the Company&#x2019;s physical therapy clinics and with certain other clinic employees which obligate subsidiaries of the Company to pay compensation of $37.1 million in 2021 and $6.1 million in the aggregate from 2022 through 2024. In addition, many of the employment agreements with the managing physical therapists provide for monthly bonus payments calculated as a percentage of each clinic&#x2019;s net revenues (not in excess of operating profits) or operating profits. &lt;/div&gt;
</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <usph:NumberOfEmployeesCoveredUnderEmployeeAgreement
      contextRef="c20200101to20201231_TitleOfIndividualAxis_ExecutiveOfficerMember"
      decimals="INF"
      id="Fact_4cf5d82a9f4541a2a00c439f2332493a"
      unitRef="U018">4</usph:NumberOfEmployeesCoveredUnderEmployeeAgreement>
    <usph:EmploymentAgreementsExpirationDate
      contextRef="c20200101to20201231"
      id="Fact_18624bf7a9a44decae930e36928cc36f">2021-12-31</usph:EmploymentAgreementsExpirationDate>
    <usph:EmploymentAgreementsExpirationDateTwo
      contextRef="c20200101to20201231"
      id="Fact_ffbb8463e1af472f9812cca9373ccd2e">2022-02-28</usph:EmploymentAgreementsExpirationDateTwo>
    <usph:EmploymentAgreementsExpirationDateThree
      contextRef="c20200101to20201231"
      id="Fact_535608f30e80454986e9d187fab6e4a2">2022-11-08</usph:EmploymentAgreementsExpirationDateThree>
    <usph:RenewalPeriodForEmploymentAgreement
      contextRef="c20200101to20201231"
      id="Fact_7b6b5a6b9a614b75b24214f01f4716d8">P2Y</usph:RenewalPeriodForEmploymentAgreement>
    <usph:EmployeeCompensationFuturePaymentDueNextFiscalYear
      contextRef="c20201231"
      decimals="-5"
      id="Fact_9261da79a3c541cfa458fc9e3404a94b"
      unitRef="U001">37100000</usph:EmployeeCompensationFuturePaymentDueNextFiscalYear>
    <usph:EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter
      contextRef="c20201231"
      decimals="-5"
      id="Fact_5437408ea5cf46bd86ad05ec8fbb69a7"
      unitRef="U001">6100000</usph:EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="c20200101to20201231"
      id="Text_66af2a7b65ca4d13bc4fcd446b96f01a">
&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;18. Earnings Per Share&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The computations of basic and diluted earnings per share for the years ended December 31, 2020, 2019 and 2018 are as follows (in thousands, except per share data):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="z70cf1bf066894e77938a1c395afa0aa6" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Year Ended&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2020&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2019&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2018&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Computation of earnings per share - USPH shareholders:&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Net income attributable to USPH shareholders&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;35,194&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;40,039&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;34,873&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Credit (charges) to retained earnings:&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Revaluation of redeemable non-controlling interest&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(4,632&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(11,893&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(24,770&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Tax effect at statutory rate (federal and state) of 26.25%&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,216&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,121&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;6,502&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;31,778&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;31,267&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;16,605&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Earnings per share (basic and diluted)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2.48&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2.45&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1.31&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Shares used in computation:&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Basic and diluted earnings per share - weighted-average shares&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;12,835&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;12,756&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;12,666&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;
</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="c20200101to20201231"
      id="Text_61234a90ba0d4e71acf5d83808f98795">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The computations of basic and diluted earnings per share for the years ended December 31, 2020, 2019 and 2018 are as follows (in thousands, except per share data):&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="z70cf1bf066894e77938a1c395afa0aa6" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Year Ended&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2020&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2019&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;December 31, 2018&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Computation of earnings per share - USPH shareholders:&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Net income attributable to USPH shareholders&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;35,194&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;40,039&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;34,873&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Credit (charges) to retained earnings:&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Revaluation of redeemable non-controlling interest&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(4,632&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(11,893&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(24,770&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;)&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Tax effect at statutory rate (federal and state) of 26.25%&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1,216&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;3,121&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;6,502&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;31,778&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;31,267&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;16,605&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Earnings per share (basic and diluted)&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2.48&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2.45&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;1.31&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Shares used in computation:&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; padding-bottom: 4px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Basic and diluted earnings per share - weighted-average shares&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;12,835&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;12,756&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;12,666&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;
</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_0ab6b252d7ac4bab9fc9970db10bd550"
      unitRef="U001">35194000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_46969e4514b74ae0848fc5eaa3babd71"
      unitRef="U001">40039000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_77177f47e5f34bee9595b98afcaa8012"
      unitRef="U001">34873000</us-gaap:NetIncomeLoss>
    <usph:ChargesToRetainedEarningsRevaluationOfNonControllingInterests
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_fd7acffd68134c9ba2ce0b06723fb0b9"
      unitRef="U001">-4632000</usph:ChargesToRetainedEarningsRevaluationOfNonControllingInterests>
    <usph:ChargesToRetainedEarningsRevaluationOfNonControllingInterests
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_d5fb04dd6c6f41dca76120050e5f8a66"
      unitRef="U001">-11893000</usph:ChargesToRetainedEarningsRevaluationOfNonControllingInterests>
    <usph:ChargesToRetainedEarningsRevaluationOfNonControllingInterests
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_28e86f9d3b034b7390c095a7d375e8b2"
      unitRef="U001">-24770000</usph:ChargesToRetainedEarningsRevaluationOfNonControllingInterests>
    <usph:EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate
      contextRef="c20200101to20201231"
      decimals="4"
      id="Fact_e8f186a3266e48e499653cf664890ee2"
      unitRef="U005">0.2625</usph:EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate>
    <usph:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_d2bf87cd23664446980cf054fda6c8b0"
      unitRef="U001">-1216000</usph:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate>
    <usph:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_191e006d46954a0d920eb71ed6ba9eff"
      unitRef="U001">-3121000</usph:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate>
    <usph:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_c299e6d3935142d5a925f87378018961"
      unitRef="U001">-6502000</usph:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate>
    <usph:IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_fba7460321e0499db8b7f706b13913d7"
      unitRef="U001">31778000</usph:IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests>
    <usph:IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_20990620da0c4b90a40520547973ac41"
      unitRef="U001">31267000</usph:IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests>
    <usph:IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_d3f0089fe57a417582698b7d08e6bf9e"
      unitRef="U001">16605000</usph:IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="c20200101to20201231"
      decimals="2"
      id="Fact_3240d35a26a74ad39f4d745a84cf5745"
      unitRef="U003">2.48</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="c20190101to20191231"
      decimals="2"
      id="Fact_b721a77640904bdfb9cd9c4e27184e35"
      unitRef="U003">2.45</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="c20180101to20181231"
      decimals="2"
      id="Fact_e8d01cf0a8ae4ed7bf947f5b443521af"
      unitRef="U003">1.31</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_55c08d082c5245488d18a9bfbaa41391"
      unitRef="U002">12835000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="c20190101to20191231"
      decimals="-3"
      id="Fact_891e150d639948f597b5cc0dbfae48e8"
      unitRef="U002">12756000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="c20180101to20181231"
      decimals="-3"
      id="Fact_57b19fe8eeb849ed9a13334a485ab097"
      unitRef="U002">12666000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock
      contextRef="c20200101to20201231"
      id="Text_1d56677262dd45f3b7d5d3ccffff37f8">
&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;FINANCIAL STATEMENT SCHEDULE*&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;&lt;/span&gt;SCHEDULE II &#x2014; VALUATION AND QUALIFYING ACCOUNTS&lt;span style="font-size: 10pt; font-family: 'Times New Roman';"&gt;&lt;br/&gt;&lt;/span&gt;U.S. PHYSICAL THERAPY, INC. AND SUBSIDIARIES&lt;/div&gt;

&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;(In Thousands)&lt;/div&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" id="z0dc91a2b2ca3420693ba57e50a133eae" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Balance at&lt;/div&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Beginning of Period&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Additions Charged&lt;/div&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;to Costs and Expenses&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Additions Charged&lt;/div&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;to Other Accounts&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Deductions&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Balance at&lt;/div&gt;&lt;div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;End of Period&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;YEAR ENDED DECEMBER 31, 2020:&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Reserves and allowances deducted from asset accounts:&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 40%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Allowance for credit losses&lt;sup&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,698&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,623&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;5,313&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;sup&gt;(2)&lt;/sup&gt;&#160;&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,008&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 40%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;YEAR ENDED DECEMBER 31, 2019:&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 40%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Reserves and allowances deducted from asset accounts:&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 40%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Allowance for credit losses&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,672&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,858&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,832&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;sup&gt;(2)&lt;/sup&gt;&#160;&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,698&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 40%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;YEAR ENDED DECEMBER 31, 2018:&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 40%;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Reserves and allowances deducted from asset accounts:&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 40%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Allowance for credit losses&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,273&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,603&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;4,204&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;sup&gt;(2)&lt;/sup&gt;&#160;&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;$&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;2,672&lt;/div&gt;&lt;/td&gt;
    &lt;td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;hr style="height: 2px; width: 20%; color: #000000; background-color: #000000; text-align: left; border: none; margin-left: 0px; margin-right: auto;"/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" id="zb21ebc1e542b426880671b0df7e72f56" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;
  &lt;tr&gt;
    &lt;td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(1)&lt;/td&gt;
    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Related to patient accounts receivable and accounts receivable-other.&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" id="zdfe066ff46504f55890afc338c74a818" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;
  &lt;tr&gt;
    &lt;td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;(2)&lt;/td&gt;
    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Uncollectible accounts written off, net of recoveries.&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" id="za82c941ee7854b2b9941fe778592b572" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"&gt;
  &lt;tr&gt;
    &lt;td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;*&lt;/td&gt;
    &lt;td style="width: auto; vertical-align: top; text-align: left;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"&gt;All other schedules are omitted because of the absence of conditions under which they are required or because the required information is shown in the financial statements or notes thereto.&lt;/div&gt;&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;
</srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="c20191231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember"
      decimals="-3"
      id="Fact_bb699c43da284af58e2748b717ff4b1b"
      unitRef="U001">2698000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="c20200101to20201231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember"
      decimals="-3"
      id="Fact_b19a53519bab4348911ce11f977f1667"
      unitRef="U001">4623000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="c20200101to20201231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember"
      decimals="-3"
      id="Fact_c9284f57288c4ed9a5b4a222fc4e71e4"
      unitRef="U001">0</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="c20200101to20201231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember"
      decimals="-3"
      id="Fact_5fde58692cd0441b89744b3b76fd84f8"
      unitRef="U001">5313000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="c20201231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember"
      decimals="-3"
      id="Fact_e131ad63ad1041799466edcdc9c10b29"
      unitRef="U001">2008000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="c20181231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember"
      decimals="-3"
      id="Fact_50866eb3b6c24bbfb0f7835e0795cafb"
      unitRef="U001">2672000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="c20190101to20191231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember"
      decimals="-3"
      id="Fact_ac52836920bf4899a0f3620e5d603e80"
      unitRef="U001">4858000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="c20190101to20191231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember"
      decimals="-3"
      id="Fact_ae62d03c79b64b4c9914d39255367290"
      unitRef="U001">0</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="c20190101to20191231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember"
      decimals="-3"
      id="Fact_ae81df1cdd664746aa4f7c582ca0406a"
      unitRef="U001">4832000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="c20191231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember"
      decimals="-3"
      id="Fact_acda1d90e3084f70a5e7d63ba76fcd72"
      unitRef="U001">2698000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="c20171231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember"
      decimals="-3"
      id="Fact_c5e00a2974b8449ba922b73e3f7e8b5c"
      unitRef="U001">2273000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="c20180101to20181231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember"
      decimals="-3"
      id="Fact_0e55fc8f7d934f33b82a3e9c7e31db06"
      unitRef="U001">4603000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts
      contextRef="c20180101to20181231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember"
      decimals="-3"
      id="Fact_0d31b70118414194a243aa683dd6cd8f"
      unitRef="U001">0</us-gaap:ValuationAllowancesAndReservesChargedToOtherAccounts>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="c20180101to20181231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember"
      decimals="-3"
      id="Fact_1f7983ae02f14d5eaa69d3a489cef97f"
      unitRef="U001">4204000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="c20181231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember"
      decimals="-3"
      id="Fact_6d0626e30596466db88668abd78c404a"
      unitRef="U001">2672000</us-gaap:ValuationAllowancesAndReservesBalance>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact_3b1220179ecd4076b3fbc66ee0581ec9"
          xlink:label="Fact_3b1220179ecd4076b3fbc66ee0581ec9"
          xlink:type="locator"/>
        <link:footnote id="Foot_09a4cffadb2444b88d15b3ec81bd76d1" xlink:label="Foot_09a4cffadb2444b88d15b3ec81bd76d1" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Industrial injury prevention services</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_3b1220179ecd4076b3fbc66ee0581ec9"
          xlink:to="Foot_09a4cffadb2444b88d15b3ec81bd76d1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_eee67263780a49acaa0581ec533a3e2a"
          xlink:label="Fact_eee67263780a49acaa0581ec533a3e2a"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_eee67263780a49acaa0581ec533a3e2a"
          xlink:to="Foot_09a4cffadb2444b88d15b3ec81bd76d1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_69726b880894406db2f8a42ee390913d"
          xlink:label="Fact_69726b880894406db2f8a42ee390913d"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_69726b880894406db2f8a42ee390913d"
          xlink:to="Foot_09a4cffadb2444b88d15b3ec81bd76d1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_8cff895473e241e59d08ae7680b476bc"
          xlink:label="Fact_8cff895473e241e59d08ae7680b476bc"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_8cff895473e241e59d08ae7680b476bc"
          xlink:to="Foot_09a4cffadb2444b88d15b3ec81bd76d1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_a9bd169930b446c6aabd97b8503b9e92"
          xlink:label="Fact_a9bd169930b446c6aabd97b8503b9e92"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_a9bd169930b446c6aabd97b8503b9e92"
          xlink:to="Foot_09a4cffadb2444b88d15b3ec81bd76d1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_6d1cfd3236f143b99ad407ad2c842c35"
          xlink:label="Fact_6d1cfd3236f143b99ad407ad2c842c35"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_6d1cfd3236f143b99ad407ad2c842c35"
          xlink:to="Foot_09a4cffadb2444b88d15b3ec81bd76d1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_1c91e22e04a04be59bf9c144d53a2b33"
          xlink:label="Fact_1c91e22e04a04be59bf9c144d53a2b33"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_1c91e22e04a04be59bf9c144d53a2b33"
          xlink:to="Foot_09a4cffadb2444b88d15b3ec81bd76d1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_4aa84586d91a445394a1e77ae4ad8e6a"
          xlink:label="Fact_4aa84586d91a445394a1e77ae4ad8e6a"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_4aa84586d91a445394a1e77ae4ad8e6a"
          xlink:to="Foot_09a4cffadb2444b88d15b3ec81bd76d1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_71db7b39649a460f8cbeab4608e180da"
          xlink:label="Fact_71db7b39649a460f8cbeab4608e180da"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_71db7b39649a460f8cbeab4608e180da"
          xlink:to="Foot_09a4cffadb2444b88d15b3ec81bd76d1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_cf8bc979288c40a7972a4f53552b1ec9"
          xlink:label="Fact_cf8bc979288c40a7972a4f53552b1ec9"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_cf8bc979288c40a7972a4f53552b1ec9"
          xlink:to="Foot_09a4cffadb2444b88d15b3ec81bd76d1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_69f109e55bc142d7adbb5f8d48c32af4"
          xlink:label="Fact_69f109e55bc142d7adbb5f8d48c32af4"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_69f109e55bc142d7adbb5f8d48c32af4"
          xlink:to="Foot_09a4cffadb2444b88d15b3ec81bd76d1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_0146285d8d254416a7685fa0372d43c7"
          xlink:label="Fact_0146285d8d254416a7685fa0372d43c7"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_0146285d8d254416a7685fa0372d43c7"
          xlink:to="Foot_09a4cffadb2444b88d15b3ec81bd76d1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_f4ccac10433342e882be0539ab3cc980"
          xlink:label="Fact_f4ccac10433342e882be0539ab3cc980"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_f4ccac10433342e882be0539ab3cc980"
          xlink:to="Foot_09a4cffadb2444b88d15b3ec81bd76d1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_97c36c006efd4508940b439ef40e5fd4"
          xlink:label="Fact_97c36c006efd4508940b439ef40e5fd4"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_97c36c006efd4508940b439ef40e5fd4"
          xlink:to="Foot_09a4cffadb2444b88d15b3ec81bd76d1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_be63fda669ef48c48951108c9fa8d90d"
          xlink:label="Fact_be63fda669ef48c48951108c9fa8d90d"
          xlink:type="locator"/>
        <link:footnote id="Foot_089e16638e954876a030f33789a71503" xlink:label="Foot_089e16638e954876a030f33789a71503" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The four clinics are in four separate partnerships. The Company's interest in the four partnerships range from 10.0% to 83.8%, with an overall 65.0% based on the initial purchase transaction.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_be63fda669ef48c48951108c9fa8d90d"
          xlink:to="Foot_089e16638e954876a030f33789a71503"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_0320094539f74ee99f3fbef241f00d39"
          xlink:label="Fact_0320094539f74ee99f3fbef241f00d39"
          xlink:type="locator"/>
        <link:footnote id="Foot_c17d1a5ce0344dbb9898dd830df565d6" xlink:label="Foot_c17d1a5ce0344dbb9898dd830df565d6" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The four clinics are in four separate partnerships.&#160; The Company's interest in the four partnerships range from 10.0% to 83.8%, with an overall 65.0% based on the initial purchase transaction.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_0320094539f74ee99f3fbef241f00d39"
          xlink:to="Foot_c17d1a5ce0344dbb9898dd830df565d6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_bfd896794afb43ceb5f52155240c54ac"
          xlink:label="Fact_bfd896794afb43ceb5f52155240c54ac"
          xlink:type="locator"/>
        <link:footnote id="Foot_aeaed244265844d580a05be145ffd595" xlink:label="Foot_aeaed244265844d580a05be145ffd595" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Sublease income was immaterial</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_bfd896794afb43ceb5f52155240c54ac"
          xlink:to="Foot_aeaed244265844d580a05be145ffd595"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_87de7115dd224e8ab5349b8ca49d2604"
          xlink:label="Fact_87de7115dd224e8ab5349b8ca49d2604"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_87de7115dd224e8ab5349b8ca49d2604"
          xlink:to="Foot_aeaed244265844d580a05be145ffd595"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_74729e999361491e8eb1757c704e74be"
          xlink:label="Fact_74729e999361491e8eb1757c704e74be"
          xlink:type="locator"/>
        <link:footnote id="Foot_b182115cb6ef4d009deff873b8909b51" xlink:label="Foot_b182115cb6ef4d009deff873b8909b51" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The business includes six management and services contracts which had a remaining term of approximately five years as of the date acquired.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_74729e999361491e8eb1757c704e74be"
          xlink:to="Foot_b182115cb6ef4d009deff873b8909b51"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_29c0aadade644e9a962b7bfbcb82c179"
          xlink:label="Fact_29c0aadade644e9a962b7bfbcb82c179"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_29c0aadade644e9a962b7bfbcb82c179"
          xlink:to="Foot_b182115cb6ef4d009deff873b8909b51"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_500b5cc37a5c47c6ab25797c123a9f6e"
          xlink:label="Fact_500b5cc37a5c47c6ab25797c123a9f6e"
          xlink:type="locator"/>
        <link:footnote id="Foot_2ef12113298047418d3d8f899b71e83a" xlink:label="Foot_2ef12113298047418d3d8f899b71e83a" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes the right-of-use assets obtained in exchange for lease liabilities for the year 2019 - $82.6 million which were recognized upon adoption of ASC Topic 842 at January 1, 2019.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_500b5cc37a5c47c6ab25797c123a9f6e"
          xlink:to="Foot_2ef12113298047418d3d8f899b71e83a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_8f96c3837ba5401590c591d7e2b74710"
          xlink:label="Fact_8f96c3837ba5401590c591d7e2b74710"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_8f96c3837ba5401590c591d7e2b74710"
          xlink:to="Foot_2ef12113298047418d3d8f899b71e83a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_bb699c43da284af58e2748b717ff4b1b"
          xlink:label="Fact_bb699c43da284af58e2748b717ff4b1b"
          xlink:type="locator"/>
        <link:footnote id="Foot_c1daa8198f5247f8b265a5b321d9c423" xlink:label="Foot_c1daa8198f5247f8b265a5b321d9c423" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Related to patient accounts receivable and accounts receivable-other.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_bb699c43da284af58e2748b717ff4b1b"
          xlink:to="Foot_c1daa8198f5247f8b265a5b321d9c423"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_e131ad63ad1041799466edcdc9c10b29"
          xlink:label="Fact_e131ad63ad1041799466edcdc9c10b29"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_e131ad63ad1041799466edcdc9c10b29"
          xlink:to="Foot_c1daa8198f5247f8b265a5b321d9c423"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_c9284f57288c4ed9a5b4a222fc4e71e4"
          xlink:label="Fact_c9284f57288c4ed9a5b4a222fc4e71e4"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_c9284f57288c4ed9a5b4a222fc4e71e4"
          xlink:to="Foot_c1daa8198f5247f8b265a5b321d9c423"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_b19a53519bab4348911ce11f977f1667"
          xlink:label="Fact_b19a53519bab4348911ce11f977f1667"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_b19a53519bab4348911ce11f977f1667"
          xlink:to="Foot_c1daa8198f5247f8b265a5b321d9c423"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_5fde58692cd0441b89744b3b76fd84f8"
          xlink:label="Fact_5fde58692cd0441b89744b3b76fd84f8"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_5fde58692cd0441b89744b3b76fd84f8"
          xlink:to="Foot_c1daa8198f5247f8b265a5b321d9c423"
          xlink:type="arc"/>
        <link:footnote id="Foot_48f584180c61464eac6330240454329a" xlink:label="Foot_48f584180c61464eac6330240454329a" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Uncollectible accounts written off, net of recoveries.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_5fde58692cd0441b89744b3b76fd84f8"
          xlink:to="Foot_48f584180c61464eac6330240454329a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_ae81df1cdd664746aa4f7c582ca0406a"
          xlink:label="Fact_ae81df1cdd664746aa4f7c582ca0406a"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_ae81df1cdd664746aa4f7c582ca0406a"
          xlink:to="Foot_48f584180c61464eac6330240454329a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_1f7983ae02f14d5eaa69d3a489cef97f"
          xlink:label="Fact_1f7983ae02f14d5eaa69d3a489cef97f"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_1f7983ae02f14d5eaa69d3a489cef97f"
          xlink:to="Foot_48f584180c61464eac6330240454329a"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438849526472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 01, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover page.</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">U S PHYSICAL THERAPY INC /NV<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000885978<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-11151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">76-0364866<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1300 WEST SAM HOUSTON PARKWAY SOUTH<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">SUITE 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">HOUSTON<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">77042<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">713<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">297-7000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $.01 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">USPH<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 565.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,897,096<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 20-F, 40-F<br> -Number 240<br> -Section 15<br> -Subsection d-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1-<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438849602152">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 32,918<span></span>
</td>
<td class="nump">$ 23,548<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Patient accounts receivable, less allowance for credit losses of $2,008 and $2,698, respectively</a></td>
<td class="nump">41,906<span></span>
</td>
<td class="nump">46,228<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsAndOtherReceivablesNetCurrent', window );">Accounts receivable - other</a></td>
<td class="nump">9,039<span></span>
</td>
<td class="nump">9,823<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">3,773<span></span>
</td>
<td class="nump">5,787<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">87,636<span></span>
</td>
<td class="nump">85,386<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Fixed assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FurnitureAndFixturesGross', window );">Furniture and equipment</a></td>
<td class="nump">55,426<span></span>
</td>
<td class="nump">54,942<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseholdImprovementsGross', window );">Leasehold improvements</a></td>
<td class="nump">35,320<span></span>
</td>
<td class="nump">33,247<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Fixed assets, gross</a></td>
<td class="nump">90,746<span></span>
</td>
<td class="nump">88,189<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation and amortization</a></td>
<td class="nump">69,081<span></span>
</td>
<td class="nump">66,099<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Fixed assets, net</a></td>
<td class="nump">21,665<span></span>
</td>
<td class="nump">22,090<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">81,595<span></span>
</td>
<td class="nump">81,586<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">345,646<span></span>
</td>
<td class="nump">317,676<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other identifiable intangible assets, net</a></td>
<td class="nump">56,280<span></span>
</td>
<td class="nump">52,588<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">1,539<span></span>
</td>
<td class="nump">1,519<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">594,361<span></span>
</td>
<td class="nump">560,845<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Accounts payable - trade</a></td>
<td class="nump">1,335<span></span>
</td>
<td class="nump">2,494<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">59,746<span></span>
</td>
<td class="nump">30,855<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">27,512<span></span>
</td>
<td class="nump">26,486<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of notes payable</a></td>
<td class="nump">4,899<span></span>
</td>
<td class="nump">728<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">93,492<span></span>
</td>
<td class="nump">60,563<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermNotesPayable', window );">Notes payable, net of current portion</a></td>
<td class="nump">596<span></span>
</td>
<td class="nump">4,361<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermLineOfCredit', window );">Revolving line of credit</a></td>
<td class="nump">16,000<span></span>
</td>
<td class="nump">46,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred taxes</a></td>
<td class="nump">7,779<span></span>
</td>
<td class="nump">10,071<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, net of current portion</a></td>
<td class="nump">61,985<span></span>
</td>
<td class="nump">60,258<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">4,539<span></span>
</td>
<td class="nump">141<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">184,391<span></span>
</td>
<td class="nump">181,394<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable non-controlling interests - temporary equity</a></td>
<td class="nump">132,340<span></span>
</td>
<td class="nump">137,750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies (Note 17)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>U.S. Physical Therapy, Inc. ("USPH") shareholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $.01 par value, 500,000 shares authorized, no shares issued and outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $.01 par value, 20,000,000 shares authorized, 15,066,282 and 14,989,337 shares issued, respectively</a></td>
<td class="nump">151<span></span>
</td>
<td class="nump">150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">95,622<span></span>
</td>
<td class="nump">87,383<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">212,015<span></span>
</td>
<td class="nump">184,352<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock at cost, 2,214,737 shares</a></td>
<td class="num">(31,628)<span></span>
</td>
<td class="num">(31,628)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total USPH shareholders' equity</a></td>
<td class="nump">276,160<span></span>
</td>
<td class="nump">240,257<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Non-controlling interests - permanent equity</a></td>
<td class="nump">1,470<span></span>
</td>
<td class="nump">1,444<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total USPH shareholders' equity and non-controlling interests</a></td>
<td class="nump">277,630<span></span>
</td>
<td class="nump">241,701<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, redeemable non-controlling interests, USPH shareholders' equity and non-controlling interests</a></td>
<td class="nump">$ 594,361<span></span>
</td>
<td class="nump">$ 560,845<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsAndOtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsAndOtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FurnitureAndFixturesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FurnitureAndFixturesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseholdImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseholdImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermLineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1336-112600<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1314-112600<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermLineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438940854104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for credit losses, patient accounts receivable</a></td>
<td class="nump">$ 2,008<span></span>
</td>
<td class="nump">$ 2,698<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>U. S. Physical Therapy, Inc. shareholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">15,066,282<span></span>
</td>
<td class="nump">14,989,337<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, shares (in shares)</a></td>
<td class="nump">2,214,737<span></span>
</td>
<td class="nump">2,214,737<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438850281416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF INCOME - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">$ 422,969<span></span>
</td>
<td class="nump">$ 481,969<span></span>
</td>
<td class="nump">$ 453,911<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Operating costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LaborAndRelatedExpense', window );">Salaries and related costs</a></td>
<td class="nump">235,629<span></span>
</td>
<td class="nump">274,233<span></span>
</td>
<td class="nump">259,228<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RentSuppliesContractLaborAndOther', window );">Rent, supplies, contract labor and other</a></td>
<td class="nump">84,336<span></span>
</td>
<td class="nump">90,379<span></span>
</td>
<td class="nump">88,426<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for credit losses</a></td>
<td class="nump">4,623<span></span>
</td>
<td class="nump">4,858<span></span>
</td>
<td class="nump">4,603<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Closure costs - lease and other</a></td>
<td class="nump">2,072<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Closure costs - derecognition of goodwill</a></td>
<td class="nump">1,859<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating costs</a></td>
<td class="nump">328,519<span></span>
</td>
<td class="nump">369,495<span></span>
</td>
<td class="nump">352,248<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">94,450<span></span>
</td>
<td class="nump">112,474<span></span>
</td>
<td class="nump">101,663<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Corporate office costs</a></td>
<td class="nump">42,037<span></span>
</td>
<td class="nump">45,049<span></span>
</td>
<td class="nump">41,349<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">52,413<span></span>
</td>
<td class="nump">67,425<span></span>
</td>
<td class="nump">60,314<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other income and expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ReliefFunds', window );">Relief funds</a></td>
<td class="nump">13,501<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfInterestInProjects', window );">Gain on sale of partnership interest and clinics</a></td>
<td class="nump">1,091<span></span>
</td>
<td class="nump">5,514<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on derecognition of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,846<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestAndOtherIncome', window );">Interest and other income, net</a></td>
<td class="nump">142<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="nump">93<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_InterestExpenseDebtAndOther', window );">Interest expense - debt and other</a></td>
<td class="num">(1,634)<span></span>
</td>
<td class="num">(2,079)<span></span>
</td>
<td class="num">(2,042)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income and expense</a></td>
<td class="nump">13,100<span></span>
</td>
<td class="nump">3,481<span></span>
</td>
<td class="num">(103)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before taxes</a></td>
<td class="nump">65,513<span></span>
</td>
<td class="nump">70,906<span></span>
</td>
<td class="nump">60,211<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">13,022<span></span>
</td>
<td class="nump">13,647<span></span>
</td>
<td class="nump">11,369<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">52,491<span></span>
</td>
<td class="nump">57,259<span></span>
</td>
<td class="nump">48,842<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract', window );"><strong>Less: net income attributable to non-controlling interests:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity', window );">Non-controlling interests - permanent equity</a></td>
<td class="num">(6,122)<span></span>
</td>
<td class="num">(6,561)<span></span>
</td>
<td class="num">(5,536)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity', window );">Redeemable non-controlling interests - temporary equity</a></td>
<td class="num">(11,175)<span></span>
</td>
<td class="num">(10,659)<span></span>
</td>
<td class="num">(8,433)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to non-controlling interests</a></td>
<td class="num">(17,297)<span></span>
</td>
<td class="num">(17,220)<span></span>
</td>
<td class="num">(13,969)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to USPH shareholders</a></td>
<td class="nump">$ 35,194<span></span>
</td>
<td class="nump">$ 40,039<span></span>
</td>
<td class="nump">$ 34,873<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted earnings per share attributable to USPH shareholders (in dollars per share)</a></td>
<td class="nump">$ 2.48<span></span>
</td>
<td class="nump">$ 2.45<span></span>
</td>
<td class="nump">$ 1.31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Shares used in computation - basic and diluted (in shares)</a></td>
<td class="nump">12,835<span></span>
</td>
<td class="nump">12,756<span></span>
</td>
<td class="nump">12,666<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per common share (in dollars per share)</a></td>
<td class="nump">$ 0.32<span></span>
</td>
<td class="nump">$ 1.14<span></span>
</td>
<td class="nump">$ 0.92<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=usph_NetPatientRevenuesMember', window );">Net Patient Revenues [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">$ 373,340<span></span>
</td>
<td class="nump">$ 433,345<span></span>
</td>
<td class="nump">$ 417,703<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember', window );">Other Revenues [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">$ 49,629<span></span>
</td>
<td class="nump">$ 48,624<span></span>
</td>
<td class="nump">$ 36,208<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfInterestInProjects">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (loss) included in earnings resulting from the sale of interest in projects.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfInterestInProjects</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndOtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndOtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LaborAndRelatedExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LaborAndRelatedExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_InterestExpenseDebtAndOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt related expenses and other expenses associated with nonoperating financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_InterestExpenseDebtAndOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to redeemable noncontrolling interest temporary equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ReliefFunds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Relief funds relates to social welfare, a fund of money set up to provide aid for people in need, especially in disaster areas.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ReliefFunds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_RentSuppliesContractLaborAndOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to rent, supplies, contract labor and other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_RentSuppliesContractLaborAndOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=usph_NetPatientRevenuesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=usph_NetPatientRevenuesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438931666584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-In Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Treasury Stock [Member]</div></th>
<th class="th"><div>Total Shareholders' Equity [Member]</div></th>
<th class="th"><div>Non-Controlling Interests [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2017</a></td>
<td class="nump">$ 148<span></span>
</td>
<td class="nump">$ 73,940<span></span>
</td>
<td class="nump">$ 162,406<span></span>
</td>
<td class="num">$ (31,628)<span></span>
</td>
<td class="nump">$ 204,866<span></span>
</td>
<td class="nump">$ 1,204<span></span>
</td>
<td class="nump">$ 206,070<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2017</a></td>
<td class="nump">14,809<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,215)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of cancellations</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of cancellations (in shares)</a></td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RevaluationOfRedeemableNonControllingInterestNetOfTax', window );">Revaluation of redeemable non-controlling interest, net of tax</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(18,268)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(18,268)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(18,268)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares', window );">Revaluation of redeemable non-controlling interest, net of tax (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Compensation expense - equity-based awards</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">5,939<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">5,939<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,939<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans', window );">Transfer of compensation liability for certain stock issued pursuant to long-term incentive plans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">373<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">373<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">373<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_SaleOfNonControllingInterestNetOfTaxAndPurchases', window );">Sale of non-controlling interest, net of purchases and tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(224)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(224)<span></span>
</td>
<td class="num">(48)<span></span>
</td>
<td class="num">(272)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends paid to USPT shareholders</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(11,664)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(11,664)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(11,664)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to non-controlling interest partners - permanent equity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(5,812)<span></span>
</td>
<td class="num">(5,812)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="nump">99<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity', window );">Net income attributable to non-controlling interest - permanent equity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,536<span></span>
</td>
<td class="nump">5,536<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to USPH shareholders</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">34,873<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">34,873<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">34,873<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2018</a></td>
<td class="nump">$ 149<span></span>
</td>
<td class="nump">80,028<span></span>
</td>
<td class="nump">167,396<span></span>
</td>
<td class="num">$ (31,628)<span></span>
</td>
<td class="nump">215,945<span></span>
</td>
<td class="nump">930<span></span>
</td>
<td class="nump">216,875<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2018</a></td>
<td class="nump">14,899<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,215)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of cancellations</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of cancellations (in shares)</a></td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RevaluationOfRedeemableNonControllingInterestNetOfTax', window );">Revaluation of redeemable non-controlling interest, net of tax</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(8,771)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(8,771)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(8,771)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares', window );">Revaluation of redeemable non-controlling interest, net of tax (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Compensation expense - equity-based awards</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">6,985<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">6,985<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,985<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans', window );">Transfer of compensation liability for certain stock issued pursuant to long-term incentive plans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">636<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">636<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">636<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PurchaseOfPartnershipInterestsRedeemableNonControllingInterests', window );">Purchase of partnership interests - redeemable non-controlling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(266)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(266)<span></span>
</td>
<td class="num">(26)<span></span>
</td>
<td class="num">(292)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_SaleOfNonControllingInterestNetOfTaxAndPurchases', window );">Sale of non-controlling interest, net of purchases and tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">196<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">196<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">196<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends paid to USPT shareholders</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(14,555)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(14,555)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(14,555)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to non-controlling interest partners - permanent equity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(6,014)<span></span>
</td>
<td class="num">(6,014)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity', window );">Net income attributable to non-controlling interest - permanent equity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,561<span></span>
</td>
<td class="nump">6,561<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to USPH shareholders</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">40,039<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">40,039<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">40,039<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2019</a></td>
<td class="nump">$ 150<span></span>
</td>
<td class="nump">87,383<span></span>
</td>
<td class="nump">184,352<span></span>
</td>
<td class="num">$ (31,628)<span></span>
</td>
<td class="nump">240,257<span></span>
</td>
<td class="nump">1,444<span></span>
</td>
<td class="nump">241,701<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2019</a></td>
<td class="nump">14,989<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,215)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of cancellations</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of cancellations (in shares)</a></td>
<td class="nump">76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RevaluationOfRedeemableNonControllingInterestNetOfTax', window );">Revaluation of redeemable non-controlling interest, net of tax</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,415)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(3,415)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,415)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares', window );">Revaluation of redeemable non-controlling interest, net of tax (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Compensation expense - equity-based awards</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">7,917<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">7,917<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,917<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans', window );">Transfer of compensation liability for certain stock issued pursuant to long-term incentive plans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">486<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">486<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">486<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PurchaseOfPartnershipInterestsRedeemableNonControllingInterests', window );">Purchase of partnership interests - redeemable non-controlling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(168)<span></span>
</td>
<td class="num">(168)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_SaleOfNonControllingInterestNetOfTaxAndPurchases', window );">Sale of non-controlling interest, net of purchases and tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(164)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(164)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(164)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends paid to USPT shareholders</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(4,110)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(4,110)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(4,110)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to non-controlling interest partners - permanent equity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(5,928)<span></span>
</td>
<td class="num">(5,928)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity', window );">Net income attributable to non-controlling interest - permanent equity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,122<span></span>
</td>
<td class="nump">6,122<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to USPH shareholders</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">35,194<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">35,194<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">35,194<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2020</a></td>
<td class="nump">$ 151<span></span>
</td>
<td class="nump">$ 95,622<span></span>
</td>
<td class="nump">$ 212,015<span></span>
</td>
<td class="num">$ (31,628)<span></span>
</td>
<td class="nump">$ 276,160<span></span>
</td>
<td class="nump">$ 1,470<span></span>
</td>
<td class="nump">$ 277,630<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2020</a></td>
<td class="nump">15,065<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,215)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326096&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PurchaseOfPartnershipInterestsRedeemableNonControllingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in redeemable noncontrolling interest through purchasing of interests from noncontrolling shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PurchaseOfPartnershipInterestsRedeemableNonControllingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_RevaluationOfRedeemableNonControllingInterestNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of distributions during the period on mandatorily redeemable securities net of tax.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_RevaluationOfRedeemableNonControllingInterestNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to redeemable non-controlling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_SaleOfNonControllingInterestNetOfTaxAndPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest or decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_SaleOfNonControllingInterestNetOfTaxAndPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to transfer of compensation liability for certain stock issued pursuant to incentive plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438849800488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income including non-controlling interests</a></td>
<td class="nump">$ 52,491<span></span>
</td>
<td class="nump">$ 57,259<span></span>
</td>
<td class="nump">$ 48,842<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income including non-controlling interests to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">10,533<span></span>
</td>
<td class="nump">10,095<span></span>
</td>
<td class="nump">9,755<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for credit losses</a></td>
<td class="nump">4,623<span></span>
</td>
<td class="nump">4,858<span></span>
</td>
<td class="nump">4,603<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Equity-based awards compensation expense</a></td>
<td class="nump">7,917<span></span>
</td>
<td class="nump">6,985<span></span>
</td>
<td class="nump">5,939<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(258)<span></span>
</td>
<td class="nump">4,651<span></span>
</td>
<td class="nump">4,813<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_GainOnSaleOfPartnershipInterestNetOfTax', window );">Gain on sale of partnership interest</a></td>
<td class="num">(1,091)<span></span>
</td>
<td class="num">(5,514)<span></span>
</td>
<td class="num">(1,846)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Write-off of goodwill - closed clinics</a></td>
<td class="nump">1,859<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other</a></td>
<td class="nump">281<span></span>
</td>
<td class="nump">96<span></span>
</td>
<td class="nump">167<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Decrease (increase) in patient accounts receivable</a></td>
<td class="nump">899<span></span>
</td>
<td class="num">(6,376)<span></span>
</td>
<td class="num">(3,434)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets', window );">Decrease (increase) in accounts receivable - other</a></td>
<td class="nump">1,661<span></span>
</td>
<td class="num">(2,499)<span></span>
</td>
<td class="num">(1,087)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Decrease (increase) in other assets</a></td>
<td class="nump">4,161<span></span>
</td>
<td class="num">(1,878)<span></span>
</td>
<td class="nump">345<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Increase (decrease) in accounts payable and accrued expenses</a></td>
<td class="nump">12,427<span></span>
</td>
<td class="num">(4,209)<span></span>
</td>
<td class="nump">4,876<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities', window );">Increase (decrease) in other long-term liabilities</a></td>
<td class="nump">4,492<span></span>
</td>
<td class="num">(1,020)<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">99,995<span></span>
</td>
<td class="nump">62,448<span></span>
</td>
<td class="nump">73,005<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Purchase of fixed assets</a></td>
<td class="num">(7,639)<span></span>
</td>
<td class="num">(10,189)<span></span>
</td>
<td class="num">(7,193)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Purchase of majority interest in businesses, net of cash acquired</a></td>
<td class="num">(23,907)<span></span>
</td>
<td class="num">(30,597)<span></span>
</td>
<td class="num">(16,367)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PaymentsToAcquireRedeemableNonControllingInterest', window );">Purchase of redeemable non-controlling interest, temporary equity</a></td>
<td class="num">(20,385)<span></span>
</td>
<td class="num">(8,651)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates', window );">Purchase of non-controlling interest, permanent equity</a></td>
<td class="num">(238)<span></span>
</td>
<td class="num">(428)<span></span>
</td>
<td class="num">(350)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates', window );">Proceeds on sale of redeemable non-controlling interest, temporary equity</a></td>
<td class="nump">127<span></span>
</td>
<td class="nump">207<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds on sales of partnership interest, clinics and fixed assets</a></td>
<td class="nump">839<span></span>
</td>
<td class="nump">11,665<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(51,203)<span></span>
</td>
<td class="num">(37,993)<span></span>
</td>
<td class="num">(23,909)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsMinorityInterest', window );">Distributions to non-controlling interests, permanent and temporary equity</a></td>
<td class="num">(18,331)<span></span>
</td>
<td class="num">(16,235)<span></span>
</td>
<td class="num">(15,646)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Cash dividends paid to shareholders</a></td>
<td class="num">(4,110)<span></span>
</td>
<td class="num">(14,555)<span></span>
</td>
<td class="num">(11,664)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds from revolving line of credit</a></td>
<td class="nump">214,000<span></span>
</td>
<td class="nump">145,000<span></span>
</td>
<td class="nump">103,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Payments on revolving line of credit</a></td>
<td class="num">(244,000)<span></span>
</td>
<td class="num">(137,000)<span></span>
</td>
<td class="num">(119,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest', window );">Payments to settle mandatorily redeemable non-controlling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(265)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Principal payments on notes payable</a></td>
<td class="num">(1,037)<span></span>
</td>
<td class="num">(1,433)<span></span>
</td>
<td class="num">(4,044)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_MedicareAcceleratedAndAdvancePaymentFunds', window );">Medicare accelerated and advance payment funds</a></td>
<td class="nump">14,054<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="nump">2<span></span>
</td>
<td class="num">(52)<span></span>
</td>
<td class="num">(42)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(39,422)<span></span>
</td>
<td class="num">(24,275)<span></span>
</td>
<td class="num">(47,661)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash and cash equivalents</a></td>
<td class="nump">9,370<span></span>
</td>
<td class="nump">180<span></span>
</td>
<td class="nump">1,435<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents - beginning of period</a></td>
<td class="nump">23,548<span></span>
</td>
<td class="nump">23,368<span></span>
</td>
<td class="nump">21,933<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents - end of period</a></td>
<td class="nump">32,918<span></span>
</td>
<td class="nump">23,548<span></span>
</td>
<td class="nump">23,368<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_CashPaidDuringPeriodForAbstract', window );"><strong>Cash paid during the period for:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes</a></td>
<td class="nump">7,677<span></span>
</td>
<td class="nump">9,856<span></span>
</td>
<td class="nump">9,183<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest</a></td>
<td class="nump">1,202<span></span>
</td>
<td class="nump">1,890<span></span>
</td>
<td class="nump">2,357<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Non-cash investing and financing transactions during the period:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PurchaseOfBusinessSellerFinancingPortion', window );">Purchase of businesses - seller financing portion</a></td>
<td class="nump">1,121<span></span>
</td>
<td class="nump">4,300<span></span>
</td>
<td class="nump">950<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionPayablesAssumed1', window );">Purchase of business - payable to common shareholders of acquired business</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">502<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity', window );">Notes payable related to purchase of redeemable non-controlling interest, temporary equity</a></td>
<td class="nump">136<span></span>
</td>
<td class="nump">283<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity', window );">Notes payable related to purchase of non-controlling interest, permanent equity</a></td>
<td class="nump">699<span></span>
</td>
<td class="nump">103<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromMinorityShareholders', window );">Notes receivable related to sale of partnership interest - redeemable non-controlling interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,870<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1', window );">Notes receivables related to sale of partnership interest</a></td>
<td class="nump">$ 994<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in receivables, and operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionPayablesAssumed1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of payables that an Entity assumes in acquiring a business or in consideration for an asset received in a noncash (or part noncash) acquisition. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionPayablesAssumed1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash consideration received for selling an asset or business through a noncash (or part noncash) transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period for redemption of redeemable noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsMinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsMinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of or advances to an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, and joint venture or equity method investment) or the acquisition of an additional interest in a subsidiary (controlled entity).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the deconsolidation of a previously consolidated subsidiary or sale of an entity that is related to it but not strictly controlled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_CashPaidDuringPeriodForAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_CashPaidDuringPeriodForAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_GainOnSaleOfPartnershipInterestNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>After tax amount of gain on sale or disposal of partnership interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_GainOnSaleOfPartnershipInterestNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_MedicareAcceleratedAndAdvancePaymentFunds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of medicare accelerated and advance payment funds.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_MedicareAcceleratedAndAdvancePaymentFunds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of business acquisition cost of acquired entity debt issued on the date of acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of business acquisition cost of acquired entity debt issued (temporary equity) on the date of acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PaymentsToAcquireRedeemableNonControllingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a redeemable non-controlling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PaymentsToAcquireRedeemableNonControllingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PurchaseOfBusinessSellerFinancingPortion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase of business - seller financing portion in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PurchaseOfBusinessSellerFinancingPortion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438845199288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization, Nature of Operations and Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Nature of Operations and Basis of Presentation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Organization, Nature of Operations and Basis of Presentation</a></td>
<td class="text">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">1. Organization, Nature of Operations and Basis of Presentation</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The consolidated financial statements include the accounts of U.S. Physical Therapy, Inc. and its subsidiaries (the &#8220;Company&#8221;). All significant intercompany transactions and balances have been eliminated.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company operates its business through two reportable business segments. The Company&#8217;s reportable segments include the physical therapy operations segment and the industrial injury prevention services segment. The Company&#8217;s physical therapy operations consist of physical therapy and occupational therapy clinics that provide pre-and post-operative care and treatment for orthopedic related disorders, sports-related injuries, preventive care, rehabilitation of injured workers and neurological injuries. The industrial injury prevention services segment includes onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments. Prior to the second quarter of 2020, the Company operated as a single segment.&#160; All prior year segment information has been reclassified to conform to the 2020 segment presentation. See Note 12. Segment Information.</div>

<div><br/></div>

<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Physical Therapy Operations</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The physical therapy operations segment primarily operates through subsidiary clinic partnerships, in which the Company generally owns a 1% general partnership interest in all the Clinic Partnerships. Our limited partnership interests typically range from 10% to 99% in the Clinic Partnerships. The managing therapist of each clinic owns, directly or indirectly, the remaining limited partnership interest in most of the clinics (hereinafter referred to as &#8220;Clinic Partnerships&#8221;). To a lesser extent, the Company operates some clinics, through wholly-owned subsidiaries, under profit sharing arrangements with therapists (hereinafter referred to as &#8220;Wholly-Owned Facilities&#8221;).</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company continues to seek to attract for employment physical therapists who have established relationships with physicians and other referral sources, by offering these therapists a competitive salary and incentives based on the profitability of the clinic that they manage. For multi-site clinic practices in which a controlling interest is acquired by the Company, the prior owners typically continue on as employees to manage the clinic operations, retaining a non-controlling ownership interest in the clinics and receiving a competitive salary for managing the clinic operations. In addition, the Company has developed satellite clinic facilities as part of existing Clinic Partnerships and Wholly-Owned Facilities, with the result that a substantial number of Clinic Partnerships and Wholly-Owned Facilities operate more than one clinic location.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">As of December 31, 2020, the Company owned and/or operated 554 clinics in 39 states. The clinics&#8217; business primarily originates from physician referrals. The principal sources of payment for the clinics&#8217; services are managed care programs, commercial health insurance, Medicare/Medicaid, workers&#8217; compensation insurance and proceeds from personal injury cases. In addition to the Company&#8217;s ownership and operation of outpatient physical therapy clinics, it also manages physical therapy facilities for third parties, such as physicians and hospitals, with 38 such third-party facilities under management as of December 31, 2020.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 27.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">During the last three years, the Company completed the following acquisitions within its physical therapy operations segment:</div>

<div><br/></div>

<table cellpadding="0" cellspacing="0" id="z329b3aa4a904444f99fe9105ae0bad7b" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">
  <tr>
    <td style="width: 34.03%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Acquisition</div></td>
    <td style="width: 2.78%; vertical-align: bottom;">&#160;</td>
    <td style="width: 25.28%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Date</div></td>
    <td style="width: 2.5%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td style="width: 16.67%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">% Interest<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/></span>Acquired</div></td>
    <td style="width: 2.5%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td style="width: 16.25%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Number of<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/></span>Clinics</div></td>
  </tr>
  <tr>
    <td style="width: 34.03%; vertical-align: bottom;">&#160;</td>
    <td style="width: 2.78%; vertical-align: bottom;">&#160;</td>
    <td style="width: 25.28%; vertical-align: bottom; border-top: #000000 2px solid;">&#160;</td>
    <td style="width: 2.5%; vertical-align: bottom;">&#160;</td>
    <td style="width: 16.67%; vertical-align: bottom;">&#160;</td>
    <td style="width: 2.5%; vertical-align: bottom;">&#160;</td>
    <td style="width: 16.25%; vertical-align: bottom;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 34.03%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">November 2020 Acquisition</div></td>
    <td style="width: 2.78%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 25.28%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">November 30, 2020</div></td>
    <td style="width: 2.5%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 16.67%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">75%</div></td>
    <td style="width: 2.5%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 16.25%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">3</div></td>
  </tr>
  <tr>
    <td style="width: 34.03%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">September 2020 Acquisition</div></td>
    <td style="width: 2.78%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 25.28%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">September 30, 2020</div></td>
    <td style="width: 2.5%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 16.67%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">70%</div></td>
    <td style="width: 2.5%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 16.25%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">*</div></td>
  </tr>
  <tr>
    <td style="width: 34.03%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">February 2020 Acquisition</div></td>
    <td style="width: 2.78%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 25.28%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">February 27, 2020</div></td>
    <td style="width: 2.5%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 16.67%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">65%</div></td>
    <td style="width: 2.5%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">**</div></td>
    <td style="width: 16.25%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">4</div></td>
  </tr>
  <tr>
    <td style="width: 34.03%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">September 2019 Acquisition</div></td>
    <td style="width: 2.78%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 25.28%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">September 30, 2019</div></td>
    <td style="width: 2.5%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 16.67%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">67%</div></td>
    <td style="width: 2.5%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 16.25%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">11</div></td>
  </tr>
  <tr>
    <td style="width: 34.03%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">August 2018 Acquisition</div></td>
    <td style="width: 2.78%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 25.28%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">August 31, 2018</div></td>
    <td style="width: 2.5%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 16.67%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">70%</div></td>
    <td style="width: 2.5%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 16.25%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">4</div></td>
  </tr>
</table>

<div><br/></div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" id="z70c8f2b5b53b4524bb7ccfe492028040" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">
  <tr>
    <td style="width: 27pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">*</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The business includes six management and services contracts which had a remaining term of approximately five years as of the date acquired.</div></td>
  </tr>
</table>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" id="z46f47f69a0da4fb98e548c6918a6352a" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">
  <tr>
    <td style="width: 27pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">**</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The four clinics are in four separate partnerships. The Company's interest in the four partnerships range from 10.0% to 83.8%, with an overall 65.0% based on the initial purchase transaction.</div></td>
  </tr>
</table>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Also during 2019, we purchased the assets and business of one physical therapy clinic in a separate transaction. The clinic operates as a satellite clinic of one of the existing partnerships. Besides the August 2018 multi-clinic acquisition, we acquired five separate clinic practices that year through several of our majority owned Clinic Partnerships. These practices operate as satellites of the respective existing Clinic Partnerships.</div>

<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">During the year ended December 31, 2020, the Company sold 14 previously closed clinics. The aggregate sales price was $1.1 million, of which $0.7 million was paid in cash and $0.4 million in a note receivable, payable in two equal installments of principal and any accrued interest on June 15, 2021 and 2022.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company intends to continue to pursue additional acquisition opportunities, develop new clinics and open satellite clinics.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Clinic Partnerships</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">For non-acquired Clinic Partnerships, the earnings and liabilities attributable to the non-controlling interests, typically owned by the managing therapist, directly or indirectly, are recorded within the balance sheets and income statements as non-controlling interests &#8211; permanent equity. For acquired Clinic Partnerships with redeemable non-controlling interests, the earnings attributable to the redeemable non-controlling interests are recorded within the consolidated statements of income line item &#8211; <span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">net income attributable to redeemable non-controlling interests &#8211; temporary equity</span> and the equity interests are recorded on the consolidated balance sheet as <span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">redeemable non-controlling interests &#8211; temporary equity</span>.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Effective December 31, 2017, the Company entered into amendments to its acquired limited partnership agreements replacing the mandatory redemption features. No monetary consideration was paid to the partners to amend the agreements. The amended limited partnership agreements provide that, upon certain events, the Company has a call right (the &#8220;Call Right&#8221;) and the selling entity has a put right (the &#8220;Put Right&#8221;) for the purchase and sale of the limited partnership interest held by the partner. Once triggered, the Put Right and the Call Right do not expire, even upon an individual partner&#8217;s death, and contain no mandatory redemption feature. The purchase price of the partner&#8217;s limited partnership interest upon the exercise of either the Put Right or the Call Right is calculated per the terms of the respective agreements. The Company accounted for the amendment of its limited partnership agreements as an extinguishment of the outstanding Seller Entity Interests, as defined in Note 5, classified as liabilities through the issuance of new Seller Entity Interests classified in temporary equity. Pursuant to ASC 470-50-40-2, the Company removed the outstanding liability-classified Seller Entity Interests at their carrying amounts, recognized the new temporary-equity-classified Seller Entity Interests at their fair value, and recorded no gain or loss on extinguishment as management believes the redemption value (i.e. the carrying amount) and fair value are the same. In summary, the redemption values of the mandatorily redeemable non-controlling interest (previously classified as liabilities) were reclassified as redeemable non-controlling interest (temporary equity) at fair value on the December 31, 2017 consolidated balance sheet. See Note 5 - Redeemable Non-Controlling Interests &#8211; for further discussion.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Wholly-Owned Facilities</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">For Wholly-Owned Facilities with profit sharing arrangements, an appropriate accrual is recorded for the amount of profit sharing due the clinic partners/directors. The amount is expensed as compensation and included in clinic operating costs&#8212;salaries and related costs. The respective liability is included in current liabilities&#8212;<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">accrued expenses</span> on the consolidated balance sheets.</div>

<div><br/></div>

<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Industrial Injury Prevention Services</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In March 2017, the Company acquired a 55% interest in the initial industrial injury prevention business. On April 30, 2018, the Company acquired a 65% interest in another business in the industrial injury prevention sector. On April 30, 2018, the Company combined the two businesses.&#160; After the combination, the Company owned a 59.45% interest in the combined business, Briotix Health, Limited Partnership (&#8220;Briotix Health&#8221;), which is the Company&#8217;s industrial injury prevention operation.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">On April 11, 2019, the Company acquired 100% of a third provider of industrial injury prevention services. The acquired company specializes in delivering injury prevention and care, post offer employment testing, functional capacity evaluations and return-to-work services. It performs these services across a network in 45 states including onsite at eleven client locations. After the acquisition, the business was then combined with Briotix Health increasing the Company&#8217;s ownership position in the partnership to approximately 76.0%.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Services provided in the industrial injury prevention services segment include onsite injury prevention and rehabilitation, performance optimization, post offer employment testing, functional capacity evaluations, and ergonomic assessments. The majority of these services are contracted with and paid for directly by employers, including a number of Fortune 500 companies. Other clients include large insurers and their contractors. The Company performs these services through Industrial Sports Medicine Professionals, consisting of both physical therapists and specialized certified athletic trainers (ATCs).</div>

<div><br/></div>

<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Impact of COVID-19</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">As previously disclosed in a series of filings with the SEC and further described in detail in our Quarterly Reports on Form 10-Q for the first three quarters of 2020, the Company&#8217;s results have been negatively impacted by the effects of the COVID-19 pandemic. Management has taken a number of steps to reduce costs, make up for operating losses incurred in March and April, and increase profits subsequently. The Company continues to experience somewhat lower physical therapy patient volumes; however revenues improved significantly in the 2020 fourth quarter compared to the 2020 second and third quarters. The Company&#8217;s average physical therapy patient volumes per day per clinic were 26.2, 18.9, 25.8, and 27.7, respectively, in the first four quarters of 2020. The Company&#8217;s industrial injury prevention business was less affected by the pandemic in 2020.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In March, with the onset of the COVID-19 pandemic, the Company began to furlough or terminate approximately 40% of its 5,500 full and part-time workforce. Since early May, approximately 1,200 of the furloughed employees have returned to work on a full or part-time basis.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">As of the filing of this annual report, the Company continues to experience lower physical therapy revenues. As stay at home orders and other restrictions have been lifted, we have seen our physical therapy volumes trending upwards. Should stay at home orders or other restrictions be reenacted, the Company could see its Company&#8217;s patient volume and revenues decline again.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company has put preparedness plans in place at its facilities to maintain continuity of operations, while also taking steps to keep employees and patients safe. In line with recommendations to reduce large gatherings and increase social distancing, the Company has, where practical, transitioned a large number of office-based employees to a remote work environment.</div>

<div><br/></div>

<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Medicare Accelerated and Advance Payment Program (&#8220;MAAPP Funds&#8221;)</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 27pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #212529;">In response to the COVID-19 pandemic, the federal government approved the Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES Act&#8221;). The CARES Act allowed for qualified healthcare providers to receive advanced payments under the existing MAAPP Funds during the COVID-19 pandemic. Under this program, healthcare providers could choose to receive advanced payments for future Medicare services provided. The Company applied for and received approval from</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #222222;">&#160;</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #212529;">Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;) in April 2020. T</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #211D1E;">he Company recorded these payments as a liability until all performance obligations have been met as the payments were made on behalf of patients before services were provided. Currently, MAAPP funds received are required to be applied to future Medicare billings commencing in August 2021, with all such remaining amounts required to be repaid by January 2024. Beginning January 2024, any unpaid balance will begin accruing interest.</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #212529;"> The Company currently intends to repay funds prior to August 2021. Included in cash and cash equivalents and accrued liabilities at December 31, 2020 is $</span>14.1<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #212529;"> million of MAAPP Funds.</span></div>

<div><br/></div>

<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Relief Funds</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The CARES Act also provided additional waivers, reimbursement, grants and other funds to assist health care providers during the COVID-19 pandemic, including $100.0 billion in appropriations for the Public Health and Social Services Emergency Fund, also referred to as the Provider Relief Fund, to be used for preventing, preparing, and responding to the coronavirus, and for reimbursing eligible health care providers for lost revenues and health care related expenses that are attributable to COVID-19.</div>

<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 27pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Through December 31, 2020, the Company&#8217;s consolidated subsidiaries received approximately $13.5 million of payments under the CARES Act (&#8220;Relief Funds&#8221;). For the year ended December 31, 2020, the Company has recognized approximately $13.5 million, as Other income &#8211; Relief Funds on the accompany consolidated statement of operations. These funds are not required to be repaid upon attestation and compliance with certain terms and conditions, which could change materially based on evolving grant compliance provisions and guidance provided by the U.S. Department of Health and Human Services. Currently, the Company can attest and comply with the terms and conditions of the grant guidance.&#160; The Company will continue to monitor the evolving guidelines and may record adjustments as additional information is released.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438845222184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies</a></td>
<td class="text">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2. Significant Accounting Policies</div>

<div><br/></div>

<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Cash Equivalents</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company maintains its cash and cash equivalents at financial institutions. The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. The combined account balances at several institutions typically exceed Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) insurance coverage and, as a result, there is a concentration of credit risk related to amounts on deposit in excess of FDIC insurance coverage. Management believes that this risk is not significant.</div>

<div><br/></div>

<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Long-Lived Assets</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Fixed assets are stated at cost. Depreciation is computed on the straight-line method over the estimated useful lives of the related assets. Estimated useful lives for furniture and equipment range from <span style="-sec-ix-hidden:Fact_82099ea63dd944a793bca0b3ef182707">three</span> to eight years and for software purchased from <span style="-sec-ix-hidden:Fact_c914f2e353b54597a7cd8a612b794874">three</span> to seven years. Leasehold improvements are amortized over the shorter of the related lease term or estimated useful lives of the assets, which is generally <span style="-sec-ix-hidden:Fact_d794a755570f470987cd83402baa1e26">three</span> to five years.</div>

<div><br/></div>

<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Impairment of Long-Lived Assets and Long-Lived Assets to Be Disposed Of</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company reviews property and equipment and intangible assets with finite lives for impairment upon the occurrence of certain events or circumstances that indicate the related amounts may be impaired. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.</div>

<div><br/></div>

<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Goodwill</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">Goodwill represents the excess of the amount paid and fair value of the non-controlling interests over the fair value of the acquired business assets, which include certain identifiable intangible assets. Historically, goodwill has been derived from acquisitions and, prior to 2009</span>,<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> from the purchase of some or all of a particular local management&#8217;s equity interest in an existing clinic. Effective January 1, 2009</span>,<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> if the purchase price of a non-controlling interest by the Company exceeds or is less than the book value at the time of purchase, any excess or shortfall is recognized as an adjustment to additional paid-in capital.</span></div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Goodwill and other indefinite-lived intangible assets are not amortized, but are instead subject to periodic impairment evaluations. The fair value of goodwill and other identifiable intangible assets with indefinite lives are evaluated for impairment at least annually and upon the occurrence of certain events or conditions, and are written down to fair value if considered impaired. These events or conditions include, but are not limited to: a significant adverse change in the business environment, regulatory environment, or legal factors; a current period operating or cash flow loss combined with a history of such losses or a projection of continuing losses; or a sale or disposition of a significant portion of a reporting unit. The occurrence of one of these events or conditions could significantly impact an impairment assessment, necessitating an impairment charge. The Company evaluates indefinite lived tradenames using the relief from royalty method in conjunction with its annual goodwill impairment test.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">The Company operates a </span>two<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> segment business which is made up of various clinics within partnerships, and the other is industrial injury prevention services business. The partnerships are components of regions and are aggregated to the operating segment level for the purpose of determining the Company&#8217;s reporting units when performing its annual goodwill impairment test. In 2020, 2019 and 2018</span>,<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> there were </span>six<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> regions. In addition to the six regions, in 2020 and 2019</span>,<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> the impairment analysis included a separate analysis for the industrial injury prevention business, as a separate reporting unit.</span></div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">As part of the impairment analysis, the Company is first required to assess qualitatively if it can conclude whether goodwill is more likely than not impaired. If goodwill is more likely than not impaired, the Company is then required to complete a quantitative analysis of whether a reporting unit&#8217;s fair value is less than its carrying amount. In evaluating whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, the Company considers relevant events or circumstances that affect the fair value or carrying amount of a reporting unit. The Company considers both the income and market approach in determining the fair value of its reporting units when performing a quantitative analysis.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">An impairment loss generally would be recognized when the carrying amount of the net assets of a reporting unit, inclusive of goodwill and other identifiable intangible assets, exceeds the estimated fair value of the reporting unit. The evaluation of goodwill in 2020, 2019 and 2018 did not result in any goodwill amounts that were deemed impaired.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">Based on the economic conditions experienced in 2020 and the decline in patient visits due to the pandemic, the Company evaluated whether events or circumstances indicated that it was more likely than not that the fair value of the reporting units were reduced below their carrying value as of December 31, 2020</span>.<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> As a result of the assessment, the Company determined that it was not more likely than not that goodwill and tradenames of the reporting units were impaired as of December 31, 2020</span>.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company will continue to monitor for any triggering events or other indicators of impairment.&#160; Due to the uncertainty of the current economic conditions resulting from the COVID-19 pandemic, the Company will continue to review its carrying amounts of goodwill and other intangibles quarterly.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">For the year ended December 31, 2020</span>,<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> the Company derecognized (wrote-off) goodwill in the amount of </span>$1.9 million<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> related to closed clinics due to COVID-19</span>.</div>

<div><br/></div>

<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Redeemable Non-Controlling Interests</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The non-controlling interests that are reflected as redeemable non-controlling interests in the consolidated financial statements consist of those in which the owners and the Company have certain redemption rights, whether currently exercisable or not, and which currently, or in the future, require that the Company purchase or the owner sell the non-controlling interest held by the owner, if certain conditions are met. The purchase price is derived at a predetermined formula based on a multiple of trailing twelve months earnings performance as defined in the respective limited partnership agreements. The redemption rights can be triggered by the owner or the Company at such time as both of the following events have occurred: 1) termination of the owner&#8217;s employment, regardless of the reason for such termination, and 2) the passage of specified number of years after the closing of the transaction, typically <span style="-sec-ix-hidden:Fact_74434238a9e847afae6e8bd50f9c3ecb">three</span> to five years, as defined in the limited partnership agreement. The redemption rights are not automatic or mandatory (even upon death) and require either the owner or the Company to exercise its rights when the conditions triggering the redemption rights have been satisfied.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">On the date the Company acquires a controlling interest in a partnership, and the limited partnership agreement for such partnership contains redemption rights not under the control of the Company, the fair value of the non-controlling interest is recorded in the consolidated balance sheet under the caption &#8211; Redeemable non-controlling interests. Then, in each reporting period thereafter until it is purchased by the Company, the redeemable non-controlling interest is adjusted to the greater of its then current redemption value or initial carrying value, based on the predetermined formula defined in the respective limited partnership agreement. As a result, the value of the non-controlling interest is not adjusted below its initial carrying value. The Company records any adjustment in the redemption value, net of tax, directly to retained earnings and are not reflected in the consolidated statements of income. Although the adjustments are not reflected in the consolidated statements of income, current accounting rules require that the Company reflects the adjustments, net of tax, in the earnings per share calculation. The amount of net income attributable to redeemable non-controlling interest owners is included in consolidated net income on the face of the consolidated statements of net income. Management believes the redemption value (i.e. the carrying amount) and fair value are the same.</div>

<div><br/></div>

<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Non-Controlling Interests</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company recognizes non-controlling interests, in which the Company has no obligation but the right to purchase the non-controlling interests, as permanent equity in the consolidated financial statements separate from the parent entity&#8217;s equity. The amount of net income attributable to non-controlling interests is included in consolidated net income on the face of the statements of net income. Changes in a parent entity&#8217;s ownership interest in a subsidiary that do not result in deconsolidation are treated as equity transactions if the parent entity retains its controlling financial interest. The Company recognizes a gain or loss in net income when a subsidiary is deconsolidated. Such gain or loss is measured using the fair value of the non-controlling equity investment on the deconsolidation date.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">When the purchase price of a non-controlling interest by the Company exceeds the book value at the time of purchase, any excess or shortfall is recognized as an adjustment to additional paid-in capital. Additionally, operating losses are allocated to non-controlling interests even when such allocation creates a deficit balance for the non-controlling interest partner.</div>

<div><br/></div>

<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Revenue Recognition</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In May 2014, March 2016, April 2016, and December 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2014-09, Revenue from Contracts with Customers, ASU 2016-08, Revenue from Contracts with Customers, Principal versus Agent Considerations, ASU 2016-10, Revenue from Contracts with Customers, Identifying Performance Obligations and Licensing, ASU 2016-12, Revenue from Contracts with Customers, Narrow Scope Improvements and Practical Expedients, and ASU 2016-20, Technical Corrections and Improvements to Topic 606, Revenue from Contracts with Customer (collectively the &#8220;standards&#8221;), respectively, which supersede most of the current revenue recognition requirements (&#8220;ASC 606&#8221;). The core principle of the new guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company implemented the new standards beginning January 1, 2018 using a modified retrospective transition method. The principal change relates to how the new standard requires healthcare providers to estimate the amount of variable consideration to be included in the transaction price up to an amount which is probable that a significant reversal will not occur. The most common forms of variable consideration the Company experiences are amounts for services provided that are ultimately not realizable from a customer. There were no changes to revenues or other revenues upon implementation. Under the new standards, the Company&#8217;s estimate for unrealizable amounts will continue to be recognized as a reduction to revenue. The bad debt expense historically reported will not materially change.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">For ASC 606, there is an implied contract between us and the patient upon each patient visit. Separate contractual arrangements exist between us and third-party payors (e.g. insurers, managed care programs, government programs, workers' compensation) which establish the amounts the third parties pay on behalf of the patients for covered services rendered. While these agreements are not considered contracts with the customer, they are used for determining the transaction price for services provided to the patients covered by the third party payors. The payor contracts do not indicate performance obligations for us, but indicate reimbursement rates for patients who are covered by those payors when the services are provided. At that time, the Company is obligated to provide services for the reimbursement rates stipulated in the payor contracts. The execution of the contract alone does not indicate a performance obligation. For self-paying customers, the performance obligation exists when we provide the services at established rates. The difference between the Company&#8217;s established rate and the anticipated reimbursement rate is accounted for as an offset to revenue &#8211; contractual allowance.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The following table details the revenue related to the various categories (in thousands).</div>

<div><br/></div>

<table cellpadding="0" cellspacing="0" id="z8c0b8e1e67b64cb6b6522cc37bfa309c" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/></td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2018</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Net patient revenues</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">373,340</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">433,345</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">417,703</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Management contract revenues</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">8,410</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">8,676</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">8,339</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Other revenues</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,020</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,486</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,403</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 17.65pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Physical therapy operations</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">383,770</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">444,507</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">428,445</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Industrial injury prevention services revenues</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">39,199</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">37,462</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">25,466</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">422,969</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">481,969</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">453,911</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
</table>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><br/></div>

<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Patient revenues</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Revenues are recognized in the period in which services are rendered. Net patient revenues consists of revenues for physical therapy and occupational therapy clinics that provide pre-and post-operative care and treatment for orthopedic related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries. Net patient revenues (patient revenues less estimated contractual adjustments) are recognized at the estimated net realizable amounts from third-party payors, patients and others in exchange for services rendered when obligations under the terms of the contract are satisfied. There is an implied contract between us and the patient upon each patient visit. Generally, this occurs as the Company provides physical and occupational therapy services, as each service provided is distinct and future services rendered are not dependent on previously rendered services. The Company has agreements with third-party payors that provide for payments to the Company at amounts different from its established rates.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Medicare Reimbursement</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Medicare program reimburses outpatient rehabilitation providers based on the Medicare Physician Fee Schedule (&#8216;&#8216;MPFS&#8217;&#8217;). For services provided in 2018, a 0.5% increase was applied to the fee schedule payment rates; for services provided in 2019, a 0.25% increase was applied to the fee schedule payment rates before applying the mandatory budget neutrality adjustment. For services provided in 2020 through 2025, a 0.0% percent update will be applied each year to the fee schedule payment rates, before applying the mandatory budget neutrality adjustment. However, in the 2020 MPFS Final Rule, CMS proposed an increase to the code values for office/outpatient evaluation and management (E/M) codes and cuts to other codes to maintain budget neutrality of the MPFS. This change in code valuations was to become effective January 1, 2021.&#160; Under the 2021 MPFS Final Rule, reimbursement for the codes applicable to physical/occupational therapy services were to be reduced by approximately 9% in the aggregate. <span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">The </span>9%<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> reduction in payment was addressed by the Consolidated Appropriations Act, </span><span style="font-size: 10pt; font-family: 'Times New Roman';">2021</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> (&#8220;Act&#8221;) signed into law on December </span><span style="font-size: 10pt; font-family: 'Times New Roman';">27,</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">&#160;</span><span style="font-size: 10pt; font-family: 'Times New Roman';">2020.</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">&#160; Based on various provisions in the Act, the Company now estimates that the Medicare rate reduction for the full year of </span><span style="font-size: 10pt; font-family: 'Times New Roman';">2021</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> will be approximately </span>3.5%<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> in aggregate.</span></div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Beginning in 2021, payments to individual therapists (Physical/Occupational Therapist in Private Practice) paid under the fee schedule may be subject to adjustment based on performance in the Merit Based Incentive Payment System (&#8220;MIPS&#8221;), which measures performance based on certain quality metrics, resource use, and meaningful use of electronic health records. Under the MIPS requirements, a provider's performance is assessed according to established performance standards each year and then is used to determine an adjustment factor that is applied to the professional's payment for the corresponding payment year. The provider&#8217;s MIPS performance in 2019 will determine the payment adjustment in 2021. Each year from 2019 through 2024, professionals who receive a significant share of their revenues through an alternate payment model (&#8220;APM&#8221;), (such as accountable care organizations or bundled payment arrangements) that involves risk of financial losses and a quality measurement component will receive a 5% bonus in the corresponding payment year. The bonus payment for APM participation is intended to encourage participation and testing of new APMs and to promote the alignment of incentives across payors. The specifics of the MIPS and APM adjustments will be subject to future notice and comment rule-making.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Budget Control Act of 2011 increased the federal debt ceiling in connection with deficit reductions over the next ten years, and requires automatic reductions in federal spending by approximately $1.2 trillion. Payments to Medicare providers are subject to these automatic spending reductions, subject to a 2% cap. On April 1, 2013, a 2% reduction to Medicare payments was implemented. The Bipartisan Budget Act of 2015, enacted on November 2, 2015, extended the 2% reductions to Medicare payments through fiscal year 2025. The Bipartisan Budget Act of 2018, enacted on February 9, 2018, extends the 2% reductions to Medicare payments through fiscal year 2027. <span style="font-size: 10pt; font-family: 'Times New Roman';">The Coronavirus Aid, Relief, and Economic Security (CARES) Act suspended the </span>2%<span style="font-size: 10pt; font-family: 'Times New Roman';"> payment reduction Medicare payments for dates of service from May 1, 2020, through December 31, 2020. The Consolidated Appropriations Act, 2021 further suspended the </span>2%<span style="font-size: 10pt; font-family: 'Times New Roman';"> payment reduction until March 31, 2021.</span></div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Historically, the total amount paid by Medicare in any one year for outpatient physical therapy, occupational therapy, and/or speech-language pathology services provided to any Medicare beneficiary was subject to an annual dollar limit (i.e., the &#8220;Therapy Cap&#8221; or &#8220;Limit&#8221;). For 2017, the annual Limit on outpatient therapy services was $1,980 for combined Physical Therapy and Speech Language Pathology services and $1,980 for Occupational Therapy services. As a result of Bipartisan Budget Act of 2018, the Therapy Caps have been eliminated, effective as of January 1, 2018.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Under the Middle Class Tax Relief and Job Creation Act of 2012 (&#8220;MCTRA&#8221;), since October 1, 2012, patients who met or exceeded $3,700 in therapy expenditures during a calendar year have been subject to a manual medical review to determine whether applicable payment criteria are satisfied. The $3,700 threshold is applied to Physical Therapy and Speech Language Pathology Services; a separate $3,700 threshold is applied to the Occupational Therapy. The MACRA directed CMS to modify the manual medical review process such that those reviews will no longer apply to all claims exceeding the $3,700 threshold and instead will be determined on a targeted basis based on a variety of factors that CMS considers appropriate. The Bipartisan Budget Act of 2018 extends the targeted medical review indefinitely, but reduces the threshold to $3,000 through December 31, 2027. For 2028, the threshold amount will be increased by the percentage increase in the Medicare Economic Index (&#8220;MEI&#8221;) for 2028 and in subsequent years the threshold amount will increase based on the corresponding percentage increase in the MEI for such subsequent year.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">CMS adopted a multiple procedure payment reduction (&#8220;MPPR&#8221;) for therapy services in the final update to the MPFS for calendar year 2011. The MPPR applied to all outpatient therapy services paid under Medicare Part B &#8212; occupational therapy, physical therapy and speech-language pathology. Under the policy, the Medicare program pays </span>100%<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> of the practice expense component of the Relative Value Unit (&#8220;RVU&#8221;) for the therapy procedure with the highest practice expense RVU, then reduces the payment for the practice expense component for the second and subsequent therapy procedures or units of service furnished during the same day for the same patient, regardless of whether those therapy services are furnished in separate sessions. Since 2013, the practice expense component for the second and subsequent therapy service furnished during the same day for the same patient was reduced by </span>50%<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">. </span>In addition, the MCTRA directed CMS to implement a claims-based data collection program to gather additional data on patient function during the course of therapy in order to better understand patient conditions and outcomes. All practice settings that provide outpatient therapy services are required to include this data on the claim form. Since 2013, therapists have been required to report new codes and modifiers on the claim form that reflect a patient&#8217;s functional limitations and goals at initial evaluation, periodically throughout care, and at discharge. Reporting of these functional limitation codes and modifiers are required on the claim for payment.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Medicare claims for outpatient therapy services furnished by therapy assistants on or after January 1, 2020 must include a modifier indicating the service was furnished by a therapy assistant. Outpatient therapy services furnished on or after January 1, 2022 in whole or part by a therapy assistant will be paid at an amount equal to 85% of the payment amount otherwise applicable for the service.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Statutes, regulations, and payment rules governing the delivery of therapy services to Medicare beneficiaries are complex and subject to interpretation. We believe that we are in compliance, in all material respects, with all applicable laws and regulations and are not aware of any pending or threatened investigations involving allegations of potential wrongdoing that would have a material effect on the our financial statements as of December 31, 2020. Compliance with such laws and regulations can be subject to future government review and interpretation, as well as significant regulatory action including fines, penalties, and exclusion from the Medicare program. For year ended December 31, 2020, net patient revenues from Medicare were approximately $101.6 million.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Given the history of frequent revisions to the Medicare program and its reimbursement rates and rules, we may not continue to receive reimbursement rates from Medicare that sufficiently compensate us for our services or, in some instances, cover our operating costs. Limits on reimbursement rates or the scope of services being reimbursed could have a material adverse effect on our revenue, financial condition and results of operations. Additionally, any delay or default by the federal or state governments in making Medicare and/or Medicaid reimbursement payments could materially and, adversely, affect our business, financial condition and results of operations.</div>

<div><br/></div>

<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Management Contract Revenues</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Management contract revenues, which are included in other revenues, are derived from contractual arrangements whereby the Company manages a clinic for third party owners. The Company does not have any ownership interest in these clinics. Typically, revenues are determined based on the number of visits conducted at the clinic and recognized at a point in time when services are performed. Costs, typically salaries for the Company&#8217;s employees, are recorded when incurred.</div>

<div><br/></div>

<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Industrial Injury Prevention Services Revenues</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Revenue from the industrial injury prevention business, which are also included in other revenues in the consolidated statements of net income, are derived from onsite services we provide to clients&#8217; employees including injury prevention, rehabilitation, ergonomic assessments and performance optimization. Revenue from the Company&#8217;s industrial injury prevention business is recognized when obligations under the terms of the contract are satisfied. Revenues are recognized at an amount equal to the consideration the company expects to receive in exchange for providing injury prevention services to its clients. The revenue is determined and recognized based on the number of hours and respective rate for services provided in a given period.</div>

<div><br/></div>

<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Other Revenues</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Additionally, other revenues include services the Company provides on-site at locations such as schools and industrial worksites for physical or occupational therapy services, athletic trainers and gym membership fees. Contract terms and rates are agreed to in advance between the Company and the third parties. Services are typically performed over the contract period and revenue is recorded at the point of service. If the services are paid in advance, revenue is recorded as a contract liability over the period of the agreement and recognized at the point in time, when the services are performed.</div>

<div><br/></div>

<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Contractual Allowances</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The allowance for estimated contractual adjustments is based on terms of payor contracts and historical collection and write-off experience. Contractual allowances result from the differences between the rates charged for services performed and expected reimbursements by both insurance companies and government sponsored healthcare programs for such services. Medicare regulations and the various third party payors and managed care contracts are often complex and may include multiple reimbursement mechanisms payable for the services provided in Company clinics. The Company estimates contractual allowances based on its interpretation of the applicable regulations, payor contracts and historical calculations. Each month the Company estimates its contractual allowance for each clinic based on payor contracts and the historical collection experience of the clinic and applies an appropriate contractual allowance reserve percentage to the gross accounts receivable balances for each payor of the clinic. Based on the Company&#8217;s historical experience, calculating the contractual allowance reserve percentage at the payor level is sufficient to allow the Company to provide the necessary detail and accuracy with its collectability estimates. However, the services authorized and provided and related reimbursement are subject to interpretation that could result in payments that differ from the Company&#8217;s estimates. Payor terms are periodically revised necessitating continual review and assessment of the estimates made by management. The Company&#8217;s billing system does not capture the exact change in its contractual allowance reserve estimate from period to period in order to assess the accuracy of its revenues and hence its contractual allowance reserves. Management regularly compares its cash collections to corresponding net revenues measured both in the aggregate and on a clinic-by-clinic basis. In the aggregate, historically the difference between net revenues and corresponding cash collections for any fiscal year has generally reflected a difference within approximately 1% to 1.5% of net revenues. Additionally, analysis of subsequent periods&#8217; contractual write-offs on a payor basis reflects a difference within approximately 1% to 1.5% between the actual aggregate contractual reserve percentage as compared to the estimated contractual allowance reserve percentage associated with the same period end balance. As a result, the Company believes that a change in the contractual allowance reserve estimate would not likely be more than 1% to 1.5% of gross billings included in accounts receivable at December 31, 2020.</div>

<div><br/></div>

<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Allowance for Credit Losses</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company determines allowances for credit losses based on the specific agings and payor classifications at each clinic. The provision for credit losses is included in operating costs in the statements of net income. Patient accounts receivable, which are stated at the historical carrying amount net of contractual allowances, write-offs and allowance for credit losses, includes only those amounts the Company estimates to be collectible.</div>

<div><br/></div>

<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Income Taxes</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount to be recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company did not have any accrued interest or penalties associated with any unrecognized tax benefits nor was any interest expense recognized during the twelve months ended December 31, 2020, 2019 and 2018. The Company will book any interest or penalties, if required, in interest and other expense, as appropriate.</div>

<div><br/></div>

<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Fair Values of Financial Instruments</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The carrying amounts reported in the balance sheets for cash and cash equivalents, accounts receivable, accounts payable and notes payable approximate their fair values due to the short-term maturity of these financial instruments. The carrying amount under the Amended Credit Agreement and the redemption value of Redeemable non-controlling interests approximate the respective fair values. The fair value of the Company&#8217;s redeemable non-controlling interests is determined based on &#8220;Level 3&#8221; inputs. The interest rate on the Amended Credit Agreement, which is tied to LIBOR, is set at various short-term intervals, as detailed in the Amended Credit Agreement.</div>

<div><br/></div>

<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Segment Reporting</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">Operating segments are components of an enterprise for which separate financial information is available that is evaluated regularly by chief operating decision makers in determining the allocation of resources and in assessing performance. </span>The Company currently operates through two segments: physical therapy operations and industrial injury prevention services.</div>

<div><br/></div>

<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Use of Estimates</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In preparing the Company&#8217;s consolidated financial statements, management makes certain estimates and assumptions, especially in relation to, but not limited to, goodwill impairment, tradenames, allocations of purchase price, allowance for receivables, tax provision and contractual allowances, that affect the amounts reported in the consolidated financial statements and related disclosures. Actual results may differ from these estimates.</div>

<div><br/></div>

<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Self-Insurance Program</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company utilizes a self-insurance plan for its employee group health and dental insurance coverage administered by a third party. Predetermined loss limits have been arranged with the insurance company to minimize the Company&#8217;s maximum liability and cash outlay. Accrued expenses include the estimated incurred but unreported costs to settle unpaid claims and estimated future claims. Management believes that the current accrued amounts are sufficient to pay claims arising from self-insurance claims incurred through December 31, 2020.</div>

<div><br/></div>

<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Restricted Stock</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Restricted stock issued to employees and directors is subject to continued employment or continued service on the board, respectively. Generally, restrictions on the stock granted to employees lapse in equal annual installments on the following <span style="-sec-ix-hidden:Fact_e171b1cb7c524fee994efb673b5c1ee0">four</span> anniversaries of the date of grant. For those shares granted to directors, the restrictions will lapse in equal quarterly installments during the <span style="-sec-ix-hidden:Fact_d66bd8ac9de54f2492bfbf867e9180fc">first</span> year after the date of grant. For those granted to officers, the restriction will lapse in equal quarterly installments during the four years following the date of grant. Compensation expense for grants of restricted stock is recognized based on the fair value per share on the date of grant amortized over the vesting period. The Company recognizes any forfeitures as they occur. The restricted stock issued is included in basic and diluted shares for the earnings per share computation.</div>

<div><br/></div>

<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Recently Adopted Accounting Guidance</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In February 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2016-02, Leases (Topic 842) (&#8220;ASC 842&#8221;), which amended prior accounting standards for leases.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company implemented the new lease standard, ASC Topic 842 &#8211; Leases as of January 1, 2019 using the transition method in ASU 2018-11 issued in July 2018 which allows the Company to initially apply the new leases standard at adoption date and recognize a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. There was no adjustment required to retained earnings upon adoption. Accordingly, no retrospective adjustments were made to the comparative periods presented. The Company elected certain of the practical expedients permitted, including the expedient that allows the Company to retain its existing lease assessment and classification.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Adoption of ASC 842 resulted in an increase to total assets and liabilities due to the recording of operating lease right-of-use assets (&#8220;ROU&#8221;) and operating lease liabilities of approximately $78.0 million and $82.6 million respectively, as of January 1, 2019 for operating leases as a lessee. The adoption did not materially impact the Company&#8217;s consolidated statement of income or cash flows. See Footnote 10 - Leases for further discussion of leases.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In August 2018, the Securities Exchange Commission (&#8220;SEC&#8221;) issued Final Rule 33-10532, Disclosure Update and Simplification, which amends certain disclosure requirements that were redundant, duplicative, overlapping or superseded by other SEC disclosure requirements. The amendments generally eliminated or otherwise reduced certain disclosure requirements of various SEC rules and regulations. However, in some cases, the amendments require additional information to be disclosed, including changes in stockholders&#8217; equity in interim periods. The rule is effective 30 days after its publication in the Federal Register. The rule was posted on October 4, 2018. On September 25, 2018, the SEC released guidance advising it will not object to a registrant adopting the requirement to include changes in stockholders&#8217; equity in the Form 10-Q for the first quarter beginning after the effective date of the rule. The Company adopted this guidance in its Form 10-Q for the period ended March 31, 2019.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In June 2016, the FASB issued ASU 2016-13, Financial Instruments &#8211; Credit Losses, which added a new impairment model (known as the current expected credit loss (CECL) model) that is based on expected losses rather than incurred losses. Under the new guidance, an entity recognizes as an allowance its estimate of expected credit losses. The CECL model applies to most debt instruments, including trade receivables. The CECL model does not have a minimum threshold for recognition of impairment losses and entities will need to measure expected credit losses on assets that have a low risk of loss. The standard is required to be applied using the modified retrospective approach with a cumulative-effect adjustment to retained earnings, if any, upon adoption.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Company completed the adoption of ASU 2016-13, <span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Financial Instruments &#8211; Credit Losses</span>&#160; on January 1, 2020. The financial instruments subject to ASU 2016-13 are the Company&#8217;s accounts receivable derived from contracts with customers. A significant portion of the Company&#8217;s accounts receivable are from highly-solvent, creditworthy payors including governmental programs such as Medicare and Medicaid, and highly regulated commercial insurers. The Company&#8217;s estimate of expected credit losses as of January 1, 2020, using its expected credit loss evaluation process, resulted in no adjustments to the allowance for credit losses and no cumulative-effect adjustment to retained earnings on the adoption date of the standard.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In January 2017, the FASB issued ASU 2017-04, <span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Simplifying the Test for Goodwill Impairment (Topic 350),</span> which eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment charge. ASU 2017-04 is effective prospectively for fiscal years, and the interim periods within those years, beginning after December 15, 2019. The Company completed the adoption of the standard effective January 1, 2020 and there was no impact to goodwill from the Company&#8217;s adoption of this change.</div>

<div><br/></div>

<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Recently Issued Accounting Guidance</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. This ASU provides temporary optional expedients and exceptions to the guidance on contract modifications and hedge accounting to ease the financial reporting burdens of the expected market transition from the London Interbank Offered Rate (&#8220;LIBOR&#8221;) and other interbank offered rates to alternative reference rates. The new guidance was effective upon issuance, and the Company is allowed to elect to apply the amendments prospectively through December 31, 2022. Borrowings under the Amended Credit Agreement bear interest based on LIBOR or an alternate base rate. Provisions within the agreement currently provide the Company with the ability to replace LIBOR with a different reference rate in the event LIBOR ceases to exist.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In August 2020, the FASB issued ASU 2020-06&#160;<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity </span>which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity&#8217;s own equity. As part of this update, convertible instruments are to be included in diluted earnings per share using the if-converted method, rather than the treasury stock method. Further, contracts which can be settled in cash or shares, excluding liability-classified share-based payment awards, are to be included in diluted earnings per share on an if-converted basis if the effect is dilutive, regardless of whether the entity or the counterparty can choose between cash and share settlement. The share-settlement presumption may not be rebutted based on past experience or a stated policy.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">This pronouncement is effective for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2021. The Company plans to adopt this pronouncement as of January 1, 2022. The use of either the modified retrospective or fully retrospective method of transition is permitted. The Company is currently evaluating the impact of the adoption of ASU 2020-06 on the Company's consolidated financial statements.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In December 2019, the FASB issued ASU 2019-12,&#160;Income Taxes (Topic 740) &#8211; Simplifying the Accounting for Income Taxes (&#8220;ASU 2019-12&#8221;). The objective of ASU 2019-12 is to simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740 and to provide more consistent application to improve the comparability of financial statements. The amendments in this ASU are effective for fiscal years beginning after December 15, 2020, and early adoption is permitted. We are currently evaluating the impact this guidance may have on our consolidated financial statements and related footnote disclosures.</div>

<div><br/></div>

<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Subsequent Event</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">On January 29, 2021, the Company, entered into the First Amendment to Second Amended and Restated Credit Agreement (hereafter referred to as &#8220;Amended Credit Agreement&#8221;) extending the maturity date from November 30, 2021 to November 30, 2025. The commitment under the Amended Credit Agreement remains at $125 million, however the accordion feature in the agreement was expanded to provide for capacity up to $150 million. See Note 9 for more information on the Amended Credit Agreement.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438853296792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions of Businesses<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Acquisitions of Businesses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Acquisitions of Businesses</a></td>
<td class="text">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">3. Acquisitions of Businesses</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">During 2020, 2019 and 2018, the Company acquired a majority interest in the following physical therapy practices:</div>

<div><br/></div>

<table cellpadding="0" cellspacing="0" id="zf55e47efd599479e982bad9962730ad0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">
  <tr>
    <td style="width: 39.03%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Acquisition</div></td>
    <td style="width: 3.06%; vertical-align: bottom;">&#160;</td>
    <td style="width: 22.92%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Date</div></td>
    <td style="width: 2.78%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td style="width: 14.72%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">% Interest<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/></span>Acquired</div></td>
    <td style="width: 2.92%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td style="width: 14.58%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Number of<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/></span>Clinics</div></td>
  </tr>
  <tr>
    <td style="width: 39.03%; vertical-align: bottom;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">November 2020 Acquisition</div></td>
    <td style="width: 3.06%; vertical-align: bottom;">&#160;</td>
    <td style="width: 22.92%; vertical-align: bottom; border-top: #000000 2px solid;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">November 30, 2020</div></td>
    <td style="width: 2.78%; vertical-align: bottom;">&#160;</td>
    <td style="width: 14.72%; vertical-align: bottom;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">75%</div></td>
    <td style="width: 2.92%; vertical-align: bottom;">&#160;</td>
    <td style="width: 14.58%; vertical-align: bottom;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">3</div></td>
  </tr>
  <tr>
    <td style="width: 39.03%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">September 2020 Acquisition</div></td>
    <td style="width: 3.06%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 22.92%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">September 30, 2020</div></td>
    <td style="width: 2.78%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 14.72%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">70%</div></td>
    <td style="width: 2.92%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 14.58%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><span style="-sec-ix-hidden:Fact_29c0aadade644e9a962b7bfbcb82c179">*</span></div></td>
  </tr>
  <tr>
    <td style="width: 39.03%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">February 2020 Acquisition</div></td>
    <td style="width: 3.06%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 22.92%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">February 27, 2020</div></td>
    <td style="width: 2.78%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 14.72%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">65%</div></td>
    <td style="width: 2.92%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">**</div></td>
    <td style="width: 14.58%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">4</div></td>
  </tr>
  <tr>
    <td style="width: 39.03%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">September 2019 Acquisition</div></td>
    <td style="width: 3.06%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 22.92%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">September 30, 2019</div></td>
    <td style="width: 2.78%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 14.72%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">67%</div></td>
    <td style="width: 2.92%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 14.58%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">11</div></td>
  </tr>
  <tr>
    <td style="width: 39.03%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">August 2018 Acquisition</div></td>
    <td style="width: 3.06%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 22.92%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">August 31, 2018</div></td>
    <td style="width: 2.78%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 14.72%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">70%</div></td>
    <td style="width: 2.92%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 14.58%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">4</div></td>
  </tr>
</table>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">*&#160; &#160; </span>The business includes six management and services contracts which had a remaining term of approximately five years as of the date acquired.</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">**&#160;&#160; </span>The four clinics are in four separate partnerships.&#160; The Company's interest in the four partnerships range from 10.0% to 83.8%, with an overall 65.0% based on the initial purchase transaction.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">On November 30, 2020, the Company acquired a 75% interest in a three-clinic physical therapy practice. The purchase price for the 75% interest was $9.1 million, of which $8.8 million was paid in cash and $0.3 million in the form of a seller note that is payable in two principal installments totaling $162,500 each. The first principal payment plus accrued interest will be paid on November 2021 with the second installment to be paid in November 2022. The note accrues interest at 3.25% per annum.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">On September 30, 2020, the Company acquired a 70% interest in an entity which holds six-management contracts that have been in place for a number of years. Currently, these contracts have a five year term. The purchase price for the 70% interest was approximately $4.2 million, with $3.7 million payable in cash and $0.5 million in notes payable. One of the notes payable of $0.2 million is payable, with any accrued interest at 5% per annum, on September 30, 2021.&#160; The remaining note of $0.3 million was paid in November 2020.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">On February 27, 2020, the Company acquired interests in a four-clinic physical therapy practice. The four clinics are operated in four separate partnerships.&#160; The Company&#8217;s interests in the four partnerships range from 10.0% to 83.8%, with an overall 65.0% based on the initial purchase transaction. The aggregate purchase price was $12.3 million, of which $11.9 million was paid in cash and $0.3 million in the form of a seller note.&#160; The note accrues interest at 4.75% per annum and the principal and interest is payable on February 2022.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The purchase price for the 2020 physical therapy operations acquisitions has been preliminarily allocated as follows (in thousands):</div>

<div><br/></div>

<table cellpadding="0" cellspacing="0" id="za1a0966005394e48a9d620aafba9caf2" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Cash paid, net of cash acquired ($500)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">23,907</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Seller note</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,121</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total consideration</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">25,028</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Estimated fair value of net tangible assets acquired:</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%;" valign="bottom"><div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total current assets</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,271</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total non-current assets</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">134</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total liabilities</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(555</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -15.85pt; margin-left: 33.85pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Net tangible assets acquired</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">850</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%;" valign="bottom"><div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Referral relationships</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">3,597</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Non-compete</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,012</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%;" valign="bottom"><div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Tradename</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,326</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Goodwill</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">28,540</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Fair value of non-controlling interest (classified as redeemable non-controlling interests)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(11,297</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">25,028</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
</table>

<div><br/></div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">On September 30, 2019, the Company acquired a 67% interest in an eleven-clinic physical therapy practice. The purchase price for the 67% interest was $12.4 million ($12.6 million less cash acquired of $0.2 million), of which $12.3 million was paid in cash and $0.3 million in a seller note payable in two principal installments totaling $150,000 each, plus accrued interest. A payment of $150,000 plus accrued interest was paid in September 2020 and a second payment is due in September 2021. The note accrues interest at 5.0% per annum.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">On April 11, 2019, the Company acquired a company that is a provider of industrial injury prevention services. The acquired company specializes in delivering injury prevention and care, post offer employment testing, functional capacity evaluations and return-to-work services. It performs these services across a network of 45 states including onsite at eleven client locations. The acquired business was then combined with Briotix Health, the Company&#8217;s industrial injury prevention operation, increasing the Company&#8217;s ownership position in the Briotix Health partnership to approximately 76.0%. The purchase price for the acquired company was $22.9 million ($23.6 million less cash acquired of $0.7 million), which consisted of $18.9 million in cash, (of which $0.5 million will be paid to certain shareholders), and a $4.0 million seller note. The note accrues interest at 5.5% and the principal and accrued interest is payable, on April 9, 2021.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The results of operations of the acquired clinics have been included in the Company&#8217;s consolidated financial statements since the date of their respective acquisition. The Company intends to continue to pursue additional acquisition opportunities, develop new clinics and open satellite clinics.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The purchase price for the 2019 acquisitions were allocated as follows (in thousands):</div>

<div><br/></div>

<table cellpadding="0" cellspacing="0" id="z0200ec8ec07146f3bd1815fa975597c6" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/></td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">IIPS*</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> Physical Therapy Operations</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Total</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Cash paid, net of cash acquired ($890)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">18,428</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">12,170</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">30,598</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%;" valign="bottom"><div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Payable to shareholders of seller</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">485</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">485</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Seller note</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">4,000</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">300</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">4,300</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px;" valign="bottom"><div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total consideration</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">22,913</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">12,470</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">35,383</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%;" valign="bottom"><div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Estimated fair value of net tangible assets acquired:</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total current assets</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,641</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">650</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,291</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%;" valign="bottom"><div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total non-current assets</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">848</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">394</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,242</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total liabilities</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(2,978</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(191</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(3,169</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%;" valign="bottom"><div style="text-align: left; text-indent: -15.85pt; margin-left: 33.85pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Net tangible assets acquired</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(489</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">853</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">364</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Referral relationships</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">3,400</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,600</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">6,000</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%;" valign="bottom"><div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Non-compete</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">250</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">270</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">520</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Tradename</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,300</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">740</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,040</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%;" valign="bottom"><div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Goodwill</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">18,452</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">14,237</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">32,689</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Fair value of non-controlling interest (classified as redeemable non-controlling interests)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(6,230</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(6,230</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">22,913</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">12,470</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">35,383</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
</table>

<div><br/></div>

<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">* Industrial injury prevention services</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">On August 31, 2018, the Company acquired a 70% interest in a four-clinic physical therapy practice. The purchase price for the 70% interest was $7.3 million in cash and $0.4 million in a seller note that was payable in two principal installments totaling $200,000 each, plus accrued interest. The first installment was paid in cash in August 2019 and the second installment was paid in August 2020.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">On April 30, 2018, the Company acquired a 65% interest in another business in the industrial injury prevention sector. The aggregate purchase price for the 65% interest was $8.6 million in cash and $400,000 in a seller note that was paid on April 30, 2019. On April 30, 2018, the Company combined its two businesses. After the combination, the Company owned a 59.45% interest in the combined business, Briotix Health. See discussion above regarding an additional acquisition on April 11, 2019 in the industrial injury prevention business.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In addition, during 2018, the Company, through several of its majority owned Clinic Partnerships, acquired five separate clinic practices. These practices operate as satellites of the existing Clinic Partnership. The aggregate purchase price was $1.0 million inclusive of cash of $850,000 and a note payable of $150,000. The note accrued interest at 4.5% and the principal and accrued interest, was paid in cash on August 31, 2019.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The purchase price for the 2018 acquisitions were allocated as follows (in thousands):</div>

<div><br/></div>

<table cellpadding="0" cellspacing="0" id="z4cea7993c4404e908d071694d5887404" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Cash paid, net of cash acquired ($372)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">16,367</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Seller note</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">950</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total consideration</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">17,317</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Estimated fair value of net tangible assets acquired:</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total current assets</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,633</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total non-current assets</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">305</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total liabilities</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(525</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Net tangible assets acquired</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,413</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Referral relationships</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,926</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Non-compete</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">298</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Tradename</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">990</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Goodwill</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">19,835</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Fair value of non-controlling interest (classified as redeemable non-controlling interests)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(8,145</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">17,317</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
</table>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The finalized purchase prices plus the fair value of the non-controlling interests for the acquisitions in 2019 and 2018 were allocated to the fair value of the assets acquired, inclusive of identifiable intangible assets, i.e. trade names, referral relationships and non-compete agreements, and liabilities assumed based on the fair values at the acquisition date, with the amount exceeding the fair values being recorded as goodwill. For the acquisitions in 2020, the Company is in the process of completing its formal valuation analysis to identify and determine the fair value of tangible and identifiable intangible assets acquired and the liabilities assumed. Thus, the final allocation of the purchase price may differ from the preliminary estimates used at December 31, 2020 based on additional information obtained and completion of the valuation of the identifiable intangible assets. Changes in the estimated valuation of the tangible assets acquired, the completion of the valuation of identifiable intangible assets and the completion by the Company of the identification of any unrecorded pre-acquisition contingencies, where the liability is probable and the amount can be reasonably estimated, will likely result in adjustments to goodwill. The Company does not expect the adjustments to be material.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">For the acquisitions in 2020, the values assigned to the referral relationships and non-compete agreements are being amortized to expense equally over the respective estimated lives. For referral relationships, the amortization period is 11.0 years. For non-compete agreements, the amortization period is 6.0 years. The values assigned to tradenames are tested annually for impairment.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">For the acquisitions in 2019 and 2018, the values assigned to the referral relationships and non-compete agreements are being amortized to expense equally over the respective estimated lives. For referral relationships, the weighted average amortization period was 10.54 and 10.10 years at December 31, 2019 and December 31, 2018, respectively. For non-compete agreements, the weighted average amortization period was 6.00 and 5.16 years at December 31, 2019 and December 31, 2018, respectively. Generally, the values assigned to tradenames are tested annually for impairment.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">For the 2020, 2019 and 2018 acquisitions, total current assets primarily represent patient accounts receivable. Total non-current assets are fixed assets, primarily equipment, used in the practices.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The consideration paid for each of the acquisitions was derived through arm&#8217;s length negotiations. Funding for the cash portions was derived from proceeds from the Company&#8217;s revolving credit facility. The results of operations of the acquisitions have been included in the Company&#8217;s consolidated financial statements since their respective date of acquisition. Unaudited proforma consolidated financial information for the acquisitions in 2020, 2019 and 2018 acquisitions have not been included as the results, individually and in the aggregate. </div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438846532904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Sale of Non-Controlling Interests<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Acquisitions and Sale of Non-Controlling Interests [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDisclosureTextBlock', window );">Acquisitions and Sale of Non-Controlling Interests</a></td>
<td class="text">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">4. Acquisitions and Sale of Non-Controlling Interests</div>

<div style="text-align: left;"><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">During </span>2020,<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> the Company acquired additional interests in </span>five<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> partnerships which are included in non-controlling interest. The additional interests purchased in each of the partnerships ranged from </span>20%<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> to </span>35%<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">. The aggregated purchase price for these acquired interests was </span>$0.3 million<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">. The Company sold an interest in a partnership for </span>$0.1 million<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">.</span></div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">Also during </span>2020,<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> the Company sold </span>14<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> previously closed clinics. The aggregate sales price was </span>$1.1 million<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">, of which </span>$0.7 million<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> was paid in cash and </span>$0.4 million<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> in a note receivable, payable in </span>two<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> equal installments of principal and any accrued interest on June </span>15,<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">&#160;</span>2021<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> and </span>2022.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">During </span>2019,<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> the Company acquired additional interests in </span>four<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> partnerships which are included in non-controlling interest. The additional interests purchased in each of the partnerships ranged from </span>1%<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> to </span>20%<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">. Also in </span>2019,<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> the Company sold a </span>1%<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> interest in a partnership. The net after-tax difference between the payments and the portion of undistributed earnings of </span>$196,000<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> was credited to additional paid-in capital. </span></div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438846775608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Non-Controlling Interest<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RedeemableNonControllingInterestAbstract', window );"><strong>Redeemable Non-Controlling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RedeemableNonControllingInterestTextBlock', window );">Redeemable Non-Controlling Interest</a></td>
<td class="text">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">5. Redeemable Non-Controlling Interest</div>

<div style="text-align: left;"><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Since October 2017, when the Company acquires a majority interest (the &#8220;Acquisition&#8221;) in a physical therapy clinic business (referred to as &#8220;Therapy Practice&#8221;), these Acquisitions occur in a series of steps which are described below.</div>

<div style="text-align: left;"><br/></div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" id="zc7bdc62a54e54a708109fb2fb4f94a6d" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">
  <tr>
    <td style="width: 18pt;"/>
    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1.</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Prior to the Acquisition, the Therapy Practice exists as a separate legal entity (the &#8220;Seller Entity&#8221;). The Seller Entity is owned by one or more individuals (the &#8220;Selling Shareholders&#8221;) most of whom are physical therapists that work in the Therapy Practice and provide physical therapy services to patients.</div></td>
  </tr>
</table>

<div><br/></div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" id="z99217b321d1b4616ac247e23558b81cb" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">
  <tr>
    <td style="width: 18pt;"/>
    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2.</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In conjunction with the Acquisition, the Seller Entity contributes the Therapy Practice into a newly-formed limited partnership (&#8220;NewCo&#8221;), in exchange for one hundred percent (100%) of the limited and general partnership interests in NewCo. Therefore, in this step, NewCo becomes a wholly-owned subsidiary of the Seller Entity.</div></td>
  </tr>
</table>

<div><br/></div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" id="z0671445f15e345a8bbe848867376c4df" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">
  <tr>
    <td style="width: 18pt;"/>
    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">3.</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company enters into an agreement (the &#8220;Purchase Agreement&#8221;) to acquire from the Seller Entity a majority (ranges from 50% to 90%) of the limited partnership interest and in <span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="text-decoration: underline;">all</span></span> cases 100% of the general partnership interest in NewCo. The Company does not purchase 100% of the limited partnership interest because the Selling Shareholders, through the Seller Entity, want to maintain an ownership percentage. The consideration for the Acquisition is primarily payable in the form of cash at closing and a small two-year note in lieu of an escrow (the &#8220;Purchase Price&#8221;). The Purchase Agreement does not contain any future earn-out or other contingent consideration that is payable to the Seller Entity or the Selling Shareholders.</div></td>
  </tr>
</table>

<div><br/></div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" id="ze02633183fb54390b58ff1885d4e4783" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">
  <tr>
    <td style="width: 18pt;"/>
    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">4.</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company and the Seller Entity also execute a partnership agreement (the &#8220;Partnership Agreement&#8221;) for NewCo that sets forth the rights and obligations of the limited and general partners of NewCo. After the Acquisition, the Company is the general partner of NewCo.</div></td>
  </tr>
</table>

<div><br/></div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" id="z7a526d32e09d4dddad04019070607f9f" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">
  <tr>
    <td style="width: 18pt;"/>
    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">5.</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">As noted above, the Company does not purchase 100% of the limited partnership interests in NewCo and the Seller Entity retains a portion of the limited partnership interest in NewCo (&#8220;Seller Entity Interest&#8221;).</div></td>
  </tr>
</table>

<div><br/></div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" id="zb058bf3e3d2847d5aedd1d3b688d4498" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">
  <tr>
    <td style="width: 18pt;"/>
    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">6.</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In most cases, some or all of the Selling Shareholders enter into an employment agreement (the &#8220;Employment Agreement&#8221;) with NewCo with an initial term that ranges from <span style="-sec-ix-hidden:Fact_52fb956c20c94f01b9b7ffcd0435f795">three</span> to five years (the &#8220;Employment Term&#8221;), with automatic one-year renewals, unless employment is terminated prior to the end of the Employment Term. As a result, a Selling Shareholder becomes an employee (&#8220;Employed Selling Shareholder&#8221;) of NewCo. The employment of an Employed Selling Shareholder can be terminated by the Employed Selling Shareholder or NewCo, with or without cause, at any time. In a few situations, a Selling Shareholder does not become employed by NewCo and is not involved with NewCo following the closing; in those situations, such Selling Shareholders sell their entire ownership interest in the Seller Entity as of the closing of the Acquisition.</div></td>
  </tr>
</table>

<div><br/></div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" id="zb9ec36386a1e4b0085e09d415fa38596" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">
  <tr>
    <td style="width: 18pt;"/>
    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">7.</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The compensation of each Employed Selling Shareholder is specified in the Employment Agreement and is customary and commensurate with his or her responsibilities based on other employees in similar capacities within NewCo, the Company and the industry.</div></td>
  </tr>
</table>

<div><br/></div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" id="z6c026b3d9d774cd0bca196d3492506cd" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">
  <tr>
    <td style="width: 18pt;"/>
    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">8.</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company and the Selling Shareholder (including both Employed Selling Shareholders and Selling Shareholders not employed by NewCo) execute a non-compete agreement (the &#8220;Non-Compete Agreement&#8221;) which restricts the Selling Shareholder from engaging in competing business activities for a specified period of time (the &#8220;Non-Compete Term&#8221;). A Non-Compete Agreement is executed with the Selling Shareholders in all cases. That is, even if the Selling Shareholder does not become an Employed Selling Shareholder, the Selling Shareholder is restricted from engaging in a competing business during the Non-Compete Term.</div></td>
  </tr>
</table>

<div><br/></div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" id="z1de0bf8dd2dc459597d038135831c4d3" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">
  <tr>
    <td style="width: 18pt;"/>
    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">9.</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Non-Compete Term commences as of the date of the Acquisition and expires on the <span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="text-decoration: underline;">later</span></span> of:</div></td>
  </tr>
</table>

<div><br/></div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" id="zda65c3f5f9174cc199fe8dd67bd83ca9" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">
  <tr>
    <td style="width: 36pt;"/>
    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">a.</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Two years after the date an Employed Selling Shareholders&#8217; employment is terminated (if the Selling Shareholder becomes an Employed Selling Shareholder) or</div></td>
  </tr>
</table>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" id="zfb76a3e74897489fa93180854bcb8faa" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">
  <tr>
    <td style="width: 36pt;"/>
    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">b.</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><span style="-sec-ix-hidden:Fact_c128a6eff4b84ab0bfde32533264356c">Five</span> to six years from the date of the Acquisition, as defined in the Non-Compete Agreement, regardless of whether the Selling Shareholder is employed by NewCo.</div></td>
  </tr>
</table>

<div><br/></div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" id="zbc85b6963e4d434897715db0819242a0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">
  <tr>
    <td style="width: 18pt;"/>
    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">10.</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Non-Compete Agreement applies to a restricted region which is defined as a 15-mile radius from the Therapy Practice. That is, an Employed Selling Shareholder is permitted to engage in competing businesses or activities outside the 15-mile radius (after such Employed Selling Shareholder no longer is employed by NewCo) and a Selling Shareholder who is not employed by NewCo immediately is permitted to engage in the competing business or activities outside the 15-mile radius.</div></td>
  </tr>
</table>

<div><br/></div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 18pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Partnership Agreement contains provisions for the redemption of the Seller Entity Interest, either at the option of the Company (the &#8220;Call Right&#8221;) or at the option of the Seller Entity (the &#8220;Put Right&#8221;) as follows:</div>

<div><br/></div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" id="zd97299e0990f4b66ad809445b4244966" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">
  <tr>
    <td style="width: 18pt;"/>
    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1.</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Put Right</div></td>
  </tr>
</table>

<div><br/></div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" id="z67d0c7c361bf43cc85f4d8b2b3482dd4" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">
  <tr>
    <td style="width: 36pt;"/>
    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">a.</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In the event that any Selling Shareholder&#8217;s employment is terminated under certain circumstances prior to the fifth anniversary of the Closing Date, the Seller Entity thereafter may have an irrevocable right to cause the Company to purchase from Seller Entity the Terminated Selling Shareholder&#8217;s Allocable Percentage of Seller Entity&#8217;s Interest at the purchase price described in &#8220;3&#8221; below.</div></td>
  </tr>
</table>

<div><br/></div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" id="z81aac4917b12463886deee6aa25f1d93" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">
  <tr>
    <td style="width: 36pt;"/>
    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">b.</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In the event that any Selling Shareholder is not employed by NewCo as of the fifth anniversary of the Closing Date and the Company has not exercised its Call Right with respect to the Terminated Selling Shareholder&#8217;s Allocable Percentage of Seller Entity&#8217;s Interest, Seller Entity thereafter shall have the Put Right to cause the Company to purchase from Seller Entity the Terminated Selling Shareholder&#8217;s Allocable Percentage of Seller Entity&#8217;s Interest at the purchase price described in &#8220;3&#8221; below.</div></td>
  </tr>
</table>

<div><br/></div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" id="z7901e88d85124eb88f96525cee10b616" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">
  <tr>
    <td style="width: 36pt;"/>
    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">c.</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In the event that any Selling Shareholder&#8217;s employment with NewCo is terminated for any reason on or after the fifth anniversary of the Closing Date, the Seller Entity shall have the Put Right, and upon the exercise of the Put Right, the Terminated Selling Shareholder&#8217;s Allocable Percentage of Seller Entity&#8217;s Interest shall be redeemed by the Company at the purchase price described in &#8220;3&#8221; below.</div></td>
  </tr>
</table>

<div><br/></div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" id="ze305be984ed843dda348b7fbea98691b" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">
  <tr>
    <td style="width: 18pt;"/>
    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2.</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Call Right</div></td>
  </tr>
</table>

<div><br/></div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" id="z0a51ba759e7e4ab7af84d58fff32e8c2" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">
  <tr>
    <td style="width: 36pt;"/>
    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">a.</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">If any Selling Shareholder&#8217;s employment by NewCo is terminated prior to the fifth anniversary of the Closing Date, the Company thereafter shall have an irrevocable right to purchase from Seller Entity the Terminated Selling Shareholder&#8217;s Allocable Percentage of Seller Entity&#8217;s Interest, in each case at the purchase price described in &#8220;3&#8221; below.</div></td>
  </tr>
</table>

<div><br/></div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" id="z05b9ea60733547efbda8408402826246" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">
  <tr>
    <td style="width: 36pt;"/>
    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">b.</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In the event that any Selling Shareholder&#8217;s employment with NewCo is terminated for any reason on or after the fifth anniversary of the Closing Date, the Company shall have the Call Right, and upon the exercise of the Call Right, the Terminated Selling Shareholder&#8217;s Allocable Percentage of Seller Entity&#8217;s Interest shall be redeemed by the Company at the purchase price described in &#8220;3&#8221; below.</div></td>
  </tr>
</table>

<div><br/></div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" id="zd051b3679ba0404d967210cec70f1639" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">
  <tr>
    <td style="width: 18pt;"/>
    <td style="width: 22.5pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">3.</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">For the Put Right and the Call Right, the purchase price is derived from a formula based on a specified multiple of NewCo&#8217;s trailing twelve months of earnings before interest, taxes, depreciation, amortization, and the Company&#8217;s internal management fee, plus an Allocable Percentage of any undistributed earnings of NewCo (the &#8220;Redemption Amount&#8221;). NewCo&#8217;s earnings are distributed monthly based on available cash within NewCo&#894; therefore, the undistributed earnings amount is small, if any.</div></td>
  </tr>
</table>

<div><br/></div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" id="zbff5a3f2289d41cf8510cf450726b116" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">
  <tr>
    <td style="width: 18pt;"/>
    <td style="width: 22.5pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">4.</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Purchase Price for the initial equity interest purchased by the Company is also based on the same specified multiple of the trailing twelve-month earnings that is used in the Put Right and the Call Right noted above.</div></td>
  </tr>
</table>

<div><br/></div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" id="z1528515d22304d02bf65e5b330c9ce23" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">
  <tr>
    <td style="width: 18pt;"/>
    <td style="width: 22.5pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">5.</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Put Right and the Call Right do not have an expiration date, but the Seller Entity Interest is not required to be purchased by the Company or sold by the Seller Entity.</div></td>
  </tr>
</table>

<div><br/></div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" id="z470f34023b2c4a63b1cd76aa3f152c47" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">
  <tr>
    <td style="width: 18pt;"/>
    <td style="width: 22.5pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">6.</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Put Right and the Call Right never apply to Selling Shareholders who do not become employed by NewCo, since the Company requires that such Selling Shareholders sell their entire ownership interest in the Seller Entity at the closing of the Acquisition.</div></td>
  </tr>
</table>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">An Employed Selling Shareholder&#8217;s ownership of his or her equity interest in the Seller Entity predates the Acquisition and the Company&#8217;s purchase of its partnership interest in NewCo. The Employment Agreement and the Non-Compete Agreement do not contain any provision to escrow or &#8220;claw back&#8221; the equity interest in the Seller Entity held by such Employed Selling Shareholder, nor the Seller Entity Interest in NewCo, in the event of a breach of the employment or non-compete terms. More specifically, even if the Employed Selling Shareholder is terminated for &#8220;cause&#8221; by NewCo, such Employed Selling Shareholder does not forfeit his or her right to his or her full equity interest in the Seller Entity and the Seller Entity does not forfeit its right to any portion of the Seller Entity Interest. The Company&#8217;s only recourse against the Employed Selling Shareholder for breach of either the Employment Agreement or the Non-Compete Agreement is to seek damages and other legal remedies under such agreements. There are no conditions in any of the arrangements with an Employed Selling Shareholder that would result in a forfeiture of the equity interest held in the Seller Entity or of the Seller Entity Interest.</div>

<div><br/></div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">For the year ended December 31, 2020, 2019 and 2018, the following table details the changes in the carrying amount (fair value) of the redeemable non-controlling interests (in thousands):</div>

<div><br/></div>

<table cellpadding="0" cellspacing="0" id="z5419bd02f8334e35b081255c66326369" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/></td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;">December 31, 2018</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Beginning balance</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">137,750</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">133,943</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">102,572</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Operating results allocated to redeemable non-controlling interest partners</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">11,175</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">10,659</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">8,433</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Distributions to redeemable non-controlling interest partners</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(12,403</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(10,221</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(9,835</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Changes in the fair value of redeemable non-controlling interest</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">4,632</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">11,893</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">24,770</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Purchases of redeemable non-controlling interest</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(20,521</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(8,934</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">8,145</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Acquired interest</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">11,297</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">6,230</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Reduction of non-controlling interest due to sale of USPH partnership interest</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(6,132</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Sales of redeemable non-controlling interest - temporary equity</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,133</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">3,120</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Notes receivable related to sales of redeemable non-controlling interest - temporary equity</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(1,006</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(2,870</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(142</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Adjustments in notes receivable related to the the sales of redeemable non-controlling interest - temporary equity</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">283</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Other</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">62</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Ending balance</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">132,340</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">137,750</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">133,943</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
</table>

<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 12pt;"><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The following table categorizes the carrying amount (fair value) of the redeemable non-controlling interests (in thousands):</div>

<div><br/></div>

<table cellpadding="0" cellspacing="0" id="z670c3e5c6ec64188aa3c22deb9e2062e" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/></td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;">December 31, 2018</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Contractual time period has lapsed but holder's employment has not been terminated</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">62,390</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">51,921</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">42,624</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Contractual time period has not lapsed and holder's employment has not been terminated</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">69,950</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">85,829</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">91,319</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Holder's employment has terminated and contractual time period has expired</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Holder's employment has terminated and contractual time period has not expired</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">132,340</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">137,750</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">133,943</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_RedeemableNonControllingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_RedeemableNonControllingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_RedeemableNonControllingInterestTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a redeemable non-controlling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_RedeemableNonControllingInterestTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438846393640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillDisclosureTextBlock', window );">Goodwill</a></td>
<td class="text">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">6. Goodwill</div>

<div style="text-align: left;"><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The changes in the carrying amount of goodwill as of December 31, 2020 and 2019 consisted of the following (in thousands):</div>

<div style="text-align: left;"><br/></div>

<table cellpadding="0" cellspacing="0" id="z004ebbf23ace473ea8af3849451f0579" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/></td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Beginning balance</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">317,676</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">293,525</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Goodwill acquired</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">28,540</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">31,330</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Goodwill related to partnership interest sold</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(7,325</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Goodwill derecognition (write-off) related to closed clinics</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(1,859</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Goodwill adjustments for purchase price allocation of businesses acquired in prior year</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,289</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">146</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Ending balance</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">345,646</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">317,676</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2144439<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438850777144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible Assets, net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets, net</a></td>
<td class="text">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">7. Intangible Assets, net</div>

<div style="text-align: left;"><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Intangible assets, net as of December 31, 2020, 2019 and 2018 consisted of the following (in thousands):</div>

<div style="text-align: left;"><br/></div>

<table cellpadding="0" cellspacing="0" id="z4aa296b7bad344d8aa0f77e9db40fba3" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/></td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Tradenames</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">32,317</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">32,049</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Referral relationships, net of accumulated amortization of $14,522 and $11,677, respectively</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">22,119</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">18,367</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Non-compete agreements, net of accumulated amortization of $5,993 and $5,424, respectively</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,844</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,172</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">56,280</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">52,588</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
</table>

<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 12pt;"><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Tradenames, referral relationships and non-compete agreements are related to the businesses acquired. The value assigned to tradenames has an indefinite life and is tested at least annually for impairment using the relief from royalty method in conjunction with the Company&#8217;s annual goodwill impairment test. The value assigned to referral relationships is being amortized over their respective estimated useful lives which range from 6 to 16 years. Non-compete agreements are amortized over the respective term of the agreements which range from 5 to 6 years.</div>

<div style="text-align: left;"><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The following table details the amount of amortization expense recorded for intangible assets for the years ended December 31, 2020, 2019 and 2018 (in thousands):</div>

<div style="text-align: left;"><br/></div>

<table cellpadding="0" cellspacing="0" id="z3d51561c2d2b4e3991aa252252acd5e0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/></td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;">Year Ended</div><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;">December 31, 2018</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Referral relationships</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,845</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,307</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,161</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Non-compete agreements</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">569</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">708</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">616</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">3,414</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">3,015</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,777</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
</table>

<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 12pt;"><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">For one acquisition, the value assigned to tradename was being amortized over the term of the six year agreement in which the Company had acquired the right to use the specific tradename.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The remaining balances of the referral relationships and non-compete agreements is expected to be amortized as follows (in thousands):</div>

<div><br/></div>

<table cellpadding="0" cellspacing="0" id="z4ca35e0153f74abcaf4ae18e8b962393" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">
  <tr>
    <td colspan="3" style="width: 48.7%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Referral Relationships</div></td>
    <td style="width: 1.33%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="3" style="width: 48.71%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Non-Compete Agreements</div></td>
    <td style="width: 1.26%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 37.23%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Years</div></td>
    <td style="width: 1.12%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td style="width: 10.35%; vertical-align: bottom;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Annual Amount</div></td>
    <td style="width: 1.33%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td style="width: 37.23%; vertical-align: bottom; white-space: nowrap;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Years</div></td>
    <td style="width: 1.12%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td style="width: 10.35%; vertical-align: bottom;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Annual Amount</div></td>
    <td style="width: 1.26%; vertical-align: bottom;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 37.23%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Ending December 31,</div></td>
    <td style="width: 1.12%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td style="width: 10.35%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td style="width: 1.33%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td style="width: 37.23%; vertical-align: bottom; white-space: nowrap;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Ending December 31,</div></td>
    <td style="width: 1.12%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td style="width: 10.35%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td style="width: 1.26%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2021</div></td>
    <td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,946</div></td>
    <td style="width: 1.33%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2021</div></td>
    <td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">556</div></td>
    <td style="width: 1.26%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2022</div></td>
    <td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,886</div></td>
    <td style="width: 1.33%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2022</div></td>
    <td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">403</div></td>
    <td style="width: 1.26%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2023</div></td>
    <td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,778</div></td>
    <td style="width: 1.33%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2023</div></td>
    <td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">335</div></td>
    <td style="width: 1.26%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2024</div></td>
    <td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,615</div></td>
    <td style="width: 1.33%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2024</div></td>
    <td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">279</div></td>
    <td style="width: 1.26%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2025</div></td>
    <td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,470</div></td>
    <td style="width: 1.33%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2025</div></td>
    <td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">212</div></td>
    <td style="width: 1.26%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Thereafter</div></td>
    <td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">8,424</div></td>
    <td style="width: 1.33%; vertical-align: bottom; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>
    <td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF; white-space: nowrap;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Thereafter</div></td>
    <td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">59</div></td>
    <td style="width: 1.26%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
  </tr>
</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438846393640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Accrued Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accrued Expenses</a></td>
<td class="text">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">8. Accrued Expenses</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Accrued expenses as of December 31, 2020 and 2019 consisted of the following (in thousands):</div>

<div style="text-align: left;"><br/></div>

<table cellpadding="0" cellspacing="0" id="z5e0ab21edcc54f1d894d4c3659803307" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/></td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Salaries and related costs</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">24,646</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">19,340</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Credit balances due to patients and payors</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">5,756</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">4,303</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Group health insurance claims</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,113</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,277</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Closure costs</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,333</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">116</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Federal income taxes payable</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">5,715</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">MAAPP funds payable</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">14,054</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Deferred employer payroll taxes - CARES ACT</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">4,170</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Other</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,959</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">4,819</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">59,746</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">30,855</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438844879256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes Payable<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Notes Payable [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Notes Payable</a></td>
<td class="text">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">9. Notes Payable</div>

<div style="text-align: left;"><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Notes payable as of December 31, 2020 and 2019 consisted of the following (in thousands):</div>

<div style="text-align: left;"><br/></div>

<table cellpadding="0" cellspacing="0" id="z2a1752aada2b4b209bdac3644d131528" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/></td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Credit Agreement average effective interest rate of 2.6% and 3.9% in 2020 and 2019, respectively (inclusive of unused fee)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">16,000</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">46,000</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Various notes payable with $4,899 plus accrued interest due in the next year, interest accrues in the range of 3.25% through 5.50% per annum</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">5,495</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">5,089</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">21,495</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">51,089</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Less current portion</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(4,899</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(728</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Long term portion</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">16,596</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">50,361</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
</table>

<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 12pt;"><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Effective December 5, 2013, the Company entered into an Amended and Restated Credit Agreement with a commitment for a $125.0 million revolving credit facility. This agreement was amended and/or restated in August 2015, January 2016, March 2017 and November 2017 and January 2021 (hereafter referred to as &#8220;Amended Credit Agreement&#8221;). The Amended Credit Agreement is unsecured and has loan covenants, including requirements that the Company comply with a consolidated fixed charge coverage ratio and consolidated leverage ratio. Proceeds from the Amended Credit Agreement may be used for working capital, acquisitions, purchases of the Company&#8217;s common stock, dividend payments to the Company&#8217;s common stockholders, capital expenditures and other corporate purposes. The pricing grid which is based on the Company&#8217;s consolidated leverage ratio with the applicable spread over LIBOR ranging from 1.25% to 2.0% or the applicable spread over the Base Rate ranging from 0.1% to 1%. Fees under the Amended Credit Agreement include an unused commitment fee of 0.3% of the amount of funds outstanding under the Amended Credit Agreement.</div>

<div style="text-align: left;"><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">The Amended Credit Agreement allows the cash and noncash consideration that the Company could pay with respect to acquisitions permitted under the Amended Credit Agreement to $</span>50,000,000<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> for any fiscal year, and the amount the Company may pay in cash dividends to its shareholders in an aggregate amount not to exceed $</span>50,000,000<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> in any fiscal year. The commitment remains at </span>$125 million<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">, however the accordion feature in the agreement was expanded to provide for capacity up to </span>$150 million<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">, and has a maturity date of </span>November 30, 2025.<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> The Amended Credit Agreement is unsecured and includes certain financial covenants which include a consolidated fixed charge coverage ratio and a consolidated leverage ratio, as defined in the agreement.</span></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt;"><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">On December 31, 2020, $16.0 million was outstanding on the Amended Credit Agreement resulting in $109.0 million of availability. As of December 31, 2020, the Company was in compliance with all of the covenants thereunder.</div>

<div style="text-align: left;"><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">The Company generally enters into various notes payable as a means of financing a portion of its acquisitions and purchasing of non-controlling interests. In conjunction with these transactions in </span>2020,<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> the Company entered into notes payable in the aggregate amount of </span>$1.4 million<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> of which an aggregate principal payment of </span>$0.5 million<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> is due in </span>2021<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> and </span>$0.6 million<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> is due in </span>2022.<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> Interest accrues in the range of </span>3.25%<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> to </span>5.50%<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> per annum and is payable with each principal installment. The balance of the various notes payable entered into prior to </span>2020<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> was </span>$4.4 million<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> which will be paid in </span>2021.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438847070536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>LEASES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">10. Leases</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company has operating leases for its corporate offices and operating facilities. The Company determines if an arrangement is a lease at the inception of a contract. Effective January 1, 2019, right-of-use assets and operating lease liabilities are included in the consolidated balance sheet. Right-of-use assets represent the Company&#8217;s right to use an underlying asset during the lease term and operating lease liabilities represent net present value of the Company&#8217;s obligation to make lease payments arising from the lease. Right-of-use assets and operating lease liabilities are recognized at commencement date based on the net present value of the fixed lease payments over the lease term. The Company&#8217;s operating lease terms are generally five years or less. The Company&#8217;s lease terms include options to extend or terminate the lease when it is reasonably certain that the option will be exercised. As most of the Company&#8217;s operating leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. Operating fixed lease expense is recognized on a straight-line basis over the lease term.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In accordance with ASC 842, the Company records on its consolidated balance sheet leases with a term greater than 12 months. The Company has elected, in compliance with current accounting standards, not to record leases with an initial term of 12 months or less in the consolidated balance sheet. ASC 842 requires the separation of the fixed lease components from the variable lease components. The Company has elected the practical expedient to account for separate lease components of a contract as a single lease cost thus causing all fixed payments to be capitalized. Non-lease and variable cost components are not included in the measurement of the right-of-use assets or operating lease liabilities. The Company also elected the package of practical expedients permitted within ASC 842, which among other things, allows the Company to carry forward historical lease classification. Variable lease payment amounts that cannot be determined at the commencement of the lease such as increases in lease payments based on changes in index rates or usage are not included in the right-of-use assets or operating lease liabilities. These are expensed as incurred and recorded as variable lease expense.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">For the years ended December 31, 2020 and 2019, the components of lease expense were as follows (in thousands):</div>

<div><br/></div>

<table cellpadding="0" cellspacing="0" id="z7b37b8c0456447ddb4283356a6996986" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; text-indent: -9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended December 31,</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/></td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2020</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; text-indent: -9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2019</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Operating lease cost</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">30,710</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">30,225</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Short-term lease cost</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,454</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,212</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Variable lease cost</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">5,752</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">6,074</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total lease cost<sup>*</sup></div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">37,916</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">37,511</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
</table>

<div><br/></div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" id="z90bdf9c7e6434fa18d41ce5d317f4a15" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">
  <tr>
    <td style="width: 18pt;"/>
    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">*</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Sublease income was immaterial</div></td>
  </tr>
</table>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Lease costs are reflected in the consolidated statements of net income in the line item &#8211; rent, supplies, contract labor and other.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">For the years ended December 31, 2020 and 2019, supplemental cash flow information related to leases was as follows (in thousands):</div>

<div><br/></div>

<table cellpadding="0" cellspacing="0" id="zefa24bda41b145dc987f251a2c72b025" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;">Year Ended December 31,</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/></td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2020</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;">2019</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Cash paid for amounts included in the measurement of operating lease liabilities (in thousands)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">30,307</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">30,077</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Right-of-use assets obtained in exchange for new operating lease liabilities (in thousands)<sup>*</sup></div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">32,710</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">113,222</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
</table>

<div><br/></div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" id="ze8f9e808d67d46619b49699a7a23f031" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">
  <tr>
    <td style="width: 18pt;"/>
    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">*</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Includes the right-of-use assets obtained in exchange for lease liabilities for the year 2019 - $82.6 million which were recognized upon adoption of ASC Topic 842 at January 1, 2019.</div></td>
  </tr>
</table>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The aggregate future lease payments for operating leases as of December 31, 2020 were as follows (in thousands):</div>

<div><br/></div>

<table cellpadding="0" cellspacing="0" id="z36a05d7ef158441a9e0ee25c617b7227" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Fiscal Year</div></td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Amount</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2021</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">29,819</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%;" valign="bottom"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2022</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">23,861</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2023</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">17,787</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%;" valign="bottom"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2024</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">11,487</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2025 and therafter</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">12,294</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total lease payments</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">95,248</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Less: imputed interest</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">5,751</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%; padding-bottom: 4px;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 33.85pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total operating lease liabilities</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">89,497</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
</table>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><br/></div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Average lease terms and discount rates were as follows:</div>

<div><br/></div>

<table cellpadding="0" cellspacing="0" id="z00c67b6139734de2b818611f02c97724" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/></td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;">Year Ended December 31,</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2020</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;">2019</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Weighted-average remaining lease term - Operating leases</div></td>
    <td colspan="1" style="vertical-align: bottom; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; background-color: #CCEEFF;" valign="bottom"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">4.05 Years</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; background-color: #CCEEFF;" valign="bottom"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -7pt;">4.05 Years</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; background-color: #FFFFFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; background-color: #FFFFFF;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; background-color: #FFFFFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; background-color: #FFFFFF;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; background-color: #FFFFFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Weighted-average discount rate - Operating leases</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">3.1</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">%</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">3.9</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">%</div></td>
  </tr>
</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438846320040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">11. Income Taxes</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Significant components of deferred tax assets and liabilities included in the consolidated balance sheets at December 31, 2020 and 2019 were as follows (in thousands):</div>

<div><br/></div>

<table cellpadding="0" cellspacing="0" id="z210002d42bc24598a6e0e37001fc2dac" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/></td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom;" valign="bottom"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Deferred tax assets:</div></td>
    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Compensation</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,865</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,964</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Allowance for credit losses</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">396</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">514</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Acquired net operating losses</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">558</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">840</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Lease obligations - including closed clinics</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">23,819</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">21,445</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Deferred tax assets</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">26,638</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">24,763</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%;" valign="bottom"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Deferred tax liabilities:</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Depreciation and amortization</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(12,650</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(13,195</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Operating lease right-of-use assets</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(21,419</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(21,416</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Other</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(348</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(223</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Deferred tax liabilities</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(34,417</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(34,834</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Net deferred tax liability</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(7,779</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(10,071</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
</table>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The deferred tax assets and liabilities related to purchased interests not yet finalized may result in an immaterial adjustment.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">During 2020, the Company recorded deferred tax assets of $1.2 million related to the revaluation of redeemable non-controlling interests and acquisitions of non-controlling interests. In addition, during 2020, the Company recorded an adjustment to the deferred tax assets of $1.4 million as a result of a detailed reconciliation of its federal and state taxes payable and receivable accounts along with its federal and state deferred tax asset and liability accounts with its federal and state tax returns for 2019. The offset of this adjustment was a decrease to the previously reported federal income tax receivable. As of December 31, 2020, the Company has a federal income tax payable of $5.7 million and state tax receivables of $0.7 million. <span style="font-size: 10pt; font-family: 'Times New Roman';">The federal income tax payable is included in </span><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">accrued liabilities</span><span style="font-size: 10pt; font-family: 'Times New Roman';"> and the tax receivable is</span> included in <span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">other current assets</span> on the accompanying consolidated balance sheets.</div>

<div style="text-align: left;"><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The differences between the federal tax rate and the Company&#8217;s effective tax rate for the years ended December 31, 2020, 2019 and 2018 were as follows (in thousands):</div>

<div style="text-align: left;"><br/></div>

<table cellpadding="0" cellspacing="0" id="z21bd67f809424afe8f722f356649b1f4" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">
  <tr>
    <td style="width: 26.72%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/></td>
    <td style="width: 1.13%; vertical-align: bottom;">&#160;</td>
    <td style="width: 1.18%; vertical-align: bottom; border-bottom: #000000 2px solid;">&#160;</td>
    <td colspan="3" style="width: 21.95%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div></td>
    <td style="width: 1.11%; vertical-align: bottom;">&#160;</td>
    <td style="width: 1.14%; vertical-align: bottom; border-bottom: #000000 2px solid;">&#160;</td>
    <td colspan="3" style="width: 21.77%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div></td>
    <td style="width: 1.08%; vertical-align: bottom;">&#160;</td>
    <td style="width: 1.1%; vertical-align: bottom; border-bottom: #000000 2px solid;">&#160;</td>
    <td colspan="3" style="width: 21.78%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2018</div></td>
    <td style="width: 1.04%; vertical-align: bottom;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 26.72%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U. S. tax at statutory rate</div></td>
    <td style="width: 1.13%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 1.18%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.51%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">10,125</div></td>
    <td style="width: 0.93%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 10.51%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">21.0%</div></td>
    <td style="width: 1.11%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 1.14%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.52%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">11,274</div></td>
    <td style="width: 0.73%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 10.52%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">21.0%</div></td>
    <td style="width: 1.08%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 1.1%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.53%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">9,710</div></td>
    <td style="width: 0.73%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 10.52%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">21.0%</div></td>
    <td style="width: 1.04%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 26.72%; vertical-align: bottom; background-color: #FFFFFF; white-space: nowrap;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">State income taxes, net of federal benefit</div></td>
    <td style="width: 1.13%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 1.18%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 10.51%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,956</div></td>
    <td style="width: 0.93%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 10.51%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">3.9%</div></td>
    <td style="width: 1.11%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 1.14%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 10.52%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,059</div></td>
    <td style="width: 0.73%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 10.52%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">3.8%</div></td>
    <td style="width: 1.08%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 1.1%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 10.53%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,722</div></td>
    <td style="width: 0.73%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 10.52%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">3.7%</div></td>
    <td style="width: 1.04%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 26.72%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Excess equity compensation deduction</div></td>
    <td style="width: 1.13%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 1.18%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 10.51%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(99)</div></td>
    <td style="width: 0.93%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 10.51%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">0.0%</div></td>
    <td style="width: 1.11%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 1.14%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 10.52%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(871)</div></td>
    <td style="width: 0.73%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 10.52%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-1.6 %</div></td>
    <td style="width: 1.08%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 1.1%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 10.53%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(806)</div></td>
    <td style="width: 0.73%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 10.52%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-1.7 %</div></td>
    <td style="width: 1.04%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 26.72%; vertical-align: bottom; background-color: #FFFFFF; white-space: nowrap;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Non-deductible expenses</div></td>
    <td style="width: 1.13%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 1.18%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 10.51%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,040</div></td>
    <td style="width: 0.93%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 10.51%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2.1%</div></td>
    <td style="width: 1.11%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 1.14%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 10.52%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,185</div></td>
    <td style="width: 0.73%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 10.52%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2.2%</div></td>
    <td style="width: 1.08%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 1.1%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 10.53%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">743</div></td>
    <td style="width: 0.73%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 10.52%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1.6%</div></td>
    <td style="width: 1.04%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 26.72%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 1.13%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 1.18%; vertical-align: bottom; border-top: #000000 2px solid; border-bottom: #000000 4px double; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.51%; vertical-align: bottom; border-top: #000000 2px solid; border-bottom: #000000 4px double; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">13,022</div></td>
    <td style="width: 0.93%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 10.51%; vertical-align: bottom; border-top: #000000 2px solid; border-bottom: #000000 4px double; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">27.0%</div></td>
    <td style="width: 1.11%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 1.14%; vertical-align: bottom; border-top: #000000 2px solid; border-bottom: #000000 4px double; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.52%; vertical-align: bottom; border-top: #000000 2px solid; border-bottom: #000000 4px double; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">13,647</div></td>
    <td style="width: 0.73%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 10.52%; vertical-align: bottom; border-top: #000000 2px solid; border-bottom: #000000 4px double; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">25.4%</div></td>
    <td style="width: 1.08%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 1.1%; vertical-align: bottom; border-top: #000000 2px solid; border-bottom: #000000 4px double; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.53%; vertical-align: bottom; border-top: #000000 2px solid; border-bottom: #000000 4px double; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">11,369</div></td>
    <td style="width: 0.73%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 10.52%; vertical-align: bottom; border-top: #000000 2px solid; border-bottom: #000000 4px double; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">24.6%</div></td>
    <td style="width: 1.04%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
  </tr>
</table>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><br/></div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Significant components of the provision for income taxes for the years ended December 31, 2020, 2019 and 2018 were as follows (in thousands):</div>

<div><br/></div>

<table cellpadding="0" cellspacing="0" id="zbf81119b8a024b268d90882988e17c64" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td style="vertical-align: top; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/></td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">December 31, </span>2020</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">December 31, </span>2019</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">December 31, </span>2018</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: top; white-space: nowrap;" valign="bottom"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Current:</div></td>
    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: top; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Federal</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="font-family: 'Times New Roman'; font-size: 10pt;">10,506</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="font-family: 'Times New Roman'; font-size: 10pt;">6,523</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="font-family: 'Times New Roman'; font-size: 10pt;">5,357</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: top; width: 64%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">State</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="font-family: 'Times New Roman'; font-size: 10pt;">2,774</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,473</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,199</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: top; width: 64%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total current</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="font-family: 'Times New Roman'; font-size: 10pt;">13,280</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">8,996</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">6,556</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: top; width: 64%; white-space: nowrap;" valign="bottom"><div style="text-align: left; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Deferred:</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: top; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="text-align: left; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Federal</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(38</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">3,730</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="font-family: 'Times New Roman'; font-size: 10pt;">3,771</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: top; width: 64%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><div style="text-align: left; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">State</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="font-family: 'Times New Roman'; font-size: 10pt;">(220</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">921</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,042</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: top; width: 64%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total deferred</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="font-family: 'Times New Roman'; font-size: 10pt;">(258</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">4,651</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">4,813</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: top; width: 64%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total income tax provision</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"><div style="font-family: 'Times New Roman'; font-size: 10pt;">13,022</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"><div style="font-family: 'Times New Roman'; font-size: 10pt;">13,647</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"><div style="font-family: 'Times New Roman'; font-size: 10pt;">11,369</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
</table>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">For 2020, 2019 and 2018, the Company performed a detailed reconciliation of its federal and state taxes payable and receivable accounts along with its federal and state deferred tax asset and liability accounts. The adjustments were immaterial. The Company considers this reconciliation process to be an annual control.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company is required to establish a valuation allowance for deferred tax assets if, based on the weight of available evidence, it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the projected future taxable income and tax planning strategies in making this assessment. Based upon the level of historical taxable income and projections for future taxable income in the periods which the deferred tax assets are deductible, management believes that a valuation allowance is not required, as it is more likely than not that the results of future operations will generate sufficient taxable income to realize the deferred tax assets.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company&#8217;s U.S. federal returns remain open to examination for <span style="-sec-ix-hidden:Fact_c614eba92f724091923d077cce15bd38">2017 through 2019</span> and U.S. state jurisdictions are open for periods ranging from <span style="-sec-ix-hidden:Fact_a3d421d0c572494d8b850b77d069a61f">2016 through 2019</span>.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company does not believe that it has any significant uncertain tax positions at December 31, 2020 and December 31, 2019, nor is this expected to change within the next twelve months due to the settlement and expiration of statutes of limitation.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company did not have any accrued interest or penalties associated with any unrecognized tax benefits nor was any interest expense recognized during the years ended December 31, 2020, 2019 and 2018.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438846419416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Information</a></td>
<td class="text">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">12. Segment Information</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">The Company&#8217;s reportable segments include the physical therapy operations segment and the industrial injury prevention services segment. Also included in the physical therapy operations segment are revenues from management contract services and other services which include services the Company provides on-site, such as schools for athletic trainers</span>.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">The Company evaluates performance of the segments based on gross profit. The Company has provided additional information regarding its reportable segments which contributes to the understanding of the Company and provides useful information</span>.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">T<span style="font-size: 10pt; font-family: 'Times New Roman';">he following table summarizes selected financial data for the Company&#8217;s reportable segments. Prior year results presented herein have been changed to conform to the current presentation</span>.</div>

<div><br/></div>

<table cellpadding="0" cellspacing="0" id="zea0754717f864c8688543b30b5aa363f" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31,</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31,</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31,</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/></td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2020</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> 2019</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2018</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(in thousands)</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(in thousands)</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom;" valign="bottom"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Net operating revenues:</div></td>
    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Physical therapy operations</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">383,770</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">444,507</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">428,445</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Industrial injury prevention services</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">39,199</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">37,462</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">25,466</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total Company</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">422,969</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">481,969</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">453,911</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: top; width: 64%;" valign="bottom"><div style="text-align: left; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Gross profit:</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: top; width: 64%;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Physical therapy operations (excluding closure costs)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">88,295</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">104,120</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">96,463</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: top; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Industrial injury prevention services</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">10,086</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">8,379</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">5,192</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: top; width: 64%;" valign="bottom"><div style="text-align: left; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">98,381</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">112,499</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">101,655</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: top; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Physical therapy operations - closure costs</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">3,931</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">25</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(8</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td style="vertical-align: top; width: 64%; padding-bottom: 4px;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Gross profit</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">94,450</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">112,474</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">101,663</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: top; width: 64%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%;" valign="bottom"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total Assets:</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: top; width: 64%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Physical therapy operations</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">550,181</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">518,027</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">421,474</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: top; width: 64%; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Industrial injury prevention services</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">44,180</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">42,818</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">21,692</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: top; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total Company</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">594,361</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">560,845</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">443,166</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438846779752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Based Plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Equity Based Plans [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Equity Based Plans</a></td>
<td class="text">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">13. Equity Based Plans</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company has the following equity based plans with outstanding equity grants:</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Amended and Restated 1999 Employee Stock Option Plan (the &#8220;Amended 1999 Plan&#8221;) permits the Company to grant to non-employee directors and employees of the Company up to 600,000 non-qualified options to purchase shares of common stock and restricted stock (subject to proportionate adjustments in the event of stock dividends, splits, and similar corporate transactions). The exercise prices of options granted under the Amended 1999 Plan are determined by the Compensation Committee. The period within which each option will be exercisable is determined by the Compensation Committee. The Amended 1999 Plan was approved by the shareholders of the Company at the 2008 Shareholders Meeting on May 20, 2008.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Amended and Restated 2003 Stock Option Plan (the &#8220;Amended 2003 Plan&#8221;) permits the Company to grant to key employees and outside directors of the Company incentive and non-qualified options and shares of restricted stock covering up to 2,100,000 shares of common stock (subject to proportionate adjustments in the event of stock dividends, splits, and similar corporate transactions). The material terms of the Amended 2003 Plan was reapproved by the shareholders of the Company at the 2015 Shareholders Meeting on May 19, 2015 and an increase in the number of shares authorized for issuance from 1,750,000 to 2,100,000 was approved at the 2016 Shareholders Meeting on March 17, 2016.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">A cumulative summary of equity plans as of December 31, 2020 follows:</div>

<div><br/></div>

<table cellpadding="0" cellspacing="0" id="z0fd35d71f4c741a1afb5a3fdfe7e4755" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/></td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Authorized</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Restricted<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/></span>Stock Issued</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Outstanding<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/></span>Stock Options</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Stock Options<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/></span>Exercised</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Stock Options<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/></span>Exercisable</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Shares Available<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/></span>for Grant</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; white-space: nowrap;" valign="bottom"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Equity Plans</span></div></td>
    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 28%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Amended 1999 Plan</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">600,000</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">416,402</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">139,791</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">7,775</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 28%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Amended 2003 Plan</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,100,000</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,106,977</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">778,300</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">224,760</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 28%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,700,000</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,523,379</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">918,091</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">232,535</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
</table>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><br/></div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">During 2020, 2019 and 2018, the Company granted the following shares of restricted stock to directors, officers and employees pursuant to its equity plans as follows:</div>

<div style="text-align: left;"><br/></div>

<table cellpadding="0" cellspacing="0" id="z87259eaa26b8463e9d0de795ce96e698" style="font-family: 'Times New Roman'; font-size: 10pt; border-collapse: collapse; text-align: left; color: #000000; width: 100%; margin-left: auto; margin-right: auto;">
  <tr>
    <td style="width: 33.07%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Granted</div></td>
    <td style="width: 0.97%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td style="width: 33.21%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Number of Shares</div></td>
    <td style="width: 1.11%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="2" style="width: 30.43%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Weighted Average Fair<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/></span>Value Per Share</div></td>
    <td style="width: 1.21%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 33.07%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2020</div></td>
    <td style="width: 0.97%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 33.21%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">86,982</div></td>
    <td style="width: 1.11%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 2.36%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 28.07%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">104.69</div></td>
    <td style="width: 1.21%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 33.07%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2019</div></td>
    <td style="width: 0.97%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 33.21%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">91,682</div></td>
    <td style="width: 1.11%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 2.36%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 28.07%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">104.85</div></td>
    <td style="width: 1.21%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 33.07%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2018</div></td>
    <td style="width: 0.97%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 33.21%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">93,801</div></td>
    <td style="width: 1.11%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 2.36%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 28.07%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">78.63</div></td>
    <td style="width: 1.21%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
  </tr>
</table>

<div style="text-align: left;"><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">During 2020, 2019 and 2018, the following shares were cancelled due to employee terminations prior to restrictions lapsing:</div>

<div style="text-align: left;"><br/></div>

<table cellpadding="0" cellspacing="0" id="z7daa2e54ca844999961717e10e62abe6" style="font-family: 'Times New Roman'; font-size: 10pt; border-collapse: collapse; text-align: left; color: #000000; width: 100%; margin-left: auto; margin-right: auto;">
  <tr>
    <td style="width: 33.06%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Cancelled</div></td>
    <td style="width: 1%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td style="width: 33.04%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Number of Shares</div></td>
    <td style="width: 1.32%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="2" style="width: 30.36%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Weighted Average Fair<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/></span>Value Per Share</div></td>
    <td style="width: 1.22%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 33.06%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2020</div></td>
    <td style="width: 1%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 33.04%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">10,037</div></td>
    <td style="width: 1.32%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 2.23%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 28.13%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">102.52</div></td>
    <td style="width: 1.22%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 33.06%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2019</div></td>
    <td style="width: 1%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 33.04%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,578</div></td>
    <td style="width: 1.32%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 2.23%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 28.13%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">87.88</div></td>
    <td style="width: 1.22%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 33.06%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2018</div></td>
    <td style="width: 1%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 33.04%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">3,867</div></td>
    <td style="width: 1.32%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 2.23%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 28.13%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">59.51</div></td>
    <td style="width: 1.22%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
  </tr>
</table>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Generally, restrictions on the stock granted to employees lapse in equal annual installments on the following <span style="-sec-ix-hidden:Fact_5193d5e0f71242e78d0ec8f60c9b56d8">four</span> anniversaries of the date of grant. For those shares granted to directors, the restrictions will lapse in equal quarterly installments during the first year after the date of grant. For those granted to officers, the restriction will lapse in equal quarterly installments during the four years following the date of grant.</div>

<div style="text-align: left;"><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">There were 127,562 and 150,771 shares outstanding as of December 31, 2020 and December 31, 2019 respectively, for which restrictions had not lapsed. The restrictions will lapse in 2021 through 2024.</div>

<div style="text-align: left;"><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Compensation expense for grants of restricted stock is recognized based on the fair value on the date of grant. Compensation expense for restricted stock grants was $7.9 million, $5.9 million, and $5.0 million, respectively, for 2020, 2019 and 2018. As of December 31, 2020, the remaining $8.8 million of compensation expense will be recognized from 2021 through 2024.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438846574472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Preferred Stock<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PreferredStockAbstract', window );"><strong>Preferred Stock [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockTextBlock', window );">Preferred Stock</a></td>
<td class="text">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">14. Preferred Stock</div>

<div style="text-align: left;"><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Board is empowered, without approval of the shareholders, to cause shares of preferred stock to be issued in one or more series and to establish the number of shares to be included in each such series and the rights, powers, preferences and limitations of each series. There are no provisions in the Company&#8217;s Articles of Incorporation specifying the vote required by the holders of preferred stock to take action. All such provisions would be set out in the designation of any series of preferred stock established by the Board. The bylaws of the Company specify that, when a quorum is present at any meeting, the vote of the holders of at least a majority of the outstanding shares entitled to vote who are present, in person or by proxy, shall decide any question brought before the meeting, unless a different vote is required by law or the Company&#8217;s Articles of Incorporation.</div>

<div style="text-align: left;"><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Because the Board has the power to establish the preferences and rights of each series, it may afford the holders of any series of preferred stock, preferences, powers, and rights, voting or otherwise, senior to the right of holders of common stock. The issuance of the preferred stock could have the effect of delaying or preventing a change in control of the Company. </div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PreferredStockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PreferredStockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438846541608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Common Stock [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Common Stock</a></td>
<td class="text">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">15. Common Stock</div>

<div style="text-align: left;"><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">From September 2001 through December 31, 2008, the Board authorized the Company to purchase, in the open market or in privately negotiated transactions, up to 2,250,000 shares of the Company&#8217;s common stock. In March 2009, the Board authorized the repurchase of up to 10% or approximately 1,200,000 shares of its common stock (&#8220;March 2009 Authorization&#8221;). The Amended Credit Agreement permits share repurchases of up to $15,000,000, subject to compliance with covenants. The Company is required to retire shares purchased under the March 2009 Authorization.</div>

<div style="text-align: left;"><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Under the March 2009 Authorization, the Company has purchased a total of 859,499 shares. There is no expiration date for the share repurchase program. There are currently an additional estimated 124,740 shares (based on the closing price of $120.25 on December 31, 2020, the last business day in 2020) that may be purchased from time to time in the open market or private transactions depending on price, availability and the Company&#8217;s cash position. The Company did not purchase any shares of its common stock during 2020 or 2019. </div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438846465192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Defined Contribution Plan<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Defined Contribution Plan [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock', window );">Defined Contribution Plan</a></td>
<td class="text">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">16. Defined Contribution Plan</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company has several 401(k) profit sharing plans covering all employees with three months of service. For certain plans, the Company makes matching contributions. The Company may also make discretionary contributions of up to 50% of employee contributions. The Company did not make any discretionary contributions for the years ended December 31, 2020, 2019 and 2018. The Company matching contributions totaled $1.9 million, $2.0 million and $1.8 million, respectively, for the years ended December 31, 2020, 2019 and 2018. </div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 712<br> -URI http://asc.fasb.org/topic&amp;trid=2197446<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -URI http://asc.fasb.org/topic&amp;trid=2127225<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndEmployeeBenefitPlansTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438844031224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">17. Commitments and Contingencies</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">We may be subject to litigation in the ordinary course of business.</div>

<div><br/></div>

<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Employment Agreements</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">At December 31, 2020, the Company had outstanding employment agreements with four of its executive officers, one of whom (Mr. McDowell) has provided notice of a planned retirement in <span style="-sec-ix-hidden:Fact_07fa882becbb4980afaa1f4e941716d5">August 2021</span>. The three remaining agreements have terms that expire December 31, 2021, February 28, 2022 and November 8, 2022, respectively; however, each of these agreements provide for an automatic two year renewal at the conclusion of the expiring term or renewal term. All of the agreements contain a provision for annual adjustment of salaries.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In addition, the Company has outstanding employment agreements with most of the managing physical therapist partners of the Company&#8217;s physical therapy clinics and with certain other clinic employees which obligate subsidiaries of the Company to pay compensation of $37.1 million in 2021 and $6.1 million in the aggregate from 2022 through 2024. In addition, many of the employment agreements with the managing physical therapists provide for monthly bonus payments calculated as a percentage of each clinic&#8217;s net revenues (not in excess of operating profits) or operating profits. </div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438845137736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share</a></td>
<td class="text">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">18. Earnings Per Share</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The computations of basic and diluted earnings per share for the years ended December 31, 2020, 2019 and 2018 are as follows (in thousands, except per share data):</div>

<div><br/></div>

<table cellpadding="0" cellspacing="0" id="z70cf1bf066894e77938a1c395afa0aa6" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/></td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2018</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Computation of earnings per share - USPH shareholders:</div></td>
    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Net income attributable to USPH shareholders</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">35,194</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">40,039</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">34,873</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Credit (charges) to retained earnings:</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Revaluation of redeemable non-controlling interest</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(4,632</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(11,893</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(24,770</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Tax effect at statutory rate (federal and state) of 26.25%</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,216</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">3,121</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">6,502</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">31,778</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">31,267</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">16,605</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Earnings per share (basic and diluted)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2.48</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2.45</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1.31</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Shares used in computation:</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Basic and diluted earnings per share - weighted-average shares</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">12,835</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">12,756</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">12,666</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438845131608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsAbstract', window );"><strong>SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock', window );">SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS</a></td>
<td class="text">
<div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">FINANCIAL STATEMENT SCHEDULE*<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/></span>SCHEDULE II &#8212; VALUATION AND QUALIFYING ACCOUNTS<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/></span>U.S. PHYSICAL THERAPY, INC. AND SUBSIDIARIES</div>

<div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(In Thousands)</div>

<div><br/></div>

<table cellpadding="0" cellspacing="0" id="z0dc91a2b2ca3420693ba57e50a133eae" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/></td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Balance at</div><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Beginning of Period</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Additions Charged</div><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">to Costs and Expenses</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Additions Charged</div><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">to Other Accounts</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Deductions</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Balance at</div><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">End of Period</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">YEAR ENDED DECEMBER 31, 2020:</div></td>
    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Reserves and allowances deducted from asset accounts:</div></td>
    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 40%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Allowance for credit losses<sup>(1)</sup></div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,698</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">4,623</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">5,313</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><sup>(2)</sup>&#160;</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,008</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 40%;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">YEAR ENDED DECEMBER 31, 2019:</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 40%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Reserves and allowances deducted from asset accounts:</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 40%;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Allowance for credit losses</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,672</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">4,858</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">4,832</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><sup>(2)</sup>&#160;</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,698</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 40%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">YEAR ENDED DECEMBER 31, 2018:</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 40%;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Reserves and allowances deducted from asset accounts:</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 40%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Allowance for credit losses</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,273</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">4,603</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">4,204</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><sup>(2)</sup>&#160;</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,672</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
</table>

<div><br/></div>

<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><hr style="height: 2px; width: 20%; color: #000000; background-color: #000000; text-align: left; border: none; margin-left: 0px; margin-right: auto;"/></div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" id="zb21ebc1e542b426880671b0df7e72f56" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">
  <tr>
    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(1)</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Related to patient accounts receivable and accounts receivable-other.</div></td>
  </tr>
</table>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" id="zdfe066ff46504f55890afc338c74a818" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">
  <tr>
    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(2)</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Uncollectible accounts written off, net of recoveries.</div></td>
  </tr>
</table>

<div><br/></div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" id="za82c941ee7854b2b9941fe778592b572" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">
  <tr>
    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">*</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">All other schedules are omitted because of the absence of conditions under which they are required or because the required information is shown in the financial statements or notes thereto.</div></td>
  </tr>
</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 09<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438842666088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash Equivalents</a></td>
<td class="text">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Cash Equivalents</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company maintains its cash and cash equivalents at financial institutions. The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. The combined account balances at several institutions typically exceed Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) insurance coverage and, as a result, there is a concentration of credit risk related to amounts on deposit in excess of FDIC insurance coverage. Management believes that this risk is not significant.</div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Long-Lived Assets</a></td>
<td class="text">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Long-Lived Assets</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Fixed assets are stated at cost. Depreciation is computed on the straight-line method over the estimated useful lives of the related assets. Estimated useful lives for furniture and equipment range from <span style="-sec-ix-hidden:Fact_82099ea63dd944a793bca0b3ef182707">three</span> to eight years and for software purchased from <span style="-sec-ix-hidden:Fact_c914f2e353b54597a7cd8a612b794874">three</span> to seven years. Leasehold improvements are amortized over the shorter of the related lease term or estimated useful lives of the assets, which is generally <span style="-sec-ix-hidden:Fact_d794a755570f470987cd83402baa1e26">three</span> to five years.</div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock', window );">Impairment of Long-Lived Assets and Long-Lived Assets to be Disposed of</a></td>
<td class="text">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Impairment of Long-Lived Assets and Long-Lived Assets to Be Disposed Of</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company reviews property and equipment and intangible assets with finite lives for impairment upon the occurrence of certain events or circumstances that indicate the related amounts may be impaired. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.</div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill</a></td>
<td class="text">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Goodwill</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">Goodwill represents the excess of the amount paid and fair value of the non-controlling interests over the fair value of the acquired business assets, which include certain identifiable intangible assets. Historically, goodwill has been derived from acquisitions and, prior to 2009</span>,<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> from the purchase of some or all of a particular local management&#8217;s equity interest in an existing clinic. Effective January 1, 2009</span>,<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> if the purchase price of a non-controlling interest by the Company exceeds or is less than the book value at the time of purchase, any excess or shortfall is recognized as an adjustment to additional paid-in capital.</span></div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Goodwill and other indefinite-lived intangible assets are not amortized, but are instead subject to periodic impairment evaluations. The fair value of goodwill and other identifiable intangible assets with indefinite lives are evaluated for impairment at least annually and upon the occurrence of certain events or conditions, and are written down to fair value if considered impaired. These events or conditions include, but are not limited to: a significant adverse change in the business environment, regulatory environment, or legal factors; a current period operating or cash flow loss combined with a history of such losses or a projection of continuing losses; or a sale or disposition of a significant portion of a reporting unit. The occurrence of one of these events or conditions could significantly impact an impairment assessment, necessitating an impairment charge. The Company evaluates indefinite lived tradenames using the relief from royalty method in conjunction with its annual goodwill impairment test.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">The Company operates a </span>two<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> segment business which is made up of various clinics within partnerships, and the other is industrial injury prevention services business. The partnerships are components of regions and are aggregated to the operating segment level for the purpose of determining the Company&#8217;s reporting units when performing its annual goodwill impairment test. In 2020, 2019 and 2018</span>,<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> there were </span>six<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> regions. In addition to the six regions, in 2020 and 2019</span>,<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> the impairment analysis included a separate analysis for the industrial injury prevention business, as a separate reporting unit.</span></div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">As part of the impairment analysis, the Company is first required to assess qualitatively if it can conclude whether goodwill is more likely than not impaired. If goodwill is more likely than not impaired, the Company is then required to complete a quantitative analysis of whether a reporting unit&#8217;s fair value is less than its carrying amount. In evaluating whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, the Company considers relevant events or circumstances that affect the fair value or carrying amount of a reporting unit. The Company considers both the income and market approach in determining the fair value of its reporting units when performing a quantitative analysis.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">An impairment loss generally would be recognized when the carrying amount of the net assets of a reporting unit, inclusive of goodwill and other identifiable intangible assets, exceeds the estimated fair value of the reporting unit. The evaluation of goodwill in 2020, 2019 and 2018 did not result in any goodwill amounts that were deemed impaired.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">Based on the economic conditions experienced in 2020 and the decline in patient visits due to the pandemic, the Company evaluated whether events or circumstances indicated that it was more likely than not that the fair value of the reporting units were reduced below their carrying value as of December 31, 2020</span>.<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> As a result of the assessment, the Company determined that it was not more likely than not that goodwill and tradenames of the reporting units were impaired as of December 31, 2020</span>.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company will continue to monitor for any triggering events or other indicators of impairment.&#160; Due to the uncertainty of the current economic conditions resulting from the COVID-19 pandemic, the Company will continue to review its carrying amounts of goodwill and other intangibles quarterly.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">For the year ended December 31, 2020</span>,<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> the Company derecognized (wrote-off) goodwill in the amount of </span>$1.9 million<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> related to closed clinics due to COVID-19</span>.</div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RedeemableNonControllingInterestsPolicyTextBlock', window );">Redeemable Non-Controlling Interests</a></td>
<td class="text">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Redeemable Non-Controlling Interests</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The non-controlling interests that are reflected as redeemable non-controlling interests in the consolidated financial statements consist of those in which the owners and the Company have certain redemption rights, whether currently exercisable or not, and which currently, or in the future, require that the Company purchase or the owner sell the non-controlling interest held by the owner, if certain conditions are met. The purchase price is derived at a predetermined formula based on a multiple of trailing twelve months earnings performance as defined in the respective limited partnership agreements. The redemption rights can be triggered by the owner or the Company at such time as both of the following events have occurred: 1) termination of the owner&#8217;s employment, regardless of the reason for such termination, and 2) the passage of specified number of years after the closing of the transaction, typically <span style="-sec-ix-hidden:Fact_74434238a9e847afae6e8bd50f9c3ecb">three</span> to five years, as defined in the limited partnership agreement. The redemption rights are not automatic or mandatory (even upon death) and require either the owner or the Company to exercise its rights when the conditions triggering the redemption rights have been satisfied.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">On the date the Company acquires a controlling interest in a partnership, and the limited partnership agreement for such partnership contains redemption rights not under the control of the Company, the fair value of the non-controlling interest is recorded in the consolidated balance sheet under the caption &#8211; Redeemable non-controlling interests. Then, in each reporting period thereafter until it is purchased by the Company, the redeemable non-controlling interest is adjusted to the greater of its then current redemption value or initial carrying value, based on the predetermined formula defined in the respective limited partnership agreement. As a result, the value of the non-controlling interest is not adjusted below its initial carrying value. The Company records any adjustment in the redemption value, net of tax, directly to retained earnings and are not reflected in the consolidated statements of income. Although the adjustments are not reflected in the consolidated statements of income, current accounting rules require that the Company reflects the adjustments, net of tax, in the earnings per share calculation. The amount of net income attributable to redeemable non-controlling interest owners is included in consolidated net income on the face of the consolidated statements of net income. Management believes the redemption value (i.e. the carrying amount) and fair value are the same.</div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NonControllingInterestsPolicyPolicyTextBlock', window );">Non-Controlling Interests</a></td>
<td class="text">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Non-Controlling Interests</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company recognizes non-controlling interests, in which the Company has no obligation but the right to purchase the non-controlling interests, as permanent equity in the consolidated financial statements separate from the parent entity&#8217;s equity. The amount of net income attributable to non-controlling interests is included in consolidated net income on the face of the statements of net income. Changes in a parent entity&#8217;s ownership interest in a subsidiary that do not result in deconsolidation are treated as equity transactions if the parent entity retains its controlling financial interest. The Company recognizes a gain or loss in net income when a subsidiary is deconsolidated. Such gain or loss is measured using the fair value of the non-controlling equity investment on the deconsolidation date.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">When the purchase price of a non-controlling interest by the Company exceeds the book value at the time of purchase, any excess or shortfall is recognized as an adjustment to additional paid-in capital. Additionally, operating losses are allocated to non-controlling interests even when such allocation creates a deficit balance for the non-controlling interest partner.</div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Revenue Recognition</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In May 2014, March 2016, April 2016, and December 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2014-09, Revenue from Contracts with Customers, ASU 2016-08, Revenue from Contracts with Customers, Principal versus Agent Considerations, ASU 2016-10, Revenue from Contracts with Customers, Identifying Performance Obligations and Licensing, ASU 2016-12, Revenue from Contracts with Customers, Narrow Scope Improvements and Practical Expedients, and ASU 2016-20, Technical Corrections and Improvements to Topic 606, Revenue from Contracts with Customer (collectively the &#8220;standards&#8221;), respectively, which supersede most of the current revenue recognition requirements (&#8220;ASC 606&#8221;). The core principle of the new guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company implemented the new standards beginning January 1, 2018 using a modified retrospective transition method. The principal change relates to how the new standard requires healthcare providers to estimate the amount of variable consideration to be included in the transaction price up to an amount which is probable that a significant reversal will not occur. The most common forms of variable consideration the Company experiences are amounts for services provided that are ultimately not realizable from a customer. There were no changes to revenues or other revenues upon implementation. Under the new standards, the Company&#8217;s estimate for unrealizable amounts will continue to be recognized as a reduction to revenue. The bad debt expense historically reported will not materially change.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">For ASC 606, there is an implied contract between us and the patient upon each patient visit. Separate contractual arrangements exist between us and third-party payors (e.g. insurers, managed care programs, government programs, workers' compensation) which establish the amounts the third parties pay on behalf of the patients for covered services rendered. While these agreements are not considered contracts with the customer, they are used for determining the transaction price for services provided to the patients covered by the third party payors. The payor contracts do not indicate performance obligations for us, but indicate reimbursement rates for patients who are covered by those payors when the services are provided. At that time, the Company is obligated to provide services for the reimbursement rates stipulated in the payor contracts. The execution of the contract alone does not indicate a performance obligation. For self-paying customers, the performance obligation exists when we provide the services at established rates. The difference between the Company&#8217;s established rate and the anticipated reimbursement rate is accounted for as an offset to revenue &#8211; contractual allowance.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The following table details the revenue related to the various categories (in thousands).</div>

<div><br/></div>

<table cellpadding="0" cellspacing="0" id="z8c0b8e1e67b64cb6b6522cc37bfa309c" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/></td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2018</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Net patient revenues</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">373,340</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">433,345</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">417,703</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Management contract revenues</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">8,410</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">8,676</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">8,339</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Other revenues</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,020</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,486</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,403</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 17.65pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Physical therapy operations</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">383,770</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">444,507</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">428,445</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Industrial injury prevention services revenues</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">39,199</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">37,462</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">25,466</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">422,969</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">481,969</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">453,911</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
</table>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><br/></div>

<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Patient revenues</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Revenues are recognized in the period in which services are rendered. Net patient revenues consists of revenues for physical therapy and occupational therapy clinics that provide pre-and post-operative care and treatment for orthopedic related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries. Net patient revenues (patient revenues less estimated contractual adjustments) are recognized at the estimated net realizable amounts from third-party payors, patients and others in exchange for services rendered when obligations under the terms of the contract are satisfied. There is an implied contract between us and the patient upon each patient visit. Generally, this occurs as the Company provides physical and occupational therapy services, as each service provided is distinct and future services rendered are not dependent on previously rendered services. The Company has agreements with third-party payors that provide for payments to the Company at amounts different from its established rates.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Medicare Reimbursement</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Medicare program reimburses outpatient rehabilitation providers based on the Medicare Physician Fee Schedule (&#8216;&#8216;MPFS&#8217;&#8217;). For services provided in 2018, a 0.5% increase was applied to the fee schedule payment rates; for services provided in 2019, a 0.25% increase was applied to the fee schedule payment rates before applying the mandatory budget neutrality adjustment. For services provided in 2020 through 2025, a 0.0% percent update will be applied each year to the fee schedule payment rates, before applying the mandatory budget neutrality adjustment. However, in the 2020 MPFS Final Rule, CMS proposed an increase to the code values for office/outpatient evaluation and management (E/M) codes and cuts to other codes to maintain budget neutrality of the MPFS. This change in code valuations was to become effective January 1, 2021.&#160; Under the 2021 MPFS Final Rule, reimbursement for the codes applicable to physical/occupational therapy services were to be reduced by approximately 9% in the aggregate. <span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">The </span>9%<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> reduction in payment was addressed by the Consolidated Appropriations Act, </span><span style="font-size: 10pt; font-family: 'Times New Roman';">2021</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> (&#8220;Act&#8221;) signed into law on December </span><span style="font-size: 10pt; font-family: 'Times New Roman';">27,</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">&#160;</span><span style="font-size: 10pt; font-family: 'Times New Roman';">2020.</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">&#160; Based on various provisions in the Act, the Company now estimates that the Medicare rate reduction for the full year of </span><span style="font-size: 10pt; font-family: 'Times New Roman';">2021</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> will be approximately </span>3.5%<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> in aggregate.</span></div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Beginning in 2021, payments to individual therapists (Physical/Occupational Therapist in Private Practice) paid under the fee schedule may be subject to adjustment based on performance in the Merit Based Incentive Payment System (&#8220;MIPS&#8221;), which measures performance based on certain quality metrics, resource use, and meaningful use of electronic health records. Under the MIPS requirements, a provider's performance is assessed according to established performance standards each year and then is used to determine an adjustment factor that is applied to the professional's payment for the corresponding payment year. The provider&#8217;s MIPS performance in 2019 will determine the payment adjustment in 2021. Each year from 2019 through 2024, professionals who receive a significant share of their revenues through an alternate payment model (&#8220;APM&#8221;), (such as accountable care organizations or bundled payment arrangements) that involves risk of financial losses and a quality measurement component will receive a 5% bonus in the corresponding payment year. The bonus payment for APM participation is intended to encourage participation and testing of new APMs and to promote the alignment of incentives across payors. The specifics of the MIPS and APM adjustments will be subject to future notice and comment rule-making.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Budget Control Act of 2011 increased the federal debt ceiling in connection with deficit reductions over the next ten years, and requires automatic reductions in federal spending by approximately $1.2 trillion. Payments to Medicare providers are subject to these automatic spending reductions, subject to a 2% cap. On April 1, 2013, a 2% reduction to Medicare payments was implemented. The Bipartisan Budget Act of 2015, enacted on November 2, 2015, extended the 2% reductions to Medicare payments through fiscal year 2025. The Bipartisan Budget Act of 2018, enacted on February 9, 2018, extends the 2% reductions to Medicare payments through fiscal year 2027. <span style="font-size: 10pt; font-family: 'Times New Roman';">The Coronavirus Aid, Relief, and Economic Security (CARES) Act suspended the </span>2%<span style="font-size: 10pt; font-family: 'Times New Roman';"> payment reduction Medicare payments for dates of service from May 1, 2020, through December 31, 2020. The Consolidated Appropriations Act, 2021 further suspended the </span>2%<span style="font-size: 10pt; font-family: 'Times New Roman';"> payment reduction until March 31, 2021.</span></div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Historically, the total amount paid by Medicare in any one year for outpatient physical therapy, occupational therapy, and/or speech-language pathology services provided to any Medicare beneficiary was subject to an annual dollar limit (i.e., the &#8220;Therapy Cap&#8221; or &#8220;Limit&#8221;). For 2017, the annual Limit on outpatient therapy services was $1,980 for combined Physical Therapy and Speech Language Pathology services and $1,980 for Occupational Therapy services. As a result of Bipartisan Budget Act of 2018, the Therapy Caps have been eliminated, effective as of January 1, 2018.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Under the Middle Class Tax Relief and Job Creation Act of 2012 (&#8220;MCTRA&#8221;), since October 1, 2012, patients who met or exceeded $3,700 in therapy expenditures during a calendar year have been subject to a manual medical review to determine whether applicable payment criteria are satisfied. The $3,700 threshold is applied to Physical Therapy and Speech Language Pathology Services; a separate $3,700 threshold is applied to the Occupational Therapy. The MACRA directed CMS to modify the manual medical review process such that those reviews will no longer apply to all claims exceeding the $3,700 threshold and instead will be determined on a targeted basis based on a variety of factors that CMS considers appropriate. The Bipartisan Budget Act of 2018 extends the targeted medical review indefinitely, but reduces the threshold to $3,000 through December 31, 2027. For 2028, the threshold amount will be increased by the percentage increase in the Medicare Economic Index (&#8220;MEI&#8221;) for 2028 and in subsequent years the threshold amount will increase based on the corresponding percentage increase in the MEI for such subsequent year.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">CMS adopted a multiple procedure payment reduction (&#8220;MPPR&#8221;) for therapy services in the final update to the MPFS for calendar year 2011. The MPPR applied to all outpatient therapy services paid under Medicare Part B &#8212; occupational therapy, physical therapy and speech-language pathology. Under the policy, the Medicare program pays </span>100%<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> of the practice expense component of the Relative Value Unit (&#8220;RVU&#8221;) for the therapy procedure with the highest practice expense RVU, then reduces the payment for the practice expense component for the second and subsequent therapy procedures or units of service furnished during the same day for the same patient, regardless of whether those therapy services are furnished in separate sessions. Since 2013, the practice expense component for the second and subsequent therapy service furnished during the same day for the same patient was reduced by </span>50%<span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">. </span>In addition, the MCTRA directed CMS to implement a claims-based data collection program to gather additional data on patient function during the course of therapy in order to better understand patient conditions and outcomes. All practice settings that provide outpatient therapy services are required to include this data on the claim form. Since 2013, therapists have been required to report new codes and modifiers on the claim form that reflect a patient&#8217;s functional limitations and goals at initial evaluation, periodically throughout care, and at discharge. Reporting of these functional limitation codes and modifiers are required on the claim for payment.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Medicare claims for outpatient therapy services furnished by therapy assistants on or after January 1, 2020 must include a modifier indicating the service was furnished by a therapy assistant. Outpatient therapy services furnished on or after January 1, 2022 in whole or part by a therapy assistant will be paid at an amount equal to 85% of the payment amount otherwise applicable for the service.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Statutes, regulations, and payment rules governing the delivery of therapy services to Medicare beneficiaries are complex and subject to interpretation. We believe that we are in compliance, in all material respects, with all applicable laws and regulations and are not aware of any pending or threatened investigations involving allegations of potential wrongdoing that would have a material effect on the our financial statements as of December 31, 2020. Compliance with such laws and regulations can be subject to future government review and interpretation, as well as significant regulatory action including fines, penalties, and exclusion from the Medicare program. For year ended December 31, 2020, net patient revenues from Medicare were approximately $101.6 million.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Given the history of frequent revisions to the Medicare program and its reimbursement rates and rules, we may not continue to receive reimbursement rates from Medicare that sufficiently compensate us for our services or, in some instances, cover our operating costs. Limits on reimbursement rates or the scope of services being reimbursed could have a material adverse effect on our revenue, financial condition and results of operations. Additionally, any delay or default by the federal or state governments in making Medicare and/or Medicaid reimbursement payments could materially and, adversely, affect our business, financial condition and results of operations.</div>

<div><br/></div>

<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Management Contract Revenues</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Management contract revenues, which are included in other revenues, are derived from contractual arrangements whereby the Company manages a clinic for third party owners. The Company does not have any ownership interest in these clinics. Typically, revenues are determined based on the number of visits conducted at the clinic and recognized at a point in time when services are performed. Costs, typically salaries for the Company&#8217;s employees, are recorded when incurred.</div>

<div><br/></div>

<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Industrial Injury Prevention Services Revenues</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Revenue from the industrial injury prevention business, which are also included in other revenues in the consolidated statements of net income, are derived from onsite services we provide to clients&#8217; employees including injury prevention, rehabilitation, ergonomic assessments and performance optimization. Revenue from the Company&#8217;s industrial injury prevention business is recognized when obligations under the terms of the contract are satisfied. Revenues are recognized at an amount equal to the consideration the company expects to receive in exchange for providing injury prevention services to its clients. The revenue is determined and recognized based on the number of hours and respective rate for services provided in a given period.</div>

<div><br/></div>

<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Other Revenues</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Additionally, other revenues include services the Company provides on-site at locations such as schools and industrial worksites for physical or occupational therapy services, athletic trainers and gym membership fees. Contract terms and rates are agreed to in advance between the Company and the third parties. Services are typically performed over the contract period and revenue is recorded at the point of service. If the services are paid in advance, revenue is recorded as a contract liability over the period of the agreement and recognized at the point in time, when the services are performed.</div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock', window );">Contractual Allowances</a></td>
<td class="text">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Contractual Allowances</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The allowance for estimated contractual adjustments is based on terms of payor contracts and historical collection and write-off experience. Contractual allowances result from the differences between the rates charged for services performed and expected reimbursements by both insurance companies and government sponsored healthcare programs for such services. Medicare regulations and the various third party payors and managed care contracts are often complex and may include multiple reimbursement mechanisms payable for the services provided in Company clinics. The Company estimates contractual allowances based on its interpretation of the applicable regulations, payor contracts and historical calculations. Each month the Company estimates its contractual allowance for each clinic based on payor contracts and the historical collection experience of the clinic and applies an appropriate contractual allowance reserve percentage to the gross accounts receivable balances for each payor of the clinic. Based on the Company&#8217;s historical experience, calculating the contractual allowance reserve percentage at the payor level is sufficient to allow the Company to provide the necessary detail and accuracy with its collectability estimates. However, the services authorized and provided and related reimbursement are subject to interpretation that could result in payments that differ from the Company&#8217;s estimates. Payor terms are periodically revised necessitating continual review and assessment of the estimates made by management. The Company&#8217;s billing system does not capture the exact change in its contractual allowance reserve estimate from period to period in order to assess the accuracy of its revenues and hence its contractual allowance reserves. Management regularly compares its cash collections to corresponding net revenues measured both in the aggregate and on a clinic-by-clinic basis. In the aggregate, historically the difference between net revenues and corresponding cash collections for any fiscal year has generally reflected a difference within approximately 1% to 1.5% of net revenues. Additionally, analysis of subsequent periods&#8217; contractual write-offs on a payor basis reflects a difference within approximately 1% to 1.5% between the actual aggregate contractual reserve percentage as compared to the estimated contractual allowance reserve percentage associated with the same period end balance. As a result, the Company believes that a change in the contractual allowance reserve estimate would not likely be more than 1% to 1.5% of gross billings included in accounts receivable at December 31, 2020.</div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts', window );">Allowance for Credit Losses</a></td>
<td class="text">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Allowance for Credit Losses</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company determines allowances for credit losses based on the specific agings and payor classifications at each clinic. The provision for credit losses is included in operating costs in the statements of net income. Patient accounts receivable, which are stated at the historical carrying amount net of contractual allowances, write-offs and allowance for credit losses, includes only those amounts the Company estimates to be collectible.</div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Income Taxes</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount to be recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company did not have any accrued interest or penalties associated with any unrecognized tax benefits nor was any interest expense recognized during the twelve months ended December 31, 2020, 2019 and 2018. The Company will book any interest or penalties, if required, in interest and other expense, as appropriate.</div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Values of Financial Instruments</a></td>
<td class="text">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Fair Values of Financial Instruments</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The carrying amounts reported in the balance sheets for cash and cash equivalents, accounts receivable, accounts payable and notes payable approximate their fair values due to the short-term maturity of these financial instruments. The carrying amount under the Amended Credit Agreement and the redemption value of Redeemable non-controlling interests approximate the respective fair values. The fair value of the Company&#8217;s redeemable non-controlling interests is determined based on &#8220;Level 3&#8221; inputs. The interest rate on the Amended Credit Agreement, which is tied to LIBOR, is set at various short-term intervals, as detailed in the Amended Credit Agreement.</div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Reporting</a></td>
<td class="text">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Segment Reporting</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">Operating segments are components of an enterprise for which separate financial information is available that is evaluated regularly by chief operating decision makers in determining the allocation of resources and in assessing performance. </span>The Company currently operates through two segments: physical therapy operations and industrial injury prevention services.</div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Use of Estimates</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In preparing the Company&#8217;s consolidated financial statements, management makes certain estimates and assumptions, especially in relation to, but not limited to, goodwill impairment, tradenames, allocations of purchase price, allowance for receivables, tax provision and contractual allowances, that affect the amounts reported in the consolidated financial statements and related disclosures. Actual results may differ from these estimates.</div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_SelfInsuranceProgramPolicyPolicyTextBlock', window );">Self-Insurance Program</a></td>
<td class="text">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Self-Insurance Program</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company utilizes a self-insurance plan for its employee group health and dental insurance coverage administered by a third party. Predetermined loss limits have been arranged with the insurance company to minimize the Company&#8217;s maximum liability and cash outlay. Accrued expenses include the estimated incurred but unreported costs to settle unpaid claims and estimated future claims. Management believes that the current accrued amounts are sufficient to pay claims arising from self-insurance claims incurred through December 31, 2020.</div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RestrictedStockPolicyPolicyTextBlock', window );">Restricted Stock</a></td>
<td class="text">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Restricted Stock</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Restricted stock issued to employees and directors is subject to continued employment or continued service on the board, respectively. Generally, restrictions on the stock granted to employees lapse in equal annual installments on the following <span style="-sec-ix-hidden:Fact_e171b1cb7c524fee994efb673b5c1ee0">four</span> anniversaries of the date of grant. For those shares granted to directors, the restrictions will lapse in equal quarterly installments during the <span style="-sec-ix-hidden:Fact_d66bd8ac9de54f2492bfbf867e9180fc">first</span> year after the date of grant. For those granted to officers, the restriction will lapse in equal quarterly installments during the four years following the date of grant. Compensation expense for grants of restricted stock is recognized based on the fair value per share on the date of grant amortized over the vesting period. The Company recognizes any forfeitures as they occur. The restricted stock issued is included in basic and diluted shares for the earnings per share computation.</div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Guidance</a></td>
<td class="text">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Recently Adopted Accounting Guidance</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In February 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2016-02, Leases (Topic 842) (&#8220;ASC 842&#8221;), which amended prior accounting standards for leases.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company implemented the new lease standard, ASC Topic 842 &#8211; Leases as of January 1, 2019 using the transition method in ASU 2018-11 issued in July 2018 which allows the Company to initially apply the new leases standard at adoption date and recognize a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. There was no adjustment required to retained earnings upon adoption. Accordingly, no retrospective adjustments were made to the comparative periods presented. The Company elected certain of the practical expedients permitted, including the expedient that allows the Company to retain its existing lease assessment and classification.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Adoption of ASC 842 resulted in an increase to total assets and liabilities due to the recording of operating lease right-of-use assets (&#8220;ROU&#8221;) and operating lease liabilities of approximately $78.0 million and $82.6 million respectively, as of January 1, 2019 for operating leases as a lessee. The adoption did not materially impact the Company&#8217;s consolidated statement of income or cash flows. See Footnote 10 - Leases for further discussion of leases.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In August 2018, the Securities Exchange Commission (&#8220;SEC&#8221;) issued Final Rule 33-10532, Disclosure Update and Simplification, which amends certain disclosure requirements that were redundant, duplicative, overlapping or superseded by other SEC disclosure requirements. The amendments generally eliminated or otherwise reduced certain disclosure requirements of various SEC rules and regulations. However, in some cases, the amendments require additional information to be disclosed, including changes in stockholders&#8217; equity in interim periods. The rule is effective 30 days after its publication in the Federal Register. The rule was posted on October 4, 2018. On September 25, 2018, the SEC released guidance advising it will not object to a registrant adopting the requirement to include changes in stockholders&#8217; equity in the Form 10-Q for the first quarter beginning after the effective date of the rule. The Company adopted this guidance in its Form 10-Q for the period ended March 31, 2019.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In June 2016, the FASB issued ASU 2016-13, Financial Instruments &#8211; Credit Losses, which added a new impairment model (known as the current expected credit loss (CECL) model) that is based on expected losses rather than incurred losses. Under the new guidance, an entity recognizes as an allowance its estimate of expected credit losses. The CECL model applies to most debt instruments, including trade receivables. The CECL model does not have a minimum threshold for recognition of impairment losses and entities will need to measure expected credit losses on assets that have a low risk of loss. The standard is required to be applied using the modified retrospective approach with a cumulative-effect adjustment to retained earnings, if any, upon adoption.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Company completed the adoption of ASU 2016-13, <span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Financial Instruments &#8211; Credit Losses</span>&#160; on January 1, 2020. The financial instruments subject to ASU 2016-13 are the Company&#8217;s accounts receivable derived from contracts with customers. A significant portion of the Company&#8217;s accounts receivable are from highly-solvent, creditworthy payors including governmental programs such as Medicare and Medicaid, and highly regulated commercial insurers. The Company&#8217;s estimate of expected credit losses as of January 1, 2020, using its expected credit loss evaluation process, resulted in no adjustments to the allowance for credit losses and no cumulative-effect adjustment to retained earnings on the adoption date of the standard.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In January 2017, the FASB issued ASU 2017-04, <span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Simplifying the Test for Goodwill Impairment (Topic 350),</span> which eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment charge. ASU 2017-04 is effective prospectively for fiscal years, and the interim periods within those years, beginning after December 15, 2019. The Company completed the adoption of the standard effective January 1, 2020 and there was no impact to goodwill from the Company&#8217;s adoption of this change.</div>

<div><br/></div>

<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Recently Issued Accounting Guidance</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. This ASU provides temporary optional expedients and exceptions to the guidance on contract modifications and hedge accounting to ease the financial reporting burdens of the expected market transition from the London Interbank Offered Rate (&#8220;LIBOR&#8221;) and other interbank offered rates to alternative reference rates. The new guidance was effective upon issuance, and the Company is allowed to elect to apply the amendments prospectively through December 31, 2022. Borrowings under the Amended Credit Agreement bear interest based on LIBOR or an alternate base rate. Provisions within the agreement currently provide the Company with the ability to replace LIBOR with a different reference rate in the event LIBOR ceases to exist.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In August 2020, the FASB issued ASU 2020-06&#160;<span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity </span>which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity&#8217;s own equity. As part of this update, convertible instruments are to be included in diluted earnings per share using the if-converted method, rather than the treasury stock method. Further, contracts which can be settled in cash or shares, excluding liability-classified share-based payment awards, are to be included in diluted earnings per share on an if-converted basis if the effect is dilutive, regardless of whether the entity or the counterparty can choose between cash and share settlement. The share-settlement presumption may not be rebutted based on past experience or a stated policy.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">This pronouncement is effective for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2021. The Company plans to adopt this pronouncement as of January 1, 2022. The use of either the modified retrospective or fully retrospective method of transition is permitted. The Company is currently evaluating the impact of the adoption of ASU 2020-06 on the Company's consolidated financial statements.</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In December 2019, the FASB issued ASU 2019-12,&#160;Income Taxes (Topic 740) &#8211; Simplifying the Accounting for Income Taxes (&#8220;ASU 2019-12&#8221;). The objective of ASU 2019-12 is to simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740 and to provide more consistent application to improve the comparability of financial statements. The amendments in this ASU are effective for fiscal years beginning after December 15, 2020, and early adoption is permitted. We are currently evaluating the impact this guidance may have on our consolidated financial statements and related footnote disclosures.</div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsPolicyPolicyTextBlock', window );">Subsequent Event</a></td>
<td class="text">
<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Subsequent Event</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">On January 29, 2021, the Company, entered into the First Amendment to Second Amended and Restated Credit Agreement (hereafter referred to as &#8220;Amended Credit Agreement&#8221;) extending the maturity date from November 30, 2021 to November 30, 2025. The commitment under the Amended Credit Agreement remains at $125 million, however the accordion feature in the agreement was expanded to provide for capacity up to $150 million. See Note 9 for more information on the Amended Credit Agreement.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for contractual adjustments and third-party settlements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 405<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491204&amp;loc=d3e4869-115612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 310<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68075217&amp;loc=d3e3111-115594<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13279-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for charging off uncollectible financing receivables, including, but not limited to, factors and methodologies used in estimating the allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (a,b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=SL6953423-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32847-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116657188&amp;loc=SL116659661-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32280-109318<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reporting subsequent events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NonControllingInterestsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for non-controlling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NonControllingInterestsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_RedeemableNonControllingInterestsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for redeemable non-controlling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_RedeemableNonControllingInterestsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_RestrictedStockPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for restricted stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_RestrictedStockPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_SelfInsuranceProgramPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for self-insurance program.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_SelfInsuranceProgramPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438849224312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization, Nature of Operations and Basis of Presentation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Nature of Operations and Basis of Presentation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock', window );">Acquisitions Within Physical Therapy Operations Segment</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 27.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">During the last three years, the Company completed the following acquisitions within its physical therapy operations segment:</div>

<div><br/></div>

<table cellpadding="0" cellspacing="0" id="z329b3aa4a904444f99fe9105ae0bad7b" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">
  <tr>
    <td style="width: 34.03%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Acquisition</div></td>
    <td style="width: 2.78%; vertical-align: bottom;">&#160;</td>
    <td style="width: 25.28%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Date</div></td>
    <td style="width: 2.5%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td style="width: 16.67%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">% Interest<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/></span>Acquired</div></td>
    <td style="width: 2.5%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td style="width: 16.25%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Number of<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/></span>Clinics</div></td>
  </tr>
  <tr>
    <td style="width: 34.03%; vertical-align: bottom;">&#160;</td>
    <td style="width: 2.78%; vertical-align: bottom;">&#160;</td>
    <td style="width: 25.28%; vertical-align: bottom; border-top: #000000 2px solid;">&#160;</td>
    <td style="width: 2.5%; vertical-align: bottom;">&#160;</td>
    <td style="width: 16.67%; vertical-align: bottom;">&#160;</td>
    <td style="width: 2.5%; vertical-align: bottom;">&#160;</td>
    <td style="width: 16.25%; vertical-align: bottom;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 34.03%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">November 2020 Acquisition</div></td>
    <td style="width: 2.78%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 25.28%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">November 30, 2020</div></td>
    <td style="width: 2.5%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 16.67%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">75%</div></td>
    <td style="width: 2.5%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 16.25%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">3</div></td>
  </tr>
  <tr>
    <td style="width: 34.03%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">September 2020 Acquisition</div></td>
    <td style="width: 2.78%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 25.28%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">September 30, 2020</div></td>
    <td style="width: 2.5%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 16.67%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">70%</div></td>
    <td style="width: 2.5%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 16.25%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">*</div></td>
  </tr>
  <tr>
    <td style="width: 34.03%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">February 2020 Acquisition</div></td>
    <td style="width: 2.78%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 25.28%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">February 27, 2020</div></td>
    <td style="width: 2.5%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 16.67%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">65%</div></td>
    <td style="width: 2.5%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">**</div></td>
    <td style="width: 16.25%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">4</div></td>
  </tr>
  <tr>
    <td style="width: 34.03%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">September 2019 Acquisition</div></td>
    <td style="width: 2.78%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 25.28%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">September 30, 2019</div></td>
    <td style="width: 2.5%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 16.67%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">67%</div></td>
    <td style="width: 2.5%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 16.25%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">11</div></td>
  </tr>
  <tr>
    <td style="width: 34.03%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">August 2018 Acquisition</div></td>
    <td style="width: 2.78%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 25.28%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">August 31, 2018</div></td>
    <td style="width: 2.5%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 16.67%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">70%</div></td>
    <td style="width: 2.5%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 16.25%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">4</div></td>
  </tr>
</table>

<div><br/></div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" id="z70c8f2b5b53b4524bb7ccfe492028040" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">
  <tr>
    <td style="width: 27pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">*</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The business includes six management and services contracts which had a remaining term of approximately five years as of the date acquired.</div></td>
  </tr>
</table>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" id="z46f47f69a0da4fb98e548c6918a6352a" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">
  <tr>
    <td style="width: 27pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">**</td>
    <td style="width: auto; vertical-align: top; text-align: left;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The four clinics are in four separate partnerships. The Company's interest in the four partnerships range from 10.0% to 83.8%, with an overall 65.0% based on the initial purchase transaction.</div></td>
  </tr>
</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of business combination completed within the physical therapy operations segment during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438845214040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue, Categories</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The following table details the revenue related to the various categories (in thousands).</div>

<div><br/></div>

<table cellpadding="0" cellspacing="0" id="z8c0b8e1e67b64cb6b6522cc37bfa309c" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/></td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2018</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Net patient revenues</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">373,340</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">433,345</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">417,703</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Management contract revenues</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">8,410</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">8,676</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">8,339</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Other revenues</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,020</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,486</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,403</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 17.65pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Physical therapy operations</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">383,770</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">444,507</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">428,445</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Industrial injury prevention services revenues</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">39,199</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">37,462</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">25,466</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">422,969</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">481,969</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">453,911</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438844874504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions of Businesses (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Acquisitions of Businesses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Clinic Acquisition</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">During 2020, 2019 and 2018, the Company acquired a majority interest in the following physical therapy practices:</div>

<div><br/></div>

<table cellpadding="0" cellspacing="0" id="zf55e47efd599479e982bad9962730ad0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">
  <tr>
    <td style="width: 39.03%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Acquisition</div></td>
    <td style="width: 3.06%; vertical-align: bottom;">&#160;</td>
    <td style="width: 22.92%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Date</div></td>
    <td style="width: 2.78%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td style="width: 14.72%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">% Interest<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/></span>Acquired</div></td>
    <td style="width: 2.92%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td style="width: 14.58%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Number of<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/></span>Clinics</div></td>
  </tr>
  <tr>
    <td style="width: 39.03%; vertical-align: bottom;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">November 2020 Acquisition</div></td>
    <td style="width: 3.06%; vertical-align: bottom;">&#160;</td>
    <td style="width: 22.92%; vertical-align: bottom; border-top: #000000 2px solid;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">November 30, 2020</div></td>
    <td style="width: 2.78%; vertical-align: bottom;">&#160;</td>
    <td style="width: 14.72%; vertical-align: bottom;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">75%</div></td>
    <td style="width: 2.92%; vertical-align: bottom;">&#160;</td>
    <td style="width: 14.58%; vertical-align: bottom;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">3</div></td>
  </tr>
  <tr>
    <td style="width: 39.03%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">September 2020 Acquisition</div></td>
    <td style="width: 3.06%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 22.92%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">September 30, 2020</div></td>
    <td style="width: 2.78%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 14.72%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">70%</div></td>
    <td style="width: 2.92%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 14.58%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><span style="-sec-ix-hidden:Fact_29c0aadade644e9a962b7bfbcb82c179">*</span></div></td>
  </tr>
  <tr>
    <td style="width: 39.03%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">February 2020 Acquisition</div></td>
    <td style="width: 3.06%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 22.92%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">February 27, 2020</div></td>
    <td style="width: 2.78%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 14.72%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">65%</div></td>
    <td style="width: 2.92%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">**</div></td>
    <td style="width: 14.58%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">4</div></td>
  </tr>
  <tr>
    <td style="width: 39.03%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">September 2019 Acquisition</div></td>
    <td style="width: 3.06%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 22.92%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">September 30, 2019</div></td>
    <td style="width: 2.78%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 14.72%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">67%</div></td>
    <td style="width: 2.92%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 14.58%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">11</div></td>
  </tr>
  <tr>
    <td style="width: 39.03%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">August 2018 Acquisition</div></td>
    <td style="width: 3.06%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 22.92%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">August 31, 2018</div></td>
    <td style="width: 2.78%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 14.72%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">70%</div></td>
    <td style="width: 2.92%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 14.58%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">4</div></td>
  </tr>
</table>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">*&#160; &#160; </span>The business includes six management and services contracts which had a remaining term of approximately five years as of the date acquired.</div>

<div style="display:none;"><br/></div>
<div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">**&#160;&#160; </span>The four clinics are in four separate partnerships.&#160; The Company's interest in the four partnerships range from 10.0% to 83.8%, with an overall 65.0% based on the initial purchase transaction.</div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock', window );">Preliminary Purchase Prices Allocation</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The purchase price for the 2020 physical therapy operations acquisitions has been preliminarily allocated as follows (in thousands):</div>

<div><br/></div>

<table cellpadding="0" cellspacing="0" id="za1a0966005394e48a9d620aafba9caf2" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Cash paid, net of cash acquired ($500)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">23,907</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Seller note</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,121</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total consideration</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">25,028</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Estimated fair value of net tangible assets acquired:</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%;" valign="bottom"><div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total current assets</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,271</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total non-current assets</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">134</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total liabilities</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(555</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -15.85pt; margin-left: 33.85pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Net tangible assets acquired</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">850</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%;" valign="bottom"><div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Referral relationships</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">3,597</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Non-compete</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,012</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%;" valign="bottom"><div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Tradename</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,326</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Goodwill</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">28,540</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Fair value of non-controlling interest (classified as redeemable non-controlling interests)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(11,297</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">25,028</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
</table>

<div><br/></div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The purchase price for the 2019 acquisitions were allocated as follows (in thousands):</div>

<div><br/></div>

<table cellpadding="0" cellspacing="0" id="z0200ec8ec07146f3bd1815fa975597c6" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/></td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">IIPS*</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> Physical Therapy Operations</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Total</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Cash paid, net of cash acquired ($890)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">18,428</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">12,170</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">30,598</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%;" valign="bottom"><div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Payable to shareholders of seller</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">485</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">485</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Seller note</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">4,000</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">300</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">4,300</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px;" valign="bottom"><div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total consideration</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">22,913</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">12,470</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">35,383</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%;" valign="bottom"><div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Estimated fair value of net tangible assets acquired:</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total current assets</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,641</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">650</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,291</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%;" valign="bottom"><div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total non-current assets</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">848</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">394</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,242</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -16.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total liabilities</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(2,978</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(191</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(3,169</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%;" valign="bottom"><div style="text-align: left; text-indent: -15.85pt; margin-left: 33.85pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Net tangible assets acquired</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(489</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">853</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">364</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Referral relationships</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">3,400</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,600</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">6,000</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%;" valign="bottom"><div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Non-compete</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">250</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">270</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">520</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Tradename</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,300</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">740</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,040</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%;" valign="bottom"><div style="text-align: left; text-indent: -14.4pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Goodwill</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">18,452</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">14,237</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">32,689</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Fair value of non-controlling interest (classified as redeemable non-controlling interests)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(6,230</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(6,230</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">22,913</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">12,470</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">35,383</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
</table>

<div><br/></div>

<div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">* Industrial injury prevention services</div>

<div><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The purchase price for the 2018 acquisitions were allocated as follows (in thousands):</div>

<div><br/></div>

<table cellpadding="0" cellspacing="0" id="z4cea7993c4404e908d071694d5887404" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Cash paid, net of cash acquired ($372)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">16,367</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Seller note</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">950</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total consideration</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">17,317</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Estimated fair value of net tangible assets acquired:</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total current assets</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,633</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total non-current assets</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">305</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total liabilities</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(525</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Net tangible assets acquired</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,413</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Referral relationships</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,926</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Non-compete</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">298</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Tradename</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">990</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Goodwill</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">19,835</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Fair value of non-controlling interest (classified as redeemable non-controlling interests)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(8,145</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">17,317</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of finite-lived and indefinite-lived intangible assets acquired as part of a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1486-128463<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438844895096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Non-Controlling Interest (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RedeemableNonControllingInterestAbstract', window );"><strong>Redeemable Non-Controlling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestTableTextBlock', window );">Changes in Carrying Amount (Fair Value) of Redeemable Non-Controlling Interest</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">For the year ended December 31, 2020, 2019 and 2018, the following table details the changes in the carrying amount (fair value) of the redeemable non-controlling interests (in thousands):</div>

<div><br/></div>

<table cellpadding="0" cellspacing="0" id="z5419bd02f8334e35b081255c66326369" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/></td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;">December 31, 2018</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Beginning balance</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">137,750</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">133,943</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">102,572</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Operating results allocated to redeemable non-controlling interest partners</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">11,175</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">10,659</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">8,433</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Distributions to redeemable non-controlling interest partners</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(12,403</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(10,221</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(9,835</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Changes in the fair value of redeemable non-controlling interest</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">4,632</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">11,893</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">24,770</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Purchases of redeemable non-controlling interest</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(20,521</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(8,934</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">8,145</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Acquired interest</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">11,297</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">6,230</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Reduction of non-controlling interest due to sale of USPH partnership interest</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(6,132</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Sales of redeemable non-controlling interest - temporary equity</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,133</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">3,120</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Notes receivable related to sales of redeemable non-controlling interest - temporary equity</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(1,006</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(2,870</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(142</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Adjustments in notes receivable related to the the sales of redeemable non-controlling interest - temporary equity</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">283</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Other</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">62</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Ending balance</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">132,340</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">137,750</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">133,943</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock', window );">Carrying Amount of (Fair Value) Redeemable Non-Controlling Interest</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The following table categorizes the carrying amount (fair value) of the redeemable non-controlling interests (in thousands):</div>

<div><br/></div>

<table cellpadding="0" cellspacing="0" id="z670c3e5c6ec64188aa3c22deb9e2062e" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/></td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;">December 31, 2018</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Contractual time period has lapsed but holder's employment has not been terminated</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">62,390</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">51,921</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">42,624</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Contractual time period has not lapsed and holder's employment has not been terminated</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">69,950</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">85,829</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">91,319</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Holder's employment has terminated and contractual time period has expired</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Holder's employment has terminated and contractual time period has not expired</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">132,340</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">137,750</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">133,943</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity. As of the date of the statement of financial position, such redeemable noncontrolling interest is currently redeemable, as defined, for cash or other assets of the entity at (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of carrying amount of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_RedeemableNonControllingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_RedeemableNonControllingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438845155448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Changes in Carrying Amount of Goodwill</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The changes in the carrying amount of goodwill as of December 31, 2020 and 2019 consisted of the following (in thousands):</div>

<div style="text-align: left;"><br/></div>

<table cellpadding="0" cellspacing="0" id="z004ebbf23ace473ea8af3849451f0579" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/></td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Beginning balance</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">317,676</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">293,525</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Goodwill acquired</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">28,540</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">31,330</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Goodwill related to partnership interest sold</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(7,325</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Goodwill derecognition (write-off) related to closed clinics</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(1,859</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Goodwill adjustments for purchase price allocation of businesses acquired in prior year</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,289</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">146</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Ending balance</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">345,646</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">317,676</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438853238520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible Assets, net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Intangible Assets, Net</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Intangible assets, net as of December 31, 2020, 2019 and 2018 consisted of the following (in thousands):</div>

<div style="text-align: left;"><br/></div>

<table cellpadding="0" cellspacing="0" id="z4aa296b7bad344d8aa0f77e9db40fba3" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/></td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Tradenames</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">32,317</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">32,049</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Referral relationships, net of accumulated amortization of $14,522 and $11,677, respectively</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">22,119</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">18,367</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Non-compete agreements, net of accumulated amortization of $5,993 and $5,424, respectively</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,844</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,172</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">56,280</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">52,588</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock', window );">Amortization Expenses</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The following table details the amount of amortization expense recorded for intangible assets for the years ended December 31, 2020, 2019 and 2018 (in thousands):</div>

<div style="text-align: left;"><br/></div>

<table cellpadding="0" cellspacing="0" id="z3d51561c2d2b4e3991aa252252acd5e0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/></td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;">Year Ended</div><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;">December 31, 2018</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Referral relationships</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,845</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,307</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,161</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Non-compete agreements</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">569</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">708</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">616</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">3,414</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">3,015</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,777</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
</table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Amortization of Referral Relationships and Non Competition Agreements</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The remaining balances of the referral relationships and non-compete agreements is expected to be amortized as follows (in thousands):</div>

<div><br/></div>

<table cellpadding="0" cellspacing="0" id="z4ca35e0153f74abcaf4ae18e8b962393" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">
  <tr>
    <td colspan="3" style="width: 48.7%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Referral Relationships</div></td>
    <td style="width: 1.33%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="3" style="width: 48.71%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Non-Compete Agreements</div></td>
    <td style="width: 1.26%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 37.23%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Years</div></td>
    <td style="width: 1.12%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td style="width: 10.35%; vertical-align: bottom;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Annual Amount</div></td>
    <td style="width: 1.33%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td style="width: 37.23%; vertical-align: bottom; white-space: nowrap;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Years</div></td>
    <td style="width: 1.12%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td style="width: 10.35%; vertical-align: bottom;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Annual Amount</div></td>
    <td style="width: 1.26%; vertical-align: bottom;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 37.23%; vertical-align: bottom;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Ending December 31,</div></td>
    <td style="width: 1.12%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td style="width: 10.35%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td style="width: 1.33%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td style="width: 37.23%; vertical-align: bottom; white-space: nowrap;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Ending December 31,</div></td>
    <td style="width: 1.12%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td style="width: 10.35%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td style="width: 1.26%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2021</div></td>
    <td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,946</div></td>
    <td style="width: 1.33%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;">&#160;</td>
    <td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2021</div></td>
    <td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">556</div></td>
    <td style="width: 1.26%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2022</div></td>
    <td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,886</div></td>
    <td style="width: 1.33%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2022</div></td>
    <td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">403</div></td>
    <td style="width: 1.26%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2023</div></td>
    <td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,778</div></td>
    <td style="width: 1.33%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2023</div></td>
    <td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">335</div></td>
    <td style="width: 1.26%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2024</div></td>
    <td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,615</div></td>
    <td style="width: 1.33%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2024</div></td>
    <td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">279</div></td>
    <td style="width: 1.26%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2025</div></td>
    <td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,470</div></td>
    <td style="width: 1.33%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 37.23%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2025</div></td>
    <td style="width: 1.12%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.35%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">212</div></td>
    <td style="width: 1.26%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Thereafter</div></td>
    <td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">8,424</div></td>
    <td style="width: 1.33%; vertical-align: bottom; background-color: #FFFFFF; white-space: nowrap;">&#160;</td>
    <td style="width: 37.23%; vertical-align: bottom; background-color: #FFFFFF; white-space: nowrap;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Thereafter</div></td>
    <td style="width: 1.12%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.35%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">59</div></td>
    <td style="width: 1.26%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
  </tr>
</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438849224312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Accrued Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Accrued Expenses</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Accrued expenses as of December 31, 2020 and 2019 consisted of the following (in thousands):</div>

<div style="text-align: left;"><br/></div>

<table cellpadding="0" cellspacing="0" id="z5e0ab21edcc54f1d894d4c3659803307" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/></td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Salaries and related costs</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">24,646</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">19,340</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Credit balances due to patients and payors</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">5,756</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">4,303</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Group health insurance claims</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,113</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,277</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Closure costs</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,333</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">116</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Federal income taxes payable</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">5,715</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">MAAPP funds payable</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">14,054</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Deferred employer payroll taxes - CARES ACT</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">4,170</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Other</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,959</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">4,819</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">59,746</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">30,855</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438846581592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes Payable (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Notes Payable [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Credit Agreement and Notes Payable</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Notes payable as of December 31, 2020 and 2019 consisted of the following (in thousands):</div>

<div style="text-align: left;"><br/></div>

<table cellpadding="0" cellspacing="0" id="z2a1752aada2b4b209bdac3644d131528" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/></td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Credit Agreement average effective interest rate of 2.6% and 3.9% in 2020 and 2019, respectively (inclusive of unused fee)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">16,000</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">46,000</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Various notes payable with $4,899 plus accrued interest due in the next year, interest accrues in the range of 3.25% through 5.50% per annum</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">5,495</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">5,089</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">21,495</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">51,089</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Less current portion</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(4,899</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(728</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Long term portion</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">16,596</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">50,361</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(e),(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21521-112644<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21538-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438849851016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>LEASES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Components of Lease Expense</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">For the years ended December 31, 2020 and 2019, the components of lease expense were as follows (in thousands):</div>

<div><br/></div>

<table cellpadding="0" cellspacing="0" id="z7b37b8c0456447ddb4283356a6996986" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; text-indent: -9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended December 31,</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/></td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2020</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; text-indent: -9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2019</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Operating lease cost</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">30,710</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">30,225</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Short-term lease cost</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,454</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,212</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Variable lease cost</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">5,752</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">6,074</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total lease cost<sup>*</sup></div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">37,916</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">37,511</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
</table>

<div><br/></div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" id="z90bdf9c7e6434fa18d41ce5d317f4a15" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">
  <tr>
    <td style="width: 18pt;"/>
    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">*</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Sublease income was immaterial</div></td>
  </tr>
</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_OperatingLeaseSupplementalInformationTableTextBlock', window );">Supplemental Information Related to Leases</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">For the years ended December 31, 2020 and 2019, supplemental cash flow information related to leases was as follows (in thousands):</div>

<div><br/></div>

<table cellpadding="0" cellspacing="0" id="zefa24bda41b145dc987f251a2c72b025" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;">Year Ended December 31,</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/></td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2020</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;">2019</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Cash paid for amounts included in the measurement of operating lease liabilities (in thousands)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">30,307</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">30,077</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Right-of-use assets obtained in exchange for new operating lease liabilities (in thousands)<sup>*</sup></div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">32,710</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">113,222</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
</table>

<div><br/></div>

<table cellpadding="0" cellspacing="0" class="DSPFListTable" id="ze8f9e808d67d46619b49699a7a23f031" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">
  <tr>
    <td style="width: 18pt;"/>
    <td style="width: 18pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">*</td>
    <td style="width: auto; vertical-align: top; text-align: justify;"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Includes the right-of-use assets obtained in exchange for lease liabilities for the year 2019 - $82.6 million which were recognized upon adoption of ASC Topic 842 at January 1, 2019.</div></td>
  </tr>
</table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Future Lease Payments for Operating Leases</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The aggregate future lease payments for operating leases as of December 31, 2020 were as follows (in thousands):</div>

<div><br/></div>

<table cellpadding="0" cellspacing="0" id="z36a05d7ef158441a9e0ee25c617b7227" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Fiscal Year</div></td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Amount</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2021</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">29,819</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%;" valign="bottom"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2022</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">23,861</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2023</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">17,787</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%;" valign="bottom"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2024</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">11,487</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2025 and therafter</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">12,294</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total lease payments</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">95,248</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Less: imputed interest</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">5,751</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 88%; padding-bottom: 4px;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 33.85pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total operating lease liabilities</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">89,497</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock', window );">Average Lease Terms and Discount Rates</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Average lease terms and discount rates were as follows:</div>

<div><br/></div>

<table cellpadding="0" cellspacing="0" id="z00c67b6139734de2b818611f02c97724" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/></td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;">Year Ended December 31,</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2020</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-indent: -7pt;">2019</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Weighted-average remaining lease term - Operating leases</div></td>
    <td colspan="1" style="vertical-align: bottom; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; background-color: #CCEEFF;" valign="bottom"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">4.05 Years</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; background-color: #CCEEFF;" valign="bottom"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -7pt;">4.05 Years</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; background-color: #FFFFFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; background-color: #FFFFFF;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; background-color: #FFFFFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; background-color: #FFFFFF;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; background-color: #FFFFFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; background-color: #FFFFFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Weighted-average discount rate - Operating leases</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">3.1</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">%</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">3.9</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">%</div></td>
  </tr>
</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_OperatingLeaseSupplementalInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental information related to leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_OperatingLeaseSupplementalInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to weighted average lease terms and discount rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438850584984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Components of Deferred Tax Assets and Liabilities Included in Consolidated Balance Sheets</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Significant components of deferred tax assets and liabilities included in the consolidated balance sheets at December 31, 2020 and 2019 were as follows (in thousands):</div>

<div><br/></div>

<table cellpadding="0" cellspacing="0" id="z210002d42bc24598a6e0e37001fc2dac" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/></td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom;" valign="bottom"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Deferred tax assets:</div></td>
    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Compensation</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,865</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,964</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Allowance for credit losses</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">396</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">514</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Acquired net operating losses</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">558</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">840</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Lease obligations - including closed clinics</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">23,819</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">21,445</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Deferred tax assets</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">26,638</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">24,763</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%;" valign="bottom"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Deferred tax liabilities:</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Depreciation and amortization</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(12,650</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(13,195</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Operating lease right-of-use assets</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(21,419</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(21,416</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Other</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(348</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(223</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Deferred tax liabilities</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(34,417</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(34,834</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Net deferred tax liability</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(7,779</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(10,071</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Differences Between Federal Tax Rate and Company's Effective Tax Rate for Results of Continuing Operations</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The differences between the federal tax rate and the Company&#8217;s effective tax rate for the years ended December 31, 2020, 2019 and 2018 were as follows (in thousands):</div>

<div style="text-align: left;"><br/></div>

<table cellpadding="0" cellspacing="0" id="z21bd67f809424afe8f722f356649b1f4" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">
  <tr>
    <td style="width: 26.72%; vertical-align: bottom;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/></td>
    <td style="width: 1.13%; vertical-align: bottom;">&#160;</td>
    <td style="width: 1.18%; vertical-align: bottom; border-bottom: #000000 2px solid;">&#160;</td>
    <td colspan="3" style="width: 21.95%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div></td>
    <td style="width: 1.11%; vertical-align: bottom;">&#160;</td>
    <td style="width: 1.14%; vertical-align: bottom; border-bottom: #000000 2px solid;">&#160;</td>
    <td colspan="3" style="width: 21.77%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div></td>
    <td style="width: 1.08%; vertical-align: bottom;">&#160;</td>
    <td style="width: 1.1%; vertical-align: bottom; border-bottom: #000000 2px solid;">&#160;</td>
    <td colspan="3" style="width: 21.78%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2018</div></td>
    <td style="width: 1.04%; vertical-align: bottom;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 26.72%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">U. S. tax at statutory rate</div></td>
    <td style="width: 1.13%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 1.18%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.51%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">10,125</div></td>
    <td style="width: 0.93%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 10.51%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">21.0%</div></td>
    <td style="width: 1.11%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 1.14%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.52%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">11,274</div></td>
    <td style="width: 0.73%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 10.52%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">21.0%</div></td>
    <td style="width: 1.08%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 1.1%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.53%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">9,710</div></td>
    <td style="width: 0.73%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 10.52%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">21.0%</div></td>
    <td style="width: 1.04%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 26.72%; vertical-align: bottom; background-color: #FFFFFF; white-space: nowrap;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">State income taxes, net of federal benefit</div></td>
    <td style="width: 1.13%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 1.18%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 10.51%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,956</div></td>
    <td style="width: 0.93%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 10.51%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">3.9%</div></td>
    <td style="width: 1.11%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 1.14%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 10.52%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,059</div></td>
    <td style="width: 0.73%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 10.52%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">3.8%</div></td>
    <td style="width: 1.08%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 1.1%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 10.53%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,722</div></td>
    <td style="width: 0.73%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 10.52%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">3.7%</div></td>
    <td style="width: 1.04%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 26.72%; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Excess equity compensation deduction</div></td>
    <td style="width: 1.13%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 1.18%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 10.51%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(99)</div></td>
    <td style="width: 0.93%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 10.51%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">0.0%</div></td>
    <td style="width: 1.11%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 1.14%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 10.52%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(871)</div></td>
    <td style="width: 0.73%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 10.52%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-1.6 %</div></td>
    <td style="width: 1.08%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 1.1%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 10.53%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(806)</div></td>
    <td style="width: 0.73%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 10.52%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-1.7 %</div></td>
    <td style="width: 1.04%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 26.72%; vertical-align: bottom; background-color: #FFFFFF; white-space: nowrap;"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Non-deductible expenses</div></td>
    <td style="width: 1.13%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 1.18%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 10.51%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,040</div></td>
    <td style="width: 0.93%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 10.51%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2.1%</div></td>
    <td style="width: 1.11%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 1.14%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 10.52%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,185</div></td>
    <td style="width: 0.73%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 10.52%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2.2%</div></td>
    <td style="width: 1.08%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 1.1%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 10.53%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">743</div></td>
    <td style="width: 0.73%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 10.52%; vertical-align: bottom; border-bottom: #000000 2px solid; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1.6%</div></td>
    <td style="width: 1.04%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 26.72%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 1.13%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 1.18%; vertical-align: bottom; border-top: #000000 2px solid; border-bottom: #000000 4px double; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.51%; vertical-align: bottom; border-top: #000000 2px solid; border-bottom: #000000 4px double; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">13,022</div></td>
    <td style="width: 0.93%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 10.51%; vertical-align: bottom; border-top: #000000 2px solid; border-bottom: #000000 4px double; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">27.0%</div></td>
    <td style="width: 1.11%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 1.14%; vertical-align: bottom; border-top: #000000 2px solid; border-bottom: #000000 4px double; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.52%; vertical-align: bottom; border-top: #000000 2px solid; border-bottom: #000000 4px double; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">13,647</div></td>
    <td style="width: 0.73%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 10.52%; vertical-align: bottom; border-top: #000000 2px solid; border-bottom: #000000 4px double; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">25.4%</div></td>
    <td style="width: 1.08%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 1.1%; vertical-align: bottom; border-top: #000000 2px solid; border-bottom: #000000 4px double; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 10.53%; vertical-align: bottom; border-top: #000000 2px solid; border-bottom: #000000 4px double; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">11,369</div></td>
    <td style="width: 0.73%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 10.52%; vertical-align: bottom; border-top: #000000 2px solid; border-bottom: #000000 4px double; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">24.6%</div></td>
    <td style="width: 1.04%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
  </tr>
</table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Significant Components of Provision for Income Taxes for Continuing Operations</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Significant components of the provision for income taxes for the years ended December 31, 2020, 2019 and 2018 were as follows (in thousands):</div>

<div><br/></div>

<table cellpadding="0" cellspacing="0" id="zbf81119b8a024b268d90882988e17c64" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td style="vertical-align: top; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/></td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">December 31, </span>2020</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">December 31, </span>2019</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">December 31, </span>2018</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: top; white-space: nowrap;" valign="bottom"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Current:</div></td>
    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: top; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Federal</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="font-family: 'Times New Roman'; font-size: 10pt;">10,506</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="font-family: 'Times New Roman'; font-size: 10pt;">6,523</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="font-family: 'Times New Roman'; font-size: 10pt;">5,357</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: top; width: 64%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">State</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="font-family: 'Times New Roman'; font-size: 10pt;">2,774</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,473</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,199</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: top; width: 64%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total current</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="font-family: 'Times New Roman'; font-size: 10pt;">13,280</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">8,996</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">6,556</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: top; width: 64%; white-space: nowrap;" valign="bottom"><div style="text-align: left; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Deferred:</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: top; width: 64%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="text-align: left; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Federal</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(38</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">3,730</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="font-family: 'Times New Roman'; font-size: 10pt;">3,771</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: top; width: 64%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><div style="text-align: left; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">State</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="font-family: 'Times New Roman'; font-size: 10pt;">(220</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">921</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,042</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: top; width: 64%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total deferred</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="font-family: 'Times New Roman'; font-size: 10pt;">(258</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">4,651</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">4,813</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: top; width: 64%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total income tax provision</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"><div style="font-family: 'Times New Roman'; font-size: 10pt;">13,022</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"><div style="font-family: 'Times New Roman'; font-size: 10pt;">13,647</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"><div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"><div style="font-family: 'Times New Roman'; font-size: 10pt;">11,369</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438846520136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Selected Financial Data for Reportable Segments</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">T<span style="font-size: 10pt; font-family: 'Times New Roman';">he following table summarizes selected financial data for the Company&#8217;s reportable segments. Prior year results presented herein have been changed to conform to the current presentation</span>.</div>

<div><br/></div>

<table cellpadding="0" cellspacing="0" id="zea0754717f864c8688543b30b5aa363f" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31,</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31,</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31,</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/></td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2020</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> 2019</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2018</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(in thousands)</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(in thousands)</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom;" valign="bottom"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Net operating revenues:</div></td>
    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Physical therapy operations</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">383,770</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">444,507</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">428,445</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Industrial injury prevention services</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">39,199</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">37,462</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">25,466</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total Company</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">422,969</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">481,969</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">453,911</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: top; width: 64%;" valign="bottom"><div style="text-align: left; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Gross profit:</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: top; width: 64%;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Physical therapy operations (excluding closure costs)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">88,295</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">104,120</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">96,463</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: top; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Industrial injury prevention services</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">10,086</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">8,379</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">5,192</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: top; width: 64%;" valign="bottom"><div style="text-align: left; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">98,381</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">112,499</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">101,655</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: top; width: 64%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Physical therapy operations - closure costs</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">3,931</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">25</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(8</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td style="vertical-align: top; width: 64%; padding-bottom: 4px;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Gross profit</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">94,450</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">112,474</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">101,663</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: top; width: 64%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%;" valign="bottom"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total Assets:</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: top; width: 64%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Physical therapy operations</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">550,181</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">518,027</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">421,474</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: top; width: 64%; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Industrial injury prevention services</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">44,180</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">42,818</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">21,692</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: top; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total Company</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">594,361</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">560,845</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">443,166</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438846607032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Based Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Equity Based Plans [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock', window );">Cumulative Summary of Equity Plans</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">A cumulative summary of equity plans as of December 31, 2020 follows:</div>

<div><br/></div>

<table cellpadding="0" cellspacing="0" id="z0fd35d71f4c741a1afb5a3fdfe7e4755" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/></td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Authorized</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Restricted<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/></span>Stock Issued</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Outstanding<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/></span>Stock Options</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Stock Options<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/></span>Exercised</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Stock Options<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/></span>Exercisable</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Shares Available<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/></span>for Grant</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; white-space: nowrap;" valign="bottom"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Equity Plans</span></div></td>
    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 28%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Amended 1999 Plan</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">600,000</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">416,402</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">139,791</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">7,775</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 28%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Amended 2003 Plan</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,100,000</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,106,977</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">778,300</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">224,760</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 28%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,700,000</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,523,379</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">918,091</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">232,535</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">Restricted Stock Granted and Cancelled</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">During 2020, 2019 and 2018, the Company granted the following shares of restricted stock to directors, officers and employees pursuant to its equity plans as follows:</div>

<div style="text-align: left;"><br/></div>

<table cellpadding="0" cellspacing="0" id="z87259eaa26b8463e9d0de795ce96e698" style="font-family: 'Times New Roman'; font-size: 10pt; border-collapse: collapse; text-align: left; color: #000000; width: 100%; margin-left: auto; margin-right: auto;">
  <tr>
    <td style="width: 33.07%; vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Granted</div></td>
    <td style="width: 0.97%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td style="width: 33.21%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Number of Shares</div></td>
    <td style="width: 1.11%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="2" style="width: 30.43%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Weighted Average Fair<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/></span>Value Per Share</div></td>
    <td style="width: 1.21%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 33.07%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2020</div></td>
    <td style="width: 0.97%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 33.21%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">86,982</div></td>
    <td style="width: 1.11%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 2.36%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 28.07%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">104.69</div></td>
    <td style="width: 1.21%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 33.07%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2019</div></td>
    <td style="width: 0.97%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 33.21%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">91,682</div></td>
    <td style="width: 1.11%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 2.36%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 28.07%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">104.85</div></td>
    <td style="width: 1.21%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 33.07%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2018</div></td>
    <td style="width: 0.97%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 33.21%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">93,801</div></td>
    <td style="width: 1.11%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 2.36%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 28.07%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">78.63</div></td>
    <td style="width: 1.21%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
  </tr>
</table>

<div style="text-align: left;"><br/></div>

<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">During 2020, 2019 and 2018, the following shares were cancelled due to employee terminations prior to restrictions lapsing:</div>

<div style="text-align: left;"><br/></div>

<table cellpadding="0" cellspacing="0" id="z7daa2e54ca844999961717e10e62abe6" style="font-family: 'Times New Roman'; font-size: 10pt; border-collapse: collapse; text-align: left; color: #000000; width: 100%; margin-left: auto; margin-right: auto;">
  <tr>
    <td style="width: 33.06%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Cancelled</div></td>
    <td style="width: 1%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td style="width: 33.04%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Number of Shares</div></td>
    <td style="width: 1.32%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
    <td colspan="2" style="width: 30.36%; vertical-align: bottom; border-bottom: #000000 2px solid; white-space: nowrap;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Weighted Average Fair<span style="font-size: 10pt; font-family: 'Times New Roman';"><br/></span>Value Per Share</div></td>
    <td style="width: 1.22%; vertical-align: bottom; white-space: nowrap;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 33.06%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2020</div></td>
    <td style="width: 1%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 33.04%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">10,037</div></td>
    <td style="width: 1.32%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 2.23%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 28.13%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">102.52</div></td>
    <td style="width: 1.22%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 33.06%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2019</div></td>
    <td style="width: 1%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 33.04%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,578</div></td>
    <td style="width: 1.32%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
    <td style="width: 2.23%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 28.13%; vertical-align: bottom; background-color: #FFFFFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">87.88</div></td>
    <td style="width: 1.22%; vertical-align: bottom; background-color: #FFFFFF;">&#160;</td>
  </tr>
  <tr>
    <td style="width: 33.06%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2018</div></td>
    <td style="width: 1%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 33.04%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">3,867</div></td>
    <td style="width: 1.32%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
    <td style="width: 2.23%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td style="width: 28.13%; vertical-align: bottom; background-color: #CCEEFF;"><div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">59.51</div></td>
    <td style="width: 1.22%; vertical-align: bottom; background-color: #CCEEFF;">&#160;</td>
  </tr>
</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438846279832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Computations of Basic and Diluted Earnings Per Share</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The computations of basic and diluted earnings per share for the years ended December 31, 2020, 2019 and 2018 are as follows (in thousands, except per share data):</div>

<div><br/></div>

<table cellpadding="0" cellspacing="0" id="z70cf1bf066894e77938a1c395afa0aa6" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">
  <tr>
    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="10" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"/></td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2020</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2019</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"><div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31, 2018</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Computation of earnings per share - USPH shareholders:</div></td>
    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Net income attributable to USPH shareholders</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">35,194</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">40,039</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">34,873</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Credit (charges) to retained earnings:</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Revaluation of redeemable non-controlling interest</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(4,632</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(11,893</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(24,770</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div></td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Tax effect at statutory rate (federal and state) of 26.25%</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,216</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">3,121</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">6,502</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">31,778</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">31,267</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">16,605</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Earnings per share (basic and diluted)</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2.48</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2.45</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div></td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1.31</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"><div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Shares used in computation:</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
  <tr>
    <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px;" valign="bottom"><div style="text-align: left; text-indent: -7.2pt; margin-left: 14.4pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Basic and diluted earnings per share - weighted-average shares</div></td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">12,835</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">12,756</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"><div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">12,666</div></td>
    <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom">&#160;</td>
  </tr>
</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438848608136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization, Nature of Operations and Basis of Presentation (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 30, 2020 </div>
<div>Clinic</div>
</th>
<th class="th">
<div>Feb. 27, 2020 </div>
<div>Clinic</div>
</th>
<th class="th">
<div>Apr. 11, 2019 </div>
<div>Location </div>
<div>State</div>
</th>
<th class="th">
<div>Aug. 31, 2018 </div>
<div>Clinic</div>
</th>
<th class="th">
<div>Apr. 30, 2018 </div>
<div>Business</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>Volume </div>
<div>Location </div>
<div>Clinic </div>
<div>State</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>Volume</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>Volume</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>Employee </div>
<div>Volume</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>Installment </div>
<div>Clinic </div>
<div>Location </div>
<div>State </div>
<div>Segment </div>
<div>Facility</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>Clinic</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 02, 2020 </div>
<div>Employee</div>
</th>
<th class="th"><div>Mar. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Change Due to Net Income Attributable to Parent and Effects of Changes, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageOfGeneralPartnershipInterestOwned', window );">Percentage of general partnership interest owned</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfClinicsOperated', window );">Number of clinics operated | Clinic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStatesInWhichEntityOperates', window );">Number of states where clinics are operated | State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfThirdPartyFacilities', window );">Number of third party facilities | Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of businesses acquired | Clinic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfClinicsOperatesAsASatelliteClinicWithExistingPartnerships', window );">Number of clinics that operate as a satellite clinic with existing partnerships | Clinic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfClosedClinicsSold', window );">Number of closed clinics sold | Clinic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_AggregateSalePriceOfCinics', window );">Aggregate sale price of clinics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_CashReceivedRelatedToSaleOfClinics', window );">Cash received related to sale of closed clinics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NoteReceivableRelatedToSaleOfClinics', window );">Note receivable related to sale of closed clinics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration', window );">Number of installments for note receivable | Installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_AveragePhysicalTherapyPatientsVolumesPerDayPerClinic', window );">Average physical therapy patient volumes per day per clinic | Volume</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27.7<span></span>
</td>
<td class="nump">25.8<span></span>
</td>
<td class="nump">18.9<span></span>
</td>
<td class="nump">26.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageOfEmployeesFurloughedOrTerminated', window );">Percentage of employees furloughed or terminated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityNumberOfEmployees', window );">Number of full and part-time workforce | Employee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfFurloughedEmployeesReturned', window );">Number of furloughed employees returned | Employee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ReliefFunds', window );">Relief funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,501<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemAxis=usph_MedicareAcceleratedAndAdvancePaymentsProgramMember', window );">Medicare Accelerated and Advance Payments Program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Change Due to Net Income Attributable to Parent and Effects of Changes, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_CashAndCashEquivalentsAndAccruedLiabilities', window );">Cash and cash equivalents and accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemAxis=usph_PublicHealthAndSocialServicesEmergencyFundMember', window );">Public Health and Social Services Emergency Fund [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Change Due to Net Income Attributable to Parent and Effects of Changes, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_GrantsAndOtherFunds', window );">Grants and other funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrantsReceivable', window );">Funds received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ReliefFunds', window );">Relief funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Change Due to Net Income Attributable to Parent and Effects of Changes, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageOfLimitedPartnershipInterestOwned', window );">Percentage of limited partnership interest owned</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Change Due to Net Income Attributable to Parent and Effects of Changes, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageOfLimitedPartnershipInterestOwned', window );">Percentage of limited partnership interest owned</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfOperatingClinicLocations', window );">Number of operating clinic locations | Location</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_ClinicPracticeMember', window );">Clinic Practice [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Change Due to Net Income Attributable to Parent and Effects of Changes, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of businesses acquired | Clinic</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="nump">75.00%<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_ClinicPracticeMember', window );">Clinic Practice [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Change Due to Net Income Attributable to Parent and Effects of Changes, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_ClinicPracticeMember', window );">Clinic Practice [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Change Due to Net Income Attributable to Parent and Effects of Changes, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_LeadingProviderOfIndustrialInjuryPreventionMember', window );">IIPS [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Change Due to Net Income Attributable to Parent and Effects of Changes, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfBusinessesMerged', window );">Number of businesses merged | Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageOfCombinedBusinessInterestOwned', window );">Percentage of combined business interest owned</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfStatesOfNetworkServices', window );">Number of states of network services | State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfOnsiteClientLocations', window );">Number of onsite client locations | Location</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_ManagementContractsMember', window );">Management Contracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Change Due to Net Income Attributable to Parent and Effects of Changes, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_AprilTwoThousandNineteenAcquisitionMember', window );">April 2019 Acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Change Due to Net Income Attributable to Parent and Effects of Changes, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfStatesOfNetworkServices', window );">Number of states of network services | State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfOnsiteClientLocations', window );">Number of onsite client locations | Location</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityNumberOfEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of persons employed by the Entity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityNumberOfEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrantsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrantsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfBusinessesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of businesses acquired by the entity during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfBusinessesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfStatesInWhichEntityOperates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of states the entity operates in as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfStatesInWhichEntityOperates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_AggregateSalePriceOfCinics">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale price of the clinics sold which were discontinued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_AggregateSalePriceOfCinics</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_AveragePhysicalTherapyPatientsVolumesPerDayPerClinic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of physical therapy patient volumes per day per clinic</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_AveragePhysicalTherapyPatientsVolumesPerDayPerClinic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_CashAndCashEquivalentsAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and Cash and cash equivalents and accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_CashAndCashEquivalentsAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_CashReceivedRelatedToSaleOfClinics">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received related to sale of discontinued clinics.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_CashReceivedRelatedToSaleOfClinics</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_GrantsAndOtherFunds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts due under the terms of grants and other funds.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_GrantsAndOtherFunds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NoteReceivableRelatedToSaleOfClinics">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Note receivable related to sale of discontinued clinics</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NoteReceivableRelatedToSaleOfClinics</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NumberOfBusinessesMerged">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of businesses merged during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NumberOfBusinessesMerged</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NumberOfClinicsOperated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of clinics operated during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NumberOfClinicsOperated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NumberOfClinicsOperatesAsASatelliteClinicWithExistingPartnerships">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of clinics operates as a satellite clinic with existing partnerships during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NumberOfClinicsOperatesAsASatelliteClinicWithExistingPartnerships</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NumberOfClosedClinicsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of closed clinics sold during the period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NumberOfClosedClinicsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NumberOfFurloughedEmployeesReturned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of furloughed employees returned to work.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NumberOfFurloughedEmployeesReturned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of installments for note receivable in sale consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NumberOfOnsiteClientLocations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of client locations that included in total operated states that are providing industrial injury prevention services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NumberOfOnsiteClientLocations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NumberOfOperatingClinicLocations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating clinic locations during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NumberOfOperatingClinicLocations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NumberOfStatesOfNetworkServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents number of states of network services provided by the company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NumberOfStatesOfNetworkServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NumberOfThirdPartyFacilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of third party facilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NumberOfThirdPartyFacilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PercentageOfCombinedBusinessInterestOwned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of combined business interest owned during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PercentageOfCombinedBusinessInterestOwned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PercentageOfEmployeesFurloughedOrTerminated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of employees furloughed or terminated due to pandemic.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PercentageOfEmployeesFurloughedOrTerminated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PercentageOfGeneralPartnershipInterestOwned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of general partnership interest owned during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PercentageOfGeneralPartnershipInterestOwned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PercentageOfLimitedPartnershipInterestOwned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of limited partnership interest owned during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PercentageOfLimitedPartnershipInterestOwned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ReliefFunds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Relief funds relates to social welfare, a fund of money set up to provide aid for people in need, especially in disaster areas.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ReliefFunds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemAxis=usph_MedicareAcceleratedAndAdvancePaymentsProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemAxis=usph_MedicareAcceleratedAndAdvancePaymentsProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemAxis=usph_PublicHealthAndSocialServicesEmergencyFundMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemAxis=usph_PublicHealthAndSocialServicesEmergencyFundMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_ClinicPracticeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_ClinicPracticeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_LeadingProviderOfIndustrialInjuryPreventionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_LeadingProviderOfIndustrialInjuryPreventionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_ManagementContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_ManagementContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_AprilTwoThousandNineteenAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_AprilTwoThousandNineteenAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438850917848">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Organization, Nature of Operations and Basis of Presentation - Acquisition (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Nov. 30, 2020 </div>
<div>Clinic</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>Contract </div>
<div>Clinic</div>
</th>
<th class="th" colspan="2">
<div>Feb. 27, 2020 </div>
<div>Partnership </div>
<div>Clinic</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>Clinic</div>
</th>
<th class="th">
<div>Aug. 31, 2018 </div>
<div>Clinic</div>
</th>
<th class="th" colspan="2">
<div>Dec. 31, 2020 </div>
<div>Clinic </div>
<div>Partnership</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>Partnership </div>
<div>Clinic</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfPartnershipInWhichInterestAcquired', window );">Number of partnerships | Partnership</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_NovemberTwoThousandTwentyAcquisitionMember', window );">November 2020 Acquisition [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1', window );">Acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov. 30,  2020<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_SeptemberTwoThousandTwentyAcquisitionMember', window );">September 2020 Acquisition [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1', window );">Acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep. 30,  2020<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_FebruaryTwoThousandTwentyAcquisitionMember', window );">February 2020 Acquisition [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1', window );">Acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Feb. 27,  2020<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_SeptemberTwoThousandNineteenAcquisitionMember', window );">September 2019 Acquisition [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1', window );">Acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep. 30,  2019<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">67.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_August2018AcquisitionMember', window );">August 2018 Acquisition [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1', window );">Acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 31,  2018<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_ManagementContractsMember', window );">Management Contracts [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfManagementContracts', window );">Number of management contracts | Contract</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RemainingContractTerm', window );">Remaining contract term</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_ClinicPracticeMember', window );">Clinic Practice [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfPartnershipInWhichInterestAcquired', window );">Number of partnerships | Partnership</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_ClinicPracticeMember', window );">Clinic Practice [Member] | Minimum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_ClinicPracticeMember', window );">Clinic Practice [Member] | Maximum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83.80%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="10"></td></tr>
<tr><td colspan="10"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The business includes six management and services contracts which had a remaining term of approximately five years as of the date acquired.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">The four clinics are in four separate partnerships. The Company's interest in the four partnerships range from 10.0% to 83.8%, with an overall 65.0% based on the initial purchase transaction.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">The four clinics are in four separate partnerships.&#160; The Company's interest in the four partnerships range from 10.0% to 83.8%, with an overall 65.0% based on the initial purchase transaction.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the business acquisition agreement was executed, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDescriptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDescriptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfBusinessesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of businesses acquired by the entity during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfBusinessesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NumberOfManagementContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of management contracts during period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NumberOfManagementContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NumberOfPartnershipInWhichInterestAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of partnership in which interest acquired during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NumberOfPartnershipInWhichInterestAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_RemainingContractTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining term of contract, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_RemainingContractTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_NovemberTwoThousandTwentyAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_NovemberTwoThousandTwentyAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_SeptemberTwoThousandTwentyAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_SeptemberTwoThousandTwentyAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_FebruaryTwoThousandTwentyAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_FebruaryTwoThousandTwentyAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_SeptemberTwoThousandNineteenAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_SeptemberTwoThousandNineteenAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_August2018AcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_August2018AcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_ManagementContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_ManagementContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_ClinicPracticeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_ClinicPracticeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438841131464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 29, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Dec. 27, 2020</div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>Segment </div>
<div>Region</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>Region</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($) </div>
<div>Region</div>
</th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Feb. 09, 2018</div></th>
<th class="th"><div>Nov. 02, 2015</div></th>
<th class="th"><div>Apr. 01, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue Recognition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue related to the various categories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 422,969,000<span></span>
</td>
<td class="nump">$ 481,969,000<span></span>
</td>
<td class="nump">$ 453,911,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationGoodwillAbstract', window );"><strong>Goodwill [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of business segments | Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfRegions', window );">Number of regions | Region</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Write-off of goodwill - closed clinics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,859,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_MedicareReimbursementAbstract', window );"><strong>Medicare Reimbursement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_EstimatedPercentageOfDecreaseInPayment', window );">Estimated percentage of decrease in payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions', window );">Federal debt ceiling in connection with deficit reductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_AmountOfReductionsInFederalSpending', window );">Reductions in federal spending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ReductionInMedicareSpendingPercentage', window );">Medicare spending cut percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ExpectedReductionInMedicareSpendingPercentage', window );">Expected reduction in Medicare spending percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses', window );">Combined physical therapy/speech language pathology expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses', window );">Reduction in combined physical therapy/speech language pathology expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit', window );">Percentage of practice expense component</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings', window );">Percentage reduction for service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageOfPaymentForOutpatientTherapyServices', window );">Percentage of payment for outpatient therapy services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NetRevenueFromMedicare', window );">Net patient revenue from Medicare accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 101,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Accrued interest and penalties associated with any unrecognized tax benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations', window );">Interest expense recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Recently Adopted Accounting Guidance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,595,000<span></span>
</td>
<td class="nump">81,586,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 89,497,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=usph_CreditAgreementMember', window );">Credit Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Event [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Revolving credit facility maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov. 30,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=usph_CreditAgreementMember', window );">Credit Agreement [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Event [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Revolving credit facility commitment</a></td>
<td class="nump">$ 125,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Revolving credit facility maturity date</a></td>
<td class="text">Nov. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate amount of notes payable</a></td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_MedicareReimbursementAbstract', window );"><strong>Medicare Reimbursement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ExpectedReductionInMedicareSpendingPercentage', window );">Expected reduction in Medicare spending percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member', window );">ASU 2016-02 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Recently Adopted Accounting Guidance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 78,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 82,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemAxis=usph_Year2018Member', window );">Year 2018 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_MedicareReimbursementAbstract', window );"><strong>Medicare Reimbursement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageOfMedicarePaymentIncrease', window );">Percentage of increase in Medicare payment rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemAxis=usph_Year2019Member', window );">Year 2019 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_MedicareReimbursementAbstract', window );"><strong>Medicare Reimbursement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageOfMedicarePaymentIncrease', window );">Percentage of increase in Medicare payment rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemAxis=usph_FromTwoThousandNineteenThroughTwoThousandTwentyFourMember', window );">From 2019 through 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_MedicareReimbursementAbstract', window );"><strong>Medicare Reimbursement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageOfBonusPayment', window );">Percentage of bonus payment by APM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemAxis=usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember', window );">From 2020 through 2025 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_MedicareReimbursementAbstract', window );"><strong>Medicare Reimbursement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageOfMedicarePaymentIncrease', window );">Percentage of increase in Medicare payment rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=usph_EmployeeMember', window );">Employee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementsAbstract', window );"><strong>Restricted Stock [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1', window );">Period in which restrictions lapse on stock granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_DirectorMember', window );">Director [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementsAbstract', window );"><strong>Restricted Stock [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1', window );">Period in which restrictions lapse on stock granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_OfficerMember', window );">Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementsAbstract', window );"><strong>Restricted Stock [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1', window );">Period in which restrictions lapse on stock granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NonControllingInterestRedeemableAbstract', window );"><strong>Redeemable Non-Controlling Interests [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod', window );">Redeemable non-controlling interest, redemption rights, commencement period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_MedicareReimbursementAbstract', window );"><strong>Medicare Reimbursement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues', window );">Difference between net revenues and corresponding cash collections, approximately of net revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage', window );">Difference between actual aggregate contractual reserve and estimated contractual allowance reserve percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_MaximumContractualAllowanceReserveEstimate', window );">Maximum contractual allowance reserve estimate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Furniture &amp; Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Long-Lived Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Long-Lived Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Long-Lived Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NonControllingInterestRedeemableAbstract', window );"><strong>Redeemable Non-Controlling Interests [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod', window );">Redeemable non-controlling interest, redemption rights, commencement period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_MedicareReimbursementAbstract', window );"><strong>Medicare Reimbursement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues', window );">Difference between net revenues and corresponding cash collections, approximately of net revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage', window );">Difference between actual aggregate contractual reserve and estimated contractual allowance reserve percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_MaximumContractualAllowanceReserveEstimate', window );">Maximum contractual allowance reserve estimate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Year 2017 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_MedicareReimbursementAbstract', window );"><strong>Medicare Reimbursement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices', window );">Annual limit on physical therapy and speech language pathology services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,980<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_AnnualLimitOccupationalTherapyServices', window );">Annual limit occupational therapy services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,980<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Furniture &amp; Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Long-Lived Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Long-Lived Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Long-Lived Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=usph_NetPatientRevenuesMember', window );">Net Patient Revenues [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue Recognition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue related to the various categories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 373,340,000<span></span>
</td>
<td class="nump">433,345,000<span></span>
</td>
<td class="nump">417,703,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=usph_ManagementContractRevenuesMember', window );">Management Contract Revenues [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue Recognition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue related to the various categories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,410,000<span></span>
</td>
<td class="nump">8,676,000<span></span>
</td>
<td class="nump">8,339,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=usph_OtherRevenuesMember', window );">Other Revenues [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue Recognition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue related to the various categories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,020,000<span></span>
</td>
<td class="nump">2,486,000<span></span>
</td>
<td class="nump">2,403,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=usph_PhysicalTherapyOperationsMember', window );">Physical Therapy Operations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue Recognition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue related to the various categories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">383,770,000<span></span>
</td>
<td class="nump">444,507,000<span></span>
</td>
<td class="nump">428,445,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=usph_IndustrialInjuryPreventionServicesRevenuesMember', window );">Industrial Injury Prevention Services Revenues [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue Recognition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue related to the various categories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39,199,000<span></span>
</td>
<td class="nump">$ 37,462,000<span></span>
</td>
<td class="nump">$ 25,466,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum period the individual is required to perform services to be fully vested under the deferred compensation arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -SubTopic 10<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=6409961&amp;loc=d3e20487-108367<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of interest expense on prepetition obligations included in the statement of operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=116635682&amp;loc=d3e55733-112764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_AmountOfReductionsInFederalSpending">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of reductions in federal spending during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_AmountOfReductionsInFederalSpending</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_AnnualLimitOccupationalTherapyServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Annual Limit occupational therapy services during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_AnnualLimitOccupationalTherapyServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Annual Limit on physical therapy and speech language pathology services during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Combined physical therapy/speech language pathology expenses during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum difference between actual aggregate contractual reserve percentage as compared to estimated contractual allowance reserve percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between net revenues and corresponding cash collections reflected percentage of net revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_EstimatedPercentageOfDecreaseInPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimated percentage of decrease in payment during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_EstimatedPercentageOfDecreaseInPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ExpectedReductionInMedicareSpendingPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected reduction in Medicare spending percentage during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ExpectedReductionInMedicareSpendingPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_MaximumContractualAllowanceReserveEstimate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum contractual allowance reserve estimate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_MaximumContractualAllowanceReserveEstimate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_MedicareReimbursementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_MedicareReimbursementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NetRevenueFromMedicare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net revenue from Medicare.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NetRevenueFromMedicare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NonControllingInterestRedeemableAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NonControllingInterestRedeemableAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NumberOfRegions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of regions of the entity operates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NumberOfRegions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PercentageOfBonusPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to percentage of bonus payment proposed by the agency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PercentageOfBonusPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PercentageOfMedicarePaymentIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of Medicare payment increase during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PercentageOfMedicarePaymentIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PercentageOfPaymentForOutpatientTherapyServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to the percentage of payment for outpatient therapy services to the therapy assistant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PercentageOfPaymentForOutpatientTherapyServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of practice expense component of relative value unit during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage reduction for service in office or other non institutional settings during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the period of federal debt ceiling in connection with deficit reductions, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to the commencement period of redemption rights for redeemable non controlling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reduction in Combined physical therapy/speech language pathology expenses during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ReductionInMedicareSpendingPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reduction in Medicare spending percentage during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ReductionInMedicareSpendingPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=usph_CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=usph_CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemAxis=usph_Year2018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemAxis=usph_Year2018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemAxis=usph_Year2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemAxis=usph_Year2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemAxis=usph_FromTwoThousandNineteenThroughTwoThousandTwentyFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemAxis=usph_FromTwoThousandNineteenThroughTwoThousandTwentyFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemAxis=usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemAxis=usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=usph_EmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=usph_EmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_OfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_OfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerSoftwareIntangibleAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerSoftwareIntangibleAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemAxis=usph_Year2017Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemAxis=usph_Year2017Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=usph_NetPatientRevenuesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=usph_NetPatientRevenuesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=usph_ManagementContractRevenuesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=usph_ManagementContractRevenuesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=usph_OtherRevenuesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=usph_OtherRevenuesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=usph_PhysicalTherapyOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=usph_PhysicalTherapyOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=usph_IndustrialInjuryPreventionServicesRevenuesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=usph_IndustrialInjuryPreventionServicesRevenuesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438830648968">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Acquisitions of Businesses (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 30, 2020 </div>
<div>USD ($) </div>
<div>Clinic </div>
<div>Installment</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>Contract </div>
<div>Clinic</div>
</th>
<th class="th" colspan="2">
<div>Feb. 27, 2020 </div>
<div>USD ($) </div>
<div>Partnership </div>
<div>Clinic</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($) </div>
<div>Clinic </div>
<div>Installment</div>
</th>
<th class="th" colspan="2">
<div>Apr. 11, 2019 </div>
<div>USD ($) </div>
<div>Location </div>
<div>State</div>
</th>
<th class="th">
<div>Aug. 31, 2018 </div>
<div>USD ($) </div>
<div>Clinic </div>
<div>Installment</div>
</th>
<th class="th">
<div>Apr. 30, 2018 </div>
<div>USD ($) </div>
<div>Business</div>
</th>
<th class="th" colspan="2">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>Clinic </div>
<div>Partnership</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>Partnership </div>
<div>Clinic</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($) </div>
<div>Clinic</div>
</th>
<th class="th"><div>Mar. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics | Clinic</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfPartnershipInWhichInterestAcquired', window );">Number of partnerships in which interest acquired | Partnership</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid, net of cash acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,367,000<span></span>
</td>
<td class="nump">$ 23,907,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 30,597,000<span></span>
</td>
<td class="nump">$ 16,367,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued', window );">Seller notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">950,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PaymentsToAcquireBusinessesConsideration', window );">Total consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,317,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract', window );"><strong>Estimated fair value of net tangible assets acquired [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Total current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,633,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets', window );">Total non-current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">305,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Total liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(525,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset', window );">Net tangible assets acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,413,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships', window );">Referral relationships</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,926,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements', window );">Non-compete</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">298,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename', window );">Tradename</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">990,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,835,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests', window );">Fair value of non-controlling interest (classified as redeemable non-controlling interests)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,145,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PaymentsToAcquireBusinessesConsideration', window );">Total consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,317,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Net of cash acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 372,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 890,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=usph_ReferralRelationshipMember', window );">Referral Relationships [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract', window );"><strong>Estimated fair value of net tangible assets acquired [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful lives of acquired intangibles</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">11 years<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">10 years 6 months 14 days<span></span>
</td>
<td class="text">10 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete Agreements [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract', window );"><strong>Estimated fair value of net tangible assets acquired [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful lives of acquired intangibles</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">6 years<span></span>
</td>
<td class="text">5 years 1 month 28 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=usph_PhysicalTherapyOperationsMember', window );">Physical Therapy Operations [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid, net of cash acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 12,170,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPayableToShareholdersOfSeller', window );">Payable to shareholders of seller</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued', window );">Seller notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PaymentsToAcquireBusinessesConsideration', window );">Total consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">12,470,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract', window );"><strong>Estimated fair value of net tangible assets acquired [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Total current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">650,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets', window );">Total non-current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">394,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Total liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(191,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset', window );">Net tangible assets acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">853,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships', window );">Referral relationships</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements', window );">Non-compete</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">270,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename', window );">Tradename</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">740,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">14,237,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests', window );">Fair value of non-controlling interest (classified as redeemable non-controlling interests)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(6,230,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PaymentsToAcquireBusinessesConsideration', window );">Total consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 12,470,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_NovemberTwoThousandTwentyAcquisitionMember', window );">November 2020 Acquisition [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1', window );">Acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov. 30,  2020<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics | Clinic</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_SeptemberTwoThousandTwentyAcquisitionMember', window );">September 2020 Acquisition [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1', window );">Acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep. 30,  2020<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics | Clinic</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_FebruaryTwoThousandTwentyAcquisitionMember', window );">February 2020 Acquisition [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1', window );">Acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Feb. 27,  2020<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics | Clinic</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_SeptemberTwoThousandNineteenAcquisitionMember', window );">September 2019 Acquisition [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1', window );">Acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep. 30,  2019<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">67.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics | Clinic</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Aggregate purchase price for the acquired clinic practices</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 12,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid for acquisition of interest in clinic</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 12,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration', window );">Number of installments | Installment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Percentage of interest accrued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid, net of cash acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 12,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued', window );">Seller notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract', window );"><strong>Estimated fair value of net tangible assets acquired [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Net of cash acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_SeptemberTwoThousandNineteenAcquisitionMember', window );">September 2019 Acquisition [Member] | September 2020 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid for acquisition of interest in clinic</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_SeptemberTwoThousandNineteenAcquisitionMember', window );">September 2019 Acquisition [Member] | September 2021 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid for acquisition of interest in clinic</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_August2018AcquisitionMember', window );">August 2018 Acquisition [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1', window );">Acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 31,  2018<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics | Clinic</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid for acquisition of interest in clinic</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 7,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration', window );">Number of installments | Installment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued', window );">Seller notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_August2018AcquisitionMember', window );">August 2018 Acquisition [Member] | August 2019 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAnnualPrincipalPayment', window );">Principal installments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_August2018AcquisitionMember', window );">August 2018 Acquisition [Member] | August 2020 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAnnualPrincipalPayment', window );">Principal installments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_ManagementAndServicesContractsMember', window );">Management and Services Contracts [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfManagementContracts', window );">Number of management contracts | Contract</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RemainingContractTerm', window );">Remaining contract term</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_ManagementContractsMember', window );">Management Contracts [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfManagementContracts', window );">Number of management contracts | Contract</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RemainingContractTerm', window );">Remaining contract term</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Aggregate purchase price for the acquired clinic practices</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid for acquisition of interest in clinic</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued', window );">Seller notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_ManagementContractsMember', window );">Management Contracts [Member] | Notes Payable One [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Percentage of interest accrued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued', window );">Seller notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_ManagementContractsMember', window );">Management Contracts [Member] | Notes Payable Two [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued', window );">Seller notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember', window );">Acquisitions [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid, net of cash acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 30,598,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPayableToShareholdersOfSeller', window );">Payable to shareholders of seller</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">485,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued', window );">Seller notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PaymentsToAcquireBusinessesConsideration', window );">Total consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">35,383,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract', window );"><strong>Estimated fair value of net tangible assets acquired [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Total current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,291,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets', window );">Total non-current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,242,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Total liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3,169,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset', window );">Net tangible assets acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">364,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships', window );">Referral relationships</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements', window );">Non-compete</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">520,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename', window );">Tradename</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,040,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">32,689,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests', window );">Fair value of non-controlling interest (classified as redeemable non-controlling interests)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(6,230,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PaymentsToAcquireBusinessesConsideration', window );">Total consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 35,383,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember', window );">Acquisitions [Member] | Physical Therapy Operations [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid, net of cash acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,907,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued', window );">Seller notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,121,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PaymentsToAcquireBusinessesConsideration', window );">Total consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,028,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract', window );"><strong>Estimated fair value of net tangible assets acquired [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Total current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,271,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets', window );">Total non-current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Total liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(555,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset', window );">Net tangible assets acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">850,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships', window );">Referral relationships</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,597,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements', window );">Non-compete</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,012,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename', window );">Tradename</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,326,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,540,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests', window );">Fair value of non-controlling interest (classified as redeemable non-controlling interests)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,297,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PaymentsToAcquireBusinessesConsideration', window );">Total consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,028,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Net of cash acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_AprilTwoThousandNineteenAcquisitionMember', window );">April 2019 Acquisition [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Aggregate purchase price for the acquired clinic practices</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,600,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid for acquisition of interest in clinic</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,900,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Percentage of interest accrued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.50%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid, net of cash acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,900,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPayableToShareholdersOfSeller', window );">Payable to shareholders of seller</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued', window );">Seller notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000,000.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract', window );"><strong>Estimated fair value of net tangible assets acquired [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Net of cash acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfStatesOfNetworkServices', window );">Number of states of network services | State</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfOnsiteClientLocations', window );">Number of onsite client locations | Location</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_LeadingProviderOfIndustrialInjuryPreventionMember', window );">IIPS [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid for acquisition of interest in clinic</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid, net of cash acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,428,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPayableToShareholdersOfSeller', window );">Payable to shareholders of seller</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">485,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued', window );">Seller notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PaymentsToAcquireBusinessesConsideration', window );">Total consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,913,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract', window );"><strong>Estimated fair value of net tangible assets acquired [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Total current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,641,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets', window );">Total non-current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">848,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Total liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,978,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset', window );">Net tangible assets acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(489,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships', window );">Referral relationships</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,400,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements', window );">Non-compete</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename', window );">Tradename</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,452,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests', window );">Fair value of non-controlling interest (classified as redeemable non-controlling interests)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PaymentsToAcquireBusinessesConsideration', window );">Total consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,913,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfStatesOfNetworkServices', window );">Number of states of network services | State</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfOnsiteClientLocations', window );">Number of onsite client locations | Location</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfBusinessesMerged', window );">Number of businesses merged | Business</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageOfCombinedBusinessInterestOwned', window );">Percentage of combined business interest owned</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_ClinicPracticeMember', window );">Clinic Practice [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics | Clinic</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfPartnershipInWhichInterestAcquired', window );">Number of partnerships in which interest acquired | Partnership</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Aggregate purchase price for the acquired clinic practices</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 9,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,300,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid for acquisition of interest in clinic</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 8,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,900,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration', window );">Number of installments | Installment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAnnualPrincipalPayment', window );">Principal installments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 162,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Percentage of interest accrued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.75%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued', window );">Seller notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_ClinicPracticeMember', window );">Clinic Practice [Member] | Minimum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_ClinicPracticeMember', window );">Clinic Practice [Member] | Maximum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83.80%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_AcquisitionOfFiveClinicPracticesMember', window );">Acquisition of Five Clinic Practices [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics | Clinic</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Aggregate purchase price for the acquired clinic practices</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 850,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid for acquisition of interest in clinic</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued', window );">Seller notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_AcquisitionOfFiveClinicPracticesMember', window );">Acquisition of Five Clinic Practices [Member] | August 2019 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Percentage of interest accrued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="15"></td></tr>
<tr><td colspan="15"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The business includes six management and services contracts which had a remaining term of approximately five years as of the date acquired.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">The four clinics are in four separate partnerships. The Company's interest in the four partnerships range from 10.0% to 83.8%, with an overall 65.0% based on the initial purchase transaction.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">The four clinics are in four separate partnerships.&#160; The Company's interest in the four partnerships range from 10.0% to 83.8%, with an overall 65.0% based on the initial purchase transaction.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">Industrial injury prevention services</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the business acquisition agreement was executed, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDescriptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDescriptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAnnualPrincipalPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the total principal payments made during the annual reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAnnualPrincipalPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfBusinessesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of businesses acquired by the entity during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfBusinessesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of business acquisition cost of acquired entity debt issued on the date of acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business acquisition number of installments for payment of purchase consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessAcquisitionPayableToShareholdersOfSeller">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount payable to shareholders of seller in business acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessAcquisitionPayableToShareholdersOfSeller</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net tangible asset acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of acquired finite-lived intangible assets in business combination, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the fair value of the redeemable noncontrolling interest in the acquiree at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-competition agreements recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of referral relationships at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of tradename recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NumberOfBusinessesMerged">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of businesses merged during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NumberOfBusinessesMerged</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NumberOfManagementContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of management contracts during period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NumberOfManagementContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NumberOfOnsiteClientLocations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of client locations that included in total operated states that are providing industrial injury prevention services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NumberOfOnsiteClientLocations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NumberOfPartnershipInWhichInterestAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of partnership in which interest acquired during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NumberOfPartnershipInWhichInterestAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NumberOfStatesOfNetworkServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents number of states of network services provided by the company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NumberOfStatesOfNetworkServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PaymentsToAcquireBusinessesConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments to acquire businesses total consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PaymentsToAcquireBusinessesConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PercentageOfCombinedBusinessInterestOwned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of combined business interest owned during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PercentageOfCombinedBusinessInterestOwned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_RemainingContractTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining term of contract, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_RemainingContractTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=usph_ReferralRelationshipMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=usph_ReferralRelationshipMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=usph_PhysicalTherapyOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=usph_PhysicalTherapyOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_NovemberTwoThousandTwentyAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_NovemberTwoThousandTwentyAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_SeptemberTwoThousandTwentyAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_SeptemberTwoThousandTwentyAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_FebruaryTwoThousandTwentyAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_FebruaryTwoThousandTwentyAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_SeptemberTwoThousandNineteenAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_SeptemberTwoThousandNineteenAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=usph_SeptemberTwoThousandTwentyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=usph_SeptemberTwoThousandTwentyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=usph_SeptemberTwoThousandTwentyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=usph_SeptemberTwoThousandTwentyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_August2018AcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_August2018AcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=usph_AugustTwoThousandNineteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=usph_AugustTwoThousandNineteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=usph_AugustTwoThousandTwentyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=usph_AugustTwoThousandTwentyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_ManagementAndServicesContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_ManagementAndServicesContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_ManagementContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_ManagementContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=usph_NotesPayableOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=usph_NotesPayableOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=usph_NotesPayableTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=usph_NotesPayableTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_AprilTwoThousandNineteenAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_AprilTwoThousandNineteenAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_LeadingProviderOfIndustrialInjuryPreventionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_LeadingProviderOfIndustrialInjuryPreventionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_ClinicPracticeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_ClinicPracticeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_AcquisitionOfFiveClinicPracticesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_AcquisitionOfFiveClinicPracticesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438843815016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Sale of Non-Controlling Interests (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>Clinic </div>
<div>Partnership </div>
<div>Installment</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>Partnership</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfPartnershipInWhichInterestAcquired', window );">Number of partnerships in which interest acquired | Partnership</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent', window );">Purchase price for additional non controlling interest</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent', window );">Cash proceeds from sale of non-controlling interest</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfClosedClinicsSold', window );">Number of closed clinics sold | Clinic</a></td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_AggregateSalePriceOfCinics', window );">Aggregate sale price of clinics</a></td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_CashReceivedRelatedToSaleOfClinics', window );">Cash received related to sale of closed clinics</a></td>
<td class="nump">700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NoteReceivableRelatedToSaleOfClinics', window );">Note receivable related to sale of closed clinics</a></td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration', window );">Number of installments for note receivable | Installment</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_SaleOfNoncontrollingInterestPercentageInPartnershipOne', window );">Sale of non-controlling interest percentage in partnership one</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_TaxEffectOnSaleOfNoncontrollingInterest', window );">Tax effect on sale price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 196,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDescriptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDescriptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the purchase by the parent of an additional equity interest in a subsidiary during the period, thereby effecting a change in total (consolidated) equity attributable to the parent. The purchase of the additional equity interest represented by this element increases the parent's controlling interest in the subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4M<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591554-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents a sale by the parent of a portion of its equity interest in a subsidiary during the period, thereby effecting a change in total (consolidated) equity attributable to the parent. The sale of the equity interest represented by this element does not result in a loss of control by the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4M<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591554-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_AggregateSalePriceOfCinics">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale price of the clinics sold which were discontinued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_AggregateSalePriceOfCinics</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_CashReceivedRelatedToSaleOfClinics">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received related to sale of discontinued clinics.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_CashReceivedRelatedToSaleOfClinics</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NoteReceivableRelatedToSaleOfClinics">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Note receivable related to sale of discontinued clinics</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NoteReceivableRelatedToSaleOfClinics</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NumberOfClosedClinicsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of closed clinics sold during the period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NumberOfClosedClinicsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of installments for note receivable in sale consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NumberOfPartnershipInWhichInterestAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of partnership in which interest acquired during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NumberOfPartnershipInWhichInterestAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_SaleOfNoncontrollingInterestPercentageInPartnershipOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to noncontrolling percentage sold by an entity during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_SaleOfNoncontrollingInterestPercentageInPartnershipOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_TaxEffectOnSaleOfNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to amount of tax effected on noncontrolling interest sale price during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_TaxEffectOnSaleOfNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438929002824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Non-Controlling Interest (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmountAbstract', window );"><strong>Changes in Carrying Amount (Fair Value) of Redeemable Non-Controlling Interests [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Beginning balance</a></td>
<td class="nump">$ 137,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity', window );">Operating results allocated to redeemable non-controlling interest partners</a></td>
<td class="nump">11,175<span></span>
</td>
<td class="nump">$ 10,659<span></span>
</td>
<td class="nump">$ 8,433<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Ending balance</a></td>
<td class="nump">132,340<span></span>
</td>
<td class="nump">137,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_CarryingAmountOfRedeemableNonControllingInterestAbstract', window );"><strong>Carrying Amount (Fair Value) of Redeemable Non-Controlling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable non-controlling interests</a></td>
<td class="nump">137,750<span></span>
</td>
<td class="nump">137,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 132,340<span></span>
</td>
<td class="nump">$ 137,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=usph_RedeemableNonControllingInterestMember', window );">Redeemable Non-Controlling Interest [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmountAbstract', window );"><strong>Changes in Carrying Amount (Fair Value) of Redeemable Non-Controlling Interests [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Beginning balance</a></td>
<td class="nump">137,750<span></span>
</td>
<td class="nump">133,943<span></span>
</td>
<td class="nump">102,572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity', window );">Operating results allocated to redeemable non-controlling interest partners</a></td>
<td class="nump">11,175<span></span>
</td>
<td class="nump">10,659<span></span>
</td>
<td class="nump">8,433<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests', window );">Distributions to redeemable non-controlling interest partners</a></td>
<td class="num">(12,403)<span></span>
</td>
<td class="num">(10,221)<span></span>
</td>
<td class="num">(9,835)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestChangeInRedemptionValue', window );">Changes in the fair value of redeemable non-controlling interest</a></td>
<td class="nump">4,632<span></span>
</td>
<td class="nump">11,893<span></span>
</td>
<td class="nump">24,770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsToMinorityShareholders', window );">Purchases of redeemable non-controlling interest</a></td>
<td class="num">(20,521)<span></span>
</td>
<td class="num">(8,934)<span></span>
</td>
<td class="nump">8,145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Acquired interest</a></td>
<td class="nump">11,297<span></span>
</td>
<td class="nump">6,230<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation', window );">Reduction of non-controlling interest due to sale of USPH partnership interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(6,132)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity', window );">Sales of redeemable non-controlling interest - temporary equity</a></td>
<td class="nump">1,133<span></span>
</td>
<td class="nump">3,120<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity', window );">Notes receivable related to sales of redeemable non-controlling interest - temporary equity</a></td>
<td class="num">(1,006)<span></span>
</td>
<td class="num">(2,870)<span></span>
</td>
<td class="num">(142)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity', window );">Adjustments in notes receivable related to the sales of redeemable non-controlling interest - temporary equity</a></td>
<td class="nump">283<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Ending balance</a></td>
<td class="nump">132,340<span></span>
</td>
<td class="nump">137,750<span></span>
</td>
<td class="nump">133,943<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_CarryingAmountOfRedeemableNonControllingInterestAbstract', window );"><strong>Carrying Amount (Fair Value) of Redeemable Non-Controlling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated', window );">Contractual time period has lapsed but holder's employment has not been terminated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,390<span></span>
</td>
<td class="nump">51,921<span></span>
</td>
<td class="nump">$ 42,624<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated', window );">Contractual time period has not lapsed and holder's employment has not been terminated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,950<span></span>
</td>
<td class="nump">85,829<span></span>
</td>
<td class="nump">91,319<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired', window );">Holder's employment has terminated and contractual time period has expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired', window );">Holder's employment has terminated and contractual time period has not expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable non-controlling interests</a></td>
<td class="nump">$ 132,340<span></span>
</td>
<td class="nump">$ 133,943<span></span>
</td>
<td class="nump">$ 102,572<span></span>
</td>
<td class="nump">$ 132,340<span></span>
</td>
<td class="nump">$ 137,750<span></span>
</td>
<td class="nump">$ 133,943<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_TherapyPracticeMember', window );">Therapy Practice [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired', window );">Business acquisition, percentage of limited partnership acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_TherapyPracticeMember', window );">Therapy Practice [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired', window );">Business acquisition, percentage of limited partnership acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_TherapyPracticeMember', window );">Therapy Practice [Member] | NewCo. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed', window );">Percentage of equity interest of subsidiary contributed for acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired', window );">Business acquisition, percentage of general partnership interest acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionConsiderationPayableTermOfNote', window );">Business acquisition, consideration payable, term of note</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_EmploymentAgreementRenewalTerm', window );">Employment agreement renewal term</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder', window );">Non-Compete agreement term under condition of termination of employment of employed selling shareholder</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_TherapyPracticeMember', window );">Therapy Practice [Member] | NewCo. [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_TermOfEmploymentAgreement', window );">Employment agreement term</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NonCompeteAgreementBasicTerm', window );">Non-Compete agreement term regardless of whether the selling shareholder is employed</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_TherapyPracticeMember', window );">Therapy Practice [Member] | NewCo. [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_TermOfEmploymentAgreement', window );">Employment agreement term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NonCompeteAgreementBasicTerm', window );">Non-Compete agreement term regardless of whether the selling shareholder is employed</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDescriptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDescriptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestChangeInRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in noncontrolling interest during the period as a result of a change in the redemption value of redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 16(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestChangeInRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the reduction or elimination during the period of a noncontrolling interest resulting from the parent's loss of control and deconsolidation of the entity in which one or more outside parties had a noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) attributable to other redeemable noncontrolling equity holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from (to) a noncontrolling interest. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmountAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmountAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessAcquisitionConsiderationPayableTermOfNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to the term of the note issued for consideration payable for the acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessAcquisitionConsiderationPayableTermOfNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to the percentage of equity interest in subsidiary contributed for acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to the percentage of general partnership interest acquired in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to the percentage of limited partnership interest acquired in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_CarryingAmountOfRedeemableNonControllingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_CarryingAmountOfRedeemableNonControllingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to amount of contractual time period had not lapsed and holder's employment had not been terminated as of balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to amount of contractual time period had lapsed but holder's employment had not been terminated as of balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of reduction in notes receivable from sale of redeemable non-controlling interest attributable to temporary equity interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The distributions during the period for redemption of mandatorily redeemable noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_EmploymentAgreementRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to the renewal term of the employment agreement with the subsidiary entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_EmploymentAgreementRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to holder's employment has terminated and contractual time period has expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to holder's employment has terminated and contractual time period has not expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to redeemable noncontrolling interest temporary equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NonCompeteAgreementBasicTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to the term of non-compete agreement regardless of whether the Selling Shareholder is employed by the subsidiary entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NonCompeteAgreementBasicTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to the term of non-compete agreement under the condition if an Employed Selling Shareholders' employment is terminated (if the Selling Shareholder becomes an Employed Selling Shareholder).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of notes receivable from sale of redeemable non-controlling interest attributable to temporary equity interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale of redeemable non-controlling interest attributable to temporary equity interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_TermOfEmploymentAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to the term of employment agreement with the subsidiary entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_TermOfEmploymentAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=usph_RedeemableNonControllingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=usph_RedeemableNonControllingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_TherapyPracticeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_TherapyPracticeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438848132504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">$ 317,676<span></span>
</td>
<td class="nump">$ 293,525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="nump">28,540<span></span>
</td>
<td class="nump">31,330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Goodwill related to partnership interest sold</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(7,325)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill derecognition (write-off) related to closed clinics</a></td>
<td class="num">(1,859)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Goodwill adjustments for purchase price allocation of businesses acquired in prior year</a></td>
<td class="nump">1,289<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">$ 345,646<span></span>
</td>
<td class="nump">$ 317,676<span></span>
</td>
<td class="nump">$ 293,525<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=116868678&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438849808616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total</a></td>
<td class="nump">$ 56,280<span></span>
</td>
<td class="nump">$ 52,588<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Tradenames [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total</a></td>
<td class="nump">$ 32,317<span></span>
</td>
<td class="nump">32,049<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=usph_ReferralRelationshipMember', window );">Referral Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total</a></td>
<td class="nump">$ 22,119<span></span>
</td>
<td class="nump">18,367<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="nump">$ 14,522<span></span>
</td>
<td class="nump">11,677<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=usph_ReferralRelationshipMember', window );">Referral Relationships [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=usph_ReferralRelationshipMember', window );">Referral Relationships [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life</a></td>
<td class="text">16 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total</a></td>
<td class="nump">$ 1,844<span></span>
</td>
<td class="nump">2,172<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="nump">$ 5,993<span></span>
</td>
<td class="nump">$ 5,424<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete Agreements [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete Agreements [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=usph_ReferralRelationshipMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=usph_ReferralRelationshipMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438848891704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, net - Amortization Expenses (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>Operation</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDeferredChargesAbstract', window );"><strong>Amortization of Deferred Charges [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Total amortization expenses</a></td>
<td class="nump">$ 3,414<span></span>
</td>
<td class="nump">$ 3,015<span></span>
</td>
<td class="nump">$ 2,777<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=usph_ReferralRelationshipMember', window );">Referral Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDeferredChargesAbstract', window );"><strong>Amortization of Deferred Charges [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Total amortization expenses</a></td>
<td class="nump">2,845<span></span>
</td>
<td class="nump">2,307<span></span>
</td>
<td class="nump">2,161<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDeferredChargesAbstract', window );"><strong>Amortization of Deferred Charges [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Total amortization expenses</a></td>
<td class="nump">$ 569<span></span>
</td>
<td class="nump">$ 708<span></span>
</td>
<td class="nump">$ 616<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Tradenames [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDeferredChargesAbstract', window );"><strong>Amortization of Deferred Charges [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfAcquiredOperations', window );">Number of acquired operations | Operation</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDeferredChargesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDeferredChargesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NumberOfAcquiredOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to number of acquired operations during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NumberOfAcquiredOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=usph_ReferralRelationshipMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=usph_ReferralRelationshipMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438850435208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets, net - Amortization of Referral Relationships and Non-Competition Agreements (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=usph_ReferralRelationshipMember', window );">Referral Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract', window );"><strong>Finite-Lived Intangible Assets, Amortization Expense, Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2021</a></td>
<td class="nump">$ 2,946<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2022</a></td>
<td class="nump">2,886<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2023</a></td>
<td class="nump">2,778<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2024</a></td>
<td class="nump">2,615<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2025</a></td>
<td class="nump">2,470<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">8,424<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract', window );"><strong>Finite-Lived Intangible Assets, Amortization Expense, Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2021</a></td>
<td class="nump">556<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2022</a></td>
<td class="nump">403<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2023</a></td>
<td class="nump">335<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2024</a></td>
<td class="nump">279<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2025</a></td>
<td class="nump">212<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">$ 59<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=usph_ReferralRelationshipMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=usph_ReferralRelationshipMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438850435528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Salaries and related costs</a></td>
<td class="nump">$ 24,646<span></span>
</td>
<td class="nump">$ 19,340<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PatientsAndPayorsRelatedLiability', window );">Credit balances due to patients and payors</a></td>
<td class="nump">5,756<span></span>
</td>
<td class="nump">4,303<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedInsuranceCurrent', window );">Group health insurance claims</a></td>
<td class="nump">2,113<span></span>
</td>
<td class="nump">2,277<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Closure costs</a></td>
<td class="nump">1,333<span></span>
</td>
<td class="nump">116<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Federal income taxes payable</a></td>
<td class="nump">5,715<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable', window );">MAAPP Funds Payable</a></td>
<td class="nump">14,054<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DeferredEmployerPayrollTaxesCARESACT', window );">Deferred employer payroll taxes - CARES ACT</a></td>
<td class="nump">4,170<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">1,959<span></span>
</td>
<td class="nump">4,819<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total</a></td>
<td class="nump">$ 59,746<span></span>
</td>
<td class="nump">$ 30,855<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedInsuranceCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable to insurance entities to mitigate potential loss from various risks or to satisfy a promise to provide certain coverage's to employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedInsuranceCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_DeferredEmployerPayrollTaxesCARESACT">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred employer payroll taxes - CARES ACT.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_DeferredEmployerPayrollTaxesCARESACT</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of funds from the CARES Act allowed for qualified healthcare providers to receive advanced payments under the existing Medicare Accelerated and Advance Payments Program ("MAAPP funds") during the COVID-19 pandemic</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PatientsAndPayorsRelatedLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred due to patients and payors . Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PatientsAndPayorsRelatedLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438927986120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes Payable - Summary of Notes Payable (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Payments/Long term debt</a></td>
<td class="nump">$ 21,495<span></span>
</td>
<td class="nump">$ 51,089<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less current portion</a></td>
<td class="num">(4,899)<span></span>
</td>
<td class="num">(728)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long term portion</a></td>
<td class="nump">16,596<span></span>
</td>
<td class="nump">50,361<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Payments/Long term debt</a></td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="nump">$ 46,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Average effective interest rate</a></td>
<td class="nump">2.60%<span></span>
</td>
<td class="nump">3.90%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=usph_PromissoryNotesMember', window );">3.25% through 5.50% Notes Payable due in Next Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Payments/Long term debt</a></td>
<td class="nump">$ 5,495<span></span>
</td>
<td class="nump">$ 5,089<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAnnualPrincipalPayment', window );">Annual installments</a></td>
<td class="nump">$ 4,899<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=usph_PromissoryNotesMember', window );">3.25% through 5.50% Notes Payable due in Next Year [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Percentage of interest accrued</a></td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=usph_PromissoryNotesMember', window );">3.25% through 5.50% Notes Payable due in Next Year [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Percentage of interest accrued</a></td>
<td class="nump">5.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAnnualPrincipalPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the total principal payments made during the annual reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAnnualPrincipalPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=usph_PromissoryNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=usph_PromissoryNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438850226744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes Payable (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 05, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Percentage of unused commitment fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=usph_NotesPayableMember', window );">Notes Payable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate amount of notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">Aggregate principal payment due in 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">$ 4,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">Aggregate principal payment due in 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DebtInstrumentBasisSpreadOnLiborVariableRate', window );">Spread on Libor variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Notes Payable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Average effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DebtInstrumentBasisSpreadOnLiborVariableRate', window );">Spread on Libor variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Notes Payable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Average effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Revolving credit facility commitment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Revolving credit facility maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov. 30,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Remaining revolving credit outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 109,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Average effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.60%<span></span>
</td>
<td class="nump">3.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=usph_CreditAgreementMember', window );">Credit Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Revolving credit facility maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov. 30,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement', window );">Cash and noncash consideration with respect to acquisition after amendment</a></td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=usph_CreditAgreementMember', window );">Credit Agreement [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DividendsCashAfterAmendment', window );">Cash dividends after amendment</a></td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and noncash consideration that could pay with respect to acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_DebtInstrumentBasisSpreadOnLiborVariableRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_DebtInstrumentBasisSpreadOnLiborVariableRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_DividendsCashAfterAmendment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_DividendsCashAfterAmendment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=usph_NotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=usph_NotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=usph_CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=usph_CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438849123704">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Leases (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Components of Lease Expense [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 30,710<span></span>
</td>
<td class="nump">$ 30,225<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short-term lease cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,454<span></span>
</td>
<td class="nump">1,212<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,752<span></span>
</td>
<td class="nump">6,074<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">37,916<span></span>
</td>
<td class="nump">37,511<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_SupplementalInformationRelatedToOperatingLeasesAbstract', window );"><strong>Supplemental Information Related to Leases [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Cash paid for amounts included in the measurement of operating lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">30,307<span></span>
</td>
<td class="nump">30,077<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for new operating lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">32,710<span></span>
</td>
<td class="nump">$ 113,222<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Future Lease Payments for Operating Leases [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">29,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">23,861<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2023</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">17,787<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2024</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">11,487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">2025 and therafter</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">12,294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">95,248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,751<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 89,497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_AverageLeaseTermsAndDiscountRatesAbstract', window );"><strong>Average Lease Terms and Discount Rates [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term - Operating leases</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">4 years 18 days<span></span>
</td>
<td class="text">4 years 18 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate - Operating leases</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3.10%<span></span>
</td>
<td class="nump">3.90%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member', window );">ASU 2016-02 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Future Lease Payments for Operating Leases [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 82,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDescriptionAbstract', window );"><strong>Operating Lease [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Sublease income was immaterial</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Includes the right-of-use assets obtained in exchange for lease liabilities for the year 2019 - $82.6 million which were recognized upon adoption of ASC Topic 842 at January 1, 2019.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseDescriptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseDescriptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_AverageLeaseTermsAndDiscountRatesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_AverageLeaseTermsAndDiscountRatesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_SupplementalInformationRelatedToOperatingLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_SupplementalInformationRelatedToOperatingLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438850521672">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Components of Deferred Tax Assets and Liabilities Included in Consolidated Balance Sheets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Deferred tax assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits', window );">Compensation</a></td>
<td class="nump">$ 1,865<span></span>
</td>
<td class="nump">$ 1,964<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts', window );">Allowance for credit losses</a></td>
<td class="nump">396<span></span>
</td>
<td class="nump">514<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Acquired net operating losses</a></td>
<td class="nump">558<span></span>
</td>
<td class="nump">840<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DeferredTaxAssetsLeaseObligations', window );">Lease obligations - including closed clinics</a></td>
<td class="nump">23,819<span></span>
</td>
<td class="nump">21,445<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Deferred tax assets</a></td>
<td class="nump">26,638<span></span>
</td>
<td class="nump">24,763<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Depreciation and amortization</a></td>
<td class="num">(12,650)<span></span>
</td>
<td class="num">(13,195)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets', window );">Operating lease right-of-use assets</a></td>
<td class="num">(21,419)<span></span>
</td>
<td class="num">(21,416)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Other</a></td>
<td class="num">(348)<span></span>
</td>
<td class="num">(223)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="num">(34,417)<span></span>
</td>
<td class="num">(34,834)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred tax liability</a></td>
<td class="num">$ (7,779)<span></span>
</td>
<td class="num">$ (10,071)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from the allowance for doubtful accounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_DeferredTaxAssetsLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from the lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_DeferredTaxAssetsLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to operating lease right-of-use assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438853070328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_IncomeTaxExaminationAbstract', window );"><strong>Income Tax Examination [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests', window );">Deferred tax assets, related to revaluation and acquisition of redeemable non-controlling interests</a></td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability', window );">Adjustment to deferred tax assets</a></td>
<td class="nump">1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Accrued interest and penalties associated with any unrecognized tax benefits</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense', window );">Interest expense recognized</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Federal [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_IncomeTaxExaminationAbstract', window );"><strong>Income Tax Examination [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Tax payable included in accrued liabilities</a></td>
<td class="nump">$ 5,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationYearUnderExamination', window );">Periods open for examination</a></td>
<td class="text">2017 2018 2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_IncomeTaxExaminationAbstract', window );"><strong>Income Tax Examination [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndOtherTaxReceivableCurrent', window );">Tax receivable included in other current assets</a></td>
<td class="nump">$ 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationYearUnderExamination', window );">Periods open for examination</a></td>
<td class="text">2016 2017 2018 2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndOtherTaxReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and other tax receivables expected to be realized or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndOtherTaxReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationYearUnderExamination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax year being audited in the income tax examination, in CCYY format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationYearUnderExamination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>us-types:gYearListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income tax expense (benefit) from continuing operations attributable to an adjustment of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense for an underpayment of income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of deferred tax assets related to revaluation of redeemable non-controlling interests and acquisitions of non-controlling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_IncomeTaxExaminationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_IncomeTaxExaminationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438848503464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Differences Between Federal Tax Rate and Company's Effective Tax Rate for Results of Continuing Operations (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">U.S. tax at statutory rate</a></td>
<td class="nump">$ 10,125<span></span>
</td>
<td class="nump">$ 11,274<span></span>
</td>
<td class="nump">$ 9,710<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State income taxes, net of federal benefit</a></td>
<td class="nump">1,956<span></span>
</td>
<td class="nump">2,059<span></span>
</td>
<td class="nump">1,722<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationDeductions', window );">Excess equity compensation deduction</a></td>
<td class="num">(99)<span></span>
</td>
<td class="num">(871)<span></span>
</td>
<td class="num">(806)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense', window );">Non-deductible expenses</a></td>
<td class="nump">1,040<span></span>
</td>
<td class="nump">1,185<span></span>
</td>
<td class="nump">743<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total income tax provision</a></td>
<td class="nump">$ 13,022<span></span>
</td>
<td class="nump">$ 13,647<span></span>
</td>
<td class="nump">$ 11,369<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">U.S. tax at statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State income taxes, net of federal benefit and tax reform</a></td>
<td class="nump">3.90%<span></span>
</td>
<td class="nump">3.80%<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationDeductions', window );">Excess equity compensation deduction</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(1.60%)<span></span>
</td>
<td class="num">(1.70%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense', window );">Nondeductible expenses</a></td>
<td class="nump">2.10%<span></span>
</td>
<td class="nump">2.20%<span></span>
</td>
<td class="nump">1.60%<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Total</a></td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">25.40%<span></span>
</td>
<td class="nump">24.60%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations attributable to deduction. Includes, but is not limited to, dividend deduction, deduction for dividend paid to employee stock ownership plan (ESOP), Medicare prescription drug benefit subsidy deduction, and other deductions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations attributable to deduction. Includes, but is not limited to, dividend deduction, deduction for dividend paid to employee stock ownership plan (ESOP), Medicare prescription drug benefit subsidy deduction, and other deductions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438979346392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Significant Components of Provision for Income Taxes for Continuing Operations (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 10,506<span></span>
</td>
<td class="nump">$ 6,523<span></span>
</td>
<td class="nump">$ 5,357<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">2,774<span></span>
</td>
<td class="nump">2,473<span></span>
</td>
<td class="nump">1,199<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current</a></td>
<td class="nump">13,280<span></span>
</td>
<td class="nump">8,996<span></span>
</td>
<td class="nump">6,556<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="num">(38)<span></span>
</td>
<td class="nump">3,730<span></span>
</td>
<td class="nump">3,771<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="num">(220)<span></span>
</td>
<td class="nump">921<span></span>
</td>
<td class="nump">1,042<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred</a></td>
<td class="num">(258)<span></span>
</td>
<td class="nump">4,651<span></span>
</td>
<td class="nump">4,813<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total income tax provision</a></td>
<td class="nump">$ 13,022<span></span>
</td>
<td class="nump">$ 13,647<span></span>
</td>
<td class="nump">$ 11,369<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438848732776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract', window );"><strong>Segment Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net operating revenues</a></td>
<td class="nump">$ 422,969<span></span>
</td>
<td class="nump">$ 481,969<span></span>
</td>
<td class="nump">$ 453,911<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">94,450<span></span>
</td>
<td class="nump">112,474<span></span>
</td>
<td class="nump">101,663<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Closure costs</a></td>
<td class="nump">2,072<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">594,361<span></span>
</td>
<td class="nump">560,845<span></span>
</td>
<td class="nump">443,166<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Reportable Segments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract', window );"><strong>Segment Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">98,381<span></span>
</td>
<td class="nump">112,499<span></span>
</td>
<td class="nump">101,655<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Reportable Segments [Member] | Physical Therapy Operations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract', window );"><strong>Segment Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net operating revenues</a></td>
<td class="nump">383,770<span></span>
</td>
<td class="nump">444,507<span></span>
</td>
<td class="nump">428,445<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Closure costs</a></td>
<td class="nump">3,931<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">550,181<span></span>
</td>
<td class="nump">518,027<span></span>
</td>
<td class="nump">421,474<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Reportable Segments [Member] | Industrial Injury Prevention Services [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract', window );"><strong>Segment Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net operating revenues</a></td>
<td class="nump">39,199<span></span>
</td>
<td class="nump">37,462<span></span>
</td>
<td class="nump">25,466<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">10,086<span></span>
</td>
<td class="nump">8,379<span></span>
</td>
<td class="nump">5,192<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">44,180<span></span>
</td>
<td class="nump">42,818<span></span>
</td>
<td class="nump">21,692<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Reportable Segments [Member] | Physical Therapy Operations (Excluding Closure Costs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract', window );"><strong>Segment Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">$ 88,295<span></span>
</td>
<td class="nump">$ 104,120<span></span>
</td>
<td class="nump">$ 96,463<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=usph_PhysicalTherapyOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=usph_PhysicalTherapyOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=usph_IndustrialInjuryPreventionServicesRevenuesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=usph_IndustrialInjuryPreventionServicesRevenuesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=usph_PhysicalTherapyOperationsExcludingClosureCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=usph_PhysicalTherapyOperationsExcludingClosureCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438936375272">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Equity Based Plans - Amended and Restated Employee Stock Option Plans (Details) - shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 17, 2016</div></th>
<th class="th"><div>Mar. 16, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized (in shares)</a></td>
<td class="nump">2,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of common shares available for grant (in shares)</a></td>
<td class="nump">232,535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=usph_AmendedTwoThousandThreePlanMember', window );">Amended 2003 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized (in shares)</a></td>
<td class="nump">2,100,000<span></span>
</td>
<td class="nump">2,100,000<span></span>
</td>
<td class="nump">1,750,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of common shares available for grant (in shares)</a></td>
<td class="nump">224,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Non Qualified Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized (in shares)</a></td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Amended 2003 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of common shares available for grant (in shares)</a></td>
<td class="nump">2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=usph_AmendedTwoThousandThreePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=usph_AmendedTwoThousandThreePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=usph_NonQualifiedStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=usph_NonQualifiedStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438849961480">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Equity Based Plans - Cumulative Summary of Equity Plans (Details) - shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 17, 2016</div></th>
<th class="th"><div>Mar. 16, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Authorized (in shares)</a></td>
<td class="nump">2,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod', window );">Restricted stock issued (in shares)</a></td>
<td class="nump">1,523,379<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding stock options (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod', window );">Stock options exercised (in shares)</a></td>
<td class="nump">918,091<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Stock options exercisable (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant (in shares)</a></td>
<td class="nump">232,535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=usph_AmendedNineteenNinetyNinePlanMember', window );">Amended 1999 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Authorized (in shares)</a></td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod', window );">Restricted stock issued (in shares)</a></td>
<td class="nump">416,402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding stock options (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod', window );">Stock options exercised (in shares)</a></td>
<td class="nump">139,791<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Stock options exercisable (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant (in shares)</a></td>
<td class="nump">7,775<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=usph_AmendedTwoThousandThreePlanMember', window );">Amended 2003 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Authorized (in shares)</a></td>
<td class="nump">2,100,000<span></span>
</td>
<td class="nump">2,100,000<span></span>
</td>
<td class="nump">1,750,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod', window );">Restricted stock issued (in shares)</a></td>
<td class="nump">1,106,977<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding stock options (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod', window );">Stock options exercised (in shares)</a></td>
<td class="nump">778,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Stock options exercisable (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant (in shares)</a></td>
<td class="nump">224,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised for the cumulative period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made for the cumulative period on restricted stock units plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=usph_AmendedNineteenNinetyNinePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=usph_AmendedNineteenNinetyNinePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=usph_AmendedTwoThousandThreePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=usph_AmendedTwoThousandThreePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438845031928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Based Plans - Restricted Stock Granted to Directors, Officers and Employees Pursuant to its Equity Plans (Details) - Restricted Stock [Member] - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Number of shares (in shares)</a></td>
<td class="nump">86,982<span></span>
</td>
<td class="nump">91,682<span></span>
</td>
<td class="nump">93,801<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average fair value (in dollars per share)</a></td>
<td class="nump">$ 104.69<span></span>
</td>
<td class="nump">$ 104.85<span></span>
</td>
<td class="nump">$ 78.63<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438844922696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Based Plans - Restricted Stock Cancelled Due to Employee Terminations Prior to Restrictions Lapsing (Details) - Restricted Stock [Member] - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Number of shares (in shares)</a></td>
<td class="nump">10,037<span></span>
</td>
<td class="nump">1,578<span></span>
</td>
<td class="nump">3,867<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Weighted average fair value (in dollars per share)</a></td>
<td class="nump">$ 102.52<span></span>
</td>
<td class="nump">$ 87.88<span></span>
</td>
<td class="nump">$ 59.51<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438849115080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Based Plans (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed', window );">Shares outstanding for which restrictions had not lapsed (in shares)</a></td>
<td class="nump">127,562<span></span>
</td>
<td class="nump">150,771<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation expense</a></td>
<td class="nump">$ 7.9<span></span>
</td>
<td class="nump">$ 5.9<span></span>
</td>
<td class="nump">$ 5.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Compensation not yet recognized</a></td>
<td class="nump">$ 8.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=usph_EmployeesMember', window );">Employees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RestrictedPeriodToEmployeesOnTheStockGranted', window );">Restricted period on the stock granted</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ExecutiveOfficerMember', window );">Executive Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RestrictedPeriodToEmployeesOnTheStockGranted', window );">Restricted period on the stock granted</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription', window );">Restrictions will lapse in</a></td>
<td class="text">2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription', window );">Restrictions will lapse in</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_RestrictedPeriodToEmployeesOnTheStockGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restricted period to employees on the stock granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_RestrictedPeriodToEmployeesOnTheStockGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares outstanding for which restrictions had not lapsed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of restriction lapse grant to employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=usph_EmployeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=usph_EmployeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438939877352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2009</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2008</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockDisclosuresAbstract', window );"><strong>Class of Stock Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Total purchased shares (in shares)</a></td>
<td class="nump">859,499<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_AdditionalEstimatedRepurchaseOfCommonStock', window );">Additional estimated shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">124,740<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Closing price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 120.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockDisclosuresAbstract', window );"><strong>Class of Stock Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Common stock authorized by the Board of Directors (in shares)</a></td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,250,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageOfRepurchaseOfCommonStock', window );">Percentage of repurchase of common stock</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock', window );">Bank credit agreement to permit share repurchases of common stock</a></td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_AdditionalEstimatedRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional estimated repurchase of common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_AdditionalEstimatedRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Bank credit agreement to permit share repurchases of common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PercentageOfRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of repurchase of common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PercentageOfRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438842549464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Defined Contribution Plan (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Defined Contribution Plan [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan', window );">Required time period for employees for profit sharing plan</a></td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch', window );">Maximum employer contribution as a percentage of employee contribution</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount', window );">Contribution expense recognized</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DefinedContributionPlanEmployerMatchingContributionAmount', window );">Employer matching contribution amount</a></td>
<td class="nump">$ 1.9<span></span>
</td>
<td class="nump">$ 2.0<span></span>
</td>
<td class="nump">$ 1.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of discretionary contributions made by an employer to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage employer matches of the employee's percentage contribution matched.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_DefinedContributionPlanEmployerMatchingContributionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of matching contributions made by an employer to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_DefinedContributionPlanEmployerMatchingContributionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period consider for new employees to cover under defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438850113240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>Officer</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_EmploymentAgreementsAbstract', window );"><strong>Employee Agreements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_EmploymentAgreementsRetirementDate', window );">Retirement date</a></td>
<td class="text">Aug. 31,  2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_EmploymentAgreementsExpirationDate', window );">Expiration date of employment agreement, one</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_EmploymentAgreementsExpirationDateTwo', window );">Expiration date of employment agreement, two</a></td>
<td class="text">Feb. 28,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_EmploymentAgreementsExpirationDateThree', window );">Expiration date of employment agreement, three</a></td>
<td class="text">Nov.  08,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RenewalPeriodForEmploymentAgreement', window );">Renewal period of employment agreements</a></td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_EmployeeCompensationFuturePaymentDueNextFiscalYear', window );">Future compensation - 2021</a></td>
<td class="nump">$ 37.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter', window );">Future compensation - 2022 through 2024</a></td>
<td class="nump">$ 6.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ExecutiveOfficerMember', window );">Executive Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_EmploymentAgreementsAbstract', window );"><strong>Employee Agreements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfEmployeesCoveredUnderEmployeeAgreement', window );">Number of officers with the company had employee agreement | Officer</a></td>
<td class="nump">4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_EmployeeCompensationFuturePaymentDueNextFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum payments for employee agreements in excess of one year due in the next fiscal year following the latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_EmployeeCompensationFuturePaymentDueNextFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum payments for employee agreements in excess of one year due after next fiscal year following the latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_EmploymentAgreementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_EmploymentAgreementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_EmploymentAgreementsExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiration date of the employment agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_EmploymentAgreementsExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_EmploymentAgreementsExpirationDateThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiration date of the employment agreements three.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_EmploymentAgreementsExpirationDateThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_EmploymentAgreementsExpirationDateTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiration date of the employment agreements two.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_EmploymentAgreementsExpirationDateTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_EmploymentAgreementsRetirementDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Retirement date of one of the employee in employment agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_EmploymentAgreementsRetirementDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NumberOfEmployeesCoveredUnderEmployeeAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of employees covered under employee agreement during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NumberOfEmployeesCoveredUnderEmployeeAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_RenewalPeriodForEmploymentAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Employment agreement renewal period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_RenewalPeriodForEmploymentAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438850677448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract', window );"><strong>Computation of earnings per share - USPH shareholders [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to USPH shareholders</a></td>
<td class="nump">$ 35,194<span></span>
</td>
<td class="nump">$ 40,039<span></span>
</td>
<td class="nump">$ 34,873<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_CreditChargesToRetainedEarningsAbstract', window );"><strong>Credit (Charges) To Retained Earnings [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests', window );">Revaluation of redeemable non-controlling interest</a></td>
<td class="num">(4,632)<span></span>
</td>
<td class="num">(11,893)<span></span>
</td>
<td class="num">(24,770)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate', window );">Tax effect at statutory rate (federal and state) of 26.25%</a></td>
<td class="nump">1,216<span></span>
</td>
<td class="nump">3,121<span></span>
</td>
<td class="nump">6,502<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests', window );">Net income attributable to common shareholders</a></td>
<td class="nump">$ 31,778<span></span>
</td>
<td class="nump">$ 31,267<span></span>
</td>
<td class="nump">$ 16,605<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Earnings per share (basic and diluted) (in dollars per share)</a></td>
<td class="nump">$ 2.48<span></span>
</td>
<td class="nump">$ 2.45<span></span>
</td>
<td class="nump">$ 1.31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Shares used in computation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Basic and diluted earnings per share - weighted-average shares (in shares)</a></td>
<td class="nump">12,835<span></span>
</td>
<td class="nump">12,756<span></span>
</td>
<td class="nump">12,666<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate', window );">Federal and state statutory income tax rate</a></td>
<td class="nump">26.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income (loss) from revaluation of redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_CreditChargesToRetainedEarningsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_CreditChargesToRetainedEarningsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal and state statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent after revaluation of noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal and state statutory tax rates to pretax income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140438849892872">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details) - Allowance for Credit Losses [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="5">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><sup>[1]</sup></th>
<th class="th" colspan="2"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Beginning Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td colspan="2" class="nump">$ 2,698<span></span>
</td>
<td class="nump">$ 2,672<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 2,273<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Additions Charged to Cost and Expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td colspan="2" class="nump">4,623<span></span>
</td>
<td class="nump">4,858<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,603<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts', window );">Additions Charged to Other Accounts</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td colspan="2" class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td colspan="2" class="nump">5,313<span></span>
</td>
<td class="nump">4,832<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,204<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Ending Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td colspan="2" class="nump">$ 2,008<span></span>
</td>
<td class="nump">$ 2,698<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 2,672<span></span>
</td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Related to patient accounts receivable and accounts receivable-other.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Uncollectible accounts written off, net of recoveries.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInValuationAllowancesAndReservesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to accounts other than cost and expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column D))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>85
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MZUOY^%EL'8K-?(6LN_XO>MS:1A-4K#HMF^U@4-!4[>8_?]H&8F\ 9IX!9#N
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M3\]#!R;3,)-OA>;P%33M7+601^X2; .78!+A,=(<=J94QYZ':W0@,SUR^%,
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M51?;;C"?P3;-#[^3KYTC3@9@/#( =P.P,(#8(P-(-X"(%IR1 ;0;0,4!=&2
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M,6PGH3AE4]0I$TQ7400V$<PSYA/S$:$M1@\>@;I-@H7T=CJ+NGJ<@ J5X]B
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MT>GH)&4IF\?^1*HZ\;.INNV1Q,.OAU.OE_U93^WW3_3#?'MV=>AF>Y3V2]*
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MM)WR:SS%%;5C1HLOOK'=>N#<@^[R3SGO,Y_W7A=DW3@MNT]&.PRFLW5/>ME
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M QD B']T3<N_%5TT7==L^".< VR,7L#WRP8@-_Q!!Z0?#[_^'U!+ P04
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M*CNUUM#.[^LO0*K\4A#\=F#@:*FRL_0(8:LW1!=\$EJ3+F(SXAOT*YTX _=
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M)DW<++*_=%UU6Y.H\#_TH";+AV'R\)2.WW1=@K1B/$:KZS?:KCT@WAKZKFD
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MSGKO.^7@I#NQV$\U:XNY0RPF20R0@V4C(XJC>N!3U.1LK@.BXDM.!B\]#37
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MY\SV?'QFC@(]I;G2"G=C4WQAYT7V=Q=T^7>D\(;_UY3=J?\;^Q$^LJVY%0Z
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MD5DG2./B7U1YE4U1KZW>I MB[!Q"AJ+(S 1GNT0UU-Q2,:!W7*K1T4\:-5O
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ME*0W]L5=GK>CIZ\LV2?JOC[D-(XF5>1UD[F'$KP%BF[5V>3$.<*VD_"0-7%
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M\K2[@\MW9U/I&T:>9"<G!T>'3T](JK[U=ID3Q-RAQL.D'(4E\C38O<&D2T9
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MO0X:A3!P[<$Q4 EQG<!'9#)LD#'[#(&[2B4;)"S<QCT84IEU>D+ON&:7BW&
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M!KDF*;N2]Z:F6X[2R89+R1WIZ]D2U=9N][AS0)@-^:?=4MN@UZ!M"3VL@^%
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MP(.ITB%Z3T@CHP=T?6-8H6BYA7H0N_-3)>@I*T-($:?/\7\#S2/^UL)"T8:
M+,$MF*_/B6HMM-]%<_7^4O-=[XIH@6@I ?U-Q SD 9(<(*.-^7U*<U"OD2[R
M,E-; D$W'-XW P[10%3D%*>/(!#V(2N1U83.'4;::+=K$-&[=L"%S(4JV/#@
M)<%A4W'K@9\ZE,>XFU(D<BE%&DBV2T&7)<:7>L@"^ .LAX5O11L,Z8ML BX#
MBH&XF1*P*A<R P- 7ZQ* <:@&1*T=Y00!  #L<RX!M=#G>"&H[P0Q5VP!9S
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M!0<OX !XOE20E_X++E"_1/SF/U!+ P04    " !4@F%2"(B$=^\"  !'!@
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M<X\7*(0CHC!^[3B#_DH'/)3W[.]\[I3+EAF\4.(KSVRY"N8!9)BS1M@;U7[
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M=@YDSY6R>\5=T/]WK'\#4$L#!!0    ( %2"85(EU6,ZU 0   ,,   9
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MG[-NPE><W?'P+>PW:5>ZI->@#*+CX7S6#XW3W'BSX6\Z2^.]*?ARK23>=^D
MGF?&^.:&#+0?^:[_!%!+ P04    " !4@F%25DS@O$\(  !W%0  &0   'AL
M+W=O<FMS:&5E=',O<VAE970Q-RYX;6S-6%MOX[@5?O>O(-Q)D0"*K:MEITF
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M:ZHCEVIQV1C1:7%.&D+1BW8U(3[X6;/S))VZ[3C!WBG=B QL.5%B-4U2$/\
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M0W\][QZLVKA/:W-EK5J[Y4IP1"H1X/U"*=L]T ']M];;_P)02P,$%     @
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M__Y?Y[/9Y+OW;Z^OZ./TNQ<XL#R:-SC5TB >TR2#Z8$/63CN*2S1M"8I\2M
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M0#XN6?E5XA%Q@ (;Q$&_0?S=9T /O17VR4<0 $&&7 ,AKLJ-G PZ37R(::W
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M4;=E)VB^ID)LI-\;V?.[K>W,VNW?+]<W=]YERUJEQ++B/"LWHR:"<>8_E;B
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M@\E-!+9])MH-F3J,YHTA'O1A6?++BM8?8/W6&#ILO(/C6[WX%U!+ P04
M" !4@F%21V.->@,#  !(!@  &0   'AL+W=O<FMS:&5E=',O<VAE970R."YX
M;6R=5=]OVC 0?N>OL*(]M%)$?D*@ B1H-VT/W5#;;9JF/9CD2+PZ=F8;*/_]
MS@ZD;&MYV$M\/ON^[SN??9GLI'K4%8 A3S47>NI5QC170:#S"FJJ^[(!@2MK
MJ6IJ<*K*0#<*:.&":A[$83@,:LJ$-YLXWU+-)G)C.!.P5$1OZIJJ_0*XW$V]
MR#LZ[EA9&>L(9I.&EG /YG.S5#@+.I2"U2 TDX(H6$^]>72U2.U^M^$+@YT^
ML8G-9"7EHYU\**9>: 4!A]Q8!(K#%JZ!<PN$,GX=,+V.T@:>VD?T=RYWS&5%
M-5Q+_I45IIIZ(X\4L*8;;N[D[CT<\AE8O%QR[;YDU^Y-$X_D&VUD?0A&!343
M[4B?#N=P$C *7PF(#P&QT]T2.94WU-#91,D=478WHEG#I>JB41P3MBCW1N$J
MPS@SNV>E8&N64V'(/,_E1A@F2K*4G.4,-+EXH"L.^G(2&&2S,4%^0%ZTR/$K
MR%%,;J4PE29O10'%GP !RNRTQD>MB_@LX@WD?9)$/HG#.#R#EW2Y)PXO^<_<
MO\]7VBB\-S_.D*4=6>K(TM?$,TW+4D%)W6V4:W('6Q ;\,DU-5!*A90OG?)9
M6/MFKW1#<YAZ^"@UJ"UXLX<*R%IR?' V'V,KB#?54,8U,;BF6F8<.5(7Q$CG
MWE+%Y$:3O--#+IC )7124>C+?N\;4-76LX?5@'H%JJL(^<L3C?_QC'H?L<\T
M> 2 9WZ0H<D;DF2)GZ0A6FEBK8&UHLS/PJ1W2P6VA]I&Y'BA;$&>0T=^&H7X
M'69#_";)N/<)4U'/&V+?2HO]=#2T7\1;5GN-1><V9T6;/<$.IUQ5G))1XF>9
M4Y*F_B#,K!4C33KH?1 %ODC%,):)GQNU)XWC<16U9\]R9.RHD[$?C<>8FY\.
M8Q(/<!CV+%KLCX=CBSN*CM8@\<=11%ZZ:,')ZZY!E:Z'897L?6T?>N?MVN2\
M[0[/V]L>>TM5R3!-#FL,#?O9P".J[5OMQ,C&]8J5--AYG%EAJP=E-^#Z6DIS
MG%B"[N<Q^PU02P,$%     @ 5()A4M_8/EQ'!0  ;@X  !D   !X;"]W;W)K
M<VAE971S+W-H965T,CDN>&ULM5??<YLX$'[GK]CQ-#-)AM8@@8%,DIDD;>_R
MT)ZGR=T]W-R##+)1"XA*(F[^^UL)3.QK[/9NVA<0DG:__?'M"IVOI?JD2\X-
M?*FK1E],2F/:L^E4YR6OF7XE6][@RE*JFAG\5*NI;A5GA1.JJRD)@MFT9J*9
M7)Z[N;FZ/)>=J43#YPIT5]=,/5[S2JXO)N%D,_%!K$IC)Z:7YRU;\3MN?F_G
M"K^FHY9"U+S10C:@^/)B<A6>7<=VO]OPA^!KO34&Z\E"RD_VX[:XF 36(%[Q
MW%@-#%\/_(97E56$9GP>=$Y&2"NX/=YH?^M\1U\63/,;6?TI"E->3-()%'S)
MNLI\D.M?^>"/,S"7E79/6/=[:3:!O--&UH,P6E"+IG^S+T,<M@328(\ &02(
ML[L'<E:^9H9=GBNY!F5WHS8[<*XZ:31.-#8I=T;AJD Y<WF5?^Z$%C9"&N02
MKCN-.[3F&H[OV:+B^N1\:A#(;I_F@]+K7BG9HS0D\$XVIM3PIBEXL:M@BA:.
M9I*-F=?DH,;7/'\%-/2!!"0XH(^.;E.GC_YWM_^Z6FBCD"U_'\")1IS(X41[
M<&YP0N2P!?=<- _JL&5YIEN6\XL)UIWFZH%/+E]W2C0K%PX;E# #UA1VD/I@
M2@XWLFY9\XBL1V3%"V#(FH]2"?,(HC$<%1D<N+U+66%M6G5M^:A%SBH[K5C[
M"*T-A,BY/O.V? "D&H<CN-TH>M_5"ZXPD-Y[^<#=V%JV[3>,*S3HTPA)? 34
MN^.MV2/RM/0D$QS!J?>6+U2'/>1KD:>59)"8(<KI*40[0!BO0T"X/$N.( R]
MJVZ%1>@"NR,QS/>4Q#5K5P2G%ND ;>*1-O%!VLP5KP16NW5DWJF\Q+X#<V43
M 5>8K)SMH])!O<]3Z1XIT&Y 6@N"C%".&2Z 7Y$"3P3%^M)AVW6$"F#!>8-*
M-N:+"BG8&VPYJ >N87-QW).=1MKJDS/OAND26B8*'QH\BK D<SLSTO?X11P$
M)_ ""/6S(,%D5A6FJY%(Q- /2>C=2X,VYFB(* ;[[/;8#TCJO=%&U,Z&)1,*
M'EC5<0MBL0QK5@(['9JGN=$CYME&9:<4;\QF^07BD62#U\CFY;\VA#0:%BO!
M%J+"Z-AN&L<QG'CO#P"BZC0.O ]\R95"<8QB'^92M!JH'V<)UA?B86USYW<0
M$N]>L8(WK,9L^93,O%^D+-:BJH"D?AP%WMM=AYU\8Q3FP5;\V N.\PK-$4O1
MYPG-X7C\6ROWB>@3. XQ%EF"?FTB#0?99-O4-F/6J.C[^'%[.[\[A?F&BO<#
M%7][HJ(+^7?P*,T<C[!11F@N#H@?)@$.L/3C+/7F[-&Y;23HDBE>R@KYY$X)
MW9,N2F-X:9\[+(S\( A028 C?.[C(_&SD/:P40\;^S2E/YJALRC$]RRV" 1S
M=("O:90"S2)+ZX@\QUPT.4G!9CL+[8OZX2S[-I>/HQ1W.5);A^DLVD_M",-&
M_!D^9S:,.S0GZ 3!4,4DV")[:(,,263E J3Y2'N;V)A &/F$)D!1:YK]U")X
M"<<SQ IL:(:!MS_1>$;<-@6>'4I@'$3SL5/VF.4/F!%+$=N479\_7$CI_RVD
M;Q<(38@KD)E/9[N--HOWT3I,?!HF/YS$E.ZG+0WB9]LL^8XV&_I12/>Q$1.'
M;72'@=@6GIB79=MLR_R4QC^WR:9^&,6.5'V8G_W#F&[= 6JN5NZFHS%176/Z
MZ\ X.UZFKOH[Q-/V_B;VCJF50%)5?(FBP:L$?RI4?[OI/XQLW8UB(0W>3]RP
MQ LA5W8#KB\ELF7XL #C%?/R'U!+ P04    " !4@F%2SA5K;&\$  !:#
M&0   'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6RU5U%OXC@0?L^O&$65#B13
M$B= 4@$296_5?=C=JMW=T^ET#R89(+=)G+5-:>_7W]A0H+T6M=N[!\!.QM]\
MGV<\'H9KJ;[K):*!VZJL]<A?&M.<=;LZ6V(E]*ELL*8W<ZDJ86BJ%EW=*!2Y
M6U2571X$_6XEBMH?#]VS2S4>RI4IBQHO%>A550EU=XZE7(_\T+]_<%4LEL8^
MZ(Z'C5C@-9JOS:6B67>'DA<5UKJ0-2B<C_Q)>';>L_;.X%N!:WTP!JMD)N5W
M._F0C_S $L(2,V,1!/W<X!3+T@(1C1];3'_GTBX\'-^COW?:2<M,:)S*\K<B
M-\N1G_B0XURL2G,EUQ>XU>,(9K+4[AO6&]M!ZD.VTD96V\7$H"KJS:^XW>[#
MP8(D>&8!WR[@CO?&D6/Y3A@Q'BJY!F6M"<T.G%2WFL@5M0W*M5'TMJ!U9GR%
M.5*89R7")UEWIK(V2I9DM8 /M4&%VD#KBWVOV\.N(8]V73?;HI]OT/DSZ"&'
MCX2XU/!KG6/^$*!+5'=\^3W?<WX4\1UFIQ"%#'C @R-XT4Y_Y/"B-^C_8S+3
M1E'^_'G$8;QS&#N'\3,.ITM1+U!#4<-4*'5G/4TJN:IIG]^+0L$W4:ZP#7(.
M+^#V5$B.^K>'_$PW(L.13Z=8H[I!?TP)#F:)<(=" =I0 6TT5C-4N\VVWV$*
MHL[M(&%NP9SXR+5E9!S/'(TH2NW>97NE;GJO5FS5SJW:FYU::Z/VBFM2G!TH
M+K:*-;0<H%QIHJ+;9][OEK3++^]?I!_+( &/GR3>.2Z*NK9.9J(4=89P F$T
M8(->X$812^/(C@+.>@/N?6Y0"6/MB1"=?@V"=B$3AK;-R)>(@$8H4Z/2$(8L
M'/0(FO5[*20LCB+O74'I5LQ6MFSI5R.V0L[B(((VC0+&>6A'*4NB'K2]Z<.8
M[$-@(_ 2-S'K1]RR3M((>,P&@\"[7"F*M2;8%X*T*)MZ&V()2Z.8!@D+XYXW
MR7ZL"D+8FY(GG@Z@SW@40,>C([':E'-R]2Q^3GIHV[0HG:ZOUY<7N_U9%LW>
ML .M/@M)4)NPK\G\Q1(Z8+!JI**+#)!(FSN@2$811"SDENDG:0A-4;(5-PY*
M87F?(?J-GEHAHSO7;A]GR2!PH8Y)A#?)_Z(K@^Y,XT)<'^%@PV\_;^7"DX@>
M=[S/!*9HU.<TH=/X^#AQ%L7!DP?K2%'M[8IJ[WA1?51)2<Z#8OJ3E?2HTZ<K
MZ9<GBJ*M# NIBK]1_[^5\.?*G]L-NMU6H@1##1=0>2MD#G2DH12-IGRA6@1+
M6>:H?M% &5#*.YMDSH22#&:(Q 05-2@NOTXH#5B4VBCW0I;243^!F+,^CX]Z
MLU!;C_::>8W'?LI2RJJDQQ*>0AJR*$R]BV< #M99/]D12GC;N(+4<4G^'P!:
M\@]!7W\ZN@?]7H5JX;I:36XIFS:MW^[IKG&>;/K%O?FFZ_XH%%U^%&B<T]+@
M=$ YKS:=[&9B9..ZQYDTU(NZX9*:?U36@-[/)169[<0ZV/V=&/\#4$L#!!0
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MM+2RB%*D2E*Q\_==2K::MDG0BT0N=V9GQUIZME/ZAZD0+>QK(<W<JZQM+H+
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M/J7I9SK/=SLY8=)CM0OJ+W0('TIE+Y@>?'TJE5'?'UO"CY?/X1Y%^!+.L!_
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MR(@_#R#' W+LD.-7D"]5NU:22VN(JLD5K[G6O,*=R+DQ'):9K,@GP1:B$5;
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M=%+=79J[B55K=U%=* O77C=<P7\&UR@ WVNE[&Z"&PQ_+F?_ %!+ P04
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M?64C=:]07JD-:O&.Y+D?%2D:-$Q\&MF*B@RYQ%]9!@W],,]([L?+@J184K1
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M=V]R:W-H965T<R]S:&5E=#,Y+GAM;(U5WV_C-@Q^]U]!&#>@ =S8EG\D#9(
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M6'%59L";'&[+JM.8P[D';^7Y0Q;3J#/5\@P7+G6B0OF$[O*Q0,A>T6\&^OQ
MCT?ZENB530!U-F@R?J$[!6A>#BCO6&](Y9A[\PVO+!0)4S"&7)%M16VMX*)L
M"$-TBA24!_B<8:M/.'*JS=',^9,H^MIPSAA><Q+;ZY.I<Y)?$]\;T5S"MX?U
MYWY3B"I'J6;.'S3=RH:R0TYK+<L-85"-@Q;GVO )HL0+KV(2XL +HBMS$GO3
M2>3<2,Q+#1<9Z>^H10R 1$VS[R2U,^<>GWC5#5Z2$=(H-82-:"XS:A%)>2-=
M<DHCO2!!QEX:,1C!11AZTZO(2"SV)I, 1LXC?P;<;FF0D?N@*/Y."_D"DFMJ
MURW!2U[9MS%W.#*D+!VSY#<(/1:F$'DA"R'UDH YGTPV)Y,I6(&E$Q+"U$N#
MQ+D[3^?%60F-2)^-XVF_),9Z'(6.+64%G:),4#&<5.+,6?U*&5["WHY0S"_Y
M$P6TP_Y"0<B\:92899*D9DG3%-YJ5O]D#M9(+V2FO2)?ND;W(W$X'7XHU_T<
M_4^]_QM]I0<NJ8DJW))I,)XD+LA^PO<;+5H[53="TXRV8D$_191&@>ZW0NCC
MQA ,O]GEOU!+ P04    " !4@F%2,@I&S1,)  # ,@  &0   'AL+W=O<FMS
M:&5E=',O<VAE970T,"YX;6S=6UN/XC@6_BL6FI5FI!J(<^$RJBJ)@JY+=UU0
MLS/S,-H'$PQ8$Q+&=JAFU3]^CY. "4F<4-M/]$-7(#['G\_M.W;"]7O$_Q8K
M2B7ZM@Y"<=-:2;GYK=,1_HJNB6A'&QK"G47$UT3"1[[LB VG9)X(K8..;5G=
MSIJPL'5[G7PWX;?742P#%M()1R)>KPG?W=$@>K]IX=;^BZ]LN9+JB\[M]88L
MZ93*WS<3#I\Z!RUSMJ:A8%&(.%W<M(;XM[=N(I",^(/1=W%TC=129E'TM_KP
M-+]I60H1#:@OE0H"?[9T1(- :0(<_V1*6X<YE>#Q]5[[?;)X6,R,"#J*@C_9
M7*YN6OT6FM,%B0/Y-7I_I-F"/*7/CP*1_(_>L[%6"_FQD-$Z$P8$:Q:F?\FW
MS!!' G:5@)T)V$T%G$S .17H50BXF8#;= 8O$_!.!>P*@6XFT#T1<+L5 KU,
MH-<44C\3Z#<5&&0"@U.!?I7CK+WGK!.1;M4J\,'9!6]7^0+OW8T+_L95(GN'
MXX+'*T7V+L>G/E=WRD7V3D\#OI-&?)(N8R+)[36/WA%7XT&?NDAR+I&'+&&A
M*@]3R>$N SEY^\:7)&3_)2I7K] KD3&G*%J@MPWER9<"D7".[HA@0GT_X530
M4":WT,]C*@D+Q"_H)\1"].]5% L8+:X[$J"I"3I^!N,NA6%7P'B-MFWD6%?(
MMFQK!'>97Z)D9%9R3V=M9/=JE(S-2H8;WD88*R5X\!SYR4JGL&!:HNM3C:YX
M":M*=?4K =TW )2:!O?O8@&W19F%'\QJQM3?8[&MWZ=C]/-/O_P1!?&:[A>9
M JQ:ZJ-9_91NM -3O25*GLQ*/L=A R6?S4I>"-<+_;3>!-&.TDIE7\ZWVE,H
M) D"X$B9FBP7)5.Z5'?NB<\")G<E4SXWGA(/LBDK8^>EN:Y^IJM$RVN=17?(
MLO,&+='RUM@ON)<7[T#1.E0N^U"Y[$2?4Z%O!+4I"M@\*UW/D!5(KDB(_EQ%
M0;!#;^\AG:-I/!-LSJ#SN4(3PL$SR0TN5FR#GD))H9[)*S0"P25%XY@B&:%7
M:,N>0C]:4S24DK-9+,DL2&YE.E1-_+180(^35,547%PEDG\-9T)RZ'O^8UBE
M<UBEDZS2K2J,\7I&N9J#TTW$4QPBC3&!OJ,LW,HB.U7<312K+G%[:U]WMB58
MW ,6UXAE0KFO:O\R88@E!3.2 &T(EWN#LLR@*%+&+P-EG@&W+>M?!JMY!Z1>
M0ZOY2>: DQ(^@X#XCBJ3Z<$K6,SSW(/-T@68Q^30=@]HNPW1"E5!!'I?@14/
MT(EB9 V_JD _= O(G,$)>..0'/;> 7NO(7:Y8GR>1,,.+=+JQZ@*44,I_-(K
M NJ7 ^H? /4; IIE7 D@B/]/S+C9^Y_Z1<_FS?=<'('+P0X.8 =GQBE4,+GW
M-B* ' FX"L!^^X" %E&N$/W&A&3A\CC]A&EYSX.FX+&E>T>K,?Q(@'GWJX#"
M;,ZT3'$.S6FFF<?D(1^UN]@(>;A<<KI4QA4$*NF&,Y\>V;^T0T@U]HYQ8,NJ
M0*+I"]M&)",B5E#4?0K;XSE<!$E^ \4DP HV+;6B74#6.P*6P;<+9NQ5HM>T
MA&MX*0(3IN@32OH8?J> WRWB-P_*X]=4ALU,HT.7Z79.H$7$47BRM._HJ.,K
M#1"W*=-B36#8S&##+90 (-K-:B>8#S0K@1/(9@?Y#F45.I!MTM$*!*4"S:%!
M4W^S O$=5;:[#]FT@V.LO78O;_/'LE%>NY\?]50R"O?;)YSSN4Q7MUUE(,V9
MV$R:^6:$9FTI>##F010O5Q!YX$MH1V#;K"*S="-AGL*U:MH1K%D2-Z7)11P$
M2?NH"O>ODD&/J0[0(/!\%6J&_OHS+K*EYU6F@B9,W)0QCVRG#<JIC'F8<*<!
MW"LN(4>[$IPF2&QFR*\T8%0A*S]6^)*)YXJSXUGXA+E+AIW4F1?CD/P.11.D
M;2;(%SJ'Y(7^;>C[-,A:..7\X7Q+0G#XA.S2PC/AT9*3-?KKA2IOF+8.MB8[
M&U_P%LD^V@DVH%(UGZ\N*/1Z6^ @95;U)?%]'L,Z T9F65=:5AGM(IEB%Q?H
MR"[2:7Y8?@V:4&TSH4[B60"U^Y&20*:+F48^@\(_I7P+38J [*,<-EW^#MU#
M-C2*%$V'MGO)D:)IU3;3Z@,G^["(%*-6%I8'N[C1 R^G_TY#HLG0/&!-<[:9
M@Y2KQ:%-+ 7:+:V !9#%O5]^6!Z@9C;;S&QU!3H3KX:7GU>SEFUFK1=H==9Q
MLX*IV<8>7' :.)J7'#,OY9NG@*V9(J;S3G)JIL!US9.C:<PQ[]GR: _(]IOZ
MLJ2HT6B7@,M6]4'!YQK!NI,M1Y.=8R:[%_*M:> [1Z>,SB4'ON8YYYPCS \&
MOGF*P:#.U9JMG*;'F.F)D#KOR?9X0?;,09WY[)\_E"9""3>=,(-Q2!ZYIBWG
MG-U9LY0U:W2\RI3]H.!SC6!9KN?-H4G2,9-D>A &3;YZ&P+:_B:YJYG0Z5]R
M[FIR=IH>EIYYLGOG%,\^G7P2C$J&5)PUNIIEW7-8MDD2W-5H[%7%\JA&L%LB
MF%^59F/7S&15L0P>.*,G<S7?N9?\G,_5%.S6; #/CI91C<;:%LP]>O)G)C63
MTYOW(ZYF/M>[9*=KGG1_-$^.:C3VG7;?['3-6JZ9M9Z>)M-&;M54Y5XR5;F:
MJEPS59WOUG&-1FQ5[3SN:R3+2G_ZOD:-H%?'&9YF0J_I@\(CZDZ.LQ1Q&UYJ
MNO>*#P$K'AUXFL&\<_:3$#(SIL)N#ZU^"S"NF:#7K?)5C: W:+N>T>2:-CWS
M-K'P4@%<A52J9PU([(\4J]\F&'O%<T[7J["\YCBOZ=LL4 BR1]HJ-1ON9L9>
M\9T67+%7\32W>69N>R$AA((ZAD=0GY(J()J4/>_H;91+9C-/LYGWH]GLL49C
MKZZ%\32;>68V&VXX"Y*7ZM!0 8+X4^^P-G&TYC?ODOG-T_SF_7!^J]%85C+S
M+U-ILNDV)9N/5;YND7*J*E]7<T[77-G_W\J7J3=6OL[1:^#JMQTOA"\9: [H
M H2L=@^J%$]_+I%^D-$F>3-\%DD9K9/+%25SRM4 N+^((KG_H%XV/_QHY?9_
M4$L#!!0    ( %2"85(IG)3*Z@8  ,PG   9    >&PO=V]R:W-H965T<R]S
M:&5E=#0Q+GAM;,U:V6[;.!1][GP%X4%F 3JVJ,5+)C&0.$[C%FF#=I:'H ^T
M3-O":"M)V<F@'S\D)8N2(U&*$QCSDM@D[^&]EU?GT!3/MA'YAZXQ9N A\$-Z
MWEDS%I_V>M1=XP#1;A3CD/<L(Q(@QK^258_&!*.%- K\GFD8_5Z O+ S/I-M
M=V1\%B7,]T)\1P!-@@"1QTOL1]OS#NSL&CY[JS43#;WQ68Q6^ MF?\9WA'_K
MY2@++\ A]:(0$+P\[US TP^.(PSDB+\\O*6%ST"$,H^B?\27V>*\8PB/L(]=
M)B 0_[?!$^S[ HG[\2T#[>1S"L/BYQWZM0R>!S-'%$\B_V]OP=;GG6$'+/ 2
M)3[['&UO<!:0=-"-?"K_@FTVUN@ -Z$L"C)C[D'@A>E_]) EHHV!F1F8>P9F
MG8&5&5C[!L,: SLSL/<,+%ACX&0&SIX!M&H,^IE!OVT,@\Q@T-9@F!D,V\8P
MR@Q&;6. QF[EC+9SP'RQTZ)+JT26V!5B:'Q&HBT@8CS'$Q]DG4I[7EE>*!ZI
M+XSP7H_;L?$GLD*A]R\2]?T6?$0L(1A$2_ IQD0V4H#"!;A$U*.B_8Y@BD,F
MN\!OX,+]EGC4D]]^N<(,>3[]]:S'N&<"O^=F7DQ2+\P:+SY&FRZPC+? -$QC
MPGL]MP+D2@_R!<<%D"ADA#^OM6!3/=@UGG>!.4C![A!A(29T[<6U>.]:.P='
MM2 W>I"+9,5!H 09UH+,]"!7V-V![')=B*\"[T-K/#AJR%2/5V=>HF9>HJ:<
MP*J9X#*AO(52,(F"N1=FI7J%J4N\6%;>_<6<RM7^JIG.RJ>SY'1V72TFP1P3
M4>NNC(!6K5,*T9<00K4V8^>LMRDF[>D(F(\H^67G?MDM_8I5DBGX#O2K-[,;
M77TZPJYVU<E==;2NWO*\!4D [F^Q\%FW*OT<LG^,(ACDTPVT$=QAX@J:6TDR
M]$*&.>\QO@'@=$?PHBK/>D#3Z!K&2=73I;>#3\U* 0WS@(;Z)4$/;9=DE$..
MCK$DT%!29;SVHC0@6D[=JC085BUG.:J" $/]<QUMY))(/BX):HNU@HI$X5%8
M%"H:A7H>+4:R0 Q7+D\#%6?;@A_>O!')T;FE6!3J:?3Y131I0!S4%='L ,-R
M5(IPH9YQVXC6),,H$KU5EH*9=DC9-\7<L*_UC6]]V LJ7%$V'!REPA6E0CVG
MMJIP/<1N6]BBPA4MP]$K5_A5 ^*@3KQF!QB6]X"*_$T]X[:I\,L&C'OXM2IZ
MO94XU#BE,7+Q>2<6OW[(!G?&H"H;KP!4SHX2$5,O(OSG"DD0>3SH$3,+._&C
MB(BI1,1\N8@T0.Q^R34_8J82$?.U163:@-BO$Y'K!L-[LZJF9X=.][YI.DN[
ML$JPS)<+UM1\JD;VGF!IAY1]4X)EMA<L.'KVTZ0$RSR*8)E*L,R7"U8#1$FP
MX$CGEA(L\[4%ZUT#8G]0)U@'&)9/$91@62\7K'<91NF8 .Z5N'Y,V3LE&)9>
M,"Z25<)S+ Z2GEO@EI(+ZS@G-X6CFY?+11-$=L:6%OA0YY:2"^NUY>*F ;%^
M1W: 83DJ1>'6RRG\QFJF<.V0LF^*PBT]A=^BD&<[X$D'NY-@VJJV%7E;1R%O
M2Y&WI6?> [;U#8C-M: HW-+SIJJ%0&7>S3/_/5^%2C='3PJ@7W-6JMC7UK/O
M9RS>)WKA*O<"\(0%5=,W(#G@$2-25=RS0RS+\2B^MO5\G9ZF@SL1B>?B-K5L
M*YZVC\+3MN)I6T^R!QS"-"#6'L),&PRK=L+EJ H']&U/Z#6',/;3T_:]0YAI
MQ9 :0K056=MMR?I9;P^F=FMRMA4YVWIRKJME[LTSWAS8BJKMHU"UK:C:?FVJ
MGC8@PB:JMA55VWJJUF6__4L"1S&Q8QPC^XZB2D=/E0=DOP%Q:'6'VNP[@FK+
M+8H+'3T!51]*7398_;'&8+[+K!>Z?K+ %%#OH2C XLV].&;BRTP+:KQ=>^X:
MK-$"($!RG13R*!*&XIA$O [X]ME_!$MO@U,9 TA> &!\8K&USO/9U>5%<:=S
MR#'&98.5R,(R2LB.< $BF&<C;:.84YWPM,AX72!L>"G&*'S\F:KRX%9LAU:B
M2()"7DE+$@5 /(4G@$5 %,3)6[#UV)HG&40;3)#O Z$E)_*&SP)$*1YWBWG(
M!W%"W#7O 'P-0HKD?2)MY@KO6O7,_N1$)LN<WNJ S/WT(^P;O__?\]<KW(4)
M,%G)ZUJB^I.0I>]_\];\2MBEO$NSUSZ%I]=5[3-X^KZJ_<(Q3]\[9D4/?Y9Y
MCU798_,>N[+'X3WR-E1/A9'><[M%9.6%%/AXR4,RN@.^U"2].I9^85$L;_S,
M(\:B0'Y<8[3 1 S@_<LH8KLO8H+\ M_X/U!+ P04    " !4@F%2UT/'+_ +
M   11   &0   'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6S%7.MO&[D1_WS]
M*PBC+:Y ;._[<74,.+:5<Q"GAGWIH2CZ@5I1TC:[2X7+E>S#_?$EJ96XLJCA
M6K9Z^1#KP1D.9X:_>9"KLP5EW^HI(1P]ED55OS^:<C[[Z?2TSJ:DQ/4)G9%*
M?#.FK,1<O&63TWK&"!XIHK(X]1PG.BUQ7AV=GZG/[MCY&6UXD5?DCJ&Z*4O,
MGCZ0@B[>'[E'JP_N\\F4RP].S\]F>$(>"/\ZNV/BW>F:RR@O257GM$*,C-\?
M7;@_?7)=3U*H(?_,R:+NO$9R+4-*O\DW-Z/W1XX4B10DXY('%G_FY)(4A60E
M!/G><CU:3RH)NZ]7W =J]6(U0UR32UK\FH_X]/U1<H1&9(R;@M_3Q<^D75$H
M^66TJ-7_:-&.=8Y0UM2<EBVQD*#,J^5?_-AJHD/@N3L(O); >T;@!CL(_);
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MT_]3HI)H*$K@\OC B8IE]M!JDD1C7G*X(CS1(); (/:')"H6F5Q+_R_1R)G
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MG.)GU2FVZBJ)Q\S[29$@DTC*<"25-BRSZ'$I J+GJ,@L;4KD7;HV1IL(( H
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M:9:N_=?3E$[#HE6\B!9#V'<*%X/"Q46%@W>:?VF8&N^.3F%'D9Z^>KE(@I'
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M;"]W;W)K<VAE971S+W-H965T-#<N>&ULO9A?;]HZ&,:_BH5VL4EK@]^$!"9
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MH5.H%/(JA<*:<D]7(E\Q/@=IY<;LV0W?A[9&M[_;,E4=RG:/<M/V*$KB0%>
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M+I;CV5NY#VEL<QFVN0RMOVC07Y,N#>DB=;K^OMXH+6&S_C,2(&H#1#9 /!#
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M50;M5=8WL7J@Q<%>9C9"P]7(/N[A]DJE,8#O6R'TR\#<C]K[\/(_4$L#!!0
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M<#)SGSE.VZ#L!3R?26DV"QN@F=]'?P%02P,$%     @ 5()A4@F91;/J P
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ML24L3PD<M*;TQW_S9^S7,DYAT2:!]X'XKN]:)C2Y&N[U+?#I]?!>C9J@7.W
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MJC8K/R&4)X*NBY?J&17R%;TX7)$H)DP!Y/T%I6)_H@+4'W*&_P)02P,$%
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M:-#)ZE5U^DQ%PN3YOD0M'S&<>#'L-H-K,_C_FR'KE)ZS@\>V95([F0P[L;4
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M/D^@K .>+Z4TVXT-T#QXH_]02P,$%     @ 5()A4MF[WH:/ P  /0T  !D
M  !X;"]W;W)K<VAE971S+W-H965T-C,N>&ULM5=-;]LX$/TKA-!# FPM4?XN
M; -QG$5[,#:(T=U#L0=:&EM$)-(EZ=CIK^^04B3%M54!N\XA)JF9-S-OR.%P
M<I#J62< AARS5.BIEQBS^^3[.DH@8[HC=R#PRT:JC!F<JJVO=PI8[)2RU ^#
M8.!GC MO-G%KCVHVD7N3<@&/BNA]EC'U.H=4'J8>]=X6GO@V,7;!GTUV; LK
M,%]WCPIG?HD2\PR$YE(0!9NI=T<_+<+ *CB)OSD<=&U,;"AK*9_MY$L\]0+K
M$:00&0O!\.<%[B%-+1+Z\;T ]4J;5K$^?D/_TP6/P:R9AGN9_L-CDTR]D4=B
MV+!]:I[DX3,4 ?4M7B13[?Z30RX[&'LDVFLCLT(9/<BXR'_9L2"BID '%Q3"
M0B$\5>A=4.@6"MVV"KU"H>>8R4-Q/"R88;.)D@>BK#2BV8$CTVEC^%S8O*^,
MPJ\<]<SLX?N>FU<R1^IB\I@RH<G- @SCJ;XE'\G7U8+<?+@E'P@79,G3%'.E
M)[Y!RU;?CPHK\]Q*>,$*#<E2"I-H\B!BB-\#^.ARZ7?XYO<\;$1<0-0A7?H'
M"8,P../0?6MU.CZCOFBO/FJ(IEMFH>OPNA?P5@E3\''MDG O,SS4FKEC\>UN
MK8W"P_%O@Y5>::7GK/2:K&B"IU\;)F(NM@0+!SDD/$KP#*,A[@ZC)@F+B9"&
MI&QG7;K!Y&NG?'LN][G5@;-JZ\P+YGO8'X03_Z6>D3-B_6 XI*78NZ#Z95#]
MQJ">"K_1S961T3/YMH1L#:J)L$&)/;AB6H:EE6%C!.^0X6C'<([F'*5?XV_8
M&9]P_*M,_U1FD<L,ZS+G4S J QBU#\!NFU>\KQ1$<BOXC]/3GL<R^L7/46<4
MU/\N;(MQZ=.XT:>';)?*5\#MWF(_T*"JEL$5=P2M567:=E?O0'$9$[1A$B#:
M[?&M8L*<9_8WP#U,#E.ZR<FP<C)LYO@(T=Y>V^2OS89'H%IQ7=5$>LVB2*NJ
M2)O+XG_@NAFX!==5E:/-96[)CCS;9ZT8KLH;O69]HU6!H\T5[JE^MQRPB\@O
M%NPISK+:#(87?J_)JZIJT>:RM>2B-:55V:'C*U(:5H4H#/Y'2G\#AI32<U[Y
MM;XR [5U_;DFD=P+D[=JY6KY!KASG>_)^AS?!GDG7\'D#XLE4UN.(:2P0<B@
M,\1CH/)>/9\8N7/=ZUH:[(7=,,'W#2@K@-\W4IJWB350OIAF/P%02P,$%
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MY_@=,'XF("9JRV_E9,^S!(0D?SVLI1*89']WN!#6+H3&A?"*"W]@.4K9AN=
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MR&G+/_:S[NU&^%F#_<TN+YIW!8>7:OH'4$L#!!0    ( %2"85*7BKL<P
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M4]9[Y]9_'#\^R\XV_5L^&_^:MW@!4$L! A0#%     @ 5()A4@=!36*!
ML0   !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M    " !4@F%2V!$3[.X    K @  $0              @ &O    9&]C4')O
M<',O8V]R92YX;6Q02P$"% ,4    " !4@F%2F5R<(Q &  "<)P  $P
M        @ ', 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( %2"
M85(Y9TR;S04  $08   8              " @0T(  !X;"]W;W)K<VAE971S
M+W-H965T,2YX;6Q02P$"% ,4    " !4@F%29=SQ1*8'  "/'P  &
M        @($0#@  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%
M  @ 5()A4H-UDOI/ P  V@H  !@              ("![!4  'AL+W=O<FMS
M:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    ( %2"85*!AP*C/P<  # ?   8
M              " @7$9  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"
M% ,4    " !4@F%2(^JXI# *   ;1   &               @('F(   >&PO
M=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @ 5()A4L[JK:'&"0
M+RP  !@              ("!3"L  'AL+W=O<FMS:&5E=',O<VAE970V+GAM
M;%!+ 0(4 Q0    ( %2"85)EZJTJU10  $@\   8              " @4@U
M  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4    " !4@F%2P5E(
M$&HJ   -A@  &               @(%32@  >&PO=V]R:W-H965T<R]S:&5E
M=#@N>&UL4$L! A0#%     @ 5()A4MD%.@R3#0  1BP  !@
M ("!\W0  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( %2"
M85*JG'#;1P,  (((   9              " @;R"  !X;"]W;W)K<VAE971S
M+W-H965T,3 N>&UL4$L! A0#%     @ 5()A4KIY!!/P#   4"P  !D
M         ("!.H8  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4
M    " !4@F%2"(B$=^\"  !'!@  &0              @(%ADP  >&PO=V]R
M:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( %2"85(EU6,ZU 0   ,,
M   9              " @8>6  !X;"]W;W)K<VAE971S+W-H965T,3,N>&UL
M4$L! A0#%     @ 5()A4NF*%M_X @  +08  !D              ("!DIL
M 'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4    " !4@F%2XGK_
M=K@&  !H$   &0              @('!G@  >&PO=V]R:W-H965T<R]S:&5E
M=#$U+GAM;%!+ 0(4 Q0    ( %2"85*EAV[B> <  / 3   9
M  " @;"E  !X;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%     @
M5()A4E9,X+Q/"   =Q4  !D              ("!7ZT  'AL+W=O<FMS:&5E
M=',O<VAE970Q-RYX;6Q02P$"% ,4    " !4@F%2M)1W!V8$  !A"@  &0
M            @('EM0  >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4
M Q0    ( %2"85+_&L!E(P8  " 0   9              " @8*Z  !X;"]W
M;W)K<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @ 5()A4@VYYVC\ P
M5PD  !D              ("!W,   'AL+W=O<FMS:&5E=',O<VAE970R,"YX
M;6Q02P$"% ,4    " !4@F%2NZZ?/=@#  "P"   &0              @($/
MQ0  >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( %2"85*S
MO-REP@(  )H&   9              " @1[)  !X;"]W;W)K<VAE971S+W-H
M965T,C(N>&UL4$L! A0#%     @ 5()A4CT_#)&* P  "0@  !D
M     ("!%\P  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( %2"85)'8XUZ P,  $@&   9              "
M@2@+ 0!X;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @ 5()A
M4M_8/EQ'!0  ;@X  !D              ("!8@X! 'AL+W=O<FMS:&5E=',O
M<VAE970R.2YX;6Q02P$"% ,4    " !4@F%2SA5K;&\$  !:#   &0
M        @('@$P$ >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0
M   ( %2"85)7%;_$  ,  &(&   9              " @888 0!X;"]W;W)K
M<VAE971S+W-H965T,S$N>&UL4$L! A0#%     @ 5()A4NHE/YW] P  ;0H
M !D              ("!O1L! 'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q0
M2P$"% ,4    " !4@F%2+7U< /L"   B!@  &0              @('Q'P$
M>&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( %2"85*M34D6
M! ,  &8&   9              " @2,C 0!X;"]W;W)K<VAE971S+W-H965T
M,S0N>&UL4$L! A0#%     @ 5()A4D587^20!   R L  !D
M ("!7B8! 'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q02P$"% ,4    " !4
M@F%2:Q85+3T%  #%#   &0              @($E*P$ >&PO=V]R:W-H965T
M<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    ( %2"85+(!F+QL ,  !@(   9
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M970T,2YX;6Q02P$"% ,4    " !4@F%2UT/'+_ +   11   &0
M    @(& 3 $ >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    (
M %2"85)8:1FY Q,  .2&   9              " @:=8 0!X;"]W;W)K<VAE
M971S+W-H965T-#,N>&UL4$L! A0#%     @ 5()A4D"XP3X#!   &@X  !D
M             ("!X6L! 'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6Q02P$"
M% ,4    " !4@F%2$QI.Q=X'  #W*   &0              @($;< $ >&PO
M=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4 Q0    ( %2"85(''<<K*@,
M %,)   9              " @3!X 0!X;"]W;W)K<VAE971S+W-H965T-#8N
M>&UL4$L! A0#%     @ 5()A4L2=$C## P  #!$  !D              ("!
MD7L! 'AL+W=O<FMS:&5E=',O<VAE970T-RYX;6Q02P$"% ,4    " !4@F%2
MM((M-DT#   ,"P  &0              @(&+?P$ >&PO=V]R:W-H965T<R]S
M:&5E=#0X+GAM;%!+ 0(4 Q0    ( %2"85)<Z>0Z$0,  $,*   9
M      " @0^# 0!X;"]W;W)K<VAE971S+W-H965T-#DN>&UL4$L! A0#%
M  @ 5()A4EN01Z R P  C@D  !D              ("!5X8! 'AL+W=O<FMS
M:&5E=',O<VAE970U,"YX;6Q02P$"% ,4    " !4@F%2MJDY;[4#  "Y#0
M&0              @(' B0$ >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+
M 0(4 Q0    ( %2"85)&H( *V00  $T6   9              " @:R- 0!X
M;"]W;W)K<VAE971S+W-H965T-3(N>&UL4$L! A0#%     @ 5()A4FT9<5Z&
M!0  )A4  !D              ("!O)(! 'AL+W=O<FMS:&5E=',O<VAE970U
M,RYX;6Q02P$"% ,4    " !4@F%2:Z.E+W\#   ;"P  &0
M@(%YF $ >&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    ( %2"
M85+K%% YEP,  ,L+   9              " @2^< 0!X;"]W;W)K<VAE971S
M+W-H965T-34N>&UL4$L! A0#%     @ 5()A4@F91;/J P  APX  !D
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M=#8P+GAM;%!+ 0(4 Q0    ( %2"85(=QEXRS0(   0'   9
M  " @4*S 0!X;"]W;W)K<VAE971S+W-H965T-C$N>&UL4$L! A0#%     @
M5()A4DIGH*3* @  _ 8  !D              ("!1K8! 'AL+W=O<FMS:&5E
M=',O<VAE970V,BYX;6Q02P$"% ,4    " !4@F%2V;O>AH\#   ]#0  &0
M            @(%'N0$ >&PO=V]R:W-H965T<R]S:&5E=#8S+GAM;%!+ 0(4
M Q0    ( %2"85)@["-V4 ,  $L*   9              " @0V] 0!X;"]W
M;W)K<VAE971S+W-H965T-C0N>&UL4$L! A0#%     @ 5()A4JM$X2;0 @
M]@<  !D              ("!E, ! 'AL+W=O<FMS:&5E=',O<VAE970V-2YX
M;6Q02P$"% ,4    " !4@F%2HNJG220#  "W"0  &0              @(&;
MPP$ >&PO=V]R:W-H965T<R]S:&5E=#8V+GAM;%!+ 0(4 Q0    ( %2"85(;
M"A%E\P,  #<,   9              " @?;& 0!X;"]W;W)K<VAE971S+W-H
M965T-C<N>&UL4$L! A0#%     @ 5()A4JW6 PC\ P  QPP  !D
M     ("!(,L! 'AL+W=O<FMS:&5E=',O<VAE970V."YX;6Q02P$"% ,4
M" !4@F%2?XS&;#\"  "V"@  #0              @ %3SP$ >&PO<W1Y;&5S
M+GAM;%!+ 0(4 Q0    ( %2"85*7BKL<P    !,"   +              "
M ;W1 0!?<F5L<R\N<F5L<U!+ 0(4 Q0    ( %2"85)3:#UR2@4  )4L   /
M              "  :;2 0!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " !4
M@F%2%MUK%"8"  !C*   &@              @ $=V $ >&PO7W)E;',O=V]R
M:V)O;VLN>&UL+G)E;'-02P$"% ,4    " !4@F%2X>Q>$?0!  "B)P  $P
M            @ %[V@$ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     3 !,
+ ,L4  "@W $    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>252</ContextCount>
  <ElementCount>498</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>71</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>18</UnitCount>
  <MyReports>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>010000 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>010100 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>020000 - Statement - CONSOLIDATED STATEMENTS OF INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/ConsolidatedStatementsOfIncome</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>030000 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/ConsolidatedStatementsOfChangesInEquity</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>040000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/ConsolidatedStatementsOfCashFlows</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>060100 - Disclosure - Organization, Nature of Operations and Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentation</Role>
      <ShortName>Organization, Nature of Operations and Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>060200 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>060300 - Disclosure - Acquisitions of Businesses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/AcquisitionsOfBusinesses</Role>
      <ShortName>Acquisitions of Businesses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>060400 - Disclosure - Acquisitions and Sale of Non-Controlling Interests</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterests</Role>
      <ShortName>Acquisitions and Sale of Non-Controlling Interests</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>060500 - Disclosure - Redeemable Non-Controlling Interest</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/RedeemableNoncontrollingInterest</Role>
      <ShortName>Redeemable Non-Controlling Interest</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>060600 - Disclosure - Goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/Goodwill</Role>
      <ShortName>Goodwill</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>060700 - Disclosure - Intangible Assets, net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/IntangibleAssetsNet</Role>
      <ShortName>Intangible Assets, net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>060800 - Disclosure - Accrued Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/AccruedExpenses</Role>
      <ShortName>Accrued Expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>060900 - Disclosure - Notes Payable</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://usph.com/role/NotesPayable</Role>
      <ShortName>Notes Payable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>061000 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>061100 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>061200 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/SegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>061300 - Disclosure - Equity Based Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/EquityBasedPlans</Role>
      <ShortName>Equity Based Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>061400 - Disclosure - Preferred Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/PreferredStock</Role>
      <ShortName>Preferred Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>061500 - Disclosure - Common Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/CommonStock</Role>
      <ShortName>Common Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>061600 - Disclosure - Defined Contribution Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/DefinedContributionPlan</Role>
      <ShortName>Defined Contribution Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>061700 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/CommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>061800 - Disclosure - Earnings Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/EarningsPerShare</Role>
      <ShortName>Earnings Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>061900 - Schedule - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/ScheduleIiValuationAndQualifyingAccounts</Role>
      <ShortName>SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>070200 - Disclosure - Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>080100 - Disclosure - Organization, Nature of Operations and Basis of Presentation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationTables</Role>
      <ShortName>Organization, Nature of Operations and Basis of Presentation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentation</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>080200 - Disclosure - Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/SignificantAccountingPoliciesTables</Role>
      <ShortName>Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://usph.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>080300 - Disclosure - Acquisitions of Businesses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/AcquisitionsOfBusinessesTables</Role>
      <ShortName>Acquisitions of Businesses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://usph.com/role/AcquisitionsOfBusinesses</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>080500 - Disclosure - Redeemable Non-Controlling Interest (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/RedeemableNoncontrollingInterestTables</Role>
      <ShortName>Redeemable Non-Controlling Interest (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://usph.com/role/RedeemableNoncontrollingInterest</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>080600 - Disclosure - Goodwill (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/GoodwillTables</Role>
      <ShortName>Goodwill (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://usph.com/role/Goodwill</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>080700 - Disclosure - Intangible Assets, net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/IntangibleAssetsNetTables</Role>
      <ShortName>Intangible Assets, net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://usph.com/role/IntangibleAssetsNet</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>080800 - Disclosure - Accrued Expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/AccruedExpensesTables</Role>
      <ShortName>Accrued Expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://usph.com/role/AccruedExpenses</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>080900 - Disclosure - Notes Payable (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://usph.com/role/NotesPayableTables</Role>
      <ShortName>Notes Payable (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://usph.com/role/NotesPayable</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>081000 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://usph.com/role/Leases</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>081100 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://usph.com/role/IncomeTaxes</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>081200 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/SegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://usph.com/role/SegmentInformation</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>081300 - Disclosure - Equity Based Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/EquityBasedPlansTables</Role>
      <ShortName>Equity Based Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://usph.com/role/EquityBasedPlans</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>081800 - Disclosure - Earnings Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/EarningsPerShareTables</Role>
      <ShortName>Earnings Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://usph.com/role/EarningsPerShare</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>090100 - Disclosure - Organization, Nature of Operations and Basis of Presentation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails</Role>
      <ShortName>Organization, Nature of Operations and Basis of Presentation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>090102 - Disclosure - Organization, Nature of Operations and Basis of Presentation - Acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails</Role>
      <ShortName>Organization, Nature of Operations and Basis of Presentation - Acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>090200 - Disclosure - Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/SignificantAccountingPoliciesDetails</Role>
      <ShortName>Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>090300 - Disclosure - Acquisitions of Businesses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/AcquisitionsOfBusinessesDetails</Role>
      <ShortName>Acquisitions of Businesses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/AcquisitionsOfBusinessesTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>090400 - Disclosure - Acquisitions and Sale of Non-Controlling Interests (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails</Role>
      <ShortName>Acquisitions and Sale of Non-Controlling Interests (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterests</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>090500 - Disclosure - Redeemable Non-Controlling Interest (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/RedeemableNoncontrollingInterestDetails</Role>
      <ShortName>Redeemable Non-Controlling Interest (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/RedeemableNoncontrollingInterestTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>090600 - Disclosure - Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/GoodwillDetails</Role>
      <ShortName>Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/GoodwillTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>090700 - Disclosure - Intangible Assets, net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/IntangibleAssetsNetDetails</Role>
      <ShortName>Intangible Assets, net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/IntangibleAssetsNetTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>090702 - Disclosure - Intangible Assets, net - Amortization Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails</Role>
      <ShortName>Intangible Assets, net - Amortization Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>090704 - Disclosure - Intangible Assets, net - Amortization of Referral Relationships and Non-Competition Agreements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails</Role>
      <ShortName>Intangible Assets, net - Amortization of Referral Relationships and Non-Competition Agreements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>090800 - Disclosure - Accrued Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/AccruedExpensesDetails</Role>
      <ShortName>Accrued Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/AccruedExpensesTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>090900 - Disclosure - Notes Payable - Summary of Notes Payable (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails</Role>
      <ShortName>Notes Payable - Summary of Notes Payable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>090902 - Disclosure - Notes Payable (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://usph.com/role/NotesPayableDetails</Role>
      <ShortName>Notes Payable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/NotesPayableTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>091000 - Disclosure - Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/LeasesDetails</Role>
      <ShortName>Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/LeasesTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>091100 - Disclosure - Income Taxes - Components of Deferred Tax Assets and Liabilities Included in Consolidated Balance Sheets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails</Role>
      <ShortName>Income Taxes - Components of Deferred Tax Assets and Liabilities Included in Consolidated Balance Sheets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>091102 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/IncomeTaxesTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>091104 - Disclosure - Income Taxes - Differences Between Federal Tax Rate and Company's Effective Tax Rate for Results of Continuing Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails</Role>
      <ShortName>Income Taxes - Differences Between Federal Tax Rate and Company's Effective Tax Rate for Results of Continuing Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>091106 - Disclosure - Income Taxes - Significant Components of Provision for Income Taxes for Continuing Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails</Role>
      <ShortName>Income Taxes - Significant Components of Provision for Income Taxes for Continuing Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>091200 - Disclosure - Segment Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/SegmentInformationDetails</Role>
      <ShortName>Segment Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/SegmentInformationTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>091300 - Disclosure - Equity Based Plans - Amended and Restated Employee Stock Option Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/EquityBasedPlansAmendedAndRestatedEmployeeStockOptionPlansDetails</Role>
      <ShortName>Equity Based Plans - Amended and Restated Employee Stock Option Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>091302 - Disclosure - Equity Based Plans - Cumulative Summary of Equity Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/EquityBasedPlansCumulativeSummaryOfEquityPlansDetails</Role>
      <ShortName>Equity Based Plans - Cumulative Summary of Equity Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>091304 - Disclosure - Equity Based Plans - Restricted Stock Granted to Directors, Officers and Employees Pursuant to its Equity Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/EquityBasedPlansRestrictedStockGrantedToDirectorsOfficersAndEmployeesPursuantToItsEquityPlansDetails</Role>
      <ShortName>Equity Based Plans - Restricted Stock Granted to Directors, Officers and Employees Pursuant to its Equity Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>091306 - Disclosure - Equity Based Plans - Restricted Stock Cancelled Due to Employee Terminations Prior to Restrictions Lapsing (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/EquityBasedPlansRestrictedStockCancelledDueToEmployeeTerminationsPriorToRestrictionsLapsingDetails</Role>
      <ShortName>Equity Based Plans - Restricted Stock Cancelled Due to Employee Terminations Prior to Restrictions Lapsing (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>091308 - Disclosure - Equity Based Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/EquityBasedPlansDetails</Role>
      <ShortName>Equity Based Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/EquityBasedPlansTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>091500 - Disclosure - Common Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/CommonStockDetails</Role>
      <ShortName>Common Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/CommonStock</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>091600 - Disclosure - Defined Contribution Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/DefinedContributionPlanDetails</Role>
      <ShortName>Defined Contribution Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/DefinedContributionPlan</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>091700 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/CommitmentsAndContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>091800 - Disclosure - Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/EarningsPerShareDetails</Role>
      <ShortName>Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/EarningsPerShareTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="brhc10020853_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>091900 - Schedule - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/ScheduleIiValuationAndQualifyingAccountsDetails</Role>
      <ShortName>SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="brhc10020853_10k.htm">brhc10020853_10k.htm</File>
    <File>brhc10020853_ex21-1.htm</File>
    <File>brhc10020853_ex23-1.htm</File>
    <File>brhc10020853_ex31-1.htm</File>
    <File>brhc10020853_ex31-2.htm</File>
    <File>brhc10020853_ex31-3.htm</File>
    <File>brhc10020853_ex32-1.htm</File>
    <File>brhc10020853_ex4-1.htm</File>
    <File>usph-20201231.xsd</File>
    <File>usph-20201231_cal.xml</File>
    <File>usph-20201231_def.xml</File>
    <File>usph-20201231_lab.xml</File>
    <File>usph-20201231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>image0.jpg</File>
    <File>image00002.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>91
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "brhc10020853_10k.htm": {
   "axisCustom": 0,
   "axisStandard": 22,
   "contextCount": 252,
   "dts": {
    "calculationLink": {
     "local": [
      "usph-20201231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "usph-20201231_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "brhc10020853_10k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "usph-20201231_lab.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-doc-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "usph-20201231_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-ref-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "usph-20201231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd",
      "https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd",
      "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd",
      "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd"
     ]
    }
   },
   "elementCount": 662,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2020-01-31": 8,
    "http://usph.com/20201231": 5,
    "http://xbrl.sec.gov/dei/2019-01-31": 8,
    "total": 21
   },
   "keyCustom": 128,
   "keyStandard": 370,
   "memberCustom": 42,
   "memberStandard": 27,
   "nsprefix": "usph",
   "nsuri": "http://usph.com/20201231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000100 - Document - Document and Entity Information",
     "role": "http://usph.com/role/DocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060400 - Disclosure - Acquisitions and Sale of Non-Controlling Interests",
     "role": "http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterests",
     "shortName": "Acquisitions and Sale of Non-Controlling Interests",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "usph:RedeemableNonControllingInterestTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060500 - Disclosure - Redeemable Non-Controlling Interest",
     "role": "http://usph.com/role/RedeemableNoncontrollingInterest",
     "shortName": "Redeemable Non-Controlling Interest",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "usph:RedeemableNonControllingInterestTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060600 - Disclosure - Goodwill",
     "role": "http://usph.com/role/Goodwill",
     "shortName": "Goodwill",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060700 - Disclosure - Intangible Assets, net",
     "role": "http://usph.com/role/IntangibleAssetsNet",
     "shortName": "Intangible Assets, net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060800 - Disclosure - Accrued Expenses",
     "role": "http://usph.com/role/AccruedExpenses",
     "shortName": "Accrued Expenses",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060900 - Disclosure - Notes Payable",
     "role": "http://usph.com/role/NotesPayable",
     "shortName": "Notes Payable",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "061000 - Disclosure - Leases",
     "role": "http://usph.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "061100 - Disclosure - Income Taxes",
     "role": "http://usph.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "061200 - Disclosure - Segment Information",
     "role": "http://usph.com/role/SegmentInformation",
     "shortName": "Segment Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "061300 - Disclosure - Equity Based Plans",
     "role": "http://usph.com/role/EquityBasedPlans",
     "shortName": "Equity Based Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "010000 - Statement - CONSOLIDATED BALANCE SHEETS",
     "role": "http://usph.com/role/ConsolidatedBalanceSheets",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "061400 - Disclosure - Preferred Stock",
     "role": "http://usph.com/role/PreferredStock",
     "shortName": "Preferred Stock",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "061500 - Disclosure - Common Stock",
     "role": "http://usph.com/role/CommonStock",
     "shortName": "Common Stock",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "061600 - Disclosure - Defined Contribution Plan",
     "role": "http://usph.com/role/DefinedContributionPlan",
     "shortName": "Defined Contribution Plan",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "061700 - Disclosure - Commitments and Contingencies",
     "role": "http://usph.com/role/CommitmentsAndContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "061800 - Disclosure - Earnings Per Share",
     "role": "http://usph.com/role/EarningsPerShare",
     "shortName": "Earnings Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "",
     "isDefault": "false",
     "longName": "061900 - Schedule - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS",
     "role": "http://usph.com/role/ScheduleIiValuationAndQualifyingAccounts",
     "shortName": "SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "070200 - Disclosure - Significant Accounting Policies (Policies)",
     "role": "http://usph.com/role/SignificantAccountingPoliciesPolicies",
     "shortName": "Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "usph:ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "080100 - Disclosure - Organization, Nature of Operations and Basis of Presentation (Tables)",
     "role": "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationTables",
     "shortName": "Organization, Nature of Operations and Basis of Presentation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "usph:ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "080200 - Disclosure - Significant Accounting Policies (Tables)",
     "role": "http://usph.com/role/SignificantAccountingPoliciesTables",
     "shortName": "Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "080300 - Disclosure - Acquisitions of Businesses (Tables)",
     "role": "http://usph.com/role/AcquisitionsOfBusinessesTables",
     "shortName": "Acquisitions of Businesses (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "010100 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://usph.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "080500 - Disclosure - Redeemable Non-Controlling Interest (Tables)",
     "role": "http://usph.com/role/RedeemableNoncontrollingInterestTables",
     "shortName": "Redeemable Non-Controlling Interest (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "080600 - Disclosure - Goodwill (Tables)",
     "role": "http://usph.com/role/GoodwillTables",
     "shortName": "Goodwill (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "080700 - Disclosure - Intangible Assets, net (Tables)",
     "role": "http://usph.com/role/IntangibleAssetsNetTables",
     "shortName": "Intangible Assets, net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "080800 - Disclosure - Accrued Expenses (Tables)",
     "role": "http://usph.com/role/AccruedExpensesTables",
     "shortName": "Accrued Expenses (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "080900 - Disclosure - Notes Payable (Tables)",
     "role": "http://usph.com/role/NotesPayableTables",
     "shortName": "Notes Payable (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "081000 - Disclosure - Leases (Tables)",
     "role": "http://usph.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "081100 - Disclosure - Income Taxes (Tables)",
     "role": "http://usph.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "081200 - Disclosure - Segment Information (Tables)",
     "role": "http://usph.com/role/SegmentInformationTables",
     "shortName": "Segment Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "081300 - Disclosure - Equity Based Plans (Tables)",
     "role": "http://usph.com/role/EquityBasedPlansTables",
     "shortName": "Equity Based Plans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "081800 - Disclosure - Earnings Per Share (Tables)",
     "role": "http://usph.com/role/EarningsPerShareTables",
     "shortName": "Earnings Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "020000 - Statement - CONSOLIDATED STATEMENTS OF INCOME",
     "role": "http://usph.com/role/ConsolidatedStatementsOfIncome",
     "shortName": "CONSOLIDATED STATEMENTS OF INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:LaborAndRelatedExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U004",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090100 - Disclosure - Organization, Nature of Operations and Basis of Presentation (Details)",
     "role": "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails",
     "shortName": "Organization, Nature of Operations and Basis of Presentation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U004",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20180831to20180831",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfBusinessesAcquired",
      "reportCount": 1,
      "unitRef": "U007",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090102 - Disclosure - Organization, Nature of Operations and Basis of Presentation - Acquisition (Details)",
     "role": "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails",
     "shortName": "Organization, Nature of Operations and Basis of Presentation - Acquisition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090200 - Disclosure - Significant Accounting Policies (Details)",
     "role": "http://usph.com/role/SignificantAccountingPoliciesDetails",
     "shortName": "Significant Accounting Policies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U004",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20180831to20180831",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfBusinessesAcquired",
      "reportCount": 1,
      "unitRef": "U007",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090300 - Disclosure - Acquisitions of Businesses (Details)",
     "role": "http://usph.com/role/AcquisitionsOfBusinessesDetails",
     "shortName": "Acquisitions of Businesses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20180430to20180430",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "usph:NumberOfPartnershipInWhichInterestAcquired",
      "reportCount": 1,
      "unitRef": "U015",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090400 - Disclosure - Acquisitions and Sale of Non-Controlling Interests (Details)",
     "role": "http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails",
     "shortName": "Acquisitions and Sale of Non-Controlling Interests (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090500 - Disclosure - Redeemable Non-Controlling Interest (Details)",
     "role": "http://usph.com/role/RedeemableNoncontrollingInterestDetails",
     "shortName": "Redeemable Non-Controlling Interest (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231_OwnershipAxis_RedeemableNonControllingInterestMember",
      "decimals": "-3",
      "lang": null,
      "name": "usph:NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090600 - Disclosure - Goodwill (Details)",
     "role": "http://usph.com/role/GoodwillDetails",
     "shortName": "Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IntangibleAssetsNetExcludingGoodwill",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090700 - Disclosure - Intangible Assets, net (Details)",
     "role": "http://usph.com/role/IntangibleAssetsNetDetails",
     "shortName": "Intangible Assets, net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:IntangibleAssetsNetExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090702 - Disclosure - Intangible Assets, net - Amortization Expenses (Details)",
     "role": "http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails",
     "shortName": "Intangible Assets, net - Amortization Expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090704 - Disclosure - Intangible Assets, net - Amortization of Referral Relationships and Non-Competition Agreements (Details)",
     "role": "http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails",
     "shortName": "Intangible Assets, net - Amortization of Referral Relationships and Non-Competition Agreements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20201231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20171231_StatementEquityComponentsAxis_CommonStockMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "030000 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY",
     "role": "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity",
     "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20171231_StatementEquityComponentsAxis_CommonStockMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090800 - Disclosure - Accrued Expenses (Details)",
     "role": "http://usph.com/role/AccruedExpensesDetails",
     "shortName": "Accrued Expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090900 - Disclosure - Notes Payable - Summary of Notes Payable (Details)",
     "role": "http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails",
     "shortName": "Notes Payable - Summary of Notes Payable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U005",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090902 - Disclosure - Notes Payable (Details)",
     "role": "http://usph.com/role/NotesPayableDetails",
     "shortName": "Notes Payable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U005",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091000 - Disclosure - Leases (Details)",
     "role": "http://usph.com/role/LeasesDetails",
     "shortName": "Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091100 - Disclosure - Income Taxes - Components of Deferred Tax Assets and Liabilities Included in Consolidated Balance Sheets (Details)",
     "role": "http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails",
     "shortName": "Income Taxes - Components of Deferred Tax Assets and Liabilities Included in Consolidated Balance Sheets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20201231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "usph:DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091102 - Disclosure - Income Taxes (Details)",
     "role": "http://usph.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20201231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "usph:DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091104 - Disclosure - Income Taxes - Differences Between Federal Tax Rate and Company's Effective Tax Rate for Results of Continuing Operations (Details)",
     "role": "http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails",
     "shortName": "Income Taxes - Differences Between Federal Tax Rate and Company's Effective Tax Rate for Results of Continuing Operations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091106 - Disclosure - Income Taxes - Significant Components of Provision for Income Taxes for Continuing Operations (Details)",
     "role": "http://usph.com/role/IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails",
     "shortName": "Income Taxes - Significant Components of Provision for Income Taxes for Continuing Operations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091200 - Disclosure - Segment Information (Details)",
     "role": "http://usph.com/role/SegmentInformationDetails",
     "shortName": "Segment Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20201231",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091300 - Disclosure - Equity Based Plans - Amended and Restated Employee Stock Option Plans (Details)",
     "role": "http://usph.com/role/EquityBasedPlansAmendedAndRestatedEmployeeStockOptionPlansDetails",
     "shortName": "Equity Based Plans - Amended and Restated Employee Stock Option Plans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20201231_AwardTypeAxis_NonQualifiedStockOptionsMember_RangeAxis_MaximumMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "040000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://usph.com/role/ConsolidatedStatementsOfCashFlows",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20201231",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091302 - Disclosure - Equity Based Plans - Cumulative Summary of Equity Plans (Details)",
     "role": "http://usph.com/role/EquityBasedPlansCumulativeSummaryOfEquityPlansDetails",
     "shortName": "Equity Based Plans - Cumulative Summary of Equity Plans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20201231",
      "decimals": "0",
      "lang": null,
      "name": "usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231_AwardTypeAxis_RestrictedStockMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091304 - Disclosure - Equity Based Plans - Restricted Stock Granted to Directors, Officers and Employees Pursuant to its Equity Plans (Details)",
     "role": "http://usph.com/role/EquityBasedPlansRestrictedStockGrantedToDirectorsOfficersAndEmployeesPursuantToItsEquityPlansDetails",
     "shortName": "Equity Based Plans - Restricted Stock Granted to Directors, Officers and Employees Pursuant to its Equity Plans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231_AwardTypeAxis_RestrictedStockMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231_AwardTypeAxis_RestrictedStockMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091306 - Disclosure - Equity Based Plans - Restricted Stock Cancelled Due to Employee Terminations Prior to Restrictions Lapsing (Details)",
     "role": "http://usph.com/role/EquityBasedPlansRestrictedStockCancelledDueToEmployeeTerminationsPriorToRestrictionsLapsingDetails",
     "shortName": "Equity Based Plans - Restricted Stock Cancelled Due to Employee Terminations Prior to Restrictions Lapsing (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231_AwardTypeAxis_RestrictedStockMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20201231",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091308 - Disclosure - Equity Based Plans (Details)",
     "role": "http://usph.com/role/EquityBasedPlansDetails",
     "shortName": "Equity Based Plans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20201231",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "usph:ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20090301to20090331",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockRepurchasedDuringPeriodShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091500 - Disclosure - Common Stock (Details)",
     "role": "http://usph.com/role/CommonStockDetails",
     "shortName": "Common Stock (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20090301to20090331",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockRepurchasedDuringPeriodShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "usph:DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091600 - Disclosure - Defined Contribution Plan (Details)",
     "role": "http://usph.com/role/DefinedContributionPlanDetails",
     "shortName": "Defined Contribution Plan (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "usph:DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "usph:EmploymentAgreementsExpirationDate",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091700 - Disclosure - Commitments and Contingencies (Details)",
     "role": "http://usph.com/role/CommitmentsAndContingenciesDetails",
     "shortName": "Commitments and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "usph:EmploymentAgreementsExpirationDate",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091800 - Disclosure - Earnings Per Share (Details)",
     "role": "http://usph.com/role/EarningsPerShareDetails",
     "shortName": "Earnings Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": "-3",
      "lang": null,
      "name": "usph:ChargesToRetainedEarningsRevaluationOfNonControllingInterests",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20191231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "",
     "isDefault": "false",
     "longName": "091900 - Schedule - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details)",
     "role": "http://usph.com/role/ScheduleIiValuationAndQualifyingAccountsDetails",
     "shortName": "SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20171231_ValuationAllowancesAndReservesTypeAxis_AllowanceForCreditLossMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060100 - Disclosure - Organization, Nature of Operations and Basis of Presentation",
     "role": "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentation",
     "shortName": "Organization, Nature of Operations and Basis of Presentation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060200 - Disclosure - Significant Accounting Policies",
     "role": "http://usph.com/role/SignificantAccountingPolicies",
     "shortName": "Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060300 - Disclosure - Acquisitions of Businesses",
     "role": "http://usph.com/role/AcquisitionsOfBusinesses",
     "shortName": "Acquisitions of Businesses",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10020853_10k.htm",
      "contextRef": "c20200101to20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 71,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityNumberOfEmployees": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of persons employed by the Entity",
        "label": "Number of full and part-time workforce"
       }
      }
     },
     "localname": "EntityNumberOfEmployees",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://usph.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r382",
      "r383",
      "r389",
      "r390",
      "r495",
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by consolidated entity or group of entities.",
        "label": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r382",
      "r383",
      "r389",
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity or group of entities consolidated into reporting entity.",
        "label": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r146",
      "r165",
      "r166",
      "r167",
      "r168",
      "r170",
      "r172",
      "r176"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://usph.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r146",
      "r165",
      "r166",
      "r167",
      "r168",
      "r170",
      "r172",
      "r176"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://usph.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_DirectorMember": {
     "auth_ref": [
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Person serving on board of directors.",
        "label": "Director [Member]"
       }
      }
     },
     "localname": "DirectorMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ExecutiveOfficerMember": {
     "auth_ref": [
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Person with designation of executive officer.",
        "label": "Executive Officer [Member]",
        "terseLabel": "Executive Officer [Member]"
       }
      }
     },
     "localname": "ExecutiveOfficerMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://usph.com/role/CommitmentsAndContingenciesDetails",
      "http://usph.com/role/EquityBasedPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r291",
      "r294",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r477",
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upper limit of the provided range.",
        "label": "Maximum [Member]",
        "terseLabel": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails",
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/CommonStockDetails",
      "http://usph.com/role/EquityBasedPlansAmendedAndRestatedEmployeeStockOptionPlansDetails",
      "http://usph.com/role/EquityBasedPlansDetails",
      "http://usph.com/role/IncomeTaxesDetails",
      "http://usph.com/role/IntangibleAssetsNetDetails",
      "http://usph.com/role/LeasesDetails",
      "http://usph.com/role/NotesPayableDetails",
      "http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails",
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails",
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r291",
      "r294",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r477",
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum [Member]",
        "terseLabel": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails",
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/EquityBasedPlansDetails",
      "http://usph.com/role/IncomeTaxesDetails",
      "http://usph.com/role/IntangibleAssetsNetDetails",
      "http://usph.com/role/NotesPayableDetails",
      "http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails",
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails",
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OfficerMember": {
     "auth_ref": [
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Person with designation of officer.",
        "label": "Officer [Member]"
       }
      }
     },
     "localname": "OfficerMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.",
        "label": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.",
        "label": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r178",
      "r274",
      "r275",
      "r443",
      "r476",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by product and service, or group of similar products and similar services.",
        "label": "Products and Services [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome",
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r178",
      "r274",
      "r275",
      "r443",
      "r476",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services.",
        "label": "Products and Services [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome",
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r288",
      "r291",
      "r294",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r477",
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails",
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/CommonStockDetails",
      "http://usph.com/role/EquityBasedPlansAmendedAndRestatedEmployeeStockOptionPlansDetails",
      "http://usph.com/role/EquityBasedPlansDetails",
      "http://usph.com/role/IncomeTaxesDetails",
      "http://usph.com/role/IntangibleAssetsNetDetails",
      "http://usph.com/role/LeasesDetails",
      "http://usph.com/role/NotesPayableDetails",
      "http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails",
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails",
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r288",
      "r291",
      "r294",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r477",
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails",
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/CommonStockDetails",
      "http://usph.com/role/EquityBasedPlansAmendedAndRestatedEmployeeStockOptionPlansDetails",
      "http://usph.com/role/EquityBasedPlansDetails",
      "http://usph.com/role/IncomeTaxesDetails",
      "http://usph.com/role/IntangibleAssetsNetDetails",
      "http://usph.com/role/LeasesDetails",
      "http://usph.com/role/NotesPayableDetails",
      "http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails",
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails",
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r292",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information reported for future period.",
        "label": "Forecast [Member]"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.",
        "label": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": {
     "auth_ref": [
      "r110",
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]",
        "terseLabel": "SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS"
       }
      }
     },
     "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://usph.com/role/ScheduleIiValuationAndQualifyingAccounts"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r239",
      "r292",
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.",
        "label": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SubsidiariesMember": {
     "auth_ref": [
      "r289",
      "r429",
      "r430",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity owned or controlled by another entity.",
        "label": "NewCo. [Member]"
       }
      }
     },
     "localname": "SubsidiariesMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r183",
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by title of individual or nature of relationship to individual or group of individuals.",
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://usph.com/role/CommitmentsAndContingenciesDetails",
      "http://usph.com/role/EquityBasedPlansDetails",
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of individual, or nature of relationship to individual or group of individuals.",
        "label": "Relationship to Entity [Domain]",
        "terseLabel": "Relationship to Entity [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://usph.com/role/CommitmentsAndContingenciesDetails",
      "http://usph.com/role/EquityBasedPlansDetails",
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ValuationAndQualifyingAccountsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS [Abstract]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsAbstract",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Valuation and Qualifying Accounts Disclosure [Line Items]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureLineItems",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://usph.com/role/ScheduleIiValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureTable": {
     "auth_ref": [
      "r110",
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of valuation and qualifying accounts and reserves.",
        "label": "Valuation and Qualifying Accounts Disclosure [Table]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureTable",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://usph.com/role/ScheduleIiValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201602Member": {
     "auth_ref": [
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2016-02 Leases (Topic 842).",
        "label": "ASU 2016-02 [Member]"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201602Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails",
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsAndOtherReceivablesNetCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer.",
        "label": "Accounts and Other Receivables, Net, Current",
        "terseLabel": "Accounts receivable - other"
       }
      }
     },
     "localname": "AccountsAndOtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable and Accrued Liabilities, Current [Abstract]",
        "terseLabel": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r38"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "terseLabel": "Accrued Expenses"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/AccruedExpenses"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "auth_ref": [
      "r14",
      "r37"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Trade, Current",
        "terseLabel": "Accounts payable - trade"
       }
      }
     },
     "localname": "AccountsPayableTradeCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r9",
      "r26",
      "r184",
      "r185"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Patient accounts receivable, less allowance for credit losses of $2,008 and $2,698, respectively"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r20",
      "r453",
      "r466"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Tax payable included in accrued liabilities"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedInsuranceCurrent": {
     "auth_ref": [
      "r13",
      "r14",
      "r43"
     ],
     "calculation": {
      "http://usph.com/role/AccruedExpensesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable to insurance entities to mitigate potential loss from various risks or to satisfy a promise to provide certain coverage's to employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Insurance, Current",
        "verboseLabel": "Group health insurance claims"
       }
      }
     },
     "localname": "AccruedInsuranceCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://usph.com/role/AccruedExpensesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/AccruedExpensesDetails",
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r35",
      "r224"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "terseLabel": "Less accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r27",
      "r321"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r112",
      "r113",
      "r114",
      "r318",
      "r319",
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r115",
      "r116",
      "r117",
      "r118",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r349",
      "r350",
      "r351",
      "r352",
      "r445",
      "r446",
      "r447",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails",
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income including non-controlling interests to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r296",
      "r298",
      "r323",
      "r324"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Compensation expense - equity-based awards"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r298",
      "r311",
      "r322"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForCreditLossMember": {
     "auth_ref": [
      "r109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance for credit loss from right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Allowance for Credit Losses [Member]"
       }
      }
     },
     "localname": "AllowanceForCreditLossMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ScheduleIiValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r32",
      "r187",
      "r196"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Allowance for credit losses, patient accounts receivable"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfDeferredChargesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization of Deferred Charges [Abstract]"
       }
      }
     },
     "localname": "AmortizationOfDeferredChargesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r84",
      "r210",
      "r217"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "verboseLabel": "Total amortization expenses"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r96",
      "r154",
      "r167",
      "r174",
      "r189",
      "r382",
      "r389",
      "r399",
      "r451",
      "r465"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Total assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets",
      "http://usph.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets",
      "http://usph.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r10",
      "r11",
      "r55",
      "r96",
      "r189",
      "r382",
      "r389",
      "r399"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets",
      "http://usph.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r299",
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansAmendedAndRestatedEmployeeStockOptionPlansDetails",
      "http://usph.com/role/EquityBasedPlansDetails",
      "http://usph.com/role/EquityBasedPlansRestrictedStockCancelledDueToEmployeeTerminationsPriorToRestrictionsLapsingDetails",
      "http://usph.com/role/EquityBasedPlansRestrictedStockGrantedToDirectorsOfficersAndEmployeesPursuantToItsEquityPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r290",
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails",
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r290",
      "r293",
      "r366",
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails",
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when the business acquisition agreement was executed, in CCYY-MM-DD format.",
        "label": "Business Acquisition, Date of Acquisition Agreement",
        "terseLabel": "Acquisition date"
       }
      }
     },
     "localname": "BusinessAcquisitionDateOfAcquisitionAgreement1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails",
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails",
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Percentage of interest acquired"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails",
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount": {
     "auth_ref": [
      "r377"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.",
        "label": "Business Acquisition, Goodwill, Expected Tax Deductible Amount",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r373",
      "r374",
      "r375"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Aggregate purchase price for the acquired clinic practices"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDescriptionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Description [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationDescriptionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails",
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails",
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r378"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Acquisitions of Businesses"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinesses"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationGoodwillAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Goodwill [Abstract]",
        "terseLabel": "Goodwill [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationGoodwillAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r369"
     ],
     "calculation": {
      "http://usph.com/role/AcquisitionsOfBusinessesDetails": {
       "order": 0.0,
       "parentTag": "usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Total current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r368",
      "r369"
     ],
     "calculation": {
      "http://usph.com/role/AcquisitionsOfBusinessesDetails": {
       "order": 2.0,
       "parentTag": "usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "terseLabel": "Total liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets": {
     "auth_ref": [
      "r369"
     ],
     "calculation": {
      "http://usph.com/role/AcquisitionsOfBusinessesDetails": {
       "order": 1.0,
       "parentTag": "usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets",
        "terseLabel": "Total non-current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquisitions of Businesses [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAcquiredFromAcquisition": {
     "auth_ref": [
      "r70"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).",
        "label": "Net of cash acquired"
       }
      }
     },
     "localname": "CashAcquiredFromAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r8",
      "r33",
      "r86"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r16",
      "r87",
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r80",
      "r86",
      "r92"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents - end of period",
        "periodStartLabel": "Cash and cash equivalents - beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r80",
      "r400"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
        "terseLabel": "Non-cash investing and financing transactions during the period:"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock Disclosures [Abstract]"
       }
      }
     },
     "localname": "ClassOfStockDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/CommonStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfTreasuryStockTable": {
     "auth_ref": [
      "r260",
      "r261",
      "r262",
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table]"
       }
      }
     },
     "localname": "ClassOfTreasuryStockTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/CommonStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r49",
      "r238",
      "r458",
      "r472"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "verboseLabel": "Commitments and Contingencies (Note 17)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r235",
      "r236",
      "r237",
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/CommitmentsAndContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Dividends declared per common share (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r112",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r25"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $.01 par value, 20,000,000 shares authorized, 15,066,282 and 14,989,337 shares issued, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": {
     "auth_ref": [
      "r286",
      "r287",
      "r295",
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.",
        "label": "Compensation and Employee Benefit Plans [Text Block]",
        "terseLabel": "Defined Contribution Plan"
       }
      }
     },
     "localname": "CompensationAndEmployeeBenefitPlansTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/DefinedContributionPlan"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Contribution Plan [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Assets [Abstract]",
        "terseLabel": "Deferred tax assets [Abstract]"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Liabilities [Abstract]",
        "terseLabel": "Deferred tax liabilities [Abstract]"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComputerSoftwareIntangibleAssetMember": {
     "auth_ref": [
      "r211",
      "r215",
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collection of computer programs and related data that provide instructions to a computer, for example, but not limited to, application program, control module or operating system, that perform one or more particular functions or tasks.",
        "label": "Computer Software, Intangible Asset [Member]",
        "terseLabel": "Software [Member]"
       }
      }
     },
     "localname": "ComputerSoftwareIntangibleAssetMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Change Due to Net Income Attributable to Parent and Effects of Changes, Net [Abstract]"
       }
      }
     },
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent": {
     "auth_ref": [
      "r259",
      "r388",
      "r394"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the purchase by the parent of an additional equity interest in a subsidiary during the period, thereby effecting a change in total (consolidated) equity attributable to the parent. The purchase of the additional equity interest represented by this element increases the parent's controlling interest in the subsidiary.",
        "label": "Purchase price for additional non controlling interest"
       }
      }
     },
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent": {
     "auth_ref": [
      "r259",
      "r388",
      "r394"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents a sale by the parent of a portion of its equity interest in a subsidiary during the period, thereby effecting a change in total (consolidated) equity attributable to the parent. The sale of the equity interest represented by this element does not result in a loss of control by the parent.",
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Sale of Interest by Parent",
        "verboseLabel": "Cash proceeds from sale of non-controlling interest"
       }
      }
     },
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]"
       }
      }
     },
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable": {
     "auth_ref": [
      "r388",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent which may have occurred during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary.",
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]"
       }
      }
     },
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock": {
     "auth_ref": [
      "r492",
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for contractual adjustments and third-party settlements.",
        "label": "Contractual Adjustments and Third Party Settlements, Policy [Policy Text Block]",
        "terseLabel": "Contractual Allowances"
       }
      }
     },
     "localname": "ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total operating costs"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs and Expenses [Abstract]",
        "terseLabel": "Operating costs:"
       }
      }
     },
     "localname": "CostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableDetails",
      "http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableDetails",
      "http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r97",
      "r345",
      "r355"
     ],
     "calculation": {
      "http://usph.com/role/IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r97",
      "r345",
      "r355",
      "r357"
     ],
     "calculation": {
      "http://usph.com/role/IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current [Abstract]"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r97",
      "r345",
      "r355"
     ],
     "calculation": {
      "http://usph.com/role/IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes Payable [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r247"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Notes Payable"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayable"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAnnualPrincipalPayment": {
     "auth_ref": [
      "r21"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the total principal payments made during the annual reporting period.",
        "label": "Principal installments",
        "verboseLabel": "Annual installments"
       }
      }
     },
     "localname": "DebtInstrumentAnnualPrincipalPayment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r19",
      "r20",
      "r21",
      "r452",
      "r455",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableDetails",
      "http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails",
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r409",
      "r410"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Aggregate amount of notes payable",
        "verboseLabel": "Aggregate amount of notes payable"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableDetails",
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r45"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Percentage of interest accrued"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableDetails",
      "http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "auth_ref": [
      "r46",
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.",
        "label": "Debt Instrument, Maturity Date",
        "terseLabel": "Revolving credit facility maturity date"
       }
      }
     },
     "localname": "DebtInstrumentMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableDetails",
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r47"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableDetails",
      "http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails",
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r47",
      "r98",
      "r254",
      "r255",
      "r256",
      "r257",
      "r408",
      "r409",
      "r410",
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableDetails",
      "http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instruments [Abstract]"
       }
      }
     },
     "localname": "DebtInstrumentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableDetails",
      "http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/CommitmentsAndContingenciesDetails",
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1": {
     "auth_ref": [
      "r285",
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum period the individual is required to perform services to be fully vested under the deferred compensation arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Period in which restrictions lapse on stock granted"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DeferredCompensationArrangementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Stock [Abstract]"
       }
      }
     },
     "localname": "DeferredCompensationArrangementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r97",
      "r346",
      "r355"
     ],
     "calculation": {
      "http://usph.com/role/IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r84",
      "r97",
      "r346",
      "r355",
      "r356",
      "r357"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://usph.com/role/IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes",
        "totalLabel": "Total deferred"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows",
      "http://usph.com/role/IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred [Abstract]"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r22",
      "r23",
      "r338",
      "r454",
      "r463"
     ],
     "calculation": {
      "http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r328",
      "r329"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxesAndOtherTaxReceivableCurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and other tax receivables expected to be realized or consumed within one year or operating cycle, if longer.",
        "label": "Deferred Income Taxes and Other Tax Receivable, Current",
        "terseLabel": "Tax receivable included in other current assets"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndOtherTaxReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRentCreditNoncurrent": {
     "auth_ref": [
      "r50",
      "r411"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For a classified balance sheet, the cumulative difference between the rental income or payments required by a lease agreement and the rental income or expense recognized on a straight-line basis, or other systematic and rational basis more representative of the time pattern in which use or benefit is granted or derived from the leased property, expected to be recognized in income or expense, by the lessor or lessee, respectively, more than one year after the balance sheet date.",
        "label": "Deferred Rent Credit, Noncurrent",
        "terseLabel": "Deferred rent"
       }
      }
     },
     "localname": "DeferredRentCreditNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r97",
      "r346",
      "r355"
     ],
     "calculation": {
      "http://usph.com/role/IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r339"
     ],
     "calculation": {
      "http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r343",
      "r344"
     ],
     "calculation": {
      "http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Acquired net operating losses"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits": {
     "auth_ref": [
      "r343",
      "r344"
     ],
     "calculation": {
      "http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits",
        "terseLabel": "Compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts": {
     "auth_ref": [
      "r343",
      "r344"
     ],
     "calculation": {
      "http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from the allowance for doubtful accounts.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts",
        "terseLabel": "Allowance for credit losses"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r329",
      "r340"
     ],
     "calculation": {
      "http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Net deferred tax liability"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "auth_ref": [
      "r343",
      "r344"
     ],
     "calculation": {
      "http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.",
        "label": "Deferred Tax Liabilities, Other",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r343",
      "r344"
     ],
     "calculation": {
      "http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "negatedLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Discretionary Contribution Amount",
        "terseLabel": "Contribution expense recognized"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/DefinedContributionPlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage employer matches of the employee's percentage contribution matched.",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Match",
        "terseLabel": "Maximum employer contribution as a percentage of employee contribution"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/DefinedContributionPlanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r84",
      "r149"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue, Categories"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Equity Based Plans"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/EquityBasedPlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Based Plans [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r258"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedLabel": "Dividends paid to USPT shareholders"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDiluted": {
     "auth_ref": [
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Basic and diluted earnings per share attributable to USPH shareholders (in dollars per share)",
        "terseLabel": "Earnings per share (basic and diluted) (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome",
      "http://usph.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r129",
      "r130",
      "r131",
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/EarningsPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r331"
     ],
     "calculation": {
      "http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r331",
      "r358"
     ],
     "calculation": {
      "http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "U.S. tax at statutory rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationDeductions": {
     "auth_ref": [
      "r331",
      "r358"
     ],
     "calculation": {
      "http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations attributable to deduction. Includes, but is not limited to, dividend deduction, deduction for dividend paid to employee stock ownership plan (ESOP), Medicare prescription drug benefit subsidy deduction, and other deductions.",
        "label": "Effective Income Tax Rate Reconciliation, Deduction, Percent",
        "negatedLabel": "Excess equity compensation deduction"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationDeductions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense": {
     "auth_ref": [
      "r331",
      "r358"
     ],
     "calculation": {
      "http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent",
        "terseLabel": "Nondeductible expenses"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r331",
      "r358"
     ],
     "calculation": {
      "http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State income taxes, net of federal benefit and tax reform"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://usph.com/role/AccruedExpensesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Salaries and related costs"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "auth_ref": [
      "r312"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "verboseLabel": "Compensation not yet recognized"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityClassOfTreasuryStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Equity, Class of Treasury Stock [Line Items]"
       }
      }
     },
     "localname": "EquityClassOfTreasuryStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/CommonStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r112",
      "r113",
      "r114",
      "r116",
      "r123",
      "r125",
      "r133",
      "r193",
      "r253",
      "r258",
      "r318",
      "r319",
      "r320",
      "r351",
      "r352",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r482",
      "r483",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r93",
      "r397",
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair Values of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts": {
     "auth_ref": [
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for charging off uncollectible financing receivables, including, but not limited to, factors and methodologies used in estimating the allowance for credit loss.",
        "label": "Allowance for Credit Losses"
       }
      }
     },
     "localname": "FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of finite-lived and indefinite-lived intangible assets acquired as part of a business combination.",
        "label": "Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]",
        "terseLabel": "Preliminary Purchase Prices Allocation"
       }
      }
     },
     "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Estimated useful life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails",
      "http://usph.com/role/IntangibleAssetsNetDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r216"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "terseLabel": "Accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r218"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life.",
        "label": "Finite-lived Intangible Assets Amortization Expense [Table Text Block]",
        "terseLabel": "Amortization Expenses"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r218"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r218"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r218"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r218"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r211",
      "r212",
      "r216",
      "r219",
      "r444",
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails",
      "http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails",
      "http://usph.com/role/IntangibleAssetsNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Maturity [Abstract]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails",
      "http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails",
      "http://usph.com/role/IntangibleAssetsNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r211",
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails",
      "http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails",
      "http://usph.com/role/IntangibleAssetsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Net [Abstract]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Federal [Member]"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FurnitureAndFixturesGross": {
     "auth_ref": [
      "r223"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures, Gross",
        "terseLabel": "Furniture and equipment"
       }
      }
     },
     "localname": "FurnitureAndFixturesGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture &amp; Equipment [Member]"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnSaleOfInterestInProjects": {
     "auth_ref": [
      "r2",
      "r228"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (loss) included in earnings resulting from the sale of interest in projects.",
        "label": "Gain (Loss) on Sale of Interest in Projects",
        "terseLabel": "Gain on sale of partnership interest and clinics"
       }
      }
     },
     "localname": "GainLossOnSaleOfInterestInProjects",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r84",
      "r245",
      "r246"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "terseLabel": "Gain on derecognition of debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r198",
      "r200",
      "r450"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets",
      "http://usph.com/role/GoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r201"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill acquired"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/GoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "auth_ref": [
      "r93",
      "r205",
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillDisclosureTextBlock": {
     "auth_ref": [
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill.",
        "label": "Goodwill Disclosure [Text Block]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/Goodwill"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r84",
      "r199",
      "r203",
      "r206"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Closure costs - derecognition of goodwill",
        "negatedLabel": "Goodwill derecognition (write-off) related to closed clinics",
        "verboseLabel": "Write-off of goodwill - closed clinics"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows",
      "http://usph.com/role/ConsolidatedStatementsOfIncome",
      "http://usph.com/role/GoodwillDetails",
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r204",
      "r364"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "terseLabel": "Goodwill adjustments for purchase price allocation of businesses acquired in prior year"
       }
      }
     },
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/GoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/GoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit": {
     "auth_ref": [
      "r202"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Written off Related to Sale of Business Unit",
        "negatedLabel": "Goodwill related to partnership interest sold"
       }
      }
     },
     "localname": "GoodwillWrittenOffRelatedToSaleOfBusinessUnit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/GoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrantsReceivable": {
     "auth_ref": [
      "r54"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants.",
        "label": "Funds received"
       }
      }
     },
     "localname": "GrantsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r65",
      "r96",
      "r154",
      "r166",
      "r170",
      "r173",
      "r176",
      "r189",
      "r399"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome",
      "http://usph.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Impairment of Long-Lived Assets and Long-Lived Assets to be Disposed of"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r93",
      "r221",
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "terseLabel": "Long-Lived Assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r60",
      "r154",
      "r166",
      "r170",
      "r173",
      "r176",
      "r449",
      "r459",
      "r461",
      "r474"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 0.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CONSOLIDATED STATEMENTS OF INCOME [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes [Abstract]",
        "terseLabel": "Income Taxes [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r332",
      "r336",
      "r342",
      "r353",
      "r359",
      "r361",
      "r362",
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExaminationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Examination [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxExaminationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExaminationTable": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A summary of income tax examinations that an enterprise is currently subject to or that have been completed in the current period typically including a description of the examination, the jurisdiction conducting the examination, the tax year(s) under examination, the likelihood of an unfavorable settlement, the range of possible losses, the liability recorded, the Increase or Decrease in the liability from the prior period, and any penalties and interest that have been incurred or accrued.",
        "label": "Income Tax Examination [Table]"
       }
      }
     },
     "localname": "IncomeTaxExaminationTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExaminationYearUnderExamination": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax year being audited in the income tax examination, in CCYY format.",
        "label": "Income Tax Examination, Year under Examination",
        "terseLabel": "Periods open for examination"
       }
      }
     },
     "localname": "IncomeTaxExaminationYearUnderExamination",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "gYearListItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r97",
      "r124",
      "r125",
      "r152",
      "r330",
      "r354",
      "r360",
      "r475"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      },
      "http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://usph.com/role/IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision for income taxes",
        "totalLabel": "Total income tax provision"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome",
      "http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails",
      "http://usph.com/role/IncomeTaxesSignificantComponentsOfProvisionForIncomeTaxesForContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability": {
     "auth_ref": [
      "r347"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income tax expense (benefit) from continuing operations attributable to an adjustment of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity.",
        "label": "Adjustment to deferred tax assets"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r58",
      "r93",
      "r326",
      "r327",
      "r336",
      "r337",
      "r341",
      "r348",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationDeductions": {
     "auth_ref": [
      "r331"
     ],
     "calculation": {
      "http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations attributable to deduction. Includes, but is not limited to, dividend deduction, deduction for dividend paid to employee stock ownership plan (ESOP), Medicare prescription drug benefit subsidy deduction, and other deductions.",
        "label": "Effective Income Tax Rate Reconciliation, Deduction, Amount",
        "negatedLabel": "Excess equity compensation deduction"
       }
      }
     },
     "localname": "IncomeTaxReconciliationDeductions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r331"
     ],
     "calculation": {
      "http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "terseLabel": "U.S. tax at statutory rate"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpense": {
     "auth_ref": [
      "r331"
     ],
     "calculation": {
      "http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount",
        "terseLabel": "Non-deductible expenses"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r331"
     ],
     "calculation": {
      "http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "terseLabel": "State income taxes, net of federal benefit"
       }
      }
     },
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesDifferencesBetweenFederalTaxRateAndCompanySEffectiveTaxRateForResultsOfContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r88"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 19.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Increase (decrease) in accounts payable and accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Decrease (increase) in patient accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in receivables, and operating assets classified as other.",
        "label": "Increase (Decrease) in Accounts Receivable and Other Operating Assets",
        "negatedLabel": "Decrease (increase) in accounts receivable - other"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 20.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other.",
        "label": "Increase (decrease) in other long-term liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedLabel": "Decrease (increase) in other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all or part of the information related to intangible assets.",
        "label": "Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Intangible Assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r209",
      "r214"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Other identifiable intangible assets, net",
        "verboseLabel": "Total"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets",
      "http://usph.com/role/IntangibleAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets, net [Abstract]"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwillAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestAndOtherIncome": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).",
        "label": "Interest and Other Income",
        "terseLabel": "Interest and other income, net"
       }
      }
     },
     "localname": "InterestAndOtherIncome",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations": {
     "auth_ref": [
      "r433"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of interest expense on prepetition obligations included in the statement of operations.",
        "label": "Interest Expense on Prepetition Liabilities Recognized in Statement of Operations",
        "terseLabel": "Interest expense recognized"
       }
      }
     },
     "localname": "InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r78",
      "r81",
      "r88"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LaborAndRelatedExpense": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.",
        "label": "Labor and Related Expense",
        "terseLabel": "Salaries and related costs"
       }
      }
     },
     "localname": "LaborAndRelatedExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r425",
      "r427"
     ],
     "calculation": {
      "http://usph.com/role/LeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total lease cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Lease Expense [Abstract]"
       }
      }
     },
     "localname": "LeaseCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Components of Lease Expense"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsGross": {
     "auth_ref": [
      "r12",
      "r223"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements, Gross",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold Improvements [Member]"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LEASES [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseDescriptionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease [Abstract]"
       }
      }
     },
     "localname": "LesseeOperatingLeaseDescriptionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Future Lease Payments for Operating Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r426"
     ],
     "calculation": {
      "http://usph.com/role/LeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://usph.com/role/LeasesDetailsCalc01": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r426"
     ],
     "calculation": {
      "http://usph.com/role/LeasesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2025 and therafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r426"
     ],
     "calculation": {
      "http://usph.com/role/LeasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2021"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r426"
     ],
     "calculation": {
      "http://usph.com/role/LeasesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r426"
     ],
     "calculation": {
      "http://usph.com/role/LeasesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r426"
     ],
     "calculation": {
      "http://usph.com/role/LeasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r426"
     ],
     "calculation": {
      "http://usph.com/role/LeasesDetailsCalc01": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "terseLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lease term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r42",
      "r96",
      "r168",
      "r189",
      "r383",
      "r389",
      "r390",
      "r399"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r31",
      "r96",
      "r189",
      "r399",
      "r457",
      "r470"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities, redeemable non-controlling interests, USPH shareholders' equity and non-controlling interests"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES, REDEEMABLE NON-CONTROLLING INTERESTS, USPH SHAREHOLDERS' EQUITY AND NON-CONTROLLING INTERESTS"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets",
      "http://usph.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r44",
      "r96",
      "r189",
      "r383",
      "r389",
      "r390",
      "r399"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r4",
      "r5",
      "r6",
      "r222",
      "r226"
     ],
     "calculation": {
      "http://usph.com/role/AccruedExpensesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Closure costs"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityInterestRateDuringPeriod": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective interest rate during the reporting period.",
        "label": "Line of Credit Facility, Interest Rate During Period",
        "verboseLabel": "Average effective interest rate"
       }
      }
     },
     "localname": "LineOfCreditFacilityInterestRateDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableDetails",
      "http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r39"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Revolving credit facility commitment"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableDetails",
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "auth_ref": [
      "r39"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "terseLabel": "Remaining revolving credit outstanding"
       }
      }
     },
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.",
        "label": "Line of Credit Facility, Unused Capacity, Commitment Fee Percentage",
        "terseLabel": "Percentage of unused commitment fee"
       }
      }
     },
     "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r21",
      "r244",
      "r455",
      "r467"
     ],
     "calculation": {
      "http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "totalLabel": "Payments/Long term debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "negatedLabel": "Less current portion",
        "terseLabel": "Current portion of notes payable"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets",
      "http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r101",
      "r243"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Aggregate principal payment due in 2021"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r101",
      "r243"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "Aggregate principal payment due in 2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long term portion"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermLineOfCredit": {
     "auth_ref": [
      "r47",
      "r241",
      "r242"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit, Noncurrent",
        "terseLabel": "Revolving line of credit"
       }
      }
     },
     "localname": "LongTermLineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermNotesPayable": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.",
        "label": "Notes Payable, Noncurrent",
        "terseLabel": "Notes payable, net of current portion"
       }
      }
     },
     "localname": "LongTermNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r53",
      "r96",
      "r189",
      "r399",
      "r456",
      "r469"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Non-controlling interests - permanent equity"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestChangeInRedemptionValue": {
     "auth_ref": [
      "r250",
      "r251",
      "r252",
      "r259"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in noncontrolling interest during the period as a result of a change in the redemption value of redeemable noncontrolling interest.",
        "label": "Noncontrolling Interest, Change in Redemption Value",
        "verboseLabel": "Changes in the fair value of redeemable non-controlling interest"
       }
      }
     },
     "localname": "MinorityInterestChangeInRedemptionValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [
      "r258"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedLabel": "Distributions to non-controlling interest partners - permanent equity"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDisclosureTextBlock": {
     "auth_ref": [
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.",
        "label": "Acquisitions and Sale of Non-Controlling Interests"
       }
      }
     },
     "localname": "MinorityInterestDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterests"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Less: net income attributable to non-controlling interests:"
       }
      }
     },
     "localname": "MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MovementInValuationAllowancesAndReservesRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Movement in Valuation Allowances and Reserves [Roll Forward]"
       }
      }
     },
     "localname": "MovementInValuationAllowancesAndReservesRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ScheduleIiValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "FINANCING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "INVESTING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r80",
      "r82",
      "r85"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "OPERATING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r6",
      "r56",
      "r57",
      "r61",
      "r85",
      "r96",
      "r115",
      "r119",
      "r120",
      "r121",
      "r122",
      "r124",
      "r125",
      "r126",
      "r154",
      "r166",
      "r170",
      "r173",
      "r176",
      "r189",
      "r399",
      "r460",
      "r473"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://usph.com/role/EarningsPerShareDetails": {
       "order": 0.0,
       "parentTag": "usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net income attributable to USPH shareholders",
        "terseLabel": "Net income attributable to USPH shareholders",
        "totalLabel": "Net income attributable to USPH shareholders"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity",
      "http://usph.com/role/ConsolidatedStatementsOfIncome",
      "http://usph.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r56",
      "r57",
      "r124",
      "r125",
      "r385",
      "r392"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedTotalLabel": "Net income attributable to non-controlling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Basic [Abstract]",
        "terseLabel": "Computation of earnings per share - USPH shareholders [Abstract]"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recently Adopted Accounting Guidance [Abstract]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "Recently Adopted Accounting Guidance"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionPayablesAssumed1": {
     "auth_ref": [
      "r89",
      "r90",
      "r91"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of payables that an Entity assumes in acquiring a business or in consideration for an asset received in a noncash (or part noncash) acquisition. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Purchase of business - payable to common shareholders of acquired business"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAcquisitionPayablesAssumed1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1": {
     "auth_ref": [
      "r89",
      "r90",
      "r91"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash consideration received for selling an asset or business through a noncash (or part noncash) transaction.",
        "label": "Notes receivables related to sale of partnership interest"
       }
      }
     },
     "localname": "NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "auth_ref": [
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
        "label": "Non-compete Agreements [Member]",
        "terseLabel": "Non-compete Agreements [Member]"
       }
      }
     },
     "localname": "NoncompeteAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails",
      "http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails",
      "http://usph.com/role/IntangibleAssetsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquisitions and Sale of Non-Controlling Interests [Abstract]"
       }
      }
     },
     "localname": "NoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation": {
     "auth_ref": [
      "r259",
      "r387"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the reduction or elimination during the period of a noncontrolling interest resulting from the parent's loss of control and deconsolidation of the entity in which one or more outside parties had a noncontrolling interest.",
        "label": "Noncontrolling Interest, Decrease from Deconsolidation",
        "negatedLabel": "Reduction of non-controlling interest due to sale of USPH partnership interest"
       }
      }
     },
     "localname": "NoncontrollingInterestDecreaseFromDeconsolidation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable": {
     "auth_ref": [
      "r66"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) attributable to other redeemable noncontrolling equity holder.",
        "label": "Noncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, Redeemable",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r112",
      "r113",
      "r114",
      "r258",
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Non-Controlling Interests [Member]"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income and expense"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfBusinessesAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of businesses acquired by the entity during the period.",
        "label": "Number of clinics",
        "verboseLabel": "Number of businesses acquired"
       }
      }
     },
     "localname": "NumberOfBusinessesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of business segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfStatesInWhichEntityOperates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of states the entity operates in as of the balance sheet date.",
        "label": "Number of States in which Entity Operates",
        "terseLabel": "Number of states where clinics are operated"
       }
      }
     },
     "localname": "NumberOfStatesInWhichEntityOperates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r154",
      "r166",
      "r170",
      "r173",
      "r176"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r418",
      "r427"
     ],
     "calculation": {
      "http://usph.com/role/LeasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Future Lease Payments for Operating Leases [Abstract]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r414"
     ],
     "calculation": {
      "http://usph.com/role/LeasesDetailsCalc01": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Lease Liability",
        "terseLabel": "Total operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails",
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r414"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Current portion of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r414"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating lease liabilities, net of current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r415",
      "r421"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Cash paid for amounts included in the measurement of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r413"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets",
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r424",
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Weighted-average discount rate - Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r423",
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Weighted-average remaining lease term - Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r165",
      "r166",
      "r167",
      "r168",
      "r170",
      "r176"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Reportable Segments [Member]"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Nature of Operations and Basis of Presentation [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r7",
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Organization, Nature of Operations and Basis of Presentation"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r13",
      "r14",
      "r15",
      "r43"
     ],
     "calculation": {
      "http://usph.com/role/AccruedExpensesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other income and expense:"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ParentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.",
        "label": "Parent [Member]",
        "terseLabel": "Total Shareholders' Equity [Member]"
       }
      }
     },
     "localname": "ParentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Expenses [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period for redemption of redeemable noncontrolling interests.",
        "label": "Payments for Repurchase of Redeemable Noncontrolling Interest",
        "negatedLabel": "Payments to settle mandatorily redeemable non-controlling interests"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfRedeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedLabel": "Cash dividends paid to shareholders"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsMinorityInterest": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.",
        "label": "Payments of Ordinary Dividends, Noncontrolling Interest",
        "negatedLabel": "Distributions to non-controlling interests, permanent and temporary equity"
       }
      }
     },
     "localname": "PaymentsOfDividendsMinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r71",
      "r376"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Cash paid for acquisition of interest in clinic"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Purchase of majority interest in businesses, net of cash acquired",
        "terseLabel": "Cash paid, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of or advances to an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, and joint venture or equity method investment) or the acquisition of an additional interest in a subsidiary (controlled entity).",
        "label": "Payments to Acquire Interest in Subsidiaries and Affiliates",
        "negatedLabel": "Purchase of non-controlling interest, permanent equity"
       }
      }
     },
     "localname": "PaymentsToAcquireInterestInSubsidiariesAndAffiliates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.",
        "label": "Payments to Acquire Productive Assets",
        "negatedLabel": "Purchase of fixed assets"
       }
      }
     },
     "localname": "PaymentsToAcquireProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToMinorityShareholders": {
     "auth_ref": [
      "r77"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.",
        "label": "Acquired interest"
       }
      }
     },
     "localname": "PaymentsToMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r299",
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansAmendedAndRestatedEmployeeStockOptionPlansDetails",
      "http://usph.com/role/EquityBasedPlansCumulativeSummaryOfEquityPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansAmendedAndRestatedEmployeeStockOptionPlansDetails",
      "http://usph.com/role/EquityBasedPlansCumulativeSummaryOfEquityPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockTextBlock": {
     "auth_ref": [
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.",
        "label": "Preferred Stock [Text Block]",
        "terseLabel": "Preferred Stock"
       }
      }
     },
     "localname": "PreferredStockTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/PreferredStock"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $.01 par value, 500,000 shares authorized, no shares issued and outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds on sales of partnership interest, clinics and fixed assets"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the deconsolidation of a previously consolidated subsidiary or sale of an entity that is related to it but not strictly controlled.",
        "label": "Proceeds from Divestiture of Interest in Subsidiaries and Affiliates",
        "terseLabel": "Proceeds on sale of redeemable non-controlling interest, temporary equity"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "auth_ref": [
      "r73",
      "r99"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Proceeds from Lines of Credit",
        "terseLabel": "Proceeds from revolving line of credit"
       }
      }
     },
     "localname": "ProceedsFromLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMinorityShareholders": {
     "auth_ref": [
      "r74"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership.",
        "label": "Proceeds from Noncontrolling Interests",
        "terseLabel": "Notes receivable related to sale of partnership interest - redeemable non-controlling interest"
       }
      }
     },
     "localname": "ProceedsFromMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r74",
      "r77",
      "r100"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsToMinorityShareholders": {
     "auth_ref": [
      "r100"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from (to) a noncontrolling interest. Excludes dividends paid to the noncontrolling interest.",
        "label": "Purchases of redeemable non-controlling interest"
       }
      }
     },
     "localname": "ProceedsFromPaymentsToMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r6",
      "r56",
      "r57",
      "r79",
      "r96",
      "r115",
      "r124",
      "r125",
      "r154",
      "r166",
      "r170",
      "r173",
      "r176",
      "r189",
      "r381",
      "r384",
      "r386",
      "r392",
      "r393",
      "r399",
      "r461"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Net income",
        "verboseLabel": "Net income including non-controlling interests"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows",
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Assets [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r35",
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r34",
      "r223"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "totalLabel": "Fixed assets, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r17",
      "r18",
      "r225",
      "r471"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "totalLabel": "Fixed assets, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Net [Abstract]",
        "terseLabel": "Fixed assets:"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r17",
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Estimated useful lives"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r62",
      "r197"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Provision for credit losses"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows",
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestByLegalEntityTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity. As of the date of the statement of financial position, such redeemable noncontrolling interest is currently redeemable, as defined, for cash or other assets of the entity at (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the entity.",
        "label": "Redeemable Noncontrolling Interest, by Legal Entity [Table]"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestByLegalEntityTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": {
     "auth_ref": [
      "r248",
      "r249",
      "r250",
      "r251"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      },
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.",
        "label": "Redeemable non-controlling interests - temporary equity",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Redeemable non-controlling interests"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets",
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmountAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in Carrying Amount (Fair Value) of Redeemable Non-Controlling Interests [Roll Forward]"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityCarryingAmountAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Redeemable Noncontrolling Interest [Line Items]"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity. As of the date of the statement of financial position, such redeemable noncontrolling interest is currently redeemable, as defined, for cash or other assets of the entity at (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the entity.",
        "label": "Redeemable Noncontrolling Interest [Table Text Block]",
        "terseLabel": "Changes in Carrying Amount (Fair Value) of Redeemable Non-Controlling Interest"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "auth_ref": [
      "r76",
      "r99"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Repayments of Lines of Credit",
        "negatedLabel": "Payments on revolving line of credit"
       }
      }
     },
     "localname": "RepaymentsOfLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.",
        "label": "Repayments of Notes Payable",
        "negatedLabel": "Principal payments on notes payable"
       }
      }
     },
     "localname": "RepaymentsOfNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock [Member]"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansDetails",
      "http://usph.com/role/EquityBasedPlansRestrictedStockCancelledDueToEmployeeTerminationsPriorToRestrictionsLapsingDetails",
      "http://usph.com/role/EquityBasedPlansRestrictedStockGrantedToDirectorsOfficersAndEmployeesPursuantToItsEquityPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r84",
      "r230",
      "r232",
      "r233"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 5.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Closure costs - lease and other",
        "verboseLabel": "Closure costs"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome",
      "http://usph.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r28",
      "r258",
      "r321",
      "r468",
      "r486",
      "r491"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r112",
      "r113",
      "r114",
      "r116",
      "r123",
      "r125",
      "r193",
      "r318",
      "r319",
      "r320",
      "r351",
      "r352",
      "r482",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue Recognition [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r145",
      "r146",
      "r165",
      "r171",
      "r172",
      "r178",
      "r179",
      "r181",
      "r273",
      "r274",
      "r443"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Net revenues",
        "verboseLabel": "Revenue related to the various categories"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome",
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r94",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r282"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r59",
      "r96",
      "r145",
      "r146",
      "r165",
      "r171",
      "r172",
      "r178",
      "r179",
      "r181",
      "r189",
      "r399",
      "r461"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Net operating revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "verboseLabel": "Credit Facility [Member]"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableDetails",
      "http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r422",
      "r427"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-use assets obtained in exchange for new operating lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Accrued Expenses"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/AccruedExpensesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r366",
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails",
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails",
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "auth_ref": [
      "r366",
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
        "verboseLabel": "Clinic Acquisition"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Significant Components of Provision for Income Taxes for Continuing Operations"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r47",
      "r98",
      "r254",
      "r255",
      "r256",
      "r257",
      "r408",
      "r409",
      "r410",
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "terseLabel": "Credit Agreement and Notes Payable"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/NotesPayableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable": {
     "auth_ref": [
      "r283",
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule, table or text reflecting arrangements that are not equity-based payments, or pension and other postretirement benefits, with individual employees. The arrangements (for example, profit sharing, deferred bonuses or certain split-dollar life insurance arrangements) are generally based on employment contracts between the entity and one or more selected officers or key employees, and which contain a promise by the employer to pay certain amounts at designated future dates, sometimes including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period and the carrying amount as of the balance sheet date of the related liability.",
        "label": "Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table]"
       }
      }
     },
     "localname": "ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/CommitmentsAndContingenciesDetails",
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Components of Deferred Tax Assets and Liabilities Included in Consolidated Balance Sheets"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Computations of Basic and Diluted Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/EarningsPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Differences Between Federal Tax Rate and Company's Effective Tax Rate for Results of Continuing Operations"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r211",
      "r215",
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails",
      "http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails",
      "http://usph.com/role/IntangibleAssetsNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r211",
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Intangible Assets, Net"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r205",
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Changes in Carrying Amount of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/GoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r154",
      "r157",
      "r169",
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r154",
      "r157",
      "r169",
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Selected Financial Data for Reportable Segments"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": {
     "auth_ref": [
      "r306",
      "r309",
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Activity [Table Text Block]",
        "terseLabel": "Cumulative Summary of Equity Plans"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r299",
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansAmendedAndRestatedEmployeeStockOptionPlansDetails",
      "http://usph.com/role/EquityBasedPlansCumulativeSummaryOfEquityPlansDetails",
      "http://usph.com/role/EquityBasedPlansDetails",
      "http://usph.com/role/EquityBasedPlansRestrictedStockCancelledDueToEmployeeTerminationsPriorToRestrictionsLapsingDetails",
      "http://usph.com/role/EquityBasedPlansRestrictedStockGrantedToDirectorsOfficersAndEmployeesPursuantToItsEquityPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]",
        "verboseLabel": "Restricted Stock Granted and Cancelled"
       }
      }
     },
     "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Amortization of Referral Relationships and Non Competition Agreements"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r141",
      "r145",
      "r146",
      "r147",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r165",
      "r166",
      "r167",
      "r168",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r176",
      "r181",
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Information [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting, Disclosure of Entity's Reportable Segments [Abstract]",
        "terseLabel": "Segment Information [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingDisclosureOfEntitysReportableSegmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r141",
      "r143",
      "r144",
      "r154",
      "r158",
      "r170",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r180",
      "r181",
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/SegmentInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r93",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segment Reporting"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Corporate office costs"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember": {
     "auth_ref": [
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the aggregation and reporting of combined amounts of individually immaterial business combinations that were completed during the period.",
        "label": "Acquisitions [Member]"
       }
      }
     },
     "localname": "SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Equity-based awards compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansAmendedAndRestatedEmployeeStockOptionPlansDetails",
      "http://usph.com/role/EquityBasedPlansCumulativeSummaryOfEquityPlansDetails",
      "http://usph.com/role/EquityBasedPlansDetails",
      "http://usph.com/role/EquityBasedPlansRestrictedStockCancelledDueToEmployeeTerminationsPriorToRestrictionsLapsingDetails",
      "http://usph.com/role/EquityBasedPlansRestrictedStockGrantedToDirectorsOfficersAndEmployeesPursuantToItsEquityPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Number of shares (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansRestrictedStockCancelledDueToEmployeeTerminationsPriorToRestrictionsLapsingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Weighted average fair value (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansRestrictedStockCancelledDueToEmployeeTerminationsPriorToRestrictionsLapsingDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Number of shares (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansRestrictedStockGrantedToDirectorsOfficersAndEmployeesPursuantToItsEquityPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average fair value (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansRestrictedStockGrantedToDirectorsOfficersAndEmployeesPursuantToItsEquityPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansAmendedAndRestatedEmployeeStockOptionPlansDetails",
      "http://usph.com/role/EquityBasedPlansCumulativeSummaryOfEquityPlansDetails",
      "http://usph.com/role/EquityBasedPlansDetails",
      "http://usph.com/role/EquityBasedPlansRestrictedStockCancelledDueToEmployeeTerminationsPriorToRestrictionsLapsingDetails",
      "http://usph.com/role/EquityBasedPlansRestrictedStockGrantedToDirectorsOfficersAndEmployeesPursuantToItsEquityPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Authorized (in shares)",
        "verboseLabel": "Number of shares authorized (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansAmendedAndRestatedEmployeeStockOptionPlansDetails",
      "http://usph.com/role/EquityBasedPlansCumulativeSummaryOfEquityPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Number of common shares available for grant (in shares)",
        "verboseLabel": "Shares available for grant (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansAmendedAndRestatedEmployeeStockOptionPlansDetails",
      "http://usph.com/role/EquityBasedPlansCumulativeSummaryOfEquityPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "verboseLabel": "Stock options exercisable (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansCumulativeSummaryOfEquityPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r303",
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "terseLabel": "Outstanding stock options (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansCumulativeSummaryOfEquityPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r297",
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Equity Award [Domain]",
        "terseLabel": "Equity Award [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansAmendedAndRestatedEmployeeStockOptionPlansDetails",
      "http://usph.com/role/EquityBasedPlansDetails",
      "http://usph.com/role/EquityBasedPlansRestrictedStockCancelledDueToEmployeeTerminationsPriorToRestrictionsLapsingDetails",
      "http://usph.com/role/EquityBasedPlansRestrictedStockGrantedToDirectorsOfficersAndEmployeesPursuantToItsEquityPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Closing price (in dollars per share)"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/CommonStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of short-term debt arrangement.",
        "label": "Short-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "ShortTermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/NotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.",
        "label": "Short-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "ShortTermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/NotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermLeaseCost": {
     "auth_ref": [
      "r419",
      "r427"
     ],
     "calculation": {
      "http://usph.com/role/LeasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.",
        "label": "Short-term lease cost"
       }
      }
     },
     "localname": "ShortTermLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State [Member]"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r3",
      "r141",
      "r145",
      "r146",
      "r147",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r165",
      "r166",
      "r167",
      "r168",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r176",
      "r181",
      "r205",
      "r227",
      "r231",
      "r234",
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r52",
      "r112",
      "r113",
      "r114",
      "r116",
      "r123",
      "r125",
      "r133",
      "r193",
      "r253",
      "r258",
      "r318",
      "r319",
      "r320",
      "r351",
      "r352",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r482",
      "r483",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity",
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CONSOLIDATED STATEMENTS OF CASH FLOWS [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CONSOLIDATED BALANCE SHEETS [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r112",
      "r113",
      "r114",
      "r133",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity",
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r24",
      "r25",
      "r253",
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Issuance of restricted stock, net of cancellations (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r253",
      "r258"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Issuance of restricted stock, net of cancellations"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.",
        "label": "Stock Repurchase Program, Number of Shares Authorized to be Repurchased",
        "terseLabel": "Common stock authorized by the Board of Directors (in shares)"
       }
      }
     },
     "localname": "StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/CommonStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r24",
      "r25",
      "r253",
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "terseLabel": "Total purchased shares (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/CommonStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r25",
      "r29",
      "r30",
      "r96",
      "r188",
      "r189",
      "r399"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total USPH shareholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "U. S. Physical Therapy, Inc. shareholders' equity:",
        "terseLabel": "U.S. Physical Therapy, Inc. (\"USPH\") shareholders' equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets",
      "http://usph.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r96",
      "r112",
      "r113",
      "r114",
      "r116",
      "r123",
      "r189",
      "r193",
      "r258",
      "r318",
      "r319",
      "r320",
      "r351",
      "r352",
      "r379",
      "r380",
      "r391",
      "r399",
      "r401",
      "r402",
      "r406",
      "r483",
      "r484"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total USPH shareholders' equity and non-controlling interests"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets",
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Equity:"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r95",
      "r258",
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/CommonStock"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityOther": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.",
        "label": "Stockholders' Equity, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "StockholdersEquityOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r407",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r407",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r407",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]",
        "terseLabel": "Subsequent Event [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsPolicyPolicyTextBlock": {
     "auth_ref": [
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reporting subsequent events.",
        "label": "Subsequent Events, Policy [Policy Text Block]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxesPayableCurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://usph.com/role/AccruedExpensesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Federal income taxes payable"
       }
      }
     },
     "localname": "TaxesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TrademarksMember": {
     "auth_ref": [
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "Trademarks [Member]",
        "terseLabel": "Tradenames [Member]"
       }
      }
     },
     "localname": "TrademarksMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails",
      "http://usph.com/role/IntangibleAssetsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r51",
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock [Member]"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r51",
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury stock, shares (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r51",
      "r260",
      "r263"
     ],
     "calculation": {
      "http://usph.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Treasury stock at cost, 2,214,737 shares"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r115",
      "r116",
      "r117",
      "r118",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r349",
      "r350",
      "r351",
      "r352",
      "r445",
      "r446",
      "r447",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails",
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r333"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "terseLabel": "Accrued interest and penalties associated with any unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesDetails",
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense": {
     "auth_ref": [
      "r333"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense for an underpayment of income taxes.",
        "label": "Unrecognized Tax Benefits, Interest on Income Taxes Expense",
        "terseLabel": "Interest expense recognized"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnusualOrInfrequentItemAxis": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by an event or transaction that is unusual in nature or infrequent in occurrence, or both.",
        "label": "Unusual or Infrequent Item, or Both [Axis]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails",
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnusualOrInfrequentItemDomain": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event or transaction that is unusual in nature or infrequent in occurrence, or both.",
        "label": "Unusual or Infrequent Item, or Both [Domain]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails",
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r134",
      "r135",
      "r136",
      "r137",
      "r138",
      "r139",
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "auth_ref": [
      "r102",
      "r108"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesBalance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ScheduleIiValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": {
     "auth_ref": [
      "r105"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense",
        "terseLabel": "Additions Charged to Cost and Expenses"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ScheduleIiValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts": {
     "auth_ref": [
      "r106"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to accounts other than cost and expense.",
        "label": "Additions Charged to Other Accounts"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToOtherAccounts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ScheduleIiValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDeductions": {
     "auth_ref": [
      "r107"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in valuation and qualifying accounts and reserves.",
        "label": "Deductions"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDeductions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ScheduleIiValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDomain": {
     "auth_ref": [
      "r102",
      "r103",
      "r104",
      "r107",
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation and qualifying accounts and reserves.",
        "label": "Valuation Allowances and Reserves [Domain]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ScheduleIiValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesTypeAxis": {
     "auth_ref": [
      "r102",
      "r103",
      "r104",
      "r107",
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation and qualifying accounts and reserves.",
        "label": "Valuation Allowances and Reserves Type [Axis]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ScheduleIiValuationAndQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r420",
      "r427"
     ],
     "calculation": {
      "http://usph.com/role/LeasesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable lease cost"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).",
        "label": "Weighted Average Number of Shares Outstanding, Basic and Diluted",
        "terseLabel": "Shares used in computation - basic and diluted (in shares)",
        "verboseLabel": "Basic and diluted earnings per share - weighted-average shares (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome",
      "http://usph.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Shares used in computation [Abstract]"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://usph.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "usph_AcquisitionOfFiveClinicPracticesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisition of five clinic practices for an aggregate amount of cash.",
        "label": "Acquisition of Five Clinic Practices [Member]",
        "terseLabel": "Acquisition of Five Clinic Practices [Member]"
       }
      }
     },
     "localname": "AcquisitionOfFiveClinicPracticesMember",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_AdditionalEstimatedRepurchaseOfCommonStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional estimated repurchase of common stock during the period.",
        "label": "Additional Estimated Repurchase Of Common Stock",
        "terseLabel": "Additional estimated shares (in shares)"
       }
      }
     },
     "localname": "AdditionalEstimatedRepurchaseOfCommonStock",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/CommonStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "usph_AggregateSalePriceOfCinics": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale price of the clinics sold which were discontinued.",
        "label": "Aggregate Sale Price of Clinics",
        "terseLabel": "Aggregate sale price of clinics"
       }
      }
     },
     "localname": "AggregateSalePriceOfCinics",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_AmendedNineteenNinetyNinePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the equity-based compensation arrangement plan.",
        "label": "Amended Nineteen Ninety Nine Plan [Member]",
        "terseLabel": "Amended 1999 Plan [Member]"
       }
      }
     },
     "localname": "AmendedNineteenNinetyNinePlanMember",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansCumulativeSummaryOfEquityPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_AmendedTwoThousandThreePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the equity-based compensation arrangement plan.",
        "label": "Amended Two Thousand Three Plan [Member]",
        "terseLabel": "Amended 2003 Plan [Member]"
       }
      }
     },
     "localname": "AmendedTwoThousandThreePlanMember",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansAmendedAndRestatedEmployeeStockOptionPlansDetails",
      "http://usph.com/role/EquityBasedPlansCumulativeSummaryOfEquityPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_AmountOfReductionsInFederalSpending": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of reductions in federal spending during the period.",
        "label": "Amount Of Reductions In Federal Spending",
        "terseLabel": "Reductions in federal spending"
       }
      }
     },
     "localname": "AmountOfReductionsInFederalSpending",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_AnnualLimitOccupationalTherapyServices": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Annual Limit occupational therapy services during the period.",
        "label": "Annual Limit Occupational Therapy Services",
        "terseLabel": "Annual limit occupational therapy services"
       }
      }
     },
     "localname": "AnnualLimitOccupationalTherapyServices",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Annual Limit on physical therapy and speech language pathology services during the period.",
        "label": "Annual Limit On Physical Therapy And Speech Language Pathology Services",
        "terseLabel": "Annual limit on physical therapy and speech language pathology services"
       }
      }
     },
     "localname": "AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_AprilTwoThousandNineteenAcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of business acquisition.",
        "label": "April Two Thousand Nineteen Acquisition [Member]",
        "terseLabel": "April 2019 Acquisition [Member]",
        "verboseLabel": "April 2019 Acquisition [Member]"
       }
      }
     },
     "localname": "AprilTwoThousandNineteenAcquisitionMember",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_August2018AcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of business acquisition.",
        "label": "August Two Thousand Eighteen Acquisition [Member]",
        "terseLabel": "August 2018 Acquisition [Member]"
       }
      }
     },
     "localname": "August2018AcquisitionMember",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_AugustTwoThousandNineteenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to the principal installment plus accrued interest payable date.",
        "label": "August Two Thousand Nineteen [Member]",
        "terseLabel": "August 2019 [Member]"
       }
      }
     },
     "localname": "AugustTwoThousandNineteenMember",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_AugustTwoThousandTwentyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to the principal installment plus accrued interest payable date.",
        "label": "August Two Thousand Twenty [Member]",
        "terseLabel": "August 2020 [Member]"
       }
      }
     },
     "localname": "AugustTwoThousandTwentyMember",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_AverageLeaseTermsAndDiscountRatesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Average Lease Terms and Discount Rates [Abstract]"
       }
      }
     },
     "localname": "AverageLeaseTermsAndDiscountRatesAbstract",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "usph_AveragePhysicalTherapyPatientsVolumesPerDayPerClinic": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of physical therapy patient volumes per day per clinic",
        "label": "Average Physical Therapy Patients Volumes per Day per Clinic",
        "terseLabel": "Average physical therapy patient volumes per day per clinic"
       }
      }
     },
     "localname": "AveragePhysicalTherapyPatientsVolumesPerDayPerClinic",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bank credit agreement to permit share repurchases of common stock during the period.",
        "label": "Bank Credit Agreement To Permit Share Repurchases Of Common Stock",
        "terseLabel": "Bank credit agreement to permit share repurchases of common stock"
       }
      }
     },
     "localname": "BankCreditAgreementToPermitShareRepurchasesOfCommonStock",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/CommonStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_BusinessAcquisitionConsiderationPayableTermOfNote": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to the term of the note issued for consideration payable for the acquisition.",
        "label": "Business Acquisition Consideration Payable, Term of Note",
        "terseLabel": "Business acquisition, consideration payable, term of note"
       }
      }
     },
     "localname": "BusinessAcquisitionConsiderationPayableTermOfNote",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of business acquisition cost of acquired entity debt issued on the date of acquisition.",
        "label": "Business Acquisition Cost Of Acquired Entity Debt Issued",
        "terseLabel": "Seller notes"
       }
      }
     },
     "localname": "BusinessAcquisitionCostOfAcquiredEntityDebtIssued",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business acquisition number of installments for payment of purchase consideration.",
        "label": "Business Acquisition Number Of Installments For Payment Of Purchase Consideration",
        "terseLabel": "Number of installments"
       }
      }
     },
     "localname": "BusinessAcquisitionNumberOfInstallmentsForPaymentOfPurchaseConsideration",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "usph_BusinessAcquisitionPayableToShareholdersOfSeller": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount payable to shareholders of seller in business acquisition.",
        "label": "Business Acquisition,Payable to Shareholders of Seller",
        "terseLabel": "Payable to shareholders of seller"
       }
      }
     },
     "localname": "BusinessAcquisitionPayableToShareholdersOfSeller",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to the percentage of equity interest in subsidiary contributed for acquisition.",
        "label": "Business Acquisition Percentage Of Equity Interest In Subsidiary Contributed",
        "terseLabel": "Percentage of equity interest of subsidiary contributed for acquisition"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to the percentage of general partnership interest acquired in the business combination.",
        "label": "Business Acquisition, Percentage of General Partnership Interest Acquired",
        "terseLabel": "Business acquisition, percentage of general partnership interest acquired"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to the percentage of limited partnership interest acquired in the business combination.",
        "label": "Business Acquisition, Percentage of Limited Partnership Interest Acquired",
        "verboseLabel": "Business acquisition, percentage of limited partnership acquired"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/AcquisitionsOfBusinessesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net tangible asset acquired at the acquisition date.",
        "label": "Business Acquisition Purchase Price Allocation Net Tangible Asset",
        "totalLabel": "Net tangible assets acquired"
       }
      }
     },
     "localname": "BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of acquired finite-lived intangible assets in business combination, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Business Combination, Acquired Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Estimated useful lives of acquired intangibles"
       }
      }
     },
     "localname": "BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the fair value of the redeemable noncontrolling interest in the acquiree at the acquisition date.",
        "label": "Business Combination Acquisition Fair Value of Redeemable Non-Controlling Interests",
        "negatedLabel": "Fair value of non-controlling interest (classified as redeemable non-controlling interests)"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of non-competition agreements recognized as of the acquisition date.",
        "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Non Competition Agreements",
        "verboseLabel": "Non-compete"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of referral relationships at the acquisition date.",
        "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Referral Relationships",
        "terseLabel": "Referral relationships"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of tradename recognized as of the acquisition date.",
        "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Tradename",
        "terseLabel": "Tradename"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_CarryingAmountOfRedeemableNonControllingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carrying Amount of Redeemable Non-Controlling Interest [Abstract]",
        "verboseLabel": "Carrying Amount (Fair Value) of Redeemable Non-Controlling Interest [Abstract]"
       }
      }
     },
     "localname": "CarryingAmountOfRedeemableNonControllingInterestAbstract",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of carrying amount of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity.",
        "label": "Carrying Amount of Redeemable Non-Controlling Interest [Table Text Block]",
        "terseLabel": "Carrying Amount of (Fair Value) Redeemable Non-Controlling Interest"
       }
      }
     },
     "localname": "CarryingAmountOfRedeemableNonControllingInterestTableTextBlock",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "usph_CashAndCashEquivalentsAndAccruedLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and Cash and cash equivalents and accrued liabilities.",
        "label": "Cash and cash equivalents and accrued liabilities"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAndAccruedLiabilities",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and noncash consideration that could pay with respect to acquisition.",
        "label": "Cash And Noncash Consideration With Respect To Acquisition After Amendement",
        "terseLabel": "Cash and noncash consideration with respect to acquisition after amendment"
       }
      }
     },
     "localname": "CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/NotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_CashPaidDuringPeriodForAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid During Period For [Abstract]",
        "terseLabel": "Cash paid during the period for:"
       }
      }
     },
     "localname": "CashPaidDuringPeriodForAbstract",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "usph_CashReceivedRelatedToSaleOfClinics": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received related to sale of discontinued clinics.",
        "label": "Cash Received Related to Sale of Clinics",
        "terseLabel": "Cash received related to sale of closed clinics"
       }
      }
     },
     "localname": "CashReceivedRelatedToSaleOfClinics",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_ChargesToRetainedEarningsRevaluationOfNonControllingInterests": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/EarningsPerShareDetails": {
       "order": 2.0,
       "parentTag": "usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income (loss) from revaluation of redeemable noncontrolling interest.",
        "label": "Charges To Retained Earnings Revaluation Of Non Controlling Interests",
        "terseLabel": "Revaluation of redeemable non-controlling interest"
       }
      }
     },
     "localname": "ChargesToRetainedEarningsRevaluationOfNonControllingInterests",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_ClinicPracticeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisition of part of a company which provides clinic practice services.",
        "label": "Clinic Practice [Member]"
       }
      }
     },
     "localname": "ClinicPracticeMember",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Combined physical therapy/speech language pathology expenses during the period.",
        "label": "Combined Physical Therapy Speech Language Pathology Expenses",
        "terseLabel": "Combined physical therapy/speech language pathology expenses"
       }
      }
     },
     "localname": "CombinedPhysicalTherapySpeechLanguagePathologyExpenses",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to amount of contractual time period had not lapsed and holder's employment had not been terminated as of balance sheet date.",
        "label": "Contractual Time Period Has Not Lapsed And Holders Employment Has Not Been Terminated",
        "terseLabel": "Contractual time period has not lapsed and holder's employment has not been terminated"
       }
      }
     },
     "localname": "ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to amount of contractual time period had lapsed but holder's employment had not been terminated as of balance sheet date.",
        "label": "Contractual Time Period Has Lapsed But Holders Employment Has Not Been Terminated",
        "terseLabel": "Contractual time period has lapsed but holder's employment has not been terminated"
       }
      }
     },
     "localname": "ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_CreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A credit agreement is a legal contract in which a bank arranges to loan a customer a certain amount of money for a specified amount of time.",
        "label": "Credit Agreement [Member]"
       }
      }
     },
     "localname": "CreditAgreementMember",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/NotesPayableDetails",
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_CreditChargesToRetainedEarningsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Credit Charges To Retained Earnings [Abstract]",
        "terseLabel": "Credit (Charges) To Retained Earnings [Abstract]"
       }
      }
     },
     "localname": "CreditChargesToRetainedEarningsAbstract",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "usph_DebtInstrumentBasisSpreadOnLiborVariableRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument Basis Spread On Libor Variable Rate",
        "verboseLabel": "Spread on Libor variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnLiborVariableRate",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/NotesPayableDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of reduction in notes receivable from sale of redeemable non-controlling interest attributable to temporary equity interest.",
        "label": "Decrease in Note Receivable form sales of redeemable non-controlling interest - temporary equity",
        "terseLabel": "Adjustments in notes receivable related to the sales of redeemable non-controlling interest - temporary equity"
       }
      }
     },
     "localname": "DecreaseInNoteReceivableFormSalesOfRedeemableNonControllingInterestTemporaryEquity",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_DeferredEmployerPayrollTaxesCARESACT": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/AccruedExpensesDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred employer payroll taxes - CARES ACT.",
        "label": "Deferred employer payroll taxes - CARES ACT",
        "terseLabel": "Deferred employer payroll taxes - CARES ACT"
       }
      }
     },
     "localname": "DeferredEmployerPayrollTaxesCARESACT",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_DeferredTaxAssetsLeaseObligations": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from the lease obligations.",
        "label": "Deferred Tax Assets Lease Obligations",
        "terseLabel": "Lease obligations - including closed clinics"
       }
      }
     },
     "localname": "DeferredTaxAssetsLeaseObligations",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of deferred tax assets related to revaluation of redeemable non-controlling interests and acquisitions of non-controlling interests.",
        "label": "Deferred Tax Assets Related to Redeemable Non-controlling Interests and Acquisitions of Non-controlling Interests",
        "terseLabel": "Deferred tax assets, related to revaluation and acquisition of redeemable non-controlling interests"
       }
      }
     },
     "localname": "DeferredTaxAssetsRelatedToRedeemableNonControllingInterestsAndAcquisitionsOfNonControllingInterests",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to operating lease right-of-use assets.",
        "label": "Deferred Tax Liabilities Operating Lease Right-of-use Assets",
        "negatedLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/IncomeTaxesComponentsOfDeferredTaxAssetsAndLiabilitiesIncludedInConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_DefinedContributionPlanEmployerMatchingContributionAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of matching contributions made by an employer to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Matching Contribution Amount",
        "terseLabel": "Employer matching contribution amount"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionAmount",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/DefinedContributionPlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period consider for new employees to cover under defined contribution plan.",
        "label": "Defined Contribution Plan Period For New Employees Covered Under Plan",
        "terseLabel": "Required time period for employees for profit sharing plan"
       }
      }
     },
     "localname": "DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/DefinedContributionPlanDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "usph_DepreciationAmortizationImpairmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Depreciation Amortization Impairment [Line Items]"
       }
      }
     },
     "localname": "DepreciationAmortizationImpairmentLineItems",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "usph_DepreciationAmortizationImpairmentTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to depreciation amortization impairment.",
        "label": "Depreciation Amortization Impairment [Table]"
       }
      }
     },
     "localname": "DepreciationAmortizationImpairmentTable",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum difference between actual aggregate contractual reserve percentage as compared to estimated contractual allowance reserve percentage.",
        "label": "Difference Between Actual Aggregate Contractual Reserve Percentages As Compared To Estimated Contractual Allowance Reserve Percentage",
        "terseLabel": "Difference between actual aggregate contractual reserve and estimated contractual allowance reserve percentage"
       }
      }
     },
     "localname": "DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between net revenues and corresponding cash collections reflected percentage of net revenues.",
        "label": "Difference Between Net Revenues And Corresponding Cash Collections Reflected Percentage Of Net Revenues",
        "terseLabel": "Difference between net revenues and corresponding cash collections, approximately of net revenues"
       }
      }
     },
     "localname": "DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The distributions during the period for redemption of mandatorily redeemable noncontrolling interests.",
        "label": "Distributions to Limited Partners and Redeemable Noncontrolling Interests",
        "negatedLabel": "Distributions to redeemable non-controlling interest partners"
       }
      }
     },
     "localname": "DistributionsToLimitedPartnersAndRedeemableNoncontrollingInterests",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_DividendsCashAfterAmendment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.",
        "label": "Dividends Cash After Amendment",
        "terseLabel": "Cash dividends after amendment"
       }
      }
     },
     "localname": "DividendsCashAfterAmendment",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/NotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal and state statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation At Federal and State Statutory Income Tax Rate",
        "terseLabel": "Federal and state statutory income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_EmployeeCompensationFuturePaymentDueNextFiscalYear": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum payments for employee agreements in excess of one year due in the next fiscal year following the latest fiscal year.",
        "label": "Employee Compensation Future Payment Due Next Fiscal Year",
        "terseLabel": "Future compensation - 2021"
       }
      }
     },
     "localname": "EmployeeCompensationFuturePaymentDueNextFiscalYear",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum payments for employee agreements in excess of one year due after next fiscal year following the latest fiscal year.",
        "label": "Employee Compensation Future Payment Due Next Fiscal Year Thereafter",
        "terseLabel": "Future compensation - 2022 through 2024"
       }
      }
     },
     "localname": "EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_EmployeeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Person who is employed by the company.",
        "label": "Employee [Member]"
       }
      }
     },
     "localname": "EmployeeMember",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_EmployeesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An individual who works part-time or full-time under a contract of employment.",
        "label": "Employees [Member]",
        "terseLabel": "Employees [Member]"
       }
      }
     },
     "localname": "EmployeesMember",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_EmploymentAgreementRenewalTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to the renewal term of the employment agreement with the subsidiary entity.",
        "label": "Employment Agreement Renewal Term",
        "terseLabel": "Employment agreement renewal term"
       }
      }
     },
     "localname": "EmploymentAgreementRenewalTerm",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "usph_EmploymentAgreementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employment Agreements [Abstract]",
        "terseLabel": "Employee Agreements [Abstract]"
       }
      }
     },
     "localname": "EmploymentAgreementsAbstract",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "usph_EmploymentAgreementsExpirationDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expiration date of the employment agreements.",
        "label": "Employment Agreements Expiration Date",
        "terseLabel": "Expiration date of employment agreement, one"
       }
      }
     },
     "localname": "EmploymentAgreementsExpirationDate",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "usph_EmploymentAgreementsExpirationDateThree": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expiration date of the employment agreements three.",
        "label": "Employment Agreements Expiration Date Three",
        "terseLabel": "Expiration date of employment agreement, three"
       }
      }
     },
     "localname": "EmploymentAgreementsExpirationDateThree",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "usph_EmploymentAgreementsExpirationDateTwo": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expiration date of the employment agreements two.",
        "label": "Employment Agreements Expiration Date Two",
        "terseLabel": "Expiration date of employment agreement, two"
       }
      }
     },
     "localname": "EmploymentAgreementsExpirationDateTwo",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "usph_EmploymentAgreementsRetirementDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Retirement date of one of the employee in employment agreements.",
        "label": "Employment Agreements Retirement Date",
        "terseLabel": "Retirement date"
       }
      }
     },
     "localname": "EmploymentAgreementsRetirementDate",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Estimated Fair Value Of Net Tangible Assets Acquired [Abstract]",
        "terseLabel": "Estimated fair value of net tangible assets acquired [Abstract]"
       }
      }
     },
     "localname": "EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "usph_EstimatedPercentageOfDecreaseInPayment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated percentage of decrease in payment during the period.",
        "label": "Estimated Percentage of Decrease in Payment",
        "terseLabel": "Estimated percentage of decrease in payment"
       }
      }
     },
     "localname": "EstimatedPercentageOfDecreaseInPayment",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_ExpectedReductionInMedicareSpendingPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected reduction in Medicare spending percentage during the period.",
        "label": "Expected Reduction In Medicare Spending Percentage",
        "terseLabel": "Expected reduction in Medicare spending percentage"
       }
      }
     },
     "localname": "ExpectedReductionInMedicareSpendingPercentage",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_FebruaryTwoThousandTwentyAcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of business acquisition.",
        "label": "February Two Thousand Twenty Acquisition [Member]",
        "terseLabel": "February 2020 Acquisition [Member]"
       }
      }
     },
     "localname": "FebruaryTwoThousandTwentyAcquisitionMember",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_FromTwoThousandNineteenThroughTwoThousandTwentyFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Insurance products service years.",
        "label": "From Two Thousand Nineteen Through Two Thousand Twenty Four [Member]",
        "terseLabel": "From 2019 through 2024 [Member]"
       }
      }
     },
     "localname": "FromTwoThousandNineteenThroughTwoThousandTwentyFourMember",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Insurance products service years.",
        "label": "From Two Thousand Twenty Through Two Thousand Twenty Five [Member]",
        "terseLabel": "From 2020 through 2025 [Member]"
       }
      }
     },
     "localname": "FromTwoThousandTwentyThroughTwoThousandTwentyFiveMember",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_GainOnSaleOfPartnershipInterestNetOfTax": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "After tax amount of gain on sale or disposal of partnership interest.",
        "label": "Gain on Sale of Partnership Interest, Net of Tax",
        "negatedLabel": "Gain on sale of partnership interest"
       }
      }
     },
     "localname": "GainOnSaleOfPartnershipInterestNetOfTax",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_GrantsAndOtherFunds": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of amounts due under the terms of grants and other funds.",
        "label": "Grants and Other Funds",
        "terseLabel": "Grants and other funds"
       }
      }
     },
     "localname": "GrantsAndOtherFunds",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to holder's employment has terminated and contractual time period has expired.",
        "label": "Holders Employment Has Terminated and Contractual Time Period Has Expired",
        "terseLabel": "Holder's employment has terminated and contractual time period has expired"
       }
      }
     },
     "localname": "HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to holder's employment has terminated and contractual time period has not expired.",
        "label": "Holders Employment Has Terminated and Contractual Time Period Has Not Expired",
        "terseLabel": "Holder's employment has terminated and contractual time period has not expired"
       }
      }
     },
     "localname": "HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/EarningsPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent after revaluation of noncontrolling interest.",
        "label": "Income Loss From Operations After Revaluation Of NonControlling Interests",
        "totalLabel": "Net income attributable to common shareholders"
       }
      }
     },
     "localname": "IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_IncomeTaxExaminationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Examination [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxExaminationAbstract",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "usph_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/EarningsPerShareDetails": {
       "order": 3.0,
       "parentTag": "usph_IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal and state statutory tax rates to pretax income.",
        "label": "Income Tax Reconciliation Income Tax Expense Benefit At Federal and State Statutory Income Tax Rate",
        "negatedLabel": "Tax effect at statutory rate (federal and state) of 26.25%"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_IndustrialInjuryPreventionServicesRevenuesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenues from the industrial injury prevention business are derived from onsite services provided to clients' employees including injury prevention, rehabilitation, ergonomic assessments and performance optimization. Revenues are determined based on the number of hours and respective rate for services provided. The Company has agreements with third-party payers that provide for payments to the Company at amounts different from its established rates. The allowance for estimated contractual adjustments is based on terms of payer contracts and historical collection and write-off experience.",
        "label": "Industrial Injury Prevention Services Revenues [Member]",
        "terseLabel": "Industrial Injury Prevention Services Revenues [Member]",
        "verboseLabel": "Industrial Injury Prevention Services [Member]"
       }
      }
     },
     "localname": "IndustrialInjuryPreventionServicesRevenuesMember",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/SegmentInformationDetails",
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_InterestExpenseDebtAndOther": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt related expenses and other expenses associated with nonoperating financing activities of the entity.",
        "label": "Interest Expense, Debt and Other Expense",
        "negatedLabel": "Interest expense - debt and other"
       }
      }
     },
     "localname": "InterestExpenseDebtAndOther",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_LeadingProviderOfIndustrialInjuryPreventionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisition of part of a company which provides services include onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments.",
        "label": "Leading Provider of Industrial Injury Prevention [Member]",
        "verboseLabel": "IIPS [Member]"
       }
      }
     },
     "localname": "LeadingProviderOfIndustrialInjuryPreventionMember",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_ManagementAndServicesContractsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisition of part of a company which holds management and service contracts.",
        "label": "Management and Services Contracts [Member]",
        "terseLabel": "Management and Services Contracts [Member]"
       }
      }
     },
     "localname": "ManagementAndServicesContractsMember",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_ManagementContractRevenuesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Management contract revenues are derived from contractual arrangements whereby the Company manages a clinic for third party owners. Revenues are determined based on the number of visits conducted at the clinic and recognized when services are performed.",
        "label": "Management Contract Revenues [Member]"
       }
      }
     },
     "localname": "ManagementContractRevenuesMember",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_ManagementContractsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisition of part of a company which holds management contracts.",
        "label": "Management Contracts [Member]",
        "terseLabel": "Management Contracts [Member]"
       }
      }
     },
     "localname": "ManagementContractsMember",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_MarchTwoThousandSeventeenAcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of business acquisition.",
        "label": "March Two Thousand Seventeen Acquisition [Member]",
        "terseLabel": "March 2017 Acquisition [Member]"
       }
      }
     },
     "localname": "MarchTwoThousandSeventeenAcquisitionMember",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_MaximumContractualAllowanceReserveEstimate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum contractual allowance reserve estimate.",
        "label": "Maximum Contractual Allowance Reserve Estimate",
        "terseLabel": "Maximum contractual allowance reserve estimate"
       }
      }
     },
     "localname": "MaximumContractualAllowanceReserveEstimate",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_MedicareAcceleratedAndAdvancePaymentFunds": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of medicare accelerated and advance payment funds.",
        "label": "Medicare Accelerated and Advance Payment Funds",
        "terseLabel": "Medicare accelerated and advance payment funds"
       }
      }
     },
     "localname": "MedicareAcceleratedAndAdvancePaymentFunds",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/AccruedExpensesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of funds from the CARES Act allowed for qualified healthcare providers to receive advanced payments under the existing Medicare Accelerated and Advance Payments Program (\"MAAPP funds\") during the COVID-19 pandemic",
        "label": "Medicare Accelerated and Advance Payments Program Funds Payable",
        "terseLabel": "MAAPP Funds Payable"
       }
      }
     },
     "localname": "MedicareAcceleratedAndAdvancePaymentsProgramFundsPayable",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_MedicareAcceleratedAndAdvancePaymentsProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Emergency financial aid grants to cover expenses related to the disruption of campus operations due to COVID-19.",
        "label": "Medicare Accelerated and Advance Payments Program [Member]",
        "terseLabel": "Medicare Accelerated and Advance Payments Program [Member]"
       }
      }
     },
     "localname": "MedicareAcceleratedAndAdvancePaymentsProgramMember",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_MedicareReimbursementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Medicare Reimbursement [Abstract]",
        "terseLabel": "Medicare Reimbursement [Abstract]"
       }
      }
     },
     "localname": "MedicareReimbursementAbstract",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "usph_NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 0.0,
       "parentTag": "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest permanent equity.",
        "label": "Net Income Loss Attributable To Noncontrolling Interest, Permanent Equity",
        "negatedLabel": "Non-controlling interests - permanent equity",
        "terseLabel": "Net income attributable to non-controlling interest - permanent equity"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity",
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to redeemable noncontrolling interest temporary equity.",
        "label": "Net Income Loss Attributable To Redeemable Noncontrolling Interest temporary Equity",
        "negatedLabel": "Redeemable non-controlling interests - temporary equity",
        "terseLabel": "Operating results allocated to redeemable non-controlling interest partners"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome",
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_NetPatientRevenuesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net patient revenues (patient revenues less estimated contractual adjustments) are reported at the estimated net realizable amounts from third-party payors, patients and others for services rendered.",
        "label": "Net Patient Revenues [Member]",
        "terseLabel": "Net Patient Revenues [Member]"
       }
      }
     },
     "localname": "NetPatientRevenuesMember",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome",
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_NetRevenueFromMedicare": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net revenue from Medicare.",
        "label": "Net revenue from Medicare",
        "terseLabel": "Net patient revenue from Medicare accounts"
       }
      }
     },
     "localname": "NetRevenueFromMedicare",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_NonCompeteAgreementBasicTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to the term of non-compete agreement regardless of whether the Selling Shareholder is employed by the subsidiary entity.",
        "label": "Non-Compete Agreement Term under Condition Two",
        "terseLabel": "Non-Compete agreement term regardless of whether the selling shareholder is employed"
       }
      }
     },
     "localname": "NonCompeteAgreementBasicTerm",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to the term of non-compete agreement under the condition if an Employed Selling Shareholders' employment is terminated (if the Selling Shareholder becomes an Employed Selling Shareholder).",
        "label": "Non-Compete Agreement Term under Condition of Termination of Employment of Employed Selling Shareholder",
        "terseLabel": "Non-Compete agreement term under condition of termination of employment of employed selling shareholder"
       }
      }
     },
     "localname": "NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "usph_NonControllingInterestRedeemableAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Controlling Interest, Redeemable [Abstract]",
        "verboseLabel": "Redeemable Non-Controlling Interests [Abstract]"
       }
      }
     },
     "localname": "NonControllingInterestRedeemableAbstract",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "usph_NonControllingInterestsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for non-controlling interests.",
        "label": "Non controlling Interests Policy [Policy Text Block]",
        "terseLabel": "Non-Controlling Interests"
       }
      }
     },
     "localname": "NonControllingInterestsPolicyPolicyTextBlock",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "usph_NonQualifiedStockOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-qualified stock options are stock options which do not qualify for the special treatment accorded to incentive stock options.",
        "label": "Non Qualified Stock Options [Member]",
        "terseLabel": "Non Qualified Stock Options [Member]"
       }
      }
     },
     "localname": "NonQualifiedStockOptionsMember",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansAmendedAndRestatedEmployeeStockOptionPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_NoteReceivableRelatedToSaleOfClinics": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Note receivable related to sale of discontinued clinics",
        "label": "Note Receivable Related to Sale of Clinics",
        "terseLabel": "Note receivable related to sale of closed clinics"
       }
      }
     },
     "localname": "NoteReceivableRelatedToSaleOfClinics",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_NotesPayableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A written promise to pay a note.",
        "label": "Notes Payable [Member]"
       }
      }
     },
     "localname": "NotesPayableMember",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/NotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_NotesPayableOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A written promise to pay a note to a third party.",
        "label": "Notes Payable One [Member]",
        "terseLabel": "Notes Payable One [Member]"
       }
      }
     },
     "localname": "NotesPayableOneMember",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of business acquisition cost of acquired entity debt issued on the date of acquisition.",
        "label": "Notes Payable Related to Purchase of Non-Controlling Interest, Permanent Equity",
        "terseLabel": "Notes payable related to purchase of non-controlling interest, permanent equity"
       }
      }
     },
     "localname": "NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of business acquisition cost of acquired entity debt issued (temporary equity) on the date of acquisition.",
        "label": "Notes Payable Related To Purchase Of Redeemable Non Controlling Interest, Temporary Equity",
        "verboseLabel": "Notes payable related to purchase of redeemable non-controlling interest, temporary equity"
       }
      }
     },
     "localname": "NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_NotesPayableTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A written promise to pay a note to a third party.",
        "label": "Notes Payable Two [Member]",
        "terseLabel": "Notes Payable Two [Member]"
       }
      }
     },
     "localname": "NotesPayableTwoMember",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of notes receivable from sale of redeemable non-controlling interest attributable to temporary equity interest.",
        "label": "Notes Receivable Related to Sale of Redeemable Non-controlling Interest Temporary Equity",
        "terseLabel": "Notes receivable related to sales of redeemable non-controlling interest - temporary equity"
       }
      }
     },
     "localname": "NotesReceivableRelatedToSaleOfRedeemableNonControllingInterestTemporaryEquity",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_NovemberTwoThousandTwentyAcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of business acquisition.",
        "label": "November Two Thousand Twenty Acquisition [Member]",
        "terseLabel": "November 2020 Acquisition [Member]"
       }
      }
     },
     "localname": "NovemberTwoThousandTwentyAcquisitionMember",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_NumberOfAcquiredOperations": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to number of acquired operations during the period.",
        "label": "Number of Acquired Operations",
        "terseLabel": "Number of acquired operations"
       }
      }
     },
     "localname": "NumberOfAcquiredOperations",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "usph_NumberOfBusinessesMerged": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of businesses merged during the period.",
        "label": "Number of Businesses Merged",
        "terseLabel": "Number of businesses merged"
       }
      }
     },
     "localname": "NumberOfBusinessesMerged",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "usph_NumberOfClinicsOperated": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of clinics operated during the period.",
        "label": "Number Of Clinics Operated",
        "terseLabel": "Number of clinics operated"
       }
      }
     },
     "localname": "NumberOfClinicsOperated",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "usph_NumberOfClinicsOperatesAsASatelliteClinicWithExistingPartnerships": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of clinics operates as a satellite clinic with existing partnerships during the period.",
        "label": "Number Of Clinics Operates As a Satellite Clinic With Existing Partnerships",
        "terseLabel": "Number of clinics that operate as a satellite clinic with existing partnerships"
       }
      }
     },
     "localname": "NumberOfClinicsOperatesAsASatelliteClinicWithExistingPartnerships",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "usph_NumberOfClosedClinicsSold": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of closed clinics sold during the period",
        "label": "Number of Closed Clinics Sold",
        "terseLabel": "Number of closed clinics sold"
       }
      }
     },
     "localname": "NumberOfClosedClinicsSold",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "usph_NumberOfEmployeesCoveredUnderEmployeeAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of employees covered under employee agreement during the period.",
        "label": "Number Of Employees Covered Under Employee Agreement",
        "terseLabel": "Number of officers with the company had employee agreement"
       }
      }
     },
     "localname": "NumberOfEmployeesCoveredUnderEmployeeAgreement",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "usph_NumberOfFurloughedEmployeesReturned": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of furloughed employees returned to work.",
        "label": "Number of Furloughed Employees Returned",
        "terseLabel": "Number of furloughed employees returned"
       }
      }
     },
     "localname": "NumberOfFurloughedEmployeesReturned",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "usph_NumberOfInstallmentsForNoteReceivableInSaleConsideration": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of installments for note receivable in sale consideration.",
        "label": "Number of Installments for Note Receivable in Sale Consideration",
        "terseLabel": "Number of installments for note receivable",
        "verboseLabel": "Number of installments for note receivable"
       }
      }
     },
     "localname": "NumberOfInstallmentsForNoteReceivableInSaleConsideration",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "usph_NumberOfManagementContracts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of management contracts during period.",
        "label": "Number of Management Contracts",
        "terseLabel": "Number of management contracts"
       }
      }
     },
     "localname": "NumberOfManagementContracts",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "usph_NumberOfOnsiteClientLocations": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of client locations that included in total operated states that are providing industrial injury prevention services.",
        "label": "Number of Onsite Client Locations",
        "terseLabel": "Number of onsite client locations"
       }
      }
     },
     "localname": "NumberOfOnsiteClientLocations",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "usph_NumberOfOperatingClinicLocations": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating clinic locations during the period.",
        "label": "Number of Operating Clinic Locations",
        "terseLabel": "Number of operating clinic locations"
       }
      }
     },
     "localname": "NumberOfOperatingClinicLocations",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "usph_NumberOfPartnershipInWhichInterestAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of partnership in which interest acquired during the period.",
        "label": "Number Of Partnership In Which Interest Acquired",
        "terseLabel": "Number of partnerships in which interest acquired",
        "verboseLabel": "Number of partnerships"
       }
      }
     },
     "localname": "NumberOfPartnershipInWhichInterestAcquired",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails",
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "usph_NumberOfRegions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of regions of the entity operates.",
        "label": "Number of regions",
        "terseLabel": "Number of regions"
       }
      }
     },
     "localname": "NumberOfRegions",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "usph_NumberOfStatesOfNetworkServices": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents number of states of network services provided by the company.",
        "label": "Number of States of Network Services",
        "terseLabel": "Number of states of network services"
       }
      }
     },
     "localname": "NumberOfStatesOfNetworkServices",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "usph_NumberOfThirdPartyFacilities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of third party facilities.",
        "label": "Number Of Third Party Facilities",
        "terseLabel": "Number of third party facilities"
       }
      }
     },
     "localname": "NumberOfThirdPartyFacilities",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "usph_OperatingLeaseSupplementalInformationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of supplemental information related to leases.",
        "label": "Operating Lease, Supplemental Information [Table Text Block]",
        "terseLabel": "Supplemental Information Related to Leases"
       }
      }
     },
     "localname": "OperatingLeaseSupplementalInformationTableTextBlock",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "usph_OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other revenues includes management contract revenues, industrial injury prevention services revenues and services provided on-site, such as schools and industrial worksites, for physical or occupational therapy services, and athletic trainers and gym membership fees. Contract terms and rates are agreed to in advance between the Company and the third parties. Services are typically performed over the contract period and revenue is recorded in accordance with the contract terms. If the services are paid in advance, revenue is deferred over the period of the agreement and recognized when the services are performed.",
        "label": "Other Revenues Including Management Contract Revenues and Industrial Injury Prevention Services Revenues [Member]",
        "verboseLabel": "Other Revenues [Member]"
       }
      }
     },
     "localname": "OtherRevenuesIncludingManagementContractRevenuesAndIndustrialInjuryPreventionServicesRevenuesMember",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_OtherRevenuesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other revenues include services provided on-site, such as schools and industrial worksites, for physical or occupational therapy services, and athletic trainers and gym membership fees. Contract terms and rates are agreed to in advance between the Company and the third parties. Services are typically performed over the contract period and revenue is recorded in accordance with the contract terms. If the services are paid in advance, revenue is deferred over the period of the agreement and recognized when the services are performed.",
        "label": "Other Revenues [Member]"
       }
      }
     },
     "localname": "OtherRevenuesMember",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_PatientsAndPayorsRelatedLiability": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/AccruedExpensesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred due to patients and payors . Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Patients And Payors Related Liability",
        "verboseLabel": "Credit balances due to patients and payors"
       }
      }
     },
     "localname": "PatientsAndPayorsRelatedLiability",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/AccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_PaymentsToAcquireBusinessesConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to acquire businesses total consideration.",
        "label": "Payments To Acquire Businesses Consideration",
        "terseLabel": "Total consideration",
        "verboseLabel": "Total consideration"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesConsideration",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_PaymentsToAcquireRedeemableNonControllingInterest": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a redeemable non-controlling interest.",
        "label": "Payments to Acquire Redeemable Non-controlling Interest",
        "negatedLabel": "Purchase of redeemable non-controlling interest, temporary equity"
       }
      }
     },
     "localname": "PaymentsToAcquireRedeemableNonControllingInterest",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_PercentageOfBonusPayment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to percentage of bonus payment proposed by the agency.",
        "label": "Percentage Of Bonus Payment",
        "terseLabel": "Percentage of bonus payment by APM"
       }
      }
     },
     "localname": "PercentageOfBonusPayment",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_PercentageOfCombinedBusinessInterestOwned": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of combined business interest owned during the period.",
        "label": "Percentage of Combined Business Interest Owned",
        "terseLabel": "Percentage of combined business interest owned"
       }
      }
     },
     "localname": "PercentageOfCombinedBusinessInterestOwned",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_PercentageOfEmployeesFurloughedOrTerminated": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of employees furloughed or terminated due to pandemic.",
        "label": "Percentage of Employees Furloughed or Terminated",
        "terseLabel": "Percentage of employees furloughed or terminated"
       }
      }
     },
     "localname": "PercentageOfEmployeesFurloughedOrTerminated",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_PercentageOfGeneralPartnershipInterestOwned": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of general partnership interest owned during the period.",
        "label": "Percentage Of General Partnership Interest Owned",
        "terseLabel": "Percentage of general partnership interest owned"
       }
      }
     },
     "localname": "PercentageOfGeneralPartnershipInterestOwned",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_PercentageOfLimitedPartnershipInterestOwned": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of limited partnership interest owned during the period.",
        "label": "Percentage Of Limited Partnership Interest Owned",
        "terseLabel": "Percentage of limited partnership interest owned"
       }
      }
     },
     "localname": "PercentageOfLimitedPartnershipInterestOwned",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_PercentageOfMedicarePaymentIncrease": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of Medicare payment increase during the period.",
        "label": "Percentage Of Medicare Payment increase",
        "terseLabel": "Percentage of increase in Medicare payment rates"
       }
      }
     },
     "localname": "PercentageOfMedicarePaymentIncrease",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_PercentageOfPaymentForOutpatientTherapyServices": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to the percentage of payment for outpatient therapy services to the therapy assistant.",
        "label": "Percentage of Payment for Outpatient Therapy Services",
        "terseLabel": "Percentage of payment for outpatient therapy services"
       }
      }
     },
     "localname": "PercentageOfPaymentForOutpatientTherapyServices",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of practice expense component of relative value unit during the period.",
        "label": "Percentage Of Practice Expense Component Of Relative Value Unit",
        "terseLabel": "Percentage of practice expense component"
       }
      }
     },
     "localname": "PercentageOfPracticeExpenseComponentOfRelativeValueUnit",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_PercentageOfRepurchaseOfCommonStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of repurchase of common stock during the period.",
        "label": "Percentage Of Repurchase Of Common Stock",
        "terseLabel": "Percentage of repurchase of common stock"
       }
      }
     },
     "localname": "PercentageOfRepurchaseOfCommonStock",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/CommonStockDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage reduction for service in office or other non institutional settings during the period.",
        "label": "Percentage Reduction For Service In Office Or Other Non Institutional Settings",
        "terseLabel": "Percentage reduction for service"
       }
      }
     },
     "localname": "PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the period of federal debt ceiling in connection with deficit reductions, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Period Of Federal Debt Ceiling In Connection With Deficit Reductions",
        "terseLabel": "Federal debt ceiling in connection with deficit reductions"
       }
      }
     },
     "localname": "PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "usph_PhysicalTherapyOperationsExcludingClosureCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Physical therapy operations excluding closure cost consist of net revenue from physical therapy and occupational therapy clinics that provide pre-and post-operative care and treatment for orthopedic related disorders, sports-related injuries, preventive care, rehabilitation of injured workers and neurological injuries.",
        "label": "Physical Therapy Operations Excluding Closure Costs [Member]",
        "terseLabel": "Physical Therapy Operations (Excluding Closure Costs) [Member]"
       }
      }
     },
     "localname": "PhysicalTherapyOperationsExcludingClosureCostsMember",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_PhysicalTherapyOperationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Physical therapy operations consist of physical therapy and occupational therapy clinics that provide pre-and post-operative care and treatment for orthopedic related disorders, sports-related injuries, preventive care, rehabilitation of injured workers and neurological injuries. Services provided by industrial injury prevention services segment include onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments.",
        "label": "Physical Therapy Operations [Member]",
        "terseLabel": "Physical Therapy Operations [Member]"
       }
      }
     },
     "localname": "PhysicalTherapyOperationsMember",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/SegmentInformationDetails",
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_PreferredStockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock [Abstract]"
       }
      }
     },
     "localname": "PreferredStockAbstract",
     "nsuri": "http://usph.com/20201231",
     "xbrltype": "stringItemType"
    },
    "usph_ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the sale of redeemable non-controlling interest attributable to temporary equity interest.",
        "label": "Proceeds from Sale of Redeemable Non-controlling Interest Temporary Equity",
        "terseLabel": "Sales of redeemable non-controlling interest - temporary equity"
       }
      }
     },
     "localname": "ProceedsFromSaleOfRedeemableNonControllingInterestTemporaryEquity",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_PromissoryNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A written promise to pay a note to a third party.",
        "label": "Promissory Notes [Member]",
        "terseLabel": "3.25% through 5.50% Notes Payable due in Next Year [Member]"
       }
      }
     },
     "localname": "PromissoryNotesMember",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/NotesPayableSummaryOfNotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_PublicHealthAndSocialServicesEmergencyFundMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Emergency financial aid grants to cover expenses related to the disruption of campus operations due to COVID-19.",
        "label": "Public Health and Social Services Emergency Fund [Member]",
        "terseLabel": "Public Health and Social Services Emergency Fund [Member]"
       }
      }
     },
     "localname": "PublicHealthAndSocialServicesEmergencyFundMember",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_PurchaseOfBusinessSellerFinancingPortion": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase of business - seller financing portion in noncash investing or financing activities.",
        "label": "Purchase Of Business Seller Financing Portion",
        "terseLabel": "Purchase of businesses - seller financing portion"
       }
      }
     },
     "localname": "PurchaseOfBusinessSellerFinancingPortion",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_PurchaseOfPartnershipInterestsRedeemableNonControllingInterests": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in redeemable noncontrolling interest through purchasing of interests from noncontrolling shareholders.",
        "label": "Purchase of partnership interests - redeemable non-controlling interests"
       }
      }
     },
     "localname": "PurchaseOfPartnershipInterestsRedeemableNonControllingInterests",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_RedeemableNonControllingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Redeemable Non-Controlling Interest [Abstract]"
       }
      }
     },
     "localname": "RedeemableNonControllingInterestAbstract",
     "nsuri": "http://usph.com/20201231",
     "xbrltype": "stringItemType"
    },
    "usph_RedeemableNonControllingInterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the upper bound of a range for the estimate of fair value as of the reporting date of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity.",
        "label": "Redeemable Non-Controlling Interest [Member]",
        "terseLabel": "Redeemable Non-Controlling Interest [Member]"
       }
      }
     },
     "localname": "RedeemableNonControllingInterestMember",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to the commencement period of redemption rights for redeemable non controlling interest.",
        "label": "Redeemable Non-controlling Interest, Redemption Rights, Commencement Period",
        "terseLabel": "Redeemable non-controlling interest, redemption rights, commencement period"
       }
      }
     },
     "localname": "RedeemableNonControllingInterestRedemptionRightsCommencementPeriod",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "usph_RedeemableNonControllingInterestTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a redeemable non-controlling interest.",
        "label": "Redeemable Non-Controlling Interest [Text Block]",
        "terseLabel": "Redeemable Non-Controlling Interest"
       }
      }
     },
     "localname": "RedeemableNonControllingInterestTextBlock",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterest"
     ],
     "xbrltype": "textBlockItemType"
    },
    "usph_RedeemableNonControllingInterestsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for redeemable non-controlling interests.",
        "label": "Redeemable Non Controlling Interests [Policy Text Block]",
        "terseLabel": "Redeemable Non-Controlling Interests"
       }
      }
     },
     "localname": "RedeemableNonControllingInterestsPolicyTextBlock",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "usph_ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reduction in Combined physical therapy/speech language pathology expenses during the period.",
        "label": "Reduction In Combined Physical Therapy Speech Language Pathology Expenses",
        "terseLabel": "Reduction in combined physical therapy/speech language pathology expenses"
       }
      }
     },
     "localname": "ReductionInCombinedPhysicalTherapySpeechLanguagePathologyExpenses",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_ReductionInMedicareSpendingPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reduction in Medicare spending percentage during the period.",
        "label": "Reduction In Medicare Spending Percentage",
        "terseLabel": "Medicare spending cut percentage"
       }
      }
     },
     "localname": "ReductionInMedicareSpendingPercentage",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_ReferralRelationshipMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Referral relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Referral Relationship [Member]",
        "terseLabel": "Referral Relationships [Member]",
        "verboseLabel": "Referral Relationships [Member]"
       }
      }
     },
     "localname": "ReferralRelationshipMember",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails",
      "http://usph.com/role/IntangibleAssetsNetAmortizationOfReferralRelationshipsAndNoncompetitionAgreementsDetails",
      "http://usph.com/role/IntangibleAssetsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_ReliefFunds": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Relief funds relates to social welfare, a fund of money set up to provide aid for people in need, especially in disaster areas.",
        "label": "Relief Funds",
        "terseLabel": "Relief funds"
       }
      }
     },
     "localname": "ReliefFunds",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_RemainingContractTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining term of contract, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Remaining Contract Term",
        "terseLabel": "Remaining contract term"
       }
      }
     },
     "localname": "RemainingContractTerm",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "usph_RenewalPeriodForEmploymentAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employment agreement renewal period.",
        "label": "Renewal Period For Employment Agreement",
        "terseLabel": "Renewal period of employment agreements"
       }
      }
     },
     "localname": "RenewalPeriodForEmploymentAgreement",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "usph_RentSuppliesContractLaborAndOther": {
     "auth_ref": [],
     "calculation": {
      "http://usph.com/role/ConsolidatedStatementsOfIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense related to rent, supplies, contract labor and other.",
        "label": "Rent Supplies Contract Labor And Other",
        "terseLabel": "Rent, supplies, contract labor and other"
       }
      }
     },
     "localname": "RentSuppliesContractLaborAndOther",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_RestrictedPeriodToEmployeesOnTheStockGranted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted period to employees on the stock granted during the period.",
        "label": "Restricted period to employees on the stock granted",
        "terseLabel": "Restricted period on the stock granted"
       }
      }
     },
     "localname": "RestrictedPeriodToEmployeesOnTheStockGranted",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "usph_RestrictedStockPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for restricted stock.",
        "label": "Restricted Stock Policy [Policy Text Block]",
        "terseLabel": "Restricted Stock"
       }
      }
     },
     "localname": "RestrictedStockPolicyPolicyTextBlock",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "usph_RevaluationOfRedeemableNonControllingInterestNetOfTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of distributions during the period on mandatorily redeemable securities net of tax.",
        "label": "Revaluation of Redeemable Non-controlling Interest Net of Tax",
        "terseLabel": "Revaluation of redeemable non-controlling interest, net of tax"
       }
      }
     },
     "localname": "RevaluationOfRedeemableNonControllingInterestNetOfTax",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_RevaluationOfRedeemableNonControllingInterestNetOfTaxShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period related to redeemable non-controlling interest.",
        "label": "Revaluation of Redeemable Non-controlling Interest Net of Tax, Shares",
        "terseLabel": "Revaluation of redeemable non-controlling interest, net of tax (in shares)"
       }
      }
     },
     "localname": "RevaluationOfRedeemableNonControllingInterestNetOfTaxShares",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "usph_SaleOfNonControllingInterestNetOfTaxAndPurchases": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest or decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).",
        "label": "Sale of non-controlling interest, net of tax and purchases",
        "terseLabel": "Sale of non-controlling interest, net of purchases and tax"
       }
      }
     },
     "localname": "SaleOfNonControllingInterestNetOfTaxAndPurchases",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_SaleOfNoncontrollingInterestPercentageInPartnershipOne": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to noncontrolling percentage sold by an entity during the period.",
        "label": "Sale of Noncontrolling Interest Percentage in Partnership One",
        "terseLabel": "Sale of non-controlling interest percentage in partnership one"
       }
      }
     },
     "localname": "SaleOfNoncontrollingInterestPercentageInPartnershipOne",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "usph_ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of business combination completed within the physical therapy operations segment during the period.",
        "label": "Schedule of Business Acquisitions Within Physical Therapy Operations Segment [Table Text Block]",
        "terseLabel": "Acquisitions Within Physical Therapy Operations Segment"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsWithinPhysicalTherapyOperationsSegmentTableTextBlock",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "usph_SelfInsuranceProgramPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for self-insurance program.",
        "label": "Self Insurance Program Policy [Policy Text Block]",
        "terseLabel": "Self-Insurance Program"
       }
      }
     },
     "localname": "SelfInsuranceProgramPolicyPolicyTextBlock",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "usph_SeptemberTwoThousandNineteenAcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of business acquisition.",
        "label": "September Two Thousand Nineteen Acquisition [Member]",
        "terseLabel": "September 2019 Acquisition [Member]"
       }
      }
     },
     "localname": "SeptemberTwoThousandNineteenAcquisitionMember",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_SeptemberTwoThousandTwentyAcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of business acquisition.",
        "label": "September Two Thousand Twenty Acquisition [Member]",
        "terseLabel": "September 2020 Acquisition [Member]"
       }
      }
     },
     "localname": "SeptemberTwoThousandTwentyAcquisitionMember",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails",
      "http://usph.com/role/OrganizationNatureOfOperationsAndBasisOfPresentationAcquisitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_SeptemberTwoThousandTwentyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to the principal installment plus accrued interest payable date.",
        "label": "September Two Thousand Twenty [Member]",
        "terseLabel": "September 2020 [Member]"
       }
      }
     },
     "localname": "SeptemberTwoThousandTwentyMember",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_SeptemberTwoThousandTwentyOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to the principal installment plus accrued interest payable date.",
        "label": "September Two Thousand Twenty One [Member]",
        "terseLabel": "September 2021 [Member]"
       }
      }
     },
     "localname": "SeptemberTwoThousandTwentyOneMember",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/AcquisitionsOfBusinessesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares outstanding for which restrictions had not lapsed.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award For Shares Outstanding Restrictions Had Not Lapsed",
        "terseLabel": "Shares outstanding for which restrictions had not lapsed (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised for the cumulative period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises For the Cumulative Period",
        "verboseLabel": "Stock options exercised (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesForTheCumulativePeriod",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansCumulativeSummaryOfEquityPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made for the cumulative period on restricted stock units plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award Restricted Stock Grants For The Cumulative Period",
        "verboseLabel": "Restricted stock issued (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsForTheCumulativePeriod",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansCumulativeSummaryOfEquityPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "usph_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of restriction lapse grant to employees.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Restriction Lapse Period Description",
        "terseLabel": "Restrictions will lapse in"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictionLapsePeriodDescription",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/EquityBasedPlansDetails"
     ],
     "xbrltype": "gYearItemType"
    },
    "usph_SupplementalInformationRelatedToOperatingLeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Information Related to Operating Leases [Abstract]",
        "terseLabel": "Supplemental Information Related to Leases [Abstract]"
       }
      }
     },
     "localname": "SupplementalInformationRelatedToOperatingLeasesAbstract",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/LeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "usph_TaxEffectOnSaleOfNoncontrollingInterest": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to amount of tax effected on noncontrolling interest sale price during the period.",
        "label": "Tax Effect on Sale of Noncontrolling Interest",
        "terseLabel": "Tax effect on sale price"
       }
      }
     },
     "localname": "TaxEffectOnSaleOfNoncontrollingInterest",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/AcquisitionsAndSaleOfNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_TermOfEmploymentAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to the term of employment agreement with the subsidiary entity.",
        "label": "Term of Employment Agreement",
        "terseLabel": "Employment agreement term"
       }
      }
     },
     "localname": "TermOfEmploymentAgreement",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "usph_TherapyPracticeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to the acquiree entity Therapy Practice.",
        "label": "Therapy Practice [Member]",
        "terseLabel": "Therapy Practice [Member]"
       }
      }
     },
     "localname": "TherapyPracticeMember",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/RedeemableNoncontrollingInterestDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Refers to transfer of compensation liability for certain stock issued pursuant to incentive plans.",
        "label": "Transfer Of Compensation Liability For Certain Stock Issued Pursuant To Incentive Plans",
        "terseLabel": "Transfer of compensation liability for certain stock issued pursuant to long-term incentive plans"
       }
      }
     },
     "localname": "TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "usph_WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to weighted average lease terms and discount rates.",
        "label": "Weighted Average Lease Terms and Discount Rates [Table Text Block]",
        "terseLabel": "Average Lease Terms and Discount Rates"
       }
      }
     },
     "localname": "WeightedAverageLeaseTermsAndDiscountRatesTableTextBlock",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "usph_Year2017Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare payment year.",
        "label": "Year 2017 [Member]"
       }
      }
     },
     "localname": "Year2017Member",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_Year2018Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare payment year.",
        "label": "Year2018 [Member]",
        "terseLabel": "Year 2018 [Member]"
       }
      }
     },
     "localname": "Year2018Member",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "usph_Year2019Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare payment year.",
        "label": "Year2019 [Member]",
        "terseLabel": "Year 2019 [Member]"
       }
      }
     },
     "localname": "Year2019Member",
     "nsuri": "http://usph.com/20201231",
     "presentation": [
      "http://usph.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    }
   },
   "unitCount": 18
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04.(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(ColumnA))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e7018-107765"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4647-111522"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a,b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=SL6953423-111524"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/subtopic&trid=2144439"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2473-110228"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=d3e1314-112600"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=d3e1336-112600"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12317-112629"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12355-112629"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "16(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130561-203045"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130564-203045"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "http://asc.fasb.org/extlink&oid=6409733&loc=d3e19524-108361"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "http://asc.fasb.org/extlink&oid=6409875&loc=d3e20015-108363"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "http://asc.fasb.org/extlink&oid=6409961&loc=d3e20487-108367"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "710",
   "URI": "http://asc.fasb.org/topic&trid=2127225"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "712",
   "URI": "http://asc.fasb.org/topic&trid=2197446"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32247-109318"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32280-109318"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e961-128460"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121600890&loc=d3e2207-128464"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5504-128473"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4M",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591554-111686"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13279-108611"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121549951&loc=d3e39927-112707"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121329987&loc=SL77916155-209984"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=116635682&loc=d3e55733-112764"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=68075217&loc=d3e3111-115594"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "405",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491204&loc=d3e4869-115612"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r496": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r497": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r498": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1-"
  },
  "r499": {
   "Name": "Forms 10-K, 20-F, 40-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d-1"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.26(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r501": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r502": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "11",
   "Subsection": "03"
  },
  "r503": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r504": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "09"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.19)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=114868883&loc=SL114871943-224233"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4273-108586"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>92
<FILENAME>0001140361-21-006642-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-21-006642-xbrl.zip
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MF!6@@$LT 3!&_6>9@6V)UWB(3@R<5S=7*GFS^)#+RFYQON(KA9=]&\51$,F
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M#G<6C"5[0@7/ O&[)83S]&YVD?9*%BP/WW=+ HL89:]HX!D ?K=$T"]OR[S
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MV!M:A1+:'*)H R7LV!E.S=!TU>ID_89,8P-1I5KK095=FV VXFT1^PK0ZFV
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M+X>8_Y=F*\Y^[GG\\2-+TF&4+!IV63BFAG@[/?LGP#7G%H^'6&5^XW,7SWH
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MFNO;M@<NN:/Z6%U#,X!N0S\,R#([ G]@G>7-BS/E/%TS>^\,\2.= (D,HZ(
MHF(QD$J6)FACQV.%@;T]5L[0P "$1G=,^4@*HIP*,3K%&Y,QFG*UJ8G!,RW%
M:4SE^O!FT[PAYE.3/,M_?)*@&W BF)*^I[(';5LEQ LH(>#\,**"Z&7,)6KH
M$H<M(W0[@MXT07-;,09;ERDD"("@,X)4B32 AF*R\%>TF@\77LB'P GPEJP2
M<P#0$!9DC)(?1@,)BF;UK0*F^GTQJ*X>@8Y@?&K<+N5I[SER <;2=?7]0Q/D
ME[7WU6US-\CKO>J&!Z=7#83Z0-[[P%2K.RO#6=/]0WV1.CO:GWAQR)BF$2/0
M@'=-P].\T# MS?-L8JN4ZNHR)RN.'MRE ]*,"G:(@#-TR.XS\ECH;&U.YM,)
MT=DQD-)MFHV;1]*LP-%,S=)T%_>509+9U,4L.(^8/G&#5:(1_(6<8 /Y0@Q,
M?%I,]"L$@PQS\>K+>- K(6 BA)_>\M2/O/8!T)]'S=-13>M(-5L'R41[/3_Z
M_1AK;W[FYXLTT<M98@OB9SWVAB(-CC<?4^Z_"XT/[OTCNGBI)(/'.6[SZW/]
MT.Q?SF2OKELX;%4#DN;&?D!\GYBZH5+/](W "ZGO$(L%GJ]JU'0W>;!OW8R_
M1"[*DSRXQ!BO3J<GB\W$/:#2"K)?.6#' JYF^%5WJ!8RRW1,PPR!<!TLV618
MCAX0AP1+%,Y8+[6NM!>S-J\K?,2]Z8&WL&08%@,,/*P N@SE.?CF92Y<(Y@U
M2RCZZ_71X,K%1]<?WQ6/\>7W$;P:?:X$IIRB"+V+<JX;$Y($$8G1J$S+A$M5
M[(%&249S992EV'.+/A#J?4,61NV.N+^D:NMQR=O@0+\0D.<'E&0D5:HZ3$Y
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M;N*BW?CI[7NBW$5I/"62?Q,YTV<83^4[L)<IF/&-$$=5)D;^5)\0\NRY(2;
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M%B8RT%T8%>"\P(\8G&QNW%?.@\P"7&;^OXO77?#7G8*NK#.;)0Q )23.4V5
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M/GU\LZYJ)!JJ8MGX:CD6C;H>DM+5(\V:EP@K5NSZG4V=,<T9^\H59L$=7'X
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M=J^<W5&HJXD 82RRH9KUQK#*&!+]$D7&9@M[/58,K*[5),U1(6^E/$8;"JE
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M!.,?\;6X"+#($5!'6?-=! 3XYE+RXMN+("A'_$&XX::^ 8CB,HON8&W@+PE
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MY1+%4I\%(\A;([AH6ISP_*>$)@ S6+;U]!*4.190S)W\@WPK^9= 6>ARPY@
MK0TI=@[SW_9]FO%%58$J# 4<,G-Z-JW&EUF"=5O?ZCX;@L6O^=];8,^Z:^!#
MR(TS,$8#FUU=VC_0 R9UE>58@ )'!V$:@OABV**6Q"FF2>$QZE\HY,'_'M-A
MZEV8D5H3AI:"UO&&4&6EPN:H*J5 +"YH=\;PX&JM.L'4!J>B_H'$_A2B8'1=
M P=T'A#)/6?<@_IDNRNZ2QO$[%%8'W:EC& P/<]X[%LGME+'#\?XO"5,LVK(
M4R[E 1'^U94T%TW)O3W]U:?DL%SJY3FL**C<IFE=[$'EK@&M-T&1CLH2PUT2
M;SG*] Q]411*,@_EE>?9S"4OLWI2U?)J-BQ1,1(V//6N*?IC7,=3D*,YCS5B
MP(?V;8TU8N*!F!$D>07KB>]"2&;B4;T]#Z2%H2CS55&1H?Q3,,0HF7[Z*R\>
M!Q()XD&+<(]AH!"J<XH1O;"4$AR7)"SL00OV\XW,W2]J.'C3HIZV"XP5PCVJ
M"XQ(N2]O(;V71:+J-R-FI#[0KN=%GX-":#2O-Q5+L6BX/ #D .;?<( ?[N \
M*+6<$/B+!6:L/,X>[^.:%H/5DE%<\ FO>[34;;99G-X&!P$GT3MH]:!$ZZ#+
MP%<S%6#3!>)+5[CL@.IPU4Y '$NY8B_&ZTR:GWZKX0O?7_6<?9533&D*TH$(
M/43%6B:AXM:>SJ+1; <-T".B1!?F17/1%BAO'XKI!PQ?-A['JR/!;&L^1X2R
M8+_;:;!&&KK?:DH@D=,B"T!Y=_0>Q1G22C\*7?"7Z5H/T_6N[BK[X$IQ8=RR
M\0$RO41)9SC$C6!4G9"C#1T[_!R>.[0/R!=9"%P$GR4W'-ALX%'.(QF98.6$
M3\KR^&6][,G=?,%\^0,7BVP0D<W'*M1?Z-'0T.44_0_0,FU7TX>\LQ@6!+,%
MTTK.L#'IBUO>G10X72[QU#L>4V)XL]?@!:.8X.FNT%EW'R_A*EJQ6TN0NFF,
M>DYE=^&+KN2+D!S\FN]Y2D*324^>J6IL1M/KHSM*6%9Q6^_0N6 )Z,M%1B:V
M'XM=K;]7X#<G5_ 8E$=4>V&FZI5O7!422%10#7HY."S2H/JY:@D'R,<=&>\\
M R^QNH9S]!__M C?DWB_T2-IC#F61)#R_@^^ $%].(S+P:->%2SL/XNM[!-!
M_)_''][VTSWZ_C./'&GYS]%7-R)_/6,@J<08%>^5]VN\.7I=NMH;I!SIE!AH
M1@&\M6^2>A??VY<U\FG]ZI;!SXZT,"DGKI/@NUSS-R7'"-A%PNAP"#[*#)L
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M F4MYE(* >ZPU2SA X8(*X!87R:Z;.IA3!/EGJ3.IZ1M/7V&//%KY/1\DC[
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M@OO#>=DH89]JA,@N8/TK;CU)(A2KNP[-FAYK-:-#J1+E0U!XGUKKH+4EJ9G
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M@8E"B^Y(I$S)F81N\7ZGZQ5)EEB4&>-A"0P]H1F]+?1BT;YHS-9MR4>9=L.
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MV4$^/-C?&Q[DT]EWN^P!8O:+\Y9_3I6<W(=/?T>MMN>(:<-8IH;MD(2T+AC
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MA>?Z9:CHJ!V"])$9NVA8/7%7=?(QGJ)7X2-F;TZ9S!;VF6K^I?FIG\H5U<R
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M&NN,+![M1&9[1,O^^2YAI&RTCQB+B P3!,DUE]4\[]A':B&+4<PAV/.E<R
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MFKN@_#PLH^&\YFY'T\N2?E+VW36!^Q0ABV:D3;L4_\.3(WCWHECABH7^9/C
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MI,:PTOAKESSNQXCRMY?YQ2A5;S<*_T3W^6RZS27T3V%]#<)CIVLT=9*C@"O
M%A]\@ Q1,G/R\T@K3O81V0"LUPQ3<E10J% TYIL.D[?Y.6G[TK+MQ3;IO/C
MF=; =B7D!GI-@MK[0*1-XB 0U=&JFG[0YW5-E:R(&>UD,"CY:":[/%S!TL;D
MJZ1_D<C9>F<1[K;82:8$MQ^\BIN)J[?@G&33#WKKX=-X([.0V^M+Y]G.@F)"
M^-8?@;$S@ Z1+26K%X\:X7X4P,,I;W&)XC=/0@/9D )@G6'RQYB;IL;+GA^
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M@N.Z^Z<]KD=G_W7R/GGQ]BPY._GU]/S]V=&;]U+[>TXPF+=ODI/__NWT_=_
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M'(Y_%V@@2O.\SM36I2MLYR?8*1EXAV?T*YBQUY5&HL1<DLV!6#RB+CV"B0K
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M!*/QD-M\W  >Y,!Z]?9 2(]G#NKX4.RMMW_,K/W#8U6QL,X?!FN7C6R&70X
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M401U'EC /(EOX54D$&:1O5#RBL5AAF@ECUZE(Y2REGA<I(?Q N!>*$S8[S#
MB\4)W;P5I[#2M:7PGW$4<5,_7FM[:\^=\H&.\1&M7GZ0,W-7OCK+TL2#F)0+
M_S8/\5!<'#+P7J>8NGQ!?CZC(X@X:TEC#\,\L+,U1P6YSN71-ZX[WYOB9#,N
MGW\JI]REU89IKJIP>/D+-%FELV5NG\JLA*=NH41E@DVF>(M,QH8-*S$9[O\,
MD]& 119A.BG_-%YD&!FG@(BB(V:W;1/L,66\@X+??@2G7G'494A*-@HQ0XZ3
MGY#D)B9,TP63F1PST!Q;!95*8Z,Q@"V.$Q14M";9?0=HG^"H&8KD96%SON#"
MX R/#8$"2@4ASE#QBLLO5RI087A]ZZ)K77C6A6,*PS2-*:ECB42E=1GB<B!<
MN1ZDJ$4>LA7W4W?+LZX,4*AS4QZOI9,)S'V#3(Z)/7A-%J]L(]Y=L!D<ND3&
MA; IZ5Z-"E[GIHLIV(-[LW;@G(D?R4#&:TP4P"P0>'XM_[Q1ERO5)[8:?YE5
MWB#-RPZ_$.D5T[3!K6]?_LT!3A/K8^+Y$4:<)?XHW=-N4A3 PTI7"#,&G!V/
M(I5 BRERQ%FD+D&*<X4-GQXZH+QAVL!G@G%JG=_:P'.>X9+?<,&_Z3Z,;',1
M:I2Z:VNW=4/,?3]>:OT!X6.>_"33_RA'*HIB7UTKK9\8F76*^M%A7?Z*,J;I
M_(=^24#YQ%DN9,K(K17JW.GX P<N1]#9^A\I%R1_%NS!&)VX?)=&<?R7TGZ"
M&2G(#)10OS'IP(:Y "G=*Z<3.#:/F<C-*6E\86Y+!SMT%&4^%ODT87"!V\3F
MR(^[ZY/':HJ:JZ@7__CR[M=W5U_?_6Q\_/3N\^77ZP^_&)<??C;>7W^X_'!U
M??FK\?/EU\M#)A5X.R:I?ZV$_(64X"X'8>HOP$[D5Y^IR('*$U1E-A\&GQ<S
M$=Y')^X.73KP255T6<4/A)=&V9G"6)<\M7+R^B(MCLC%O$JS871'7\0&OM]$
M5;$>']QZ65CRXPOK!?T;JTG4OW<LD*D-M_HP9S9/X1GU5[6.9S4J:EEO7QAA
M\..+_W1[5G?  @O^K^>Q88^-QP'W6'\T=@:>UQN]J$'[D'-7*![#CMU_M5II
MD\7SW>!>\QJ1*K<-=^0VO(ZOK2>J+J-O=09NBY<A[-Z_-N0<+"UR#53+TS;O
M/?U/DYMGU_=D?=KF-;V,AS9O99$'V;RF61:_O1*9*F<@@'(E:(30N,2ET%6P
MR&]!-R4%G:. _D:AF@-N<],+VK#-\R1$#S<V_H?-%G@RE?N:UQ_ 1,"ES&L.
MZO=[ZVK15MXD(PB2ODE^7C?)2Z&.'6,==5[_'#QR>?26-U5%P0[%M?)C.IQS
MF2D\]=%].6X&1[:_^+W*#::*95&+6HQ4R@#9Z+F7Z%(M1!XHT=K.MQ>.-1OR
M7I>-!X$3>-; &@T&CM?U^ET^]'EOS'<_ CSHVBM)&EBOWM;Y[X^$!*@#$GP(
MH6^'4-B>@0SJ9[T9_J'WZ+<\""FYGE [*.*E!.1_43;:NQ5GX_#H";78D@T"
M2.ZRN<VPD',:+%3GC[:*3_3F[7 H;LG>[14DMM][1!?:1J%B/^1IP;(<PU3A
M9\PLP.@SY60=$$NV/2C0[<%X/AB"<[=[6MV*-:.=*J,-F@47;!4F^#IU_V 8
MZ.#J'M&S\#3Y,[L_)#[XIK4?6]2>/)&]B5HM.^S@276;[<*\?B6MT.F:T0['
M:,U"<#Z5T9Z)"W\),\=R/PE1@.F= ;NG_PJ?7COOY^%3.5[GZ)I>>^_/@M/Z
M)\9IS\1]I\8^2Y@TVHT_#^_*-;NN:[I]^]B"IYWYY\!NGFD-;7/8ZY\4NST3
ME_X#SW(MKR"HT9\GC?_<W?G3:C9PN"ZC5K?3.RTO3;/J\V758;.-!_=TH"CE
M.1ZU3.;SNR^___KUB_'QO2J4^?CA2\-3JJ8 UD[S_?67J\M?C7^]N_PLDDJO
M/O[VZ?+SNY^-KQ\-^65Q\;^I]&0OI25;U(]04>>/+W[^\NG]KV&:40[BB^V2
MX_J6UQTQC_<&PY'G]YRAU8/_[8_ZO;'?'8^&#U>=R)R\C:G&(GNQ-M&X*LF[
M)/0/'*>WK">KKT<DKC6OK\M??JJF^$Q8,+)N4'H^ F:!V FQ$%YZCMNQ<GQ)
M)EK!, DV_=(;.*5OQ2_M8<?X@NAEQ%H"&65,#0("A#")! Q[W9M?4T55O$C9
M+$C??/_$9.B*<^CNDI!I.9R-/+LWZ-H#SW<LY@9^SQK;_GC0#X(1:R@AL^KF
M4N)S-;^6V.9 :9MK%/AFE;?DE^^()M)$?N=.KM0!DCX?2>9=,\'J[4@I.53D
MAIY_JEC+T@QW>O4!<@^/R88/%3^UB@LU%S3#!<\B;74'"WO <)CLIY8N^U]/
MCR<TPMW[%=]''(>;B<EH&C89E3Z0;#K=/<:J&[Z3/$P,LIFPTYE$" ^R.K?O
MFJYW6G%#S>J:U7>YC<6K?^_HZ95'SKEIFVG[K:C0)E0O[. I3=P!+5P+9+L9
M5;=9 @\A9@/3LYNU)XT;#<T]!^2>7K_9"_<CZ>':\,,)'4D^$BIR@X>2_1"L
M6??MP9#;T5WA!SRT_2_@B4G39B,1XM:P7>LGJ.6B)7+A#9HUFP=ANU,Y[MA>
MQ]O-;'Z:W*<X9VK P^;W):C:YWC<.:EXQ4'B;P/7[/?U>4FSWU'8S_,\LVLU
M6Y_PK ]<NUN.ZUFP2+,$,0[#V9^+Y!Y!$;%Q$.;@I3RY#7U]_M)^YH&OBX:F
M/6P@.:,U?-?Z"6K!:(=@]$VOYYR^8!S>[GK-9=MM(-8!9K%/20SB!>:K;YCE
M2;FN1UJEYSCFL'=<<Z797;-[4^P^L$^(W1]5_7<R!6N.[WOCL>MSR[6]D>4.
M V?$@Y[;ZSK.>-@-GE/!&E'WJ4S]7M:EF835OZ%W'K6+GL012)YH1HA-59.
M&LY1:Z]?+B\_F:*\S>UVG/75;=92<9OHHH=/B%X$HH-Z/)95;]?8ER_%7F&J
MXQ[,Y$9TN8,3.HL6HA\>MOY;T[NNV@R;FA=00[/I?)%A'[MHD95;@!?=L=<N
ML^996KG3\0:ES_*J/VRB@%]V5[[$)>(F@(1/BF?Q\UHJU_0%OUF$](#J+%HA
MR18]/I=:A:>R_7G1#;'$%=AE,F%T-RVV(=C<3OVM,8GO.+"RN;QUV01;^D[8
M[(8O=U]<:54^8FGHR]9T8J]JFI<O5T=6ZAY-:CHXSTKDQTX6;SI[+8?L[5 .
M.;)LV^D'%O<<YOEVE_6& XL[?&QQW[5YOX%RR.'Q^E,<L.)"-[)X2L504;:H
M6UHT5*AV%ET1:IGI>18>GN]^/HL*PB.:KBOR3',?KL;9O#!^__+IGQ6G?-^5
MA7MGW];4NFG*M*$*\''R9=OB8K>:7FOO7N^WYIB[(E8:JNZ4(H,'6XC;->VA
M;CRC6;7]K.I9IN4V&Z9NW;7H'C*)>KLB+%TE/ @SX[4(=J5O:@-C^\>!R'>C
M68EL.#6A%7F-AU.T>N\:WKOV>KQU2LGU=E5*GQ]]+?#<'=^CHZ3OR1UX[9D]
MM]G4J8:3P]YH5CT35K5M<S!L>=?%_?)J,XGXQ[0\7]DW@X_'W,^P+6^:L6R1
MQ<D]7B-SX_48#%'"(KK<Q>_X&[KY[W6<[JN&L^W;D:M5#N:W+.GWR1CJIF.W
MH(KRZ-F"FMD:8#;7M)UF^Q =^^;ZP:SP)EV(AW(8V^-7/9Q,>CXQQV.NU;7-
M?G]P_.S9-H75M6AHT1"BX33<Q>P@HM&,'3MB8L:[U4R,URO)J8<,1]33HV5:
MX>Q$_\GP,1VO!8:O%=9-,^L),&NS(*ZZQJE:$3#N]WLCVW6Z07_@6:P[M/H>
M'[O<'0U'XWY@ZQJG)]4X?12(4+,;XS-/%U&6&J]9:@1\3/?S5#ORQI3U*.*I
M*.1CXSUX1?#H\G.BWFG0\51)$[PDP5*?X9"<A$K!BKE2#.7VBF(H]<N!L_I+
M+(LI:H4V+(8*76IFKF9J=7K+[W,/--.:N3&Z;?R%SS#F&]T;ESX6Y<!/+XMR
MID\)T#Z<@ZR^)D:RWF+)%?UIOWUC3#E+%SA!_N\%B])-)6M(H'(J'TU65)O-
M*-#$:-88=4: Y)1*R(KAYM$BE15+5)^$E5<!U2[Y48QS$-H(1DMQ;1%/4^.&
MP?)C4<*4LHAJUH"&&2PXG83S_'(U)8?1C\)9Z*O? D5BGZ:T[DHVWUV8$/\V
MY[-T>6;XWBQALS2DFUY)A!F(Q]6$>"&<,: NBXR/XW'H8UT6O+94 -8QOBY7
M7\EJM22>UL@.;$%<3 I?'P+3^)DJUGM\.=KF/G<\D'5[8LBMBKR>VO/.CX >
M9+HF^4$"-)4R#?(39;ZDTI&CKN]CN4-&OE3K:(7AS/C#=_1'/N.:F<_9#;\8
M)9S]=<'&\+;O673'[E,<9))4:]C([HH^>!5;)QT.^1FP^T36 E!X<[FBK.8$
MJ;XJ4_'%$J4WD&G5ON)Q])%$J^O^"31@QB3AXQ]?_(W,<SR^@J=0$>Q2<S>0
MEUTC(?1JJ!^^8ZL[]*"7LIV?,'('W<!BP;#'O%[?'0[&_C" S[R>QUSN-% Y
M2"S2BM)!X<Y4.S@ZUNHU9D\7$^IB0EU,>,+%9[J8\.SV4U<3ZFK"DZV9TY0Y
MC]SJW:%C=3FAKM'2Y82:5<^3574YX5[*"7>V+KJ<\)F5I.F].]V].RV7=_?V
M=+J<\-G6:.ER0LVJ)\*JNIQP_QFX^RDGW-WRZ')"7>&ERPDUL^ER0EU.>-BY
MZ)JIEM=,Z7)"+1I:-'0YH2XGW*?":)U6.#O1U^6$FEF?$[.>6#GAB5S>[&QU
M+H,_%VE&%4\'O#9ND=]Y$J'NEI!$YP)I/M&)./7>NJJX3'A$99I9;%R]_UBJ
MM]1).#LF<CSU(L!UFXW-ZCR>%FW_1?NV_K0\R2?D)HI">%$"KWW)MO@(3[WJ
M&C:L3K4[^DQ9K5G5K;W9$NE_D4@EFU!*RB EVK<]BG/SVC:M81N<V];F5&KV
MV<0^7;-K-UMG=IIICNWTK\L(7MJ]/@^?Y[7MFEVK 02+]F0E:UX]45[5_OG1
M5/^E0 .4*'[-5U5IMVIS-G##J><ZXMRB[=<1YR-ZQ+KP]'GZ(B=0=ZK#TN?!
M:J=0-]IXKO1^"C]WU_RZ\/-1.:EG7(OGV<?-*-5EG\^&U5[;9J_?;/S\$=S6
M]J#ZH^O1CI837=,4Y"[$Q@)9I8M&T[4X+7+[=/%>0\5[EMFSFSWGZ+I6+1HG
M(1I=<]@_ ]$XJWN*9JZH=3AZ4[BB^0ME?1W1HOW7UQ'/]I:V15[0,X@+OW;:
M'Q?6F3N:577FCKZ]T"'EMH:4';,_>"8A9<VL)\ZLS9J1DX:\;-/=17WW<GU[
MH4.TAP[1#DS/;0'>D[Z]T*+1-M'0MQ>/,+5'M*<_+2-P&MMF!Q0XGAJS\\P4
MP]-A$!ONH:<Q.S6S[LZL@Q88JA99HW8>_+8R5&N.@D<S5=KS;:?...!:G<ZP
M!;9/'PFU8+1.,-I@9_6!\(%M^H)F,C46*5C8< :;,YTO,I'T<6&L]&O01[]6
MW('LT1VV'7/0AJ!F*\R4YK<F^*W?/6YGPT<?P. _6(6/?]&T1XGQW3_$$N C
M^FY7@N3SM*Q7U<T1RU-&2VS$VQ>&'[$T_?'%SU\^O?\U3+.O^'+XE$>17.:/
M+RSQ;UR;^G<8_/CB/Y[O#;J./QSRGN/9[F#@6,/>V'/L49]YWFCXHL;0R66I
M60YH#Y?VK>:9E6W)XOE;H\IVC^>=__K;P'%ZR\)0?3U;9/&:UZ]0]ZF\_#Y.
M#,=R+-/()MRX M/)9O?_G1JB"048U'<_77_]^=*X8ZGQLF]U+ ,&C]"THID%
MNTLPZR_[X"KEWX -=BQ[V#&V'-PT^+>Z0[ IWMKM=;IJ[,[*Q,+4"/@XG,$G
M\#!7'9M&?!PGO$#*A&-V/.5F\0$7:/$&;HAMOX5!1@)/,X:Y)C!C]HW## (^
M3[@?DC=A&FP:PZ;\1_X+U SWXYM9J- N;N(XN(.)TCC\WXLPN[\ _P.G=L>2
M("6:P5N%;R)GT#&^<&[@2#,_C,(<.F-YH9B_RM5"#)9E23A:",&%K^*%#!=,
MX@CFE>(F(-''<13%=TA9\>AK^CQ>I RC#,O]1;92%B5^\R,@."FL2>[, 9\J
MQ2 _44I+LIP<M3I2F;%]CIOT*.F20HVZ]Q^(0D%_Y#.NF?F<W?"+4<+97Q=L
M#&_[GD5W[#[%02:)>DC,G[2M89'&+6LZ:6CD9]9;8\)1*\BTB"6M5^?%JZ_*
M5'RQ1.D-9%K5KG@D>"31Y+]Q].^-,(.A?:0!,R8)'__XXF^DG./Q%3R%#6E>
M[*!I!C+!;B2 ;-50/WS'5G>HO/+U;%?-^1LHKA(<OI4=<08^YP.+]7JLZ[FN
M/^P//7_8'7E^,![WQM8NZQ0\_Z#]RWT5Z]7;.G/U2&?H,(F4.Y_%]GVZVB6K
MK/?HMSPR3^N)RDHP"GUP)U7&"+0VO.1?H B,=[ Q@?$S]_ETQ!/#M<W#NYK'
MSNS:;_+@/M_BG"PSD>O59M;1^_G8_;0;B-,?6Q4T552VLXG[L-X+__W+IW]6
MW/#G7JYS6G<-A\PMLX?-UA2TZ3I-L^KIL*IGF5;#J5"MN^ Z^^:O9UZNWZA.
MT5 +9[YWI^76[EX"^W,IU$T1['*T^[D[LN=2=VY;9M=M.43"<_=$SXC7K&&S
M>1EGZ$KNJ?NK<;'^OE([FL?!!3,'W69/6MI7;='V:UBP,P=%U-Z&[MMW,O M
MFE<U^M=S<(JOJQF!VO4]BN_SVO::K:PY,76LF6<3\WAMZ.W8]N8>[?2\KY?S
MKR^6,J^UBW,>+HYM]ER=\:!9K0%6<TRKKS,6CJ;2/R7Q;9AB2'D<)RHSCLIG
MM']TG+BR:UI.&]QK'5@^UO[WO'[[]O_P0 3.H;& =M>2[[8L!VP8H;E%GLI#
M:?9M\F6>-->G27??'-K-"O<C^>;X. B:L4^1L7OF<-""QL&M\^W;5N*Y7)A^
M]$ZL[>PT<%KU!(=>3[=G=MM@MEIAFS2SMIM9^X[9/S(D8IM::QS\5+6S*6HH
MCT?[E^?@7QXA/TB?G#1G-\#9+>@"U?Y3TY%!2I=.31J%]!Q<SCTNJ&^9UI$/
M2!K$5+/K"1V1GH*!NAW.W ,&PA[L9@J^3KC!1O$M%YB,:0[^R!^%\ C4\A<1
MRP3J-?-]V'0V\[F!\3CCE\O+3_BSY6@=)EJMM*$PJ34Z_63*&1:-E5 U<:8=
MXP]NC/"TA;.>L*QN#-@+?V+ 0]-P!M."&<*F,I@;;-$4!TQ]6)$:4@SCLQF,
M:Z2+T9_8>Q<F?!O#FL(HS.YIKHO9(EVP2!2QF0CW&<\(1Q#1+><)$"N<P]?Y
MM&$$#ERWP+Z]^/MI/ NS.#%@,4"<$!Z%B8_C9$JD@K_#.#!@.HG\FU;*HC1^
M8+DXDT7*QXL(J$_C944*Q"U/X9TT&7A&@9*SA' X*U"HXJ4767PAIY+(X5EJ
MW'&$$DUIS.+WM+N4*F>D0.F()<9HD<)6I2E/*_M4 Y7ZX(S7395@4OMOMYOP
MTF17IRE9)>'S.,D,MLRB!?.-[G$2H5S_[+ZS@^3BX.'XOE9XI6^7"* M=V\=
M/I'S5B0O ?F.LX)5@8GKN1*\:-A=%,=.#>/5C9U.XD44T/ C+/B<I2%6>Y)F
M"%.2*"SY3)"V('$LRG@",AHB>\<F?@$2"&3*%AEBQB;FHS31'%:#2&>!0IW%
M">#!AY13L49JG4W8)KOLH]# NT&IT7 E@%/$\/H$ZX>Y %UO^6RALI5.'"![
M/' MK\M&7>XS;^#TA_ZXU^TSR^E9;M<;]C5 ]@YH;W/)*8GD%&.<Q%-C/KE/
M\?W(\>!VW!NQ$%7@?=!??L)%JL=\GL3?0E"V/+HW;+<S>(7B]K)7QM)&"&VW
M[W;<*H:V8XDWO?3<E>\07_N:>D<)L9O5S5,86E0\^4<)%RX#O-*/PEGHIQBC
M"'!.?A3+%AKT:M0S^![44R^]CK<R-WS@I3/H]%9G]O."U/\*^+=X5XCFLZC#
M,6POGPN.*>?AYI^6QK.'6XS'@!))-@/5- GGTM:(/EO<<*VZ=]EV\:[WA;E-
M84WS13*'9\#WR.T4FDQ)4+%!I/-JJ6G6;\R##(3(YU76>>GVAB66D9M@BH6E
MJ,EQGX:=?OY(::N1QZ]*RW[I65X=8GLMMY?&^8UEB"B@ABK8' SU2Z]; +7G
M3%*&B1?O0/<7/ECX9)/ *0'?X 97N&QGD*HL #$'%XJ/Q^ ?ILKQN_KX?]<_
M7P!O A,$?!KZ D5=_!3\G_B.-HG!#,$#C?!GN^W#?O'2*Z$D=Q?@:M?N>:-@
MZ'<'7=\;V,%@U!L&/<\;]H*N[_-^0\#5U: 88:-772E2T0>"M]ZB(.?I?D,S
M4-8[A5L.@&_]2)+N%=<6]2W*= %^??X@MRT#3=[IU0= 4CXF&Y8!UY\G=+;F
M@A4NT(#;CP"TV(?1_;S.USQ*7>B>A?$4,$9: V1\D-6YW:'I:"1NS>KGS^IP
MPC?[@]-B]?T;M,:M5BG2<D"3U0)A;49W;1:I0\C-T.SUFI6:QJV YIZ#<<\S
M!W5L2-^^Q[ MA9<IVEX*Y/OZM'!<9[-=/I#I#IH%0C@Z_36GGB2GVEVSVS D
M7ON<]2->]DB+8@^/8%$:" ,?J/RB%8*ZAW!RV_V\]I:R:CYM-Y\B%E03EQ@G
M4LKJM;T K]D)'JA:XMP#N:TC@-MW3=<[;FVK%BTM6F<H6IZ+HG5<7**]<.ZC
MBJ!.)M]]9/<&;M?OC[W1T.MW^P,^[C''#OK!>#SJ>P.=[_YH@&[,D\9D:Q9%
M>5)SGA'+(B,H<KOS''&1E,U@BNR&UZ7:8GV+@3"Q&:4VO[2M;J?7$[G(^/?0
MPD*B.?>Q)B6Z[QA?XPRK8N0H]$LL,$JXX6('0]/MVY5$=,^TAK8Y[/6+9.;#
M)!H_,078CSA+2.HG><XL[*02'?F)DGRY*7+4];4Q.^1 2;9'!?8/[ A)?^0S
MKIGY'+;V8I1P]M<%&\/;OF?1';M/<9!)4LUP)I4ETH(KND"J=_F9]=:8R.PK
M.B,LYQO7:#SU59F*+Y8H_6 )47DP5)^/)%I]1=$/S)@D?/SCB[^1^HK'5_ 4
MECKMDI$M]H8&0D940_WP'5O=H9-3V<P+^&!HCWI#O^N!TF9]+W!=U[;Z;#ST
MF*]5]CY*E+#H1X#-(K9LBMP1IA.LU, "#=#?"97H1CQ-4=/'=UAY*(I#@C#U
M0>HR47DJ1\:JSELJ*1S=8WU?EC _P\+<>1+?)&PJ?GH7)W^!&I75HA6 V[7%
M)>,(*W_+0^;-(&3)#94,JOKB.UX4^$[A1Y/HWA0E*E2R&N>O*"T#@[NJ&'G.
M[N,D[1B?V#V-B]77'(Q.(,LNX;TIWVF%59K/@58<U.24"ED%M:FK,CQTPV=@
M*2,P143_;,)$W>3Z?9+F2!4I/=$(':JL\B-MVC8%E=M7V3M6Q^[N6)=+TU&L
M9HJZV)3X9)Z$8*I@**1LM1P(RUOAY<!W"1:MAK,_%\D];B<\1-NLZIA%?3F;
M@5U$3C+&G/B9QJ*ZK%)ME%V4;IFJJ*^F<HXJ ;WA\A= @YRJXM>EURI6E>[1
MRT&I5 \%6+A(JBI;9"G!0_VEA]!C^EPN:MN>#L52O4[OE:AF'':<C;5@+]W^
M<K48SJ"Z97)%SFK=FRP^7*Y*Q"$>*@035><P"W13\S?5%GH]KJ"KZ^U0T&4[
MP_%@P =\U+>\OC\8]4:6TW>#(1;PL@%OJ*"K3:5:!T1ATC5=NJ9+UW0]UVH>
M7=.EN>"9U'2UR^PJWW6Y?O[IUSV-</?1;H::N3+3-&Q]BO0A.Q/5A65T_O1Y
M7J^>?UI"FS(0-*L_&U8_1II ^Q*XVV;:?EN-DBH3IXLS#RV!AQ"S@>G9S=H3
M79QY3MS3Z_?:QST-%=*<T)%$W (U>"@Y;J.6QINCM$+"#[" )_>1;R)"W!JV
M:_T$M5RT1"Z\0;-F\T1:#+4LROYI/8[M<SSMG%2XXB#AMX%K]OOZN*39[RCL
MYWF>V;6:;6GUK,];.QN.ZTU9?BE/;D-?G[ZTEWG@RZ*A:;>AZ?+1]ZTU$]2"
MT0[!Z)M>KUEHH!,Y?[6W@66+);%<2WT&GNN15NDYCCGLG4H#3,WNFMV?QNX#
M^X38_5%0!TV4Q>4]'*^PB^E!>UCN>.,FRNWC?**RW2K_IM  $ T/VS'(+T1A
MENMXJZ5JYDJQ&78NJZOUJKY-C-GO=?JOJ$TE0@9@'C@B"LC^77FU%HP!;#&I
M@A!4&^(MK:4HA2/\@7*17'V?M-7YX0@;&Z"Y=DT'O]4&:,OCEMY?6]97?8E5
M5.YM' K+;[8KWY-%=L..79Y\'7T?*JW;EG_V46UG[](^;="W?"\8#1RO/_+\
M?G]@=X?^T+.\?I\/AKZEJ^UTM=WI%;CH:CM=9]4"-M35=IH+=+7=\<UNG@?P
M5>8!?#Q<'H"N'=,TU/5W3TIVU2T/GSR[TPKA-9R]U\<^</9)529I5M>LOLM-
MJ=4S;6=P4JQ^*EFI>[%ONCGBR5=0>78+*Z@T]YP$]^CFB*W5S.*J2G2\POL>
MZH*EFRFV.U.M6>^J:W8'[DGY5II3GR>GVAZPJCX&M-C8V,,C&)L6R&D;A/$@
M^6&ZRNP\UMP\Z]B.Z33L5[0D7?W44#E6ZHOKLM5TF9BNACFD;]<S>UWO](MA
MM%QHN=BK7/1-=W &U9.G<@[:.3E')-HWF:)S E[L25UJ'N22?M@UO7ZS=DT?
MHC3[J8MSSP+ST6S$[%D?PC14A_8U3]?7=(:F;>M#6(LFJ 6C+8)A#314QQ9F
M=\M*]2,<S;:M86W0R&J(A6< L> ZS=]::T01S>['8O?>T/0:!B=M Z+(@P >
M._:ZOJK@*X2BG[B_2!*\G0.3%L8!(C2\=#O#$LH#P65@V_%PJMJ,)WS*PAF:
MNPA!)XQX!-,7H4G3 $[A?GPS"^F\"4_?Q'%P!\.5>K:O(%&LR?3H&.^8/R%\
MC'B&LX3AQ%<KV!UA2MW<%RF!8"#TQ+:0$3XL(B%FF.2$SN*Y*F"5GRB&D+24
MHZ[?RAT*9@5:Q0_(U_]PX>Q$?^0SKIGYG-WPBU'"V5\7; QO^YY%=^P^Q4$F
MB7I(S)\XV;"(FR6W6U8AVO(SZZTQD:6ZY"0NXU/4.(WJJS(57RQ1^D&.+P^&
M'N@CB58/J?,#,R8)'__XXF]?42+C\14\!;N2[H+@(?:&!D(F5$/]\!U;W:&M
MA'P5J.0P2$+_];>!8SMOO["()2$7#>E5GM6N4$-U:FK8&>ZFE2HS4RI!R'2!
M:H,008[;+2$)Y5@]U(C^I=/WEKO)VT.3D&?$&$*S#8H13 -&L+V._:H*"I2N
MGT\5'ZA; BQ:AP^T87$XF%1S0N?1OTD-EAO84R*<A%(J];BGWO9VKP#Z6?F1
M">]+Y]S/PEL>W3\XE;6H10A9Y&P!6?3 ^ _ %KVT"K2E!\?:'K<(S)=Z@5U@
M%VU\P4.X4KCWW2XB4.7L@(-T>YVA^F@;'*0-;'8TY"/6<X;NR.:^Y7A=%@Q]
M/O9Y;S0<!6,G\,<:^6A_H81:7 P-AJ3!D X5:=,P.*UC0PV&I+E @R$=VQ)K
M,"0-AG1J--0ER1H,22/$'*C8:-@S>PTW,SQZ$H5F]>?(ZH[3-P?=9DL"VI=W
MTF+[IL&03KQRM6MZPV[[<J8U]YP$]V@PI-9J9@V&U$8WME7>E6M:#9=;'IW^
MFE-/DE.'X*4T6ZNA3P$:"TD[=F=%1<TY37!.WW0\781[6F<%#8JDZPZ/7G?8
M-8=.LQT>=#VNEHOVRT7/=-W^Z<O%J1R(-"B21J79YPVF;9OVL%F[IH]3FOT4
M^W4M<^CJ\UC[09%*QS&-CZ3=SJ.[G8YG>N?@=VK!T(*Q7\%P3:?AE)D3.9"=
M#C[2^NI:C8BD(6+VJRVZ9J_A=IX:$4FS^['8O>^9CMML)Y0V("(U#);R&2RC
M:7Q9S.<16#&3T%[PDL[XE8T0Q@&LVD>\R]L/=(IC=>P=$9W$1--\HNHVT8CR
MB98!EZIX*@.OXZZ#4QF6X#AR4(L5.)5> 4A":"J]3G\)3"5YW 2K "M.9_ @
MP,HC*5 &72D-.6=)-N-).@GG,.N,)QP?EBDW\!/*N%F#RN*4*$6H+,/2M#>#
MLIB/I4^RKO1-S 4Q#5(VY;1,D->)1/5*JY-X--7*D"BU>"CVH#,HP$_H]P@(
M5$"D/(R'\DA*' LCI>_W6# >V':/C3QF<^8. ]8/?#L8N /./(V1HC%2S@*6
M0&.D:'2,%K"AQDC17* Q4HYMB35&BL9(.34:ZDI%C9&B@2,.5(7@FGU'0Z1H
M3G\6G-X[+4X_E51@C9#2OJS3(Z10F@.O6?G2^;OGPSTM+*35YPZ-D'+\V9V$
M<^4TG@-[=/IK3CU)3O7,P5"? EIL:S1"RGDY=IZNZ3N/-1^!=<RAI4OR3NNP
MH"%2=.G1T4N/^FZS('BZ($]+1?NEPC:MKG/Z<G$JYR$-D*(1*O9ITX9F?]"L
M6=-G*<U]<@D#S^PYS1J/9WT6T_ HVND\"Z?3,[OGX'1JN=!RL6<4UW[W#%"#
MGC,X"M;>+I>S:E@4C1.Q9[_;=9N]K]:H*)K;C[3*H66Z_68[+3U#4)1/27P;
MI@H/Y"KA09@9O\9IJDZ#3\5!V6T)8%8G'(ZHY<GY8G(138X^0<2*.:P);6_"
M?1[>(O4%>,5+K]-;Q4$A* ^O,UQ!0>D8ER4X#';#%2)&,;Y QC"I?G[3S @Z
MHV._JK[5[E@%ED9G3[0==H:[4??C(MFX!K9*C(S\'$4.YOO@*!)XB:([+=SK
M=%\9+#-6*KR)"-WZ;Y'\#^TW_ H)S]'%&AN<^0H&Q0A3\%P)TF668X_PP)29
M0A>C^POQ%VYA"%2!G\>@#((%+U:!DPMQ,3>+B"71O7Q6P-W@>]G-#7S),HX?
M1*@C<9Q)F&9Q0I%Y_@VGPV<^?VAS-^RW'W&6D&J:Y)H@B^=*KN4G2CW)O92C
MKN><'8JV!8C*#ZAE_^%V?_B._LAG7#/S.7#)Q2CA[*\+-H:W?<^B.W:?XB"3
M1#TDYD]ZU;!(MTK=:UF%G9&?66^-B2P7I\/),FQ*S6%%?56FXHMEXC\D8.7!
M\.3S2*+5Z]X?F#%)^/C'%W_[BI(2CQ%["G8EW0581NP-#80\J(;ZX3NVND.[
MZQ3):XG8@I)=>;069R!LJ$/J5$8 /&+$BRS-0 +1-A'BD>N(+];J$===]P"J
MD@]KS((2Y2E.@Z"N0%M549Z\$LH33>4N"3,@[T4\'C\ ^[2[3M^/??\E 45I
M@#T?A]E^S4N5%78\)HOIS6EZ)FA+1!/##<?\3JQDIA.SN805-AP4,%PF&B4_
MGLY9(J'.;-LI[1_M#FY_^4WK7E1GX$KX5S0-Y)4K?-_LGIRE_EL8=3FC2<&.
MX70=%ZV^XI+R5.&;WJMBAB@5-^59EB<RJ\V2@A^74-X<"V&X<GZLTL7V$+9+
M,ON:%ZKUA9NN!4:+-)SQ5/I3MM6Q*[AP3K?3?U5'R(V#%G[4FNF_K.PYOL?I
M>$]\#RY5O(.T#B46"^]!T*8,828<B)1^<[,-TQX-M<RS?&L\8+YGN2//[?&1
M-^Y[?8_[O6[?[?EV ZAE@^>"6J8ARC;07D.4:8BR,P>GTA!EF@LT1-D1S.Y6
MYX;O-5J91BMK(0V?-6K 2O6/A@G0$$[[NPSOF5VO :>L3<7SFM.?(Z?;EF,.
M&FX/TKY4L+99M]^:+65M@5"W(77S,*5P_6ZSK>ET+<TY<8\S:#9WMR6YN*>&
M2Z K8'2F_]$S_6W+M ;'3>%MQ[ZU9H):,%HA&(.C)_OJ$IC#QNAU-8RN#]AK
M?0"HC$&S>'*Z&D9S^Y%6:=N.Z0V?7SG,?G)CK^)D'B>8O?]Q/(9SGBB!.781
M1C&K6,Q*YL#Z\2P-4RK5F2<AF&@8$O,=4Q;!WYC2..(S#K96U"WP?R_"[%[6
M0&"6(Y^EA V$O_&7WS'G21K/9CRBWP9APOTL3E+5M#:<@<5FLV(R 8=CLA^*
M ?$G;!H#Y_R'/C"-+&&W/#*!,#<L,NGU48B_-\D?X"F6<^ WL(R_.*T)!X$A
M$Y@U_G/,<46BZZ[G%+V'EXMVNBM?869K/0T?2.^5C74KO6SI+<..6Z3I'IEG
MBWJMZQF0E>^M+779\5/I_?:.943Y'$.:XU+Z=K?217DIS;?7KVE&W3%6AGP@
M4[OH?DT]KFT/ZZSD%E(V-&4/RUSCH^\I%8>+_30NC%\8S M6_X6)4HY/I8;5
MU[)A]2&WO;]K)*UH!2[*W>56X:93VC2M:VR\M(N4\3S=&Q:UB(3DXX:)[M9B
M_;9',;DP7J31O4)^5AGV()^FVECL69Z_I%LJ M@P.*OM!P[V+IL8KJ5>TS(.
M^<RCD(^-]W @W9.Y4IRPQVU7.RO*!-S2=@#9RROH"#>!NH8'8>HOR#HL/X42
M@>5D!I6?55RF%?)M6,!2QOJ+?SB]SG(AVW'V6(FV\>X;VFIN4'F)_=;XF8\$
MB 1QP2$EW]V5!>3,^=+, S5SP1B"$]86X#HEM5 JP*VI]C)AF%[)\./ Y7(Q
MX!=X.EXDQN648ZZX*F&^O$FXN)U]#3\)P%N:P9>BPD/\"*?N6&]E'?2O(7A1
M ?I1.,,K-@\%JD<*8_N<JJ4=^^T;T?&^^E-CN]_*E^-ZV1+WHYH"PDY3JDW=
ML)AC:Z=JM;C44E_9MWT5B]<SZXX7/JL5Q5)?9>Q;KJO6N9OPU3+WUE<IE\:L
M+5&B;T<<'J6'8-81EE2A"Z,<G"Q+PM%"%/Z QS*+9Q>44A##V\D/DD+WFH_'
MHMJ07H=>[QM1>-8OBLM5?6(7W9YBXLBVY2JGUR^-G:J6VEFAW-,5RF=0H;S,
M=H\HA;,MH/:8L]%PZ'F.-1SV;:OG^IXS]IP!&W<;*(4C%M&U<+H6;H_E)[H&
M3E<_M:?Z2=? :2YX)C5PQZRXV=DJ7Z\>-G2MC:Y >/KJ>EVS:Y]6 8+F=,WI
MNS36L,RAI5N"MLJL_<K3]/M= F8'* O7)15;E52<(1GTUI_JUI_!D6#WJI</
MZW2C<8%7%? SO",3*43ZL-#29/UF?:#7/=-NN+U3PRM\HSE=<[K@]&ZOV13R
M(W-Z0V6A;;."GWG ^93."VL/"V 0,S[%9-+D_O &L8$X]X$JVUJA)_80+]]!
M7=BV:?>;A0K84;S:91,ULY\BLUMFK]N"DLS3-(M'=[3.UR75\>M-4MLWG6&S
M>"3Z\':>A'X&DM)$1DM[).5Y@A/49$7LG(*M00QT6?=>5^D-3,?6+3TUMS\+
M;N^Z9N_(Z%>/QC XM+4\G?3"3VOJGAI%S=N-9FU3(6?NR;>. +9K6@U?:1Z7
M<5L_02U99R-9/:_9>--!&/=YGHW?K104ZP/N]LYP*ZZ!#NVS8VWY\<7[$"M[
MI7E=\WJ5U[L=[WGP^BI WW$ 1;!5MPS07B[%8)<S5Z^K,=A'3?G/19J%X_OM
ML-!VQ,;YL$,XV7B]G(,K #U>]FJ LPB7I%>")<G[26]X=;)-YM/KY<0G.0O;
M[CCUT["MFGDT#$ZS5*;ZZ_7__G[]\_77?QF7'WXVKBX_77^]_-7X_.[+Q]\_
M7[W[<LB6Z#NBY_U!8"PA1_=KPC)"_LE[;H>I<<-G"@LO72"Z(76T]UDZ,<8$
M)8009W&.E\?0DPNS$-X+&\\B@CJBOZ><B]'329QD%P@U1-L8Q:![Z%\T:(*;
MGQ#04&I*)">8&,'$I%P@I<F.]SCJ>)$AN',*M IA<@SFQGP8(0T1&C)=!^AT
MQXT) Q9RG<ZPS$(T!9P5_8%3 4V+4ZG"!CIE?#&V\@8"DHH0U^9F(N#?,@9+
M7LQS8,@T1C1+&(W6 ^2;(?%FL%,EI#FBUCQB,T2-\B6B$X%>!2&N&AZJ+IW6
MM;*;Z]=$2)JW+(S8*(P0.FH+)"MZ9<$(M 4P#*[R+D[^(L1M.=49YT&.)E6P
M2+H8I6$02A11N8%BV48 ,X_BN7@3SJZTE_1!.+L%;4'< >],B,*PSHBSM+0-
ML,EVQ_BRABE@HHL(&"_\BT?WBN&,<3AC,W\[/*_=M<RR[K>[3STTY8ON$NNY
MQ 14>D\H>2B%LWPA2,+/0$#BO96])69DR.K3D&@L@<)>VDX9^#3AMW%T2SLM
M1A@SG_@'H:E 9;!B0$2CDJ\&Z;I<W( -Q%G"7/^'S1:H[.%?/=/XC27^!/_N
MTQP_Q+=J)^&3UZ $..$EP;O'/)%B"(-+$+1U^U0@IB%FUEJ>ACDO9BGW%XDD
MT02&CF*@FP_S +9 513.%*)\644),;OC G3VOB#AC%+CB,[C\!L*\ 34-:<1
M$P3F0FF(A5R6'XYX^?N.\2F)?9*C'$MR[3*F[!ZD']0MOA,V;DD>S8H0F,9\
M 21G*<]%%/<=V]!DL?^7:0 ;A\"F ?B']W*I\<IC$S!['(%[Z]53CL57( ##
M6^>@R%,%8Q:2R-TD88#;(/"#$9".7K26+H+.2 TVGX,71[Y%.@<N@5_#@\:O
MUS]]_ S/SFYR'$[P([JO<!$. I7)!N]K?HY?_01S,3[CG"O#@,S2*/:KCO&>
M\U2JBXT[(WB'HR0N9@L)D9S+&%]Y@YRHA4C  2>*PI=;D(5)5<RF\0*&AHT=
M"S3+%;C"3?/=DWJS![OI-F2,LG80*F0JS<U#A)9 O/A8;OG ZZ2_"=0Z($,4
MSTJBB^8 V'S%NZA8#?22PPR)OL6.HY?0M4PX,.+_"3TZNP=5D&(SVGO.$E/:
ML_*$Y;;!G%"6<4;*)U'2F$MA"NJ$2_'#IX"UV V\_@895HXSBVDB_!MJ$/27
M\_G0#RK3$?)85L.*Z"8.A^PGX%;!31?:L+EY=Q^<=]5>;)XZ"_ D)F=>44 $
MTIGZ<'9!.S"",5<6NCS5AY;\TBF(7D<!PD[_E@DNPC=,&>A.],50OL415"[-
MM4SAV!SR%.'V=@3AGCT>-Y5$<(,,%3C*0%K@WF%I+,12+GFNX&^G"L0T$$#L
M\#<8E(2#W1&.,<&MXR;E\/#26D>1^FEN[JE=-"<YWY;<[02E[&M0RC, I7R4
MP:T*]([GBRO49 0RBZ(YNE?G-SH^85AF."R=G,G&PO%^7G%6-Y\C27_*\[1K
M%:(M%/J4_0DF<R&]4Q%NH(0///ZI!@[%D:T4=I"^5O!][N *#%P59P(-H.(;
M\/1K/,OG"WFSY!5O$;@R5PKV<$RK:"NP/*8X#3!X.P:]7O:+&-8;LR @.M@2
M,[X6,?[U2ZLS*/TP"%,1<Z,=VASN>VD/.F[YI<K!5Y3>;+1?O_2*P. ;X<84
M0\S0>L-*X1.B&[RMV-LW^W0LE\)?6^&QUQJN90LKXD/D^]&!T.AW7Q641Q<$
M0P^<7\B@Q7QRGV*,G8P&FV-/3^1'G\LSCF)#]#5$=PJT-95!2:0&)8EZC>*D
M]D--!8@-']U-0O#1X.E>Q;+.61A40EC (6XYMH4OA9=/11^"E$<1+!DW2SC"
M8;%G^/!=C/,%Z9I3KU(PVE&DCH&H&H&EP+H[9A<<&\[\B5CK.$S2K/1#R1?&
M/%J K^/[R4($)53; S"]<&*EJ<>SLA?GV,41#T[F,;G*^220+]7OPNKO'#$1
M6I=X85J\$);ITN$*E!G0:+:8'OFH ]SWA<^S!]C/6F*_&<9W4-,(5D#!3(TT
M_ 8BL=H/7.SNA-UB:) 3)\PC)AF1&4 #?#?P!'K3J0Q_H&Z%'XB/$E"!X:SP
MV,+$$-';W.4JG9/(_=K,^-82X\,9/(F_A>#Y8CP.M$L>[S<%$[QT._V<DTM,
M6F;U;IG5*RJH8WR<<373JG+"SAU6^7HA_TJ^&0\;*VP+Y"RSD$G=4Y9WT18T
M*&A''"E>Z-8*;IF+G] DYD%-N6.:!K#J>SY*Q*F\7\>I%1O+8(A%LJ6*'%-<
M0T6^P4T7WH:(&M*7*0<S2/&CPAK*&-(51N9G]]0(H?\VK4XC4Z.7?T?A%BZC
M0A9&@T"?#-S.X%6^[10&PI-!KXO?YW$I' ^FF6$'YYR_0=!F*:Y'>2_%,7%)
M!M2-UK#@\$*CV_;>5/H#2M#K],L<G(>-"L4M8A-*YU1,0\$%J&T/QZ<[PBS4
MJ%3LU5-5J;W^JDK%4-KL:3:],JS8ZU+WJ<I>E]N/',M\BP#5[N:[-.V"Y*(+
MS]:VN_)#^P&^)5D\C.W>RV4J\-XE4"\R;+N>[WRAJ_(M8^J,E8A#RA;=X:6&
M46.J$3%F"3^$V9#>"W@$!CP1GO_R4.(R,,'V>'&*;N88W@^GF"@6VYV),Q9>
MSLU(J\&$?(;M#L#GX+<L6K#B1B[AV2+!4,<%WC>4IGF=X58ARU(X)>7Y=S![
M:M;+\-!(OX+%>UV#[J74"4[X&^!48#Z!E$ZT$3C!*/:9O-]%8N3WU;+W%\5X
M1M1LAQCQIR2,,W"/_LE9E$U,8LQ5J[&!]OGA-X\'XNSJAHGOU%$-2"L<(BF[
MU4E43G48::[X0/T>,/I&3;.R_Z1MG/)U-AUM"X-"Y8:5XX3T1OJELYS03K+W
MHWS"'JS>D9O&ZT*7E9VOBDL/Z_)YDF&/M/()4IX9&;IZ141O>^O5[8#QJC=9
M*SJJI!9C)9S#W>.H]3D\:Q(R=C^1BC"\IW0(!2V!*84P%LJU'.!@VP4K5NZ&
M!9G+IJ-R?00L-3!MT.CBLH2M6!G^[\6RA2&FL3W3&@C;8M;;C[+)*=N'LEE1
M]Q$RY6>-11%.=F5J^0_W%B[?JR<M;\)ENLC@H0/?8WSI;4]=+_M5_Z)P/+S2
M9<M>' W'*AR-)S!#D3XPW,0-M3\YZ(EJ]\-_X4L/!">8>59++ ZM>':A8"C:
M7K0N0>4H4W4P2'9%9!$)E-M%//SB1BUSCCQRF?)^<OVY!46ZW\O9HN 5Y4.N
M\(JP#?E>,$SSDH>K91T=+\O#$[+X'MPK=\=CQ34L, B$19>WT%.\G5)26<U4
MPKM#E:Q8W2**J^2G62724H*+G*:4[O6C90ZX$!QP)7[V:?DL3/NEAB)3+ _2
M&*M)T;>(PHSG81MYTXTSXM]DLV<UHV+H@]XW[JA"_PFS!8( +T?W,IL/%B%S
M%8% *ZF*I2Q%&2"GM#6D;27GK+A'( T3BWR=XJ<JK:UC_,$I-T\\ VZBZ -,
M0]7E\DT9Y>(H'D)_I9*G^(=<@TCS":=T]TO_5:(8R #6NK@^;&H43L.LI"&0
M!7&)M?SRA[RZ5I)>FMKZEZB#*&7M=8Q?B.*T"2)45L0!0:.4_9,-0Z:4->3+
MRZ 1.7UT1YM.,-F"?&TF7?JBI[A20?DE4,>XA"E$E&55GLCF;+_3OMX=Z.O=
M9W2]*S7H3DG>H']0X;,4!!RG1Z<E/'2"@4<#P<?@ X@D/Z!SA E0*(8+].02
M[O/P5H3%B\-Y*74NX,$"-*<:UX\O5.1(G"1 VUQ%+)S*C.7%2"92P<O@P1@4
M5<!"H<GY7R"EH#NFL(A)1%DU.(\D*!(V*)P;P[OI01H@/W^7<S-!Q6$L  [B
M:2A"^NK=(H].S(CC6I-X)HR)\$,E!>BZ 6]D12H\:6,\&R^FZ@8ZNY^+W^'-
M=!S=<M%[G-Z2=]:5+\(<>/08YA%7J[ZCG'9%J^)1F<DI4O_PJ\5<QIY+S[*9
M2&NBL7("B]PT,//A#<N#/;<<O+$%J$;</KS:Q81VM%W(%(RN>9"4Z*-A8EO.
M AWC-QZ$&"HJY7+2^]1,$QZ)K&Z\<BZ;O#L6TN=7OWT1?'9+YP.*G .Y<(68
MYC4JLP-ZH72-A7N?"BY *T/;B,'X$O^2_:# 5+%7BH>+RR[^;<(HV<LLN!E7
M<Y?@&W%WQNCAQK3H5.99PBJGXN8[PVS!\AO@@#)%OD(V%)=M*I*&"9T\P1 <
M*$<1X0'O0-A^\(O'*!&2=, TO"13J0A(X93X!4[H1AE5(_;]!=[)4>JS"/O0
M(DJ_IEQE6FLYM0HIB:?V !1]L;,']>3L'3/'<L='% +$HTAR;DJKH*;>"5<)
M!F8Y3IDGF@LRRQ% .,/I8@H_FH&25Q)1U!]@K8 *HY;?)JXS5[+8I,J:PFIA
MVI0D.(ZQKB4U7F_?O?@1;61'[JCO!6S0&S'/ZUJ<\7YW..;.T.T-7;\_.O$V
MLF?>,?8(?1GWWX(1?!@,WK2YQZ+>O/6;1W%/O7FGNWD-H 3IS3O4YC70HU)O
MWJ$VKP'H!;UYA]J\!KIBZ,T[B+>9%_BV>0?W"L]E;V[0<,13TG*IQE&@[EN#
M:G]JX'P'6XC=PXO>=D/5'Z5_B695S:J:536K[K20"\VEFDLUEVHNU5RJN51S
MJ>92S:6:2S67'A,X'R-S1PR_?: *]4^BQ.)PL;=F1:YA[.XG]X@RO6&S+;:;
M5L9Z^S<UQ#,'PV:;3NOM;]'V=X?-MH?3F]^BS6_6\=%;K[=>;[W>>KWU>NN?
M7:*):J9S^,/N:82>&FYO=;CK=[O9!E8ZQOE<&<UJMNFG9K1GRFB:S32;Z4L7
MS6::S32;:3;3;*;93+.9SE1X1T@<G!>E0JG.5SC.A77?' R:#;KH&':+]M\=
MFI[5 &B WO]V[G_?M#V=K_1LM]\V75=+_[/=?BWYSW;K6WAYK;?^V6[]_O,6
M:L$Z6IG,\#''E_R5\"4/F,SP:*(T&W-Z"$"F35&I)\WUJ5D20W/@-GMH?R3G
M-!\YU:Q]#JSM]DW/:?;.7'.VYNP&.-L9FKUNL^<MS=F:LYO@;,=TW :@2S5G
M:\YNV-'V3+??;#FGYFS-V0UP=M\<6IJQ-6.?'6,/P!=IH('!H1G[\/%0;PL,
MZ+W*T]->N$^A">(%MM3Q5B"IVX_:<_ %V8.AZ1XY N,UAXRN^?7$^778-P?N
M<<,JFETUNSXFOFT=-U:BV56SZ]:A/=?L]OX?>V_>W<9QYHU^E;Y*YGWM<R"Y
M]L5.? Y-43;OR*2&I&=N_LJI540,HCD-0!+SZ6]5=3<6 MRQLY(XY@)VU_+\
MGGW)W#63ZVZ0:_37K3F9/9-K)M?==<)E:LW4NCN>M<=3:^,^"_^*W8%^7M'8
MZF=/K9Z,Z4YSS^)$\C*<7-4M1X,XVSP\X[IN;!1G1JOBRL5YX*4O?+>O^G'F
M<QI#K\S_CKJ#;II!_:XXC;/M*S=(,]ZG!GK//N^ZZL9QU.'5:?ZZB]/*Z_'@
MDV>E$?&%'@VZ_3B_OJSF?GNE_E56W>%-/4O=#8:#\-7X+^*([(/A_#SL3EIU
MY:Y4MU_O8;)*K7IA9ZZHA]4/7+-L]?ESY3ZK..+]K_0=+<(Y]\(BZA'<LSN+
M([]O[20N=;*H^-WT0])X[O:OP_+CZ-LT#3R.47U7U-V4XV<FUS7U:?>_(]4+
M'^^/TG3ZL)%>KQXH7J;!\.&:KL-ORB]Q_OK7LKAQJ@J+[8WBQ/&;.(Z]&L69
MX.%]H_ZUZMKQ6;XKSEW8A@Y_6@S'6U.%=4/5[24RJ,>53][2SCA_5XP[8]4O
M""\;CBFK?4%1J;BU2O4_IXGO57E5X'>(_D<DAG! X#^*Z[#JN+>K3C$8Z7\Y
M,XR_4_9?H\$POFFE\^#)<YN"!4[4_]>H;]+=?^T.+V<(MU-\=37@G*TAI\)6
M;'UIX;M(G+WN53<2V[6JAN'2!Y?=Z^E9\?$BQLBK9C_7S(6__PF=!.CX6F<[
MX0+++UT;;OE2#3O%Z+HF_F(8SN&SJ^+=N"_U7WUM1MVKXC#067$6#RK13OS\
MP 5ZCA_N#R,FR\A0PAUT;23-R\1!/HV&S1^U,+D>52;\SJ6G#%2@LD!8PSLV
M,*:<2]>SA;ZIGU!_('">"-QFT7%;\9>3%[:KG%JX+2-V"_?M.AQB)VVRWKWJ
M3R^]><'_^8M D/\T" !0P\M.>F"XZ "&?GA,H)V^5<.RBAS-NJOK=/D^?#1
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MW;Y+0JURMIN'J[Q.];AA(Q\#+9SZPT0)TW7!' 5FP0#F@8TP9*22"G%KE)8
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M1#><HK1UQNF*,HJ7W)2^5X85#EUUM:8<I9P&N?5ID(DPI@V%1=S&48!48"%
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M$>2,1%P:21T'A'I"5M0*XQ92..A(L L9M!DIKQ<IV$.!X@PB##DQR@H.,%=
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MQ]V^L@5F9_NKZ5-\<^ND[SFFFG:G'Q9MV"<>6O-]?/J/17<8'FWB&:CBLHJ
M_<M%)-K2'T:(!\(8@^C)=Y,>5)2^:!_UMQ_4_ VM"0_U#[XV]Z7+G@TK_./=
M^;OBTV__.#\^//A87/QV=';PZ1^=XOCD\%UQ</*^./_CE_/C]\<'9\='YQM=
MZ.'IR?GIQ^/W!Q='8547X5^_'YU<G!>G'XK#WPY.?CTZ#XLNCO[KC^.+?VQT
MH=\=]XOA93D:J"!BOK^/I]0E7\;U>@VC31(A?A^Y:_M]E$G_]IIY!C&6/"B1
MCL-@[3&N#(+6"L]C-XRGDVB]A?O!%4]E&O]O7NX$6MQ>]2F.'SGG]I'+<?HL
M6T5Z3B=9Q)[\FB<V9UTS;[F\&<1%%Q>7+J@*-X&W],V[U:LQ3VANNFQ3XUG7
M_M2WK,-@R6>XR3-<CL]]/:,KED8I*^!^CVAIO#XMIHX?)#MTMWA@57Y])LJ6
MMPSTHF7L%*$<A".+!K_J-62RB45\4EW[-JBSA^HZ6DD/$NPC+B<3[RL@WC,W
M5-W^.#%_$TMH*S)WEV:S!%X)85Q43@U&U4V6P9F-/40J91!ZQ?E4*Y[_\Q>!
M(/]IDWSM<?.ZMY:K91)>*[F<E/VWAY-I.!LDW'80SPY+Y$R[ZV>_NT(MN^ZL
M6;IO;6N]TG5M\6XI?OF"G^(ZN2I'_6&^X+V]X(S@/;_@[4?P4NLA('B@5&0K
M@N._J)[J&U?\OZH_4M5- 3M%3'9;817$#E3/K+.@B#^!2E:=3EFSX*F2XZG<
M22^PA08P"1TE7'JI*<*4$.4=I!BC^=Q)'C,F_WG>9N+5/H[#\NJZ[,>DJ8-O
MW<$_IQ(X?W>Q['DIE<BD(\"&Y[OD$KXG+F1G\Z*W"L 12(U7L\;;<=_T1A'*
MG\HJ_L$3IRIS0;W%%&A'(#&(*Q+_WRB.C"=4+<B87@+JGS<Z!FZZI72&?(;\
M/D#>88J"C)>&.4*@U\XS +A#"GKGS8)F(H^!_"3S(:8?'/>;Y(/EP9_CCB0@
M<X#, 3('>"$'(!@B8P!Q6')",=0 60PAQP0A1@Q]'@=HTT?:'(XE2GZ&.@1L
MN/50QGXVL1-8OWN^C1TT:TX0$$1R1"PAVE%H&</ :(^M>::-W>;&/,?*'J0;
M>'O_B(@.@AON</ED\"WWRK]_[>ZR+,>7PAJ6+<@--$PI%RQV"@BF4CDKE#!2
M"Z>9)&9%_.0>*?X8?H)AAZ%=L^4S0\D,9>\- XXLX4  )"$G0A@=FVDK(J"S
M6DOY3/WD4U"(^L/EF0,(D([8="?2; YDQ.\!XBTR"&-.O,*,$$"EQ)X#XQ@5
M!FHYWT/_48A?_-HE.@0Z@0=D_&?\9_R_$/]0.V^(53B(=P*M5H%H,;'$6*FX
MP?X._"]'C+,.X#ONT5]Z1M$J&<5ZN<&:/8!K9G7K9O+Y[O+=Y;O+=Y?O+M]=
MOKM\=_GN\MWEN\MWE^]N@W?W"NN)C@>#42HH*GT1?4E5U\3.S(/HF.H4?3>,
MOS#Q$[U>&OW[[(J_?7%\[FL>U",\E9%8G'T_JJ)_TE7=TM;946=CPDD?._BJ
M*GOBAJ?^0UEYUQV.PF>FTQP(!)@XBH&5T3<II-," 0HE5LH1\&!;]TT4*<D=
M]VQFG+YFG/ZWZHW<$V%*E<"$$1]G<1,ED(*<,VV]!QP!9]V*8?K,4&)&:4;I
M:T*IE$8@@HV37@6D8L6DE)1!8:UU%I*7HG3YA4#_=E5IU>#RS<]O,U@S6%\3
M6*E )HE122GQ2DOBA+)$:V&P-8L*!IX&UB76[&249I3N 4J?9: ZI"0W@#F@
M!5$&:V4]@)9[SHU35KP4IB^I\,D8S1C=,XP^1Y)ZJH5'BB&*' &>*6;C]UP2
M3(12+U9[7U(TDR&:(9HA^D_I'1.$* 04(DI9"2W%2&E+G9<!M2^%Z++K4++K
M* /T50$44,:4-9(Q8@FR0$N-E6?<"F[#5^RE %UZV4@6IAFKKQ2K7#DDO8?$
M>$DT)QH21Y&%*!BD1I,%A1WWCL)^E1)R!<4=6Y'#<>;"%D8I.Z-.X[#.7:6I
MMN&JWDZQX*+;\.!Q9L=0?5M=/L>>YR^MAY-<7_XX=;^G_FQ\NT&\'LZ+U\1#
M+M2WVO$UW26*6B:T]4AP3(PS F.. /8(6V.QWU36!=A2$9^3_5X16&8ZJ&ID
M*3,88T^"M2J9DLA+#KW"G%&['5D/&289)AN%B6>. 1(0H20CFBC)%;"$(XYL
M@ I]<7+0'J<=9,AL,63N;/FU!,R@(%B<@ 0[SXG%6#",-*3 , X<DWK#T?_'
M]/J"HH/8AGM][7A#KPS';;**$$+&F& 061K4/1J4/T ,\IAIPSTS<&.A_FP7
M9;AL'"[3G66$T((*2IQVA%.D/6*$&.:\TDJ*%P<+]B[@GH&RQ4!9I9I'/ K
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M1$S$D3/IE7NVKKN*6$P*863;C'@VD5+5*BJ Y!&MKH$RM=W%U4CW%SA*I;#
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MN; __9G NESE#>3;7F]CC@REIJBHZ1=C;5Y4#]Z.:&^DRML,P?323R"NZ%Y
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MS\@I*07CH +[V,C1E#C4Z#3'K+V%#66!WE'_UTO?ZN&E@Z[-ZGWU)2MW\&)
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M<Q2RLQMB__AOS+0U_WY\TJ$*' WE:P*)3?F\@=^8O_K9VH,Q*\7Z_A7X:0:
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MX[K!L)?8V?L*5&$Q5E.B]=*V@+D<$GBGU"#V$#UC6F>[VX3D'A+V:Y)V+"J
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M1OYS"=N8/O3U!H-_M >,8L/M4)"ZNI/W6$,_K>YAIVM](.:P(SS5YVJZ!(P
M*0"_^PR_)#T/WP? JBF!K@%\ \T@Y[BZT2EIZ"CV;H.[US>CU"(\ETZMI=^
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ME,2GV'Q>5++I0X]O@-^E\Y8N<5H 39!]G'?V+*T_^)BB+0VF^Q8P*Q!;=!2
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M:>S+T QGVF)\'(6"$^^%@E\H^(6"1V4E9 67J9O'B>NS/!,<+(*@B)(P*9*
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M]M7M3\==UO>H\!X?UU&8;BC0P :Z9)E5S.YPN77A=%$=5=7<D(NF:Z&Q84.
M\G 1O<8,VI5S0Y,U](B71CMM"'(9GRJ MZ=1N^]MY;(;K#CDSK+.U1UFT@&Z
MK;;;<]-&[Z.-3$'!G"+WZ/)X=(UW==^[,C5E1'G_:"8!]HG!4A !>%-.%3A!
MR8<M/*C,3'6U=!%&16WOW9IVW-<UEXM;..N_-%-H$5ZIKE.^QB!6^]ROX#*E
M**F\&,VQNA&ING)0<:[-WD1KSQ\(9-KNJ&6_S([RLF!["C+DX:0\)B6BVKXJ
M!*?6UVD0H2.(.PX0SAZLL<P]TFZWE6'^(RS0J(E7;<P4%$5*<J6W?D$+H9O
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M?IH&/.#"$X$0<G=!R_,BOU$P")@;NEGDBX#GS$N3+(F$X+E,1,Q"U_.?(<6
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MAGK3_.BB>FLP*W)K29^,ZP1MFN>2WJ'(TF2]4WI,C<TJO-NB?NW)],KKA!V
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M,[]^C==(K%_B-V5C[,9;$'*MR6'(5-G,!R%4"B,\@4+D6JH-J[N_&<S"53H
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MF\RWT]"X4[Z)V:$.02A!D"):&P5T#F (1BP)HLZ&Y&GLT)JS@=I/*CY8'3@
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MWP/%J/J]V4WHI3Y-,WJHD;%[IO?\"I4P<?"RYE-X'_][/&O&&ZLR[J:I3F4
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M%N_[ $(J-%O;B:$N<NHU#YJ1:)72C#NLM4(AV+"NH>W)<FF:-^5J<X,..;&
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MNVB<\CSA?OAPE?RRW+Q\6[1/-.IFOBU%#KSEZ_'"K$F!NB\N%[KDTIHDM6[
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M6AZSTX:3+E?J4N5TOT:;O:NA^3[5T.*X_2SD[FD3'3<O?X\]RZ;W13P4\*7
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M'@>K;>"<R6B[66\M<AQ'[P4QX5<$\PZ2K6-=L6T/_>EYL1U5VPIH$P34&.Z
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M@_T*XW''%>74G;OA*!U7ZW(_;U_@F^VURG*AO3>>.::1T"ZZWL19P:3'"+.
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M/X6C%=P7+K@Z2BB74G-#F!9!RU3=+"AE D"[T]@:HHODF6WIHPCN:8:--<0
M^3B</%3E)>MC/+W[X?_^];OT?R<>+M8,K34W/^?2HX$GW^"&UN!ZIPDDQMQ[
M0A@H8WF*#2AGF/9$H,W(Z0<)!LJNQDT<!'9V.Z,5RY<IEC9XI874S(14N <)
M'(]@S@E#CC.SW$%[E!B]['+<Q,E<YQB_M;FV<I\N9?24BLS:WJ1-7]JA-^F
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M/\1$N6=,/%-^V2TF2BZQ\Y$I'00S-H"^5(XQQY524K#9,YOE7')P3%SF+NT
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M,1NG+<[Y\'H_#O!9 @ZUVB$;HO2(,2.<)1H<7^1Q!!V'Z1P&VX//J] L@S6
M<Q3 830X(XB*7"-&M58X>!4<,Y9&YO&<;)D]>+EXWJ7EYFSX0&[NVU[W>>W/
MICMJH4I%F5_ ^I0.@E?=PMC[R>"C)G":45/@A7M6J).2)LM56V4"]^ ?:<N4
MX$:E6[5<,BN-4WQ>/81]'"0CMF6ZT5$/DL^97=;1+RMX1WA% X_:.X+!E=8J
M&$<4]5X@3IC<E'>VS$*ZF'5U3O^8^1!(MU2OG3/K;H=T"D6)E=8!_F$"4Z61
ML00ISI'1@6YZ$+DMTF&UY?6;HYX-G3.[[ #IC%+,.,NQ-IC%%$RFD;N@(B4:
M_C?;U&$O&>AS*KJ=_"'V(8!NJ6"<,^=N!W1."*F\8M*E6Q* >(0)XR2.# 5A
MU1R@VT- 0+(U.R8U,'<Z,!><(!ZQ$'F,3#%F.%-1:!L,MV"P'>: ?%ZL\DD=
MD*\+JT<\8J[D8-"[G2\$\\6$P3>JPN/G<?%H#;UU8 H<6JU,WU&:5"'<2N>]
M541+YDRZM&Z1AB4%QH5EFQZ7;FDKTQ;:-I'JJ.?G3YEWYFN9><5T)\L@2X;
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M<6*5O1L$:!#@0 B@B/&I:HI"2+(0A):1,@M00 )GG*L#>T?'0 #" 0'$N2+
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M%0JGI.%E2\HC%QP[J?:Z^9AC9W<1CG' ,;Z7VK2\:,I@'QTEYQUT&&RH(":
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MTT^_G"+ EW:G\W"-\$\?C+G.W?0R?94YD)?:[I>#XBX=Z>6B(,MG-#&549V
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M):L4LXMB3* B4VAA"<2%=L7JQ6U!D9T4']QZRG.C#*M^-!-D.#7S*;D[O_0
M*Y)1%&YN>\EU]RV0T<$U>%Z%N;WM]\ >&H7VLE-V#9Q2!<IZA3/#^\ >?.EV
MS#KC6IP@ZNVR!+(E!PK670!LW_3Z\*N0HX8)MU-<LTS1\G9YG0?JCA/(ZV?7
M#^JZSM!7CPH&G+ERF/Z9>%!"^,30,+V\FO3?/*?0=?5W.NV;]J"^%@0#5,_)
MC\C^'\P,1@2OL$AK;Y?Y>^WN9$W2?_V+(EC^5!:7Z:R@4RW]3=?U^K>]?L58
M25&UX]TH#O:Y-TB(]\]A.]'&WN4W:T(NH-O _ DSR: **@TP,Z]U8DY?>L..
M3U0IPR#YR:-)^E "WU33@$>G&JHUA>8,-";[_;0R0U2NL+WKF"_CP.ZH(FN]
M-GC/#(!7KD.W,,4_A[W^\";Q$0Q1 I<69I#'O@D!Q.93ZYX.]>,FE@]?[013
MP@^*&_-'KY]*L=;?F@P U+P #T^1S,PV^8%?KGMYS^J16XD2M_#H1(!^6A90
M[2M8#/![H&-27S[DN?US".M/=+)9[0R FC&Q9AIX/.]A%W886*?P[9@9:5"-
MFOV(^QT%2A6]_F9LLI6KN1IUMH"JG5RKW'K*)Q_8_"542#>6C^(:'+OT*J/,
M+( ]!)T*E![@#3#J !C^KC 1V,[/2,4RR9W"M7NPNQ^KE;@T20TP92^9F%_:
M90 9"-WZ)N08*]/3)X8%J^TF(5@:I8*!A-_I?M1()A^"B,M(=&T^5P0*("8N
M/]4'V,1Z#O"CSTER4R"O<-<I(I/D-#%,O]=Y@#$7Q9Z,OVS1U(NMCLK!/ \O
MVZ7K],IA?VXU[TB$=)2GA$G&F(\VF=\!C'"-.55F]>6 U>8@<X&*:(E23#&1
M;B)$%;5"U"&'C*5',P=YCGDD?MC2%ER]LBW(L5];</7H6TSYY&W!U\D)^QAN
M!Y77G'AX[(X]\*51?2.[0D(S[CX]924 PMP.^R#H"75JTZ0'+F"ZF/IGLECZ
M64WWVY_- /SYHAL^ 5Z9?!S;-^ U5A%XT+^WZ5DKTF42<WX(HP'?]WN?^N9F
M49?LJ]XOX?[+4ZG1W)+@,5$<*R:14P%4%&@J'KPDVL^VED)J:8!Y%\VT"9_?
M3'O"[)YG=$S#^)MN\9N!]:;=TTMVKS\F2WKN<M+?7O_X/O13?J7Y%-[%>XJ^
MBQ5FY%V93)?5VB 4B+$ID$&PX8HRAC'VU-@09L-02".Z+G7Y_&RAYV3%+9 9
MNOY+8LWL^<!8%6\>BOE(D"GR+E+)2^.5=11HP(3$6ELV>[RS"7FVS, G"SJY
M3S!?:I\PR6S%=XD'"?KIGN&*T?(STN:/\4_?5\;%Y4WH)I?N!=@38 Y=?NJ'
M?'*4+/B;].P\T@1CEO><N3"$!ZSYB^G^63US_,BKWOO\S+PE]WM0+N+7(#RR
MP*#(!IO*!5A)J1-<QZ"U\G/2NS?9$+S=<6G:C;D[ J;=T/Z1#*_DEP,8=-K9
M9DN^/+P&VRL=2%0T'V'TI N3:V,,VOVQ.S]F49BVKS-I%FWI5H[,:I6YA9[=
MKR.S\>BGIN5_7[F5T]U7DIMSSP@&N&10A8,V@D1?U7:I#GDK0)QL,T^)=)A1
M(< QY%(;KS6.G+!4&\JC.4H7Q*RRKRN!VT5];*Y;3,\YEZF$8109 H'9X<*]
MU%AJCB4-CD5M8/64:.RX%];'2-9P++9H:9FSN6#YXVRN':Y("&0,QEHEIYY&
M;Y67U%&!>11:^]57RW:SHFYO3@;PPYT-7V_;=;0NG_+&.GKS4-^DZ%%2Z)/1
M03?LIT 0F :F6Z3*,.DQ(!@IG'23;=@EFNER_/U7HZ^OMITBY0[X!*"&@<W$
ME#%:@OVD@-0^6#VO2_+:O+)^.A-K2;;8&/ANZC ]>=3)VP<3OPH=K#APJYCI
M38X5OT^_ 1[+[TVF<E&):.0F.IF2%&S"82X<$1'HP>>>S,RN?;OKP@1=D-D2
MJ&FQ"TX:.RF@:8= @Q0^]";EBN:/O\^1TQSXL6$"7?,Q&#!$+F.5_SO?;:I]
MIBDW"58$7\I1TEZW(GFK,%57S'8GQ5-'X?$9/\&4U\4M;%45:9XT#WR[RHX:
M2T*.2"TV_/Q]!:\B'\YB_8A SD@SGF:'0M)T*'P2'0HWC!].I;EU_2A)X)?0
M#;$]>)_:Q\T+(6)KJ,?16,= +TIAJ)!"T'1;%.VH(2!S&DEP6(2*EJ'(5< L
M6K!,C:$8>7NT$**X (2,@((^;TN_;8<9_1.QMHDGKEKF%K0AZ[=0W7IB)W\3
MY>J!V5^&="VL4S"$O_OS^V0% 8=G^,]:/7=*3'YE?ID.UNZOIF2?<W'6:,T.
MD]R0F*&R*5_W^C#/\96(%VF$X+/?DKXT6;0'C&:"1-2. *F5L\AX#):GX)@)
MP]=)TUAVR6$ Z!0*T&Z#Z]EK#NEDNDH,JNZ3N- ?F!3/3&29=J%NS)] $AC&
M72=*N8E5/W#'\U%0I^SEGX#V+5WRR,%0[-]-_VQU;*Y"JP6$KHG;_ZV>T]3G
M543O7<P?3AJ@AG*;PIU2(89M*I:DB58&*ZTEYJN3CW<1KN-SPW7QONCG$NHF
M:^91Y'HYN2&37[J\ 94[V7(\$B<D9T))2IBDS 9EG.5:66I3\<65^7;+LK/$
M@NRL#?VZG2W681V(8L*!)#*LA5':15@&IUI@RC?U^4Y[L3HYN)J NP$.+H<E
M,A*)5SK=E"!L5*AT;2G8<K'K^+<S;PPJ6*E$83&TC-S@?+VKJ&*S<SR<!SF7
MTS V#^JJT%%8DMRZ6#,L ZR9+;+,Q,!13!U(F;$4W',G7-04<0F3W12HMDN-
MQ-NE/N^(!)@ZA0RA%&G'D.>&>Y]*^WB9KG3&.776-Q#)=4E EN3R+L]RWA$5
M6% Z*2UCC6<\G=MK1B/@<L!&>S<G(7P#%%Z?$1;GR,[+:-Y<]/:4*9'"4.U!
MOM<*CLZ+_-Q/H>O:H5R>+J$Y#1(+IA A@(K!*,*C,.GN3J3:K"X M]K704'0
M%(AG!'F&HU5>,!L3#Q.'L,%'\W5DE2Y1TRUOTA3E-O=W5B]U"_KLPM]9/<86
M$SOY+(G_#*.XW<1I6Z<]:'^JR5-'[/J^7>O68;\Z2Q]% K<Z*EM-MRV(S0[
M!7.OO:WZT>I;;SL2W^F0U%R1KC1./I >GR.7^Z#4W$K]JWXD#K"%<SN#K/J1
M/'5!OAPLBMO?QT#\5/9QN.<$,^:$J5#'/$-FE 8R-Z Q>G/,69/6BXO<*V+
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M"U"SGS>C#'.Y/:_ISR[P5Q&#J93P.)(WRSDUKU]D;SN ]QG 2L[Q D"N*E@
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MN6_ULUNY.'GS>7/^/ ?S>5_H=7KF\PXBEWC]:Q'GBF9;ABYW F /0Y<-@#4
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MC73IOZ)EM[:263!2=^O&3%)EP$F8(807D]E-[8=42]V*51&25Y(#S*_?;EW
M!AM\:;!DGWR)+0NI+^=YSJ7/Z=X49E,0JT>;GZ2_9*Q>"8NICM4#BP&+M:.J
M:#9K*8C-HRH9?Z63Z!]6A4T>0[_)C+A"W%\)*ZJ.^S>,%5]_6U[@P=99<T7
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M>'&JG<197FSA<YSX([E8"(@"1*T%4?VC3QN!J$MZD\3)U:W0CCF/,ZG*^OZ
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M/4?J,VHP5^=8=P3"=6IRFUG8H[85^,Q&4&L(R];*,Q =6)Z&\"\L$X"<@)R
MG("<@)R G#1J4$!.8'FZR2FH&QZF;U[6-<P=S!W,'<P=S!W,W3;,W1:&:]>2
M@=@&R[_=JT^MW1K#-[FN4^3:Q',(<3WJ(N39F./ YHYG^H\7INQF+4PANVV;
M[&Q[T -PWH#T29V;9N [@<U<3 *,/0=1S%W?YMA@GFY-266^2SQI5%(SV;5T
M8(!V,4!SPIX-A.RL5$V=8<.S=<-PB$$,EU!$,*66@QFS?.8$S45L8U(U :B@
MJIN&^ZEIH49@NPZF7$>!09C)!<Y=ABEQ7)\'KMU@K#_2SD@G+0-]FS-&@5:
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M<13P 2CD=2CD9_?6F';IY?;91K/VV=[W$G9;?!CD5]'[_P=02P,$%     @
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MD YW!\?J5?DL[&89_2<BDU_MWW7K=UW55:*0#HM)ZS'T.6D?Y,52SUF6D>V
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MC0?/TBP;N81+[0"5;:@O L!D<A#,'$HFXY82&&8.*PE-V0A-50U!!F8-2^T
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M&2_^0-#JY\\%W<[5BNJ"LP$2>/;3>.8HNFHZGHW05:D=P+-5>):GG0:3@<G
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M.F882^T IA4ZXV'KZR$6OP.\$*(">4DLXU>0%P)D$ONGX2B::[B&BDJ*I7:
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MHJR2R;BE((^E@-BV(5='RR':M#143"BW RQ4[(P^^<*%%N0K#0*VG-X$P4Y
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MR%!Y3A8&0=[#C5Z1V9[IJJA;7&H'KLA>PMWB NR@@ZS8&Q!8!GA_R=USO"T
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M4>;'27!X$(N>$\1N-@+PAU=IX">GN@51FXN;E5\6!5:9ZDB_MM%Y33!SM[#
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M]:,(@$FR*(Y9&D8IB;PL8GZ6QPEY?)QV5V@]CP?A=0LL7X'9 S!RQ/;B=F\
M[+CTK?@]P+^K&AZ[,+.;QDW=Z.[LQ?(#^-A*:45II2UV.C)UC]6I,B5<MR\'
MP9:Q;UA^JT#E@NFC>[KDD!6 &+=:BV+?BM1HIH!7MPE>;+[J>5V[.L%FI?PM
MS[K4PIE3)&Z1&K6P1%+<<=GLB&^U[W_SND&/++HWA=P;15NIQ/YL99I.2JFO
M;"2,;B;Y+L0/R8,,O2"(:1I$G''BIQ[UAC[0/@U W+\<XH__0-ML[C4K:S-.
M?\V9EM.[J%_3IX7H ^J%G7)\Y1V&DKQ4VJP4N;L )J=349:<-PI@%V![;!$%
M58'MP 0X[*P>05X @6"L(H'?=J>@S7#\MTK ?%PVJPKJMMM?/_O=M-C",\M(
M1%,:D9"0-(DP(QF-6(Y#_)*D^1/<37LCH;*$"P(0:#=Q[78P%1SPTLCKU:[6
M@N,[JY?K2M,I9E<TN[?![>NA!Z&PV6^J]]3WT"1FT-'P%4O>B]BZU+9= &50
M /=WP>E4O $);ZKI%&L('#>[1L/L?;/V% 3Y-Z,OA>+7#X9A'H=IE.49";"'
MO33T,G^8<R]^0>A[@MM=;T [YQH(I@]8X(X6E:X_8&A@UZ]5IBCF2LZYE9H%
M'C<?9NB&2?ET)M62P]W%1-7<B3= #2!\%'%^F,)X5#0<!H#ZTT5W^+7?<&[$
M?VW/?EPI\<Q F_;H,]]ZZC$Y\OK(_GM]VJ#/BPEEH9][&92[8< (#?+48W$:
M<,P2[JT#IJ.PMQ2YC488 J9?G/?\;;S&UMV#L&47]0JB:H3^B36D7;_OOI/=
M?:2[#W2-AZ\:=?UHUT-\8="M&'JT-?GAE9]XI]\VP[TV_C<.HR;(!T25I9J.
M4##[]"BS:".\8Q>YETU;8;SO<9Z8DXWO9I_UP]PSOS_RW/X-=19ZKT&X,=Z\
MLK]4&M*[_8KOLD[_DNN'3;M-VQOY_0L*YQ#Q\Q6?RP??[7/Y]33:H[,3^V<&
M[J#Y4XK_ E!+ P04    " !5@F%2.CSC!EX%  !L%P  %P   &)R:&,Q,# R
M,#@U,U]E>#,R+3$N:'1MY5AM;]LV$/X^8/_AYF!M OA%DN,VL1T#CN.L[KHX
ML-VA^TB)E,5%)C62BN/^^AWUXMBNN[5-7Q'!@"F^W#W/\>ZH8S<RB[CW\T\
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MU(4E@AW#;IL6WS9'MIWB4^Y.O6]V=[IE@'6[;'4;]OXY:Q1W[/\"4$L#!!0
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M@)LPAM7FG%^>XJ)_0?P;4$L#!!0    ( %6"85*96O9G=%\  "&A   *
M:6UA9V4P+FIP9^R\!UQ4RY8OO,F"()*#0*L@(%&0# JH2)*<LTBF)6<0&E%
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MIJQ+CB(KLB#V\ML15UDTR[UUO("P-737$OGYE74(@OT3!HC-O0!%2*]+IF&
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MMJS\5G+OG$*C9@\=%*XN@U11?J^[/99,4DFS0#L>*\I9> G>^&SGP&ZA_LW
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M?/<Y81)T(4$;/\2,[]96H9%C^VPIQCW%VOJ35^QC.^5FP>)^1L:*=PN-'NZ
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MCSU=75XG=4]OR_/CT?!))S9*76!G+7)X6TF66#K<\\S2:IEJ661$C*V&*V?
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MADIEQ\96W-ONAH/PZX\->$ ^Q]J@V4YRLMRX(&;@W3R6998$#4T0PBY1R8;
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MTB_::H]:-^:1/\H% E<;&1>2)1C=2D%ELZHP/WX5 H+D<WZ.!2:[C%97>EX
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M/ER*8)TK$LQ'P2>]/W)!^SEY;S7?X$*P\(!1=>]7!$+9=6-7:S>O!&[]#41
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M<;XPU8LJS<Y)0P&7EYSD<=LL)GL&I@E"^9_^<O/<CHW1(\R O&)NG01]N_^
MKFXL?,_LM,I4S,DO( '.+OJDA^83N%)H36(J_)14T..B>V?@(OF:S7JLV16]
MXH.CX,*&?0BTOA-8S:CR<ZY)_ F@.W_](LQK1:#$Z2E:3R(;<KEDE9P74DY4
M>"=A3G/+9N+'9OVR2PH+AZ:1WDR:):96#K'_'@[E0P5C9<"T2U'2;**4>]I)
M*8Z-.MC8XUB*O7$3E8 ,T<"P8E(/D7D2:XI;\8N@G9>:OEK8U>/L?!03/)
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MDST3OVJWVIYLC=PT(C-OPYY@ZIW*4S1]U;^<9>JAN%=-.''[#?A!P0</KU?
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M[HC!!TP^.)C)1[GD^W$7/P+4E<7(V] UB+R)9+6_)TX'IB;YF1[,\2XWW57
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MLZ[4/R>$Z:KE(E -AW_<=(L@&X&X;'><.P*U50M_T)HOK 0C0'GZL;K[ >E
M,IVP%L5P%&NW9<6Q<6A4(MDJRN,5T84KS$4NQ:QFWY*!HR\E,L/:M!@P>+2;
M%-]30P-<[.4UO.@[7M(L1 X/M\/#[?!P^T\9;KV9?T9'_S0?>527,4^/-;B0
M\2M9E[!&G\B8+.H*[+.:@51)J8ZI3"F9AG>04A>Q1_ _-8XBK_X?4$L#!!0
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M0RY2>67% PJSN['ML2QR;:8D<<?#)2=K.36EAD#'6:T:Q;$P2=T F)XMX4
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M#!;LHNBTI&E0EGF@JOTXN3^HPL/6'L0R6DU>+GR_EOMXZ1L6N%>@8* CBE+
MX1#(=/[8D0.K N[WE*T?8B[DNPH=,+2S3/!7;+&@> <=O:31DSS#@>66L@(7
M6@FF>RK ]*;Y3EH,470;@G[3,',@:!!#WP^?<!]7 BT<>/I./?BFN_TVZ_4S
M6\?KALXK @LK=WL@R^C5/3(J"R_DTSC:)'D^Z49=;?=J?#FM("VC_)8J^PK-
M335?%,^M5S:P)CW1? F(%[MRR@Y4[V<;&GC)D8#R'-"RO65R+.AA>H(J+:F
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M9FAG&UGU.C8-RA&M5JUM([&J;'YZ+4VHW6HDIHOD++6AXGXSJ"U)5FVGT&D
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M6*\K(KB_&A..-VM467"M(2PSYA(YW(1"X+&@O(*)O"7LGCX2/R:)4\[LXC@
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M^]UF=UY%C_8V "!U:1\G-;I&]]//UOY.3@ACSEI&0,G[:DY@0NFU^14M/3I
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M,0!CKMM)C>#4$73H@Q%7SQ>!!T%T:/'2%8X3%UM\9Q9+1)/&Z&8$"9B^M!V
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M!+2SH!LUG<C211.>( &$<%<>O5\4!:BG<_=I](+74B6>S.%2685[AKL<FZ:
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M'6=CR8Y)ZS93)A^]53@Q[EG;A*G$MGGS)-W_<>_L"T!KA=W14S+NWB@E^^A
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M6A^%B^-46-U:+V%>%6R R,@8'<<IV;1 H*BNHR[BM ;J:-/M;[ZC4Y@L5K<
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M*-VU>C%OK2M2TV@6&;6_:)]:LL6NCN'/UWT1.;?:-4N=6$&AE*?FI^I3:&J
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M*^81J:.R?_&X1X7)(?17 ANA[W4Q>-;%N/4ZY T,HIL@9..MTV 7LFF_^)@
MB&T]]%#;CI4L573\00(@FU)?M/Z+QH1PF^.+F%16OAP) .K[Q**+>EQ5N74(
MJ(_O&F1XQ0Z2:13"3H80"]\^Q&3U  UC'BHW3+-A:NV*0E,IM+TV#U1Y5U%F
M57[O)5,,.&(LP !:N!3=*>1VA-"*)98T$OL6\&*FID# S*N@?]MG.1^%9U?L
MQPNRIXN<;K/[Y);R'S,L]AZ52Y!\P]9]<LI,V$C^.5S3]?N7WS.^0'F]XZ?C
MAO'CDF\B+-9O9>]#3Y3NH.FNTXVFNML&.J@RDS18K3\3-&'1RL)IG-:Q24QS
M_O""1:^>8?"3E>(D/F8&.?L1(_[?8<Q^29J5OMR#-Y/LJD;P4Z23N@$D.+3@
ME[DE<B)R)O,0H*_9;C-WQ7^*O_(5:!'B^&6:QLXM1"<=)3HB52)29#KB&#LD
MXR_=D#(=^98G_(Y_S7.2FY;P?,OS,H'ZCAQ2DR:W/R_OOU$QDHX@WY8:>3*F
MO4\DX^Z[IR"E_ J#]6FRY9L"BR7J6_KG/LS"G-[1]#E<T?)X<?ZS/,9%E#^"
M:-_7SZG2#<>TCM+AU1$G#70YIG798& I<=>$1=NOW@M+C@F/D+\<%Z%)P ]R
MGGO[S52,$FN_<]1*I=])9HGT._PK7X& N!B(.FWLW.K!!Z(W%Z='I A4B<5-
M\%(\%%ZF*6L;Y?\^XD/0E/(;B(J7_9(L)ZUX7X7%*9K?MK)X,JC\D*17]-.R
M.3,Z36+VSU6!_TQT\XF-[W"X!_'%DUY]-M1=QQ:)@9((C-=9\>/2Q9PZAZ=W
MW/RXUL,*5V)M,NMNJ<[HPTA$ YI_/@&(BN!T7:C8^[Z*5<=O]YEOY%13'N@T
MENN@-/BS+9.T2HK# PEG/C-SUPP9R9A^Z[$5Y-^AJ4'&R4")-X(W2HF#2#::
MUHZCS[\4F,I&KPYQ.NM(LCX-A96\LV3_D&_VT?#(#\D[:#:^K;)BX(M 9' V
M)T7&-+N.V6;Q%DOY,4Q'9"<_Q6E^OIL#+$'H]R'YP6'Z&F"8?VJDHU8NX\RH
M,)>=^^3]B4^3PUQ1Y*;!N2\EKP0#QX+X!0N J:"@#4T16=T/CKKPH<\#9:S0
M?2&E(G_8[\>F=TB72[BGZAHYT_I>,F*)H\]'H];;5->;BSAGJ CY+0"L,_/!
MHB/(N*:2QG@LF93A71S,!DFHY)4^0'DX3.<=8U\.&()U?6+303U2*?TZM )D
M<(XRO)$7*-4X@/&Q51M;R88T9J2T>WLXDXV3$($VZTBHT[HSNJ%L@+8^?0K2
M1_FF>1,?H:!+?5 9)\F".EHR2 AGGRK.@(.U,:FL_=DQ:003*2D!O:BBIL1=
MSE!EOOEX6JB%C)#"+VOF];X<2[%../R%,E%X)7.&#HOEW=WY_=W,Z!?W20+Y
M)7MX[MAU@"N(@-Z]>&,486BSON5CD++">J-R%OTL&U,8=/2L8P;A]$XXC4.:
MKEE-R_0G=8(G7\-)E@^C7?FH5C=+&@Y2$6<]#F8W\%E,>[;RNKI**0KBOII?
M!"1/!47?=20![:E>.YHC@3!X*C>PKS"XJM;+_<&BZE&"[#<5 5/T)&#HC]W+
MR,IB\D1JZ%"-2'QYDF3<O4KA@?2O-S*DG!Y);$2RA#Q9ZD5U-&<29P%CN3N#
M.NT(UMSO@2O[3P9MZ,2J9RY%NH-IEB"R&V4SGW0)'?M*Y]DD; Q"(")H!)$Y
M1?']/@MCFF7+5?DF0YC$9T%.KS>M#Y:/*2TV]IWT(&KG7/ULILXC:626#EUX
MK=*KN&<1<-'ZBJR9\;Q,M$1/@M&G7>J:Q6ESVJ8%DP,9K5#8I<9%,2LMM1-I
M&1T1[L<?<K1!?G#]\I NJ5)30MV'NG::;!_"N'A><YK$6;@NCGY(XOLTB+/R
MZ8VLJIFX]FH:S!5)""#)G-4S@^00'0"'6RP?&=8>.>=W[#=ZXB_M[M*PVBJ6
M/U$2<%CRAYTKUOYPQ;[EIU6MYM[@8H4N@1*8]KI8!B!11"( SSXQR-%KG4EB
M3(2WZUS+ATVHVEZDY?9EX5I3WUP#V[/:5KUR_@^ZOEBS\AMNPN"P;VA9">$R
M;M]@Q;[;;^F:GZ)4S4A%C^JF2"6OG8BI\&4(K7%3U&;LQAHJ'6[ZZDE)<7"E
M1T]+)N&*6C&=8%(KL&A9-8*,_-=Y+@DN1S+H#9U3#Z0CI28+::>IGY/7B8JK
M>EJI2)6K/+&R$A@?]BR_-8&!#^%>I<*\E2'B:?L/:][/<SE4U*5T,&24I_2H
M3L@:Z?404M/HJ4J'LAD>;KZ9E$^.5!^"5W?B+\ONJ@BH_]I7(B->#CMU#?9!
M0]P-0T\[8]"CUFD%7R5J&BY\&1KEV8#UUR19?PJC2+)5S\!#/EP<>N#+=#_'
M%(,U24Y#G11&6=2?>K.ERP0):A51=956 _K.&@J+<TT#/Y=%7I8/ 7O2$ON%
M01)>EQ PZ4-5:&\Q*:L;/4NV01CK-R2*[>5[$/OV^+NUNADP7S&')C/<D26(
M(=F#55N2CZ6M)RS4PT&]U4K>8]K-55U7S7XJ41Z?N'=#&=#C/'BDUYL_$G[4
M\45]65P]Z-03TB"(G*6@(/C4!:2=8N<PO!F&3(<&7C2&?,ME?67@8<^5=[0W
M 9U:"PPAH!4(0#R-:H!;-!L?7&Y -FB"&S)(-R1W.5)&((<0AW6?KUR!;U6>
MC"R>#7HOV0?%17?Z\CHPE1?1EBF^-!R".Q[@]O,8DKSK+F0R^<B-RFLK_1O0
M#OM;S4EAOVB)=_#2T*L7?78.M>:VLA.1(*;R!42\TY)4P5UP2)''<*FF?Z12
M X>,5[[:PZ/SQD!]KEZ7 9S&I/+2+,3X<I:8:)(ZO"1*8Z58;,&X^$D2U_7"
M"NPR)Y6GI-IX<#N3KD,URR7*&Y<D#KJED?EO41*-)JM7CV[XFT?5%1ZM951^
M:\<JI^O[X/,97>]7>7&8YY8?= Y8)QD=6[%\,B*V@UFD=6LF66P9VSK3:>>X
M?(?'<]XI" *@-=--%!SI)Z'6:71STY'M]XV93I=]1K=L4EI*%XEJ__+.+!Z!
ML!"DB4'*(%_9;(F]UTIG'U:@6A.2,YJMTG!7#,7 \VB%DWQ&+73"GUL+TCB>
M9<LS&LZW98$DFR-:YCY/P%5@44_%-5VIG90+_#73<VE&GRAK_S(+!7 ;([J+
M-W^I$[48TQZO7\YHVC?9*WRT<]YIU!AX)TDH&'?U0ATU$[DQB9R]-4>=[7H<
MVR8O7X-HM6UBMCI\QY9Z,K=Y7;R?XMU9Y\3W;8X39JLHR?8IO:>?\_<L^=\!
M<QRYDV*.(W)R,,<9IIEB,")/:SK1D012/&+T3DM4^-!,:]2]IY_6#/UUTQI9
MQLF@Z;+L*E+BX%)2)$EC3CYR!U)X>#@#QX8JO$BA877.DG(:9$^LW/'_.6?Z
M]!Q$K"AFR_PT2-.7,'[\(XCV?8H8^50_(]!G)&E!6=#+B4E6%6OA<1;<IAB?
MKO@_:&,]+T'-D)&,Z+@N.T'N;7(:Y)L*DFAEQ"@C"AY/6H L_M$R/R)!3FH/
M4KB\=8Q*2H@[D,Y=0'HMO*59GH;\.5'U%W0_:%G>T#1,UA?Q*J5!1L]H^;_L
MOZ/]FOV!YY]73PR<]#;(Z?EF0P?/;^9)WBII4R9'$*+IFFM<9'675<W2?)TZ
M3MR@!5_>""LG]H^R^OLY#)B!EHD/8!]J_G3MZ!>/J7^!5Z=0J&.NZ9ONESQ5
MH\ CP1"P240. \7^9QV'L@&D;@'YMF[#=T?DT Q2MX/PAI"R)5^5;S82?;G2
M-_< O'YP\8&!L+7.+%JW45NV5VMDEA@38G%LS,U,^C3:J:_"NQB))9MJ .;%
M6[&0WNW/9O7=()C"BIT&$U=5[-<Y6\6<?&+.)><=>)F2=E<(['F\=C;;<SUY
MTRS!DF-"V<=,'<H_=7Y9&(]2K &&HYD26O6??QYC/"TI07:7!VGNE%%.)QS]
M560!IQ[H8QC'?-C_E5DZW/A*K?$7R(UNPCLOIOQU2YP2ZAW:A/PKT20@\I5H
M[^:>D X>6]TD4;AZD6U2,_)1;BD8^#AY?MO+,M&6 G%6\T>XHC@+_S@/!X3V
M*:VBOR /:7ON^H>TPGQ3(='Q3@))1A08JG<2E [D8_6_WNQ+<P]6HRT%&&B=
M>T7S0Y1\XA<4L7]>Q,^LU+&!/VOXAS .XA7_]RH/GXOMV<VF.LE+GECA6F5G
M7#@$'1C3 "?%"J%!.@$9G6)QQ6]?Y*H2UOZ%T&SJ""3G-Z;R*Y?Y'NWU/BT^
M>Z+5=/.7^54&!<>)&RP-I6E,Y+YJC6^E![1#K<P8C7'-N;J>\SCEW83\ORXZ
M]#L$(TVTSOYS3][_]I5_BK&!3P2<=401!5EVO;GGSW+WZ<M=SD8Y]_R]K_Y0
M06=7CP'D=F-51A89]=FH)HE2%92^B^)KOD);&Y#"@GPL;.9FL+9[$\.>Z%%.
MYM+ADCKNW!PIVM,P6'8"*="ZRQ>Y-0YK9/$=<$>3"L @982&1R5]6G;^U$,@
M!(:<@O23D%DR1P&_U#GF8UFRW8;YMMC(S^;A2<S+*&4%=' W+<"R9I?*<BRS
MY+%-6?5,TX=$,Y/49E,22^.]:!F4*TQM$_+M59)3<O+OW\U,*T"_)\8=U*.3
MW*E#)5ULM^#"FRWI\XS U8D&6&\)3K*Y!@J>9ITAR)NF/V+!SEFOWBZ.7#!+
MA[]6:)/>DIS2HQA>)UV!K[K;=S"8TYHWWVU:,#FJIR@NEJ<WV$34C&V\/,YA
M#JR;%S!TL'M?YF13?AM?DR*'MQQ@D@UU<< B\6@EZ"T<*'7 F[4#*RR9,A^P
MKF 2QICV'JTY)'&Q(/(;W3[05$!LX?<M\O:^1R!H)Z*3<:8H@XYM0Y]%^7&]
MCEU^XP%]Q#V6 '_D(0TZIGVH"^*X@ #JH$P8W;C_3]X8 !0#(#,$S#V,J1IT
M%CZ':QJO^8N;=T]!RE_9C(+AK;XF+D/=4[C@\4":Q*4ZZI("":,.LSA\3=;5
MYWQ/#5F5S,JX _DVC,DZB=BW6?%E\:D'B[%@U(BI!^I5*1FEWA)^:K)-!%87
M.JY-B('4GMH?D8-U<28!*1SX]02ER]L&I[Y4H*+3DX)R$Z37Z5T>Y'1='+!5
M-U5>3W0>PW(B]\ CJ"R'RV*BR0EDJ#)*S<^LY.<N2,ES<7":Y^5#"Q(Q02&]
M**6GS%G"3G6N:9#IHG+H\B' <E WF#%)6+THS,MC#YL"\I9!J2\:B*CTI&04
M[<DNLFROFG:(K(:EH6N%1[IV7)<E0) 'R*^!9T_J"T'/2%@8%')??N*/Q@M[
M6$PA67=(6=-VD#!E&-,=?%SHM"B')78&>EP:')'2Y"T@1B^T%I#Q2E"7^_PI
M2?E5'3I1'5K*A+5MB<V.)K9[@1WD,B)*SULLM,'!R&.Q%?2\BC[B+M(PJ'%2
MLJ@?VRV\W GP,,\(;$F$F#16;PE04$VV0I0GVOR'Z$8(R==#%?X#YYZ'7D"7
M>MM. "1"X])3UG_Z_L>39LGBB+S[\>C''XO_?RBZ1^3D7X]^_+=_.WKW'^^*
M)_DG_W+T\W_\?/333__>'0H?$?9O?B]O^$RC%V_H](?T''U%YTEY\\?@<'QA
M% >X<B&TG>"FH!I(ZA\EF#P;VAKUOUXX00"862)W-,Z*BWZ6\?I\NXN2%TK?
MTYANPOR&=7&FV#]L[-I(JX'K>'J D[F09-/D&F:9A5N<L2]B6NZH2L.'?7'J
M*3><G7+FX$G&=^J J> H/18;9I\8PYCR;YP8$\!EV3BX%$.*VHE47@6<,[^V
M"$\*;GD=F@3='M6O6YJ'*>4;'"$;@TT]Q=5+[8E+?%4NY"W!AFD-2*^-)B]:
M/FT%-D:/G.'0;E7R6Q5$06]][EG)G<1\M_+UAD&"IBE=WP>?JVN/Y;0&^[0(
M#?!!H+(VBY,!*#2KCL.P.(OZ:Y('GTE07D_N$V_A\$A&]-Z0JUKW/DN!^:;"
M)>J@$IP1!935,+*TY0=4'##*S,GR2\.H8L#H!J1S#Q$%C;P,@X<P*HY^,BLE
M"D=U/1$ZNB&O(-54E46>VH+)LF#=&A,U5KZ36 4>/9,UW0IBLR &@-+2S)/B
MUW4%4J3% Z^Z%EU^X5@V*TVH8)Z[2.V9Y-XEF_Q3D-*+.&=H"Q\B6A13V1N0
M<)]6:0+X(+!:F\5)08)FU=$9%F=1F_CS@IT!(I(1'39DI]:]3TQ@OJF@B%I;
MP!E1<%A5%&Y+:F-^XVAM7DYPOAB,*DJ(&Y#.6SCB+(G"=;&<=TFS[/XIB/_Z
ME$31R_6GF*[O]@]9N Z#].6&_0EQSC],LZ=PQ_X:RKB3E_>!L@)Y6EP1FEW1
M7'C(K.L\AP+E+,]H)7'4,MR%>[>-5.N5R]R+3O@CPA.0G!F2,@4I<I F2?$Z
M"TM##GE(G>BHNG:Y&'Y7R8X(OQW5CQ-_G7,MF1C6?25VE+*KWD[_KM<K^.6?
M<[:G]PG[DR[B5;*ER[Q\SL;_OOND=.2/?H<_@72MS*M68143K%;-77IP_@ZO
M"A7JG^2TK"&V%+<(EDG(6;E%D9>_LG&DW3K^516CV'PC*YS>K%5YT5M.*BT^
MBY'K,DX#4:LXYF_VVFM^=A=$]'I3?_B^LG93RC7)<"NT-)D?A5?2/--Z"CJ+
M?H(&3U M50TH+V?:I<F*TG5&N.Z3C)GSFA3SR]+XKC&6D%_.%%8!WD11TE$*
MO]8 @.NDA$CR.J@,RK_0>_5 7+2>HJGS"L>)D^$S&__>5>)3?T4>7BJ_K[+C
M#/%O5W?>VN.$RS"F%SG=#N\*FB"7P\<*K5QS%PI5Z[Q:M0$T=.I'#-W\$SUF
MX$E)D?6UKY> 2.CX>8,0Z^Z?.1S2NG[NT/O[7F]UJ/ZD&Z:%3T$VW5J$/B'R
M>H0JX=S%0MM$KRH&M+53S"TTC5C4WY-=&JXHV20I"=;KD&<-(KXV0=[NV@2
M8@XF"C 0NYDKR'.[F"_H_M(YBT*Q1KX/HN7Z;_OL<+_(_5.8KED3\Y<[FK,.
M*#Z_8;_%ZJ7\O_*3)= B-K(^/N)XW1[;!@=;9K':I)%?E"R+5B"RC*+D4\!D
M;?:[[_# FCA#RT !QP;O21Q.6_U@&.:B*E9[)J#728]?3:CBP7\1C!312"L<
MF_X6H<C'ZG\].H7#9V+*US$]9.:\*Y)9T>+SS_S4 L7+FFJSPT! 9C9:>\2!
M'91L92*U4"A<%]<[F@;\0C@V26%VO\S-7DU_)F:_?9]F8H\N=U11'<(%L?ZH
MD]ABI:@46547:@./=H#A($>JT..@XY.6:C14HYWH)##6RB0/(A.MM-#(4AOO
M>2:2=!72+YA#X T71!6:G0B@4^&S$3RIT+W.;@>JF:[?9U6OE*[#_$.PXN]N
MOYPEVR",^PJF,*E53&@R%LV"H*BKZ/+X2DS+W!;E-Z3^BGPLOYR[=*NZ+X'_
MW#V,"ZP[.)=&\P3JR\_AH%1+#80P+PU00<Y#NH-X*SH<X >G(;SY5UZ!N]-E
M4FCW?V05L+FM'-9-I/E O4_YXXH/=,V&4=%]\+DJ+-7!HGV$PZQKN.NLQV)?
M'1]_E@_*IZ0&(,*B^G9F8@![.K'JCAYEU(X=_D!RN(<5WJ 8EFLDIOB0N;0B
ME5EQK%%E2+ZM3.>^D<<)Y&1C;%3,S3H"+YM7W&O()@:7+!-4QV$^7377^>"0
M3YW%E;*#L@*X"(BS*&R\(!P0!4/:P3M)R#VUNX"!D'Q3P0^[ L RHF"O50T*
MXV(AI3#WN"HX!*FZ0CA J0?5HGSG%E@F-,;=^B UQF&F)#S^*C4D'8".J@#5
M"O:JM/2"9KJN'O(+T"%"7DG\!(129G".*FRAUZ0:!ZF6M%>G1OBKZ*A04VLX
M"M;\56V^H22,]V'\6&T72&+ICHS1@4!JKP[DE+.JU*[F#?9-L:>[-OA!";S9
M S >>V!-@*+ 1"Y4,>%2HF_9K/28J-Q!FN&.&\ R>42:0*2)])50*MSXQZ@Y
M"_=9F 6/CRE]+)IUO;FESS3>4]%AKA#3ZL=5FX[4#U5PS&>+@#PJ!="Z+[H6
M_'7?RL:/ T5!_9V8]TN7@"JO-L7TT7WCT*7D! .HN9I+EVCG".@23,"I?BX+
M7G5#J+AUZ<M;]& @Z$DF["P0T2Y%KZ/#LOA&N$(+9*\'&OD RAC>*WZ@+%,5
M-I,W].!QY'1D0]@@IX])&LZ]1](,(,"Z!WBM#N0.K83J5^,F9"A]T%^FJS:J
M.2@Q&DLZ85A4EJDR*&DE=UQ<)3G-R$WP4@R/?)GG:3HR,?G9>^00VG?8H(@X
M*_PO8M:4/7]%[GV0A=G=+J7!^CK^(TA#WGFW3/9.!(0P<6M1!.:&0!I((O1E
M3,/$.G:!0RW*KP@K6<_5ER2=?5N$,4R2<5TXI"0D0I^D\*P3HA1M-=$T*19$
M3_BME@]\F;"V/R*%!VF@6SN1VR\&NI+5/M?8G74EK]/.#\&*+K?)?G XELY,
M6%/:9JCL; *;U@S L=::5' *]EP7RVKX34E0?%J>(<U'9KMR9.83R01=+"65
MN#M4'&H\Y)SI1W6((",]-QQV##/9(NCDBX$02(?-,80]E.U&?^=F4#!,8HN?
M=X*BSRU(:?(VH//.#73>>5.BA<_8Y!;"PHST1&T8$WLE1!P>3H#68[.[U1-=
M[\O#TR^3^/&8Z?B6] B1>?(,3=&?4A[HGI@-C>7@]^+Y6*=%@O=2Y09"T*.\
MESH,Z0[RP/=2)4Y]K??BO51%ETEQK7XO=6@K1[4'[Z7V&A3'^R"Z2<-X%>[8
M/X(7_JD:YDH7,? E+KA4$"9Q/CU3IC5@C3S,HOR.A,PXB**B2GA%(C4@Y+32
M=IB2:$)O!?44V2;"H:-%.W5"# BR>=_AXR\(AJ!)(!X.YUZ$:YY&2?<BJ*V$
M3SX1]QN(XSIY:"// W\"VMM*T'D$.C]Q5/TH?? )V18@=I _^L0]%5<1&U5^
M%3DL$5(_$6F^9E-!7XZ7Q4&,0E#M(3.W;#;2?BG;.*FV$@Z9+_&V28KCNILU
M]E/ 1R"7O;V0_?GCI3<[(#4]*AUL"']^U?#B4KC-4173$S)<!5LJ/+5.9R:D
M0]L,E0]-8'>$&.2 ,Z+G.EP^YP:>G&>G[5@I*\2=H*)%XR'G13^J)\2H+S3A
M#]^+(PW6-Y2A-<Z#1_6J.L112!ZU(RJ=5*D<[ZX"I(;S3AMLT?PW7\^O;S<B
MP6J5[NG:)R:"<"/E)K1'56Q5Q9#S5Y]Y4N@Z6KV!I,7#K6C;U>$B7^YT5!Y=
MLR:-WY>#9=""CQLP^S.+D9UPH+$25AZ\LPDD<=T-VDP.%%!Y]OGFSUO.N@Z5
MT@CPPK_$0<X/]:OZ<W'AMR#?I_R89$98)1U$AD)&= U12=$.[7BL)4@%Y\?
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MP$8UBH3UIV9D*0^B'&[J<OO#:O:/^K-*?SKO=\3K^@UE'<F- \DX;Q (6P+
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MO,8/;-\;8ROLD8J$- /^DR-@1HCNJF,L[H(H2,/J=ONTM"4K?@20'ZJFAX%
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M85^^7B#H9,X "3-+6TJ#C)[1\G\OXNO\B:;\;,M]FM+X<"1#*%I&,79MY-#
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MFE'0>U78^L-><5=+J"GM%3GM.BXR3@GBNL22DUHCS&(-I$&5*"R*<ZO?%(
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M^;Z=U*NJ2*+]Y;M0[PFWT2ZQY08=@,%.:G\$-,X;V+C+L>'#>;EV>)#&OC&
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M4[S^Y9$\_:\-#NGW/?_(_O&!_:/!;?KHOR[($TXD&;?P758>N]=Z-Y)[O1)
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MM,D=M\31@;J>.1^TARR!1$\[HHPV6846RT+-QB:8Y-&Z"&YX=,[.9\KIT!1
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MDBI-SU!([B55P_'YS2!9(ZERA&30I&KU1-T]XLXUB+<T5V#K>OY&(IHZI+2
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M"6N_OH8QOLKPOKN?=X1FN7K01--J*E;?$?PJ/6/?\CE/0U-+]E\4LO_3Q/+
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MP+1:UD5P0PK:SC%]1,50*8=*$ZBPT7Z;FT',CB?-H"?$D32<,S/'<G6!E6_
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M0LR7#<Z<+9KCR&111Z^*S1=QY.MA3%9M-)Q.!N'I5O.U7,* UV"]7KX\Z4U
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M60+5,-?<DA0$YY+S8HHD-OPUUU5;DT"AO48,1P(PCK=JR! #NMSG_)O$Z:/
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MFBP*IDBE+?<U)1VHHO*A0JG8)9,_!#$"U(@@-_5UW;DIF+),RDPTS+H\BJT
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M[>^RJFB/AU;A?X\G*YO'(*E/?SDA(^8;!?CRB*+^@8A;1U@RXMG&@GX0./5
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MQE-R=>MC6^;IGW\+J^YOAK6J]/S^]*3W]69#HSH^HZ.EZ%#Y@$*<AD1W]4[
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M-!#_Z K$+[;;#&U)!WT,$G2?Q2&-0%?)V\.XFI"]9980+B@_H1QL4&=A+M.
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MZO A?(Y#\_D:$61Q;)QAAEX<&Q?'1KB" L?&>B-U3.##O>N2TG1\;P8TCDR
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MT5](MD))-*>8,<H?T*%)?K3:')]:WZ9?T&NQ?D'),_J,TV+7OY:RPHL3Y,.
ME],HMF@FHY A!I6R(VT/WS5H:?[?*,C6+W@,L'LL3/!\9/%N8,PWRC3H/=;%
M0.NK)^'R%/]=/<6WE?QR>8KO\%/\.Q3D*)_[$7XMA<"_AO^1S5.]C_--VRC/
M$:K$N4)YF,4'VC2\1_< RJ-R$LKEJ8S_3V66AQ6 AQ4>3N++FXJ>02!C'OAM
MA809_XV%A[O B^B/,J]N?O,;G'U!+TTR1'J6D^&4_!FB>LT[')2-RK(<H7IE
M9[,/=9Y>;2XB7+4]=P25D33:\DGF3/C:V/JQ"-(HR*+\ZR$*"O3+SQ_^]/,O
M7"VURIP2P4+*S#9:2%L.F^G<'4)X-;12CJHX^SL0FXT-&-2;NB;6JHG:GE^#
MOZ8&SGEC1FNM>5&S(F?>\EO:B@W.2J3;,=')BI)Z9JU7A\KU)MWV111NKK5*
M=:P *.64->B)[&ISB5.H(?@%)#;H%YAY[($W*S8P &_P4=98G8X#:GIOPS[W
M--RL\T$&_<XI.;@:?[=+E4Z7.!_DG6^?(?*^MX\1N]]GTZ7;4%2HGC)B@D8;
M'L&,_4%D>@Q0I0_V'B\*;QX/?Y%\?"(L:GTQ03_T@/.MKU0%T/H\'OXN7=G#
M%5'C"[\W!N-\=[/I58H 6I[#PM^8*J(&%]G'^08>T;##!C5YN25,+>;J6E"^
M0C%8]0T8SC$N"AY8/):'0U(=-U 7F W.]I5F#RBA^2G6N#NIBZZ&1W)A$Z8I
M%T>6B$U.F?[!AIR(NU0\$<T7RV9DDPX6E0+%>\%NS&H=+C]/M?F[!'V(M[MB
MM?F:HPLRRA2KIR(@ TMTFUZ_ACMZN7:#LZ[6=V0BKCR/^Y?NXSFQ2_HQG'P&
MLST36D/\*)'\30.M,9G;F9>TIWSC:CU/Q,@'6UQ%>*M&XZM2E-G%I"AWZE05
M=>HD_-@?6Z*J'DN,9",Y-8>QF:W?&T%$<+IK8+'N** CC.CL%R:$O^L7J,Z"
MQQ-FI37Q/?^3B:EA#7E",16:!T\JWCF(2<5\+V.#\B9 KLN_;RAS;'1&,->U
M^WR^"5?V!I=]+S?3X@9@KHN_:RQS+'0^*->5^QOR%JIK%=6D4CA^-AV<N3PT
M,=WC\6Z!+;/5>=#=D\#R,SH'(6Z(:D,@OV/LS@+745&WA+=KKL#T:QK%>>7?
MBJ+KUY"0<D/=C.(! ;"8Q_M",]!6$T);+('G <5@=RVP2P#W[DA,T6ARZ:&+
M-]4MAM4X8&Y>98PX(->^O]"K:XXMA,";X>*9"+Y%1T_F_"*-KIK!B 9A$ODO
M:)=C#[C@Y1P9M7Y']-(018WDQQA[1Q7ZH;--BW/'.4CQ^9YD:8-@T"VUS=-[
MJ@658-A)(37[>Y,@U;5MH28VLPZ&)<4A&.86?T<85IMG*@QS:_XFW!9,IR/M
MB5ZC(G^#$0'??^J]/]1Z\:ED;?D^X=R^Q_PX;^#P.AQ7Y'RXVQ1P\CO2TV60
MA#\?%SUV*[I-R9]H';RB_!+O#SA%5<2[J\9&Y$/E-D;[?&N)3THE942]R&@$
M>9S$]-5]]"E(@C1$CSM$"LP=I>JHF#C$6#/Q R@;#$HI9UOWR-N-K[-6&9:4
M 59FQGC9/9EH0S6_7;\>4$H][/?TO_68ET:?4(HV\< 7>SRC8\QM<T:S#=9Z
MT, 6S=4=XD%RU+']S.OW/@F?4O4'8M/L&=$!_"(,LS)(\HLDP2]TI+[!V14N
MGXI-F33A)0RZ@F$%\"ZB7<&[ZCKCS#M=E]*6:[;$A1-UM=.V%.=DB99E;QN<
MO= @1*H^I"XIZARRDAZC'FP06W"653B'VY8PMV9/[FI;L'I*XFUE B721/0B
M? WI/4:50GE;6!I6XWD&PX&&OV6DEZB@UB$2X:LA\AA4/#5M(:GA/2)=H O/
MJ"';:6RV ^T:6E)1E>D.5H'G.P"!EJVS&KT3 $E!^3$ MZ +8UC[9CK#9.(O
MWNZ3("W(PO7ZGV5\X*4)-"L]'/5@I5T;#F48P&.M QHL.1+T1DQ8S0:=^V/=
MN5.TI4>:YMU;O:1KJ="]XNH]V95,O=HLI!!5L7@7.-6RDWVPJJHWV"7;0NR4
M(^^JV V"(0,HY7"M*=\'*CE:3P"^NA:#':Z;&#NN %LZ"D F(^VAC$_J*<P
M>MO &;\:@XUP%VAK_S<TZ@6UC5T-MY;W<^*J[M^@GNU,GP9""J2<%GQ$'$=/
M"<.>>CYGB98/P^)U<'9-KU^#?9P& [^=OIXBNKZ60[KY=;PHBQW.XN*-D\!%
M3M37KD?DD&I7F'H#*Y7KD@G58V2S*7B#,Q1OTTMZ^YB]<;.QR$@:Q?@D\\\;
MHN; (*T$4T:/*9TO^,S\]1%_)$HCZLM&JDC^GS*+\R@.J1FX  %2L\B4*FJG
M8:.G*QQ!2KY3K%)GM6T_&0]P#%69E&7>$;/S-PV#>I' M:,RR8Z0+]^0CN6A
M6Y)]SI?L,T[%R3YYWUBRS^XWYY)]2D3O]IQ^LL]N0;<N39?TK=;2MWKX9&I)
MWVHRF<*2MTKGSV'J5@\C]_$TO!,DGP/12HXS[D8EGA-<*/,J4ATY24@EXH\Z
M=()Z.![#'S^@"*$]Q=H7G%:IQG!"^&UO4S*%H+RH'8__6<9Y7+G=K38".I7C
MVG0UBKS@IJC1J=$&Y$DWN=W50YG4&V\*^=Q:-XT9+*LW ,T[&JIKG)9$U<:[
M@1CAE+]TZ'TG"HHS%?OAF&:)O?.=;F*+ZO4P^\+XN^RHGLRTKLU1?EEFV= 3
M44EW2A(NHG,>I% =]= FX>IO8-Z!NT7U_JIRZR'_>$ ABI_I1,4'DV%ID7N,
MJK3SP!MG#[/E!;@NSQ^1?$TS%.)M&O^K&KG9B]NC^O<H#9+*726-V *IZ;(]
MU%K@U+38*$[.H]F>G?20/:K>$6]=G$9YK>8J;77W9M4#1;>:@PK5,@[^HAEL
M%TLHEM4W(B2O"^CEV81&Q/Z:$K5:OP&.D63%)$=*_&+.@]/0 L;;)44E4T3,
MG=GJPV-5@=GU?&IY-8AL;>.)H!=7 3K'VB;7ZWRV_D8S SKO0AT?M?QW)4R]
MBW'6=MN--T1>E(8H_X2*%X32&T2T"1*Z-ZK]AZCC>Y"^/5X3RK"(GU'SZ09G
M#R@O$^H0SSM*6CR"SZXIV<WB-(R3N&H!P;'?1=$T,740*XE(;Z?RI%E%MK')
MNV]-.[R]&9<F,*796&9'D/=RM]*U1L=]LC5BPOJ'JK2\!XA+>XIQH#ELH%A<
ME>>OL@3Z7J&HK-QZ@<@<TLNQV*;W%'U"E6W@K<W<^_>] AV_8+JRI&J2!2__
M.,V@I!QW_)*>(A!@!AM8Y%?C^86&8%D"<V& >2)XA"NI>J8[VB[+*<)@G1$O
MQWUJ9YG:[2AZ>R"+')N&LL+1=<S:-YL6OJU4[_E% \0&P(V.#58:Z/=W"V31
M4-;QKMP<^9K\#Z*\<*=D5E@#S#[MH489PSI@.;LKG6R";NVN( H#MEICV6@
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MI4-<!,EDEC463:US?30^V* A)8$-4Y^NY[E;9L+?W19IE!RJ''4UW<M7<PD
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M:&,Q,# R,#@U,U]E>#(S+3$N:'1M4$L! A0#%     @ 58)A4B!PSOHH"0
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M,2YH=&U02P$"% ,4    " !5@F%2F5KV9W1?   AH0  "@
M@ $RR@, :6UA9V4P+FIP9U!+ 0(4 Q0    ( %6"85*A14?P^S   ,&D   .
M              "  <XI! !I;6%G93 P,# R+FIP9U!+ 0(4 Q0    ( %6"
M85*)]L.ZO1P  /)( 0 1              "  ?5:! !U<W!H+3(P,C Q,C,Q
M+GAS9%!+ 0(4 Q0    ( %6"85+4[!J)0AD  $UQ 0 5              "
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8;6Q02P4&      \ #P#C P  %H8&

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
